PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Shahbeyk, S; Kamalan, A; Osanlou, M				Shahbeyk, S; Kamalan, A; Osanlou, M			A comparative study on vehicle aluminum and steel hood assemblies	INTERNATIONAL JOURNAL OF CRASHWORTHINESS			English	Article								A vehicle hood experiences several loading conditions during its lifetime. It may vary from the application of moderate torsion and bending moments during hood opening and closing to a severe dynamic crumpling in vehicle frontal crash. Hence, hood assembly should be capable to fulfill various structural requirements. The present study alms at comparing two alternative designs (steel and aluminum) from static strength, pedestrian protection, and crashworthy points of view. Torsion and bending strengths, head injury criterion (HIC) values, energy absorption capacities, and hinge forces are the main results which the comparison is made on. In spite of a forty percent reduction in hood assembly weight, the aluminum hood shows an acceptable level of behavior in most cases.	IKCo Res & Dev Ctr, CAE Dept, Crash & Safety Div, Tehran, Iran; IKCo Res & Dev Ctr, Strength & Durabil Div, Tehran, Iran		Shahbeyk, S (corresponding author), IKCo Res & Dev Ctr, CAE Dept, Crash & Safety Div, Iran Khodro,Karaj Special Rd, Tehran, Iran.						Bosma F, 2001, 17 INT TECHN C ENH S; DEFRANK WJ, 1998, 982307 SAE; Fredriksson R, 2001, 17 INT TECHN C ENH S; HEIM R, 2001, 17 INT TECHN C ENH S; HODGINS B, 2001, 2001010757 SAE; Holding PN, 2001, 17 INT TECHN C ENH S, P330; KALLISKE I, 2001, 17 INT TECHN C ENH S; MARINE M, 2002, 2002010556 SAE; Mizuno K, 2000, 2000010157 SAE; SHAH B, 2000, INT C VEH SAF 2002 L; WESTWOOD SJ, 2000, INT C VEH SAF 2002 L; 1998, 17 EEVCCEVE	12	3	3	0	5	WOODHEAD PUBL LIMITED	LETCHWORTH	BLACKHORSE RD, LETCHWORTH SG6 1HN, HERTS, ENGLAND	1358-8265			INT J CRASHWORTHINES	Int. J. Crashworthiness		2003	8	4					367	374		10.1533/ijcr.2003.0244			8	Engineering, Manufacturing; Engineering, Mechanical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	704PM	WOS:000184348700005					2022-02-06	
J	Stengler-Wenzke, K; Muller, U; Matthes-von-Cramon, G				Stengler-Wenzke, K; Muller, U; Matthes-von-Cramon, G			Compulsive-obsessive disorder after severe head trauma: Diagnosis and treatment	PSYCHIATRISCHE PRAXIS			German	Article							COGNITIVE FUNCTION	An 18-year-old man suffered a severe head trauma from a car accident. Eight months later the patient had a good general state of,health. But at this time he was referred to our psychiatric hospital and he reported increased checking compulsions and aggressive obsessions. In addition there was increased impulsivity. The patient was treated with an selective-serotonin-reuptake-inhibitor (SSRI) and showed a clinical response. Obsessive-compulsive disorder (OCD) has rarely been described after traumatic brain injury. Clinical symptoms, neuropsychological dysfunctions, brain imaging and therapy are illustrated. The represented connections of the frontal brain lesions and OCD-symptoms with interventions in the serotonin system support the neurobiological hypotheses of the obsessive-compulsive disorder.	Univ Leipzig, Klin & Poliklin Psychiat, D-04317 Leipzig, Germany; Univ Leipzig, Tagesklin Kognit Neurol, Leipzig, Germany		Stengler-Wenzke, K (corresponding author), Univ Leipzig, Klin & Poliklin Psychiat, Johannisallee 20, D-04317 Leipzig, Germany.						Baxter LR, 2001, FRONTAL-SUBCORTICAL CIRCUITS IN PSYCHIATRIC AND NEUROLOGICAL DISORDERS, P207; Bergqvist PBF, 1999, BIOL PSYCHIAT, V45, P164, DOI 10.1016/S0006-3223(98)00154-1; Berthier ML, 1996, NEUROLOGY, V47, P353, DOI 10.1212/WNL.47.2.353; Berthier ML, 2001, NEUROPSY NEUROPSY BE, V14, P23; Berthier ML, 2000, REV NEUROLOGIA, V30, P769, DOI 10.33588/rn.3008.99647; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Fujii DEM, 1996, NEUROPSY NEUROPSY BE, V9, P133; GRIFFITHS C, 1994, BRIT J GEN PRACT, V44, P201; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; Saxena S, 2001, Semin Clin Neuropsychiatry, V6, P82, DOI 10.1053/scnp.2001.21833; Zald DH, 1996, J NEUROPSYCH CLIN N, V8, P249	11	3	3	0	3	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0303-4259	1439-0876		PSYCHIAT PRAX	Psychiatr. Prax.	JAN	2003	30	1					37	39		10.1055/s-2003-36625			3	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	640ZA	WOS:000180717900010	12524581				2022-02-06	
J	Lukacova, N; Pavel, J; Jalc, P; Cizkova, D; Marsala, M; Silvasiova, M; Lukac, I; Marsala, J				Lukacova, N; Pavel, J; Jalc, P; Cizkova, D; Marsala, M; Silvasiova, M; Lukac, I; Marsala, J			The effect of spinal cord constriction on NOS-cGMP signaling pathway in the white matter of rabbit	BIOLOGIA			English	Article						NO-cGMP signaling pathway; rabbit; spinal cord constriction; white matter	NITRIC-OXIDE SYNTHASE; DINUCLEOTIDE PHOSPHATE-DIAPHORASE; CENTRAL-NERVOUS-SYSTEM; CYCLIC-GMP; MYELINATED AXONS; SENSORY NEURONS; INJURY; RAT; ISCHEMIA; BRAIN	In order to clarify whether the midthoracic spinal cord constriction affects nitric oxide synthase (NOS) activity equally with the cyclic 3',5'-guanosine monophosphate (cGMP) formation, both compounds known to form NO-cGMP signaling pathway were identified in the dorsal, lateral and ventral white matter columns and in non-compartmentalized white matter. The extent of white matter damage was determined in segments Th5-Th6 located rostrally and in segments Th8-Th9 located caudally to the epicenter of the spinal cord injury. The results have shown that traumatic injury, produced at Th7 segment level affected both compounds of NO-cGMP signaling pathway in similar manner. While significant decrease of NOS activity and cGMP level was detected in the ventral columns in segments located rostrally to the constriction site, no such reduction of both compounds forming NO-cGMP signaling pathway was seen in Th8-Th9 segments. Similar, diametrally opposed effect of Th7 segment constriction was found in lateral columns, where a significant increase of NOS activity and cGMP level was detected in Th8-Th9 segments. No significant decrease in NOS activity and cGMP level in response to spinal cord constriction was found in Th5-Th6 segments.	Slovak Acad Sci, Inst Neurobiol, SK-04001 Kosice, Slovakia; Univ Calif San Diego, Anesthesiol Res Lab, La Jolla, CA 92093 USA; Safarik Univ, Fac Med, Dept Neurosurg, SK-04011 Kosice, Slovakia		Lukacova, N (corresponding author), Slovak Acad Sci, Inst Neurobiol, Soltesovej 4, SK-04001 Kosice, Slovakia.	lukacova@saske.sk	Pavel, Jaroslav/F-9877-2018; Lukacova, Nadezda/F-5090-2018; Cizkova, Dasa/AAF-8976-2019	Pavel, Jaroslav/0000-0002-3898-9286; Lukacova, Nadezda/0000-0002-8834-6852; cizkova, dasa/0000-0002-2504-3993			Agrawal SK, 1997, J NEUROSCI, V17, P1055; BARILARI MG, 1969, BRAIN RES, V14, P321; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; BLIGHT AR, 1986, NEUROSCIENCE, V19, P321, DOI 10.1016/0306-4522(86)90025-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Christopherson KS, 1997, J CLIN INVEST, V100, P2424, DOI 10.1172/JCI119783; DEVENTE J, 1990, GLIA, V3, P43, DOI 10.1002/glia.440030107; Fedele E, 1996, BRIT J PHARMACOL, V119, P590, DOI 10.1111/j.1476-5381.1996.tb15713.x; Garthwaite G, 1999, EUR J NEUROSCI, V11, P4367, DOI 10.1046/j.1460-9568.1999.00874.x; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; GARTHWAITE J, 1978, NATURE, V275, P328, DOI 10.1038/275328a0; GARTHWAITE J, 1982, NEUROSCIENCE, V7, P2491, DOI 10.1016/0306-4522(82)90209-3; HALAT G, 1987, GEN PHYSIOL BIOPHYS, V6, P387; HORROCKS LA, 1984, CEREBRAL ISCHEMIA, V654, P211; Kucharova K, 2001, BIOLOGIA, V56, P321; LEE JH, 1993, BRAIN RES, V608, P324, DOI 10.1016/0006-8993(93)91474-7; Lehotsky J, 1999, NEUROCHEM INT, V35, P221, DOI 10.1016/S0197-0186(99)00062-5; Lukacova N, 2001, NEUROCHEM INT, V39, P275, DOI 10.1016/S0197-0186(01)00036-5; Lukacova N, 2000, NEUROCHEM RES, V25, P1139, DOI 10.1023/A:1007682315257; Lukacova N, 1999, NEUROSCIENCE, V94, P229, DOI 10.1016/S0306-4522(99)00233-X; LUKACOVA N, 2000, PHYSIOL RES, V49, P871; LUO DS, 1994, J NEUROSCI, V14, P263; Luo Z D, 2000, Curr Rev Pain, V4, P459; Luo ZD, 1999, J NEUROSCI, V19, P9201; Marsala J, 2001, BIOLOGIA, V56, P685; Marsala J, 1998, NEUROSCIENCE, V85, P847, DOI 10.1016/S0306-4522(97)00690-8; Marsala J, 1999, J COMP NEUROL, V406, P263, DOI 10.1002/(SICI)1096-9861(19990405)406:2<263::AID-CNE9>3.0.CO;2-4; McAdoo DJ, 1997, J NEUROTRAUM, V14, P507, DOI 10.1089/neu.1997.14.507; Miyazaki M, 1996, J CHEM NEUROANAT, V10, P203, DOI 10.1016/0891-0618(96)00136-6; Morton DB, 1998, J NEUROCHEM, V71, P440; NAKANO S, 1990, J NEUROCHEM, V54, P1911, DOI 10.1111/j.1471-4159.1990.tb04890.x; NOBLE LJ, 1985, EXP NEUROL, V88, P135, DOI 10.1016/0014-4886(85)90119-0; NOVELLI A, 1987, DEV BRAIN RES, V34, P307, DOI 10.1016/0165-3806(87)90219-7; Pavel J, 2001, Bratisl Lek Listy, V102, P273; RANSOM BR, 1993, RES P ARNMD, V71, P121; Rosenberg LJ, 1999, J NEUROSCI, V19, P6122, DOI 10.1523/JNEUROSCI.19-14-06122.1999; Sherrington CS, 1903, J PHYSIOL-LONDON, V29, P58; STEINER AL, 1972, J BIOL CHEM, V247, P1121; Strosznajder J, 1996, ACTA NEUROBIOL EXP, V56, P71; Stys PK, 1996, ANN NY ACAD SCI, V779, P366, DOI 10.1111/j.1749-6632.1996.tb44808.x; STYS PK, 1991, ANN NEUROL, V30, P375, DOI 10.1002/ana.410300309; Toborek M, 2000, EXP NEUROL, V161, P609, DOI 10.1006/exnr.1999.7308; VALLEBUONA F, 1993, NEUROSCIENCE, V57, P577, DOI 10.1016/0306-4522(93)90007-3	44	3	3	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0006-3088	1336-9563		BIOLOGIA	Biologia	DEC	2002	57	6					789	795					7	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	641CK	WOS:000180726700020					2022-02-06	
J	Golding, EM; Bryan, RM; Golding, RM				Golding, EM; Bryan, RM; Golding, RM			The effect of surgery and severe injury on blood vessels	PHYSIOLOGICAL MEASUREMENT			English	Article						middle cerebral artery (MCA); model; myogenic response; myogenic tone; tension	MYOGENIC TONE; DIAMETER; ARTERIES	This paper evolves from our previous work that developed a blood vessel model based on the way in which the total tension within the blood vessel wall varies with pressure due to the interaction of specific ions. We use the previous outcomes to examine the diameter of rat middle cerebral arteries (MCAs) as a function of pressure. The MCAs were isolated at 2 h, 1 and 5 days following sham injury and severe traumatic brain injury (TBI). First, we are able to quantify the diameter versus pressure curve in a way that yields three parameters. One of these parameters is the diameter at zero pressure that incorporates properties of the blood vessel walls and the vascular smooth muscle cells. The other two parameters are associated with the myogenic response and the myogenic tone. These parameters enable us to characterize, from the MCAs as a function of pressure in a calcium buffer, each blood vessel into one of three distinct distributions. One of these distributions reflects the optimum conditions. From our data with our blood vessel model, we demonstrate the effect of sham injury on the way in which blood vessels respond to pressure change that appears to recover over time with a half-life of about 40 It. In contrast, severe TBI greatly affects the blood vessel with no indication of recovery over the five-day monitoring period.	Baylor Coll Med, Dept Anesthesiol, Houston, TX 77030 USA; Townsville Gen Hosp, Natl Unit Multidisciplinary Studies Spinal Pain, Townsville, Qld 4810, Australia		Golding, EM (corresponding author), Baylor Coll Med, Dept Anesthesiol, Houston, TX 77030 USA.	egolding@bcm.tmc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS027616] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS27616] Funding Source: Medline		DAVIS MJ, 1993, AM J PHYSIOL, V264, pH2168, DOI 10.1152/ajpheart.1993.264.6.H2168; Golding EM, 2001, PHYSIOL MEAS, V22, P727, DOI 10.1088/0967-3334/22/4/307; Golding EM, 1998, J NEUROTRAUM, V15, P973, DOI 10.1089/neu.1998.15.973; JOHANSSON B, 1989, J HYPERTENS, V7, pS5; Knot HJ, 1998, J PHYSIOL-LONDON, V508, P199, DOI 10.1111/j.1469-7793.1998.199br.x; KOCH AR, 1964, CIRC RES, V15, P269; ThorinTrescases N, 1997, STROKE, V28, P2486, DOI 10.1161/01.STR.28.12.2486	7	3	3	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0967-3334	1361-6579		PHYSIOL MEAS	Physiol. Meas.	NOV	2002	23	4					615	628	PII S09673334(02)37341-6	10.1088/0967-3334/23/4/302			14	Biophysics; Engineering, Biomedical; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering; Physiology	618MN	WOS:000179422000003	12450263				2022-02-06	
J	Sancho-Rieger, J; Parra-Martinez, J				Sancho-Rieger, J; Parra-Martinez, J			Preventive and therapeutic attitude in post-traumatic epileptic seizures	REVISTA DE NEUROLOGIA			Spanish	Article; Proceedings Paper	6th Refresher Course on Epilepsy	FEB 21-22, 2002	SANTANDER, SPAIN			brain injury; epilepsy; post-traumatic epilepsy; post-traumatic epileptic seizures; preventive treatment; symptomatic seizures	SEVERE BRAIN INJURIES; POSTTRAUMATIC EPILEPSY; HEAD-INJURY; PROPHYLAXIS; PHENYTOIN; POPULATION; VALPROATE; TRIAL; RISK	Introduction and development. Due to the vast number of different circumstances surrounding them, the frequency with which post-traumatic epileptic seizures occur varies greatly from study to study. Immediate and early epileptic seizures, within a week of the traumatism having taken place, are usually of little importance as regards the risk of post-traumatic seizures. The most important factors governing the presentation of post-traumatic seizures have to do with the seriousness of the injury, the extension of the brain tissue that is affected and the penetrating nature of the brain traumatism. Conclusion. Although antiepileptic medication significantly reduces the risk of early seizures from occurring, a review of well-designed clinical trials has found no evidence that these drugs reduce the morbidity and mortality associated with head injuries, or the appearance of late seizures.	Hosp Gen Univ Valencia, Serv Neurol, E-46014 Valencia, Spain								Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Beenen LFM, 1999, J NEUROL NEUROSUR PS, V67, P474, DOI 10.1136/jnnp.67.4.474; CASAS C, 2001, PROTOCOLOS AEP, V17, P159; DELAPENA P, 2000, REV NEUROL CLIN, V1, P246; GLOTZNER FL, 1983, NEUROCHIRURGIA, V26, P66; Haltiner AM, 1999, J NEUROSURG, V91, P588, DOI 10.3171/jns.1999.91.4.0588; JENNET B, 1995, EPILEPSIA, V16, P251; JENNET B, 1995, EPILEPSY, P320; MCQUEEN JK, 1983, J NEUROL NEUROSUR PS, V46, P899, DOI 10.1136/jnnp.46.10.899; PAGNI CA, 1990, ACT NEUR S, V50, P38; PECHADRE JC, 1991, PRESSE MED, V20, P841; PohlmannEden B, 1997, ACTA NEUROL SCAND, V95, P257, DOI 10.1111/j.1600-0404.1997.tb00206.x; SALAZAR AM, 1998, EPILEPSIA S2, V39, pS29; SCHIERHOUT G, 2000, COCHRANE LIB; TEMKIN N, 1989, J NEUROSURG, V70, P314; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; TREIMAN DM, 1993, EPILEPSIA, V34, pS17, DOI 10.1111/j.1528-1157.1993.tb05919.x; WALKER AE, 1970, EPILEPSIA, V11, P17, DOI 10.1111/j.1528-1157.1970.tb03861.x; WILMORE LJ, 1992, NEUROL CLIN, V4, P869; YOUG B, 1983, J NEUROSURG, V58, P231; YOUNG B, 1979, EPILEPSIA, V20, P671, DOI 10.1111/j.1528-1157.1979.tb04851.x; 1998, ARCH PHYS MED REHABI, V79, P597	25	3	4	0	2	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010			REV NEUROLOGIA	Rev. Neurologia	SEP	2002	35			1			S39	S42					4	Clinical Neurology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	605WG	WOS:000178699600005	12373653				2022-02-06	
J	McDonald, C; Carter, BS				McDonald, C; Carter, BS			Medical management of increased intracranial pressure after spontaneous intracerebral hemorrhage	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article							HEAD-INJURED PATIENTS; TRAUMATIC BRAIN INJURY; HYPERTONIC SALINE; MILD HYPOTHERMIA; CEREBRAL EDEMA; HYPERTENSION; MANNITOL; HYDROCEPHALUS	The clinician is frequently faced with the patient who has suffered a spontaneous intracerebral hemorrhage. This article discusses the role of differing modes of intracranial pressure (ICP) management. ICP management can serve as either a primary therapeutic modality or an adjunct to other surgical efforts to control ICP (eg, direct hematoma evacuation). At the heart of all these management strategies is the notion that sustained increased ICP leads to further permanent neurologic injury. Because increased ICP is correlated with an increased volume of intracranial contents, all ICP therapies attempt to reduce the volume occupied by the intracranial contents while preserving maximum tissue perfusion and oxygenation.	Harvard Univ, Sch Med, Dept Neurol, S Shore Hosp, Weymouth, MA 02190 USA; Harvard Univ, Sch Med, Cerebrovasc Surg Serv, Massachusetts Gen Hosp, Boston, MA 02114 USA		McDonald, C (corresponding author), Harvard Univ, Sch Med, Dept Neurol, S Shore Hosp, Weymouth, MA 02190 USA.		Carter, Bob/AAB-4868-2021	Carter, Bob/0000-0002-3586-1324			Broderick JP, 1999, STROKE, V30, P905, DOI 10.1161/01.STR.30.4.905; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Chambers IR, 2001, BRIT J NEUROSURG, V15, P140; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; De Vivo P, 2001, Minerva Anestesiol, V67, P603; Diringer MN, 1998, STROKE, V29, P1352, DOI 10.1161/01.STR.29.7.1352; FELDMAN Z, 1992, J NEUROSURG, V76, P207, DOI 10.3171/jns.1992.76.2.0207; FRESHMAN SP, 1993, J TRAUMA, V35, P344, DOI 10.1097/00005373-199309000-00003; Hartl R, 1997, ACT NEUR S, V70, P126; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kidwell CS, 2001, NEUROLOGY, V57, P1611, DOI 10.1212/WNL.57.9.1611; Mirski MA, 2000, J NEUROSURG ANESTH, V12, P334, DOI 10.1097/00008506-200010000-00006; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Phan TG, 2000, STROKE, V31, P2157, DOI 10.1161/01.STR.31.9.2157; Qureshi AI, 1999, NEUROSURGERY, V44, P1055, DOI 10.1097/00006123-199905000-00064; Qureshi AI, 2002, J NEUROSURG ANESTH, V14, P22, DOI 10.1097/00008506-200201000-00005; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Schatzmann C, 1998, ACT NEUR S, V71, P31; Schwab S, 2001, STROKE, V32, P2033, DOI 10.1161/hs0901.095394; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038	27	3	3	0	2	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	1042-3680			NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	JUL	2002	13	3					335	+	PII S1042-3680(02)00016-5	10.1016/S1042-3680(02)00016-5			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	605BD	WOS:000178654800007	12486922				2022-02-06	
J	Walker, JP				Walker, JP			Functional outcome: a case for mild traumatic brain injury	BRAIN INJURY			English	Article							ATTENTION	The purpose of this case study was to demonstrate the successful incorporation of the strengths of process-specific and functional treatment approaches within a therapy programme for a patient with a MTBI. A patient with MTBI and deficits in attention, executive functioning, memory, reasoning and problem solving participated in a 4-month treatment programme. The interactions between the patient's cognitive deficits and problematic activities of daily living were identified. Treatment focused on teaching the patient compensatory strategies to offset the cognitive deficits following a cognitive framework within the context of hierarchically arranged activities of daily living. At the end of this programme, the patient consistently used his compensatory strategies to independently complete activities of daily living that were problematic prior to the receipt of treatment. Implications of this study for the treatment of patients with MTBI suggest that a combined approach is most beneficial in maximizing the recovery of these patients.	Univ Maine, Dept Commun Sci & Disorders, Orono, ME 04469 USA		Walker, JP (corresponding author), Univ Maine, Dept Commun Sci & Disorders, 339 Dunn Hall, Orono, ME 04469 USA.						BARKLEY RA, 1989, ASSESSMENT ISSUES CH, P145; BARTH JT, 1983, NEUROSURGERY, V13, P853; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; Hartley L. L, 1995, COGNITIVE COMMUNICAT; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2d; MAPOU RL, 1992, HDB HEAD TRAUMA ACUT, P75; MAPOU RL, 1988, COGNITIVE APPROACHES, P101; MIRSKY AF, 1987, ENVIRON HEALTH PERSP, V74, P191, DOI 10.2307/3430449; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Ross J. D., 1976, ROSS TEST HIGHER COG; Rutherford W. H., 1989, MILD HEAD INJURY, P217; SCHAPIRO SR, 1993, MINOR HEAD TRAUMA AS, P86; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Wechsler D., 1981, WAIS R MANUAL	16	3	3	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUL	2002	16	7					611	625		10.1080/02699050110119790			15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	569RN	WOS:000176616100005	12119079				2022-02-06	
J	Bose, B				Bose, B			Emergency decompressive craniectomy for traumatic malignant intracranial hypertension	NEUROSURGERY QUARTERLY			English	Article						head injury; decompressive craniectomy; increased intracranial pressure.	SEVERE HEAD-INJURY; ACUTE SUBDURAL-HEMATOMA; COMA DATA-BANK; CEREBRAL EDEMA; BRAIN INJURY; MODERATE HYPOTHERMIA; MANAGEMENT; AGE	Decompressive craniectomy surgery to relieve intracranial hypertension is a controversial treatment. The outcome of treatment is related to factors such as the timing of surgery, patient age, Glasgow Coma Scale score, level of intracranial pressure (ICP), and appearance of the basal cisterns on computed tomography scan evaluation. This report reviews the results of decompressive craniectomy surgery, factors related to outcome, and indications for surgery. The ability to control ICP is the main factor for determining if a decompressive craniectomy is needed. If ICP cannot be maintained below 50 mmHg by conservative measures, aggressive treatment with a decompressive craniectomy is recommended.	Jefferson Med Coll, Dept Neurosurg, Christiana Care Hlth Syst, Newark, DE USA; Jefferson Med Coll, Dept Neurosurg, Philadelphia, PA USA			RANA1@msn.com					Brain Trauma Foundation The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P527; Browder Jefferson, 1943, BULL NEW YORK ACAD MED, V19, P168; Chesnut R M, 1991, Neurosurg Clin N Am, V2, P267; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Cooper P R, 1976, Surg Neurol, V5, P25; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; GAAB MR, 1990, ACT NEUR S, V51, P326; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; GOWER DJ, 1988, NEUROSURGERY, V23, P417, DOI 10.1227/00006123-198810000-00002; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Gurdjian E S, 1964, Clin Neurosurg, V12, P56; Hatashita Shizuo, 1993, Neurologia Medico-Chirurgica, V33, P13, DOI 10.2176/nmc.33.13; HOROWITZ NH, 1967, POSTOPERATIVE COMPLI; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; KUNZE E, 1987, ACTA NEUROCHIR S, V1, pS16; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Marion DW, 2000, CRIT CARE MED, V28, P16, DOI 10.1097/00003246-200001000-00003; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MCLAURIN RL, 1961, J NEUROSURG, V18, P61, DOI 10.3171/jns.1961.18.1.0061; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; POMERANZ S, 1993, J NEUROSURG, V79, P241, DOI 10.3171/jns.1993.79.2.0241; RANSOHOFF J, 1971, J NEUROSURG, V34, P70, DOI 10.3171/jns.1971.34.1.0070; SIESJO BK, 1989, ANN NY ACAD SCI, V568, P234; SIESJPO B K, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P165; STUART FP, 1970, ANN SURG, V172, P190, DOI 10.1097/00000658-197008000-00004; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; VENES JL, 1975, J NEUROSURG, V42, P429, DOI 10.3171/jns.1975.42.4.0429; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212	33	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-6438	1534-4916		NEUROSURG QUART	Neurosurg. Q.	JUN	2002	12	2					171	181		10.1097/00013414-200206000-00009			11	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	555KW	WOS:000175794100009					2022-02-06	
J	Gauggel, S; Lammler, G; Borchelt, M; Steinhagen-Thiessen, E; Bocker, M; Heinemann, A				Gauggel, S; Lammler, G; Borchelt, M; Steinhagen-Thiessen, E; Bocker, M; Heinemann, A			Patient-staff agreement in the Barthel Index: a rasch analysis of the data of elderly stroke patients	ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE			German	Article						Barthel Index; staff-patient ratings; rasch analyse; awareness; activity restrictions	TRAUMATIC BRAIN-INJURY; BEHAVIORAL LIMITATIONS; IMPAIRED AWARENESS; HEALTH-STATUS; TIMED TEST; ADL INDEX; COMPETENCE; DISABILITY; PEOPLE; SCALE	The relationship between staff and patient ratings of activity restrictions (Barthel Index, BI) was investigated in 120 elderly stroke patients (on average 78 years old) using the Rasch model and the rating scale analysis. In addition, the relationship between the rated activity restrictions and measures from the Geriatric Assessment was analyzed. We found good patient-staff agreement (r=0.90) with the poorest agreement in the item "bathing" of the BI. There was also a highly significant correlation between staff and patient ratings and the Tinetti Gait and Balance Scales (r = 0.72 and r = 0.76, respectively). Correlations between other measures of the Geriatric Assessment and the rated activity restrictions were low explaining less than 8% of variance. Our Findings merit the use of patient ratings of activity restrictions in stroke outcome research. However, self-ratings of activity restrictions were measured by an unstructured interview and it cannot be ruled out that this method had an influence on the correlation between self-rating and staff rating.	TU Chemnitz, Inst Psychol, D-09120 Chemnitz, Germany; Humboldt Univ, Ev Geriatriezentrum Berlin gGmbH, Forschungsgruppe Geriat, Charite Med Fak, D-13347 Berlin, Germany; Rehabil Inst Chicago, Chicago, IL 60611 USA		Gauggel, S (corresponding author), TU Chemnitz, Inst Psychol, Wilhelm Raabe Str 43, D-09120 Chemnitz, Germany.	siegfried.gauggel@phil.tu-chemnitz.de	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326; Gauggel, Siegfried/0000-0002-2742-4917			Baker KA, 1998, REHABIL PSYCHOL, V43, P30, DOI 10.1037/0090-5550.43.1.30; Collin C, 1988, Int Disabil Stud, V10, P61; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; Dittmar S., 1997, FUNCTIONAL ASSESSMEN; Embretson S.E., 2013, ITEM RESPONSE THEORY; Gatterer G, 1990, ALTERS KONZENTRATION; Gauggel S, 2000, J HEAD TRAUMA REHAB, V15, P710, DOI 10.1097/00001199-200002000-00009; Harlacher R, 1999, Z GERONTOL GERIATR, V32, P200, DOI 10.1007/s003910050105; KAPLAN CP, 1994, ARCH PHYS MED REHAB, V75, P643, DOI 10.1016/0003-9993(94)90186-4; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; LINACRE JM, 1999, WIN STEPS PC COMPATI; Loewenstein DA, 2001, J GERONTOL B-PSYCHOL, V56, pP78, DOI 10.1093/geronb/56.2.P78; MAHONEY F I, 1965, Md State Med J, V14, P61; MASUR H, 2000, SKALEN SCORES NEUROL; McHorney CA, 2000, MED CARE, V38, P43; Nikolaus T, 2001, Z GERONTOL GERIATR, V34, P36; NIKOLAUS T, 1995, AGE AGEING, V24, P257, DOI 10.1093/ageing/24.3.257; NIKOLAUS T, 1995, AGING-CLIN EXP RES, V7, P179, DOI 10.1007/BF03324310; Prigatano George P, 1993, Clin Neuropsychol, V7, P123, DOI 10.1080/13854049308401514; Prigatano GP, 1996, CLIN NEUROPSYCHOL, V10, P191, DOI 10.1080/13854049608406680; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Prosiegel M., 1996, NEUROL REHABIL, V1, P7; RANHOFF AH, 1993, AGE AGEING, V22, P171, DOI 10.1093/ageing/22.3.171; Rose, 1982, CLIN GERONTOLOGIST, V1, P37, DOI [10.1300/J018v01n01_06, DOI 10.1300/J018V01N01_06]; Roth EJ, 1998, ARCH PHYS MED REHAB, V79, P329, DOI 10.1016/S0003-9993(98)90015-6; SEGAL ME, 1994, STROKE, V25, P2391, DOI 10.1161/01.STR.25.12.2391; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Tennant A, 2000, BRIT MED BULL, V56, P287, DOI 10.1258/0007142001903210; TENNANT A, 1996, CLIN REHABIL, V0010, P00301, DOI DOI 10.1177/026921559601000407; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Wade D, 1992, MEASUREMENT NEUROLOG; Wahl HW, 1998, Z GERONTOL GERIATR, V31, P243, DOI 10.1007/s003910050040; WATSON YI, 1993, J AM GERIATR SOC, V41, P1235, DOI 10.1111/j.1532-5415.1993.tb07308.x; Wright B, 1979, BEST TEST DESIGN; WRIGHT BD, 1989, ARCH PHYS MED REHAB, V70, P857; WYLLER TB, 1995, AGE AGEING, V24, P398, DOI 10.1093/ageing/24.5.398; Wyller TB, 1996, DISABIL REHABIL, V18, P454, DOI 10.3109/09638289609165909; Zimprich D, 2001, Z GERONTOL GERIATR, V34, P232, DOI 10.1007/s003910170067	40	3	3	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0948-6704	1435-1269		Z GERONTOL GERIATR	Z. Gerontol. Geriatr.	APR	2002	35	2					102	110		10.1007/s003910200014			9	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	546CK	WOS:000175254200003	12080573				2022-02-06	
J	Oliveros-Juste, A; Bertol, V; Oliveros-Cid, A				Oliveros-Juste, A; Bertol, V; Oliveros-Cid, A			Preventive-prophylactic treatment in posttraumatic epilepsy	REVISTA DE NEUROLOGIA			Spanish	Article; Proceedings Paper	1st Congress of the Spanish-League-Against-Epilepsy	NOV 14-17, 2001	BILBAO, SPAIN	Spanish League Against Epilepsy		cranio-encephalic traumatism; pathophysiology; posttraumatic epilepsy; prophylaxis; risk factors; traumatic brain injury	TRAUMATIC BRAIN-INJURY; ADD-ON THERAPY; DOUBLE-BLIND; HEAD-INJURY; CLINICAL-TRIAL; EARLY SEIZURES; VITAMIN-E; PHENYTOIN; STROKE; EPILEPTOGENESIS	Posttraumatic epilepsy (PTE) represents about 2-3% of all the etiologies of epilepsy. The so called 'early seizures, which appear in the first week after the traumatic brain injury (TBI), are related to the severity of the injury, they do not have an strictly epileptic mechanism, but they become a risk factor to the development of PTE. PTE appears in 5% of all the patients suffering from all TBI, and in 15-20% of the patients suffering from a severe TBI. However, the endpoint uses to be to use antiepileptic drugs (AEDs) as prophylactic treatment in all well established PTE. The efficacy of 'classic' antiepileptic drugs (Phenobarbital, Phenytoin, Carbamazepine, Valproate acid) to control the 'kindling 'effect has not been confirmed yet as a prophylactic treatment for PTE. Prophylactic efficacy of other drugs, like lipid peroxidation inhibitors, neuroprotectors (especially antioxidants), glutamic receptor blockers, NMDA receptor blockers, and drugs that modulate apoptosis via caspasas inhibition,- however, they constitute new ways of therapeutic investigation with a strong experimental basis. Our recommended therapeutic strategy is not to administrate AEDs indiscriminately, but analyzing risk factors, designing a careful prevention for late seizures using AEDs with proven efficacy in partial seizures and with the best achievable tolerability: being also attentive to the possible use of new drugs in the future, like lipid peroxidation inhibitors, and drugs designed to inhibit other excitotoxic, ionic or oxidative processes.	Hosp Miguel Servet, Serv Neurol, E-50009 Zaragoza, Spain; Policlin Sagasta, Zaragoza, Spain								*AM ASS NEUR SURG, 1996, GUID MAN SEV HEAD IN; Anderson D.K., 1983, NEUROCHEM PATHOL, V1, P249; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; AUST SD, 1982, FREE RADICALS BIOL, P1; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; Chadwick D, 2000, LANCET, V355, P334, DOI 10.1016/S0140-6736(99)00452-3; CHADWICK DV, 1993, TXB EPILEPSY, P165; de la Pena P, 1998, REV NEUROLOGIA, V26, P256, DOI 10.33588/rn.26150.981066; DESAI BT, 1983, EPILEPSIA, V24, P289, DOI 10.1111/j.1528-1157.1983.tb04892.x; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; Ditcher M. A., 1987, SCIENCE, V237, P157; Dudek FE, 1997, J CLIN NEUROPHYSIOL, V14, P90, DOI 10.1097/00004691-199703000-00002; Dugan Ellen M., 1994, Emergency Medicine Clinics of North America, V12, P1081; Faden AI, 2001, ARCH NEUROL-CHICAGO, V58, P1553, DOI 10.1001/archneur.58.10.1553; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FAUGHT E, 1989, NEUROLOGY, V39, P1089, DOI 10.1212/WNL.39.8.1089; Haley EC, 1998, STROKE, V29, P1256; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; Haltiner AM, 1999, J NEUROSURG, V91, P588, DOI 10.3171/jns.1999.91.4.0588; HAUSER WA, 1980, EPILEPSIA, V21, P399, DOI 10.1111/j.1528-1157.1980.tb04088.x; IKEDA Y, 1990, NEUROSURGERY, V27, P1; JABBARI B, 1986, ELECTROEN CLIN NEURO, V64, P285, DOI 10.1016/0013-4694(86)90151-3; JENNET B, 1995, EPILEPSIA, V16, P251; JENNET B, 1995, EPILEPSY, P320; JENNETT B, 1975, EPILEPSY NONMISSILE, P35; KILPATRICK CJ, 1991, EPILEPSIA, V32, P358, DOI 10.1111/j.1528-1157.1991.tb04664.x; King MA, 1998, LANCET, V352, P1007, DOI 10.1016/S0140-6736(98)03543-0; Lafuente JV, 1998, REV NEUROLOGIA, V26, P224, DOI 10.33588/rn.26150.981062; LEE ST, 1992, J NEUROSURG, V76, P435, DOI 10.3171/jns.1992.76.3.0435; Lee ST, 1995, ACTA NEUROCHIR, V137, P151, DOI 10.1007/BF02187187; LEVY SL, 1990, EPILEPSY RES, V6, P12, DOI 10.1016/0920-1211(90)90003-E; MAJKOWSKI J, 1991, COMPREHENSIVE EPILEP, P281; MARKS DA, 1995, NEUROLOGY, V45, P2051, DOI 10.1212/WNL.45.11.2051; MASDEU JC, 1995, J NEUROIMAGING, V5, pS53; OGUNMEKAN AO, 1989, EPILEPSIA, V30, P84, DOI 10.1111/j.1528-1157.1989.tb05287.x; OLLERDAURELLA L, 1994, ETIOLOGIA TRAUMATISM, P272; PAGNI CA, 1990, ACT NEUR S, V50, P38; PRINCE DA, 1984, ANN NEUROL, V16, pS59, DOI 10.1002/ana.410160710; RAJU GB, 1994, EPILEPSIA, V35, P368, DOI 10.1111/j.1528-1157.1994.tb02446.x; SALAZAR A, 1987, ADV EPILEPTOL, V16, P75; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; SALAZAR AM, 1999, EPILEPSIES ETIOLOGIE, P293; SANDER JWAS, 1990, LANCET, V336, P1267, DOI 10.1016/0140-6736(90)92959-L; SCHAUMANN BA, 1994, EPILEPSIA, V35, P48, DOI 10.1111/j.1528-1157.1994.tb02911.x; Schierhout G, 1998, J NEUROL NEUROSUR PS, V64, P108, DOI 10.1136/jnnp.64.1.108; Scott P, 1996, STROKE, V27, P1453; TEASDALE G, 1974, LANCET, V2, P81; Temkin N R, 1991, Neurosurg Clin N Am, V2, P425; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; TREIMAN DM, 1993, EPILEPSIA, V34, pS17, DOI 10.1111/j.1528-1157.1993.tb05919.x; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vidal JA, 1997, REV NEUROLOGIA, V25, P48; WEISS GH, 1983, ARCH NEUROL-CHICAGO, V40, P7, DOI 10.1001/archneur.1983.04050010027006; WILLMORE LJ, 1983, BRAIN RES, V277, P393, DOI 10.1016/0006-8993(83)90954-X; WILLMORE LJ, 1992, NEUROL CLIN, V10, P869, DOI 10.1016/S0733-8619(18)30184-1; WILLMORE LJ, 1990, EPILEPSIA, V31, pS67, DOI 10.1111/j.1528-1157.1990.tb05861.x; WILLMORE LJ, 1984, EXP NEUROL, V83, P62, DOI 10.1016/0014-4886(84)90046-3; WILLMORE LJ, 1993, NEUROL CLIN, V11, P823, DOI 10.1016/S0733-8619(18)30126-9; WILLMORE LJ, 1986, BRAIN RES, V382, P422; WILLMORE LJ, 1999, EPILEPSIES ETIOLOGIE, P289; Yamaguchi T, 1998, STROKE, V29, P12, DOI 10.1161/01.STR.29.1.12; YOUNG B, 1983, J NEUROSURG, V58, P236, DOI 10.3171/jns.1983.58.2.0236	65	3	4	0	2	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	MAR 1	2002	34	5					448	459		10.33588/rn.3405.2001439			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	557BH	WOS:000175887100006	12040514				2022-02-06	
J	Birnboim, S; Breznitz, Z; Pratt, H; Aharon, Y				Birnboim, S; Breznitz, Z; Pratt, H; Aharon, Y			Automatic and controlled verbal-information processing in patients with frontal lobe lesions	GENETIC SOCIAL AND GENERAL PSYCHOLOGY MONOGRAPHS			English	Article						cognitive neuroscience; evoked potentials; frontal lobes; neuropsychology	CLOSED-HEAD-INJURY; SPREADING ACTIVATION; ATTENTION; SEARCH; MEMORY; PERFORMANCE; POTENTIALS; P300	The selectivity of frontal lobe lesion effects in the domains of verbal-information processing has not been well established. The authors hypothesized that capacity-limited controlled processing would be more impaired than automatic processing in frontal lobe patients (FLPs). Fifteen FLPs were compared with 2 matched control groups: 14 posterior-lesion patients and 15 normal controls. Both behavioral and event-related brain potential (ERP) measures were collected. Results suggest that both automatic and controlled processing were affected by frontal lobe lesions. ERP results indicated that the main difficulty for the FLPs was in the perceptual stage of information processing. This rather unexpected result may be explained by a basic difficulty of FLPs in attending to a new stimulus in order to process it.	Univ Haifa, Fac Educ, Lab Neurocognit Res, IL-31999 Haifa, Israel; Technion Israel Inst Technol, Evoked Potentials Lab, IL-32000 Haifa, Israel; Rambam Med Ctr, Cognit Neurol Unit, Haifa, Israel		Birnboim, S (corresponding author), Univ Haifa, Fac Educ, Lab Neurocognit Res, IL-31999 Haifa, Israel.	smadarb@research.haifa.ac.il					Benson D.F., 1986, FRONTAL LOBES; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; Daffner KR, 2000, BRAIN, V123, P927, DOI 10.1093/brain/123.5.927; Damasio AR, 1996, PREFRONTAL CORTEX EX, P36, DOI [10.1093/acprof:oso/9780198524410.003.0004, DOI 10.1093/ACPROF:OSO/9780198524410.003.0004]; DEACON D, 1991, ELECTROEN CLIN NEURO, V78, P133, DOI 10.1016/0013-4694(91)90113-I; DEACON D, 1991, J CLIN EXP NEUROPSYC, V13, P639, DOI 10.1080/01688639108401079; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; DONCHIN E, 1980, MOTIVATION MOTOR SEN, P697; FISK AD, 1984, J EXP PSYCHOL LEARN, V10, P181, DOI 10.1037/0278-7393.10.2.181; FISK AD, 1983, J EXP PSYCHOL LEARN, V9, P177, DOI 10.1037/0278-7393.9.2.177; GAZZANIGA MS, 1998, COGNITIVE NEUROSCIEN; HOFFMAN JE, 1983, COGNITIVE PSYCHOL, V15, P379, DOI 10.1016/0010-0285(83)90013-0; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; KNIGHT RT, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P139; KNIGHT RT, 1984, ELECTROEN CLIN NEURO, V59, P9, DOI 10.1016/0168-5597(84)90016-9; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2d; MOSCOVITCH M, 1992, J COGNITIVE NEUROSCI, V4, P257, DOI 10.1162/jocn.1992.4.3.257; Moscovitch M., 1994, NEUROPSYCHOLOGY, V8, P524; NAATANEN R, 1986, CEREBRAL PSYCHOPHYSI, P169; NEELY JH, 1977, J EXP PSYCHOL GEN, V106, P226, DOI 10.1037/0096-3445.106.3.226; Norman D., 1986, CONSCIOUSNESS SELF R, P1, DOI DOI 10.1007/978-1-4757-0629-1_1; OLBRICH HM, 1986, ACTA NEUROCHIR, V80, P116, DOI 10.1007/BF01812285; ONOFRJ M, 1991, ACTA NEUROL SCAND, V83, P273, DOI 10.1111/j.1600-0404.1991.tb04700.x; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; Posner MI, 1975, INFORM PROCESSING CO, P55; PRATAPCHAND R, 1988, ACTA NEUROL SCAND, V78, P185, DOI 10.1111/j.1600-0404.1988.tb03643.x; Raven J. C., 1960, GUIDE STANDARD PROGR; RUGG MD, 1993, NEUROPSYCHOLOGIA, V31, P373, DOI 10.1016/0028-3932(93)90161-R; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; SCHNEIDER W, 1982, PERCEPT PSYCHOPHYS, V31, P160, DOI 10.3758/BF03206216; Schneider W., 1984, VARIETIES ATTENTION, P1; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shallice T, 1996, PHILOS T R SOC B, V351, P1405, DOI 10.1098/rstb.1996.0124; SHALLICE T, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P125; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; STRAYER DL, 1990, J EXP PSYCHOL LEARN, V16, P67, DOI 10.1037/0278-7393.16.1.67; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; STUSS DT, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P157; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY	39	3	3	0	4	HELDREF PUBLICATIONS	WASHINGTON	1319 EIGHTEENTH ST NW, WASHINGTON, DC 20036-1802 USA	8756-7547			GENET SOC GEN PSYCH	Genet. Soc. Gen. Psychol. Monogr.	FEB	2002	128	1					29	46					18	Psychology, Developmental; Psychology, Social	Social Science Citation Index (SSCI)	Psychology	549PV	WOS:000175454000002	12017187				2022-02-06	
J	Feinsod, M				Feinsod, M			A flask full of jelly: The first in vitro model of concussive head injury - 1830	NEUROSURGERY			English	Article						contrecoup; head injury; history of medicine; physical models	BRAIN INJURY; IMPACT	IN 1830, THE French Military Surgeon Jean-Pierre Gama reported an experiment planned to unravel the mechanical events caused by head injury. His model was a round glass flask with a long neck filled with a gelatinous substance that resembled the consistency of the brain. Thumping the walls of the flask caused the movement of thin wires embedded in the "brain-like" material, thought to represent the spread of forces within the brain. Gama thought that he could thus observe oscillatory and vibratory movements of the wires representing the effects of concussion without visible structural brain lesions. Although it was crudely constructed, entirely subjective as to evaluation of results, and lacking the essential instrumentation that only modern technology can provide, this hypothesis-driven pioneer experiment should be regarded as the first to use the novel approach of physical modeling of the brain. Even today, this approach has not been fully exploited.	Technion Israel Inst Technol, Ctr Appl Res Head Injuries, Dept Neurosurg,Fac Med, Ramban Maimonides Med Ctr, IL-31096 Haifa, Israel		Feinsod, M (corresponding author), Technion Israel Inst Technol, Ctr Appl Res Head Injuries, Dept Neurosurg,Fac Med, Ramban Maimonides Med Ctr, IL-31096 Haifa, Israel.	mfeinsod@rambam.health.gov.il					ACKERKNECHT HE, 1968, SHORT HIST MED; Alquie A., 1865, GAZ MED PARIS, V20, P226; BAKAY L, 1987, NEUROSURGEONS PAST, P65; Brodie BC, 1828, MEDICO CHIRURGICAL T, V14, P337; BRYANT T, 1888, LANCET, V2, P405; BRYANT T, 1888, LANCET, V2, P507; CHIPAULT A, 1895, ARCH GEN MED       8, V4, P279; CHIPAULT A, 1895, ARCH GEN MED       8, V4, P665; CHIPAULT A, 1895, ARCH GEN MED       8, V4, P394; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; FANO S, 1851, THESIS FM PARIS; Feinsod M, 2001, NEUROSURGERY, V48, P660, DOI 10.1097/00006123-200103000-00043; FERRIER D, 1878, BRAIN, V1, P101; GAMA JP, 1835, TRAITE PLAIES TETE E, P98; Goggio AF, 1941, J NEUROL PSYCHIATRY, V4, P11, DOI 10.1136/jnnp.4.1.11; GROSS AG, 1958, J NEUROSURG, V15, P548, DOI 10.3171/jns.1958.15.5.0548; HEWETT P, 1861, SYSTEM SURG THEORETI, V2, P142; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Hutchinson J., 1867, CLIN LECT REPORTS LO, V4, P10; KING AI, 1995, J NEUROTRAUM, V12, P651, DOI 10.1089/neu.1995.12.651; KOCHER T, 1901, HIRNERSCHUTTERUNG HI, P380; LITTRE A, 1706, HIST ACAD ROYAL SCI, V54, P54; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; MILLER J, 1856, PRACTICE SURG, P14; NUSHOLTZ GS, 1995, AVIAT SPACE ENVIR MD, V66, P661; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; RUAN JS, 1994, J BIOMECH ENG-T ASME, V116, P44, DOI 10.1115/1.2895703; VERNEUIL A, 1876, DICT ENCY SCI MED, P298; VONBERGMANN E, 1880, LEHRE KOPFVERLETZUNG, P138; WARD JW, 1948, SCIENCE, V107, P349, DOI 10.1126/science.107.2779.349; [No title captured]	32	3	3	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	FEB	2002	50	2					386	390					5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	514FE	WOS:000173427300036	11844275				2022-02-06	
J	Pickl, GB				Pickl, GB			Changes during long-term management of locked-in syndrome: A case report	FOLIA PHONIATRICA ET LOGOPAEDICA			English	Article						locked-in syndrome; Pons; Vojta therapy; Bobath therapy; rood approach; acupressure; reflex zones; proprioceptive neuromuscular facilitation; sensory integration; noninvasive computer-aided biofeedback	MIDBRAIN INFARCTS; RECOVERY; STATE	This paper describes various approaches of treatment to a male client suffering from the locked-in syndrome following closed head injury. During the course of therapy, which started more than 5 years after onset and lasted for as much as 11 years, the client progressed from the so-called classical to the incomplete locked-in state. The different approaches as well as the outcomes are presented in detail, followed by a discussion about interdisciplinary issues, duration of treatment and the impact of a patient's personality on the course and goals of the treatment as well as on the mode of communication. Copyright (C) 2002 S. Karger AG, Basel.	Sonderpadagog Zentrum Graz, Graz, Austria; Padagog Akad Diozese Graz Seckau, Graz, Austria		Pickl, GB (corresponding author), Berliner Ring 32-1, A-8047 Graz, Austria.						Al-Wardi D A, 1975, Bull Los Angeles Neurol Soc, V40, P60; Ayres A. J., 1979, SENSORY INTEGRATION; BARRY M, 1996, J CHILDHOOD NEURO S1, V11, P51; BAUER G, 1979, J NEUROL, V221, P77, DOI 10.1007/BF00313105; BAUER G, 1980, J NEUROL, V223, P191, DOI 10.1007/BF00313183; BAUER G, 1971, ARCH NEUROL-CHICAGO, V39, P1140; BAUER H, 1992, Indian Journal of Pediatrics, V59, P37, DOI 10.1007/BF02760897; BOBATH K, 1964, PHYSIOTHERAPY, V50, P3; BRITT RH, 1977, ANN NEUROL, V1, P590, DOI 10.1002/ana.410010614; CAPPA SF, 1982, ANN NEUROL, V11, P545, DOI 10.1002/ana.410110521; CHERINGTON M, 1976, NEUROLOGY, V26, P180, DOI 10.1212/WNL.26.2.180; CHIA LG, 1984, NEUROLOGY, V34, P1365; CHIA LG, 1991, NEUROLOGY, V41, P445, DOI 10.1212/WNL.41.3.445; CRICKMAY MC, 1966, SPEECH THERAPY BOBAT; DEHAENE J, 1976, EUR NEUROL, V14, P81; Duffy JR., 2020, MOTOR SPEECH DISORDE; DUMAS A, 1984, GRAF MONTE CHRISTO; Feldenkrais Moshe, 1977, AWARENESS MOVEMENT H; FELDERHOF BU, 1971, REP MATH PHYS, V2, P1; GOEBEL HH, 1971, ARCH NEUROL-CHICAGO, V24, P431, DOI 10.1001/archneur.1971.00480350065007; GOEBEL M, 1986, COMPUTER AIDED FLUEN; GOEBEL MD, 1986, COMP C P ORL AM SPEE; GSCHWEND J, 1977, FORTSCHR NEUROL PSYC, V45, P552; GUILMETTE TJ, 1997, POCKET GUIDE BRAIN I; HAIG AJ, 1987, ARCH PHYS MED REHAB, V68, P24; HAWKES CH, 1974, NEUROLOGY, V24, P1015, DOI 10.1212/WNL.24.11.1015; IFFT LM, 1991, CAFET FUNCTIONAL ORG; KABAT H, 1962, PERM FDN MED B, P10; KARP JS, 1974, ARCH NEUROL-CHICAGO, V30, P176, DOI 10.1001/archneur.1974.00490320064009; KHURANA RK, 1980, ANN NEUROL, V8, P439, DOI 10.1002/ana.410080418; MARKAND ON, 1976, ELECTROEN CLIN NEURO, V40, P529, DOI 10.1016/0013-4694(76)90083-3; MARQUARDT H, 1981, REFLEXZONENARBEIT FU; MCCUSKER EA, 1982, ARCH NEUROL-CHICAGO, V39, P145, DOI 10.1001/archneur.1982.00510150015004; MCGANN WM, 1991, AM J SPEECH-LANG PAT, V1, P32; MORARIU MA, 1979, MAJOR NEUROLOGICAL S; MURRAY TJ, 1976, NEUROLOGY, V26, P1185; Netsell R., 1986, NEUROBIOLOGIC VIEW S; NORDGREN RE, 1971, NEUROLOGY, V21, P1140, DOI 10.1212/WNL.21.11.1140; PATTERSON JR, 1986, STROKE, V17, P758, DOI 10.1161/01.STR.17.4.758; Plum F, 1966, DIAGNOSIS STUPOR COM; Rood MS, 1976, TREATMENT NEUROMUSCU; ROSENBEK JC, 1984, SEMINARS SPEECH LANG; RUFF FL, 1987, J NEUROL REHABIL, V1, P31; STOCKERT K, 1988, WIEN MED WOCHENSCHR, V148, P434; TENK H, 1983, AKUPUNKTUR PRAKTIKUM; VOJTA V, 1984, CEREBRALEN BEWEGUNGS; WEBER S, 1983, KLIN PADIATR, V195, P347, DOI 10.1055/s-2008-1034395; WELCH MV, 1993, ARCH PHYS MED REHAB, V74, P178; [No title captured]	49	3	3	0	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7762			FOLIA PHONIATR LOGO	Folia Phoniatr. Logop.	JAN-FEB	2002	54	1					26	43		10.1159/000048594			18	Audiology & Speech-Language Pathology; Otorhinolaryngology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Otorhinolaryngology; Rehabilitation	536XX	WOS:000174728100005	11901263				2022-02-06	
J	Brion, S; Plas, J; Mikol, J; Jeanneau, A; Brion, F				Brion, S; Plas, J; Mikol, J; Jeanneau, A; Brion, F			Post traumatic Korsakoff's syndrom: clinical and anatomical report	ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE			French	Article						amnestic syndrome; cingular gyrus; Korsakoff; traumatism	BILATERAL CINGULOTOMY; INJURY; MEMORY	Clinical and anatomical report of a post traumatic amnestic syndrom (Korsakoffs syndrom), associating anterograd amnesia persisting for fifteen years, with temporal disorientation, false recognitions, initially intense transitory confabulation and secondarily bursts of confabulation, intact remote memory and persistence of old learnings. Death after twelve years from mesenteric infarction. Anatomically, post-traumatic sequellae are limited to both cingulate gyri in their anterior part. This cingular involvement is easy to understand if one knows that post-traumatic Korsakoff's syndrom appears after severe cranial traumatisms, with at least three days of coma, and develops constantly, even if transitory, after long duration comas with 20 to 30 days of loss of consciousness. Anatomical explanation depends on the fact that Korsakoff's syndroms from various etiologies need, to be produced, a bilateral damage of the limbic circuit and that severe head traumatisms, when dying early in the evolution without possibility of a neuro-psychological investigation, have always a destruction of corpus callosum or cingulate gyri or both, resulting from crushing of these structures by the edge of the faulx cerebri. Consistent with these constatations, it is logical that a Korsakoffs syndrom develops after severe head traumas with bilateral lesions of the limbic circuit and especially of the cingulate gyri. But anatomical evidence remains rare, because early fatal evolution does not permit psychological evaluation and, reversely, long survivals who may die from another pathology would not have brain examination. We prefer the name of 44 Korsakoffs syndrom, rather than that of 4 amnesic syndrom, to denominate the anterograd amnesia (amnesie des faits recents) encountered in nutritional disorders due to B1 deficiency in true Korsakoffs disease, but also with other etiologies such as cerebral tumours, vascular cerebral disorders, post-comitial anoxia, herpetic encephalopathy, head traumas, all of them developing amnesia for recent events, formerly classified under the title of "korsakowian syndrom" or "mental syndrom of Korsakoff" and more recently under the denomination of "amnesic syndrom". But whatever is the etiology of the memory disorder, the amnesic syndrom remains identical and the advanced small differences, such as euphoria in alcoholics or mood depression in tumours, are often fallacious, so that the only way of differenciation deals with accessory symptoms such as intracranial hypertension in tumours, sudden onset in vascular etiologies or polyneuritis in B 1 deficiency. Post-traumatic Korsakoffs syndrom joins with this scheme, for its clinical aspect is so similar to that of nutritional disorders that it might be difficult to reach the exact diagnosis when an alcohol addict develops, after a head trauma, an amnesia which could be the consequence of the trauma but also of a nutritional disorder developped after the accident with inadequate parenteral treatment. Our case, which is the first well documented observation of this disease reported with long clinical survey and final pathological examination, was presented in 1981 at a joint meeting of the French and Dutch neurological societies. It gives the proof of the importance, in limbic circuit, of the cingulate gyri. A comparison is made with four other clinical cases of post traumatic amnestic syndrom with MNR procedures which show, for two of them, cingular lesions explaining the clinical features, for one of them a bilateral lesion of Ammon's horns and for the last one extra-limbic lesions, with destruction of the inferior part of both frontal lobes, associated with a possible deafferentation of the right cingular cortex.									ANGELERGUES, 1958, 56 C PSYCH NEUR LANG; BENEDEK L, 1940, ARCH PSYCHIAT NERVEN, V112, P503; Benedek L, 1941, SCHWEIZ ARCH NEUROL, V46, P178; BOUDIN G, 1968, REV NEUROL, V119, P341; BRION S, 1985, REV NEUROL, V141, P627; BRION S, 1968, REV NEUROL-FRANCE, V118, P293; CONRAD K, 1951, Dtsch Z Nervenheilkd, V165, P430, DOI 10.1007/BF00216318; CORKIN S, 1979, NEUROPSYCHOLOGIA, V17, P585, DOI 10.1016/0028-3932(79)90034-4; DAVID M, 1968, REV NEUROL-FRANCE, V118, P150; Delay J, 1965, Rev Neurol (Paris), V113, P583; DELAY J, 1958, ENCEPHALE, V57, P475; DELAY J, 1984, REV NEUROL PARIS, V111, P97; DELAY J, 1969, SYNDROME KORSAKOFF, P170; DEMORSIER L, 1929, ENCEPHALE, V24, P19; EVRARD E, 1958, C PSYCH NEUR LANG FR, V56, P214; FAILLACE LA, 1971, DIS NERV SYST, V32, P171; FLAMENT J, 1957, Acta Neurol Psychiatr Belg, V57, P119; GIANNULI F, 1914, RIV SPERIMENT FRENIA, V11, P396; HOREL JA, 1978, BRAIN, V101, P403, DOI 10.1093/brain/101.3.403; JARHO L, 1973, ACTA NEUROL SCAND, V49, P1; KELLY D, 1973, BRIT J PSYCHIAT, V123, P141, DOI 10.1192/bjp.123.2.141; KLEIST K, 1934, GEHIRN PATHOLOGIE, P1318; KORSAKOFF S, 1889, CIMM, P75; LINDQVIST G, 1966, ACTA PSYCHIAT SCAND, V42, P24, DOI 10.1111/j.1600-0447.1966.tb01913.x; MABILLEH PA, 1913, REV MED, V33, P257; MAZARS, COMMUNICATION; MITCHELLHEGGS N, 1976, BRIT J PSYCHIAT, V128, P226, DOI 10.1192/bjp.128.3.226; OMMAYA AK, 1972, CONFIN NEUROL, V34, P398; PATTERSON A, 1944, BRAIN, V67, P54; Plas J, 1999, REV NEUROL, V155, P569; RUBENS AB, 1977, ARCH NEUROL-CHICAGO, V34, P750, DOI 10.1001/archneur.1977.00500240038006; Russell WR, 1935, LANCET, V2, P762; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; SABOURAUD O, 1974, CORTEX, V12, P154; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; VANDERHORST J, 1956, EVOL PSYCHIAT, V51, P189; VILKKI J, 1981, NEUROPSYCHOLOGIA, V19, P553, DOI 10.1016/0028-3932(81)90021-X; WHITTY CWM, 1960, BRAIN, V83, P648, DOI 10.1093/brain/83.4.648; WHITTY CWM, 1955, P ROY SOC MED, V48, P463, DOI 10.1177/003591575504800619; WHITTY CWM, 1957, BRAIN, V80, P72, DOI 10.1093/brain/80.1.72	40	3	3	0	7	MASSON EDITEUR	PARIS 06	120 BLVD SAINT-GERMAIN, 75280 PARIS 06, FRANCE	0013-7006			ENCEPHALE	Enceph.-Rev. Psychiatr. Clin. Biol. Ther.	NOV-DEC	2001	27	6					513	525					13	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	527DK	WOS:000174170900002	11865559				2022-02-06	
J	Kravetz, S; Faust, M; Shalit, M				Kravetz, S; Faust, M; Shalit, M			The mental health of men with a psychiatric disorder or traumatic brain injury: Wives' labeling and husbands' perceived control	REHABILITATION PSYCHOLOGY			English	Article							AWARENESS; ILLNESS; SCHIZOPHRENIA; MOOD	Objective: To investigate the relations among wives' labeling of their husbands' psychiatric disorder or brain injury as an organic illness, the husbands' perceived control over their disabilities, and the husbands' mental health. Participants: Fifty-seven male clients of the Department of Rehabilitation, Israel's Ministry of Defence (26 with a psychiatric disorder and 31 with a traumatic brain injury) and their wives. Measures: Illness Labeling Questionnaire, the Perceived Control Over Illness Questionnaire, and the Mental Health Inventory. Results: Husbands' mental health was low but did not differ according to disability; wives' labeling of husbands' condition was negatively related to the husbands' mental health; husbands' perceived control was positively related to their mental health for both disabilities. Conclusion: Organic illness labels, even when adopted by the wives of the persons with the disability, seem to be negatively related to that person's mental health, whereas perceived control over a mental disorder or a brain injury seems to contribute positively to mental health, independently of how the disorder or injury is labeled.	Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel; Minist Def, Dept Rehabil, Tel Aviv, Israel		Kravetz, S (corresponding author), Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel.	kravets@mail.biu.ac.il					AFFLECK G, 1987, J PERS SOC PSYCHOL, V53, P273, DOI 10.1037/0022-3514.53.2.273; Amador XF, 1998, INSIGHT AND PSYCHOSIS, P15; AMADOR XF, 1993, AM J PSYCHIAT, V150, P873; AMADOR XF, 1991, SCHIZOPHRENIA BULL, V17, P113, DOI 10.1093/schbul/17.1.113; AMADOR XF, 1994, ARCH GEN PSYCHIAT, V51, P826; Amador XF, 1996, AM J PSYCHIAT, V153, P1185; Anthony W. A., 1992, HDB PSYCHIAT REHABIL, P1; BORINSTEIN AB, 1997, PSYCHOL SOCIAL ASPEC, P452; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; COHEN J, 1983, APPL MRC ANAL BEHAV; Crow TJ, 1997, SCHIZOPHRENIA BULL, V23, P521, DOI 10.1093/schbul/23.3.521; DOHERTY EG, 1975, ARCH GEN PSYCHIAT, V32, P562; Drori, 1990, PSYCHOLOGIA, V2, P26; English R. M., 1977, PSYCHOL SOCIAL IMPAC, P162; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; Florian V, 1991, NEUROPSYCHOLOGY, V5, P267, DOI DOI 10.1037/0894-4105.5.4.267; Frith C.D., 1992, COGN NEUROPSYCHOL; Gosling J, 1999, BRAIN INJURY, V13, P785; KAY SR, 1990, SCHIZOPHRENIA BULL, V16, P635, DOI 10.1093/schbul/16.4.635; Kirmayer LJ, 1998, INSIGHT AND PSYCHOSIS, P193; Kravetz S, 2000, PSYCHIATR REHABIL J, V23, P323, DOI 10.1037/h0095147; KRAVETZ S, 1995, BRAIN INJURY, V9, P131, DOI 10.3109/02699059509008186; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; LINK BG, 1989, AM SOCIOL REV, V54, P400, DOI 10.2307/2095613; MEUSER KT, 1994, COPING SCHIZOPHRENIA; MILES A, 1987, MENTALLY ILL CONTEMP; NOH S, 1988, J MARRIAGE FAM, V50, P377, DOI 10.2307/352004; Phelan JC, 1998, SCHIZOPHRENIA BULL, V24, P115, DOI 10.1093/oxfordjournals.schbul.a033304; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; Schlund MW, 1999, BRAIN INJURY, V13, P375, DOI 10.1080/026990599121566; VAUGHN CE, 1984, ARCH GEN PSYCHIAT, V41, P1169; VEIT CT, 1983, J CONSULT CLIN PSYCH, V51, P730, DOI 10.1037/0022-006X.51.5.730; WARNER R, 1989, AM J ORTHOPSYCHIAT, V59, P398, DOI 10.1111/j.1939-0025.1989.tb01675.x; WARNER R, 1994, RECOVERY SCHIZOPHREN; Zencius AH, 1999, BRAIN INJURY, V13, P723	38	3	3	0	1	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2001	46	4					436	451					16	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	493FP	WOS:000172211600005					2022-02-06	
J	Gillette, Y				Gillette, Y			Pictures to print: A software scaffold to written literacy	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						literacy software; traumatic brain injury; written language; written literacy	STUDENTS; SYSTEMS	Background: Successful school placements require effective written literacy skills. When a student has traumatic brain injury (TBI), written literacy instruction may need to be individualized and intense to facilitate optimal reintegration into the school program. Software products can provide a method that assists in creating the needed individualized, intense experiences. Written literacy-learning experiences span a continuum from preconventional messages expressed through pictures, to conventional printed expressions designed to convey meaning, to the literate writing needed to create stories and reports. Design: This article is designed to familiarize rehabilitation and research professionals in TBI with the range of written literacy software and to stimulate clinical applications and research related to their use with students who have sustained a TBI.	Univ Akron, Sch Speech Language Pathol & Audiol, Akron, OH 44325 USA		Gillette, Y (corresponding author), Univ Akron, Sch Speech Language Pathol & Audiol, Akron, OH 44325 USA.						Adams M., 1990, BEGINNING READ THINK; ADAMSON LB, 1992, J SPEECH HEAR RES, V35, P1333, DOI 10.1044/jshr.3506.1333; American Speech-Language-Hearing Association, 2001, ROL RESP SPEECH LANG; Ashton T. M., 1999, TEACHING EXCEPTIONAL, V32, P24; BROGH K, 1992, J RES COMPUTING ED, V24, P533; BRUNER JS, 1966, STUDIES COGNITIVE GR; CHAPMAN SB, 1997, AM J SPEECH-LANG PAT, V6, P50, DOI DOI 10.1044/1058-0360.0602.50; CHESTER CC, 1998, TRAUMATIC BRAIN INJU; CHOMSKY C, 1992, MONTESSORI CONT AM C; CHOMSKY C, 1979, THEORY PRACTICE EARL, V2; DYSON AH, 1986, RES TEACH ENGL, V20, P379; Genishi C, 1984, LANGUAGE ASSESSMENT; GILLETTE Y, 1999, HEARSAY, V13, P40; Graham S, 1997, J EDUC PSYCHOL, V89, P170, DOI 10.1037/0022-0663.89.1.170; JUEL C, 1998, READING SPELLING DEV; Kufera J. A., 1997, AM J SPEECH-LANG PAT, V6, P66, DOI 10.1044/1058-0360.0602.66; LABBO L, 1998, HDB LIT TECHNOLOGY T; LIGHT J, 1992, J SPEECH HEAR RES, V35, P865, DOI 10.1044/jshr.3504.865; MACARTHUR C, 1993, SCHOOL PSYCHOL REV, V22, P671; MacArthur CA, 1999, LEARN DISABILITY Q, V22, P158, DOI 10.2307/1511283; MCCUTCHEN D, 1995, ISSUES ED CONTRIBUTI, V1, P123; MCNAUGHTON S, 1993, TOP LANG DISORD, V13, P58, DOI 10.1097/00011363-199302000-00007; Nelson K., 1985, MAKING SENSE ACQUISI; Nippold M. A., 1988, LATER LANGUAGE DEV; SEVCIK RA, 1991, AUGMENT ALTERNATIVE, V7, P1616; SHILLING W, 1997, EARLY CHILD EDUC J, V24, P253; Sulzby E., 1985, ADV WRITING RES, P127; Sulzby E., 1992, LANG ARTS, V69, P290; Sulzby E., 1996, CHILDRENS EARLY TEXT, P25; TURKSTRA IS, 1996, J COMMUN DISORD, V32, P327; WESTBY CE, 1999, LANGUAGE READING DIS, P259; Ylvisaker M. E., 1998, TRAUMATIC BRAIN INJU; [No title captured]	33	3	3	1	3	ASPEN PUBL INC	GAITHERSBURG	200 ORCHARD RIDGE DR, STE 200, GAITHERSBURG, MD 20878 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	2001	16	5					484	497		10.1097/00001199-200110000-00007			14	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	483JF	WOS:000171631700007	11574043				2022-02-06	
J	McHenry, M				McHenry, M			The effect of a dopamine agonist on dysarthric, speech production - A case study	JOURNAL OF COMMUNICATION DISORDERS			English	Article						dopamine agonist; dysarthria; traumatic brain injury	TRAUMATIC BRAIN INJURY; PARKINSONS-DISEASE; SPATIOTEMPORAL STABILITY; STIMULATION; APOMORPHINE; SPEAKERS; THERAPY; PATIENT; VOICE	The effect of Permax (pergolide mesylate), a dopamine agonist, was assessed in an individual with traumatic brain injury. The participant evidenced symptoms of hypokinetic dysarthria. His performance on and off Permax was evaluated in a BABA design. Measures were obtained across physiological systems. There were few differences in the on and off conditions. In the on condition, he evidenced an abnormally large velopharyngeal orifice area, dysfluencies in stimulus sentences, and less precise articulation. However, listeners perceived him to be more animated in the on condition. In addition, he reported better performance in the on condition. The study highlights potential discrepancies among participant report, listener perception, and objective measures. Learning outcomes: As a result of this activity, the participant will be able (1) to recognize the effect of dopamine agonists as an adjunct to other pharmacological interventions and (2) to determine potential discrepancies among participant report, listener perception and objective physiological and acoustic measures. (C) 2001 Elsevier Science Inc. All rights reserved.	Univ Houston, Dept Commun Disorders, Transit Learning Ctr, Houston, TX 77204 USA		McHenry, M (corresponding author), Univ Houston, Dept Commun Disorders, Transit Learning Ctr, 100 Clin Res Ctr, Houston, TX 77204 USA.	mmchenry@uh.edu					BARLOW SM, 1983, J SPEECH HEAR RES, V26, P283, DOI 10.1044/jshr.2602.283; Barrett AM, 1999, ARCH PHYS MED REHAB, V80, P600, DOI 10.1016/S0003-9993(99)90205-8; Calne DB, 1999, J NEURAL TRANSM-SUPP, P185; Chase TN, 1998, DRUGS, V55, P1, DOI 10.2165/00003495-199855001-00001; Cramer D., 1998, FUNDAMENTAL STAT SOC; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Dromey C, 1998, J SPEECH LANG HEAR R, V41, P1003, DOI 10.1044/jslhr.4105.1003; Factor SA, 1999, MED CLIN N AM, V83, P415, DOI 10.1016/S0025-7125(05)70112-7; FACTOR SA, 1988, MOVEMENT DISORD, V3, P30, DOI 10.1002/mds.870030105; Fahn S., 1986, RECENT DEV PARKINSON; FORREST K, 1988, J ACOUST SOC AM, V84, P115, DOI 10.1121/1.396977; HESSELINK JM, 1989, MOVEMENT DISORD, V4, P283; HOIT JD, 1987, J SPEECH HEAR RES, V30, P351, DOI 10.1044/jshr.3003.351; HOLMBERG EB, 1988, J ACOUST SOC AM, V84, P511, DOI 10.1121/1.396829; JULIEN RM, 1998, PRIMER DRUG ACTION; Karli DC, 1999, BRAIN INJURY, V13, P63, DOI 10.1080/026990599121908; KLATT DH, 1975, J SPEECH HEAR RES, V18, P686, DOI 10.1044/jshr.1804.686; Koeda T, 1998, BRAIN DEV-JPN, V20, P124, DOI 10.1016/S0387-7604(98)00004-7; Kompoliti K, 2000, NEUROLOGY, V54, P458, DOI 10.1212/WNL.54.2.458; Kraus MF, 1997, BRAIN INJURY, V11, P455, DOI 10.1080/026990597123430; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; McHenry M., 1997, AM J SPEECH-LANG PAT, V6, P55; O'Sullivan JD, 1999, HOSP MED, V60, P816, DOI 10.12968/hosp.1999.60.11.1236; Passler MA, 2001, ARCH PHYS MED REHAB, V82, P311, DOI 10.1053/apmr.2001.20831; Rascol O, 1999, J NEURAL TRANSM-SUPP, P33; Scherer R, 1993, NCVS STATUS PROGR RE, V5, P73; SMITH A, 1995, EXP BRAIN RES, V104, P493; *SPSS, 2000, SPSS WIND; STATHOPOULOS ET, 1993, J SPEECH HEAR RES, V36, P64, DOI 10.1044/jshr.3601.64; STERN MB, 1991, MOVEMENT DISORD, V6, P95, DOI 10.1002/mds.870060202; VOGEL D, 2000, EFFECT DRUGS COMMUNI; Wang E, 2000, J MED SPEECH-LANG PA, V8, P175; WARREN D W, 1964, Cleft Palate J, V16, P52; WARREN DW, 1994, CLEFT PALATE-CRAN J, V31, P257, DOI 10.1597/1545-1569(1994)031<0257:HAVI>2.3.CO;2; WEISMER G, 1992, J ACOUST SOC AM, V91, P1085, DOI 10.1121/1.402635; WEISMER G, 1988, J ACOUST SOC AM, V84, P1281, DOI 10.1121/1.396627; Wohlert AB, 1998, J SPEECH LANG HEAR R, V41, P41, DOI 10.1044/jslhr.4101.41; Yorkston K., 1984, COMPUTERIZED ASSESSM	38	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0021-9924	1873-7994		J COMMUN DISORD	J. Commun. Disord.	SEP-OCT	2001	34	5					397	414					18	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	474FY	WOS:000171096700003	11565961				2022-02-06	
J	Perring, S; Jepson, R				Perring, S; Jepson, R			The use of a two-dimensional ultrasound time-of-flight system for location of the centre of gravity in posturography measurements	PHYSIOLOGICAL MEASUREMENT			English	Article						balance assessment; posturography; vertigo; ultrasound		A method has been developed for objective assessment of balance using ultrasound time-of-flight (ToF) posturography measurements to accurately locate the centre of gravity (CoG) of a subject. Two orthogonal 40 kHz ultrasound transmitters are mounted on the subject's waist at the height of the CoG. Anterior/posterior and lateral motions are detected independently by measuring variations in the ToF from the transmitters to appropriately positioned wall-mounted receivers. The motion of the CoG is accurately traced during the course of 20 second assessment periods as the subject stands on a solid surface with eyes open and eyes closed. The tests are repeated with the subject standing on a standardized soft surface. Trials of day-to-day repeatability and repeated tests on patients prior to therapy indicate there is no significant improvement to balance measures with experience of the system. Balance measures are significantly worse in patients suffering vertigo symptoms following traumatic brain injury than for equivalent normal volunteers. Repeated measures post-therapy indicate significant improvement in balance measures following vestibular therapy in patients with vertigo. CoG location using ultrasound ToF is a suitable method of tracking sway and thus assessing balance in normals and balance-compromised patients.	Poole Hosp NHS Trust, Poole BH15 2JB, Dorset, England		Perring, S (corresponding author), Poole Hosp NHS Trust, Longfleet Rd, Poole BH15 2JB, Dorset, England.						ASAI M, 1993, ACTA OTO-LARYNGOL, P120; DIFABIO RP, 1995, PHYS THER, V75, P290, DOI 10.1093/ptj/75.4.290; FITZGERALD JE, 1994, ACTA OTO-LARYNGOL, V114, P115, DOI 10.3109/00016489409126028; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; Shahal B, 1999, LARYNGOSCOPE, V109, P1996, DOI 10.1097/00005537-199912000-00019; SHEPARD NT, 1995, OTOLARYNG HEAD NECK, V112, P173, DOI 10.1016/S0194-5998(95)70317-9; YARDLEY L, 1992, CLIN OTOLARYNGOL, V17, P231, DOI 10.1111/j.1365-2273.1992.tb01833.x; YARDLEY L, 1995, BEHAV RES THER, V33, P435, DOI 10.1016/0005-7967(94)00060-W; Yardley L, 1998, BRIT J GEN PRACT, V48, P1136; YARDLEY L, 1996, CLIN ASPECTS BALANCE	10	3	3	0	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0967-3334	1361-6579		PHYSIOL MEAS	Physiol. Meas.	AUG	2001	22	3					447	452		10.1088/0967-3334/22/3/303			6	Biophysics; Engineering, Biomedical; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering; Physiology	468MZ	WOS:000170762600005	11556665				2022-02-06	
J	Pierce, SM; Mayer, NH; Whyte, J				Pierce, SM; Mayer, NH; Whyte, J			Computer-assisted exercise systems in traumatic brain injury: Cases and commentary	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							STROKE		MossRehab, Drucker Brain Injury Ctr, Philadelphia, PA USA; Temple Univ, Sch Med, Dept Phys Med & Rehabil, Philadelphia, PA 19122 USA; MossRehab, Moss Rehabil Res Inst, Philadelphia, PA 19141 USA; Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA		Pierce, SM (corresponding author), MossRehab Hosp, 1200 W Tabor Rd, Philadelphia, PA 19141 USA.			Whyte, John/0000-0002-4381-1474			BADDELEY AD, 1978, ERGONOMICS, V21, P627, DOI 10.1080/00140137808931764; Bourbonnais D, 1997, NEUROREHABILITATION, V9, P3, DOI 10.3233/NRE-1997-9102; BUTEFISCH C, 1995, J NEUROL SCI, V130, P59, DOI 10.1016/0022-510X(95)00003-K; CROSSMAN E. R. F. W., 1959, ERGONOMICS, V2, P153, DOI 10.1080/00140135908930419; GODDEN DR, 1975, BRIT J PSYCHOL, V66, P325, DOI 10.1111/j.2044-8295.1975.tb01468.x; Haas JF, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199702000-00003; HALEY SM, 1990, UNPUB MODIFICATION R; Hanlon RE, 1996, ARCH PHYS MED REHAB, V77, P811, DOI 10.1016/S0003-9993(96)90262-2; KEELE SW, 1968, PSYCHOL BULL, V70, P387, DOI 10.1037/h0026739; KRIZ G, 1995, ARCH PHYS MED REHAB, V76, P653, DOI 10.1016/S0003-9993(95)80635-0; MAULUCCI RA, 1987, PSYCHOPHARMACOL BULL, V23, P294; MAULUCCI RA, 1989, PHYS MED REHABIL, V3, P43; MAULUCCI RA, 1986, RESNA 9 ANN C; MAULUCCI RA, 1989, QUANTIFYING PERFORMA; Newell K. M, 1981, HUMAN SKILLS; SMITH DS, 1981, BMJ-BRIT MED J, V282, P517, DOI 10.1136/bmj.282.6263.517; SUNDERLAND A, 1995, NEUROL REP, V19, P11	17	3	3	0	3	ASPEN PUBL INC	GAITHERSBURG	200 ORCHARD RIDGE DR, STE 200, GAITHERSBURG, MD 20878 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	2001	16	4					406	413		10.1097/00001199-200108000-00009			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	459YA	WOS:000170278000009	11461661				2022-02-06	
J	Cuevas, P; Carceller, F				Cuevas, P; Carceller, F			Therapeutic implications of fibroblast growth factors in traumatic spinal cord injury	NEUROLOGICAL RESEARCH			English	Article						traumatic spinal cord injury; secondary injury; reparative process; fibroblast growth factor	HIPPOCAMPAL-NEURONS; BRAIN INJURY; DEATH; RAT; NEUROTOXICITY; EXPRESSION; MECHANISMS; ISCHEMIA; RECOVERY	Neurological damage after acute traumatic spinal cord injury (SCI) results from both the primary mechanical injury as well as the subsequent activation of cell death cascades mediating delayed tissue damage. Since secondary injury following traumatic SCI is a tightly regulated process in which several neurotrophic factors seem to be implicated, administration of these proteins has a clinical interest. Fibroblast growth factor may be one of the agents to be used for the treatment of traumatic SCI.	Hosp Ramon & Cajal, Serv Histol, Dept Invest, E-28034 Madrid, Spain		Cuevas, P (corresponding author), Hosp Ramon & Cajal, Serv Histol, Dept Invest, E-28034 Madrid, Spain.	pedro.cuevas@hrc.es					CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Cohen RI, 2000, J NEUROSCI RES, V61, P273, DOI 10.1002/1097-4547(20000801)61:3<273::AID-JNR5>3.0.CO;2-I; COLLAZO D, 1992, NEURON, V9, P643, DOI 10.1016/0896-6273(92)90028-C; Cuevas P, 1998, NEUROL RES, V20, P271, DOI 10.1080/01616412.1998.11740518; Cuevas P, 1998, SURG NEUROL, V49, P77, DOI 10.1016/S0090-3019(97)00193-6; Cuevas P, 1998, SURG NEUROL, V49, P176, DOI 10.1016/S0090-3019(97)00167-5; Dietrich WD, 1996, J NEUROTRAUM, V13, P309, DOI 10.1089/neu.1996.13.309; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; FOLLESA P, 1994, MOL BRAIN RES, V22, P1, DOI 10.1016/0169-328X(94)90026-4; FRESSINAUD C, 1994, J NEUROSCI RES, V38, P202, DOI 10.1002/jnr.490380211; GERHART KA, 1991, J TRAUMA, V31, P1529, DOI 10.1097/00005373-199111000-00012; HALL ED, 1986, J NEUROSURG, V64, P951, DOI 10.3171/jns.1986.64.6.0951; Klint P., 1999, FRONT BIOSCI, V4, P165; MASON IJ, 1994, CELL, V78, P547, DOI 10.1016/0092-8674(94)90520-7; MATTSON MP, 1995, J NEUROCHEM, V65, P1740; MATTSON MP, 1993, J NEUROSCI, V13, P4575; McDermott KL, 1997, J NEUROTRAUM, V14, P191, DOI 10.1089/neu.1997.14.191; MCINTOSH TK, 1998, J NEUROTRAUM, V74, P315; Mocchetti I, 1996, EXP NEUROL, V141, P154, DOI 10.1006/exnr.1996.0149; PRICE C, 1994, AM J EPIDEMIOL, V139, P37, DOI 10.1093/oxfordjournals.aje.a116933; Rabchevsky AG, 2000, EXP NEUROL, V164, P280, DOI 10.1006/exnr.2000.7399; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; SIESJO BK, 1989, ANN NY ACAD SCI, V568, P234; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; YANUDA T, 1995, J NEUROSCI RES, V40, P306; Yong C, 1998, J NEUROTRAUM, V15, P459, DOI 10.1089/neu.1998.15.459	27	3	7	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAR-APR	2001	23	2-3					207	209		10.1179/016164101101198352			3	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	422DX	WOS:000168104200014	11320601				2022-02-06	
J	Ladera-Fernandez, V				Ladera-Fernandez, V			Post-traumatic amnesia disorder	REVISTA DE NEUROLOGIA			Spanish	Article						anterograde memory; head injury; neuropsychology; post-traumatic amnesia; retrograde memory; severity of trauma	CLOSED-HEAD-INJURY; DIFFUSE AXONAL INJURY; LONG-TERM-MEMORY; BRAIN INJURY; RETROGRADE-AMNESIA; NEUROPSYCHOLOGICAL DEFICITS; COGNITIVE SEQUELAE; EARLY INDEXES; MILD; IMPAIRMENT	Introduction. Mnesic deficits are frequent in subjects which have suffered from head injury and may persist during may years. Objective. We will analyze posttraumatic amnesia characteristics (PTA) as well as learning and memory deficits which are normally observed once the PTA phase is over. Development. The PTA is defined as the period that follows a brain injury in which the affected person is incapable of consistently remembering at least the last 24 hours. That is, the period after the head injury in which the incorporation of new information in long term memory is not possible. The study of PTA has generally been focussed on the analysis of the alterations of temporo-spatial orientation and mnesic deficits, however other cognitive and behavioral alterations do exist (linguistic, attentional, critical judgement, information processing, perception, etc.), and they are associated with the particular memory disorder that we are studying, given their influence on it. We will take on board the different theories that have been proposed to explain mnesic deficits which occur during the PTA phase: lack of consolidation of new information within long term memory; recall deficit as a result of inefficient coding of information, failures of the mechanisms to carry out the process of consolidation-recall, and poor organization in the coding of new material. We will put forward a guide for the neuropsychological assessment of memory based on the analytic and concrete study of each mnesic cognitive component, sustained generally by specific neurophysiological functional systems which allow us to establish a diagnosis, prognosis, and adequate therapeutic focus for each concrete case.	Univ Salamanca, Fac Psicol, Dept Psicol Bas Psicobiol Metodol Ciencias Compor, E-37005 Salamanca, Spain				Ladera, Valentina/Q-6132-2017	Ladera, Valentina/0000-0003-4075-4483			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Alexandre A, 1979, J Neurosurg Sci, V23, P201; ALEXANDRE A, 1983, J NEUROSURG, V59, P751, DOI 10.3171/jns.1983.59.5.0751; ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; ARCIA E, 1993, BRAIN INJURY, V7, P481, DOI 10.3109/02699059309008175; ARTIOLA I, 1980, J NEUROL NEUROSUR PS, V43, P377; Baddeley, 1990, HUMAN MEMORY THEORY; BADDELEY AD, 1986, AUTOBIOGRAPHICAL MEM, P225; BENSON DF, 1967, J NEUROL NEUROSUR PS, V30, P539, DOI 10.1136/jnnp.30.6.539; Bigler E. D., 1990, TRAUMATIC BRAIN INJU; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P232; BLACHSTEIN H, 1993, NEUROPSYCHOLOGY, V7, P530, DOI DOI 10.1037/0894-4105.7.4.530; BOND MR, 1990, REHABILITATION ADULT; BROOKS D N, 1975, Cortex, V11, P329; BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; BROOKS DN, 1984, CLOSED HEAD INJURY P, P44; CARLSSON GS, 1987, J NEUROSURG, V67, P197, DOI 10.3171/jns.1987.67.2.0197; COOKE DL, 1995, J CLIN EXP NEUROPSYC, V17, P90, DOI 10.1080/13803399508406585; DELLAROCCHETTA AI, 1993, NEUROPSYCHOLOGIA, V31, P503; DERENZI E, 1995, CORTEX, V31, P531, DOI 10.1016/S0010-9452(13)80064-0; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; DYWAN J, 1993, BRAIN COGNITION, V21, P20, DOI 10.1006/brcg.1993.1002; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; GALE SD, 1993, BRAIN RES BULL, V32, P345, DOI 10.1016/0361-9230(93)90198-K; GOLDBERG E, 1981, SCIENCE, V213, P1392, DOI 10.1126/science.7268442; GOLDSTEIN FC, 1991, MEMORY DISORDERS RES, P255; GRONWALL D, 1989, ASSESSMENT BEHAV CON, V7; Haut M., 1992, NEUROPSYCHOLOGY, V6, P51; Jennett B, 1981, MANAGEMENT HEAD INJU; JETTER W, 1986, CORTEX, V22, P229, DOI 10.1016/S0010-9452(86)80047-8; KAPUR N, 1993, CORTEX, V29, P217, DOI 10.1016/S0010-9452(13)80177-3; KOLB B, 1986, FUNDAMENTALS NEUROPS; LARSSON C, 1987, SCAND J REHABIL MED, V19, P99; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1985, J NEUROL NEUROSUR PS, V48, P556, DOI 10.1136/jnnp.48.6.556; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1127, DOI 10.1136/jnnp.38.11.1127; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Millis Scott R., 1993, Brain Injury, V7, P53, DOI 10.3109/02699059309008156; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Moes Elisabeth, 1994, P217; Parkin A. J., 1993, NEUROPSYCHOLOGY AMNE; Patton G, 1992, NEUROPSYCHOL REHABIL, V2, P169; PETRIDES M, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P256; PONSFORD J, 1995, TRAUMATIC BRAIN INJU, P1; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; RHAWN J, 1993, NEUROPSYCHOLOGY NEUR; RUSELL WR, 1971, TRAUMATIC AMNESIAS; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; RUSSELL WR, 1946, BRAIN, V69, P183; SHIMAMURA AP, 1990, NEUROPSYCHOLOGIA, V28, P803, DOI 10.1016/0028-3932(90)90004-8; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Squires EJ, 1997, NEUROPSYCHOLOGIA, V35, P1103, DOI 10.1016/S0028-3932(97)00039-0; Starkstein SE, 1997, NEUROCASE, V3, P105, DOI 10.1093/neucas/3.2.105; STRACCIARI A, 1994, CORTEX, V30, P459, DOI 10.1016/S0010-9452(13)80341-3; Stuss D.T., 1994, NEUROPSYCHOLOGY, V8, P355, DOI [https://doi.org/10.1037/0894-4105.8.3.355, DOI 10.1037/0894-4105.8.3.355]; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Symonds C.P., 1940, INJURIES SKULL BRAIN, P69; TABADDOR K, 1984, NEUROSURGERY, V14, P701, DOI 10.1227/00006123-198406000-00010; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; Taverni JP, 1998, BRAIN INJURY, V12, P77; Van Zomeren A. H., 1981, REACTION TIME ATTENT; Walsh K. W., 1985, UNDERSTANDING BRAIN; Wilson BA, 1997, BRAIN INJURY, V11, P259, DOI 10.1080/026990597123566; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; YARNELL PR, 1970, LANCET, V1, P863; [No title captured]; [No title captured]	79	3	7	0	10	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010			REV NEUROLOGIA	Rev. Neurologia	MAR 1	2001	32	5					467	472		10.33588/rn.3205.2000170			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	425WE	WOS:000168314000015	11426411				2022-02-06	
J	Goodall, P; Ghiloni, CT				Goodall, P; Ghiloni, CT			The changing face of publicly funded employment services	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; employment; legislation; traumatic brain injury; vocational rehabilitation		The federal-state vocational rehabilitation (VR) program has been a significant stream of funding for individuals with traumatic brain injury (TBI). However, the success of this traditional rehabilitation approach with people with brain injuries remains limited. Recently, the use of specialized employment services, such as Supported Employment, has proven to be far more effective, but funding for this population remains limited. In addition, even individuals who receive specialized employment services often require more intensive, ongoing supports to remain employed. In response, many states have developed innovative services and approaches that are improving the placement and retention rates of individuals with TBI. In this article, the authors provide an overview of selected federal funding initiatives related to the provision of employment services to people with brain injuries, including recent amendments to the Rehabilitation Act. The article also highlights progressive state employment policies and makes suggestions for creative use of government employment monies.	Virginia Dept Rehabilitat Serv, Brain Injury & Spinal Cord Injury Serv, Richmond, VA USA; Massachusetts Rehabil Commiss, Statewide Employment Serv, Boston, MA USA		Goodall, P (corresponding author), Virginia Dept Rehabilitat Serv, Brain Injury & Spinal Cord Injury Serv, Richmond, VA USA.						BICKELMAN E, 1998, COMMUNITY BASED EMPL; *BRAIN INJ ASS STA, 1998, MED WAIV; CLARK G, 1997, PERSON CTR PLANNING; CLINTON WJ, 1999, COMMUNICATION    DEC; CONDELUCI A, 1990, VOCATIONAL REHABILIT; GHILONI CT, 1998, COMMUNITY BASED EMPL; GOODALL P, 1994, J HEAD TRAUMA REHAB, V9, P61; *NAT ASS STAT HEAD, 1998, NAT DIR STAT GOV HEA; *NY STAT DEP HLTH, 1994, TRAUM BRAIN INJ IN H; REVELL G, 2000, REHABILITATION SERVI; RUBIN SE, 1995, FDN VOCATIONAL REHAB; SHALALA DE, 1998, TRAUMATIC BRAIN INJU; *SOC SEC ADM, 1999, LEG B SOC SEC ADM, P106; *US DEP ED, 1999, RSAIM9913 USDA; *US DEP HHS, 2000, ASS ACC COMM LIV DIS; *US DEP LAB, 1998, WORKF INV ACT 1998; VELDHEER L, 1990, COMMUNITY INTEGRATIO; WEHMAN P, 1990, VOCATIONAL REHABILIT; 2000, FED REG         0605, P35792; 1994, FED REG         0218, P8332	20	3	3	0	5	ASPEN PUBL INC	GAITHERSBURG	200 ORCHARD RIDGE DR, STE 200, GAITHERSBURG, MD 20878 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	FEB	2001	16	1					94	106		10.1097/00001199-200102000-00010			13	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	403ZC	WOS:000167072100012	11277853				2022-02-06	
J	Harner, CD				Harner, CD			Specialty update: What's new in sports medicine?	JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME			English	Article							CONCUSSION		Univ Pittsburgh, Dept Orthopaed Surg, Ctr Sports Med, Pittsburgh, PA 15203 USA		Harner, CD (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, Ctr Sports Med, 3200 S Water St, Pittsburgh, PA 15203 USA.	harnercd@msx.upmc.edu					*AM ORTH SOC SPORT, 2000, SUBSP CERT ORTH SPOR; Andriacchi TP, 1998, J BIOMECH ENG-T ASME, V120, P743, DOI 10.1115/1.2834888; Boenisch UW, 1999, AM J SPORT MED, V27, P626, DOI 10.1177/03635465990270051401; Burkhart SS, 2000, ARTHROSCOPY, V16, P82, DOI 10.1016/S0749-8063(00)90133-6; Cole BJ, 2000, J BONE JOINT SURG AM, V82A, P1108, DOI 10.2106/00004623-200008000-00007; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Evans CH, 1999, RHEUM DIS CLIN N AM, V25, P333, DOI 10.1016/S0889-857X(05)70071-5; Griffin L Y, 2000, J Am Acad Orthop Surg, V8, P141; Harner CD, 2000, AM J SPORT MED, V28, P144, DOI 10.1177/03635465000280020201; Hewett TE, 1999, AM J SPORT MED, V27, P699, DOI 10.1177/03635465990270060301; Jackson DW, 1999, CLIN ORTHOP RELAT R, pS31, DOI 10.1097/00003086-199910001-00005; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Lu Y, 2000, ARTHROSCOPY, V16, P527, DOI 10.1053/jars.2000.7690; Menetrey J, 1999, TISSUE ENG, V5, P435, DOI 10.1089/ten.1999.5.435; Rodeo SA, 2000, J BONE JOINT SURG AM, V82A, P1071, DOI 10.2106/00004623-200008000-00002; Schottenfeld MA, 1999, AM J SPORT MED, V27, P122, DOI 10.1177/03635465990270010701; Wall MS, 1999, J SHOULDER ELB SURG, V8, P339, DOI 10.1016/S1058-2746(99)90157-X; Wojtys EM, 1999, AM J SPORT MED, V27, P676, DOI 10.1177/03635465990270052401; WOO SL, 1999, CLIN ORTHOP S, V367, pS312	19	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0021-9355	1535-1386		J BONE JOINT SURG AM	J. Bone Joint Surg.-Am. Vol.	FEB	2001	83A	2					305	310		10.2106/00004623-200102000-00036			6	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	400AL	WOS:000166846400037	11216699				2022-02-06	
J	Lemesle-Martin, M				Lemesle-Martin, M			Antiepileptic drugs in cerebral lesions: What are the indications and the main practical uses?	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article; Proceedings Paper	22nd Conference of the Association-de-Neuroanesthesie-et-Reanimation-de-Langue-Francaise	NOV 23-24, 2000	DIJON, FRANCE	Assoc Neuroanesthes & Reanimat Langue Francaise		antiepileptic drug; cerebral lesion; prophylaxis; seizure; status epilepticus	CLOSED-HEAD INJURY; EARLY SEIZURES; ARTERIOVENOUS-MALFORMATIONS; INTRACEREBRAL HEMORRHAGE; NATURAL-HISTORY; SURGERY; PHENYTOIN; EPILEPSY; STROKE; BRAIN	The aim of this report is to review the indication and the practical use of the antiepileptic drugs in patients with cerebral lesions. The use of antiepileptic drugs to treat seizure or status epilepticus in an emergency is well catalogued and reported in this paper. Practical use of antiepileptic drugs, after a first seizure or to prevent a seizure, in patients with a cerebral lesion, is controversial. The question of antiepileptic drugs in seizures and in prophylaxis is discussed in different types of cerebral lesions: head injury, stroke, cerebral arteriovenous malformation and cerebral tumour. (C) 2001 Editions scientifiques et medicales Elsevier SAS.	Hop Gen, Serv Neurol, Lab Explorat Syst Nerveux, F-21000 Dijon, France		Lemesle-Martin, M (corresponding author), Hop Gen, Serv Neurol, Lab Explorat Syst Nerveux, 3 Rue Faubourg Raines, F-21000 Dijon, France.						Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Arboix A, 1996, NEUROLOGY, V47, P1429, DOI 10.1212/WNL.47.6.1429; Broderick JP, 1999, STROKE, V30, P905, DOI 10.1161/01.STR.30.4.905; CRAWFORD PM, 1986, J NEUROL NEUROSUR PS, V49, P1, DOI 10.1136/jnnp.49.1.1; DEUTSCHMAN CS, 1985, NEUROSURGERY, V17, P510, DOI 10.1227/00006123-198509000-00021; Dugan Ellen M., 1994, Emergency Medicine Clinics of North America, V12, P1081; FOY PM, 1992, J NEUROL NEUROSUR PS, V55, P753, DOI 10.1136/jnnp.55.9.753; FRANCESCHETTI S, 1990, ACTA NEUROCHIR, V103, P47, DOI 10.1007/BF01420191; GIROUD M, 1994, EPILEPSIA, V35, P959, DOI 10.1111/j.1528-1157.1994.tb02540.x; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Jordan K G, 1994, Neurosurg Clin N Am, V5, P671; Lee ST, 1995, ACTA NEUROCHIR, V137, P151, DOI 10.1007/BF02187187; Lee ST, 1997, CAN J NEUROL SCI, V24, P40, DOI 10.1017/S0317167100021077; Levati A, 1992, Minerva Anestesiol, V58, P107; MATTHEW E, 1980, CAN J NEUROL SCI, V7, P285, DOI 10.1017/S0317167100022757; MISIRLI H, 1996, EPILEPSIES, V8, P259; NORTH J B, 1989, British Journal of Neurosurgery, V3, P425, DOI 10.3109/02688698909002827; Pace A, 1998, J EXP CLIN CANC RES, V17, P479; PIEPGRAS DG, 1993, J NEUROSURG, V78, P5, DOI 10.3171/jns.1993.78.1.0005; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; So EL, 1996, NEUROLOGY, V46, P350, DOI 10.1212/WNL.46.2.350; SUNG CY, 1989, J NEUROL NEUROSUR PS, V52, P1273, DOI 10.1136/jnnp.52.11.1273; Temkin N R, 1995, New Horiz, V3, P518; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; THOMAS P, 1999, ENCY MED CHIR; TSUJI M, 1993, JPN J PSYCHIAT NEUR, V47, P331; UZUNER N, 1996, EPILEPSIES, V8, P261; WHONS RN, 1979, J NEUROSURG, V51, P507; YOUNG B, 1983, J NEUROSURG, V58, P231, DOI 10.3171/jns.1983.58.2.0231; ZIMM S, 1981, CANCER, V48, P384, DOI 10.1002/1097-0142(19810715)48:2<384::AID-CNCR2820480227>3.0.CO;2-8	30	3	4	0	1	EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS CEDEX 15	23 RUE LINOIS, 75724 PARIS CEDEX 15, FRANCE	0750-7658			ANN FR ANESTH	Ann. Fr. Anest. Reanim.	FEB	2001	20	2					115	122					8	Anesthesiology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	411LC	WOS:000167500700004	11270233				2022-02-06	
J	Borek, LL; Butler, R; Fleminger, S				Borek, LL; Butler, R; Fleminger, S			Are neuropsychiatric symptoms associated with evidence of right brain injury in referrals to a neuropsychiatric brain injury unit?	BRAIN INJURY			English	Article							CLOSED-HEAD-INJURY	Studies suggest that neuropsychiatric symptoms are more common in patients with injury to the right side of the brain. However, most studies have examined patients with penetrating injuries because these allow more accurate localization of brain damage. This study investigates whether a similar association would be found in patients with non-penetrating brain injuries presenting to a neuropsychiatric unit. Over a 2 year period, 98 referrals were examined. Damage was localized using routine operation notes, EEG and neuroimaging. In total, 34 patients (35%) had a predominately right-sided injury, 33 (34%) had a left-sided injury and 31 (32%) had a diffuse or bilateral injury. Right-sided injuries were associated with hallucinations (p = 0.05), and left-sided injuries were associated with confabulation (p = 0.05) and lack of insight (p = 0.07). These results are consistent with findings from patients with penetrating head injuries. They suggest that evidence of the laterality of injury may be useful for planning the rehabilitation of patients seen in neuropsychiatric brain injury units.	Maudsley Hosp, Lishman Brain Injury Unit, London SE5 8AZ, England; Brockton VA Med Ctr, Dept Psychiat, Brockton, MA USA		Borek, LL (corresponding author), 170 Cliff Rd, Wellesley Hills, MA 02481 USA.						DACEY R, 1991, J TRAUMA, V31, P217, DOI 10.1097/00005373-199131020-00011; FLORHENRY P, 1979, BIOL PSYCHIAT, V14, P677; GAINOTTI G, 1991, HDB NEUROPSYCHOLOGY, V3, P343; GRAFMAN J, 1986, BRAIN, V109, P1127, DOI 10.1093/brain/109.6.1127; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; Gualtari CT, 1991, BRAIN INJURY, V5, P219; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; HILLBOM E, 1960, Acta Psychiatr Scand Suppl, V35, P1; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; MacHale SM, 1998, J NEUROL NEUROSUR PS, V64, P371, DOI 10.1136/jnnp.64.3.371; MACNIVEN E, 1993, BRAIN INJURY, V7, P241, DOI 10.3109/02699059309029676; PIERCY M, 1964, BRIT J PSYCHIAT, V110, P310, DOI 10.1192/bjp.110.466.310; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340	16	3	5	0	1	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JAN	2001	15	1					65	69		10.1080/02699050150209147			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	384UF	WOS:000165963600007	11201316				2022-02-06	
J	Broglio, SP; Guskiewicz, KM				Broglio, SP; Guskiewicz, KM			Soccer heading: Are there risks involved?	ATHLETIC THERAPY TODAY			English	Article						soccer injury; neurocognitive function; mild head injury	TRAUMATIC BRAIN-INJURY		Univ Pittsburgh, Dept Hlth Phys & Recreat Educ, Pittsburgh, PA 15260 USA; Univ N Carolina, Dept Exercise & Sport Sci, Sports Med Res Lab, Chapel Hill, NC USA		Broglio, SP (corresponding author), Univ Pittsburgh, Dept Hlth Phys & Recreat Educ, Pittsburgh, PA 15260 USA.						ARNHEIM DD, 1997, PRINCIPLES ATHLETIC; Asken MJ, 1998, PHYSICIAN SPORTSMED, V26, P37, DOI 10.3810/psm.1998.11.1190; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; BROGLIO S, 2000, THESIS U N CAROLINA; CASTO S, 2000, DO SOCCER PLAYERS EX; DAILEY SW, 1992, PHYSICIAN SPORTSMED, V20, P79, DOI 10.1080/00913847.1992.11947468; Delaney JS, 1999, CLIN J SPORT MED, V9, P121; FIELDS KB, 1989, PHYSICIAN SPORTSMED, V17, P69, DOI 10.1080/00913847.1989.11709682; GRONWALL D, 1975, LANCET, V2, P995; GRONWALL D, 1974, LANCET, V2, P605; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; HEY D, 1925, DTSCH Z GESAMTE GERI, V5, P12; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; MILLER A, 1997, THESIS U N CAROLINA; Nilsson S, 1978, Am J Sports Med, V6, P358, DOI 10.1177/036354657800600608; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; ROSS RJ, 1987, CLIN SPORT MED, V6, P41; Ruchinskas R A, 1997, Appl Neuropsychol, V4, P43, DOI 10.1207/s15324826an0401_5; Smodlaka VN, 1984, PHYSICIAN SPORTSMED, V12, P127, DOI DOI 10.1080/00913847.1984.11701777; SULLIVAN JA, 1980, AM J SPORT MED, V8, P325, DOI 10.1177/036354658000800505; Tysvaer A, 1981, Br J Sports Med, V15, P163; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; 1976, LANCET           FEB, P401	25	3	3	0	6	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1078-7895			ATHLET THER TODAY	Athlet. Ther. Today	JAN	2001	6	1					28	32		10.1123/att.6.1.28			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	482AT	WOS:000171553200006					2022-02-06	
J	Guterman, H; Nehmadi, Y; Chistyakov, A; Soustiel, J; Hafner, H; Feinsod, M				Guterman, H; Nehmadi, Y; Chistyakov, A; Soustiel, J; Hafner, H; Feinsod, M			Classification of brain-stem trigeminal evoked potentials in multiple sclerosis, minor head injuries and post-concussion syndrome pathologies by similarity measurements	INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS			English	Article						brainstem; evoked potentials; multiple sclerosis; post-concussion syndrome; fuzzy similarity	FUZZY CLUSTER-ANALYSIS; POSITIVE STRESS TESTS	In this study measurements obtained from brain-stem trigeminal evoked potentials (BTEP) are applied to the problem of diagnosing Multiple Sclerosis (MS) and Post-concussion syndrome (PCS), We present a simplistic model that depicts the BTEP waveform as the linear combination of a set of filters excited by a short stimulus. The relation between the BTEP latencies and the Ist to 4th harmonic components is shown. The performance of a fuzzy similarity measure based classifier is compared with that of human experts. The efficiency of the proposed classifier in conjunction with delay time and amplitude features is examined, Using this novel approach, a classification rate of 93.55% and 84.1% for MS and PCS pathologies, respectively, was achieved, This performance compares favorably to the classification rates of 84.28% for MS and 70.47% for PCS pathologies achieved by human experts. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.	Ben Gurion Univ Negev, Dept Elect & Comp Engn, IL-84105 Beer Sheva, Israel; Technion Israel Inst Technol, Bruce Rappaport Fac Med, Rambam Maimonides Med Ctr, Dept Neurosurg, IL-31096 Haifa, Israel		Guterman, H (corresponding author), Ben Gurion Univ Negev, Dept Elect & Comp Engn, POB 653, IL-84105 Beer Sheva, Israel.	hugo@ee.bgu.ac.il	GUTERMAN, HUGO/F-1245-2012	Guterman, Hugo/0000-0002-3803-9862			Adlassnig K-P, 1982, APPROXIMATE REASONIN, P203; BOSTON JR, 1989, IEEE T BIO-MED ENG, V36, P528, DOI 10.1109/10.24254; CHIAPPA KH, 1989, EVOKED POTENTIALS CL, P371; Esogbue A. O., 1980, Fuzzy Sets and Systems, V3, P1, DOI 10.1016/0165-0114(80)90002-0; Esogbue A. O., 1979, Fuzzy Sets and Systems, V2, P279, DOI 10.1016/0165-0114(79)90002-2; ESOGBUE AO, 1983, FUZZY SET SYST, V10, P223, DOI 10.1016/S0165-0114(83)80117-1; FORDON WA, 1979, FUZZY SETS SYSTEMS, V2, P5; Fukunaga K., 1990, INTRO STAT PATTERN R, DOI 10.1016/c2009-0-27872-x; GATH I, 1989, PATTERN RECOGN LETT, V9, P77, DOI 10.1016/0167-8655(89)90040-8; GATH I, 1994, PATTERN RECOGN LETT, V15, P977, DOI 10.1016/0167-8655(94)90029-9; GEVA AB, 1994, MED BIOL ENG COMPUT, V32, P543, DOI 10.1007/BF02515313; Geva AB, 1999, INT SER COMPUTAT INT, P57; GUPTA MM, 1984, FUZZY INFORMATION KN, P29; Guterman H, 1996, INT J BIOMED COMPUT, V43, P203, DOI 10.1016/S0020-7101(96)01211-1; HOLDAWAY RM, 1990, IEEE ENG MED BIOL, V9, P43, DOI 10.1109/51.59212; HUDSON DL, 1992, HYBIRD ARCHITECTURES; HUGHES C, 1989, MED INFORM, V14, P269, DOI 10.3109/14639238908999281; KRAJCA V, 1991, INT J BIOMED COMPUT, V28, P71, DOI 10.1016/0020-7101(91)90028-D; Peters RM, 1999, CARDIOLOGY, V91, P66, DOI 10.1159/000006879; PETERS RM, 1995, AM J CARDIOL, V76, P648, DOI 10.1016/S0002-9149(99)80190-8; Proakis J. G., 1989, INTRO DIGITAL SIGNAL; SOUSTIEL JF, 1993, ELECTROEN CLIN NEURO, V88, P255, DOI 10.1016/0168-5597(93)90049-U; SOUSTIEL JF, 1991, ELECTROEN CLIN NEURO, V80, P119, DOI 10.1016/0168-5597(91)90149-R; SOUSTIEL JF, 1993, ELECTROEN CLIN NEURO, V87, P277, DOI 10.1016/0013-4694(93)90180-4; SOUSTIEL JF, 1995, BRAIN INJURY, V9, P805, DOI 10.3109/02699059509008236; SOUSTIEL JF, 1996, CLIN NEUROPHYSIOL, V103, P233; Teodorescu HNL, 1999, INT SER COMPUTAT INT, P3; THOMPSON AJ, 1992, DIS NERVOUS SYSTEM C, P1209; Zouridakis G, 1997, IEEE T BIO-MED ENG, V44, P673, DOI 10.1109/10.605424	29	3	4	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1386-5056	1872-8243		INT J MED INFORM	Int. J. Med. Inform.	DEC	2000	60	3					303	318		10.1016/S1386-5056(00)00125-8			16	Computer Science, Information Systems; Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Health Care Sciences & Services; Medical Informatics	454RV	WOS:000169986300005	11137473				2022-02-06	
J	Mirdad, T				Mirdad, T			Operative treatment of femoral shaft fractures in children: a nine-year experience in a Saudi Arabian population	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article							EXTERNAL FIXATION; INJURED CHILDREN; FEMUR FRACTURES; ADOLESCENTS	This is a retrospective analysis of 56 children under the age of 16 years who had femoral shaft fractures and were treated at the Asir Central Hospital by open reduction and internal fixation. The age range was 5-16 years (average 10.8 years). Two patients had bilateral femoral shaft fractures. Female-male ratio was 1.5.2. The two legs were almost equally affected. The most common area of fracture location was the mid-diaphyseal region, 35 cases (60.3%) and the most common type of fracture seen was closed transverse, 22 cases (37.9%). The most common cause of injury was motor vehicle accident, 36 cases (64.3%) and the most common associated injury was head injury, 28 cases (48.3%). A plate was most commonly used for internal fixation, 44 cases (75.9%). The most common immediate post-operative complication was bleeding, 25 cases (43.1%) and the most common late complication was knee joint stiffness, three cases (5.2%). Hospital stay ranged between 7 and 48 days (average 25.9 days). The most common causes of prolonged hospital stay were the associated injuries with the fractured femur. Of the total 58 femoral shaft fractures, there was one case (1.7%) of non-union, and of the 56 patients in this series one (1.8%) died. It is concluded that open reduction and internal fixation of femoral shaft fractures is a good modality of treatment in children in our environment. (C) 2000 Elsevier Science Ltd. All rights reserved.	King Khalid Univ, Abha & Asir Cent Hosp, Coll Med & Med Sci, Dept Surg, Abha, Saudi Arabia		Mirdad, T (corresponding author), King Khalid Univ, Abha & Asir Cent Hosp, Coll Med & Med Sci, Dept Surg, POB 641, Abha, Saudi Arabia.						Batouk A N, 1996, J Family Community Med, V3, P29; FRY K, 1976, J TRAUMA, V16, P371, DOI 10.1097/00005373-197605000-00008; Heinrich S D, 1992, J Orthop Trauma, V6, P452, DOI 10.1097/00005131-199212000-00011; KIRSCHENBAUM D, 1990, J PEDIATR ORTHOPED, V10, P588, DOI 10.1097/01241398-199009000-00003; KREGOR PJ, 1993, J BONE JOINT SURG AM, V75A, P1774, DOI 10.2106/00004623-199312000-00006; MANN DC, 1986, J PEDIATR ORTHOPED, V6, P651, DOI 10.1097/01241398-198611000-00002; PORAT S, 1986, J TRAUMA, V26, P81, DOI 10.1097/00005373-198601000-00015; REEVES RB, 1990, J PEDIATR ORTHOPED, V10, P592, DOI 10.1097/01241398-199009000-00004; SHIH HN, 1989, J TRAUMA, V29, P498, DOI 10.1097/00005373-198904000-00014; TIMMERMAN LA, 1993, J ORTHOP TRAUMA, V7, P331, DOI 10.1097/00005131-199308000-00008; TOLO VT, 1983, J PEDIATR ORTHOPED, V3, P435, DOI 10.1097/01241398-198309000-00004; WARD WT, 1992, J PEDIATR ORTHOPED, V12, P626; ZIV I, 1984, J TRAUMA, V24, P432, DOI 10.1097/00005373-198405000-00011	13	3	5	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	DEC	2000	31	10					769	771		10.1016/S0020-1383(00)00092-9			3	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	384LP	WOS:000165944400004	11154745				2022-02-06	
J	Bernstein, DM; de Ruiter, SW				Bernstein, DM; de Ruiter, SW			The influence of motivation on neurocognitive performance long after mild traumatic brain injury	BRAIN AND COGNITION			English	Article								Motivation and the presence of mild traumatic brain injury (MTBI) were crossed to determine whether individuals with MTBI could overcome attention deficits many years after injury. Contrary to prediction, university students with self-reported MTBI (average time since injury = 6.4 years) performed no differently from controls on a short but demanding set of neurocognitive tasks. As predicted, however, motivation differentially affected these groups by elevating controls' performance while leaving the MTBI group's performance unaffected. This finding was mainly due to individuals with more than one MTBI. These results suggest that university students who have sustained more than one MTBI may demonstrate subtle, longterm neurocognitive impairment. Additionally, motivation may be an important variable to consider in MTBI research, (C) 2000 Academic Press.	Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; Leiden Univ, Leiden, Netherlands		Bernstein, DM (corresponding author), Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada.						BERNSTEIN DM, 1996, J INT NEUROPSYCH SOC, V2, P18; BERNSTEIN DM, 1999, 27 M INT NEUR SOC BO; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; GRONWALL D, 1975, LANCET, V2, P995; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002	5	3	3	0	0	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626			BRAIN COGNITION	Brain Cogn.	OCT	2000	44	1					50	54		10.1006/brcg.1999.1209			5	Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	358FJ	WOS:000089547300013					2022-02-06	
J	Landolt, MA				Landolt, MA			The psychology of children after trauma	ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE			German	Article						accident; child; adolescent; psychology; post-traumatic stress disorder	POSTTRAUMATIC-STRESS-DISORDER; ROAD TRAFFIC ACCIDENTS; BRAIN INJURY; PHYSICAL INJURY; ADOLESCENTS; CONSEQUENCES; SURVIVORS; DISASTER; SYMPTOMS; PARENTS	A significant number of child victims of accidents develops psychological symptoms which can be described as posttraumatic stress reactions. This article reviews the literature on psychological consequences of accidents. Classification, diagnosis, prevalence, pathogenesis, biology, prevention, and therapy of post-traumatic stress reactions in children and adolescents are discussed. Consideration of psychotraumatological aspects in the treatment of children and adolescents after accidents is recommended.	Univ Kinderspital Zurich, CH-8032 Zurich, Switzerland		Landolt, MA (corresponding author), Univ Kinderspital Zurich, Steinwiesstr 75, CH-8032 Zurich, Switzerland.	mlandolt@kispi.unizh.ch		Landolt, Markus/0000-0003-0760-5558			Aaron J, 1999, J PEDIATR PSYCHOL, V24, P335, DOI 10.1093/jpepsy/24.4.335; American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; American Psychiatric Association, 1980, DIAGN STAT MAN MENT; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BLANCHARD EB, 1995, J NERV MENT DIS, V183, P495, DOI 10.1097/00005053-199508000-00001; Cohen JA, 1998, J AM ACAD CHILD PSY, V37, P997; DaCosta JM, 1871, AM J MED SCI, V121, P2, DOI [10.1097/00000441-187101000-00001, DOI 10.1097/00000441-187101000-00001]; de Vries APJ, 1999, PEDIATRICS, V104, P1293, DOI 10.1542/peds.104.6.1293; DEBELLIS MD, 1994, J CLIN ENDOCR METAB, V78, P249, DOI 10.1210/jc.78.2.249; DiGallo A, 1997, BRIT J PSYCHIAT, V170, P358, DOI 10.1192/bjp.170.4.358; Dilling H, 1991, INT KLASSIFIKATION P; Everly, 1997, CRITICAL INCIDENT ST; Folkman, STRESS APPRAISAL COP; GREEN BL, 1991, J AM ACAD CHILD PSY, V30, P945, DOI 10.1097/00004583-199111000-00012; Hersov, 1985, CHILD ADOLESCENT PSY, P152; JONES RW, 1993, J FAM PRACTICE, V36, P223; Joseph S, 1999, J TRAUMA STRESS, V12, P437, DOI 10.1023/A:1024762919372; JOSEPH SA, 1993, J CHILD PSYCHOL PSYC, V34, P247, DOI 10.1111/j.1469-7610.1993.tb00982.x; Kemp A, 1997, J ACCID EMERG MED, V14, P316; Landolt MA, 1998, J PAEDIATR CHILD H, V34, P539, DOI 10.1046/j.1440-1754.1998.00303.x; LANDOLT MA, 1998, TRANSAKTIONALE BELAS; LASK B, 1994, CHILD ADOLESCENT PSY, P996; Levi RB, 1999, J CLIN CHILD PSYCHOL, V28, P232, DOI 10.1207/s15374424jccp2802_10; MARTI D, 1997, 5 WORKSH LISS EUR CL; Max JE, 1998, J NERV MENT DIS, V186, P589, DOI 10.1097/00005053-199810000-00001; Mayou R, 1997, PSYCHOSOM MED, V59, P578, DOI 10.1097/00006842-199711000-00004; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; MCFARLANE AC, 1987, J AM ACAD CHILD PSY, V26, P764, DOI 10.1097/00004583-198709000-00025; Mirza KAH, 1998, BRIT J PSYCHIAT, V172, P443, DOI 10.1192/bjp.172.5.443; NADER K, 1990, AM J PSYCHIAT, V147, P1526; Nader Kathleen O., 1997, P291; ODWIN O, 1993, J CHILD PSYCHOL PSYC, V34, P115; Pfefferbaum B, 1997, J AM ACAD CHILD PSY, V36, P1503, DOI 10.1016/S0890-8567(09)66558-8; Rose S, 1998, J TRAUMA STRESS, V11, P697, DOI 10.1023/A:1024441315913; SCHEERINGA MS, 1995, J AM ACAD CHILD PSY, V34, P191, DOI 10.1097/00004583-199502000-00014; Stallard P, 1998, BRIT MED J, V317, P1619, DOI 10.1136/bmj.317.7173.1619; STALLARD P, 1993, BRIT J PSYCHIAT, V163, P660, DOI 10.1192/bjp.163.5.660; STODDARD FJ, 1989, J AM ACAD CHILD PSY, V28, P589, DOI 10.1097/00004583-198907000-00020; THOMPSON A, 1993, BRIT MED J, V307, P1282, DOI 10.1136/bmj.307.6914.1282-c; van der Kolk BA, 1998, PRAX KINDERPSYCHOL K, V47, P19; Van Der Kolk Bessel A., 1996, P214; YULE W, 1991, BRIT J CLIN PSYCHOL, V30, P131, DOI 10.1111/j.2044-8260.1991.tb00928.x; YULE W, 1992, VULNERABILITY RESILI, P82; YULE W, 1994, CHILD ADOLESCENT PSY, P392; Yule W, 1990, J TRAUMA STRESS, V3, P279, DOI DOI 10.1002/JTS.2490030209; Yule W., 1998, CHILDREN TRAUMA STRE, P219	46	3	3	0	5	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0939-2661	1439-1074		ANASTH INTENSIV NOTF	Anasthesiol. Intensivmed. NotfMed. Schmerzther.	OCT	2000	35	10					615	622		10.1055/s-2000-11990			8	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Anesthesiology; General & Internal Medicine	369FE	WOS:000165054600002	11116492				2022-02-06	
J	Pincus, JH				Pincus, JH			Neurologic evaluation of violent juveniles	CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article							CLINICAL-NEUROPHYSIOLOGY-SOCIETY; DEFICIT HYPERACTIVITY DISORDER; ACADEMY-OF-NEUROLOGY; UNITED-STATES; BRAIN; CONCUSSION; MURDERERS; ABNORMALITIES; DYSFUNCTION; CHILDREN	Any juvenile who has acted violently requires a systematic, meticulous neurologic evaluation There is no substitute for an adequate medical, family and social history, the latter focusing on abuse and neglect. Evaluation should include a full physical and a conventional neurologic examination. if the neurologic or neuropsychologic examinations demonstrate brain dysfunction, the patient has brain dysfunction, even if MR imaging is normal.	Georgetown Univ, Dept Neurol, Washington, DC 20007 USA		Pincus, JH (corresponding author), Georgetown Univ, Dept Neurol, 3800 Reservoir Rd NW, Washington, DC 20007 USA.						BAE C, 1998, AM AC NEUR M APR 28; Benes FM, 1998, AM J PSYCHIAT, V155, P1489, DOI 10.1176/ajp.155.11.1489; BLAKE PY, 1995, NEUROLOGY, V45, P1641, DOI 10.1212/WNL.45.9.1641; Castellanos FX, 1996, ARCH GEN PSYCHIAT, V53, P607; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; FOLSTEIN M, 1985, J AM GERIATR SOC, V33, P228, DOI 10.1111/j.1532-5415.1985.tb07109.x; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Hoffman DA, 1999, J NEUROPSYCH CLIN N, V11, P401, DOI 10.1176/jnp.11.3.401; JENKYN LR, 1977, J NEUROL NEUROSUR PS, V40, P956, DOI 10.1136/jnnp.40.10.956; JENKYN LR, 1985, ARCH NEUROL-CHICAGO, V42, P1154, DOI 10.1001/archneur.1985.04060110036012; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; Lewis D O, 1989, J Neuropsychiatry Clin Neurosci, V1, P413; LEWIS DO, 1979, J AM ACAD CHILD PSY, V18, P307, DOI 10.1016/S0002-7138(09)61045-1; LEWIS DO, 1988, AM J PSYCHIAT, V145, P584; LEWIS DO, 1986, AM J PSYCHIAT, V143, P838; LEZAK MD, 1977, NEUROPSYCHOLOGICAL A; Luria A. R, 1962, HIGHER CORTICAL FUNC; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; Nuwer M, 1997, NEUROLOGY, V49, P277, DOI 10.1212/WNL.49.1.277; OZERETSKII NI, 1930, PSYCHOMOTOR FUNCTION; PAULSON G, 1968, BRAIN, V91, P37, DOI 10.1093/brain/91.1.37; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Pearl GS, 1998, CLIN LAB MED, V18, P39; RAINE A, 1994, BIOL PSYCHIAT, V36, P365, DOI 10.1016/0006-3223(94)91211-4; Raine A, 1997, BIOL PSYCHIAT, V42, P495, DOI 10.1016/S0006-3223(96)00362-9; RODIN EA, 1964, ARCH NEUROL-CHICAGO, V10, P327, DOI 10.1001/archneur.1964.00460150097010; SHAHANI B, 1970, BRAIN, V93, P181, DOI 10.1093/brain/93.1.181; Shaywitz SE, 1998, P NATL ACAD SCI USA, V95, P2636, DOI 10.1073/pnas.95.5.2636; SHUE KL, 1992, BRAIN COGNITION, V20, P104, DOI 10.1016/0278-2626(92)90064-S; Teasdale TW, 1997, BRIT MED J, V315, P569; WOLFGANG ME, 1975, NEURAL BASES VIOLENC, P456; Yarvis R M, 1994, Bull Am Acad Psychiatry Law, V22, P133; 1997, MMWR, V14, P224	33	3	3	0	6	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	1056-4993			CHILD ADOL PSYCH CL	Child Adolesc. Psychiatr. N. Am.	OCT	2000	9	4					777	+					17	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	360CL	WOS:000089648800006	11005006				2022-02-06	
J	Podoll, K; Kunert, HJ; Sass, H				Podoll, K; Kunert, HJ; Sass, H			Posttraumatic stress disorder in patients with neurogenic amnesia for the traumatic event	FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE			German	Article							CLOSED-HEAD-INJURY; BRAIN INJURY; MEMORY; DISSOCIATION; SYSTEMS	The development of symptoms of posttraumatic stress disorder (PTSD) in patients with neurogenic amnesia for the traumatic event is recorded in 2 own patients and in 19 cases from the clinical literature. With a single exception, all patients were accident victims with closed head injuries. Only about three quarters of the patients completely fulfilled DSM-III-R criteria of PTSD. Nineteen patients displayed involuntary conscious memories of aspects of the traumatic event (presenting as recurrent intrusive thoughts, images or dreams) co-existent with a complete or partial lack of voluntary conscious memories of the trauma, suggesting that different memory systems and distinct brain mechanisms subserve these phenomena. The said clinical observations are discussed against the background of current neuropsychological models of multiple memory systems. The recorded cases demonstrate that declarative episodic memory is not necessary for symptoms of PTSD to emerge, whereas preserved functions of non-declarative memory systems represent a sufficient condition for the development of PTSD symptoms.	Rhein Westfal TH Aachen, Klin Psychiat & Psychotherapie, Fak Med, D-52074 Aachen, Germany		Podoll, K (corresponding author), Rhein Westfal TH Aachen, Klin Psychiat & Psychotherapie, Fak Med, Pauwelsstr 30, D-52074 Aachen, Germany.						ADLER A, 1945, ARCH NEURO PSYCHIATR, V53, P34, DOI 10.1001/archneurpsyc.1945.02300010044003; Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; American Psychiatric Association, 1980, DIAGN STAT MAN MENT; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BENSON DF, 1967, J NEUROL NEUROSUR PS, V30, P539, DOI 10.1136/jnnp.30.6.539; Brewin CR, 1996, PSYCHOL REV, V103, P670, DOI 10.1037/0033-295X.103.4.670; Brickenkamp R., 1981, TEST D2 AUFMERKSAMKE, V7th ed.; BROOK S, 1949, INJURIES BRAIN SPINA, P304; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bryant RA, 1996, J TRAUMA STRESS, V9, P621; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; DAVIDOFF DA, 1988, COGNITIVE REHABILITA, V6, P8; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; Ferenczi Sandor, 1916, INT Z ARZTL PSYCHOAN, V4, P131; Ferenczi Sandor, 1919, PSYCHOANALYSE KRIEGS, P9; Freud S., 1900, TRAUMDEUTUNG; Freud S, 1913, INT Z ARZTL PSYCHOAN, V1, P117; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Harvey AG, 1998, J NERV MENT DIS, V186, P333, DOI 10.1097/00005053-199806000-00002; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; Horton A.M., 1991, ARCH CLIN NEUROPSYCH, V6, P195; HORTON AM, 1993, PERCEPT MOTOR SKILL, V76, P243, DOI 10.2466/pms.1993.76.1.243; HYER L, 1992, J CLIN PSYCHOL, V48, P479; KEANE TM, 1985, TRAUMA ITS WAKE, V1, P257; King NS, 1997, J NEUROL NEUROSUR PS, V62, P82, DOI 10.1136/jnnp.62.1.82; KOLB LC, 1987, AM J PSYCHIAT, V144, P989; Krikorian R, 1998, J NEUROPSYCH CLIN N, V10, P359, DOI 10.1176/jnp.10.3.359; LAYTON BS, 1995, CLIN NEUROPSYCHOL, V9, P2, DOI 10.1080/13854049508402050; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; MARKOWITSCH HJ, 1992, NEUROPSYCHOLOGIE GED; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; McGrath J, 1997, NEUROPSYCHOL REHABIL, V7, P231, DOI 10.1080/713755532; McMillan TM, 1996, BRAIN INJURY, V10, P749, DOI 10.1080/026990596124016; McMillan TM, 1997, CURR OPIN NEUROL, V10, P479, DOI 10.1097/00019052-199712000-00008; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; MCMILLAN TM, 1991, BRIT J PSYCHIAT, V159, P431, DOI 10.1192/bjp.159.3.431; Meares R, 1999, AM J PSYCHIAT, V156, P1850; Meares R, 1999, AM J PSYCHOTHER, V53, P392, DOI 10.1176/appi.psychotherapy.1999.53.3.392; Middelboe T., 1992, European Psychiatry, V7, P183; MORGENSTERN C, 1910, PALMSTROM; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; Price K. P., 1994, DEF LAW J, V43, P113; RATTOK J, 1993, J CLIN EXP NEUROPSYC, V15, P403; Reisner H, 1943, NERVENARZT, V16, P317; ROBINSON PK, 1947, BRAIN, V70, P440, DOI 10.1093/brain/70.4.440; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; SBORDONE RJ, 1991, NEUROPSYCHOLOGY ATTO; SBORDONE RJ, 1992, NEUROLAW LETT   0503; SQUIRE LR, 1992, J COGNITIVE NEUROSCI, V4, P232, DOI 10.1162/jocn.1992.4.3.232; TEASDALE G, 1974, LANCET, V2, P81; Tewes U., 1991, HAMBURG WECHSLER INT, V2nd; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; VANDERKOLK BA, 1995, J TRAUMA STRESS, V8, P505, DOI 10.1002/jts.2490080402; Warden DL, 1997, J NEUROPSYCH CLIN N, V9, P18; Wechsler D, 1987, WECHSLER MEMORY SCAL; Zimmermann P., 1993, TESTBATTERIE AUFMERK; [No title captured]	59	3	3	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0720-4299			FORTSCHR NEUROL PSYC	Forschritte Neurol. Psychiatr.	OCT	2000	68	10					458	467		10.1055/s-2000-7736			14	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	368MP	WOS:000090121300004	11103682				2022-02-06	
J	Stocker, R; Burgi, U; Keller, E; Imhof, HG				Stocker, R; Burgi, U; Keller, E; Imhof, HG			Acute craniocerebral injury. Pathophysiology, monitoring and treatment	ANAESTHESIST			German	Article						primary and secondary brain injury; secondary insult; ICP; monitoring; treatment	SEVERE HEAD-INJURY; TRAUMATIC BRAIN INJURY; CEREBRAL-ISCHEMIA; HYPERVENTILATION; HYPOTHERMIA; DAMAGE; PHASE		Univ Zurich Hosp, Dept Chirurg, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Neurochirurg Klin, CH-8091 Zurich, Switzerland		Stocker, R (corresponding author), Univ Zurich Hosp, Dept Chirurg, CH-8091 Zurich, Switzerland.		Keller, Emanuela/M-2917-2015	Keller, Emanuela/0000-0001-7892-8261; Keller, Emanuela, Elisabeth, Sophia/0000-0002-7560-7574			Bullock MR, 1996, J NEUROTRAUM, V13, P705; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESTNUT RM, 1995, NEW HORIZ, V3, P448; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Dearden NM, 1998, CLIN NEUROPATHOL, V17, P221; DEMANN D, 1990, INT J NEUROSCI, V54, P101, DOI 10.3109/00207459008986624; Dings J, 1996, ZBL NEUROCHIR, V57, P177; Fandino J, 2000, J CLIN NEUROSCI, V7, P226, DOI 10.1054/jocn.1999.0202; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Imhof H G, 1993, Aktuelle Traumatol, V23, P7; IMHOF HG, 1993, HELV CHIR ACTA, V60, P195; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; Mayberg MR, 1998, NEUROSURG CLIN N AM, V9, P615; McLaughlin MR, 1996, J NEUROSURG, V85, P871, DOI 10.3171/jns.1996.85.5.0871; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Murray GD, 1996, ACTA NEUROCHIR, V138, P1163, DOI 10.1007/BF01809745; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Roberts I, 1999, CORTICOSTEROIDS ACUT; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SCHNEIDER GH, 1995, ACTA NEUROCHIR, V134, P71, DOI 10.1007/BF01428507; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Stover JF, 1998, EUR J CLIN PHARMACOL, V54, P529, DOI 10.1007/s002280050508; Stover JF, 1999, CRIT CARE MED, V27, P1351, DOI 10.1097/00003246-199907000-00028; STRINGER WA, 1993, AM J NEURORADIOL, V14, P475; UNTERBERG AW, 1997, J TRAUMA S, V42, P32; Yundt KD, 1997, CRIT CARE CLIN, V13, P163, DOI 10.1016/S0749-0704(05)70300-6	28	3	3	0	1	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0003-2417			ANAESTHESIST	Anaesthesist	OCT	2000	49	10					913	926		10.1007/s001010070050			14	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	370PE	WOS:000165130800013	11100260				2022-02-06	
J	Koniaris, LG; Kross, ME; O'Malley, N; Cornwell, EE				Koniaris, LG; Kross, ME; O'Malley, N; Cornwell, EE			Traumatic asphyxia complicated by unwitnessed cardiac arrest	SOUTHERN MEDICAL JOURNAL			English	Article							INJURY	We report a case of traumatic asphyxia complicated by unwitnessed cardiac arrest in which the patient has made a good, functional recovery. Traumatic asphyxia is an uncommon clinical syndrome usually occurring after chest compression. Associated physical findings include subconjunctival hemorrhage and purple-blue neck and face discoloration. These facial changes can mimic those seen with massive closed head injury; however, cerebral injury after traumatic asphyxia usually occurs due to cerebral hypoxia. When such features are observed, the diagnosis of traumatic asphyxia should be considered. Prompt treatment with attention to the reestablishment of oxygenation and perfusion may result in good outcomes.	Johns Hopkins Univ Hosp, Dept Surg, Baltimore, MD 21287 USA; Johns Hopkins Univ Hosp, Dept Mol Biol, Baltimore, MD 21287 USA; Washington Cty Hosp, Hagerstown, MD USA		Koniaris, LG (corresponding author), Johns Hopkins Univ Hosp, Dept Mol Biol & Genet, 725 N Wolfe St,607 PCTB, Baltimore, MD 21205 USA.						CHOUINARD MJ, 1993, J CLIN EXP NEUROPSYC, V15, P591, DOI 10.1080/01688639308402581; D'Angers O, 1837, ANN HYG, V18, P485; DiMaio D., 2000, CRC SER PR CRIM, P230; ECTORS P, 1979, J NEUROSURG, V51, P375, DOI 10.3171/jns.1979.51.3.0375; FELDMAN EA, 1969, J TRAUM, V9, P347, DOI 10.1097/00005373-196904000-00008; Finch M, 1997, BRAIN INJURY, V11, P713, DOI 10.1080/026990597123089; FRED HL, 1960, AM J MED, V29, P508, DOI 10.1016/0002-9343(60)90046-2; JONGEWAARD WR, 1992, J TRAUMA, V32, P28, DOI 10.1097/00005373-199201000-00006; LANDERCASPER J, 1985, J TRAUMA, V25, P838, DOI 10.1097/00005373-198509000-00005; SANDIFORD JA, 1974, J TRAUMA, V14, P805, DOI 10.1097/00005373-197409000-00011; SCHIOWITZ MF, 1991, AM J EMERG MED, V9, P325, DOI 10.1016/0735-6757(91)90051-K; SKLAR DP, 1988, AM J EMERG MED, V6, P219; THOMPSON A, 1989, ANN THORAC SURG, V47, P247, DOI 10.1016/0003-4975(89)90279-8; WILLIAMS JS, 1968, ANN SURG, V167, P384, DOI 10.1097/00000658-196803000-00012	14	3	3	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0038-4348	1541-8243		SOUTH MED J	South.Med.J.	SEP	2000	93	9					905	908					4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353LC	WOS:000089274800014	11005353				2022-02-06	
J	Godfrey, HPD; Unsworth, R; Linscott, RJ; Sander, MR				Godfrey, HPD; Unsworth, R; Linscott, RJ; Sander, MR			Psychometric evaluation of the profile of functional impairment in communication with traumatically brain-injured children	NEW ZEALAND JOURNAL OF PSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; ADOLESCENTS	The Profile of Functional Impairment of Communication (PFIC) was employed to examine communication by children with a traumatic brain-injury (TBI) during a family problem-solving discussion. Communication by 11 children with a TBI was compared with that of 11 children with orthopaedic injuries. Children with a TBI evidenced impaired communication on five of the 10 subscales of the PFIC. Injury severity was significantly correlated with scores on nine of the 10 PFIC subscales. Adequate inter-rater reliability was found for eight of the PFIC subscales. These results provide encouraging preliminary evidence for the use of the PFIC in assessing children with a TBI.	Univ Otago, Dept Psychol, Dunedin, New Zealand		Godfrey, HPD (corresponding author), Univ Otago, Dept Psychol, POB 56, Dunedin, New Zealand.		Linscott, Richard J/C-1431-2008	Linscott, Richard J/0000-0001-5456-917X			CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; ELLEY WB, 1985, NEW ZEAL J EDUC STUD, V20, P115; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; Godfrey HPD, 1996, J HEAD TRAUMA REHAB, V11, P29, DOI 10.1097/00001199-199612000-00006; GODFREY HPD, IN PRESS J SPEECH HE; Grice H. P., 1975, SYNTAX SEMANTICS, P41; GRICE HP, 1978, PRAGMATICS, V0001, P00013; Jennett B, 1981, MANAGEMENT HEAD INJU; JORDAN FM, 1993, APHASIOLOGY, V7, P503, DOI 10.1080/02687039308248626; Linscott RJ, 1996, BRAIN INJURY, V10, P397, DOI 10.1080/026990596124269; LINSCOTT RJ, 1993, UNPUB MANUAL PROFILE; MCDONALD CM, 1994, ARCH PHYS MED REHAB, V75, P328, DOI 10.1016/0003-9993(94)90038-8; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; ROBIN AL, 1981, BEHAV THER, V12, P593, DOI 10.1016/S0005-7894(81)80132-3; RUSSELL WR, 1961, TRAUMATIC AMNESIAS; WILSON JTL, 1994, J NEUROL NEUROSUR PS, V57, P198, DOI 10.1136/jnnp.57.2.198; Ylvisaker M., 1986, J HEAD TRAUMA REHAB, V1, P48	17	3	3	0	3	NEW ZEALAND PSYCHOL SOC	WELLINGTON	BUSINESS MANAGER PO BOX 4092, WELLINGTON, NEW ZEALAND	0112-109X			NEW ZEAL J PSYCHOL	N. Z. J. Psychol.	JUN	2000	29	1					20	23					4	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	344AL	WOS:000088735400004					2022-02-06	
J	Rosenow, J; Das, K; Weitzner, I; Couldwell, WT				Rosenow, J; Das, K; Weitzner, I; Couldwell, WT			Rupture of a large ophthalmic segment saccular aneurysm associated with closed head injury: Case report	NEUROSURGERY			English	Article						giant aneurysm; head injury; subarachnoid hemorrhage	HEMORRHAGE	OBJECTIVE AND IMPORTANCE: Although each year approximately 30,000 to 50,000 cases of subarachnoid hemorrhage in the United States are caused by the rupture of intracranial saccular aneurysms, there is little information in the literature documenting the association of aneurysmal rupture with closed head injury. CLINICAL PRESENTATION: A 61-year-old woman presented after a motor vehicle accident with multiple injuries, including a severe closed head injury. Computed tomography revealed a diffuse basal subarachnoid hemorrhage. Angiography revealed the source as a large aneurysm arising from the ophthalmic segment of the left carotid artery. INTERVENTION: After the patient was stabilized for her multiple injuries, she underwent craniotomy and clipping of the aneurysm. She recovered without developing new neurological deficits. CONCLUSION: Although the association of head trauma and aneurysmal subarachnoid hemorrhage is rave, the presence of significant basal subarachnoid blood on a computed tomographic scan should alert the physician to the possibility of a ruptured aneurysm.	New York Med Coll, Dept Neurosurg, Valhalla, NY 10595 USA; New York Med Coll, Dept Radiol, Valhalla, NY 10595 USA		Couldwell, WT (corresponding author), New York Med Coll, Dept Neurol Surg, Munger Pavil,Room 329, Valhalla, NY 10595 USA.						BLAU A, 1978, CAN J NEUROL SCI, V5, P263, DOI 10.1017/S031716710002432X; DAY AL, 1990, J NEUROSURG, V72, P677, DOI 10.3171/jns.1990.72.5.0677; de Villiers J, 1975, Forensic Sci, V5, P11, DOI 10.1016/0300-9432(75)90082-5; DRAKE CG, 1979, CLIN NEUROSURG, V26, P12; HEIDRICH R, 1972, HDB CLINICAL NEUROLO, V12, P68; HUNT WE, 1962, J NEUROSURG, V19, P34, DOI 10.3171/jns.1962.19.1.0034; LOCKSLEY HB, 1966, J NEUROSURG, V25, P219, DOI 10.3171/jns.1966.25.2.0219; LONGSTRETH WT, 1985, STROKE, V16, P377, DOI 10.1161/01.STR.16.3.377; MCCORMICK WF, 1980, AM J FOREN MED PATH, V1, P223, DOI 10.1097/00000433-198009000-00006; MCCORMICK WF, 1970, J NEUROSURG, V33, P422, DOI 10.3171/jns.1970.33.4.0422; NOMES H, 1973, J NEUROSURG, V39, P226; SACCO RL, 1984, NEUROLOGY, V34, P847, DOI 10.1212/WNL.34.7.847; Sahjpaul RL, 1998, J NEUROSURG, V89, P822, DOI 10.3171/jns.1998.89.5.0822; STEHBENS WE, 1979, HEMODYNAMICS BLOOD V, P465; *US DEP HHS, 1992, DET DIAGN PROC NAT H; Wiebers D, 1998, NEW ENGL J MED, V339, P1725, DOI 10.1056/nejm199812103392401	16	3	4	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	JUN	2000	46	6					1515	1517		10.1097/00006123-200006000-00041			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	316WU	WOS:000087191700100	10834656				2022-02-06	
J	Katzlberger, F; Oder, W				Katzlberger, F; Oder, W			Psychosocial sequelae after severe head injury - Interviews of patients and their relatives in comparison	PSYCHOTHERAPIE PSYCHOSOMATIK MEDIZINISCHE PSYCHOLOGIE			German	Article						rehabilitation after severe head trauma; assessing signs; follow-up investigations; psychosocial factors; psychotherapy	TRAUMATIC BRAIN INJURY; FOLLOW-UP; REHABILITATION; PSYCHOTHERAPY; SURVIVORS; ILLNESS; SPECT	Head injury patients often suffer from psychosocial sequelae in the long-term. Since patient reports are regarded as little reliable due to lack of awareness, we compared the patients' to the relatives' view of such sequelae. By means of a semi-structured interview, 37 patients and their relatives were investigated on average 4.4 years after severe head injury. Psychosocial and neuropsychological effects were markedly severe in most cases. However, patients' compared to relatives' perspectives differed significantly only regarding report of aggressive-disinhibited behaviour of the patients, which was more often reported on by the relatives than by the patients themselves. This difference was also found in respect of pre-injury behaviour. Surprisingly, in six patients "positive" psychosocial sequelae were reported. For example, a patient said he had become more tender and more serious. Residual morphological findings in these six patients were either rather minor, or marked left-brain lesions. We conclude that the patients' significant other signs should be included in diagnostic and therapeutic efforts of rehabilitation procedures. Since besides neuropsychological factors psychosocial factors seem to influence outcome after brain injury, psychotherapeutic techniques should be more intensively studied in treatment of head injury patients.	AUVA, Neurotraumatol Rehabil Zentrum Meidling, Vienna, Austria								BECKER ME, 1993, BRAIN INJURY, V7, P515, DOI 10.3109/02699059309008179; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; CHRISTENSEN AL, 1992, ACTA NEUROL SCAND, V85, P32; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; Fleming JM, 1996, BRAIN INJURY, V10, P1; Frankowski R F, 1986, Adv Psychosom Med, V16, P153; Gauggel S, 1997, PSYCHOTHERAPEUT, V42, P51, DOI 10.1007/s002780050054; Goldbeck R, 1997, J PSYCHOSOM RES, V43, P575, DOI 10.1016/S0022-3999(97)00168-2; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; HOFMANNSTOCKER E, 1990, Z NEUROPSYCHOLOGIE, V1, P75; JENNETT B, 1990, REHABILITATION ADULT; JOCHIMS S, 1990, PSYCHOTHER PSYCH MED, V40, P115; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; KAITARO T, 1995, BRAIN INJURY, V9, P713, DOI 10.3109/02699059509008227; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V16, P88; Livingston M G, 1985, Int Rehabil Med, V7, P145; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P474; PRAYER L, 1993, ACTA RADIOL, V34, P593; ROSENTHAL M, 1990, REHABILITATION ADULT; SCHALEN W, 1994, BRAIN INJURY, V8, P49, DOI 10.3109/02699059409150958; Spatt J, 1997, ACTA NEUROL SCAND, V95, P173, DOI 10.1111/j.1600-0404.1997.tb00091.x; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; [No title captured]	27	3	3	0	4	GEORG THIEME VERLAG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0937-2032			PSYCHOTHER PSYCH MED	Psychother. Psychosom. Med. Psychol.	MAY	2000	50	5					209	214		10.1055/s-2000-13248			6	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	316AQ	WOS:000087145500004	10857394				2022-02-06	
J	Reeves, RH; Beltzman, D; Killu, K				Reeves, RH; Beltzman, D; Killu, K			Implications of traumatic brain injury for survivors of sexual abuse: A preliminary report of findings	REHABILITATION PSYCHOLOGY			English	Article							POSTTRAUMATIC-STRESS	The authors' purpose for presenting these cases is to report on some clinical observations that may have relevance for a subgroup of individuals recovering from a traumatic brain injury. Specifically, the authors observe that a group of patients who reported histories of childhood sexual trauma and then sustained a TBI as adults are experiencing a reemergence of intrusive recollections and other symptoms related to the abuse. Further, the appearance of these posttraumatic stress-type symptoms-sometimes after years of nonoccurrence- frequently proves disruptive to the patient's rehabilitation process. Possible structural, chemical, and phenomenological factors are discussed. The authors' observations raise the possibility that individuals who have made the best recoveries from childhood sexual trauma are the most vulnerable to the reemergence of posttraumatic stress disorder symptoms subsequent to the TBI. These provisory observations would suggest that sensitive inquiry regarding abuse history should be considered as part of any clinical interview with patients who have sustained neurological trauma.	Univ Michigan, Sch Educ, Dearborn, MI 48128 USA; Special Tree Rehabil Syst, Troy, MI USA; St Joseph Mercy Hosp, Ann Arbor, MI USA		Killu, K (corresponding author), Univ Michigan, Sch Educ, 4901 Evergreen Rd, Dearborn, MI 48128 USA.	kimkillu@umich.edu					BRIERE J, 1989, AM J PSYCHIAT, V146, P1602; Briere JN, 1992, CHILD ABUSE TRAUMA T; FOLLETTE VM, 1994, ACCEPTANCE CHANGE CO, P225; Goleman D., 1995, EMOTIONAL INTELLIGEN; Kraus JF, 1993, HEAD INJURY, P1; Liem JH, 1997, AM J ORTHOPSYCHIAT, V67, P594, DOI 10.1037/h0080257; Lishman W. A., 1987, ORGANIC PSYCHIAT; SOUTHWICK SM, 1993, ARCH GEN PSYCHIAT, V50, P266; VANDERKOLK BA, 1994, HARVARD REV PSYCHIAT, V1, P253, DOI 10.3109/10673229409017088	9	3	3	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2000	45	2					205	211					7	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	315PT	WOS:000087122700007					2022-02-06	
J	Bissonnette, B				Bissonnette, B			From the macroscopic lesion to cellular ischaemia.	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article						head trauma	ISCHEMIC BRAIN-DAMAGE; HEAD-INJURY; ANTAGONISTS; TRAUMA	Traumatic brain injury (TBI) constitutes a major health and economic problem for developed countries, being one of the main causes of mortality and morbidity in children and young adults. Because of the immense importance and future consequences of TBI, the physician who sees a patient soon after brain injury must have a complete understanding of the pathophysiology and develop a practical knowledge of initial management of such patients. TBI may have intracranial and systemic effects that combine to give overall cerebral ischaemia. Injury to the nervous system is characterised by a stereotypic pattern, irrespective of the primary injury. The primary injury initiates a multitude of inflammatory cascades resulting in secondary brain injury, the effect of which is as important as the primary injury. This period of brain inflammation can last up to three weeks and renders the brain more susceptible to the effects of systemic insults such as hypotension, hypoxia and/or pyrexia. It has been shown in postmortem examination of patients dying from severe TBI that more than 90% had evidence of secondary ischaemic damage. The concept of 'cerebral protection' has been extended to encompass pretreatment of secondary injury. Preventing and treating cerebral ischaemia is the main goal of initial management of head-injured patients. Initial care focuses on achieving oxygenation, airway control and treatment of arterial hypotension. (C) 2000 Editions scientifiques et medicales Elsevier SAS.	Hosp Sick Children, Dept Anaesthesia, Div Neurosurg Anasthesia & Cardiovasc Anaesthesia, Toronto, ON M5G 1X8, Canada		Bissonnette, B (corresponding author), Hosp Sick Children, Dept Anaesthesia, Div Neurosurg Anasthesia & Cardiovasc Anaesthesia, Toronto, ON M5G 1X8, Canada.						ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; BISSONNETTE B, 1997, PAED AN C, P46; CHOI DW, 1988, J NEUROSCI, V8, P185; CHOI DW, 1993, P NATL ACAD SCI USA, V90, P9741, DOI 10.1073/pnas.90.21.9741; GENTLEMAN D, 1993, BRIT MED J, V307, P547, DOI 10.1136/bmj.307.6903.547; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; MCCULLOCH J, 1992, BRIT J CLIN PHARMACO, V34, P106, DOI 10.1111/j.1365-2125.1992.tb04118.x; MCNICHOLL BP, 1994, INJURY, V25, P251, DOI 10.1016/0020-1383(94)90073-6; Vigue B, 1999, INTENS CARE MED, V25, P445, DOI 10.1007/s001340050878	9	3	3	0	0	EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS CEDEX 15	23 RUE LINOIS, 75724 PARIS CEDEX 15, FRANCE	0750-7658			ANN FR ANESTH	Ann. Fr. Anest. Reanim.	APR	2000	19	4					270	274					5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	313GX	WOS:000086992900009	10836113				2022-02-06	
J	Spitz, MC; Towbin, JA; Shantz, D				Spitz, MC; Towbin, JA; Shantz, D			Closed head injury resulting in paradoxical improvement of a seizure disorder	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						epilepsy; intractable; remission; trauma; surgery; temporal lobe	POST-TRAUMATIC EPILEPSY; LATERALIZATION	People with epilepsy are prone to head injuries and these traumas are usually considered adverse events. We report the case of a 31-year-old woman who sustained a closed head injury as a result of a seizure. This accidental trauma resulted in a 1-year remission of her previously intractable complex partial seizures. The paradoxical improvement of a seizure disorder can occur as a result of a closed head injury. We postulate it simulated ablative epilepsy surgery. (C) 2000 BEA Trading Ltd.	Univ Colorado, Hlth Sci Ctr, Denver, CO 80262 USA		Spitz, MC (corresponding author), Univ Colorado, Hlth Sci Ctr, Box B150,4200 E 9th Ave, Denver, CO 80262 USA.		Towbin, Jeffrey A./J-5595-2019	Towbin, Jeffrey A./0000-0002-6585-714X			ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Buck D, 1997, EPILEPSIA, V38, P439, DOI 10.1111/j.1528-1157.1997.tb01733.x; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; Cukiert A, 1992, Arq Neuropsiquiatr, V50, P365; DESAI BT, 1983, EPILEPSIA, V24, P289, DOI 10.1111/j.1528-1157.1983.tb04892.x; ENGE J, 1994, SURG TREATMENT EPILE; FEENEY DM, 1979, ARCH NEUROL-CHICAGO, V36, P8, DOI 10.1001/archneur.1979.00500370038005; GABR M, 1989, ANN NEUROL, V25, P82, DOI 10.1002/ana.410250113; HAUSER WA, 1984, NEUROLOGY, V34, P746, DOI 10.1212/WNL.34.6.746; JENNETT WB, 1975, EPILEPSY NONMISSILE; LUDERS H, 1992, EPILEPSY SURG; Pedley T. A., 1980, American Journal of EEG Technology, V20, P101; PRIVITERA MD, 1991, ANN NEUROL, V30, P391, DOI 10.1002/ana.410300311; QUESNEY LF, 1986, EPILEPSIA S2, V27, P27; WYLLIE E, 1986, NEUROLOGY, V36, P606, DOI 10.1212/WNL.36.5.606	15	3	3	0	2	W B SAUNDERS CO LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1059-1311			SEIZURE-EUR J EPILEP	Seizure	MAR	2000	9	2					142	144		10.1053/seiz.1999.0360			3	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	332FP	WOS:000088063800012	10845740	Bronze			2022-02-06	
J	Goldstein, LB; Vitek, MP; Dawson, H; Bullman, S				Goldstein, LB; Vitek, MP; Dawson, H; Bullman, S			Expression of the apolipoprotein E gene does not affect motor recovery after sensorimotor cortex injury in the mouse	NEUROSCIENCE			English	Article						motor cortex; recovery; knockout mice; locomotion	E-DEFICIENT MICE; TRAUMATIC BRAIN INJURY; E EPSILON-4 ALLELE; ALZHEIMER-DISEASE; NEURITE OUTGROWTH; HEAD-INJURY; CEREBRAL-CORTEX; APOE GENOTYPE; KNOCKOUT MICE; TYPE-4 ALLELE	Motor recovery after unilateral sensorimotor cortex ablation or sham-injury was measured in apolipoprotein E knockout and wild-type mice by testing their abilities to traverse a narrow beam. All mice trained without difficulty. Sham-operated mice performed perfectly regardless of genotype throughout testing. There was no difference in motor scores between lesioned apolipoprotein E knockout and wild-type mice on a first trial 24 h after injury (P > 0.05). There was a significant overall effect of lesion on motor performance (two-way repeated measures analysis of variance F-1,F-42 = 304, P < 0.0001), a significant time effect (F-17,F-714 = 58, P < 0.0001) and a lesion by time interaction (F-17,F-714 = 58, P < 0.0001). However, there was no effect of apolipoprotein E genotype group on recovery rate (i.e, there was no lesion group by genotype group by time interaction, F-17,F-714 = 0.33, P = 1.00) and no effect of genotype on the final level of motor performance 12 days after the lesion (Kruskal-Wallis H = 5.79, P = 0.12). These data suggest that motor recovery after unilateral injury to the sensorimotor cortex does not vary with apolipoprotein E genotype. (C) 2000 IBRO, Published by Elsevier Science Ltd. All rights reserved.	Duke Univ, Med Ctr, Duke Ctr Cerebrovasc Dis, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med Neurol, Durham, NC 27710 USA; Durham Dept Vet Affairs Med Ctr, Durham, NC USA		Goldstein, LB (corresponding author), Duke Univ, Med Ctr, Duke Ctr Cerebrovasc Dis, Box 3651, Durham, NC 27710 USA.			Vitek, Michael/0000-0001-8140-8048			ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; Anderson R, 1998, NEUROSCIENCE, V85, P93, DOI 10.1016/S0306-4522(97)00598-8; Anderson R, 1997, PSYCHOPHARMACOLOGY, V132, P135, DOI 10.1007/s002130050329; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; GOLDSTEIN LB, 1990, J NEUROSCI METH, V31, P101, DOI 10.1016/0165-0270(90)90154-8; GOLDSTEIN LB, 1995, NEUROLOGY, V45, P865, DOI 10.1212/WNL.45.5.865; GOLDSTEIN LB, 1993, J NEUROSCI METH, V48, P35, DOI 10.1016/S0165-0270(05)80005-6; GOLDSTEIN LB, 1990, J NEURO REHAB, V4, P137; GOLDSTEIN LB, 1990, BEHAV NEUROSCI, V104, P318; GOLDSTEIN LB, 1993, NEUROSCI PROTOCOLS, V10, P1; GORDON I, 1995, NEUROSCI LETT, V199, P1, DOI 10.1016/0304-3940(95)12006-P; HANDELMANN GE, 1992, J LIPID RES, V33, P1677; HEINEMANN AW, 1987, ARCH NEUROL-CHICAGO, V44, P1167, DOI 10.1001/archneur.1987.00520230051013; HOLTZMAN DM, 1995, P NATL ACAD SCI USA, V92, P9480, DOI 10.1073/pnas.92.21.9480; JORDAN BD, 1995, ANN NEUROL, V38, P698, DOI 10.1002/ana.410380429; Krugers HJ, 1997, NEUROREPORT, V8, P2505, DOI 10.1097/00001756-199707280-00018; Laskowitz DT, 1997, J CEREBR BLOOD F MET, V17, P753; Laskowitz DT, 1997, J NEUROIMMUNOL, V76, P70, DOI 10.1016/S0165-5728(97)00021-0; Laskowitz DT, 1998, J CEREBR BLOOD F MET, V18, P465, DOI 10.1097/00004647-199805000-00001; Laskowitz DT, 1998, ALZHEIMERS REP, V1, P5; LINCOLN NB, 1989, J NEUROL NEUROSUR PS, V52, P493, DOI 10.1136/jnnp.52.4.493; Masliah E, 1997, BRAIN RES, V751, P307, DOI 10.1016/S0006-8993(96)01420-5; McCarron MO, 1998, STROKE, V29, P1882, DOI 10.1161/01.STR.29.9.1882; MERRILL JE, 1993, J IMMUNOL, V151, P2132; NATHAN BP, 1995, J BIOL CHEM, V270, P19791, DOI 10.1074/jbc.270.34.19791; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Oitzl MS, 1997, BRAIN RES, V752, P189, DOI 10.1016/S0006-8993(96)01448-5; OXBURY JM, 1975, BRIT MED J, V3, P125, DOI 10.1136/bmj.3.5976.125; PEARLSON GD, 1981, BRAIN RES, V218, P233, DOI 10.1016/0006-8993(81)91303-2; PETITO CK, 1987, NEUROLOGY, V37, P1281, DOI 10.1212/WNL.37.8.1281; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; POIRIER J, 1991, MOL BRAIN RES, V11, P97, DOI 10.1016/0169-328X(91)90111-A; POIRIER J, 1993, NEUROSCIENCE, V55, P81, DOI 10.1016/0306-4522(93)90456-P; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Puttfarcken PS, 1997, J NEUROCHEM, V68, P760; ROSES AD, 1994, J NEUROPATH EXP NEUR, V53, P429, DOI 10.1097/00005072-199409000-00002; Rosner B, 1986, FUNDAMENTALS BIOSTAT; Royle SJ, 1999, BRAIN RES, V816, P337, DOI 10.1016/S0006-8993(98)01122-6; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SAUNDERS DE, 1995, STROKE, V26, P1007, DOI 10.1161/01.STR.26.6.1007; Seliger Glenn, 1997, Neurology, V48, pA213; Sheng HX, 1998, J CEREBR BLOOD F MET, V18, P361, DOI 10.1097/00004647-199804000-00003; Sheng HX, 1999, STROKE, V30, P1118, DOI 10.1161/01.STR.30.5.1118; Slooter AJC, 1997, JAMA-J AM MED ASSOC, V277, P818, DOI 10.1001/jama.277.10.818; Sorbi S., 1996, Neurology, V46, pA307; Stone DJ, 1998, J NEUROSCI, V18, P3180; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; STRITTMATTER WJ, 1994, EXP NEUROL, V125, P163, DOI 10.1006/exnr.1994.1019; SZELE FG, 1995, J NEUROSCI, V15, P4429; Tardiff BE, 1997, ANN THORAC SURG, V64, P715, DOI 10.1016/S0003-4975(97)00757-1; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Teter B., 1999, Society for Neuroscience Abstracts, V25, P1346; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249	59	3	3	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience		2000	99	4					705	710		10.1016/S0306-4522(00)00234-7			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	353AD	WOS:000089250800012	10974433				2022-02-06	
J	Nast-Kolb, D				Nast-Kolb, D			Medical, ethical and economical limitations in the treatment of multi-trauma patients	ANAESTHESIST			German	Article						head injury; shock; multiple organ failure; ethics; economy	GERIATRIC TRAUMA; INJURY PATTERN; MAJOR TRAUMA; CARE; FRACTURES; SURVIVAL; COSTS	In the early post-traumatic period severe traumatic brain injuries and massive bleeding from disrupted parenchymal organs, large vessels or crush injuries of the pelvis may present as morphological damage that renders survival impossible, although aggressive fluid and blood replacement therapy in conjunction with immediately stopping blood loss surgically may result in survival in selected cases. In contrast, late mortality from multiple organ failure which in the past limited survival in 10 to 30% of patients in that condition - has in recent yea rs reduced this as the cause of death to less than 5%. Part of the responsibility of the surgeon careing for the severely injured into consider the ethical limitations to avoid futile use of the sophisticated lifesupport measures in the intensive care setting. A threat to optimal care of the severely injured patient may arise from the economical restraints imposed on healthcare providers. When one considers the enormous political and socioeconomical importance of rehabilitating the predominantly young trauma patients and reintegrating them into the work world, an appeal has to be made to all those responsible to secure optimal ca re for severely injured patients in the future.	Univ Essen Gesamthsch, Klin & Poliklin Unfallchirurg, Essen, Germany		Nast-Kolb, D (corresponding author), Univ Klinikum Essen, Klin & Poliklin Unfallchirurg, Hufelandstr 55, D-45122 Essen, Germany.						BARDENHEUER M, UNFALLCHIRURG; BROOS PLO, 1993, ACTA CHIR BELG, P126; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; FINELLI FC, 1989, J TRAUMA, V29, P541, DOI 10.1097/00005373-198905000-00001; FROWEIN RA, 1978, CHIRURG, V49, P663; HORST HM, 1986, CRIT CARE MED, V14, P681, DOI 10.1097/00003246-198608000-00003; LORENZ HP, 1992, J TRAUMA, V32, P780, DOI 10.1097/00005373-199206000-00020; Meyerhof M, 1931, DT Z CHIR, V231, P645; Nast-Kolb D, 1999, UNFALLCHIRURG, V102, P338, DOI 10.1007/s001130050415; NASTKOLB D, 1991, HEFTE UNFALLHEILKD, V215, P1; Neudeck F, 1996, J TRAUMA, V40, P980, DOI 10.1097/00005373-199606000-00020; Obertacke U, 1997, UNFALLCHIRURG, V100, P44, DOI 10.1007/s001130050094; ORESKOVICH MR, 1984, J TRAUMA, V24, P565, DOI 10.1097/00005373-198407000-00003; PAAR O, 1992, UNFALLCHIRURG, V95, P78; PAPE HC, 1995, ORTHOPADE, V24, P164; REGEL G, 1993, UNFALLCHIRURG, V96, P350; ROSEMURGY AS, 1993, J TRAUMA, V35, P468, DOI 10.1097/00005373-199309000-00022; Ruchholtz S, 1996, UNFALLCHIRURG, V99, P633, DOI 10.1007/s001130050036; RUCHHOLTZ S, 1995, CHIRURG, V66, P684; RUCHHOLTZ S, IN PRESS CRIT CARE M; SCALEA TM, 1990, J TRAUMA, V30, P129, DOI 10.1097/00005373-199002000-00001; Schweiber L., 1996, Intensivmedizin und Notfallmedizin, V33, P51; SEEKAMP A, 1994, UNFALLCHIRURG, V97, P57; SHAPIRO MB, 1994, AM SURGEON, V60, P695; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28; Waydhas C, 1996, J TRAUMA, V40, P624, DOI 10.1097/00005373-199604000-00018; WILSON RF, 1994, CRIT CARE CLIN, V10, P461, DOI 10.1016/S0749-0704(18)30114-3	28	3	3	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0003-2417	1432-055X		ANAESTHESIST	Anaesthesist	JAN	2000	49	1					51	57		10.1007/s001010050009			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	281ZY	WOS:000085192400009	10662989				2022-02-06	
J	Radanov, BP				Radanov, BP			Controversy about brain damage following cranio-cervical acceleration-deceleration trauma	JOURNAL OF MUSCULOSKELETAL PAIN			English	Article							LATE WHIPLASH SYNDROME; MILD HEAD-INJURY; SOFT-TISSUE INJURIES; CEREBRAL BLOOD-FLOW; TECHNETIUM-99M-HMPAO SPECT; SYMPTOMS; DYSFUNCTION; LONG; PET; CONCUSSION	Objectives: To ascertain the levels of trauma from an acceleration-deceleration event which would expose a person to brain trauma, and to suggest clinical guidelines to the evaluation of injury outcomes which would indicate significant brain trauma was a potential sequelae. Methods: The brain-injury literature that related to clinical, psychological, biomechanical, and imaging studies was reviewed and compared for correlation to injury outcomes. Results: The severity of cranio-cervical tissue damage is clearly correlated to the degree of acceleration-deceleration trauma exposure. The size of a brain lesion is in a direct correlation to the duration and depth of unconsciousness, and the duration of post-traumatic amnesia. The acceleration-deceleration mechanism of injury would expose the prefrontal, frontal, or temporal cortex to diffuse axonal injury. These brain regions are crucial for complex attentional functioning. Indicators of trauma severity [loss of consciousness] are correlated to both clinical [cognitive impairment] and neuro-imaging findings [PET]. Presumed head-neck trauma that leads to an unconscious period of less than 10 minutes, or an amnesia period that spans less than four hours [a minor concussion] is not likely to cause any lasting brain damage or dysfunctional mental sequelae based on brain trauma. If these relationships cannot be established, factors other than brain damage [pain, adverse effect of medication, alcohol, psychological-personality problems, other agendas] should be considered the basis of complaints following cranio-cervical acceleration-deceleration trauma. Conclusions: Minor trauma exposure without a significant unconscious period, including amnesia, is very unlikely to have caused diffuse axonal injury, nor brain trauma.	Univ Bern, Inselspital, Psychiat Poliklin, CH-3010 Bern, Switzerland		Radanov, BP (corresponding author), Univ Bern, Inselspital, Psychiat Poliklin, CH-3010 Bern, Switzerland.						ADANOV BP, 1999, J NEUROL NEUROSUR PS, V66, P485; ALAVI A, 1994, J NUCL MED, V35, P1466; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BAHR M, 1994, NERVENARZT, V65, P355; Baker SC, 1997, PSYCHOL MED, V27, P565, DOI 10.1017/S0033291797004856; BALLA JI, 1982, CULT MED PSYCHIAT, V6, P191, DOI 10.1007/BF00051428; Bicik I, 1998, NEUROLOGY, V51, P345, DOI 10.1212/WNL.51.2.345; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BRYAN RM, 1990, AM J PHYSIOL, V259, P269; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Diller L, 1994, BRAIN INJURY NEUROPS, P1; DOLAN RJ, 1992, J NEUROL NEUROSUR PS, V55, P768, DOI 10.1136/jnnp.55.9.768; DOLAN RJ, 1994, PSYCHOL MED, V24, P849, DOI 10.1017/S0033291700028944; ELSON LM, 1994, SEMIN NEUROL, V14, P8, DOI 10.1055/s-2008-1041053; ESSELMAN PC, 1995, BRAIN INJURY, V9, P17; ETTLIN TM, 1992, J NEUROL NEUROSUR PS, V55, P943, DOI 10.1136/jnnp.55.10.943; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Fiez JA, 1996, J NEUROSCI, V16, P808; Fletcher PC, 1997, TRENDS NEUROSCI, V20, P213, DOI 10.1016/S0166-2236(96)01013-2; GARGAN MF, 1990, J BONE JOINT SURG BR, V72, P901, DOI 10.1302/0301-620X.72B5.2211780; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; GEORGE MS, 1995, AM J PSYCHIAT, V152, P341; Goldman-Rakic P. S., 1994, MOTOR COGNITIVE FUNC, P112; GRONWALL D, 1975, LANCET, V2, P995; GRONWALL D, 1974, LANCET, V2, P605; HAYES RL, 1994, SEMIN NEUROL, V14, P25, DOI 10.1055/s-2008-1041055; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; ICHISE M, 1994, J NUCL MED, V35, P217; JACOBS A, 1994, J NUCL MED, V35, P942; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jennett B, 1981, MANAGEMENT HEAD INJU; KATZ DI, 1989, NEUROLOGY, V39, P897, DOI 10.1212/WNL.39.7.897; KAY T, 1992, PHYSICAL MED REHABIL, V6, P109; KEIDEL M, 1992, NERVENARZT, V63, P731; KISCHKA U, 1991, EUR NEUROL, V31, P136, DOI 10.1159/000116663; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LOESSNER A, 1995, J NUCL MED, V36, P1141; Lord SM, 1996, SPINE, V21, P1737, DOI 10.1097/00007632-199608010-00005; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; Mayou R, 1996, INJURY, V27, P617, DOI 10.1016/S0020-1383(96)00114-3; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; MILLER H, 1961, BRIT MED J, V1, P992, DOI 10.1136/bmj.1.5231.992; Muri RM, 1996, J NEUROPHYSIOL, V76, P2102, DOI 10.1152/jn.1996.76.3.2102; NAKAMURA S, 1991, PROG BRAIN RES, V88, P587; NAKAMURA S, 1991, BRAIN RES BULL, V26, P759, DOI 10.1016/0361-9230(91)90172-G; NEWCOMBE F, 1994, J NEUROL NEUROSUR PS, V57, P709, DOI 10.1136/jnnp.57.6.709; OMMAYA K, 1975, HDB CLIN NEUROLOGY, P67; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Otte A, 1996, EUR J NUCL MED, V23, P72, DOI 10.1007/BF01736993; OTTE A, 1995, LANCET, V345, P1513, DOI 10.1016/S0140-6736(95)91075-1; Otte A, 1997, J NUCL MED, V38, P1002; PENTREATH VW, 1986, NEUROCHEM INT, V9, P1, DOI 10.1016/0197-0186(86)90025-2; RADANOV B, 1986, FORTSCHR NEUROL PSYC, V54, P375, DOI 10.1055/s-2007-1001942; RADANOV BP, 1991, LANCET, V338, P712, DOI 10.1016/0140-6736(91)91441-V; RADANOV BP, 1995, MEDICINE, V74, P281, DOI 10.1097/00005792-199509000-00005; Radanov BP, 1996, PAIN, V64, P429, DOI 10.1016/0304-3959(95)00148-4; RADANOV BP, 1989, SCHWEIZ MED WSCHR, V119, P536; RADANOV BP, 1992, SPINE, V17, P127, DOI 10.1097/00007632-199202000-00001; RADANOV BP, 1996, J MUSCULOSKELET PAIN, V4, P47; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Schellhas KP, 1996, SPINE, V21, P300, DOI 10.1097/00007632-199602010-00009; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; STURZENEGGER M, 1994, NEUROLOGY, V44, P688, DOI 10.1212/WNL.44.4.688; STUSS DT, 1995, NEUROLOGY, V45, P1251, DOI 10.1212/WNL.45.7.1251; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; TRELEAVEN J, 1994, CEPHALALGIA, V14, P273, DOI 10.1046/j.1468-2982.1994.1404273.x; Wallis BJ, 1997, PAIN, V73, P15, DOI 10.1016/S0304-3959(97)00060-2; Wallis BJ, 1996, PAIN, V66, P223, DOI 10.1016/0304-3959(96)03044-8; WANG GJ, 1994, J NUCL MED, V35, P1457; WATKINSON A, 1991, INJURY, V22, P307, DOI 10.1016/0020-1383(91)90012-4; Wilson B, 1994, BRAIN INJURY NEUROPS, P85; World Health Organization, 1992, ICD 10 CLASSIFICATIO	77	3	3	0	3	HAWORTH PRESS INC	BINGHAMTON	10 ALICE ST, BINGHAMTON, NY 13904-1580 USA	1058-2452			J MUSCULOSKELET PAIN	J. Musculoskelet. Pain		2000	8	1-2					179	192		10.1300/J094v08n01_15			14	Rehabilitation; Rheumatology	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Rheumatology	330GV	WOS:000087955200017					2022-02-06	
J	Wang, JN; Tsai, YC; Chen, SL; Chen, Y; Lin, CS; Wu, JM				Wang, JN; Tsai, YC; Chen, SL; Chen, Y; Lin, CS; Wu, JM			Dangerous impact - Commotio cordis	CARDIOLOGY			English	Article						commotio cordis; cardiac contussion; blunt chest trauma; ventricular fibrillation; bifascicular block; sports, injuries	BLUNT CARDIAC TRAUMA; SUDDEN-DEATH; CHEST; SPORTS	Sudden death following blunt chest trauma is a frightening occurrence known as 'commotio cordis' or 'concussion of the heart', It is speculated that commotio cordis could be caused by ventricular fibrillation secondary to an impact-induced energy that was transmitted via the chest wall to the myocardium during its vulnerable repolarization period. We describe a survivor of commotio cordis caused by a baseball. In this patient, an initial ventricular fibrillation was documented and converted by direct current defibrillation. Serial electrocardiographic changes (bifascicular conduction block and T wave inversion in precordial leads) were noticed in this patient. Our case suggested that coronary vasospasm might also play a role in commotio cordis, Copyright (C) 2000 S. Karger AG, Basel.	Natl Cheng Kung Univ Hosp, Dept Pediat, Tainan 70428, Taiwan; Tainan Municipal Hosp, Dept Pediat, Tainan, Taiwan; Tainan Municipal Hosp, Dept Emergency Med, Tainan, Taiwan		Wu, JM (corresponding author), Natl Cheng Kung Univ Hosp, Dept Pediat, 138 Sheng Li Rd, Tainan 70428, Taiwan.						ABRUNZO TJ, 1991, AM J DIS CHILD, V145, P1279, DOI 10.1001/archpedi.1991.02160110071023; Crown LA, 1997, AM FAM PHYSICIAN, V55, P2467; GREEN ED, 1980, ANN EMERG MED, V9, P155, DOI 10.1016/S0196-0644(80)80272-1; KAPLAN JA, 1993, J TRAUMA, V34, P151, DOI 10.1097/00005373-199301000-00030; LIEDTKE AJ, 1980, J TRAUMA, V20, P777, DOI 10.1097/00005373-198009000-00012; Link MS, 1998, CHEST, V114, P326, DOI 10.1378/chest.114.1.326; MARON BJ, 1995, NEW ENGL J MED, V333, P337, DOI 10.1056/NEJM199508103330602; Maron BJ, 1999, J CARDIOVASC ELECTR, V10, P114, DOI 10.1111/j.1540-8167.1999.tb00648.x; TENZER ML, 1985, J TRAUMA, V25, P620, DOI 10.1097/00005373-198507000-00008	9	3	5	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0008-6312	1421-9751		CARDIOLOGY	Cardiology		2000	93	1-2					124	126		10.1159/000007013			3	Cardiac & Cardiovascular Systems	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	336HW	WOS:000088296700020	10894918				2022-02-06	
J	Hobbs, A				Hobbs, A			Mapping variation in brain structure and function: Implications for rehabilitation	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						neuroinformatics; Human Brain Project	EINSTEIN,ALBERT	The recognition of structural and functional variability of the human brain promoted the development of a system to organize and analyze the rapidly growing body of knowledge acquired among diverse disciplines. The Human Brain Project (HBP) was initiated and has evolved as a means of establishing an information infrastructure through tools related to the emerging science of neuroinformatics. This article mill briefly describe the implications that such an endeavor has for the field of traumatic brain injury (TBI) rehabilitation.	Kaiser Fdn, Rehabil Ctr, Dept Res & Informat, Vallejo, CA 94589 USA		Hobbs, A (corresponding author), Kaiser Fdn, Rehabil Ctr, Dept Res & Informat, 975 Sereno Dr, Vallejo, CA 94589 USA.						Anderson B, 1996, NEUROSCI LETT, V210, P161, DOI 10.1016/0304-3940(96)12693-8; BRIAN D, 1996, EINSTEIN LIFE, P437; DIAMOND MC, 1985, EXP NEUROL, V88, P198, DOI 10.1016/0014-4886(85)90123-2; HUERTA MF, 1997, NEUROINFORMATICS OVE; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; MAZZIOTTA JC, 1997, NEUROINFORMATICS OVE; SHAHAR Y, 1996, ARTIF INTELL MED, V8, P255; Witelson SF, 1999, LANCET, V353, P2149, DOI 10.1016/S0140-6736(98)10327-6	8	3	3	0	2	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	1999	14	6					616	621		10.1097/00001199-199912000-00010			6	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	269AV	WOS:000084454300009	10671707				2022-02-06	
J	Komiyama, M; Kan, M; Shigemoto, T; Kaji, A				Komiyama, M; Kan, M; Shigemoto, T; Kaji, A			Marked regional heterogeneity in venous oxygen saturation in severe head injury studied by superselective intracranial venous sampling: Case report	NEUROSURGERY			English	Article						head injury; hyperemia; jugular bulb oximetry; traumatic carotid-cavernous sinus fistula	CAVERNOUS SINUS FISTULA; JUGULAR BULB; COMATOSE PATIENTS; METABOLISM; DIAGNOSIS	OBJECTIVE: Continuous monitoring of jugular venous oxygen saturation (SjvO(2)) is useful in the management of severe head injury. Abnormally high SjvO(2) values can be caused by increased cerebral blood flow, decreased cerebral metabolism, brain death, contamination from extracerebral venous blood, or traumatic arteriovenous fistula. CLINICAL PRESENTATION: A 20-year-old man with severe head injury was diagnosed to have a traumatic dural carotid-cavernous sinus fistula on the day of trauma. Continuous left SjvO(2) monitoring from Days 4 to 12 revealed oxygen saturation ranging between 85 and 98%. INTERVENTION: Superselective intracranial and extracranial venous sampling on Day 5 demonstrated marked regional heterogeneity in venous oxygen saturation as follows: superior sagittal sinus, 95 to 97%; straight sinus, 88%; right transverse sinus, 94%; left transverse sinus, 74%; right SjvO(2), 95%; left SjvO(2), 89%; the basilar plexus, 99%; right internal jugular vein, 98%; the left internal jugular vein, 94%. Extremely high oxygen saturation in the superior sagittal sinus and basilar plexus was attributed to severe brain damage and carotid-cavernous sinus fistula, respectively. CONCLUSION: Although jugular bulb oximetry is useful in the management of severe head injury, high oxygen saturation values should be interpreted with caution because they cannot show the intracranial heterogeneity of venous oxygen saturation.	Osaka City Gen Hosp, Dept Neurosurg, Osaka 5340021, Japan; Osaka City Gen Hosp, Dept Crit Care & Emergency Med, Osaka 5340021, Japan		Komiyama, M (corresponding author), Osaka City Gen Hosp, Dept Neurosurg, 2-13-22 Miyakojima Hondohri, Osaka 5340021, Japan.			komiyama, masaki/0000-0003-0998-6315			BARROW DL, 1985, J NEUROSURG, V62, P248, DOI 10.3171/jns.1985.62.2.0248; CALON B, 1995, J NEUROSURG, V83, P910, DOI 10.3171/jns.1995.83.5.0910; Carrillo A, 1998, INTENS CARE MED, V24, P71, DOI 10.1007/s001340050517; Chieregato A, 1998, J NEUROSURG ANESTH, V10, P16, DOI 10.1097/00008506-199801000-00004; CRUZ J, 1990, J NEUROSURG, V73, P725, DOI 10.3171/jns.1990.73.5.0725; DellaCorte F, 1996, NEUROSURGERY, V39, P390; FORTUNE JB, 1994, J NEUROSURG, V80, P461, DOI 10.3171/jns.1994.80.3.0461; Gibbs EL, 1942, J BIOL CHEM, V144, P325; Kim Y, 1976, No To Shinkei, V28, P951; Komiyama M, 1998, AM J NEURORADIOL, V19, P1641; LEWIS SB, 1995, ANAESTH INTENS CARE, V23, P307, DOI 10.1177/0310057X9502300307; Metz C, 1998, ACT NEUR S, V71, P324; MINAMI T, 1973, J NEUROSURG, V39, P442, DOI 10.3171/jns.1973.39.4.0442; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; ROBERTSON CS, 1995, J NEUROTRAUM, V12, P891, DOI 10.1089/neu.1995.12.891; SCHNEIDER GH, 1995, ACTA NEUROCHIR, V134, P71, DOI 10.1007/BF01428507; SHEINBERG M, 1992, J NEUROSURG, V76, P212, DOI 10.3171/jns.1992.76.2.0212; STOCCHETTI N, 1994, NEUROSURGERY, V34, P38; TEASDALE G, 1974, LANCET, V2, P81	19	3	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	DEC	1999	45	6					1469	1472		10.1097/00006123-199912000-00040			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	262WV	WOS:000084092000102	10598716				2022-02-06	
J	Schols, G; Van Havenbergh, T; Parizel, PM; Delrue, F; Ceulemans, B; Jorens, PG				Schols, G; Van Havenbergh, T; Parizel, PM; Delrue, F; Ceulemans, B; Jorens, PG			Traumatic basilar artery dissection in a child: Need for anticoagulation?	NEUROPEDIATRICS			English	Article						basilar artery; brain; (neuro) trauma; dissection; thrombosis; anticoagulation; heparin		Dissection of a cerebral blood vessel is a rare complication of acute neurotrauma with a high incidence of morbidity and mortality. We report on a case of a pediatric patient with severe neurological symptoms in whom angiography showed evidence of a basilar artery dissection. The patient was heparinized and recovered uneventfully.	Univ Antwerp Hosp, Dept Intens Care, B-2650 Edegem, Belgium; Univ Antwerp Hosp, Dept Neurosurg, B-2650 Edegem, Belgium; Univ Antwerp Hosp, Dept Radiol, B-2650 Edegem, Belgium; Univ Antwerp Hosp, Dept Child Neurol, B-2650 Edegem, Belgium		Jorens, PG (corresponding author), Univ Antwerp Hosp, UZA, Dept Intens Care Med, Wilrijkstr 10, B-2650 Edegem, Belgium.			Parizel, Paul M./0000-0002-0221-2854			BILLER J, 1986, ARCH NEUROL-CHICAGO, V43, P1234, DOI 10.1001/archneur.1986.00520120019010; deBray JM, 1997, J NEUROL NEUROSUR PS, V63, P46, DOI 10.1136/jnnp.63.1.46; FRISONI GB, 1991, STROKE, V22, P1452, DOI 10.1161/01.STR.22.11.1452; GARG BP, 1993, NEUROLOGY, V43, P2555, DOI 10.1212/WNL.43.12.2555; HART RG, 1988, NEUROLOGY, V38, P987, DOI 10.1212/WNL.38.6.987; HOSODA K, 1991, J NEUROSURG, V75, P628, DOI 10.3171/jns.1991.75.4.0628; MASSON C, 1993, STROKE, V24, P1264, DOI 10.1161/str.24.8.1264b; MEYDINGLAMADE U, 1995, J NEUROL, V242, P335, DOI 10.1007/BF00878878; POZZATI E, 1991, J NEUROSURG, V75, P69, DOI 10.3171/jns.1991.75.1.0069; PROVENZALE JM, 1995, AM J ROENTGENOL, V165, P1099, DOI 10.2214/ajr.165.5.7572483; ROSS GJ, 1994, J COMPUT ASSIST TOMO, V18, P292, DOI 10.1097/00004728-199403000-00024; Scazzeri F, 1997, NEURORADIOLOGY, V39, P654, DOI 10.1007/s002340050485; SCHIEVINK WI, 1994, NEUROLOGY, V44, P1607, DOI 10.1212/WNL.44.9.1607; SCHWAIGHOFER BW, 1990, J COMPUT ASSIST TOMO, V14, P895, DOI 10.1097/00004728-199011000-00005; Tekin S, 1997, PEDIATR NEUROL, V16, P67, DOI 10.1016/S0887-8994(96)00252-4; Yoshimoto Y, 1997, STROKE, V28, P370, DOI 10.1161/01.STR.28.2.370	16	3	3	0	1	HIPPOKRATES VERLAG GMBH	STUTTGART	RUDIGERSTRASSE 14, POSTFACH 30 11 20, 70469 STUTTGART, GERMANY	0174-304X			NEUROPEDIATRICS	Neuropediatrics	DEC	1999	30	6					328	330		10.1055/s-2007-973514			3	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	285BY	WOS:000085369600011	10706029				2022-02-06	
J	Manavis, J; Lee, PL; Blumbergs, PC; Lewis, SB; Finnie, JW; Reilly, PL; Jones, NR				Manavis, J; Lee, PL; Blumbergs, PC; Lewis, SB; Finnie, JW; Reilly, PL; Jones, NR			Widespread early dendritic injury associated with loss of cortical MAP-2 immunostaining in a focal ovine head impact model	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						dendrites; head injury; sheep model; microtubule-associated proteins; immunohistochemistry	TRAUMATIC BRAIN INJURY; MICROTUBULE-ASSOCIATED PROTEIN-2; CALPAIN-I; RATS; IMMUNOREACTIVITY; ACTIVATION; HIPPOCAMPUS; IMPAIRMENT; MORPHOLOGY; INHIBITION	Dendritic pathology associated with traumatic brain injury may be identified by microtubule associated protein-2 (MAP-2) immunohistochemistry. The aim of this study was to examine the dendritic response in the cerebral cortical mantle in an ovine head impact model using MAP-2 immunostaining as a marker for dendritic injury. The loss of cortical MAP-P immunoreactivity at 2 h was recorded and quantitated using a computerised image analysis system applied to standard coronal brain sections obtained from 10 impacted and 3 control sheep. Coup and contrecoup cortical contusions were present in 9 of 10 impacted brains examined 2 h after injury. MAP-2 immunoreactivity was lost in all areas of cortical contusion irrespective of site and in otherwise histologically normal cortex. MAP-2 immunostaining was lost in over 45% of the whole cortical area (range 32-54%) and only 2% (range 0-5.5%) was associated with contusions. This study has shown that there is widespread loss of MAP-2 immunostaining following head impact in the cerebral cortical mantle (up to 54%) suggestive of early dendritic injury. (C) 1999 Harcourt Publishers Ltd.	Inst Med & Vet Sci, Neuropathol Lab, Adelaide, SA 5000, Australia; Royal Adelaide Hosp, Dept Neurosurg, Adelaide, SA, Australia; Inst Med & Vet Sci, Vet Serv Div, Adelaide, SA 5000, Australia; Univ Adelaide, Dept Surg Neurosurg, Adelaide, SA, Australia		Blumbergs, PC (corresponding author), Inst Med & Vet Sci, Neuropathol Lab, POB 14,Rundle Mall, Adelaide, SA 5000, Australia.			Reilly, Peter/0000-0003-3173-0666			BARINAGA M, 1995, SCIENCE, V268, P200, DOI 10.1126/science.7536341; CACERES A, 1988, MOL BRAIN RES, V3, P233, DOI 10.1016/0169-328X(88)90046-0; EVERS P, 1994, J NEUROSCI METH, V55, P163, DOI 10.1016/0165-0270(94)90208-9; FADDIS B, 1997, J NEUROSCI, V3, P951; Faden AI., 1994, NEUROBIOLOGY CENTRAL, P3; Finnie J, 1999, J CLIN NEUROSCI, V6, P38, DOI 10.1016/S0967-5868(99)90601-X; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; Hicks RR, 1997, MOL CHEM NEUROPATHOL, V32, P1, DOI 10.1007/BF02815164; HICKS RR, 1995, BRAIN RES, V678, P151, DOI 10.1016/0006-8993(95)00179-T; JOHNSON GVW, 1992, J NEUROSCI RES, V33, P505, DOI 10.1002/jnr.490330402; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Kaufmann WE, 1997, MOL CHEM NEUROPATHOL, V31, P235, DOI 10.1007/BF02815127; KITAGAWA K, 1989, NEUROSCIENCE, V31, P401, DOI 10.1016/0306-4522(89)90383-7; KUDO T, 1990, STROKE, V21, P1205, DOI 10.1161/01.STR.21.8.1205; Lewen A, 1996, BRAIN RES, V719, P161, DOI 10.1016/0006-8993(96)00081-9; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MACCIONI RB, 1995, PHYSIOL REV, V75, P835, DOI 10.1152/physrev.1995.75.4.835; MANDELL JW, 1995, NEUROBIOL AGING, V16, P229, DOI 10.1016/0197-4580(94)00164-V; MATESIC DF, 1994, J NEUROCHEM, V63, P1012; MATUS A, 1987, J NEUROCHEM, V49, P714, DOI 10.1111/j.1471-4159.1987.tb00952.x; MULTANI P, 1994, EPILEPSIA, V35, P728, DOI 10.1111/j.1528-1157.1994.tb02503.x; Park JS, 1996, NEUROBIOL DIS, V3, P215, DOI 10.1006/nbdi.1996.0022; Posmantur RM, 1996, J NEUROTRAUM, V13, P125, DOI 10.1089/neu.1996.13.125; Posmantur RM, 1996, J NEUROPATH EXP NEUR, V55, P68, DOI 10.1097/00005072-199601000-00007; Regehr Wade G., 1994, Current Opinion in Neurobiology, V4, P373, DOI 10.1016/0959-4388(94)90099-X; SCHORMAIR C, 1993, BRAIN RES BULL, V32, P329, DOI 10.1016/0361-9230(93)90196-I; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; SIMAN R, 1989, J NEUROSCI, V9, P1579; TAFT WC, 1993, J CEREBR BLOOD F MET, V13, P796, DOI 10.1038/jcbfm.1993.101; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; TANAKA E, 1995, J CELL BIOL, V128, P127, DOI 10.1083/jcb.128.1.127; UPTON R, 1994, J CEREBR BLOOD F MET, V14, P680, DOI 10.1038/jcbfm.1994.85; Van Den Heuvel C, 1998, ACT NEUR S, V71, P209; WANG KKW, 1994, TRENDS PHARMACOL SCI, V15, P412, DOI 10.1016/0165-6147(94)90090-6; YAMAMOTO H, 1983, J NEUROCHEM, V41, P1119, DOI 10.1111/j.1471-4159.1983.tb09060.x; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X	38	3	3	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	1999	6	6					500	505		10.1016/S0967-5868(99)90010-3			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	265FE	WOS:000084230800011	18639190				2022-02-06	
J	Van Gelder, CM; Doherty, JM; Shatos, MA				Van Gelder, CM; Doherty, JM; Shatos, MA			Effects of alpha-thrombin on superoxide dismutase levels in human cerebral microvascular endothelial cells	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							TRAUMATIC BRAIN INJURY; SEVERE HEAD-INJURY; INTRACEREBRAL HEMORRHAGE; VASCULAR-PERMEABILITY; ANTIOXIDANT ENZYMES; FREE-RADICALS; STRESS; TISSUE; EDEMA; INDUCTION	Background: Sequelae of traumatic brain injury include generation of oxygen-free radicals and fibrin deposition, which worsen the initial injury, Superoxide dismutases (SODs) scavenge and bind to the free-radical superoxide anion (O-2(-)), potentially defending against oxidative stress. rn the present study, me investigated the production of SOD within human cerebral microvascular endothelial (HCME) cells after exposure to alpha-thrombin, hypothesizing that manganese SOD (MnSOD) expression is increased. Our aims were to determine whether alterations in SOD are observed at the mRNA level, to examine whether a particular species is preferentially expressed, and to determine the requirement of the active site of alpha-thrombin. Methods: HCME cells were characterized and grown to confluence, Control cells and cells exposed to 10 nmol/L alpha-thrombin were harvested for mRNA isolation using reverse transcriptase-polymerase chain reaction. Quantitation of mRNA production determined the levels of copper-zinc SOD and MnSOD, Active site blocked alpha-thrombin was used as a negative control and determined the specificity of the response. Results: The cells in culture were identified as endothelial after fulfilling criteria, such as positive immunocytochemical staining for factor VIII/von Willebrand factor antigen and binding of Ulex europaeus agglutinin-1 lectin, Levels of MnSOD mRNA were elevated at all time points in response to alpha-thrombin, whereas the cytosolic form was undetectable. HCME cells that were exposed to active site-blocked alpha-thrombin produced mRNA levels of MnSOD that were increased above those of controls, but this increase was half that of mRNA levels of MnSOD produced by HCME cells that were exposed to alpha-thrombin. Conclusion: Our study showed for the first time that alpha-thrombin partially modulates SOD in HCME cells, causing a preferential increase in MnSOD, Further investigation into secondary brain injury will provide insights into the role of alpha-thrombin in the mechanism of free radical-induced alterations, potentially improving the outcome of patients with head injury.	Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA		Van Gelder, CM (corresponding author), 16 Fairview Ave, E Haven, CT 06512 USA.						Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; BARSHAVIT R, 1992, AM J RESP CELL MOL, V6, P123, DOI 10.1165/ajrcmb/6.2.123; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; COSTELLO P, 1990, J NEURO-ONCOL, V8, P231, DOI 10.1007/BF00177356; DELMAESTRO RF, 1982, CAN J PHYSIOL PHARM, V60, P1406; DOROVINIZIS K, 1991, LAB INVEST, V64, P425; Engelman DT, 1996, WORLD J SURG, V20, P5, DOI 10.1007/s002689900001; FREEMAN BA, 1982, LAB INVEST, V47, P412; FRIDOVICH I, 1986, ADV ENZYMOL RAMB, V58, P61; GELEHRTER TD, 1986, J CLIN INVEST, V77, P165, DOI 10.1172/JCI112271; Gennarelli T.A., 1985, CENTRAL NERVOUS SYST, P391; Gort AS, 1998, J BACTERIOL, V180, P1402, DOI 10.1128/JB.180.6.1402-1410.1998; HALL ED, 1996, NEUROTRAUMA, P1405; Hallikwell B., 1989, FREE RADICAL BIO MED, p[152, 253]; HORMIA M, 1982, CELL BIOL INT REP, V6, P1123, DOI 10.1016/0309-1651(82)90030-3; HORMIA M, 1983, CELL BIOL INT REP, V7, P467, DOI 10.1016/0309-1651(83)90136-4; HUBER W, 1968, TOXICOL APPL PHARM, V12, P308; JAFFE EA, 1977, NEW ENGL J MED, V296, P377; JANSSEN YMW, 1994, FREE RADICAL BIO MED, V16, P315, DOI 10.1016/0891-5849(94)90032-9; JOHNSON A, 1986, CIRC RES, V59, P405, DOI 10.1161/01.RES.59.4.405; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; Lee KR, 1997, J NEUROSURG, V86, P272, DOI 10.3171/jns.1997.86.2.0272; Lee KR, 1996, J NEUROSURG, V84, P91, DOI 10.3171/jns.1996.84.1.0091; LEVIN EG, 1984, J CLIN INVEST, V74, P1988, DOI 10.1172/JCI111620; Lundblad R L, 1976, Methods Enzymol, V45, P156; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; MELDRUM B, 1985, BRIT J ANAESTH, V57, P44, DOI 10.1093/bja/57.1.44; MEYER JS, 1970, J NEUROSURG, V32, P304, DOI 10.3171/jns.1970.32.3.0304; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; Murakami K, 1998, J NEUROSCI, V18, P205; Nguyen T, 1996, Adv Surg, V30, P53; NISHINO A, 1993, J NEUROTRAUM, V10, P167, DOI 10.1089/neu.1993.10.167; ORFEO T, 1994, J TRAUMA, V37, P347, DOI 10.1097/00005373-199409000-00003; POBER JS, 1988, AM J PATHOL, V133, P426; QUINLAN T, 1994, ENVIRON HEALTH PERSP, V102, P79, DOI 10.2307/3431823; ROSEN GM, 1984, P NATL ACAD SCI-BIOL, V81, P7269, DOI 10.1073/pnas.81.23.7269; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; SHATOS MA, 1995, ARTERIOSCL THROM VAS, V15, P903, DOI 10.1161/01.ATV.15.7.903; SHATOS MA, 1991, ARTERIOSCLER THROMB, V11, P594, DOI 10.1161/01.ATV.11.3.594; Shoshan Y, 1996, NEUROSURGERY, V39, P1206, DOI 10.1097/00006123-199612000-00025; SHULL S, 1991, J BIOL CHEM, V266, P24398; VANDERSANDE JJ, 1978, J NEUROSURG, V49, P357, DOI 10.3171/jns.1978.49.3.0357; WEKSLER BB, 1978, J CLIN INVEST, V62, P923, DOI 10.1172/JCI109220; Young B, 1996, JAMA-J AM MED ASSOC, V276, P538, DOI 10.1001/jama.276.7.538	45	3	3	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	1999	47	5					885	890		10.1097/00005373-199911000-00012			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	254QM	WOS:000083623700012	10568717				2022-02-06	
J	Pop, E; Soti, F; Rachwal, S				Pop, E; Soti, F; Rachwal, S			Hemiesters of dexanabinol and their water-soluble salts	ORGANIC PREPARATIONS AND PROCEDURES INTERNATIONAL			English	Article							CLOSED-HEAD INJURY; NMDA ANTAGONIST; HU-211; RECEPTOR; ESTERS; RAT; DERIVATIVES		Pharmacos Corp, Alachua, FL 32615 USA; Univ Florida, Dept Chem, Florida Ctr Heterocyclic Cpds, Gainesville, FL 32611 USA; Neurogen Corp, Branford, CT 06405 USA		Pop, E (corresponding author), Alcon Labs Corp, 13305 Rachael Blvd, Alachua, FL 32615 USA.						BARJOSEPH A, 1994, MOL CHEM NEUROPATHOL, V23, P125, DOI 10.1007/BF02815406; Brewster ME, 1997, INT J CLIN PHARM TH, V35, P361; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; ESHHAR N, 1995, EUR J PHARMACOL, V283, P19, DOI 10.1016/0014-2999(95)00271-L; ESHHAR N, 1993, NEUROREPORT, V5, P237, DOI 10.1097/00001756-199312000-00013; FEIGENBAUM JJ, 1989, P NATL ACAD SCI USA, V86, P9584, DOI 10.1073/pnas.86.23.9584; MECHOULAM R, 1990, TETRAHEDRON-ASYMMETR, V1, P315, DOI 10.1016/S0957-4166(00)86322-3; Pop E, 1996, PHARMACEUT RES, V13, P469, DOI 10.1023/A:1016017331353; Pop E, 1996, PHARMACEUT RES, V13, P62, DOI 10.1023/A:1016025216390; Pop E, 1997, ORG PREP PROCED INT, V29, P341, DOI 10.1080/00304949709355209; POP E, 1995, P 1 WORLD M PHARM BI, P127; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I	13	3	3	0	1	ORGANIC PREP PROCEDURES INC	NEWTON HIGHLANDS	PO BOX 9, NEWTON HIGHLANDS, MA 02161 USA	0030-4948			ORG PREP PROCED INT	Org. Prep. Proced. Int.	OCT	1999	31	5					565	570		10.1080/00304949909355342			6	Chemistry, Organic	Index Chemicus (IC); Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	261DH	WOS:000083993000008					2022-02-06	
J	Kannan, S; Marudachalam, KS; Puri, GD; Chari, P				Kannan, S; Marudachalam, KS; Puri, GD; Chari, P			Severe head injury patients in a multidisciplinary ICU: are they a burden?	INTENSIVE CARE MEDICINE			English	Article						head injury; outcome; prognosis; age; intensive care	MANAGEMENT; MORTALITY; IMPACT	Objective: Patients with severe head injury (HI) are often considered to be a burden in a multidisciplinary intensive care unit (ICU). This study was undertaken to compare the severe closed HI patients with all other patients in the ICU in terms of age group involved, stay in the unit, complications and outcome. Design: Retrospective analysis. Setting: Multidisciplinary ICU of a tertiary care hospital in Northern India. Patients and participants: All the patients admitted to the ICU between January 1995 and December 1997. The patients were classified into two groups: group A comprising patients with severe closed HI and group B consisting of all other patients. Results: The mean age of the patients was around 30 years in both the groups. The average stay of the patients in the unit was 12.71 +/- 11.9 days in group A, compared to 9.9 +/- 14.4 days for group B (p < 0.05). The duration on the ventilator or on an endotracheal airway was not different between the groups (p > 0.05). The mortality in group A was 46.8% and that in group B was 38.5% (p > 0.05). The mortality was directly proportional to the age in group A. Hypotension, renal failure and septicaemia were the commonest complications in both the groups but the difference was not statistically significant. Conclusions: This study demonstrates that patients with severe HI do not pose an extra burden in a multidisciplinary ICU.	Postgrad Inst Med Educ & Res, Dept Anaesthesia & Intens Care, Chandigarh 160012, India		Kannan, S (corresponding author), Cty Hosp, Dept Anaesthet, Union Walk, Hereford MR1 2ER, England.		Kannan, Santhana/B-7275-2012	Kannan, Santhana/0000-0003-3685-2056			BAXT WG, 1987, J TRAUMA, V27, P365, DOI 10.1097/00005373-198704000-00004; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BOWERS SA, 1980, NEUROSURGERY, V6, P237; CHOKSEY M, 1993, BRIT J NEUROSURG, V7, P611, DOI 10.3109/02688699308995090; Combes P, 1996, INTENS CARE MED, V22, P1391, DOI 10.1007/BF01709556; COOKE RS, 1995, INJURY, V26, P395, DOI 10.1016/0020-1383(95)00003-R; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; KAGAN RJ, 1994, AM SURGEON, V60, P394; Stocchetti N, 1999, INTENS CARE MED, V25, P371, DOI 10.1007/s001340050860	10	3	3	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0342-4642			INTENS CARE MED	Intensive Care Med.	AUG	1999	25	8					855	858		10.1007/s001340050965			4	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	231KH	WOS:000082306900016	10447546				2022-02-06	
J	Beaumont, JG; Connolly, SAV; Rogers, MJC				Beaumont, JG; Connolly, SAV; Rogers, MJC			Inpatient cognitive and behavioural rehabilitation: Assessing the outcomes	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							FUNCTIONAL INDEPENDENCE MEASURE; TRAUMATIC BRAIN INJURY	Following a brief initial discussion of the conceptual problems associated with the identification of valid outcomes, the specific difficulties in assessing rehabilitation outcomes for two inpatient client populations of the Royal Hospital for Neuro-disability are presented. An evaluation of the assessment of the outcomes of the cognitive rehabilitation programme at Haberdashers House, the Transitional Living Unit, is followed by a discussion of the problems of measuring the outcomes of the behavioural programme of the Behaviour Disorder Unit. Current directions of development are identified with an emphasis on the multifaceted nature of outcome, and the need for assessment instruments that reflect the specific problems of the individual client and the peculiar nature of a given service.	Royal Hosp Neurodisabil, Dept Clin Psychol, London SW15 3SW, England								Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hunt SM, 1997, QUAL LIFE RES, V6, P205; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; MacKay G, 1996, EDUC RES, V38, P161, DOI 10.1080/0013188960380204; Malec James F., 1993, Brain Injury, V7, P15, DOI 10.3109/02699059309008153; Novak S., 1996, CLIN REHABILITATION, V10, P128; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; Tofil S, 1996, BRAIN INJURY, V10, P901, DOI 10.1080/026990596123873; Turner-Stokes L, 1998, CLIN REHABIL, V12, P304, DOI 10.1191/026921598669173600	10	3	3	0	0	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL-OCT	1999	9	3-4					401	411		10.1080/096020199389464			11	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	242GV	WOS:000082932900014					2022-02-06	
J	Hux, K; Marquardt, J; Skinner, S; Bond, V				Hux, K; Marquardt, J; Skinner, S; Bond, V			Special education services provided to students with and without parental reports of traumatic brain injury	BRAIN INJURY			English	Article							HEAD-INJURY; CHILDREN; EPIDEMIOLOGY; POPULATION; SEQUELAE; COUNTY	The purpose of this study was to determine the frequency and type of special education services provided to youths who had sustained one or more traumatic brain injuries (TBIs) according to parental report but who did not have verified TBIs according to school records. A parental questionnaire formulated for a related research project served as the basis for data collection. Results indicated the most common special education verification categories both for students with and without reported TBIs were speech-language impairment and specific learning disability. Approximately 29% of children with reported TBIs received special education services-a percentage not differing significantly from students without TBIs. However, students with TBIs whose parents reported long-term consequences were significantly more likely to receive special education services than students with TBIs whose parents did not report long-term consequence or students without TBIs. A chi-square analysis using the number of students whose reported TBIs occurred before versus after special education evaluations revealed no significant difference in the types of services received. However, those evaluated for special education services after sustaining TBIs were more than two times as likely to receive services for behavioural disorders than those evaluated prior to sustaining TBIs.	Univ Nebraska, Barkley Mem Ctr 318E, Lincoln, NE 68583 USA		Hux, K (corresponding author), Univ Nebraska, Barkley Mem Ctr 318E, Lincoln, NE 68583 USA.	khux@unlinfo.unl.edu	Hux, Karen/AAQ-2078-2020				ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; BIJUR PE, 1986, AM J DIS CHILD, V140, P487, DOI 10.1001/archpedi.1986.02140190097036; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Caveness W F, 1979, Adv Neurol, V22, P1; FIFE D, 1986, AM J PUBLIC HEALTH, V76, P773, DOI 10.2105/AJPH.76.7.773; FRANK EM, J CHILDRENS COMMUNIC, V18, P49; Hux D, 1998, BRAIN INJURY, V12, P667; Hux K, 1996, LANG SPEECH HEAR SER, V27, P171, DOI 10.1044/0161-1461.2702.171; JAGGER J, 1984, J TRAUMA, V24, P40, DOI 10.1097/00005373-198401000-00006; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; JONES A, 1994, BR J SPEC ED, V21, P113; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; MILLER JD, 1985, LANCET, V1, P1141; MIRA MP, 1988, DIAGNOSTIQUE, V13, P174; *NEBR DEP ED, 1997, NEBR SPEC ED STAT RE; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; 1992, FED REG, V57, P44974	22	3	3	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	1999	13	6					447	455					9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	204DA	WOS:000080746600005	10401545				2022-02-06	
J	Sarphie, TG; Carey, ME; Davidson, JF; Soblosky, JS				Sarphie, TG; Carey, ME; Davidson, JF; Soblosky, JS			Scanning electron microscopy of the floor of the fourth ventricle in rats subjected to graded impact injury to the sensorimotor cortex	JOURNAL OF NEUROSURGERY			English	Article						brain injury; respiration; fourth ventricle; ependyma; scanning electron microscopy; sensorimotor cortex; apnea	TRAUMATIC BRAIN INJURY; BLUNT HEAD-INJURIES; 4TH VENTRICLE; CEREBRAL CONCUSSION; AXONAL INJURY; MODEL; DAMAGE; STEM; PATHOPHYSIOLOGY; PERMEABILITY	Object. Respiratory dysfunction including apnea frequently follows head injury in humans. The purpose of this study was to identify any structural alterations in the region of brainstem respiratory nuclei that might account for immediate postinjury respiratory abnormalities in anesthetized experimental animals. Methods. Using scanning electron microscopy, the authors examined the floor of the fourth ventricle in injured rats after a piston strike to the sensorimotor cortex that depressed the dura 1, 2, or 4 mm. The rats were killed within minutes of Injury. Cortical impact depths measuring either 1 or 2 mm (eight rats) produced no respiratory abnormalities, and the structural integrity of the ependymal lining of the ventricular floor in these animals was not compromised. Thirteen rats were subjected to impact to a 4-mm depth and 10 of these exhibited immediate temporary or permanent apnea. The medullae of nine of these rats were studied using scanning electron microscopy, and the fourth ventricular floors of all nine rats showed tears. Four rats that exhibited immediate, permanent apnea had tears in the caudal fourth ventricle floor near the obex, whereas five rats with no or only transient apnea had tears located more anteriorly, near the aqueduct or laterally. Changes in cerebrospinal fluid flow or pressure dynamics may have caused these tears. Light microscopy, focused near the area postrema, revealed a shearing defect through the ependyma of the fourth ventricular floor into the subjacent neuropil with a disruption of axonal pathways. Conclusions. Respiratory neuronal network components lying within 1 mm of the area postrema may well have been disrupted by the caudal tears producing permanent apnea. A similar phenomenon could account for the transient or permanent postinjury apnea seen in humans with severe head injury.	Louisiana State Univ, Med Ctr, Dept Cell Biol & Anat, New Orleans, LA 70112 USA; Louisiana State Univ, Med Ctr, Dept Neurosurg, Neurotrauma Res Lab, New Orleans, LA 70112 USA		Sarphie, TG (corresponding author), Louisiana State Univ, Med Ctr, Dept Cell Biol & Anat, 1901 Perdido St, New Orleans, LA 70112 USA.	tsarph@lsumc.edu					ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; ALVAREZMORUJO AJ, 1992, HISTOL HISTOPATHOL, V7, P259; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; BRUNI JE, 1987, ACTA ANAT, V128, P265; CAREY ME, 1995, NEUROSURG CLIN N AM, V6, P629; CAREY ME, 1989, J NEUROSURG, V71, P754, DOI 10.3171/jns.1989.71.5.0754; CROMPTON MR, 1971, LANCET, V1, P669; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DURET H, 1920, TREATUMATISMS CRANIO, V2, P171; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; FOLTZ EL, 1956, J NEUROSURG, V13, P145, DOI 10.3171/jns.1956.13.2.0145; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENNARELLI TA, 1992, J NEUROTRAUM, V9, P60; GRUBB RL, 1970, J NEUROSURG, V32, P320, DOI 10.3171/jns.1970.32.3.0320; HALL RD, 1974, BRAIN RES, V66, P23, DOI 10.1016/0006-8993(74)90076-6; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; KISS A, 1978, ACTA ANAT, V100, P521; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MITCHELL DE, 1973, LANCET, V2, P215; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; OMMAYA AK, 1964, J NEUROSURG, V21, P249, DOI 10.3171/jns.1964.21.4.0249; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PAIXNOS G, 1986, RAT BRAIN STEREOTAXI; PAIXNOS G, 1995, RAT NERVOUS SYSTEM; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Povlishock J T, 1985, Cent Nerv Syst Trauma, V2, P285; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; POVLISHOCK JT, 1985, LAB INVEST, V52, P540; Povlishock JT, 1996, ACT NEUR S, V66, P81; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; POVLISHOCK JT, 1990, ADV NEUROTRAUMA RES, V2, P1; SAETHER K, 1987, BRAIN RES, V419, P87, DOI 10.1016/0006-8993(87)90571-3; Sarphie G, 1997, ALCOHOL CLIN EXP RES, V21, P1128, DOI 10.1097/00000374-199709000-00028; SARPHIE TG, 1995, ALCOHOL CLIN EXP RES, V19, P291, DOI 10.1111/j.1530-0277.1995.tb01505.x; Sarphie TG, 1996, HEPATOLOGY, V23, P788, DOI 10.1053/jhep.1996.v23.pm0008666333; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHIMA K, 1991, J NEUROSURG, V74, P270, DOI 10.3171/jns.1991.74.2.0270; SINGH DR, 1980, ACTA ANAT, V107, P198; Soblosky JS, 1996, BEHAV BRAIN RES, V79, P79, DOI 10.1016/0166-4328(95)00264-2; SOBLOSKY JS, 1992, J NEUROSURG, V76, P119, DOI 10.3171/jns.1992.76.1.0119; STRICH SJ, 1961, LANCET, V2, P443; Windle W. F., 1944, SURG GYNECOL AND OBSTET, V79, P561; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006	49	3	3	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	APR	1999	90	4					734	742		10.3171/jns.1999.90.4.0734			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	180CD	WOS:000079366700016	10193619				2022-02-06	
J	Ashford, DA; Knutson, RS; Sacks, JJ				Ashford, DA; Knutson, RS; Sacks, JJ			Injury among cavers: results of a preliminary national survey	JOURNAL OF SPORTS MEDICINE AND PHYSICAL FITNESS			English	Article						caving; rabies; athletic injuries		Background. To estimate the frequency of and risk factors for caving-associated injuries,, Methods. A standardized questionnaire covering demographics, caving exposure, and injury history was distributed to all members of the National Speleological Society by inclusion in the monthly newsletter. Results, Of 9,532 members sent a questionnaire, 301 responded (3.2 %). Respondents had an average of 18 years of caving experience, and 37 % had sustained one of more injuries while caving. Hypothermia was the most frequent injury, followed by fractures, animal bites, and concussions, The rate of injury was about 1 per 1,990 hours in a cave, Injury rates for females were about twice those of males; older persons and those with more than 5 years of caving experience seemed to have lower injury rates. Conclusions. Many caving injuries appear potentially preventable. proper technique for safe climbing should be a part of exploration training. There is a need for proper belaying or rappelling for even short ascents or descents, Helmet use should be stressed, as should adequate protection from hypothermia.	US Dept HHS, Ctr Dis Control & Prevent, Epidemiol Program Off, CDC,US Publ Hlth Serv, Atlanta, GA 30333 USA; Natl Speleol Soc, Huntsville, AL USA		Ashford, DA (corresponding author), US Dept HHS, Ctr Dis Control & Prevent, Epidemiol Program Off, CDC,US Publ Hlth Serv, MS-CO9,1600 Clifton Rd, Atlanta, GA 30333 USA.						Baker SP, 1992, THE INJURY FACT BOOK, VSecond; DEN AG, 1994, EPILNFO VERSION 6 WO; HALLIDAY WR, 1949, NATIONAL SPEOLOGICAL, V11, P28; SACKS JJ, 1986, J MED VET MYCOL, V24, P313; SUDMAN S, 1973, J AM STAT ASSOC, V68, P805, DOI 10.2307/2284504; 1994, AM CAVING ACCIDENT, V51, P347	6	3	3	0	0	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0022-4707			J SPORT MED PHYS FIT	J. Sports Med. Phys. Fit.	MAR	1999	39	1					71	73					3	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	188YG	WOS:000079876500013	10230173				2022-02-06	
J	Heubrock, D				Heubrock, D			Subjective organization of verbal memory and learning in adolescents with brain damage	CHILD NEUROPSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; NEUROPSYCHOLOGICAL ASSESSMENT; FRONTAL-LOBE; TERM-MEMORY; FREE-RECALL; DISTINCTION; PERFORMANCE; AMNESIA; DISEASE	Subjective organization (SO) of verbal memory and learning was investigated for 44 adolescent neurological patients, who were subdivided into four clinical groups by localization of lesion as follows: right hemisphere (RH), left hemisphere (LH), frontal (FL), and brain stem (BS). As expected, patients with RH lesions performed best on a verbal learning task, whereas patients with FL and BS lesions demonstrated very poor SO, suggesting a failure in categorizing memory input. Patients with LH lesions increased SO following successive trials, suggesting an active learning strategy. It is argued that SO analysis,in neuropsychology appears to be a particularly heuristic direction of further research in order to establish a better understanding of memory and learning impairments of patients with brain damage.	Univ Bremen, Rehabil Res Ctr, D-28359 Bremen, Germany		Heubrock, D (corresponding author), Univ Bremen, Rehabil Res Ctr, Grazer Str 8, D-28359 Bremen, Germany.	gaden@reha.uni-bremen.de					APPEL LF, 1972, CHILD DEV, V43, P1365, DOI 10.2307/1127522; BADDELEY AD, 1970, J VERB LEARN VERB BE, V9, P176, DOI 10.1016/S0022-5371(70)80048-2; BEESON PM, 1993, J CLIN EXP NEUROPSYC, V15, P91; Boyd T. A., 1988, ASSESSMENT ISSUES CH, P177; BROOKS D N, 1975, Cortex, V11, P329; Butters N., 1980, ALCOHOLIC KORSAKOFFS; COLE M, 1971, DEV PSYCHOL, V4, P109, DOI 10.1037/h0030435; Craik FIM, 1996, J EXP PSYCHOL GEN, V125, P159, DOI 10.1037/0096-3445.125.2.159; Crosson B., 1992, SUBCORTICAL FUNCTION; CUSHMAN LA, 1988, J CLIN EXP NEUROPSYC, V10, P685, DOI 10.1080/01688638808402807; DOUGLAS VI, 1983, DEV NEUROPSYCHIATRY, P280; FREDERIKS JAM, 1969, HDB CLIN NEUROLOGY, V3, P187; FREEDMAN M, 1986, BRAIN COGNITION, V5, P108, DOI 10.1016/0278-2626(86)90063-1; Garb HN, 1996, PSYCHOL BULL, V120, P140, DOI 10.1037/0033-2909.120.1.140; GEYER M, 1985, Z KLIN PSYCHOL-FORSC, V14, P12; GOLDSTEIN FC, 1989, CORTEX, V25, P541, DOI 10.1016/S0010-9452(89)80016-4; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P286, DOI 10.1080/01688639008400975; GUTBROD K, 1989, J CLIN EXP NEUROPSYC, V11, P821, DOI 10.1080/01688638908400938; HEATON R K, 1981, Journal of Clinical Neuropsychology, V3, P121, DOI 10.1080/01688638108403118; HEUBROCK D, 1995, EUR J PSYCHOL ASSESS, V11, P21, DOI 10.1027/1015-5759.11.1.21; Heubrock D, 1994, Z DIFFERENTIELLE DIA, V15, P65; Heubrock D, 1992, Z DIFFERENTIELLE DIA, V3, P161; JOSEPH R, 1986, J CLIN PSYCHOL, V42, P507, DOI 10.1002/1097-4679(198605)42:3<507::AID-JCLP2270420318>3.0.CO;2-R; Kaczmarek B. L. J., 1987, FRONTAL LOBES REVISI, P225; KIMURA D, 1963, ARCH NEUROL-CHICAGO, V8, P264, DOI 10.1001/archneur.1963.00460030048004; LANGE G, 1978, MEMORY DEV CHILDREN, P101; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; Levin HS., 1982, NEUROBEHAVIORAL CONS; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Luria A.R., 1973, WORKING BRAIN INTRO; MANDLER G, 1966, J VERB LEARN VERB BE, V5, P126, DOI 10.1016/S0022-5371(66)80005-1; Mandler G., 1967, PSYCHOL LEARN MOTIV, V1, P327; MCDOWALL J, 1981, NEUROPSYCHOLOGIA, V19, P43, DOI 10.1016/0028-3932(81)90042-7; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Milner B, 1972, Clin Neurosurg, V19, P421; MILNER B, 1968, NEUROPSYCHOLOGIA, V6, P191, DOI 10.1016/0028-3932(68)90019-5; MOELY BE, 1969, DEV PSYCHOL, V1, P26, DOI 10.1037/h0026804; MOELY BE, 1977, PERSPECTIVE DEV MEMO; MOSCOVITCH M, 1992, J COGNITIVE NEUROSCI, V4, P257, DOI 10.1162/jocn.1992.4.3.257; MUNGAS D, 1983, J CONSULT CLIN PSYCH, V51, P848, DOI 10.1037/0022-006X.51.6.848; MUTTER SA, 1990, COGNITIVE NEUROPSYCH, V7, P329, DOI 10.1080/02643299008253447; PARKIN AJ, 1984, CORTEX, V20, P479, DOI 10.1016/S0010-9452(84)80053-2; PRESSLEY M, 1982, VERBAL PROCESSES CHI, P125; RISSE GL, 1984, BRAIN, V107, P605, DOI 10.1093/brain/107.2.605; STERNBERG RJ, 1977, PSYCHOL BULL, V84, P539, DOI 10.1037/0033-2909.84.3.539; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; STUSS DT, 1987, FRONTAL LOBES REVIS; TULVING E, 1962, PSYCHOL REV, V69, P344, DOI 10.1037/h0043150; VANDERPLOEG RD, 1994, J CLIN EXP NEUROPSYC, V16, P243, DOI 10.1080/01688639408402635; VONHECKER U, 1989, Z DIFFERENTIELLE DIA, V10, P103; Waldmann H. C., 1997, SOZIALWISSENSCHAFTLI; WALDMANN HC, IN PRESS COMPREHENSI, V3; Warrington E. K., 1967, CORTEX, V3, P317; WEINGARTNER H, 1983, SCIENCE, V221, P380, DOI 10.1126/science.6867715; Wilson JTL, 1990, NEUROPSYCHOLOGY, V4, P261, DOI 10.1037/0894-4105.4.4.261; [No title captured]	58	3	3	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	MAR	1999	5	1					24	33		10.1076/chin.5.1.24.7074			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	171CV	WOS:000078845600002					2022-02-06	
J	de Sousa, RMC; Regis, FC; Koizumi, MS				de Sousa, RMC; Regis, FC; Koizumi, MS			Traumatic brain injury: differences among pedestrians and motor vehicle occupants	REVISTA DE SAUDE PUBLICA			Portuguese	Article						brain injuries, epidemiology; accidents, traffic; trauma severity indices	HEAD-INJURY; SEVERITY SCORE; MAJOR TRAUMA	Objective The purpose of this study was to discover the differences among victims who had traumatic brain injury due to traffic accidents. Methods Medical records of the head injury patients were analyzed according to their classification as traffic accident victims (pedestrian, motorcyclist or passenger and other motor vehicle driver or passenger), age, gender admission type (admitted from scene of the injury or from another hospital). duration of hospitalization type of head injury types of lesions present in other body segments and mortality Patient's injury severity,cas measured by Injury Severity Score and head injury severity was analyzed rising the ranking on the Glasgow Coma Scale, recorded by neurosurgeons during their first neuro assessment All head injured patients admitted to a trauma center in S. Paulo city over a four-month period from March through June 1993, were included in the study. The sample was of 156 victims, with subsets of 80 pedestrians. 26 occupants of motorcycles and 50 occupants of other motor vehicles. Results and Conclusion The results of this study showed that the mortality rate Mns higher in the pedestrian subset (25,0%) than among other victims and higher for motorcycle occupants (19,2%) than for motels vehicle victims (8,0%). Statistical differences between the subsets were established when the head injury severity variable was analyzed using the Glasgow Coma Scale. On the other hand, the differences between the three subsets was not statistically significant when the measurement used was the Injury Severity Score. Analyses of other variables showed important differences among subset distributions.	Univ Sao Paulo, Escola Enfermagem, Dept Enfermagem Medicocirurg, Sao Paulo, Brazil		de Sousa, RMC (corresponding author), Av Dr Eneas Carvalho Aguiar,419 Cerqueira Cesar, BR-05403000 Sao Paulo, Brazil.		Sousa, Regina M/H-1108-2012	Sousa, Regina M/0000-0002-2575-7937			*ASS ADV AUT MED, 1990, ABR INJ SCAL; BAXT WG, 1987, J TRAUMA, V27, P602, DOI 10.1097/00005373-198706000-00003; *CET, 1996, AC TRANS NO MUN SAO; *CET, 1993, FAT EST AC TRANS 199; CIRICILLO SF, 1992, J TRAUMA, V33, P899, DOI 10.1097/00005373-199212000-00018; DACEY R, 1991, J TRAUMA, V31, P217, DOI 10.1097/00005373-199131020-00011; DALOSSI T, 1994, REV BRAS NEUROL, V30, P181; GARDNER D, 1986, NURS CLIN N AM, V21, P555; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; KOIZUMI MS, 1990, THESIS USP SAO PAULO; KOIZUMI MS, 1984, THESIS USP SAO PAULO; Kraus JF, 1993, HEAD INJURY, P1; LONG WB, 1986, AM J SURG, V151, P581, DOI 10.1016/0002-9610(86)90553-2; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MANREZA LA, 1991, NEUROLOGIA QUE TODO, P149; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Maset A, 1993, ARQ BRAS NEUROCIRURG, V12, P293; *MIN SAUD, 1993, EST MORT BRAS 1989; MORANO FG, 1997, 2 C BRAS SOC BRAS AT, P42; *ORG MUND SAUD, 1980, MAN CLASS EST INT DO; PAL J, 1989, J TRAUMA, V29, P746, DOI 10.1097/00005373-198906000-00008; SEID ME, 1994, FOLHA SAO PAULO 0307, P2; SIEGEL S., 1975, ESTATISTICA NAO PARA; VOLLMER DG, HEAD INJURY, P553; YOUNG WW, 1991, J TRAUMA, V31, P1125, DOI 10.1097/00005373-199131080-00013	26	3	5	0	3	REVISTA DE SAUDE PUBLICA	SAO PAULO	FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01255 SAO PAULO, BRAZIL	0034-8910			REV SAUDE PUBL	Rev. Saude Publica	FEB	1999	33	1					85	94		10.1590/S0034-89101999000100011			10	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	191YZ	WOS:000080051000011	10436625	gold, Green Submitted			2022-02-06	
J	Fuchs, KL; Hannay, HJ; Huckeba, WM; Espy, KA				Fuchs, KL; Hannay, HJ; Huckeba, WM; Espy, KA			Construct validity of the continuous recognition memory test	CLINICAL NEUROPSYCHOLOGIST			English	Article							CLOSED-HEAD-INJURY	A principal factor analysis was performed on variables derived from a neuropsychological battery administered to 100 healthy young adults in order to investigate the construct validity of the Continuous Recognition Memory test (CRM). It was hypothesized that CRM 'hits" and "false alarms" would load on different factors. The factors that emerged in the analysis were labeled "Verbal Ability". "Divided Attention", "Attention to Visual Detail", "Visuomotor Integration and Planning", and "Learning and Memory". As expected, CRM hits had a significant loading on the Learning and Memory factor. However, CRM false alarms did not have a significant loading on the Divided Attention factor as expected and, instead, loaded significantly on the Attention to Visual Detail factor. A second analysis was performed using variables from the delayed condition of the memory measures. In this analysis, the CRM delayed recognition variable had significant loadings on both a "Nonverbal Memory" factor and a "Verbal Memory" factor. These analyses support the construct validity of CRM hits as a measure of learning and memory and suggest that false alarms provide a measure of attention to visual detail.	Univ Houston, Dept Psychol, Houston, TX 77204 USA; Psychol Corp, San Antonio, TX USA; So Illinois Univ, Sch Med, Dept Social & Behav Sci, Carbondale, IL 62901 USA		Hannay, HJ (corresponding author), Univ Houston, Dept Psychol, Houston, TX 77204 USA.			Hannay, H. Julia/0000-0001-7023-912X			Cattell R. B., 1988, HDB MULTIVARIATE EXP, P131; DESROSIERS G, 1987, INT J CLIN NEUROPSYC, V9, P162; DRAKE AI, 1993, 21 ANN M INT NEUR SO; Gorsuch Richard L, 1988, HDB MULTIVARIATE EXP, P231, DOI [10.1007/978-1-4613-0893-5_6, DOI 10.1007/978-1-4613-0893-5_6]; HANNAY HJ, 1979, CORTEX, V15, P269, DOI 10.1016/S0010-9452(79)80031-3; HANNAY HJ, 1988, CONTINUOUS RECOGNITI; HANNAY HJ, 1988, J CLIN EXPT NEUROPSY, V4, P444; HATCHER L, 1994, STEP BY STEP APPROAC; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; LARRABEE GJ, 1995, J CLIN EXP NEUROPSYC, V17, P536, DOI 10.1080/01688639508405144; LARRABEE GJ, 1985, J CLIN EXP NEUROPSYC, V7, P239, DOI 10.1080/01688638508401257; LEZAK M, 1995, NEUROPSYCHOLICAL ASS; LORING DW, 1987, J CLIN EXP NEUROPSYC, V9, P340, DOI 10.1080/01688638708405055; Ruff RM, 1997, BRAIN LANG, V57, P394, DOI 10.1006/brln.1997.1755; RYAN JJ, 1984, INT J CLIN NEUROPSYC, V6, P239; STREINER DL, 1994, CAN J PSYCHIAT, V39, P135, DOI 10.1177/070674379403900303; Tabachnick B. G., 1989, USING MULTIVARIATE S; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; WALKER ML, 1991, THESIS U HOUSTON	19	3	3	0	0	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	FEB	1999	13	1					54	65		10.1076/clin.13.1.54.1977			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	226CD	WOS:000082002000006	10937648	Green Submitted			2022-02-06	
J	Kropyvnytskyy, I; Shevaga, V; Goscinski, I; Kwiatkowski, S; Klemfuss, H				Kropyvnytskyy, I; Shevaga, V; Goscinski, I; Kwiatkowski, S; Klemfuss, H			Changes in body temperature rhythm after traumatic brain injury	BIOLOGICAL RHYTHM RESEARCH			English	Article						temperature; circadian rhythm; head injury; cosinor method		We performed this study to determine whether in head injured patients body temperature rhythmicity exists outside the usual spectrum. Temperature data of in total 22 patients with head injury were analyzed using the Regressive and Iterative Cosinor methods. We found that circadian rhythm often remained, and usually was combined with rhythms in ultradian or infradian ranges. Tau shifts over consecutive days were observed in three severely head injured patients (Glasgow Coma Scale score less than or equal to 8). To validate the results we used surrogate data. Detection of temperature rhythms in this study may serve to estimate the clinical importance of biological rhythms in head injury.	Lviv Med Univ, Dept Neurosurg, Lviv, Ukraine; Jagiellonian Univ, Sch Med, Dept Neurotraumatol, Krakow, Poland; Univ Calif San Diego, Anim Subject Program 0614, San Diego, CA 92103 USA		Kropyvnytskyy, I (corresponding author), 45-44 Torfiana St, UA-290020 Lviv, Ukraine.		Shevaga, Volodymyr/G-4089-2019	Shevaga, Volodymyr/0000-0003-2402-1829			Alster Jason, 1993, Brain Injury, V7, P191, DOI 10.3109/02699059309029672; Fukudome Y, 1996, AM J PHYSIOL-REG I, V270, pR1109, DOI 10.1152/ajpregu.1996.270.5.R1109; KLEMFUSS H, 1993, J INTERDISCIPL CYCLE, V24, P1, DOI 10.1080/09291019309360191; Lanuza D M, 1989, Appl Nurs Res, V2, P135; MINORS DS, 1988, PSYCHONEUROENDOCRINO, V13, P443, DOI 10.1016/0306-4530(88)90030-3; MONK T, 1982, BIOL RHYTHMS SLEEP P, P53; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; TWEEDIE IE, 1989, CRIT CARE MED, V17, P1159, DOI 10.1097/00003246-198911000-00012	8	3	3	0	2	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0929-1016			BIOL RHYTHM RES	Biol. Rhythm Res.	FEB	1999	30	1					82	90		10.1076/brhm.30.1.82.3067			9	Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Physiology	193YH	WOS:000080165000005					2022-02-06	
J	Kravtsov, YI; Seliverstova, GA; Kalashnikova, TP				Kravtsov, YI; Seliverstova, GA; Kalashnikova, TP			The state of adaptive-compensatory mechanisms in children after concussion of the brain	ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA			Unspecified	Article							INJURY	80 children of preschool age were observed after concussion of the brain. In follow-up from 6 months 3 years clinical-anamnestic and neuropsychologic methods were used. The functions of autonomic nervous system were evaluated according to the results of estimation of intial autonomic tonus, autonomic reactivity, autonomic maintenance of the activity and the data of cardiointervalography. The state of nonspecific systems of the brain was studied with day time polygraphic research with a visual EEC evaluation, construction of histogramms by Fora method, estimation of speed and order of the fading of the components of a rough response. Psychovegetative stress was the ground for neurologic disorders in posttraumatic period. The disorders of adaptive regulation were manifested in exhausting of ergotropic systems with compensatory overstrain of trophotropic mechanisms, resulted in predominance of inhibiting influences with an inadequate responce of synchronization on EEC during functional loads. Severity of clinical manifestations and disorders of adaptive regulation were more pronounced in children 1-3 year-old and with hypoxic-traumatic damages of the brain in anamnesis. Disintegration of cerebral activity correlated with the remote period. In the first 6-12 months after the concussion of the brain changes of vegetative reactivity prevailed, after 18 months the alterations in vegetative maintenance progressed.	Perm State Med Acad, Dept Pediat, Chair Neurol, Perm, Russia		Kravtsov, YI (corresponding author), Perm State Med Acad, Dept Pediat, Chair Neurol, Perm, Russia.						LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; MYCHELL J, 1988, J PEDIAT NEUROSCIENC, V6, P304; OSETROV AS, 1994, ZH NEVROPATOL PSIKH, V94, P77; ROMODANOV AP, 1990, MEKHANIZMY ADAPTATSI, P41; SHOGAM II, 1989, ZH NEVROPATOL PSIKH, V89, P141; SUMERKINA MM, 1987, THESIS MOSCOW	6	3	5	0	3	IZDATELSTVO MEDITSINA	MOSCOW	PETROVERIGSKII PER 6-8, K-142 MOSCOW, RUSSIA	0044-4588			ZH NEVROPATOL PSIKH	Zhurnal Nevropatol. Psikhiatrii Im. S S Korsakova		1999	99	3					24	28					5	Clinical Neurology; Pathology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology; Psychiatry	182FP	WOS:000079488600006					2022-02-06	
J	Rohde, V; Irle, S; Hassler, WE				Rohde, V; Irle, S; Hassler, WE			Prediction of the post-comatose motor function by motor evoked potentials obtained in the acute phase of traumatic and non-traumatic coma	ACTA NEUROCHIRURGICA			English	Article						motor evoked potential; coma; motor function	TRANSCRANIAL MAGNETIC STIMULATION; SEVERE HEAD-INJURY; NITROUS-OXIDE; ELECTRICAL-STIMULATION; CORTEX STIMULATION; HUMAN-BRAIN; NERVOUS PROPAGATION; MULTIPLE-SCLEROSIS; ANESTHETIC AGENTS; SPINAL-CORD	Objective. To define the Value of electrically elicited motor evoked potentials (MEP), obtained during the initial phase of the coma, for correct prediction of the post-coma motor status. Methods: Fifty-two patients were investigated by MEP within 72 hours after onset of the coma. It was the aim to correlate the MEP findings to the motor function two months after coma onset. Results: Three patients with normal MEP showed no post-coma motor deficit. In 21 patients, a bilateral, symmetric prolongation of the central motor conduction time (CMCT) was registered. Eighteen of these 21 patients (86%) showed a normal post-coma motor status. In 28 patients, unilaterally absent evoked potential, or unilaterally prolonged CMCT, or bilaterally prolonged CMCT with significant difference in each hemispere were observed. A post-coma contralateral paresis was found in 25 of these 28 patients (89%). That paresis was functionally important in 15 patients (54%) and functionally unimportant in 13 patients (46%). Conclusion. We identified certain MEP patterns (unilateral extinction of the evoked potential, unilateral, bilateral prolongation of the CMCT with significant "side" difference), which indicated a pyramidal tract lesion and a post-coma motor deficit with an accuracy of 89%. This refers to the motor results, which may not be the final post-coma motor results which are usually assessed six months after the coma onset. The MEP changes did not allow one to predict the severity of the paresis. The accuracy of prediction of a motor deficit increased from the MEP finding of unilaterally prolonged CMCT to the MEP finding of unilateral extinction of the potential. The most common finding, bilateral central motor slowing without significant "side" difference, did not indicate a post-coma paresis in 86%, leading to the assumption, that bilateral, symmetrical prolongation of the CMCT was not caused by lesions of the descending motor pathways, but by the drugs administered for treating the comatose patient. In conclusion, MEP allows one to predict the presence of a post-coma motor deficit with a high degree of accuracy already in the initial phase of coma, but MEP fails to predict the severity of that deficit.	Klinikum Kalkweg, Dept Neurosurg, Duisburg, Germany		Rohde, V (corresponding author), Univ Technol, Rhein Westfal TH Aachen, Dept Neurosurg, Pauwelsstr 30, D-52057 Aachen, Germany.		Irle, Stephan/E-8984-2011	Irle, Stephan/0000-0003-4995-4991			Abbruzzese G, 1997, MOVEMENT DISORD, V12, P315, DOI 10.1002/mds.870120309; Andersson T, 1995, Electromyogr Clin Neurophysiol, V35, P17; BARKER AT, 1987, NEUROSURGERY, V20, P100; Bernard JM, 1996, ANESTHESIOLOGY, V85, P1013, DOI 10.1097/00000542-199611000-00008; CALANCIE B, 1991, J NEUROSURG, V74, P897, DOI 10.3171/jns.1991.74.6.0897; CALANCIE B, 1987, J NEUROPHYSIOL, V58, P1168, DOI 10.1152/jn.1987.58.5.1168; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; COWAN JMA, 1984, LANCET, V2, P304; CRACCO R Q, 1987, Journal of Clinical Neurophysiology, V4, P221; CRACCO RQ, 1987, NEUROSURGERY, V20, P199; DAY BL, 1987, NEUROSCI LETT, V75, P101, DOI 10.1016/0304-3940(87)90083-8; Facco E., 1993, Neurophysiologie Clinique, V23, P237, DOI 10.1016/S0987-7053(05)80233-3; FIRSCHING R, 1991, ACTA NEUROCHIR, V112, P106, DOI 10.1007/BF01405136; GHALY RF, 1990, J NEUROSURG ANESTH, V2, P79, DOI 10.1097/00008506-199006000-00004; GHALY RF, 1990, NEUROSURGERY, V27, P936, DOI 10.1227/00006123-199012000-00012; GHALY RF, 1991, J NEUROSURG ANESTH, V3, P20, DOI 10.1097/00008506-199103000-00004; GLASSMAN SD, 1993, SPINE, V18, P1083, DOI 10.1097/00007632-199306150-00020; Haghighi SS, 1996, J NEUROSURG ANESTH, V8, P47, DOI 10.1097/00008506-199601000-00011; Haghighi SS, 1998, NEUROL RES, V20, P555; HAGHIGHI SS, 1993, SURG NEUROL, V39, P399, DOI 10.1016/0090-3019(93)90208-I; HAGHIGHI SS, 1989, NEUROSURGERY, V24, P246, DOI 10.1227/00006123-198902000-00015; HERDMANN J, 1993, SPINE, V18, P551, DOI 10.1097/00007632-199304000-00006; Herdmann J, 1996, SPINE, V21, P879, DOI 10.1097/00007632-199604010-00023; HESS CW, 1986, LANCET, V2, P355; HESS CW, 1987, J PHYSIOL-LONDON, V388, P397, DOI 10.1113/jphysiol.1987.sp016621; INGHILLERI M, 1989, J NEUROL NEUROSUR PS, V52, P970, DOI 10.1136/jnnp.52.8.970; KALKMAN CJ, 1994, NEUROSURGERY, V35, P1066, DOI 10.1227/00006123-199412000-00008; KALKMAN CJ, 1992, ANESTHESIOLOGY, V76, P502, DOI 10.1097/00000542-199204000-00003; Kaneko M, 1995, No To Shinkei, V47, P491; KAUFMANN MA, 1992, RESUSCITATION, V23, P199, DOI 10.1016/0300-9572(92)90003-U; KAWAGUCHI M, 1993, BRIT J ANAESTH, V71, P849, DOI 10.1093/bja/71.6.849; Kawaguchi M, 1996, ANESTHESIOLOGY, V85, P1176, DOI 10.1097/00000542-199611000-00027; KELLER BP, 1992, NEUROSURGERY, V30, P557; Lang EW, 1996, SPINE, V21, P1676, DOI 10.1097/00007632-199607150-00013; LANGFITT TW, 1978, J NEUROSURG, V48, P673, DOI 10.3171/jns.1978.48.5.0673; MERTON PA, 1980, NATURE, V285, P227, DOI 10.1038/285227a0; MEYER B, 1992, EUR ARCH PSY CLIN N, V241, P201, DOI 10.1007/BF02190253; MEYER B, 1990, EEG-EMG-Z ELEK ELEKT, V21, P247; MILLS KR, 1987, NEUROSURGERY, V20, P164; MILLS KR, 1985, ANN NEUROL, V18, P601, DOI 10.1002/ana.410180514; MILLS KR, 1991, ELECTROEN CLIN NEURO, P100; NAGAO S, 1992, Neurologia Medico-Chirurgica, V32, P268, DOI 10.2176/nmc.32.268; Pechstein U, 1998, EVOKED POTENTIAL, V108, P175, DOI 10.1016/S0168-5597(97)00086-5; Rohde V., 1992, Intensiv- und Notfallbehandlung, V17, P147; ROHDE V, 1991, ADV NEUROSURG, V19, P194; ROSSINI PM, 1987, NEUROSURGERY, V20, P183; ROSSINI PM, 1985, ELECTROEN CLIN NEURO, V61, P272, DOI 10.1016/0013-4694(85)91094-6; ROTHWELL JC, 1987, BRAIN, V110, P1173, DOI 10.1093/brain/110.5.1173; Salerno A, 1996, Electromyogr Clin Neurophysiol, V36, P361; SCHMID UD, 1992, NEUROSURGERY, V30, P85, DOI 10.1227/00006123-199201000-00015; SCHONLE PW, 1989, NEUROSCI LETT, V101, P321, DOI 10.1016/0304-3940(89)90553-3; TANIGUCHI M, 1993, NEUROSURGERY, V33, P407; TEASDALE G, 1974, LANCET, V2, P81; TUNG H C, 1988, Anesthesiology (Hagerstown), V69, pA313, DOI 10.1097/00000542-198809010-00312; TURNER DA, 1996, NEUROSURGERY, P2667; Ubags LH, 1997, BRIT J ANAESTH, V79, P590, DOI 10.1093/bja/79.5.590; Ubags LH, 1998, NEUROSURGERY, V43, P90, DOI 10.1097/00006123-199807000-00058; UOZUMI T, 1991, ELECTROEN CLIN NEURO, V81, P251, DOI 10.1016/0168-5597(91)90010-U; VanHam LML, 1996, VET REC, V138, P642, DOI 10.1136/vr.138.26.642; YAMADA H, 1994, SPINE, V19, P1512, DOI 10.1097/00007632-199407000-00018; ZENTNER J, 1989, NEUROSURGERY, V24, P60, DOI 10.1227/00006123-198901000-00009; ZENTNER J, 1994, NEUROL RES, V16, P89; ZENTNER J, 1989, NEUROSURGERY, V24, P253, DOI 10.1227/00006123-198902000-00016; Zentner J, 1997, SPINE, V22, P1002, DOI 10.1097/00007632-199705010-00012; ZENTNER J, 1989, FORTSCHR ANASTH, V3, P986	65	3	3	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.		1999	141	8					841	848		10.1007/s007010050385			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	230NP	WOS:000082257500012	10536720				2022-02-06	
J	Langerhorst, CT; Safran, AB				Langerhorst, CT; Safran, AB			Progressive shrinkage of the visual field during automated perimetry following traumatic brain injury - Patients' experience	NEURO-OPHTHALMOLOGY			English	Article						visual field; attention; traumatic brain injury	SELECTIVE ATTENTION; DISORDERS; SPECT; MILD	Purpose: To establish a distinction between the visual field and the attentional field in patients with traumatic brain injury, and to elucidate the patients' experience with attentional field defects. Methods: We retrospectively reviewed the clinical observations of 25 traumatic brain-injury patients. On the basis of the 30-degree visual field printout, we identified six patients with concentric contraction and analyzed their visual fields by comparing the two consecutive stages of the Octopus NI screening and threshold program. The recorded fields were compared with the results of clinical confrontational field testing. Three of the six patients had been asked to describe their experience during automated perimetric evaluation. Results: The visual fields showed various degrees of contraction, some severe. All six showed progressive shrinking of the field during the perimetric evaluation procedure. However, no defects were apparent with confrontational field testing. False-negative catch trials ranged from 0 to 50% (mean 18.1%). When asked, the three patients had all described a striking progressive darkening of the background and shrinkage of the visual field during the automated perimetric examination. Conclusions: During automated perimetry, patients with traumatic brain injury may develop mild to severe concentric contraction, which is progressive over time. This is associated with the experience of dramatic obscuration of the visual field. This may reflect an organic disturbance in attentional mechanisms, revealed when executing dual task demands. When analyzing results from automated perimetry in such patients, a distinction should be made between visual and attentional fields.	Univ Hosp Geneva, Dept Clin Neurosci & Dermatol, Neuroophthalmol Unit, Ophthalmol Clin, Geneva, Switzerland		Langerhorst, CT (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, G2-221,POB 22700, NL-1100 DE Amsterdam, Netherlands.						ANDERSON DR, 1992, AUTOMATED STATIC PER, P77; BAVETTA S, 1994, NUCL MED COMMUN, V15, P961, DOI 10.1097/00006231-199412000-00007; BURG JS, 1995, BRAIN INJURY, V9, P395, DOI 10.3109/02699059509005779; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; DUBOISPOULSEN A, 1952, CHAMP VISUEL TOPOGRA, P1027; HEILMAN KM, 1993, BAILLIERE CLIN NEUR, V2, P389; IKEDA M, 1975, PERCEPT PSYCHOPHYS, V18, P255, DOI 10.3758/BF03199371; JACOBS A, 1994, J NUCL MED, V35, P942; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; OTTE A, 1995, LANCET, V345, P1513, DOI 10.1016/S0140-6736(95)91075-1; Ross SK, 1996, J NEUROL NEUROSUR PS, V61, P388, DOI 10.1136/jnnp.61.4.388; SABATES NR, 1991, J CLIN NEURO-OPHTHAL, V11, P273; SAFRAN AB, 1989, PERIMETRY UPDATE 198, P151; SMITH TJ, 1987, OPHTHALMOLOGY, V94, P1562; THOMPSON HS, 1985, AM J OPHTHALMOL, V100, P209, DOI 10.1016/S0002-9394(14)75008-1; Thompson JC, 1996, OPHTHALMOLOGY, V103, P117, DOI 10.1016/S0161-6420(96)30751-3; VAKIL E, 1995, J CLIN EXP NEUROPSYC, V17, P335, DOI 10.1080/01688639508405127; van de Weijgert E.C.M., 1993, VISUAL SEARCH, V2, P341; WHALEN W, 1985, COMPUTERIZED VISUAL; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3	21	3	3	0	1	AEOLUS PRESS	BUREN	PO BOX 740, 4116 ZJ BUREN, NETHERLANDS	0165-8107			NEURO-OPHTHALMOLOGY	Neuro-Ophthalmol.	DEC	1998	20	4					177	185		10.1076/noph.20.4.177.3934			9	Clinical Neurology; Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Ophthalmology	153QY	WOS:000077844900002					2022-02-06	
J	Takami, H; Takahashi, S; Ando, M				Takami, H; Takahashi, S; Ando, M			Complete dorsal dislocation of the metacarpophalangeal joint of the thumb	ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY			English	Article								In the pathology of simple complete dislocation involving the metacarpophalangeal joint of the thumb, whether or not the palmar plate is interposed within the joint is controversial. Nine cases of complete dorsal dislocation of the joint were reviewed, and cadaver dissection was performed to study the pathology of this injury. Eight of the nine patients were seen within 4 days of injury and treated successfully by closed manipulation. One patient treated 7 days after the injury required open reduction. We were able to reproduce the pathological anatomy of the dislocation, wedging of the palmar plate in the joint of the cadaver. In this cadaver and in all clinical cases, radiographs showed a complete dislocation with an increased distance between the palmar edge of the base of the proximal phalanx and the metacarpal head, indicating an interposition of the palmar plate. Our study suggests that in simple complete dislocations of this joint, the palmar plate is interposed between the displaced bones.	Kanto Rosai Hosp, Sect Orthopaed Surg, Nakahara Ku, Kawasaki, Kanagawa, Japan		Takami, H (corresponding author), Kanto Rosai Hosp, Sect Orthopaed Surg, Nakahara Ku, Kawasaki, Kanagawa, Japan.						Boyes JH, 1970, BUNNELLS SURG HAND; GILBERT A, 1985, HAND, P922; GREEN DP, 1973, J BONE JOINT SURG AM, VA 55, P1480, DOI 10.2106/00004623-197355070-00015; GREEN DP, 1991, ROCKWOOD GREENS FRAC, P441; McLaughlin H L, 1965, J Trauma, V5, P683, DOI 10.1097/00005373-196511000-00001; OBRIEN ET, 1991, FRACTURES CHILDREN, P319; ONUBA O, 1987, J HAND SURG-BRIT EUR, V12B, P60, DOI 10.1016/0266-7681(87)90059-3; RUBY LK, 1980, ORTHOP CLIN N AM, V11, P819; SEDEL L, 1985, HAND, P915; STENER B, 1963, Acta Chir Scand, V125, P275	10	3	3	0	1	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0936-8051			ARCH ORTHOP TRAUM SU	Arch. Orthop. Trauma Surg.	NOV	1998	118	1-2					21	24		10.1007/s004020050303			4	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	138FA	WOS:000076959600004	9833099				2022-02-06	
J	Coats, DK; Paysse, EA; Kong, J				Coats, DK; Paysse, EA; Kong, J			Unrecognized microscopic hyphema masquerading as a closed head injury	PEDIATRICS			English	Article						hyphema; sickle cell; masquerade; microscopic; glaucoma		Objective. To present a child with an unrecognized microscopic traumatic hyphema and acute glaucoma who was initially treated as a closed head injury patient. Design. Case report and discussion. Results. Symptoms attributable to unrecognized occult ocular injury in a child with sickle cell trait resulted in evaluation and treatment of the child for a closed head injury. Evaluation included a computed tomography scan of the head and lumbar puncture. An ophthalmologic consultation later revealed a microscopic hyphema and acute glaucoma as the etiology of the child's signs and symptoms. Conclusions. Children who present with neurologic symptoms and a history of ocular trauma should undergo an ophthalmologic examination as soon as possible. Hyphema, even if not readily visible on physical examination, can result in the development of acute glaucoma with signs and symptoms that resemble a closed head injury.	Texas Childrens Hosp, Baylor Coll Med, Cullen Eye Inst, Houston, TX 77030 USA		Coats, DK (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Cullen Eye Inst, 1102 Bates,Suite 300, Houston, TX 77030 USA.						GREENWALD MJ, 1985, OPHTHALMIC SURG LAS, V16, P170; LIEBMANN JM, 1996, J GLAUCOMA, V5, P71; SPOOR TC, 1990, AM J OPHTHALMOL, V109, P23, DOI 10.1016/S0002-9394(14)75573-4; WRIGHT KW, 1997, TXB OPHTHALMOLOGY, V893, pCH64	4	3	3	0	0	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005			PEDIATRICS	Pediatrics	SEP	1998	102	3					652	654		10.1542/peds.102.3.652			3	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	117EB	WOS:000075766800033	9738193				2022-02-06	
J	Voogt, RD; Teasdale, TW; Patrick, PD; Carman, J				Voogt, RD; Teasdale, TW; Patrick, PD; Carman, J			Reintegration into the family and the community following traumatic brain injury	NEUROREHABILITATION			English	Article; Proceedings Paper	2nd International-Brain-Injury-Association Meeting	MAY, 1997	SEVILLE, SPAIN	Int Brain Injury Assoc		traumatic brain injury; reintegration; family; work; community	HEAD-INJURY; RELATIVES; REHABILITATION; SERVICES; ADULTS; STRESS; RETURN; WORK; INTEGRATION; SEQUELAE	When establishing a community or family setting where individuals with traumatic brain injury can live, the setting must be sensitive to the individual's specific needs, as well as basic human needs. All individuals are in need of loving relationships, meaningful work activities, and the ability to enjoy themselves. They also want access to community events, and to be a part of a respectful environment that stimulates growth. Often, return to the family has resulted in disruption, return to work has been the exception, and relationships are forever altered. Reintegration must take place where needs can be met; where individuals are not simply cared for, but where they enjoy the same opportunities as those who are not disabled. The authors of this article each presented at The Second World Conference on Brain Injury, in Seville, Spain. In this article, they look at the impediments to reintegration and possibilities for creating a rehabilitation environment that values life and allows for reintegration into the community and a return to work and family. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.	Rehabil Living Ctr, New Orleans, LA 70119 USA; NeuroPsych HealthCare, Fairfax, VA 22030 USA; Univ Copenhagen, Psychol Lab, Copenhagen, Denmark; Success Rehabil, Bensalem, PA USA		Voogt, RD (corresponding author), Rehabil Living Ctr, 3524 Canal St, New Orleans, LA 70119 USA.						Antonak R. F., 1993, J HEAD TRAUMA REHAB, V8, P87, DOI DOI 10.1097/00001199-199312000-00009; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; CHELUNE GJ, 1981, CLIN PSYCHOL REV, V1, P181; CHRISTENSEN A, 1997, NEUROPSYCHOL REHABIL, P63; Davison K, 1969, CURRENT PROBLEMS NEU, P113; Douglas JM, 1996, BRAIN INJURY, V10, P819, DOI 10.1080/026990596123936; Elliott ML, 1996, BRAIN INJURY, V10, P703, DOI 10.1080/026990596123972; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; Florian V, 1991, Int Disabil Stud, V13, P150; Gervasio AH, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199706000-00003; Godfrey HPD, 1996, J HEAD TRAUMA REHAB, V11, P29, DOI 10.1097/00001199-199612000-00006; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; GROSWASSER Z, 1994, BRAIN INJURY NEUROPS, P187; HALL KM, 1994, BRAIN INJURY, V9, P141; HALLETT JD, 1994, AM J OCCUP THER, V48, P241, DOI 10.5014/ajot.48.3.241; Hillbom E., 1960, ACTA PSYCHIATRICA S, VS142, P1; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; KAITARO T, 1995, BRAIN INJURY, V9, P713, DOI 10.3109/02699059509008227; KAY T, 1994, NEUROPSYCHIATRY TRAU; KEITH RA, 1995, AM J PHYS MED REHAB, V74, P73, DOI 10.1097/00002060-199501000-00013; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V11, P58, DOI 10.1097/00001199-199610000-00006; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; LEAF LE, 1993, BRAIN INJURY, V7, P543, DOI 10.3109/02699059309008182; Leathem J, 1996, BRAIN INJURY, V10, P27; LEONCARRION J, 1994, DANO CEREBRAL GUIA F; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LINN RT, 1994, BRAIN INJURY, V8, P135, DOI 10.3109/02699059409150965; LISHMAN WA, 1987, ACTA MED SCAND, P5; MALEC JF, 1995, MAYO CLIN PROC, V70, P1165, DOI 10.4065/70.12.1165; MALTZ EA, 1995, J HEAD TRAUMA REHAB, V10, P1; McLaughlin Anne Marie, 1993, Brain Injury, V7, P45, DOI 10.3109/02699059309008155; MELAMED S, 1992, Brain Injury, V6, P233, DOI 10.3109/02699059209029665; MINTZ MC, 1995, BRAIN INJURY, V9, P173, DOI 10.3109/02699059509008190; MOORE A, 1993, BRAIN INJURY, V7, P247, DOI 10.3109/02699059309029677; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; NOVACK TA, 1991, J HEAD TRAUMA REHAB, V6, P69, DOI DOI 10.1097/00001199-199112000-00014; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; PESSAR LF, 1993, BRAIN INJURY, V7, P231, DOI 10.3109/02699059309029675; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; SCHALEN W, 1994, BRAIN INJURY, V8, P49, DOI 10.3109/02699059409150958; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; SHAPIRO LB, 1939, ILLINOIS MED J, V76, P250; Shaw L R, 1990, Brain Inj, V4, P87, DOI 10.3109/02699059009026152; SINGER GHS, 1994, J HEAD TRAUMA REHAB, V9, P38, DOI DOI 10.1097/00001199-199412000-00006; SPARADEO FR, 1995, J HEAD TRAUMA REHAB, V4, P75; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; TEASDALE TW, 1994, BRAIN INJURY NEUROPS, P235; Tepper S, 1996, BRAIN INJURY, V10, P575, DOI 10.1080/026990596124142; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; VIOLON A, 1987, ACTA NEUROCHIR, V85, P96, DOI 10.1007/BF01456104; VOOGT R, 1996, 15 ANN NAT S DALL TE; WILLER B, 1994, BRAIN INJURY, V8, P647, DOI 10.3109/02699059409151017; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183	65	3	3	0	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation	SEP	1998	11	2					107	117		10.1016/S1053-8135(98)00015-8			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Neurosciences & Neurology; Rehabilitation	121CY	WOS:000075995600005					2022-02-06	
J	Cox, RG				Cox, RG			Retropharyngeal haematoma leading to airway obstruction in a child with closed head trauma	PAEDIATRIC ANAESTHESIA			English	Article						airway, obstruction; haematoma, retropharyngeal; prevertebral trauma; head; neck	HEMATOMA; HEMORRHAGE; INJURY	Retropharyngeal haematoma is a rare complication of head trauma that has been chiefly reported in adults, particularly in the elderly. A case is presented of retropharyngeal haematoma in a 13-year-old child following closed head trauma. Acute upper airway obstruction resulted, requiring tracheal intubation. Surgical drainage of the haematoma was not required and the trachea was successfully extubated on the third day. The case presented serves to remind practitioners that this complication of closed head injury may occur in children and strategies for airway management are discussed.	Alberta Childrens Prov Gen Hosp, Div Pediat Anaesthesia, Calgary, AB T2T 5C7, Canada		Cox, RG (corresponding author), Alberta Childrens Prov Gen Hosp, Div Pediat Anaesthesia, 1820 Richmond Rd SW, Calgary, AB T2T 5C7, Canada.						BIBY L, 1990, ANESTH ANALG, V70, P112; BRANTZAWADZKI M, 1981, AM J ROENTGENOL, V136, P369, DOI 10.2214/ajr.136.2.369; BUSER KB, 1984, AM SURGEON, V50, P33; COLEMAN JA, 1986, OTOLARYNG HEAD NECK, V94, P387, DOI 10.1177/019459988609400326; COOK LB, 1992, BRIT J ANAESTH, V69, P322, DOI 10.1093/bja/69.3.322; Daniello N J, 1994, Ear Nose Throat J, V73, P41; GHURYE M, 1992, INJURY, V23, P424, DOI 10.1016/0020-1383(92)90027-P; KATTAN B, 1991, Journal of Emergency Medicine, V9, P421; KELLY CP, 1995, INJURY, V26, P339, DOI 10.1016/0020-1383(95)00011-W; KUHN JE, 1991, J SPINAL DISORD, V4, P264; MACKENZIE JW, 1986, ANAESTHESIA, V41, P57, DOI 10.1111/j.1365-2044.1986.tb12705.x; MCCOOK TA, 1979, AM J DIS CHILD, V133, P41, DOI 10.1001/archpedi.1979.02130010047007; MCLAUCHLAN CAJ, 1991, ARCH EMERG MED, V8, P135; Mitchell Robert O., 1995, Journal of Emergency Medicine, V13, P165, DOI 10.1016/0736-4679(94)00137-5; MYSSIOREK D, 1989, ARCH OTOLARYNGOL, V115, P1130; SHAW CB, 1995, OTOLARYNG HEAD NECK, V113, P485, DOI 10.1016/S0194-5998(95)70091-9; SMITH JP, 1988, J TRAUMA, V28, P553, DOI 10.1097/00005373-198804000-00027; TEASDALE G, 1974, LANCET, V2, P81; THATCHER J, 1987, J RHEUMATOL, V14, P1172; WOODMANSEE VA, 1992, ANN EMERG MED, V21, P440, DOI 10.1016/S0196-0644(05)82669-1	20	3	3	0	0	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	1155-5645			PAEDIATR ANAESTH	Paediatr. Anaesth.	JUL	1998	8	4					353	356					4	Anesthesiology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Pediatrics	ZZ108	WOS:000074696500015	9672937				2022-02-06	
J	Zebenholzer, K; Oder, W				Zebenholzer, K; Oder, W			Neurological and psychosocial sequelae 4 and 8 years after severe head injury: a catamnestic study	WIENER KLINISCHE WOCHENSCHRIFT			German	Article						head injury; psychosocial and vocational outcome; psychiatric disturbances; neurological deficits	TRAUMATIC BRAIN INJURY; CONSECUTIVE SERIES; RELATIVES VIEW; SURVIVORS; SPECT	Thirty-three patients (29 male, 4 female) were examined 4 and 8 years after severe head injury. The patients underwent a detailed neurological examination. A semistructured interview according to the Glasgow Assessment Schedule was administered to the patients and their relatives. Most frequent neurological features were motor deficits (55%, at both follow-up investigations, mostly monoparesis), dysarthria (39% versus 33%), ataxia (49% versus 39%) and anosmia (46% versus 33%) at 4 and 8 years, respectively. There was a slight, but not significant improvement between the 2 examinations with respect to frequency and severity of neurological impairment. There was no significant improvement in the activities of daily living and 18% remained totally dependent on other people's help. At both follow-ups 85% complained of memory deficits. 67% and 70% respectively, suffered from poor initiative and increasing irritability at the first and second examination. The patients were more socially isolated and more irritable at the second follow-up. Only 12% and 18%, respectively held the same job as they had had before the injury; nearly half of them had retired. Occupational and psychosocial reintegration appeared to be rather poor in many patients. Excessive alcohol intake prior to trauma was identified as a person-related predictive factor. In contrast to other studies we found persistent, although slight neurological deficits. In the long-term, a combination of neurological and neuropsychological deficits seems to contribute to residual handicap.	Univ Vienna, Neurol Klin, Klin Abt Klin Neurol, A-1090 Vienna, Austria; Rehabil Zentrum Beruflichen Wiederherstellung Hir, Vienna, Austria		Zebenholzer, K (corresponding author), Univ Vienna, Neurol Klin, Klin Abt Klin Neurol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.						American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; ARNOLD U, 1993, NEUROPSYCHOLOGISCHE; BENYISHAY Y, 1990, REHABILITATION ADULT, P393; Bond M. R., 1990, REHABILITATION ADULT, P179; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BROOKS N, 1988, SCAND J REHABIL MED, P41; CHRISTENSEN AL, 1992, ACTA NEUROL SCAND, V85, P32; DIKMEN SS, 1985, JINS, V1, P67; FARMER RH, 1978, DISABILITY REHABILIT; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; FRIEDMANN A, 1992, LEITFADEN PSYCHIAT; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JENNETT B, 1990, REHABILITATION ADULT, P3; JENNETT B, 1990, REHABILITATION ADULT, P89; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; LEVIN HS, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P89; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Livingston M G, 1985, Int Rehabil Med, V7, P145; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MELAMED S, 1992, Brain Injury, V6, P233, DOI 10.3109/02699059209029665; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; PRIGATANO GP, 1987, NEUROPSYCHOLOGICAL R, P29; PROSIEGEL M, 1988, NEUROPSYCHOLOGISCHE; Rimel RW, 1990, REHABILITATION ADULT, P8; STOHR M, NEUROLOGISCHE SYNDRO; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; TATE RL, 1989, ACTA NEUROL SCAND, V79, P97, DOI 10.1111/j.1600-0404.1989.tb03719.x; TEASDALE G, 1986, CLOSED HEAD INJURY P, P4; THOMPSON GB, 1975, HDB CLIN NEUROLOGY 1, V23; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; THOMSEN IV, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P52; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; THOMSEN IV, 1974, J NEUROL NEUROSUR PS, V47, P260; VANZOMEREN A, 1986, CLOSED HEAD INJURY P; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WURZER W, 1994, 8 ALP S INT ZUS REH, P165; ZANGWILL OL, 1975, INJURIES BRAIN SKU 1, V23; [No title captured]; [No title captured]	48	3	4	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0043-5325	1613-7671		WIEN KLIN WOCHENSCHR	Wien. Klin. Wochen.	APR 10	1998	110	7					253	261					9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZH398	WOS:000073104700003	9611341				2022-02-06	
J	Berre, J; Moraine, JJ; Melot, C				Berre, J; Moraine, JJ; Melot, C			Cerebral CO2 vasoreactivity evaluation with and without changes in intrathoracic pressure in comatose patients	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						cerebral CO2 vasoreactivity; cerebral blood flow; jugular thermodilution; transcranial Doppler ultrasonography; jugular bulb oximetry; brain injury; mechanical ventilation	TRAUMATIC BRAIN-LESIONS; END-EXPIRATORY PRESSURE; BLOOD-FLOW VELOCITY; CARBON-DIOXIDE; INTRACRANIAL-PRESSURE; HEAD-INJURY; DOGS; DOPPLER; ARTERY; OXYGENATION	It is well established that cerebral blood flow (CBF) is sensitive to variations in arterial PCO2 (PaCO2) and can be influenced by changes in jugular venous return due to elevated intrathoracic pressure. Therefore, we compared cerebral CO2 vasoreactivity when PaCO2 was altered either by changing inspired PCO2 or tidal volume. In addition. we sought to determine if noninvasive transcranial Doppler ultrasonography can be used instead of invasive CBF measurement to determine cerebral CO2 vasoreactivity. In 36 mechanically ventilated patients in coma due to acute brain lesion, we evaluated CBF by continuous jugular thermodilution, middle cerebral artery flow velocity (Vm) by transcranial Doppler ultrasonography, intracranial pressure (ICP; in only 23 of them) by intraventricular catheter, systemic and pulmonary hemodynamic variables, and arterial and jugular bulb blood gases. Measurements were taken at four levels of PaCO2 (25, 30, 35, and 40 mmHg) by modifying in a random order either tidal volume or inspired. PCO2. Cerebral, pulmonary, and systemic hemodynamic changes were similar in magnitude during both methods of altering PaCO2. From the highest to the lowest PaCO2, CBF decreased from 61 +/- 7 to 36 +/- 4 ml/min/100 g (p < 0.001, mean +/- SE), Vm from 89 +/- 7 to 65 +/- 5 cm/s (p < 0.001), and ICP from 29 +/- 2 to 12 +/- 2 mmHg (p < 0.001), but cerebral perfusion pressure remained constant, ranging from 65 +/- 3 to 67 +/- 4 mmHg (p = NS). Arteriojugular oxygen content difference increased from 3.2 +/- 0.2 to 5.7 +/- 0.4 ml/dl (p < 0.001). Eleven of the 20 patients with a preserved CBF response to CO2 survived to 6 months, whereas only two of the 16 patients with an altered response were alive at 6 months (p < 0.05). When compared with CBF by jugular thermodilution, the rates of sensitivity and specificity of transcranial Doppler ultrasonography to detect impaired cerebral CO2 vasoreactivity were 69% and 65%, respectively. In conclusion, the reduction of PaCO2 from 40 to 25 mmHg by modifying either tidal volume or inspired PCO2 resulted in similar effects on cerebral, pulmonary, and systemic circulations. Cerebral CO2 vasoreactivity is of prognostic value in brain-injured patients when determined using CBF but may be misleading when evaluated using velocities measured by transcranial Doppler ultrasonography.	Free Univ Brussels, Hop Erasme, Dept Intens Care, B-1070 Brussels, Belgium		Berre, J (corresponding author), Free Univ Brussels, Hop Erasme, Dept Intens Care, 808 Route Lennik, B-1070 Brussels, Belgium.		Moraine, Jean-Jacques/O-3364-2014	MELOT, Christian/0000-0002-6172-0330			Berre J, 1997, CRIT CARE MED, V25, P392, DOI 10.1097/00003246-199703000-00004; BISHOP CCR, 1986, STROKE, V17, P913, DOI 10.1161/01.STR.17.5.913; COLD GE, 1981, ACTA ANAESTH SCAND, V25, P397, DOI 10.1111/j.1399-6576.1981.tb01673.x; CRUZ J, 1993, CRIT CARE MED, V21, P1225, DOI 10.1097/00003246-199308000-00025; Demolis P, 1996, STROKE, V27, P1835, DOI 10.1161/01.STR.27.10.1835; DOMINO KB, 1993, ANESTHESIOLOGY, V78, P91, DOI 10.1097/00000542-199301000-00014; FELDMAN Z, 1992, J NEUROSURG, V76, P207, DOI 10.3171/jns.1992.76.2.0207; GOTOH F, 1965, ARCH NEUROL-CHICAGO, V12, P410, DOI 10.1001/archneur.1965.00460280080008; GUYTON AC, 1957, AM J PHYSIOL, V189, P609, DOI 10.1152/ajplegacy.1957.189.3.609; Hamilton WF, 1944, AM J PHYSIOL, V141, P0042, DOI 10.1152/ajplegacy.1944.141.1.42; HEISTAD DD, 1978, J CLIN INVEST, V62, P761, DOI 10.1172/JCI109187; HUSEBY JS, 1978, J APPL PHYSIOL, V44, P25, DOI 10.1152/jappl.1978.44.1.25; JENNETT B, 1975, LANCET, V1, P480; KLINGELHOFER J, 1992, STROKE, V23, P962, DOI 10.1161/01.STR.23.7.962; LUCE JM, 1982, J APPL PHYSIOL, V53, P1496, DOI 10.1152/jappl.1982.53.6.1496; LUCE JM, 1982, J APPL PHYSIOL, V52, P231, DOI 10.1152/jappl.1982.52.1.231; MAEDA H, 1993, STROKE, V24, P670, DOI 10.1161/01.STR.24.5.670; MARKWALDER TM, 1984, J CEREBR BLOOD F MET, V4, P368, DOI 10.1038/jcbfm.1984.54; MCPHERSON RW, 1988, AM J PHYSIOL, V255, pH1516; Melot C, 1996, J CEREBR BLOOD F MET, V16, P1263, DOI 10.1097/00004647-199611000-00022; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Olesen J, 1971, STROKE, V2, P519, DOI 10.1161/01.STR.2.6.519; PINSKY MR, 1985, J APPL PHYSIOL, V58, P1189, DOI 10.1152/jappl.1985.58.4.1189; RINGELSTEIN EB, 1988, STROKE, V19, P963, DOI 10.1161/01.STR.19.8.963; Rosner B, 1995, FUNDAMENTALS BIOSTAT, P423; Sahuquillo J, 1996, ACTA NEUROCHIR, V138, P435, DOI 10.1007/BF01420306; SCHALEN W, 1991, ACTA ANAESTH SCAND, V35, P113, DOI 10.1111/j.1399-6576.1991.tb03258.x; Spann W, 1965, Dtsch Z Gesamte Gerichtl Med, V56, P299, DOI 10.1007/BF00574453; SWENSON ER, 1994, AM J RESP CRIT CARE, V149, P1563, DOI 10.1164/ajrccm.149.6.8004314; TEASDALE G, 1974, LANCET, V2, P81; TOMINAGA S, 1976, STROKE, V7, P507, DOI 10.1161/01.STR.7.5.507; Waltz AG, 1970, STROKE, V1, P27, DOI 10.1161/01.STR.1.1.27; WINER BJ, 1971, STAT PRINCIPLES EXPT, P172	34	3	3	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0898-4921			J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	APR	1998	10	2					70	79		10.1097/00008506-199804000-00002			10	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	ZF382	WOS:000072891900003	9559764				2022-02-06	
J	Shapira, Y; Talmor, D; Artru, AA; Rubin, M; Holkuvski, A; Merkind, V; Kaplanski, J				Shapira, Y; Talmor, D; Artru, AA; Rubin, M; Holkuvski, A; Merkind, V; Kaplanski, J			Effects of closed head trauma and lipopolysaccharide on body temperature, brain tissue water content, and PGE2 production in rats	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						body temperature; cerebral cortex; fever; head injury; hypothalamus; inflammatory reaction; lipopolysaccharide; prostaglandins	ARACHIDONIC-ACID; INJURY; EDEMA; ISCHEMIA; PROSTAGLANDINS; HYPERTHERMIA; ENDOTOXIN; INJECTION; RABBITS; FLUID	Closed head trauma (CHT) increases brain tissue prostaglandin E2 (PGE2) concentration, and that increase is associated with cerebral edema formation and worsening of the neurologic severity score (NSS). Injection of the bacterial endotoxin lipopolysaccharide (LPS) increases cerebral and hypothalamic PGE2, and the hypothalamic increase is associated with increased body temperature. The present study determined (a) whether LPS-induced increase of PGE2 causes brain edema or worsens NSS and (b) whether CHT increases hypothalamic PGE2 and thereby increases body temperature. Halothane-anesthetized rats were divided into four groups: group 1 = surgery with no CHT and no LPS (n = 8), group 2 = surgery with LPS and no CHT (n = 8); group 3 = surgery with CHT and no LPS (n = 8); and group 4 = surgery with CHT plus LPS (n = 8). NSS was determined at 1 and 24 h after injury, and brain tissue PGE2 and edema were determined when animals were killed 24 h after injury. As compared with group I,LPS alone, but not CHT or CRT plus LPS, increased rectal temperature. CHT and CHT plus LPS, but not LPS alone increased brain water content and worsened NSS. LPS, CHT, and CHT plus LPS all increased hypothalamic and cerebral PGE2 production. We conclude that although LPS and CHT increased PGE2 levels, LPS alone did not affect neurologic status or brain edema, CHT did not increase rectal temperature, and addition of LPS to CHT did not aggravate the sequelae of CHT.	Univ Washington, Sch Med, Dept Anesthesiol, Seattle, WA 98195 USA; Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Med Ctr, Div Anesthesiol, Beer Sheva, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Med Ctr, Dept Clin Pharmacol, Beer Sheva, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Med Ctr, Dept Neurosurg, Beer Sheva, Israel; Kaplan Hosp, Dept Anesthesiol, IL-76100 Rehovot, Israel		Artru, AA (corresponding author), Univ Washington, Sch Med, Dept Anesthesiol, 1959 NE Pacific St,Box 356540, Seattle, WA 98195 USA.						BAZAN NG, 1970, BIOCHIM BIOPHYS ACTA, V218, P1, DOI 10.1016/0005-2760(70)90086-X; BERNHEIM HA, 1980, J PHYSIOL-LONDON, V301, P69, DOI 10.1113/jphysiol.1980.sp013189; CHAN PH, 1983, ANN NEUROL, V13, P625, DOI 10.1002/ana.410130608; COCEANI F, 1991, FEVER BASIC MECH MAN, P59; COELHO MM, 1995, AM J PHYSIOL-REG I, V269, pR527, DOI 10.1152/ajpregu.1995.269.3.R527; DANON A, 1983, J PHARM PHARMACOL, V35, P576, DOI 10.1111/j.2042-7158.1983.tb04336.x; DEMPSEY RJ, 1986, J NEUROSURG, V64, P118, DOI 10.3171/jns.1986.64.1.0118; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; FRAIFELD V, IN PRESS PROG BRAIN; IANNOTTI F, 1981, STROKE, V12, P301, DOI 10.1161/01.STR.12.3.301; Kaplanski J, 1997, ANN NY ACAD SCI, V813, P474, DOI 10.1111/j.1749-6632.1997.tb51735.x; KAPLANSKI J, 1992, SYMP PHARMA, V7, P33; KAPLANSKI J, 1994, THERMAL BALANCE HLTH, P379; KAPLANSKI J, 1993, THERMAL PHYSL, P61; KAPLANSKI J, 1996, BIODIVERSITY ADAPTAT, P163; KLUGER MJ, 1986, YALE J BIOL MED, V59, P89; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; MINAMISAWA H, 1990, ANN NEUROL, V28, P26, DOI 10.1002/ana.410280107; NEWELL DW, 1995, ANESTHETIC MANAGEMEN, P243; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; SAMUELSSON B, 1979, ADV INFLAMMAT RES, V1, P405; Seydel U, 1994, Prog Clin Biol Res, V388, P17; SHAPIRA Y, 1992, J NEUROSURG ANESTH, V4, P231, DOI 10.1097/00008506-199210000-00001; SHAPIRA Y, 1993, EUR J ANAESTH, V10, P155; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHAPIRA Y, 1989, PROSTAG LEUKOTR ESS, V36, P49, DOI 10.1016/0952-3278(89)90162-2; SHAPIRA Y, 1992, ANESTH ANALG, V75, P238; SHAPIRA Y, 1988, J CEREBR BLOOD F MET, V8, P395, DOI 10.1038/jcbfm.1988.75; SHOHAMI E, 1987, J CEREBR BLOOD F MET, V7, P58, DOI 10.1038/jcbfm.1987.8; SHOHAMI E, 1989, ANN NY ACAD SCI, V559, P485; SHOHAMI E, 1989, J NEUROCHEM, V53, P1541, DOI 10.1111/j.1471-4159.1989.tb08550.x; SHOHAMI E, 1988, NEUROSURGERY, V22, P859, DOI 10.1227/00006123-198805000-00007; SIRCO SI, 1989, AM J PHYSIOL, V256, pR616; TEISNER B, 1974, NATURE, V247, P568, DOI 10.1038/247568a0; WATANABE T, 1994, BRAIN RES, V652, P201, DOI 10.1016/0006-8993(94)90228-3; WEIDENFELD J, 1993, ENDOCRINOLOGY, V132, P941, DOI 10.1210/en.132.3.941; WOLFE LS, 1979, ANNU REV PHYSIOL, V41, P669, DOI 10.1146/annurev.ph.41.030179.003321; WOLFE LS, 1982, J NEUROCHEM, V38, P1, DOI 10.1111/j.1471-4159.1982.tb10847.x	38	3	3	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	APR	1998	10	2					94	100		10.1097/00008506-199804000-00005			7	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	ZF382	WOS:000072891900006	9559767				2022-02-06	
J	Michaud, LJ				Michaud, LJ			Brain injury rehabilitation. 5. Acute brain injury in children	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							CLOSED HEAD-INJURY; BEHAVIOR PROBLEMS; YOUNG-ADULTS; SEVERITY; PREDICTORS; RECOVERY; ADOLESCENTS; COHORT; MILD; PRESCHOOLERS	This self-directed learning module highlights new advances in this topic area. It is part of the chapter on brain injury rehabilitation in the Self-Directed Physiatric Education Program for practitioners and trainees in physical medicine and rehabilitation. This article contains an overview of epidemiology and prevention of pediatric traumatic brain injury (TBI) and highlights issues of assessment and management that differ in the child as compared with the adult with TBI. Prediction and description of outcome after pediatric TBI across the spectrum of injury severity are discussed. Special categories of common pediatric brain injury, including shaking-impact syndrome and near drowning, are also briefly reviewed. New advances covered in this article include new information on pediatric TBI outcomes and recent availability of functional neuroimaging as a tool to explore developmental differences in brain function and plasticity and mechanisms of neurologic and functional recovery after pediatric TBI. More research is needed to evaluate the effectiveness of rehabilitation interventions in improving outcomes after TBI in children. (C) 1998 by the American Academy of Physical Medicine and Rehabilitation.	Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA		Michaud, LJ (corresponding author), Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA.						ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; BIJUR PE, 1990, PEDIATRICS, V86, P337; BRATTON SL, 1994, ARCH PEDIAT ADOL MED, V148, P167, DOI 10.1001/archpedi.1994.02170020053008; BRINK JD, 1970, DEV MED CHILD NEUROL, V12, P565; Broman S. H., 1995, TRAUMATIC HEAD INJUR; CARNEY J, 1994, PEDIATR ANN, V23, P47, DOI 10.3928/0090-4481-19940101-10; CARNEY J, 1990, Pediatrician, V17, P222; Chapman S.B, 1995, TRAUMATIC HEAD INJUR, P95; CHAPMAN SB, 1995, J HEAD TRAUMA REHAB, V10, P36, DOI 10.1097/00001199-199510000-00006; CHUGANI HT, 1992, PEDIATR CLIN N AM, V39, P777; COCKRELL J, 1996, MED REABILITATION TR, P171; COSTEFF H, 1990, J NEUROSURG, V73, P684, DOI 10.3171/jns.1990.73.5.0684; DEPOMPEI R, 1991, NEUROREHABILITATION, V1, P29; DUHAIME AC, 1992, PEDIATRICS, V90, P179; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; EIBEN CF, 1984, ARCH PHYS MED REHAB, V65, P168; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; EWINGCOBBS L, 1995, J HEAD TRAUMA REHAB, V10, P13, DOI 10.1097/00001199-199510000-00004; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P7233; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P1328, DOI 10.1097/00003246-199309000-00016; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; KRIEL RL, 1988, PEDIATR NEUROL, V4, P337, DOI 10.1016/0887-8994(88)90079-3; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; KRIEL RL, 1993, PEDIATR NEUROL, V9, P362, DOI 10.1016/0887-8994(93)90104-K; LASH M, 1992, WHEN YOUR CHILD GOES; LAVELLE JM, 1993, CRIT CARE MED, V21, P368, DOI 10.1097/00003246-199303000-00013; LAZAR MF, 1995, J HEAD TRAUMA REHAB, V10, P55, DOI 10.1097/00001199-199510000-00007; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LEVIN HS, 1984, AGING RECOVERY FUNCT; LIVINGSTON M G, 1990, Pediatrician, V17, P255; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; MCDONALD CM, 1994, ARCH PHYS MED REHAB, V75, P328, DOI 10.1016/0003-9993(94)90038-8; MCLEAN DE, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510000-00003; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; MICHAUD LJ, 1993, PEDIATR CLIN N AM, V40, P553; Mira M. P., 1992, TRAUMATIC BRAIN INJU; ORLOWSKI JP, 1987, PEDIATR CLIN N AM, V34, P75; PERROTT SB, 1991, DEV NEUROPSYCHOL, V7, P69, DOI 10.1080/87565649109540477; RIVARA FP, 1994, PEDIATR ANN, V23, P12, DOI 10.3928/0090-4481-19940101-06; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P627; ROSENTHAL M, 1990, REHABILITATION ADULT; SAVAGE RC, 1988, ED MANUAL WHAT ED NE; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; TYLER JS, 1992, TRAUMATIC BRAIN INJU; Ylvisaker M, 1991, J HEAD TRAUMA REHAB, V6, P10, DOI DOI 10.1097/00001199-199103000-00006	58	3	3	0	2	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	1998	79	3		1			S26	S30		10.1016/S0003-9993(98)90117-4			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	ZC421	WOS:000072576300006					2022-02-06	
J	Blauth, M; Knop, C; Bastian, L; Schmidt, U				Blauth, M; Knop, C; Bastian, L; Schmidt, U			Reduction and positioning of cervical spine injuries	ZENTRALBLATT FUR CHIRURGIE			German	Article						cervical spine; reduction manoeuver; traction; dislocation; positioning device	ATLANTO-OCCIPITAL DISLOCATION; BILATERAL LOCKED FACETS; CLOSED REDUCTION; FRACTURE DISLOCATIONS; TRACTION; CORD; MANAGEMENT; STABILIZATION; COMPRESSION; FUSION	Prerequisites for successful reduction of cervical spine injuries are an exact analysis and classification of every lesion. In locked dislocations disc protrusion should be excluded Drier to reduction by MRI or CT-scan. For manual reduction and closed manipulation by the trauma surgeon we use a halo-ring which is applied in local anaesthesia and fluoroscopic control. The anatomic position is maintained by a halo-fixator until surgery. Skeletal traction is used mainly for locked dislocations and late malalignements. Traction is provided by a halo-ring and weights up to 20 kg. Repeated clinical and neurological examinations are necessary to rule out overdistraction of the spine or neurologic deterioration. The weight may be reduced after reduction to 2 kg. For intraoperative positioning and reduction of cervical spine injuries we designed a special device which is connected to the halo ring and allows to fix the head and spine in any desired position. It may be used in prone or supine position of the patient. Operative reductions are rarely necessary on the cervical spine. Typical indication are fractures of posterior elements of the spine preventing closed reduction. Reduction manoeuvers depend on the kind of injury and are mainly composed of traction and a reversal of the trauma mechanism. The most severe complication is a neurologic deterioration. Reports in literature about 13 patients having sustained such a fate are showing the following: In most cases disc material dislocated in the spinal canal during reduction could be made reponsible for the catastrophic course. Especially at risk are patients with open reduction from a posterior approach.	Hannover Med Sch, Unfallchirurg Klin, D-30623 Hannover, Germany		Blauth, M (corresponding author), Hannover Med Sch, Unfallchirurg Klin, D-30623 Hannover, Germany.	Blauth.Michael@MH-Hannover.de					ALLEN RL, 1985, J NEUROSURG, V63, P510, DOI 10.3171/jns.1985.63.4.0510; APPLE JS, 1987, PEDIATR RADIOL, V17, P45, DOI 10.1007/BF02386594; BARNES R, 1948, J BONE JOINT SURG BR, V30, P234, DOI 10.1302/0301-620X.30B2.234; BEDBROOK GM, 1979, J BONE JOINT SURG BR, V61, P267, DOI 10.1302/0301-620X.61B3.225332; BERRINGTON NR, 1993, SURG NEUROL, V40, P395, DOI 10.1016/0090-3019(93)90219-Q; Blauth M, 1997, Oper Orthop Traumatol, V9, P242, DOI 10.1007/s00064-006-0035-3; Blauth M, 1996, UNFALLCHIRURG, V99, P925, DOI 10.1007/s001130050076; BLAUTH M, 1994, ORTHOP TRAUMATOL, V3, P267; BLAUTH M, 1998, TSCHERNE UNFALLCHIRU, P383; Blauth M, 1998, TSCHERME UNFALLCHIRU, P1; BOHLMAN HH, 1978, COMPLICATIONS ORTHOP, P611; BRAAKMAN R., 1967, J BONE JOINT SURG B BRIT, V49, P249; Brookes TP, 1933, SURG GYNECOL OBSTET, V57, P772; Burke D C, 1971, J Bone Joint Surg Br, V53, P165; Cheshire D J, 1969, Paraplegia, V7, P193; COTLER HB, 1985, SPINE, V10, P748, DOI 10.1097/00007632-198510000-00010; COTLER HB, 1987, CLIN ORTHOP RELAT R, V214, P185; COTLER JM, 1993, SPINE, V18, P386, DOI 10.1097/00007632-199303000-00015; COTLER JM, 1992, ASIA ANN M; Crooks F, 1944, BRIT J SURG, V31, P252, DOI 10.1002/bjs.18003112309; Crutchfield WG, 1933, S SURG, V2, P156; DAVIS D, 1971, J NEUROSURG, V34, P603, DOI 10.3171/jns.1971.34.5.0603; de Oliveira J C, 1979, Spine (Phila Pa 1976), V4, P195; DELACAMP HB, 1959, ARCH KLIN CHIR, V292, P514; DORAN SE, 1993, J NEUROSURG, V79, P341, DOI 10.3171/jns.1993.79.3.0341; DURBIN FC, 1957, J BONE JOINT SURG BR, V39, P23, DOI 10.1302/0301-620X.39B1.23; EISMONT FJ, 1991, J BONE JOINT SURG AM, V73A, P1555, DOI 10.2106/00004623-199173100-00014; ELLIS VH, 1946, P ROY SOC MED, V40, P19, DOI 10.1177/003591574604000115; EVANS DK, 1961, J BONE JOINT SURG BR, V43, P552, DOI 10.1302/0301-620X.43B3.552; EVARTS CM, 1970, J BONE JOINT SURG AM, VA 52, P1653, DOI 10.2106/00004623-197052080-00017; FORSYTH HF, 1959, J BONE JOINT SURG AM, V41, P17, DOI 10.2106/00004623-195941010-00005; FREDRICKSON BE, 1992, SKELETAL TRAUMA, V1, P623; FRIED LC, 1974, JAMA-J AM MED ASSOC, V229, P181, DOI 10.1001/jama.229.2.181; FRUIN AH, 1977, J NEUROSURG, V46, P663, DOI 10.3171/jns.1977.46.5.0663; GALIBERT P, 1962, Lille Chir, V17, P172; JEANNERET B, 1991, ARCH ORTHOP TRAUM SU, V110, P242, DOI 10.1007/BF00572880; Jeanneret B, 1991, Aktuelle Probl Chir Orthop, V41, P118; JEANNERET B, 1994, CLIN ORTHOP RELAT R, P130; JEANNERET B, 1991, J SPINAL DISORD, V4, P203, DOI 10.1097/00002517-199106000-00011; JEANNERET B, 1994, OPERAT ORTHOP TRAUMA, V6, P71; KAUFMANN RA, 1982, JAMA-J AM MED ASSOC, P415; KLEYN PJ, 1984, PARAPLEGIA, V22, P271, DOI 10.1038/sc.1984.45; LEE AS, 1994, J BONE JOINT SURG BR, V76B, P352, DOI 10.1302/0301-620X.76B3.8175833; MAHALE YJ, 1993, J BONE JOINT SURG BR, V75, P403, DOI 10.1302/0301-620X.75B3.8496208; MAIMAN DJ, 1986, NEUROSURGERY, V18, P542, DOI 10.1227/00006123-198605000-00005; MEYER PR, 1989, SURG SPINE TRAUMA, P397; MONTANE I, 1991, SPINE, V16, P112, DOI 10.1097/00007632-199116020-00002; OBRIEN PJ, 1982, J TRAUMA, V22, P710, DOI 10.1097/00005373-198208000-00012; OLERUD C, 1991, ACTA ORTHOP SCAND, V62, P599, DOI 10.3109/17453679108994506; OSTI OL, 1989, J BONE JOINT SURG BR, V71, P275; OWEN JH, 1990, SPINE, V15, P852, DOI 10.1097/00007632-199009000-00003; RAYNOR R B, 1977, Spine, V2, P39, DOI 10.1097/00007632-197703000-00004; RIZZOLO SJ, 1994, SPINE, V19, P2288, DOI 10.1097/00007632-199410150-00007; RIZZOLO SJ, 1991, SPINE, V16, pS187, DOI 10.1097/00007632-199106001-00002; RIZZOLO SJ, 1993, AAOS ANN M; Roberts SM, 1937, J BONE JOINT SURG, V19, P477; ROBERTSON PA, 1992, J BONE JOINT SURG BR, V74, P224, DOI 10.1302/0301-620X.74B2.1544957; Rogers WA, 1942, J BONE JOINT SURG, V24, P245; RORABECK CH, 1987, SPINE, V12, P23, DOI 10.1097/00007632-198701000-00004; SABISTON CP, 1988, J TRAUMA, V28, P832, DOI 10.1097/00005373-198806000-00020; SCOTT EW, 1990, J NEUROSURG, V72, P488, DOI 10.3171/jns.1990.72.3.0488; SHROSBREE RD, 1979, PARAPLEGIA, V17, P212, DOI 10.1038/sc.1979.44; SONNTAG VKH, 1981, NEUROSURGERY, V8, P150, DOI 10.1227/00006123-198102000-00002; STAR AM, 1990, SPINE, V15, P1068, DOI 10.1097/00007632-199015100-00016; Taylor AS, 1924, ARCH NEURO PSYCHIATR, V12, P625, DOI 10.1001/archneurpsyc.1924.02200060026003; WALTON GL, 1893, J NERV MENT DIS, V20, P609; WOODRING JH, 1981, AM J ROENTGENOL, V137, P21, DOI 10.2214/ajr.137.1.21; [No title captured]	68	3	3	0	3	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0044-409X	1438-9592		ZBL CHIR	Zent.bl. Chir.		1998	123	8					894	906					13	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	114BW	WOS:000075590100002	9757534				2022-02-06	
J	Giulian, D				Giulian, D			A strategy for identifying immunosuppressive therapies for Alzheimer disease	ALZHEIMER DISEASE & ASSOCIATED DISORDERS			English	Article; Proceedings Paper	Scientific Symposium on Glial Cell Reactions in Dementia - Pathophysiology and Therapeutic Interventions, at the World Congress of Neurology	SEP, 1997	BUENOS AIRES, ARGENTINA	Hoechst Marion Roussel Inc		Alzheimer disease; microglia; beta amyloid; neurotoxicity; plaques; immune system	CENTRAL-NERVOUS-SYSTEM; AMYLOID-BETA-PROTEIN; MONONUCLEAR PHAGOCYTES; TRAUMATIC INJURY; MAMMALIAN BRAIN; MICROGLIA; RELEASE; ASSOCIATION; ACTIVATION; NEURONS	There is increasing evidence that the immune system plays an important role in the pathology of Alzheimer disease (AD). The fundamental steps in this process involve induction of neurotoxic microglia by senile plaques. Recent studies have shown that microglia in contact with isolated plaque fragments secrete neurotoxins that can cause neuronal injury and brain damage typical of AD. In vitro models help to delineate individual steps of this activation cascade by which quiescent microglia become neuron-killing cells. Moreover, such model systems provide rapid screening assays to identify immunosuppressive drugs that might slow brain damage brought on by neurotoxic microglia.	Baylor Coll Med, Dept Neurol, Alzheimers Dis Res Ctr, Houston, TX 77030 USA		Giulian, D (corresponding author), Baylor Coll Med, Dept Neurol, Alzheimers Dis Res Ctr, Houston, TX 77030 USA.						BANATI RB, 1993, GLIA, V7, P111, DOI 10.1002/glia.440070117; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; BOLSI DINO, 1927, RIV PAT NERV E MENT, V32, P65; BREITNER JCS, 1994, NEUROLOGY, V44, P227, DOI 10.1212/WNL.44.2.227; EIKELENBOOM P, 1994, TRENDS PHARMACOL SCI, V15, P447, DOI 10.1016/0165-6147(94)90057-4; FOLK JE, 1985, METHOD ENZYMOL, V113, P358; GIULIAN D, 1993, J NEUROSCI, V13, P29; GIULIAN D, 1989, J NEUROSCI, V9, P4416; GIULIAN D, 1995, J NEUROSCI, V15, P7712; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Giulian D, 1996, J NEUROSCI, V16, P6021; GIULIAN D, 1993, J NEUROSCI RES, V36, P681, DOI 10.1002/jnr.490360609; GIULIAN D, 1990, ANN NEUROL, V27, P33, DOI 10.1002/ana.410270107; GIULIAN D, 1995, NEUROCHEM INT, V27, P119, DOI 10.1016/0197-0186(95)00067-I; Giulian D., 1992, CURR TOP NEUROL, V12, P23; Hunter M J, 1972, Methods Enzymol, V25, P585, DOI 10.1016/S0076-6879(72)25058-3; KOO EH, 1993, P NATL ACAD SCI USA, V90, P4748, DOI 10.1073/pnas.90.10.4748; LUCCA U, 1994, BIOL PSYCHIAT, V36, P854, DOI 10.1016/0006-3223(94)90598-3; MCGEER PL, 1987, NEUROSCI LETT, V79, P195, DOI 10.1016/0304-3940(87)90696-3; MCGEER PL, 1990, LANCET, V335, P1037, DOI 10.1016/0140-6736(90)91101-F; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; MRAK RE, 1995, HUM PATHOL, V26, P816, DOI 10.1016/0046-8177(95)90001-2; PATTHY L, 1975, J BIOL CHEM, V250, P557; PERLMUTTER LS, 1992, J NEUROSCI RES, V33, P549, DOI 10.1002/jnr.490330407; Riordan J F, 1972, Methods Enzymol, V25, P515, DOI 10.1016/S0076-6879(72)25048-0; ROGERS J, 1988, NEUROBIOL AGING, V9, P339, DOI 10.1016/S0197-4580(88)80079-4; ROGERS J, 1992, P NATL ACAD SCI USA, V89, P10016, DOI 10.1073/pnas.89.21.10016; ROHER AE, 1988, J CELL BIOL, V107, P2703, DOI 10.1083/jcb.107.6.2703; SCHNABEL J, 1993, SCIENCE, V260, P1719, DOI 10.1126/science.8323582; SELKOE DJ, 1993, TRENDS NEUROSCI, V16, P403, DOI 10.1016/0166-2236(93)90008-A; THERY C, 1991, EUR J NEUROSCI, V3, P1155, DOI 10.1111/j.1460-9568.1991.tb00050.x; Wujek JR, 1996, NEUROBIOL AGING, V17, P107, DOI 10.1016/0197-4580(95)02020-9	32	3	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0893-0341			ALZ DIS ASSOC DIS	Alzheimer Dis. Assoc. Dis.		1998	12			2			S7	S14					8	Clinical Neurology; Pathology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	145DH	WOS:000077355400002	9769024				2022-02-06	
J	Max, JE; Bowers, WA; Baldus, D; Gaylor, EE				Max, JE; Bowers, WA; Baldus, D; Gaylor, EE			Pediatric traumatic brain injury and burn patients in the civil justice system: The prevalence and impact of psychiatric symptomatology	JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW			English	Article							CLOSED-HEAD-INJURY; CHILDREN	The goal of this research was to conduct an assessment of psychopathology in plaintiffs following pediatric traumatic brain injury (TBI) and burns and its relationship to awards of total compensatory damages. Childhood TBI (n = 43) and burn (n = 51) plaintiffs were ascertained through a survey of the U.S. civil justice system involving a review of judicial opinions and verdict reporters in cases that had resulted in an award of compensatory damages in all states from 1978 to 1988. Narrative summaries, drawn from these sources with supplemental information from counsel of record, where possible, were prepared. Psychiatric and disability ratings were made from the summaries, blind to award data. Outcome measures were the pattern and prevalence of psychiatric disorders and their correlation with the awards. It was found that psychiatric disorders, which were almost exclusively internalizing disorders (e.g., anxiety), were present in approximately 25 percent of the subjects in each group. Psychiatric symptoms were not related to the award amount. Significantly greater awards in the TBI group were accounted for by greater disability measures. Physical disability and total disability (including physical and quality of life limitations) were significantly and independently correlated with the award. It is concluded that the prevalence of psychiatric disorders in childhood TBI and burn plaintiffs is similar to that found in TBI and burn subjects in clinical studies. Distribution of disorders is atypical in that externalizing disorders (e.g., attention deficit/hyperactivity disorder) were not commonly reported for either class of injuries. Awards are strongly correlated with disability variables reflecting mainly the severity of physical injury. Internalizing psychopathology may be underappreciated in decisions involving magnitude of awards following selected childhood injuries.	Univ Iowa, Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; Univ Calif Davis, Dept Psychol, Davis, CA USA; Univ Iowa, Coll Law, Iowa City, IA 52242 USA		Max, JE (corresponding author), Univ Iowa, Coll Med, Dept Psychiat, Iowa City, IA 52242 USA.	jmax@blue.weeg.uiowa.edu		Bowers, Wayne/0000-0002-0733-0665	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R37MH031593, R01MH040856, R01MH031593] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH40856, MH31593] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [MCH-197054] Funding Source: Medline		American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; Baldus D, 1995, IOWA LAW REV, V80, P1109; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BLACK P, 1981, BRAIN DYSFUNCTION CH, P171; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; KRAUS JF, 1987, PEDIATRICS, V79, P501; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LEMKUHL G, 1990, BRAIN BEHAV CHILD PS, P267; Max JE, 1997, BRAIN INJURY, V11, P699; Max JE, 1997, J AM ACAD CHILD PSY, V36, P404, DOI 10.1097/00004583-199703000-00020; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1595, DOI 10.1016/S0890-8567(09)66570-9; MAX JE, 1998, IN PRESS J AM ACAD C; SAKS MJ, 1992, U PENN LAW REV, V140, P147; STODDARD F J, 1992, Journal of Burn Care and Rehabilitation, V13, P340, DOI 10.1097/00004630-199205000-00007; STODDARD FJ, 1989, J AM ACAD CHILD PSY, V28, P589, DOI 10.1097/00004583-198907000-00020; Tarnowski K, 1994, BEHAV ASPECTS PEDIAT, P1; [No title captured]	21	3	3	0	3	AMER ACAD PSYCHIATRY LAW	BLOOMFIELD	ONE REGENCY DR, PO BOX 30, BLOOMFIELD, CT 06002 USA	0091-634X			J AM ACAD PSYCHIATRY	J. Am. Acad. Psychiatry Law		1998	26	2					247	258					12	Law; Psychiatry	Social Science Citation Index (SSCI)	Government & Law; Psychiatry	ZY242	WOS:000074600500007	9664260				2022-02-06	
J	Seliger, GM; Lichtman, SW; Hornstein, A				Seliger, GM; Lichtman, SW; Hornstein, A			Naltrexone improves severe posttraumatic abulia	JOURNAL OF NEUROLOGIC REHABILITATION			English	Article						naltrexone; brain injury; abulia		A single case study is presented of a 22-year-old women who sustained severe abulia and akinesia after a traumatic brain injury. After intensive rehabilitation and unsuccessful pharmacologic interventions, a trial of naltrexone coincided with a significant improvement in Functional Independence Measure (FIM) scores.	Helen Hayes Hosp, Dept Neurol, W Haverstraw, NY 10993 USA; Helen Hayes Hosp, Dept Internal Med, W Haverstraw, NY 10993 USA; Helen Hayes Hosp, Dept Psychiat, W Haverstraw, NY 10993 USA; Columbia Univ, Coll Phys & Surg, New York, NY USA								*CTR FUNCT ASS RES, 1990, GUID US UN DAT SET M; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; HAMILTON B B, 1991, Archives of Physical Medicine and Rehabilitation, V72, P790; LEBOYER M, 1992, J AUTISM DEV DISORD, V22, P309, DOI 10.1007/BF01058158; Portney LG, 1993, FDN CLIN RES APPL PR, V3rd; TENNANT FS, 1987, AM J PSYCHIAT, V144, P813	6	3	3	0	1	DEMOS PUBLICATIONS	NEW YORK	386 PARK AVE S STE 201, NEW YORK, NY 10016-8804 USA	0888-4390			J NEUROL REHABIL	J. Neurol. Rehabil.		1998	12	1					29	31					3	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	ZL209	WOS:000073409700005					2022-02-06	
J	Vinas, FC; Verweij, BH; Muizelaar, JP				Vinas, FC; Verweij, BH; Muizelaar, JP			Invasive monitoring of cerebral oxygenation	CRITICAL REVIEWS IN NEUROSURGERY			English	Article						cerebral oxygenation; head trauma; Licox; paratrend 7; secondary brain injury	SEVERE HEAD-INJURY; BRAIN; PRESSURE	Despite medical and technological advances in neurosurgical intensive care, severe traumatic brain injury still carries a poor prognosis. Invasive monitoring of cerebral oxygenation has recently been proposed as a means for the detection and prevention of cerebral ischemia in comatose patients; however, it has not proven to influence the patient's outcome after severe brain injury. Eight recent reports selected from the literature are reviewed, and the authors' own clinical experience is presented in order to define the indications, usefulness, limitations, and potential complications of the available methodology for the invasive monitoring of cerebral interstitial oxygen saturation.	Wayne State Univ, Dept Neurosurg, Detroit, MI 48201 USA			Vinas@neurosurg.wayne.edu					BOUMA GJ, 1993, ACTA NEUROCHIR, P34; Dings J, 1996, ACTA NEUROCHIR, V138, P425, DOI 10.1007/BF01420305; Dings J, 1997, NEUROL RES, V19, P241, DOI 10.1080/01616412.1997.11740806; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; MAAS AIR, 1993, ACTA NEUROCHIR, P50; MEIXENSBERGER J, 1993, ACTA NEUROCHIR, P58; ROBERTSON C, 1993, ACTA NEUROCHIR, P98; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; ZAUNER A, 1995, NEUROSURGERY, V37, P1168, DOI 10.1227/00006123-199512000-00017	10	3	3	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0939-0146			CRIT REV NEUROSURG	Crit. Rev. Neurosurg.	JAN	1998	8	1					31	40		10.1007/s003290050058			10	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	YX063	WOS:000072002700005					2022-02-06	
J	Levine, B; Cabeza, R; Black, S; Sinden, M; Toth, JP; Tulving, E; Stuss, DT				Levine, B; Cabeza, R; Black, S; Sinden, M; Toth, JP; Tulving, E; Stuss, DT			Functional and structural neuroimaging correlates of selective retrograde amnesia: A case study with MRI and PET	BRAIN AND COGNITION			English	Article								The neuroanatomical and neurophysiological systems underlying episodic memory functioning were assessed in a case of retrograde amnesia without anterograde amnesia following traumatic brain injury (TBT). MRI showed evidence of a focal right inferior frontal injury affecting both cortical tissue and frontal-subcortical pathways, including the uncinate fasciculus, a frontal-temporal band of fibers previously hypothesized to be involved in retrieval of personal episodic memories. On an (H2O)-O-15 PET activation paradigm that reliably elicits right frontal activation on retrieval and left frontal activation on encoding, the index case did not show increased right frontal activation on retrieval. The normal pattern of right frontal activation was observed in a matched TBI control subject without retrograde amnesia. Both the index case and the matched control showed additional posterior activations which suggested TBI-related disinhibition, compensation, or both. Taken together, the neuroimaging findings converge to suggest a right frontal-temporal system mediating retrieval of episodic memories.	Baycrest Ctr, Rotman Res Inst, N York, ON, Canada		Levine, B (corresponding author), Baycrest Ctr, Rotman Res Inst, N York, ON, Canada.		Black, Sandra E./C-7294-2011; Levine, Brian/O-2725-2019	Levine, Brian/0000-0003-4343-811X; Black, Sandra/0000-0001-7093-8289			MARKOWITSCH HJ, 1993, J CLIN EXP NEUROPSYC, V15, P947, DOI 10.1080/01688639308402610; Nyberg L, 1996, PSYCHON B REV, V3, P135, DOI 10.3758/BF03212412	2	3	3	0	4	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626			BRAIN COGNITION	Brain Cogn.	DEC	1997	35	3					372	376					5	Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	YU863	WOS:000071763600040					2022-02-06	
J	White, SM; Seckinger, S; Doyle, M; Strauss, DL				White, SM; Seckinger, S; Doyle, M; Strauss, DL			Compensatory strategies for people with traumatic brain injury	NEUROREHABILITATION			English	Article						traumatic brain injury; compensatory strategies		This article will describe the development and use of compensatory strategies for people with traumatic brain injury. Brain injury results in a wide variety of physical, cognitive, communication and behavioural deficits which impact on daily living skills, work and recreation. Because of these problems, strategy development may be required to address many aspects of a client's life. As this article shows, the compensatory strategies incorporated into one community-based, real-life rehabilitation programme in Philadelphia, Pennsylvania, are as varied as the challenges they seek to address. (C) 1997 Elsevier Science Ireland Ltd.	REMED,CONSHOHOCKEN,PA 19428								Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; GOBBLE EMR, 1987, COMMUNITY REENTRY HE, P107; HARRELL M, 1992, COGNITIVE REHABILITA, P185; *LARRI, RANCH AM SCAL COGN L; MILTON SB, 1985, COGN REHABIL     NOV, P8; PARENTE F, 1991, RETRAINING MEMORY TE, P175; STRAUSS D, 1995, COMPENSATORY STRATEG	7	3	3	0	1	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	NOV	1997	9	3					205	212		10.1016/S1053-8135(97)00031-0			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YD196	WOS:A1997YD19600005	24525343				2022-02-06	
J	Zasler, ND				Zasler, ND			The role of medical rehabilitation in vocational reentry	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							TRAUMATIC BRAIN INJURY; SUBSTANCE-ABUSE; DISORDERS	For many, successful vocational rehabilitation is the ultimate measure of the efficacy of rehabilitation efforts for survivors of acquired brain injury (ABI). Often, the physician's role is perceived as minimal to none in the context of ongoing work reentry efforts. This article will explore the physician's role in the postacute phase of care and in particular as germane to optimizing vocational reentry efforts. Traditional viewpoints regarding the role of the physician in long-term care of persons with ABI relative to the medical model of care will be reviewed. Methods by which the neurorehabilitation physician may optimize work reentry will be examined including exploring medical readiness for work, as well as addressing impairments that may produce functional disability and/or handicap in the workplace environment.	CEO,RICHMOND,VA; TREE LIFE,LLC,RICHMOND,VA; NATL NEUROREHABIL CONSORTIUM INC,RICHMOND,VA; CONCUSS CARE CTR VIRGINIA LTD,RICHMOND,VA								American Medical Association, 1993, GUID EV PERM IMP; BENYISHAY B, 1990, REHABILITATION ADULT; BLACKERBY WF, 1991, NEUROREHABILITATION, V1, P53; Bond M. R., 1990, REHABILITATION ADULT, P179; BRAILOWSKY S, 1986, BRAIN RES, V362, P322, DOI 10.1016/0006-8993(86)90457-9; BUCHHOLZ DW, 1995, DYSPHAGIA, V10, P255, DOI 10.1007/BF00431418; BUSCHBACHER R, 1992, CRIT REV PHYS MED RE, V4, P199; COPE DN, 1996, MED REHABILITATION T, P573; CORRIGAN JD, 1995, BRAIN INJURY, V9, P221, DOI 10.3109/02699059509008195; Dalmady-Israel Christina, 1993, Brain Injury, V7, P263, DOI 10.3109/02699059309029679; DJERGAIAN RS, 1996, MED REHABILITATION T; FRASER RT, 1990, COMMUNITY INTEGRATIO, P169; FULLER MG, 1994, J NEUROPSYCH CLIN N, V6, P143; GUALTIERI CT, 1991, NEUROPSYCHIATRY BEHA; HAUSER WA, 1988, EPILEPSIA, V29, pS66, DOI 10.1111/j.1528-1157.1988.tb05800.x; HORN LJ, 1992, PHYSICAL MED REHABIL; JONES BE, 1991, PROG BRAIN RES, V88, P533; KATZ DI, 1990, J HEAD TRAUMA REHAB, V5, P86; LADOWSKYBROOKS R, 1996, MAGAZINE, V3, P40; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; LAL S, 1988, BRAIN INJURY, V23, P225; LAZARUS C, 1987, ARCH PHYS MED REHAB, V68, P79; LOU JS, 1995, ARCH NEUROL-CHICAGO, V52, P982, DOI 10.1001/archneur.1995.00540340074015; MAHOWALD MW, 1996, HEAD INJURY POSTCONC; MAYER NH, 1996, MED REHABILITATION T; McMahon B.T., 1991, ADV BRAIN INJURY REH; ROLAND PS, 1995, TRAUMATIC BRAIN INJU, P131; Silver JM., 1994, NEUROPSYCHIATRY TRAU; SUTER PS, 1995, TRAUMATIC BRAIN INJU; Temkin N R, 1995, New Horiz, V3, P518; Travell JG., 1983, MYOFASCIAL PAIN DYSF; Tusa R. J., 1996, P177; WEHMAN PH, 1990, ARCH PHYS MED REHAB, V71, P1047; *WEST LAB INC, TECHN INF SHEET ER 1; WHYTE J, 1992, ARCH PHYS MED REHAB, V73, P1094; ZASLER ND, 1995, J HEAD TRAUMA REHAB, V10, P101, DOI 10.1097/00001199-199508000-00010; ZASLER ND, 1990, VOCATIONAL REHABILIT; ZASLER ND, 1993, STAFF DEV CLIN INTER; ZASLER ND, 1996, MED REHABILITATION T; ZASLER ND, 1992, J HEAD TRAUMA REHAB, V7, P66; ZASLER ND, 1996, HIGHWAYS HEALING SER; Zasler ND, 1991, J HEAD TRAUMA REHAB, V6, P78; ZASLER ND, 1991, COGNITIVE REHABILITA; ZASLER ND, IN PRESS REHABILITAT; ZASLER ND, 1990, J HEAD TRAUMA REHAB, V5, P14, DOI DOI 10.1097/00001199-199005020-00004; ZOLTAN B, 1990, REHABILITATION ADULT	46	3	3	0	0	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	1997	12	5					42	56		10.1097/00001199-199710000-00005			15	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YA515	WOS:A1997YA51500005					2022-02-06	
J	Wobker, G				Wobker, G			Utility of barbiturates in intracranial hypertension	ANASTHESIOLOGIE & INTENSIVMEDIZIN			German	Article						brain injuries; intracranial pressure; barbiturates	SEVERE HEAD-INJURY; TRAUMATIC BRAIN-LESIONS; CEREBRAL BLOOD-FLOW; AGGRESSIVE TREATMENT; THERAPY; PRESSURE; MANAGEMENT; COMA; VASOREACTIVITY; THIOPENTONE				Wobker, G (corresponding author), UNIV DUSSELDORF, NEUROCHIRURG KLIN, MOORENSTR 5, D-40225 DUSSELDORF, GERMANY.						CHESNUT RM, 1995, NEW HORIZONS, V3; Cold G E, 1990, Acta Neurochir Suppl (Wien), V49, P1; DIETZ H, 1981, NEUROCHIRURGIA S; EBERHARDT KEW, 1992, INFECTION, V20, P12, DOI 10.1007/BF01704886; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; FRANK JI, 1993, MED CLIN N AM, V77, P61, DOI 10.1016/S0025-7125(16)30272-3; Horsley JS, 1937, LANCET, V1, P141; LANGFITT TW, 1982, J NEUROSURG, V56, P19, DOI 10.3171/jns.1982.56.1.0019; LEE MW, 1994, J NEUROTRAUM, V11, P325, DOI 10.1089/neu.1994.11.325; LOUIS PT, 1993, CRIT CARE MED, V21, P1200, DOI 10.1097/00003246-199308000-00021; LUNDAR T, 1983, CRIT CARE MED, V11, P559, DOI 10.1097/00003246-198307000-00017; MACMILLAN V, 1973, J NEUROCHEM, V20, P1669, DOI 10.1111/j.1471-4159.1973.tb00283.x; MARSH ML, 1977, ANESTHESIOLOGY, V47, P149, DOI 10.1097/00000542-197708000-00006; MARSHALL LF, 1978, CRIT CARE MED, V6, P1, DOI 10.1097/00003246-197801000-00001; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1977, ACTA NEUROL SCAND, V56, P156; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; MARUISHI M, 1993, ACTA NEUROCHIR, V120, P88, DOI 10.1007/BF02001475; MESSETER K, 1972, ACTA PHYSIOL SCAND, V85, P174, DOI 10.1111/j.1748-1716.1972.tb05248.x; MESSETER K, 1986, J NEUROSURG, V64, P231, DOI 10.3171/jns.1986.64.2.0231; MICHENFE.JD, 1974, ANESTHESIOLOGY, V41, P231, DOI 10.1097/00000542-197409000-00004; MICHENFELDER JD, 1976, ARCH NEUROL-CHICAGO, V33, P345, DOI 10.1001/archneur.1976.00500050031006; MICHENFELDER JD, 1973, ANESTHESIOLOGY, V39, P510, DOI 10.1097/00000542-197311000-00010; MICHENFELDER JD, 1975, STROKE, V6, P405, DOI 10.1161/01.STR.6.4.405; Miller J D, 1993, Acta Neurochir Suppl (Wien), V57, P152; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; PIEK J, 1993, ADV NEUROSURGERY, V21; PIERCE EC, 1962, J CLIN INVEST, V41, P1664, DOI 10.1172/JCI104623; REA GL, 1983, NEUROSURGERY, V12, P401, DOI 10.1227/00006123-198304000-00005; ROCKOFF MA, 1979, ANN NEUROL, V6, P194, DOI 10.1002/ana.410060303; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; SCHALEN W, 1991, ACTA ANAESTH SCAND, V35, P113, DOI 10.1111/j.1399-6576.1991.tb03258.x; SCHALEN W, 1992, ACTA NEUROCHIR, V117, P153, DOI 10.1007/BF01400613; SCHWARTZ ML, 1984, CAN J NEUROL SCI, V11, P434, DOI 10.1017/S0317167100045960; SHAPIRO HM, 1973, BRIT J ANAESTH, V45, P1057, DOI 10.1093/bja/45.10.1057; SHAPIRO HM, 1974, J NEUROSURG, V40, P90, DOI 10.3171/jns.1974.40.1.0090; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; SIDI A, 1983, CRIT CARE MED, V11, P478, DOI 10.1097/00003246-198306000-00020; SIESJO BK, 1981, J CEREBR BLOOD F MET, V1, P155, DOI 10.1038/jcbfm.1981.18; SIESJO BK, 1984, J NEUROSURG, V60, P883, DOI 10.3171/jns.1984.60.5.0883; SMITH AL, 1972, ANESTHESIOLOGY, V36, P378, DOI 10.1097/00000542-197204000-00015; SPRING A, 1983, NEUROCHIRURGIA, V26, P104; STEEN PA, 1978, STROKE, V9, P140, DOI 10.1161/01.STR.9.2.140; TRAUNER DA, 1986, J PEDIATR-US, V109, P742, DOI 10.1016/S0022-3476(86)80686-2; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; WOSTER PS, 1990, CLIN PHARMACY, V9, P762; [No title captured]	49	3	3	0	1	AKTIV DRUCK & VERLAG GMBH	EBELSBACH	AN DER LOHWIESE 36, EBELSBACH, 97500, GERMANY	0170-5334	1439-0256		ANASTH INTENSIVMED	Anasthesiol. Intensivmed.	JUL-AUG	1997	38	7-8					410	414					5	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	XR973	WOS:A1997XR97300016					2022-02-06	
J	Croteau, D; Nolin, P				Croteau, D; Nolin, P			A comparative study of two methods for assessing memory deficit anosognosia in traumatic brain injury patients	REVUE DE NEUROPSYCHOLOGIE			French	Article						anosognosia; memory; subjective assessment; traumatic brain injury; TBI; CHI	HEAD-INJURY; PERFORMANCE; AWARENESS	This study explored two methods for assessing memory deficit anosognosia with 30 traumatic brain injury (TBI) patients, their relatives, and their therapists. The first method consisted of questionnaire-based reports of everyday memory problems. A memory self-assessment questionnaire, the ''Questionnaire d'Auto-evaluation de la Memoire'' (QAM, Van der Linden et al., 1987) was administered to TBI patients, and an analogous form was given to their relatives and therapists who were asked to estimate the memory problems of the TBI patients. The second method consisted of having TBI patients, relatives, and therapists make predictions about the TBI patient's performance on the California Verbal Learning Test (CVLT, Delis et al., 1987), prior to administration of the test. The results indicated that TBIs contribute to memory deficit anosognosia and that the prediction method seems to be more effective than questionnaire-based assessments. Finally, therapists seem to be more accurate in their predictions about a TBI subject's performance than relatives. The main conclusion sggested by the results is that predictions made by therapists provide the most accurate evaluation of anosognosia.	UNIV QUEBEC,DEPT PSYCHOL,TROIS RIVIERES,PQ G9A 5H7,CANADA								ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; Anderson S. W., 1989, CLIN NEUROPSYCHOL, V3, P327, DOI DOI 10.1080/13854048908401482; BOAKE C, 1987, J CLIN EXPT NEUROPSY, V2; Cooley E L, 1991, Arch Clin Neuropsychol, V6, P355, DOI 10.1016/0887-6177(91)90011-W; Delis D.C., 1987, CVLT CALIFORNIA VERB; Feher EP., 1991, ANOSOGNOSIA ALZHEIME, V4, P136; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; GREEN J, 1993, NEUROPSY NEUROPSY BE, V6, P159; JARHO L, 1973, ACTA NEUROL SCAND, V49, P44; MCGLYNN SM, 1991, J COGNITIVE NEUROSCI, V3, P183, DOI 10.1162/jocn.1991.3.2.183; McGlynn SM, 1991, AWARENESS DEFICIT BR, P84; NOLIN P, 1996, B PSYCHOL, V49, P480; NOLIN P, 1991, THESIS U QUEBEC MONT; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; PRIGATANO GP, 1988, BNI Q, V4, P40; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P96; PRIGATANO GP, 1986, BNI Q, V2, P9; RANSEEN JD, 1990, INT J CLIN NEUROPSYC, V12, P29; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Schacter D. L., 1991, AWARENESS DEFICIT BR, P258; Schacter D. L., 1990, NEUROPSYCHOLOGY EVER, P231; SCHACTER DL, 1990, J CLIN EXP NEUROPSYC, V12, P155, DOI 10.1080/01688639008400962; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; Sunderland A, 1984, EVERYDAY MEMORY ACTI, P191; VANDERLINDEN M, 1987, QUESTIONNAIRE AUTOEV; WEST RL, 1984, EXP AGING RES, V10, P197, DOI 10.1080/03610738408258464; YOUNGJOHN JR, 1989, REHABIL PSYCHOL, V34, P217, DOI 10.1037//0090-5550.34.3.217; [No title captured]	29	3	3	0	4	ADRSC-ASSOC DIFFUSION RECHERCHES SCIENCES COGNITIVES	MARSEILLE CEDEX 20	C N R S-C R N C, 31, CHEMIN JOSEPH ALGUIER, 13402 MARSEILLE CEDEX 20, FRANCE	1155-4452			REV NEUROPSYCHOL	Rev. Neuropsychol.	MAR	1997	7	1					3	28					26	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	WU433	WOS:A1997WU43300001					2022-02-06	
J	Bontke, CF				Bontke, CF			Managed care in traumatic brain injury rehabilitation: Physiatrists' concerns and ethical dilemmas	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; cost containment; managed care; medical ethics; rehabilitation medicine	PHENYTOIN	This article deals with concerns and ethical dilemmas of physiatrists who specialize in brain injury rehabilitation in a managed care environment. Challenged to provide daily cost-effective care in a quality manner, physiatrists have become increasingly concerned with their clinical decision-making autonomy and with perceptions of changing standards in clinical care. This article explores these concerns and raises potential solutions that may help manage them.			Bontke, CF (corresponding author), REHABIL HOSP CONNECTICUT,490 BLUE HILLS AVE,HARTFORD,CT 06112, USA.						COPE DN, 1988, ARCH PHYS MED REHAB, V69, P483; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; FREED JH, 1982, PARAPLEGIA, V20, P208, DOI 10.1038/sc.1982.39; MASSAGLI TL, 1991, ARCH PHYS MED REHAB, V72, P219; YABLON S, 1993, ARCH PHYS MED REHAB, V74, P83	5	3	3	0	1	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	FEB	1997	12	1					37	43		10.1097/00001199-199702000-00007			7	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WG280	WOS:A1997WG28000007					2022-02-06	
J	Thobaben, JR				Thobaben, JR			The impact of managed care on the moral character of rehabilitation institutions	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						managed care; medical ethics; organizational values; rehabilitation; traumatic brain injury		Recent developments in the organization of health care services and financing, usually subsumed within the category of managed care, seem to be altering the character of the providing institutions. The purpose of this presentation is (1) to clarify what managed care is and what the operating assumptions are of those who advocate for it; (2) to examine the impact of managed care, and the associated assumptions, on the character of and moral analysis within nongovernmental health care institutions; and (3) to suggest possible correctives to the negative aspects of managed care, while acknowledging the numerous benefits. The preferred corrective is the ''community of care,'' an institutional model based on value-centered organizational identity.	MISSISSIPPI METHODIST REHABIL CTR, JACKSON, MS USA		Thobaben, JR (corresponding author), ASHBURY THEOL SEMINARY, SOCIAL & MED ETH, 204 N LEXINGTON AVE, WILMORE, KY 40390 USA.						Beauchamp T.L., 1989, PRINCIPLES BIOMEDICA; Hauerwas, 1981, COMMUNITY CHARACTER; MACINTYRE Alisdair, 1984, AFTER VIRTUE; Pellegrino Edmund D., 1993, VIRTUES MED PRACTICE; Walzer M., 1983, SPHERES JUSTICE; [No title captured]	6	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	FEB	1997	12	1					10	20		10.1097/00001199-199702000-00004			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WG280	WOS:A1997WG28000004					2022-02-06	
J	Bracco, D; Bissonnette, B; Favre, JB; Moeschler, O; Boulard, G; Ravussin, P				Bracco, D; Bissonnette, B; Favre, JB; Moeschler, O; Boulard, G; Ravussin, P			Cerebral haemodynamics and intracranial hypertensions.	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article; Proceedings Paper	18th French Language Conference on Neuroanesthesia and Reanimation	NOV 21-22, 1996	CLERMONT FERRA, FRANCE			intracranial hypertension; cerebral perfusion pressure; head injury	TRAUMATIC BRAIN-LESIONS; HEAD-INJURED PATIENTS; PERFUSION-PRESSURE; BLOOD-FLOW; THERAPY; DIHYDROERGOTAMINE; AUTOREGULATION; MANAGEMENT; HEMATOMA; INSULTS	Various cerebral aggressions, either primary or secondary, can lead to the development of raised intracranial pressure. The presence of an elevated intracranial pressure often results in cerebral ischaemia/hypoxia and, eventually, neuronal death. In face of this cascade of events, several therapeutic approaches have been suggested. Two management concepts for patients with raised intracranial pressure have retained the most attention in recent years: the first suggests a therapeutic increase in cerebral perfusion pressure with the objectives to improve perilesional collateral perfusion and decreased cerebral blood volume, and consequently intracranial pressure in areas where autoregulation is preserved. The second concept supports the diminution in perilesional capillary pressure with the aim of decreasing vasogenic oedema. Although these two concepts are antagonistic and cannot be used simultaneously, they are probably complementary in the sequence of therapeutic events of patients experiencing severe head injury. This article reviews these therapeutic concepts and their clinical applications.	HOP SION,DEPT ANESTHESIOL,CH-1950 SION,SWITZERLAND				Moeschler, Olivier/B-1694-2008				ALBRECHT RF, 1987, STROKE, V18, P649, DOI 10.1161/01.STR.18.3.649; ANDREWS PJD, 1995, ACTA ANAESTH SCAND, V39, P112, DOI 10.1111/j.1399-6576.1995.tb04287.x; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; ASGEIRSSON B, 1995, ACTA ANAESTH SCAND, V39, P103, DOI 10.1111/j.1399-6576.1995.tb04285.x; ASGEIRSSON B, 1995, ACTA ANAESTH SCAND, V39, P922, DOI 10.1111/j.1399-6576.1995.tb04199.x; ASGEIRSSON B, 1995, ACTA ANAESTH SCAND, V39, P347, DOI 10.1111/j.1399-6576.1995.tb04075.x; ASGEIRSSON B, 1994, INTENS CARE MED, V15, P523; ASTRUP J, 1991, CURR OPIN ANAESTH, V4, P653; Boulard G, 1996, J NEUROSURG ANESTH, V8, P244, DOI 10.1097/00008506-199607000-00011; BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; CARREL M, 1994, ANN FR ANESTH, V13, P326, DOI 10.1016/S0750-7658(94)80041-3; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; COLD GE, 1978, ACTA ANAESTH SCAND, V22, P270, DOI 10.1111/j.1399-6576.1978.tb01301.x; DRUMMOND JC, 1989, STROKE, V20, P1538, DOI 10.1161/01.STR.20.11.1538; GENTLEMAN D, 1990, INJURY, V21, P305, DOI 10.1016/0020-1383(90)90047-X; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRANDE PO, 1989, INTENS CARE MED, V15, P523, DOI 10.1007/BF00273564; GRANDE PO, 1995, ACTA ANAESTH SCAND, V39, P115; HAYASHI Y, 1993, BRIT J ANAESTH, V71, P108, DOI 10.1093/bja/71.1.108; Hulme A, 1976, INTRACRANIAL PRESSUR, VIII, P259; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; LEVY ML, 1993, J NEUROSURG, V79, P494, DOI 10.3171/jns.1993.79.4.0494; MELLANDER S, 1970, CLIN SCI, V39, P183, DOI 10.1042/cs0390183; MENDELOW AD, 1979, BRIT MED J, V1, P1240, DOI 10.1136/bmj.1.6173.1240; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; *MONR SEC, 1983, OBS STRUCT FUNCT NER; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; Muizelaar JP, 1991, J NEUROSURG, V64, P81; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; ORIGITANO TC, 1990, NEUROSURGERY, V27, P729, DOI 10.1227/00006123-199011000-00010; PAYEN D, 1990, CRIT CARE MED, V18, P392, DOI 10.1097/00003246-199004000-00008; ROSNER MJ, 1986, J NEUROSURG, V65, P636, DOI 10.3171/jns.1986.65.5.0636; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SIMARD JM, 1989, AM J CARDIOL, V63, pC32, DOI 10.1016/0002-9149(89)90403-7; TODD NV, 1990, ACT NEUR S, V51, P296; Williams A, 1993, Am J Crit Care, V2, P68; Yoshida A., 1993, INTRACRANIAL PRESSUR, P433	40	3	3	0	0	EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	141 RUE JAVEL, 75747 PARIS, FRANCE	0750-7658			ANN FR ANESTH	Ann. Fr. Anest. Reanim.		1997	16	4					429	434		10.1016/S0750-7658(97)81475-X			6	Anesthesiology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	XF746	WOS:A1997XF74600017	9750594				2022-02-06	
J	Clements, AD				Clements, AD			Mild traumatic brain injury in persons with multiple trauma: The problem of delayed diagnosis	JOURNAL OF REHABILITATION			English	Article								Though there is a consensus among many medical and rehabilitation professionals as to the symptoms indicative of mild traumatic brain injury (MTBI), many individuals go undiagnosed for long periods of time after their injuries. Three case studies were performed in order to describe the process and timing of arriving at the diagnosis of MTBI. In individuals with multiple traumatic injuries, there is often a delay between injury and diagnosis. All three persons in this study were traumatically injured, married, white males in their 30's and 40's. One was injured in an industrial accident, and the other two in motor vehicle accidents. One was diagnosed with MTBI six months post injury, one was diagnosed 1 year 8 months post injury, and the individual who was injured in the industrial accident was not diagnosed for almost four years. Visibility and ease of treatment of orthopedic and tissue injuries, and the physicians' lack of premorbid knowledge of an individual's behavior may explain the lack of MTBI diagnosis. An implication for medical practice is the need to incorporate screening for TBI symptoms into post traumatic diagnostic routines. However. if persons with multiple traumatic injuries are not screened for MTBI during the acute stage after sustaining their injury(ies), they will often have contact with rehabilitation professionals before they leave the healthcare system entirely. These professionals could incorporate MTBI screening into the rehabilitation process, possibly catching those cases that have filtered through the system without being identified.			Clements, AD (corresponding author), E TENNESSEE STATE UNIV,JOHNSON CITY,TN 37614, USA.			Clements, Andrea/0000-0002-5985-8277			Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Bigler E, 1990, TRAUMATIC BRAIN INJU, P13; BIGLER ED, 1987, J LEARN DISABIL, V20, P458, DOI 10.1177/002221948702000804; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; CULLUM CM, 1990, TRAUMATIC BRAIN INJU, P129; GENNARELLI TA, 1986, J HEAD TRAUMA REHAB, V1, P23; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; KWENTUS JA, 1985, PSYCHOSOMATICS, V26, P8, DOI 10.1016/S0033-3182(85)72900-3; LEZAK MD, 1990, TRAUMATIC BRAIN INJU; PRIGATANO GP, 1990, TRAUMATIC BRAIN INJU, P273; SWEENEY JE, 1992, CLIN NEUROPSYCHOL, V6, P443, DOI 10.1080/13854049208401870; TELZROW CF, 1990, TRAUMATIC BRAIN INJU, P251; VERDUYN W H, 1992, Brain Injury, V6, P245, DOI 10.3109/02699059209029666; Wood R. L., 1987, BRAIN INJURY REHABIL; Zasler N., 1993, J HEAD TRAUMA REHAB, V8, P13, DOI 10.1097/00001199-199309000-00004; [No title captured]	16	3	3	0	2	NATL REHABILITATION ASSN-NRA	ALEXANDRIA	633 S WASHINGTON ST, ALEXANDRIA, VA 22314-4109	0022-4154			J REHABIL	J. Rehabil.	JAN-MAR	1997	63	1					3	6					4	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	WJ088	WOS:A1997WJ08800001					2022-02-06	
J	Eames, P				Eames, P			Traumatic brain injury	CURRENT OPINION IN PSYCHIATRY			English	Article							SEVERE HEAD-INJURY; ALZHEIMERS-DISEASE; PERSONALITY; DISORDER	Traumatic brain injury is still a rapidly expanding field, particularly in relation to neuropsychiatry. Most current issues remain unresolved. Outcome and the influence of rehabilitation are clear, but prediction remains difficult. Issues under scrutiny are post-concussional syndrome and the validity of complaints after minor traumatic brain injury, post-traumatic stress disorder and the frequency of psychiatric disorders after traumatic brain injury, and neuropsychopharmacology in both prevention and treatment.			Eames, P (corresponding author), GRAFTON MANOR BRAIN INJURY REHABIL UNIT,GRAFTON REGIS,TOWCESTER NN12 722,NORTHANTS,ENGLAND.						ALOIA MS, 1995, BRAIN INJURY, V9, P575, DOI 10.3109/02699059509008216; Anderson SI, 1996, BRAIN INJURY, V10, P115, DOI 10.1080/026990596124601; Breteler MMB, 1995, AM J EPIDEMIOL, V142, P1300, DOI 10.1093/oxfordjournals.aje.a117597; BRYANT RA, 1995, PSYCHOL MED, V25, P869, DOI 10.1017/S0033291700035121; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; EAMES P, 1995, BRAIN INJURY, V9, P729, DOI 10.3109/02699059509008228; EAMES P, 1990, J NEUROL NEUROSUR PS, V53, P1111, DOI 10.1136/jnnp.53.12.1111-a; Eames P, 1996, BRAIN INJURY, V10, P631, DOI 10.1080/026990596124061; EDWARDS JK, 1991, J AM GERIATR SOC, V39, P477, DOI 10.1111/j.1532-5415.1991.tb02493.x; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FLANAGAN S, 1995, BRAIN INJURY, V9, P321, DOI 10.3109/02699059509005773; GOLDSTEIN LB, 1993, J NEURAL TRANSP PLAS, V4, P175, DOI 10.1155/NP.1993.175; GOLDSTEIN LB, 1995, J NEUROL NEUROSUR PS, V58, P753, DOI 10.1136/jnnp.58.6.753; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; GUTLING E, 1995, NEUROLOGY, V45, P915, DOI 10.1212/WNL.45.5.915; HAAS JF, 1987, J NEUROL NEUROSUR PS, V50, P52, DOI 10.1136/jnnp.50.1.52; Hornstein A, 1996, BRAIN INJURY, V10, P145, DOI 10.1080/026990596124647; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; JOHNSTONE B, 1995, BRAIN INJURY, V9, P377, DOI 10.3109/02699059509005777; KANT R, 1996, BRAIN INJURY, V10, P550; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; Levin HS, 1996, ARCH NEUROL-CHICAGO, V53, P88, DOI 10.1001/archneur.1996.00550010108024; MALIA K, 1995, BRAIN INJURY, V9, P697, DOI 10.3109/02699059509008226; MALIA K, 1992, BRAIN INJURY, V9, P607; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; NEWCOMBE F, 1994, J NEUROL NEUROSUR PS, V57, P709, DOI 10.1136/jnnp.57.6.709; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; Parker RS, 1996, BRAIN INJURY, V10, P287, DOI 10.1080/026990596124467; Powell JH, 1996, J NEUROL NEUROSUR PS, V60, P416, DOI 10.1136/jnnp.60.4.416; RASMUSSON DX, 1995, BRAIN INJURY, V9, P213, DOI 10.3109/02699059509008194; ROBERTS MA, 1995, BRAIN INJURY, V9, P427, DOI 10.3109/02699059509008202; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Sangal RB, 1996, BIOL PSYCHIAT, V39, P305, DOI 10.1016/0006-3223(95)00447-5; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; STREETER CC, 1995, J NERV MENT DIS, V183, P577, DOI 10.1097/00005053-199509000-00003; Stringer AY, 1996, BRAIN INJURY, V10, P583, DOI 10.1080/026990596124151; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; VERDOUX H, 1995, ANN MED-PSYCHOL, V153, P161; VOSS M, 1995, BRIT MED J, V311, P1395, DOI 10.1136/bmj.311.7017.1395; WRIGHTSON P, 1995, J NEUROL NEUROSUR PS, V59, P375, DOI 10.1136/jnnp.59.4.375; Zeilig G, 1996, BRAIN INJURY, V10, P591, DOI 10.1080/026990596124160	43	3	3	0	1	RAPID SCIENCE PUBLISHERS	LONDON	2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8NH	0951-7367			CURR OPIN PSYCHIATR	Curr. Opin. Psychiatr.	JAN	1997	10	1					49	52		10.1097/00001504-199701000-00011			4	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	WE668	WOS:A1997WE66800012					2022-02-06	
J	McNeill, DE; Schuyler, BA; Ezrachi, O				McNeill, DE; Schuyler, BA; Ezrachi, O			Assessing family involvement in traumatic brain injury rehabilitation: The development of a new instrument	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article								A measure for assessing family involvement in traumatic brain injury rehabilitation (TBI) was developed. The Family Involvement Assessment Scale (FIAS) is theoretically based on Barrer's (1988) model of family involvement in TBI rehabilitation which highlights two dimensions, ''support'' and ''involvement.'' An initial pool of 337 items believed to be related to the constructs of ''support'' and ''involvement'' was generated. Forty-nine items were systematically selected from the initial pool and included in a preliminary assessment form in which 172 professionals rated the items an the dimensions of support and involvement. Eleven items were subsequently eliminated from the original pool based on these ratings. The remaining 38 items were used by 181 of the professionals to evaluate the involvement of actual actual family members of patients receiving TBI rehabilitation services in their programs. A factor analysis was performed on a remaining pool of 38 items. Three factors with an eigenvalue greater than 2.0 accounted for 48.8% of the total variance. One item that did plot significantly load on any of the factors was eliminated The FIAS includes a final set of 37 items, comprised of three subscales based on the factor analysis. Two of the scales, the Involvement-Rehabilitation (IR) scale and the Support (S) scale correspond, respectively, to Barrer's (1988) dimensions of ''involvement'' and ''support.'' The third scale, Involvement-Patient (IP), is a unique construct that measures the degree to,which a family member is involved in the rehabilitation process with respect to their involvement and relationship with the patient. The three scales yielded adequate internal reliabilities. Correlation coefficients between the scales indicated that the IR and S scales are not statistically related bur the IP scale is significantly related to both the IR and S scales. Interrater and test-retest reliability, and concurrent and predictive validity for the FIAS are still to be determined. (C) 1997 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	NYU,MED CTR,RUSK INST REHABIL MED,NEW YORK,NY 10016; CALIF SCH PROFESS PSYCHOL,RES FAC,FRESNO,CA								BARRER AE, 1988, SYSTEMS APPROACH WOR; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; McLaughlin Anne Marie, 1993, Brain Injury, V7, P45, DOI 10.3109/02699059309008155; Shaw L R, 1990, Brain Inj, V4, P87, DOI 10.3109/02699059009026152; SHAW LR, 1991, UNPUB PSYCHOMETRIC V; SHAW LR, 1990, THESIS FLORIDA STATE	6	3	3	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.		1997	12	7					645	660					16	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	YB885	WOS:A1997YB88500004	14590658				2022-02-06	
J	Moeller, JL				Moeller, JL			Contraindications to athletic participation - Cardiac, respiratory, and central nervous system conditions	PHYSICIAN AND SPORTSMEDICINE			English	Article							PREPARTICIPATION PHYSICAL-EXAMINATION; SUDDEN-DEATH; SPORTS; RISK; CONCUSSIONS; GUIDELINES; EXERCISE	Sports activities promote health and fitness for most participants, but for some, activity can complicate an illness or even be fatal. This article, the first of a two-part series on contraindications to activity, examines the cardiac, respiratory, and central nervous system conditions that warrant activity disqualification and provides guidelines about when it's safe for patients to participate.	UNIV PITTSBURGH,MED CTR,DEPT ORTHOPAED SURG,PITTSBURGH,PA; AMER COLL SPORTS MED,INDIANAPOLIS,IN		Moeller, JL (corresponding author), UNIV PITTSBURGH,MED CTR,DEPT FAMILY MED,PITTSBURGH,PA, USA.						ADES PA, 1992, PHYSICIAN SPORTSMED, V20, P75, DOI 10.1080/00913847.1992.11947484; ALLISON TG, 1992, PHYSICIAN SPORTSMED, V20, P140, DOI 10.1080/00913847.1992.11710302; [Anonymous], 1994, J Am Coll Cardiol, V24, P845; BERNHARDT DT, 1994, PHYSICIAN SPORTSMED, V22, P70, DOI 10.1080/00913847.1994.11947653; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; CANTU RC, 1992, PHYSICIAN SPORTSMED, V20, P55, DOI 10.1080/00913847.1992.11947483; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; CANTWELL JD, 1994, PHYSICIAN SPORTSMED, V22, P83, DOI 10.1080/00913847.1994.11947627; CANTWELL JD, 1992, PHYSICIAN SPORTSMED, V20, P115, DOI 10.1080/00913847.1992.11947453; COWART VS, 1986, PHYSICIAN SPORTSMED, V14, P183, DOI 10.1080/00913847.1986.11709178; Fields K B, 1994, N C Med J, V55, P116; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; KULUND DN, 1982, INJURED ATHLETE; MAGNES SA, 1992, PHYSICIAN SPORTSMED, V20, P143, DOI 10.1080/00913847.1992.11947434; MARON BJ, 1993, PHYSICIAN SPORTSMED, V21, P83, DOI 10.1080/00913847.1993.11710417; MAROON JC, 1992, PHYSICIAN SPORTSMED, V20, P37, DOI 10.1080/00913847.1992.11710269; MCKEAG DB, 1993, PRIMARY SPORTS MED; MITTEN MJ, 1994, MED SCI SPORT EXER, V26, pS238; Nelson W. E., 1984, PHYSICIAN SPORTSMED, V12, P103; PETERSON DM, 1993, FAMILY PRACTICE RECE, V15, P30; RIFAT SF, 1995, J FAM PRACTICE, V41, P42; ROBERTS WO, 1992, PHYSICIAN SPORTSMED, V20, P66, DOI 10.1080/00913847.1992.11710295; SHELL D, 1993, PHYSICIAN SPORTSMED, V21, P74, DOI 10.1080/00913847.1993.11710364; SHERMAN C, 1993, PHYSICIAN SPORTSMED, V21, P93; SIMONEAUX SF, 1990, AM J SPORT MED, V18, P647, DOI 10.1177/036354659001800617; SMITH DM, 1995, SPORTS MED ARTHROSC, V3, P84; STENGER A, 1992, PHYSICIAN SPORTSMED, V20, P54; TANJI JL, 1990, AM FAM PHYSICIAN, V42, P397; Torg JS, 1982, ATHLETIC INJURIES HE; TUCKER JB, 1984, AM FAM PHYSICIAN, V29, P149; WASHINGTON RL, 1993, PHYSICIAN SPORTSMED, V21, P136, DOI 10.1080/00913847.1993.11710320; 1988, PEDIATRICS, V81, P737	32	3	3	0	1	MCGRAW HILL HEALTHCARE PUBLICATIONS	MINNEAPOLIS	4530 WEST 77TH ST, MINNEAPOLIS, MN 55435-5000	0091-3847			PHYSICIAN SPORTSMED	Physician Sportsmed.	AUG	1996	24	8					47	58		10.3810/psm.1996.08.1376			12	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	VA063	WOS:A1996VA06300010	20087013				2022-02-06	
J	Vakil, E; LanglebenCohen, D; Frenkel, Y; Groswasser, Z; Aberbuch, S				Vakil, E; LanglebenCohen, D; Frenkel, Y; Groswasser, Z; Aberbuch, S			Saving during relearning as an implicit measure of memory in closed-head-injured patients	NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY			English	Article						closed-head injury; saving; relearning; memory	AMNESIA; EBBINGHAUS; RETENTION	Memory disturbance is the most prominent residual deficit after closed-head injury (CHI). Recent studies have demonstrated that CHI patients, just like global amnesic patients, show impaired memory when measured explicitly, but not when measured implicitly. Many theorists have concluded that the saving paradigm introduced by Ebbinghaus in 1885 can be viewed as a measure of implicit memory. Thus, it was hypothesized that saving will be preserved in CHI patients, Thirteen CHI patients and 13 control subjects were tested individually on three word lists. Each list was tested in two phases: learning and relearning. There was a different time delay between the two phases for each list: 1 h, 1 day, and 3 days. The groups were compared on explicit-recall and implicit-saving measures of memory. Time delay from learning to relearning did not affect the performance of either group. As expected, the results show that overall, the control group recalled more words than the CHI group, but the groups did not differ on the overall amount of saving measure. However, when saving was measured just on the initial learning and relearning trials, the groups did differ. The results are discussed in terms of the relationship between saving and implicit memory.	LOEWENSTEIN HOSP & REHABIL CTR,RAANANA,ISRAEL; TEL AVIV UNIV,SACKLER FAC MED,IL-69978 TEL AVIV,ISRAEL		Vakil, E (corresponding author), BAR ILAN UNIV,DEPT PSYCHOL,IL-52900 RAMAT GAN,ISRAEL.						BALGURE R, 1968, LIST BASIC WORDS SCH; BROOKS D N, 1975, Cortex, V11, P329; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; EBBINGHAUS H, 1985, GEDACHTNIS; GRONINGER LK, 1980, B PSYCHONOMIC SOC, V15, P263; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; MACLEOD CM, 1988, J EXP PSYCHOL LEARN, V14, P195, DOI 10.1037/0278-7393.14.2.195; Mayes A., 1988, HUMAN ORGANIC MEMORY; MUTTER SA, 1990, COGNITIVE NEUROPSYCH, V7, P329, DOI 10.1080/02643299008253447; NELSON TO, 1978, J EXP PSYCHOL-HUM L, V4, P453, DOI 10.1037/0278-7393.4.5.453; NELSON TO, 1985, J EXP PSYCHOL LEARN, V11, P472, DOI 10.1037/0278-7393.11.3.472; PARKIN AJ, 1988, BRIT J PSYCHOL, V79, P361, DOI 10.1111/j.2044-8295.1988.tb02295.x; PARKIN AJ, 1982, CORTEX, V18, P417, DOI 10.1016/S0010-9452(82)80040-3; SCHACTER DL, 1987, J EXP PSYCHOL LEARN, V13, P501, DOI 10.1037/0278-7393.13.3.501; SHIMAMURA AP, 1986, Q J EXP PSYCHOL-A, V38, P619, DOI 10.1080/14640748608401617; SLAMECKA NJ, 1985, J EXP PSYCHOL LEARN, V11, P496, DOI 10.1037/0278-7393.11.3.496; VAKIL E, 1994, J CLIN EXP NEUROPSYC, V16, P539, DOI 10.1080/01688639408402665; VAKIL E, 1991, J CLIN EXP NEUROPSYC, V13, P291, DOI 10.1080/01688639108401044; WEISKRANTZ L, 1979, NEUROPSYCHOLOGIA, V17, P187, DOI 10.1016/0028-3932(79)90009-5; [No title captured]	20	3	3	0	1	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0894-878X			NEUROPSY NEUROPSY BE	Neuropsychiatr. Neuropsychol. Behav. Neurol.	JUL	1996	9	3					171	175					5	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	UR707	WOS:A1996UR70700004					2022-02-06	
J	Vieth, AZ; Johnstone, B; Dawson, B				Vieth, AZ; Johnstone, B; Dawson, B			Extent of intellectual, cognitive, and academic decline in adolescent traumatic brain injury	BRAIN INJURY			English	Article							HEAD-INJURIES	Pre-injury cognitive-data are rarely available for review for individuals suffering from traumatic brain injury (TBI). Although pre-injury intelligence and academic scores may be available, particularly if an individual is learning-disabled (LD), data on specific cognitive abilities are unlikely to exist. We present neuropsychological data for a 15-year-old Caucasian female with a learning disability who was administered IQ testing 2 weeks prior to a significant TBI, as well as other measures of specific cognitive abilities (e.g. memory and perceptual-motor skills) throughout her education. Comparison of pre- and post-TBI data showed: (1) global and generally consistent decline iri all cognitive areas and (2) relatively stable performance on tests of academic ability, supporting the validity of such test scores as estimates of premorbid intelligence.	UNIV MISSOURI,SCH MED,DEPT PHYS MED & REHABIL,COLUMBIA,MO					Johnstone, Brick/0000-0001-8845-9649			ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Brooks D. N, 1990, REHABILITATION ADULT, P163; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Crawford J.R., 1992, HDB NEUROPSYCHOLOGIC, P21; Halstead W.C., 1947, BRAIN INTELLIGENCE; Hooper HE., 1983, HOOPER VISUAL ORG TE; Kaplan E, 1983, BOSTON NAMING TEST; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; MATTHEWS CG, 1964, INSTRUCTION MANUAL A; MOSS AR, 1991, BRIT J CLIN PSYCHOL, V30, P179, DOI 10.1111/j.2044-8260.1991.tb00934.x; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P1; Reitan R, 1985, HALSTEAD REITAN NEUR; Rey A., 1964, EXAMEN CLIN PSYCHOL; SHESLOW R, 1990, WIDE RANGE ASSESSMEN; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; TERMAN LM, 1973, STNAFORD BINET INTEL; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1974, WECHSLER INTELLIGENC; Wilkinson, 1984, WIDE RANGE ACHIEVEME; [No title captured]; [No title captured]	23	3	3	0	3	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JUN	1996	10	6					465	470		10.1080/026990596124322			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	UR327	WOS:A1996UR32700007	8816100				2022-02-06	
J	Waxman, DL; France, MP; Harryman, DT				Waxman, DL; France, MP; Harryman, DT			Late lateral displacement of the humeral head after closed reduction of glenohumeral dislocation: A sign of vascular injury - Report of a case	JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME			English	Article							AXILLARY ARTERY; ANTERIOR DISLOCATION; SHOULDER		UNIV WASHINGTON,DEPT ORTHOPAED,SEATTLE,WA 98195								ANTAL CS, 1973, J TRAUMA, V13, P564, DOI 10.1097/00005373-197306000-00012; Brieda M, 1992, G Ital Cardiol, V22, P1335; CURR J F, 1970, Journal of Bone and Joint Surgery British Volume, V52, P313; DRURY JK, 1980, BRIT J SURG, V67, P579, DOI 10.1002/bjs.1800670817; FITZGERALD JF, 1975, ANN SURG, V181, P785, DOI 10.1097/00000658-197506000-00002; GUGENHEIM S, 1984, SURGERY, V95, P55; JORDON OM, 1973, J BONE JOINT SURG AM, V55, P189; MATSEN FA, 1990, SHOULDER, V1, P564; MATTENS M, 1992, ACTA CHIR BELG, V92, P201; MUSTONEN PK, 1990, ACTA CHIR SCAND, V156, P643; NEER CS, 1984, FRACTURES ADULTS, V1, P675; STEIN E, 1986, SKELETAL RADIOL, V15, P391, DOI 10.1007/BF00348869; STRANDNESS ED, 1993, DUPLEX SCANNING VASC, P181; TERMINASSIAN A, 1992, ANN FR ANESTH, V11, P598, DOI 10.1016/S0750-7658(05)80767-1	14	3	3	0	0	JOURNAL BONE JOINT SURGERY INC	NEEDHAM	20 PICKERING ST, NEEDHAM, MA 02192	0021-9355			J BONE JOINT SURG AM	J. Bone Joint Surg.-Am. Vol.	JUN	1996	78A	6					907	910		10.2106/00004623-199606000-00015			4	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	UT143	WOS:A1996UT14300015	8666610				2022-02-06	
J	Body, R; Herbert, C; Campbell, M; Parker, M; Usher, A				Body, R; Herbert, C; Campbell, M; Parker, M; Usher, A			An integrated approach to team assessment in head injury	BRAIN INJURY			English	Article								The development of multidisciplinary teams for the assessment and treatment of traumatic brain injury has not seen a parallel development in methods of coordinating and collating the information gathered by different professions. The team at the Head Injury Rehabilitation Centre (HIRC), Sheffield uses a process of assessment that encourages the coordination of such information, particularly across the areas that do not fall neatly into the remit of specific disciplines. The framework of the assessment is presented, together with discussion of methods of gathering information and of sharing that information. The advantages of this approach are discussed in terms of benefits for the client, for the professionals involved in the assessment and for other services that might be involved with the client.	COMMUNITY THERAPISTS INC,VANCOUVER,BC,CANADA		Body, R (corresponding author), HEAD INJURY REHABIL CTR,ALBERT TERRACE RD,SHEFFIELD S6 3EB,S YORKSHIRE,ENGLAND.						BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; HARTLEY LL, 1990, APHASIOLOGY, V4, P353, DOI 10.1080/02687039008249088; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; POWELL T, 1994, BRIT J THERAPY REHAB, V1, P8	4	3	3	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	APR	1996	10	4					311	318		10.1080/026990596124485			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	UJ541	WOS:A1996UJ54100008	9044696				2022-02-06	
J	Haig, AJ; Khangcheng, H; Ludwig, G				Haig, AJ; Khangcheng, H; Ludwig, G			Clinical, physiologic, and pathologic evidence ter vagus dysfunction in a case of traumatic brain injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							LOCKED-IN SYNDROME; MOTILITY	A trauma victim with locked-in syndrome demonstrated severely decreased bowel sounds, intact response to suppository, and elevated, but unchanging pulse, Absent cardiac response to tracheal suctioning, high gastric residual volumes, and pulmonary edema in response to a urecholine challenge demonstrated dysfunction in the autonomic system, Symptoms persisted for 21/2 years until death, At autopsy, asymmetric bilateral involvement of the dorsal motor nucleus of the vagus and of the nerve tract in the medulla were demonstrated, In contrast, a control subject with locked-in syndrome caused by a stroke did not demonstrate these phenomenon, In trauma patients with delayed gastric emptying, measurement of the heart rate response to deep suctioning may lead to the diagnosis of this vagus dysfunction syndrome.	UNIV MICHIGAN,DEPT SURG,ANN ARBOR,MI 48109; MED COLL WISCONSIN,DEPT PATHOL,MILWAUKEE,WI 53226; FOX VALLEY PATHOLOGISTS SC,NEENAH,WI		Haig, AJ (corresponding author), UNIV MICHIGAN,MED CTR,DEPT PHYS MED & REHABIL,1500 E MED CTR DR,ANN ARBOR,MI 48109, USA.						AWADA A, 1991, J NEUROL NEUROSUR PS, V54, P277, DOI 10.1136/jnnp.54.3.277; CAMILERRI M, 1984, EUR J CLIN INVEST, V14, P412; FEALEY RD, 1984, GASTROENTEROLOGY, V87, P69; Haig A.J., 1986, CURR CONCEPTS REHABI, V3, P12; HAIG AJ, 1987, ARCH PHYS MED REHAB, V68, P24; HOUSE EL, 1979, SYSTEMS APPROACH NEU, P36; Ito A, 1973, STROKE, V4, P80, DOI 10.1161/01.STR.4.1.80; Johnson PM, 1992, FETAL MATERN MED REV, V4, P1; KATZ RT, 1992, ARCH PHYS MED REHAB, V73, P403; KHURANA RK, 1982, ANN NEUROL, V12, P86; KHURANA RK, 1980, NEUROLOGY, V30, P804; LABAR DR, 1988, NEUROLOGY, V38, P1679, DOI 10.1212/WNL.38.11.1679; LOW PA, 1983, ANN NEUROL, V13, P412, DOI 10.1002/ana.410130407; LOW PA, 1992, CLIN AUTONOMIC DISOR; MATHIAS CJ, 1976, EUR J INTEN CARE MED, V2, P147, DOI 10.1007/BF00624607; MONTGOMERY BM, 1961, ARCH INTERN MED, V108, P115; NORIVING BS, 1991, NEUROLOGY, V41, P244; ORRINGER MB, 1991, TXB SURG BIOL BASIS; OTT L, 1991, J NEUROSURG, V74, P738, DOI 10.3171/jns.1991.74.5.0738; REYNOLDS BJ, 1977, ANN NEUROL, V1, P305, DOI 10.1002/ana.410010321; SCHAEFER SD, 1991, OTOLARYNG CLIN N AM, V24, P1053; WEBER J, 1985, DIGEST DIS SCI, V30, P419, DOI 10.1007/BF01318173; WOOD JR, 1985, GASTROENTEROLOGY, V89, P1411, DOI 10.1016/0016-5085(85)90663-8	23	3	3	0	2	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	1996	40	3					441	444		10.1097/00005373-199603000-00020			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	UA973	WOS:A1996UA97300021	8601864				2022-02-06	
J	Knight, RG; Godfrey, HPD				Knight, RG; Godfrey, HPD			Psychosocial aspects of neurological disorders: Implications for research in neuropsychology	AUSTRALIAN PSYCHOLOGIST			English	Article							CLOSED-HEAD-INJURY; HUNTINGTONS-DISEASE; APPRAISAL; MEMORY	It is proposed that the expansion of the research base in clinical neuropsychology to reflect client and clinician concerns with a range of psychosocial consequences of brain impairments is a priority. As neuropsychologists have become involved in patient management, their need for data of relevance to assessing and treating the broader social and interpersonal aspects of their clients' competencies has become increasingly obvious. In addition, study of the adaptation of patients to the effects of brain damage can provide important information about the effects of social support, stress appraisal, and coping in response to mental and physical impairment.			Knight, RG (corresponding author), UNIV OTAGO, DEPT PSYCHOL, CLIN RES & TRAINING CTR, BOX 56, DUNEDIN, NEW ZEALAND.						BLOCH M, 1990, AM J HUM GENET, V46, P1; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V48, P870; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; DILLER L, 1981, J CONSULT CLIN PSYCH, V49, P822, DOI 10.1037/0022-006X.49.6.822; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; ENGEL GL, 1980, AM J PSYCHIAT, V137, P535; Folkman S., 1984, STRESS; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Goldstein K., 1942, AFTEREFFECTS BRAIN I; HALEY WE, 1987, PSYCHOL AGING, V2, P323, DOI 10.1037/0882-7974.2.4.323; LEVIN HS, 1976, CORTEX, V12, P175, DOI 10.1016/S0010-9452(76)80021-4; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; MACCALLUM RC, 1993, PSYCHOL BULL, V114, P533, DOI 10.1037/0033-2909.114.3.533; MASTROMAURO C, 1987, AM J MED GENET, V26, P271, DOI 10.1002/ajmg.1320260205; MEISSEN GJ, 1988, NEW ENGL J MED, V318, P535, DOI 10.1056/NEJM198803033180903; POWELLPROCTOR L, 1982, BRIT J PSYCHIAT, V140, P457, DOI 10.1192/bjp.140.5.457; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; TIBBEN A, 1994, PSYCHOSOM MED, V56, P526, DOI 10.1097/00006842-199411000-00008; TROSS S, 1988, AM PSYCHOL, V43, P929, DOI 10.1037/0003-066X.43.11.929; TYLER A, 1992, BRIT J PSYCHIAT, V161, P481, DOI 10.1192/bjp.161.4.481; WEXLER NS, 1989, MOL GENETICS DISEASE, P429; WIGGINS S, 1992, NEW ENGL J MED, V327, P1401, DOI 10.1056/NEJM199211123272001; ZARIT SH, 1982, GERONTOLOGIST, V22, P373, DOI 10.1093/geront/22.4.373	26	3	3	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0005-0067			AUST PSYCHOL	Aust. Psychol.	MAR	1996	31	1					48	51		10.1080/00050069608260176			4	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	UK574	WOS:A1996UK57400011					2022-02-06	
J	Elovic, E				Elovic, E			Pharmacology of attention and arousal in the low level patient	NEUROREHABILITATION			English	Article						brain injury; low level patient; pharmacology; stimulants; dopamine; antidepressants; anticonvulsants	SEVERE BRAIN INJURIES; CLOSED HEAD-INJURY; CORTICAL HEMIPLEGIA; VEGETATIVE STATE; PHENYTOIN; RECOVERY; BROMOCRIPTINE; PROPHYLAXIS; AMANTADINE; SEIZURES	Pharmacological management of the low level patient is a very challenging prospect for the doctor treating these patients. The use of medications to expedite recovery and improve the function of arousal and attention in this population is both an exciting prospect and at the same time a most daunting task. Review of past literature is of limited value as it consists primarily of case reports, studies with small sample sizes and studies demonstrating limited clinical efficacy. The author has tried in this paper to offer some guidance by reviewing literature defining arousal and attention, briefly discussing the neuroanatomy of the brain, critiquing past literature and offering his own recommendations based on experience.	ROBERT WOOD JOHNSON MED SCH, DEPT REHABIL MED, PISCATAWAY, NJ USA		Elovic, E (corresponding author), JFK JOHNSON REHABIL INST, CTR HEAD INJURY, HARTWYCK & OAK TREE RD, EDISON, NJ 08820 USA.						ANDERSON B, 1992, J NEUROSURG, V76, P152, DOI 10.3171/jns.1992.76.1.0152; AUERBACH SH, 1986, J HEAD TRAUMA REHAB, V1, P1, DOI DOI 10.1097/00001199-198609000-00004; BARRETT K, 1991, J NEUROL NEUROSUR PS, V54, P718, DOI 10.1136/jnnp.54.8.718; BOYESON MG, 1993, AM J PHYS MED REHAB, V72, P286, DOI 10.1097/00002060-199310000-00007; BRAILOWSKY S, 1986, BRAIN RES, V362, P322, DOI 10.1016/0006-8993(86)90457-9; BRAILOWSKY S, 1986, BRAIN RES, V376, P71, DOI 10.1016/0006-8993(86)90900-5; Cassidy John W., 1994, P43; CASSIDY JW, 1994, J HEAD TRAUMA REHAB, V9, P43, DOI 10.1097/00001199-199409000-00005; Chandler M C, 1988, Brain Inj, V2, P309; CHANDRA B, 1978, EUR NEUROL, V17, P265, DOI 10.1159/000114956; COPE DN, 1986, J HEAD TRAUMA REHAB, V1, P34; CRIMSON MI, 1988, CLIN NEUROPHARMACOL, V11, P462; CRINISON ML, 1988, CLIN NEUROPHARMACOL, V11, P462; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; Dombovy Mary L., 1992, Archives of Physical Medicine and Rehabilitation, V73, P975; Eames P, 1989, Brain Inj, V3, P319, DOI 10.3109/02699058909029645; EVANS RW, 1987, J NERV MENT DIS, V175, P106, DOI 10.1097/00005053-198702000-00007; FEENEY DM, 1983, PSYCHOPHARMACOLOGY, V79, P67, DOI 10.1007/BF00433018; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; GLOTZNER FL, 1983, NEUROCHIRURGIA, V26, P66; GOLDSTEIN LB, 1995, NEUROLOGY, V45, P865, DOI 10.1212/WNL.45.5.865; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Gualtieri C T, 1988, Brain Inj, V2, P101, DOI 10.3109/02699058809150936; GUALTIERI CT, 1991, J CLIN PSYCHOPHARM, V11, P155; GUALTIERI CT, 1991, NEUROPSYCHIARTRY BEH; GUALTIERI T, 1989, CLIN NEUROPHARMACOL, V12, P258, DOI 10.1097/00002826-198908000-00003; HAIG AJ, 1990, ARCH PHYS MED REHAB, V71, P1081; HERNANDEZ TD, 1994, BRAIN RES, V635, P300, DOI 10.1016/0006-8993(94)91451-6; Hockey G. R. J., 1986, ENERGETICS HUMAN INF, P3, DOI [10.1007/978-94-009-4448-0_1, DOI 10.1007/978-94-009-4448-0_1]; HORIGUCHI J, 1990, CLIN NEUROPHARMACOL, V13, P84, DOI 10.1097/00002826-199002000-00009; KAELIN DL, 1994, ARCH PHYS MED REHAB, V75, P1030; LaBerge D., 1995, ATTENTIONAL PROCESSI; Lal S, 1988, Brain Inj, V2, P225, DOI 10.3109/02699058809150946; LEVINE R, 1994, J CLIN PSYCHOPHARM, V14, P145, DOI 10.1097/00004714-199404000-00011; MARION D, 1995, COMMUNICATION; MENA MA, 1995, CLIN NEUROPHARMACOL, V18, P410, DOI 10.1097/00002826-199510000-00004; MESULAM M, 1985, ATTENTION CONFUSIONA, P125; PECHADRE JC, 1991, PRESSE MED, V20, P841; Plum F., 1982, DIAGNOSIS STUPOR COM, V3rd; Porch B. E., 1986, CLIN APHASIOLOGY, V16, P309; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; ROBBINS TW, 1986, ENERGETICS HUMAN INF, P71; Robinson Robert G., 1994, P219; SCHALLERT T, 1986, BRAIN RES, V379, P104, DOI 10.1016/0006-8993(86)90261-1; SILVER JM, 1994, J HEAD TRAUMA REHAB, V9, P61, DOI 10.1097/00001199-199409000-00006; TEMIN NR, 1990, NEW ENGL J MED, V323, P497; WEINSHENKER BG, 1992, NEUROLOGY, V42, P1468, DOI 10.1212/WNL.42.8.1468; WHYTE J, 1992, ARCH PHYS MED REHAB, V73, P940; WHYTE J, 1992, ARCH PHYS MED REHAB, V73, P1094; WROBLEWSKI BA, 1994, J HEAD TRAUMA REHAB, V9, P19, DOI 10.1097/00001199-199409000-00004; WROBLEWSKI BA, 1990, J CLIN PSYCHOPHARM, V10, P124, DOI 10.1097/00004714-199004000-00009; Wroblewski Bruno, 1993, Brain Injury, V7, P353, DOI 10.3109/02699059309034962	53	3	3	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation	FEB	1996	6	1					57	67		10.1016/1053-8135(95)00148-4			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TZ377	WOS:A1996TZ37700007	24525686				2022-02-06	
J	Munno, I; Damiani, S; Lacedra, G; Mastropasqua, V; Megna, GF				Munno, I; Damiani, S; Lacedra, G; Mastropasqua, V; Megna, GF			Impairment of non-specific immunity in patients in persistent vegetative state	IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY			English	Article							NATURAL-KILLER ACTIVITY; MONONUCLEAR PHAGOCYTES; HYPOTHALAMIC-LESIONS; INTERFERON-GAMMA; IDENTIFICATION; MODULATION; MACROPHAGE; BRAIN; CELLS; NEUROIMMUNOMODULATION	In fourtheen patients in persistent vegetative state (PVS) immune responsivenes was investigated. In particular, we studied the relationship between brain lesions following traumatic injury and immune system. In this respect, phagocytosis and killing of Candida albicans by polymorphonuclear cells (PMN) and monocytes were tested. In addition serum levels of interferon-gamma (IFN-gamma) were evaluated. The patients come out from PVS by 3-4 month were used as control group. Data shown a profound impairement of phagocytosis and killing of monocytes and low serum levels of IFN gamma when compared with normal values. Taken together, these findings suggest that brain lesions, may affect non-specific immune response.	UNIV BARI,FAC MED,INST MICROBIOL,BARI,ITALY; UNIV BARI,FAC MED,DEPT NEUROL,REHABIL UNIT,BARI,ITALY								ARDER R, 1987, BRAIN BEHAV IMMUNITY, V1, P1; BESEDOVSKY H, 1975, P SOC EXP BIOL MED, V150, P466; BESEDOVSKY HO, 1981, J IMMUNOL, V126, P385; BEUTLER B, 1988, ENDOCR REV, V9, P57, DOI 10.1210/edrv-9-1-57; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; BRANCENI D, 1966, IMMUNOLOGY, V10, P35; BRIERLEY JB, 1971, LANCET, V2, P560; BROOKS WH, 1982, ANN NEUROL, V12, P56, DOI 10.1002/ana.410120111; CASTLE S, 1995, CLIN EXP IMMUNOL, V101, P487; CREUTZFELD O, 1978, P 11 WORLD C NEUR AM, P194; CROSS RJ, 1984, IMMUNOLOGY, V51, P399; CROSS RJ, 1982, J NEUROL SCI, V53, P557, DOI 10.1016/0022-510X(82)90250-7; DOUGHERTY JH, 1981, NEUROLOGY, V31, P991, DOI 10.1212/WNL.31.8.991; EZINE S, 1981, IMMUNOLOGY, V43, P535; Fahey J, 1981, ADV INFLAMMAT RES, V2, P21; FELTEN DL, 1987, IMMUNOL REV, V100, P225, DOI 10.1111/j.1600-065X.1987.tb00534.x; FELTEN DL, 1983, BRAIN RES BULL, V10, P171, DOI 10.1016/0361-9230(83)90045-X; GUNN T, 1981, PEDIATRICS, V67, P61; GUYRE PM, 1983, J CLIN INVEST, V72, P393, DOI 10.1172/JCI110980; HOLBROOK NJ, 1983, CANCER RES, V43, P4019; JENNETT B, 1972, LANCET, V1, P734; JENNETT B, 1975, LANCET, V1, P480; KATAYAMA M, 1987, ANN NY ACAD SCI, V496, P366, DOI 10.1111/j.1749-6632.1987.tb35789.x; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; Levy D E, 1978, Ann N Y Acad Sci, V315, P293, DOI 10.1111/j.1749-6632.1978.tb50347.x; MANDELL GL, 1969, AM J MED, V47, P473, DOI 10.1016/0002-9343(69)90231-9; MANDELL GL, 1980, J MED, V11, P263; MORUZZI G, 1972, ERG PHYSIOL BIOL CH, V64, P1; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; MURRAY HW, 1988, ANN INTERN MED, V108, P595, DOI 10.7326/0003-4819-108-4-595; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; NEVEU PJ, 1986, LIFE SCI, V38, P1907, DOI 10.1016/0024-3205(86)90219-5; PARKS DR, 1979, P NATL ACAD SCI USA, V76, P1962, DOI 10.1073/pnas.76.4.1962; PIERCE J P, 1990, Brain Injury, V4, P191, DOI 10.3109/02699059009026165; QUINN MT, 1987, P NATL ACAD SCI USA, V84, P2995, DOI 10.1073/pnas.84.9.2995; RAMESH C, 1991, ACTA PSYCHIAT SCAND, V84, P396, DOI 10.1111/j.1600-0447.1991.tb03166.x; ROILIDES E, 1993, HEMATOL ONCOL CLIN N, V7, P841, DOI 10.1016/S0889-8588(18)30224-7; ROSZMAN TL, 1985, J NEUROIMMUNOL, V10, P59, DOI 10.1016/0165-5728(85)90034-7; ROSZMAN TL, 1982, IMMUNOLOGY, V45, P737; TECOMA ES, 1985, LIFE SCI, V36, P1799, DOI 10.1016/0024-3205(85)90152-3; UNANUE ER, 1980, NEW ENGL J MED, V303, P977, DOI 10.1056/NEJM198010233031706; WOODROOFE MN, 1986, J NEUROL SCI, V74, P135, DOI 10.1016/0022-510X(86)90100-0; YAM LT, 1971, AM J CLIN PATHOL, V55, P283; YINGLING CD, 1975, ELECTROEN CLIN NEURO, V39, P635, DOI 10.1016/0013-4694(75)90076-0	44	3	3	0	1	MARCEL DEKKER INC	NEW YORK	270 MADISON AVE, NEW YORK, NY 10016	0892-3973			IMMUNOPHARM IMMUNOT	Immunopharmacol. Immunotoxicol.		1996	18	4					549	569		10.3109/08923979609052753			21	Immunology; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Pharmacology & Pharmacy; Toxicology	VT455	WOS:A1996VT45500005	8933169				2022-02-06	
J	RIED, S; STRONG, G; WRIGHT, L; WOOD, A; GOLDMAN, A; BOGEN, D				RIED, S; STRONG, G; WRIGHT, L; WOOD, A; GOLDMAN, A; BOGEN, D			COMPUTERS, ASSISTIVE DEVICES, AND AUGMENTATIVE COMMUNICATION AIDS - TECHNOLOGY FOR SOCIAL INCLUSION	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							CHILDREN; REHABILITATION; MOBILITY; INFANTS	Assistive technology, in the form of both devices and services, can significantly improve the lives of children with disabilities following traumatic brain injury. a powerful goal of assistive technology is social inclusion, defined as full meaningful inclusion of the child into the social fabric of the culture. A series of recently enacted legislation has made assistive technology for these children more readily obtainable. A needs assessment by a competency-based assistive technology team that includes the family, is environmentally and task specific, and relates to social roles will be more meaningful to the child and family and enhance social inclusion for children with traumatic brain injuries.	DREXEL UNIV,COLL INFORMAT STUDIES,PHILADELPHIA,PA 19104; TEMPLE UNIV HOSP & MED SCH,INST DISABIL,AFFILIATED PROGRAM,PHILADELPHIA,PA; UNIV PENN,PHILADELPHIA,PA 19104								BATES PS, 1993, AM J OCCUP THER, V47, P1014, DOI 10.5014/ajot.47.11.1014; Blackstone S., 1990, AUGMENTATIVE COMMUNI, V3, P1; BRINKER RP, 1982, EXCEPT CHILDREN, V49, P163, DOI 10.1177/001440298204900210; BUTLER C, 1986, DEV MED CHILD NEUROL, V28, P325, DOI 10.1111/j.1469-8749.1986.tb03881.x; BUTLER C, 1988, INFANT YOUNG CHILD, V1, P66; BUZOLICH M, 1994, NOV AM SPEECH LANG H; CAMPOS JJ, 1987, CHILDHOOD POWERED MO; CASESMITH J, 1993, PEDIATRIC OCCUPATION; Cook AM, 1995, ASSISTIVE TECHNOLOGI; GATHERCOLE SE, 1993, SPEECH PRODUCTION WO; HORN EM, 1987, J ASSOC PERS SEVERE, V12, P205, DOI 10.1177/154079698701200306; HUTINGER PL, 1987, CLOSING GAP, V6, P16; KAUFERT JM, 1990, SOC SCI MED, V30, P867, DOI 10.1016/0277-9536(90)90214-D; KERMOIAN R, 1988, CHILD DEV, V59, P908, DOI 10.1111/j.1467-8624.1988.tb03244.x; Kohn M., 1977, SOCIAL COMPETENCE SY; Korpela R, 1993, Disabil Rehabil, V15, P143; KORPELA RA, 1992, PEDIATRICS, V90, P597; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; KYES K, 1994, REHAB MANAGE, V7, P26; LAHM EA, 1988, DISS ABSTR INT, V49, pA788; Letts R. M., 1991, PRINCIPLES SEATING D; LEVINE SP, 1992, J HEAD TRAUMA REHAB, V7, P46, DOI DOI 10.1097/00001199-199209000-00007; LLOYD LL, 1994, NOV AM SPEECH LANG H; MANN WC, 1991, ASSISTIVE TECHNOLOGY; MCDERMOTT JF, 1972, CLIN PEDIATR, V11, P130, DOI 10.1177/000992287201100303; MILNER M, 1990, Pediatrician, V17, P287; OCONNOR L, 1986, J SPEECH HEAR DISORD, V51, P356, DOI 10.1044/jshd.5104.356; PEHRINGER JL, 1989, OTOLARYNG CLIN N AM, V22, P143; PLATTS RGS, 1993, PARAPLEGIA, V31, P280, DOI 10.1038/sc.1993.51; PORTER LK, 1986, J DIVISION EARLY CHI, V10, P231; STRONG GW, 1994, SEP INT WORKSH HUM I; STRONG GW, 1994, APR ASS COMP MACH C; *US NAT COUNC DIS, 1993, STUD FIN ASS TECHN D; YASUDA YL, 1986, ARCH PHYS MED REHAB, V67, P253; [No title captured]	35	3	3	0	5	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	1995	10	5					80	90		10.1097/00001199-199510000-00009			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RY617	WOS:A1995RY61700009					2022-02-06	
J	CIFU, DX; ANDERSON, JC; LOPEZ, E				CIFU, DX; ANDERSON, JC; LOPEZ, E			AGITATION IN THE OLDER ADULT WITH TRAUMATIC BRAIN INJURY	NEUROREHABILITATION			English	Article						AGITATION; BRAIN INJURY; GERIATRIC	CLOSED HEAD-INJURY; PHARMACOLOGICAL TREATMENT; NEUROLEPTIC TREATMENT; BEHAVIORAL SEQUELAE; RATING-SCALE; DEMENTIA; PATIENT; PROPRANOLOL; MANAGEMENT; PROGNOSIS	Improvements in medical care and health have resulted in an increase in life expectancy and with it a steady increase in the number of older adults, which has resulted in an increasing number of brain-injured older adults. There is limited information available however, which specifically defines the incidence, management and outcome of behavioral sequelae, specifically agitation, in the older adult with TBI. The vast majority of the available literature addressing interventions in the agitated older adult, focuses on the individual with a psychiatric or dementing process who is a resident of a long-term care facility. Agitated behavior in the older adult with acute brain injury differs from this patient population and therefore management must also differ. Management includes behavioral strategies, environmental modifications, structured therapy sessions, appropriate medical management and neuropharmacologic interventions. There are no controlled studies which utilize standardized measures and examine the efficacy of these behavioral, environmental, therapeutical and pharmacological interventions for agitation in the older adult following TBI. In general, considerable care must be taken when using medications in the older adult. Alterations in absorption, pharmacokinetics, liver and renal metabolism, receptor sensitivity, side-effect tolerance, and compliance must all be considered. This article aims to present available information and provide a practical and clinically effective guide for the management of agitation in the older adult with brain injury.	VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, CTR REHABIL & RES, DEPT PM&R, RICHMOND, VA 23298 USA					Cifu, David/0000-0003-1600-9387			Alessi C A, 1991, Clin Geriatr Med, V7, P787; AMACHER AL, 1987, NEUROSURGERY, V20, P954; ANCILL RJ, 1991, INT CLIN PSYCHOPHARM, V6, P141, DOI 10.1097/00004850-199100630-00002; BAKCHINE S, 1989, NEUROLOGY, V39, P777, DOI 10.1212/WNL.39.6.777; BECK JG, 1991, J ANXIETY DISORD, V5, P281; BILLIG N, 1991, J AM GERIATR SOC, V39, P1002, DOI 10.1111/j.1532-5415.1991.tb04048.x; BRANDSTATER ME, 1990, AM ACAD PHYS MED REH, V1, P26; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; BROTMAN HB, 1982, 97332 HOUS REPR SEL; BRUNGARDT GS, 1994, GERIATRICS, V49, P43; CARDENAS DD, 1992, PHYS MED REH CLIN N, V3, P273; CARLSSON CA, 1968, J NEUROSURG, V29, P242, DOI 10.3171/jns.1968.29.3.0242; CASSIDY JW, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P219; Chandler M C, 1988, Brain Inj, V2, P309; Chrisman M, 1991, J Gerontol Nurs, V17, P9; Cifu D X, 1993, Clin Geriatr Med, V9, P473; CIFU DX, 1993, ARCH PHYS MED REHAB, V74, P44; CLARK GS, 1988, REHABILITATION MED, P10; Cohen-Mansfield J, 1992, Int Psychogeriatr, V4 Suppl 2, P221; Cohen-Mansfield J, 1989, Adv Psychosom Med, V19, P101; COLENDA CC, 1991, HOSP COMMUNITY PSYCH, V42, P287; CORRIGAN JD, 1985, ARCH PHYS MED REHAB, V66, P626; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; CORRIGAN JD, 1988, ARCH PHYS MED REHAB, V69, P487; DENNYBROWN D, 1945, JAMA-J AM MED ASSOC, V127, P429, DOI 10.1001/jama.1945.02860080001001; EDLUND MJ, 1991, INT J PSYCHIAT MED, V21, P173, DOI 10.2190/Q21D-EWW7-53EJ-FUC6; ELLIOTT FA, 1977, ANN NEUROL, V1, P489, DOI 10.1002/ana.410010516; FAUMAN MA, 1978, JAMA-J AM MED ASSOC, V240, P380, DOI 10.1001/jama.240.4.380; Frankowski R F, 1986, Adv Psychosom Med, V16, P153; FRANKOWSKI RF, 1985, TRAUMA STATUS REPORT, V109, P33; GALBRAITH S, 1976, BRIT J SURG, V63, P128, DOI 10.1002/bjs.1800630210; GALBRAITH S, 1987, BRIT MED J, V294, P325, DOI 10.1136/bmj.294.6568.325; GERCHER LA, 1994, J GERONTOL NURS, V20, P11; Gershkoff A M, 1993, Arch Phys Med Rehabil, V74, pS402; Goddaer J, 1994, Arch Psychiatr Nurs, V8, P150, DOI 10.1016/0883-9417(94)90048-5; GOODMAN H, 1992, PHYS MED REH CLIN N, V3, P441; GREENDYKE RM, 1986, J NERV MENT DIS, V174, P290, DOI 10.1097/00005053-198605000-00005; GUALTIERI CT, 1991, NEUROPSYCHIATRY BEHA, P37; HEISKANEN O, 1970, ACTA NEUROL SCAND, V46, P343, DOI 10.1111/j.1600-0404.1970.tb05798.x; HENDEE WR, 1990, ARCH INTERN MED, V150, P2459; Herbel K, 1990, Rehabil Nurs, V15, P66; HERNESNIEMI J, 1979, ACTA NEUROCHIR, V49, P67, DOI 10.1007/BF01809175; HORN LJ, 1989, TRAUMATIC BRAIN INJU, pR10; JACKSON RD, 1985, ARCH PHYS MED REHAB, V66, P180; JENNETT B, 1976, LANCET, V1, P1031; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; KATZ DI, 1990, NEUROLOGY, V40, P862, DOI 10.1212/WNL.40.5.862-b; KLAUBER MR, 1981, NEUROSURGERY, V9, P236, DOI 10.1227/00006123-198109000-00003; Kolcaba K, 1989, J Gerontol Nurs, V15, P29; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1980, J NEUROSURG, V53, pS3; KUNIK ME, 1994, J CLIN PSYCHIAT, V55, P13; LEHMAN LB, 1988, POSTGRAD MED, V83, P140; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Levine A M, 1988, Brain Inj, V2, P165, DOI 10.3109/02699058809150940; LUDWIG BI, 1989, J NEUROL REHABIL, V3, P147; MALKMUS D, 1980, PROFESSIONAL STAFF A; MARKS W, 1992, ARCH INTERN MED, V152, P2203, DOI 10.1001/archinte.152.11.2203; MILLER JD, 1990, REHABILITATION ADULT, P236; MYSIW WJ, 1988, AM J PHYS MED REHAB, V67, P29, DOI 10.1097/00002060-198802000-00006; OSHANICK GJ, 1988, PSYCHIATRY; Patterson T S, 1990, Rehabil Nurs, V15, P248; PINNER E, 1988, AM J PSYCHIAT, V145, P1295; Pollock B G, 1990, J Geriatr Psychiatry Neurol, V3, P221, DOI 10.1177/089198879000300408; RATEY JJ, 1993, PSYCHOPHARMACOL BULL, V29, P65; REYES RL, 1981, ARCH PHYS MED REHAB, V62, P20; ROSEN J, 1990, ACTA PSYCHIAT SCAND, V82, P170, DOI 10.1111/j.1600-0447.1990.tb05312.x; SAYWELL RM, 1989, J AM GERIATR SOC, V37, P625, DOI 10.1111/j.1532-5415.1989.tb01253.x; SCHNEIDER LS, 1990, J AM GERIATR SOC, V38, P553, DOI 10.1111/j.1532-5415.1990.tb02407.x; SCHNEIDER LS, 1992, PSYCHOPHARMACOL BULL, V28, P71; SCHROEDER JA, 1994, ANESTH ANALG, V78, P359, DOI 10.1213/00000539-199402000-00027; Silver J M, 1991, J Neuropsychiatry Clin Neurosci, V3, pS22; SIMPSON DM, 1986, J CLIN PSYCHIAT, V47, P191; SINNETT PF, 1994, DRUG AGING, V4, P443, DOI 10.2165/00002512-199404060-00001; SLAGLE DA, 1990, INT J PSYCHIAT MED, V20, P1, DOI 10.2190/BE6W-DCY1-V71N-N7J7; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; SULTZER DL, 1992, J AM GERIATR SOC, V40, P549, DOI 10.1111/j.1532-5415.1992.tb02101.x; TAEUBER CM, 1983, CURRENT POPULATI P23, V128; TESAR GE, 1993, HOSP COMMUNITY PSYCH, V44, P627; TESAR GE, 1993, HOSP COMMUNITY PSYCH, V44, P329; *US SEN, 1988, DEV AG, V1, P2; VANWOERKOM TCAM, 1977, LANCET, V1, P812; Williams L M, 1990, Rehabil Nurs, V15, P30; Wilson J A, 1987, Brain Inj, V1, P183, DOI 10.3109/02699058709034456; ZASLER N D, 1992, Brain Injury, V6, P1, DOI 10.3109/02699059209008117	87	3	3	0	9	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation	JUL	1995	5	3					245	254		10.1016/1053-8135(95)00122-O			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RP776	WOS:A1995RP77600007	24525539				2022-02-06	
J	HIGGINS, GL				HIGGINS, GL			DELAYED SUBLUXATION OF AN OCCULT TRAUMATIC ODONTOID FRACTURE IN AN ELDERLY PATIENT	ACADEMIC EMERGENCY MEDICINE			English	Article						CERVICAL SPINE FRACTURE; NEUROTRAUMA; RADIOGRAPHY; ODONTOID; GERIATRICS	CERVICAL-SPINE FRACTURE; BLUNT TRAUMA; RADIOGRAPHY	The issue of whether a traumatic but occult cervical spine fracture can exist has generated significant debate in emergency medicine. The profound clinical and legal implications of missing an unstable cervical spine injury are well known to the emergency care provider. An elderly patient who satisfies all of the rigorous criteria for this type of injury is discussed. The patient experienced delayed subluxation of her acute odontoid fracture during a flexion/extension examination completed in the ED, with resultant development of cervical discomfort. Elderly victims of trauma with an appropriate mechanism of injury should be suspected of subtle or occult neck injuries.	UNIV VERMONT,COLL MED,DEPT SURG,BURLINGTON,VT 05405		HIGGINS, GL (corresponding author), MAINE MED CTR,DEPT EMERGENCY MED,22 BRAMHALL ST,PORTLAND,ME 04102, USA.						BACHULIS BL, 1987, AM J SURG, V153, P473, DOI 10.1016/0002-9610(87)90796-3; BAYLESS P, 1989, AM J MERG MED, V7, P129; BRESLER MJ, 1982, ANN EMERG MED, V11, P440, DOI 10.1016/S0196-0644(82)80043-7; CADOUX CG, 1986, ANN EMERG MED, V15, P236, DOI 10.1016/S0196-0644(86)80554-6; FISCHER RP, 1984, ANN EMERG MED, V13, P905, DOI 10.1016/S0196-0644(84)80667-8; HAINES JD, 1986, POSTGRAD MED, V80, P73, DOI 10.1080/00325481.1986.11699483; HOFFMAN JR, 1992, ANN EMERG MED, V21, P1454, DOI 10.1016/S0196-0644(05)80059-9; KREIPKE DL, 1989, J TRAUMA, V29, P1438, DOI 10.1097/00005373-198910000-00024; Lieberman J F, 1988, J Tenn Med Assoc, V81, P243; MACE SE, 1991, ANN EMERG MED, V20, P1373, DOI 10.1016/S0196-0644(05)81083-2; MCKEE TR, 1990, J TRAUMA, V30, P623, DOI 10.1097/00005373-199005000-00018; MCNAMARA R M, 1990, Journal of Emergency Medicine, V8, P177, DOI 10.1016/0736-4679(90)90229-O; MOUW MW, 1988, ANN EMERG MED, V17, P879; NEIFELD G L, 1988, Journal of Emergency Medicine, V6, P203, DOI 10.1016/0736-4679(88)90327-7; OGDEN W, 1986, ANN EMERG MED, V15, P604, DOI 10.1016/S0196-0644(86)81009-5; RINGENBERG BJ, 1988, ANN EMERG MED, V17, P792, DOI 10.1016/S0196-0644(88)80555-9; ROBERGE R J, 1992, Journal of Emergency Medicine, V10, P539, DOI 10.1016/0736-4679(92)90133-E; ROBERGE RJ, 1988, J TRAUMA, V28, P784, DOI 10.1097/00005373-198806000-00010; Thambyrajah K, 1972, Med J Malaya, V26, P244; WALTER J, 1984, ANN EMERG MED, V13, P512, DOI 10.1016/S0196-0644(84)80515-6	20	3	3	0	0	HANLEY & BELFUS INC	PHILADELPHIA	210 S 13TH ST, PHILADELPHIA, PA 19107	1069-6563			ACAD EMERG MED	Acad. Emerg. Med.	JUL	1995	2	7					634	638		10.1111/j.1553-2712.1995.tb03603.x			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	RF085	WOS:A1995RF08500016	8521211	Bronze			2022-02-06	
J	LITSCHER, G; SCHWARZ, G; KIRISITS, H				LITSCHER, G; SCHWARZ, G; KIRISITS, H			DISSOCIATION OF EEG, EVOKED-POTENTIALS AND TRANSCRANIAL DOPPLER SONOGRAPHY IN COMA DEPASSE	EEG-EMG-ZEITSCHRIFT FUR ELEKTROENZEPHALOGRAPHIE ELEKTROMYOGRAPHIE UND VERWANDTE GEBIETE			German	Article						NEUROPHYSIOLOGIC MONITORING; EVOKED POTENTIALS (BAEP, SSEP); EEG; TRANSCRANIAL DOPPLER SONOGRAPHY(TCD); BRAIN DEATH; COMA DEPASSE; ULTRASONOGRAPHY	INTRACRANIAL CIRCULATORY ARREST; BRAIN-DEATH; ULTRASOUND; ULTRASONOGRAPHY; FLOW	EEG, multimodal evoked potentials and transcranial Doppler sonography are ancillary non-invasive methods to determine brain death. Arrest of the cerebral circulation is correlated with the following transcranial Doppler sonography findings: (a) no signal, (b) systolic spikes, and (c) diastolic reverse flow. We describe a 42-year-old patient after head injury with nasoliquorrhea. The EEG was isoelectric, brainstem auditory evoked potentials showed continuous loss of components I-V bilaterally, and early somatosensory evoked potentials showed a loss of cortical components bilaterally. Transcranial Doppler sonography of the right middle cerebral artery showed diastolic reverse now compatible with brain death. 40 hours later transcranial Doppler sonography showed an increase of the systolic and diastolic flow velocities. The results show that signs of cerebral perfusion can be found in patients with clinically and electrophysiologically defined brain death. This suggests that transcranial Doppler sonography cannot be used as an isolated parameter to determine brain death. Reperfusion in a patient with no electric brain activity could be due to surgical or traumatic alleviation of increased intracranial pressure.	GRAZ UNIV,ANASTHESIOL KLIN,A-8036 GRAZ,AUSTRIA; KRANKENHAUS BARMHERZIGEN BRUDER GRAZ,NEUROL ABT,GRAZ,AUSTRIA				Litscher, Gerhard/A-5527-2012	Litscher, Gerhard/0000-0001-6287-0130			AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; ALVAREZ LA, 1988, ARCH NEUROL-CHICAGO, V45, P225, DOI 10.1001/archneur.1988.00520260117031; BATZ B, 1994, EEG-EMG-Z ELEK ELEKT, V25, P163; BODE H, 1988, ARCH DIS CHILD, V63, P1474, DOI 10.1136/adc.63.12.1474; ELDEVIK OP, 1983, AM J NEURORADIOL, V4, P585; HANSEN AVE, 1993, CLIN NUCL MED, V18, P502, DOI 10.1097/00003072-199306000-00009; HASSLER W, 1988, J NEUROSURG, V68, P745; HASSLER W, 1989, J NEUROSURG, V71, P195, DOI 10.3171/jns.1989.71.2.0195; HASSLER W, 1988, Intensivbehandlung, V13, P169; KIRKHAM FJ, 1987, J NEUROL NEUROSUR PS, V50, P1504, DOI 10.1136/jnnp.50.11.1504; LAUMER R, 1991, SCHWERPUNKTE NEUROLO, P41; LINDEGAARD KF, 1985, J NEUROSURG, V63, P890, DOI 10.3171/jns.1985.63.6.0890; LITSCHER G, 1994, MED WELT, V45, P161; LITSCHER G, 1988, Intensivbehandlung, V13, P154; LITSCHER G, 1994, MULTIVARIABLE NICHT; LITSCHER G, 1995, IN PRESS J NEUROSCI; LITSCHER G, 1995, IN PRESS ELECTROENCE; NAU R, 1992, INTENS CARE MED, V18, P82, DOI 10.1007/BF01705037; NEWELL DW, 1989, NEUROSURGERY, V24, P509, DOI 10.1227/00006123-198904000-00004; PENDL G, 1986, HIRNTOD EINFUHRUNG S; PETTY GW, 1990, NEUROLOGY, V40, P300, DOI 10.1212/WNL.40.2.300; PFADENHAUER K, 1991, NEUROPHYSIOLOGISCHE, P69; POWERS AD, 1989, NEUROSURGERY, V24, P884, DOI 10.1227/00006123-198906000-00015; ROPPER AH, 1987, NEUROLOGY, V37, P1733, DOI 10.1212/WNL.37.11.1733; SANKER P, 1992, NEUROSURG REV, V15, P315; SCHRODER R, 1983, ACTA NEUROPATHOL, V62, P15, DOI 10.1007/BF00684915; SCHWARZ G, 1995, BEITR ANAESTH INTENS, V45, P223; Schwarz G, 1990, DISSOZIIERTER HIRNTO; SCHWARZ G, 1994, INTENSIVMED, V35, P376; SPITTLER JF, 1991, DEUT MED WOCHENSCHR, V116, P1828, DOI 10.1055/s-2008-1063825; STELLER E, 1990, BIOMED TECH, V35, P90, DOI 10.1515/bmte.1990.35.5.90; VONREUTERN GM, 1987, INTENSIVMED, V24, P2; WALKER AE, 1995, CEREBRAL DEATH; Werner C, 1992, Anasthesiol Intensivmed Notfallmed Schmerzther, V27, P336, DOI 10.1055/s-2007-1000310; ZURYNSKI Y, 1991, Neurological Research, V13, P248	35	3	3	0	0	GEORG THIEME VERLAG	STUTTGART	P O BOX 30 11 20, D-70451 STUTTGART, GERMANY	0012-7590			EEG-EMG-Z ELEK ELEKT	EEG-EMG-Z. Elektroenz. Elektron. Geb.	JUN	1995	26	2					112	116					5	Engineering, Biomedical; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology	RH765	WOS:A1995RH76500008					2022-02-06	
J	KERTESZ, A				KERTESZ, A			RECOVERY IN APHASIA AND LANGUAGE NETWORKS	NEUROREHABILITATION			English	Article						RECOVERY; APHASIA; ARTICULATED LANGUAGE; COMPREHENSION; NETWORK MODEL	CEREBRAL BLOOD-FLOW; GLOBAL APHASIA; SPEECH; HEMISPHERE; BRAIN; LOCALIZATION; INJURY; STROKE; HEMIPARESIS; ASYMMETRIES	Recovery from aphasia is presented as a model of compensation after vascular or traumatic brain damage. Initial severity, time from onset, and etiology are the major prognostic factors. Initial severity is closely related to the size and location of the lesion. Asphasic syndromes reflect the deficit in various language networks. Lesion studies suggest that ipsilateral connected cortex plays a major role in compensation; contralateral contribution may occur in large lesions. Articulated language output network includes Broca's area, rolandic operculum, anterior insula, and the striatum. The comprehension network includes the superior posterior temporal gyrus and temporal operculum, the supramarginal gyrus and the angular gyrus.			KERTESZ, A (corresponding author), UNIV WESTERN ONTARIO, ST JOSEPHS HLTH CTR, DEPT CLIN NEUROL SCI, LONDON, ON N6A 4V2, CANADA.						AGUAYO AJ, 1981, J EXP BIOL, V95, P231; ALBINGER G, 1988, SIGMA SCAN VERSION 3; ARSENI C., 1961, ACTA PSYCHIAT ET NEUROL SCAND, V36, P279, DOI 10.1111/j.1600-0447.1961.tb01047.x; Binder J. R., 1994, LOCALIZATION NEUROIM, P185; BJORKLUND A, 1984, ANNU REV NEUROSCI, V7, P279, DOI 10.1146/annurev.ne.07.030184.001431; BOROD JC, 1990, APHASIOLOGY, V4, P561, DOI 10.1080/02687039008248507; Bucy PC, 1934, J NERV MENT DIS, V79, P621, DOI 10.1097/00005053-193406000-00001; CAMBIER J, 1983, REV NEUROL-FRANCE, V139, P55; CAPPA S, 1981, NEUROPSYCHOLOGIA, V19, P171, DOI 10.1016/0028-3932(81)90102-0; CHERTKOW H, 1994, LOCALIZATION NEUROIM, P152; CHUSID JG, 1954, J NEUROSURG, V11, P193, DOI 10.3171/jns.1954.11.2.0193; CUMMINGS JL, 1979, NEUROLOGY, V29, P1547, DOI 10.1212/WNL.29.11.1547; CZOPF J, 1972, ARCH PSYCHIAT NERVEN, V216, P162, DOI 10.1007/BF00346417; Dejerine JJ, 1895, ANATOMIE CTR NERVEUX; DEMEURISSE G, 1983, STROKE, V14, P77, DOI 10.1161/01.STR.14.1.77; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; FERRO JM, 1987, J CLIN EXP NEUROPSYC, V9, P365, DOI 10.1080/01688638708405057; FERRO JM, 1983, NEUROLOGY, V33, P1106, DOI 10.1212/WNL.33.8.1106; Fritsch G., 1870, ARCH ANAT PHYSIOL, V37, P300, DOI DOI 10.1016/J.YEBEH.2009.03.001; GESCHWIND N, 1968, SCIENCE, V161, P186, DOI 10.1126/science.161.3837.186; Geschwind N, 1974, PLASTICITY RECOVERY, P467; Gloning I, 1969, CORTEX, V5, P43, DOI DOI 10.1016/S0010-9452(69)80006-7; GLONING K, 1976, PROGNOSIS SPEECH THE, V4; GODFREY CM, 1959, CANAD MAJ, V80, P618; Goldstein K., 1948, LANGUAGE LANGUAGE DI; Goodglass H., 1972, ASSESSMENT APHASIA R; Henschen S. E, 1920, KLINISCHE ANATOMISCH, V5; Huber W., 1983, AACHENER APHASIE TES; Jackson J. H, 1873, LANCET, V1, P232; Jenkins WM, 1987, PROG BRAIN RES <D>, V71, P249; Kertesz A, 1988, Adv Neurol, V47, P277; KERTESZ A, 1979, BRAIN LANG, V8, P34, DOI 10.1016/0093-934X(79)90038-5; KERTESZ A, 1982, ARCH NEUROL-CHICAGO, V39, P475, DOI 10.1001/archneur.1982.00510200017002; KERTESZ A, 1993, BRAIN LANG, V44, P153, DOI 10.1006/brln.1993.1010; KERTESZ A, 1977, BRAIN, V100, P1, DOI 10.1093/brain/100.1.1; KERTESZ A, 1977, ARCH NEUROL-CHICAGO, V34, P590, DOI 10.1001/archneur.1977.00500220024004; Kertesz A, 1970, Cortex, V6, P362; KERTESZ A, 1992, BRAIN, V115, P589, DOI 10.1093/brain/115.2.589; KERTESZ A, 1977, BRAIN LANG, V4, P1, DOI 10.1016/0093-934X(77)90001-3; Kertesz A., 1982, W APHASIA BATTERY; Kertesz A, 1983, LOCALIZATION NEUROPS, P209; Kertesz A, 1979, APHASIA ASS DISORDER; KINSBOURNE M, 1971, ARCH NEUROL-CHICAGO, V25, P302, DOI 10.1001/archneur.1971.00490040028003; KNOPMAN DS, 1983, NEUROLOGY, V33, P1170, DOI 10.1212/WNL.33.9.1170; KNOPMAN DS, 1984, ANN NEUROL, V15, P530, DOI 10.1002/ana.410150604; KORNYEY E, 1975, REV NEUROL, V131, P347; Landis T, 1980, Rev Med Suisse Romande, V100, P171; Lashley KS, 1938, J NERV MENT DIS, V88, P733, DOI 10.1097/00005053-193812000-00001; LECOURS AR, 1976, BRAIN LANG, V3, P88, DOI 10.1016/0093-934X(76)90008-0; LEISCHNER A, 1976, RECOVERY APHASICS, P112; Leske M C, 1981, ASHA, V23, P229; LEVINE DN, 1979, NEUROLOGY, V29, P927, DOI 10.1212/WNL.29.7.927; LEVINE DN, 1983, LOCALIZATION NEUROPS, P185; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; LOMAS J, 1978, BRAIN LANG, V5, P388, DOI 10.1016/0093-934X(78)90034-2; LUDLOW CL, 1986, BRAIN, V109, P55, DOI 10.1093/brain/109.1.55; MAYENDORF NV, 1930, VOM LOKALISATIONSPRO; MCCARTHY RA, 1990, COGNITIVE NEUROPSYCH; MCGLONE J, 1980, BEHAV BRAIN SCI, V3, P215, DOI 10.1017/S0140525X00004398; METTER EJ, 1981, ANN NEUROL, V10, P173, DOI 10.1002/ana.410100208; Mohr JP, 1976, STUDIES NEUROLINGUIS, V1; MOSCOVITCH M, 1981, TOP LANG DISORD, V1, P41; Muratoff V., 1893, NEUROLOGISCHES CENTR, V12, P714; NA DL, 1994, NEUROLOGY, V44, pA134; NAESER MA, 1989, BRAIN, V112, P1, DOI 10.1093/brain/112.1.1; NAGATA K, 1986, STROKE, V17, P417, DOI 10.1161/01.STR.17.3.417; Nielsen J.M., 1946, AGNOSIA APRAXIA APHA; PAPPIUS HM, 1991, NEUROCHEM RES, V16, P941, DOI 10.1007/BF00965837; Penfield W., 1959, SPEECH BRAIN MECHANI; PETERSEN SE, 1990, SCIENCE, V249, P1041, DOI 10.1126/science.2396097; PIENIADZ JM, 1983, CORTEX, V19, P371, DOI 10.1016/S0010-9452(83)80007-0; RUBENS A B, 1975, Cortex, V11, P239; Russell W.R., 1961, TRAUMATIC APHASIA ST; SANDS E, 1969, Archives of Physical Medicine and Rehabilitation, V50, P202; SANIDES F, 1970, PRIMATE BRAIN; SARNO MT, 1970, J SPEECH HEAR RES, V13, P607, DOI 10.1044/jshr.1303.607; SARNO MT, 1970, J AM GERIATR SOC, V18, P405, DOI 10.1111/j.1532-5415.1970.tb03673.x; Schuell H, 1964, APHASIA ADULTS; SHEWAN CM, 1984, BRAIN LANG, V23, P272, DOI 10.1016/0093-934X(84)90068-3; SUBIRANA A, 1969, HDB CLIN NEUROLOGY; VANHORN G, 1982, NEUROLOGY, V32, P403; von Monakow C., 1914, LOKALISATION GROSSHI; WEILLER C, 1992, ANN NEUROL, V31, P463, DOI 10.1002/ana.410310502; Weintraub S., 1983, BOSTON NAMING TEST; Wernicke C., 1886, FORTSCHRITTE MED, V4, P371; YAKOVLEV PI, 1961, ARCH NEUROL-CHICAGO, V5, P364, DOI 10.1001/archneur.1961.00450160014002; ZAIDEL E, 1976, CORTEX, V12, P191, DOI 10.1016/S0010-9452(76)80001-9; [No title captured]	88	3	3	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation	APR	1995	5	2					103	113		10.1016/1053-8135(94)00109-8			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RJ880	WOS:A1995RJ88000002	24525492				2022-02-06	
J	Kriel, RL; Krach, LE; Luxenberg, MG; Chun, C				Kriel, RL; Krach, LE; Luxenberg, MG; Chun, C			Recovery of language skills in children after prolonged unconsciousness	JOURNAL OF NEUROLOGIC REHABILITATION			English	Article						pediatric; persistent vegetative state; language recovery; prolonged unconsciousness	VEGETATIVE STATE; HEAD-INJURY; PROGNOSIS	The regaining of language skills in thirty children unconscious for ninety days or more following acquired brain injury is reported. Although language skills were limited in twenty-six children, four children with closed head injuries were sufficiently functional to be placed in mainstream classes. The recovery of language was correlated with cause of injury-children with closed head injuries were much more likely to regain language. Ten children acquired language more than one year after injury, two at nearly four years after injury. In the four children who were most functional, initial language attempts were observed within 96 to 133 days after injury. Only children with closed head injuries regained higher language skills.	HENNEPIN CTY MED CTR,DEPT PEDIAT,MINNEAPOLIS,MN 55415; GILLETTE CHILDRENS HOSP,DEPT PEDIAT NEUROL,ST PAUL,MN; GILLETTE CHILDRENS HOSP,DEPT REHABIL,ST PAUL,MN; PROFESS DATA ANAL,MINNEAPOLIS,MN; HENNEPIN CTY MED CTR,DEPT NEUROL,MINNEAPOLIS,MN 55415					Krach, Linda/0000-0002-0993-8199			ANDREWS K, 1993, BRIT MED J, V306, P1597, DOI 10.1136/bmj.306.6892.1597; BRAAKMAN R, 1988, ACTA NEUROCHIR, V95, P49, DOI 10.1007/BF01793082; CAMPBELL TF, 1990, J SPEECH HEAR DISORD, V55, P567, DOI 10.1044/jshd.5503.567; GROSWASSER Z, 1990, J NEUROSURG, V72, P81, DOI 10.3171/jns.1990.72.1.0081; JORDAN F M, 1990, Brain Injury, V4, P101, DOI 10.3109/02699059009026154; KRIEL RL, 1993, PEDIATR NEUROL, V9, P362, DOI 10.1016/0887-8994(93)90104-K; KRIEL RL, 1988, ARCH PHYS MED REHAB, V69, P678; KRIEL RL, 1994, PEDIATR NEUROL, V10, P207, DOI 10.1016/0887-8994(94)90024-8; OVERGAARD J, 1973, LANCET, V2, P631; SAZBON L, 1993, J NEUROL NEUROSUR PS, V56, P407, DOI 10.1136/jnnp.56.4.407; STOVER SL, 1976, ARCH PHYS MED REHAB, V57, P201	11	3	3	0	1	DEMOS PUBLICATIONS	NEW YORK	386 PARK AVE S STE 201, NEW YORK, NY 10016-8804	0888-4390			J NEUROL REHABIL	J. Neurol. Rehabil.		1995	9	3					145	150					6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	UT012	WOS:A1995UT01200002					2022-02-06	
J	TEENER, JW; RAPS, EC; GALETTA, SL				TEENER, JW; RAPS, EC; GALETTA, SL			INTENSIVE-CARE NEUROLOGY	CURRENT OPINION IN NEUROLOGY			English	Article							INTRACRANIAL-PRESSURE; BRAIN INJURY; EVOKED-POTENTIALS; MYASTHENIC CRISIS; MANAGEMENT; HYPOTHERMIA; GLOBULIN; INFUSION; STROKE	Critical care neurology is a rapidly developing subspecialty of neurology. The neuro-intensivist is called upon to manage critically ill patients with stroke, neuromuscular disease, traumatic injury, increased intracranial pressure, and other disorders. Therapeutic and technologic advances are rapidly being incorporated into practice and will improve patient care and outcome.	UNIV PENN,SCH MED,PHILADELPHIA,PA 19104								ALEXANDROV AV, 1994, STROKE, V25, P1378, DOI 10.1161/01.STR.25.7.1378; ALLOZI MT, 1994, ANN NEUROL, V35, P273, DOI 10.1002/ana.410350306; CASTRO LHM, 1993, NEUROLOGY, V43, P1034, DOI 10.1212/WNL.43.5.1034; CHAD DA, 1994, ANN NEUROL, V35, P257, DOI 10.1002/ana.410350303; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CRUZ J, 1993, J NEUROSURG, V79, P228, DOI 10.3171/jns.1993.79.2.0228; DIRINGER MN, 1993, CRIT CARE MED, V21, P1591, DOI 10.1097/00003246-199310000-00032; FITT GJ, 1993, MED J AUSTRALIA, V159, P331, DOI 10.5694/j.1326-5377.1993.tb137871.x; HANSENFLASCHEN J, 1993, AM REV RESPIR DIS, V147, P234, DOI 10.1164/ajrccm/147.1.234; Hurst R W, 1994, J Stroke Cerebrovasc Dis, V4, P30, DOI 10.1016/S1052-3057(10)80143-0; IWASHITA Y, 1994, NATURE, V367, P167, DOI 10.1038/367167a0; KRIEGER D, 1993, CRIT CARE MED, V21, P1944, DOI 10.1097/00003246-199312000-00024; KRIEGER D, 1993, CRIT CARE MED, V21, P1169, DOI 10.1097/00003246-199308000-00016; LANGHORNE P, 1993, LANCET, V342, P395, DOI 10.1016/0140-6736(93)92813-9; LEVI L, 1993, NEUROSURGERY, V33, P1007, DOI 10.1097/00006123-199312000-00008; LEVY DE, 1994, STROKE, V25, P291, DOI 10.1161/01.STR.25.2.291; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; OSULLIVAN MG, 1994, J NEUROSURG, V80, P46, DOI 10.3171/jns.1994.80.1.0046; PESSIN MS, 1993, NEUROLOGY, V43, P1298, DOI 10.1212/WNL.43.7.1298; PETERSON W, 1994, PARAPLEGIA, V32, P98, DOI 10.1038/sc.1994.17; PICKARD JD, 1993, J NEUROL NEUROSUR PS, V56, P845, DOI 10.1136/jnnp.56.8.845; ROPPER AH, 1993, J NEUROL NEUROSUR PS, V56, P932, DOI 10.1136/jnnp.56.8.932; ROPPER AH, 1993, ARCH NEUROL-CHICAGO, V50, P687, DOI 10.1001/archneur.1993.00540070007005; SALTIS LM, 1993, CRIT CARE MED, V21, P938, DOI 10.1097/00003246-199306000-00025; SIEBLER M, 1994, NEUROLOGY, V44, P615, DOI 10.1212/WNL.44.4.615; STRICKER RB, 1993, ARCH NEUROL-CHICAGO, V50, P837, DOI 10.1001/archneur.1993.00540080046012; THORNTON CA, 1994, ANN NEUROL, V35, P260, DOI 10.1002/ana.410350304; UEDA T, 1994, STROKE, V25, P298, DOI 10.1161/01.STR.25.2.298; WINFIELD JA, 1993, NEUROSURGERY, V33, P424	30	3	3	0	0	RAPID SCIENCE PUBLISHERS	LONDON	2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8NH	1350-7540			CURR OPIN NEUROL	Curr. Opin. Neurol.	DEC	1994	7	6					525	529		10.1097/00019052-199412000-00009			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PV143	WOS:A1994PV14300009	7866584				2022-02-06	
J	VAKIL, E				VAKIL, E			CLINICAL NEUROPSYCHOLOGY AND BRAIN INJURY REHABILITATION IN ISRAEL - A 20-YEAR PERSPECTIVE	NEUROPSYCHOLOGY REVIEW			English	Article						ISRAEL; NEUROPSYCHOLOGY; TRAUMATIC BRAIN INJURY; REHABILITATION		The development of the field of neuropsychology in Israel is primarily the result of the development of rehabilitation services for traumatic brain-injured patients. The responsibility to care for and help disabled veterans has always been an important motivation for the establishment of rehabilitation services. Israel is probably one of the first countries in the world to develop community-based services specifically designed to address the needs of young patients with severe traumatic brain injury. The fairly extensive therapeutic and community services available today for both military and civilian brain-injured persons in Israel are the result of initiatives and funding by the Israel Ministry of Defense's Department of Rehabilitation. There are two principles that characterize most of the programs in Israel: (1) multidimensional remedial intervention and (2) life-time commitment to provide support. The accessibility of patients in a small country enables professionals to conduct follow-up studies in order to evaluate the long-term effects of brain injury. Current developments in neuropsychology are in three directions. First, formal training programs in neuropsychology are being set up. Second, the involvement of neuropsychologists is being extended beyond the treatment of young patients suffering from traumatic brain injury to include the treatment of different brain pathologies in children and the elderly. Third, sophisticated neuroimaging techniques are being applied to studies in cognitive neuropsychology.			VAKIL, E (corresponding author), BAR ILAN UNIV, DEPT PSYCHOL, IL-52900 RAMAT GAN, ISRAEL.						BECKER ME, 1993, BRAIN INJURY, V7, P515, DOI 10.3109/02699059309008179; GROSS Y, 1982, COGNITIVE REHABILITA, P91; Gross Y., 1986, CLIN NEUROPSYCHOLOGY, P179, DOI DOI 10.1007/978-1-4613-2291-7; GROSWASSER Z, 1977, SCAND J REHABIL MED, V9, P147; Groswasser Z., 1990, REHABILITATION BRAIN, P143; GUGGENHEIM N, 1990, REHABILITATION BRAIN, P61; Hoofien D., 1991, MONOGRAPH, V50, P41; HOOFIEN D, 1990, REHABILITATION BRAIN, P157; KATZ S, 1978, SCAND J REHABIL MED, V10, P51; Katz S., 1991, MONOGRAPH, V50, P9; KATZ S, 1991, MONOGRAPH, V50, P41; KLAG E, 1991, MONOGRAPH, V50, P61; Najenson T, 1980, Int Rehabil Med, V2, P17; Stern M. J., 1991, MONOGRAPH, V50, P23; Vakil E., 1990, REHABILITATION BRAIN, P125; VAKIL E, 1990, REHABILITATION BRAIN	16	3	4	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1040-7308	1573-6660		NEUROPSYCHOL REV	Neuropsychol. Rev.	DEC	1994	4	4					271	278		10.1007/BF01876078			8	Psychology, Clinical; Neurosciences	Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	RD853	WOS:A1994RD85300003	7550358				2022-02-06	
J	MATTIS, PJ; HANNAY, HJ; PLENGER, PM; POLLOCK, L				MATTIS, PJ; HANNAY, HJ; PLENGER, PM; POLLOCK, L			HEAD-INJURY AND THE SATZ-MOGEL TYPE SHORT-FORM WAIS-R	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article							STROKE; TUMOR	The current study investigated the efficacy of a Satz-Mogel type short form of the WAIS-R in a closed head injury (CHI) population and whether the short form's effectiveness varied by lesion site. Data were taken from the files of 79 CHI patients, 20 with left hemisphere damage, 15 with right hemisphere damage, 29 with bilateral damage, and 15 with only diffuse damage. Information about IQ scores and age-corrected subtest scores was examined. As expected, correlations between two forms, for both IQ scores and subtest scores were high. However, there was a remarkable percentage of deviation in scaled score points and changes in intellectual classification for some of these scores. No evidence was found to support the notion that usefulness of the short form varied according to the location of lesion.	UNIV TEXAS,HLTH SCI CTR,HOUSTON,TX 77225		MATTIS, PJ (corresponding author), UNIV HOUSTON,DEPT PSYCHOL,HOUSTON,TX 77204, USA.			Hannay, H. Julia/0000-0001-7023-912X			ANDERSON SW, 1990, ARCH NEUROL-CHICAGO, V47, P397, DOI 10.1001/archneur.1990.00530040039017; CAPLAN B, 1983, J CLIN NEUROPSYCHOL, V5, P239, DOI 10.1080/01688638308401172; DINNING WD, 1983, J CONSULT CLIN PSYCH, V51, P781; ESTES BW, 1963, J CLIN PSYCHOL, V19, P103, DOI 10.1002/1097-4679(196301)19:1<103::AID-JCLP2270190119>3.0.CO;2-0; EVANS RG, 1985, J CLIN PSYCHOL, V41, P100, DOI 10.1002/1097-4679(198501)41:1<100::AID-JCLP2270410118>3.0.CO;2-9; HAALAND KY, 1981, NEUROPSYCHOLOGIA, V19, P17; HOLMES DS, 1965, PSYCHOL REP, V16, P1163, DOI 10.2466/pr0.1965.16.3c.1163; HOLMES DS, 1966, PSYCHOL REP, V18, P992, DOI 10.2466/pr0.1966.18.3.992; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; LUSZKI MB, 1970, J CONSULT CLIN PSYCH, V34, P425, DOI 10.1037/h0029271; MARSH GG, 1973, J CLIN PSYCHOL, V29, P451, DOI 10.1002/1097-4679(197310)29:4<451::AID-JCLP2270290415>3.0.CO;2-G; MASSAD PM, 1988, J CLIN PSYCHOL, V44, P924, DOI 10.1002/1097-4679(198811)44:6<924::AID-JCLP2270440612>3.0.CO;2-9; MATTIS PJ, 1992, PSYCHOL ASSESSMENT, V4, P357, DOI DOI 10.1037/1040-3590.4.3.357; PAUKER JD, 1963, J CLIN PSYCHOL, V19, P98, DOI 10.1002/1097-4679(196301)19:1<98::AID-JCLP2270190116>3.0.CO;2-A; Robiner WD, 1988, CLIN NEUROPSYCHOL, V2, P365, DOI [10.1080/13854048808403274, DOI 10.1080/13854048808403274]; SATZ P, 1967, J CONSULT PSYCHOL, V31, P108, DOI 10.1037/h0020994; SATZ P, 1962, J CLIN PSYCHOL, V18, P77, DOI 10.1002/1097-4679(196201)18:1<77::AID-JCLP2270180124>3.0.CO;2-R; SCHEIBEL R, 1991, THESIS U HOUSTON HOU; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; TEASDALE G, 1974, LANCET, V2, P81; Wechsler, 1997, WECHSLER ADULT INTEL	21	3	3	0	0	CLINICAL PSYCHOLOGY PUBL CO	BRANDON	4 CONANT SQUARE, BRANDON, VT 05733	0021-9762			J CLIN PSYCHOL	J. Clin. Psychol.	JUL	1994	50	4					605	614		10.1002/1097-4679(199407)50:4<605::AID-JCLP2270500418>3.0.CO;2-V			10	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	PC923	WOS:A1994PC92300017	7983211				2022-02-06	
J	FINNIE, JW				FINNIE, JW			NEURORADIOLOGICAL ASPECTS OF EXPERIMENTAL TRAUMATIC MISSILE INJURY IN SHEEP	NEW ZEALAND VETERINARY JOURNAL			English	Article							GUNSHOT WOUNDS; BRAIN; SCAN; HEAD	Radiological assessment of ovine brains subjected to experimental gunshot injury was performed using computed tomography. This imaging procedure enabled precise localisation of the projectile and metal and bony fragments, and depicted parenchymal damage, distortion and displacement of the brain, and skull fractures. Computed tomography scanning was found to be useful in the clinical evaluation of craniocerebral missile injuries and confirmed the acceptability of the 0.22 calibre rifle and 12-gauge shotgun for the euthanasia of sheep.			FINNIE, JW (corresponding author), DEPT PRIMARY IND,CENT VET LABS,GPO BOX 1671,ADELAIDE,SA 5001,AUSTRALIA.						Adams JH, 1992, GREENFIELDS NEUROPAT, P106; ALLEN IV, 1982, INJURY, V14, P183, DOI 10.1016/0020-1383(82)90057-2; BAKAY L, 1984, ACTA NEUROCHIR, V71, P189, DOI 10.1007/BF01401314; BLACKMORE DK, 1985, VET REC, V116, P36, DOI 10.1136/vr.116.2.36; CAREY ME, 1984, J NEUROSURG, V60, P947, DOI 10.3171/jns.1984.60.5.0947; CLEMEDSON CJ, 1973, Z RECHTSMED, V73, P103, DOI 10.1007/BF01882332; COOPER PR, 1979, NEUROSURGERY, V4, P373, DOI 10.1227/00006123-197905000-00001; DiMaio V, 1985, GUNSHOT WOUNDS PRACT; FINNIE JW, 1993, J COMP PATHOL, V108, P93, DOI 10.1016/S0021-9975(08)80231-9; KAUFMAN HH, 1986, NEUROSURGERY, V18, P689, DOI 10.1227/00006123-198606000-00002; LEE J, 1989, COMPUTED BODY TOMOGR; LONGAIR J, 1991, CAN VET J, V32, P724; PHILLIPS CD, 1992, RADIOL CLIN N AM, V30, P307; RAPPAPORT ZH, 1984, ISRAEL J MED SCI, V20, P668; TURNER AF, 1988, MANAGEMENT GUNSHOT W, P187; 1991, AUSTR CODE PRACTICE	16	3	3	0	1	NEW ZEALAND VETERINARY ASSOC INC	WELLINGTON	203-209 WILLIS ST, 6TH FLOOR, WELLINGTON, NEW ZEALAND	0048-0169			NEW ZEAL VET J	N. Z. Vet. J.	APR	1994	42	2					54	57		10.1080/00480169.1994.35786			4	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	ND872	WOS:A1994ND87200002	16031746				2022-02-06	
J	ANTONIADIS, G; RICHTER, HP				ANTONIADIS, G; RICHTER, HP			TREATMENT FOLLOWING TRAUMATIC EXTRACEREBRAL HEMORRHAGES - MANAGEMENT OF EPIDURAL SUBDURAL HEMORRHAGES AND PROGNOSIS	UNFALLCHIRURG			German	Article								Surgical therapy for intracranial extracerebral haemorrhages is one of the oldest surgical techniques. The low mortality and morbidity in recent years have come about through of the emergency service, modem neurosurgical techniques, widespread use of the CT scanner, and adequate intensive care. The treatment target in the case of head injuries is to provide the optimal milieu for recovery from the primary injury and to prevent secondary damage to the brain. Acute subdural haematomas (SDH) are the most frequent traumatic lesion. The outcome is related more to the degree of associated brain damage than to the subdural clot itself. Once the stability of vital functions has been assured to prevent intracranial hypertension, a craniotomy to remove the haematoma must follow immediately. Intracranial pressure (ICP) monitoring is mandatory after evacuation of the clot. Results of the preliminary analysis of the Traumatic Coma Data Bank (TCDB) show a 50% mortality rate after operative treatment of subdural haematomas. Chronic SDH is a different entity in terms of manifestations, time course and outcome. Twist drill evacuation of the fluid (= chronic haematoma) in local anaesthesia is now accepted as the treatment of choice. An extradural haematoma is a potentially lethal lesion with a mortality rate of 5 %. Emergency surgical intervention is appropriate before neurological signs appear.			ANTONIADIS, G (corresponding author), UNIV ULM,BEZIRKSKRANKENHAUS GUNZBURG,NEUROCHIRURG KLIN,LUDWIG HEILMEYER STR 2,D-89312 GUNZBURG,GERMANY.							0	3	3	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0177-5537			UNFALLCHIRURG	Unfallchirurg	NOV	1993	96	11					582	586					5	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	MK626	WOS:A1993MK62600005	8284679				2022-02-06	
J	GROTE, EH				GROTE, EH			EXPERT REPORT FROM A SURGEON FOLLOWING CRANIOCEREBRAL TRAUMA	UNFALLCHIRURG			German	Article								The officially appointed external expert needs a precise documentation of the initial clinical findings and the findings at follow-up of the patient with craniocerebral trauma. The next step in preparation of the expert report consists in a pathophysiological and a neurological examination, including CT scan and EEG repeated at intervals; a stable condition can be expected after 1-2 years. In the case of reversible closed head syndrome (brain concussion) the expert should certify a disability for about 6 months; a degree of 20% for over 3 months should not be certified unless there are massive vegetative signs and symptoms. Persisting damage should only be recognized if a substantial brain lesion is present. In cases of cerebral compression or open skull fracture with manifest damage to the substance of the brain the duration of unconsciousness must be taken into account. For children and young people up to 10 days' unconsciousness is not taken to imply later disability; after 10 - 20 days' unconsciousness such young people are considered fit for work or school to a qualified extent; a persistent defect must be expected to follow unconsciousness lasting over 20 days. Adults who are unconscious for up to 5 days can be expected to make a complete recovery, while a longer duration of coma and more advanced age are associated with a worse outcome. The degree of functional impairment ist thus important in the expert's decision on the level of disability. A flow chart is presented for guidance in the preparation of expert reports. A brain lesion detectable by CT scan can be present without resulting functional impairment; in this case the expert should suggest a 20% disability. The expert report should conclude with suggestions for rehabilitation direct at reducing the level of disability.			GROTE, EH (corresponding author), UNIV TUBINGEN,KLINIKUM SCHNARRENBERG,NEUROCHIRURG ABT,HOPPE SEYLER STR 3,D-72076 TUBINGEN,GERMANY.							0	3	3	0	1	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0177-5537			UNFALLCHIRURG	Unfallchirurg	NOV	1993	96	11					609	613					5	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	MK626	WOS:A1993MK62600010	8284684				2022-02-06	
J	BURTON, LA; VOLPE, B				BURTON, LA; VOLPE, B			SOCIAL-ADJUSTMENT SCALE ASSESSMENTS IN TRAUMATIC BRAIN INJURY	JOURNAL OF REHABILITATION			English	Article							DEPRESSED WOMEN; HEAD TRAUMA; SELF-REPORT; SYMPTOMS; PATIENT	The Social Adjustment Scale was used in this sample of 33 persons with traumatic brain injury at an average post-injury time of 2.6 years to (a) evaluate functioning in the categories of Work, Social and Leisure, Extended Family, Marital, Parental, and Family Unit roles, and (b) to evaluate the relationship between the report of an Informant and the Injured Person. Moderate impairment was reported by both the Informant and the Injured Person for Work, Parental, and Extended Family role functioning. Although good agreement was found between the reports of the Injured Person and the Informant for the Work, Social and Leisure, and Extended Family scales, little agreement was seen for the Parental, Family Unit, and the Marital scales. It is notable that less agreement was seen for the categories for which the Informant, usually the spouse, would have to assume greater responsibility in proportion to the Injured Person assuming less responsibility.			BURTON, LA (corresponding author), CORNELL UNIV,MED CTR,COLL MED,DEPT NEUROL,1300 YORK AVE,NEW YORK,NY 10021, USA.		volpe, b/U-8409-2019				BRAY GP, 1977, REHABIL COUNS BULL, V20, P236; BRAY GP, 1987, REHABILITATION PSYCH; BURTON LA, 1988, J NEUROLOGICAL REHAB, V2, P151; Cartlidge N E, 1981, HEAD INJURY; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; GLENN M, 1985, SEMINARS NEUROLOGY, V5, P80; GURLAND B, 1972, ARCH GEN PSYCHIAT, V27, P249; Levin HS., 1982, NEUROBEHAVIORAL CONS; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; MCKINLAY W, 1981, J NEUROL NEUROSUR PS, V41, P611; MCKINLAY WW, 1983, J NEUROL NEUROSUR PS, V46, P1084, DOI 10.1136/jnnp.46.12.1084; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; Paykel E. S., 1974, DEPRESSED WOMAN; PAYKEL ES, 1971, J NERV MENT DIS, V152, P158, DOI 10.1097/00005053-197103000-00002; ROSENTHAL M, 1984, BEHAVIORAL APPROACHE; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; WEISSMAN MM, 1978, J NERV MENT DIS, V166, P317, DOI 10.1097/00005053-197805000-00002; WEISSMAN MM, 1976, ARCH GEN PSYCHIAT, V33, P1111; WEISSMAN MY, 1971, AM J ORTHOPSYCHIAT, V41, P390, DOI 10.1111/j.1939-0025.1971.tb01126.x; WOOD F, 1984, INT J PSYCHIAT MED, V14, P277	21	3	3	0	1	NATL REHABILITATION ASSN-NRA	ALEXANDRIA	633 S WASHINGTON ST, ALEXANDRIA, VA 22314-4109	0022-4154			J REHABIL	J. Rehabil.	OCT-DEC	1993	59	4					34	37					4	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	MU146	WOS:A1993MU14600006					2022-02-06	
J	PERRY, DC; GETZ, R; LEE, IY; PANCHISON, D; OKUDA, Y; MILLER, LP				PERRY, DC; GETZ, R; LEE, IY; PANCHISON, D; OKUDA, Y; MILLER, LP			FOREBRAIN ISCHEMIA IN THE GERBIL INCREASES LAMBDA-OPIATE BINDING IN HIPPOCAMPAL MOSSY FIBERS	BRAIN RESEARCH			English	Article						CEREBRAL ISCHEMIA; LAMBDA-OPIATE RECEPTOR; HIPPOCAMPUS; MOSSY FIBER; MK-801	TRAUMATIC BRAIN INJURY; METHYL-D-ASPARTATE; SPINAL-CORD INJURY; ENDOGENOUS OPIOIDS; KAINIC ACID; CEREBRAL-ISCHEMIA; RAT HIPPOCAMPUS; NEURONAL DAMAGE; DYNORPHIN; ANTAGONIST	Transient forebrain ischemia was produced in gerbils by short-term occlusion of the common carotid arteries under halothane anesthesia. Histological analysis of brains 7 days post-ischemia demonstrated characteristic destruction of CA1 pyramidal cells. Lambda Opiate binding (measured with [H-3]naloxone in the presence of 300 nM diprenorphine) at 7 days post-ischemia was significantly increased in the stratum lucidum of the hippocampus (the mossy fiber layer), but not in any other region measured, including other hippocampal regions, cortex, amygdala, caudate putamen, thalamus, and hypothalamus. The increase in mossy fiber lambda binding was slow to develop (no increase detected up to 48 h post-ischemia), and long-lasting (binding remained elevated at 32 days post-ischemia). While MK-801 significantly inhibited CA1 pyramidal cell destruction when administered 20 min prior to ischemia, the increase in mossy fiber A binding was still evident. None of seven different opioid agonists and antagonists examined had an effect on either the pyramdal cell damage or increased mossy fiber lambda binding seen 7 days after ischemia.	VET ADM MED CTR,NEUROSCI LAB 1515,WASHINGTON,DC 20422		PERRY, DC (corresponding author), GEORGE WASHINGTON UNIV,MED CTR,DEPT PHARMACOL,2300 I ST NW,WASHINGTON,DC 20037, USA.				NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [NIDA DA 04191] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA004191] Funding Source: NIH RePORTER		ANDREWS BT, 1988, J PHARMACOL EXP THER, V247, P1248; ANIKSZTEJN L, 1987, BRAIN RES, V404, P58, DOI 10.1016/0006-8993(87)91355-2; BUCHAN A, 1990, J NEUROSCI, V10, P311; CHOI DW, 1990, J NEUROSCI, V10, P2493; CRAIN BJ, 1988, NEUROSCIENCE, V27, P387; CREPEL V, 1989, NEUROSCIENCE, V31, P605, DOI 10.1016/0306-4522(89)90426-0; FADEN AI, 1987, CLIN NEUROPHARMACOL, V10, P193, DOI 10.1097/00002826-198706000-00001; FADEN AI, 1981, ANN NEUROL, V10, P326, DOI 10.1002/ana.410100403; FADEN AI, 1988, J PHARMACOL EXP THER, V245, P742; FLAMM ES, 1982, NEUROSURGERY, V10, P227, DOI 10.1227/00006123-198202000-00009; FOSTER AC, 1988, J NEUROSCI, V8, P4745; FRIED RL, 1987, STROKE, V18, P765, DOI 10.1161/01.STR.18.4.765; GALL C, 1988, J NEUROSCI, V8, P1852; HALL ED, 1988, STROKE, V19, P1008, DOI 10.1161/01.STR.19.8.1008; HANDA N, 1985, J CEREBR BLOOD F MET, V5, P469, DOI 10.1038/jcbfm.1985.64; HAYES RL, 1983, J NEUROSURG, V58, P720, DOI 10.3171/jns.1983.58.5.0720; HAYES RL, 1990, J NEUROSURG, V72, P252, DOI 10.3171/jns.1990.72.2.0252; JARVIS MF, 1988, SYNAPSE, V2, P577, DOI 10.1002/syn.890020603; KANAMATSU T, 1986, J NEUROSCI, V6, P3094; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; MCGINTY JF, 1983, P NATL ACAD SCI-BIOL, V80, P589, DOI 10.1073/pnas.80.2.589; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; MCINTOSH TK, 1987, BRAIN RES, V425, P225, DOI 10.1016/0006-8993(87)90505-1; MILLER LP, 1989, BRAIN RES, V495, P367, DOI 10.1016/0006-8993(89)90230-8; MITCHELL CL, 1987, BRAIN RES, V435, P343, DOI 10.1016/0006-8993(87)91621-0; ONDODERA H, 1991, STROKE, V21, P771; Paxinos G, 1986, RAT BRAIN STEREOTAXI; PERRY DC, 1989, BRAIN RES, V477, P100, DOI 10.1016/0006-8993(89)91397-8; PERRY DC, 1986, EUR J PHARMACOL, V129, P147, DOI 10.1016/0014-2999(86)90346-8; PERRY DC, 1992, MOL CHEM NEUROPATHOL, V16, P95, DOI 10.1007/BF03159963; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; REPRESA A, 1987, NEUROSCIENCE, V20, P739, DOI 10.1016/0306-4522(87)90237-5; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; TANG AH, 1985, LIFE SCI, V37, P1475, DOI 10.1016/0024-3205(85)90178-X; TAUCK DL, 1985, J NEUROSCI, V5, P1016; WESTERBERG E, 1989, J NEUROSCI, V9, P798; WOODSON W, 1989, J COMP NEUROL, V280, P254, DOI 10.1002/cne.902800207	38	3	3	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JUL 23	1993	617	2					296	302		10.1016/0006-8993(93)91097-C			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LM852	WOS:A1993LM85200014	8402157				2022-02-06	
J	EVANS, RL; DINGUS, CM; HASELKORN, JK				EVANS, RL; DINGUS, CM; HASELKORN, JK			LIVING WITH A DISABILITY - A SYNTHESIS AND CRITIQUE OF THE LITERATURE ON QUALITY-OF-LIFE, 1985-1989	PSYCHOLOGICAL REPORTS			English	Article							ARTERY BYPASS-SURGERY; CLOSED-HEAD-INJURY; OF-LIFE; CANCER-PATIENTS; CARDIAC TRANSPLANTATION; MYOCARDIAL-INFARCTION; CLINICAL-TRIALS; INTENSIVE-CARE; THERAPY; ARTHRITIS	The current study describes articles cross-indexed under the keywords ''quality of life'' and ''disability'' in Index Medicus for the years 1985 through 1989 to compare their relative merits in terms of research design, sampling details, and the type of quality of life criteria included. Of 833 articles indexed under ''quality of life,'' 52 (16%) included data about a a disabling condition requiring rehabilitation. Of those 52, only seven (13%) were randomized clinical trials. The modal design was a descriptive survey or case study (N = 22 or 42%). Given the limited rigor in research design and invalid measurements, conclusions about improvement in the quality of life for disabled individuals after rehabilitative care could not be drawn from the studies reviewed. It may be concluded that research on quality of life needs to be better designed and should include more uniform and valid criteria.	UNIV WASHINGTON,DEPT VET AFFAIRS MED CTR,SEATTLE,WA 98195								BAIRD AD, 1988, J CONSULT CLIN PSYCH, V56, P148; BERDEL WE, 1988, ANTICANCER RES, V8, P313; BLAKE DJ, 1987, J RHEUMATOL, V14, P570; BRENNAN AF, 1987, PSYCHOSOMATICS, V28, P566, DOI 10.1016/S0033-3182(87)72454-2; BURCKHARDT CS, 1985, NURS RES, V34, P11; CAMPBELL DT, 1966, EXPT QUASI-EXPT DESI; CORNELISSEN PGJ, 1988, ANN RHEUM DIS, V47, P150, DOI 10.1136/ard.47.2.150; D'Ambrosio R, 1987, Int Disabil Stud, V9, P10; DEJONG R, 1989, CLIN THER, V11, P545; Eriksson H, 1988, Scand J Prim Health Care, V6, P161, DOI 10.3109/02813438809009310; FEENY DH, 1989, MED CARE, V27, pS190, DOI 10.1097/00005650-198903001-00016; FEINSTEIN AR, 1989, AM J CARDIOL, V64, P50, DOI 10.1016/0002-9149(89)90652-8; FINKELSTEIN DM, 1988, AM J CLIN ONCOL-CANC, V11, P630, DOI 10.1097/00000421-198812000-00007; FLYNN MK, 1987, HEART LUNG, V16, P159; FOLKS DG, 1986, SOUTHERN MED J, V79, P397, DOI 10.1097/00007611-198604000-00002; GANZ PA, 1988, CANCER, V61, P849, DOI 10.1002/1097-0142(19880215)61:4<849::AID-CNCR2820610435>3.0.CO;2-B; GLIMELIUS B, 1989, EUR J CANCER CLIN ON, V25, P829, DOI 10.1016/0277-5379(89)90128-4; HAVILL JH, 1989, NEW ZEAL MED J, V102, P179; HEINEMANN AW, 1987, ARCH NEUROL-CHICAGO, V44, P1167, DOI 10.1001/archneur.1987.00520230051013; HERNDON DN, 1986, J TRAUMA, V26, P609, DOI 10.1097/00005373-198607000-00004; HOLLANDSWORTH J, 1988, SOC SCI MED, V26, P434; HUBER D, 1988, PHARMACOPSYCHIATRY, V21, P453, DOI 10.1055/s-2007-1017050; JACOBS CJ, 1988, INTENS CARE MED, V14, P217, DOI 10.1007/BF00717992; JONES BM, 1988, MED J AUSTRALIA, V149, P118, DOI 10.5694/j.1326-5377.1988.tb120532.x; KAASA S, 1988, ACTA ONCOL, V27, P335, DOI 10.3109/02841868809093551; Kendall J, 1989, Arch Psychiatr Nurs, V3, P159; KIBELE A, 1989, AM J OCCUP THER, V43, P371, DOI 10.5014/ajot.43.6.371; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; LABORDE JM, 1985, RES NURS HEALTH, V8, P183, DOI 10.1002/nur.4770080212; LOMAS J, 1987, MED CARE, V25, P764, DOI 10.1097/00005650-198708000-00009; LOUGH ME, 1987, HEART LUNG, V16, P193; MORRIS HN, 1987, J CHORNIC DISEASE, V60, P545; MORRIS JN, 1986, J CHRON DIS, V39, P47, DOI 10.1016/0021-9681(86)90106-2; NAJMAN JM, 1981, SOC SCI MED F-MED S, V15, P107, DOI 10.1016/0271-5392(81)90012-5; NIEMI ML, 1988, STROKE, V19, P1101, DOI 10.1161/01.STR.19.9.1101; NWUGA VCB, 1985, J TROP MED HYG, V88, P287; OBRIEN BJ, 1988, J EPIDEMIOL COMMUN H, V42, P232, DOI 10.1136/jech.42.3.232; OBRIEN BJ, 1987, J CHRON DIS, V40, pS137, DOI 10.1016/S0021-9681(87)80043-7; OLSSON G, 1986, BRIT MED J, V292, P1491, DOI 10.1136/bmj.292.6534.1491; ORENSTEIN DM, 1989, CHEST, V95, P344, DOI 10.1378/chest.95.2.344; OSBERG JS, 1987, J GERONTOL, V42, P228, DOI 10.1093/geronj/42.2.228; PEARLMAN RA, 1988, J GERONTOL, V43, P35; PEDUZZI P, 1987, AM J CARDIOL, V59, P1017, DOI 10.1016/0002-9149(87)90841-1; RAMUND B, 1988, SCAND J PSYCHOL, V29, P137, DOI 10.1111/j.1467-9450.1988.tb00783.x; ROHRER MJ, 1988, ARCH SURG-CHICAGO, V123, P1213; SIEGRIST J, 1987, J CHRON DIS, V40, P571, DOI 10.1016/0021-9681(87)90016-6; STENSMAN R, 1985, SCAND J REHABIL MED, V17, P87; STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907; TROJANOWSKI T, 1989, J NEUROSURG, V70, P18, DOI 10.3171/jns.1989.70.1.0018; WALDEN JA, 1989, HEART LUNG, V18, P497; WIKLUND I, 1989, EUR HEART J, V10, P464, DOI 10.1093/oxfordjournals.eurheartj.a059511; WORTMAN PM, 1985, CONTROL CLIN TRIALS, V6, P289, DOI 10.1016/0197-2456(85)90105-9; ZAREN B, 1987, CRIT CARE MED, V15, P743, DOI 10.1097/00003246-198708000-00006; Zyzanski S J, 1989, Fam Med, V21, P199	55	3	3	0	2	PSYCHOLOGICAL REPORTS	MISSOULA	P O BOX 9229, MISSOULA, MT 59807	0033-2941			PSYCHOL REP	Psychol. Rep.	JUN	1993	72	3	1				771	777		10.2466/pr0.1993.72.3.771			7	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	LE391	WOS:A1993LE39100011	8332680				2022-02-06	
J	GUNZENHAUSSER, E; MANN, W				GUNZENHAUSSER, E; MANN, W			UNUSUAL DEVELOPMENT OF TEMPORAL BONE-FRACTURES WITH LIQUORRHEA	LARYNGO-RHINO-OTOLOGIE			German	Article						TEMPORAL BONE FRACTURES; OTO-RHINO-LIQUORRHEA; BRAIN HERNIATION		In the literature the persistence of cerebrospinal Liquorrhea after temporal bone fractures is a rare event. Between 1989 and 1992 four cases of temporal bone fractures with dural involvement were operated at the University ENT Department Mainz. These temporal bone fractures showed delayed or persistent symptoms of dural lacerations between three and sixty months after head injury. During operation we found larger bone-dura defects (1-1.5 cm in diameter) and brain herniations in all cases. Strohm stated that only in rare cases a temporal bone fracture produced a larger gap in the tegmen tympani or antri. Therefore, we assumed that in our cases such larger bone-dura defects were caused by a gradual widening of the bony gap by a local elevation of intracranial pressure. Ferguson described this phenomenon in cases with spontaneous cerebrospinal Liquorrhea. Our cases showed that the cessation of cerebrospinal Liquorrhea is not a reliable sign of a healed dura defect. Therefore we propose that temporal bone fractures should be controlled closely in the first twelve months after trauma even if the dura defect seems to close spontaneously.	JOHANNES GUTENBERG UNIV MAINZ,HALS NASEN OHRENKLIN,MAINZ,GERMANY									0	3	3	0	0	GEORG THIEME VERLAG	STUTTGART	P O BOX 30 11 20, D-70451 STUTTGART, GERMANY	0935-8943			LARYNGO RHINO OTOL	Laryngo-Rhino-Otol.	JUN	1993	72	6					284	287		10.1055/s-2007-997901			4	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	LH927	WOS:A1993LH92700003	8333882				2022-02-06	
J	ZUGER, RR; BOEHM, M				ZUGER, RR; BOEHM, M			VOCATIONAL-REHABILITATION COUNSELING OF TRAUMATIC BRAIN INJURY - FACTORS CONTRIBUTING TO STRESS	JOURNAL OF REHABILITATION			English	Article								The vocational rehabilitation of persons with traumatic brain injury can be an arduous and stressful process, likely to place counselors and patients in oppositional roles. Persons with traumatic brain injury persist, often unsuccessfully, in resuming pre-injury vocational objectives, while counselors frequently persist in redirecting patients away from their pursuits, perceived by counselors as unrealistic. The persistence by patients and counselors to pursue their respective and discrepant objectives can place the vocational rehabilitation process at an impasse, exposing counselors to undue stress and exacerbating patient dissatisfaction. Counselors need to identify the stressors contributed by both themselves as well as their patients, and reassess their approach in order to reduce the stress they experience and allow the process to advance.			ZUGER, RR (corresponding author), MT SINAI MED CTR,5E 98TH ST,BOX 1240,NEW YORK,NY 10029, USA.						Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; Burke W H, 1988, Brain Inj, V2, P313, DOI 10.3109/02699058809150902; GOBBLE EM, 1987, COMMUNITY REENTRY HE; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JELLINEK H, 1988, ARCH PHYSICAL MED RE, V63, P160; PECK E, 1984, ANN M INT NEUROPSYCH; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; WACHTER JF, 1987, COMMUNITY REENTRY HE; WEHMAN P, 1989, ARCH PHYS MED REHAB, V70, P109; Wehman P., 1989, J HEAD TRAUMA REHAB, V4, P66, DOI [10.1097/00001199-198909000-00010, DOI 10.1097/00001199-198909000-00010]; Zasler N D, 1989, Brain Inj, V3, P331, DOI 10.3109/02699058909004557	13	3	3	0	1	NATL REHABILITATION ASSN-NRA	ALEXANDRIA	633 S WASHINGTON ST, ALEXANDRIA, VA 22314-4109	0022-4154			J REHABIL	J. Rehabil.	APR-JUN	1993	59	2					28	30					3	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	LN427	WOS:A1993LN42700008					2022-02-06	
J	CHEVALLIER, B; RENAUD, C; PARAT, S; BARRE, O; KHECHAREM, M; LACOMBE, P; LAGARDERE, B				CHEVALLIER, B; RENAUD, C; PARAT, S; BARRE, O; KHECHAREM, M; LACOMBE, P; LAGARDERE, B			NEUROLOGICAL SIGNS AS 1ST INDICATIONS OF A POSTTRAUMATIC ANEURYSM OF THE SUBCLAVIAN ARTERY	ARCHIVES FRANCAISES DE PEDIATRIE			French	Article						ANEURYSM; SUBCLAVIAN ARTERY; WOUNDS AND INJURIES; CHILD; ADOLESCENT	CHILD; RIB	Background. Aneurysms of the subclavian artery are rare in childhood and may be due to traumatic, infectious or congenital causes. Case report. A 15 year-old boy presented with a sudden left visual disturbance plus decreased muscle strength and paresthesias of the left arm; these manifestations disappeared within 15 minutes. His neurological examination on admission was normal. The right arm radial pulse was weak and the blood pressures of the right and left arms were significantly different. Doppler showed a right subclavian artery aneurysm containing several clots, that was confirmed by angiography. There were no signs of inflammation or indication of autoimmune disease. This aneurysm might have been caused by trauma as the patient had had a violent cervical traumatism after a diving accident 2 years earlier. The aneurysm was surgically removed and the right vertebral artery arising from it was reimplanted. Histological examination of the aneurysm gave no evidence of etiology. The post-surgical MRI showed no brain abnormaly. Conclusions. This aneurysm is probably of post-traumatic origin. The cerebral disturbance could be due to embolism or transient ischemia; the latter is more compatible with the normal NMR.	HOP AMBROISE PARE,SERV RADIOL,F-92100 BOULOGNE,FRANCE		CHEVALLIER, B (corresponding author), HOP AMBROISE PARE,SERV PEDIAT,9 AV GL DE GAULLE,F-92100 BOULOGNE,FRANCE.						AKASAKA T, 1989, J CARDIOVASC SURG, V30, P945; ALLEN DB, 1986, J PEDIATR-US, V109, P302, DOI 10.1016/S0022-3476(86)80001-4; BRZOWSKI BK, 1990, J TRAUMA, V30, P616, DOI 10.1097/00005373-199005000-00016; ECHAVE V, 1981, CAN J SURG, V24, P651; ENGEL A, 1989, CARDIOVASC INTER RAD, V12, P92, DOI 10.1007/BF02577396; FEE H, 1983, AM J DIS CHILD, V137, P1101, DOI 10.1001/archpedi.1983.02140370061020; KIEFFER E, 1979, J CHIR-PARIS, V116, P333; MCCREADY RA, 1982, ARCH SURG-CHICAGO, V117, P1243; MCCULLUM CH, 1979, J CARDIOVASC SURG, V20, P159; PERSAUD V, 1968, BRIT HEART J, V30, P436; Salo J A, 1990, Eur J Vasc Surg, V4, P271, DOI 10.1016/S0950-821X(05)80206-3; VAKSMANN G, 1987, EUR J PEDIATR, V146, P209, DOI 10.1007/BF02343239; VERNANT P, 1986, ENCY MED CHIR PARIS; Wolff F, 1991, Rev Prat, V41, P1759	14	3	3	0	0	EDITIONS TECHNIQUES	PARIS	18 RUE SEGUIER, 75006 PARIS, FRANCE	0003-9764			ARCH FR PEDIATR		MAR	1993	50	3					235	238					4	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	KT573	WOS:A1993KT57300012	8338419				2022-02-06	
J	WHITE, BD; FIRTH, JL; ROWLES, JM				WHITE, BD; FIRTH, JL; ROWLES, JM			THE EFFECTS OF BRACE POSITION ON INJURIES SUSTAINED IN THE M1 BOEING-737/400 DISASTER, JANUARY 1989	AVIATION SPACE AND ENVIRONMENTAL MEDICINE			English	Article								Of the initial 87 survivors of the East Midlands Boeing 737/400 aircraft, 77 sustained head and facial trauma during the crash, 45 of whom were rendered unconscious. There were 21 who received injuries to the back of their head, including 5 of the 6 severely head-injured adults. Those passengers who adopted the fully flexed ''brace'' position for crash-landing achieved significant protection against head injury, concussion, and injuries from behind irrespective of local aircraft structural damage. A computer graphics simulation developed by a commercial firm (H. W. Structures, Ltd.) using the predicted crash pulse of the accident has validated these clinical findings and allows theoretical biomechanical modeling for the design of occupant protection systems in the future. Although the major role of structural failure should not be forgotten, bracing maximizes the chance of uninjured survival in the current generation of aircraft and should be demonstrated and practiced as a pre-flight routine.	UNIV NOTTINGHAM HOSP,QUEENS MED CTR,DEPT ORTHOPED,NOTTINGHAM NG7 2UH,ENGLAND		WHITE, BD (corresponding author), UNIV NOTTINGHAM HOSP,QUEENS MED CTR,DEPT NEUROSURG,NOTTINGHAM NG7 2UH,ENGLAND.						BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; FRYER DI, 1965, GILLIES TXB AVIATION, P1166; HASBROOK AH, 1957, J AVIAT MED, V28, P5141; HAWKES R, 1956, AVIATION WEEK, V65, P61; MASON JK, 1962, AVIATION ACCIDENT PA, P106; MASON JK, 1973, BR J HOSP MED    MAY, P645; MOSELEY H G, 1958, J Aviat Med, V29, P739; MUIR HC, 1989, AEROSPACE        APR, P18; STAPP JP, 1953, AERONAUT ENG REV, V12, P71; STEPHENS PJ, 1970, FATAL CIVIL AIRCRAFT, P52; SWEARINGEN RR, 1962, AEROSPACE MED, V33, P188; WHITE B D, 1990, British Journal of Neurosurgery, V4, P503, DOI 10.3109/02688699008993800; WHITE BD, 1993, AVIAT SPACE ENVIR MD, V64, P95; 1989, FED REG, V54; 1985, ABBREVIATED INJURY S; 1990, CAA90012 CIV AV AUTH	16	3	3	0	0	AEROSPACE MEDICAL ASSOC	ALEXANDRIA	320 S HENRY ST, ALEXANDRIA, VA 22314-3579	0095-6562			AVIAT SPACE ENVIR MD	Aviat. Space Environ. Med.	FEB	1993	64	2					103	109					7	Public, Environmental & Occupational Health; Medicine, General & Internal; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; General & Internal Medicine; Sport Sciences	KJ341	WOS:A1993KJ34100002	8431182				2022-02-06	
J	JOHNSON, D; ROETHIGJOHNSTON, K; RICHARDS, D				JOHNSON, D; ROETHIGJOHNSTON, K; RICHARDS, D			BIOCHEMICAL PARAMETERS OF RECOVERY IN ACUTE SEVERE HEAD-INJURY	BRITISH JOURNAL OF NEUROSURGERY			English	Article						ADULTS; BIOCHEMISTRY; HEAD INJURY; RECOVERY	TRAUMATIC BRAIN INJURY; CATECHOLAMINES; DAMAGE	Levels of urinary catecholamines (noradrenaline, adrenaline, dopamine), plasma acetylcholinesterase, serum serotonin and plasma 3-methoxy-4-hydroxyphenylglycol were recorded in 38 adult subjects during the first 21 days after severe head injury. Levels of acetylcholinesterase, serotonin and 3-methoxy-4-hydroxyphenylglycol differed significantly between survivors and those who died. For survivors, initially abnormal biochemical levels recovered toward the norm as time after injury progressed.	ATKINSON MORLEYS HOSP,DEPT PSYCHOL,LONDON SW20,ENGLAND; ROYAL SUSSEX CTY HOSP,DEPT CLIN BIOCHEM,BRIGHTON BN2 5BE,E SUSSEX,ENGLAND								CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; DICKERSON JWT, 1989, CHILDRENS HEAD INJUR; Dietz M A, 1991, J Stroke Cerebrovasc Dis, V1, P37, DOI 10.1016/S1052-3057(11)80018-2; HAIDER W, 1975, EUR J INTEN CARE MED, V1, P115, DOI 10.1007/BF00571658; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; HILLERED L, 1991, MONITORING MOL NEURO; IKEDA Y, 1984, J NIPPON MED SCH, V51, P105; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; MACCARIO M, 1972, NEUROLOGY, V22, P781, DOI 10.1212/WNL.22.8.781; MILLER BL, 1984, PRIMARY CARE, V11, P693; MINDERHOUD JM, 1976, ACTA NEUROCHIR, V32, P23; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PEERLESS SJ, 1975, SUBARACHNOID HAEMORR; Plum F., 1982, DIAGNOSIS STUPOR COM, V3rd; RATGE D, 1982, ACTA ENDOCRINOL-COP, V101, P428, DOI 10.1530/acta.0.1010428; ROSE FD, 1992, MECHANISMS RECOVERY; Rosner M., 1987, CEREBRAL BLOOD FLOW, P425; TEASDALE G, 1974, LANCET, V2, P81; VANWOERKOM TCA, 1982, EUR NEUROL, V21, P221; VANWOERKOM TCAM, 1977, LANCET, V1, P812; VANWOERKOM TCAM, 1984, CLIN NEUROL NEUROSUR, V86, P21, DOI 10.1016/0303-8467(84)90274-9; VECHT CJ, 1975, LIFE SCI, V16, P1179, DOI 10.1016/0024-3205(75)90201-5; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; YATES CM, 1979, J NEUROL NEUROSUR PS, V42, P887, DOI 10.1136/jnnp.42.10.887	25	3	3	0	0	CARFAX PUBL CO	ABINGDON	PO BOX 25, ABINGDON, OXFORDSHIRE, ENGLAND OX14 3UE	0268-8697			BRIT J NEUROSURG	Br. J. Neurosurg.		1993	7	1					53	59		10.3109/02688699308995056			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KM136	WOS:A1993KM13600008	8094621				2022-02-06	
J	OPESKIN, K; LEE, KAP				OPESKIN, K; LEE, KAP			DEATH BY GREYHOUND	FORENSIC SCIENCE INTERNATIONAL			English	Article						INJURIES; WOUNDS; BLUNT; NONPENETRATING; DOG		We present the ease of a man who was last seen leaving to feed his greyhound dogs. He was found dead lying in a yard just outside the gate to one of the dog pens. Holes were present in the fence on both sides of the gate. The holes were of sufficient size to allow the passage of the head and neck of a greyhound to the shoulders. To open the gate one had to bend down to unfasten a latch 45 cm above ground level. Leaning down to unfasten the latch brought one into close proximity to the holes on either side of the gate. The scene and clothing appeared undisturbed. Autopsy (K.A.L.) revealed the cause of death to be blunt throat trauma. The throat trauma was of marked degree and consistent with at least a single heavy crushing injury directed from the front and somewhat below. In addition there were a series of almost vertical light abrasions on one side of the neck. There were minimal injuries to the rest of the body. There were no injuries specific for assault. In an attempt to explain the almost vertical abrasions on the side of the neck, the scene was re-examined by the pathologist. This revealed loose wire strands on the gate post. It is consistent that a fall against this area could account for the almost vertical abrasions on one side of the neck. We concluded that the overall pattern of injuries was compatible with an impact to the throat by the head of a greyhound in association with a separate lighter impact to the fence post area. At the inquest a veterinary surgeon gave evidence that he had witnessed a number of injuries caused by the sudden forceful extension of a greyhound's head. These injuries included lacerated lips, damage to the teeth, jaw and nose as well as broken and dislocated fingers. He had spoken to a dog trainer who had been knocked unconscious by a blow to the jaw inflicted by the head of a greyhound whilst feeding or handling. A dog trainer gave evidence that he had witnessed a person who whilst leaning over had his nose broken by a blow caused by the greyhound suddenly rearing. We are unaware of any previously reported case of this type.	ROYAL DARWIN HOSP,CASUARINA,NT 0811,AUSTRALIA		OPESKIN, K (corresponding author), VICTORIAN INST FORENS PATHOL,57-83 KAVANAGH ST,S MELBOURNE 3205,AUSTRALIA.						ROTHROCK S G, 1990, Pediatric Emergency Care, V6, P293, DOI 10.1097/00006565-199012000-00011	1	3	3	0	4	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0379-0738			FORENSIC SCI INT	Forensic Sci.Int.	SEP	1992	56	1					51	57		10.1016/0379-0738(92)90146-N			7	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	JU612	WOS:A1992JU61200007	1398377				2022-02-06	
J	MEYTHALER, JM; TUEL, SM; CROSS, LL				MEYTHALER, JM; TUEL, SM; CROSS, LL			SPINAL-CORD SEIZURES - A POSSIBLE CAUSE OF ISOLATED MYOCLONIC ACTIVITY IN TRAUMATIC SPINAL-CORD INJURY - CASE-REPORT	PARAPLEGIA			English	Article						SPINAL CORD INJURY; SEIZURES; MYOCLONUS; BENZODIAZEPINES; AUTONOMIC DYSREFLEXIA; SPASTICITY		Spinal cord seizures are infrequently reported. They have been associated with intravenous dye placement, transverse myelitis and multiple sclerosis, but never with traumatic spinal cord injury (SCI). We report the case of a 48-year-old SCI male with complete C6 quadriplegia, and apparent spinal cord seizures. These seizures were characterised by myoclonus simplex activity involving the upper extremities only. The lower extremities were spared. The patient was conscious throughout the myoclonic activity and an electroencephalogram of the brain obtained during an event revealed no cortical epiliptiform activity. The seizures lasted approximately 30 seconds to a few minutes, and an acute increase in blood pressure and a decrease in pulse generally occurred 30 to 60 seconds prior to the event. Previously reported spinal cord seizures in multiple sclerosis were frequently treated with carbamazepine. In this case successful treatment was with diazepam. Spinal cord seizures may present in those with traumatic SCI. Benzodiazepines may be useful in the treatment of spinal cord seizures.			MEYTHALER, JM (corresponding author), UNIV VIRGINIA,HLTH SCI CTR,VIRGINIA SPINAL CORD INJURY SYST,CHARLOTTESVILLE,VA 22908, USA.							0	3	3	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0031-1758			PARAPLEGIA	Paraplegia	OCT	1991	29	8					557	560		10.1038/sc.1991.81			4	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	GN223	WOS:A1991GN22300009	1775364	Bronze			2022-02-06	
J	SALCIDO, R; COSTICH, JF; CONDER, R; OSHANICK, GJ				SALCIDO, R; COSTICH, JF; CONDER, R; OSHANICK, GJ			RECURRENT SEVERE TRAUMATIC BRAIN INJURY - SERIES OF 6 CASES	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						BRAIN INJURY; TRAUMA; RECURRENCE; RISK FACTORS	HEAD-INJURY; DAMAGE	Six of 141 persons treated for severe traumatic brain injury at the Medical College of Virginia were found to have a history of similar previous injury. These cases are presented in the context of the phenomenon of recurrent severe traumatic brain injury, which has received no systematic attention in epidemiologic studies of trauma.	UNIV KENTUCKY,MED CTR,DEPT REHABIL MED,LEXINGTON,KY 40506; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,RICHMOND,VA 23298; CAROLINA NEUROPSYCHOL SERV,RALEIGH,NC								ADAMS CWM, 1989, J NEUROL NEUROSUR PS, V52, P600, DOI 10.1136/jnnp.52.5.600; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; BABICHENKO E I, 1971, Voprosy Neirokhirurgii, V35, P35; BECKER DP, 1982, NEUROLOGICAL SURGERY, V4; BRAKE JF, 1989, THESIS; BRISMAR B, 1983, ACTA CHIR SCAND, V149, P11; BRUNO LA, 1987, CLIN SPORT MED, V6, P17; CARLSSON GS, 1987, J NEUROSURG, V67, P197, DOI 10.3171/jns.1987.67.2.0197; ENZENAUER RW, 1989, JAMA-J AM MED ASSOC, V261, P1463, DOI 10.1001/jama.261.10.1463; FOSTER JB, 1976, LANCET, P981; GRONWALL D, 1975, LANCET          1122, P995; HAAS JF, 1987, J NEUROL NEUROSUR PS, V50, P52, DOI 10.1136/jnnp.50.1.52; HILLBOM M, 1986, J NEUROL NEUROSUR PS, V49, P1348, DOI 10.1136/jnnp.49.12.1348; JAGGER J, 1984, J TRAUMA, V24, P40, DOI 10.1097/00005373-198401000-00006; KLONOFF H, 1971, AM J PUBLIC HEALTH N, V61, P2405, DOI 10.2105/AJPH.61.12.2405; Levin HS., 1982, NEUROBEHAVIORAL CONS; Muller E, 1967, Monatsschr Unfallheilkd Versicher Versorg Verkehrsmed, V70, P422; NATH FP, 1986, INJURY, V17, P150, DOI 10.1016/0020-1383(86)90320-7; PATEL AR, 1977, LANCET, V1, P1969; PEDACHENKO EG, 1989, VRACHEBNOE DELO, V2, P82; Rinder L, 1972, Scand J Rehabil Med, V4, P97; SORTLAND O, 1989, NEURORADIOLOGY, V31, P44; WEITBRECHT WU, 1976, ARCH PSYCHIAT NERVEN, V223, P59, DOI 10.1007/BF00367453	23	3	3	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	AUG	1991	70	4					215	219		10.1097/00002060-199108000-00011			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	GB568	WOS:A1991GB56800011	1878182				2022-02-06	
J	NADEAU, SE				NADEAU, SE			MULTIINFARCT DEMENTIA, SUBCORTICAL DEMENTIA, AND HYDROCEPHALUS	SOUTHERN MEDICAL JOURNAL			English	Article; Proceedings Paper	INAUGURAL MEETING OF THE SOUTHERN ASSOC FOR GERIATRIC MEDICINE / 84TH ANNUAL SCIENTIFIC ASSEMBLY OF THE SOUTHERN MEDICAL ASSOC	OCT   13, 1990	NASHVILLE, TN	SO ASSOC GERIATR MED, GLAXO, GERIATR DEV GRP, SO MED ASSOC			NORMAL-PRESSURE HYDROCEPHALUS; DIFFUSE AXONAL INJURY; ALZHEIMERS-DISEASE; HEAD-INJURY; NEURONS; DEGENERATION; DEFICITS; LESIONS; COMPLEX; ATROPHY	The diagnostic evaluation of dementia is directed toward the identification of treatable causes. It can be facilitated by classification of the dementia into one of four categories: attentional, amnestic, cognitive, and intentional. Intentional dementia reflects dysfunction of frontal lobe systems, components of which include the frontal cortex, basal ganglia, thalamus, limbic structures, and subcortical white matter. Disorders that affect one or more of these components and produce intentional dementia include Binswanger's disease, Parkinson's disease, Huntington's disease, HIV infection, closed head injury, normal pressure hydrocephalus, neoplasms, syphilis, vitamin B12 deficiency, multiple sclerosis, and a number of uncommon degenerative and acquired syndromes. Depression may resemble intentional dementia. Guidelines for diagnosis and management are discussed.	UNIV FLORIDA,COLL MED,DEPT NEUROL,GAINESVILLE,FL 32611		NADEAU, SE (corresponding author), VET AFFAIRS MED CTR,GERIATR RES EDUC & CLIN CTR 182,GAINESVILLE,FL 32608, USA.						ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALBERT ML, 1974, J NEUROL NEUROSUR PS, V37, P121, DOI 10.1136/jnnp.37.2.121; BABIKIAN V, 1987, STROKE, V18, P2, DOI 10.1161/01.STR.18.1.2; BECK JC, 1982, ANN INTERN MED, V97, P231, DOI 10.7326/0003-4819-97-2-231; Benson D.F., 1986, FRONTAL LOBES; Benton A., 1976, MULTILINGUAL APHASIA; BRIERLY JB, 1984, GREENFIELDS NEUROPAT, P124; BRUN A, 1976, ARCH PSYCHIAT NERVEN, V223, P15, DOI 10.1007/BF00367450; CLARFIELD AM, 1988, ANN INTERN MED, V109, P476, DOI 10.7326/0003-4819-109-6-476; CUDKOWICZ M, 1990, ANN NEUROL, V27, P200, DOI 10.1002/ana.410270217; Cummings J. L., 1983, DEMENTIA CLIN APPROA; DEFILLIPIS NA, 1979, BOOKLET CATEGORY TES; DELAMONTE SM, 1988, ARCH NEUROL-CHICAGO, V45, P990, DOI 10.1001/archneur.1988.00520330076013; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Folstein SE, 1990, SUBCORTICAL DEMENTIA, P87; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GINSBERG MD, 1976, ARCH NEUROL-CHICAGO, V33, P5, DOI 10.1001/archneur.1976.00500010007002; GOLDBERG ME, 1987, NEUROPSYCHOLOGIA, V25, P107, DOI 10.1016/0028-3932(87)90047-9; GRAFFRADFORD NR, 1986, ARCH NEUROL-CHICAGO, V43, P940, DOI 10.1001/archneur.1986.00520090068020; GUITTON D, 1985, EXP BRAIN RES, V58, P455; HANSEN L, 1990, NEUROLOGY, V40, P1; HARPER C, 1987, BRIT MED J, V294, P534, DOI 10.1136/bmj.294.6571.534; Hecaen H., 1978, HUMAN NEUROPSYCHOLOG; HEILMAN KM, 1979, COMMON NEUROLOGIC DI; HIER DB, 1990, SUBCORTICAL DEMENTIA, P199; HUBER SJ, 1990, SUBCORTICAL DEMENTIA, P71; Katzman R, 1983, NEUROLOGY AGING, P15; KING DA, 1990, SUBCORTICAL DEMENTIA, P218; KISH SJ, 1988, ANN NEUROL, V24, P200, DOI 10.1002/ana.410240205; KNOX DL, 1976, MEDICINE, V55, P467, DOI 10.1097/00005792-197611000-00003; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; LHERMITTE F, 1983, BRAIN, V106, P237, DOI 10.1093/brain/106.2.237; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2d; McDaniel KD, 1990, SUBCORTICAL DEMENTIA, P132; Milner B., 1964, FRONTAL GRANULAR COR, P313; MOUNTCASTLE VB, 1981, J NEUROSCI, V1, P1218; NADEAU SE, 1988, ANN NEUROL, V24, P270, DOI 10.1002/ana.410240216; NADEAU SE, 1987, J NEUROL, V234, P14, DOI 10.1007/BF00314002; NADEAU SE, 1990, CLIN NEUROLOGY, pCH59; NAVIA BA, 1990, SUBCORTICAL DEMENTIA, P181; NEARY D, 1988, J NEUROL NEUROSUR PS, V51, P353, DOI 10.1136/jnnp.51.3.353; PORTEGIES P, 1989, BRIT MED J, V299, P819, DOI 10.1136/bmj.299.6703.819; RAO SM, 1990, SUBCORTICAL DEMENTIA, P164; REBEIZ JJ, 1968, ARCH NEUROL-CHICAGO, V18, P20, DOI 10.1001/archneur.1968.00470310034003; ROMAN GC, 1987, JAMA-J AM MED ASSOC, V258, P1782, DOI 10.1001/jama.258.13.1782; ROSEBUSH P, 1989, AM J PSYCHIAT, V146, P717; RUSSELL EW, 1975, J CONSULT CLIN PSYCH, V43, P800, DOI 10.1037/0022-006X.43.6.800; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; STUSS DT, 1990, SUBCORTICAL DEMENTIA, P145; THOMSEN AM, 1986, ANN NEUROL, V20, P304, DOI 10.1002/ana.410200306; VANGORP WG, 1990, SUBCORTICAL DEMENTIA, P231; VANPUTTEN T, 1987, J CLIN PSYCHIAT, V48, P13; VOLPE BT, 1990, ARCH NEUROL-CHICAGO, V47, P220, DOI 10.1001/archneur.1990.00530020128026; WATSON RT, 1986, ARCH NEUROL-CHICAGO, V43, P787, DOI 10.1001/archneur.1986.00520080035016; Wechsler, 1997, WECHSLER ADULT INTEL; WOLFSON LI, 1983, NEUROLOGY AGING, P221; WRAGG RE, 1988, PSYCHIAT CLIN N AM, V11, P195; YARCHOAN R, 1987, LANCET, V1, P132, DOI 10.1016/S0140-6736(87)91968-4; [No title captured]; 1983, NEW ENGL J MED, V308, P1406; [No title captured]; [No title captured]	63	3	3	0	0	SOUTHERN MEDICAL ASSN	BIRMINGHAM	35 LAKESHORE DR PO BOX 190088, BIRMINGHAM, AL 35219	0038-4348			SOUTHERN MED J	South.Med.J.	MAY	1991	84	5					S41	S52					12	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FM494	WOS:A1991FM49400051	2035108				2022-02-06	
J	COBBLE, ND; BONTKE, CF; BRANDSTATER, ME; HORN, LJ				COBBLE, ND; BONTKE, CF; BRANDSTATER, ME; HORN, LJ			REHABILITATION IN BRAIN DISORDERS .3. INTERVENTION STRATEGIES	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						TRAUMATIC BRAIN INJURY; BRAIN DISEASES; REHABILITATION	INTRATHECAL BACLOFEN INFUSION	This self-directed learning module highlights advances in the principles of management of brain disorders. It is part of the chapter on rehabilitation in brain disorders for the Self-Directed Medical Knowledge Program Study Guide for practitioners and trainees in physical medicine and rehabilitation. The chapter is composed of four articles, and each builds on principles established in the others. This article covers rehabilitation philosophy, management of cognitive remediation, and behavioral management, with attention to communication disorders, social factors, vocational/educational/avocational issues, treatment of motor deficits, dysphagia, sensory dysfunction sexual dysfunction, and substance abuse. Advances that are covered in this section include pharmacologic and rehabilitative interventions for acute, chronic, and progressive brain injuries and diseases. The learner is directed to articles 1, 2, and 4 in this chapter for supporting information.	BAYLOR UNIV,HOUSTON,TX 77030; LOMA LINDA UNIV,MED CTR,LOMA LINDA,CA 92354; MAGEE MEM REHABILITAT CTR,PHILADELPHIA,PA 19102		COBBLE, ND (corresponding author), ROCKY MT MULTIPLE SCLEROSIS CTR,ENGLEWOOD,CO 80110, USA.						Adams RD, 1989, PRINCIPLES NEUROLOGY; BACHYRITA P, 1989, TRAUMATIC BRAIN INJU; BASMAJIAN JV, 1985, MUSCLES ALIVE THEIR, P273; BASMAJIAN JV, 1984, THERAPEUTIC EXERCISE, P110; BLACK FO, 1985, AM J OTOL, V6, P39; BRANDSTATER ME, 1987, STROKE REHABILITATIO; BRODY SJ, 1986, AGING REHABILITATION; CHILDS A, 1986, ARCH PHYS MED REHAB, V67, P554; CIALLIET R, 1980, SHOULDER HEMIPLEGIA; COHEN D, 1986, LOSS SELF FAMILY RES; CONINE TA, 1990, ARCH PHYS MED REHAB, V71, P310; COPE DN, 1987, J HEAD TRAUMA REHABI, V2; DELATEUR BJ, 1990, ARCH PHYS MED REHAB, V71, pS260; FROST F, 1989, AM J PHYS MED REHAB, V68, P112, DOI 10.1097/00002060-198906000-00002; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Gualtieri C T, 1988, Brain Inj, V2, P101, DOI 10.3109/02699058809150936; HINDERER SR, 1990, ARCH PHYS MED REHAB, V71, pS267; HORN LJ, 1989, STATE ART REV, V3; JOHNS DF, 1985, CLIN MANAGEMENT NEUR; KAPLAN PE, 1986, STROKE REHABILITATIO; KOLLER WC, 1986, HDB PARKINSONS DISEA; KOTTKE FJ, 1990, KRUSENS HDB PHYSICAL; Lance J W, 1986, Adv Neurol, V43, P33; Logemann JA, 1983, EVALUATION TREATMENT; McLean A Jr, 1987, Brain Inj, V1, P145, DOI 10.3109/02699058709034453; PENN RD, 1987, J NEUROSURG, V66, P181, DOI 10.3171/jns.1987.66.2.0181; ROPER BA, 1982, J BONE JOINT SURG BR, V64, P156, DOI 10.1302/0301-620X.64B2.7040409; ROSENTHAL M, 1989, REHABILITATION ADULT; RUSKIN AP, 1984, CURRENT THERAPY PHYS; SHUMWAYCOOK A, 1988, ARCH PHYS MED REHAB, V69, P395; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; STRUB RL, 1988, NEUROBEHAVIORAL DISO, P70; VANOUWENALLER C, 1986, ARCH PHYS MED REHAB, V67, P23; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; [No title captured]; [No title captured]; 1988, J HEAD TRAUMA REHABI, V3; 1990, J HEAD TRAUMA REHABI, V5; 1987, J HEAD TRAUMA REHABI, V2; 1989, J HEAD TRAUMA REHABI, V4	40	3	3	0	4	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	1991	72			4			S324	S331					8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FC427	WOS:A1991FC42700008	2003765				2022-02-06	
J	KAPLAN, CP				KAPLAN, CP			DIFFERENTIAL READING RECOVERY IN PATIENTS WITH SEVERE TO MODERATE CLOSED HEAD-INJURY	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						ACQUIRED DYSLEXIA; READING; ALEXIA; ALCOHOL INTOXICATION; MULTIPLE TRAUMA; HEAD INJURY	TRAUMA; REHABILITATION	A differential recovery was seen when alternate forms of a nationally standardized test of Reading Vocabulary, Literal Reading Comprehension and Inferential Reading Comprehension was administered serially to 10 consecutive closed head injury admissions to a university rehabilitation hospital. Inferential Reading Comprehension was the most impaired and had the fastest recovery rate. Subtle cognitive deficits in Inferential Reading Comprehension were detected when Reading Vocabulary was at or better than a twelfth grade level. Maximal recovery of all three reading functions occurred within 4 months after trauma, with most occurring in the first 3 months. The reading recovery pattern parallels the recovery of intelligence scores in the literature.			KAPLAN, CP (corresponding author), OHIO STATE UNIV,DEPT PSYCHOL,1885 NEIL AVE,COLUMBUS,OH 43210, USA.						BECKER B, 1975, J CLIN PSYCHOL, V31, P307, DOI 10.1002/1097-4679(197504)31:2<307::AID-JCLP2270310231>3.0.CO;2-Y; Bond M R, 1975, Ciba Found Symp, P141; BOND MR, 1976, SCAND J REHABIL MED, V8, P127; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; FULD PA, 1977, DEV MED CHILD NEUROL, V19, P495; GARDNER EF, 1983, MANUAL STANFORD TEST; Hagen C, 1984, LANGUAGE DISORDERS A, P245; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; MARQUARDT TP, 1988, J LEARN DISABIL, V21, P340, DOI 10.1177/002221948802100605; NAJENSON T, 1975, SCAND J REHABIL MED, V7, P101; Newcombe F, 1975, Ciba Found Symp, P227; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; Wilson J A, 1987, Brain Inj, V1, P183, DOI 10.3109/02699058709034456	15	3	3	0	2	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	DEC	1990	69	6					297	301		10.1097/00002060-199012000-00004			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	ER001	WOS:A1990ER00100004	2264948				2022-02-06	
J	Kreutzer, JS; Harris-Marwttz, J; Myers, SL				Kreutzer, Jeffrey S.; Harris-Marwttz, Jennifer; Myers, Stefanie L.			Neuropsychological Issues in Litigation Following Traumatic Brain Injury	NEUROPSYCHOLOGY			English	Article						Neuropsychology; traumatic brain injury; litigation	MINOR HEAD-INJURY; DAMAGE	Traumatic brain injury is primarily caused by traffic accidents, and an increasing number of survivors are ultimately involved in litigation. Attorneys seek to obtain optimal treatment, as well as compensation for disability for their clients. Neuropsychologists are often involved as experts in the litigation process because of their unique role in assessment and treatment of brain injury sequelae. Discussion provides information for neuropsychologists regarding a variety of issues including evaluation, reporting, testimony, professional credibility, ethics, divided loyalties, and responsibilities to the patient. Criteria for evaluating the expertise and credentials of psychologists hired by attorneys are presented.	[Kreutzer, Jeffrey S.] Virginia Commonwealth Univ, Med Coll Virginia, Dept Rehabil Med, Box 677 MCV Stn, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Div Neurol Surg, Richmond, VA 23298 USA		Kreutzer, JS (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Rehabil Med, Box 677 MCV Stn, Richmond, VA 23298 USA.				National Institute on Disability and Rehabilitation Research, United States Department of EducationUS Department of Education [G0087C0219]	This work was partly supported by Grant #G0087C0219 from the National Institute on Disability and Rehabilitation Research, United States Department of Education.	American Psychological Association, 1987, CAS ETH STAND PSYCH; American Psychological Association, 1977, AM PSYCH, V32, P495; [Anonymous], 1981, AM PSYCHOL, V36, P633; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Boake C., 1990, COMMUNITY INTEGRATIO, P115; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; COSTA L, 1983, J CLIN NEUROPSYCHOL, V5, P1, DOI 10.1080/01688638308401147; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; HART T, 1986, CLIN NEUROPSYCHOLOGY, P21; KREUTZER JS, 1990, COMMUNITY INTEGRATIO, P49; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Levin HS., 1982, NEUROBEHAVIORAL CONS; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; MAPOU RL, 1988, J CLIN EXP NEUROPSYC, V10, P271, DOI 10.1080/01688638808408241; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; Rimel R. W., 1989, REHABILITATION ADULT, P8; Rutherford W. H., 1989, MILD HEAD INJURY, P217; Thomson I. V., 1984, J SCANDINAVIAN REHAB, V6, P180	21	3	3	0	1	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	OCT	1990	4	4					249	259		10.1037/0894-4105.4.4.249			11	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	V44KA	WOS:000209746700005					2022-02-06	
J	STONE, LR; KEENAN, MAE; SHIN, DY				STONE, LR; KEENAN, MAE; SHIN, DY			ACQUIRED LIMB LOSS IN PATIENTS WITH TRAUMATIC BRAIN INJURY	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article									UNIV SO CALIF, SCH MED, DEPT ORTHOPED SURG, LOS ANGELES, CA 90033 USA		STONE, LR (corresponding author), RANCHO LOS AMIGOS MED CTR, ADUCT BRAIN INJURY SERV, 800 ANNEX, 7601 E IMPERIAL HIGHWAY, DOWNEY, CA 90242 USA.		Keenan, Mary Ann/ABB-1551-2020				ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BRINK JD, 1980, J PEDIATR-US, V97, P721, DOI 10.1016/S0022-3476(80)80253-8; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; Garland D. E., 1983, CLIN ORTHOP RELAT R, V176, P190; GARLAND DE, 1978, CLIN ORTHOP RELAT R, P111; GARLAND DE, 1982, CLIN ORTHOP RELAT R, P219; GARLAND DE, 1980, CLIN ORTHOP RELAT R, V150, P198; ILIZAROV GA, 1989, CLIN ORTHOP RELAT R, P249, DOI 10.1097/00003086-198901000-00038; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; LANCE JW, 1980, SPASTICITY DISORDERE, P495; MALKMUS D, 1980, REHABILITATION HEAD; RHOADES ME, 1978, CLIN ORTHOP RELAT R, P104; VARGHESE G, 1978, ARCH PHYS MED REHAB, V59, P121	15	3	3	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	JUN	1990	69	3					135	139		10.1097/00002060-199006000-00007			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	DM770	WOS:A1990DM77000007	2363904				2022-02-06	
J	BLAIR, JR; SPELLACY, FJ				BLAIR, JR; SPELLACY, FJ			EMPLOYER ACCEPTABILITY OF BEHAVIORAL-CHANGES WITH TRAUMATIC BRAIN INJURY	JOURNAL OF REHABILITATION			English	Article											BLAIR, JR (corresponding author), UNIV VICTORIA, DEPT PSYCHOL, VICTORIA V8W 2Y2, BC, CANADA.						BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; Bruckner F E, 1972, Rheumatol Phys Med, V11, P344, DOI 10.1093/rheumatology/11.7.344; *CONT INFL INC, 1986, CONT INFL; ENGLISH RW, 1971, COMBATTING STIGMA PH; Fuqua DR., 1984, J APPL REHABIL COUNS, V15, P40; HARTLAGE LC, 1971, REHABILITATION RES P, V2, P45; HPAY H, 1970, P INT S HEAD INJURY, P110; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEZAK MD, 1978, AM J PHYS MED REHAB, V57, P9; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; LONG CJ, 1984, J REHABIL, V50, P39; MAY VR, 1983, J REHABIL, V49, P43; MCKINLAY WW, 1983, J NEUROL NEUROSUR PS, V46, P1084, DOI 10.1136/jnnp.46.12.1084; Najenson T, 1980, Int Rehabil Med, V2, P17; NEWCOMBE F, 1982, INJURY, V14, P111, DOI 10.1016/0020-1383(82)90046-8; *STAT CAN, 1986, REP CAN HLTH DIS SUR; U.S. Department of Labor, 1977, DICT OCC TITL; Vogenthaler D R, 1987, Brain Inj, V1, P113; *WA DEP COMM EC DE, 1986, WASH STAT MAN REG; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3	22	3	3	0	1	NATL REHABILITATION ASSOC-NRA	ALEXANDRIA	633 S WASHINGTON ST, ALEXANDRIA, VA 22314-4109 USA	0022-4154			J REHABIL	J. Rehabil.	JUL-SEP	1989	55	3					46	48					3	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	AM608	WOS:A1989AM60800009					2022-02-06	
J	TZIAFAS, D				TZIAFAS, D			PULPAL REACTIONS FOLLOWING EXPERIMENTAL ACUTE TRAUMA OF CONCUSSION TYPE ON IMMATURE DOG TEETH	ENDODONTICS & DENTAL TRAUMATOLOGY			English	Article									ARISTOTELIAN UNIV SALONIKA,SCH DENT,DEPT DENT PATHOL & THERAPEUT,SALONIKA,GREECE									0	3	3	0	0	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0109-2502			ENDOD DENT TRAUMATOL	Endod. Dent. Traumatol.	FEB	1988	4	1					27	31					5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	L9586	WOS:A1988L958600006	2908326				2022-02-06	
J	SODERSTROM, S; FOGELSJOO, A; FUGLMEYER, KS; STENSSON, S				SODERSTROM, S; FOGELSJOO, A; FUGLMEYER, KS; STENSSON, S			A PROGRAM FOR CRISIS-INTERVENTION AFTER TRAUMATIC BRAIN INJURY	SCANDINAVIAN JOURNAL OF REHABILITATION MEDICINE			English	Article											SODERSTROM, S (corresponding author), UMEA UNIV,DEPT PHYS MED & REHABIL,S-90187 UMEA,SWEDEN.			Sjogren Fugl-Meyer, Kerstin/0000-0003-4794-0959				0	3	3	0	0	SCANDINAVIAN UNIVERSITY PRESS	OSLO	PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO, NORWAY	0036-5505			SCAND J REHABIL MED	Scand. J. Rehabil. Med.		1988				17			47	49					3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	P5160	WOS:A1988P516000008	3165210				2022-02-06	
J	VOGENTHALER, DR				VOGENTHALER, DR			REHABILITATION AFTER CLOSED HEAD-INJURY - A PRIMER	JOURNAL OF REHABILITATION			English	Article																	ANDERSON DW, 1980, J NEUROSURG, V53, pS11; ANDERSON DW, 1980, J NEUROSURGERY S, V53; Ben-Yishay Y, 1983, REHABILITATION HEAD, P367; BENYISHAY Y, 1978, REHABILITATION MONOG, V59; BENYISHAY Y, 1979, REHABILITATION MONOG, V60; BENYISHAY Y, 1983, REHABILITATION HEAD, P167; BENYISHAY Y, 1980, REHABILITATION MONOG, V61; BOND MR, 1983, REHABILITATION HEAD, P97; Bruckner F E, 1972, Rheumatol Phys Med, V11, P344, DOI 10.1093/rheumatology/11.7.344; BUCK WM, 1968, DYSPHASIA PROFESSION; CERNY J, 1983, REHABILITATION HEAD, P345; DIEHL LN, 1983, REHABILITATION HEAD, P395; GOLDEN CJ, 1983, CLIN NEUROPSYCHOLOGY; GREIF E, 1982, BEHAVIORAL APPROACHE; GRIFFITH ER, 1983, REHABILITATION HEAD, P23; HACKLER E, 1983, REHABILITATION HEAD, P421; Jennett B, 1981, MANAGEMENT HEAD INJU; Jennett B., 1983, REHABILITATION HEAD, P3; JOHNSON GA, 1980, 4TH ANN POST GRAD CO; Klein F. C., 1982, WALL STREET J, P1; KLEIN FC, 1982, WALL STREET J   1124, P12; Knott M., 1968, PROPRIOCEPTIVE NEURO; LEFTOFF S, 1983, J CLIN NEUROPSYCHOL, V5, P51, DOI 10.1080/01688638308401150; LEZAK MD, 1979, CORTEX, V15, P63, DOI 10.1016/S0010-9452(79)80007-6; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; LONG CJ, 1984, J REHABIL, V50, P39; LONG CJ, 1984, J REHABIL, V50, P70; LYNCH WJ, 1983, REHABILITATION HEAD, P59; MANDLEBERG IA, 1976, J NEUROL NEUROSUR PS, V39, P1001, DOI 10.1136/jnnp.39.10.1001; MARSHALL LF, HEAD INJURY; MILLER E, 1980, J NEUROL NEUROSUR PS, V43, P525, DOI 10.1136/jnnp.43.6.525; Miller JD., 1983, REHABILITATION HEAD, P37; MOSS CS, 1972, RECOVERY APHASIA AFT; MUIR CA, 1983, REHABILITATION HEAD, P381; NELSON AJ, 1983, REHABILITATION HEAD, P241; NELSON AJ, 1983, REHABILITATION HEAD, P313; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; OLSON DA, 1983, MANUAL BEHAVIOR MANA; PEUSER G, 1984, LANGUAGE REHABILITAT; RIMEL RW, 1983, REHABILITATION HEAD, P9; Rosenthal M., 1983, REHABILITATION HEAD, P197; *SANT CLAR VALL ME, 1982, SEV HEAD TRAUM COMPR; SMITH R, 1983, REHABILITATION HEAD, P279; TEASDALE G, 1974, LANCET, V2, P81; THOMAS JD, 1982, COGNITIVE REHABILITA, P27; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; TREXLER LE, 1982, COGNITIVE REHABILITA; WAHLSTROM PE, 1983, REHABILITATION HEAD, P271; 1982, REHABILITATION BRIEF, V9, P1	49	3	3	0	0	NATL REHABILITATION ASSN-NRA	ALEXANDRIA	633 S WASHINGTON ST, ALEXANDRIA, VA 22314-4109	0022-4154			J REHABIL	J. Rehabil.	OCT-DEC	1987	53	4					15	21					7	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	K8999	WOS:A1987K899900005					2022-02-06	
J	BERGMAN, TA; ROCKSWOLD, GL; HAINES, SJ; FORD, SE				BERGMAN, TA; ROCKSWOLD, GL; HAINES, SJ; FORD, SE			OUTCOME OF SEVERE CLOSED HEAD-INJURY IN THE MIDWEST - A REVIEW AND COMPARISON WITH OTHER MAJOR HEAD TRAUMA STUDIES	MINNESOTA MEDICINE			English	Article											BERGMAN, TA (corresponding author), UNIV MINNESOTA,DEPT NEUROSURG,MINNEAPOLIS,MN 55455, USA.		Haines, Stephen J./L-3209-2013	Haines, Stephen J./0000-0002-4263-0268				0	3	3	0	0	MINN MED ASSN	MINNEAPOLIS	SUITE 400 2221 UNIV AVE S E, MINNEAPOLIS, MN 55414	0026-556X			MINN MED		JUL	1987	70	7					397	401					5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	J1577	WOS:A1987J157700006	3614179				2022-02-06	
J	COELHO, CA				COELHO, CA			SIGN ACQUISITION AND USE FOLLOWING TRAUMATIC BRAIN INJURY - CASE-REPORT	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article											COELHO, CA (corresponding author), GAYLORD HOSP,DEPT COMMUN DISORDERS,WALLINGFORD,CT 06492, USA.						BONVILLIAN JD, 1978, SIGN LANGUAGE STUDIE, V19, P111; Chen L C, 1971, Arch Phys Med Rehabil, V52, P381; CHEN LCY, 1968, GERIATRICS, V23, P145; Coelho C., 1985, CLIN APHASIOLOGY, V15, P222; COELHO CA, IN PRESS PERCEPTUAL; Eagleson H M Jr, 1970, Arch Phys Med Rehabil, V51, P111; GUILFORD AM, 1982, ARCH PHYS MED REHAB, V63, P601; Porch B. E., 1981, PORCH INDEX COMMUNIC; STOKES TF, 1977, J APPL BEHAV ANAL, V10, P349, DOI 10.1901/jaba.1977.10-349; [No title captured]	10	3	3	0	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	1987	68	4					229	231					3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	G7707	WOS:A1987G770700008	3566516				2022-02-06	
J	ROUSEY, CG; ARJUNAN, KN; ROUSEY, CL				ROUSEY, CG; ARJUNAN, KN; ROUSEY, CL			SUCCESSFUL TREATMENT OF STUTTERING FOLLOWING CLOSED HEAD-INJURY	JOURNAL OF FLUENCY DISORDERS			English	Article									MENNINGER FDN,DEPT NEUROSURG,TOPEKA,KS 66601								DEAL JL, 1982, J SPEECH HEAR DISORD, V47, P301, DOI 10.1044/jshd.4703.301; FARMER A, 1975, Cortex, V11, P391; Golden C, 1981, DIAGNOSIS REHABILITA; HELM NA, 1978, NEUROLOGY, V28, P1159, DOI 10.1212/WNL.28.11.1159; KENT LR, 1963, J SPEECH HEAR DISORD, V28, P197, DOI 10.1044/jshd.2802.197; Luria A.R., 1973, WORKING BRAIN; MOSES JA, 1983, INTERPRETATION LURIA, V1; ROSENBEK J, 1978, BRAIN LANG, V6, P82, DOI 10.1016/0093-934X(78)90046-9; ROSENFIELD B, 1981, J FLUENCY DISORDERS, V6, P175; ROUSEY CL, 1958, J SPEECH HEAR RES, V1, P40, DOI 10.1044/jshr.0101.40; Van Riper, 1971, NATURE STUTTERING; WALLEN V, 1961, J SPEECH HEAR DISORD, V26, P394, DOI 10.1044/jshd.2604.394; WEINER AE, 1981, J FLUENCY DISORD, V6, P181, DOI 10.1016/0094-730X(81)90015-2	13	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010	0094-730X			J FLUENCY DISORD	J. Fluency Disord.	SEP	1986	11	3					257	261		10.1016/0094-730X(86)90013-6			5	Audiology & Speech-Language Pathology; Education, Special; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Education & Educational Research; Linguistics; Rehabilitation	D7692	WOS:A1986D769200007					2022-02-06	
J	HERNESNIEMI, J; TROUPP, H				HERNESNIEMI, J; TROUPP, H			A RETROSPECTIVE STUDY ON THE EFFECTS OF LOW AND HIGH-DOSES OF BETAMETHASONE ON SEVERE CLOSED HEAD-INJURY	ACTA NEUROCHIRURGICA			English	Article											HERNESNIEMI, J (corresponding author), UNIV HELSINKI,CENT HOSP,DEPT NEUROSURG,SF-00260 HELSINKI 26,FINLAND.						BEKS JWF, 1972, STEROIDS BRAIN EDEMA, P233; BENSON VM, 1970, ARCH NEUROL-CHICAGO, V23, P179, DOI 10.1001/archneur.1970.00480260085012; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; CLASEN RA, 1965, ARCH NEUROL-CHICAGO, V13, P584, DOI 10.1001/archneur.1965.00470060020002; DICK AR, 1976, J NEUROSURG, V45, P141, DOI 10.3171/jns.1976.45.2.0141; Faupel G, 1976, DYNAMICS BRAIN EDEMA, P337; FOX J L, 1965, Med Ann Dist Columbia, V34, P261; FRENCH L A, 1964, Clin Neurosurg, V10, P212; FRENCH LA, 1966, B NEW YORK ACAD MED, V42, P301; GALICICH JH, 1961, AM PRACT DIG TREAT, V12, P169; GOBIET W, 1977, ACTA NEUROCHIR, V39, P201, DOI 10.1007/BF01406730; GUTTERMAN P, 1970, J NEUROSURG, V32, P330, DOI 10.3171/jns.1970.32.3.0330; HOYT HJ, 1972, CLIN PHARMACOL THER, V13, P141; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; Kobrine A I, 1973, Surg Neurol, V1, P38; LONG DM, 1972, STEROIDS BRAIN EDEMA, P65; Long DM, 1972, STEROIDS BRAIN EDEMA, P87; NELSON SR, 1974, J NEUROSURG, V41, P193, DOI 10.3171/jns.1974.41.2.0193; PAPPIUS HM, 1972, STEROIDS BRAIN EDEMA, P57; RAIMONDI AJ, 1959, SURG GYNECOL OBSTET, V108, P333; Ransohoff J, 1972, STEROIDS BRAIN EDEMA, P211; RASMUSSEN T, 1962, J NEUROSURG, V19, P535, DOI 10.3171/jns.1962.19.7.0535; Reulen H. J., 1972, STEROIDS BRAIN EDEMA, P239; SPARACIO RR, 1965, SURG GYNECOL OBSTETR, V121, P513; TAYLOR JM, 1965, NEUROLOGY, V15, P667, DOI 10.1212/WNL.15.7.667; TORNHEIM PA, 1978, J NEUROSURG, V48, P220, DOI 10.3171/jns.1978.48.2.0220; WEINSTEIN JD, 1973, NEUROLOGY, V23, P121, DOI 10.1212/WNL.23.2.121; [No title captured]	29	3	3	0	1	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1980	51	3-4					149	155		10.1007/BF01406740			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JM237	WOS:A1980JM23700001	7368991				2022-02-06	
J	KARPMAN, RR; WEINSTEIN, PR; SILVERSTEIN, ME; HUGHES, J				KARPMAN, RR; WEINSTEIN, PR; SILVERSTEIN, ME; HUGHES, J			OBSERVATION OF THE ALERT, CONSCIOUS PATIENT WITH CLOSED HEAD-INJURY	ARIZONA MEDICINE			English	Article									UNIV ARIZONA,ARIZONA HLTH SCI CTR,DEPT SURG,NEUROSURG SECT,TUCSON,AZ 85724									0	3	3	0	0	ARIZ MEDICINE	PHOENIX	810 W BETHANY HOME RD, PHOENIX, AZ 85013	0004-1556			ARIZ MED			1980	37	11					772	775					4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KS041	WOS:A1980KS04100008	7224868				2022-02-06	
J	BOND, MR				BOND, MR			ASSESSMENT OF OUTCOME FOLLOWING SEVERE CLOSED HEAD-INJURY	SCOTTISH MEDICAL JOURNAL			English	Article											BOND, MR (corresponding author), UNIV GLASGOW,DEPT PSYCHOL MED,GLASGOW G12 8QQ,SCOTLAND.						BOND MR, 1976, SCAND J REHABIL MED, V8, P127; BOND MR, 1976, ACTA NEUROCHIR, V34, P57, DOI 10.1007/BF01405863; BOND MR, 1976, OUTCOME SEVERE DAMAG, P141; JENNETT B, 1975, LANCET, V1, P480; ROBERTS AH, 1976, P ROY SOC MED, V69, P137, DOI 10.1177/003591577606900228	5	3	3	0	1	HERMISTON PUBLICATIONS LTD	EAST LOTHIAN	9 STONELAWS WHITEKIRK, EAST LOTHIAN EH40 3DX, SCOTLAND	0036-9330			SCOT MED J	Scott. Med. J.		1978	23	1					105	106		10.1177/003693307802300149			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ925	WOS:A1978EJ92500049	635527				2022-02-06	
J	DICHGANS, J; KOUFEN, H; KEHRLE, G; SAUER, M; KLIESER, J				DICHGANS, J; KOUFEN, H; KEHRLE, G; SAUER, M; KLIESER, J			NEUROLOGICAL AND EEG-FOLLOW-UP STUDIES IN HEAD-INJURED ADULTS - CRITERIA FOR CLINICAL DIAGNOSIS CONCUSSION AND CONTUSION	FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE			German	Article											DICHGANS, J (corresponding author), UNIV FREIBURG,NERVEN KLIN,NEUROL KLIN,KLIN NEUROPHYSIOL & PSYCHIAT ABT,D-7800 FREIBURG,FED REP GER.						ADAMS AE, 1967, DEUT MED WOCHENSCHR, V92, P1173, DOI 10.1055/s-0028-1103761; BAY E, 1941, HIPPOKRATES, V12, P561; BAY E, 1941, HIPPOKRATES STUTTG, V12, P585; Bay E, 1953, FORTSCHR NEUROL P I, V21, P151; Brenner C, 1944, J NEUROSURG, V1, P379, DOI 10.3171/jns.1944.1.6.0379; BROWN WJ, 1972, AM J PATHOL, V67, P41; BUES E, 1961, Bruns Beitr Klin Chir, V203, P265; BUES E, 1965, Acta Neurochir (Wien), V12, P702, DOI 10.1007/BF01404621; CARLSSON S, 1973, JUN P INT C BIOK IMP, P131; CHASON JL, 1957, J NEUROPATH EXP NEUR, V16, P102, DOI 10.1097/00005072-195701000-00012; COBB WA, 1956, ELECTROENCEPHALOGRAP; Davis H, 1936, ARCH NEURO PSYCHIATR, V36, P1214, DOI 10.1001/archneurpsyc.1936.02260120061004; DELANK HW, 1970, GRUNDRISS UNFALLNEUR; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DOW RS, 1945, J NEUROSURG, V2, P154, DOI 10.3171/jns.1945.2.2.0154; Enge S, 1966, Wien Med Wochenschr, V116, P417; EVANS JP, 1944, RES PUBL ASS NERV ME, V24, P254; FAUST C, 1972, PSYCHIATRIE GEGENWAR, V2; Fendel K, 1966, Z Laryngol Rhinol Otol, V45, P631; FRANKE K, 1973, SCHADELHIRNTRAUMA NO; FRIEDE RL, 1961, ARCH NEUROL-CHICAGO, V4, P449, DOI 10.1001/archneur.1961.00450100097012; FUNFGELD E W, 1957, Zentralbl Neurochir, V17, P326; GANSHIRT H, 1963, Dtsch Med J, V14, P257; GROAT RA, 1945, J NEUROSURG, V2, P26, DOI 10.3171/jns.1945.2.1.0026; GUARDJIAN ES, 1958, HEAD INJURIES MECHAN; HAPPEL W, 1963, Dtsch Z Nervenheilkd, V184, P487; HARRIS P, 1971, HEAD INJURIES; HESS R, 1951, SCHWEIZ MED WSCHR, V81, P180; HOOPER RS, 1969, PATTERNS ACUTE HEAD; JANZEN R, 1955, Monatsschr Unfallheilkd Versicherungsmed, V58, P225; JENKNER FL, 1972, WIEN KLIN WOCHENSCHR, V84, P537; JENNETT B, 1974, ARCH NEUROL-CHICAGO, V30, P394, DOI 10.1001/archneur.1974.00490350052008; Jung R., 1953, HDB INNEREN MED, P1206, DOI [10.1007/978-3-642-94610-3_11, DOI 10.1007/978-3-642-94610-3_11]; KINZEL W, 1972, FORTSCHR NEUROL P I, V40, P169; KLIESER J, 1976, THESIS FREIBURG; KLONOFF H, 1969, CAN MED ASSOC J, V100, P235; KORNMULLER AE, 1944, KLINISCHE ELEKTROENZ; KOSLOWSKI L, 1964, Monatsschr Unfallheilkd Versicher Versorg Verkehrsmed, V67, P97; KOSLOWSKI L, 1970, FRISCHE SCHADELHIRN; KOUFEN H, 1977, MED KLIN, V72, P739; KOUFEN H, 1975, THESIS FREIBURG; KOUFEN H, FORTSCHR NEUROL PSYC; LARSSON LE, 1954, ACTA PSYCHIAT NE S95; LECHNER H, 1957, Zentralbl Neurochir, V17, P65; LORENZONI E, 1963, Wien Med Wochenschr, V113, P787; MEYER-MICKELEIT R W, 1953, Dtsch Med Wochenschr, V78, P480; MILLER H, 1961, BRIT MED J, V1, P992, DOI 10.1136/bmj.1.5231.992; MILLER H, 1968, HDB CLINICAL NEUROLO, V5, P178; MULLER GE, 1970, B SOC SCI MED LUX, V107, P7; MULLER R, 1955, ELECTROEN CLIN NEURO, V7, P75, DOI 10.1016/0013-4694(55)90061-4; NORRMAN B, 1961, ACTA PSYCHIAT SCAND, V37, P236, DOI 10.1111/j.1600-0447.1961.tb07359.x; OMMAYA AK, 1966, J TRAUM, V6, P605, DOI 10.1097/00005373-196609000-00006; Ommaya AK, 1975, HDB CLIN NEUROLOGY, V23, P67; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PETERS G, 1962, ERGEBNISSE VERGLEICH; PETIT JL, 1944, OEUVRES COMPLETES JL; RADERMECKER J, 1954, MUNCH MED WSCHR, V106, P1315; Richter H, 1967, Bruns Beitr Klin Chir (1971), V214, P298; ROSS A, 1970, ELECTROEN CLIN NEURO, V29, P219; RUSSELL WR, 1968, TRAUMATIC AMNESIAE; SCHERZER E, 1970, ELECTROEN CLIN NEURO, V28, P216; SCHRADER A, 1969, ARZTLICHE GUTACHTEN, V2; SMITH A, 1961, DIS NERV SYST, V22, P69; STEINMANN HW, 1951, ZBL NEUROCHIR, V11, P65; SYMONDS C, 1962, LANCET, V1, P1; TONNIS W, 1953, ARZTL PRAXIS, V36, P13; TONNIS W, 1956, HEFTE UNFALLHEILK, V52, P1301; UNTERHARNSCHEID.FJ, 1975, HDB CLINICAL NEUROLO, V23; VERJAAL A, 1975, HDB CLIN NEUROLOGY, V23, P417; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; WEBER R, 1954, Munch Med Wochenschr, V96, P1001; WEBER R, 1963, KLINISCHE BEURTEILUN, P290; Williams D, 1941, J NEUROL PSYCHIATRY, V4, P107, DOI 10.1136/jnnp.4.2.107; WINDLE W. F., 1944, TRANS AMER NEUROL ASSOC, V70, P117; Wolter J, 1970, Arch Psychiatr Nervenkr (1970), V213, P46, DOI 10.1007/BF00342947; [No title captured]; [No title captured]; [No title captured]; 1966, CLIN NEUROSURG, V12, P386	79	3	3	0	0	GEORG THIEME VERLAG	STUTTGART	P O BOX 30 11 20, D-70451 STUTTGART, GERMANY	0720-4299			FORTSCHR NEUROL PSYC	Forschritte Neurol. Psychiatr.		1978	46	3					144	155					12	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	ET543	WOS:A1978ET54300002	246414				2022-02-06	
J	STONE, JL; LOPES, JR; MOODY, RA				STONE, JL; LOPES, JR; MOODY, RA			FLUENT APHASIA AFTER CLOSED HEAD-INJURY	SURGICAL NEUROLOGY			English	Article											STONE, JL (corresponding author), COOK CTY HOSP,DIV NEUROSURG,CHICAGO,IL 60612, USA.							0	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010	0090-3019			SURG NEUROL	Surg. Neurol.		1978	9	1					27	29					3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EG437	WOS:A1978EG43700006	622678				2022-02-06	
J	PUVANENDRAN, K; VITHARANA, M; WONG, PK				PUVANENDRAN, K; VITHARANA, M; WONG, PK			ELECTRODIAGNOSTIC STUDY IN DELAYED FACIAL PALSY AFTER CLOSED HEAD-INJURY	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article									UNIV SINGAPORE,DEPT MED,SINGAPORE 10,SINGAPORE; SINGAPORE GEN HOSP,DEPT OTORHINOLARYNGOL,SINGAPORE,SINGAPORE								GILLIATT RW, 1960, J NEUROL NEUROSUR PS, V23, P312, DOI 10.1136/jnnp.23.4.312; GILLIATT RW, 1959, P ROY SOC MED, V52, P1080; LANDAU WM, 1953, J NEUROSURG, V10, P64, DOI 10.3171/jns.1953.10.1.0064; LAUMANS EPJ, 1965, ARCHIV OTOLARYNGOL, V81, P478; PUVANENDRAN K, 1977, J NEUROL NEUROSUR PS, V40, P342, DOI 10.1136/jnnp.40.4.342; TAVERNER D, 1955, BRAIN, V78, P209, DOI 10.1093/brain/78.2.209; TAVERNER D, 1965, ARCHIV OTOLARYNGOL, V81, P470	7	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry		1977	40	4					351	357		10.1136/jnnp.40.4.351			7	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	DK027	WOS:A1977DK02700006	874512	Green Published, Bronze, Green Submitted			2022-02-06	
J	GAGEY, PM; BARON, JB; AMPHOUX, M; BLAIZOT, M; GENTAZ, R; GOUMOT, H				GAGEY, PM; BARON, JB; AMPHOUX, M; BLAIZOT, M; GENTAZ, R; GOUMOT, H			DISTURBANCES OF POSTURAL TONIC ACTIVITY OF LOWER-LIMBS IN CATHEDROSTATIC PHASE DURING HORIZONTAL OCULAR MOVEMENTS FOUND IN CERTAIN POST-CONCUSSION SYNDROME OF TRUNK ORIGIN	AGRESSOLOGIE			French	Article									ASSOC PARITAIRE ACTION SOCIALE,4 RUE AUGUSTE PERRET,75013 PARIS,FRANCE								BARON J B, 1963, Bull Soc Belge Ophtalmol, V133, P264; BARON J B, 1964, Arch Mal Prof, V25, P328; BARON JB, 1973, AGRESSOLOGIE, V14, P79; BARON JB, 1955, THESIS PARIS; BRUNIA C, 1966, ARCHIV OTOLARYNGOL, V84, P409; Brunia C H, 1966, Acta Otolaryngol, V61, P547, DOI 10.3109/00016486609127093; CLARK JM, 1974, J NEUROL NEUROSUR PS, V37, P463, DOI 10.1136/jnnp.37.4.463; FUKUDA T, 1959, Acta Otolaryngol, V50, P95, DOI 10.3109/00016485909129172; FUKUDA T, 1961, ACTA OTOLARYNG  S161; GAGEY PM, 1973, AGRESSOLOGIE, V14, P87; HINOKI M, 1971, EQUILIBRIUM RES S, V1, P5; JORDAN P, 1963, ARCHIV OTOLARYNGOL, V77, P243; MAIGNE R, 1973, CINESIOLOGIE, V12, P25; MORSIER GD, 1971, ARCH SUISSES NEUROL, V109, P245; Onkelinx A, 1972, Rev Med Liege, V27, P572; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Paillard J, 1973, ARCH ITAL BIOL, V3, P451; UEMURA T, 1973, ACTA OTOLARYNG  S315; ZILSTORFFPEDERSEN K, 1963, ARCHIV OTOLARYNGOL, V77, P237; 1975, 3E S POST PAR	20	3	3	0	0	MASSON EDITEUR	PARIS 06	120 BLVD SAINT-GERMAIN, 75280 PARIS 06, FRANCE	0002-1148			AGRESSOLOGIE			1975	16				D		77	82					6	Psychology, Clinical; Pharmacology & Pharmacy; Physiology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Psychology; Pharmacology & Pharmacy; Physiology; Psychiatry	BE298	WOS:A1975BE29800011	1232847				2022-02-06	
J	JOELE, LJ; ENDTZ, LJ				JOELE, LJ; ENDTZ, LJ			TRAUMATIC DISORDERS OF PITUITARY HYPOTHALAMIC FUNCTION .1. EXCRETION OF FOLLICLE-STIMULATING HORMONE AFTER CLOSED HEAD-INJURY - PRELIMIGATION	APPLIED NEUROPHYSIOLOGY			English	Article									MUNICIPAL HOSP,DEPT NEUROL,THE HAGUE,NETHERLANDS								BUES E, 1959, Neurochirurgia (Stuttg), V2, P91; CANTALUPPI G, 1963, Minerva Ginecol, V15, P440; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; DEVLIN JG, 1973, 7TH ANN M EUR SOC CL; Lafon R, 1954, Rev Otoneuroophtalmol, V26, P404; LENIEZ, 1909, PRESSE MED, V17, P683; MORSIER GD, 1949, LYON CHIR, V44, P302; PETIT-DUTAILLIS D., 1958, REV NEUROL, V99, P448; Rotkina I E, 1966, Probl Endokrinol Gormonoter, V12, P41; THIRY S, 1954, Acta Chir Belg, V53, P598; THIRY S, 1954, Acta Chir Belg, V53, P517; VANGILSE H, 1953, THESIS LEIDEN	12	3	3	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0302-2773			APPL NEUROPHYSIOL			1975	38	2					110	114					5	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	BK396	WOS:A1975BK39600005	1221918				2022-02-06	
J	ROUQUET, Y; BABIC, R; MARSTAL, N; GOUMOT, J; GAGEY, PM; GENTAZ, R; BARON, JB				ROUQUET, Y; BABIC, R; MARSTAL, N; GOUMOT, J; GAGEY, PM; GENTAZ, R; BARON, JB			STATOKINESIMETRIC AND RHEOGRAPHIC ASPECTS OF POST-CONCUSSION SYNDROME	AGRESSOLOGIE			French	Article									CTR HOSP ST ANNE,LAB STATOKINESIMETRIE,1 RUE CABANIS,75014 PARIS,FRANCE								BARON JB, 1975, AGRESSOLOGIE, V16; BARON JB, 1956, PRESSE MED, V64, P863; BOISMARE F, 1973, AGRESSOLOGIE, V14, P57; BOISMARE F, 1972, PRESSE MED, P1742; BOISMARE F, 1972, THERAPIE, V27, P827; NYBOER, 1970, MEDICAL PHYSICS, P340	6	3	3	0	0	MASSON EDITEUR	PARIS 06	120 BLVD SAINT-GERMAIN, 75280 PARIS 06, FRANCE	0002-1148			AGRESSOLOGIE			1975	16				D		15	22					8	Psychology, Clinical; Pharmacology & Pharmacy; Physiology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Psychology; Pharmacology & Pharmacy; Physiology; Psychiatry	BE298	WOS:A1975BE29800003	1232840				2022-02-06	
J	STALHAMMAR, D; OLSSON, Y				STALHAMMAR, D; OLSSON, Y			EXPERIMENTAL BRAIN-DAMAGE FROM FLUID PRESSURES DUE TO IMPACT ACCELERATION .4. COMPARATIVE STUDIES WITH ACCELERATION-CONCUSSION	ACTA NEUROLOGICA SCANDINAVICA			English	Article									UNIV UPPSALA,INST PATHOL,NEUROPATHOL LAB,UPPSALA,SWEDEN; UNIV GOTHENBURG,DEPT HYG,GOTHENBURG,SWEDEN; UNIV GOTHENBURG,DEPT NEUROSURG,41345 GOTHENBURG,SWEDEN								CHASON JL, 1957, J NEUROPATH EXP NEUR, V16, P102, DOI 10.1097/00005072-195701000-00012; CHASON JL, 1966, J TRAUM, V6, P767, DOI 10.1097/00005373-196611000-00008; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; FRIEDE RL, 1961, ARCH NEUROL-CHICAGO, V4, P449, DOI 10.1001/archneur.1961.00450100097012; GENNARELLI TA, IN PRESS; GIERKE HEV, 1966, HEAD INJURY C P, P383; GOLDSMITH W, 1972, BIOMECHANICS ITS F O, P585; GURDJIAN ES, 1955, SURG GYNECOL OBSTET, V101, P680; HAMBERGER A, 1966, Z ZELLFORSCH MIK ANA, V70, P386, DOI 10.1007/BF00336504; Higgins L. S., 1967, 11 STAPP CAR CRASH C, P57; HOLLISTER NR, 1958, AD203385 ASTIA DOC; HOLLISTER NR, 1958, WADC58193 TECHN REP; JOHANSSON B, 1974, THESIS U GOTEBORG; KLUVER H, 1953, J NEUROPATH EXP NEUR, V12, P400; OMMAYA AK, 1964, J NEUROSURG, V21, P249, DOI 10.3171/jns.1964.21.4.0249; OMMAYA AK, IN PRESS; OMMAYA AK, 1966, HEAD INJURY, P260; RINDER L, 1968, ACTA PATHOL MIC SC, V74, P333; RINDER L, 1969, ACTA PHYSIOL SCAND, V76, P352, DOI 10.1111/j.1748-1716.1969.tb04478.x; RINDER L, 1968, ACTA NEUROPATHOL, V11, P183; RINDER L, 1969, ACTA PHYSIOL SCAND, V76, P340; STALHAMMAR D, 1975, ACTA NEUROL SCAND, V52, P38; STALHAMMAR D, 1975, ACTA NEUROL SCAND, V52, P7; STALHAMMAR D, 1975, ACTA NEUROL SCAND, V52, P27; STEINWALL O, 1966, J NEUROPATH EXP NEUR, V25, P542, DOI 10.1097/00005072-196610000-00004; THOMAS LM, 1970, IMPACT INJURY CRASH, P27; UNTERHARNSCHEID.FJ, 1963, GEDECKTEN SCHADEN GE; UNTERHARNSCHEIDT F, 1969, ACTA NEUROPATHOL, V12, P200, DOI 10.1007/BF00692508; UNTERHARNSCHEIDT FJ, 1972, Z RECHTSMED, V71, P153, DOI 10.1007/BF02076624; WARD AA, 1966, HEAD INJURY C P, P203; [No title captured]; [No title captured]; [No title captured]	33	3	3	0	0	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-6314			ACTA NEUROL SCAND	Acta Neurol. Scand.		1975	52	2					94	110		10.1111/j.1600-0404.1975.tb05764.x			17	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AK538	WOS:A1975AK53800003	1155034				2022-02-06	
J	TERAO, H; SATO, S				TERAO, H; SATO, S			VENTRICULO-ORBITAL FISTULA IN CLOSED HEAD-INJURY - CASE REPORT	JOURNAL OF NEUROSURGERY			English	Article									TOKYO MUNICIPAL HIROO HOSP,NEUROSURG SERV,TOKYO,JAPAN								BHANDARI YS, 1969, J NEUROSURG, V30, P612, DOI 10.3171/jns.1969.30.5.0612; JUNGMANN A, 1963, RADIOLOGY, V80, P92, DOI 10.1148/80.1.92; KING AB, 1951, AMA ARCH OPHTHALMOL, V46, P49; TAPTAS J N, 1964, Presse Med, V72, P3383; TENG P, 1963, RADIOLOGY, V81, P802, DOI 10.1148/81.5.802	5	3	3	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.		1975	43	6					754	756		10.3171/jns.1975.43.6.0754			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AX760	WOS:A1975AX76000014	1194943				2022-02-06	
J	KEYMOLENJARDINI, V; MOUAWAD, E; CLAEYSDE.P; VANLAER, E; LEVIN, S; BORKOWSKI, A				KEYMOLENJARDINI, V; MOUAWAD, E; CLAEYSDE.P; VANLAER, E; LEVIN, S; BORKOWSKI, A			GLUCOSE-METABOLISM IN TRAUMATIC BRAIN INJURY	ACTA ENDOCRINOLOGICA			English	Article									UNIV LIBRE BRUSSELS, SERV NEUROSURG, BRUSSELS, BELGIUM; UNIV BRUSSELS, CTR ANTICANC,INST JULES BORDET, SERV MED & CLIN INVEST,LAB ENDOCRINOL, BRUSSELS, BELGIUM; INST JULES BORDET, SERV ANAESTHESIOL, BRUSSELS, BELGIUM								ALLISON SP, 1968, LANCET, V2, P1113; ALLISON SP, 1967, LANCET, V1, P478; BAUDOURESQUES J, 1967, ENCYCLOPEDIE MEDICOC, V1; BODEN G, 1971, DIABETOLOGIA, V7, P240, DOI 10.1007/BF01211875; CAHILL GF, 1971, DIABETES, V20, P785, DOI 10.2337/diab.20.12.785; CONARD V, 1953, ARCH INT PHARMACOD T, V93, P277; DEMOOR P, 1960, ACTA ENDOCRINOL-COP, V33, P297; FOSSATI P, 1968, Acta Anaesthesiologica Belgica, V19, P284; Frame EG, 1943, J BIOL CHEM, V149, P255; GOODNER CJ, 1969, J CLIN INVEST, V48, P1878, DOI 10.1172/JCI106154; HALES CN, 1963, BIOCHEM J, V88, P137, DOI 10.1042/bj0880137; HUME DM, 1959, ANN SURG, V150, P697, DOI 10.1097/00000658-195910000-00013; LAURELL S, 1967, CLIN CHIM ACTA, V16, P57, DOI 10.1016/0009-8981(67)90269-0; LERNER RL, 1971, J CLIN INVEST, V50, P2453, DOI 10.1172/JCI106744; LONG CL, 1971, J APPL PHYSIOL, V31, P110, DOI 10.1152/jappl.1971.31.1.110; MALAISSE W, 1967, ENDOCRINOLOGY, V80, P975, DOI 10.1210/endo-80-5-975; MARKS PA, 1957, J CLIN INVEST, V36, P254, DOI 10.1172/JCI103419; MARTIN JB, 1973, NEW ENGL J MED, V288, P1384, DOI 10.1056/NEJM197306282882606; PORTE D, 1967, J CLIN INVEST, V46, P86, DOI 10.1172/JCI105514; SLEIN MW, 1963, METHODS ENZYMATIC AN; WILLIAMSON DH, 1962, BIOCHEM J, V82, P90, DOI 10.1042/bj0820090	21	3	3	0	0	SCANDINAVIAN UNIVERSITY PRESS	OSLO	PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO, NORWAY	0001-5598			ACTA ENDOCRINOL-COP	Acta Endocrinol.		1974	77	1					103	110		10.1530/acta.0.0770103			8	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	T8882	WOS:A1974T888200013	4408224				2022-02-06	
J	KUNST, H; WEINMANN, S				KUNST, H; WEINMANN, S			DILATATION OF CEREBRAL-VENTRICLES AFTER CONCUSSION - RESULTS OF ECHOENCEPHALOGRAPHY AND PSYCHOLOGICAL TESTS	DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT			German	Article									UNIV COLOGNE,NERVE KLIN,JOSEPH STELZMANN STR 9,5 COLOGNE 41,WEST GERMANY								Busemann A, 1947, NERVENARZT, V18, P337; Fischer R. A., 1936, ANN EUGEN, V7, P179; FISCHER RA, 1938, ANN EUGEN LOND, V9, P376; Foerstei O, 1925, Z GESAMTE NEUROL PSY, V94, P512, DOI 10.1007/BF02878072; Gross G, 1970, Nervenarzt, V41, P392; HUBER G, 1962, Nervenarzt, V33, P248; KUNST H, 1973, EXCERPTA MED INT C S, V227, P37; Muller C, 1967, ALTERSPSYCHIATRIE; POPPELREUTER W, 1917, PSYCHOLOGISCHEN SCHA, V1; RITZEL G, 1972, NERVENARZT, V43, P465; Schiefer W, 1965, Zentralbl Neurochir, V26, P281; VOGEL T, 1972, NERVENARZT, V43, P412; VOGEL T, 1970, FORTSCHR NEUROL P I, V38, P79; Wartenberg R, 1925, Z GESAMTE NEUROL PSY, V94, P585, DOI 10.1007/BF02878073; WEINMANN S, 1973, ANGEWANDTE PSYCHOPAT; Witter H, 1952, NERVENARZT, V23, P89; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	21	3	3	0	1	GEORG THIEME VERLAG	STUTTGART	P O BOX 30 11 20, D-70451 STUTTGART, GERMANY	0012-0472			DEUT MED WOCHENSCHR	Dtsch. Med. Wochenschr.		1974	99	52					2631	2634		10.1055/s-0028-1108183			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V0468	WOS:A1974V046800001	4448149				2022-02-06	
J	ROBERTS, M; OWENS, G				ROBERTS, M; OWENS, G			DELAYED TRAUMATIC BILATERAL ABDUCENS PARALYSIS WITHOUT SKULL FRACTURE OR BRAIN INJURY	JOURNAL OF TRAUMA			English	Article																	BUXTON PH, 1967, J NEUROL NEUROSUR PS, V30, P511, DOI 10.1136/jnnp.30.6.511; CANT J S, 1962, Scott Med J, V7, P183; CHHUTTANI PN, 1967, NEUROLOGY, V17, P269, DOI 10.1212/WNL.17.3.269; Cushing H, 1910, BRAIN, V33, P204, DOI 10.1093/brain/33.3.204; DEMARTINI R, 1942, B MAL ORECCH GOLO NA, V60, P357; GRINKER R, 1966, NEUROLOGY; HOOPER RS, 1951, BRIT J SURG, V39, P126, DOI 10.1002/bjs.18003915406; Hummelsheim E., 1908, ARCH AUGENHEILKD, V62, P71; Humphrey JH, 1944, BMJ-BRIT MED J, V1944, P315, DOI 10.1136/bmj.1.4339.315; KALSBEEK F, 1960, Ned Tijdschr Geneeskd, V104, P1414; KESTENBAUM A, 1961, CLINICAL METHODS NEU; KOEPPEN AH, 1970, P WEEKLY SEMINAR NEU, V17, P68; LYLE D J, 1961, J Occup Med, V3, P478; MALAPAZ JS, 1959, J PEDIAT, V55, P73; MIEHLKE A, 1963, Arch Ohren Nasen Kehlkopfheilkd, V181, P154, DOI 10.1007/BF02105660; RIBEIRO L A, 1952, Hospital (Rio J), V42, P361; Robinson Jr HM, 1945, AM J SYPH, V29, P422; ROBLES R, 1968, Northwest Medicine, V67, P845; RUCKER CW, 1966, AM J OPHTHALMOL, V61, P1293, DOI 10.1016/0002-9394(66)90258-3; SCHEIE HG, 1969, ALDERS TEXTBOOK OPHT; SHRADER EC, 1960, ARCH OPHTHALMOL-CHIC, V63, P84; SMITH JL, 1961, ARCH OPHTHALMOL-CHIC, V65, P61, DOI 10.1001/archopht.1961.01840020063012; Stopford JSB, 1916, J ANAT PHYSIOL, V50, P131; STOREY WE, 1949, J NEUROSURG, V6, P539, DOI 10.3171/jns.1949.6.6.0539; SUNDELIN F, 1951, ACTA MED SCAND, V117, P1; VONOETTINGEN WF, 1959, POISONING GUIDE CLIN; WALSH F, 1969, CLINICAL NEURO OPHTH; Wolff E, 1968, ANATOMY EYE ORBIT	28	3	3	0	0							J TRAUM			1972	12	3					254	+		10.1097/00005373-197203000-00010			1	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	M0282	WOS:A1972M028200011	5012821				2022-02-06	
J	DURRER, J; POLACKOVA, J				DURRER, J; POLACKOVA, J			LABYRINTHINE CONCUSSION	PRACTICA OTO-RHINO-LARYNGOLOGICA			English	Article																	Brunner H, 1925, MSCHR OHRENHEILK, V59, P697; ESCHER F, 1948, PRACT OTORHINOLAR S1, V10, P74; FALTYNEK L, 1970, PRACT-OTO-RHINO-LARY, V32, P149; Grove WE, 1939, LARYNGOSCOPE, V49, P678; Kelemen G, 1944, ARCHIV OTOLARYNGOL, V40, P333; NAGER F R, 1949, Pract Otorhinolaryngol (Basel), V11, P134; RUEDI L, 1947, AKUSTISCHE TRAUMA; Sakai K, 1911, ARCH OHRENHEILK, V85, P188; SCHUKNECHT HF, 1956, ARCHIV OTOLARYNGOL, V63, P513; WARD PH, 1969, ANN OTO RHINOL LARYN, V78, P227, DOI 10.1177/000348946907800203	10	3	4	0	1				0032-6305			PRACT-OTO-RHINO-LARY			1971	33	3					185	+					1	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	K1196	WOS:A1971K119600003	5001941				2022-02-06	
J	SATO, K; ZULCH, KJ				SATO, K; ZULCH, KJ			EXPERIMENTAL CONCUSSION IN CAT - CLINICAL AND MORPHOLOGICAL FINDINGS	ZEITSCHRIFT FUR NEUROLOGIE			English	Article																	AIRD RB, 1952, J NEUROSURG, V9, P331, DOI 10.3171/jns.1952.9.4.0331; BOIREL A, 1874, TRAITE PLAGES TETE; CASSEN B, 1960, AM J PHYSIOL, V198, P1296, DOI 10.1152/ajplegacy.1960.198.6.1296; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; EICHELBERGER L, 1949, AM J PHYSIOL, V156, P129, DOI 10.1152/ajplegacy.1949.156.1.129; FAAS FH, 1968, J NEUROSURG, V28, P137, DOI 10.3171/jns.1968.28.2.0137; FOLTZ EL, 1956, J NEUROSURG, V13, P145, DOI 10.3171/jns.1956.13.2.0145; HOLDER HV, 1904, PATHOLOGISCHE ANATOM; KOCH W, 1874, LANGENBECKS ARCH KLI, V17, P190; KOENIG H, 1945, STAIN TECHNOL, V20, P13, DOI 10.3109/10520294509107124; LOEW F, 1958, Dtsch Z Nervenheilkd, V178, P358, DOI 10.1007/BF02388077; LOHR W, 1933, ARCH ORTHOP CHIR, V33, P516; MASSING W, 1971, THESIS U KOLN; Miller GG, 1927, ARCH SURG-CHICAGO, V14, P891, DOI 10.1001/archsurg.1927.01130160100005; OMMAYA AK, 1964, J NEUROSURG, V21, P249, DOI 10.3171/jns.1964.21.4.0249; PETIT JL, 1937, OEUVRES COMPLETES; POLIS A, 1894, REV CHIR, V14, P645; Polis A, 1894, REV CHIR, V14, P273; RINDER L, 1968, ACTA NEUROPATHOL, V11, P183; SCHOLZ W, 1951, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V186, P264, DOI 10.1007/BF00353608; SCHRODER M, 1965, NATURWISSENSCHAFTEN, V52, P86, DOI 10.1007/BF00622769; Scott WW, 1940, ARCH NEURO PSYCHIATR, V43, P270, DOI 10.1001/archneurpsyc.1940.02280020078006; SLONIMSKI P, 1948, MIKDOSKOPISCHE TECHN, P470; STRICH ST, 1969, LATE EFFECTS HEAD IN; TONNIS W, 1948, Arztl Forsch, V2, P179; UNTERHARNSCHEID.F, 1963, EXPERIMENTELLE UNTER; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; White JC, 1943, ANN SURG, V119, P619, DOI 10.1097/00000658-194310000-00010; ZULCH K J, 1953, Dtsch Z Nervenheilkd, V170, P179; ZULCH KJ, 1969, B SOC SCI MED LUX, V106, P153; Zulch KJ, 1943, VIRCHOWS ARCH A, V310, P1, DOI 10.1007/BF02598063; ZULCH KJ, 1971, ZBL ALLG PATH, V114, P282; ZULCH KJ, 1967, BRAIN EDEMA, P95; ZULCH KJ, 1940, ZBL NEUROCHIR, V5, P166; ZULCH KJ, 1950, J BRAS NEUROL, V2, P31; [No title captured]	36	3	3	0	1							Z NEUROL			1971	200	3					201	+		10.1007/BF00316918			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	L2249	WOS:A1971L224900001	4109627				2022-02-06	
J	KLUGE, DN				KLUGE, DN			CRANIAL TREPHINATION FOR DIAGNOSIS AND THERAPY IN CLOSED INJURIES TO THE HEAD - A 5-YEAR REVIEW	AMERICAN JOURNAL OF SURGERY			English	Article																	ECHLIN FA, 1956, JAMA-J AM MED ASSOC, V161, P1345, DOI 10.1001/jama.1956.02970140001001; GURDJIAN ES, 1958, J NEUROSURG, V15, P125, DOI 10.3171/jns.1958.15.2.0125	2	3	3	0	0	CAHNERS PUBL CO	NEW YORK	249 WEST 17 STREET, NEW YORK, NY 10011	0002-9610			AM J SURG	Am. J. Surg.		1960	99	5					707	712		10.1016/0002-9610(60)90018-0			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	WG651	WOS:A1960WG65100018	14410005				2022-02-06	
J	WANKE, R				WANKE, R			THE SYNDROME OF TRAUMATIC BRAIN INJURY	DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT			German	Article																	BORCHARDTBALL E, 1935, ARCH ORTH CHIR, V35, P227; BUES E, 1956, Bruns Beitr Klin Chir, V193, P69; BUES E, 1957, VERH DTSCH GES UNFAL, V56, P151; FRATTINI PG, 1942, Z ORG CHIR, V106, P214; GAMPER E, 1936, MED KLIN, V39, P1353; HALLERVORDEN J, 1957, DEUT MED WOCHENSCHR, V82, P129, DOI 10.1055/s-0028-1114649; LAPIDARI M, 1937, ZBL CHIR, V64, P2254; MEYER JS, 1955, ELECTROEN CLIN NEURO, V7, P529, DOI 10.1016/0013-4694(55)90078-X; REICHARDT M, 1911, Z NEUR, V3, P1; REICHARDT M, 1927, HDB NORMALEN PATHOLO, V10, P103; REICHERDT M, 1933, MUNCH MED WSCHR, V80, P1922; WANKE R, 1951, Langenbecks Arch Klin Chir Ver Dtsch Z Chir, V270, P384, DOI 10.1007/BF01400430; WANKE R, 1947, PATHOPHYSIOL FRISCHE; WANKE R, 1950, WIENER MED WSCHR, V100, P196; WARD LW, 1943, VIRCH ARCH, V310, P1; WARD LW, 1940, ZBL NEUROCHIR, V5, P166; [No title captured]	17	3	3	0	0	GEORG THIEME VERLAG	STUTTGART	P O BOX 30 11 20, D-70451 STUTTGART, GERMANY	0012-0472			DEUT MED WOCHENSCHR	Dtsch. Med. Wochenschr.		1959	84	4					137	&		10.1055/s-0028-1113560			0	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WU769	WOS:A1959WU76900002	13619409				2022-02-06	
J	HOOPER, RS				HOOPER, RS			THE CLOSED HEAD INJURY - MODERN CONCEPTIONS AND THEIR INFLUENCE ON TREATMENT	MEDICAL JOURNAL OF AUSTRALIA			English	Article																		0	3	3	0	0	AUSTRALASIAN MED PUBL CO LTD	SYDNEY	LEVEL 1, 76 BERRY ST, SYDNEY NSW 2060, AUSTRALIA	0025-729X			MED J AUSTRALIA	Med. J. Aust.		1949	2	24					840	845		10.5694/j.1326-5377.1949.tb37400.x			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YH140	WOS:A1949YH14000005	15400696				2022-02-06	
J	Engel, D				Engel, D.			BLOOD-BRAIN BARRIER IN CONCUSSION	ACTA PSYCHIATRICA ET NEUROLOGICA			English	Article																	KATZENELBOGEN S, 1935, CEREBRO SPINAL FLUID; ZETTERHOLM S, 1947, ACTA PSYCHIAT NEUR S, V45	2	3	3	0	1	BLACKWELL MUNKSGAARD	FREDERIKSBERG C	1 ROSENORNS ALLE, DK-1970 FREDERIKSBERG C, DENMARK	0365-558X			ACTA PSYCH NEUROL	Acta Psychiatr. Neurol.		1948	23	3-4					231	234		10.1111/j.1600-0447.1948.tb09365.x			4	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	V01GI	WOS:000206843700003					2022-02-06	
J	SCHWAB, RS				SCHWAB, RS			THE SYNDROME OF AIRBLAST CONCUSSION - CEREBRAL	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article																	Abbott WD, 1943, J AMER MED ASSOC, V121, P739, DOI 10.1001/jama.1943.02840100025007; Abbott WD, 1943, J AMER MED ASSOC, V121, P664, DOI 10.1001/jama.1943.02840090034010; Bailey P, 1918, J AMER MED ASSOC, V71, P2148, DOI 10.1001/jama.1918.26020520017010e; DENNYBROWN D, 1945, PHYSIOL REV, V25, P296, DOI 10.1152/physrev.1945.25.2.296; FABING H, UNPUB ARCH NEUROL PS; FULTON JF, 1946, NEW ENGLAND J MED, V226, P1; Grinker Roy R, 1943, WAR NEUROSES N AFRIC; IRELAND MW, 1929, MED DEP US ARMY WORL, V10, P336; Mott FW, 1916, LANCET, V1, P441; Mott FW, 1916, LANCET, V1, P331; Mott FW, 1916, LANCET, V1, P545; Myers CS, 1916, LANCET, V1, P65; Myers CS, 1915, LANCET, V1, P316; Penhallow DP, 1916, BOSTON MED SURG J, V174, P131, DOI 10.1056/NEJM191601271740403; SOUTHARD EE, 1917, J MENT HYG, V1, P397; VIETS HR, 1917, JAMA, V59, P1779; Zuckerman S, 1940, LANCET, V2, P219	17	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.		1946	131	2					101	103		10.1001/jama.1946.02870190025006			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UC966	WOS:A1946UC96600006	21025613				2022-02-06	
J	Perlman, HB				Perlman, H. B.			THE EFFECTS OF NOISE AND CONCUSSION ON HEARING	JOURNAL OF SPEECH DISORDERS			English	Article																		0	3	3	0	0	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	10801 ROCKVILLE PIKE, ROCKVILLE, MD 20852-3279 USA	0885-9426			J SPEECH DISORD	J. Speech Disord.	SEP	1943	8	3					289	295		10.1044/jshd.0803.289			7	Linguistics	Social Science Citation Index (SSCI)	Linguistics	V57YQ	WOS:000203917200010					2022-02-06	
J	Fleck, U				Fleck, U			Concerning sexual disturbances from cerebral concussion	ZEITSCHRIFT FUR DIE GESAMTE NEUROLOGIE UND PSYCHIATRIE			German	Article																		0	3	3	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-4194			Z GESAMTE NEUROL PSY	Z. Gesamte Neurol. Psychiatr.		1939	165						318	320		10.1007/BF02871516			3	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	V37ZL	WOS:000202567300040					2022-02-06	
J	Symonds, CP				Symonds, CP			Prognosis in cerebral concussion and contusion	LANCET			English	Article																		0	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet		1936	1						854	856					3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V9601	WOS:000188727800318					2022-02-06	
J	Bennett, AE; Hunt, HB				Bennett, AE; Hunt, HB			Traumatic encephalitis - Case reports of so-called cerebral concussion with encephalographic findings	ARCHIVES OF SURGERY			English	Article									Univ Nebraska, Coll Med, Dept Neurol, Lincoln, NE USA; Univ Nebraska, Coll Med, Dept Radiol, Lincoln, NE USA								Bagley C, 1928, ARCH SURG-CHICAGO, V17, P18, DOI 10.1001/archsurg.1928.01140070021002; FAY T, 1929, T SECT SURG GEN, P186; Glaser MA, 1932, J AMER MED ASSOC, V98, P271, DOI 10.1001/jama.1932.02730300001001; Osnato M, 1927, ARCH NEURO PSYCHIATR, V18, P181, DOI 10.1001/archneurpsyc.1927.02210020025002; POMME B, 1931, REV NEUROL, V1, P483; 1931, NEUROLOGY PRACTICAL, P60	6	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0004-0010	1538-3644		ARCH SURG-CHICAGO	Arch. Surg.	MAR	1933	26	3					397	406		10.1001/archsurg.1933.01170030054004			10	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	V05WF	WOS:000200395700004					2022-02-06	
J	Linthicum, FH; Rand, CW				Linthicum, FH; Rand, CW			Neuro-otological observations in concussion of the brain	JOURNAL OF OTOLARYNGOLOGY			English	Article																	AMBERG E, 1914, J MICHIGAN M SOC, V13, P84; Brunner H, 1925, MSCHR OHRENHEILK, V59, P697; BRUNNER H, 1925, MONATSCHR OHRENH, V59, P763; BRUNNER H, 1925, MONATSCHR OHRENH, V59, P922; Fletcher HA, 1922, J AMER MED ASSOC, V79, P529, DOI 10.1001/jama.1922.02640070017005; GOTTLIEB MJ, 1922, LARYNGOSCOPE, V32, P783; Greenacre P, 1917, B JOHNS HOPKINS HOSP, V28, P86; Grove WE, 1928, ARCHIV OTOLARYNGOL, V8, P249; HALSZ H, 1901, WIEN MED WCHNSCHR, V51, P1538; HOFMANN L, 1925, ANN MAL OREILLE LARY, V44, P1254; Hubby LM, 1927, ARCHIV OTOLARYNGOL, V6, P405; LINTHICUM FH, 1923, T PACIFIC COAST OTO; MYGIND SH, 1918, ACTA OTO-LARYNGOL, V1, P513; Osnato M, 1927, ARCH NEURO PSYCHIATR, V18, P181, DOI 10.1001/archneurpsyc.1927.02210020025002; PASSOW KA, 1905, MUNICH; RHESE, 1906, Z OHRENH, V52, P320; RISK EJE, 1890, BRIT MED J, V1, P234; SCHUSTER FB, 1927, SW MED, V11, P116; STENGER, 1909, ARCH OHRENHEILK, V79, P43; ZACHS MA, 1928, LARYNGOSCOPE, V38, P288	20	3	3	0	0	B C DECKER INC	HAMILTON	20 HUGHSON ST SOUTH, PO BOX 620, L C D 1, HAMILTON, ONTARIO L8N 3K7, CANADA	0381-6605			J OTOLARYNGOL	J. Otolaryngol.	JUN	1931	13	6					785	821					37	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	V09ZL	WOS:000200674500001					2022-02-06	
J	Pignede, MM; Abely, P				Pignede, M. M.; Abely, Paul			DISTANT SEQUELAE OF CEREBRAL CONCUSSIONS	ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE			French	Article																		0	3	3	0	0	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0013-7006			ENCEPHALE	Enceph.-Rev. Psychiatr. Clin. Biol. Ther.	JUN	1930	25	6					436	443					8	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	V02NY	WOS:000206931100002					2022-02-06	
J	Lhermitte, J; Cornil, L				Lhermitte, J.; Cornil, L.			THE HETERESTHESIA IN DIRECT CONCUSSION OF THE SPINAL CORD	ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE			French	Article																	CLAUDE H, 1916, REV MED          SEP, P535; CLAUDE H, 1917, PARIS MED        JUI; CLAUDE H, 1915, ANN MED          OCT; FLATAU E, HDB NEUROLOGIE, V2, P687; GRAHAMBROWN, J NEUROLOGY PSYCHOPA, V1, P54; HENNEBERG, HDB NEUROLOGIE LEWAN, V2, P740; LHERMITTE J, 1917, ANN MED          JUI; LHERMITTE J, 1920, REV NEUROL, V1, P257; OPPENHEIM H, 1907, BEITRAGE DIAGNOSTIK; RANSON, 1894, BRIT MED J      0224; Roussy G, 1918, BLESSURES MOELLE QUE	11	3	3	0	0	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0013-7006			ENCEPHALE	Enceph.-Rev. Psychiatr. Clin. Biol. Ther.	APR	1922	17	4					201	212					12	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	V02KO	WOS:000206922300001					2022-02-06	
J	Dawson, GD				Dawson, GD			A case of shell concussion treatment by general an ae sthesia	LANCET			English	Article																		0	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet		1916	1						463	464					2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V9561	WOS:000188723900152					2022-02-06	
J	Tromner, E				Tromner, E			Concerning traumatic (concussion) psychoses	ZEITSCHRIFT FUR DIE GESAMTE NEUROLOGIE UND PSYCHIATRIE			German	Article																	ARONSOHN, 1909, DTSCH MED WOCHENSCHR; BERGMANN, 1880, LEHRE KOPFVERLETZUNG; BERLINER K, 1908, SOMMERS KLIN PSYCHIS, V3, P291; BINSWANGER, 1907, LEHRBUCH PSYCHIAT; BRUSH, MED RECORD, V72, P813; BURR, J AM MED ASS, V48, P33; CALBERLAH, 1904, ARCH PSYCH, V38; FRIEDMANN, 1891, ARCH PSYCH, V23; GUDER, 1886, GEISTESSTORUNGEN KOP; HEILBRONNER, MUNCH MED WOCHENSCHR, P2354; KOCHER, 1901, NOTHNAGELS SPEZ PATH, V9, P3; KOPPEN, 1900, ARCH PSYCHIAT, P568; KRAEPELIN, 1909, LEHRBUCH PSYCH, V1, P36; KRAEPELIN, 1904, LEHRBUCH PSYCH, V5, P436; KRAFFT, 1890, LEHRBUCH PSYCH, P189; KRAFFT, 1868, DURCH GEHIRNERSCHUTT; OPPENHEIM, 1908, LEHRBUCH; SCHLAGER, 1857, Z ARZTE WIEN; TRENDELENBURG, 1910, DTSCH MED WOCHENSCHR, P1; TROMNER, 1899, BERL KLIN WOCHENSCHR; TROMNER, 1908, MITT GRENZGEB MED CH, V18, P5; WINDSCHEID, 1910, DTSCH MED WOCHENSCHR, P8	22	3	3	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-4194			Z GESAMTE NEUROL PSY	Z. Gesamte Neurol. Psychiatr.		1910	3						548	562		10.1007/BF02893610			15	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	V39BP	WOS:000202640500019					2022-02-06	
J	Puybasset, L; Perlbarg, V; Unrug, J; Cassereau, D; Galanaud, D; Torkomian, G; Battisti, V; Lefort, M; Velly, L; Degos, V; Citerio, G; Bayen, E; Pelegrini-Issac, M				Puybasset, Louis; Perlbarg, Vincent; Unrug, Jean; Cassereau, Didier; Galanaud, Damien; Torkomian, Gregory; Battisti, Valentine; Lefort, Muriel; Velly, Lionel; Degos, Vincent; Citerio, Guiseppe; Bayen, Eleonore; Pelegrini-Issac, Melanie		MRI-COMA Investigators; CENTER-TBI MRI Participants; MRI Only Investigators	Prognostic value of global deep white matter DTI metrics for 1-year outcome prediction in ICU traumatic brain injury patients: an MRI-COMA and CENTER-TBI combined study	INTENSIVE CARE MEDICINE			English	Article						Traumatic brain injury; Outcome; Prognosis; Diffusion tensor imaging; Deep white matter	CARDIAC-ARREST; RECOVERY; MULTICENTER; MODELS; STATE; CARE	Purpose A reliable tool for outcome prognostication in severe traumatic brain injury (TBI) would improve intensive care unit (ICU) decision-making process by providing objective information to caregivers and family. This study aimed at designing a new classification score based on magnetic resonance (MR) diffusion metrics measured in the deep white matter between day 7 and day 35 after TBI to predict 1-year clinical outcome. Methods Two multicenter cohorts (29 centers) were used. MRI-COMA cohort (NCT00577954) was split into MRI-COMA-Train (50 patients enrolled between 2006 and mid-2014) and MRI-COMA-Test (140 patients followed up in clinical routine from 2014) sub-cohorts. These latter patients were pooled with 56 ICU patients (enrolled from 2014 to 2020) from CENTER-TBI cohort (NCT02210221). Patients were dichotomised depending on their 1-year Glasgow outcome scale extended (GOSE) score: GOSE 1-3, unfavorable outcome (UFO); GOSE 4-8, favorable outcome (FO). A support vector classifier incorporating fractional anisotropy and mean diffusivity measured in deep white matter, and age at the time of injury was developed to predict whether the patients would be either UFO or FO. Results The model achieved an area under the ROC curve of 0.93 on MRI-COMA-Train training dataset, and 49% sensitivity for 96.8% specificity in predicting UFO and 58.5% sensitivity for 97.1% specificity in predicting FO on the pooled MRI-COMA-Test and CENTER-TBI validation datasets. Conclusion The model successfully identified, with a specificity compatible with a personalized decision-making process in ICU, one in two patients who had an unfavorable outcome at 1 year after the injury, and two-thirds of the patients who experienced a favorable outcome.	[Puybasset, Louis; Unrug, Jean; Torkomian, Gregory; Battisti, Valentine] Sorbonne Univ, Hop Pitie Salpetriere, AP HP, Neurosurg Intens Care Unit, Paris, France; [Puybasset, Louis; Unrug, Jean; Cassereau, Didier; Galanaud, Damien; Lefort, Muriel; Bayen, Eleonore; Pelegrini-Issac, Melanie] Sorbonne Univ, CNRS, INSERM, Lab Imagerie Biomed LIB, Paris, France; [Puybasset, Louis] Grp Hosp Pitie Salpetriere, AP HP, Dept Anesthesiol & Intens Care, 47-83 Blvd Hop, F-75013 Paris, France; [Puybasset, Louis; Degos, Vincent] Sorbonne Univ, Clin Res Grp 29, Paris, France; [Perlbarg, Vincent] BrainTale SAS, Paris, France; [Galanaud, Damien] Sorbonne Univ, Hop Pitie Salpetriere, AP HP, Dept Neuroradiol, Paris, France; [Velly, Lionel] Aix Marseille Univ, Univ Hosp Timone, AP HM, Dept Anesthesiol & Crit Care Med, Marseille, France; [Velly, Lionel] Aix Marseille Univ, Inst Neurosci Timone, CNRS, UMR7289, Marseille, France; [Degos, Vincent] Sorbonne Univ, Hop Pitie Salpetriere, AP HP, Dept Anesthesia Crit Care & Perioperat Med, Paris, France; [Degos, Vincent] INSERM, UMR 1141, Paris, France; [Citerio, Guiseppe] Univ Milano Bicocca, Dept Med & Surg, Monza, Italy; [Citerio, Guiseppe] San Gerardo Hosp, ASST Monza, Dept Emergency & Urgency, Neurointens Care Unit, Monza, Italy; [Bayen, Eleonore] Sorbonne Univ, Hop Pitie Salpetriere, AP HP, Rehabil Unit, Paris, France		Puybasset, L (corresponding author), Sorbonne Univ, Hop Pitie Salpetriere, AP HP, Neurosurg Intens Care Unit, Paris, France.; Puybasset, L (corresponding author), Sorbonne Univ, CNRS, INSERM, Lab Imagerie Biomed LIB, Paris, France.; Puybasset, L (corresponding author), Grp Hosp Pitie Salpetriere, AP HP, Dept Anesthesiol & Intens Care, 47-83 Blvd Hop, F-75013 Paris, France.; Puybasset, L (corresponding author), Sorbonne Univ, Clin Res Grp 29, Paris, France.	louis.puybasset@aphp.fr	; Cassereau, Didier/P-4384-2017	Juarez Del Toro, Juan Miguel/0000-0002-1461-0091; Perlbarg, Vincent/0000-0002-3438-2479; Cassereau, Didier/0000-0003-2412-2144; Velly, Lionel/0000-0001-5009-1711; PUYBASSET, Louis/0000-0002-6849-1825	French Ministry of Health, Paris, France (Programme Hospitalier de Recherche Clinique 2005) [051061]; French National Agency for Research (ANR)French National Research Agency (ANR) [ANR-10-IAIHU-06]; Regione LombardiaRegione Lombardia [2010-RF-2010-2319503]; European UnionEuropean Commission [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA); Italian Ministry of healthMinistry of Health, Italy	The MRI-COMA trial was funded by independent research grants from non-profit or governmental agencies: French Ministry of Health, Paris, France (Programme Hospitalier de Recherche Clinique 2005 #051061), and the French National Agency for Research (ANR) for the program "Investissements d'avenir" ANR-10-IAIHU-06 (to the Brain and Spine Institute); Italian Ministry of health and Regione Lombardia (Ricerca Finalizzata 2010-RF-2010-2319503). CENTERTBI data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Union 7th Framework program (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA) and from Integra LifeSciences Corporation (USA).	Baricich A, 2017, FUNCT NEUROL, V32, P131; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Budde MD, 2007, MAGN RESON MED, V57, P688, DOI 10.1002/mrm.21200; Collins GS, 2015, ANN INTERN MED, V162, P55, DOI [10.7326/M14-0697, 10.1002/bjs.9736, 10.1111/dme.12654, 10.1038/bjc.2014.639, 10.1016/j.jclinepi.2014.11.010, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594]; Cox SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13629; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Fraser EE, 2019, J NEUROTRAUM, V36, P2753, DOI 10.1089/neu.2019.6430; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Gravesteijn BY, 2020, J CLIN EPIDEMIOL, V122, P95, DOI 10.1016/j.jclinepi.2020.03.005; Haveman ME, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2656-6; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hutchinson EB, 2018, J NEUROSCI RES, V96, P612, DOI 10.1002/jnr.24065; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; JENNETT B, 1975, LANCET, V1, P480; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Lazaridis C, 2015, J CRIT CARE, V30, P1258, DOI 10.1016/j.jcrc.2015.08.003; Luyt CE, 2012, ANESTHESIOLOGY, V117, P1311, DOI 10.1097/ALN.0b013e318275148c; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; NEWCOMBE V, 2011, ONE, V6, DOI DOI 10.1371/JOURNAL.PONE.0019214; O'Donnell LJ, 2011, NEUROSURG CLIN N AM, V22, P185, DOI 10.1016/j.nec.2010.12.004; Pagani E, 2010, J MAGN RESON IMAGING, V31, P1458, DOI 10.1002/jmri.22186; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Provencio JJ, 2020, NEUROCRIT CARE, V33, P1, DOI 10.1007/s12028-020-01028-9; R Development Core Team, 2012, R LANG ENV STAT COMP; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Souza Edna Marina de, 2017, Res. Biomed. Eng., V33, P156, DOI 10.1590/2446-4740.07816; Stevens RD, 2014, CURR OPIN CRIT CARE, V20, P168, DOI 10.1097/MCC.0000000000000069; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Velly L, 2018, LANCET NEUROL, V17, P317, DOI 10.1016/S1474-4422(18)30027-9; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	35	2	2	8	8	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	FEB	2022	48	2					201	212		10.1007/s00134-021-06583-z		DEC 2022	12	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YQ3NH	WOS:000729722800001	34904191	Green Submitted			2022-02-06	
J	Jarvis, JL; Lyng, JW; Miller, BL; Perlmutter, MC; Abraham, H; Sahni, R				Jarvis, Jeffrey L.; Lyng, John W.; Miller, Brian L.; Perlmutter, Michael C.; Abraham, Heidi; Sahni, Ritu			Prehospital Drug Assisted Airway Management: An NAEMSP Position Statement and Resource Document	PREHOSPITAL EMERGENCY CARE			English	Article						prehospital; out-of-hospital; airway management; rapid sequence intubation; rapid sequence airway; delayed sequence airway; apneic oxygenation; capnography	RAPID-SEQUENCE INTUBATION; EMERGENCY-DEPARTMENT; CARDIAC-ARREST; ENDOTRACHEAL INTUBATION; FACEMASK VENTILATION; HEAD-INJURY; NEUROMUSCULAR BLOCKADE; TRACHEAL INTUBATION; INCREASED MORTALITY; APNEIC OXYGENATION	Airway management is a critical intervention for patients with airway compromise, respiratory failure, and cardiac arrest. Many EMS agencies use drug-assisted airway management (DAAM) - the administration of sedatives alone or in combination with neuromuscular blockers - to facilitate advanced airway placement in patients with airway compromise or impending respiratory failure who also have altered mental status, agitation, or intact protective airway reflexes. While DAAM provides several benefits including improving laryngoscopy and making insertion of endotracheal tubes and supraglottic airways easier, DAAM also carries important risks. NAEMSP recommends: DAAM is an appropriate tool for EMS clinicians in systems with clear guidelines, sufficient training, and close EMS physician oversight. DAAM should not be used in settings without adequate resources. EMS physicians should develop clinical guidelines informed by evidence and oversee the training and credentialing for safe and effective DAAM. DAAM programs should include best practices of airway management including patient selection, assessmenct and positioning, preoxygenation strategies including apneic oxygenation, monitoring and management of physiologic abnormalities, selection of medications, post-intubation analgesia and sedation, equipment selection, airway confirmation and monitoring, and rescue airway techniques. Post-DAAM airway placement must be confirmed and continually monitored with waveform capnography. EMS clinicians must have the necessary equipment and training to manage patients with failed DAAM, including bag mask ventilation, supraglottic airway devices and surgical airway approaches. Continuous quality improvement for DAAM must include assessment of individual and aggregate performance metrics. Where available for review, continuous physiologic recordings (vital signs, pulse oximetry, and capnography), audio and video recordings, and assessment of patient outcomes should be part of DAAM continuous quality improvement.	[Jarvis, Jeffrey L.] Williamson Cty EMS, Georgetown, TX 78626 USA; [Jarvis, Jeffrey L.] Texas A&M Coll Med, Baylor Scott & White, Temple, TX 76508 USA; [Lyng, John W.] Univ Minnesota, Med Sch, Minneapolis, MN USA; [Miller, Brian L.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Miller, Brian L.] MedStar Mobile Healthcare, Metropolitan Area EMS Author, Ft Worth, TX USA; [Lyng, John W.; Perlmutter, Michael C.] North Mem Hlth Air Care, Brooklyn Ctr, MN USA; [Abraham, Heidi] Austin Travis Cty EMS, Austin, TX USA; [Sahni, Ritu] Clackamas Cty EMS, Oregon City, OR USA; [Sahni, Ritu] Washington Cty EMS, Hillsboro, OR USA; [Sahni, Ritu] Oregon Hlth & Sci Univ, Portland, OR 97201 USA		Jarvis, JL (corresponding author), Williamson Cty EMS, Georgetown, TX 78626 USA.; Jarvis, JL (corresponding author), Texas A&M Coll Med, Baylor Scott & White, Temple, TX 76508 USA.	jjarvis@wilco.org		Lyng, John/0000-0001-5191-5700; Miller, Brian/0000-0002-2736-4336			Aguilar SA, 2012, J EMERG MED, V42, P424, DOI 10.1016/j.jemermed.2011.06.127; Alfahel W, 2020, ANESTH ANALG, V131, P1210, DOI 10.1213/ANE.0000000000004802; [Anonymous], 2017, PREHOSP EMERG CARE, V21, P397, DOI 10.1080/10903127.2017.1282565; April MD, 2021, RESUSCITATION, V162, P403, DOI 10.1016/j.resuscitation.2021.02.039; April MD, 2018, ANN EMERG MED, V72, P645, DOI 10.1016/j.annemergmed.2018.03.042; Baekgaard JS, 2019, ANESTH ANALG, V128, P504, DOI 10.1213/ANE.0000000000003568; Baillard C, 2006, AM J RESP CRIT CARE, V174, P171, DOI 10.1164/rccm.200509-1507OC; Binks MJ, 2017, AM J EMERG MED, V35, P1542, DOI 10.1016/j.ajem.2017.06.046; Bodily JB, 2016, ANN EMERG MED, V67, P389, DOI 10.1016/j.annemergmed.2015.06.006; Boehringer B, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/821302; Bonomo JB, 2008, AM J EMERG MED, V26, P469, DOI 10.1016/j.ajem.2007.05.024; Bossers SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141034; Bouvet L, 2014, ANESTHESIOLOGY, V120, P326, DOI 10.1097/ALN.0000000000000094; Bozeman WP, 2006, PREHOSP EMERG CARE, V10, P8, DOI 10.1080/10903120500366854; Bozeman William P, 2002, Air Med J, V21, P32, DOI 10.1067/mmj.2002.125935; Braude D, 2007, PREHOSP EMERG CARE, V11, P250, DOI 10.1080/10903120701206032; Brown CA, 2020, ACAD EMERG MED, V27, P100, DOI 10.1111/acem.13851; Brown DJ, 2018, J EMERG MED, V55, P481, DOI 10.1016/j.jemermed.2018.05.029; Brown DJ, 2018, AM J EMERG MED, V36, P942, DOI 10.1016/j.ajem.2017.10.055; Bulger EM, 2005, J TRAUMA, V58, P718, DOI 10.1097/01.TA.0000159239.14181.BC; Burns Brian, 2016, Air Med J, V35, P28, DOI 10.1016/j.amj.2015.10.002; Caputo ND, 2019, ANN EMERG MED, V74, P410, DOI 10.1016/j.annemergmed.2019.01.038; Cemalovic N, 2016, EMERG MED AUSTRALAS, V28, P295, DOI 10.1111/1742-6723.12575; Choi YF, 2004, EMERG MED J, V21, P700, DOI 10.1136/emj.2002.004143; Chong ID, 2014, AM J EMERG MED, V32, P452, DOI 10.1016/j.ajem.2014.01.002; Clemency BM, 2014, PREHOSP EMERG CARE, V18, P239, DOI 10.3109/10903127.2013.864352; Cuvas O, 2011, ACTA ANAESTH SCAND, V55, P530, DOI 10.1111/j.1399-6576.2011.02417.x; Davis D P, 2001, Prehosp Emerg Care, V5, P163, DOI 10.1080/10903120190940065; Davis Daniel P, 2017, Air Med J, V36, P195, DOI 10.1016/j.amj.2017.04.001; Davis Daniel P, 2015, Air Med J, V34, P82, DOI 10.1016/j.amj.2014.12.007; Davis DP, 2011, PREHOSP EMERG CARE, V15, P18, DOI 10.3109/10903127.2010.514091; Davis DP, 2005, J TRAUMA, V59, P484, DOI 10.1097/00005373-200508000-00037; Davis DP, 2005, NEUROCRIT CARE, V2, P165, DOI 10.1385/NCC:2:2:165; Davis DP, 2004, J TRAUMA, V56, P808, DOI 10.1097/01.TA.0000100217.05066.87; Denninghoff KR, 2017, PREHOSP EMERG CARE, V21, P539, DOI 10.1080/10903127.2017.1315201; Di Cicco M, 2021, PEDIATR PULM, V56, P240, DOI 10.1002/ppul.25169; Dorsett M, 2022, PREHOSP EMERG CARE, V26, P3, DOI 10.1080/10903127.2021.1977877; Drayna PC, 2012, AM J EMERG MED, V30, P1215, DOI 10.1016/j.ajem.2011.06.001; Driver B, 2017, ANN EMERG MED, V70, P473, DOI 10.1016/j.annemergmed.2017.04.033; Driver BE, 2020, J EMERG MED, V60, P265, DOI 10.1016/j.jemermed.2020.10.042; Silva LOJE, 2017, ANN EMERG MED, V70, P483, DOI 10.1016/j.annemergmed.2017.05.001; El-Orbany M, 2011, ANESTH ANALG, V113, P103, DOI 10.1213/ANE.0b013e31821c7e9c; Farrell NM, 2020, J EMERG MED, V59, P508, DOI 10.1016/j.jemermed.2020.06.054; Filanovsky Y, 2010, CAN J EMERG MED, V12, P154; Fouche PF, 2019, EMERG MED J, V36, P416, DOI 10.1136/emermed-2019-208613; Gencay ZK, 2019, PEDIATR ANESTH, V29, P814, DOI 10.1111/pan.13685; Grmec S, 2002, INTENS CARE MED, V28, P701, DOI 10.1007/s00134-002-1290-x; Groombridge CJ, 2017, ANAESTHESIA, V72, P580, DOI 10.1111/anae.13852; Groombridge C, 2016, ACAD EMERG MED, V23, P342, DOI 10.1111/acem.12889; Guihard B, 2019, JAMA-J AM MED ASSOC, V322, P2303, DOI 10.1001/jama.2019.18254; Hasegawa K, 2012, ANN EMERG MED, V60, P749, DOI 10.1016/j.annemergmed.2012.04.005; Heffner AC, 2013, RESUSCITATION, V84, P1500, DOI 10.1016/j.resuscitation.2013.07.022; Hubble MW, 2010, PREHOSP EMERG CARE, V14, P515, DOI 10.3109/10903127.2010.497903; Ishimaru T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53360-6; Jabre P, 2009, LANCET, V374, P293, DOI 10.1016/S0140-6736(09)60949-1; Jacoby J, 2006, ANN EMERG MED, V47, P525, DOI 10.1016/j.annemergmed.2005.12.009; Jarvis JL, 2019, RESUSCITATION, V141, P136, DOI 10.1016/j.resuscitation.2019.06.002; Jarvis JL, 2018, RESUSCITATION, V130, P57, DOI 10.1016/j.resuscitation.2018.07.002; Jarvis JL, 2018, ANN EMERG MED, V72, P272, DOI 10.1016/j.annemergmed.2018.01.044; Jarvis JL, 2015, PREHOSP EMERG CARE, V19, P482, DOI 10.3109/10903127.2015.1005259; Jemmett ME, 2003, ACAD EMERG MED, V10, P961, DOI 10.1197/S1069-6563(03)00315-4; Joffe AM, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0111-z; Johnson EG, 2015, J EMERG MED, V49, P43, DOI 10.1016/j.jemermed.2014.12.028; Katz SH, 2001, ANN EMERG MED, V37, P32, DOI 10.1067/mem.2001.112098; Khandelwal N, 2016, ANESTH ANALG, V122, P1101, DOI 10.1213/ANE.0000000000001184; Kim EH, 2017, AM J EMERG MED, V35, P867, DOI 10.1016/j.ajem.2017.01.048; Kim EH, 2016, EUR J ANAESTH, V33, P528, DOI 10.1097/EJA.0000000000000448; Kim J, 2014, RESUSCITATION, V85, P623, DOI 10.1016/j.resuscitation.2014.01.017; Kim WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112779; Kwok H, 2013, RESUSCITATION, V84, P1353, DOI 10.1016/j.resuscitation.2013.04.015; Langhan ML, 2011, ACAD EMERG MED, V18, P590, DOI 10.1111/j.1553-2712.2011.01090.x; Latimer AJ, 2021, ANN EMERG MED, V77, P296, DOI 10.1016/j.annemergmed.2020.10.016; Lebin JA, 2019, ACAD EMERG MED, V26, P889, DOI 10.1111/acem.13725; Lembersky O, 2020, AM J EMERG MED, V38, P466, DOI 10.1016/j.ajem.2019.05.010; Leslie K, 2010, ANESTH ANALG, V110, P823, DOI 10.1213/ANE.0b013e3181b8b6ca; Levin NM, 2021, CAN J EMERG MED, V23, P518, DOI 10.1007/s43678-021-00119-6; Lyng JW, 2022, PREHOSP EMERG CARE, V26, P32, DOI 10.1080/10903127.2021.1983680; Mandt M, 2022, PREHOSP EMERG CARE, V26, P111, DOI 10.1080/10903127.2021.1986184; McPhee LC, 2013, CRIT CARE MED, V41, P774, DOI 10.1097/CCM.0b013e318274190d; McQuade D, 2018, ANESTH ANALG, V126, P1214, DOI 10.1213/ANE.0000000000002341; Merelman AH, 2019, WEST J EMERG MED, V20, P466, DOI 10.5811/westjem.2019.4.42753; Miller M, 2016, ANN EMERG MED, V68, P181, DOI 10.1016/j.annemergmed.2016.03.041; Mohr NM, 2020, ACAD EMERG MED, V27, P1140, DOI 10.1111/acem.14070; Mort TC, 2004, J CLIN ANESTH, V16, P508, DOI 10.1016/j.jclinane.2004.01.007; Murphy DL, 2019, AM J EMERG MED, V37, P937, DOI 10.1016/j.ajem.2019.02.038; Nausheen F, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0614-6; Nimmagadda U, 2017, ANESTH ANALG, V124, P507, DOI 10.1213/ANE.0000000000001589; Okamoto H, 2019, RESUSCITATION, V136, P70, DOI 10.1016/j.resuscitation.2018.10.005; Okubo M, 2017, INT J EMERG MED, V10, DOI 10.1186/s12245-017-0129-8; Oliver M, 2020, JACEP OPEN, V1, P706, DOI 10.1002/emp2.12260; ORNATO JP, 1992, ANN EMERG MED, V21, P518, DOI 10.1016/S0196-0644(05)82517-X; Panchal AR, 2020, CIRCULATION, V142, pS366, DOI 10.1161/CIR.0000000000000916; Pappal RD, 2021, ANN EMERG MED, V77, P532, DOI 10.1016/j.annemergmed.2020.10.012; Parameters COSAP, 2020, PAR COSAP STAND BAS; Patanwala AE, 2016, PHARMACOTHERAPY, V36, P57, DOI 10.1002/phar.1683; Patanwala AE, 2014, ACAD EMERG MED, V21, P87, DOI 10.1111/acem.12292; Pavlov I, 2017, AM J EMERG MED, V35, P1184, DOI 10.1016/j.ajem.2017.06.029; Pelucio M, 1997, ACAD EMERG MED, V4, P563, DOI 10.1111/j.1553-2712.1997.tb03579.x; Poirier MP, 1998, AM J EMERG MED, V16, P350, DOI 10.1016/S0735-6757(98)90125-5; Powell EK, 2020, PREHOSP EMERG CARE, V24, P470, DOI 10.1080/10903127.2019.1670299; Price B, 2013, AM J EMERG MED, V31, P1124, DOI 10.1016/j.ajem.2013.03.041; Priebe HJ, 2016, J ANESTH, V30, P132, DOI 10.1007/s00540-015-2072-2; Reardon RF, 2022, PREHOSP EMERG CARE, V26, P96, DOI 10.1080/10903127.2021.1995552; Reed David B, 2002, Prehosp Emerg Care, V6, P50, DOI 10.1080/10903120290938779; Russotto V, 2021, JAMA-J AM MED ASSOC, V325, P1164, DOI 10.1001/jama.2021.1727; Sagarin MJ, 2002, PEDIATR EMERG CARE, V18, P417, DOI 10.1097/00006565-200212000-00004; Sakles JC, 2016, INTERN EMERG MED, V11, P983, DOI 10.1007/s11739-016-1396-8; Sakles JC, 2013, ACAD EMERG MED, V20, P71, DOI 10.1111/acem.12055; Schenarts CL, 2001, ACAD EMERG MED, V8, P1, DOI 10.1111/j.1553-2712.2001.tb00537.x; Seet MM, 2009, EUR J ANAESTH, V26, P913, DOI 10.1097/EJA.0b013e328329b0ab; Silvestri S, 2005, ANN EMERG MED, V45, P497, DOI 10.1016/j.annemergmed.2004.09.014; Silvestri S, 2017, RESUSCITATION, V115, P192, DOI 10.1016/j.resuscitation.2017.01.002; Soltesz S, 2017, ANAESTHESIA, V72, P1484, DOI 10.1111/anae.14035; Southard A, 2010, RESUSCITATION, V81, P576, DOI 10.1016/j.resuscitation.2009.12.026; Stoecklein HH, 2019, ACAD EMERG MED, V26, P1144, DOI 10.1111/acem.13805; Taha SK, 2010, ANAESTHESIA, V65, P358, DOI 10.1111/j.1365-2044.2010.06243.x; Tekwani KL, 2010, ANN EMERG MED, V56, P481, DOI 10.1016/j.annemergmed.2010.05.034; Thompson Bastin Melissa L, 2014, Hosp Pharm, V49, P177, DOI 10.1310/hpj4902-177; Timmermann A, 2007, ANESTHESIOLOGY, V107, P570, DOI 10.1097/01.anes.0000281940.92807.23; Tran DTT, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002788.pub3; Trivedi S, 2015, J CRIT CARE, V30, DOI 10.1016/j.jcrc.2015.04.013; Upchurch CP, 2017, ANN EMERG MED, V69, P24, DOI 10.1016/j.annemergmed.2016.08.009; Vialet R, 2008, PEDIATR ANESTH, V18, P525, DOI 10.1111/j.1460-9592.2008.02530.x; Vialet R, 2009, CURR OPIN ANESTHESIO, V22, P396, DOI 10.1097/ACO.0b013e3283294cc7; Vithalani V, 2022, PREHOSP EMERG CARE, V26, P14, DOI 10.1080/10903127.2021.1989530; Walker RG, 2018, PREHOSP EMERG CARE, V22, P300, DOI 10.1080/10903127.2017.1380095; Wang H E, 2000, Prehosp Emerg Care, V4, P14, DOI 10.1080/10903120090941560; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wang HE, 2018, ANN EMERG MED, V71, P597, DOI 10.1016/j.annemergmed.2017.12.012; Wang Henry E, 2004, Prehosp Emerg Care, V8, P58; Warters RD, 2011, ANAESTHESIA, V66, P163, DOI 10.1111/j.1365-2044.2010.06601.x; Weingart SD, 2015, ANN EMERG MED, V65, P349, DOI 10.1016/j.annemergmed.2014.09.025; Weingart SD, 2012, ANN EMERG MED, V59, P165, DOI 10.1016/j.annemergmed.2011.10.002; Wimalasena Y, 2015, ANN EMERG MED, V65, P371, DOI 10.1016/j.annemergmed.2014.11.014	134	2	2	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	JAN 4	2022	26			1	SI		42	53		10.1080/10903127.2021.1990447			12	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	YE0WI	WOS:000740852400006	35001829	hybrid			2022-02-06	
J	Balakrishnan, S; Naik, S; Chakrabarti, D; Konar, S; Sriganesh, K				Balakrishnan, Sweatha; Naik, Shwetha; Chakrabarti, Dhritiman; Konar, Subhas; Sriganesh, Kamath			Effect of Respiratory Physiological Changes on Optic Nerve Sheath Diameter and Cerebral Oxygen Saturation in Patients With Acute Traumatic Brain Injury	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						traumatic brain injury; optic nerve sheath diameter; positive end-expiratory pressure; end-tidal carbon dioxide; regional cerebral oxygen saturation	END-EXPIRATORY PRESSURE; NEAR-INFRARED SPECTROSCOPY; INTRACRANIAL-PRESSURE; PEEP	Background: Severe traumatic brain injury (TBI) results in raised intracranial pressure (ICP). Ultrasonographic measurement of the optic nerve sheath diameter (ONSD) is a noninvasive method for the assessment of raised ICP. Manipulation of positive end-expiratory pressure (PEEP) and end-tidal carbon dioxide (ETCO2) are often used to optimize ICP and improve oxygenation in TBI patients. This study evaluated the effects of PEEP and ETCO2 on ONSD and regional cerebral oxygen saturation (rScO(2)) in patients with acute TBI. Methods: A total of 14 patients (11 males) aged older than 18 years with acute severe TBI were included in this study. ONSD and rScO(2) were assessed before and after changes in PEEP from 5 to 10 cmH(2)O and in ETCO2 from 40 to 30mmHg on both pathologic and nonpathologic sides. Results: Increasing PEEP and reducing ETCO2 resulted in changes in ONSD and rScO(2) on both pathologic and nonpathologic sides. On the pathologic side, ONSD and rScO(2) were highest with a PEEP of 10 cmH(2)O:ETCO2 40mmHg combination and lowest with PEEP of 5 cmH(2)O:ETCO2 30mmHg (ONSD 5.24 +/- 0.49 vs. 4.27 +/- 0.36 mm, P < 0.001; rScO(2) 70.7 +/- 9.91% vs. 66.3 +/- 9.75%, P < 0.001); both PEEP and ETCO2 had significant effects on ONSD and rScO(2) (P < 0.001). On the nonpathologic side, ONSD and rScO(2) were highest and lowest with PEEP of 10 cmH(2)O: ETCO2 40mmHg and PEEP of 5 cmH(2)O:ETCO2 30mmHg combinations, respectively (ONSD: 4.93 +/- 0.46 vs. 4.02 +/- 0.40mm, P < 0.001; rScO(2): 74.77 +/- 8.30% vs. 70.69 +/- 8.12%, P < 0.001). ETCO2 had a significant effect on rScO(2) (P < 0.001), but the impact of PEEP on rScO(2) was not statistically significant (P = 0.05). Conclusion: Increasing PEEP resulted in significant increases in ONSD and rScO(2), whereas reducing ETCO2 significantly decreased ONSD and rScO(2).	[Balakrishnan, Sweatha; Naik, Shwetha; Chakrabarti, Dhritiman; Konar, Subhas; Sriganesh, Kamath] Natl Inst Mental Hlth & Neurosci, Bengaluru, Karnataka, India		Sriganesh, K (corresponding author), Natl Inst Mental Hlth & Neurosci, Bengaluru, Karnataka, India.	drsri23@gmail.com					Bala R, 2019, INDIAN J ANAESTH, V63, P537, DOI 10.4103/ija.IJA_861_18; Boone MD, 2017, NEUROCRIT CARE, V26, P174, DOI 10.1007/s12028-016-0328-9; Budohoski KP, 2012, BRIT J ANAESTH, V108, P89, DOI 10.1093/bja/aer324; Caricato A, 2005, J TRAUMA, V58, P571, DOI 10.1097/01.TA.0000152806.19198.DB; COOPER KR, 1985, J NEUROSURG, V63, P552, DOI 10.3171/jns.1985.63.4.0552; Donnelly J, 2020, NEUROCRIT CARE, V32, P437, DOI 10.1007/s12028-019-00748-x; Ishiyama T, 2016, EUR J ANAESTH, V33, P929, DOI 10.1097/EJA.0000000000000507; Jacob Mathews, 2019, Med J Armed Forces India, V75, P190, DOI 10.1016/j.mjafi.2018.08.007; Restrepo JNJ, 2019, EMERG MED INT, V2019, DOI 10.1155/2019/9215853; Khandelwal A, 2018, J PEDIATR NEUROSCI, V13, P165, DOI 10.4103/jpn.JPN_112_17; Kim JY, 2014, KOREAN J ANESTHESIOL, V67, P240, DOI 10.4097/kjae.2014.67.4.240; Leal-Noval SR, 2010, INTENS CARE MED, V36, P1309, DOI 10.1007/s00134-010-1920-7; Maissan IM, 2015, J NEUROSURG, V123, P743, DOI 10.3171/2014.10.JNS141197; McGuire G, 1997, CRIT CARE MED, V25, P1059, DOI 10.1097/00003246-199706000-00025; Nemer SN, 2015, J CRIT CARE, V30, P1263, DOI 10.1016/j.jcrc.2015.07.019; Robba C, 2017, J NEUROSURG ANESTH, V29, P243, DOI 10.1097/ANA.0000000000000295; SHAPIRO HM, 1978, J TRAUMA, V18, P254, DOI 10.1097/00005373-197804000-00005; Suazo JAC, 2000, CRIT CARE MED, V28, P3268, DOI 10.1097/00003246-200009000-00024; TATEISHI A, 1995, CRIT CARE MED, V23, P1734, DOI 10.1097/00003246-199510000-00019; Venkateswaran P, 2019, J NEUROSURG ANESTH, V31, P241, DOI 10.1097/ANA.0000000000000498	20	2	2	4	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JAN	2022	34	1					E52	E56		10.1097/ANA.0000000000000706			5	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	XJ4ZX	WOS:000726799100016	32555065				2022-02-06	
J	Cardim, D; Czosnyka, M; Chandrapatham, K; Badenes, R; Bertuccio, A; Corradi, F; Donnelly, J; Pelosi, P; Hutchinson, PJ; Robba, C				Cardim, Danilo; Czosnyka, Marek; Chandrapatham, Karthikka; Badenes, Rafael; Bertuccio, Alessandro; Corradi, Francesco; Donnelly, Joseph; Pelosi, Paolo; Hutchinson, Peter J.; Robba, Chiara			Arterial and Venous Cerebral Blood Flow Velocities and Their Correlation in Healthy Volunteers and Traumatic Brain Injury Patients	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						transcranial Doppler ultrasonography; cerebral blood flow; arteriovenous correlation; traumatic brain injury; healthy volunteers	PULSED DOPPLER MEASUREMENTS; TRANSCRANIAL DOPPLER; INTRACRANIAL-PRESSURE; REFERENCE VALUES; SINUS THROMBOSIS; SEX-DIFFERENCES; AGE; HEMODYNAMICS; ULTRASONOGRAPHY; SONOGRAPHY	Background: Few studies have explored the cerebral venous compartment or the correlation between venous and arterial cerebral blood flows. We aimed to correlate cerebral blood flow velocities in the arterial (middle cerebral artery) and venous (straight sinus) compartments in healthy volunteers and traumatic brain injury (TBI) patients. In addition, we determined the normative range of these parameters. Materials and Methods: A total of 122 healthy volunteers and 95 severe TBI patients of both sexes were included and stratified into 3 age groups as follows: group 1 (aged, 18 to 44 y); group 2 (aged, 45 to 64 y); group 3 (older than 65 y). Transcranial Doppler systolic cerebral blood flow velocity, diastolic cerebral blood flow velocity, and mean cerebral blood flow velocity (FVs, FVd, FVm, respectively) were measured in the middle cerebral artery and peak cerebral venous blood flow velocity (FVVs) was measured in the straight sinus. The arteriovenous correlation was assessed on the basis of a positive relationship between FVs and FVVs. Results: There was an arteriovenous correlation (FVs vs. FVVs) in healthy volunteers (R = 0.39, P < 0.0001). We found no arteriovenous correlation in the TBI cohort overall, but FVs and FVVs were correlated in age group 1 (R = 0.28, P = 0.05) and in males (R = 0.29, P = 0.01). In healthy volunteers, FVs and FVm were significantly higher in males compared with females; and FVs, FVm, FVd, FVVs all increased across the age spectrum. There were no significant differences in any of these parameters in TBI patients. Conclusions: There are age and sex differences in arterial and venous cerebral blood flow velocities in healthy volunteers. Arteriovenous correlation is present in healthy volunteers but absent in TBI patients.	[Cardim, Danilo; Czosnyka, Marek; Donnelly, Joseph; Robba, Chiara] Univ Cambridge, Addenbrookes Hosp, Brain Phys Lab, Cambridge, England; [Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Cardim, Danilo] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Cardim, Danilo] Texas Hlth Presbyterian Hosp, Inst Exercise & Environm Med, Dallas, TX 75231 USA; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland; [Chandrapatham, Karthikka; Pelosi, Paolo] Univ Genoa, IRCCS Oncol, San Martino Policlin Hosp, Dept Surg Sci & Integrated Diagnost, Genoa, Italy; [Pelosi, Paolo; Robba, Chiara] Univ Genoa, IRCCS Oncol, San Martino Policlin Hosp, Anaesthesia & Intens Care, Genoa, Italy; [Bertuccio, Alessandro] Dept Neurosurg S Cesare, Biagio, Alessandria, Italy; [Corradi, Francesco] Univ Pisa, Florence, Italy; [Badenes, Rafael] Univ Valencia Hosp Clin, Anesthesiol & Surg Trauma Intens Care, Valencia, Spain; [Donnelly, Joseph] Univ Auckland, Dept Anesthesiol, Auckland, New Zealand		Cardim, D (corresponding author), Univ Cambridge, Addenbrookes Hosp, Brain Phys Lab, Cambridge, England.; Cardim, D (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA.; Cardim, D (corresponding author), Texas Hlth Presbyterian Hosp, Inst Exercise & Environm Med, Dallas, TX 75231 USA.	danilo.cardim@gmail.com	Donnelly, Joseph/E-9235-2018; Corradi, Francesco/C-5207-2009	Donnelly, Joseph/0000-0002-6502-8069; Corradi, Francesco/0000-0002-5588-2608; Badenes, Rafael/0000-0001-7017-0150; Cardim, Danilo/0000-0002-9261-1321	NIHR Brain Injury Healthcare Technology Co-operative, Cambridge, UK; Woolf Fisher Scholarship (NZ); Cambridge Commonwealth, European & International Trust Scholarship, University of Cambridge; NIHR (Research Professorship, Cambridge BRC); NIHR (NIHR Research Group on Global Neurotrauma)	NIHR Brain Injury Healthcare Technology Co-operative, Cambridge, UK, provided financial support in the form of equipment funding for D.C. and M.C. J.D. is supported by a Woolf Fisher Scholarship (NZ). Cambridge Commonwealth, European & International Trust Scholarship, University of Cambridge provided financial support in the form of Scholarship funding for D.C. P.J.H. is supported by the NIHR (Research Professorship, Cambridge BRC and NIHR Research Group on Global Neurotrauma). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	AASLID R, 1991, STROKE, V22, P1148, DOI 10.1161/01.STR.22.9.1148; Baumgartner RW, 1997, STROKE, V28, P1319, DOI 10.1161/01.STR.28.7.1319; Becker G, 1995, J Neuroimaging, V5, P87; BROUWERS PJAM, 1990, ULTRASOUND MED BIOL, V16, P1, DOI 10.1016/0301-5629(90)90079-R; Canhao P, 1998, J NEUROL, V245, P276, DOI 10.1007/s004150050218; Citerio G, 2001, CRIT CARE MED, V29, P1466, DOI 10.1097/00003246-200107000-00027; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; DuBose LE, 2018, HYPERTENSION, V72, P476, DOI 10.1161/HYPERTENSIONAHA.118.11143; Dunn LT, 2002, J NEUROL NEUROSUR PS, V73, pI23; Famaey N, STRUCTURAL MECH CHAR; Favre ME, 2019, AM J PHYSIOL-HEART C, V316, pH920, DOI 10.1152/ajpheart.00474.2018; GROLIMUND P, 1988, ULTRASOUND MED BIOL, V14, P191, DOI 10.1016/0301-5629(88)90139-1; Hart EC, 2012, J PHYSIOL-LONDON, V590, P2069, DOI 10.1113/jphysiol.2011.224642; Jefferson AL, 2018, CIRCULATION, V138, P1951, DOI 10.1161/CIRCULATIONAHA.118.032410; Krejza J, 1999, AM J ROENTGENOL, V172, P213, DOI 10.2214/ajr.172.1.9888770; Matteis M, 1998, STROKE, V29, P963, DOI 10.1161/01.STR.29.5.963; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Miller J D, 1972, Prog Brain Res, V35, P411; Moretti R, 2011, ACTA ANAESTH SCAND, V55, P644, DOI 10.1111/j.1399-6576.2011.02432.x; Patel N, 2016, PHYSIOL MEAS, V37, P1485, DOI 10.1088/0967-3334/37/9/1485; Robba C, 2019, INTENS CARE MED, V45, P913, DOI 10.1007/s00134-019-05610-4; Robba C, 2018, J NEUROSCI RES, V96, P720, DOI 10.1002/jnr.24148; Robba C, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002356; Sarkar S, 2007, POSTGRAD MED J, V83, P683, DOI 10.1136/pgmj.2007.058602; Scalea TM, 2007, J TRAUMA, V62, P647, DOI 10.1097/TA.0b013e31802ee542; Schoser BGH, 1999, J NEUROSURG, V91, P744, DOI 10.3171/jns.1999.91.5.0744; Sekhon MS, 2019, RESUSCITATION, V141, P96, DOI 10.1016/j.resuscitation.2019.05.036; Tegeler CH, 2013, J NEUROIMAGING, V23, P466, DOI 10.1111/j.1552-6569.2012.00711.x; Teixeira SC, 2019, EUR J APPL PHYSIOL, V119, P519, DOI 10.1007/s00421-018-4036-3; Tomoto T, 2019, J CEREBR BLOOD F MET, V119, P600; VALDUEZA JM, 1995, STROKE, V26, P1196, DOI 10.1161/01.STR.26.7.1196; von Elm E, 2007, EPIDEMIOLOGY, V18, P800, DOI 10.1097/EDE.0b013e3181577654; VRIENS EM, 1988, ULTRASOUND MED BIOL, V15, P1; WARDLAW JM, 1994, J NEUROSURG, V80, P332, DOI 10.3171/jns.1994.80.2.0332; Wilson MH, 2016, J CEREBR BLOOD F MET, V36, P1338, DOI 10.1177/0271678X16648711; Xing CY, 2017, HYPERTENSION, V69, P712, DOI 10.1161/HYPERTENSIONAHA.116.08986; Zhu YS, 2011, J APPL PHYSIOL, V111, P376, DOI 10.1152/japplphysiol.01418.2010; Ziegler D, 2017, J NEUROTRAUM, V34, P121, DOI 10.1089/neu.2015.3967; Zweifel C, 2012, NEUROSURGERY, V71, P853, DOI 10.1227/NEU.0b013e3182675b42	39	2	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JAN	2022	34	1					E24	E33		10.1097/ANA.0000000000000704			10	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	XJ4ZX	WOS:000726799100008	32555064				2022-02-06	
J	Lien, WC; Wang, WM; Wang, FH; Wang, JD				Lien, Wei-Chih; Wang, Wei-Ming; Wang, Fuhmei; Wang, Jung-Der			Savings of loss-of-life expectancy and lifetime medical costs from prevention of spinal cord injuries: analysis of nationwide data followed for 17 years	INJURY PREVENTION			English	Article						spinal cord injury; cohort study; economic analysis; longitudinal; burden of disease; costs	TRAUMATIC BRAIN; SURVIVAL; RISK; EPIDEMIOLOGY; BURDEN; TAIWAN; ADULTS	Background The objectives of this research were to determine the savings of loss-of-life expectancy (LE) and lifetime medical costs (LMC) from prevention of spinal cord injuries (SCI) in Taiwan. Methods From the claims database of Taiwan National Health Insurance, we identified 6164 adult patients with newly diagnosed SCI with permanent functional disability from 2000 to 2015 and followed them until the end of 2016. We estimated survival function through the Kaplan-Meier method and extrapolated it to lifetime. Results For the SCI cohort, the LE and loss-of-LE were 17.6 and 13.3 years, respectively, while those for SCI with coding of external causes (E-code) were 18.1 and 13.0 years, respectively. For the SCI cohort with E-code, the loss-of-LE of motor vehicle (MV)-related SCI was significantly higher than that of fall-related SCI. In young and middle-aged patients with SCI with E-code, the loss-of-LE of MV-related paraplegia was significantly higher than that of MV-related quadriplegia and fall-related SCI. With a 3% discount rate, the LMC for patients with SCI after diagnosis were US$82 772, while those for patients with SCI with E-code were US$81 473. The LMC and the cost per year for those living with quadriplegia were significantly higher than those for paraplegia in all age groups, possibly related to the higher frequencies of stroke, chronic lung disease and dementia. Conclusions We conclude that quadriplegia has a higher impact on medical costs than paraplegia, and MV-related SCI has a higher impact on loss-of-LE than fall-related SCI. We recommend comprehensive SCI prevention be established, including infrastructures of construction and transportation.	[Lien, Wei-Chih] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Phys Med & Rehabil, Tainan, Taiwan; [Lien, Wei-Chih] Natl Cheng Kung Univ, Dept Phys Med & Rehabil, Coll Med, Tainan, Taiwan; [Lien, Wei-Chih] Natl Chung Hsing Univ, PhD Program Tissue Engn & Regenerat Med, Taichung, Taiwan; [Wang, Wei-Ming] Natl Cheng Kung Univ, Dept Stat, Coll Management, Tainan, Taiwan; [Wang, Fuhmei] Natl Cheng Kung Univ, Dept Econ, Tainan, Taiwan; [Wang, Fuhmei] Natl Cheng Kung Univ, Dept Publ Hlth, Coll Med, Tainan, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Internal Med, Tainan, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Occupat & Environm Med, Tainan, Taiwan		Wang, JD (corresponding author), Natl Cheng Kung Univ, Dept Publ Hlth, Coll Med, Tainan, Taiwan.	jdwang121@gmail.com			Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST 106-2314-B-006-017-MY3, MOST 108-2314-B-006-015, MOST 107-2627-M-006-007, MOST 108-2627-M-006-001]; National Cheng Kung University Hospital [NCKUH-11004013]	We are grateful to the Ministry of Science and Technology, Taiwan, for funding this research under MOST 106-2314-B-006-017-MY3, MOST 108-2314-B-006-015, MOST 107-2627-M-006-007, and MOST 108-2627-M-006-001. We are grateful for grants from National Cheng Kung University Hospital (NCKUH-11004013).	Aung TS, 1997, SPINAL CORD, V35, P147, DOI 10.1038/sj.sc.3100375; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Basu A, 2010, HEALTH ECON, V19, P1010, DOI 10.1002/hec.1640; CHEN CF, 1985, PARAPLEGIA, V23, P364, DOI 10.1038/sc.1985.58; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Chiu WT, 2010, ASIA-PAC J PUBLIC HE, V22, P9, DOI 10.1177/1010539509355470; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Forget Evelyn L, 2008, Healthc Policy, V4, pe148; Gabbe BJ, 2016, ANN SURG, V263, P623, DOI 10.1097/SLA.0000000000001564; HARTUNIAN NS, 1980, AM J PUBLIC HEALTH, V70, P1249, DOI 10.2105/AJPH.70.12.1249; Hendrie Delia, 2004, Inj Control Saf Promot, V11, P193, DOI 10.1080/156609704/233/289689; Huang HY, 2014, CELL TRANSPLANT, V23, pS5, DOI 10.3727/096368914X684952; Hwang JS, 2017, HEALTH ECON, V26, pE332, DOI 10.1002/hec.3512; Hwang JS, 1999, STAT MED, V18, P1627, DOI 10.1002/(SICI)1097-0258(19990715)18:13<1627::AID-SIM159>3.3.CO;2-4; Jones T, 2005, ARCH PHYS MED REHAB, V86, P2240, DOI 10.1016/j.apmr.2005.07.286; Krueger H, 2013, CHRON DIS INJ CAN, V33, P113; Lai YJ, 2014, SPINE J, V14, P1957, DOI 10.1016/j.spinee.2013.12.011; MacIntyre CR, 1997, AUST NZ J PUBL HEAL, V21, P779; McDaid D, 2019, SPINAL CORD, V57, P778, DOI 10.1038/s41393-019-0285-1; Middleton JW, 2012, SPINAL CORD, V50, P803, DOI 10.1038/sc.2012.55; Moorin R, 2014, J NEUROL, V261, P1726, DOI 10.1007/s00415-014-7411-y; Nas K, 2015, WORLD J ORTHOP, V6, P8, DOI 10.5312/wjo.v6.i1.8; *NAT STAT, 2016, DIR GEN BUDG ACC STA; Neumann P. J., 2016, Cost-effectiveness in health and medicine; O'Connor P, 2002, ACCIDENT ANAL PREV, V34, P477, DOI 10.1016/S0001-4575(01)00045-8; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Savic G, 2017, SPINAL CORD, V55, P651, DOI 10.1038/sc.2017.23; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Selvarajah S, 2014, J NEUROTRAUM, V31, P228, DOI 10.1089/neu.2013.3098; SHINGU H, 1995, PARAPLEGIA, V33, P183, DOI 10.1038/sc.1995.42	30	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	DEC	2021	27	6					567	573		10.1136/injuryprev-2020-043943			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	XK9AG	WOS:000727748300010	33483326				2022-02-06	
J	Muller, C; Zentgraf, K				Mueller, Carsten; Zentgraf, Karen			Neck and Trunk Strength Training to Mitigate Head Acceleration in Youth Soccer Players	JOURNAL OF STRENGTH AND CONDITIONING RESEARCH			English	Article						resistance exercise; header; ball velocity; neuromuscular stabilization; cervical strength; risk reduction	SEX-DIFFERENCES; IMPACT; RELIABILITY; PERFORMANCE; CONCUSSION; KINEMATICS; COLLEGIATE; FOOTBALL; SPORTS; RISK	Heading in soccer involves repetitive head accelerations that may be detrimental for brain health. One way to mitigate adverse effects may be to increase head-neck stabilization and thus reduce the kinematic response after intentional headers. This study aimed to (a) assess associations between neck strength and head kinematics and (b) evaluate an exercise intervention designed to increase strength and attenuate head acceleration during intentional heading in youth soccer players. In 22 athletes, we used accelerometers to assess associations between neck strength and peak linear acceleration (PLA). We attached the accelerometers to the occiput and sternum, allowing us to differentiate between total, trunk, and head PLA. Longitudinally, we evaluated the effects of a 14-week twice-weekly resistance training in a subsample of 14 athletes compared with regular soccer training (N = 13). Results showed that female athletes had lower isolated neck strength (p <= 0.004), lower functional neck strength (p <= 0.017), and higher total PLA during purposeful headers compared with males (17.2 +/- 3.5 g and 13.0 +/- 2.3 g, respectively, at 9.6 m.s(-1) ball velocity during impact; p = 0.003). The intervention group showed moderate to large strength gains (eta(2)(rho) = 0.16-0.42), resulting in lower PLA (total -2.4 g, trunk -0.8 g, and head -1.5 g) during headers. We conclude that a resistance training focusing on cervical and trunk musculature is practicable in youth soccer, elicits strength gains, and helps to mitigate PLA during purposeful heading. Results should encourage youth strength and conditioning professionals to incorporate neck exercises as a risk reduction strategy into their training routine.	[Mueller, Carsten] Univ Munster, Inst Sport & Exercise Sci, Munster, Germany; [Mueller, Carsten] Univ Munster, Univ Sports, Munster, Germany; [Zentgraf, Karen] Goethe Univ Frankfurt, Inst Sport Sci, Dept Movement Sci & Training Sports, Frankfurt, Germany		Muller, C (corresponding author), Univ Munster, Inst Sport & Exercise Sci, Munster, Germany.; Muller, C (corresponding author), Univ Munster, Univ Sports, Munster, Germany.	c.mueller@uni-muenster.de	Muller, Carsten/G-6683-2014	Muller, Carsten/0000-0002-6364-9937	Federal Institute for Sport Sciences (Bundesinstitut fur Sportwissenschaft, BISp) [ZMVI4-070605/17-18]	This project was supported by research funding from the Federal Institute for Sport Sciences (Bundesinstitut fur Sportwissenschaft, BISp) after a decision of the German Bundestag (Grant number ZMVI4-070605/17-18). The authors thank Dr. Annette Kerkhoff and Dr. Marc H E de Lussanet for their assistance in motion analysis and data processing. Furthermore, the authors thank all the youth athletes who took part in this project.	Audette I, 2010, J ORTHOP SPORT PHYS, V40, P318, DOI 10.2519/jospt.2010.3180; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Becker S, 2019, J SPORT SCI MED, V18, P729; Becker S, 2018, SPORTS, V6, DOI 10.3390/sports6020033; Bretzin AC, 2017, SPORTS HEALTH, V9, P168, DOI 10.1177/1941738116678615; Caccese JB, 2018, SPORT BIOMECH, V17, P462, DOI 10.1080/14763141.2017.1360385; Caccese JB, 2018, RES SPORTS MED, V26, P64, DOI 10.1080/15438627.2017.1393756; Caccese JB, 2016, SPORTS MED, V46, P1591, DOI 10.1007/s40279-016-0544-7; Caswell SV., 2014, INT J ATHL THER TRAI, V19, P22; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Dezman ZDW, 2013, SPORTS HEALTH, V5, P320, DOI 10.1177/1941738113480935; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Dorminy M, 2015, BRAIN INJURY, V29, P1158, DOI 10.3109/02699052.2015.1035324; Eckner JT, 2018, AM J PHYS MED REHAB, V97, P292, DOI 10.1097/PHM.0000000000000843; Fleiss JL, 1986, RELIABILITY MEASUREM, DOI DOI 10.1002/9781118032923; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Hildenbrand KJ, 2013, J STRENGTH COND RES, V27, P3173, DOI 10.1519/JSC.0b013e31828a1fe2; Hrysomallis C, 2016, SPORTS MED, V46, P1111, DOI 10.1007/s40279-016-0490-4; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kontos AP, 2017, BRIT J SPORT MED, V51, P1118, DOI 10.1136/bjsports-2016-096276; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lisman P., 2012, INT J SPORTS SCI ENG, V6, P131; Mansell J, 2005, J ATHL TRAINING, V40, P310; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Muehlbauer T, 2011, J STRENGTH COND RES, V25, P2228, DOI 10.1519/JSC.0b013e3181fb393b; Peek K, 2020, J SCI MED SPORT, V23, P453, DOI 10.1016/j.jsams.2019.11.004; Pelland, 2015, J ATHL ENHANCE, V4, P1; Putukian M, 2019, BRIT J SPORT MED, V53, P1332, DOI 10.1136/bjsports-2018-100232; Rodrigues AC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00038; Rubin TG, 2018, RADIOLOGY, V289, P478, DOI 10.1148/radiol.2018180217; Salmon DM, 2015, J STRENGTH COND RES, V29, P637, DOI 10.1519/JSC.0000000000000689; Sandmo SB, 2020, SCAND J MED SCI SPOR, V30, P193, DOI 10.1111/sms.13562; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI10, DOI 10.1136/bjsm.2005.019034; Stewart WF, 2017, NEUROLOGY, V88, P901, DOI 10.1212/WNL.0000000000003657; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Versteegh TH, 2020, J STRENGTH COND RES, V34, P708, DOI 10.1519/JSC.0000000000003091; Wilson JC, 2021, J STRENGTH COND RES, V35, P1149, DOI 10.1519/JSC.0000000000002907; Wood TA, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00053	40	2	2	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1064-8011	1533-4287		J STRENGTH COND RES	J. Strength Cond. Res.	DEC	2021	35			2			S81	S89					9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	XE9PK	WOS:000723713500013	33065700				2022-02-06	
J	Yoon, TJ; Ko, Y; Lee, J; Huh, Y; Kim, JH				Yoon, Tae Jin; Ko, Yura; Lee, Jisook; Huh, Yo; Kim, Jung Heon			Performance of the BIG Score in Predicting Mortality in Normotensive Children With Trauma	PEDIATRIC EMERGENCY CARE			English	Article						Glasgow Coma Scale; international normalized ratio; lactic acid; hemorrhagic shock; wounds and injuries	PEDIATRIC TRAUMA; COAGULOPATHY; OUTCOMES; SCALE	Objectives Children have a larger reserve for traumatic hemorrhagic shock, requiring a score that uses physiologic variables other than hypotension. Recently, the BIG score comprising admission base deficit, international normalized ratio, and the Glasgow Coma Scale has been reported to predict traumatic mortality. We aimed to validate the performance of the BIG score in mortality prediction of normotensive children with trauma. Methods We reviewed 1046 injured children (<18 years) who visited a Korean academic hospital from 2010 to 2018, excluding those with age-adjusted hypotension. In-hospital mortality, the BIG score and its predicted mortality, Revised Trauma Score, and Pediatric Trauma Score were calculated. We compared areas under the curve (AUCs) for in-hospital mortality of the 3 scores and did in-hospital and BIG-predicted mortalities. Results Of the 1046 children, 554 were enrolled with a 4.9% in-hospital mortality rate. The median BIG score was higher in the nonsurvivors (6.4 [interquartile range, 4.4-9.2] vs 20.1 [16.5-24.8]; P < 0.001). The AUC of the BIG score was 0.94 (95% confidence interval [CI], 0.92-0.96), which was higher than that of Pediatric Trauma Score (0.87 [95% CI, 0.84-0.90]; P < 0.001). The AUC of the BIG score tended to be higher than that of Revised Trauma Score without statistical significance (0.90 [95% CI, 0.87-0.92]; P = 0.130). We noted a parallel between in-hospital and BIG-predicted mortalities. The hemorrhage-related nonsurvivors showed higher median base deficit and BIG score than did the isolated traumatic brain injury-related ones. Conclusions The BIG score can predict mortality with excellent accuracy in normotensive children with trauma.	[Yoon, Tae Jin; Ko, Yura; Lee, Jisook; Huh, Yo; Kim, Jung Heon] Ajou Univ, Dept Emergency, Dept Trauma Surg, Sch Med, Suwon, South Korea		Kim, JH (corresponding author), Ajou Univ, Dept Emergency Med, Sch Med, 164 World Cup Ro, Suwon 16499, South Korea.	medjh@daum.net		Kim, Jung Heon/0000-0001-7303-0241			APRAHAMIAN C, 1990, ARCH SURG-CHICAGO, V125, P1128; Bialek L, REVISED TRAUMA SCORE; Borgman MA, 2015, J PEDIATR-US, V167, P513, DOI 10.1016/j.jpeds.2015.06.039; Borgman MA, 2011, PEDIATRICS, V127, pE892, DOI 10.1542/peds.2010-2439; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Cicero MX, 2013, PEDIATR EMERG CARE, V29, P43, DOI 10.1097/PEC.0b013e31827b52bf; Davis AL, 2015, J PEDIATR-US, V167, P593, DOI 10.1016/j.jpeds.2015.05.041; Ernst G., 2020, TINTINALLIS EMERGENC, V9th ed, P689; Grandjean-Blanchet C, 2018, CAN J EMERG MED, V20, P592, DOI 10.1017/cem.2017.379; Guzzo JL, 2005, J AM COLL SURGEONS, V201, P891, DOI 10.1016/j.jamcollsurg.2005.07.013; Hoffmann F, 2016, PREHOSP EMERG CARE, V20, P493, DOI 10.3109/10903127.2016.1139216; Huh Y, 2015, PEDIAT EMERG MED J, V2, P8; Hwang K, 2018, WORLD J SURG, V42, P2067, DOI 10.1007/s00268-017-4441-5; Kim J, PEDIAT TRAUMA BIG SC; Kim Jung Heon, 2019, [Pediatric Emergency Medicine Journal, 대한소아응급의학회지], V6, P1, DOI 10.22470/pemj.2019.00066; Kim Y, 2014, J KOREAN MED SCI, V29, P1007, DOI 10.3346/jkms.2014.29.7.1007; Lecuyer M, PEDIAT TRAUMA SCORE; Leeper CM, 2018, J TRAUMA ACUTE CARE, V85, P674, DOI 10.1097/TA.0000000000001823; Marcin JP, 2002, CRIT CARE MED, V30, pS457, DOI 10.1097/00003246-200211001-00011; McGee S, 2002, J GEN INTERN MED, V17, P646; Merrick C, 2018, ADV TRAUMA LIFE SUPP, V10th ed, P186; Neff LP, 2015, J TRAUMA ACUTE CARE, V78, P22, DOI 10.1097/TA.0000000000000488; Nuttall AGL, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023216; Samson RA., 2016, PEDIAT ADV LIFE SUPP, P56; Strumwasser A, 2016, J TRAUMA ACUTE CARE, V81, P312, DOI 10.1097/TA.0000000000001060; Whittaker B, 2013, SHOCK, V39, P421, DOI 10.1097/SHK.0b013e31828e08cb	26	2	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	DEC	2021	37	12					E1582	E1588		10.1097/PEC.0000000000002122			7	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	XK6NI	WOS:000727579500162	32555014				2022-02-06	
J	Yousif, JE; Liao, E; Trobe, JD				Yousif, Jonah E.; Liao, Eric; Trobe, Jonathan D.			Dorsal Midbrain Syndrome: Clinical and Imaging Features in 75 Cases	JOURNAL OF NEURO-OPHTHALMOLOGY			English	Article							CHILDREN	Background:Dorsal midbrain syndrome (DMS) consists of a constellation of clinical features, including reduced upgaze, pupillary light-near dissociation, lid retraction, convergence retraction, and eye misalignment. This syndrome results mostly from intrinsic or extrinsic mesodiencephalic tumors or strokes, obstructive hydrocephalus, failure of cerebrospinal fluid shunting to correct obstructive hydrocephalus, and head trauma. Published reports that include imaging corroboration are based on relatively small cohorts and have not included comprehensive patient self-reports on the impact of these abnormalities on quality of life.Methods:We conducted a retrospective review of cases of DMS identified between 1998 and 2019 at the University of Michigan using the Electronic Medical Record Search Engine. Patients were included only if they had been evaluated by a neuro-ophthalmologist and had a corroborative imaging abnormality. We collected data on symptoms and on neuro-ophthalmic and neurologic signs. We reviewed brain imaging reports on all 75 patients, and the study neuroradiologist analyzed the imaging in 57 patients. Using a uniform list of questions, we conducted telephone interviews of 26 patients to assess lingering symptoms and their impact on quality of life.Results:There were 75 patients, only 5 of whom were younger than 10 years. Neoplasms accounted for 47%, strokes (mostly thalamic) for 25%, nonneoplastic masses for 12%, nonneoplastic hydrocephalus for 7%, traumatic brain injury for 5%, and demyelination for 4%. Reduced upgaze occurred in 93% of patients, being completely absent or reduced to less than 50% amplitude in 67%. Convergence retraction on attempted upgaze occurred in 52%, horizontal misalignment in 49%, vertical misalignment in 47%, and pupillary light-near dissociation in 37%. Optic neuropathy attributed to chronic papilledema occurred in only 3%. Three or more neuro-ophthalmic signs were present in 84%, and only 4% had a single sign-reduced upgaze. Imaging features did not correlate with the frequency or severity of clinical signs. There was some improvement in the clinical signs among the patients with stroke but no change among the patients with neoplasms. In the 26 telephone interviews, patients with neoplasms reported that imbalance had a greater impact on quality of life than did diplopia. Patients with strokes reported that imbalance had the greatest impact initially but that its effect dissipated. Neither group reported lingering effects of impaired upgaze.Conclusions:This large series expands on the clinical profile of DMS. Neoplasms and strokes were the most common causes. Obstructive hydrocephalus alone, identified as a major cause in the largest previously published series, was uncommon. At least 3 neuro-ophthalmic signs were present in nearly all patients, with upgaze deficit as predominant. Unlike an earlier report, this study found no correlation between brain imaging and clinical signs. Neuro-ophthalmic signs persisted even after neoplasms were successfully treated and improved only slightly after stroke. Telephone interviews with patients revealed that diplopia and upgaze deficit had less lasting impact on quality of life than did ataxia and concurrent nonneurologic problems.	[Yousif, Jonah E.; Trobe, Jonathan D.] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, 1000 Wall St, Ann Arbor, MI 48105 USA; [Liao, Eric] Univ Michigan, Dept Radiol Neuroradiol, Ann Arbor, MI 48105 USA; [Trobe, Jonathan D.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48105 USA		Trobe, JD (corresponding author), Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, 1000 Wall St, Ann Arbor, MI 48105 USA.	jdtrobe@umich.edu					CHATTHA AS, 1975, J NEUROL NEUROSUR PS, V38, P288, DOI 10.1136/jnnp.38.3.288; Dinc C, 2013, TURK NEUROSURG, V23, P446, DOI 10.5137/1019-5149.JTN.6219-12.0; Goldenberg-Cohen N, 2010, OPHTHAL SURG LAS IM, V41, P467, DOI 10.3928/15428877-20100426-02; Hankinson EV, 2016, J NEUROSURG-PEDIATR, V17, P558, DOI 10.3171/2015.10.PEDS15415; Hart MG, 2013, J NEUROSURG, V119, P420, DOI 10.3171/2013.3.JNS122137; Hoehn ME, 2016, J AAPOS, V21, P34, DOI 10.1016/j.jaapos.2016.09.024; Horn Anja K E, 2011, Handb Clin Neurol, V102, P21, DOI 10.1016/B978-0-444-52903-9.00008-X; Hura N, 2019, CLIN IMAG, V58, P170, DOI 10.1016/j.clinimag.2019.07.010; KEANE JR, 1990, NEUROLOGY, V40, P684; Leigh JR., 2015, NEUROLOGY EYE MOVEME, P881; Miller NR., 2005, WALSH HOYTS CLIN NEU, V5th edition; Pollak L, 2017, ACTA NEUROL SCAND, V136, P721, DOI 10.1111/ane.12795; Shields M, 2017, ACTA OPHTHALMOL, V95, pe792, DOI 10.1111/aos.13283; Thompson HS., 1998, WALSH HOYTS CLIN NEU, P961; TZEKOV C, 1992, PEDIATR NEUROSURG, V17, P317, DOI 10.1159/000120617; Vuppala AAD, 2019, NEURORADIOLOGY, V61, P507, DOI 10.1007/s00234-019-02166-4	16	2	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1070-8022	1536-5166		J NEURO-OPHTHALMOL	J. Neuro-Ophthal.	DEC	2021	41	4					E644	E654		10.1097/WNO.0000000000001052			11	Clinical Neurology; Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Ophthalmology	YJ9IZ	WOS:000744840900050	32868578				2022-02-06	
J	Zhou, Z; Li, XG; Liu, YZ; Fahlstedt, M; Georgiadis, M; Zhan, XH; Raymond, SJ; Grant, G; Kleiven, S; Camarillo, D; Zeineh, M				Zhou, Zhou; Li, Xiaogai; Liu, Yuzhe; Fahlstedt, Madelen; Georgiadis, Marios; Zhan, Xianghao; Raymond, Samuel J.; Grant, Gerald; Kleiven, Svein; Camarillo, David; Zeineh, Michael			Toward a Comprehensive Delineation of White Matter Tract-Related Deformation	JOURNAL OF NEUROTRAUMA			English	Article						axonal injury; computational brain modeling; finite element analysis; injury criteria; tract-related deformation	TRAUMATIC BRAIN-INJURY; MAXIMUM PRINCIPAL STRAIN; SPINAL-CORD AXONS; MECHANICAL-PROPERTIES; IN-VITRO; TISSUE; MODEL; CONCUSSION; PREDICTION; RESPONSES	Finite element (FE) models of the human head are valuable instruments to explore the mechanobiological pathway from external loading, localized brain response, and resultant injury risks. The injury predictability of these models depends on the use of effective criteria as injury predictors. The FE-derived normal deformation along white matter (WM) fiber tracts (i.e., tract-oriented strain) recently has been suggested as an appropriate predictor for axonal injury. However, the tract-oriented strain only represents a partial depiction of the WM fiber tract deformation. A comprehensive delineation of tract-related deformation may improve the injury predictability of the FE head model by delivering new tract-related criteria as injury predictors. Thus, the present study performed a theoretical strain analysis to comprehensively characterize the WM fiber tract deformation by relating the strain tensor of the WM element to its embedded fiber tract. Three new tract-related strains with exact analytical solutions were proposed, measuring the normal deformation perpendicular to the fiber tracts (i.e., tract-perpendicular strain), and shear deformation along and perpendicular to the fiber tracts (i.e., axial-shear strain and lateral-shear strain, respectively). The injury predictability of these three newly proposed strain peaks along with the previously used tract-oriented strain peak and maximum principal strain (MPS) were evaluated by simulating 151 impacts with known outcome (concussion or non-concussion). The results preliminarily showed that four tract-related strain peaks exhibited superior performance than MPS in discriminating concussion and non-concussion cases. This study presents a comprehensive quantification of WM tract-related deformation and advocates the use of orientation-dependent strains as criteria for injury prediction, which may ultimately contribute to an advanced mechanobiological understanding and enhanced computational predictability of brain injury.</p>	[Zhou, Zhou; Liu, Yuzhe; Zhan, Xianghao; Raymond, Samuel J.; Camarillo, David] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Georgiadis, Marios; Zeineh, Michael] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Grant, Gerald] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Grant, Gerald; Camarillo, David] Stanford Univ, Dept Neurol, Stanford, CA 94305 USA; [Camarillo, David] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Zhou, Zhou; Li, Xiaogai; Fahlstedt, Madelen; Kleiven, Svein] KTH Royal Inst Technol, Neuron Engn, Stockholm, Sweden		Zhou, Z (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	zhouz@stanford.edu					Anderson ED, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00309; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bain AC, 2001, J NEUROTRAUM, V18, P499, DOI 10.1089/089771501300227305; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Budday S, 2020, ARCH COMPUT METHOD E, V27, P1187, DOI 10.1007/s11831-019-09352-w; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Cai YL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197992; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Cloots RJH, 2012, J MECH BEHAV BIOMED, V5, P41, DOI 10.1016/j.jmbbm.2011.09.012; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Cullen DK, 2006, J NEUROTRAUM, V23, P1304, DOI 10.1089/neu.2006.23.1304; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; de Rooij R, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00144; de Rooij R, 2018, BIOPHYS J, V114, P201, DOI 10.1016/j.bpj.2017.11.010; Domel AG, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-87085-2; Duckworth H, 2021, INT J NUMER METH BIO, V37, DOI 10.1002/cnm.3440; Fahlstedt M, 2021, ANN BIOMED ENG, V49, P1097, DOI 10.1007/s10439-020-02703-w; Finan JD, 2017, ACTA BIOMATER, V55, P333, DOI 10.1016/j.actbio.2017.03.037; Franck, 2021, BRAIN MULTIPHYS, V2; Frank LR, 2001, MAGN RESON MED, V45, P935, DOI 10.1002/mrm.1125; Gabler LF, 2018, ANN BIOMED ENG, V46, P972, DOI 10.1007/s10439-018-2015-9; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; Garimella HT, 2019, ANN BIOMED ENG, V47, P1889, DOI 10.1007/s10439-018-02166-0; Garimella HT, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2823; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Ghazi K, 2021, J NEUROTRAUM, V38, P1023, DOI 10.1089/neu.2020.7281; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Giordano C, 2017, BIOMECH MODEL MECHAN, V16, P1269, DOI 10.1007/s10237-017-0887-5; Giudice JS, 2021, FRONT BIOENG BIOTECH, V9, DOI 10.3389/fbioe.2021.664268; Giudice JS, 2020, ANN BIOMED ENG, V48, P2412, DOI 10.1007/s10439-020-02584-z; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Hajiaghamemar M, 2021, J NEUROTRAUM, V38, P144, DOI 10.1089/neu.2019.6791; Hajiaghamemar M, 2020, BIOMECH MODEL MECHAN, V19, P1109, DOI 10.1007/s10237-019-01273-8; Hernandez F, 2019, BIOMECH MODEL MECHAN, V18, P631, DOI 10.1007/s10237-018-01106-0; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Ho J, 2017, J BIOMECH, V60, P243, DOI 10.1016/j.jbiomech.2017.06.023; Holzapfel GA., 2000, NONLINEAR SOLID MECH; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2011, FINITE ELEM ANAL DES, V47, P1178, DOI 10.1016/j.finel.2011.05.007; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; KHOSROSHAHI SF, 2021, SCI REP-UK, V11, P1; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Kleiven A, 2021, BRAIN MULTIPHYS, V2, P10027; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S., 2014, STAPP CAR CRASH J, V58, P29, DOI [DOI 10.4271/2014-22-0002, 10.4271/2014-22-0002]; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Li, 2021, HEAD MODEL PERSONALI; Li XG, 2021, BIOMECH MODEL MECHAN, V20, P403, DOI 10.1007/s10237-020-01391-8; Li XG, 2019, FORENSIC SCI INT, V294, P173, DOI 10.1016/j.forsciint.2018.11.008; Li XG, 2017, BIOMECH MODEL MECHAN, V16, P823, DOI 10.1007/s10237-016-0855-5; Liu YZ, 2020, ANN BIOMED ENG, V48, P2580, DOI 10.1007/s10439-020-02629-3; MacManus DB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13727-z; Magdesian MH, 2012, BIOPHYS J, V103, P405, DOI 10.1016/j.bpj.2012.07.003; Maier-Hein KH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01285-x; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McMurry TL, 2015, TRAFFIC INJ PREV, V16, P618, DOI 10.1080/15389588.2014.991820; Meng SY, 2020, ACCIDENT ANAL PREV, V134, DOI 10.1016/j.aap.2019.105297; Menichetti A, 2020, INT J ENG SCI, V155, DOI 10.1016/j.ijengsci.2020.103355; Mihai LA, 2017, J MECH PHYS SOLIDS, V106, P60, DOI 10.1016/j.jmps.2017.05.015; Montanino A, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00025; Montanino A, 2019, J BIOMECH ENG-T ASME, V141, DOI 10.1115/1.4044953; Montanino A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00643; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Nakadate Hiromichi, 2017, Stapp Car Crash J, V61, P53; Newman J.A., 2000, STAPP CAR CRASH J; O'Keeffe E, 2020, J NEUROTRAUM, V37, P347, DOI 10.1089/neu.2019.6483; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rose SC, 2015, BRAIN INJURY, V29, P798, DOI 10.3109/02699052.2015.1004756; Saeedimasine M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44318-9; Sanchez EJ, 2019, CLIN BIOMECH, V64, P82, DOI 10.1016/j.clinbiomech.2018.02.019; Scimone MT, 2018, NAT PROTOC, V13, P3042, DOI 10.1038/s41596-018-0077-7; Shi R, 2002, NEUROSCIENCE, V110, P765, DOI 10.1016/S0306-4522(01)00596-6; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Singh Anita, 2006, Stapp Car Crash J, V50, P601; Singh A, 2009, J NEUROTRAUM, V26, P627, DOI 10.1089/neu.2008.0621; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 2020, NAT REV NEUROL, V16, P457, DOI 10.1038/s41582-020-0382-y; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Takhounts EG, 2008, STAPP CAR C, V52, P1; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tsitsopoulos PP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00599; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Wu SJ, 2020, BIOMECH MODEL MECHAN, V19, P927, DOI 10.1007/s10237-019-01261-y; Wu TT, 2021, J NEUROTRAUM, V38, P1879, DOI 10.1089/neu.2020.7445; Wu TT, 2020, J NEUROTRAUM, V37, P410, DOI 10.1089/neu.2019.6576; Wu TT, 2019, ANN BIOMED ENG, V47, P1908, DOI 10.1007/s10439-019-02239-8; Zhan XH, 2021, ANN BIOMED ENG, V49, P2901, DOI 10.1007/s10439-021-02813-z; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhao W, 2019, J NEUROTRAUM, V36, P250, DOI 10.1089/neu.2018.5634; Zhao W, 2017, ANN BIOMED ENG, V45, P2437, DOI 10.1007/s10439-017-1888-3; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P1709, DOI 10.1007/s10237-017-0915-5; Zhao W, 2016, J NEUROTRAUM, V33, P1834, DOI 10.1089/neu.2015.4239; Zhou Z, 2019, J NEUROTRAUM, V36, P2099, DOI 10.1089/neu.2018.6143; Zhou Z, 2021, J NEUROTRAUM, V38, P1730, DOI 10.1089/neu.2020.7412; Zhou Z, 2020, J BIOMECH, V105, DOI 10.1016/j.jbiomech.2020.109787; Zhou Zhou, 2019, Stapp Car Crash J, V63, P1; Zhou Z, 2020, J NEUROTRAUM, V37, P1074, DOI 10.1089/neu.2019.6634; Zhou Zhou, 2018, Stapp Car Crash J, V62, P293; Zhou Z, 2019, BIOMECH MODEL MECHAN, V18, P155, DOI 10.1007/s10237-018-1074-z; Zhou Z, 2016, COMPUT METH PROG BIO, V131, P13, DOI 10.1016/j.cmpb.2016.04.013	121	2	2	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2021	38	23					3260	3278		10.1089/neu.2021.0195		NOV 2021	19	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	XJ2CB	WOS:000717775500001	34617451	Green Submitted			2022-02-06	
J	Auffenberg, E; Hedrich, UBS; Barbieri, R; Miely, D; Groschup, B; Wuttke, TV; Vogel, N; Luhrs, P; Zanardi, I; Bertelli, S; Spielmann, N; Gailus-Durner, V; Fuchs, H; de Angelis, MH; Pusch, M; Dichgans, M; Lerche, H; Gavazzo, P; Plesnila, N; Freilinger, T				Auffenberg, Eva; Hedrich, Ulrike B. S.; Barbieri, Raffaella; Miely, Daniela; Groschup, Bernhard; Wuttke, Thomas, V; Vogel, Niklas; Luehrs, Philipp; Zanardi, Ilaria; Bertelli, Sara; Spielmann, Nadine; Gailus-Durner, Valerie; Fuchs, Helmut; de Angelis, Martin Hrabe; Pusch, Michael; Dichgans, Martin; Lerche, Holger; Gavazzo, Paola; Plesnila, Nikolaus; Freilinger, Tobias			Hyperexcitable interneurons trigger cortical spreading depression in an Scn1a migraine model	JOURNAL OF CLINICAL INVESTIGATION			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; SEVERE MYOCLONIC EPILEPSY; ACTION-POTENTIAL INITIATION; REDUCED SODIUM CURRENT; MOUSE MODEL; INHIBITORY INTERNEURONS; GABAERGIC INTERNEURONS; SUDDEN-DEATH; GENE SCN1A; CHANNEL	Cortical spreading depression (CSD), a wave of depolarization followed by depression of cortical activity, is a pathophysiological process implicated in migraine with aura and various other brain pathologies, such as ischemic stroke and traumatic brain injury. To gain insight into the pathophysiology of CSD, we generated a mouse model for a severe monogenic subtype of migraine with aura, familial hemiplegic migraine type 3 (FHM3). FHM3 is caused by mutations in SCN1A, encoding the voltage-gated Na+ channel Na(V)1.1 predominantly expressed in inhibitory interneurons. Homozygous Scn1a(L1649Q) knock-in mice died prematurely, whereas heterozygous mice had a normal lifespan. Heterozygous Scn1a(L1649Q) knock-in mice compared with WT mice displayed a significantly enhanced susceptibility to CSD. We found L1649Q to cause a gain-of-function effect with an impaired Na+-channel inactivation and increased ramp Na+ currents leading to hyperactivity of fast-spiking inhibitory interneurons. Brain slice recordings using K+-sensitive electrodes revealed an increase in extracellular K+ in the early phase of CSD in heterozygous mice, likely representing the mechanistic link between interneuron hyperactivity and CSD initiation. The neuronal phenotype and premature death of homozygous Scn1a(L1649Q) knock-in mice was partially rescued by GS967, a blocker of persistent Na+ currents. Collectively, our findings identify interneuron hyperactivity as a mechanism to trigger CSD.	[Auffenberg, Eva; Hedrich, Ulrike B. S.; Miely, Daniela; Wuttke, Thomas, V; Vogel, Niklas; Luehrs, Philipp; Lerche, Holger; Freilinger, Tobias] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Epileptol, Tubingen, Germany; [Auffenberg, Eva; Groschup, Bernhard; Dichgans, Martin; Plesnila, Nikolaus] Ludwig Maximilians Univ Munchen, Inst Stroke & Dementia Res ISD, Univ Hosp, Munich, Germany; [Barbieri, Raffaella; Zanardi, Ilaria; Bertelli, Sara; Pusch, Michael; Gavazzo, Paola] Consiglio Nazl Ric CNR, Biophys Inst, Genoa, Italy; [Wuttke, Thomas, V] Univ Tubingen, Dept Neurosurg, Tubingen, Germany; [Spielmann, Nadine; Gailus-Durner, Valerie; Fuchs, Helmut; de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen, Inst Expt Genet, German Res Ctr Environm Hlth, German Mouse Clin, Neuherberg, Germany; [de Angelis, Martin Hrabe] Tech Univ Munich, Sch Life Sci Weihenstephan, Chair Expt Genet, Freising Weihenstephan, Germany; [de Angelis, Martin Hrabe] German Ctr Diabet Res DZD, Neuherberg, Germany; [Dichgans, Martin; Plesnila, Nikolaus] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Freilinger, Tobias] Klinikum Passau, Dept Neurol, Innstr 76, D-94032 Passau, Germany		Freilinger, T (corresponding author), Klinikum Passau, Dept Neurol, Innstr 76, D-94032 Passau, Germany.	tobias.freilinger@klinikum-passau.de	de Angelis, Martin Hrabe/F-5531-2012	de Angelis, Martin Hrabe/0000-0002-7898-2353; Wuttke, Thomas/0000-0001-5655-8490	German Research Foundation (DFG)German Research Foundation (DFG) [PL 249/11-1, FR 3324/2-1]; German Federal Ministry of Education and Research (BMBF project TREAT-Ion)Federal Ministry of Education & Research (BMBF) [01GM1907G, 01KX1012]; Faculty of Medicine, University of Tubingen intramural fortune grant [2364-0-0]; Vascular Dementia Research Foundation; Italian Telethon FoundationFondazione Telethon [GGP17178]; Faculty of Medicine, University of Tubingen [419-0-0]; International School for Advanced Studies (SISSA); DFGGerman Research Foundation (DFG)European Commission [HE8155/1-1, HE8155/1-2, KO4877/3-1, WU590/4-2, LE1030/15-1, LE1030/15-2, FOR2715]	The authors thank Ana Fulgencio-Maisch, Heidi Loffler, Uta Mamrak, and Francesca Quartino for excellent technical assistance. This work was supported by the German Research Foundation (DFG) (PL 249/11-1 and FR 3324/2-1), the German Federal Ministry of Education and Research (BMBF project TREAT-Ion, grant 01GM1907G and Infrafrontier grant 01KX1012), the Faculty of Medicine, University of Tubingen intramural fortune grant (2364-0-0), the Vascular Dementia Research Foundation, and the Italian Telethon Foundation (GGP17178). This work was also supported by a grant from the Fondazione AIRC per la Ricerca sul Cancro (IG 21558). TVW was supported by an intramural Clinician Scientist Fellowship from the Faculty of Medicine, University of Tubingen (419-0-0). SB was supported by the PhD program of the International School for Advanced Studies (SISSA). UBSH, TVW, and HL were supported in part by the research unit FOR2715 of the DFG (grants HE8155/1-1, HE8155/1-2, KO4877/3-1, WU590/4-2, LE1030/15-1, and LE1030/15-2).	AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Aiba I, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4050; Anderson LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01851-9; [Anonymous], 2021, R PROJECT STAT COMPU; Barbieri R, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-1056-2; Berecki G, 2019, ANN NEUROL, V85, P514, DOI 10.1002/ana.25438; Carter BC, 2009, NEURON, V64, P898, DOI 10.1016/j.neuron.2009.12.011; Castro MJ, 2009, CEPHALALGIA, V29, P308, DOI 10.1111/j.1468-2982.2008.01721.x; Cestele S, 2013, P NATL ACAD SCI USA, V110, P17546, DOI 10.1073/pnas.1309827110; Cestele S, 2013, EPILEPSIA, V54, P927, DOI 10.1111/epi.12123; Cheah CS, 2013, CHANNELS, V7, P468, DOI 10.4161/chan.26023; Cheah CS, 2012, P NATL ACAD SCI USA, V109, P14646, DOI 10.1073/pnas.1211591109; Chever O., J CLIN INVEST, V131; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Desroches M, 2019, J COMPUT NEUROSCI, V47, P125, DOI 10.1007/s10827-019-00730-8; Dichgans M, 2005, LANCET, V366, P371, DOI 10.1016/S0140-6736(05)66786-4; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Ducros A, 2001, NEW ENGL J MED, V345, P17, DOI 10.1056/NEJM200107053450103; Eikermann-Haerter K, 2009, J CLIN INVEST, V119, P99, DOI 10.1172/JCI36059; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Fan CX, 2016, CEPHALALGIA, V36, P1238, DOI 10.1177/0333102415608360; Ferrari MD, 2015, LANCET NEUROL, V14, P65, DOI 10.1016/S1474-4422(14)70220-0; Fuchs H, 2009, CURR PHARM BIOTECHNO, V10, P236, DOI 10.2174/138920109787315051; Fuchs H, 2018, BEHAV BRAIN RES, V352, P187, DOI 10.1016/j.bbr.2017.09.048; Fuchs H, 2011, METHODS, V53, P120, DOI 10.1016/j.ymeth.2010.08.006; Gailus-Durner V, 2005, NAT METHODS, V2, P403, DOI 10.1038/nmeth0605-403; Gormley P, 2016, NAT GENET, V48, P856, DOI 10.1038/ng.3598; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Hedrich UBS, 2014, J NEUROSCI, V34, P14874, DOI 10.1523/JNEUROSCI.0721-14.2014; Hu H, 2018, NEURON, V98, P156, DOI 10.1016/j.neuron.2018.02.024; Jansen NA, 2020, ANN CLIN TRANSL NEUR, V7, P132, DOI 10.1002/acn3.50971; Jurkat-Rott K, 2004, NEUROLOGY, V62, P1857, DOI 10.1212/01.WNL.0000127310.11526.FD; Kahlig KM, 2008, P NATL ACAD SCI USA, V105, P9799, DOI 10.1073/pnas.0711717105; Kalume F, 2007, J NEUROSCI, V27, P11065, DOI 10.1523/JNEUROSCI.2162-07.2007; Kros L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35285-8; Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Leo L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002129; Lipton RB, 2007, NEUROLOGY, V68, P343, DOI 10.1212/01.wnl.0000252808.97649.21; Martina M, 1997, J PHYSIOL-LONDON, V505, P593, DOI 10.1111/j.1469-7793.1997.593ba.x; Octeau JC, 2018, JOVE-J VIS EXP, DOI 10.3791/57511; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Ogiwara I, 2013, HUM MOL GENET, V22, P4784, DOI 10.1093/hmg/ddt331; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Pietrobon D, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-1029-5; Pietrobon D, 2013, ANNU REV PHYSIOL, V75, P365, DOI 10.1146/annurev-physiol-030212-183717; Potet F, 2016, MOL PHARMACOL, V90, P52, DOI 10.1124/mol.116.103358; Royeck M, 2008, J NEUROPHYSIOL, V100, P2361, DOI 10.1152/jn.90332.2008; Schubert V, 2018, CEPHALALGIA, V38, P1503, DOI 10.1177/0333102417742365; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Thomsen LL, 2007, BRAIN, V130, P346, DOI 10.1093/brain/awl334; Thomsen LL, 2002, BRAIN, V125, P1379, DOI 10.1093/brain/awf132; Tottene A, 2009, NEURON, V61, P762, DOI 10.1016/j.neuron.2009.01.027; van den Maagdenberg AMJM, 2004, NEURON, V41, P701, DOI 10.1016/S0896-6273(04)00085-6; van den Maagdenberg AMJM, 2010, ANN NEUROL, V67, P85, DOI 10.1002/ana.21815; Vanmolkot KRJ, 2003, ANN NEUROL, V54, P360, DOI 10.1002/ana.10674; Victor TW, 2010, CEPHALALGIA, V30, P1065, DOI 10.1177/0333102409355601; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754	62	2	2	5	5	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	NOV 1	2021	131	21							e142202	10.1172/JCI142202			14	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	WS2JU	WOS:000715014400004	34546973	hybrid, Green Published, Green Submitted			2022-02-06	
J	Bedard, M; Taler, V				Bedard, Marc; Taler, Vanessa			Social Support Buffers Against Cognitive Decline in Single Mild Traumatic Brain Injury With Loss of Consciousness: Results From the Canadian Longitudinal Study on Aging	JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES			English	Article						USA; Cognitive reserve; Mild cognitive impairment; Social interaction; Social support	LEISURE ACTIVITY; RESERVE; CONCUSSION; SYMPTOMS; RECOVERY; ATROPHY; AGE	Objectives: We investigated rates of cognitive decline at 3-year follow-up from initial examination in people reporting mild traumatic brain injury (mTBI) with loss of consciousness (LOC) more than a year prior to initial examination. We examined the role of social support as predictor of preserved cognitive function in this sample. Method: Analyses were conducted on 440 participants who had self-reported LOC of <1 min, 350 with LOC of 1-20 min, and 10,712 healthy controls, taken from the Canadian Longitudinal Study on Aging (CLSA), a nationwide study on health and aging. Results: People who reported at baseline that they had experienced mTBI with LOC of 1-20 min more than a year prior were 60% more likely to have experienced global cognitive decline than controls at three-year follow-up. Cognitive decline was most apparent on measures of executive functioning. Logistic regression identified increased social support as predictors of relatively preserved cognitive function. Discussion: mTBI with longer time spent unconscious (i.e., LOC 1-20 min) is associated with greater cognitive decline years after the head injury. Perceived social support, particularly emotional support, may help buffer against this cognitive decline.	[Bedard, Marc; Taler, Vanessa] Univ Ottawa, Sch Psychol, 136 Jean Jacques Lussier,Vanier Hall, Ottawa, ON K1N 6N5, Canada; [Bedard, Marc; Taler, Vanessa] Bruyere Res Inst, Ottawa, ON, Canada		Taler, V (corresponding author), Univ Ottawa, Sch Psychol, 136 Jean Jacques Lussier,Vanier Hall, Ottawa, ON K1N 6N5, Canada.	vtaler@uottawa.ca			Government of Canada through the Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [LSA 94473]; Canada Foundation for Innovation - CIHR	Funding for the Canadian Longitudinal Study on Aging (CLSA) is provided by the Government of Canada through the Canadian Institutes of Health Research (CIHR; grant number LSA 94473) and the Canada Foundation for Innovation. M. Bedard is a Vanier Scholar, funded by the CIHR.	ACRM, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI 10.1097/00001199-199309000-00010; Anaturk M, 2018, NEUROSCI BIOBEHAV R, V93, P71, DOI 10.1016/j.neubiorev.2018.06.012; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Bedard M, 2020, J CLIN EXP NEUROPSYC, V42, P344, DOI 10.1080/13803395.2020.1714552; Bedard M, 2018, CLIN NEUROPSYCHOL, V32, P1002, DOI 10.1080/13854046.2017.1404644; Bigler Erin D, 2015, Handb Clin Neurol, V128, P691, DOI 10.1016/B978-0-444-63521-1.00043-1; Bolin JH, 2014, J EDUC MEAS, V51, P335, DOI 10.1111/jedm.12050; Canadian Longitudinal Study on Aging (CLSA), 2017, SAMPL COMP RESP RAT; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Curran PJ, 1996, PSYCHOL METHODS, V1, P16, DOI 10.1037//1082-989X.1.1.16; Donders J, 2019, ARCH CLIN NEUROPSYCH, V34, P206, DOI 10.1093/arclin/acy035; Duff K, 2012, ARCH CLIN NEUROPSYCH, V27, P248, DOI 10.1093/arclin/acr120; Evans IEM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201008; Fleck JI, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00310; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Helzner EP, 2007, ARCH NEUROL-CHICAGO, V64, P1749, DOI 10.1001/archneur.64.12.1749; Hernandez Cardenache Rene, 2014, ISRN Neurol, V2014, P805929, DOI 10.1155/2014/805929; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Levi Y, 2013, J INT NEUROPSYCH SOC, V19, P664, DOI 10.1017/S1355617713000192; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Mathias JL, 2015, NEUROSCI BIOBEHAV R, V55, P573, DOI 10.1016/j.neubiorev.2015.06.001; McCarrey AC, 2016, PSYCHOL AGING, V31, P166, DOI 10.1037/pag0000070; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Murman Daniel L., 2015, Seminars in Hearing, V36, P111, DOI 10.1055/s-0035-1555115; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Pekkala S, 2009, CLIN LINGUIST PHONET, V23, P431, DOI 10.1080/02699200902839800; Raina P, 2019, INT J EPIDEMIOL, V48, P1752, DOI 10.1093/ije/dyz173; Raina PS, 2009, CAN J AGING, V28, P221, DOI 10.1017/S0714980809990055; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rock PL, 2014, PSYCHOL MED, V44, P2029, DOI 10.1017/S0033291713002535; ROSEN W G, 1980, Journal of Clinical Neuropsychology, V2, P135, DOI 10.1080/01688638008403788; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Santhanam P, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1161; Sasson E, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00032; Scarmeas N, 2001, NEUROLOGY, V57, P2236, DOI 10.1212/WNL.57.12.2236; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Stenberg J, 2020, ARCH PHYS MED REHAB, V101, P72, DOI 10.1016/j.apmr.2019.08.477; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Steward KA, 2018, J HEAD TRAUMA REHAB, V33, pE18, DOI 10.1097/HTR.0000000000000325; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Teng E.L., 1994, MENTAL ALTERNATION T; Tremblay S, 2019, NEUROIMAGE-CLIN, V23, DOI 10.1016/j.nicl.2019.101907; Wilson RS, 2009, NEUROLOGY, V72, P460, DOI 10.1212/01.wnl.0000341782.71418.6c; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	49	2	2	0	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1079-5014	1758-5368		J GERONTOL B-PSYCHOL	J. Gerontol. Ser. B-Psychol. Sci. Soc. Sci.	NOV	2021	76	9					1777	1787		10.1093/geronb/gbaa213			11	Geriatrics & Gerontology; Gerontology; Psychology; Psychology, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Psychology	YL2EL	WOS:000745710100010	33254227	Green Published			2022-02-06	
J	Clark, G; Johnson, NA; Saluja, SS; Correa, JA; Delaney, JS				Clark, Gregory; Johnson, Nathalie A.; Saluja, Sanjeet S.; Correa, Jose A.; Delaney, J. Scott			Do Mountain Bikers Know When They Have Had a Concussion and, Do They Know to Stop Riding?	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; symptoms; mountain bike; broken helmet	METABOLIC BRAIN VULNERABILITY; TEMPORAL WINDOW; BICYCLE HELMETS; RISK-FACTORS; INJURY; SPORT; ROAD; PROGRAM; IMPACT	Objective: To establish the prevalence of concussions in mountain bikers and to determine factors that increase their risk of concussion. Secondary objectives include determination of whether mountain bikers have undiagnosed concussions, continue to ride after experiencing concussion symptoms, and if they knowingly ride with a broken helmet. Design: Retrospective survey. Setting: Seven-day mountain bike stage race. Participants: Two hundred nineteen mountain bikers. Main Outcome Measures: Number of rider concussions diagnosed, number of riders experiencing concussion symptoms without diagnosed concussions, number of riders who continue to ride after experiencing a concussion symptom, and number of riders who rode with a broken helmet. Independent Variables: The independent variables studied included age, gender, nationality, number of times riding in past year, style of riding (cross-country, downhill, or freeride), years mountain biking, years mountain bike racing, whether they are a sponsored cyclist, and whether they also ride a road bike. Results: Fifteen of 219 mountain bikers (6.9%) had a diagnosed concussion after being hit in the head while mountain biking within the past year, with older riders having a decreased risk [odds ratio (OR), 0.91; P = 0.04], and sponsored riders having a 5-fold increased risk compared with nonsponsored riders (OR, 4.20; P = 0.05). Twenty-eight riders (12.8%) experienced a concussion symptom without being diagnosed with a concussion and 67.5% of the riders who experienced a concussion symptom continued to ride afterward. Overall, 29.2% of riders reported riding with a broken helmet. Conclusions: The yearly prevalence of diagnosed concussions in mountain bikers is 6.9%. More than one-third of mountain bikers do not recognize when they have had a concussion and continue riding after experiencing concussion symptoms or with a broken helmet. These behaviors increase their risk of worsening concussion symptoms and acquiring a second injury.	[Clark, Gregory; Saluja, Sanjeet S.; Delaney, J. Scott] McGill Univ, Dept Emergency Med, Hlth Ctr, Montreal, PQ, Canada; [Johnson, Nathalie A.] McGill Univ, Jewish Gen Hosp, Dept Med, Montreal, PQ, Canada; [Correa, Jose A.] McGill Univ, Dept Math & Stat, Montreal, PQ, Canada; [Delaney, J. Scott] McGill Univ, McGill Sport Med Clin, Montreal, PQ, Canada		Clark, G (corresponding author), Royal Victoria Hosp, Dept Emergency Med MUHC, 1001 Blvd Decarie, Montreal, PQ H4A 3J1, Canada.	greg.clark@muhc.mcgill.ca		Clark, Gregory/0000-0002-6752-9676			Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Allison P, 2012, LOGISTIC REGRESSION; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; BOX GEP, 1962, TECHNOMETRICS, V4, P531, DOI 10.2307/1266288; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Brook EM, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117714445; Chow TK, 2002, WILD ENVIRON MED, V13, P27, DOI 10.1580/1080-6032(2002)013[0027:MOIICO]2.0.CO;2; Cripton PA, 2014, ACCIDENT ANAL PREV, V70, P1, DOI 10.1016/j.aap.2014.02.016; Cusimano MD, 2017, CLIN J SPORT MED, V27, P375, DOI 10.1097/JSM.0000000000000372; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Eagles ME, 2016, CAN J NEUROL SCI, V43, P659, DOI 10.1017/cjn.2016.263; Fuller GW, 2015, BRIT J SPORT MED, V49, P529, DOI 10.1136/bjsports-2014-093498; Hanninen T, 2018, J SCI MED SPORT, V21, P794, DOI 10.1016/j.jsams.2017.12.001; Hosmer DW., 2000, APPL LOGISTIC REGRES; Hoye A, 2018, ACCIDENT ANAL PREV, V117, P85, DOI 10.1016/j.aap.2018.03.026; International Mountain Bike Association of Canada, DEM MOUNT BIK; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kotlyar S, 2016, WILD ENVIRON MED, V27, P316, DOI 10.1016/j.wem.2016.01.007; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Olivier J, 2017, TRAFFIC INJ PREV, V18, P755, DOI 10.1080/15389588.2017.1298748; Olivier J, 2017, INT J EPIDEMIOL, V46, P278, DOI [10.1093/ije/dyw153, 10.1093/ije/dyw360]; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Rivara FP, 1997, J FAM PRACTICE, V44, P481; Roberts DJ, 2013, CAN J SURG, V56, pE32, DOI 10.1503/cjs.027411; Sethi M, 2015, INJURY, V46, P2483, DOI 10.1016/j.injury.2015.07.030; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Thompson D C, 2000, Cochrane Database Syst Rev, pCD001855; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Willick SE, 2019, CLIN J SPORT MED, V29, P329, DOI 10.1097/JSM.0000000000000527	35	2	2	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2021	31	6					E414	E419		10.1097/JSM.0000000000000819			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	WM5NJ	WOS:000711131700018	31895715				2022-02-06	
J	Huibregtse, ME; Bazarian, JJ; Shultz, SR; Kawata, K				Huibregtse, Megan E.; Bazarian, Jeffrey J.; Shultz, Sandy R.; Kawata, Keisuke			The biological significance and clinical utility of emerging blood biomarkers for traumatic brain injury	NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS			English	Article						Blood biomarkers; Traumatic brain injury; Proteomics; Metabolomics; microRNA; Extracellular vesicles	FIBRILLARY ACIDIC PROTEIN; SERUM NEUROFILAMENT LIGHT; MICRORNA EXPRESSION; CEREBROSPINAL-FLUID; CIRCULATING MICRORNAS; ALZHEIMERS-DISEASE; CEREBRAL EDEMA; TAU PROTEINS; S100B LEVELS; HEAD-INJURY	HUIBREGTSE, M.E, Bazarian, J.J., Shultz, S.R., and Kawata K. The biological significance and clinical utility of emerging blood biomarkers for traumatic brain injury. NEUROSCI BIOBEHAV REV XX (130) XXX-XXX, 2021.Blood biomarkers can serve as objective measures to gauge traumatic brain injury (TBI) severity, identify patients at risk for adverse outcomes, and predict recovery duration, yet the clinical use of blood biomarkers for TBI is limited to a select few and only to rule out the need for CT scanning. The biomarkers often examined in neurotrauma research are proteomic markers, which can reflect a range of pathological processes such as cellular damage, astrogliosis, or neuroinflammation. However, proteomic blood biomarkers are vulnerable to degradation, resulting in short half-lives. Emerging biomarkers for TBI may reflect the complex genetic and neurometabolic alterations that occur following TBI that are not captured by proteomics, are less vulnerable to degradation, and are comprised of microRNA, extracellular vesicles, and neurometabolites. Therefore, this review aims to summarize our understanding of how biomarkers for brain injury escape the brain parenchymal space and appear in the bloodstream, update recent research findings in several proteomic biomarkers, and characterize biological significance and examine clinical utility of microRNA, extracellular vesicles, and neurometabolites.	[Huibregtse, Megan E.; Kawata, Keisuke] Indiana Univ, Sch Publ Hlth, Dept Kinesiol, 1025 E 7th St,Suite 112, Bloomington, IN 47405 USA; [Bazarian, Jeffrey J.] Univ Rochester, Dept Emergency Med, Med Ctr, 200 E River Rd, Rochester, NY 14623 USA; [Shultz, Sandy R.] Monash Univ, Alfred Ctr, Dept Neurosci, Level 6,99 Commercial Rd, Melbourne, Vic 3004, Australia; [Shultz, Sandy R.] Univ Melbourne, Dept Med, Clin Sci Bldg,4th Floor,300 Grattan St, Parkville, Vic 3050, Australia; [Kawata, Keisuke] Indiana Univ, Coll Arts & Sci, Program Neurosci, 1101 E 10th St, Bloomington, IN 47405 USA		Kawata, K (corresponding author), Indiana Univ, Sch Publ Hlth, Dept Kinesiol, 1025 E 7th St,Suite 112, Bloomington, IN 47405 USA.	mhuibreg@indiana.edu; Jeff_Bazarian@urmc.rochester.edu; Sandy.Shultz@monash.edu; kkawata@indiana.edu		Shultz, Sandy/0000-0002-2525-8775	Indiana Clinical and Translational Sciences Institute TL1 Pre-Doctoral Training Award [UL1TR002529]; National Institutes of Health/National Center for Advancing Translational Sciences [NIH/NCATS], Clinical and Translational Sciences Award [5/18/2018-4/30/2023]; National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS113950, 1R21NS116548]	This publication was made possible with support from the Indiana Clinical and Translational Sciences Institute TL1 Pre-Doctoral Training Award (M.E. Huibregtse; Grant #UL1TR002529 [S. Moe and S. Wiehe, co-PIs], 5/18/2018 -4/30/2023 from the National Institutes of Health/National Center for Advancing Translational Sciences [NIH/NCATS], Clinical and Translational Sciences Award). This work was also partly supported by National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)1R01NS113950 (K. Kawata) and 1R21NS116548 (K. Kawata).	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abou-El-Hassan H, 2017, METHODS MOL BIOL, V1598, P65, DOI 10.1007/978-1-4939-6952-4_4; Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Amoruso A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63282-3; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Ashwal S, 2004, PEDIATR RES, V56, P630, DOI 10.1203/01.PDR.0000139928.60530.7D; Baslow MH, 2003, NEUROCHEM RES, V28, P941, DOI 10.1023/A:1023250721185; Bauernfeind F, 2012, J IMMUNOL, V189, P4175, DOI 10.4049/jimmunol.1201516; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Bittsansky M, 2012, GEN PHYSIOL BIOPHYS, V31, P101, DOI 10.4149/gpb_2012_007; Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; Bolte AC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18113-4; Buller B, 2010, FEBS J, V277, P4299, DOI 10.1111/j.1742-4658.2010.07818.x; Capitano F, 2017, NEUROBIOL LEARN MEM, V139, P63, DOI 10.1016/j.nlm.2016.12.019; Chang WS, 2017, MED SCI MONITOR, V23, P2721, DOI 10.12659/MSM.905064; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng L, 2015, MOL PSYCHIATR, V20, P1188, DOI 10.1038/mp.2014.127; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Clarke GJB, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.643743; Czeiter E, 2020, EBIOMEDICINE, V56, DOI 10.1016/j.ebiom.2020.102785; Daley M, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1131-5; Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412; Das Gupta S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22041563; De Benedittis S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22020702; De Luna N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61246-1; Devoto C, 2020, J NEUROTRAUM, V37, P2482, DOI 10.1089/neu.2019.6933; Di Pietro V., 2021, BR J SPORTS MED, DOI 10.1136/bjsports-2020-103274 bjsports-2020-103274; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Diez-Planelles C, 2016, PHARMACOL RES, V108, P102, DOI 10.1016/j.phrs.2016.05.005; Dobrowolny G, 2021, CELL DEATH DISCOV, V7, DOI 10.1038/s41420-020-00397-6; Fenoglio C, 2011, NEUROSCI LETT, V504, P9, DOI 10.1016/j.neulet.2011.08.021; Flynn S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82875-0; Fu LM, 2018, BIOMED PHARMACOTHER, V107, P703, DOI 10.1016/j.biopha.2018.08.040; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Gao Z, 2020, BMC OPHTHALMOL, V20, DOI 10.1186/s12886-020-01400-5; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Gardner RC, 2018, J NEUROTRAUM, V35, P2341, DOI 10.1089/neu.2018.5694; Geekiyanage H, 2012, EXP NEUROL, V235, P491, DOI 10.1016/j.expneurol.2011.11.026; Ghai V, 2020, J NEUROTRAUM, V37, P1418, DOI 10.1089/neu.2019.6826; Gill J, 2018, BRAIN INJURY, V32, P1277, DOI 10.1080/02699052.2018.1471738; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goetzl EJ, 2019, FASEB J, V33, P5082, DOI 10.1096/fj.201802319R; Guedes VA, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00663; Gurunathan S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040307; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Haarbauer-Krupa J, 2018, J PEDIATR-US, V197, P241, DOI 10.1016/j.jpeds.2018.01.075; Haorah J, 2007, J NEUROCHEM, V101, P566, DOI 10.1111/j.1471-4159.2006.04393.x; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; Hicks SD, 2018, J NEUROTRAUM, V35, P64, DOI 10.1089/neu.2017.5111; Hu ZH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4263; Huang S, 2018, FASEB J, V32, P512, DOI 10.1096/fj.201700673R; Huibregtse ME, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239507; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ji W, 2018, NEUROCHEM RES, V43, P1863, DOI 10.1007/s11064-018-2602-z; Jia HN, 2020, NEUROSCI RES, V161, P44, DOI 10.1016/j.neures.2019.12.002; Johnson JJ, 2018, JAMA PEDIATR, V172, P65, DOI 10.1001/jamapediatrics.2017.3884; Kauppinen A, 2013, CELL SIGNAL, V25, P1939, DOI 10.1016/j.cellsig.2013.06.007; Kawata K, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00239; Kawata K, 2017, J NEUROTRAUM, V34, P2254, DOI 10.1089/neu.2016.4786; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kiko T, 2014, J ALZHEIMERS DIS, V39, P253, DOI 10.3233/JAD-130932; Kobeissy FH, 2015, BRAIN NEUROTRAUMA MO; Korley F, 2021, J NEUROTRAUM, V38, P1953, DOI 10.1089/neu.2020.7072; KUDO S, 1990, CANCER RES, V50, P5751; Kumar P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069807; Leidinger P, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r78; Lenting PJ, 2015, BLOOD, V125, P2019, DOI 10.1182/blood-2014-06-528406; Letellier M, 2014, NAT NEUROSCI, V17, P1040, DOI 10.1038/nn.3762; Li YQ, 2016, ONCOTARGET, V7, P35607, DOI 10.18632/oncotarget.9597; Li YX, 2021, INFECT GENET EVOL, V89, DOI 10.1016/j.meegid.2020.104681; Liu YP, 2015, J CLIN NEUROSCI, V22, P291, DOI 10.1016/j.jocn.2014.05.042; Liu Y, 2021, CELL MOL BIOL LETT, V26, DOI 10.1186/s11658-021-00247-y; Lu Y, 2020, BIOMED PHARMACOTHER, V132, DOI 10.1016/j.biopha.2020.110778; Lugli G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139233; Madelaine R, 2017, CELL REP, V20, P1533, DOI 10.1016/j.celrep.2017.07.051; Mainieri A, 2019, BIOL DIRECT, V14, DOI 10.1186/s13062-019-0250-0; Manning KY, 2017, NEUROLOGY, V89, P2157, DOI 10.1212/WNL.0000000000004669; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Michetti F, 2019, J NEUROCHEM, V148, P168, DOI 10.1111/jnc.14574; Miller MR, 2021, J NEUROTRAUM, V38, P1608, DOI 10.1089/neu.2020.7125; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mohammadipoor-Ghasemabad L, 2019, NEUROSCIENCE, V414, P49, DOI 10.1016/j.neuroscience.2019.06.037; Mondello S, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00651; Mondello S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040977; Morel L, 2013, J BIOL CHEM, V288, P7105, DOI 10.1074/jbc.M112.410944; Ohmichi T, 2019, PARKINSONISM RELAT D, V61, P82, DOI 10.1016/j.parkreldis.2018.11.021; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Papa L, 2019, J NEUROTRAUM, V36, P1343, DOI 10.1089/neu.2018.6072; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Polito F, 2020, MOL BIOL REP, V47, P2941, DOI 10.1007/s11033-020-05386-7; Puhakka N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172521; Randall J, 2013, RESUSCITATION, V84, P351, DOI 10.1016/j.resuscitation.2012.07.027; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Rogatzki MJ, 2018, SCAND J MED SCI SPOR, V28, P2505, DOI 10.1111/sms.13297; Rosas-Hernandez H, 2018, MOL NEUROBIOL, V55, P258, DOI 10.1007/s12035-017-0738-5; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Sanders KA, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0253-y; Schindler CR, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155381; Schipper HM, 2007, GENE REGUL SYST BIO, V1, P263; Schonrock N, 2012, J MOL NEUROSCI, V46, P324, DOI 10.1007/s12031-011-9587-2; Shah R, 2018, NEW ENGL J MED, V379, P958, DOI 10.1056/NEJMra1704286; Shahim P, 2020, NEUROLOGY, V95, pE623, DOI 10.1212/WNL.0000000000009985; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shang YJ, 2019, CELL CYCLE, V18, P3160, DOI 10.1080/15384101.2019.1670509; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Straume-Naesheim TM, 2008, NEUROSURGERY, V62, P1297, DOI 10.1227/01.neu.0000333301.34189.3d; Svingos AM, 2019, BRAIN INJURY, V33, P1, DOI 10.1080/02699052.2019.1573379; Tan KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007689; Tan L, 2014, J ALZHEIMERS DIS, V40, P1017, DOI 10.3233/JAD-132144; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Thelin EP, 2013, J NEUROTRAUM, V30, P519, DOI 10.1089/neu.2012.2553; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Wallace C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206466; Wan YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121975; Wang BX, 2019, EUR REV MED PHARMACO, V23, P732, DOI 10.26355/eurrev_201901_16887; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Wang KKW, 2016, J NEUROTRAUM, V33, P1270, DOI 10.1089/neu.2015.3881; Wang Q, 2014, MOL MED REP, V10, P3310, DOI 10.3892/mmr.2014.2583; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wang WX, 2010, AM J PATHOL, V177, P334, DOI 10.2353/ajpath.2010.091202; Wang XY, 2009, BRAIN RES BULL, V80, P268, DOI 10.1016/j.brainresbull.2009.08.006; Wang Y, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-77; Wei CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057080; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; Wirsching A, 2019, J NEUROTRAUM, V36, P548, DOI 10.1089/neu.2018.5836; Wu H, 2019, EUR REV MED PHARMACO, V23, P9517, DOI 10.26355/eurrev_201911_19446; Yang T, 2016, J NEUROCHEM, V137, P122, DOI 10.1111/jnc.13534; Yang YX, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00055; Yang ZB, 2016, INTERNAL MED, V55, P1279, DOI 10.2169/internalmedicine.55.5925; Yuan AD, 2012, J CELL SCI, V125, P3257, DOI 10.1242/jcs.104729; ZAHN G, 1989, ARZNEIMITTEL-FORSCH, V39-2, P1180; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang YL, 2017, NEUROCHEM INT, V111, P69, DOI 10.1016/j.neuint.2016.08.003; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698; Zhong ZG, 2018, NEUROREPORT, V29, P1365, DOI 10.1097/WNR.0000000000001118; Zimering Mark B, 2020, J Endocrinol Diabetes, V7, P1; Zonner SW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00327	151	2	2	11	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0149-7634	1873-7528		NEUROSCI BIOBEHAV R	Neurosci. Biobehav. Rev.	NOV	2021	130						433	447		10.1016/j.neubiorev.2021.08.029			15	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	WB3BG	WOS:000703450400002	34474049	Green Accepted			2022-02-06	
J	Moss, LD; Sode, D; Patel, R; Lui, A; Hudson, C; Patel, NA; Bickford, PC				Moss, Lauren D.; Sode, Derek; Patel, Rekha; Lui, Ashley; Hudson, Charles; Patel, Niketa A.; Bickford, Paula C.			Intranasal delivery of exosomes from human adipose derived stem cells at forty-eight hours post injury reduces motor and cognitive impairments following traumatic brain injury	NEUROCHEMISTRY INTERNATIONAL			English	Article						Exosomes; Adipose derived stem cells; MALAT1; Inflammation; NRTK3; TrkC; TBI	EXPRESSION; NT-3; MALAT1	The neuroprotective role of human adipose-derived stems cells (hASCs) has raised great interest in regenerative medicine due to their ability to modulate their surrounding environment. Our group has demonstrated that exosomes derived from hASC (hASCexo) are a cell-free regenerative approach to long term recovery following traumatic brain injury (TBI). Previously, we demonstrated the efficacy of exosome treatment with intravenous delivery at 3 h post TBI in rats. Here, we show efficacy of exosomes through intranasal delivery at 48 h post TBI in mice lengthening the therapeutic window of treatment and therefore increasing possible translation to clinical studies. Our findings demonstrate significant recovery of motor impairment assessed by an elevated body swing test in mice treated with exosomes containing MALAT1 compared to both TBI mice without exosomes and exosomes depleted of MALAT1. Significant cognitive improvement was seen in the reversal trial of 8 arm radial arm water maze in mice treated with exosomes containing MALAT1. Furthermore, cortical damage was significantly reduced in mice treated with exosomes containing MALAT1 as well as decreased MHCII+ staining of microglial cells. Mice without exosomes or treated with exosomes depleted of MALAT1 did not show similar recovery. Results demonstrate both inflammation related genes and NRTK3 (TrkC) are target genes modulated by hASC exosomes and further that MALAT1 in hASC exosomes regulates expression of full length TrkC thereby activating the MAPK pathway and promoting recovery. Exosomes are a promising therapeutic approach following TBI with a therapeutic window of at least 48 h and contain long noncoding RNA's, specifically MALAT1 that play a vital role in the mechanism of action.	[Moss, Lauren D.; Bickford, Paula C.] Univ S Florida, Morsani Coll Med, Dept Neurosurg & Brain Repair, Tampa, FL 33620 USA; [Patel, Rekha; Hudson, Charles; Patel, Niketa A.; Bickford, Paula C.] James A Haley Vet Hosp, Res Serv, Tampa, FL USA; [Sode, Derek; Lui, Ashley; Patel, Niketa A.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33620 USA		Bickford, PC (corresponding author), James A Haley Vet Hosp, USF Hlth Morsani COM, Dept Neurosurg & Brain Repair, USF Hlth Ctr Excellence Aging & Brain Repair MDC-, Tampa, FL 33612 USA.; Patel, NA (corresponding author), Univ S Florida, Dept Mol Med, MCOM, Res Serv, 13000 Bruce B Downs Blvd,VAR151, Tampa, FL 33612 USA.	niketa.patel@va.gov; pbickfor@usf.edu	; Bickford, Paula/J-5970-2012	Lui, Ashley/0000-0003-4090-4680; Bickford, Paula/0000-0001-9657-7725	Department of Veterans' AffairsUS Department of Veterans Affairs [I01BX003421, IK6BX004214, I01BX003836, IK6BX005387]; VA Medical Research ServiceUS Department of Veterans Affairs; USF internal fund	We have read the guidelines for Conflicts of Interest and all authors declare no conflict of interest. PCB and NAP have an issued US Patent No. 10,857,187 Exosomes from human adipose-derived stem cells for treatment of traumatic brain injury (December 8, 2020) . This work was supported by Department of Veterans' Affairs grant I01BX003421 (PCB) and IK6BX004214 (PCB) , USF internal funding (PCB) , Department of Veterans' Affairs grant I01BX003836 (NAP) and IK6BX005387 (NAP) . This work was supported by the VA Medical Research Service; however, this work does not reflect the view or opinion of the James A. Haley VA Hospital nor the US Government.	Acabchuk R., 2016, CONCUSSION, V1; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Akyol O, 2018, EXP NEUROL, V307, P82, DOI 10.1016/j.expneurol.2018.06.002; Asami T, 2006, BIOCHEM BIOPH RES CO, V344, P941, DOI 10.1016/j.bbrc.2006.03.228; Bachstetter AD, 2020, EXP NEUROL, V326, DOI 10.1016/j.expneurol.2020.113180; Bachstetter AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149451; Bachstetter AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0289-5; BORLONGAN CV, 1995, J NEUROSCI, V15, P5372; Brahimi F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162307; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; Chou A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061616; Dedoni S, 2017, MOL NEUROBIOL, V54, P1825, DOI 10.1007/s12035-016-9789-2; Eissmann M, 2012, RNA BIOL, V9, P1076, DOI 10.4161/rna.21089; El Bassit G, 2017, ENDOCRINOLOGY, V158, P183, DOI 10.1210/en.2016-1819; Ferguson S, 2017, J NEUROTRAUM, V34, P1676, DOI 10.1089/neu.2016.4636; Grundy PL, 2004, MOL BRAIN RES, V120, P188, DOI 10.1016/j.molbrainres.2003.09.018; Gutschner T, 2013, J MOL MED, V91, P791, DOI 10.1007/s00109-013-1028-y; Koo HM, 2013, J PHYS THER SCI, V25, P1103, DOI 10.1589/jpts.25.1103; Liu SK, 2016, TUMOR BIOL, V37, P633, DOI 10.1007/s13277-015-3732-4; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Mohamadpour M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00007; Morganti JM, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1493-5; Morganti JM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0547-1; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Mouzon B, 2019, J NEUROTRAUM, V36, P576, DOI 10.1089/neu.2018.5720; Ozen I, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020387; Palko ME, 1999, J NEUROSCI, V19, P775; Patel NA, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1240-3; Patel Rekha S, 2016, Stem Cell Investig, V3, P2, DOI 10.3978/j.issn.2306-9759.2016.01.02; Prevention CfDCa, 2019, SURV REP TRAUM BRAIN; Rowe RK, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1200-y; Shi Y, 2019, CELL CHEM BIOL, V26, P319, DOI 10.1016/j.chembiol.2018.11.012; Tang Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0073402, 10.1371/journal.pone.0091571]; Yang JT, 2005, EXP NEUROL, V192, P437, DOI 10.1016/j.expneurol.2004.12.023	34	2	2	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	NOV	2021	150								105173	10.1016/j.neuint.2021.105173			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	WK0HT	WOS:000709416700001	34453976	Green Accepted			2022-02-06	
J	Orban, SA; Epstein, JN; Carr, D; Logan, K; Gubanich, PJ; Sidol, C; Myer, GD				Orban, Sarah A.; Epstein, Jeffery N.; Carr, Devon; Logan, Kelsey; Gubanich, Paul J.; Sidol, Craig; Myer, Gregory D.			Attention-Deficit/Hyperactivity Disorder Status and Sex Moderate Mild Traumatic Brain Injury Symptom Severity in Children and Adolescents: Implications for Clinical Management	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						mTBI; concussion; sports injury; attention-deficit; hyperactivity disorder	DEFICIT HYPERACTIVITY DISORDER; SPORTS-RELATED CONCUSSION; BASE-LINE; NEUROPSYCHOLOGICAL OUTCOMES; PEDIATRIC CONCUSSIONS; SELF-PERCEPTIONS; TEST-PERFORMANCE; ADHD; RECOVERY; SCORES	Objective: To investigate the impact of pediatric mild traumatic brain injury (mTBI), using a broad parent-reported measure, and to determine whether parent-ratings of mTBI symptoms are higher among those with premorbid attention-deficit/hyperactivity disorder (ADHD) and females. Design: Retrospective case-control. Setting: Hospital-based sports medicine clinic. Participants: The retrospective chart review included 1346 (age: M = 13.11 years, SD = 2.6; 61.7% male) pediatric patients with (n = 209) and without (n = 1137) ADHD. Independent Variables: Group membership (ADHD vs non-ADHD) and sex (male vs female). Main Outcome Measures: Baseline and current Post-Concussion Symptom Inventory-Parent Report Form (PCSI-P) Physical, Emotional, Cognitive, and Fatigue subscale scores. This study used a retrospective chart review; therefore, the hypotheses reported for the current study were formed after data were collected. Results: Controlling for patient age and days from mTBI, patients with ADHD had significantly higher retrospective parent-reported pre-mTBI ratings of physical, emotional, and cognitive symptoms (ds = 0.17-0.62) and higher post-mTBI ratings across all 4 symptom domains (ds = 0.18-0.57) than those without ADHD. There was no group x time interaction for any of the PCSI-P subscales. Females overall had higher retrospective parent-reported pre-injury Fatigue and Emotional symptoms (ds = 0.13-0.19) and higher post-mTBI symptoms in all 4 PCSI-P symptom domains (ds = 0.23-0.35), relative to males. Conclusions: Attention-deficit/hyperactivity disorder-related postinjury exacerbations in parent-reported symptoms can be explained, in part, by elevated retrospective parent-reported ADHD-related pre-mTBI ratings. These results highlight the importance of assessing a patient's baseline symptoms post-mTBI. These data also indicate that ADHD status and sex should be considered when interpreting mTBI symptom severity during clinical evaluation of concussion.	[Orban, Sarah A.] Univ Tampa, Coll Math Social Sci & Educ, Dept Psychol, Tampa, FL 33606 USA; [Epstein, Jeffery N.; Logan, Kelsey; Gubanich, Paul J.; Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Epstein, Jeffery N.; Logan, Kelsey; Gubanich, Paul J.; Sidol, Craig; Myer, Gregory D.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Epstein, Jeffery N.; Sidol, Craig] Univ Cincinnati, Dept Psychol, Coll Arts & Sci, Cincinnati, OH 45221 USA; [Carr, Devon; Myer, Gregory D.] Univ Cincinnati, Coll Med, Dept Orthopaed Surg, Cincinnati, OH USA; [Myer, Gregory D.] Reddy Med Grp, Athens, GA USA		Orban, SA (corresponding author), Univ Tampa, 401 W Kennedy Blvd,Box Q, Tampa, FL 33606 USA.	sorban@ut.edu		Sidol, Craig/0000-0002-2654-882X	Akili Interactive Labs; Novo NordiskNovo Nordisk; National Institutes of Health/NIAMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [U01AR067997, R01 AR070474, R01 AR056259-01]	J. N. Epstein has received research support from Akili Interactive Labs, received royalties from Multi-Health Systems, Inc, received consulting fees from the American Academy of Pediatrics and American Board of Pediatrics, and received licensing fees from Optimal Medicine, Inc and IXICO. P. Gubanich has received an honorarium from the American Medical Society of Sports Medicine for working as faculty for the Fellows' Research Conference, is a co-investigator on a research project funded by Novo Nordisk, and has worked as a consultant for O'Brien & Ryan, LLP, Kempsville Law Office, and Blue & Blue Attorney at Law. G. D. Myer has current and ongoing funding support from National Institutes of Health/NIAMS Grants U01AR067997, R01 AR070474, R01 AR056259-01, and industry-sponsored research funding related to brain injury prevention and assessment with Q30 Innovations, LLC and ElMinda, Ltd, and book royalties from Human Kinetics. S. A. Orban, D. Carr, K. Logan, and C. Sidol have no financial relationships relevant to the article to disclose. The authors report no conflicts of interest.	[Anonymous], 2017, IBM SPSS STAT WINDOW; Barkley RA, 2015, ATTENTION-DEFICIT HYPERACTIVITY DISORDER IN ADULTS AND CHILDREN, P53; Barkley RA, 2011, PSYCHOL ASSESSMENT, V23, P437, DOI 10.1037/a0022172; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Biederman J, 2015, J NERV MENT DIS, V203, P813, DOI 10.1097/NMD.0000000000000375; Bonfield CM, 2013, J NEUROSURG-PEDIATR, V12, P97, DOI 10.3171/2013.5.PEDS12424; Brewer TL, 2002, RES NURS HEALTH, V25, P269, DOI 10.1002/nur.10045; Brooks BL, 2016, APPL NEUROPSYCH-CHIL, V5, P119, DOI 10.1080/21622965.2014.1003066; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Byerley AK, 2013, REHABIL PSYCHOL, V58, P412, DOI 10.1037/a0034228; Collings LJ, 2017, BRAIN INJURY, V31, P1479, DOI 10.1080/02699052.2017.1377351; Cook Nathan E, 2016, PM R, V8, pS156, DOI 10.1016/j.pmrj.2016.07.032; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Daviss WB, 2008, J CHILD ADOL PSYCHOP, V18, P565, DOI 10.1089/cap.2008.032; Donders J, 2017, CHILD NEUROPSYCHOL, V23, P554, DOI 10.1080/09297049.2016.1161015; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Egger HL, 1999, J AM ACAD CHILD PSY, V38, P852, DOI 10.1097/00004583-199907000-00015; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Gardner RM, 2017, PHYSICIAN SPORTSMED, V45, P1, DOI 10.1080/00913847.2017.1248221; Granito V.J., 2002, J SPORT BEHAV, V25, P243; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hoza B, 2004, J CONSULT CLIN PSYCH, V72, P382, DOI 10.1037/0022-006X.72.3.382; Hsu HL, 2015, RADIOLOGY, V276, P828, DOI 10.1148/radiol.2015142549; Iaccarino MA, 2018, NEUROL-CLIN PRACT, V8, P403, DOI 10.1212/CPJ.0000000000000525; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2016, J NEUROTRAUM, V33, P2077, DOI 10.1089/neu.2014.3424; Iverson GL, 2010, BRAIN INJURY, V24, P1246, DOI 10.3109/02699052.2010.490513; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Klassen AF, 2006, CHILD CARE HLTH DEV, V32, P397, DOI 10.1111/j.1365-2214.2006.00609.x; Kooij JJS, 2008, J ATTEN DISORD, V11, P445, DOI 10.1177/1087054707299367; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Littleton AC, 2015, ARCH CLIN NEUROPSYCH, V30, P683, DOI 10.1093/arclin/acv043; Mautner K, 2015, CLIN J SPORT MED, V25, P355, DOI 10.1097/JSM.0000000000000151; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; NIXON HL, 1994, SOCIOL SPORT J, V11, P79, DOI 10.1123/ssj.11.1.79; Owens JS, 2007, CLIN CHILD FAM PSYCH, V10, P335, DOI 10.1007/s10567-007-0027-3; Plotts C. A., 2001, ADULT LEARNING, V12, P5; Poysophon P, 2018, SPORTS HEALTH, V10, P317, DOI 10.1177/1941738117751387; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schatz David Beck, 2006, J Atten Disord, V10, P141, DOI 10.1177/1087054706286698; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; Shaw P, 2014, AM J PSYCHIAT, V171, P276, DOI 10.1176/appi.ajp.2013.13070966; Stewart TC, 2014, J TRAUMA ACUTE CARE, V76, P736, DOI 10.1097/TA.0b013e3182aafdf5; Taylor AM, 2015, J PEDIATR-US, V167, P738, DOI 10.1016/j.jpeds.2015.05.036; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Van Patten R, 2016, J CLIN EXP NEUROPSYC, V38, P12, DOI 10.1080/13803395.2015.1091064; Wassenberg R, 2004, BRAIN INJURY, V18, P751, DOI 10.1080/02699050410001671775; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	60	2	2	2	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2021	31	6					E298	E305		10.1097/JSM.0000000000000821			8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	WM5NJ	WOS:000711131700001	32058452				2022-02-06	
J	Tucker, R; Falvey, E; Fuller, G; Brown, J; Raftery, M				Tucker, Ross; Falvey, Eanna; Fuller, Gordon; Brown, James; Raftery, Martin			Baseline SCAT Performance in Men and Women: Comparison of Baseline Concussion Screens Between 6288 Elite Men's and 764 Women's Rugby Players	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; SCAT; Rugby Union; neurological screening; concussion management	ASSESSMENT TOOL-3RD EDITION; NORMATIVE REFERENCE VALUES; SEX-DIFFERENCES; NEUROPSYCHOLOGICAL FUNCTION; NEUROCOGNITIVE PERFORMANCE; SYMPTOMS; TIME; AGE	Objective: This study compared Sports Concussion Assessment Tool (SCAT) performance in elite male (6288 players) and female (764 players) rugby players, to determine whether reference limits used for the management and diagnosis of concussion should differ between sexes. Design: Cross-sectional census sample. Setting: Data from World Rugby's Head Injury Assessment management system were analyzed. This data set covers global professional rugby. Participants: All professional players who underwent baseline SCAT testing as part of World Rugby's concussion management requirement formed the study cohort. Ten thousand seven hundred fifty-four SCAT assessments from 6288 elite male rugby players and 1071 assessments from 764 elite female players were analyzed. Intervention: Elite men and women rugby players are independent variables. Main Outcome Measures: Sports Concussion Assessment Tool performance, including symptoms endorsed, cognitive submode performance, and balance performance. Results: Women endorsed significantly more symptoms, with greater symptom severity, than men (relative ratio 1.34, 95% confidence interval, 1.25-1.45 women vs men). Women outperformed men in cognitive submodes with the exception of immediate memory and delayed recall and made fewer balance errors than men during the modified Balance Error Scoring System. Clinical reference limits, defined as submode score achieved by the worst-performing 50% of the cohort, did not differ between men and women. Conclusions: Women and men perform differently during SCAT baseline testing, although differences are small and do not affect either the baseline or clinical reference limits that identify abnormal test results for most submodes. The greater endorsement of symptoms by women suggests increased risk of adverse concussion outcomes and highlights the importance of accurate evaluation of any symptom endorsement at baseline.	[Tucker, Ross; Raftery, Martin] World Rugby, World Rugby House,8-10 Lower Pembroke St, Dublin 2, Ireland; [Tucker, Ross] Univ Cape Town, Dept Management Studies, Cape Town, South Africa; [Falvey, Eanna] Univ Coll Cork, Dept Med, Cork, Ireland; [Fuller, Gordon] Univ Sheffield, Ctr Urgent & Emergency Care Res, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Brown, James] Stellenbosch Univ, Inst Sport & Exercise Med, Dept Orthopaed, Stellenbosch, South Africa		Tucker, R (corresponding author), World Rugby, World Rugby House,8-10 Lower Pembroke St, Dublin 2, Ireland.	Ross.tucker@mweb.co.za		Fuller, Gordon Ward/0000-0001-8532-3500; Falvey, Eanna/0000-0003-3961-1805			[Anonymous], 2019, ARCH CLIN NEUROPSYCH, V32, P963; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2018, INT J PSYCHOPHYSIOL, V132, P9, DOI 10.1016/j.ijpsycho.2017.09.010; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Fuller CW, 2017, BRIT J SPORT MED, V51, P64, DOI 10.1136/bjsports-2016-096461; Fuller GW, 2018, J SCI MED SPORT, V21, P347, DOI 10.1016/j.jsams.2017.07.025; Fuller GW, 2020, CLIN J SPORT MED, V30, pE150, DOI 10.1097/JSM.0000000000000713; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2017, BRIT J SPORT MED, V51, P837, DOI 10.1136/bjsports-2017-097878; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Merritt VC, 2014, J CLIN EXP NEUROPSYC, V36, P1098, DOI 10.1080/13803395.2014.983463; Mrazik M, 2013, J ATHL TRAINING, V48, P654, DOI 10.4085/1062-6050-48.3.19; Norheim N, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000412; Raftery M, 2016, BRIT J SPORT MED, V50, P642, DOI 10.1136/bjsports-2016-095959; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Trinh LN, 2020, AM J SPORT MED, V48, P1516, DOI 10.1177/0363546519882626	26	2	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2021	31	6					E398	E405		10.1097/JSM.0000000000000847			8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	WM5NJ	WOS:000711131700016	32852305	Green Accepted			2022-02-06	
J	Whiffin, CJ; Gracey, F; Ellis-Hill, C				Whiffin, Charlotte Jane; Gracey, Fergus; Ellis-Hill, Caroline			The experience of families following traumatic brain injury in adult populations: A meta-synthesis of narrative structures	INTERNATIONAL JOURNAL OF NURSING STUDIES			English	Article						Head injury; Traumatic brain injury; Family; Qualitative; Meta-synthesis; Narrative	PERSONALITY-CHANGE; QUALITATIVE-ANALYSIS; SEVERE TBI; CAREGIVERS; REHABILITATION; PERSPECTIVES; TRANSITION; ADJUSTMENT; STRESS; IMPACT	A B S T R A C T Background: Traumatic brain injury has a significant effect on uninjured family members. Typically, this has been examined with a focus on psychopathological outcomes including stress, depression and anxiety. However, in recent years there has been increasing interest in the subjective experiences of families post -injury leading to a plethora of qualitative studies. Therefore, an in-depth examination and synthesis of this literature is now relevant and timely. Objective: To examine the subjective experiences of families following traumatic brain injury in adult populations in the sub/post-acute period through the synthesis of original qualitative research. Design: This paper presents a meta-synthesis using Thomas and Harden's framework of 'thematic synthe-sis' rooted in a critical realist philosophy. Data sources: In July 2019 five electronic databases, were searched for the terms 'traumatic brain injury', 'family' and 'qualitative'. Studies were included if the primary research reported qualitative data about the subjective experiences of family members of adults with traumatic brain injury and had been pub-lished in a peer reviewed journal. Studies with mixed brain injury samples, child or adolescent traumatic brain injury or disorders of consciousness were excluded. Hand searching and citation searches were also completed. Review methods: Two reviewers screened titles, abstracts and full text and reached consensus through critical discussion. Thirty papers were finally agreed for inclusion in this review. Each study was then assessed for relevance, resonance and rigour using the Critical Appraisal Skills Programme (CASP) tool. Line by line coding of the findings in each paper was conducted as the basis for a thematic analysis and synthesis. Results: Descriptive themes were identified followed later by analytical themes. This final stage was in -formed by a narrative lens and from these, eight narrative functions belonging to four dimensions were identified from the subjective experiences of families post-traumatic brain injury. Specifically, these were: (1) Displacing and Anchoring; (2) Rupturing and Stabilising; (3) Isolating and Connecting; (4) Harming and Healing. Conclusions: The interpretation of the narrative functions revealed the substantial existential work in -volved in negotiating lives, maintaining family system equilibrium and moving forward. As such, family members have their own unique narrative needs. Despite contemporary service models built around the injured person, service providers are well placed to support families in this everyday narrative work through actively attending to narrative structures and understanding the implications of these for family experience. The study protocol was registered with PROSPERO (International prospective register of systematic reviews) in July 2018 (Registration number: CRD42018085824). Tweetable abstract: This synthesis showed the immense and invisible work required for family mem-bers to maintain family system equilibrium and negotiate their lives post-TBI. (c) 2021 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )	[Whiffin, Charlotte Jane] Univ Derby, Coll Hlth Psychol & Social Care, Kedleston Rd, Derby DE22 1GB, England; [Gracey, Fergus] Univ East Anglia, Norwich Med Sch, Dept Clin Psychol & Psychol Therapies, Norwich NR4 7TJ, Norfolk, England; [Ellis-Hill, Caroline] Bournemouth Univ, Fac Hlth & Social Sci, Royal London House R110,Christchurch Rd, Bournemouth BH1 3LT, Dorset, England		Whiffin, CJ (corresponding author), Univ Derby, Coll Hlth Psychol & Social Care, Kedleston Rd, Derby DE22 1GB, England.	c.whiffin@derby.ac.uk; f.gracey@uea.ac.uk; cehill@bournemouth.ac.uk		Gracey, Fergus/0000-0002-1416-7894	University of Derby	University of Derby provided initial seed funding to commence this study. However, there was no external funding.	Acorn S, 1992, J Neurosci Nurs, V24, P324; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Blake H, 2008, INT J THER REHABIL, V15, P263, DOI 10.12968/ijtr.2008.15.6.29878; Bodley-Scott SEM, 2015, BRAIN IMPAIR, V16, P205, DOI 10.1017/BrImp.2015.22; Burnham J., 2012, CULTURAL REFLEXIVITY; Butera-Prinzi F, 2014, AUST NZ J FAM THER, V35, P81, DOI 10.1002/anzf.1046; Carroll C, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-37; Carson P, 1993, J Neurosci Nurs, V25, P165; Chhuom TW, 2021, J NEUROSCI NURS, V53, P57, DOI 10.1097/JNN.0000000000000569; CONNOLLY D, 2001, BR J OCCUP THER, V64, P41, DOI DOI 10.1177/030802260106400108; Couchman G, 2014, NEUROPSYCHOL REHABIL, V24, P809, DOI 10.1080/09602011.2014.912957; D'Cruz K, 2019, NEUROPSYCHOL REHABIL, V29, P985, DOI 10.1080/09602011.2017.1361844; Degeneffe CE, 2010, BRAIN INJURY, V24, P1416, DOI 10.3109/02699052.2010.514317; Degeneffe CE, 2008, REHABIL COUNS BULL, V51, P240, DOI 10.1177/0034355207311319; Dixon-Woods M, 2004, QUAL SAF HEALTH CARE, V13, P223, DOI 10.1136/qshc.2003.008714; Duggleby W, 2010, QUAL HEALTH RES, V20, P148, DOI 10.1177/1049732309358329; Ellis-Hill C, 2008, DISABIL REHABIL, V30, P150, DOI 10.1080/09638280701195462; Engstrom A, 2011, J NEUROSCI NURS, V43, P253, DOI 10.1097/JNN.0b013e318227ef9b; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Fumiyo I, 2009, J NEUROSCI NURS, V41, P277, DOI 10.1097/JNN.0b013e3181b2c73c; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Garside R, 2014, INNOVATION-ABINGDON, V27, P67, DOI 10.1080/13511610.2013.777270; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Giovannetti AM, 2015, BRAIN INJURY, V29, P473, DOI 10.3109/02699052.2014.990514; Godwin E, 2014, BRAIN INJURY, V28, P398, DOI 10.3109/02699052.2014.880514; Gosling J, 1999, BRAIN INJURY, V13, P785; Grayson L, 2021, BRAIN INJURY, V35, P15, DOI 10.1080/02699052.2020.1849800; Hammond FM, 2012, BRAIN INJURY, V26, P1287, DOI 10.3109/02699052.2012.706352; Hammond FM, 2011, J HEAD TRAUMA REHAB, V26, P69, DOI 10.1097/HTR.0b013e318205174d; Harris D, 2006, HEALTH SA GESONDHEID, V11; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Hawkins LG, 2019, CONTEMP FAM THER, V41, P304, DOI 10.1007/s10591-018-9484-8; Jackson D, 2009, BRAIN INJURY, V23, P433, DOI 10.1080/02699050902788451; Jumisko E, 2007, J FAM NURS, V13, P353, DOI 10.1177/1074840707303842; Kao Hsueh-Fen S, 2004, J Neurosci Nurs, V36, P73; Kean S, 2010, NURS CRIT CARE, V15, P66, DOI 10.1111/j.1478-5153.2010.00379.x; Keenan Alanna, 2010, Can J Neurosci Nurs, V32, P25; Knox L, 2016, NEUROPSYCHOL REHABIL, V26, P236, DOI 10.1080/09602011.2015.1019519; Knox L, 2015, BRAIN INJURY, V29, P745, DOI 10.3109/02699052.2015.1004753; Kratz AL, 2017, NEUROPSYCHOL REHABIL, V27, P16, DOI 10.1080/09602011.2015.1051056; Kreitzer N, 2020, J HEAD TRAUMA REHAB, V35, pE299, DOI 10.1097/HTR.0000000000000525; Landau J., 2008, FAMILIES SYSTEMS HLT, V26, P69, DOI [10.1037/1091-7527.26.1.69, DOI 10.1037/1091-7527.26.1.69]; Layman DE, 2005, BRAIN INJURY, V19, P909, DOI 10.1080/02699050500109928; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; Makela P, 2017, SUBJECTIVITY, V10, P358, DOI 10.1057/s41286-017-0036-8; McAdams D. P, 1993, STORIES WE LIVE PERS; Mertova, 2007, USING NARRATIVE INQU; Murphy E., 1998, HLTH TECHNOL ASSESS, V2, P1, DOI DOI 10.3310/HTA2160; Nalder E, 2012, BRAIN IMPAIR, V13, P108, DOI 10.1017/BrImp.2012.4; Newby G., 2020, PUTTING CONVERSATION; Norup A, 2015, ARCH PHYS MED REHAB, V96, P56, DOI 10.1016/j.apmr.2014.08.009; Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847; Noyes J., 2019, COCHRANE HDB SYSTEMA, P525; O'Keeffe F, 2020, BRAIN INJURY, V34, P496, DOI 10.1080/02699052.2020.1725641; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Popay J, 2005, J CLIN EPIDEMIOL, V58, P1079, DOI 10.1016/j.jclinepi.2005.08.004; Riessman CK., 2005, QUALITATIVE SOCIAL W, V4, P391, DOI DOI 10.1177/1473325005058643; Riley GA, 2007, CLIN REHABIL, V21, P82, DOI 10.1177/0269215506071279; Riley GA, 2020, NEUROPSYCHOL REHABIL, V30, P1169, DOI 10.1080/09602011.2019.1566078; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Salter K, 2008, J REHABIL MED, V40, P595, DOI 10.2340/16501977-0238; Sandelowski M, 1997, RES NURS HEALTH, V20, P365, DOI 10.1002/(SICI)1098-240X(199708)20:4<365::AID-NUR9>3.3.CO;2-7; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Seeley HM, 2006, BRIT J NEUROSURG, V20, P9, DOI 10.1080/02688690600601218; Stejskal TM, 2012, NEUROREHABILITATION, V31, P75, DOI 10.3233/NRE-2012-0776; Stenberg M, 2020, DISABIL REHABIL, DOI 10.1080/09638288.2020.1774668; Tam S, 2015, BRAIN INJURY, V29, P813, DOI 10.3109/02699052.2015.1005134; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45; Todres, 2013, CARING WELL BEING LI; Todres L, 2009, INT J QUAL STUD HEAL, V4, P68, DOI 10.1080/17482620802646204; Tong A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-181; Townshend J, 2018, FAM J, V26, P77, DOI 10.1177/1066480717752905; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Tyerman E, 2017, BRAIN INJURY, V31, P1553, DOI 10.1080/02699052.2017.1341999; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Weddell RA, 2006, BRAIN INJURY, V20, P1221, DOI 10.1080/02699050601049783; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Whiffin CJ, 2019, NEUROPSYCHOL REHABIL, V29, P1256, DOI 10.1080/09602011.2017.1387577; Whiffin CJ, 2015, J ADV NURS, V71, P849, DOI 10.1111/jan.12551; Wongvatunyu S, 2005, J NURS SCHOLARSHIP, V37, P48, DOI 10.1111/j.1547-5069.2005.00015.x; Wongvatunyu S, 2008, QUAL HEALTH RES, V18, P1062, DOI 10.1177/1049732308320111; World Health Organisation, 2021, NEUROTRAUMA; Yeates G, 2007, NEUROPSYCHOL REHABIL, V17, P151, DOI 10.1080/09602010600696423; Yeates GN, 2008, NEUROPSYCHOL REHABIL, V18, P566, DOI 10.1080/09602010802151532	89	2	2	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7489	1873-491X		INT J NURS STUD	Int. J. Nurs. Stud.	NOV	2021	123								104043	10.1016/j.ijnurstu.2021.104043			20	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	WF9RP	WOS:000706638300014	34388366	Green Published, Green Accepted, hybrid			2022-02-06	
J	Benedet, AL; Mila-Aloma, M; Vrillon, A; Ashton, NJ; Pascoal, TA; Lussier, F; Karikari, TK; Hourregue, C; Cognat, E; Dumurgier, J; Stevenson, J; Rahmouni, N; Pallen, V; Poltronetti, NM; Salvado, G; Shekari, M; Operto, G; Gispert, JD; Minguillon, C; Fauria, K; Kollmorgen, G; Suridjan, I; Zimmer, ER; Zetterberg, H; Molinuevo, JL; Paquet, C; Rosa-Neto, P; Blennow, K; Suarez-Calvet, M				Benedet, Andrea L.; Mila-Aloma, Marta; Vrillon, Agathe; Ashton, Nicholas J.; Pascoal, Tharick A.; Lussier, Firoza; Karikari, Thomas K.; Hourregue, Claire; Cognat, Emmanuel; Dumurgier, Julien; Stevenson, Jenna; Rahmouni, Nesrine; Pallen, Vanessa; Poltronetti, Nina M.; Salvado, Gemma; Shekari, Mahnaz; Operto, Gregory; Gispert, Juan Domingo; Minguillon, Carolina; Fauria, Karine; Kollmorgen, Gwendlyn; Suridjan, Ivonne; Zimmer, Eduardo R.; Zetterberg, Henrik; Molinuevo, Jose Luis; Paquet, Claire; Rosa-Neto, Pedro; Blennow, Kaj; Suarez-Calvet, Marc		Translational Biomarkers Aging Dem; Alzheimers Families ALFA Study; BioCogBank Paris Lariboisiere Coho	Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum	JAMA NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; SENILE PLAQUES; SERUM-GFAP; ASTROCYTES; SEVERITY; PERFORMANCE; METABOLISM; BIOMARKERS; BREAKDOWN; MARKERS	Question What are the levels of plasma glial fibrillary acidic protein (GFAP) throughout the Alzheimer disease (AD) continuum, and how do they compare with the levels of cerebrospinal fluid (CSF) GFAP? Findings In this cross-sectional study, plasma GFAP levels were elevated in the preclinical and symptomatic stages of AD, with levels higher than those of CSF GFAP. Plasma GFAP had a higher accuracy than CSF GFAP to discriminate between amyloid-beta (A beta)-positive and A beta-negative individuals, also at the preclinical stage. Meaning This study suggests that plasma GFAP is a sensitive biomarker that significantly outperforms CSF GFAP in indicating A beta pathology in the early stages of AD. Importance Glial fibrillary acidic protein (GFAP) is a marker of reactive astrogliosis that increases in the cerebrospinal fluid (CSF) and blood of individuals with Alzheimer disease (AD). However, it is not known whether there are differences in blood GFAP levels across the entire AD continuum and whether its performance is similar to that of CSF GFAP. Objective To evaluate plasma GFAP levels throughout the entire AD continuum, from preclinical AD to AD dementia, compared with CSF GFAP. Design, Setting, and Participants This observational, cross-sectional study collected data from July 29, 2014, to January 31, 2020, from 3 centers. The Translational Biomarkers in Aging and Dementia (TRIAD) cohort (Montreal, Canada) included individuals in the entire AD continuum. Results were confirmed in the Alzheimer's and Families (ALFA+) study (Barcelona, Spain), which included individuals with preclinical AD, and the BioCogBank Paris Lariboisiere cohort (Paris, France), which included individuals with symptomatic AD. Main Outcomes and Measures Plasma and CSF GFAP levels measured with a Simoa assay were the main outcome. Other measurements included levels of CSF amyloid-beta 42/40 (A beta 42/40), phosphorylated tau181 (p-tau181), neurofilament light (NfL), Chitinase-3-like protein 1 (YKL40), and soluble triggering receptor expressed on myeloid cells 2 (sTREM2) and levels of plasma p-tau181 and NfL. Results of amyloid positron emission tomography (PET) were available in TRIAD and ALFA+, and results of tau PET were available in TRIAD. Results A total of 300 TRIAD participants (177 women [59.0%]; mean [SD] age, 64.6 [17.6] years), 384 ALFA+ participants (234 women [60.9%]; mean [SD] age, 61.1 [4.7] years), and 187 BioCogBank Paris Lariboisiere participants (116 women [62.0%]; mean [SD] age, 69.9 [9.2] years) were included. Plasma GFAP levels were significantly higher in individuals with preclinical AD in comparison with cognitively unimpaired (CU) A beta-negative individuals (TRIAD: A beta-negative mean [SD], 185.1 [93.5] pg/mL, A beta-positive mean [SD], 285.0 [142.6] pg/mL; ALFA+: A beta-negative mean [SD], 121.9 [42.4] pg/mL, A beta-positive mean [SD], 169.9 [78.5] pg/mL). Plasma GFAP levels were also higher among individuals in symptomatic stages of the AD continuum (TRIAD: CU A beta-positive mean [SD], 285.0 [142.6] pg/mL, mild cognitive impairment [MCI] A beta-positive mean [SD], 332.5 [153.6] pg/mL; AD mean [SD], 388.1 [152.8] pg/mL vs CU A beta-negative mean [SD], 185.1 [93.5] pg/mL; Paris: MCI A beta-positive, mean [SD], 368.6 [158.5] pg/mL; AD dementia, mean [SD], 376.4 [179.6] pg/mL vs CU A beta-negative mean [SD], 161.2 [67.1] pg/mL). Plasma GFAP magnitude changes were consistently higher than those of CSF GFAP. Plasma GFAP more accurately discriminated A beta-positive from A beta-negative individuals than CSF GFAP (area under the curve for plasma GFAP, 0.69-0.86; area under the curve for CSF GFAP, 0.59-0.76). Moreover, plasma GFAP levels were positively associated with tau pathology only among individuals with concomitant A beta pathology. Conclusions and Relevance This study suggests that plasma GFAP is a sensitive biomarker for detecting and tracking reactive astrogliosis and A beta pathology even among individuals in the early stages of AD. This cross-sectional cohort study evaluates plasma glial fibrillary acidic protein levels throughout the entire Alzheimer disease continuum, from preclinical Alzheimer disease to Alzheimer disease dementia, compared with cerebrospinal fluid glial fibrillary acidic protein.	[Benedet, Andrea L.; Vrillon, Agathe; Ashton, Nicholas J.; Karikari, Thomas K.; Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, SE-43180 Gothenburg, Sweden; [Benedet, Andrea L.; Pascoal, Tharick A.; Lussier, Firoza; Stevenson, Jenna; Rahmouni, Nesrine; Pallen, Vanessa; Poltronetti, Nina M.; Rosa-Neto, Pedro] McGill Univ, McGill Ctr Studies Aging, Translat Neuroimaging Lab, Montreal, PQ, Canada; [Mila-Aloma, Marta; Salvado, Gemma; Shekari, Mahnaz; Operto, Gregory; Gispert, Juan Domingo; Minguillon, Carolina; Fauria, Karine; Molinuevo, Jose Luis; Suarez-Calvet, Marc] Pasqual Maragall Fdn, Barcelonasseta Brain Res Ctr, Barcelona, Spain; [Mila-Aloma, Marta; Salvado, Gemma; Shekari, Mahnaz; Operto, Gregory; Gispert, Juan Domingo; Minguillon, Carolina; Molinuevo, Jose Luis; Suarez-Calvet, Marc] IMIM Hosp Mar Med Res Inst, Barcelona, Spain; [Mila-Aloma, Marta; Operto, Gregory; Minguillon, Carolina; Fauria, Karine; Molinuevo, Jose Luis; Suarez-Calvet, Marc] Ctr Invest Biomed Red Fragilidad & Envejecimiento, Madrid, Spain; [Mila-Aloma, Marta; Shekari, Mahnaz; Gispert, Juan Domingo] Univ Pompeu Fabra, Barcelona, Spain; [Vrillon, Agathe; Cognat, Emmanuel; Paquet, Claire] Univ Paris, Inst Natl Sante & Rech Med Optimisat Therapeut Ne, Paris, France; [Vrillon, Agathe; Hourregue, Claire; Cognat, Emmanuel; Dumurgier, Julien; Paquet, Claire] Grp Hosp Univ, Hop Lariboisiere Fernand Widal, Assistance Publ Hop Paris Nord, Ctr Neurol Cognit, Paris, France; [Ashton, Nicholas J.] Univ Gothenburg, Sahlgrenska Acad, Wallenberg Ctr Mol & Translat Med, Inst Neurosci & Physiol,Dept Psychiat & Neurochem, Gothenburg, Sweden; [Ashton, Nicholas J.] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem,Wallenberg Ctr Mol & Tr, Gothenburg, Sweden; [Ashton, Nicholas J.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Maurice Wohl Clin Neurosci Inst, London, England; [Ashton, Nicholas J.] Res Unit Dementia South London & Maudsley Natl Hl, Res Ctr Mental Hlth & Biomed, Natl Inst Hlth Res Biomed, London, England; [Gispert, Juan Domingo] Ctr Invest Biomed Red Bioingn Biomat & Nanomed, Madrid, Spain; [Kollmorgen, Gwendlyn] Roche Diagnost GmbH, Penzberg, Germany; [Suridjan, Ivonne] Roche Diagnost Int Ltd, Rotkreuz, Switzerland; [Zimmer, Eduardo R.] Univ Fed Rio Grande do Sul, Dept Pharmacol, Grad Program Biol Sci Biochem PPGBioq & Phamacol, Porto Alegre, RS, Brazil; [Zetterberg, Henrik; Blennow, Kaj] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL, Dept Neurodegenerat Dis, Inst Neurol, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England; [Rosa-Neto, Pedro] Montreal Neurol Inst, Montreal, PQ, Canada; [Rosa-Neto, Pedro] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Suarez-Calvet, Marc] Hosp Mar, Serv Neurol, Barcelona, Spain		Blennow, K (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, SE-43180 Gothenburg, Sweden.; Suarez-Calvet, M (corresponding author), Barcelonasseta Brain Res Ctr, Alzheimer Prevent Program, Wellington 30, Barcelona 08005, Spain.	kaj.blennow@neuro.gu.se; msuarez@barcelonabeta.org		Karikari, Thomas/0000-0003-1422-4358	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP-11-51-31, RFN 152985, 159815, 162303]; Canadian Consortium of Neurodegeneration and Aging [MOP-11-51-31]; Weston Brain Institute; Brain Canada Foundation (Canadian Foundation for Innovation Project) [34874, 33397]; Fonds de Recherche du Quebec-Sante (Chercheur Boursier) [2020-VICO-279314]; "La Caixa" FoundationLa Caixa Foundation [LCF/PR/GN17/10300004]; Alzheimer's AssociationAlzheimer's Association; TriBEKa Imaging Platform project [TriBEKa-17-519007]; Swedish Alzheimer Foundation; Stiftelsen for Gamla Tjanarinnor; Stohne Stiftelsen; Fondation Adolphe de Rotschild; Fondation Philippe Chatrier; Association des Anciens Internes des Hopitaux de Paris; Fondation Vaincre Alzheimer; Demensfundet; Swedish Research CouncilSwedish Research CouncilEuropean Commission [2018-02532, 2017-00915]; European Research CouncilEuropean Research Council (ERC)European Commission [681712]; Swedish State Support for Clinical Research [ALFGBG-720931]; Alzheimer Drug Discovery Foundation (ADDF) [201809-2016862]; Alzheimer Disease (AD) Strategic Fund; Alzheimer's AssociationAlzheimer's Association [ADSF-21-831376-C, ADSF-21-831381-C, ADSF-21-831377-C]; Olav Thon Foundation; Erling-Persson Family Foundation; Hjarnfonden, Sweden [FO2019-0228, FO2017-0243]; European UnionEuropean Commission [860197]; UK Dementia Research Institute at University College London; ADDF [RDAPB-201809-2016615]; Swedish Alzheimer Foundation [AF-742881]; Swedish government [ALFGBG-715986]; Swedish County Councils, the Avtal om Lakarutbildning och Forskining agreement [ALFGBG-715986]; European Union Joint Program for Neurodegenerative Disorders [JPND2019-466-236]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01AG068398-01]; European Research Council under the European Union's Horizon 2020 research and innovation programmeEuropean Research Council (ERC) [948677]; Instituto de Salud Carlos IIIInstituto de Salud Carlos IIIEuropean Commission [PI19/00155]; Spanish Ministry of Science, Innovation and Universities (Juan de la Cierva Programme grant) [IJC2018-037478-1]	The Translational Biomarkers in Aging and Dementia (TRIAD) is supported by the Canadian Institutes of Health Research (MOP-11-51-31; RFN 152985, 159815, 162303); Canadian Consortium of Neurodegeneration and Aging (MOP-11-51-31 -team 1); Weston Brain Institute, Brain Canada Foundation (Canadian Foundation for Innovation Project 34874; 33397), and the Fonds de Recherche du Quebec-Sante (Chercheur Boursier, 2020-VICO-279314). The Alzheimer's and Families (ALFA) study receives funding from "La Caixa" Foundation (LCF/PR/GN17/10300004) and the Alzheimer's Association and an international anonymous charity foundation through the TriBEKa Imaging Platform project (TriBEKa-17-519007). Dr Benedet is supported by the Swedish Alzheimer Foundation, Stiftelsen for Gamla Tjanarinnor, and Stohne Stiftelsen. Dr Vrillon is supported by Fondation Adolphe de Rotschild, Fondation Philippe Chatrier, Association des Anciens Internes des Hopitaux de Paris, Fondation Vaincre Alzheimer, Stiftelsen for Gamla Tjanarinnor, Demensfundet, and Stohne Stiftelsen. Dr Zetterberg is aWallenberg Scholar supported by grants from the Swedish Research Council (grant 2018-02532), the European Research Council (grant 681712), Swedish State Support for Clinical Research (grant ALFGBG-720931), the Alzheimer Drug Discovery Foundation (ADDF) (grant 201809-2016862), the Alzheimer Disease (AD) Strategic Fund and the Alzheimer's Association (grants ADSF-21-831376-C, ADSF-21-831381-C, and ADSF-21-831377-C), the Olav Thon Foundation, the Erling-Persson Family Foundation, Stiftelsen for Gamla Tjanarinnor, Hjarnfonden, Sweden (grant FO2019-0228), the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 860197 (MIRIADE), and the UK Dementia Research Institute at University College London. Dr Blennow is supported by the Swedish Research Council (grant 2017-00915), the ADDF (grant RDAPB-201809-2016615), the Swedish Alzheimer Foundation (grant AF-742881), Hjarnfonden, Sweden (grant FO2017-0243), the Swedish state under the agreement between the Swedish government and the County Councils, the Avtal om Lakarutbildning och Forskining agreement (grant ALFGBG-715986), the European Union Joint Program for Neurodegenerative Disorders (grant JPND2019-466-236), and the National Institutes of Health (grant 1R01AG068398-01). Dr Suarez-Calvet receives funding from the European Research Council under the European Union's Horizon 2020 research and innovation programme (grant 948677), the Instituto de Salud Carlos III (grant PI19/00155), and the Spanish Ministry of Science, Innovation and Universities (Juan de la Cierva Programme grant IJC2018-037478-1).	Abdelhak A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00280; Abu-Rumeileh S, 2019, ALZHEIMERS RES THER, V12, DOI 10.1186/s13195-019-0562-4; Alcolea D, 2015, NEUROLOGY, V85, P626, DOI 10.1212/WNL.0000000000001859; Ashton NJ, 2021, ALZH DEMENT-DADM, V13, DOI 10.1002/dad2.12168; Ashton NJ, 2021, ACTA NEUROPATHOL, V141, P709, DOI 10.1007/s00401-021-02275-6; Asken BM, 2020, J ALZHEIMERS DIS, V78, P265, DOI 10.3233/JAD-200755; Bellaver B, 2021, NEUROLOGY, V96, pE2944, DOI 10.1212/WNL.0000000000012109; Benussi A, 2020, J ALZHEIMERS DIS, V77, P1129, DOI 10.3233/JAD-200608; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Carter SF, 2019, TRENDS MOL MED, V25, P77, DOI 10.1016/j.molmed.2018.11.006; Carter SF, 2012, J NUCL MED, V53, P37, DOI 10.2967/jnumed.110.087031; Chatterjee P, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-020-01137-1; Dumurgier J, 2011, J ALZHEIMERS DIS, V27, P845, DOI 10.3233/JAD-2011-111007; Elahi FM, 2020, ALZHEIMERS DEMENT, V16, P681, DOI 10.1016/j.jalz.2019.09.004; Escartin C, 2021, NAT NEUROSCI, V24, P312, DOI 10.1038/s41593-020-00783-4; Fontana IC, 2020, J NEUROCHEM, V155, P348, DOI 10.1111/jnc.15030; Fukuyama R, 2001, EUR NEUROL, V46, P35, DOI 10.1159/000050753; Giannoni P, 2018, CLIN SCI, V132, P361, DOI 10.1042/CS20171634; Iliff Jeffrey J, 2012, Sci Transl Med, V4, p147ra111, DOI 10.1126/scitranslmed.3003748; Ishiki A, 2016, J NEUROCHEM, V136, P258, DOI 10.1111/jnc.13399; Jack CR, 2016, NEUROLOGY, V87, P539, DOI 10.1212/WNL.0000000000002923; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Janelidze S, 2020, NAT MED, V26, P379, DOI 10.1038/s41591-020-0755-1; Janelidze S, 2016, SCI REP-UK, V6, DOI 10.1038/srep26801; Jesse S, 2009, J ALZHEIMERS DIS, V17, P541, DOI 10.3233/JAD-2009-1075; Karikari TK, 2020, LANCET NEUROL, V19, P422, DOI 10.1016/S1474-4422(20)30071-5; Keshavan A, 2021, BRAIN, V144, P434, DOI 10.1093/brain/awaa403; Koevari Enikoe, 2009, V24, P149, DOI 10.1159/000197894; Rodriguez JL, 2020, ACTA NEUROPATHOL, V140, P267, DOI 10.1007/s00401-020-02195-x; Larsson IM, 2014, RESUSCITATION, V85, P1654, DOI 10.1016/j.resuscitation.2014.09.007; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Mila-Aloma M, 2021, ALZHEIMERS RES THER, V13, DOI 10.1186/s13195-021-00863-y; Mila-Aloma M, 2020, ALZHEIMERS DEMENT, V16, P1358, DOI 10.1002/alz.12131; Molinuevo Jose Luis, 2016, Alzheimers Dement (N Y), V2, P82, DOI 10.1016/j.trci.2016.02.003; Muramori F, 1998, PSYCHIAT CLIN NEUROS, V52, P593, DOI 10.1111/j.1440-1819.1998.tb02706.x; Nagele RG, 2003, BRAIN RES, V971, P197, DOI 10.1016/S0006-8993(03)02361-8; Nakamura A, 2018, NATURE, V554, P249, DOI 10.1038/nature25456; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Nylen K, 2007, STROKE, V38, P1489, DOI 10.1161/STROKEAHA.106.478362; Oeckl P, 2019, J ALZHEIMERS DIS, V67, P481, DOI 10.3233/JAD-180325; Palmqvist S, 2020, JAMA-J AM MED ASSOC, V324, P772, DOI 10.1001/jama.2020.12134; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Pascoal TA, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0402-y; PIKE CJ, 1995, EXP NEUROL, V132, P172, DOI 10.1016/0014-4886(95)90022-5; Rodriguez-Vieitez E, 2015, EUR J NUCL MED MOL I, V42, P1119, DOI 10.1007/s00259-015-3047-0; Schindler SE, 2019, NEUROLOGY, V93, pE1647, DOI 10.1212/WNL.0000000000008081; Scholl M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16404; Simpson JE, 2010, NEUROBIOL AGING, V31, P578, DOI 10.1016/j.neurobiolaging.2008.05.015; Simren J, 2021, ALZHEIMERS DEMENT, V17, P1145, DOI 10.1002/alz.12283; Sun MJ, 2021, MULT SCLER RELAT DIS, V51, DOI 10.1016/j.msard.2021.102870; Sweeney MD, 2018, NAT REV NEUROL, V14, P133, DOI 10.1038/nrneurol.2017.188; Thijssen EH, 2020, NAT MED, V26, P387, DOI 10.1038/s41591-020-0762-2; Verberk IMW, 2020, ALZHEIMERS RES THER, V12, DOI 10.1186/s13195-020-00682-7; Verberk IMW, 2018, ANN NEUROL, V84, P648, DOI 10.1002/ana.25334; Verkhratsky A, 2010, NEUROTHERAPEUTICS, V7, P399, DOI 10.1016/j.nurt.2010.05.017	56	2	2	6	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6149	2168-6157		JAMA NEUROL	JAMA Neurol.	DEC	2021	78	12					1471	1483		10.1001/jamaneurol.2021.3671		OCT 2021	13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XM5TE	WOS:000709921500002	34661615				2022-02-06	
J	Biller, A; Badde, S; Heckel, A; Guericke, P; Bendszus, M; Nagel, AM; Heiland, S; Mairbaurl, H; Bartsch, P; Schommer, K				Biller, Armin; Badde, Stephanie; Heckel, Andreas; Guericke, Philipp; Bendszus, Martin; Nagel, Armin M.; Heiland, Sabine; Mairbaurl, Heimo; Baertsch, Peter; Schommer, Kai			Exposure to 16 h of normobaric hypoxia induces ionic edema in the healthy brain	NATURE COMMUNICATIONS			English	Article							ACUTE MOUNTAIN-SICKNESS; CEREBRAL EDEMA; SODIUM MRI; BARRIER PERMEABILITY; MULTIPLE-SCLEROSIS; ALTITUDE; WATER; ACCUMULATION; DISABILITY; HYPOBARIA	Prolonged hypoxia, which can be due to stroke or ascent to high altitude, can lead to cerebral edema. Here, the authors used a combination of sodium and proton MRI and experimentally induced hypoxic conditions to identify the cause for brain swelling: Ionic edema, an intermediate between cytotoxic and vasogenic edema defined by sodium ion accumulation in extracellular space and an intact endothelium. Following prolonged exposure to hypoxic conditions, for example, due to ascent to high altitude, stroke, or traumatic brain injury, cerebral edema can develop. The exact nature and genesis of hypoxia-induced edema in healthy individuals remain unresolved. We examined the effects of prolonged, normobaric hypoxia, induced by 16 h of exposure to simulated high altitude, on healthy brains using proton, dynamic contrast enhanced, and sodium MRI. This dual approach allowed us to directly measure key factors in the development of hypoxia-induced brain edema: (1) Sodium signals as a surrogate of the distribution of electrolytes within the cerebral tissue and (2) K-trans as a marker of blood-brain-barrier integrity. The measurements point toward an accumulation of sodium ions in extra- but not in intracellular space in combination with an intact endothelium. Both findings in combination are indicative of ionic extracellular edema, a subtype of cerebral edema that was only recently specified as an intermittent, yet distinct stage between cytotoxic and vasogenic edemas. In sum, here a combination of imaging techniques demonstrates the development of ionic edemas following prolonged normobaric hypoxia in agreement with cascadic models of edema formation.	[Biller, Armin; Heckel, Andreas; Bendszus, Martin; Heiland, Sabine] Heidelberg Univ, Dept Neuroradiol, MDMI Lab, Heidelberg, Germany; [Badde, Stephanie] Tufts Univ, Dept Psychol, Medford, MA 02155 USA; [Badde, Stephanie] NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA; [Guericke, Philipp; Mairbaurl, Heimo; Baertsch, Peter; Schommer, Kai] Heidelberg Univ, Dept Sports Med, Heidelberg, Germany; [Nagel, Armin M.] German Canc Res Ctr, Med Phys Radiol, Heidelberg, Germany; [Nagel, Armin M.] Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Hosp Erlangen, Inst Radiol, Erlangen, Germany		Biller, A (corresponding author), Heidelberg Univ, Dept Neuroradiol, MDMI Lab, Heidelberg, Germany.	armin.biller@med.uni-heidelberg.de	Nagel, Armin/C-4671-2016	Nagel, Armin/0000-0003-0948-1421	Projekt DEAL	Open Access funding enabled and organized by Projekt DEAL.	Ainslie PN, 2014, HIGH ALT MED BIOL, V15, P133, DOI 10.1089/ham.2013.1138; Bartsch P, 2013, NEW ENGL J MED, V368, P2294, DOI 10.1056/NEJMcp1214870; Bailey DM, 2006, J CEREBR BLOOD F MET, V26, P99, DOI 10.1038/sj.jcbfm.9600169; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biller A, 2016, AM J NEURORADIOL, V37, P66, DOI 10.3174/ajnr.A4493; Biller A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31269; Chappell MA, 2011, MAGN RESON MED, V65, P1173, DOI 10.1002/mrm.22641; Chappell MA, 2009, IEEE T SIGNAL PROCES, V57, P223, DOI 10.1109/TSP.2008.2005752; DiPasquale DM, 2015, AEROSP MED HUM PERF, V86, P614, DOI 10.3357/AMHP.4266.2015; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Fischer R, 2004, CEPHALALGIA, V24, P66, DOI 10.1111/j.1468-2982.2004.00619.x; GOTOH O, 1985, STROKE, V16, P101, DOI 10.1161/01.STR.16.1.101; Hackett PH, 2019, AM J NEURORADIOL, V40, P464, DOI 10.3174/ajnr.A5897; Hackett PH, 1998, JAMA-J AM MED ASSOC, V280, P1920, DOI 10.1001/jama.280.22.1920; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; Hunt JS, 2013, J CEREBR BLOOD F MET, V33, P372, DOI 10.1038/jcbfm.2012.184; Inglese M, 2010, BRAIN, V133, P847, DOI 10.1093/brain/awp334; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Johnston AJ, 2003, BRIT J ANAESTH, V90, P774, DOI 10.1093/bja/aeg104; Kallenberg K, 2007, J CEREBR BLOOD F MET, V27, P1064, DOI 10.1038/sj.jcbfm.9600404; Lawley JS, 2014, ANN NEUROL, V75, P890, DOI 10.1002/ana.24171; Lawley JS, 2013, J CEREBR BLOOD F MET, V33, P1286, DOI 10.1038/jcbfm.2013.83; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Loeppky JA, 2005, HIGH ALT MED BIOL, V6, P60, DOI 10.1089/ham.2005.6.60; Luh WM, 1999, MAGNET RESON MED, V41, P1246, DOI 10.1002/(SICI)1522-2594(199906)41:6<1246::AID-MRM22>3.0.CO;2-N; Madelin G, 2013, J MAGN RESON IMAGING, V38, P511, DOI 10.1002/jmri.24168; Mairer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050334; Mark KS, 2001, J PHARMACOL EXP THER, V297, P1051; McGuire SA, 2014, ANN NEUROL, V76, P719, DOI 10.1002/ana.24264; Morocz IA, 2001, EXP NEUROL, V168, P96, DOI 10.1006/exnr.2000.7596; Muza S. R., 1998, ACUTE MOUNTAIN SICKN; Nagel AM, 2009, MAGN RESON MED, V62, P1565, DOI 10.1002/mrm.22157; Nagel AM, 2011, INVEST RADIOL, V46, P759, DOI 10.1097/RLI.0b013e31822836f6; Nagel AM, 2011, INVEST RADIOL, V46, P539, DOI 10.1097/RLI.0b013e31821ae918; Paling D, 2013, BRAIN, V136, P2305, DOI 10.1093/brain/awt149; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Rawat C, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1592-3; Roach RC, 1996, J APPL PHYSIOL, V81, P1908, DOI 10.1152/jappl.1996.81.5.1908; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; Roach RC, 2018, HIGH ALT MED BIOL, V19, P4, DOI 10.1089/ham.2017.0164; Sagoo RS, 2017, J CEREBR BLOOD F MET, V37, P319, DOI 10.1177/0271678X15625350; SAMPSON JB, 1983, AVIAT SPACE ENVIR MD, V54, P1063; Schepkin VD, 2016, NMR BIOMED, V29, P175, DOI 10.1002/nbm.3347; Schommer K, 2013, NEUROLOGY, V81, P1776, DOI 10.1212/01.wnl.0000435563.84986.78; Schommer K, 2012, BRIT J SPORT MED, V46, P828, DOI 10.1136/bjsports-2012-091270; Schoonman GG, 2008, J CEREBR BLOOD F MET, V28, P198, DOI 10.1038/sj.jcbfm.9600513; Sevick R. J., CYTOTOXIC BRAIN EDEM; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Starling E H, 1896, J Physiol, V19, P312; Stobbe R, 2005, MAGN RESON MED, V54, P1305, DOI 10.1002/mrm.20696; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; SWENSON ER, 1995, J APPL PHYSIOL, V78, P377, DOI 10.1152/jappl.1995.78.2.377; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; TUCKER A, 1983, RESP PHYSIOL, V54, P363, DOI 10.1016/0034-5687(83)90079-8; Walcott BP, 2012, NEUROTHERAPEUTICS, V9, P65, DOI 10.1007/s13311-011-0087-4; Wetterling F, 2015, J CEREBR BLOOD F MET, V35, P103, DOI 10.1038/jcbfm.2014.174; Wilson MH, 2009, LANCET NEUROL, V8, P175, DOI 10.1016/S1474-4422(09)70014-6; Winter PM, 2001, MAGN RESON MED, V45, P436, DOI 10.1002/1522-2594(200103)45:3<436::AID-MRM1057>3.0.CO;2-6; Yushmanov VE, 2013, BRAIN RES, V1527, P199, DOI 10.1016/j.brainres.2013.06.012; Zaaraoui W, 2012, RADIOLOGY, V264, P859, DOI 10.1148/radiol.12112680	63	2	2	2	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY		2041-1723		NAT COMMUN	Nat. Commun.	OCT 13	2021	12	1							5987	10.1038/s41467-021-26116-y			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5IK	WOS:000707028100019	34645793	Green Published, gold			2022-02-06	
J	Cournoyer, J; Karton, C; Koncan, D; Gilchrist, MD; Cantu, RC; Hoshizaki, TB				Cournoyer, J.; Karton, C.; Koncan, D.; Gilchrist, M. D.; Cantu, R. C.; Hoshizaki, T. B.			Brain trauma exposure for American tackle football players 5 to 9 and 9 to 14 years of age	JOURNAL OF BIOMECHANICS			English	Article						Brain trauma; Biomechanics; Helmet; Testing standard	HEAD IMPACT EXPOSURE; DEFAULT MODE NETWORK; 1ST EXPOSURE; INJURY; CONCUSSION; CHILD	American football helmets used by youth players are currently designed and tested to the same standards as professionals. The National Operating Committee on Standard and Safety requested research aiming at understanding the differences in brain trauma in youth American football for players aged five to nine and nine to fourteen years old to inform a youth specific American football standard. Video analysis and laboratory reconstructions of head impacts were undertaken to measure differences in head impact frequency, event types, and magnitudes of maximum principal strain (MPS) for the two age groups. Overall frequencies and frequencies for five categories of MPS representing different magnitudes of risk were tabulated. The MPS categories were very low ( 0.08), low (0.08-0.169), medium (0.17-0.259), high (0.26-0.349) and very high ( 0.35). Both cohorts experienced a majority of head impacts (>56%) at very low magnitude of MPS. Youth American football players aged 9-14 yrs. sustained a greater frequency of head impacts at MPS between 0.08 and 0.169 % associated with changes in brain structure and function. There were no differences in overall frequency, or in frequency of head impacts in other categories of MPS. The proportion of impacts considered injurious (MPS > 0.08) was greater in the 5-9 group (44%), than the 9-14 group (39%), and impacts above 0.35 % were only reported for the younger age group. The larger helmet-to-shoulder ratio in the younger age groups may have contributed to this finding suggesting that youth American football players under the age of nine would benefit from a childspecific football helmet.	[Cournoyer, J.; Karton, C.; Koncan, D.; Hoshizaki, T. B.] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada; [Gilchrist, M. D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland; [Cantu, R. C.] Boston Univ, Sch Med, Alzheimers Dis & Chron Encephalopathy Ctr, Boston, MA 02118 USA; [Cantu, R. C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Cantu, R. C.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Cantu, R. C.] Emerson Hosp, Dept Neurosurg, Concord, MA USA; [Cantu, R. C.] Concuss Legacy Fdn, Boston, MA USA		Cournoyer, J (corresponding author), Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada.	jcournoy@uottawa.ca		Cournoyer, Janie/0000-0001-9043-7756	National Operating Committee on Safety of Athletic Equipment (NOCSAE)	This study was funded by the National Operating Committee on Safety of Athletic Equipment (NOCSAE).	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Abbas K, 2015, DEV NEUROPSYCHOL, V40, P51, DOI 10.1080/87565641.2014.990455; Ahmadzadeh H, 2015, BIOPHYS J, V109, P2328, DOI 10.1016/j.bpj.2015.09.010; Alosco M., 2017, TRANSL PSYCHIAT, V7, P1; Alosco Michael L, 2018, Alzheimers Dement (Amst), V10, P56, DOI 10.1016/j.dadm.2017.10.003; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bay R. C., 2010, ATHLETIC TRAINING SP, V2, P208, DOI DOI 10.3928/19425864-20100524-03; Breedlove KM., 2014, ATHL TRAIN SPORTS HL, V6, P1; Campolettano Eamon T, 2018, Proc Int IRCOBI Conf Biomech Impacts, V2018, P326; Chatelin S, 2012, J MECH BEHAV BIOMED, V6, P166, DOI 10.1016/j.jmbbm.2011.09.013; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Cournoyer J, 2021, J APPL BIOMECH, V37, P288, DOI 10.1123/jab.2020-0070; Cournoyer J, 2019, J ATHL TRAINING, V54, P765, DOI 10.4085/1062-6050-253-18; Cournoyer J, 2019, SPORT BIOMECH, DOI 10.1080/14763141.2019.1600004; Daniel RW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027872; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Foss KDB, 2019, CLIN J SPORT MED, V29, P442, DOI 10.1097/JSM.0000000000000753; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Karton C., 2016, P TRAUM BRAIN INJ CL; Karton C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-54874-9; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Koncan D, 2019, P I MECH ENG P-J SPO, V233, P277, DOI 10.1177/1754337118822940; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; NELLHAUS G, 1968, PEDIATRICS, V41, P106; NOCSAE, 2011, STANDARD TEST METHOD; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; Poole VN, 2015, DEV NEUROPSYCHOL, V40, P12, DOI 10.1080/87565641.2014.984810; Post A, 2018, SPORTS ENG, V21, P235, DOI 10.1007/s12283-018-0263-4; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Rizzone K, 2013, CURR SPORT MED REP, V12, P143, DOI 10.1249/JSR.0b013e3182955d1c; Rousseau P., 2014, THESIS U OTTAWA; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Singh Anita, 2006, Stapp Car Crash J, V50, P601; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Tsushima WT, 2016, APPL NEUROPSYCH-CHIL, V5, P149, DOI 10.1080/21622965.2015.1052813; Vickers VS, 1943, J PEDIATR-US, V22, P155, DOI 10.1016/S0022-3476(43)80074-3; Walsh ES, 2018, SPORTS ENG, V21, P479, DOI 10.1007/s12283-018-0286-x; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Zanetti K., 2013, IDENTIFYING RISK PRO; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	50	2	2	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	OCT 11	2021	127								110689	10.1016/j.jbiomech.2021.110689			8	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	WK0BR	WOS:000709400700007	34416530				2022-02-06	
J	Mayerhofer, T; Wiedermann, CJ; Joannidis, M				Mayerhoefer, Timo; Wiedermann, Christian J.; Joannidis, Michael			Use of albumin State of the art	MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN			German	Article						Fluid therapy; Sepsis; Ascites; Liver cirrhosis; Hemodynamics	ACUTE KIDNEY INJURY; CRITICALLY-ILL PATIENTS; HOSPITALIZED-PATIENTS; FLUID RESUSCITATION; SEVERE SEPSIS; METAANALYSIS; REPLACEMENT; MANAGEMENT; CONSENSUS; HYPOALBUMINEMIA	The Saline versus Albumin Fluid Evaluation (SAFE) study has demonstrated that the use of albumin as an infusion solution in volume therapy can be regarded as safe. An exception is hypo-oncotic albumin in traumatic brain injury. While clear indications of albumin exist for some patients with liver cirrhosis, large studies that demonstrate a clinically relevant advantage beyond hemodynamic effects and would therefore justify wider use in many other areas are still lacking. In large-volume paracentesis, spontaneous bacterial peritonitis, but also in hepatorenal syndrome, use of albumin is recommended and established due to clinical benefit in randomized controlled trials. In septic shock, use of albumin may be considered, with two large studies addressing this issue in Germany and Italy being still in the recruitment phase. For volume therapy, albumin can be used primarily when other measures for hemodynamic stabilization have been exhausted. This applies to volume resuscitation in hypovolemia as well as in conservative fluid management in the so-called "de-resuscitation" phase. The extent to which the correction of severe hypoalbuminemia with exogenous albumin can improve the impaired outcome of these patients is also part of ongoing studies. On the way to a more individualized medicine, hypoalbuminemia may serve as a parameter in future decision making for or against the use of albumin in volume therapy.	[Mayerhoefer, Timo; Joannidis, Michael] Med Univ Innsbruck, Gemeinsame Einrichtung Intens & Notfallmed, Abt Innere Med 1, Anichstr 35, A-6020 Innsbruck, Austria; [Wiedermann, Christian J.] UMIT Private Univ Gesundheitswissensch Med Inform, Inst Publ Hlth Med Decis Making & HTA, Hall In Tirol, Austria; [Wiedermann, Christian J.] Landesfachhsch Gesundheitsberufe Claudiana, Inst Aligemeinmed, Bolzano, Italy		Joannidis, M (corresponding author), Med Univ Innsbruck, Gemeinsame Einrichtung Intens & Notfallmed, Abt Innere Med 1, Anichstr 35, A-6020 Innsbruck, Austria.	michael.joannidis@i-med.ac.at			University of Innsbruck; Medical University of Innsbruck	Open access funding provided by University of Innsbruck and Medical University of Innsbruck.	Alhazzani W, 2021, CRIT CARE MED, V49, pE219, DOI 10.1097/CCM.0000000000004899; Amouzandeh M, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2053-6; Angeli P, 2015, GUT, V64, P531, DOI 10.1136/gutjnl-2014-308874; Arora V, 2020, HEPATOLOGY, V71, P600, DOI 10.1002/hep.30208; AWMF, 2021, BEH THERM VERL ERW; Aziz M, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02995-3; Bernardi M, 2012, HEPATOLOGY, V55, P1172, DOI 10.1002/hep.24786; Biggins SW, 2021, HEPATOLOGY, V74, P1014, DOI 10.1002/hep.31884; Caironi P, 2014, NEW ENGL J MED, V371, P84, DOI 10.1056/NEJMc1405675; Caironi P, 2014, NEW ENGL J MED, V370, P1412, DOI 10.1056/NEJMoa1305727; Caraceni P, 2018, LANCET, V391, P2417, DOI 10.1016/S0140-6736(18)30840-7; Caraceni P, 2016, BLOOD TRANSFUS-ITALY, V14, P8, DOI 10.2450/2016.0294-15; Charpentier J, 2011, INTENS CARE MED, V37, pS115; Chen Charles B, 2021, Curr Gastroenterol Rep, V23, P11, DOI 10.1007/s11894-021-00813-6; China L, 2021, NEW ENGL J MED, V384, P808, DOI 10.1056/NEJMoa2022166; Di Pascoli M, 2019, LIVER INT, V39, P98, DOI 10.1111/liv.13968; Dubois MJ, 2006, CRIT CARE MED, V34, P2536, DOI 10.1097/01.CCM.0000239119.57544.0C; Eljaiek R, 2017, BURNS, V43, P17, DOI 10.1016/j.burns.2016.08.001; EMA, 2018, HYDR STARCH HES CONT; European Assoc Study Liver, 2018, J HEPATOL, V69, P406, DOI 10.1016/j.jhep.2018.03.024; FDA, 2021, LAB CHANG MORT KIDN; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Finfer S, 2006, BRIT MED J, V333, P1044, DOI 10.1136/bmj.38985.398704.7C; Garcia-Martinez R, 2013, HEPATOLOGY, V58, P1836, DOI 10.1002/hep.26338; Gerbes AL., 2019, Z GASTROENTEROL, V57, P571, DOI [10.1055/a-0873-4641, DOI 10.1055/A-0873-4641]; German Med Assoc Recommendation, 2016, TRANSFUS MED HEMOTH, V43, P223, DOI 10.1159/000446043; Grande PO, 2008, ACTA ANAESTH SCAND, V52, P738, DOI 10.1111/j.1399-6576.2008.01688.x; Hansrivijit P, 2021, J CRIT CARE, V61, P96, DOI 10.1016/j.jcrc.2020.10.013; Hryciw N, 2021, CLIN J AM SOC NEPHRO, V16, P820, DOI 10.2215/CJN.09670620; Jia XM, 2008, CHEST, V133, P853, DOI 10.1378/chest.07-1121; Joannidis M, 2020, INTENS CARE MED, V46, P654, DOI 10.1007/s00134-019-05869-7; Kitsios GD, 2014, J CRIT CARE, V29, P253, DOI 10.1016/j.jcrc.2013.10.004; Komaromi A, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1536-6; Leao GS, 2019, J GASTROEN HEPATOL, V34, P2071, DOI 10.1111/jgh.14791; Lee EH, 2016, ANESTHESIOLOGY, V124, P1001, DOI 10.1097/ALN.0000000000001051; Liumbruno G, 2009, BLOOD TRANSFUS-ITALY, V7, P216, DOI 10.2450/2009.0094-09; Macedo E, 2021, CRIT CARE, V25, DOI 10.1186/s13054-020-03441-0; Malbrain MLNG, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00679-3; Martensson J, 2018, INTENS CARE MED, V44, P1797, DOI 10.1007/s00134-018-5253-2; Martin GS, 2019, J CRIT CARE, V50, P144, DOI 10.1016/j.jcrc.2018.11.031; Martin GS, 2005, CRIT CARE MED, V33, P1681, DOI 10.1097/01.CCM.0000171539.47006.02; Merlot AM, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00299; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Navickis RJ, 2016, J BURN CARE RES, V37, pE268, DOI 10.1097/BCR.0000000000000201; O'Brien Z, 2021, BLOOD PURIFICAT, DOI 10.1159/000517957; Oddo M, 2018, INTENS CARE MED, V44, P449, DOI 10.1007/s00134-018-5086-z; Paugam-Burtz C, 2020, ANAESTH CRIT CARE PA, V39, P143, DOI 10.1016/j.accpm.2019.06.014; Perner A, 2017, INTENS CARE MED, V43, P807, DOI 10.1007/s00134-017-4817-x; POZZI M, 1994, GASTROENTEROLOGY, V106, P709, DOI 10.1016/0016-5085(94)90706-4; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Roberts I, 1998, BMJ-BRIT MED J, V317, P235; Russell JA, 2004, J CARDIOTHOR VASC AN, V18, P429, DOI 10.1053/j.jvca.2004.05.019; Sakr Y, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04921-y; Salerno F, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0389-9; Sola E, 2018, J HEPATOL, V69, P1250, DOI 10.1016/j.jhep.2018.08.006; Sort P, 1999, NEW ENGL J MED, V341, P403, DOI 10.1056/NEJM199908053410603; Such J, 1998, CLIN INFECT DIS, V27, P669, DOI 10.1086/514940; Uhlig C, 2014, CRIT CARE, V18, DOI 10.1186/cc13187; Vignon P, 2020, INTENS CARE MED, V46, P2252, DOI 10.1007/s00134-020-06310-0; WAXMAN K, 1987, J TRAUMA, V27, P136, DOI 10.1097/00005373-198702000-00006; Weiler P, 2019, THORAC CARDIOV SURG, V67, P475, DOI 10.1055/s-0038-1667328; Wengenmayer T, 2018, INTENS CARE MED, V44, P2312, DOI 10.1007/s00134-018-5443-y; Wiedermann CJ, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094496; Wiedermann CJ, 2020, CURR MED RES OPIN, V36, P1961, DOI 10.1080/03007995.2020.1840970; Wiedermann CJ, 2018, INTENS CARE MED, V44, P1735, DOI 10.1007/s00134-018-5289-3	65	2	2	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	2193-6218	2193-6226		MED KLIN-INTENSIVMED	Med Klin Intensivmed Notfmed	NOV	2021	116	8			SI		655	663		10.1007/s00063-021-00875-4		OCT 2021	9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WR2UX	WOS:000705722100001	34618163	Green Published, hybrid			2022-02-06	
J	Berweck, S; Bonikowski, M; Kim, H; Althaus, M; Flatau-Baque, B; Mueller, D; Banach, MD				Berweck, Steffen; Bonikowski, Marcin; Kim, Heakyung; Althaus, Michael; Flatau-Baque, Birgit; Mueller, Daniela; Banach, Marta Dagmara			Placebo-Controlled Clinical Trial of IncobotulinumtoxinA for Sialorrhea in Children SIPEXI	NEUROLOGY			English	Article							BOTULINUM-TOXIN-A; GLYCOPYRROLATE ORAL SOLUTION; CEREBRAL-PALSY; SALIVARY-GLANDS; DOUBLE-BLIND; NEUROLOGICAL DISORDERS; ONABOTULINUM TOXIN; RANDOMIZED-TRIAL; INJECTIONS; EFFICACY	Background and Objectives To investigate the efficacy and safety of repeated injections of incobotulinumtoxinA (incoBoNT/A) for treatment of chronic sialorrhea (drooling) associated with neurologic disorders (e.g., cerebral palsy, traumatic brain injury) or intellectual disability in children and adolescents in a prospective phase III study (SIPEXI [Sialorrhea Pediatric Xeomin Investigation]). Methods The study enrolled 2- to 17-year-old patients with sialorrhea due to neurologic disorders or intellectual disability. Patients received body weight-dependent doses of incoBoNT/A (20-75 U). A main period with 1 injection cycle (placebo-controlled, double-blind, 6- to 17-year-olds) was followed by an open-label extension with up to 3 further cycles. An additional cohort of 2- to 5-year-olds received active treatment throughout the study. Coprimary endpoints were the change in unstimulated salivary flow rate (uSFR) from baseline to week 4 and the carers' Global Impression of Change Scale (GICS) rating at week 4. Adverse events were recorded. Results In the main period, 220 patients aged 6-17 years were randomized and treated (148 patients in incoBoNT/A group, 72 patients in placebo group). A total of 35 patients aged 2-5 years received incoBoNT/A (no placebo). A total of 214 patients aged 6-17 years and 33 patients aged 2-5 years continued treatment in the open-label extension period. For the 6- to 17-year-olds, a significant difference between incoBoNT/A and placebo was seen in mean uSFR decrease (difference -0.06 g/min; p = 0.0012) and the carers' GICS rating (difference 0.28 points; p = 0.032) at week 4, in favor of active treatment. The secondary endpoints consistently supported these results. A sustained benefit was observed during the extension. Incidences of adverse events were comparable between incoBoNT/A and placebo and did not increase notably with repeated injections. The most common adverse events were respiratory infections. Efficacy and safety were also favorable in the uncontrolled cohort of 2- to 5-year-olds. Discussion Both co-primary efficacy endpoints were reached and superiority of incoBoNT/A over placebo was confirmed. IncoBoNT/A (up to 75 U, up to 4 cycles) is an effective and well-tolerated treatment for sialorrhea associated with neurologic disorders in children.	[Berweck, Steffen] Schoen Klin, Specialist Ctr Paediat Neurol Neurorehabil & Epil, Vogtareuth, Germany; [Berweck, Steffen] Ludwig Maximilians Univ Munchen, Dr von Hauner Childrens Hosp, LMU Ctr Children Med Complex, Dept Pediat Neurol & Dev Med,Integrated Social Pe, Munich, Germany; [Bonikowski, Marcin] Mazovian Neuropsychiat Ctr LLC, Neuro Rehabil Dept, Movement Anal Lab, Warsaw, Poland; [Kim, Heakyung] Columbia Univ, Irving Med Ctr, New York Presbyterian Hosp, Pediat Rehabil Med,Dept Rehabil & Regenerat Med, York, N Yorkshire, England; [Althaus, Michael; Flatau-Baque, Birgit] Merz Pharmaceut GmbH, Frankfurt, Germany; [Mueller, Daniela] Kantar Hlth, Munich, Germany; [Banach, Marta Dagmara] Jagiellonian Univ, Dept Neurol, Krakow, Poland		Berweck, S (corresponding author), Schoen Klin, Specialist Ctr Paediat Neurol Neurorehabil & Epil, Vogtareuth, Germany.; Berweck, S (corresponding author), Ludwig Maximilians Univ Munchen, Dr von Hauner Childrens Hosp, LMU Ctr Children Med Complex, Dept Pediat Neurol & Dev Med,Integrated Social Pe, Munich, Germany.	sberweck@schoen-klinik.de			Merz Pharmaceuticals GmbH, Frankfurt am Main, Germany	This study was funded by Merz Pharmaceuticals GmbH, Frankfurt am Main, Germany.	Alrefai AH, 2009, CLIN NEUROL NEUROSUR, V111, P79, DOI 10.1016/j.clineuro.2008.09.001; Banerjee KJ, 2006, DEV MED CHILD NEUROL, V48, P883, DOI 10.1017/S0012162206001939; Bekkers S, 2019, NEUROLOGY, V92, pE1195, DOI 10.1212/WNL.0000000000007081; Cardona I, 2015, LARYNGOSCOPE, V125, pE328, DOI 10.1002/lary.25222; Chan KH, 2013, JAMA OTOLARYNGOL, V139, P134, DOI 10.1001/jamaoto.2013.1328; Daniel SJ, 2012, LARYNGOSCOPE, V122, pS67, DOI 10.1002/lary.23803; Dos Santos BF, 2016, INT J PAEDIATR DENT, V26, P45, DOI 10.1111/ipd.12156; Eiland LS, 2012, CLIN THER, V34, P735, DOI 10.1016/j.clinthera.2012.02.026; Erasmus CE, 2012, EUR J PEDIATR, V171, P409, DOI 10.1007/s00431-011-1570-y; Erasmus CE, 2010, DEV MED CHILD NEUROL, V52, pE114, DOI 10.1111/j.1469-8749.2009.03601.x; Fairhurst CBR, 2011, ARCH DIS CHILDHOOD-E, V96, P25, DOI 10.1136/adc.2007.129478; Forcella Luca, 2018, Swiss Dent J, V128, P962; Gonzalez-Luis MD, 2017, AM J PHYS MED REHAB, V96, P68, DOI 10.1097/PHM.0000000000000525; Gubbay A, 2019, INT J PEDIATR OTORHI, V124, P124, DOI 10.1016/j.ijporl.2019.05.044; Isaacson SH, 2020, JAMA NEUROL, V77, P461, DOI 10.1001/jamaneurol.2019.4565; Jongerius PH, 2004, NEUROLOGY, V63, P1371; Jongerius PH, 2004, PEDIATRICS, V114, P620, DOI 10.1542/peds.2003-1104-L; Jost WH, 2020, PARKINSONISM RELAT D, V70, P23, DOI 10.1016/j.parkreldis.2019.11.024; Jost WH, 2019, NEUROLOGY, V92, pE1982, DOI 10.1212/WNL.0000000000007368; Khan WU, 2011, ARCH OTOLARYNGOL, V137, P339, DOI 10.1001/archoto.2010.240; Lakraj AA, 2013, TOXINS, V5, P1010, DOI 10.3390/toxins5051010; Lawrence Rachael, 2018, Curr Otorhinolaryngol Rep, V6, P99, DOI 10.1007/s40136-018-0188-2; Lipp A, 2003, NEUROLOGY, V61, P1279, DOI 10.1212/WNL.61.9.1279; Lungren MP, 2016, PEDIATR NEUROL, V54, P70, DOI 10.1016/j.pediatrneurol.2015.09.014; Martinez-Poles J, 2018, TOXINS, V10, DOI 10.3390/toxins10060217; Mier RJ, 2000, ARCH PEDIAT ADOL MED, V154, P1214, DOI 10.1001/archpedi.154.12.1214; Moller E, 2015, TOXINS, V7, P2481, DOI 10.3390/toxins7072481; Morgante F, 2019, THER ADV NEUROL DISO, V12, DOI 10.1177/1756286419888601; Nordgarden H, 2012, J CHILD NEUROL, V27, P458, DOI 10.1177/0883073811419365; Parr JR, 2018, ARCH DIS CHILD, V103, P371, DOI 10.1136/archdischild-2017-313763; Reid SM, 2008, DEV MED CHILD NEUROL, V50, P123, DOI 10.1111/j.1469-8749.2007.02010.x; Restivo DA, 2018, TOXINS, V10, DOI 10.3390/toxins10020055; Rheims S, 2008, PLOS MED, V5, P1223, DOI 10.1371/journal.pmed.0050166; Rodwell K, 2012, DEV MED CHILD NEUROL, V54, P977, DOI 10.1111/j.1469-8749.2012.04370.x; Sandler A, 2005, MENT RETARD DEV D R, V11, P164, DOI 10.1002/mrdd.20065; Scheffer ART, 2010, ARCH OTOLARYNGOL, V136, P873, DOI 10.1001/archoto.2010.147; Schroeder AS, 2012, NEUROPEDIATRICS, V43, P27, DOI 10.1055/s-0032-1307457; Scully C, 2005, BRIT DENT J, V199, P423, DOI 10.1038/sj.bdj.4812740; Suskind DL, 2002, LARYNGOSCOPE, V112, P73, DOI 10.1097/00005537-200201000-00014; Taib BG, 2019, BRIT J ORAL MAX SURG, V57, P442, DOI 10.1016/j.bjoms.2019.04.001; Tiigimae-Saar J, 2018, NEUROL SCI, V39, P871, DOI 10.1007/s10072-018-3279-4; Van Hulst K, 2020, DEV MED CHILD NEUROL, V62, P354, DOI 10.1111/dmcn.14391; van Hulst K, 2017, DEV MED CHILD NEUROL, V59, P531, DOI 10.1111/dmcn.13333; Walshe M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008624.pub2; Wilken B, 2008, NEUROPEDIATRICS, V39, P200, DOI 10.1055/s-0028-1112115; Wu KPH, 2011, J CHILD NEUROL, V26, P838, DOI 10.1177/0883073810395391; Zeller RS, 2012, THER CLIN RISK MANAG, V8, P25, DOI 10.2147/TCRM.S27362; Zeller RS, 2012, THER CLIN RISK MANAG, V8, P15, DOI 10.2147/TCRM.S26893	48	2	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	OCT 5	2021	97	14					E1425	E1436		10.1212/WNL.0000000000012573			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WN1YY	WOS:000711572500024	34341153	hybrid, Green Published			2022-02-06	
J	Ali, BA; Brinck, T; Handolin, L; Otano, TB				Ali Ali, Bismil; Brinck, Tuomas; Handolin, Lauri; Belzunegui Otano, Tomas			Severe head injury in elderly: 6-year comparison of treatment and outcome between southern Finland and Navarra (Spain)	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Elderly trauma patients; Severe traumatic brain injury; Major trauma; Trauma registry; Benchmarking	TRAUMA PATIENTS; MAJOR TRAUMA; OLDER-ADULTS; MORTALITY; EPIDEMIOLOGY	Purpose To compare the profile, treatment and outcome of elderly patients with severe traumatic brain injuries (TBI) between southern Finland and Navarra (Spain). Methods Data collected from, 2010 to 2015, in the Major Trauma Registry of Navarra (MTR-N) and the Helsinki Trauma Registry (HTR) were compared. Patients with New Injury Severity Score (NISS) >= 16 and age >= 65 with isolated severe TBI were considered. Patients who had been admitted to the hospital >= 24 h after the trauma, had been pronounced dead before hospital arrival, or had been injured by hanging, drowning or burns, were excluded. Outcome was defined by 30-day hospital mortality. The expected mortality was calculated using the Revised Injury Severity Classification score II (RISC II). Other compared data included demographics, injury mechanism, pre-hospital and hospital treatment, and time intervals. Results A total of 305 (MTR-N) and 137 (HTR) patients were included in the outcome analysis. The standardized mortality ratio with 95% confidence interval was for MTR-N 1.4 (1.1-1.6) and for HTR 0.8 (0.6-1.1). Patients in Navarra were older (average 79.7 vs. 75.0) while in southern Finland the percentage of pre-hospital intubation in patients with GCS <= 8 (75.0% vs 50.0%) and ICU admission (72.2% vs 22.0%) were higher. Conclusion The better adjusted outcome of elderly patients with severe TBI in southern Finland in comparison to Navarra could be due to higher rate of pre-hospital intubation and/or higher rate of ICU admissions in southern Finland. Increasing number of elderly patients with severe TBI necessitate uniformly accepted protocols in pre- and in-hospital management.	[Ali Ali, Bismil; Belzunegui Otano, Tomas] Complejo Hosp Navarra, Accid & Emergency Dept, Hlth Serv Navarra Osasunbidea, Pamplona 31011, Spain; [Brinck, Tuomas; Handolin, Lauri] Univ Helsinki, Helsinki Univ Hosp, Trauma Unit, Helsinki, Finland; [Belzunegui Otano, Tomas] Univ Publ Navarra, Dept Hlth, Pamplona, Spain		Ali, BA (corresponding author), Complejo Hosp Navarra, Accid & Emergency Dept, Hlth Serv Navarra Osasunbidea, Pamplona 31011, Spain.	bismilnawazish@gmail.com	Otano, Tomas Belzunegui/A-8726-2017	Otano, Tomas Belzunegui/0000-0002-4615-5396			Adams SD, 2015, CURR OPIN CRIT CARE, V21, P520, DOI 10.1097/MCC.0000000000000246; Aitken LM, 2010, J AM GERIATR SOC, V58, P442, DOI 10.1111/j.1532-5415.2010.02728.x; Alberdi F, 2014, MED INTENSIVA, V38, P580, DOI 10.1016/j.medin.2014.06.012; Ali BA, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0453-2; Ali BA, 2019, INT J INJ CONTROL SA, V26, P137, DOI 10.1080/17457300.2018.1515229; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; Centre for Clinical Practice at NICE (UK), 2013, NICE CLIN GUIDELINES; CHAMPION HR, 1989, AM J PUBLIC HEALTH, V79, P1278, DOI 10.2105/AJPH.79.9.1278; Chatrath Veena, 2015, J Anaesthesiol Clin Pharmacol, V31, P308, DOI 10.4103/0970-9185.161664; Cranshaw J, 2006, BJA EDUC, V6, P124, DOI 10.1093/bjaceaccp/mkl015; Fleischman RJ, 2010, J AM GERIATR SOC, V58, P1843, DOI 10.1111/j.1532-5415.2010.03065.x; Giannoudis PV, 2009, INJURY, V40, P362, DOI 10.1016/j.injury.2008.10.016; Grossman MD, 2012, J TRAUMA ACUTE CARE, V72, P1181, DOI 10.1097/TA.0b013e31824d0e6d; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hansen Luke, 2014, J Emerg Trauma Shock, V7, P256, DOI 10.4103/0974-2700.142612; Heinanen M, 2017, SCAND J SURG, V106, P269, DOI 10.1177/1457496916685236; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; JENNETT B, 1975, LANCET, V1, P480; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Lefering R, 2012, EUR J TRAUMA EMERG S, V38, P3, DOI 10.1007/s00068-011-0168-4; Lefering R, 2008, J TRAUMA, V65, P1036, DOI 10.1097/TA.0b013e318184ee48; Lefering R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0476-2; Logan PA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2102; Padron-Monedero A, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0670-6; Peck KA, 2014, J TRAUMA ACUTE CARE, V77, P978, DOI 10.1097/TA.0000000000000356; Raj R, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-67; Ringdal KG, 2008, SCAND J TRAUMA RESUS, V16, DOI 10.1186/1757-7241-16-7; Sammy I, 2016, INJURY, V47, P1170, DOI 10.1016/j.injury.2016.02.027; Thies KC, 2014, RESUSCITATION, V85, P19, DOI 10.1016/j.resuscitation.2013.06.027; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thompson HJ, 2012, J NEUROTRAUM, V29, P1864, DOI 10.1089/neu.2011.2284; Wang HE, 2009, RESUSCITATION, V80, P50, DOI 10.1016/j.resuscitation.2008.08.016; WHO Geneva: Switzerland., 2010, WHO DEF OLD ELD PERS	33	2	2	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	OCT	2021	47	5			SI		1429	1436		10.1007/s00068-019-01091-8			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	UW8UR	WOS:000700428900022	30747276	Green Published, Bronze			2022-02-06	
J	Bhatti, UF; Remmer, H; Williams, AM; Biesterueld, BE; Russo, R; Wakam, G; Kemp, M; Tagett, R; Liu, BL; Li, YQ; Alam, HB				Bhatti, Umar F.; Remmer, Henriette; Williams, Aaron M.; Biesterueld, Ben E.; Russo, Rachel; Wakam, Glenn; Kemp, Michael; Tagett, Rebecca; Liu, Baoling; Li, Yongqing; Alam, Hasan B.			Assessment of the Cytoprotective Effects of High-Dose Valproic Acid Compared to a Clinically Used Lower Dose	JOURNAL OF SURGICAL RESEARCH			English	Article						Hemorrhagic shock; Histone deacetylase inhibitors; Traumatic brain injuries	TRAUMATIC BRAIN-INJURY; HEMORRHAGIC-SHOCK; PORCINE MODEL; RESUSCITATION; APOPTOSIS; PROTEOME; STRATEGIES; DEATH	Objective: Valproic acid (VPA) treatment improves survival in animal models of injuries on doses higher than those allowed by Food and Drug Administration (FDA). We investigated the proteomic alterations induced by a single high-dose (140mg/kg) of VPA (VPA140) compared to the FDA-approved dose of 30mg/kg (VPA30) in healthy humans. We also describe the proteomic and transcriptomic changes induced by VPA140 in an injured patient. We hypothesized that VPA140 would induce cytoprotective changes in the study participants. Methods: Serum samples were obtained from healthy subjects randomized to two groups; VPA140 and VPA30 at 3 timepoints: 0h(baseline), 2h, and 24h following infusion( n = 3/group). Samples were also obtained from an injured patient that received VPA140 at 0h, 6h and 24h following infusion. Proteomic analyses were performed using liquid chromatographymass spectrometry (LC-MS/MS), and transcriptomic analysis was performed using RNAsequencing. Differentially expressed (DE) proteins and genes were identified for functional annotation and pathway analysis using iPathwayGuide and gene set enrichment analysis (GSEA), respectively. Results: For healthy individuals, a dose comparison was performed between VPA140 and VPA30 groups at 2 and 24 h. Functional annotation showed that top biological processes in VPA140 versus VPA30 analysis at 2 h included regulation of fatty acid ( P = 0.002) and ATP biosynthesis ( P = 0.007), response to hypoxia ( P = 0.017), cell polarity regulation ( P = 0.031), and sequestration of calcium ions ( P = 0.031). Top processes at 24 h in VPA140 versus VPA30 analysis included amino acid metabolism ( P = 0.023), collagen catabolism ( P = 0.023), and regulation of protein breakdown ( P = 0.023). In the injured patient, annotation of the DE proteins in the serum showed that top biological processes at 2 h included neutrophil chemotaxis ( P = 0.002), regulation of cellular response to heat ( P = 0.008), regulation of oxidative stress ( P = 0.008) and regulation of apoptotic signaling pathway ( P = 0.008). Top biological processes in the injured patient at 24 h included autophagy ( P = 0.01), glycolysis ( P = 0.01), regulation of apoptosis ( P = 0.01) and neuron apoptotic processes ( P = 0.02). Conclusions: VPA140 induces cytoprotective changes in human proteome not observed in VPA30. These changes may be responsible for its protective effects in response to injuries. (c) 2021 Elsevier Inc. All rights reserved.	[Bhatti, Umar F.; Williams, Aaron M.; Biesterueld, Ben E.; Russo, Rachel; Wakam, Glenn; Kemp, Michael; Liu, Baoling; Li, Yongqing; Alam, Hasan B.] Univ Michigan Hlth Syst, Dept Surg, Ann Arbor, MI USA; [Bhatti, Umar F.] Washington Univ Sch Med, Dept Surg, St Louis, MO USA; [Alam, Hasan B.] Northwestern Univ, Feinberg Sch Med, Dept Surg, 676 N St Clair St,Suite 2320, Chicago, IL 60611 USA; [Remmer, Henriette; Tagett, Rebecca] Univ Michigan, Ann Arbor, MI 48109 USA		Alam, HB (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Surg, 676 N St Clair St,Suite 2320, Chicago, IL 60611 USA.	alamh@med.umich.edu		Tagett, Rebecca/0000-0001-8604-7683	Office of Naval ResearchOffice of Naval Research [N000141310071]	We would like to acknowledge the personnel and support staff at the Alam lab at the University of Michigan, the MS Bioworks LLC for the experimental processing of the proteomics samples, and the Bioinformatics Core of the University of Michi-gan Medical School's Biomedical Research Core Facilities for RNA sequencing and analysis. Research grant from the Office of Naval Research (N000141310071) to HBA	Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Adibhatla RM, 2008, FRONT BIOSCI-LANDMRK, V13, P1250, DOI 10.2741/2759; Alam HB, 2015, CRIT CARE MED, V43, P2701, DOI 10.1097/CCM.0000000000001360; Alam HB, 2002, RESUSCITATION, V54, P195, DOI 10.1016/S0300-9572(02)00095-3; Aztopal N, 2018, CHEM-BIOL INTERACT, V280, P51, DOI 10.1016/j.cbi.2017.12.003; Bambakidis T, 2016, J NEUROTRAUM, V33, P1514, DOI 10.1089/neu.2015.4163; Barton MD, 2012, SOURCE CODE BIOL MED, V7, DOI 10.1186/1751-0473-7-4; Berger JA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-194; Bhatti UF, 2019, TRAUMA SURG ACUTE CA, V4; Bhatti UF, 2019, PROTEOM CLIN APPL, V13, DOI 10.1002/prca.201900068; BOYUM A, 1977, LYMPHOLOGY, V10, P71; Caldwell CC, 2007, J LEUKOCYTE BIOL, V82, P457, DOI 10.1189/jlb.0107062; Caruso J M, 2001, Surg Infect (Larchmt), V2, P231, DOI 10.1089/109629601317202713; Chen HZ, 2006, J TRAUMA, V60, P701, DOI 10.1097/01.ta.0000203699.91475.f6; Chen X, 2020, BLOOD ADV, V4, P76, DOI 10.1182/bloodadvances.2019000467; Curry N, 2011, CRIT CARE, V15, DOI 10.1186/cc10096; Dekker SE, 2018, J NEUROSCI RES, V96, P711, DOI 10.1002/jnr.24125; Dekker SE, 2014, J TRAUMA ACUTE CARE, V77, P906, DOI 10.1097/TA.0000000000000345; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Geeraedts LMG, 2009, INJURY, V40, P11, DOI 10.1016/j.injury.2008.10.007; Georgoff PE, 2018, J TRAUMA ACUTE CARE, V84, P642, DOI 10.1097/TA.0000000000001763; Georgoff PE, 2018, CLIN PHARMACOKINET, V57, P209, DOI 10.1007/s40262-017-0553-1; Georgoff PE, 2016, J TRAUMA ACUTE CARE, V81, P1020, DOI 10.1097/TA.0000000000001249; Geyer PE, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201910427; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Goldenberg Marvin M, 2010, P T, V35, P392; Halaweish I, 2015, J TRAUMA ACUTE CARE, V79, P911, DOI 10.1097/TA.0000000000000789; Halaweish I, 2015, SHOCK, V44, P6, DOI 10.1097/SHK.0000000000000319; Huang YF, 2007, CELL IMMUNOL, V248, P4, DOI 10.1016/j.cellimm.2007.03.009; Hwabejire JO, 2014, J SURG RES, V186, P363, DOI 10.1016/j.jss.2013.09.016; Insinga A, 2005, NAT MED, V11, P71, DOI 10.1038/nm1160; Jin G, 2014, SURGERY, V156, P221, DOI 10.1016/j.surg.2014.03.038; Li HC, 2019, CANCER GENOM PROTEOM, V16, P81, DOI 10.21873/cgp.20114; Li YQ, 2008, SURGERY, V144, P217, DOI 10.1016/j.surg.2008.03.037; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Peart MJ, 2003, CANCER RES, V63, P4460; Pitcher JM, 2005, J SURG RES, V129, P202, DOI 10.1016/j.jss.2005.04.015; Raju R, 2008, MOL MED, V14, P213, DOI 10.2119/2008-00001.Raju; Scheschowitsch K, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00016; Sergushichev A.A., 2016, ALGORITHM FAST PRERA, P60012, DOI [DOI 10.1101/060012V1, 10.1101/060012]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; UniProt C, 2008, NUCLEIC ACIDS RES, V36; Weykamp M, 2018, J SURG RES, V228, P84, DOI 10.1016/j.jss.2018.02.046; Williams AM, 2019, J TRAUMA ACUTE CARE, V87, P393, DOI 10.1097/TA.0000000000002281; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	46	2	2	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	OCT	2021	266						125	141		10.1016/j.jss.2021.03.025			17	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	TT3VU	WOS:000680279900017	33991999				2022-02-06	
J	Li, YK; Chen, JG; Wang, F				Li, Yu-Ke; Chen, Jian-Guo; Wang, Fang			The emerging roles of absent in melanoma 2 (AIM2) inflammasome in central nervous system disorders	NEUROCHEMISTRY INTERNATIONAL			English	Article						AIM2 inflammasome; Inflammatory cascade; Pyroptosis; Central nervous system diseases	POSTSTROKE COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; CYTOSOLIC DNA SENSOR; CYCLIC GMP-AMP; NLRP3 INFLAMMASOME; ALZHEIMERS-DISEASE; ANIMAL-MODELS; CELL-DEATH; MULTIPLE-SCLEROSIS; INNATE IMMUNITY	As a double-stranded DNA (dsDNA) sensor, the PYHIN family member absent in melanoma 2 (AIM2) is an essential component of the inflammasome families. Activation of AIM2 by dsDNA leads to the assembly of cytosolic multimolecular complexes termed the AIM2 inflammasome, resulting in activation of caspase-1, the maturation and secretion of pro-inflammatory cytokines interleukin (IL)-113 and IL-18, and pyroptosis. Multiple central nervous system (CNS) diseases are accompanied by immune responses and inflammatory cascade. As the resident macrophage cells, microglia cells act as the first and main form of active immune defense in the CNS. AIM2 is highly expressed in microglia as well as astrocytes and neurons and is essential in neurodevelopment. In this review, we highlight the recent progress on the role of AIM2 inflammasome in CNS disorders, including cerebral stroke, brain injury, neuropsychiatric disease, neurodegenerative diseases, and glioblastoma.	[Li, Yu-Ke; Chen, Jian-Guo; Wang, Fang] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Pharmacol, Wuhan 430030, Peoples R China; [Chen, Jian-Guo; Wang, Fang] Huazhong Univ Sci, Tongji Med Coll, Res Ctr Depress, Wuhan 430030, Peoples R China; [Chen, Jian-Guo; Wang, Fang] Key Lab Drug Target Res & Pharmacodynam Evaluat H, Wuhan 430030, Peoples R China		Wang, F (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Pharmacol, Wuhan 430030, Peoples R China.	wangfanghust@hust.edu.cn		Li, Yu-Ke/0000-0001-6806-5984	Foundation for Inno-vative Research Groups of National Natural Scientific Foundation of ChinaNational Natural Science Foundation of China (NSFC)	This work was supported by grants from the Foundation for Inno-vative Research Groups of National Natural Scientific Foundation of China (No. 81721005to J.-G.C. and F. W.) .	Adamczak SE, 2014, J CEREBR BLOOD F MET, V34, P621, DOI 10.1038/jcbfm.2013.236; Ahn H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76251-7; Alfonso-Loeches S, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00216; Alifieris C, 2015, PHARMACOL THERAPEUT, V152, P63, DOI 10.1016/j.pharmthera.2015.05.005; Amantea D, 2010, BRAIN RES, V1313, P259, DOI 10.1016/j.brainres.2009.12.017; Andujar I, 2013, CURR MED CHEM, V20, P2892, DOI 10.2174/09298673113209990008; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Calsolaro V, 2016, ALZHEIMERS DEMENT, V12, P719, DOI 10.1016/j.jalz.2016.02.010; Cao XT, 2016, NAT REV IMMUNOL, V16, P35, DOI 10.1038/nri.2015.8; Chen J, 2019, BRAIN RES BULL, V152, P85, DOI 10.1016/j.brainresbull.2019.07.011; Chen PA, 2019, J NEURO-ONCOL, V144, P265, DOI 10.1007/s11060-019-03230-y; Choi DY, 2012, J NEUROCHEM, V120, P1048, DOI 10.1111/j.1471-4159.2011.07642.x; Chou WC, 2021, NATURE, V591, P300, DOI 10.1038/s41586-021-03231-w; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Courchesne E, 2019, MOL PSYCHIATR, V24, P88, DOI 10.1038/s41380-018-0056-y; Cox DJ, 2015, GLIA, V63, P812, DOI 10.1002/glia.22786; Dendrou CA, 2015, NAT REV IMMUNOL, V15, P545, DOI 10.1038/nri3871; Denes A, 2015, P NATL ACAD SCI USA, V112, P4050, DOI 10.1073/pnas.1419090112; DeYoung KL, 1997, ONCOGENE, V15, P453, DOI 10.1038/sj.onc.1201206; Di Micco A, 2016, P NATL ACAD SCI USA, V113, pE4671, DOI 10.1073/pnas.1602419113; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Fan KQ, 2019, CELL, V179, P864, DOI 10.1016/j.cell.2019.10.001; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Feng YS, 2020, AGEING RES REV, V64, DOI 10.1016/j.arr.2020.101192; Feng YS, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00155; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Ge XT, 2018, BRAIN RES, V1697, P10, DOI 10.1016/j.brainres.2018.06.008; Gelderblom M, 2012, BLOOD, V120, P3793, DOI 10.1182/blood-2012-02-412726; Gondi V, 2014, J CLIN ONCOL, V32, P3810, DOI 10.1200/JCO.2014.57.2909; Gris D, 2010, J IMMUNOL, V185, P974, DOI 10.4049/jimmunol.0904145; Caceres LG, 2010, BRAIN RES, V1312, P67, DOI 10.1016/j.brainres.2009.11.053; Guo CQ, 2017, ACS CHEM NEUROSCI, V8, P2194, DOI 10.1021/acschemneuro.7b00124; Habib P, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21134795; Han B, 2018, AUTOPHAGY, V14, P1164, DOI 10.1080/15548627.2018.1458173; Han XJ, 2019, AUTOPHAGY, V15, P1860, DOI 10.1080/15548627.2019.1596481; Hanamsagar R, 2014, J NEUROCHEM, V129, P704, DOI 10.1111/jnc.12669; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He XF, 2020, J CEREBR BLOOD F MET, V40, P1048, DOI 10.1177/0271678X19856226; Heneka MT, 2018, NAT REV NEUROSCI, V19, P610, DOI 10.1038/s41583-018-0055-7; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hoeffner EG, 2016, HEMATOL ONCOL CLIN N, V30, P899, DOI 10.1016/j.hoc.2016.03.010; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Huang SX, 2021, J NEUROIMMUNOL, V354, DOI 10.1016/j.jneuroim.2021.577543; Inoue M, 2012, P NATL ACAD SCI USA, V109, P10480, DOI 10.1073/pnas.1201836109; Jha S, 2010, J NEUROSCI, V30, P15811, DOI 10.1523/JNEUROSCI.4088-10.2010; Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014; Johnson ECB, 2020, NAT MED, V26, P769, DOI 10.1038/s41591-020-0815-6; Jokinen H, 2015, EUR J NEUROL, V22, P1288, DOI 10.1111/ene.12743; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kaminski JJ, 2013, J IMMUNOL, V191, P3876, DOI 10.4049/jimmunol.1300530; Karki R, 2019, NAT REV CANCER, V19, P197, DOI 10.1038/s41568-019-0123-y; Kaufmann FN, 2017, BRAIN BEHAV IMMUN, V64, P367, DOI 10.1016/j.bbi.2017.03.002; Kim H, 2020, BRAIN BEHAV IMMUN, V87, P765, DOI 10.1016/j.bbi.2020.03.011; Kim J, 2014, IMMUNOL LETT, V158, P143, DOI 10.1016/j.imlet.2013.12.017; Kim J, 2019, PHYTOMEDICINE, V63, DOI 10.1016/j.phymed.2019.153019; Kronenberg G, 2018, ACTA NEUROPATHOL, V135, P551, DOI 10.1007/s00401-017-1795-6; Kwak SB, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/6054069; Lammerding L, 2016, NEUROENDOCRINOLOGY, V103, P460, DOI 10.1159/000439435; Lammert CR, 2020, NATURE, V580, P647, DOI 10.1038/s41586-020-2174-3; Lampron A, 2013, NEURON, V78, P214, DOI 10.1016/j.neuron.2013.04.005; Leng FD, 2021, NAT REV NEUROL, V17, P157, DOI 10.1038/s41582-020-00435-y; Li Q, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201911002; Li XQ, 2019, NEUROPHARMACOLOGY, V160, DOI 10.1016/j.neuropharm.2019.05.038; Li XH, 2009, J NEUROIMMUNOL, V207, P111, DOI 10.1016/j.jneuroim.2008.12.002; Liang J, 2020, EXP NEUROL, V325, DOI 10.1016/j.expneurol.2019.113139; Liao H, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1948985; Liston A, 2017, NAT REV IMMUNOL, V17, P208, DOI 10.1038/nri.2016.151; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Liu XX, 2016, AUTISM RES, V9, P340, DOI 10.1002/aur.1536; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Lu HH, 2018, J CELL PHYSIOL, V233, P1712, DOI 10.1002/jcp.26083; Luheshi NM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-186; Lv RX, 2019, INT IMMUNOPHARMACOL, V70, P28, DOI 10.1016/j.intimp.2019.02.006; Ma CM, 2021, J EXP MED, V218, DOI 10.1084/jem.20201796; Majidpoor J, 2020, CELL TISSUE RES, V381, P397, DOI 10.1007/s00441-020-03250-5; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Matsuyama H, 2020, BRAIN RES, V1736, DOI 10.1016/j.brainres.2020.146779; McKenzie BA, 2018, P NATL ACAD SCI USA, V115, pE6065, DOI 10.1073/pnas.1722041115; Miller BA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/384342; Mo WM, 2018, NORD J PSYCHIAT, V72, P179, DOI 10.1080/08039488.2017.1410570; Morrone SR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8827; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Nazarian A, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051489; Noroozi S, 2017, MOL NEUROBIOL, V54, P3031, DOI 10.1007/s12035-016-9864-8; Ortiz JMP, 2019, BRIT J PHARMACOL, V176, P3489, DOI 10.1111/bph.14585; Patchell RA, 1998, JAMA-J AM MED ASSOC, V280, P1485, DOI 10.1001/jama.280.17.1485; Perl DP, 2010, MT SINAI J MED, V77, P32, DOI 10.1002/msj.20157; Pettigrew LC, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-47; Poh L, 2021, MOL PSYCHIATR, V26, P4544, DOI [10.1038/s41380-020-00971-5, 10.1002/alz.051709]; Poh L, 2019, BRAIN BEHAV IMMUN, V75, P34, DOI 10.1016/j.bbi.2018.09.001; Ransohoff RM, 2012, NAT NEUROSCI, V15, P1074, DOI 10.1038/nn.3168; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Roth S, 2021, IMMUNITY, V54, P648, DOI 10.1016/j.immuni.2021.02.004; Ryan NP, 2019, J NEUROTRAUM, V36, P2895, DOI 10.1089/neu.2018.6308; Saadi M, 2020, BRAIN RES BULL, V154, P81, DOI 10.1016/j.brainresbull.2019.10.010; Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37; Saresella M, 2016, BRAIN BEHAV IMMUN, V57, P125, DOI 10.1016/j.bbi.2016.03.009; Sarkar S, 2020, J CLIN INVEST, V130, P4195, DOI 10.1172/JCI136174; Savarraj JPJ, 2018, CYTOKINE, V111, P334, DOI 10.1016/j.cyto.2018.09.003; Scholwer I, 2020, MOL NEUROBIOL, V57, P2588, DOI 10.1007/s12035-020-01909-2; Sharma N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44854-4; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Sliter DA, 2018, NATURE, V561, P258, DOI 10.1038/s41586-018-0448-9; Stoecklein VM, 2015, J IMMUNOL, V194, P1178, DOI 10.4049/jimmunol.1303051; Stoner R, 2014, NEW ENGL J MED, V370, P1209, DOI 10.1056/NEJMoa1307491; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun ZZ, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/7879629; Swanson KV, 2017, J EXP MED, V214, P3611, DOI 10.1084/jem.20171749; Swardfager W, 2010, BIOL PSYCHIAT, V68, P930, DOI 10.1016/j.biopsych.2010.06.012; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tofilon PJ, 2000, RADIAT RES, V153, P357, DOI 10.1667/0033-7587(2000)153[0357:TROTCN]2.0.CO;2; Tyrer P, 2006, LANCET, V368, P2156, DOI 10.1016/S0140-6736(06)69865-6; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Vegeto E, 2006, ENDOCRINOLOGY, V147, P2263, DOI 10.1210/en.2005-1330; Vogelzangs N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.27; Wang PH, 2018, EMBO REP, V19, DOI 10.15252/embr.201845737; Wang Y, 2020, BIOTECHNOL BIOTEC EQ, V34, P1234, DOI 10.1080/13102818.2020.1829049; Warren SE, 2010, J IMMUNOL, V185, P818, DOI 10.4049/jimmunol.1000724; Werner Y, 2020, NAT NEUROSCI, V23, P351, DOI 10.1038/s41593-020-0585-y; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Wu PJ, 2017, NEUROIMMUNOMODULAT, V24, P29, DOI 10.1159/000477092; Wu PJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32405; Xu PF, 2021, TRANSL STROKE RES, V12, P643, DOI 10.1007/s12975-020-00840-x; Yamin TT, 1996, J BIOL CHEM, V271, P13273, DOI 10.1074/jbc.271.22.13273; Yang J, 2020, RADIAT ONCOL, V15, DOI 10.1186/s13014-020-01525-3; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yuan B, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2248-z; Zendedel A, 2018, MOL NEUROBIOL, V55, P1364, DOI 10.1007/s12035-017-0400-2; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhang MJ, 2020, FASEB J, V34, P648, DOI 10.1096/fj.201900394RRR; Zhang X, 2003, J CLIN ENDOCR METAB, V88, P5119, DOI 10.1210/jc.2003-030222; Zhang XS, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00611; Zorman J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159826	143	2	2	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	OCT	2021	149								105122	10.1016/j.neuint.2021.105122			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	UE4AQ	WOS:000687833200001	34284076				2022-02-06	
J	Mastorakos, P; Russo, MV; Zhou, TZ; Johnson, K; McGavern, DB				Mastorakos, Panagiotis; Russo, Matthew, V; Zhou, Tianzan; Johnson, Kory; McGavern, Dorian B.			Antimicrobial immunity impedes CNS vascular repair following brain injury	NATURE IMMUNOLOGY			English	Article							ACUTE ISCHEMIC-STROKE; INFECTION; MACROPHAGES; INTERFERONS; MECHANISMS; RESPONSES; VIRUS; ANGIOGENESIS; RECRUITMENT; INDUCTION	Traumatic brain injury and stroke are commonly complicated by systemic infections, which impede recovery and lead to poor clinical outcomes. Using a mouse model, McGavern and colleagues show systemic microbial infections impair central nervous system revascularization and repair by a mechanism involving type I interferon signaling. Traumatic brain injury (TBI) and cerebrovascular injury are leading causes of disability and mortality worldwide. Systemic infections often accompany these disorders and can worsen outcomes. Recovery after brain injury depends on innate immunity, but the effect of infections on this process is not well understood. Here, we demonstrate that systemically introduced microorganisms and microbial products interfered with meningeal vascular repair after TBI in a type I interferon (IFN-I)-dependent manner, with sequential infections promoting chronic disrepair. Mechanistically, we discovered that MDA5-dependent detection of an arenavirus encountered after TBI disrupted pro-angiogenic myeloid cell programming via induction of IFN-I signaling. Systemic viral infection similarly blocked restorative angiogenesis in the brain parenchyma after intracranial hemorrhage, leading to chronic IFN-I signaling, blood-brain barrier leakage and a failure to restore cognitive-motor function. Our findings reveal a common immunological mechanism by which systemic infections deviate reparative programming after central nervous system injury and offer a new therapeutic target to improve recovery.	[Mastorakos, Panagiotis; Russo, Matthew, V; Zhou, Tianzan; McGavern, Dorian B.] NINDS, Viral Immunol & Intravital Imaging Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Mastorakos, Panagiotis] NINDS, Dept Surg Neurol, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Johnson, Kory] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA		McGavern, DB (corresponding author), NINDS, Viral Immunol & Intravital Imaging Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	mcgavernd@mail.nih.gov	Mastorakos, Panagiotis/ABG-1157-2021				Abdullah A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1354-7; Ahmed NA, 1999, CRIT CARE MED, V27, P2459, DOI 10.1097/00003246-199911000-00023; Amarante-Mendes GP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02379; Andraweera N, 2016, AUST HEALTH REV, V40, P114, DOI 10.1071/AH15062; Angus DC, 2016, JAMA-J AM MED ASSOC, V315, P1457, DOI 10.1001/jama.2016.2762; Barrett JP, 2020, J NEUROSCI, V40, P2357, DOI 10.1523/JNEUROSCI.2516-19.2020; Becker KJ, 2005, J CEREBR BLOOD F MET, V25, P1634, DOI 10.1038/sj.jcbfm.9600160; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Crane MJ, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007212; Cumming TB, 2011, INT J STROKE, V6, P416, DOI 10.1111/j.1747-4949.2011.00666.x; Davis FM, 2019, ARTERIOSCL THROM VAS, V39, P2353, DOI 10.1161/ATVBAHA.119.312754; Doran SJ, 2020, CRIT CARE MED, V48, pE418, DOI 10.1097/CCM.0000000000004273; Erdur H, 2015, STROKE, V46, P1031, DOI 10.1161/STROKEAHA.114.006886; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Fensterl V, 2009, BIOFACTORS, V35, P14, DOI 10.1002/biof.6; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Gliem M, 2012, ANN NEUROL, V71, P743, DOI 10.1002/ana.23529; Gorelick PB, 2015, JAMA-J AM MED ASSOC, V314, P29, DOI 10.1001/jama.2015.7149; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Karve IP, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0128-15.2016; KENYON AJ, 1983, AM J VET RES, V44, P652; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Kliper E, 2013, STROKE, V44, P1433, DOI 10.1161/STROKEAHA.111.000536; Koskela M, 2009, CRIT CARE, V13, DOI 10.1186/cc7932; Kourbeti IS, 2012, CLIN MICROBIOL INFEC, V18, P359, DOI 10.1111/j.1469-0691.2011.03625.x; Kraemer M, 2004, J NEUROIMAGING, V14, P265, DOI 10.1177/1051228404264950; KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794; Lord AS, 2014, STROKE, V45, P3535, DOI 10.1161/STROKEAHA.114.006435; Manglani Monica, 2018, Curr Protoc Immunol, V120, DOI 10.1002/cpim.46; Mastorakos P, 2021, NAT NEUROSCI, V24, P245, DOI 10.1038/s41593-020-00773-6; Mastorakos P, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav0492; McColl BW, 2007, J NEUROSCI, V27, P4403, DOI 10.1523/JNEUROSCI.5376-06.2007; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Moseman EA, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abb1817; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Navarathna DHMLP, 2005, J ANTIMICROB CHEMOTH, V56, P1156, DOI 10.1093/jac/dki383; Nitkunan A, 2011, STROKE, V42, P133, DOI 10.1161/STROKEAHA.110.594267; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; OLDSTONE MBA, 1986, NATURE, V321, P239, DOI 10.1038/321239a0; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158; Prigge JR, 2015, J IMMUNOL, V195, P5347, DOI 10.4049/jimmunol.1501553; Rico RM, 2002, J SURG RES, V102, P193, DOI 10.1006/jsre.2001.6316; Ritzel RM, 2018, J NEUROTRAUM, V35, P1419, DOI 10.1089/neu.2017.5399; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rothenburg LS, 2010, J GERIATR PSYCH NEUR, V23, P199, DOI 10.1177/0891988710373598; Russo MV, 2018, NAT IMMUNOL, V19, P442, DOI 10.1038/s41590-018-0086-2; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Santoro MM, 2005, EXP CELL RES, V304, P274, DOI 10.1016/j.yexcr.2004.10.033; Schumacher R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0801-7; Sharma R, 2019, BRAIN BEHAV IMMUN, V79, P63, DOI 10.1016/j.bbi.2019.04.034; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shim R, 2018, BRAIN BEHAV IMMUN, V70, P10, DOI 10.1016/j.bbi.2018.03.019; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Traub E, 1936, J EXP MED, V63, P847, DOI 10.1084/jem.63.6.847; Tsirogianni AK, 2006, INJURY, V37, pS5, DOI 10.1016/j.injury.2006.02.035; Vannella KM, 2017, ANNU REV PHYSIOL, V79, P593, DOI 10.1146/annurev-physiol-022516-034356; Vermeij FH, 2009, CEREBROVASC DIS, V27, P465, DOI 10.1159/000210093; VOLKERT M, 1965, ACTA PATHOL MIC SC, V63, P161, DOI 10.1111/apm.1965.63.2.161; Wardlaw JM, 2003, STROKE, V34, P806, DOI 10.1161/01.STR.0000058480.77236.B3; Wattananit S, 2016, J NEUROSCI, V36, P4182, DOI 10.1523/JNEUROSCI.4317-15.2016; Welsh RM., 2008, CURR PROTOC MICROBIO; Westendorp WF, 2015, LANCET, V385, P1519, DOI 10.1016/S0140-6736(14)62456-9; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Zhou SH, 2010, J VIROL, V84, P9452, DOI 10.1128/JVI.00155-10	75	2	2	13	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2021	22	10					1280	+		10.1038/s41590-021-01012-1			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UZ9IQ	WOS:000702512800017	34556874				2022-02-06	
J	Nebie, O; Carvalho, K; Barro, L; Delila, L; Faivre, E; Renn, TY; Chou, ML; Wu, YW; Nyam-Erdene, A; Chou, SY; Buee, L; Hu, CJ; Peng, CW; Devos, D; Blum, D; Burnouf, T				Nebie, Ouada; Carvalho, Kevin; Barro, Lassina; Delila, Liling; Faivre, Emilie; Renn, Ting-Yi; Chou, Ming-Li; Wu, Yu-Wen; Nyam-Erdene, Ariunjargal; Chou, Szu-Yi; Buee, Luc; Hu, Chaur-Jong; Peng, Chih-Wei; Devos, David; Blum, David; Burnouf, Thierry			Human platelet lysate biotherapy for traumatic brain injury: preclinical assessment	BRAIN			English	Article						human platelet lysate; traumatic brain injury; neuroprotection; neurorestoration; neurotrophins	CHAIN FATTY-ACIDS; RECOVERY; NEUROPROTECTION; MATURATION; RESPONSES; PATHWAYS; SURVIVAL; NEURONS; DISEASE; CELLS	Traumatic brain injury (TBI) leads to major brain anatomopathological damages underlined by neuroinflammation, oxidative stress and progressive neurodegeneration, ultimately leading to motor and cognitive deterioration. The multiple pathological events resulting from TBI can be addressed not by a single therapeutic approach, but rather by a synergistic biotherapy capable of activating a complementary set of signalling pathways and providing synergistic neuroprotective, anti-inflammatory, antioxidative, and neurorestorative activities. Human platelet lysate might fulfil these requirements as it is composed of a plethora of biomolecules readily accessible as a TBI biotherapy. In the present study, we tested the therapeutic potential of human platelet lysate using in vitro and in vivo models of TBI. We first prepared and characterized platelet lysate from clinical-grade human platelet concentrates. Platelets were pelletized, lysed by three freeze-thaw cycles, and centrifuged. The supernatant was purified by 56 degrees C 30 min heat treatment and spun to obtain the heat-treated platelet pellet lysate that was characterized by ELISA and proteomic analyses. Two mouse models were used to investigate platelet lysate neuroprotective potential. The injury was induced by an in-house manual controlled scratching of the animals' cortex or by controlled cortical impact injury. The platelet lysate treatment was performed by topical application of 60 mu l in the lesioned area, followed by daily 60 mu l intranasal administration from Day 1 to 6 post-injury. Platelet lysate proteomics identified over 1000 proteins including growth factors, neurotrophins, and antioxidants. ELISA detected several neurotrophic and angiogenic factors at similar to 1-50 ng/ml levels. We demonstrate, using two mouse models of TBI, that topical application and intranasal platelet lysate consistently improved mouse motor function in the beam and rotarod tests, mitigated cortical neuroinflammation, and oxidative stress in the injury area, as revealed by downregulation of pro-inflammatory genes and the reduction in reactive oxygen species levels. Moreover, platelet lysate treatment reduced the loss of cortical synaptic proteins. Unbiased proteomic analyses revealed that heat-treated platelet pellet lysate reversed several pathways promoted by both controlled cortical impact and cortical brain scratch and related to transport, postsynaptic density, mitochondria or lipid metabolism. The present data strongly support, for the first time, that human platelet lysate is a reliable and effective therapeutic source of neurorestorative factors. Therefore, brain administration of platelet lysate is a therapeutical strategy that deserves serious and urgent consideration for universal brain trauma treatment.	[Nebie, Ouada; Delila, Liling; Chou, Ming-Li; Wu, Yu-Wen; Burnouf, Thierry] Taipei Med Univ, Coll Biomed Engn, Grad Inst Biomed Mat & Tissue Engn, 250 Wu Xing St, Taipei 11031, Taiwan; [Nebie, Ouada; Carvalho, Kevin; Faivre, Emilie; Buee, Luc; Devos, David; Blum, David] Univ Lille, LilNCog Lille Neurosci & Cognit U1172, CHU Lille, INSERM, F-59000 Lille, France; [Nebie, Ouada; Carvalho, Kevin; Faivre, Emilie; Buee, Luc; Blum, David] LiCEND, LabEx DISTALZ, Alzheimer & Tauopathies, F-59000 Lille, France; [Barro, Lassina; Nyam-Erdene, Ariunjargal; Peng, Chih-Wei; Burnouf, Thierry] Taipei Med Univ, Int PhD Program Biomed Engn, Taipei 11031, Taiwan; [Renn, Ting-Yi] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei 11031, Taiwan; [Chou, Ming-Li; Burnouf, Thierry] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Chou, Szu-Yi; Hu, Chaur-Jong] Taipei Med Univ, NeuroTMULille Int Lab, Taipei 11031, Taiwan; [Chou, Szu-Yi; Hu, Chaur-Jong] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei 11031, Taiwan; [Chou, Szu-Yi; Hu, Chaur-Jong] Natl Hlth Res Inst, Taipei 11031, Taiwan; [Chou, Szu-Yi; Hu, Chaur-Jong; Blum, David] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Neural Regenerat Med, Taipei 11031, Taiwan; [Buee, Luc; Devos, David] Univ Lille, NeuroTMULille Int Lab, F-59000 Lille, France; [Hu, Chaur-Jong] Taipei Med Univ, Shuang Ho Hosp, Dementia Ctr, Dept Neurol, New Taipei 23561, Taiwan; [Hu, Chaur-Jong] Taipei Med Univ, Coll Med, Sch Med, Neurol, Taipei 11031, Taiwan; [Peng, Chih-Wei; Burnouf, Thierry] Taipei Med Univ, Coll Biomed Engn, Sch Biomed Engn, Taipei 11031, Taiwan; [Burnouf, Thierry] Taipei Med Univ, Coll Med, Int PhD Program Cell Therapy & Regenerat, Taipei 11031, Taiwan; [Burnouf, Thierry] Taipei Med Univ, Brain & Consciousness Res Ctr, Shuang Ho Hosp, New Taipei 23561, Taiwan		Burnouf, T (corresponding author), Taipei Med Univ, Coll Biomed Engn, Grad Inst Biomed Mat & Tissue Engn, 250 Wu Xing St, Taipei 11031, Taiwan.; Blum, D (corresponding author), Lille Neurosci & Cognit, Inserm UMR 51172, Alzheimer & Tauopathies, 1 Pl Verdun, F-59045 Lille, France.	david.blum@inserm.fr; thburnouf@gmail.com	BUEE, Luc/B-3126-2010	BUEE, Luc/0000-0002-6261-4230; Blum, David/0000-0001-5691-431X; Emilie, Faivre/0000-0002-8608-9848; Chou, Szu-Yi/0000-0002-4387-749X	Ministry of Science and Technology (MOST) of TaiwanMinistry of Science and Technology, Taiwan [107-2314B-038-084]; Taipei Medical University (TMU) Higher Education Sprout Project MoE [DP2-107-21121-01N-09]; TMU; Universite de Lille, France (CABRI/MOBLILEX grant); Bilateral Orchid research project (MOST); Bilateral Orchid research project (French Association of Taiwan-Campus France) [108-2911-I-038-503]; InsermInstitut National de la Sante et de la Recherche Medicale (Inserm)European Commission; Centre National de la Recherche Scientifique (CNRS)Centre National de la Recherche Scientifique (CNRS); Universite de Lille; Centre Hospitalier Universitaire (CHU) Lille (Programmes d'Investissements d'Avenir LabEx (excellence laboratory)); DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to Alzheimer's disease)	Ministry of Science and Technology (MOST) of Taiwan (107-2314B-038-084); Taipei Medical University (TMU) Higher Education Sprout Project MoE (DP2-107-21121-01N-09); PhD fellowship from TMU and Universite de Lille, France (CABRI/MOBLILEX grant) to O.N.; Bilateral Orchid research project (MOST and French Association of Taiwan-Campus France; 108-2911-I-038-503); Inserm, Centre National de la Recherche Scientifique (CNRS), Universite de Lille and Centre Hospitalier Universitaire (CHU) Lille (Programmes d'Investissements d'Avenir LabEx (excellence laboratory), DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to Alzheimer's disease).	Agrahari V, 2019, ADV DRUG DELIVER REV, V148, P146, DOI 10.1016/j.addr.2019.02.008; Agrahari V, 2019, TRENDS BIOTECHNOL, V37, P707, DOI 10.1016/j.tibtech.2018.11.012; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Burnouf T, 2014, BLOOD REV, V28, P155, DOI 10.1016/j.blre.2014.04.002; Burnouf T, 2013, BLOOD REV, V27, P77, DOI 10.1016/j.blre.2013.02.001; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chang CY, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041463; Chou ML, 2017, BIOMATERIALS, V142, P77, DOI 10.1016/j.biomaterials.2017.07.018; Cox CS, 2018, PEDIATR RES, V83, P325, DOI 10.1038/pr.2017.253; Crespo-Diaz R, 2011, CELL TRANSPLANT, V20, P797, DOI 10.3727/096368910X543376; Deacon RMJ, 2013, JOVE-J VIS EXP, DOI 10.3791/2609; Delila LL, 2021, PLATELETS, V32, P259, DOI 10.1080/09537104.2020.1849603; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Garcia A, 2004, PROTEOMICS, V4, P656, DOI 10.1002/pmic.200300665; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Gonzalez-Dominguez R, 2016, EBIOMEDICINE, V12, P8, DOI 10.1016/j.ebiom.2016.09.024; Gouel F, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00835; Gouel F, 2017, J TISSUE ENG REGEN M, V11, P3236, DOI 10.1002/term.2222; Habib N, 2020, NAT NEUROSCI, V23, P701, DOI 10.1038/s41593-020-0624-8; Habtemariam S, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/8512048; Hanson Leah R, 2013, J Vis Exp, DOI 10.3791/4440; Hayon Y, 2013, THROMB HAEMOSTASIS, V110, P323, DOI 10.1160/TH12-11-0875; Johnson J, 2021, TRENDS BIOTECHNOL, V39, P598, DOI 10.1016/j.tibtech.2020.10.004; Kazanis I, 2015, EXP NEUROL, V269, P75, DOI 10.1016/j.expneurol.2015.03.018; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kornyei Z, 2000, J NEUROSCI RES, V61, P421, DOI 10.1002/1097-4547(20000815)61:4<421::AID-JNR8>3.0.CO;2-4; Kucur M, 2005, NEUROSURG QUART, V15, P186, DOI 10.1097/01.wnq.0000173450.16339.77; Leiter O, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00747; Leiter O, 2019, PROG NEUROBIOL, V183, DOI 10.1016/j.pneurobio.2019.101695; LIM R, 1989, P NATL ACAD SCI USA, V86, P3901, DOI 10.1073/pnas.86.10.3901; Liu XF, 2001, J NEUROL SCI, V187, P91, DOI 10.1016/S0022-510X(01)00532-9; Lv QS, 2013, BRAIN RES, V1493, P80, DOI 10.1016/j.brainres.2012.11.028; Menet R, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.565667; Moosavi F, 2016, DRUG DES DEV THER, V10, P23, DOI 10.2147/DDDT.S96936; Nebie O, 2021, PLATELETS, V32, P226, DOI 10.1080/09537104.2020.1732324; Nebie O, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0579-9; Nurden AT, 2008, FRONT BIOSCI-LANDMRK, V13, DOI 10.2741/2947; Paganoni S, 2010, NEUROSCIENCE, V165, P1261, DOI 10.1016/j.neuroscience.2009.11.056; Pilitsis JG, 2003, NEUROSCI LETT, V349, P136, DOI 10.1016/S0304-3940(03)00803-6; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Saso L, 2014, CURR DRUG TARGETS, V15, P1177, DOI 10.2174/1389450115666141024113925; Schuck PF, 2009, NEUROCHEM INT, V54, P519, DOI 10.1016/j.neuint.2009.02.009; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Sharma B, 2020, SYST REV-LONDON, V9, DOI 10.1186/s13643-020-1281-4; Smith JM, 2007, BRAIN, V130, P915, DOI 10.1093/brain/awl393; Song J, 2016, J MOL NEUROSCI, V60, P115, DOI 10.1007/s12031-016-0784-x; Sulhan S, 2020, J NEUROSCI RES, V98, P19, DOI 10.1002/jnr.24331; Vasicek O, 2020, J PHYSIOL BIOCHEM, V76, P49, DOI 10.1007/s13105-019-00714-3; World Health Organization, 2019, WHO MOD LIST ESS MED; Xu ZX, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15530-3; Zhang JY, 2018, J NEUROTRAUM, V35, P802, DOI 10.1089/neu.2016.4871; Zhao ML, 2018, J ALZHEIMERS DIS, V63, P303, DOI 10.3233/JAD-180002	55	2	2	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	OCT	2021	144		10				3142	3158		10.1093/brain/awab205			17	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XT1SM	WOS:000733375400028	34086871	Green Published, hybrid			2022-02-06	
J	Vedin, T; Karlsson, M; Edelhamre, M; Clausen, L; Svensson, S; Bergenheim, M; Larsson, PA				Vedin, Tomas; Karlsson, Mathias; Edelhamre, Marcus; Clausen, Linus; Svensson, Sebastian; Bergenheim, Mikael; Larsson, Per-Anders			A proposed amendment to the current guidelines for mild traumatic brain injury: reducing computerized tomographies while maintaining safety	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Brain injuries; Traumatic; Tomography; X-ray computed; Practice guidelines as topic; Intracranial hemorrhage; Traumatic	CT HEAD RULE; NEW-ORLEANS CRITERIA; GLASGOW COMA SCALE; INTRACRANIAL HEMORRHAGE; EMERGENCY-DEPARTMENT; EPIDEMIOLOGY; RISK; ELIMINATION; MANAGEMENT; SERUM	Purpose Head trauma is a common complaint in emergency departments. Identifying patients with serious injuries can be difficult and generates many computerized tomographies. Reducing the number of computerized tomographies decreases both cost and radiation exposure. The aim of this study was to evaluate whether the current Scandinavian Neurotrauma Committee guidelines could be revised in such a way that would enable hospitals to perform fewer computerized tomographies while maintaining the ability to identify all patients requiring neurological intervention. Methods A retrospective study of the medical records of adult patients suffering a traumatic brain injury was performed. A total of 1671 patients over a period of 365 days were included, and 25 parameters were extracted. Multitrauma patients managed with ATLS (TM) were excluded. The Scandinavian Neurotrauma Committee guidelines were amended with the previously derived "low-risk proposal" and applied retrospectively to the cohort. Results Incidence of intracranial hemorrhage was 5.6% (93/1671). Application of the current Scandinavian Neurotrauma Committee guidelines would have resulted in 860 computerized tomographies and would have missed 11 intracranial hemorrhages. The proposed amendment with the low-risk proposal would have resulted in 748 CT scans and would have missed 19 intracranial hemorrhages (a relative reduction of 13%). None of the missed intracranial hemorrhages required neurological intervention. Conclusion For patients with mild and moderate traumatic brain injuries, application of the Scandinavian Neurotrauma Committee guidelines amended with the low-risk proposal may result in a significant reduction of computerized tomographies without missing any patients in need of neurological intervention.	[Vedin, Tomas; Edelhamre, Marcus; Clausen, Linus; Svensson, Sebastian; Larsson, Per-Anders] Lund Univ, Clin Sci, Svartbrodragranden 3-5, S-25187 Helsingborg, Sweden; [Karlsson, Mathias] Cent Sjukhuset, Dept Clin Chem, Ctr Clin Res, Karlstad, Sweden; [Bergenheim, Mikael] Cent Sjukhuset Karlstad, Rosenborgsgatan 9, S-65230 Karlstad, Sweden		Vedin, T (corresponding author), Lund Univ, Clin Sci, Svartbrodragranden 3-5, S-25187 Helsingborg, Sweden.	tvedin@gmail.com; mathias.karlsson@liv.se; marcus_c@telia.com; linus.clausen@skane.se; sebastian.svensson@skane.se; mikael.bergenheim@liv.se; p-a.larsson@telia.com		Vedin, Tomas/0000-0003-1913-7958			Alonso JV, 2016, MED CLIN-BARCELONA, V147, P523, DOI 10.1016/j.medcli.2016.07.024; Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Brenner David J., 2010, Reviews on Environmental Health, V25, P63; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Ganti L, 2015, WEST J EMERG MED, V16, P481, DOI 10.5811/westjem.2015.2.23546; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; Goldberg J, 2011, J PEDIATR SURG, V46, P1777, DOI 10.1016/j.jpedsurg.2011.02.052; Hankey GJ, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0480-9; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hodgkinson S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g104; Hong CK, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0774-6; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Joseph B, 2015, BRAIN INJURY, V29, P11, DOI 10.3109/02699052.2014.945959; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2018, CURR SPORT MED REP, V17, P262, DOI 10.1249/JSR.0000000000000505; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Mata-Mbemba D, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1781-9; Medaglia JD, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00407; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Orlando A, 2017, WORLD NEUROSURG, V107, P94, DOI [10.1016/j.wneu.2017.07.130, 10.1016/J.WNEU.2017.07.130]; Paul AB, 2015, J AM COLL RADIOL, V12, P453, DOI 10.1016/j.jacr.2014.12.016; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Sweeney TE, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0017-6; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; TraumaticBrainInjury.com, 2016, SEV TBI SYMPT; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Unden L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0533-y; Vassar M, 2013, J EDUC EVAL HEALTH P, V10, DOI 10.3352/jeehp.2013.10.12; Vedin T, 2019, EUR J TRAUMA EMERG S, V45, P901, DOI 10.1007/s00068-018-0941-8; Vedin T, 2017, QUAL MANAG HEALTH CA, V26, P190, DOI 10.1097/QMH.0000000000000151; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Webster NJ, 2017, ADV EMERG NURS J, V39, P300, DOI 10.1097/TME.0000000000000169; Xu WW, 2017, J ZHEJIANG UNIV-SC B, V18, P567, DOI 10.1631/jzus.B1600143; Yarmohammadian MH, 2017, J RES MED SCI, V22, DOI 10.4103/1735-1995.200277	49	2	2	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	OCT	2021	47	5			SI		1451	1459		10.1007/s00068-019-01145-x			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	UW8UR	WOS:000700428900024	31089789	hybrid, Green Published			2022-02-06	
J	Willick, SE; Cushman, DM; Klatt, J; Brobeck, M; Spencer, C; Teramoto, M				Willick, Stuart E.; Cushman, Daniel M.; Klatt, Joshua; Brobeck, Matthew; Spencer, Chris; Teramoto, Masaru			The NICA injury surveillance system: Design, methodology and preliminary data of a prospective, longitudinal study of injuries in youth cross country mountain bike racing	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Sports; Epidemiology; Methods; Injury; Injury prevention	BIKING INJURIES; EPIDEMIOLOGY; ISSUES; RISK	Objectives: To describe the design and implementation of an injury surveillance system for youth mountain bike racing in the United States, and to report preliminary first-year results. Design: Descriptive sports injury epidemiology study. Methods: After two and a half years of development and extensive beta-testing, an electronic injury surveillance system went live in January, 2018. An automated email is sent to a Designated Reporter on each team, with links to the injury reporting form. Data collected include demographic information, injured body part, injury diagnosis, trail conditions and other factors associated with injury occurrence. Results: 837 unique injuries were reported in 554 injury events among 18,576 student-athletes. The overall injury event proportion was 3.0%. The most common injury among student-athletes was concussion/possible concussion (22.2%), followed by injuries to the wrist and hand (19.0%). Among 8,738 coaches, there were 134 unique injuries reported that occurred in 68 injury events, resulting in an overall injury event proportion of 0.8%. The shoulder (38.2%) was the most commonly injured body part among coaches. Injuries among coaches tended to more frequently result in fractures, dislocations and hospital admission compared with injuries among student-athletes. Among student-athletes, female riders sustained lower limb injuries more than male riders (34.0% vs. 20.7%, p < 0.001). Conclusions: A nationwide injury surveillance system for youth mountain bike racing was successfully implemented in the United States. Overall injury event proportions were relatively low, but many injury events resulted in concussions/possible concussions, fractures, dislocations and 4 weeks or longer of time loss from riding. (c) 2020 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Willick, Stuart E.; Cushman, Daniel M.; Brobeck, Matthew; Teramoto, Masaru] Univ Utah, Div Phys Med & Rehabil, Salt Lake City, UT 84112 USA; [Klatt, Joshua] Univ Utah, Dept Orthopaed, Salt Lake City, UT 84112 USA; [Spencer, Chris] Natl Interscholast Cycling Assoc, Berkeley, CA USA		Willick, SE (corresponding author), Univ Utah, Div Phys Med & Rehabil, Salt Lake City, UT 84112 USA.	Stuart.willick@hsc.utah.edu		Cushman, Daniel/0000-0002-4580-1173	NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR002538] Funding Source: Medline		Ahmad CS, 2014, AM J SPORT MED, V42, P1464, DOI 10.1177/0363546514529083; Aleman KB, 2010, SPORTS MED, V40, P77, DOI 10.2165/11319640-000000000-00000; Ansari M, 2017, CURR SPORT MED REP, V16, P404, DOI 10.1249/JSR.0000000000000429; Ashwell Z, 2012, WILD ENVIRON MED, V23, P140, DOI 10.1016/j.wem.2012.02.002; Becker J, 2013, BRIT J SPORT MED, V47, P458, DOI 10.1136/bjsports-2012-091755; Brant JA, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119873059; Bush Kevin, 2013, Hand (N Y), V8, P397, DOI 10.1007/s11552-013-9550-5; Carmont MR, 2008, BRIT MED BULL, V85, P101, DOI 10.1093/bmb/ldn009; Carter EA, 2011, J ATHL TRAINING, V46, P484; CHOW TK, 1993, WESTERN J MED, V159, P145; Chow TK, 2002, WILD ENVIRON MED, V13, P27, DOI 10.1580/1080-6032(2002)013[0027:MOIICO]2.0.CO;2; Dick R, 2007, J ATHL TRAINING, V42, P173; Ekegren CL, 2016, SPORTS MED, V46, P49, DOI 10.1007/s40279-015-0410-z; Finch CF, 1997, SPORTS MED, V24, P157, DOI 10.2165/00007256-199724030-00002; Jeys LM, 2001, BRIT J SPORT MED, V35, P197, DOI 10.1136/bjsm.35.3.197; Kerr ZY, 2018, J ATHL TRAINING, V53, P729, DOI 10.4085/1062-6050-143-17; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kim PTW, 2006, J TRAUMA, V60, P312, DOI 10.1097/01.ta.0000202714.31780.5f; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Kronisch RL, 1996, AM J SPORT MED, V24, P88, DOI 10.1177/036354659602400116; Kronisch RL, 2002, CLIN J SPORT MED, V12, P158, DOI 10.1097/00042752-200205000-00003; Kronisch RL, 2002, SPORTS MED, V32, P523, DOI 10.2165/00007256-200232080-00004; National Bicycle Dealers Association, 2015, IND OV 2015; Nelson NG, 2011, AM J SPORT MED, V39, P404, DOI 10.1177/0363546510383478; Rivara FP, 1997, J FAM PRACTICE, V44, P481; Roberts DJ, 2013, CAN J SURG, V56, pE32, DOI 10.1503/cjs.027411; Smith S., 2017, GLOBAL MOUNTAIN BIKE; The Outdoor Foundation, 2017, OUTD PART REP; Willick SE, 2013, BRIT J SPORT MED, V47, P426, DOI 10.1136/bjsports-2013-092374	29	2	2	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	OCT	2021	24	10					1032	1037		10.1016/j.jsams.2020.05.021			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	WC4UW	WOS:000704254800016	32546436				2022-02-06	
J	Audrit, H; Beauchamp, MH; Tinawi, S; Lague-Beauvais, M; de Guise, E				Audrit, Helene; Beauchamp, Miriam H.; Tinawi, Simon; Lague-Beauvais, Maude; de Guise, Elaine			Development and description of SAAM intervention: A brief, multidimensional and psycho-educational intervention for adults with mild traumatic brain injury	ANNALS OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Mild traumatic brain injury; Psychoeducation; Post-concussion symptoms; Intervention	CONCUSSION SYMPTOMS QUESTIONNAIRE; FEAR-AVOIDANCE MODEL; HEAD-INJURY; POSTCONCUSSION SYMPTOMS; POSTTRAUMATIC SYMPTOMS; COLLABORATING-CENTER; TASK-FORCE; PSYCHOGENESIS; PHYSIOGENESIS; TRIAL	Background: Mild traumatic brain injury (mTBI) is associated with persistent post-concussive symptoms (PCSs) in approximately 15% of cases. These symptoms can be somatic (e.g., headache), cognitive (e.g., forgetfulness, poor attention and concentration capacities), emotional (e.g., anxiety, depression, irritability) and/or sleep-arousal complaints (e.g., fatigue, sleep problems). Although practice guidelines recommend early intervention to prevent and treat PCS, we still lack an effective, standardized, integrative, post-acute intervention based on a sound and validated theoretical model. Objectives: The purpose of this article is to present the development and theoretical background underpinning a novel intervention for patients with PCSs in the post-acute phase after mTBI (1-3 months post-injury). Procedure: With a biopsychosocial approach (Hou et al., 2012) and best practice recommendations, we developed a novel multidimensional intervention targeting factors that perpetuate PCSs and that can be changed with the intervention. This individual-session intervention provides practical tools for managing PCSs and is designed to provide psycho-education and reassurance, reinforce individual objectives and promote a return to activities. Each session targets one category of PCSs: Sleep/fatigue, Attention, Anxiety/depressed mood, Memory/Organization (SAAM intervention). The rationale underlying the choices of format and content for the intervention is discussed, as are the associated strengths, limitations, opportunities and challenges. Conclusion: This article could support researchers and clinicians to develop, replicate and/or implement interventions addressing current best practices in mTBI management. (C) 2020 Elsevier Masson SAS. All rights reserved.	[Audrit, Helene; Beauchamp, Miriam H.; de Guise, Elaine] Univ Montreal, Dept Psychol, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Audrit, Helene; de Guise, Elaine] Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; [Beauchamp, Miriam H.] St Justine Hosp Res Ctr, Montreal, PQ, Canada; [Tinawi, Simon; Lague-Beauvais, Maude] McGill Univ, Hlth Ctr, Traumat Brain Injury Program, Montreal, PQ, Canada; [de Guise, Elaine] McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ, Canada		de Guise, E (corresponding author), Univ Montreal, Dept Psychol, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	elaine.de.guise@umontreal.ca			Fonds de recherche du Quebec-Sante (FRQS) Strategic Innovative Projects Programme [302541]; Centre de recherche interdisciplinaire en readaptation du Montreal mtropolitain (CRIR)/Laboratoire vivant en readaptation [301444]	This work was supported by the Fonds de recherche du Quebec-Sante (FRQS) Strategic Innovative Projects Programme (grant no. 302541) and the Centre de recherche interdisciplinaire en readaptation du Montreal mtropolitain (CRIR)/Laboratoire vivant en readaptation (grant no. 301444).	Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Audrit H, 2014, J READAP MED, V34, P109; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Berquin A, 2010, MED SPORT, V258, P1511; Bertisch H, 2019, J HEAD TRAUMA REHAB, V34, P36, DOI 10.1097/HTR.0000000000000399; Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; Caplain S, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00929; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Cassidy JD, 2004, J REHABIL MED, V36, P15, DOI 10.1080/16501960410023688; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Cooper DB, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000254; Crombez G, 2012, CLIN J PAIN, V28, P475, DOI 10.1097/AJP.0b013e3182385392; Delmonico R, 2019, PREVALENCE DEPRESSIO, DOI [10.2139/ssrn.3471336, DOI 10.2139/SSRN.3471336]; Dhawan P, 2006, BCMJ, V9, P442; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Gilbert KS, 2015, CLIN PSYCHOL REV, V40, P195, DOI 10.1016/j.cpr.2015.05.008; Gravel J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-63; Greenberger D, 2015, MIND MOOD CHANGE YOU; Helmick K, 2012, MIL MED, V177, P86, DOI 10.7205/MILMED-D-12-00174; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hunt Cindy, 2016, Concussion, V1, pCNC21, DOI 10.2217/cnc-2016-0009; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Jacobson E, 1938, INTERVIEW BEHAV J AB, V75, P18; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; Julien J, 2017, BRAIN INJURY, V31, P1846, DOI 10.1080/02699052.2017.1346289; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; King N, 2015, OVERCOMING MILD TRAU; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kurowski BG, 2016, J HEAD TRAUMA REHAB, V31, P369, DOI 10.1097/HTR.0000000000000180; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Marshall S., 2018, GUIDELINE CONCUSSION, V3rd; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2010, ATHLET THER TODAY, V15, P1, DOI 10.1123/att.15.2.1; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Morin CM, 2009, VAINCRE ENNEMIS SOMM; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; ONF, 2017, STAND POSTC CAR DIAG; Ouellet MC, 2015, INSOMNIE FATIGUE APR; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Potter SDS, 2016, J NEUROL NEUROSUR PS, V87, P1075, DOI 10.1136/jnnp-2015-312838; Renaud MI, 2018, CLIN REHABIL, V32, P1440, DOI 10.1177/0269215518785418; SAFREN SA, 2005, CLIENT WORKBOOK; Scheenen ME, 2017, J NEUROTRAUM, V34, P2713, DOI 10.1089/neu.2016.4885; Scheenen ME, 2017, CLIN REHABIL, V31, P1019, DOI 10.1177/0269215516687101; Silverberg ND, 2020, ARCH PHYS MED REHAB, V101, P382, DOI 10.1016/j.apmr.2019.10.179; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Snell DL, 2020, DISABIL REHABIL, V42, P1942, DOI 10.1080/09638288.2018.1542461; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Snell DL., 2016, J BEHAV BRAIN SCI, V6, P227, DOI [10.4236/jbbs.2016.66023, DOI 10.4236/JBBS.2016.66023]; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Stillman AM, 2020, J NEUROTRAUM, V37, P305, DOI 10.1089/neu.2018.5925; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Sullivan KA, 2020, DISABIL REHABIL, V42, P2243, DOI 10.1080/09638288.2018.1558292; Sveen U, 2013, DISABIL REHABIL, V35, P749, DOI 10.3109/09638288.2012.707741; Thompson C, 2016, BRAIN INJURY, V30, P770; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928; VA/DoD, 2016, CLIN PRACTICE GUIDEL, P1; Vanderploeg RD, 2019, REHABIL PSYCHOL, V64, P1, DOI 10.1037/rep0000255; Vikane E, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/8026414; Wijenberg MLM, 2017, BRAIN INJURY, V31, P1597, DOI 10.1080/02699052.2017.1366551	70	2	2	2	2	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	1877-0657	1877-0665		ANN PHYS REHABIL MED	Ann. Phys. Rehabil. Med.	SEP	2021	64	5			SI				101424	10.1016/j.rehab.2020.07.007			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	WG9RK	WOS:000707327800012	32771586				2022-02-06	
J	Brilliant, AN; Meehan, WP; Howell, DR				Brilliant, Anna N.; Meehan, William P., III; Howell, David R.			Static and Dynamic Cognitive Performance in Youth and Collegiate Athletes With Concussion	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						mild traumatic brain injury; cognition; performance; adolescent; locomotion	DUAL-TASK GAIT; SPORTS-RELATED CONCUSSION; DETECTING GAIT; SINGLE-TASK; ADOLESCENTS; STABILITY; LOCOMOTOR; CHILDREN; HISTORY; BALANCE	Objective: To determine if individuals with a concussion demonstrate altered cognitive performance while standing still or while walking relative to uninjured controls. Design: Cross-sectional. Setting: Sports-medicine clinic. Participants: Youth and collegiate athletes diagnosed with a concussion, assessed within 10 days of injury, and a group of uninjured control subjects. Independent Variables: Concussion and control groups. Main Outcome Measures: Participants stood still for 30 seconds while completing a cognitive task (spelling words backward, serial subtraction, or reverse month recitation) and completed a similar set of cognitive tasks while walking. Our primary outcome variables were (1) overall cognitive task performance (accuracy) and (2) the total number of task items completed during testing (completion rate) during standing and walking conditions. Results: One hundred ninety-one participants completed the study: 94 with concussion (tested mean = 5.1 +/- 2.9 days postconcussion; 51% female; mean age = 17.1 +/- 3.3 years) and 97 control subjects (40% female; mean age = 17.5 +/- 2.1 years). The concussion group completed significantly fewer responses than the control group while standing still (37.3 +/- 14.5 vs 45.1 +/- 17.6 responses; P = 0.03) and while walking (22.7 +/- 7.5 vs 33.6 +/- 13.4 responses; P < 0.001). They were also significantly less accurate at spelling words backward (81.2 +/- 28.6% correct vs 89.8 +/- 15.0% correct; P = 0.049) and reciting months in reverse order (95.8 +/- 10.4% correct vs 98.2 +/- 4.2% correct; P = 0.034) while walking. Conclusions: Athletes displayed lower cognitive task accuracy rates after concussion compared with control subjects during backward spelling and reverse month recitation tasks while walking but similar levels of accuracy while standing. Assessment of cognitive performance during dynamic tasks may be a clinically viable method to evaluate post-concussion deficits.	[Brilliant, Anna N.; Meehan, William P., III; Howell, David R.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Brilliant, Anna N.; Meehan, William P., III] Boston Childrens Hosp, Dept Orthopaed, Div Sports Med, Boston, MA USA; [Meehan, William P., III] Harvard Med Sch, Dept Pediat, Boston, MA USA; [Meehan, William P., III] Harvard Med Sch, Dept Orthopaed Surg, Boston, MA USA; [Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Howell, David R.] Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO 80045 USA		Howell, DR (corresponding author), Univ Colorado, Sch Med, Dept Orthoped, Sports Med Ctr,Childrens Hosp Colorado, 13123 E 16th Ave,B060 Aurora, Aurora, CO 80045 USA.	David.Howell@ucdenver.edu			Boston Children's Hospital; Cincinnati Children's Hospital Medical Center; ElMindA Ltd.; Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1R03HD094560-01]; National Institute of Neurological Disorders And StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS100952-01A1, 1R41NS103698-01A1]; National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament; National Football League	This study was funded in part by a research contract between Boston Children's Hospital, Cincinnati Children's Hospital Medical Center, and ElMindA Ltd.; D. R. Howell has received research support from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (1R03HD094560-01) and the National Institute of Neurological Disorders And Stroke (1R01NS100952-01A1 and 1R41NS103698-01A1). W. P. Meehan receives royalties from (1) ABC-Clio publishing for the sale of his books, Kids, Sports, and Concussion: A guide for coaches and parents, and Concussions; (2) Springer International for the book Head and Neck Injuries in the Young Athlete; and (3) Wolters Kluwer for working as an author for UpToDate. His research is funded, in part, by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament and The National Football League.	Berkner J, 2017, J ATHL TRAINING, V52, P1089, DOI 10.4085/1062-6050-52.11.23; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-8; Cossette I, 2014, ARCH PHYS MED REHAB, V95, P1594, DOI 10.1016/j.apmr.2014.03.019; Fabri TL, 2017, GAIT POSTURE, V54, P154, DOI 10.1016/j.gaitpost.2017.03.002; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; Howell DR, 2019, CLIN J SPORT MED, V29, P238, DOI 10.1097/JSM.0000000000000509; Howell DR, 2018, J SCI MED SPORT, V21, P358, DOI 10.1016/j.jsams.2017.08.004; Howell DR, 2017, J NEUROTRAUM, V34, P3288, DOI 10.1089/neu.2017.5191; Howell DR, 2017, J SCI MED SPORT, V20, P622, DOI 10.1016/j.jsams.2016.11.020; Howell DR, 2017, GAIT POSTURE, V54, P284, DOI 10.1016/j.gaitpost.2017.03.034; Howell DR, 2017, J NEUROTRAUM, V34, P838, DOI 10.1089/neu.2016.4609; Kleiner M, 2018, J ORTHOP SPORT PHYS, V48, P87, DOI 10.2519/jospt.2018.7432; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Martini DN, 2016, GAIT POSTURE, V49, P264, DOI 10.1016/j.gaitpost.2016.06.028; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Rochefort C, 2017, J SCI MED SPORT, V20, P970, DOI 10.1016/j.jsams.2017.04.008; Sambasivan K, 2015, J PEDIATR REHAB MED, V8, P335, DOI 10.3233/PRM-150351; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	25	2	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2021	31	5					442	447		10.1097/JSM.0000000000000779			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	WN3KG	WOS:000711670400022	31860545				2022-02-06	
J	Feng, XY; Ma, WW; Zhu, J; Jiao, W; Wang, YH				Feng, Xiaoyan; Ma, Weiwei; Zhu, Jie; Jiao, Wei; Wang, Yuhai			Dexmedetomidine alleviates early brain injury following traumatic brain injury by inhibiting autophagy and neuroinflammation through the ROS/Nrf2 signaling pathway	MOLECULAR MEDICINE REPORTS			English	Article						dexmedetomidine; traumatic brain injury; early brain injury; autophagy; neuroinflammation	ERYTHROPOIETIN; INFLAMMATION; APOPTOSIS; SEPSIS	Traumatic brain injury (TBI) is a major public health problem and a major cause of mortality and disability that imposes a substantial economic burden worldwide. Dexmedetomidine (DEX), a highly selective alpha-2-adrenergic receptor agonist that functions as a sedative and analgesic with minimal respiratory depression, has been reported to alleviate early brain injury (EBI) following traumatic brain injury by reducing reactive oxygen species (ROS) production, apoptosis and autophagy. Autophagy is a programmed cell death mechanism that serves a vital role in neuronal cell death following TBI. However, the precise role of autophagy in DEX-mediated neuroprotection following TBI has not been confirmed. The present study aimed to investigate the neuroprotective effects and potential molecular mechanisms of DEX in TBI-induced EBI by regulating neural autophagy in a C57BL/6 mouse model. Mortality, the neurological score, brain water content, neuroinflammatory cytokine levels, ROS production, malondialdehyde levels and neuronal death were evaluated by TUNEL staining, Evans blue extravasation, ELISA, analysis of ROS/lipid peroxidation and western blotting. The results showed that DEX treatment markedly increased the survival rate and neurological score, increased neuron survival, decreased the expression of the LC3, Beclin-1 and NF-kappa B proteins, as well as the cytokines IL-1 beta, IL-6 and TNF-alpha, which indicated that DEX-mediated inhibition of autophagy and neuroinflammation ameliorated neuronal death following TBI. The neuroprotective capacity of DEX is partly dependent on the ROS/nuclear factor erythroid 2-related factor 2 signaling pathway. Taken together, the results of the present study indicated that DEX improves neurological outcomes in mice and reduces neuronal death by protecting against neural autophagy and neuroinflammation.	[Feng, Xiaoyan; Zhu, Jie; Jiao, Wei; Wang, Yuhai] Anhui Med Univ, Wuxi Clin Coll, Hosp Joint Logist Support Force PLA 904, Dept Neurosurg, 101 Xing Yuan North Rd, Wuxi 214044, Jiangsu, Peoples R China; [Ma, Weiwei] Wannan Med Coll, Clin Med Five Year Program, 11 Class,2019 Grade, Wuhu 241002, Jiangsu, Peoples R China		Wang, YH (corresponding author), Anhui Med Univ, Wuxi Clin Coll, Hosp Joint Logist Support Force PLA 904, Dept Neurosurg, 101 Xing Yuan North Rd, Wuxi 214044, Jiangsu, Peoples R China.	wangyuhai1516@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81871589]; Wuxi Municipal Bureau on Science and Technology [N20201008]	The present study was supported. by the National Natural Science Foundation of China (grant. no. 81871589) and the Wuxi Municipal Bureau on Science and Technology (grant no. N20201008).	Aron R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05653-z; Biegon A, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.576366; Bilodeau V, 2021, J CLIN PHARM THER, V46, P1020, DOI 10.1111/jcpt.13389; Bu LL, 2021, NEUROTHERAPEUTICS, V18, P962, DOI 10.1007/s13311-021-01018-5; Ceccariglia S, 2020, AUTOPHAGY, V16, P28, DOI 10.1080/15548627.2019.1630223; Chen JL, 2021, AGING-US, V13, P6182, DOI 10.18632/aging.202626; Chen JH, 2020, NEURAL REGEN RES, V15, P1947, DOI 10.4103/1673-5374.280326; Chen JH, 2018, WORLD NEUROSURG, V113, pE690, DOI 10.1016/j.wneu.2018.02.122; Chen JH, 2021, J CELL PHYSIOL, V236, P6920, DOI 10.1002/jcp.30351; Chen JH, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.00110; Chen JH, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00107; Chen JH, 2019, J CELL MOL MED, V23, P2256, DOI 10.1111/jcmm.14105; Chen XH, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/6643171; Cooper DJ, 2018, JAMA-J AM MED ASSOC, V320, P2211, DOI 10.1001/jama.2018.17075; Council N. R, 2010, GUIDE CARE USE LAB A; Cui GQ, 2021, ENVIRON TOXICOL, V36, P1389, DOI 10.1002/tox.23134; Dando I, 2017, FREE RADICAL BIO MED, V113, P176, DOI 10.1016/j.freeradbiomed.2017.09.022; Das S, 2021, BBA-MOL BASIS DIS, V1867, DOI 10.1016/j.bbadis.2020.166050; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dou RJ, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03510-4; Fang J, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01006; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gao Y, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.555532; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Huang GR, 2021, CRIT REV EUKAR GENE, V31, DOI 10.1615/CritRevEukaryotGeneExpr.2021037390; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Kawazoe Y, 2017, JAMA-J AM MED ASSOC, V317, P1321, DOI 10.1001/jama.2017.2088; Li FY, 2019, ANN CLIN TRANSL NEUR, V6, P1825, DOI 10.1002/acn3.50878; Li G, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00551; Li HC, 2020, AGING-US, V12, P21687, DOI 10.18632/aging.103975; Li J, 2021, AUTOPHAGY, V17, P4062, DOI 10.1080/15548627.2021.1900498; Mei B, 2021, BRAIN BEHAV IMMUN, V91, P296, DOI 10.1016/j.bbi.2020.10.008; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Rowell SE, 2020, JAMA-J AM MED ASSOC, V324, P961, DOI 10.1001/jama.2020.8958; Shankar JJS, 2013, AM J NEURORADIOL, V34, P1175, DOI 10.3174/ajnr.A3376; Shen RR, 2021, SHOCK, V55, P388, DOI 10.1097/SHK.0000000000001637; Shi J, 2021, REDOX BIOL, V41, DOI 10.1016/j.redox.2021.101954; Skrobik Y, 2018, AM J RESP CRIT CARE, V197, P1147, DOI 10.1164/rccm.201710-1995OC; Subramaniam B, 2019, JAMA-J AM MED ASSOC, V321, P686, DOI 10.1001/jama.2019.0234; Sun YB, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1416-5; Tang CH, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/2923182; Tian J, 2020, NEUROCHEM RES, V45, P2926, DOI 10.1007/s11064-020-03141-9; Wang MM, 2021, BIOMED PHARMACOTHER, V138, DOI 10.1016/j.biopha.2021.111305; Wang YF, 2020, NEUROL RES, V42, P487, DOI 10.1080/01616412.2020.1747717; Wang Y, 2020, INT J NEUROSCI, V130, P621, DOI 10.1080/00207454.2019.1702535; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xue H, 2021, LIFE SCI, V270, DOI 10.1016/j.lfs.2020.118980; Yang TY, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00790; Yang YF, 2021, J INFLAMM RES, V14, P1217, DOI 10.2147/JIR.S292263; Zeng ZQ, 2020, J CELL PHYSIOL, V235, P1973, DOI 10.1002/jcp.29173; Zhao MM, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/5472605; Zhao SH, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-020-03336-6; Zhao Y, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00128	56	2	2	5	6	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	SEP	2021	24	3							661	10.3892/mmr.2021.12300			11	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	TV2OZ	WOS:000681566000001	34278508	Green Published, hybrid			2022-02-06	
J	Green, K; Cairncross, M; Panenka, WJ; Stubbs, JL; Silverberg, ND				Green, Katherine; Cairncross, Molly; Panenka, William J.; Stubbs, Jacob L.; Silverberg, Noah D.			History of Functional Somatic Syndromes and Persistent Symptoms After Mild Traumatic Brain Injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							IRRITABLE-BOWEL-SYNDROME; CHRONIC-FATIGUE-SYNDROME; CLINICAL RECOVERY; HEAD-INJURY; FIBROMYALGIA; SOMATIZATION; CONCUSSION; QUESTIONNAIRE; PREVALENCE; PREDICTORS	Objective: Somatization is thought to underlie functional somatic syndromes (FSSs) and may also contribute to prolonged symptoms after mild traumatic brain injury (mTBI). The investigators evaluated the prevalence of FSSs in patients seeking specialty care after mTBI and whether a history of FSSs was associated with symptom persistence. Methods: A total of 142 patients with mTBI completed questionnaires regarding demographic information, injury characteristics, and medical history, including history of diagnosed FSSs at clinic intake (mean=41 days postinjury [SD=22.41]). Postconcussion symptoms were assessed at clinic intake and again 1 and 3 months later. A linear mixed-effects model was used to determine whether history of FSSs was related to persistent mTBI symptoms over time. Results: A history of at least one FSS was reported by 20.4% of patients. In the linear mixed model, postconcussion symptom scores were not significantly different over time among patients with a history of one or more FSSs or two or more FSSs from those with no FSSs. A history of one or more FSSs or two or more FSSs (versus no FSS) was not associated with increased odds of severe postconcussion symptoms at clinic intake (one or more FSSs: odds ratio=0.88, 95% CI=0.38-2.03; two or more FSSs: odds ratio=1.78, 95% CI=0.45-7.03), at the 1-month follow-up visit (one or more FSSs: odds ratio=0.57, 95% CI=0.22-1.45; two or more FSSs: odds ratio=0.57, 95% CI=0.14-2.37), or at the 3-month follow-up visit (one or more FSSs: odds ratio=0.97, 95% CI=0.36-2.63; two or more FSSs: odds ratio=1.27, 95% CI=0.29-5.65). Conclusions: In this sample, the prevalence rates of FSSs were higher than rates previously reported for the general population. However, FSS history did not predict higher postconcussion symptom burden at clinic intake or persistence over the following 3 months. Further research is needed to clarify the potential role of somatization in poor mTBI outcome.	[Green, Katherine; Panenka, William J.; Stubbs, Jacob L.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Silverberg, Noah D.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Panenka, William J.; Stubbs, Jacob L.] British Columbia Mental Hlth & Subst Use Serv Res, Vancouver, BC, Canada; [Panenka, William J.] Univ British Columbia, British Columbia Neuropsychiat Program, Vancouver, BC, Canada; [Cairncross, Molly; Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Cairncross, Molly; Silverberg, Noah D.] Vancouver Coastal Hlth Res Inst, Rehabil Res Program, Vancouver, BC, Canada		Silverberg, ND (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.; Silverberg, ND (corresponding author), Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada.; Silverberg, ND (corresponding author), Vancouver Coastal Hlth Res Inst, Rehabil Res Program, Vancouver, BC, Canada.	noah.silverberg@ubc.ca		Panenka, William/0000-0001-7143-6512	Vancouver General Hospital; University of British Columbia Hospital Foundation	Supported by the Vancouver General Hospital and University of British Columbia Hospital Foundation.	Aaron LA, 2000, ARCH INTERN MED, V160, P221, DOI 10.1001/archinte.160.2.221; Aggarwal VR, 2006, INT J EPIDEMIOL, V35, P468, DOI 10.1093/ije/dyi265; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Carrozzino D, 2017, PROG NEURO-PSYCHOPH, V78, P18, DOI 10.1016/j.pnpbp.2017.05.011; Espay AJ, 2018, JAMA NEUROL, V75, P1132, DOI 10.1001/jamaneurol.2018.1264; Fedorak RN, 2012, CAN J GASTROENTEROL, V26, P252, DOI 10.1155/2012/861478; GOLDENBERG DL, 1990, ARTHRITIS RHEUM, V33, P381, DOI 10.1002/art.1780330311; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Hauser W, 2014, EUR J PAIN, V18, P1052, DOI 10.1002/j.1532-2149.2014.00453.x; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hixson KM, 2017, J SPORT REHABIL, V26, P588, DOI 10.1123/jsr.2016-0122; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hudson J, 1993, SURV ANESTHESIA, V37, P93, DOI DOI 10.1097/00132586-199304000-00037; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lee JEC, 2015, PSYCHOSOM MED, V77, P1006, DOI 10.1097/PSY.0000000000000250; LIPOWSKI ZJ, 1988, AM J PSYCHIAT, V145, P1358; Martin A, 2007, J PSYCHOSOM RES, V63, P147, DOI 10.1016/j.jpsychores.2007.05.007; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; Mayou R, 2002, BRIT MED J, V325, P265, DOI 10.1136/bmj.325.7358.265; Michie S, 2013, ANN BEHAV MED, V46, P81, DOI 10.1007/s12160-013-9486-6; Miller A R, 2001, Ann Clin Psychiatry, V13, P25, DOI 10.3109/10401230109147126; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Park Jungwee, 2007, Health Rep, V18, P43; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Root JM, 2016, J PEDIATR-US, V174, P39, DOI 10.1016/j.jpeds.2016.03.020; Rusu C, 2015, HEALTH PROMOT CHRON, V35, P3, DOI 10.24095/hpcdp.35.1.02; Silverberg ND, 2018, J NEUROTRAUM, V35, P1864, DOI 10.1089/neu.2018.5662; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Sivri A, 1996, CLIN RHEUMATOL, V15, P283, DOI 10.1007/BF02229708; Stubbs JL, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00043; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Vanderploeg RD, 2019, REHABIL PSYCHOL, V64, P1, DOI 10.1037/rep0000255; Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2; Whitehead WE, 2002, GASTROENTEROLOGY, V122, P1140, DOI 10.1053/gast.2002.32392; Zahniser E, 2019, J NEUROTRAUM, V36, P1786, DOI 10.1089/neu.2018.6172	41	2	2	0	0	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FAL	2021	33	2					109	115		10.1176/appi.neuropsych.20060159			7	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	SH9CC	WOS:000654427000004	33203306				2022-02-06	
J	Jurick, SM; Crocker, LD; Merritt, VC; Sanderson-Cimino, ME; Keller, AV; Glassman, LH; Twamley, EW; Rodgers, CS; Schiehser, DM; Aupperle, RL; Jak, AJ				Jurick, Sarah M.; Crocker, Laura D.; Merritt, Victoria C.; Sanderson-Cimino, Mark E.; Keller, Amber, V; Glassman, Lisa H.; Twamley, Elizabeth W.; Rodgers, Carie S.; Schiehser, Dawn M.; Aupperle, Robin L.; Jak, Amy J.			Independent and Synergistic Associations Between TBI Characteristics and PTSD Symptom Clusters on Cognitive Performance and Postconcussive Symptoms in Iraq and Afghanistan Veterans	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; CONFIRMATORY FACTOR-ANALYSIS; MILITARY SERVICE-MEMBERS; POST-CONCUSSIVE SYMPTOMS; OEF/OIF VETERANS; NEUROPSYCHOLOGICAL OUTCOMES; MILD TBI; PSYCHOLOGICAL SYMPTOMS; MULTIPLE CONCUSSIONS	Objective: The investigators sought to evaluate the independent and interactive associations between mild traumatic brain injury (mTBI) characteristics and posttraumatic stress disorder (PTSD) symptoms with regard to postconcussive symptoms and cognition among treatment-seeking veterans of the U.S. conflicts in Iraq and Afghanistan. Methods: Sixty-seven Iraq and Afghanistan veterans who had a history of mTBI and comorbid PTSD were grouped based on injury mechanism (blast versus nonblast) and number of lifetime mTBIs (one to two versus three or more). Independent associations between mTBI characteristics and PTSD symptom clusters were evaluated with regard to cognition and postconcussive symptoms. Follow-up analyses were conducted to determine any interactive associations between TBI characteristics and PTSD symptom clusters. Results: Higher PTSD symptoms, particularly hyperarousal, were associated with poorer executive functioning and higher postconcussive symptoms. No direct relationships were observed between PTSD symptom clusters and memory or processing speed. The relationship between hyperarousal and processing speed was moderated by lifetime mTBIs, such that those with a history of at least three mTBIs demonstrated a negative association between hyperarousal and processing speed. Blast-related mTBI history was associated with reduced processing speed, compared with non-blast-related mTBI. However, an interaction was observed such that among those with blast-related mTBI history, higher re-experiencing symptoms were associated with poorer processing speed, whereas veterans without history of blast-related mTBI did not demonstrate an association between processing speed and re-experiencing symptoms. Conclusions: Higher hyperarousal and re-experiencing symptoms were associated with reduced processing speed among veterans with repetitive and blast-related mTBI history, respectively. PTSD symptoms, specifically hyperarousal, were associated with poorer executive functioning and higher postconcussive symptoms. Limited associations were found between injury characteristics and cognition chronically following mTBI. However, these results support synergistic effects of specific PTSD symptom clusters and TBI characteristics.	[Jurick, Sarah M.; Crocker, Laura D.; Twamley, Elizabeth W.; Schiehser, Dawn M.; Jak, Amy J.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA 92161 USA; [Jurick, Sarah M.; Merritt, Victoria C.; Glassman, Lisa H.; Twamley, Elizabeth W.; Schiehser, Dawn M.; Jak, Amy J.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Jurick, Sarah M.; Crocker, Laura D.; Merritt, Victoria C.; Glassman, Lisa H.; Twamley, Elizabeth W.; Schiehser, Dawn M.; Jak, Amy J.] VA San Diego Healthcare Syst, San Diego, CA 92161 USA; [Sanderson-Cimino, Mark E.; Keller, Amber, V] San Diego State Univ, Univ Calif San Diego Joint Doctoral Program Clin, San Diego, CA 92182 USA; [Rodgers, Carie S.] PsychArmor Inst, San Diego, CA USA; [Aupperle, Robin L.] Univ Tulsa, Laureate Inst Brain Res, Tulsa, OK 74104 USA		Jurick, SM (corresponding author), VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA 92161 USA.; Jurick, SM (corresponding author), Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA.; Jurick, SM (corresponding author), VA San Diego Healthcare Syst, San Diego, CA 92161 USA.	sjurick@ucsd.edu			Department of DefenseUnited States Department of Defense [W81XWH-11-1-0641]	Supported by the Department of Defense (award W81XWH-11-1-0641).	Aase DM, 2017, PSYCHIAT RES, V257, P156, DOI 10.1016/j.psychres.2017.07.041; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGNOSTIC STAT MANU DIAGNOSTIC STAT MANU; Amick MM, 2013, J INT NEUROPSYCH SOC, V19, P792, DOI 10.1017/S1355617713000544; Andrews RJ, 2018, NEUROLOGY, V91, pE732, DOI 10.1212/WNL.0000000000006034; Armistead-Jehle P, 2018, J CLIN EXP NEUROPSYC, V40, P213, DOI 10.1080/13803395.2017.1329406; Asmundson GJG, 2000, BEHAV RES THER, V38, P203, DOI 10.1016/S0005-7967(99)00061-3; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cernich AN, 2012, J HEAD TRAUMA REHAB, V27, P253, DOI 10.1097/HTR.0b013e3182585cd5; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Clark AL, 2014, CLIN NEUROPSYCHOL, V28, P802, DOI 10.1080/13854046.2014.904928; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Cooper DB, 2018, J HEAD TRAUMA REHAB, V33, P81, DOI 10.1097/HTR.0000000000000375; Cooper DB, 2010, NEUROREHABILITATION, V26, P233, DOI 10.3233/NRE-2010-0559; Costanzo ME, 2014, NEUROSCI LETT, V577, P11, DOI 10.1016/j.neulet.2014.05.054; Crocker LD, 2019, J PSYCHIATR RES, V116, P7, DOI 10.1016/j.jpsychires.2019.05.022; Crocker LD, 2019, J INT NEUROPSYCH SOC, V25, P79, DOI 10.1017/S1355617718000851; Crocker LD, 2018, BEHAV RES THER, V108, P68, DOI 10.1016/j.brat.2018.07.004; Crocker LD, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00261; DeGutis J, 2015, J INT NEUROPSYCH SOC, V21, P342, DOI 10.1017/S1355617715000235; Delis D., 2001, DELIS KAPLAN EXECUTI, DOI DOI 10.1037/T15082-000; Delis D.C., 2000, CALIFORNIA VERBAL LE; Donovan J, 2014, CHIROPR MAN THER, V22, DOI 10.1186/s12998-014-0038-3; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; Dursa EK, 2014, J TRAUMA STRESS, V27, P542, DOI 10.1002/jts.21956; Esterman M, 2019, NEUROPSYCHOLOGY, V33, P711, DOI 10.1037/neu0000525; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Golier J, 2002, PSYCHIAT CLIN N AM, V25, P295, DOI 10.1016/S0193-953X(01)00004-1; Grande LJ, 2018, J INT NEUROPSYCH SOC, V24, P466, DOI 10.1017/S1355617717001242; Greer N, 2016, PREVALENCE EPIDEMIOL; Haaland KY, 2016, J INT NEUROPSYCH SOC, V22, P643, DOI 10.1017/S1355617716000424; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Heaton R., 2000, WISCONSIN CARD SORTI; Jackson CE, 2017, BRAIN INJURY, V31, P485, DOI 10.1080/02699052.2017.1280740; Jak AJ, 2019, J NEUROL NEUROSUR PS, V90, P333, DOI 10.1136/jnnp-2018-319315; Jak AJ, 2015, CONTEMP CLIN TRIALS, V45, P210, DOI 10.1016/j.cct.2015.10.009; Janak J, 2015, J HEAD TRAUMA REHAB, V30, pE76; Karr JE, 2014, NEUROPSYCHOL REV, V24, P428, DOI 10.1007/s11065-014-9271-8; Kaup AR, 2019, J NEUROTRAUM, V36, P338, DOI 10.1089/neu.2018.5695; King DW, 1998, PSYCHOL ASSESSMENT, V10, P90, DOI 10.1037/1040-3590.10.2.90; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Lange RT, 2012, J INT NEUROPSYCH SOC, V18, P595, DOI 10.1017/S1355617712000239; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Management of Concussion-mTBI Working Group, 2016, VA DOD CLIN PRACT GU; McCrea M., 2008, MILD TRAUMATIC BRAIN; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Merritt VC, 2018, NEUROPSYCHOLOGIA, V119, P340, DOI 10.1016/j.neuropsychologia.2018.08.026; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Monson CM, 2008, PSYCHOL ASSESSMENT, V20, P131, DOI 10.1037/1040-3590.20.2.131; Morey RA, 2009, J PSYCHIATR RES, V43, P809, DOI 10.1016/j.jpsychires.2008.10.014; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Porter KE, 2018, J PSYCHIATR RES, V102, P8, DOI 10.1016/j.jpsychires.2018.03.004; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Reeves RR, 2011, J PSYCHOSOC NURS MEN, V49, P42, DOI 10.3928/02793695-20110201-03; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Riley E, 2019, NEUROPSYCHOLOGY, V33, P534, DOI 10.1037/neu0000529; Rosenblatt AS, 2019, PSYCHOL TRAUMA-US, V11, P442, DOI 10.1037/tra0000399; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sadeh N, 2015, HUM BRAIN MAPP, V36, P3076, DOI 10.1002/hbm.22829; Santhanam P, 2019, J NEUROTRAUM, V36, P1093, DOI 10.1089/neu.2017.5541; Schiehser DM, 2011, J CLIN EXP NEUROPSYC, V33, P704, DOI 10.1080/13803395.2011.553587; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Shah-Basak PP, 2018, J NEUROTRAUM, V35, P267, DOI 10.1089/neu.2017.5117; Shandera-Ochsner AL, 2013, CLIN NEUROPSYCHOL, V27, P881, DOI 10.1080/13854046.2013.802017; Shiromani P, 2009, POSTTRAUMATIC STRESS, P105, DOI DOI 10.1007/978-1-60327-329-9_5; Shu IW, 2014, PSYCHIAT RES-NEUROIM, V224, P58, DOI 10.1016/j.pscychresns.2014.07.010; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Stricker NH, 2017, J CLIN EXP NEUROPSYC, V39, P768, DOI 10.1080/13803395.2016.1264575; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vasterling JJ, 2010, HANDBOOK OF MEDICAL NEUROPSYCHOLOGY: APPLICATIONS OF COGNITIVE NEUROSCIENCE, P447, DOI 10.1007/978-1-4419-1364-7_24; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Vasterling JJ, 2012, PTSD MILD TRAUMATIC; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Verfaellie M, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI 10.1017/S1355617712000902; Weathers F.W., 1993, ANN M INT SOC TRAUM; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Woon FL, 2017, COGN NEUROPSYCHIATRY, V22, P1, DOI 10.1080/13546805.2016.1255603; Wrocklage KM, 2016, J INT NEUROPSYCH SOC, V22, P399, DOI 10.1017/S1355617716000059; Young JC, 2016, CLIN NEUROPSYCHOL, V30, P497, DOI 10.1080/13854046.2016.1159730	102	2	2	1	2	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FAL	2021	33	2					98	108		10.1176/appi.neuropsych.20050128			11	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	SH9CC	WOS:000654427000003	33441014				2022-02-06	
J	Kim, M; Mok, H; Yeo, WS; Ahn, JH; Choi, YK				Kim, Minsu; Mok, Hyejung; Yeo, Woon-Seok; Ahn, Joong-Hoon; Choi, Yoon Kyung			Role of ginseng in the neurovascular unit of neuroinflammatory diseases focused on the blood-brain barrier	JOURNAL OF GINSENG RESEARCH			English	Article						central nervous system; ginseng; neuroinflammation; neurovascular unit; regeneration	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; NEURAL PROGENITOR CELLS; IGF-I RECEPTOR; RG1 PROTECTS; INFLAMMASOME ACTIVATION; PROMOTES ANGIOGENESIS; VASCULAR-PERMEABILITY; PARKINSONS-DISEASE; GENE-EXPRESSION; ALPHA-SYNUCLEIN	Ginseng has long been considered as an herbal medicine. Recent data suggest that ginseng has antiinflammatory properties and can improve learning-and memory-related function in the central nervous system (CNS) following the development of CNS neuroinflammatory diseases such as Alzheimer's disease, cerebral ischemia, and other neurological disorders. In this review, we discuss the role of ginseng in the neurovascular unit, which is composed of endothelial cells surrounded by astrocytes, pericytes, microglia, neural stem cells, oligodendrocytes, and neurons, especially their blood-brain barrier maintenance, anti-inflammatory effects and regenerative functions. In addition, cell-cell communication enhanced by ginseng may be attributed to regeneration via induction of neurogenesis and angiogenesis in CNS diseases. Thus, ginseng may have therapeutic potential to exert cognitive improvement in neuroinflammatory diseases such as stroke, traumatic brain injury, multiple sclerosis, Parkinson's disease, and Alzheimer's disease. (c) 2021 The Korean Society of Ginseng. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Kim, Minsu; Mok, Hyejung; Yeo, Woon-Seok; Ahn, Joong-Hoon; Choi, Yoon Kyung] Konkuk Univ, Dept Biosci & Biotechnol, Bio Mol Informat Ctr, Seoul 05029, South Korea		Choi, YK (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, Bio Mol Informat Ctr, Seoul 05029, South Korea.	ykchoi@konkuk.ac.kr		Choi, Yoon Kyung/0000-0003-0242-9612	Konkuk University Premier Research Fund	This paper was supported by the Konkuk University Premier Research Fund received in 2019.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abhinand CS, 2016, J CELL COMMUN SIGNAL, V10, P347, DOI 10.1007/s12079-016-0352-8; Ahn S, 2016, IMMUNOL INVEST, V45, P439, DOI 10.3109/08820139.2016.1168830; Ahn S, 2016, IN VITRO CELL DEV-AN, V52, P287, DOI 10.1007/s11626-015-9983-y; Angelova N, 2008, PHYTOCHEM ANALYSIS, V19, P2, DOI DOI 10.1002/pca.1049; Ardah MT, 2015, NEUROBIOL DIS, V74, P89, DOI 10.1016/j.nbd.2014.11.007; Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; Bates DO, 2002, VASC PHARMACOL, V39, P225, DOI 10.1016/S1537-1891(03)00011-9; Beers DR, 2019, LANCET NEUROL, V18, P211, DOI 10.1016/S1474-4422(18)30394-6; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Carvalho FA, 2012, MUCOSAL IMMUNOL, V5, P288, DOI 10.1038/mi.2012.8; Chen F, 2006, FASEB J, V20, P1269, DOI 10.1096/fj.05-5530fje; Chen JM, 2019, EUR J PHARMACOL, V856, DOI 10.1016/j.ejphar.2019.172418; Chen LJ, 2015, NEUROBIOL AGING, V36, P2533, DOI 10.1016/j.neurobiolaging.2015.05.018; Chen W, 2016, CELL MOL NEUROBIOL, V36, P1057, DOI 10.1007/s10571-015-0299-y; Chen XC, 2005, ACTA PHARMACOL SIN, V26, P56, DOI 10.1111/j.1745-7254.2005.00019.x; Chen Y, 2020, J FUNCT FOODS, V65, DOI 10.1016/j.jff.2019.103713; Cheng Y, 2005, ACTA PHARMACOL SIN, V26, P143, DOI 10.1111/j.1745-7254.2005.00034.x; Cheng Z, 2019, MOLECULES, V24; Cho YL, 2015, J BIOL CHEM, V290, P467, DOI 10.1074/jbc.M114.603142; Choi SH, 2018, SCIENCE, V361, P991, DOI 10.1126/science.aan8821; Choi YK, 2008, BMB REP, V41, P345, DOI 10.5483/BMBRep.2008.41.5.345; Choi YK, 2007, J NEUROSCI, V27, P4472, DOI 10.1523/JNEUROSCI.5368-06.2007; Choi YK, 2018, BIOMOL THER, V26, P93, DOI 10.4062/biomolther.2017.144; Choi YK, 2016, NAT MED, V22, P1335, DOI 10.1038/nm.4188; Chu SH, 2014, INT IMMUNOPHARMACOL, V19, P317, DOI 10.1016/j.intimp.2014.01.018; Combs CK, 2001, J NEUROSCI, V21, P1179; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Desai BS, 2007, CELL TRANSPLANT, V16, P285, DOI 10.3727/000000007783464731; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Fan LM, 2019, J CLIN INVEST, V129, P3374, DOI 10.1172/JCI125173; Fang EF, 2019, NAT NEUROSCI, V22, P401, DOI 10.1038/s41593-018-0332-9; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Freeman L, 2017, J EXP MED, V214, P1351, DOI 10.1084/jem.20150237; Gao QG, 2009, J NEUROCHEM, V109, P1338, DOI 10.1111/j.1471-4159.2009.06051.x; Gao Y, 2020, INT IMMUNOPHARMACOL, V87, DOI 10.1016/j.intimp.2020.106805; Ge KL, 2010, J ETHNOPHARMACOL, V127, P118, DOI 10.1016/j.jep.2009.09.038; Girouard H, 2010, P NATL ACAD SCI USA, V107, P3811, DOI 10.1073/pnas.0914722107; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Harrell CR, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0423-7; He YC, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1843142; Heneka MT, 2018, NAT REV NEUROSCI, V19, P610, DOI 10.1038/s41583-018-0055-7; Heng Y, 2016, TOXICOL LETT, V243, P7, DOI 10.1016/j.toxlet.2015.12.005; Im DS, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10030444; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Jakaria M, 2019, J GINSENG RES, V43, P163, DOI 10.1016/j.jgr.2018.01.001; Ji YC, 2005, J KOREAN MED SCI, V20, P291, DOI 10.3346/jkms.2005.20.2.291; Jiang B, 2012, BRIT J PHARMACOL, V166, P1872, DOI 10.1111/j.1476-5381.2012.01902.x; Joo SS, 2005, ARCH PHARM RES, V28, P1164, DOI 10.1007/BF02972981; Jung E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072273; Jung JS, 2016, BIOMOL THER, V24, P33, DOI 10.4062/biomolther.2015.129; Kang JI, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41115-2; Kim HJ, 2013, J GINSENG RES, V37, P8, DOI 10.5142/jgr.2013.37.8; Kim J, 2014, IMMUNOL LETT, V158, P143, DOI 10.1016/j.imlet.2013.12.017; Kim KH, 2018, J GINSENG RES, V42, P239, DOI 10.1016/j.jgr.2017.03.011; Kim S, 2020, BIOMOL THER, V28, P45, DOI 10.4062/biomolther.2019.119; Kim Y, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8050121; Kook SY, 2012, J NEUROSCI, V32, P8845, DOI 10.1523/JNEUROSCI.6102-11.2012; Kwok HH, 2012, BIOCHEM PHARMACOL, V83, P893, DOI 10.1016/j.bcp.2011.12.039; Lee H, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010078; Leung K. W., 2010, CHIN MED-UK, V5, P20, DOI DOI 10.1186/1749-8546-5-20; Leung KW, 2006, J BIOL CHEM, V281, P36280, DOI 10.1074/jbc.M606698200; Li QH, 2017, CELL PHYSIOL BIOCHEM, V44, P21, DOI 10.1159/000484578; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu D, 2014, MOL MED REP, V9, P1434, DOI 10.3892/mmr.2014.1958; Lo EH, 2009, STROKE, V40, pS2, DOI 10.1161/STROKEAHA.108.534404; Lu HX, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00783; Lu JM, 2009, CURR VASC PHARMACOL, V7, P293, DOI 10.2174/157016109788340767; Mahar M, 2018, NAT REV NEUROSCI, V19, P323, DOI 10.1038/s41583-018-0001-8; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Min JK, 2007, BLOOD, V109, P1495, DOI 10.1182/blood-2006-06-029298; Min JK, 2006, BIOCHEM BIOPH RES CO, V349, P987, DOI 10.1016/j.bbrc.2006.08.129; Mitic LL, 1998, ANNU REV PHYSIOL, V60, P121, DOI 10.1146/annurev.physiol.60.1.121; Mohanan P, 2018, J GINSENG RES, V42, P123, DOI 10.1016/j.jgr.2017.01.008; Naval MV, 2007, J ETHNOPHARMACOL, V112, P262, DOI 10.1016/j.jep.2007.03.010; Ni N, 2014, MOLECULES, V19, P3012, DOI 10.3390/molecules19033012; Nitti M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082260; Paik S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40690-8; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Qin M, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00953; Quan QK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059155; Razgonova MP, 2019, MOL MED REP, V19, P2975, DOI 10.3892/mmr.2019.9972; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Ryu S, 2020, NEURAL REGEN RES, V15, P887, DOI 10.4103/1673-5374.268905; Sagare AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3932; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Saresella M, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0088-1; Sevenich L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00697; Shen LH, 2004, NEUROL RES, V26, P422, DOI 10.1179/016164104225016047; Shi YQ, 2010, J ALZHEIMERS DIS, V19, P977, DOI 10.3233/JAD-2010-1296; Shi YH, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00285; Shi YH, 2020, FASEB J, V34, P208, DOI 10.1096/fj.201901537R; Shieh PC, 2008, NEUROSCI LETT, V434, P1, DOI 10.1016/j.neulet.2007.12.032; Si YC, 2011, AM J CHINESE MED, V39, P999, DOI 10.1142/S0192415X11009366; Tedeschi A, 2017, CURR OPIN NEUROBIOL, V42, P118, DOI 10.1016/j.conb.2016.12.005; Tian JW, 2005, NEUROSCI LETT, V374, P92, DOI 10.1016/j.neulet.2004.10.030; Tohda C, 2004, NEUROPSYCHOPHARMACOL, V29, P860, DOI 10.1038/sj.npp.1300388; Tu LH, 2009, CELL MOL NEUROBIOL, V29, P1257, DOI 10.1007/s10571-009-9421-3; Wan WB, 2015, J NEUROCHEM, V134, P382, DOI 10.1111/jnc.13122; Wang L, 2011, J NEUROSCI METH, V194, P274, DOI 10.1016/j.jneumeth.2010.10.025; Wu CF, 2007, INT IMMUNOPHARMACOL, V7, P313, DOI 10.1016/j.intimp.2006.04.021; Xie Yu-hua, 2007, Yaoxue Xuebao, V42, P828; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Xu L, 2009, BRIT J PHARMACOL, V158, P738, DOI 10.1111/j.1476-5381.2009.00361.x; Xu M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20236086; Yang LL, 2009, J PHARM PHARMACOL, V61, P375, DOI [10.1211/jpp/61.03.0013, 10.1211/jpp.61.03.0013]; Ye J, 2016, MOL MED REP, V13, P3083, DOI 10.3892/mmr.2016.4914; Ye RD, 2011, NEUROCHEM INT, V58, P391, DOI 10.1016/j.neuint.2010.12.015; Yu SE, 2019, J GINSENG RES, V43, P361, DOI 10.1016/j.jgr.2018.09.001; Zhang JY, 2019, PHARMACOL RES, V144, P292, DOI 10.1016/j.phrs.2019.04.021; Zhang XP, 2018, FASEB J, V32, P3782, DOI 10.1096/fj.201701074RR; Zhao HF, 2009, BRAIN RES, V1256, P111, DOI 10.1016/j.brainres.2008.12.031; Zhu DL, 2014, J NEUROSCI RES, V92, P1217, DOI 10.1002/jnr.23397; Zipser BD, 2007, NEUROBIOL AGING, V28, P977, DOI 10.1016/j.neurobiolaging.2006.05.016	117	2	2	6	6	KOREAN SOC GINSENG	SEOCHO-GU	1807 SEOCHO WORLD OFFICETEL, 1355-3 SEOCHO-DONG, SEOCHO-GU, SEOUL 137-862, SOUTH KOREA	1226-8453	2093-4947		J GINSENG RES	J. Ginseng Res.	SEP	2021	45	5					599	609		10.1016/j.jgr.2021.02.003			11	Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine	UF1UT	WOS:000688366900008	34803430	Green Published, gold			2022-02-06	
J	Krausz, AD; Korley, FK; Burns, MA				Krausz, Alyse D.; Korley, Frederick K.; Burns, Mark A.			A Variable Height Microfluidic Device for Multiplexed Immunoassay Analysis of Traumatic Brain Injury Biomarkers	BIOSENSORS-BASEL			English	Article						microfluidics; traumatic brain injury; multiplex; immunoassay; biomarkers	FIBRILLARY ACIDIC PROTEIN; ASSAY; ANTIBODIES; FLUID; MILD	Traumatic brain injury (TBI) is a leading cause of global morbidity and mortality, partially due to the lack of sensitive diagnostic methods and efficacious therapies. Panels of protein biomarkers have been proposed as a way of diagnosing and monitoring TBI. To measure multiple TBI biomarkers simultaneously, we present a variable height microfluidic device consisting of a single channel that varies in height between the inlet and outlet and can passively multiplex bead-based immunoassays by trapping assay beads at the point where their diameter matches the channel height. We developed bead-based quantum dot-linked immunosorbent assays (QLISAs) for interleukin-6 (IL-6), glial fibrillary acidic protein (GFAP), and interleukin-8 (IL-8) using Dynabeads M-450, M-270, and MyOne, respectively. The IL-6 and GFAP QLISAs were successfully multiplexed using a variable height channel that ranged in height from similar to 7.6 mu m at the inlet to similar to 2.1 mu m at the outlet. The IL-6, GFAP, and IL-8 QLISAs were also multiplexed using a channel that ranged in height from similar to 6.3 mu m at the inlet to similar to 0.9 mu m at the outlet. Our system can keep pace with TBI biomarker discovery and validation, as additional protein biomarkers can be multiplexed simply by adding in antibody-conjugated beads of different diameters.	[Krausz, Alyse D.; Burns, Mark A.] Univ Michigan, Biomed Engn Dept, Ann Arbor, MI 48109 USA; [Korley, Frederick K.] Univ Michigan, Dept Emergency Med & Michigan Medicle, Ann Arbor, MI 48109 USA; [Burns, Mark A.] Univ Michigan, Chem Engn Dept, Ann Arbor, MI 48109 USA		Krausz, AD; Burns, MA (corresponding author), Univ Michigan, Biomed Engn Dept, Ann Arbor, MI 48109 USA.; Burns, MA (corresponding author), Univ Michigan, Chem Engn Dept, Ann Arbor, MI 48109 USA.	alysekr@umich.edu; korley@umich.edu; maburns@umich.edu		Krausz, Alyse/0000-0002-8045-1623	Joyce and Don Massey Family Foundation through the Michigan Center for Integrative Research in Critical Care (MCIRCC) at the University of Michigan; Microfluidics in Biomedical Sciences Training Program (MBSTP) [T32 EB005582]; Scholars Awards grant program of Precision Health at the University of Michigan	This research was supported by the Joyce and Don Massey Family Foundation through the Michigan Center for Integrative Research in Critical Care (MCIRCC) at the University of Michigan, the Microfluidics in Biomedical Sciences Training Program (MBSTP) (T32 EB005582), and the Scholars Awards grant program of Precision Health at the University of Michigan.	Adrian H, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0294-16.2016; Barteneva N.S, 2010, MICROSC SCI TECHNOL, V1, P710; Bernard A, 2001, ANAL CHEM, V73, P8, DOI 10.1021/ac0008845; Bogoslovsky T, 2016, DIAGNOSTICS, V6, DOI 10.3390/diagnostics6040037; Crichton A, 2021, J NEUROTRAUM, V38, P1151, DOI 10.1089/neu.2018.6083; Edwards KA, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00348; Fan R, 2008, NAT BIOTECHNOL, V26, P1373, DOI 10.1038/nbt.1507; Francis JE, 2017, BEILSTEIN J NANOTECH, V8, P1238, DOI 10.3762/bjnano.8.125; Ghodbane M, 2015, LAB CHIP, V15, P3211, DOI 10.1039/c5lc00398a; Giacoppo S, 2012, NEUROCRIT CARE, V16, P470, DOI 10.1007/s12028-012-9707-z; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Henares TG, 2007, ANAL CHIM ACTA, V589, P173, DOI 10.1016/j.aca.2007.02.060; Klostranec JM, 2007, NANO LETT, V7, P2812, DOI 10.1021/nl071415m; Korley Frederick K, 2021, Neurotrauma Rep, V2, P193, DOI 10.1089/neur.2020.0037; Korley FK, 2019, J NEUROTRAUM, V36, P182, DOI 10.1089/neu.2017.5623; Krausz AD, 2019, J APPL LAB MED, V4, P201, DOI 10.1373/jalm.2019.030031; Lee H, 2010, NAT MATER, V9, P745, DOI [10.1038/NMAT2815, 10.1038/nmat2815]; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Mena SE, 2020, LAB CHIP, V20, P2510, DOI 10.1039/d0lc00320d; Messina GA, 2008, ANAL BIOCHEM, V380, P262, DOI 10.1016/j.ab.2008.05.055; Mohamadpour M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00007; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Okonkwo DO, 2020, J NEUROTRAUM, V37, P2460, DOI 10.1089/neu.2020.7140; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Peterson AB, 2019, SURVEILLANCE REPORT; Rickard JJS, 2020, NAT BIOMED ENG, V4, P610, DOI 10.1038/s41551-019-0510-4; Rissin DM, 2013, LAB CHIP, V13, P2902, DOI 10.1039/c3lc50416f; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Roth S, 2019, SMALL, V15, DOI 10.1002/smll.201803751; Wilson DH, 2016, JALA-J LAB AUTOM, V21, P533, DOI 10.1177/2211068215589580; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zhao YF, 2016, BIOSENS BIOELECTRON, V85, P261, DOI 10.1016/j.bios.2016.05.028; Zoltewicz JS, 2012, BIOMARK INSIGHTS, V7, P71, DOI 10.4137/BMI.S9873	37	2	2	4	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2079-6374		BIOSENSORS-BASEL	Biosensors-Basel	SEP	2021	11	9							320	10.3390/bios11090320			17	Chemistry, Analytical; Nanoscience & Nanotechnology; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Science & Technology - Other Topics; Instruments & Instrumentation	UV2WM	WOS:000699345500001	34562910	gold, Green Published			2022-02-06	
J	Lee, TA; Lycke, RJ; Lee, PJ; Cudal, CM; Torolski, KJ; Bucherl, SE; Leiva-Molano, N; Auerbach, PS; Talavage, TM; Nauman, EA				Lee, Taylor A.; Lycke, Roy J.; Lee, Patrick J.; Cudal, Caroline M.; Torolski, Kelly J.; Bucherl, Sean E.; Leiva-Molano, Nicolas; Auerbach, Paul S.; Talavage, Thomas M.; Nauman, Eric A.			Distribution of Head Acceleration Events Varies by Position and Play Type in North American Football	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						traumatic brain injury; offensive linemen; run versus pass; player stance	CHRONIC TRAUMATIC ENCEPHALOPATHY; DEFAULT-MODE NETWORK; HIGH-SCHOOL FOOTBALL; BRAIN-INJURY; FUNCTIONAL CONNECTIVITY; IMPACTS; FMRI; ABNORMALITIES; CONCUSSION; TAUOPATHY	Objective: The goal of this pilot study was to evaluate the number of head acceleration events (HAEs) based on position, play type, and starting stance. Design: Prospective cohort study. Setting: Postcollegiate skill development camp during practice sessions and 1 exhibition game. Participants: Seventy-eight male adult North American football athletes. Independent Variables: A position was assigned to each participant, and plays in the exhibition game were separated by play type for analysis. During the exhibition game, video data were used to determine the effects of the starting position ("up" in a 2-point stance or "down" in a 3- or 4-point stance) on the HAEs experienced by players on the offensive line. Main Outcome Measures: Peak linear acceleration and number of HAEs greater than 20 g (g = 9.81 m/s(2)) were measured using an xPatch (X2 Biosystems, Seattle, WA). Results: Four hundred thirty-seven HAEs were recorded during practices and 272 recorded during the exhibition game; 98 and 52 HAEs, the greatest number of HAEs by position in the game, were experienced by the offensive and defensive linemen, respectively. Linebackers and tight ends experienced high percentages of HAEs above 60 g. Offensive line players in a down stance had a higher likelihood of sustaining a HAE than players in an up stance regardless of the type of play (run vs pass). Conclusions: Changing the stance of players on the offensive line and reducing the number of full-contact practices will lower HAEs.	[Lee, Taylor A.; Lee, Patrick J.; Torolski, Kelly J.; Nauman, Eric A.] Purdue Univ, Dept Mech Engn, W Lafayette, IN USA; [Lycke, Roy J.; Cudal, Caroline M.; Bucherl, Sean E.; Leiva-Molano, Nicolas; Talavage, Thomas M.; Nauman, Eric A.] Purdue Univ, Dept Biomed Engn, Weldon Sch Biomed Engn, W Lafayette, IN USA; [Auerbach, Paul S.] Uniformed Serv Univ Hlth Sci, Mil Emergency Med, Bethesda, MD USA; [Auerbach, Paul S.] Stanford Univ, Dept Emergency Med, Sch Med, Stanford, CA USA; [Talavage, Thomas M.] Purdue Univ, Dept Elect & Comp Engn, W Lafayette, IN USA; [Nauman, Eric A.] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN USA		Nauman, EA (corresponding author), Sch Mech Engn, 3061A Mech Engn Bldg,585 Purdue Mall, W Lafayette, IN 47907 USA.	enauman@purdue.edu		Lee, Taylor/0000-0001-9218-9194	National Science Foundation Graduate Research Fellowships Program [DGE-1333468]	T. A. Lee is currently receiving a grant (DGE-1333468) from National Science Foundation Graduate Research Fellowships Program. The remaining authors report no conflicts of interest.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Abbas K, 2015, DEV NEUROPSYCHOL, V40, P51, DOI 10.1080/87565641.2014.990455; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; Auerbach PS, 2016, JAMA-J AM MED ASSOC, V316, P1260, DOI 10.1001/jama.2016.8184; Bailes Julian E, 2015, Neurosurgery, V62 Suppl 1, P15, DOI 10.1227/NEU.0000000000000811; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bari S, 2019, BRAIN IMAGING BEHAV, V13, P735, DOI 10.1007/s11682-018-9861-9; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Breedlove KM., 2014, ATHL TRAIN SPORTS HL, V6, P1; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; Coronado V.G., 2012, BRAIN INJURY MED PRI; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Nauman EA, 2015, DEV NEUROPSYCHOL, V40, P85, DOI 10.1080/87565641.2015.1016161; Omalu B, 2018, NEUROSURGERY, V82, P237, DOI 10.1093/neuros/nyx536; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Robinson ME, 2015, DEV NEUROPSYCHOL, V40, P74, DOI 10.1080/87565641.2015.1012204; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Shenk TE, 2015, DEV NEUROPSYCHOL, V40, P63, DOI 10.1080/87565641.2015.1014088; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Svaldi DO, 2015, DEV NEUROPSYCHOL, V40, P80, DOI 10.1080/87565641.2014.973959; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Talavage TM, 2016, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00273; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Turner RC, 2016, BRAIN INJURY, V30, P1279, DOI 10.1080/02699052.2016.1193631; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	50	2	2	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2021	31	5					E245	E250		10.1097/JSM.0000000000000778			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	WN3KG	WOS:000711670400006	32032162				2022-02-06	
J	Liu, X; Shen, L; Han, B; Yao, HH				Liu, Xi; Shen, Ling; Han, Bing; Yao, Honghong			Involvement of noncoding RNA in blood-brain barrier integrity in central nervous system disease	NON-CODING RNA RESEARCH			English	Article						Noncoding RNA; Blood-brain barrier; Central nervous system disease	INTRINSIC ANTIVIRAL IMMUNITY; TUMOR BARRIER; TIGHT JUNCTIONS; INTRACEREBRAL HEMORRHAGE; EXTRACELLULAR-MATRIX; BASEMENT-MEMBRANE; PERMEABILITY; EXPRESSION; DISRUPTION; INJURY	Given the important role of the blood-brain barrier (BBB) in the central nervous system (CNS), increasing studies have been carried out to determine how the structural and functional integrity of the BBB impacts the pathogenesis of CNS diseases such as stroke, traumatic brain injuries (TBIs), and gliomas. Emerging studies have revealed that noncoding RNAs (ncRNAs) help to maintain the integrity and permeability of the BBB, thereby mediating CNS homeostasis. This review summarizes recent studies that focus on the effects of ncRNAs on the BBB in CNS diseases, including regulating the biological processes of inflammation, necrosis, and apoptosis of cells, affecting the translational dysfunction of proteins and regulating tight junctions (TJs). A comprehensive and detailed understanding of the interaction between ncRNAs and the BBB will lay a solid foundation for the development of early diagnostic methods and effective treatments for CNS diseases.	[Liu, Xi; Shen, Ling; Han, Bing; Yao, Honghong] Southeast Univ, Sch Med, Nanjing 210009, Jiangsu, Peoples R China		Yao, HH (corresponding author), Southeast Univ, Sch Med, Nanjing 210009, Jiangsu, Peoples R China.	yaohh@seu.edu.cn					Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342; Akella A, 2019, NEUROMOL MED, V21, P474, DOI 10.1007/s12017-019-08542-w; Algotsson A, 2007, ACTA NEUROL SCAND, V115, P403, DOI 10.1111/j.1600-0404.2007.00823.x; Alvarez JI, 2015, NEUROBIOL DIS, V74, P14, DOI 10.1016/j.nbd.2014.09.016; Amjad N, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8040268; Amorini AM, 2016, BBA-MOL BASIS DIS, V1862, P679, DOI 10.1016/j.bbadis.2016.01.023; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Aurrand-Lions M, 2001, BLOOD, V98, P3699, DOI 10.1182/blood.V98.13.3699; Baeten KM, 2011, DEV NEUROBIOL, V71, P1018, DOI 10.1002/dneu.20954; Bai Y, 2018, J NEUROSCI, V38, P32, DOI 10.1523/JNEUROSCI.1348-17.2017; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Barbagallo D, 2019, CANCERS, V11, DOI 10.3390/cancers11020194; Barker KR, 2017, MOL MED, V23, DOI 10.2119/molmed.2016.00139; Bassett AR, 2014, ELIFE, V3, DOI 10.7554/eLife.03058; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Biron KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023789; Bukeirat M, 2016, J CEREBR BLOOD F MET, V36, P387, DOI 10.1177/0271678X15606147; Burek M, 2019, TRANSL STROKE RES, V10, P672, DOI 10.1007/s12975-018-0683-2; Caballero-Garrido E, 2015, J NEUROSCI, V35, P12446, DOI 10.1523/JNEUROSCI.1641-15.2015; Cai H, 2015, ONCOTARGET, V6, P19759, DOI 10.18632/oncotarget.4331; Cerutti C, 2017, SCI REP-UK, V7, DOI 10.1038/srep45284; Claycomb JM, 2014, CURR BIOL, V24, pR703, DOI 10.1016/j.cub.2014.06.009; COOMBER BL, 1985, MICROVASC RES, V30, P99, DOI 10.1016/0026-2862(85)90042-1; Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Dueck A, 2014, BIOL CHEM, V395, P611, DOI 10.1515/hsz-2014-0116; Fang Z, 2016, FASEB J, V30, P2097, DOI 10.1096/fj.201500126; Ortiz GG, 2014, ARCH MED RES, V45, P687, DOI 10.1016/j.arcmed.2014.11.013; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Ge XT, 2019, J NEUROTRAUM, V36, P1291, DOI 10.1089/neu.2018.5728; Ge XT, 2016, BRAIN RES, V1650, P31, DOI 10.1016/j.brainres.2016.07.015; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; Gingrich MB, 2000, J NEUROSCI, V20, P4582, DOI 10.1523/JNEUROSCI.20-12-04582.2000; Gordon GRJ, 2011, EXP PHYSIOL, V96, P393, DOI 10.1113/expphysiol.2010.053132; Guo JQ, 2017, BBA-MOL BASIS DIS, V1863, P2240, DOI 10.1016/j.bbadis.2017.02.005; Haley MJ, 2017, J CEREBR BLOOD F MET, V37, P456, DOI 10.1177/0271678X16629976; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Hartz AMS, 2012, STROKE, V43, P514, DOI 10.1161/STROKEAHA.111.627562; Henninger DD, 1997, J IMMUNOL, V158, P1825; Hirase T, 1997, J CELL SCI, V110, P1603; Hombach S, 2016, ADV EXP MED BIOL, V937, P3, DOI 10.1007/978-3-319-42059-2_1; Huang RR, 2017, AUTOPHAGY, V13, P1722, DOI 10.1080/15548627.2017.1356975; Hudson LC, 2005, BRAIN RES, V1058, P148, DOI 10.1016/j.brainres.2005.07.071; Ji W, 2018, NEUROCHEM RES, V43, P1863, DOI 10.1007/s11064-018-2602-z; Jia JY, 2018, J CELL PHYSIOL, V233, P8839, DOI 10.1002/jcp.26798; Keaney J, 2015, FEBS J, V282, P4067, DOI 10.1111/febs.13412; Kim J, 2015, J NEUROSCI, V35, P14717, DOI 10.1523/JNEUROSCI.2053-15.2015; Klingenberg M, 2017, J HEPATOL, V67, P603, DOI 10.1016/j.jhep.2017.04.009; Leng X, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0886-0; Li H, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2191-z; Li LJ, 2017, BIOMED PHARMACOTHER, V96, P165, DOI 10.1016/j.biopha.2017.09.113; Li R, 2020, CELL MOL LIFE SCI, V77, P1661, DOI 10.1007/s00018-019-03345-5; Liebner S, 2000, EUR J CELL BIOL, V79, P707, DOI 10.1078/0171-9335-00101; Liebner S, 2018, ACTA NEUROPATHOL, V135, P311, DOI 10.1007/s00401-018-1815-1; Lim DA, 2007, NEUROSURG CLIN N AM, V18, P81, DOI 10.1016/j.nec.2006.10.002; Liu JD, 2008, CURR OPIN CELL BIOL, V20, P214, DOI 10.1016/j.ceb.2008.01.006; Liu Qianshuo, 2020, RNA Biol, V17, P1293, DOI 10.1080/15476286.2020.1756055; Liu WJ, 2016, EXP CELL RES, V343, P248, DOI 10.1016/j.yexcr.2016.03.026; Lopez-Ramirez MA, 2014, FASEB J, V28, P2551, DOI 10.1096/fj.13-248880; Lu YH, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/7461727; Luteijn MJ, 2013, NAT REV GENET, V14, P523, DOI 10.1038/nrg3495; Ma FF, 2020, EXP NEUROL, V323, DOI 10.1016/j.expneurol.2019.113094; Ma J, 2016, BBA-GENE REGUL MECH, V1859, P324, DOI 10.1016/j.bbagrm.2015.11.008; Ma J, 2014, J CEREBR BLOOD F MET, V34, P1826, DOI 10.1038/jcbfm.2014.152; Ma QY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071356; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; Mehta SL, 2020, PROG NEUROBIOL, V186, DOI 10.1016/j.pneurobio.2020.101746; Mehta SL, 2015, J NEUROSCI, V35, P16443, DOI 10.1523/JNEUROSCI.2943-15.2015; Mizee MR, 2013, J NEUROSCI, V33, P1660, DOI 10.1523/JNEUROSCI.1338-12.2013; Morita K, 1999, J CELL BIOL, V145, P579, DOI 10.1083/jcb.145.3.579; Nayak A, 2013, CURR TOP MICROBIOL, V371, P183, DOI 10.1007/978-3-642-37765-5_7; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Nie JH, 2019, NON-CODING RNA, V5, DOI 10.3390/ncrna5020036; Nischwitz V, 2008, ANAL CHIM ACTA, V627, P258, DOI 10.1016/j.aca.2008.08.018; Noell S, 2011, EUR J NEUROSCI, V33, P2179, DOI 10.1111/j.1460-9568.2011.07688.x; OLDENDORF WH, 1977, ANN NEUROL, V1, P409, DOI 10.1002/ana.410010502; Olson EN, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009008; Ozata DM, 2019, NAT REV GENET, V20, P89, DOI 10.1038/s41576-018-0073-3; Pan JJ, 2020, STROKE, V51, P619, DOI 10.1161/STROKEAHA.119.027531; Pan YB, 2017, NEUROSCIENCE, V367, P189, DOI 10.1016/j.neuroscience.2017.10.046; Papadopoulos MC, 2001, NEUROPATH APPL NEURO, V27, P384, DOI 10.1046/j.0305-1846.2001.00341.x; Pena-Philippides JC, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009244; Profaci CP, 2020, J EXP MED, V217, DOI 10.1084/jem.20190062; REESE TS, 1967, J CELL BIOL, V34, P207, DOI 10.1083/jcb.34.1.207; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Reijerkerk A, 2013, J NEUROSCI, V33, P6857, DOI 10.1523/JNEUROSCI.3965-12.2013; Ren WM, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00096; Rom S, 2015, J CEREBR BLOOD F MET, V35, P1957, DOI 10.1038/jcbfm.2015.154; Ruan ZH, 2019, INT J CARDIOL, V288, P122, DOI 10.1016/j.ijcard.2019.04.015; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Sa LB, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00194; Sagare AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3932; Shindo A, 2021, CNS NEUROSCI THER, V27, P60, DOI 10.1111/cns.13510; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Song J, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0157-3; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Stamatovic SM, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00864; Szittya G, 2013, CURR TOP MICROBIOL, V371, P153, DOI 10.1007/978-3-642-37765-5_6; Tian JN, 2021, J BIOCHEM MOL TOXIC, V35, DOI 10.1002/jbt.22724; Tietz S, 2015, J CELL BIOL, V209, P493, DOI 10.1083/jcb.201412147; Tominaga N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7716; Toyama K, 2018, ARTERIOSCL THROM VAS, V38, P1392, DOI 10.1161/ATVBAHA.118.310822; Treiber T, 2012, THROMB HAEMOSTASIS, V107, P605, DOI 10.1160/TH11-12-0836; Ujiie M, 2003, MICROCIRCULATION, V10, P463, DOI 10.1038/sj.mn.7800212; Wang S, 2019, NEUROSCIENCE, V397, P116, DOI 10.1016/j.neuroscience.2018.11.024; Wang SW, 2018, CELL TRANSPLANT, V27, P1763, DOI 10.1177/0963689718806818; Wang Y, 2018, FASEB J, V32, P935, DOI 10.1096/fj.201700139RRR; Wolburg H, 2003, ACTA NEUROPATHOL, V105, P586, DOI 10.1007/s00401-003-0688-z; Wu C, 2009, NAT MED, V15, P519, DOI 10.1038/nm.1957; Wu JC, 2020, J NEUROCHEM, V153, P710, DOI 10.1111/jnc.14963; Wu PQ, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1771-2; Xi TY, 2017, BIOCHEM BIOPH RES CO, V494, P144, DOI 10.1016/j.bbrc.2017.10.064; Xing F, 2015, ONCOGENE, V34, P4890, DOI 10.1038/onc.2014.412; Yamazaki Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091965; Yang RC, 2020, MOL THER-NUCL ACIDS, V22, P708, DOI 10.1016/j.omtn.2020.09.034; Yao XF, 2018, J MOL NEUROSCI, V65, P43, DOI 10.1007/s12031-018-1067-5; Yin DL, 2021, LIFE SCI, V284, DOI 10.1016/j.lfs.2021.119244; Yu CC, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/2591248; Yu H, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.7; Zhang C, 2020, FASEB J, V34, P9941, DOI 10.1096/fj.202000045R; Zhang YW, 2017, NEUROCHEM INT, V107, P182, DOI 10.1016/j.neuint.2016.11.011; Zhao YY, 2015, J NEUROSCI RES, V93, P1891, DOI 10.1002/jnr.23628; Zhu L, 2019, J CELL MOL MED, V23, P3280, DOI 10.1111/jcmm.14214; Zuo XK, 2019, EXP NEUROL, V316, P12, DOI 10.1016/j.expneurol.2019.03.017	127	2	2	10	10	KEAI PUBLISHING LTD	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING, DONGHENG DISTRICT 100717, PEOPLES R CHINA	2468-2160	2468-0540		NON-CODING RNA RES	Non-Coding RNA Res.	SEP	2021	6	3					130	138		10.1016/j.ncrna.2021.06.003			9	Biochemistry & Molecular Biology	Emerging Sources Citation Index (ESCI)	Biochemistry & Molecular Biology	WD6UU	WOS:000705075100003	34377876	Green Published, gold			2022-02-06	
J	Messerschmidt, EL; Hall, EE; Ketcham, CJ; Patel, K; Vallabhajosula, S				Messerschmidt, Emily L.; Hall, Eric E.; Ketcham, Caroline J.; Patel, Kirtida; Vallabhajosula, Srikant			Gait Assessment in College Athletes: Do Concussion History, Symptoms, Gender, and Type of Sport Matter?	JOURNAL OF SPORT REHABILITATION			English	Article						dual-task gait; GAITRite; collision sports; gait variability; spatiotemporal gait parameters; ImPACT	DUAL-TASK GAIT; GAITRITE(R) WALKWAY SYSTEM; MILD COGNITIVE IMPAIRMENT; EMOTIONAL STATE AFFECTS; BALANCE CONTROL; WALKING SPEED; BASE-LINE; PARKINSONS-DISEASE; TANDEM GAIT; ADOLESCENTS	Context: Though previous research has focused on examining the effects of concussion history using a dual-task paradigm, the influence of factors like symptoms (unrelated to concussion), gender, and type of sport on gait in college athletes is unknown. Objective: To examine the effect of concussion history, symptoms, gender, and type of sport (noncontact/limited contact/contact) individually on gait among college athletes. Design: Exploratory cross-sectional study. Setting: Laboratory. Participants: In total, 98 varsity athletes (age, 18.3 [1.0] y; height, 1.79 [0.11] m; mass, 77.5 [19.2] kg; 27 with concussion history, 58 reported at least one symptom, 44 females; 8 played noncontact sports and 71 played contact sports) walked under single- and dual-task (walking while counting backward by 7) conditions. Interventions: Not applicable. Main Outcome Measures: Dual-task cost (DTC; % difference between single task and dual task) of gait speed, cadence, step length and width, percentage of swing and double-support phases, symptom score, and total symptom severity score. Independent samples t tests and 1-way analysis of variance were conducted (a value = .05). Results: Self-reported concussion history resulted in no significant differences (P >.05). Those who reported symptoms at testing time showed significantly greater DTC of step length (mean difference [MD], 2.7%; 95% confidence interval [CI], 0.3% to 5.1%; P = .012),% of swing phase (MD, 1.0%; 95% CI, -0.2 to 2.1%; P = .042), and % of double-support phase (MD, 3.9%; 95% CI, 0.2% to 7.8%; P = .019). Females demonstrated significantly higher DTC of gait speed (MD, 5.3%; 95% CI, 1.3% to 9.3%; P = .005), cadence (MD, 4.0%; 95% CI, 1.4% to 6.5%; P =.002), % of swing phase (MD, 1.2%; 95% CI, 0.1% to 2.3%; P = .019), and % of double-support phase (MD, 4.1%; 95% CI, 0.4% to 7.9%; P = .018). Noncontact sports athletes had significantly greater step width DTC than contact sports athletes (MD, 14.2%; 95% CI, 0.9% to 27.6%; P = .032). Conclusions: Reporting symptoms at testing time may influence gait under dual-task conditions. Additionally, female athletes showed more gait changes during a dual task. Sports medicine professionals should be aware that these variables, while unrelated to injury, may affect an athlete's gait upon analysis.	[Messerschmidt, Emily L.; Vallabhajosula, Srikant] Elon Univ, Dept Phys Therapy Educ, Elon, NC 27244 USA; [Hall, Eric E.; Ketcham, Caroline J.] Elon Univ, Dept Exercise Sci, Elon, NC USA; [Patel, Kirtida] Elon Univ, Dept Sports Med, Elon, NC USA		Vallabhajosula, S (corresponding author), Elon Univ, Dept Phys Therapy Educ, Elon, NC 27244 USA.	svallabhajosula@elon.edu		Ketcham, Caroline/0000-0002-6713-130X			Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; Bahureksa L, 2017, GERONTOLOGY, V63, P67, DOI 10.1159/000445831; Beauchet O, 2005, J MOTOR BEHAV, V37, P259; Bilney B, 2003, GAIT POSTURE, V17, P68, DOI 10.1016/S0966-6362(02)00053-X; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Brach JS, 2008, GAIT POSTURE, V27, P431, DOI 10.1016/j.gaitpost.2007.05.016; Brach JS, 2007, J GERONTOL A-BIOL, V62, P983, DOI 10.1093/gerona/62.9.983; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Brown LA, 2020, J SPORT REHABIL, V29, P448, DOI 10.1123/jsr.2018-0129; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P417, DOI 10.1016/j.jshs.2015.03.010; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Evans K.M., 2015, INT J PHYS MED REHAB, V3, P568, DOI [10.4172/2329-9096.1000268, DOI 10.4172/2329-9096.1000268, https://doi.org/10.4172/2329-9096.1000268]; Fritz S, 2009, J GERIATR PHYS THER, V32, P2, DOI 10.1519/00139143-200932020-00002; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Helt M, 2008, NEUROPSYCHOL REV, V18, P339, DOI 10.1007/s11065-008-9075-9; Howel DR, 2017, J APPL BIOMECH, V33, P24, DOI 10.1123/jab.2015-0323; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2018, GAIT POSTURE, V62, P291, DOI 10.1016/j.gaitpost.2018.03.038; Howell DR, 2017, J NEUROTRAUM, V34, P3288, DOI 10.1089/neu.2017.5191; Howell DR, 2017, GAIT POSTURE, V54, P284, DOI 10.1016/j.gaitpost.2017.03.034; Howell DR, 2017, J NEUROTRAUM, V34, P838, DOI 10.1089/neu.2016.4609; Howell DR, 2016, GAIT POSTURE, V49, P176, DOI 10.1016/j.gaitpost.2016.07.008; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Hunter SW, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0894-0; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Ketcham CJ, 2014, JOVE-J VIS EXP, DOI 10.3791/52046; Kirkland MC, 2015, MULT SCLER INT, V2015, DOI 10.1155/2015/650645; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; Mansoubi M, 2020, J SPORT SCI MED, V19, P364; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; MCDOWD JM, 1986, J GERONTOL, V41, P764, DOI 10.1093/geronj/41.6.764; Menz HB, 2004, GAIT POSTURE, V20, P20, DOI 10.1016/S0966-6362(03)00068-7; Middleton A, 2015, J AGING PHYS ACTIV, V23, P314, DOI 10.1123/japa.2013-0236; Montero-Odasso MM, 2017, JAMA NEUROL, V74, P857, DOI 10.1001/jamaneurol.2017.0643; Muci B, 2020, PHYSIOTHER THEOR PR, DOI 10.1080/09593985.2020.1777603; Nadkarni Neelesh K, 2010, Motor Control, V14, P195; Naugle KM, 2012, COGN AFFECT BEHAV NE, V12, P207, DOI 10.3758/s13415-011-0071-9; Naugle KM, 2011, EMOTION, V11, P267, DOI 10.1037/a0022577; Naugle KM, 2010, J BIOMECH, V43, P3099, DOI 10.1016/j.jbiomech.2010.08.008; Oldham JR, 2017, SPORTS HEALTH, V9, P305, DOI 10.1177/1941738116680999; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Parrington L, 2019, J ATHL TRAINING, V54, P429, DOI 10.4085/1062-6050-46-18; Pessiglione M, 2007, SCIENCE, V316, P904, DOI 10.1126/science.1140459; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; dos Santos PCR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226939; Rochester L, 2004, ARCH PHYS MED REHAB, V85, P1578, DOI 10.1016/j.apmr.2004.01.025; Roemmich RT, 2012, GAIT POSTURE, V36, P340, DOI 10.1016/j.gaitpost.2012.01.018; Salazar RD, 2017, NEUROPSYCHOLOGY, V31, P613, DOI 10.1037/neu0000331; Springer S, 2006, MOVEMENT DISORD, V21, P950, DOI 10.1002/mds.20848; Stevens D, 2020, J GERONTOL A-BIOL, V75, P2450, DOI 10.1093/gerona/glaa014; Tombu M, 2003, J EXP PSYCHOL HUMAN, V29, P3, DOI 10.1037/0096-1523.29.1.3; Vallabhajosula S, 2015, J BIOMECH, V48, P921, DOI 10.1016/j.jbiomech.2015.02.024; Verghese J, 2007, ARCH PHYS MED REHAB, V88, P50, DOI 10.1016/j.apmr.2006.10.007; Webster KE, 2005, GAIT POSTURE, V22, P317, DOI 10.1016/j.gaitpost.2004.10.005; Yang YR, 2007, GAIT POSTURE, V25, P185, DOI 10.1016/j.gaitpost.2006.03.007; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	68	2	2	0	1	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	SEP	2021	30	7					988	999		10.1123/jsr.2019-0331			12	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	UI1MM	WOS:000690380400003	33418540				2022-02-06	
J	Paul, R; Nath, J; Paul, S; Mazumder, MK; Phukan, BC; Roy, R; Bhattacharya, P; Borah, A				Paul, Rajib; Nath, Joyobrato; Paul, Satinath; Mazumder, Muhammed Khairujjaman; Phukan, Banashree Chetia; Roy, Rubina; Bhattacharya, Pallab; Borah, Anupom			Suggesting 7,8-dihydroxyflavone as a promising nutraceutical against CNS disorders	NEUROCHEMISTRY INTERNATIONAL			English	Article						BDNF-TrkB; Neurodegenerative disorders; Neuroprotection; Anti-inflammatory	TRAUMATIC BRAIN-INJURY; MOUSE MODEL; TRKB AGONIST; NEUROTROPHIC FACTOR; ALZHEIMERS-DISEASE; MEMORY DEFICITS; MOTOR DEFICITS; THERAPEUTIC-EFFICACY; PREPULSE INHIBITION; CEREBRAL-ISCHEMIA	7,8-dihydroxyflavone (DHF), a naturally-occurring plant-based flavone, is a high-affinity tyrosine kinase receptor B (TrkB) agonist and a bioactive molecule of therapeutic interest for neuronal survival, differentiation, synaptic plasticity and neurogenesis. In the family of neurotrophic factors, this small BDNF-mimetic molecule has attracted considerable attention due to its oral bioavailability and ability to cross the blood-brain barrier. Recent evidences have shed light on the neuroprotective role of this pleiotropic flavone against several neurological disorders, including Alzheimer's disease, Parkinson's disease, cerebral ischemia, Huntington's disease, and other CNS disorders. DHF also elicits potent protective actions against toxins-induced insults to brain and neuronal cells. DHF shows promising anti-oxidant and anti-inflammatory properties in ameliorating the neurodegenerative processes affecting the CNS. This review provides an overview of the significant neuroprotective potentials of DHF and discusses how it exerts its multitudinous beneficial effects by modulating different pathways linked with the pathophysiology of CNS disorders, and thus proposes it to be a nutraceutical against a broad spectrum of neurological disorders.	[Paul, Rajib; Paul, Satinath] Pandit Deendayal Upadhyaya Adarsha Mahavidyalaya, Dept Zool, Karimganj 788723, Assam, India; [Nath, Joyobrato] Cachar Coll, Dept Zool, Silchar 788001, Assam, India; [Mazumder, Muhammed Khairujjaman] Dhemaji Coll, Dept Zool, Dhemaji 787057, Assam, India; [Phukan, Banashree Chetia; Roy, Rubina; Borah, Anupom] Assam Univ, Dept Life Sci & Bioinforrnat, Cellular & Mol Neurobiol Lab, Silchar 788011, Assam, India; [Bhattacharya, Pallab] Natl Inst Pharmaceut Educ & Res NIPER Ahmedabad, Dept Pharmacol & Toxicol, Gandhinagar 382355, Gujarat, India		Paul, R (corresponding author), Pandit Deendayal Upadhyaya Adarsha Mahavidyalaya, Dept Zool, Karimganj 788723, Assam, India.; Borah, A (corresponding author), Assam Univ, Dept Life Sci & Bioinforrnat, Cellular & Mol Neurobiol Lab, Silchar 788011, Assam, India.	rajibpaul.aus47@gmail.com; anupomborahh@gmail.com	Borah, Anupom/I-2967-2019	Borah, Anupom/0000-0002-6283-5367; Paul, Rajib/0000-0002-2433-9266; Mazumder, Muhammed Khairujjaman/0000-0003-3100-1164			Aarons T, 2019, J ALZHEIMERS DIS, V69, P1089, DOI 10.3233/JAD-190049; Agrawal R, 2015, BBA-MOL BASIS DIS, V1852, P862, DOI 10.1016/j.bbadis.2015.01.018; Ahad MA, 2020, REV NEUROSCIENCE, V31, P521, DOI 10.1515/revneuro-2019-0099; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Arvanitakis Z, 2019, JAMA-J AM MED ASSOC, V322, P1589, DOI 10.1001/jama.2019.4782; Aytan N, 2018, EUR J PHARMACOL, V828, P9, DOI 10.1016/j.ejphar.2018.02.045; Banerjee A, 2019, BRAIN, V142, P239, DOI 10.1093/brain/awy323; Baydyuk M, 2011, EXP NEUROL, V228, P118, DOI 10.1016/j.expneurol.2010.12.018; Beck S., 2018, Journal of Plant Studies, V7, P19, DOI 10.5539/jps.v7n1p19; Blugeot A, 2011, J NEUROSCI, V31, P12889, DOI 10.1523/JNEUROSCI.1309-11.2011; Bollen E, 2013, BEHAV BRAIN RES, V257, P8, DOI 10.1016/j.bbr.2013.09.029; Borah A, 2013, CNS NEUROSCI THER, V19, P847, DOI 10.1111/cns.12175; Bostrom C, 2016, NEUROSCI BIOBEHAV R, V68, P563, DOI 10.1016/j.neubiorev.2016.06.033; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Cai DW, 2019, EXP THER MED, V18, P1677, DOI 10.3892/etm.2019.7745; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Castello NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091453; Chen C, 2014, REJUV RES, V17, P249, DOI 10.1089/rej.2013.1519; Chen C, 2018, P NATL ACAD SCI USA, V115, P578, DOI 10.1073/pnas.1718683115; Chen J, 2011, NEUROSCI LETT, V499, P181, DOI 10.1016/j.neulet.2011.05.054; Chen YF, 2020, FOOD FUNCT, V11, P1810, DOI [10.1039/c9fo02704a, 10.1039/C9FO02704A]; Chen YF, 2020, INT J BIOL MACROMOL, V146, P179, DOI 10.1016/j.ijbiomac.2019.12.251; Chitranshi N, 2015, INT J MOL SCI, V16, P21087, DOI 10.3390/ijms160921087; Cho SJ, 2019, BIOMOL THER, V27, P85, DOI 10.4062/biomolther.2018.202; Cikla U, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0025-15.2015; Cumming C, 2020, DRUG ALCOHOL REV, V39, P505, DOI 10.1111/dar.13062; Dadhania VP, 2016, CURR NEUROPHARMACOL, V14, P627, DOI 10.2174/1570159X14666160104142223; Dean AC, 2013, NEUROPSYCHOPHARMACOL, V38, P259, DOI 10.1038/npp.2012.179; Devi L, 2012, NEUROPSYCHOPHARMACOL, V37, P434, DOI 10.1038/npp.2011.191; Dias V, 2013, J PARKINSON DIS, V3, P461, DOI 10.3233/JPD-130230; Du X, 2015, NEUROCHEM INT, V89, P170, DOI 10.1016/j.neuint.2015.07.021; Emili M, 2022, CRIT REV FOOD SCI, V62, P13, DOI 10.1080/10408398.2020.1810625; Erkkinen MG, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a033118; Gao L, 2016, J NEUROCHEM, V136, P620, DOI 10.1111/jnc.13432; Barriga GGD, 2017, HUM MOL GENET, V26, P3144, DOI 10.1093/hmg/ddx198; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; Gitler AD, 2017, DIS MODEL MECH, V10, P499, DOI 10.1242/dmm.030205; Goldenberg Marvin M, 2012, P T, V37, P175; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hagerman RJ, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.65; Han XH, 2014, NEUROCHEM INT, V64, P18, DOI 10.1016/j.neuint.2013.10.018; He JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34339; Howells DW, 2000, EXP NEUROL, V166, P127, DOI 10.1006/exnr.2000.7483; Hsiao YH, 2014, J NEUROSCI, V34, P16207, DOI 10.1523/JNEUROSCI.0747-14.2014; Hung PL, 2013, STROKE, V44, P2275, DOI 10.1161/STROKEAHA.113.001552; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Jiang ML, 2013, HUM MOL GENET, V22, P2462, DOI 10.1093/hmg/ddt098; Johnson RA, 2012, J APPL PHYSIOL, V112, P704, DOI 10.1152/japplphysiol.01361.2011; Krishna G, 2017, BBA-MOL BASIS DIS, V1863, P1204, DOI 10.1016/j.bbadis.2017.03.007; Kumar A, 2015, PHARMACOL REP, V67, P195, DOI 10.1016/j.pharep.2014.09.004; Kumar A, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10010043; Latif R., 2015, SAUDI J HLTH SCI, V4, P1; Lewerenz J, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00469; Li W, 2014, NEUROPHARMACOLOGY, V76, P737, DOI 10.1016/j.neuropharm.2013.03.024; Li XH, 2016, CNS NEUROSCI THER, V22, P617, DOI 10.1111/cns.12555; Li Y, 2012, P NATL ACAD SCI USA, V109, P15491, DOI 10.1073/pnas.1212899109; Liu X, 2013, PHARMACOLOGY, V91, P185, DOI 10.1159/000346920; Liu X, 2010, J MED CHEM, V53, P8274, DOI 10.1021/jm101206p; Luo DD, 2016, NEUROSCI LETT, V620, P43, DOI 10.1016/j.neulet.2016.03.042; Mahmoud B.K., 2019, BIGNONIA, V2, P83; Makar TK, 2012, J NEUROIMMUNOL, V252, P1, DOI 10.1016/j.jneuroim.2012.07.005; Mason LH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/840547; Massaquoi MS, 2020, NEUROSCIENCE, V433, P53, DOI 10.1016/j.neuroscience.2020.02.046; Mazumder MK, 2014, MED HYPOTHESES, V83, P697, DOI 10.1016/j.mehy.2014.09.021; Mendsaikhan A, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030230; Mohankumar T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57417-9; Catorce MN, 2020, CURR NEUROPHARMACOL, V18, P636, DOI 10.2174/1570159X18666200114125628; Neal AP, 2010, TOXICOL SCI, V116, P249, DOI 10.1093/toxsci/kfq111; Nie SK, 2019, PARKINSONS DIS-US, V2019, DOI 10.1155/2019/9193534; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Pandey RP, 2018, BIOTECHNOL APPL BIOC, V65, P128, DOI 10.1002/bab.1570; Pandey SN, 2020, PSYCHOPHARMACOLOGY, V237, P1827, DOI 10.1007/s00213-020-05502-2; Park HY, 2012, INT J MOL MED, V29, P1146, DOI 10.3892/ijmm.2012.935; Paul R, 2020, NEUROCHEM INT, V140, DOI 10.1016/j.neuint.2020.104823; Paul R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17911-z; Paul R, 2017, NEUROCHEM INT, V108, P15, DOI 10.1016/j.neuint.2017.01.021; Paul R, 2016, BBA-GEN SUBJECTS, V1860, P1989, DOI 10.1016/j.bbagen.2016.06.018; Perez-Vizcaino F, 2018, ARCH BIOCHEM BIOPHYS, V646, P107, DOI 10.1016/j.abb.2018.03.022; Poewe W, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.13; Ralph-Williams RJ, 2002, J NEUROSCI, V22, P9604; Reich DS, 2018, NEW ENGL J MED, V378, P169, DOI 10.1056/NEJMra1401483; Ren Q, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.157; Ren Q, 2014, PSYCHOPHARMACOLOGY, V231, P159, DOI 10.1007/s00213-013-3221-7; Ren Q, 2013, PHARMACOL BIOCHEM BE, V106, P124, DOI 10.1016/j.pbb.2013.03.016; Romeika J, 2017, NEW THERAPEUTICS FOR TRAUMATIC BRAIN INJURY: PREVENTION OF SECONDARY BRAIN DAMAGE AND ENHANCEMENT OF REPAIR AND REGENERATION, P225, DOI 10.1016/B978-0-12-802686-1.00014-6; Sconce MD, 2015, NEUROSCIENCE, V290, P454, DOI 10.1016/j.neuroscience.2014.12.080; SEIDEN LS, 1993, ANNU REV PHARMACOL, V33, P639, DOI 10.1146/annurev.pa.33.040193.003231; Shin JE, 2014, EXP NEUROL, V252, P1, DOI 10.1016/j.expneurol.2013.11.007; Sun TP, 2017, J CHROMATOGR B, V1061, P97, DOI 10.1016/j.jchromb.2017.07.001; Tabrizi SJ, 2019, NEURON, V101, P801, DOI 10.1016/j.neuron.2019.01.039; Tecuatl C, 2018, EUR J NEUROSCI, V47, P1096, DOI 10.1111/ejn.13880; Tian M, 2015, NEUROPHARMACOLOGY, V89, P43, DOI 10.1016/j.neuropharm.2014.09.006; Tomlinson DR, 2008, NAT REV NEUROSCI, V9, P36, DOI 10.1038/nrn2294; Tsai T, 2013, MOL CELL NEUROSCI, V56, P18, DOI 10.1016/j.mcn.2013.02.007; Uluc K, 2013, CNS NEUROL DISORD-DR, V12, P360, DOI 10.2174/18715273113129990061; van Es MA, 2017, LANCET, V390, P2084, DOI 10.1016/S0140-6736(17)31287-4; Wang B, 2014, J MOL HISTOL, V45, P129, DOI 10.1007/s10735-013-9539-y; Wu CH, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0543-8; Wu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113397; Wurzelmann M, 2017, NEURAL REGEN RES, V12, P7, DOI 10.4103/1673-5374.198964; Zafonte RD, 2017, LANCET NEUROL, V16, P766, DOI 10.1016/S1474-4422(17)30300-9; Zhang XL, 2018, TOXICOL SCI, V161, P186, DOI 10.1093/toxsci/kfx210; Zhang ZT, 2014, NEUROPSYCHOPHARMACOL, V39, P638, DOI 10.1038/npp.2013.243; Zhao S, 2016, MOL NEUROBIOL, V53, P1884, DOI 10.1007/s12035-015-9128-z; Zhou WT, 2015, CURR ALZHEIMER RES, V12, P47, DOI 10.2174/1567205012666141218124243; Zuccato C, 2007, PROG NEUROBIOL, V81, P294, DOI 10.1016/j.pneurobio.2007.01.003	107	2	2	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	SEP	2021	148								105068	10.1016/j.neuint.2021.105068			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	TM9LE	WOS:000675867400007	34022252	Bronze			2022-02-06	
J	Sanchez-Molina, D; Garcia-Vilana, S; Lluma, J; Galtes, I; Velazquez-Ameijide, J; Rebollo-Soria, MC; Arregui-Dalmases, C				Sanchez-Molina, David; Garcia-Vilana, Silvia; Lluma, Jordi; Galtes, Ignasi; Velazquez-Ameijide, Juan; Rebollo-Soria, Mari Carmen; Arregui-Dalmases, Carlos			Mechanical Behavior of Blood Vessels: Elastic and Viscoelastic Contributions	BIOLOGY-BASEL			English	Article						biomechanics; collagenous tissue; tissue characterization; strain rate dependent materials; viscoelasticity	TRAUMATIC BRAIN-INJURIES; TENSILE FAILURE PROPERTIES; SUPERIOR SAGITTAL SINUS; BRIDGING VEINS; CONSTITUTIVE MODEL; STRAIN-RATE; PREDICTORS	Simple Summary A frequent type of injuries in traffic collisions and falls from a moderate height is associated with subdural hematomas caused by the mechanical failure of cerebral bridging veins, which link the superior sagittal sinus to the brain. For this reason, both to design safe restraint systems for motor vehicles and to study how these injuries occur, it is important to study the mechanical properties of the bridging veins. Although the mechanical properties of bridging veins have been studied for the last half century, some viscoelastic effects in these vessels that alter their mechanical response have not been analyzed in detail until now. This is the first study that measures, quantifies, and models these viscoelastic effects, thus improving our knowledge of the mechanical response of cerebral bridging veins. The mechanical properties of the cerebral bridging veins (CBVs) were studied using advanced microtensile equipment. Detailed high-quality curves were obtained at different strain rates, showing a clearly nonlinear stress-strain response. In addition, the tissue of the CBVs exhibits stress relaxation and a preconditioning effect under cyclic loading, unequivocal indications of viscoelastic behavior. Interestingly, most previous literature that conducts uniaxial tensile tests had not found significant viscoelastic effects in CBVs, but the use of more sensitive tests allowed to observe the viscoelastic effects. For that reason, a careful mathematical analysis is presented, clarifying why in uniaxial tests with moderate strain rates, it is difficult to observe any viscoelastic effect. The analysis provides a theoretical explanation as to why many recent studies that investigated mechanical properties did not find a significant viscoelastic effect, even though in other circumstances, the CBV tissue would clearly exhibit viscoelastic behavior. Finally, this study provides reference values for the usual mechanical properties, as well as calculations of constitutive parameters for nonlinear elastic and viscoelastic models that would allow more accurate numerical simulation of CBVs in Finite Element-based computational models in future works.	[Sanchez-Molina, David; Garcia-Vilana, Silvia; Lluma, Jordi; Velazquez-Ameijide, Juan] Univ Politecn Cataluna, Escola Engn Barcelona Est, Av Eduard Maristany 16, Barcelona 08019, Spain; [Galtes, Ignasi] Inst Med Legal & Ciencies Forenses Catalunya, GV Corts Catalanes 111, Barcelona 08014, Spain; [Galtes, Ignasi] Univ Autonoma Barcelona, Dept Psiquiatria & Med Legal, E-08193 Barcelona, Spain; [Rebollo-Soria, Mari Carmen] Inst Med Legal Aragon, Huesca 22005, Spain; [Arregui-Dalmases, Carlos] Ctr Zaragoza, Crtra 232,Km 273, Pedrola 50690, Spain		Sanchez-Molina, D (corresponding author), Univ Politecn Cataluna, Escola Engn Barcelona Est, Av Eduard Maristany 16, Barcelona 08019, Spain.	david.sanchez-molina@upc.edu; silvia.garcia.vilana@upc.edu; jordi.lluma@upc.edu; ignasigaltes@gmail.com; juan.velazquez@upc.edu; mcrebollos@aragon.es; carlos.arregui@centro-zaragoza.com	Sanchez-Molina, David/I-2149-2014; Galtes, Ignasi/K-3053-2014	Sanchez-Molina, David/0000-0002-0671-4106; Galtes, Ignasi/0000-0002-5758-2668; Garcia-Vilana, Silvia/0000-0002-8659-1985; Lluma, Jordi/0000-0002-4982-206X; Velazquez-Ameijide, Juan/0000-0001-6872-3609	Fundacio La Marato de TV3 (Barcelona) [289/C/2017, 201704.30]	This research was funded by Fundacio La Marato de TV3 (Barcelona, No. Grant 289/C/2017, 201704.30). The research was developed within the studies of the research project "Age Effects on Traumatic Brain Injuries".	Barrett JM, 2021, J MECH BEHAV BIOMED, V115, DOI 10.1016/j.jmbbm.2020.104273; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chen WW, 2011, J TRIBOL-T ASME, V133, DOI 10.1115/1.4004928; Costa JMC, 2020, J MECH BEHAV BIOMED, V111, DOI 10.1016/j.jmbbm.2020.103976; Davis FM, 2012, ANN BIOMED ENG, V40, P2541, DOI 10.1007/s10439-012-0596-2; Delteil C., 2020, REV MED LEGALE, V11, P68, DOI [10.1016/j.medleg.2020.04.003, DOI 10.1016/J.MEDLEG.2020.04.003]; Delye Hans, 2006, Stapp Car Crash J, V50, P625; DENG SX, 1994, AM J PHYSIOL, V266, pH1, DOI 10.1152/ajpheart.1994.266.1.H1; Depreitere B, 2006, J NEUROSURG, V104, P950, DOI 10.3171/jns.2006.104.6.950; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Doorly M.C., 2007, THESIS U COLL DUBLIN; Famaey N, 2015, J MECH BEHAV BIOMED, V41, P222, DOI 10.1016/j.jmbbm.2014.06.009; Fernandes FAO, 2018, ENG COMPUTATION, V35, P477, DOI 10.1108/EC-09-2016-0321; Fernandes FAO, 2015, P I MECH ENG H, V229, P592, DOI 10.1177/0954411915592906; Fung Y.C., 2013, BIOMECHANICS MECH PR; Funk JR, 2000, J BIOMECH ENG-T ASME, V122, P15, DOI 10.1115/1.429623; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Han H, 2007, NEURORADIOLOGY, V49, P169, DOI 10.1007/s00234-006-0175-z; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Holzapfel G. A., 2008, P285, DOI 10.1007/978-0-387-73906-9_11; Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564; Holzapfel GA., 2000, NONLINEAR SOLID MECH; Jourdan C, 2018, AM J PHYS MED REHAB, V97, P323, DOI 10.1097/PHM.0000000000000848; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Konda S, 2016, AM J IND MED, V59, P212, DOI 10.1002/ajim.22557; Kroon M, 2008, J BIOMECH, V41, P2766, DOI 10.1016/j.jbiomech.2008.05.033; Lee KS, 2016, J KOREAN NEUROSURG S, V59, P1, DOI 10.3340/jkns.2016.59.1.1; LEE MC, 1992, J BIOMECH, V25, P925, DOI 10.1016/0021-9290(92)90232-P; LEE MC, 1989, J BIOMECH, V22, P537, DOI 10.1016/0021-9290(89)90005-5; Lodi C.A., 1997, WIT T BIOMED HLTH, V4, DOI [10.2495/BIO970101, DOI 10.2495/BIO970101]; Luo MJ, 2014, APPL MATH COMPUT, V248, P631, DOI 10.1016/j.amc.2014.09.110; Monea AG, 2014, J MECH BEHAV BIOMED, V32, P155, DOI 10.1016/j.jmbbm.2013.12.007; Monson KL, 2019, CLIN BIOMECH, V64, P98, DOI 10.1016/j.clinbiomech.2018.02.011; Monson KL, 2005, J BIOMECH, V38, P737, DOI 10.1016/j.jbiomech.2004.05.004; Monson KL, 2003, J BIOMECH ENG-T ASME, V125, P288, DOI 10.1115/1.1554412; Morro A, 2017, MECCANICA, V52, P3015, DOI 10.1007/s11012-016-0585-x; Natali AN, 2009, MED ENG PHYS, V31, P1056, DOI 10.1016/j.medengphy.2009.07.003; NORLUND NE, 1955, ACTA MATH-DJURSHOLM, V94, P289, DOI 10.1007/BF02392494; Padula WV, 2017, BRAIN INJURY, V31, P589, DOI 10.1080/02699052.2017.1291991; Porto L, 2021, NEURORADIOLOGY, V63, P417, DOI 10.1007/s00234-020-02564-z; Raul JS, 2008, INT J LEGAL MED, V122, P337, DOI 10.1007/s00414-008-0242-6; Sanchez Molina D., 2013, THESIS UPC BARCELONA; Sanchez-Molina D, 2016, COMPUT METH PROG BIO, V136, P55, DOI 10.1016/j.cmpb.2016.08.007; Sanchez-Molina D, 2012, TRAFFIC INJ PREV, V13, P278, DOI 10.1080/15389588.2011.650803; Sanchez-Molina D., 2021, STRAIN RATE DEPENDEN; Sanchez-Molina D, 2020, BIOMED ENG-APP BAS C, V32, DOI 10.4015/S1016237220500404; SOKOLOWSKI S, 1961, Rocz Pomor Akad Med, V7, P301; Subramaniam DR, 2021, BIOMED ENG ONLINE, V20, DOI 10.1186/s12938-021-00847-x; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts EG, 2008, STAPP CAR C, V52, P1; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Yan WY, 2011, COMPUT METHOD BIOMEC, V14, P1049, DOI 10.1080/10255842.2010.506435; Yang JA, 2006, J BIOMECH, V39, P894, DOI 10.1016/j.jbiomech.2005.01.022; Zhao W, 2020, J BIOMECH, V104, DOI 10.1016/j.jbiomech.2020.109732; Zoghi-Moghadam M, 2009, COMPUT METHOD BIOMEC, V12, P1, DOI [10.1080/10255840802020420, 10.1080/10255840903064897]	56	2	2	2	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2079-7737		BIOLOGY-BASEL	Biology-Basel	SEP	2021	10	9							831	10.3390/biology10090831			18	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	UV9SK	WOS:000699809200001	34571709	gold, Green Published			2022-02-06	
J	Sheynin, S; Wolf, L; Ben-Zion, Z; Sheynin, J; Reznik, S; Keynan, JN; Admon, R; Shalev, A; Hendler, T; Liberzon, I				Sheynin, Shelly; Wolf, Lior; Ben-Zion, Ziv; Sheynin, Jony; Reznik, Shira; Keynan, Jackob Nimrod; Admon, Roee; Shalev, Arieh; Hendler, Talma; Liberzon, Israel			Deep learning model of fMRI connectivity predicts PTSD symptom trajectories in recent trauma survivors	NEUROIMAGE			English	Article						fMRI; Deep learning; Attention mechanism; End-to-end neural network; PTSD symptom clusters	POSTTRAUMATIC-STRESS-DISORDER; FUSIFORM FACE AREA; FUNCTIONAL CONNECTIVITY; RISK-FACTORS; NETWORK; CORTEX; INJURY; DEPRESSION; VETERANS; AMYGDALA	Early intervention following exposure to a traumatic life event could change the clinical path from the develop-ment of post traumatic stress disorder (PTSD) to recovery, hence the interest in early detection and underlying biological mechanisms involved in the development of post traumatic sequelae. We introduce a novel end-to-end neural network that employs resting-state and task-based functional MRI (fMRI) datasets, obtained one month af -ter trauma exposure, to predict PTSD symptoms at one-, six-and fourteen-months after the exposure. FMRI data, as well as PTSD status and symptoms, were collected from adults at risk for PTSD development, after admission to emergency room following a traumatic event. Our computational method utilized a per-region encoder to extract brain regions embedding, which were subsequently updated by applying the algorithmic technique of pairwise attention. The affinities obtained between each pair of regions were combined to create a pairwise co-activation map used to perform multi-label classification. The results demonstrate that the novel method's performance in predicting PTSD symptoms, in a prospective manner, outperforms previous analytical techniques reported in the fMRI literature, all trained on the same dataset. We further show a high predictive ability for predicting PTSD symptom clusters and PTSD persistence. To the best of our knowledge, this is the first deep learning method applied on fMRI data with respect to prospective clinical outcomes, to predict PTSD status, severity and symptom clusters. Future work could further delineate the mechanisms that underlie such a prediction, and potentially improve single patient characterization.	[Sheynin, Shelly; Wolf, Lior] Tel Aviv Univ, Sch Comp Sci, Tel Aviv, Israel; [Ben-Zion, Ziv; Reznik, Shira; Keynan, Jackob Nimrod; Hendler, Talma] Tel Aviv Sourasky Med Ctr, Sagol Brain Inst Tel Aviv, Wohl Inst Adv Imaging, Tel Aviv, Israel; [Ben-Zion, Ziv; Hendler, Talma] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Keynan, Jackob Nimrod] Stanford Univ, Dept Psychiat & Behav Sci, Sch Med, Stanford, CA 94305 USA; [Sheynin, Jony; Liberzon, Israel] Texas A&M Univ, Dept Psychiat & Behav Sci, Hlth Sci Ctr, College Stn, TX 77843 USA; [Admon, Roee] Univ Haifa, Sch Psychol Sci, Haifa, Israel; [Admon, Roee] Univ Haifa, Integrated Brain & Behav Res Ctr IBBRC, Haifa, Israel; [Shalev, Arieh] NYU, Dept Psychiat, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA; [Hendler, Talma] Tel Aviv Univ, Fac Social Sci, Sch Psychol Sci, Tel Aviv, Israel; [Hendler, Talma] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel		Wolf, L (corresponding author), Tel Aviv Univ, Sch Comp Sci, Tel Aviv, Israel.	liorwolf@gmail.com	Ben-Zion, Ziv/Y-9587-2019	Ben-Zion, Ziv/0000-0003-3629-5851; Shalev, Arieh/0000-0001-9425-050X; Admon, Roee/0000-0002-9886-5111	National Institute of Mental Health (NIMH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01-MH-103287]; ISF Israel Precision Medicine Partnership (IPMP) Program [2923/20]; European Research Council (ERC) under the European UnionEuropean Research Council (ERC) [ERC CoG 725974]; U.S. Department of DefenseUnited States Department of Defense [W81XWH-16-C-0198]; ISRAEL SCIENCE FOUNDATION within the Israel Precision Medicine Partnership program [2923/20]	The work was supported by award number R01-MH-103287 from the National Institute of Mental Health (NIMH) given to A. Y.S. (PI), I.L. and T.H. (co-Investigators, subcontractors), and had undergone critical review by the NIMH Adult Psychopathology and Disorders of Aging study section. Additional funding was provided by the ISF Israel Precision Medicine Partnership (IPMP) Program (grant 2923/20). This project has also received funding from the European Research Council (ERC) under the European Unions Horizon 2020 research and innovation programme (grant ERC CoG 725974). Lastly, this work was additionally supported by a grant from the U.S. Department of Defense, award number W81XWH-16-C-0198 and also by the ISRAEL SCIENCE FOUNDATION (grant No. 2923/20), within the Israel Precision Medicine Partnership program. We would like to thank the research team at Tel-Aviv Sourasky Medical Center -including Nili Green, Mor Halevi, Sheli Luvton, Yael Shavit, Olga Nevenchannaya, Iris Rashap, Efrat Routledge, and Ophir Leshets for their major contribution in carrying out this research, including subjects recruitment and screening, and performing clinical, cognitive, and neural assessments. We also want to thank Naomi Fine and Michal Achituv for setting up the clinical aspect of the research. Last but not least, we extend our gratitude to all the participants of this study, who completed all the assessments at three different time-points after experiencing a traumatic event.	Admon R, 2013, CEREB CORTEX, V23, P28, DOI 10.1093/cercor/bhr369; Assaf M, 2009, BRAIN IMAGING BEHAV, V3, P24, DOI 10.1007/s11682-008-9047-y; Ben-Zion Z, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-00898-z; Ben-Zion Z, 2019, EUR J PSYCHOTRAUMATO, V10, DOI 10.1080/20008198.2019.1683941; Ben-Zion Z, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00477; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bleich-Cohen M, 2014, SCHIZOPHR RES, V160, P196, DOI 10.1016/j.schres.2014.10.033; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Brewin Chris R, 2005, J Trauma Dissociation, V6, P123, DOI 10.1300/J229v06n02_11; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Brown VM, 2014, NEUROPSYCHOPHARMACOL, V39, P351, DOI 10.1038/npp.2013.197; Bryant RA, 2015, BRIT J PSYCHIAT, V206, P417, DOI 10.1192/bjp.bp.114.145516; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Campbell SB, 2020, PSYCHIAT RES, V285, DOI 10.1016/j.psychres.2020.112779; Dakka J., 2017, ARXIV171200512; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Dierks T, 1999, NEURON, V22, P615, DOI 10.1016/S0896-6273(00)80715-1; DiGangi JA, 2016, NEUROSCI LETT, V615, P37, DOI 10.1016/j.neulet.2016.01.010; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Etkin A, 2015, NAT REV NEUROSCI, V16, P693, DOI 10.1038/nrn4044; Galatzer-Levy IR, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.38; Galatzer-Levy IR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070084; Gonen T, 2012, J NEUROSCI, V32, P7218, DOI 10.1523/JNEUROSCI.6188-11.2012; Gong QY, 2014, NEUROPSYCHOPHARMACOL, V39, P681, DOI 10.1038/npp.2013.251; Gradus JL, 2017, J TRAUMA STRESS, V30, P362, DOI 10.1002/jts.22210; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Haller S, 2014, BRAIN TOPOGR, V27, P329, DOI 10.1007/s10548-014-0360-z; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Hendler T, 2003, NEUROIMAGE, V19, P587, DOI 10.1016/S1053-8119(03)00141-1; Hendler T., 2021, PSYCHOPATHOLOGY; Hepp U, 2008, BRIT J PSYCHIAT, V192, P376, DOI 10.1192/bjp.bp.106.030569; Heron-Delaney M, 2013, INJURY, V44, P1413, DOI 10.1016/j.injury.2013.07.011; Hyatt CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034917; Jin CF, 2017, HUM BRAIN MAPP, V38, P4479, DOI 10.1002/hbm.23676; K/tter, 2003, NEUROSCIENCE DATABAS, P237, DOI [10.1007/978-1-4615-1079-6_16, DOI 10.1007/978-1-4615-1079-6{\_}16]; Kahn I, 2002, NEURON, V33, P983, DOI 10.1016/S0896-6273(02)00626-8; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Karstoft KI, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0399-8; Kendrick D, 2018, J PSYCHOSOM RES, V112, P15, DOI 10.1016/j.jpsychores.2018.06.008; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; Khosla M, 2018, LECT NOTES COMPUT SC, V11045, P137, DOI 10.1007/978-3-030-00889-5_16; Kilpatrick DG, 2013, J TRAUMA STRESS, V26, P537, DOI 10.1002/jts.21848; King AP, 2016, DEPRESS ANXIETY, V33, P289, DOI 10.1002/da.22481; Koutsouleris N, 2016, KEY ISSUES MENT HEAL, V181, P95, DOI 10.1159/000440917; Li XX, 2019, LECT NOTES COMPUT SC, V11768, P485, DOI 10.1007/978-3-030-32254-0_54; Liu F, 2015, BRAIN TOPOGR, V28, P221, DOI 10.1007/s10548-014-0386-2; Liu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040968; Mao ZY, 2019, INFORM SCIENCES, V499, P1, DOI 10.1016/j.ins.2019.05.043; Markiewicz C.J., 2018, NAT METHODS, DOI 10.1101/306951; Mason S, 2002, EMERG MED J, V19, P400, DOI 10.1136/emj.19.5.400; McLafferty M, 2019, J ANXIETY DISORD, V65, P47, DOI 10.1016/j.janxdis.2019.05.001; Mikolas P, 2016, PSYCHOL MED, V46, P2695, DOI 10.1017/S0033291716000878; MIYASHITA Y, 1993, ANNU REV NEUROSCI, V16, P245, DOI 10.1146/annurev.ne.16.030193.001333; Mourao-Miranda J, 2012, PSYCHOL MED, V42, P1037, DOI 10.1017/S0033291711002005; Muller M, 2018, PSYCHIAT RES, V260, P262, DOI 10.1016/j.psychres.2017.11.068; Niepert M, 2016, PR MACH LEARN RES, V48; Omurca SI, 2015, 2015 INTERNATIONAL SYMPOSIUM ON INNOVATIONS IN INTELLIGENT SYSTEMS AND APPLICATIONS (INISTA) PROCEEDINGS, P231; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Pai A, 2017, BEHAV SCI-BASEL, V7, DOI 10.3390/bs7010007; Patel P, 2016, TENTH INDIAN CONFERENCE ON COMPUTER VISION, GRAPHICS AND IMAGE PROCESSING (ICVGIP 2016), DOI 10.1145/3009977.3010050; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Qi W, 2018, EUR J PSYCHOTRAUMATO, V9, DOI 10.1080/20008198.2018.1476442; Rabinak Christine A, 2011, Front Psychiatry, V2, P62, DOI 10.3389/fpsyt.2011.00062; Riaz A, 2018, I S BIOMED IMAGING, P1419, DOI 10.1109/ISBI.2018.8363838; Richmond TS, 2011, GEN HOSP PSYCHIAT, V33, P327, DOI 10.1016/j.genhosppsych.2011.05.003; Rive MM, 2016, BIPOLAR DISORD, V18, P612, DOI 10.1111/bdi.12446; Rosellini AJ, 2018, J PSYCHIATR RES, V96, P15, DOI 10.1016/j.jpsychires.2017.09.010; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Saxe GN, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1384-1; Scher CD, 2017, PSYCHOL TRAUMA-US, V9, P750, DOI 10.1037/tra0000258; Schlaefer A, 2019, INT C MEDICAL IMAGIN; Schultebraucks K, 2019, J TRAUMA STRESS, V32, P215, DOI 10.1002/jts.22384; Schwartz I, 2019, PROC CVPR IEEE, P2039, DOI 10.1109/CVPR.2019.00214; Shalev A, 2017, NEW ENGL J MED, V376, P2459, DOI 10.1056/NEJMra1612499; Shalev AY, 2019, WORLD PSYCHIATRY, V18, P77, DOI 10.1002/wps.20608; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Sripada Rebecca K, 2012, J Psychiatry Neurosci, V37, P241, DOI 10.1503/jpn.110069; Sripada RK, 2012, PSYCHOSOM MED, V74, P904, DOI 10.1097/PSY.0b013e318273bf33; Stein DJ, 2014, DEPRESS ANXIETY, V31, P494, DOI 10.1002/da.22279; Thaler A, 2019, BRAIN IMAGING BEHAV, V13, P1009, DOI 10.1007/s11682-018-9920-2; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; van der Ploeg T, 2016, J CLIN EPIDEMIOL, V78, P83, DOI 10.1016/j.jclinepi.2016.03.002; Vaswani A, 2017, ADV NEUR IN, V30; Wang ZX, 2021, EUR ARCH PSY CLIN N, V271, P1053, DOI 10.1007/s00406-020-01104-3; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486; Yuan H, 2018, NEUROIMAGE-CLIN, V19, P260, DOI 10.1016/j.nicl.2018.04.014; Zeevi Y, 2019, BIOL PSYCHIAT; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zou L, 2017, IEEE ACCESS, V5, P23626, DOI 10.1109/ACCESS.2017.2762703	91	2	2	5	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	SEP	2021	238								118242	10.1016/j.neuroimage.2021.118242			13	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	TS0WQ	WOS:000679378500010	34098066	Green Published, gold			2022-02-06	
J	Tierney, G; Weaving, D; Tooby, J; Al-Dawoud, M; Hendricks, S; Phillips, G; Stokes, KA; Till, K; Jones, B				Tierney, Gregory; Weaving, Daniel; Tooby, James; Al-Dawoud, Marwan; Hendricks, Sharief; Phillips, Gemma; Stokes, Keith A.; Till, Kevin; Jones, Ben			Quantifying head acceleration exposure via instrumented mouthguards (iMG): a validity and feasibility study protocol to inform iMG suitability for the TaCKLE project	BMJ OPEN SPORT & EXERCISE MEDICINE			English	Article						concussion; head; rugby; injury; American football	NATIONAL OPERATING COMMITTEE; RUGBY LEAGUE; HYBRID III; STANDARDS; IMPACTS; DEMANDS; SEASON	Instrumented mouthguards (iMGs) have the potential to quantify head acceleration exposures in sport. The Rugby Football League is looking to deploy iMGs to quantify head acceleration exposures as part of the Tackle and Contact Kinematics, Loads and Exposure (TaCKLE) project. iMGs and associated software platforms are novel, thus limited validation studies exist. The aim of this paper is to describe the methods that will determine the validity (ie, laboratory validation of kinematic measures and on-field validity) and feasibility (ie, player comfort and wearability and practitioner considerations) of available iMGs for quantifying head acceleration events in rugby league. Phase 1 will determine the reliability and validity of iMG kinematic measures (peak linear acceleration, peak rotational velocity, peak rotational acceleration), based on laboratory criterion standards. Players will have three-dimensional dental scans and be provided with available iMGs for phase 2 and phase 3. Phase 2 will determine the on-field validity of iMGs (ie, identifying true positive head acceleration events during a match). Phase 3 will evaluate player perceptions of fit (too loose, too tight, bulky, small/thin, held mouth open, held teeth apart, pain in jaw muscles, uneven bite), comfort (on lips, gum, tongue, teeth) and function (speech, swallowing, dry mouth). Phase 4 will evaluate the practical feasibility of iMGs, as determined by practitioners using the system usability scale (preparing iMG system and managing iMG data). The outcome will provide a systematic and robust assessment of a range of iMGs, which will help inform the suitability of each iMG system for the TaCKLE project.	[Tierney, Gregory] Ulster Univ, Sport & Exercise Sci Res Inst, Belfast, Antrim, North Ireland; [Tierney, Gregory; Weaving, Daniel; Tooby, James; Al-Dawoud, Marwan; Hendricks, Sharief; Phillips, Gemma; Till, Kevin; Jones, Ben] Leeds Beckett Univ, Carnegie Appl Rugby Res CARR Ctr, Leeds, W Yorkshire, England; [Weaving, Daniel; Al-Dawoud, Marwan; Till, Kevin; Jones, Ben] Leeds Rhinos Rugby League Club, Leeds, W Yorkshire, England; [Hendricks, Sharief; Jones, Ben] Univ Cape Town, Div Exercise Sci & Sports Med, Dept Human Biol, Rondebosch, South Africa; [Phillips, Gemma; Jones, Ben] Rugby Football League, England Performance Unit, Leeds, W Yorkshire, England; [Stokes, Keith A.] Univ Bath, Dept Hlth, Bath, Avon, England; [Stokes, Keith A.] Rugby Football Union, Twickenham, England; [Jones, Ben] Univ New England, Sch Sci & Technol, Armidale, NSW, Australia		Jones, B (corresponding author), Leeds Beckett Univ, Carnegie Appl Rugby Res CARR Ctr, Leeds, W Yorkshire, England.; Jones, B (corresponding author), Leeds Rhinos Rugby League Club, Leeds, W Yorkshire, England.; Jones, B (corresponding author), Univ Cape Town, Div Exercise Sci & Sports Med, Dept Human Biol, Rondebosch, South Africa.; Jones, B (corresponding author), Rugby Football League, England Performance Unit, Leeds, W Yorkshire, England.; Jones, B (corresponding author), Univ New England, Sch Sci & Technol, Armidale, NSW, Australia.	b.jones@leedsbeckett.ac.uk		Hendricks, Sharief/0000-0002-3416-6266; Jones, Ben/0000-0002-4274-6236; Tierney, Gregory/0000-0002-4666-4473	Rugby Football League; Super League Europe	The TaCKLE project will be funded by the Rugby Football League and Super League Europe. No specific funding was received for this study.	Bangor A, 2008, INT J HUM-COMPUT INT, V24, P574, DOI 10.1080/10447310802205776; Bartsch AJ, 2020, ANN BIOMED ENG, V48, P2667, DOI 10.1007/s10439-020-02640-8; Brooke J., 1996, USABILITY EVALUATION; Carey L, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0182-3; Cobb BR, 2016, P I MECH ENG P-J SPO, V230, P50, DOI 10.1177/1754337115599133; Cobb BR, 2015, P I MECH ENG P-J SPO, V229, P39, DOI 10.1177/1754337114548245; Hendricks S, 2020, BRIT J SPORT MED, V54, P566, DOI 10.1136/bjsports-2019-101293; Johnston RD, 2019, J SPORT SCI, V37, P2144, DOI 10.1080/02640414.2019.1622882; Kieffer EE., 2020, IRCOBI C, V13, P846; Kieffer EE, 2020, ANN BIOMED ENG, V48, P2613, DOI 10.1007/s10439-020-02647-1; King D, 2016, SPORTS MED, V46, P151, DOI 10.1007/s40279-015-0423-7; King D, 2017, J NEUROSURG-PEDIATR, V19, P13, DOI 10.3171/2016.7.PEDS1684; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; King DA, 2018, J SCI MED SPORT, V21, P139, DOI 10.1016/j.jsams.2017.10.026; Kuo C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199238; Liu YZ, 2020, ANN BIOMED ENG, V48, P2580, DOI 10.1007/s10439-020-02629-3; McClelland C, 1999, BRIT J SPORT MED, V33, P186, DOI 10.1136/bjsm.33.3.186; Miller LE, 2020, BIOMECH MODEL MECHAN, V19, P1003, DOI 10.1007/s10237-019-01267-6; Naughton M, 2020, SPORTS MED-OPEN, V6, DOI 10.1186/s40798-019-0233-9; Patton DA, 2020, ANN BIOMED ENG, V48, P2497, DOI 10.1007/s10439-020-02642-6; Sauro J, 2012, QUANTIFYING THE USER EXPERIENCE: PRACTICAL STATISTICS FOR USER RESEARCH, P1; Tierney GJ, 2020, J BIOMECH, V110, DOI 10.1016/j.jbiomech.2020.109969; Weaving D, 2019, J SPORT SCI, V37, P322, DOI 10.1080/02640414.2018.1500425; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3	24	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2398-9459	2055-7647		BMJ OPEN SPORT EXERC	BMJ Open Sport Exerc. Med.	SEP	2021	7	3							e001125	10.1136/bmjsem-2021-001125			6	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	UT0WT	WOS:000697846500002	34603742	Green Published, gold			2022-02-06	
J	Churchill, NW; Hutchison, MG; Graham, SJ; Schweizer, TA				Churchill, Nathan W.; Hutchison, Michael G.; Graham, Simon J.; Schweizer, Tom A.			Concussion Risk and Resilience: Relationships with Pre-Injury Salience Network Connectivity	JOURNAL OF NEUROTRAUMA			English	Article						concussion; DTI; fMRI; prospective; risk	DEFAULT-MODE; FUNCTIONAL CONNECTIVITY; COGNITIVE IMPAIRMENT; RECURRENT CONCUSSION; SEX-DIFFERENCES; WHITE-MATTER; INTEROCEPTION; SEVERITY; SPORTS; INSULA	Concussion is a major health concern, making it critical to identify factors that influence risk and resilience. The salience network (SN) likely plays a key role in concussion risk, given its roles in orienting attention, functional adaptability, and interoceptive awareness. The SN's functions are thought to be mediated through causal control of other networks, including the default mode network (DMN) and executive control network (ECN). It was therefore hypothesized that the SN of at-risk individuals would have altered functional and structural connectivity with the DMN and ECN. For this prospective study, 167 university athletes had baseline clinical assessments and magnetic resonance imaging scans and were monitored for the rest of their varsity career, with any concussions recorded. Athletes concussed in the same season as imaging (CSS; n = 17) and those concussed in later seasons (CLS; n = 15) were matched to controls that were not concussed after imaging. Functional connectivity and white matter fractional anisotropy (FA) were compared between concussed and control groups. Prior to injury, CSS athletes had significantly elevated total symptom severity scores, elevated SN-DMN functional connectivity and reduced FA of connecting white matter tracts, whereas CLS athletes showed no significant clinical or imaging effects. These findings provide new insights into the neurobiology of concussion risk and resilience, as indices of SN-DMN network connectivity are associated with short-term but not long-term concussion risk.	[Churchill, Nathan W.; Hutchison, Michael G.; Schweizer, Tom A.] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Churchill, Nathan W.; Schweizer, Tom A.] St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada; [Hutchison, Michael G.] Univ Toronto, Dept Kinesiol & Phys Educ, Toronto, ON, Canada; [Graham, Simon J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Graham, Simon J.] Univ Toronto, Dept Neurosurg, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Inst Biomat & Biomed Engn IBBME, Toronto, ON, Canada; [Schweizer, Tom A.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Phys Sci Platform, Toronto, ON, Canada		Churchill, NW (corresponding author), St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.; Churchill, NW (corresponding author), St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada.; Churchill, NW (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Neurosci Res Program, Keenan Res Ctr, 209 Victoria St, Toronto, ON M5B 1M8, Canada.	nchurchill.research@gmail.com			Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [RN294001367456, RN294001-367456]; Canadian Institutes of Military and Veterans Health (CIMVHR) [W7714-145967]; Siemens Canada Ltd.	This work was supported by the Canadian Institutes of Health Research (CIHR) [grant numbers RN294001367456, RN294001-367456]; the Canadian Institutes of Military and Veterans Health (CIMVHR) [grant number W7714-145967]; and funding from Siemens Canada Ltd.	Ainley V, 2013, CONSCIOUS COGN, V22, P1231, DOI 10.1016/j.concog.2013.08.004; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Birn RM, 2013, NEUROIMAGE, V83, P550, DOI 10.1016/j.neuroimage.2013.05.099; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Caccese JB, 2020, RES SPORTS MED, V28, P594, DOI 10.1080/15438627.2019.1641500; Caseras X, 2013, HUM BRAIN MAPP, V34, P1220, DOI 10.1002/hbm.21503; Chand GB, 2017, BRAIN CONNECT, V7, P401, DOI 10.1089/brain.2017.0509; Churchill N, 2017, BRAIN INJURY, V31, P39, DOI 10.1080/02699052.2016.1221135; Churchill NW, 2019, NEUROLOGY, V93, pE1980, DOI 10.1212/WNL.0000000000008523; Churchill NW, 2018, NEUROIMAGE-CLIN, V18, P518, DOI 10.1016/j.nicl.2018.02.011; Churchill NW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00390; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Churchill NW, 2016, NEURAL COMPUT, V28, P2250, DOI 10.1162/NECO_a_00877; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Fling BW, 2012, NEUROBIOL AGING, V33, P2521, DOI 10.1016/j.neurobiolaging.2011.11.018; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goulden N, 2014, NEUROIMAGE, V99, P180, DOI 10.1016/j.neuroimage.2014.05.052; Graham NSN, 2019, J NEUROL NEUROSUR PS, V90, P1221, DOI 10.1136/jnnp-2017-317557; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hawellek DJ, 2011, P NATL ACAD SCI USA, V108, P19066, DOI 10.1073/pnas.1110024108; Hillary FG, 2017, TRENDS COGN SCI, V21, P385, DOI 10.1016/j.tics.2017.03.003; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; JohansenBerg H, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P1; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS115, DOI 10.1016/j.acn.2006.10.006; Langan J, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00017; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laule C, 2004, J NEUROL, V251, P284, DOI 10.1007/s00415-004-0306-6; Laumann TO, 2021, CURR OPIN BEHAV SCI, V40, P130, DOI 10.1016/j.cobeha.2021.04.002; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lin QX, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.56; Matthias E, 2009, INT J PSYCHOPHYSIOL, V72, P154, DOI 10.1016/j.ijpsycho.2008.12.001; Meehan WP, 2016, J NEUROTRAUM, V33, P254, DOI 10.1089/neu.2015.3930; Menon Vinod, 2010, Brain Struct Funct, V214, P655, DOI 10.1007/s00429-010-0262-0; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Milton J, 2007, NEUROIMAGE, V35, P804, DOI 10.1016/j.neuroimage.2007.01.003; Mullenix, 2018, APPL NEUROPSYCH-ADUL, P1; Namkung H, 2017, TRENDS NEUROSCI, V40, P200, DOI 10.1016/j.tins.2017.02.002; Noble S, 2019, NEUROIMAGE, V203, DOI 10.1016/j.neuroimage.2019.116157; Roosendaal SD, 2010, BRAIN, V133, P1612, DOI 10.1093/brain/awq058; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Simmonds DJ, 2014, NEUROIMAGE, V92, P356, DOI 10.1016/j.neuroimage.2013.12.044; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Uddin LQ, 2015, NAT REV NEUROSCI, V16, P55, DOI 10.1038/nrn3857; Valovich McLeod, 2017, DEV NEUROPSYCHOL, P1, DOI DOI 10.1007/978-3-319-45438-2; Wright MJ, 2011, NEUROSCI LETT, V500, P216, DOI 10.1016/j.neulet.2011.06.045; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	52	2	2	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2021	38	22					3097	3106		10.1089/neu.2021.0123		AUG 2021	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	WY7FJ	WOS:000691353000001	34314246				2022-02-06	
J	Tas, J; Beqiri, E; van Kaam, RC; Czosnyka, M; Donnelly, J; Haeren, RH; van der Horst, ICC; Hutchinson, PJ; van Kuijk, SMJ; Liberti, AL; Menon, DK; Hoedemaekers, CWE; Depreitere, B; Smielewski, P; Meyfroidt, G; Ercole, A; Aries, MJH				Tas, Jeanette; Beqiri, Erta; van Kaam, Ruud C.; Czosnyka, Marek; Donnelly, Joseph; Haeren, Roel H.; van der Horst, Iwan C. C.; Hutchinson, Peter J.; van Kuijk, Sander M. J.; Liberti, Analisa L.; Menon, David K.; Hoedemaekers, Cornelia W. E.; Depreitere, Bart; Smielewski, Peter; Meyfroidt, Geert; Ercole, Ari; Aries, Marcel J. H.			Targeting Autoregulation-Guided Cerebral Perfusion Pressure after Traumatic Brain Injury (COGiTATE): A Feasibility Randomized Controlled Clinical Trial	JOURNAL OF NEUROTRAUMA			English	Article						cerebral autoregulation; cerebral perfusion; intensive care; optimal cerebral perfusion pressure; precision medicine; traumatic brain injury	MANAGEMENT; CARE; HYPERTENSION; REACTIVITY; ADULT	Managing traumatic brain injury (TBI) patients with a cerebral perfusion pressure (CPP) near to the cerebral autoregulation (CA)-guided "optimal" CPP (CPPopt) value is associated with improved outcome and might be useful to individualize care, but has never been prospectively evaluated. This study evaluated the feasibility and safety of CA-guided CPP management in TBI patients requiring intracranial pressure monitoring and therapy (TBIicp patients). The CPPopt Guided Therapy: Assessment of Target Effectiveness (COGiTATE) parallel two-arm feasibility trial took place in four tertiary centers. TBIicp patients were randomized to either the Brain Trauma Foundation (BTF) guideline CPP target range (control group) or to the individualized CA-guided CPP targets (intervention group). CPP targets were guided by six times daily software-based alerts for up to 5 days. The primary feasibility end-point was the percentage of time with CPP concordant (+/- 5 mm Hg) with the set CPP targets. The main secondary safety end-point was an increase in therapeutic intensity level (TIL) between the control and intervention group. Twenty-eight patients were randomized to the control and 32 patients to the intervention group. CPP in the intervention group was in the target range for 46.5% (interquartile range, 41.2-58) of the monitored time, significantly higher than the feasibility target specified in the published protocol (36%; p < 0.001). There were no significant differences between groups for TIL or for other safety end-points. Conclusively, targeting an individual and dynamic CA-guided CPP is feasible and safe in TBIicp patients. This encourages a prospective trial powered for clinical outcomes.	[Tas, Jeanette; van der Horst, Iwan C. C.; Liberti, Analisa L.; Ercole, Ari; Aries, Marcel J. H.] Maastricht Univ, Univ Maastricht KEMTA, Med Ctr, Dept Intens Care Med, Maastricht, Netherlands; [Tas, Jeanette; Haeren, Roel H.; Depreitere, Bart; Aries, Marcel J. H.] Maastricht Univ, Univ Maastricht KEMTA, Med Ctr, Sch Mental Hlth & Neurosci MHeNS, Maastricht, Netherlands; [Haeren, Roel H.] Maastricht Univ, Univ Maastricht KEMTA, Med Ctr, Dept Neurosurg, Maastricht, Netherlands; [van der Horst, Iwan C. C.] Maastricht Univ, Univ Maastricht KEMTA, Cardiovasc Res Inst Maastricht CARIM, Med Ctr, Maastricht, Netherlands; [van Kuijk, Sander M. J.] Maastricht Univ, Univ Maastricht KEMTA, Deptt Clin Epidemiol & Med Technol Assessme, Med Ctr, Maastricht, Netherlands; [Beqiri, Erta; Czosnyka, Marek; Donnelly, Joseph; Smielewski, Peter; Meyfroidt, Geert] Univ Cambridge, Brain Phys Lab, Div Neurosurg, Dept Clin Neurosci, Cambridge, England; [Hutchinson, Peter J.] Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Cambridge, England; [Menon, David K.; Ercole, Ari] Univ Cambridge, Div Anaesthesia, Cambridge, England; [van Kaam, Ruud C.] Radboud Univ Nijmegen, Med Ctr, Dept Intens Care Med, Nijmegen, Netherlands; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland; [Liberti, Analisa L.] San Carlo Borromeo Hosp, Dept Anaesthesia & Intens Care, Milan, Italy; [Depreitere, Bart] Univ Hosp Leuven, Neurosurg, Leuven, Belgium; [Meyfroidt, Geert] Katholieke Univ Leuven, Dept & Lab Intens Care Med, Leuven, Belgium		Tas, J (corresponding author), Maastricht Univ, Med Ctr, Dept Intens Care, POB 616, NL-6200 MD Maastricht, Netherlands.	tasjeanette@gmail.com	Ercole, Ari/B-6288-2009	Ercole, Ari/0000-0001-8350-8093	NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR) [BRC-1215-20014]; European Society of Intensive Care (ESICM); University Maastricht, Maastricht, The NetherlandsNetherlands Government; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR N013433-1]; Gates Cambridge Scholarship; National Institute for Health Research (NIHR), Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); NIHR Senior Investigator Award; European Union Foundation Program 7 Grant (CENTER-TBI) [602150]; National Institute for Health Research (NIHR): research professorship, Biomedical Research Centre and Global Neurotrauma Research groupNational Institute for Health Research (NIHR); Royal College of Surgeons of England; Research Foundation, Flanders (FWO)FWO [1843118N]; KU LeuvenKU Leuven [C24/17/072]; Belgian Health Care Knowledge Center [COV201003]	This research was supported by the NIHR Cambridge Biomedical Research Centre (BRC-1215-20014). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. The COGiTATE study was funded with a grant from the European Society of Intensive Care (ESICM). Jeanette Tas is supported by ``HersenStrijd fonds'' (translated as ``Brain Battle foundation''), a non-profit foundation of the University Maastricht, Maastricht, The Netherlands. Erta Beqiri is supported by the Medical Research Council (grant no.: MR N013433-1) and by the Gates Cambridge Scholarship. Marek Czosnyka is supported by National Institute for Health Research (NIHR), Cambridge Biomedical Research Centre. David K. Menon is supported by the National Institute for Health Research (NIHR), Cambridge Biomedical Research Centre, an NIHR Senior Investigator Award, and by a European Union Foundation Program 7 Grant (CENTER-TBI; award no.: 602150). Peter J. Hutchinson is supported by the National Institute for Health Research (NIHR): research professorship, Biomedical Research Centre and Global Neurotrauma Research group and the Royal College of Surgeons of England. Geert Meyfroidt is supported by the Research Foundation, Flanders (FWO) as a senior clinical researcher (1843118N) and receives project funding from the KU Leuven (C24/17/072) and the Belgian Health Care Knowledge Center (COV201003).	Akerlund CA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243427; Aries MJH, 2018, CRIT CARE MED, V46, pE350, DOI 10.1097/CCM.0000000000002923; Aries MJH, 2016, CRIT CARE MED, V44, pE996, DOI 10.1097/CCM.0000000000001816; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Beqiri E, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030727; Cabeleira M, 2018, ACTA NEUROCHIR SUPPL, V126, P121, DOI 10.1007/978-3-319-65798-1_26; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Claassen JAHR, 2021, PHYSIOL REV, V101, P1487, DOI 10.1152/physrev.00022.2020; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2020, CURR OPIN CRIT CARE, V26, P109, DOI 10.1097/MCC.0000000000000704; Depreitere B, 2021, NEUROCRIT CARE, V34, P731, DOI 10.1007/s12028-020-01185-x; Donnelly J, 2017, CRIT CARE MED, V45, P1464, DOI 10.1097/CCM.0000000000002575; Donnelly J, 2015, EXPERT REV NEUROTHER, V15, P169, DOI 10.1586/14737175.2015.996552; Guiza F, 2017, J NEUROTRAUM, V34, P2425, DOI 10.1089/neu.2016.4807; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; HARPER AM, 1966, J NEUROL NEUROSUR PS, V29, P398, DOI 10.1136/jnnp.29.5.398; Hawryluk GWJ, 2019, INTENS CARE MED, V45, DOI 10.1007/s00134-019-05805-9; Huijben JA, 2021, CRIT CARE, V25, DOI 10.1186/s13054-020-03370-y; Jakkula P, 2018, INTENS CARE MED, V44, P2091, DOI 10.1007/s00134-018-5446-8; Klein SP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50046-x; Kompanje EJO, 2020, LANCET NEUROL, V19, P1033, DOI 10.1016/S1474-4422(20)30276-3; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Meng LZ, 2015, ANESTHESIOLOGY, V122, P196, DOI 10.1097/ALN.0000000000000506; R Development Core Team, 2012, R LANG ENV STAT COMP; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Tzeng YC, 2010, HYPERTENSION, V56, P268, DOI 10.1161/HYPERTENSIONAHA.110.152066; Weersink CSA, 2015, CRIT CARE MED, V43, P1952, DOI 10.1097/CCM.0000000000001165; Wettervik TS, 2020, NEUROSURGERY, V86, pE300, DOI 10.1093/neuros/nyz515; Zuercher P, 2016, J NEUROTRAUM, V33, P1768, DOI 10.1089/neu.2015.4266	31	2	2	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2021	38	20					2790	2800		10.1089/neu.2021.0197		AUG 2021	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WL5LP	WOS:000685856800001	34407385	Green Accepted, hybrid			2022-02-06	
J	Alosco, ML; Mariani, ML; Adler, CH; Balcer, LJ; Bernick, C; Au, RD; Banks, SJ; Barr, WB; Bouix, S; Cantu, RC; Coleman, MJ; Dodick, DW; Farrer, LA; Geda, YE; Katz, DI; Koerte, IK; Kowall, NW; Lin, ADP; Marcus, DS; Marek, KL; McClean, MD; McKee, AC; Mez, J; Palmisano, JN; Peskind, ER; Tripodis, Y; Turner, RW; Wethe, JV; Cummings, JL; Reiman, EM; Shenton, ME; Stern, RA				Alosco, Michael L.; Mariani, Megan L.; Adler, Charles H.; Balcer, Laura J.; Bernick, Charles; Au, Rhoda; Banks, Sarah J.; Barr, William B.; Bouix, Sylvain; Cantu, Robert C.; Coleman, Michael J.; Dodick, David W.; Farrer, Lindsay A.; Geda, Yonas E.; Katz, Douglas I.; Koerte, Inga K.; Kowall, Neil W.; Lin, Alexander P.; Marcus, Daniel S.; Marek, Kenneth L.; McClean, Michael D.; McKee, Ann C.; Mez, Jesse; Palmisano, Joseph N.; Peskind, Elaine R.; Tripodis, Yorghos; Turner, Robert W., II; Wethe, Jennifer V.; Cummings, Jeffrey L.; Reiman, Eric M.; Shenton, Martha E.; Stern, Robert A.		DIAGNOSE CTE Res	Developing methods to detect and diagnose chronic traumatic encephalopathy during life: rationale, design, and methodology for the DIAGNOSE CTE Research Project	ALZHEIMERS RESEARCH & THERAPY			English	Article						Neurodegenerative disease; Biomarkers; Chronic traumatic encephalopathy; Cognitive function; Concussion; Football; Head trauma; MRI; MRS; National Football League; College football; Neuroimaging; Repetitive head impacts; Traumatic brain injury; Subconcussion; Traumatic encephalopathy syndrome; Positron emission tomography; Tau; Remote assessment	FOOTBALL LEAGUE PLAYERS; ALZHEIMERS ASSOCIATION WORKGROUPS; REPETITIVE HEAD IMPACTS; 1ST EXPOSURE; COGNITIVE IMPAIRMENT; NATIONAL INSTITUTE; RATING-SCALE; OLDER-ADULTS; NFL PLAYERS; MDS-UPDRS	Background: Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease that has been neuropathologically diagnosed in brain donors exposed to repetitive head impacts, including boxers and American football, soccer, ice hockey, and rugby players. CTE cannot yet be diagnosed during life. In December 2015, the National Institute of Neurological Disorders and Stroke awarded a seven-year grant (U01NS093334) to fund the "Diagnostics, Imaging, and Genetics Network for the Objective Study and Evaluation of Chronic Traumatic Encephalopathy (DIAGNOSE CTE) Research Project." The objectives of this multicenter project are to: develop in vivo fluid and neuroimaging biomarkers for CTE; characterize its clinical presentation; refine and validate clinical research diagnostic criteria (i.e., traumatic encephalopathy syndrome [TES]); examine repetitive head impact exposure, genetic, and other risk factors; and provide shared resources of anonymized data and biological samples to the research community. In this paper, we provide a detailed overview of the rationale, design, and methods for the DIAGNOSE CTE Research Project. Methods: The targeted sample and sample size was 240 male participants, ages 45-74, including 120 former professional football players, 60 former collegiate football players, and 60 asymptomatic participants without a history of head trauma or participation in organized contact sports. Participants were evaluated at one of four U.S. sites and underwent the following baseline procedures: neurological and neuropsychological examinations; tau and amyloid positron emission tomography; magnetic resonance imaging and spectroscopy; lumbar puncture; blood and saliva collection; and standardized self-report measures of neuropsychiatric, cognitive, and daily functioning. Study partners completed similar informant-report measures. Follow-up evaluations were intended to be in-person and at 3 years post-baseline. Multidisciplinary diagnostic consensus conferences are held, and the reliability and validity of TES diagnostic criteria are examined. Results: Participant enrollment and all baseline evaluations were completed in February 2020. Three-year follow-up evaluations began in October 2019. However, in-person evaluation ceased with the COVID-19 pandemic, and resumed as remote, 4-year follow-up evaluations (including telephone-, online-, and videoconference-based cognitive, neuropsychiatric, and neurologic examinations, as well as in-home blood draw) in February 2021. Conclusions: Findings from the DIAGNOSE CTE Research Project should facilitate detection and diagnosis of CTE during life, and thereby accelerate research on risk factors, mechanisms, epidemiology, treatment, and prevention of CTE.	[Alosco, Michael L.; McKee, Ann C.; Stern, Robert A.] Boston Univ, Sch Med, Dept Neurol, Alzheimers Dis Res Ctr,CTE Ctr, Boston, MA 02118 USA; [Mariani, Megan L.] Boston Univ, Sch Med, CTE Ctr, Boston, MA 02118 USA; [Adler, Charles H.; Dodick, David W.] Mayo Clin Arizona, Dept Neurol, Mayo Clin, Coll Med, Scottsdale, AZ USA; [Balcer, Laura J.; Barr, William B.] NYU, Dept Neurol, Grossman Sch Med, New York, NY 10016 USA; [Balcer, Laura J.] NYU, Dept Populat Hlth & Ophthalmol, Grossman Sch Med, New York, NY USA; [Bernick, Charles] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Las Vegas, NV USA; [Au, Rhoda] Boston Univ, Alzheimers Dis Res Ctr, CTE Ctr, Framingham Heart Study, Boston, MA 02215 USA; [Au, Rhoda] Slone Epidemiol Ctr, Boston, MA USA; [Banks, Sarah J.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Banks, Sarah J.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Bouix, Sylvain; Koerte, Inga K.; Shenton, Martha E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Psychiat Neuroimaging Lab, Boston, MA 02115 USA; [Cantu, Robert C.; Kowall, Neil W.] Boston Univ, Sch Med, Dept Neurol, Alzheimers Dis Res Ctr, Boston, MA 02118 USA; [Cantu, Robert C.; Kowall, Neil W.] Boston Univ, Sch Med, Dept Neurosurg, Alzheimers Dis Res Ctr, Boston, MA 02118 USA; [Coleman, Michael J.] Brigham & Womens Hosp, Psychiat Neuroimaging Lab, 75 Francis St, Boston, MA 02115 USA; [Farrer, Lindsay A.] BU Sch Med & Publ Hlth, Dept Med Biomed Genet, Boston, MA USA; [Farrer, Lindsay A.] BU Sch Med & Publ Hlth, Dept Neurol, Boston, MA USA; [Farrer, Lindsay A.] BU Sch Med & Publ Hlth, Dept Ophthalmol, Boston, MA USA; [Farrer, Lindsay A.] BU Sch Med & Publ Hlth, Dept Epidemiol, Boston, MA USA; [Farrer, Lindsay A.] BU Sch Med & Publ Hlth, Dept Biostat, Boston, MA USA; [Geda, Yonas E.] Barrow Neurol Inst, Dept Neurol, Alzheimers Dis & Memory Disorders Program, Phoenix, AZ 85013 USA; [Au, Rhoda; Katz, Douglas I.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Lin, Alexander P.] Harvard Med Sch, Brigham & Womens Hosp, Psychiat Neuroimaging Lab, Ctr Clin Spect,Dept Radiol,Dept Psychiat, Boston, MA 02115 USA; [Marcus, Daniel S.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Marek, Kenneth L.] Invicro LLC, Inst Neurodegenerat Disorders, New Haven, CT USA; [McClean, Michael D.] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Mez, Jesse] Boston Univ, Sch Med, Framingham Heart Study, Alzheimers Dis Res Ctr,CTE Ctr,Dept Neurol, Boston, MA 02118 USA; [Palmisano, Joseph N.] Boston Univ, Sch Publ Hlth, Biostat & Epidemiol Data Analyt Ctr BEDAC, Boston, MA USA; [Peskind, Elaine R.] Univ Washington, Dept Psychiat & Behav Sci, VA Northwest Mental Illness Res Educ & Clin Ctr, Sch Med,VA Puget Sound Hlth Care Syst, Seattle, WA 98195 USA; [Tripodis, Yorghos] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Turner, Robert W., II] George Washington Univ, Sch Med & Hlth Sci, Dept Clin Res & Leadership, Washington, DC 20052 USA; [Wethe, Jennifer V.] Mayo Clin Arizona, Mayo Clin, Sch Med, Dept Psychiat & Psychol, Scottsdale, AZ USA; [Cummings, Jeffrey L.] Univ Nevada, Dept Brain Hlth, Sch Integrated Hlth Sci, Chambers Grundy Ctr Transformat Neurosci, Las Vegas, NV 89154 USA; [Reiman, Eric M.] Arizona State Univ, Univ Arizona, Translat Genom Res Inst, Banner Alzheimers Inst, Phoenix, AZ USA; [Reiman, Eric M.] Arizona Alzheimers Consortium, Phoenix, AZ USA; [Shenton, Martha E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Psychiat Neuroimaging Lab, Boston, MA 02115 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Neurosurg, Alzheimers Dis Res Ctr,CTE Ctr, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Alzheimers Dis Res Ctr,CTE Ctr, Boston, MA 02118 USA; [Bernick, Charles] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Au, Rhoda] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Au, Rhoda] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Katz, Douglas I.] Encompass Hlth Braintree Rehabil Hosp, Braintree, MA USA; [Koerte, Inga K.] Ludwigs Maximilians Univ, Dept Child & Adolescent Psychiat, Psychosomat & Psychotherapy, cBRAIN, Munich, Germany; [Kowall, Neil W.; McKee, Ann C.] VA Boston Healthcare Syst, Boston, MA USA		Stern, RA (corresponding author), Boston Univ, Sch Med, Dept Neurol, Alzheimers Dis Res Ctr,CTE Ctr, Boston, MA 02118 USA.; Stern, RA (corresponding author), Boston Univ, Sch Med, Dept Neurosurg, Alzheimers Dis Res Ctr,CTE Ctr, Boston, MA 02118 USA.; Stern, RA (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, Alzheimers Dis Res Ctr,CTE Ctr, Boston, MA 02118 USA.	bobstern@bu.edu	Adler, Charles/ABD-5276-2021		National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01NS093334, P30AG13846, R01NS078337, K23NS102399, P30AG019610, K01AG054762, R01NS100952, K00NS113419]; National Center for Advancing Translational Sciences, National Institutes of Health, through BU-CTSI Grant [1UL1TR001430]; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS093334]	This work was supported by grants from the National Institutes of Health (U01NS093334; P30AG13846; R01NS078337; K23NS102399; P30AG019610; K01AG054762; R01NS100952; K00NS113419). This publication was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through BU-CTSI Grant Number 1UL1TR001430. The primary funding source is the National Institute of Neurological Disorders and Stroke (NINDS), through a U01 Research Project Cooperative Agreement (U01NS093334).	Adams JW, 2018, J NEUROPATH EXP NEUR, V77, P757, DOI 10.1093/jnen/nly065; Adler CM, 2018, CLIN J SPORT MED, V28, P100, DOI 10.1097/JSM.0000000000000391; Ali R, 2002, ADDICTION, V97, P1183; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco ML, 2021, NEUROTHERAPEUTICS, V18, P772, DOI 10.1007/s13311-021-01028-3; Alosco ML, 2020, ACTA NEUROPATHOL, V140, P495, DOI 10.1007/s00401-020-02197-9; Alosco ML, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00440; Alosco ML, 2019, JAMA NEUROL, V76, P1298, DOI 10.1001/jamaneurol.2019.2244; Alosco ML, 2020, BRAIN IMAGING BEHAV, V14, P1419, DOI 10.1007/s11682-019-00060-4; Alosco ML, 2018, ALZHEIMERS DEMENT, V14, P1159, DOI 10.1016/j.jalz.2018.05.004; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Alosco Michael L, 2018, Alzheimers Dement (Amst), V10, P56, DOI 10.1016/j.dadm.2017.10.003; Alosco ML, 2017, BRAIN INJURY, V31, P1116, DOI 10.1080/02699052.2017.1294709; Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; Alosco ML, 2017, J NEUROPSYCH CLIN N, V29, P6, DOI 10.1176/appi.neuropsych.16030043; Amariglio RE, 2020, J ALZHEIMERS DIS, V75, P1437, DOI 10.3233/JAD-191291; Amen DG, 2016, J ALZHEIMERS DIS, V53, P237, DOI 10.3233/JAD-160207; American Psychiatric Association D-TF, 2013, DIAGNOSTIC STAT MANU, V5th; Andronesi OC, 2012, RADIOLOGY, V262, P647, DOI 10.1148/radiol.11110277; Avila JF, 2021, ALZHEIMERS DEMENT, V17, P70, DOI 10.1002/alz.12176; Babor T., 1989, ALCOHOL USE DISORDER; Backx R, 2020, J MED INTERNET RES, V22, DOI 10.2196/16792; BARRATT ES, 1965, PSYCHOL REP, V16, P547, DOI 10.2466/pr0.1965.16.2.547; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beck A., 1977, MANUAL BDI 2; Beck A.T., 1988, MANUAL BECK HOPELESS; Beck AT, 1993, BECK ANXIETY INVENTO; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benton A., 1994, CONTRIBUTIONS NEUROP; Bieniek KF, 2021, J NEUROPATH EXP NEUR, V80, P210, DOI 10.1093/jnen/nlab001; Bieniek KF, 2020, BRAIN PATHOL, V30, P63, DOI 10.1111/bpa.12757; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Boeve BF, 2011, SLEEP MED, V12, P445, DOI 10.1016/j.sleep.2010.12.009; Bowman KM., 1940, PSYCHOTIC STATES FOL; BROWN GL, 1979, PSYCHIAT RES, V1, P131, DOI 10.1016/0165-1781(79)90053-2; Buckland ME, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0751-1; BUSS AH, 1957, J CONSULT PSYCHOL, V21, P343, DOI 10.1037/h0046900; Cambridge-Cognition, CANTAB WEB BAS TEST; Carlew AR, 2020, ARCH CLIN NEUROPSYCH, V35, P1215, DOI 10.1093/arclin/acaa096; Caunca MR, 2020, JAMA NEUROL, V77, P1000, DOI 10.1001/jamaneurol.2020.0860; Cherry JD, 2020, BRAIN PATHOL, V30, P913, DOI 10.1111/bpa.12867; Cherry JD, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0619-9; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Clark CM, 2012, LANCET NEUROL, V11, P669, DOI 10.1016/S1474-4422(12)70142-4; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Coric Vladimir, 2009, Psychiatry (Edgmont), V6, P26; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Critchley M., 1949, NEUROCHIRURGIE HOMMA; Dickstein DL, 2021, MOL PSYCHIATR, V26, P5940, DOI 10.1038/s41380-020-0674-z; Doty R.L., 2001, BRIEF SMELL IDENTIFI; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Esopenko C, 2017, J NEUROL NEUROSUR PS, V88, P512, DOI 10.1136/jnnp-2016-315260; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Falcon B, 2018, NATURE, V561, P137, DOI 10.1038/s41586-018-0454-y; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fleisher AS, 2020, JAMA NEUROL, V77, P829, DOI 10.1001/jamaneurol.2020.0528; Galvin James E, 2015, Alzheimers Dement (Amst), V1, P249; Gardner Raquel C, 2015, Neurol Clin Pract, V5, P285; Gardner RC, 2016, J NEUROTRAUM, V33, P157, DOI 10.1089/neu.2014.3805; Gavett BE, 2010, J INT NEUROPSYCH SOC, V16, P651, DOI 10.1017/S1355617710000421; Ghisays V, 2020, ALZHEIMERS DEMENT, V16, P598, DOI 10.1016/j.jalz.2019.08.195; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Goetzl EJ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00452; Golden CJ., 2002, STROOP COLOR WORD TE; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Hampshire A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02972; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Ioannidis JPA, 2021, JAMA-J AM MED ASSOC, V325, P623, DOI 10.1001/jama.2021.0003; Ismail Z, 2017, J ALZHEIMERS DIS, V56, P929, DOI 10.3233/JAD-160979; Jack CR, 2016, NEUROLOGY, V87, P539, DOI 10.1212/WNL.0000000000002923; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Jeste DV, 2007, ARCH GEN PSYCHIAT, V64, P966, DOI 10.1001/archpsyc.64.8.966; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Katz DI, 2021, NEUROLOGY, V96, P848, DOI 10.1212/WNL.0000000000011850; Katz MJ, 2021, ALZH DEMENT-DADM, V13, DOI 10.1002/dad2.12144; Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/jnp.12.2.233; Kaufmann D, 2021, CEREB CORTEX, V31, P3426, DOI 10.1093/cercor/bhab021; Keller S, 2004, CLIN J PAIN, V20, P309, DOI 10.1097/00002508-200409000-00005; Kelley ME, 2017, J NEUROSURG-PEDIATR, V20, P489, DOI 10.3171/2017.5.PEDS16627; Kmush BL, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.4442; Kochsiek J, 2021, J MAGN RESON IMAGING, V54, P1819, DOI 10.1002/jmri.27774; Koerte IK, 2016, J NEUROTRAUM, V33, P346, DOI 10.1089/neu.2015.3880; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Kurasz AM, 2020, J ALZHEIMERS DIS, V77, P165, DOI 10.3233/JAD-200395; Lepage C, 2019, BRAIN IMAGING BEHAV, V13, P725, DOI 10.1007/s11682-018-9895-z; Lesman-Segev OH, 2020, SEMIN NEUROL, V40, P394, DOI 10.1055/s-0040-1715134; Lesman-Segev OH, 2019, NEUROIMAGE-CLIN, V24, DOI 10.1016/j.nicl.2019.102025; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lin A, 2018, HAND CLINIC, V158, P309, DOI 10.1016/B978-0-444-63954-7.00029-X; Lin AP, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0094-5; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Mantyh WG, 2020, JAMA NEUROL; Mariani M, 2020, SEMIN NEUROL, V40, P370, DOI 10.1055/s-0040-1713624; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; Marquie M, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0808-1; Marra DE, 2020, CLIN NEUROPSYCHOL, V34, P1411, DOI 10.1080/13854046.2020.1769192; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKeith IG, 2017, NEUROLOGY, V89, P88, DOI 10.1212/WNL.0000000000004058; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; McMillan TM, 2017, J NEUROL NEUROSUR PS, V88, P505, DOI 10.1136/jnnp-2016-314279; Meeker KL, 2021, ANN NEUROL, V89, P254, DOI 10.1002/ana.25948; Mez J, 2021, ALZHEIMERS DEMENT, V17, P1709, DOI 10.1002/alz.12338; Mez J, 2020, ANN NEUROL, V87, P116, DOI 10.1002/ana.25611; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Mishra VR, 2017, RADIOLOGY, V285, P555, DOI 10.1148/radiol.2017162403; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Montenigro PH, 2015, BRAIN PATHOL, V25, P304, DOI 10.1111/bpa.12250; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Moore SR, 1997, J NEUROL NEUROSUR PS, V63, P89, DOI 10.1136/jnnp.63.1.89; Morley WA, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00166; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Muraoka S, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01059; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; NHANES, 2013, PHYS ACT PHYS FITN Q; Nieuwenhuijsen M. J., 2003, EXPOSURE ASSESSMENT, DOI [10.1093/acprof:oso/9780198528616.001.0001, DOI 10.1093/ACPROF:OSO/9780198528616.001.0001]; Nuechterlein KH, 2008, AM J PSYCHIAT, V165, P203, DOI 10.1176/appi.ajp.2007.07010042; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Parks AC, 2021, ARCH CLIN NEUROPSYCH, V36, P887, DOI 10.1093/arclin/acab002; Peskind ER., 2005, LUMBAR PUNCTURE PROC; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Phelps A, 2020, SEMIN NEUROL, V40, P439, DOI 10.1055/s-0040-1713633; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Prevention CfDCa, 2013, NHANES WEIGHT HIST Q; Reitan RM, 1992, TRAIL MAKING TEST MA; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Roberts AL, 2019, AM J SPORT MED, V47, P2871, DOI 10.1177/0363546519868989; Rowland B, 2017, P INT SOC MAGN RESON, V25, P687; RUSSELL D, 1978, J PERS ASSESS, V42, P290, DOI 10.1207/s15327752jpa4203_11; Schneider RB, 2020, J PARKINSON DIS, V10, P1379, DOI 10.3233/JPD-202121; Schoemaker D, 2021, NEUROLOGY, V96, pE1975, DOI 10.1212/WNL.0000000000011745; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Smith, 1973, SYMBOL DIGIT MODALIT; Soleimani-Meigooni DN, 2020, BRAIN, V143, P3477, DOI 10.1093/brain/awaa276; Solomon G., 2016, CLIN NEUROSURG, V63, P173, DOI [10.1227/01.neu.0000489753.67038.ae, DOI 10.1227/01.NEU.0000489753.67038.AE]; Spielberger C. D., 1999, STATE TRAIT ANGER EX; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Standring OJ, 2019, ACTA NEUROPATHOL, V138, P401, DOI 10.1007/s00401-019-02031-x; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stemper BD, 2019, ANN BIOMED ENG, V47, P2073, DOI 10.1007/s10439-019-02335-9; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Stern RA, 2019, NEW ENGL J MED, V380, P1716, DOI 10.1056/NEJMoa1900757; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stillerova T, 2016, NEUROL RES INT, V2016, DOI 10.1155/2016/4802570; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Strain JF, 2017, J NEUROTRAUM, V34, P372, DOI 10.1089/neu.2016.4446; Tailby C, 2020, SEIZURE-EUR J EPILEP, V83, P89, DOI 10.1016/j.seizure.2020.10.005; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Tsai RM, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0470-7; Victoroff J, 2013, NEUROREHABILITATION, V32, P211, DOI 10.3233/NRE-130839; Weathers FW, 1991, PCL C DSM 4; Weintraub S, 2018, ALZ DIS ASSOC DIS, V32, P10, DOI 10.1097/WAD.0000000000000223; Whittington A, J NUCL MED, V2021, DOI [10.2967/jnumed.120.258962, DOI 10.2967/JNUMED.120.258962]; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Wright MJ, 2016, J CLIN EXP NEUROPSYC, V38, P561, DOI 10.1080/13803395.2016.1139057; Zhang WJ, 2020, NATURE, V580, P283, DOI 10.1038/s41586-020-2043-0	180	2	2	29	29	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1758-9193		ALZHEIMERS RES THER	Alzheimers Res. Ther.	AUG 12	2021	13	1							136	10.1186/s13195-021-00872-x			23	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UA6ZN	WOS:000685308500001	34384490	Green Published, gold			2022-02-06	
J	Soumoff, AA; Clark, NG; Spinks, EA; Kemezis, PA; Raiciulescu, S; Driscoll, MY; Kim, SY; Benedek, DM; Choi, KH				Soumoff, Alyssa A.; Clark, Neil G.; Spinks, Elizabeth A.; Kemezis, Patricia A.; Raiciulescu, Sorana; Driscoll, Mercedes Y.; Kim, Sharon Y.; Benedek, David M.; Choi, Kwang H.			Somatic Symptom Severity, Not Injury Severity, Predicts Probable Posttraumatic Stress Disorder and Major Depressive Disorder in Wounded Service Members	JOURNAL OF TRAUMATIC STRESS			English	Article; Early Access							TRAUMATIC BRAIN-INJURY; PSYCHOLOGICAL DISTRESS; PHYSICAL INJURY; DSM-IV; PTSD; COMORBIDITY; RISK; IRAQ; AFGHANISTAN; PREVALENCE	Although previous studies have reported an association between patient-reported somatic symptom severity and the development of posttraumatic stress disorder (PTSD) or major depressive disorder (MDD) in injured military service members (SMs), conclusions from other studies regarding the association between clinician-determined injury severity and PTSD or MDD remain unclear. The present study investigated whether somatic symptoms or injury severity predict the development of probable PTSD or MDD in wounded SMs medically evacuated from combat areas. Data including SM demographic characteristics, clinician-determined injury severity (i.e., Injury Severity Score [ISS] and Abbreviated Injury Scale [AIS] values), and self-report assessments of PTSD (PTSD Checklist-Civilian Version), MDD (Patient Health Questionnaire [PHQ]-9), and somatic symptoms (PHQ-15) were analyzed. A total of 2,217 SMs completed at least one self-assessment between 2003 and 2014, with 425 having completed assessments at each assessment period (AP), conducted 1-75 (AP1), 76-165 (AP2), and 166-255 (AP3) days postinjury. Between AP1 and AP3, the rates of probable PTSD and MDD increased from 3.0% to 11.7% and from 2.8% to 9.2%, respectively. Somatic symptom severity at AP1 predicted probable PTSD and MDD at all three APs, odds ratios (ORs) = 3.5-11.5; however, ISS values did not predict probable PTSD or MDD at any AP, ORs = 0.6-0.9. This suggests that the initial severity of self-reported somatic symptoms rather than clinician-determined injury severity predicts the development of probable PTSD and MDD in wounded SMs.	[Soumoff, Alyssa A.; Clark, Neil G.; Spinks, Elizabeth A.; Kemezis, Patricia A.] Walter Reed Natl Mil Med Ctr, Behav Hlth Directorate, 8901 Rockville Pike, Bethesda, MD 20889 USA; [Soumoff, Alyssa A.; Driscoll, Mercedes Y.; Kim, Sharon Y.; Benedek, David M.; Choi, Kwang H.] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD USA; [Raiciulescu, Sorana] Uniformed Serv Univ Hlth Sci, Biostat Consulting Ctr, Dept Prevent Med & Biostat, Bethesda, MD USA; [Kim, Sharon Y.; Benedek, David M.; Choi, Kwang H.] Uniformed Serv Univ Hlth Sci, Ctr Study Traumat Stress, Bethesda, MD USA; [Benedek, David M.; Choi, Kwang H.] Uniformed Serv Univ Hlth Sci, Program Neurosci, Bethesda, MD USA		Soumoff, AA (corresponding author), Walter Reed Natl Mil Med Ctr, Behav Hlth Directorate, 8901 Rockville Pike, Bethesda, MD 20889 USA.	alyssa.a.soumoff.mil@mail.mil		Soumoff, Alyssa/0000-0002-6497-108X; Clark, Neil/0000-0002-3605-214X; Benedek, David/0000-0001-9480-1412			Ahl R, 2017, INJURY, V48, P1082, DOI 10.1016/j.injury.2017.03.019; Armenta RF, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2375-1; Armenta RF, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1590-5; Baecher K, 2018, STRESS HEALTH, V34, P545, DOI 10.1002/smi.2815; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Boals A, 2017, J ANXIETY DISORD, V50, P1, DOI 10.1016/j.janxdis.2017.04.004; Boals A, 2009, J ANXIETY DISORD, V23, P458, DOI 10.1016/j.janxdis.2008.09.003; Brand Stephan, 2014, Int J Emerg Ment Health, V16, P233; Brasel KJ, 2010, J TRAUMA, V68, P263, DOI 10.1097/TA.0b013e3181caa58f; Bryant RA, 2015, BRIT J PSYCHIAT, V206, P417, DOI 10.1192/bjp.bp.114.145516; Flory JD, 2015, DIALOGUES CLIN NEURO, V17, P141; French LM, 2012, J HEAD TRAUMA REHAB, V27, P63, DOI 10.1097/HTR.0b013e3182248344; Gabert-Quillen CA, 2012, INT J STRESS MANAGE, V19, P69, DOI 10.1037/a0026488; Gabert-Quillen CA, 2011, J HEALTH PSYCHOL, V16, P678, DOI 10.1177/1359105310386823; Giordano NA, 2018, WORLDV EVID-BASED NU, V15, P113, DOI 10.1111/wvn.12274; Gold SD, 2005, J ANXIETY DISORD, V19, P687, DOI 10.1016/j.janxdis.2004.06.002; Gouweloos J, 2016, INJURY, V47, P250, DOI 10.1016/j.injury.2015.07.005; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Gupta MA, 2013, INT REV PSYCHIATR, V25, P86, DOI 10.3109/09540261.2012.736367; Haagsma JA, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-236; Herrera-Escobar JP, 2018, SURGERY, V164, P1246, DOI 10.1016/j.surg.2018.07.017; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Howlett JR, 2016, NEUROPSYCHOPHARMACOL, V41, P357, DOI 10.1038/npp.2015.261; Jakupcak M, 2009, J TRAUMA STRESS, V22, P303, DOI 10.1002/jts.20423; Jaycox, 2008, INVISIBLE WOUNDS WAR; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kilpatrick DG, 2013, J TRAUMA STRESS, V26, P537, DOI 10.1002/jts.21848; Kimbrel NA, 2016, PSYCHIAT RES, V243, P97, DOI 10.1016/j.psychres.2016.06.011; Kimbrel NA, 2014, PSYCHIAT RES, V220, P397, DOI 10.1016/j.psychres.2014.07.064; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LaRocca MA, 2020, J OCCUP ENVIRON MED, V62, P74, DOI 10.1097/JOM.0000000000001767; Lindqvist D, 2017, BRAIN BEHAV IMMUN, V59, P260, DOI 10.1016/j.bbi.2016.09.012; Papadakaki M, 2017, INJURY, V48, P297, DOI 10.1016/j.injury.2016.11.011; Qi W, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-015-0655-0; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Ramsawh HJ, 2014, J AFFECT DISORDERS, V161, P116, DOI 10.1016/j.jad.2014.03.016; Rosellini AJ, 2015, DEPRESS ANXIETY, V32, P13, DOI 10.1002/da.22316; Sandweiss DA, 2011, ARCH GEN PSYCHIAT, V68, P496, DOI 10.1001/archgenpsychiatry.2011.44; Skogstad L, 2014, INJURY, V45, P289, DOI 10.1016/j.injury.2012.10.001; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stewart IJ, 2015, CIRCULATION, V132, P2126, DOI 10.1161/CIRCULATIONAHA.115.016950; Troyanskaya M, 2015, MIL MED, V180, P285, DOI 10.7205/MILMED-D-14-00256; Wain H.J., 2011, COMBAT OPERATIONAL B, P243; Xue C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120270; Zatzick DF, 2002, AM J PSYCHIAT, V159, P941, DOI 10.1176/appi.ajp.159.6.941	49	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress												10.1002/jts.22722		AUG 2021	12	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	TX5WT	WOS:000683161500001	34374129				2022-02-06	
J	Carpentier, VT; Salga, M; Gatin, L; Genet, F; Paquereau, J				Carpentier, Vincent T.; Salga, Marjorie; Gatin, Laure; Genet, Francois; Paquereau, Julie			Early diagnosis of heterotopic ossification among patients admitted to a neurological Post-Intensive Care Rehabilitation Unit	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Ossification; heterotopic; Brain injuries; traumatic; Spinal cord injuries; Stroke; Rehabilitation	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; RISK-FACTORS; CIGARETTE-SMOKING; RECURRENCE; ULTRASOUND; IMPACT	BACKGROUND: Heterotopic ossification (HO) is defined as the formation of endochondral bone within soft tissue. Non-genetic forms, mainly corresponding to a consequence of bone, brain or spinal cord injury, are the most common. HO leads to important functional limitations and alteration of quality of life. To our knowledge, the time between brain, bone, or spinal cord injury and clinical suspicion of HO has never been studied. By admitting patients with severe neurological disorders, we hypothesized that the prevalence of HO in neurological post-intensive care rehabilitation units (PICRU) might be significant as these patients have recognized risk factors for HO. AIM: This study aimed to investigate HO among patients admitted to a neurological PICRU with two objectives: 1) to describe the prevalence of HO in PICRU; 2) to assess the time between neurological disorder, clinical suspicion of HO and radiological diagnosis. DESIGN: A monocentric retrospective cohort study. SETTING: PICRU in our public university teaching hospital. This inpatient referral department is specifically dedicated to the early discharge from Intensive Care Units (ICU) of patients with severe neurological impairment who need rehabilitation. POPULATION: We study all patients admitted between April 2016 and January 2019. One hundred twenty-five subjects were admitted for a rehabilitation program after neuro-trauma or stroke. We included all first-time stays in PICRU lasting 7 days or longer. METHODS: Retrospective data extraction using administrative data from an electronic patient management program was done to select eligible subjects. Included subjects were then identified by a retrospective review of electronic inpatient medical records after patient discharge. Data of interest were collected from these same medical records. RESULTS: Forty-four HO were diagnosed in 24 subjects (24/125; 19%), with a median number of 2 [1; 2] HO per subject. Neurological trauma was the main reason for admission to ICU (89/125; 71%) and half of patients had a traumatic brain injury (TBI) (67/125; 54%). The diagnosis of HO was made in PICRU in 75% of cases. Clinical suspicion of HO (autonomic dysfunction, local inflammatory signs, pain, or reduced joint range of motion) was made 6 [5; 7] weeks after admission to ICU. Radiological confirmation of clinical suspicion or fortuitous diagnosis by imaging (50% of the cases) occurred 8 [7; 12] weeks after admission to ICU. The median time of clinical suspicion or radiological diagnosis was 1 week after admission to PICRU. CONCLUSIONS: HO is a sub-acute complication which develops in patients admitted to ICU for severe central nervous system disorders as clinical suspicion or radiological confirmation of diagnosis was made within the first week after admission in neurological PICRU (i.e. 6 to 8 weeks after ICU admission). CLINICAL REHABILITATION IMPACT: As treatment for HO may at least partially improves rehabilitation and quality of life, we recommend a systematic screening in PICRU patients for HO by clinical examination supplemented by imaging in case of suspicion.	[Carpentier, Vincent T.; Salga, Marjorie; Paquereau, Julie] Hop Raymond Poincare, Assistance Publ Hosp Paris, AP HP, Dept Phys Med & Rehabil, 104 Blvd Raymond Poincare, F-92380 Garches, France; [Carpentier, Vincent T.] Univ Paris, Fac Med, Paris, France; [Carpentier, Vincent T.; Salga, Marjorie; Gatin, Laure; Genet, Francois; Paquereau, Julie] Garches Neuro Orthoped Res Grp GRENOG, Garches, France; [Salga, Marjorie; Gatin, Laure; Genet, Francois] Univ Paris Saclay, Versailles St Quentin Yvelines Univ UVSQ, INSERM, U1179 END ICAP, Montigny Le Bretonneux, France; [Gatin, Laure] Hop Raymond Poincare, Assistance Publ Hosp Paris, AP HP, Dept Orthoped Surg, Garches, France		Paquereau, J (corresponding author), Hop Raymond Poincare, Assistance Publ Hosp Paris, AP HP, Dept Phys Med & Rehabil, 104 Blvd Raymond Poincare, F-92380 Garches, France.	julie.paquereau@aphp.fr	Carpentier, Vincent T./H-4719-2011	Carpentier, Vincent T./0000-0002-7239-1202			Almangour W, 2016, ANN PHYS REHABIL MED, V59, P263, DOI 10.1016/j.rehab.2016.03.009; Argyropoulou MI, 2006, CRIT CARE, V10, DOI 10.1186/cc5083; Banovac K, 2004, SPINAL CORD, V42, P707, DOI 10.1038/sj.sc.3101628; Bargellesi S, 2018, CLIN REHABIL, V32, P255, DOI 10.1177/0269215517723161; Beckmann JT, 2015, J BONE JOINT SURG AM, V97A, P2032, DOI 10.2106/JBJS.N.01156; Christakou A, 2019, HEALTH RES J, V5, P66; Coelho CVC, 2009, ARQ NEURO-PSIQUIAT, V67, P382, DOI 10.1590/S0004-282X2009000300002; Dizdar D, 2013, BRAIN INJURY, V27, P807, DOI 10.3109/02699052.2013.775490; Falsetti P, 2011, J CLIN ULTRASOUND, V39, P12, DOI 10.1002/jcu.20742; Genet F, 2019, ANN PHYS REHABIL MED, V62, P225, DOI 10.1016/j.rehab.2018.09.004; Genet F, 2015, SPINAL CORD, V53, P340, DOI 10.1038/sc.2015.20; Genet F, 2012, J HEAD TRAUMA REHAB, V27, P443, DOI 10.1097/HTR.0b013e31822b54ba; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016632; Goodman TA, 1997, ARTHRITIS RHEUM, V40, P1619, DOI 10.1002/art.1780400911; Hendricks HT, 2007, CLIN REHABIL, V21, P545, DOI 10.1177/0269215507075260; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Huang H, 2018, J ORTHOP TRANSL, V12, P16, DOI 10.1016/j.jot.2017.10.002; Jodoin M, 2019, BONE REP, V11, DOI 10.1016/j.bonr.2019.100222; Kaplan FS, 2004, J AM ACAD ORTHOP SUR, V12, P116, DOI 10.5435/00124635-200403000-00007; Krauss H, 2015, SPINAL CORD, V53, P345, DOI 10.1038/sc.2014.186; Lee J, 2012, J DENT RES, V91, P142, DOI 10.1177/0022034511421200; Lewis PC, 2017, MIL MED, V182, pE1742, DOI 10.7205/MILMED-D-16-00350; Meyers Carolyn, 2019, JBMR Plus, V3, pe10172, DOI 10.1002/jbm4.10172; Parikh J, 2002, CLIN RADIOL, V57, P1058, DOI 10.1053/crad.2002.1120; Ploumis A, 2015, J SPINAL CORD MED, V38, P193, DOI 10.1179/2045772314Y.0000000213; Ranganathan K, 2015, J BONE JOINT SURG AM, V97A, P1101, DOI 10.2106/JBJS.N.01056; Rawat N, 2019, SPINAL CORD SER CASE, V5, DOI 10.1038/s41394-019-0216-6; Reznik JE, 2014, J MUSCULOSKEL NEURON, V14, P19; Riklin C, 2003, SPINAL CORD, V41, P192, DOI 10.1038/sj.sc.3101421; Rizzoli R, 2012, BONE, V51, P606, DOI 10.1016/j.bone.2012.05.018; Rosteius T, 2017, SPINAL CORD, V55, P71, DOI 10.1038/sc.2016.93; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Simonsen LL, 2007, INJURY, V38, P1146, DOI 10.1016/j.injury.2007.03.019; Stefanidis K, 2017, J HEAD TRAUMA REHAB, V32, pE54, DOI 10.1097/HTR.0000000000000293; Sullivan MP, 2013, BONE JOINT RES, V2, P51, DOI 10.1302/2046-3758.23.2000152; Teasell RW, 2010, SPINAL CORD, V48, P512, DOI 10.1038/sc.2009.175; Thefenne L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182303; van Kampen PJ, 2011, J HEAD TRAUMA REHAB, V26, P384, DOI 10.1097/HTR.0b013e3181f78a59; van Kuijk AA, 2002, SPINAL CORD, V40, P313, DOI 10.1038/sj.sc.3101309; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; Wentworth KL, 2019, BRIT J CLIN PHARMACO, V85, P1180, DOI 10.1111/bcp.13823; Yoon V, 2012, OSTEOPOROSIS INT, V23, P2081, DOI 10.1007/s00198-012-1940-y	42	2	2	0	0	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087	1973-9095		EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	AUG	2021	57	4					527	534		10.23736/S1973-9087.21.06589-8			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	UQ1KC	WOS:000695829000005	33448758				2022-02-06	
J	Cigel, A; Sayin, O; Gurgen, SG; Sonmez, A				Cigel, Ayse; Sayin, Oya; Gurgen, Seren Gulsen; Sonmez, Atac			Long term neuroprotective effects of acute single dose MK-801treatment against traumatic brain injury in immature rats	NEUROPEPTIDES			English	Article						Traumatic brain injury; MK-801; Hippocampus; Cognition; BDNF; NGF; NMDA-R	ANXIETY-LIKE BEHAVIOR; NERVE GROWTH-FACTOR; NEUROTROPHIC FACTOR; GLUTAMATE; DAMAGE; MK-801; MECHANISMS; EXPRESSION; RECEPTOR; MEMORY	Because brain development continues during adolescence, childhood trauma is a major health problem in pediatric ages. It is known traumatic brain injury (TBI) results in damage in hippocampal and cortical areas of the brain and impairs cognitive functions. The study aims to investigate the long-term effects of MK-801 (dizocilpine), an N-methyl D-aspartate (NMDA) receptor antagonist, on hippocampal damage, locomotor activity, and cognitive functions following TBI in immature rats. MK-801 (1 mg/kg) was injected intraperitoneally immediately after TBI. Thirty-seven litters were randomly allocated into three groups at 7 days (P7) of postnatal age: a control group, a trauma group, and an MK-801 treatment group. The control group received no treatment; the trauma group received saline as vehicle control for the MK-801 group and the MK-801 group received a single dose of 1 mg/kg MK-801 immediately after TBI. Hippocampal damage was examined by Hematoxylin-Eosin staining. Brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), NMDA-R, and glial fibrillar acidic protein (GFAP) immunohistochemistry and, BDNF, NGF, and NMDA-R ELISA protein levels were evaluated 125 days after trauma. Histopathological and immunohistochemical evaluations showed that treatment with MK-801 significantly ameliorated the trauma-induced hippocampal neuron loss and increased BDNF, NGF, NMDA-R, GFAP expressions in CA1, CA3, and DG hippocampal regions. Additionally, treatment with MK-801 decreased anxiety and increased hippocampus-dependent memory of animals subjected to brain injury after TBI. These results show that acute treatment of MK-801 has a neuroprotective role against trauma-induced hippocampal neuron loss and associated cognitive impairment in rats.	[Cigel, Ayse; Sonmez, Atac] Dokuz Eylul Univ, Dept Physiol, Fac Med, Izmir, Turkey; [Sayin, Oya] Dokuz Eylul Univ, Res Lab, Fac Med, Izmir, Turkey; [Gurgen, Seren Gulsen] Celal Bayar Univ, Dept Histol & Embryol, Fac Med, Manisa, Turkey		Cigel, A (corresponding author), Adnan Menderes Univ, Dept Physiol, Fac Med, Basic Med Sci Bldg, TR-09100 Aydin, Turkey.	acigel@adu.edu.tr; oya.sayin@deu.edu.tr; atac.sonmez@deu.edu.tr			Dokuz Eylul University Research FoundationDokuz Eylul University [2018, KB.FAG.034]	This work was supported by Dokuz Eylul University Research Foundation. Grant No: 2018.KB.FAG.034.	Al-Amin H, 2011, EXP NEUROL, V228, P30, DOI 10.1016/j.expneurol.2010.11.005; Allen SJ, 2013, PHARMACOL THERAPEUT, V138, P155, DOI 10.1016/j.pharmthera.2013.01.004; Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Bittigau P, 2003, NEUROTOX RES, V5, P475, DOI 10.1007/BF03033158; Broussard JI, 2018, BRAIN INJURY, V32, P113, DOI 10.1080/02699052.2017.1380228; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chang CH, 2018, NEUROPHARMACOLOGY, V143, P95, DOI 10.1016/j.neuropharm.2018.09.019; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Conte V., 2003, EUR J TRAUMA, V7, P335; De Oliveira PA, 2017, BRAIN RES, V1663, P78, DOI 10.1016/j.brainres.2017.03.002; Genrikhs EE, 2018, BRAIN RES BULL, V140, P148, DOI 10.1016/j.brainresbull.2018.05.002; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Gold M, 2015, J NEUROL SCI, V359, P356, DOI 10.1016/j.jns.2015.11.016; GOODLETT CR, 1993, DEV BRAIN RES, V72, P85, DOI 10.1016/0165-3806(93)90162-4; Guo CM, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/783297; Han RZ, 2009, NEUROSCI BULL, V25, P367, DOI 10.1007/s12264-009-0608-x; Hausmann R, 2004, INT J LEGAL MED, V118, P32, DOI 10.1007/s00414-003-0413-4; He BL, 2013, NEUROPEPTIDES, V47, P1, DOI 10.1016/j.npep.2012.06.001; Krishna G, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201801055; Kuczewski N, 2010, EUR J NEUROSCI, V32, P1239, DOI 10.1111/j.1460-9568.2010.07378.x; Kumar A, 2002, J NEUROSCI RES, V67, P781, DOI 10.1002/jnr.10181; Kuniishi H, 2017, NEUROSCI RES, V123, P27, DOI 10.1016/j.neures.2017.04.012; Lan YL, 2019, INFLAMM RES, V68, P311, DOI 10.1007/s00011-019-01217-z; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Lee JS, 2018, BIOMED PHARMACOTHER, V106, P1031, DOI 10.1016/j.biopha.2018.07.032; Li M, 2016, GEN MED OPEN ACCESS, V4, P1, DOI [10.4172/2327-5146.1000275, DOI 10.4172/2327-5146.1000275]; Linden AM, 2000, J MOL NEUROSCI, V14, P27, DOI 10.1385/JMN:14:1-2:027; Liu F, 2016, NEUROPEPTIDES, V58, P1, DOI 10.1016/j.npep.2016.03.004; Matsuki H, 2001, NEUROPSYCHOPHARMACOL, V25, P258, DOI 10.1016/S0893-133X(00)00246-3; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; PAETAU A, 1985, ACTA NEUROPATHOL, V65, P190, DOI 10.1007/BF00686997; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Peters AJ, 2018, ANESTHESIOLOGY, V129, P278, DOI 10.1097/ALN.0000000000002197; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; ROESSMANN U, 1980, BRAIN RES, V200, P13, DOI 10.1016/0006-8993(80)91090-2; Sahay A, 2020, NEUROPEPTIDES, V83, DOI 10.1016/j.npep.2020.102075; Schurr A, 2004, CURR DRUG TARGETS, V5, P603, DOI 10.2174/1389450043345209; Sencer A, 2008, NEUROL RES, V30, P497, DOI 10.1179/016164107X251664; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Sonmez A, 2015, NEUROSCI LETT, V597, P137, DOI 10.1016/j.neulet.2015.05.001; Tucker LB, 2018, NEUROSCI BIOBEHAV R, V88, P187, DOI 10.1016/j.neubiorev.2018.03.010; Xiong LL, 2018, MOL NEUROBIOL, V55, P2696, DOI 10.1007/s12035-017-0551-1; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yi NX, 2019, NEURAL REGEN RES, V14, P1919, DOI 10.4103/1673-5374.259619; Yu WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145651; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037; Zhao J, 2018, J NEUROTRAUM, V35, P362, DOI 10.1089/neu.2017.5102	54	2	2	0	2	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0143-4179	1532-2785		NEUROPEPTIDES	Neuropeptides	AUG	2021	88								102161	10.1016/j.npep.2021.102161			10	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	TF4ID	WOS:000670681100003	34098454				2022-02-06	
J	Elkbuli, A; Shaikh, S; McKenney, K; Shanahan, H; McKenney, M; McKenney, K				Elkbuli, Adel; Shaikh, Saamia; McKenney, Kelly; Shanahan, Hunter; McKenney, Mark; McKenney, Kimberly			Utility of the Marshall & Rotterdam Classification Scores in Predicting Outcomes in Trauma Patients	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury; Rotterdam computed tomography score; Marshall classification system score; Trauma outcomes; Traumatic injuries prognosis	BRAIN-INJURY; SCORING SYSTEM; CT SCORES; MORTALITY	Background: Traumatic Brain Injury (TBI) is a leading cause of mortality in the trauma population. Accurate prognosis remains a challenge. Two common Computed Tomography (CT)-based prognostic models include the Marshall Classification and the Rotterdam CT Score. This study aims to determine the utility of the Marshall and Rotterdam scores in predicting mortality for adult patients in coma with severe TBI. Method: Retrospective review of our Level 1 Trauma Center's registry for patients >= 18 years of age with blunt TBI and a Glasgow Coma Scale (GCS) of 3-5, with no other significant in-juries. Admission Head CT was evaluated for the presence of extra-axial blood (SDH, EDH, SAH, IVH), intra-axial blood (contusions, diffuse axonal injury), midline shift and mass effect on basilar cisterns. Rotterdam and Marshall scores were calculated for all patients; subsequently patients were divided into two groups according to their score (< 4, >= 4). Results: 106 patients met inclusion criteria; 75.5% were males (n = 80) and 24.5% females (n = 26). The mean age was 52. The odds ratio (OR) of dying from severe TBI for patients in coma with a Rotterdam score of >= 4 compared to < 4 was OR = 17 (P < 0.05). The odds of dying from severe TBI for patients in coma with a Marshall score of >= 4 versus < 4 was OR = 11 (P < 0.05). Conclusion: Higher scores in the Marshall classification and the Rotterdam system are associated with increased odds of mortality in adult patients in come from severe TBI after blunt injury. The results of our study support these scoring systems and revealed that a cutoff score of < 4 was associated with improved survival. (C) 2021 Elsevier Inc. All rights reserved.	[Elkbuli, Adel; Shaikh, Saamia; McKenney, Kelly; Shanahan, Hunter; McKenney, Mark; McKenney, Kimberly] Kendall Reg Med Ctr, Dept Surg, Div Trauma & Acute Care Surg, Miami, FL USA; [McKenney, Mark; McKenney, Kimberly] Univ S Florida, Dept Surg, Tampa, FL 33620 USA		Elkbuli, A (corresponding author), Kendall Reg Med Ctr, Dept Surg, 11750 Bird Rd, Miami, FL 33175 USA.	adel.elkbuli@hcahealthcare.com		Elkbuli, Adel/0000-0001-7730-617X			[Anonymous], 2018, ADV TRAUM LIF SUPP; Charry JD, 2017, J NEUROSCI RURAL PRA, V8, P23, DOI 10.4103/jnrp.jnrp_434_16; Deepika A, 2015, ACTA NEUROCHIR, V157, P2033, DOI 10.1007/s00701-015-2575-5; Fujimoto K, 2016, J NEUROSURG, V124, P1640, DOI 10.3171/2015.4.JNS142760; Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150; Majdan M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0068-9; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; Mohammadifard M, 2018, EUR J TRANSL MYOL, V28, P265, DOI 10.4081/ejtm.2018.7542; Munakomi S, 2016, CHIN J TRAUMATOL, V19, P25, DOI 10.1016/j.cjtee.2015.12.005; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Pargaonkar R, 2019, J CLIN NEUROSCI, V66, P100, DOI 10.1016/j.jocn.2019.05.011; Stenberg M, 2017, BRAIN INJURY, V31, P351, DOI 10.1080/02699052.2016.1261303; Talari HR, 2016, WORLD NEUROSURG, V87, P195, DOI 10.1016/j.wneu.2015.11.055; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Thelin EP, 2017, PLOS MED, P14; Waqas M, 2016, BRIT J NEUROSURG, V30, P258, DOI 10.3109/02688697.2016.1139047; Wintermark M, 2018, J NEUROTRAUM, V35, P2665, DOI 10.1089/neu.2017.5311	17	2	2	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	AUG	2021	264						194	198		10.1016/j.jss.2021.02.025			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	SV7XD	WOS:000664031200030	33838403				2022-02-06	
J	Gamberini, L; Coniglio, C; Lupi, C; Tartaglione, M; Mazzoli, CA; Baldazzi, M; Cecchi, A; Ferri, E; Chiarini, V; Semeraro, F; Gordini, G				Gamberini, Lorenzo; Coniglio, Carlo; Lupi, Cristian; Tartaglione, Marco; Mazzoli, Carlo Alberto; Baldazzi, Marzia; Cecchi, Alessandra; Ferri, Enrico; Chiarini, Valentina; Semeraro, Federico; Gordini, Giovanni			Resuscitative endovascular occlusion of the aorta (REBOA) for refractory out of hospital cardiac arrest. An Utstein-based case series	RESUSCITATION			English	Article						Resuscitation; Out-of-hospital cardiac arrest; Trauma; Wounds and injuries	INTERNATIONAL LIAISON COMMITTEE; BALLOON OCCLUSION; CARDIOPULMONARY-RESUSCITATION; EUROPEAN RESUSCITATION; COUNCIL GUIDELINES; HEMORRHAGE; DURATION; CARE	Aims: Out of hospital cardiac arrest (OHCA) is still a leading cause of mortality worldwide. In recent years, resuscitative endovascular balloon occlusion of the aorta (REBOA) has been progressively studied as an adjunct to standard advanced life support (ALS) in both traumatic and non-traumatic refractory OHCA. Since January 2019, the REBOA procedure has been applied to all the patients experiencing both traumatic and non-traumatic refractory OHCA (>15 min of cardiopulmonary resuscitation) not eligible for ECPR for clinical or logistic reasons. We aimed at describing the feasibility and effects of REBOA performed both in the Emergency Department and in the pre-hospital environment served by the local HEMS for refractory OHCA. Methods: Twenty consecutive patients experiencing refractory OHCA and in whom REBOA was attempted in 2019 and 2020 were included in the study, Utstein data and REBOA specific variables were recorded. Results: Successful catheter placement was achieved in 18 out of 20 patients, 11 of these were non-traumatic OHCAs while 7 were traumatic OHCAs, the 2 failures were related to repeated arterial puncture failure. Median time between the EMS dispatch and REBOA catheter placing attempt was 46 min. An increase in etCO(2) over 10 mmHg was observed after balloon inflation in 12 out of 18 patients (8/11 non-traumatic and 4/7 traumatic OHCAs), a sustained ROSC was observed in 5 patients (1 traumatic and 4 non-traumatic OHCA) that were subsequently admitted to the ICU. Four out of the 5 patients reached the criteria for brain death in the subsequent 24 h while one patient experienced another episode of refractory cardiac arrest in ICU and subsequently died. Conclusion: Our data confirm the feasibility of REBOA technique as an adjunct to ALS in both the ED and prehospital phase and most of the treated patients experienced a transient ROSC after balloon inflation while 5 out of 18 experienced a sustained ROSC. However, while in the trauma setting increasing evidence suggests an improved survival when REBOA is applied to refractory OHCA, in non-traumatic OHCA this has yet to be demonstrated and large studies are needed.	[Gamberini, Lorenzo; Coniglio, Carlo; Lupi, Cristian; Tartaglione, Marco; Mazzoli, Carlo Alberto; Baldazzi, Marzia; Cecchi, Alessandra; Ferri, Enrico; Chiarini, Valentina; Semeraro, Federico; Gordini, Giovanni] Maggiore Hosp Carlo Alberto Pizzardi, Dept Anesthesia Intens Care & Prehosp Emergency, Bologna, Italy		Semeraro, F (corresponding author), Maggiore Hosp Carlo Alberto Pizzardi, Dept Anesthesia Intens Care & Prehosp Emergency, Bologna, Italy.	federicofsemeraro@gmail.com	Coniglio, Carlo/AAB-7128-2022; Semeraro, Federico Fiorenzo/AAK-7200-2021; Gordini, Giovanni/AAB-8170-2022; Gordini, Giovanni/AAB-7065-2022; Gamberini, Lorenzo/S-5476-2017	Coniglio, Carlo/0000-0002-8207-0525; Semeraro, Federico Fiorenzo/0000-0002-3895-0242; Gordini, Giovanni/0000-0003-4518-0204; Gamberini, Lorenzo/0000-0002-4364-9163; tartaglione, marco/0000-0002-3758-0227; Moro, Federico/0000-0001-6763-2676; Chiarini, Valentina/0000-0002-8993-6715			Adnet F, 2017, RESUSCITATION, V111, P74, DOI 10.1016/j.resuscitation.2016.11.024; Bailey ZS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01309; Brede JR, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.014394; Brede JR, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027980; Brenner ML, 2013, J TRAUMA ACUTE CARE, V75, P506, DOI 10.1097/TA.0b013e31829e5416; Coniglio C, 2019, PREHOSP DISASTER MED, V34, P566, DOI 10.1017/S1049023X19004795; Daley J, 2020, J ENDOVASC RESUSC TR, V4, P88, DOI 10.26676/jevtm.v4i2.140; Daley J, 2017, AM J EMERG MED, V35, P731, DOI 10.1016/j.ajem.2017.01.010; Dogan EM, 2020, RESUSCITATION, V151, P150, DOI 10.1016/j.resuscitation.2020.04.011; Donnino MW, 2014, CRIT CARE MED, V42, P1804, DOI 10.1097/CCM.0000000000000332; Elkbuli A, 2021, SURGERY, V170, P284, DOI 10.1016/j.surg.2021.01.043; Evans C, 2018, EMERG MED CLIN N AM, V36, P19, DOI 10.1016/j.emc.2017.08.004; Gamberini L, 2021, PREHOSPITAL DISASTER, V36, P195, DOI 10.1017/S1049023X21000030; Grasner JT, 2021, RESUSCITATION, V161, P61, DOI 10.1016/j.resuscitation.2021.02.007; Harhash AA, 2021, J AM COLL CARDIOL, V77, P360, DOI 10.1016/j.jacc.2020.11.043; Hilbert-Carius P, 2020, WORLD J EMERG SURG, V15, DOI 10.1186/s13017-020-00301-8; Holmberg MJ, 2018, RESUSCITATION, V131, P91, DOI 10.1016/j.resuscitation.2018.07.029; Johnson MA, 2017, J TRAUMA ACUTE CARE, V83, P61, DOI [10.1097/TA.0000000000001372, 10.1097/TA.0000000000001518]; Kiguchi T, 2020, RESUSCITATION, V152, P39, DOI 10.1016/j.resuscitation.2020.02.044; Kim SJ, 2016, RESUSCITATION, V103, P106, DOI 10.1016/j.resuscitation.2016.01.019; Lendrum R, 2019, RESUSCITATION, V135, P6, DOI 10.1016/j.resuscitation.2018.12.018; Levis A, 2020, RESUSCITATION, V156, P27, DOI 10.1016/j.resuscitation.2020.08.118; Nolan JP, 2021, INTENS CARE MED, V47, P369, DOI [10.1007/s00134-021-06368-4, 10.1016/j.resuscitation.2021.02.012]; Nolan JP, 2015, RESUSCITATION, V95, P202, DOI 10.1016/j.resuscitation.2015.07.018; Nowadly CD, 2020, JACEP OPEN, V1, P737, DOI 10.1002/emp2.12241; Perkins GD, 2015, CIRCULATION, V132, P1286, DOI 10.1161/CIR.0000000000000144; Reynolds JC, 2013, CIRCULATION, V128, P2488, DOI 10.1161/CIRCULATIONAHA.113.002408; Soar J, 2015, RESUSCITATION, V95, P100, DOI 10.1016/j.resuscitation.2015.07.016; Tibbits EM, 2018, J TRAUMA ACUTE CARE, V85, P101, DOI 10.1097/TA.0000000000001858; Truhlar A, 2015, RESUSCITATION, V95, P148, DOI 10.1016/j.resuscitation.2015.07.017; Uchino H, 2016, AM J CASE REP, V17, P810, DOI 10.12659/AJCR.900267; Wasicek PJ, 2019, EUR J TRAUMA EMERG S, V45, P1097, DOI 10.1007/s00068-018-0989-5; Williams AM, 2019, J TRAUMA ACUTE CARE, V86, P415, DOI 10.1097/TA.0000000000002149; Yamamoto R, 2020, JACEP OPEN, V1, P624, DOI 10.1002/emp2.12177	34	2	2	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572	1873-1570		RESUSCITATION	Resuscitation	AUG	2021	165						161	169		10.1016/j.resuscitation.2021.05.019			9	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	TQ8QG	WOS:000678542100025	34089774				2022-02-06	
J	Guty, E; Riegler, K; Meyer, J; Walter, AE; Slobounov, SM; Arnett, P				Guty, Erin; Riegler, Kaitlin; Meyer, Jessica; Walter, Alexa E.; Slobounov, Semyon M.; Arnett, Peter			Symptom Factors and Neuropsychological Performance in Collegiate Athletes with Chronic Concussion Symptoms	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Attention; Learning and memory; Head injury	SPORT-RELATED CONCUSSION; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; POSTTRAUMATIC MIGRAINE; DEPRESSIVE SYMPTOMS; PROLONGED RECOVERY; NORMATIVE DATA; RISK-FACTORS; PREVALENCE; PREDICTORS	Objective: The present study explored the relationship between specific types of postconcussion symptoms and cognitive outcomes in student-athletes with chronic concussion symptoms. Method: Forty student-athletes with chronic concussion symptoms were given a battery of neuropsychological tests and rated themselves on a variety of postconcussion symptoms, which included the following factors derived from prior work: Physical, Sleep, Cognitive, Affective, and Headache. Cognitive outcomes included performance on composites for the memory and attention/executive functioning speed tests, respectively. The following covariates were also explored: Sex, depression symptoms, number of previous concussions, and time since injury. Results: Headache was the only individual symptom factor that significantly (p < .05) predicted worse attention/executive functioning performance. None of the symptom factors were significantly related to memory performance over and above the variable of time since injury, such that longer time since injury was related to worse memory performance. Conclusion: Comparable to work examining symptom predictors of cognitive outcomes in acutely concussed samples, headache predicted worse attention/executive functioning performance. Additionally, we found that the longer athletes had been symptomatic since injury, the "worse" their memory functioning. Understanding how headache and the length of time an individual is symptomatic are related to cognitive outcomes can help inform treatment and recommendations for athletes with prolonged symptom recovery.	[Guty, Erin; Riegler, Kaitlin; Arnett, Peter] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Meyer, Jessica] Summa Hlth Syst, Dept Behav Hlth, Akron, OH USA; [Walter, Alexa E.; Slobounov, Semyon M.] Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA		Guty, E (corresponding author), Penn State Univ, 372 Moore Bldg, University Pk, PA 16802 USA.	erin.guty@gmail.com			ENZO Nutraceutical Ltd. and HeadRehab Funding Source: Medline		Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Benedict R., 1997, BRIEF VISUOSPATIAL M; Branca Barbaranne, 2006, Curr Pain Headache Rep, V10, P54, DOI 10.1007/s11916-006-0010-6; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Brown G.K., 2000, BECK DEPRESSION INVE; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Conder A, 2020, NEUROREHABILITATION, V46, P167, DOI 10.3233/NRE-192966; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Guty E, 2018, J INT NEUROPSYCH SOC, V24, P684, DOI 10.1017/S135561771800036X; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; IBMCorp, 2017, IBM SPSS STAT WINDOW; Irick E., 2016, STUDENT ATHLETE PART; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kontos A.P., 2018, CONCUSSION CLIN PROF, P59, DOI DOI 10.1037/0000087-004; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Martelli MF, 1999, J HEAD TRAUMA REHAB, V14, P49, DOI 10.1097/00001199-199902000-00007; McConnell B, 2020, J CHILD NEUROL, V35, P63, DOI 10.1177/0883073819876473; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Merritt VC, 2017, ARCH CLIN NEUROPSYCH, V32, P168, DOI 10.1093/arclin/acw090; Merritt VC, 2014, J CLIN EXP NEUROPSYC, V36, P1098, DOI 10.1080/13803395.2014.983463; Meyer JE, 2015, J CLIN EXP NEUROPSYC, V37, P316, DOI 10.1080/13803395.2015.1012486; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Pardini J., 2004, BRIT J SPORT MED, V38, P661; Patel VP, 2018, MULT SCLER J, V24, P186, DOI 10.1177/1352458517692887; Putukian M, 2016, BRIT J SPORT MED, V50, P145, DOI 10.1136/bjsports-2015-095586; Riegler KE, 2021, J INT NEUROPSYCH SOC, V27, P35, DOI 10.1017/S135561772000065X; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sandel N, 2017, SPORT EXERC PERFORM, V6, P304, DOI 10.1037/spy0000098; Schwedt TJ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00615; Smith A., 1991, SYMBOL DIGIT MODALIT; Stein E, 2017, BRAIN INJURY, V31, P1736, DOI 10.1080/02699052.2017.1380843; Stocker RPJ, 2017, ARCH CLIN NEUROPSYCH, V32, P349, DOI 10.1093/arclin/acx003; Trenerry MR, 1989, STROOP NEUROPSYCHOLO; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Walter A, 2017, DEV NEUROPSYCHOL, V42, P93, DOI 10.1080/87565641.2016.1256404; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Wechsler, 1997, WECHSLER ADULT INTEL; Wolanin A, 2016, BRIT J SPORT MED, V50, P167, DOI 10.1136/bjsports-2015-095756; Yang JZ, 2007, CLIN J SPORT MED, V17, P481, DOI 10.1097/JSM.0b013e31815aed6b; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	51	2	2	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2021	36	5					746	756		10.1093/arclin/acaa092			11	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	WX1CC	WOS:000718340500009	33140096				2022-02-06	
J	Hornsby, BWY; Camarata, S; Cho, SJ; Davis, H; McGarrigle, R; Bess, FH				Hornsby, Benjamin W. Y.; Camarata, Stephen; Cho, Sun-Joo; Davis, Hilary; McGarrigle, Ronan; Bess, Fred H.			Development and Validation of the Vanderbilt Fatigue Scale for Adults (VFS-A)	PSYCHOLOGICAL ASSESSMENT			English	Article						Vanderbilt Fatigue Scale; listening-related fatigue; fatigue; adults with hearing loss; outcome measures	SUBJECTIVE FATIGUE; HEARING IMPAIRMENT; MENTAL FATIGUE; CHILDREN; RELIABILITY; INVENTORY; DEPRESSION; STATES; MILD	Listening-related fatigue can be a significant burden for adults with hearing loss (AHL), and potentially those with other health or language-related issues (e.g., multiple sclerosis, traumatic brain injury, second language learners) who must allocate substantial cognitive resources to the process of listening. The 40-item Vanderbilt Fatigue Scale for Adults (VFS-A-40) was designed to measure listening-related fatigue in such populations. This article describes the development, and psychometric properties, of the VFS-A-40. Initial qualitative analyses in AHL suggested listening-related fatigue was multidimensional, with physical, mental, emotional, and social domains. However, exploratory factor analyses revealed a unidimensional structure. Item and test characteristics were evaluated using Item Response Theory (IRT). Results confirmed that all test items were of high quality. IRT analyses revealed high marginal reliability and an analysis of test-retest scores revealed adequate reliability. In addition, an analysis of differential item functioning provided evidence of good construct validity across age, gender, and hearing loss groups. In sum, the VFS-A-40 is a reliable and valid tool for quantifying listening-related fatigue in adults. We believe the VFS-A-40 will be useful for identifying those most at risk for severe listening-related fatigue and for assessing interventions to reduce its negative effects.	[Hornsby, Benjamin W. Y.; Camarata, Stephen; Davis, Hilary; Bess, Fred H.] Vanderbilt Univ, Sch Med, Dept Hearing & Speech Sci, Nashville, TN 37232 USA; [Cho, Sun-Joo] Vanderbilt Univ, Peabody Coll, Dept Psychol & Human Dev, Nashville, TN 37232 USA; [McGarrigle, Ronan] Univ York, Dept Psychol, York, N Yorkshire, England		Hornsby, BWY (corresponding author), Vanderbilt Univ, Sch Med, Dept Hearing & Speech Sci, Vanderbilt Bill Wilkerson Ctr, 1215 21st Ave South,MCE South Tower,Room 8310, Nashville, TN 37232 USA.	ben.hornsby@vumc.org		McGarrigle, Ronan/0000-0003-1704-1135; Davis, Hilary/0000-0002-8323-4691; Hornsby, Benjamin/0000-0001-6518-2747	Starkey Inc; NIH NIDCDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R21DC012865]; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD15052]; Vanderbilt Institute for Clinical and Translational Research grant (NCATS/NIH) [UL1 TR000445]	This work was supported by a grant from Starkey Inc (Hornsby, PI), by the NIH NIDCD Grant #R21DC012865 (Hornsby, PI), by an NICHD Grant P30HD15052 to the Vanderbilt Kennedy Center for Research on Human Development, and by a Vanderbilt Institute for Clinical and Translational Research grant (UL1 TR000445 from NCATS/NIH). The opinions expressed are those of the authors and do not represent the views of the NIH or other institutions. Portions of this work were presented at the 2018 American Academy of Audiology meeting, Nashville, Tennessee. R-code for calculating VFS-A-40 IRT (Item response theory) scale scores is available at https://osf.io/dpy9m/.The authors have no conflicts of interest to disclose.	Alhanbali S, 2017, EAR HEARING, V38, pE39, DOI 10.1097/AUD.0000000000000361; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bess FH, 2014, EAR HEARING, V35, P592, DOI 10.1097/AUD.0000000000000099; Borghini G, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00152; Bryant D, 2004, REHABIL PSYCHOL, V49, P114, DOI 10.1037/0090-5550.49.2.114; Camarata S, 2018, EXCEPT CHILDREN, V84, P420, DOI 10.1177/0014402918773316; Choi SW, 2011, J STAT SOFTW, V39, P1; Cole DA, 2012, J ABNORM PSYCHOL, V121, P838, DOI 10.1037/a0028175; Collins D, 2003, QUAL LIFE RES, V12, P229, DOI 10.1023/A:1023254226592; Davis H, 2021, INT J AUDIOL, V60, P458, DOI 10.1080/14992027.2020.1834631; DEAYALA RJ, 1994, APPL PSYCH MEAS, V18, P155, DOI 10.1177/014662169401800205; Donovan KA, 2015, SUPPORT CARE CANCER, V23, P191, DOI 10.1007/s00520-014-2389-7; Dwyer RT, 2019, AM J AUDIOL, V28, P686, DOI 10.1044/2019_AJA-19-0009; Embretson S.E., 2013, ITEM RESPONSE THEORY; Evans E J, 1999, Medsurg Nurs, V8, P363; Gibson SJ, 1997, J GERONTOL B-PSYCHOL, V52, pP167, DOI 10.1093/geronb/52B.4.P167; GREEN BF, 1984, J EDUC MEAS, V21, P347, DOI 10.1111/j.1745-3984.1984.tb01039.x; Hockey R, 2013, PSYCHOLOGY OF FATIGUE: WORK, EFFORT AND CONTROL, P132; Holman JA, 2019, INT J AUDIOL, V58, P408, DOI 10.1080/14992027.2019.1597284; Hornsby BWY, 2017, AM J AUDIOL, V26, P393, DOI 10.1044/2017_AJA-17-0007; Hornsby BWY, 2016, EAR HEARING, V37, p136S, DOI 10.1097/AUD.0000000000000289; Hornsby BWY, 2016, EAR HEARING, V37, pe1, DOI 10.1097/AUD.0000000000000203; Hornsby BWY, 2013, EAR HEARING, V34, P523, DOI 10.1097/AUD.0b013e31828003d8; Hospers JMB, 2016, J SPEECH LANG HEAR R, V59, P373, DOI 10.1044/2015_JSLHR-H-15-0156; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kang T, 2008, J EDUC MEAS, V45, P391, DOI 10.1111/j.1745-3984.2008.00071.x; KELLERMAN S, 1992, APPL LINGUIST, V13, P239, DOI 10.1093/applin/13.3.239; Krueger AB, 2008, J PUBLIC ECON, V92, P1833, DOI 10.1016/j.jpubeco.2007.12.015; Lai JS, 2006, QUAL LIFE RES, V15, P1179, DOI 10.1007/s11136-006-0060-6; LORD FM, 1984, APPL PSYCH MEAS, V8, P453, DOI 10.1177/014662168400800409; Masterson EA, 2016, MMWR-MORBID MORTAL W, V65, P389, DOI 10.15585/mmwr.mm6515a2; McGarrigle R., PSYCHOL AGING; McNair D. M., 2010, PROFILE MOOD STATES; McNair DM, 1971, PROFILE MOOD STATES; Michielsen HJ, 2004, EUR J PSYCHOL ASSESS, V20, P39, DOI 10.1027/1015-5759.20.1.39; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; PATRICK DL, 1989, MED CARE, V27, pS217, DOI 10.1097/00005650-198903001-00018; Paul RH, 1998, APPL NEUROPSYCHOL, V5, P143, DOI 10.1207/s15324826an0503_5; Pichora-Fuller MK, 2016, EAR HEARING, V37, p5S, DOI 10.1097/AUD.0000000000000312; Piper B F, 1998, Oncol Nurs Forum, V25, P677; R Core Team, 2013, LANGUAGE ENV STAT CO, DOI DOI 11/44679/INDEX.HTM; Robinson-Smith G, 2000, ARCH PHYS MED REHAB, V81, P460, DOI 10.1053/mr.2000.3863; Salinsky MC, 2001, J INT NEUROPSYCH SOC, V7, P597, DOI 10.1017/S1355617701755075; SAMEJIMA F, 1969, PSYCHOMETRIKA, V34, P1; Sinharay S, 2010, J EDUC MEAS, V47, P150, DOI 10.1111/j.1745-3984.2010.00106.x; Steiger J. H., 1980, ANN SPRING M PSYCH S; Stein KD, 2004, J PAIN SYMPTOM MANAG, V27, P14, DOI 10.1016/j.jpainsymman.2003.06.003; Thompson B., 2002, SCORE RELIABILITY CO; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Wilson M., 2005, ITEM RESPONSE MODELI; Yu C-Y, 2002, EVALUATING CUTOFF CR; Zumbo B.D., 1999, HDB THEORY METHODS D, P1	53	2	2	4	4	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	AUG	2021	33	8					777	788		10.1037/pas0001021			12	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	TY4RN	WOS:000683773400008	33856826	Green Accepted			2022-02-06	
J	Kummer, KK; Zeidler, M; Kalpachidou, T; Kress, M				Kummer, Kai K.; Zeidler, Maximilian; Kalpachidou, Theodora; Kress, Michaela			Role of IL-6 in the regulation of neuronal development, survival and function	CYTOKINE			English	Article						IL-6; Gp130; Neuron development; Neuropathic pain; Brain disorders; Regeneration	TRAUMATIC BRAIN-INJURY; CILIARY NEUROTROPHIC FACTOR; LEUKEMIA INHIBITORY FACTOR; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; CHRONIC INTERLEUKIN-6 ALTERS; MESSENGER-RNA EXPRESSION; SIGNAL TRANSDUCER GP130; SODIUM-CHANNEL ACTIVITY; NECROSIS-FACTOR-ALPHA	The pleiotropic cytokine interleukin-6 (IL-6) is emerging as a molecule with both beneficial and destructive potentials. It can exert opposing actions triggering either neuron survival after injury or causing neurodegeneration and cell death in neurodegenerative or neuropathic disorders. Importantly, neurons respond differently to IL-6 and this critically depends on their environment and whether they are located in the peripheral or the central nervous system. In addition to its hub regulator role in inflammation, IL-6 is recently emerging as an important regulator of neuron function in health and disease, offering exciting possibilities for more mechanistic insight into the pathogenesis of mental, neurodegenerative and pain disorders and for developing novel therapies for diseases with neuroimmune and neurogenic pathogenic components.	[Kummer, Kai K.; Zeidler, Maximilian; Kalpachidou, Theodora; Kress, Michaela] Med Univ Innsbruck, Inst Physiol, Schoepfstr 41-EG, A-6020 Innsbruck, Austria		Kress, M (corresponding author), Med Univ Innsbruck, Inst Physiol, Schoepfstr 41-EG, A-6020 Innsbruck, Austria.	michaela.kress@i-med.ac.at	Kalpachidou, Theodora/AAW-6538-2020; Kummer, Kai/G-3294-2014	Kalpachidou, Theodora/0000-0002-7924-7772; Kress, Michaela/0000-0002-8921-7470; Kummer, Kai/0000-0002-5854-6503	Austrian Science Fund FWFAustrian Science Fund (FWF) [P-28611]	Authors are grateful for funding provided for their research by the Austrian Science Fund FWF (grant P-28611 to MK)	Al-Hakeim HK, 2015, J AFFECT DISORDERS, V182, P106, DOI 10.1016/j.jad.2015.04.044; Ali C, 2000, J CEREBR BLOOD F MET, V20, P956, DOI 10.1097/00004647-200006000-00008; Alonzi T, 2001, MOL CELL NEUROSCI, V18, P270, DOI 10.1006/mcne.2001.1018; ALTSTIEL LD, 1991, PROG NEURO-PSYCHOPH, V15, P481, DOI 10.1016/0278-5846(91)90023-T; Alvarez P, 2019, PAIN, V160, P1876, DOI 10.1097/j.pain.0000000000001570; Andratsch M, 2009, J NEUROSCI, V29, P13473, DOI 10.1523/JNEUROSCI.1822-09.2009; ARAKAWA Y, 1990, J NEUROSCI, V10, P3507; Arruda JL, 2000, BRAIN RES, V879, P216, DOI 10.1016/S0006-8993(00)02807-9; Barkho BZ, 2006, STEM CELLS DEV, V15, P407, DOI 10.1089/scd.2006.15.407; Bassi MS, 2019, NEUROREHAB NEURAL RE, V33, P825, DOI 10.1177/1545968319868713; BAUER J, 1991, FEBS LETT, V285, P111, DOI 10.1016/0014-5793(91)80737-N; Beederman Maureen, 2013, J Biomed Sci Eng, V6, P32; Benedict C, 2009, FASEB J, V23, P3629, DOI 10.1096/fj.08-122853; BlumDegen D, 1995, NEUROSCI LETT, V202, P17, DOI 10.1016/0304-3940(95)12192-7; Boettger MK, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3079; BOLIN LM, 1995, J NEUROCHEM, V64, P850; Bolmont T, 2008, J NEUROSCI, V28, P4283, DOI 10.1523/JNEUROSCI.4814-07.2008; Borovcanin MM, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00221; Bowen KK, 2011, NEUROREPORT, V22, P126, DOI 10.1097/WNR.0b013e3283430a44; Boyette-Davis J, 2011, EXP NEUROL, V229, P353, DOI 10.1016/j.expneurol.2011.02.019; Boyette-Davis J, 2011, PAIN, V152, P308, DOI 10.1016/j.pain.2010.10.030; Bradburn S, 2018, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00438; Brady JJ, 2013, NAT CELL BIOL, V15, P1244, DOI 10.1038/ncb2835; Brenn D, 2007, ARTHRITIS RHEUM, V56, P351, DOI 10.1002/art.22282; Burke NN, 2013, GENES BRAIN BEHAV, V12, P705, DOI 10.1111/gbb.12080; Burke NN, 2014, BRAIN BEHAV IMMUN, V42, P147, DOI 10.1016/j.bbi.2014.06.015; Burke NN, 2013, J PAIN, V14, P1173, DOI 10.1016/j.jpain.2013.05.003; Burton MD, 2013, BRAIN BEHAV IMMUN, V30, P66, DOI 10.1016/j.bbi.2013.01.002; Bustamante A, 2014, J NEUROIMMUNOL, V274, P215, DOI 10.1016/j.jneuroim.2014.07.015; Cafferty WBJ, 2004, J NEUROSCI, V24, P4432, DOI 10.1523/JNEUROSCI.2245-02.2004; Cameron NE, 2007, EXP NEUROL, V207, P23, DOI 10.1016/j.expneurol.2007.05.009; Campbell IL, 1998, ANN NY ACAD SCI, V840, P83, DOI 10.1111/j.1749-6632.1998.tb09552.x; Cannella B, 2004, ANN NEUROL, V55, P46, DOI 10.1002/ana.10764; Cao ZX, 2006, J NEUROSCI, V26, P5565, DOI 10.1523/JNEUROSCI.0815-06.2006; Chakrabarty P, 2010, FASEB J, V24, P548, DOI 10.1096/fj.09-141754; Chandran V, 2016, NEURON, V89, P956, DOI 10.1016/j.neuron.2016.01.034; Chen HW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8095; Chen WQ, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0847-0; Chojnacki A, 2003, J NEUROSCI, V23, P1730; Choy EH, 2020, NAT REV RHEUMATOL, V16, P335, DOI 10.1038/s41584-020-0419-z; Codeluppi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092649; Cohen JA, 2019, CELL, V178, P919, DOI 10.1016/j.cell.2019.06.022; Conroy SM, 2004, J NEUROIMMUNOL, V155, P43, DOI 10.1016/j.jneuroim.2004.06.014; Cotter MA, 2010, DIABETES OBES METAB, V12, P689, DOI 10.1111/j.1463-1326.2010.01221.x; Cox AA, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00089; D'Arcangelo G, 2000, EUR J NEUROSCI, V12, P1241, DOI 10.1046/j.1460-9568.2000.00011.x; Del Giudice M, 2018, BRAIN BEHAV IMMUN, V70, P61, DOI 10.1016/j.bbi.2018.02.013; DeLeo JA, 1996, J INTERF CYTOK RES, V16, P695, DOI 10.1089/jir.1996.16.695; Dimitrov S, 2006, FASEB J, V20, P2174, DOI 10.1096/fj.06-5754fje; Ding CP, 2016, NEUROCHEM RES, V41, P3042, DOI 10.1007/s11064-016-2023-9; Dolcet X, 2001, MOL CELL NEUROSCI, V18, P619, DOI 10.1006/mcne.2001.1058; Drogemuller K, 2008, J IMMUNOL, V181, P2683, DOI 10.4049/jimmunol.181.4.2683; Dubovy P, 2019, HISTOCHEM CELL BIOL, V152, P109, DOI 10.1007/s00418-019-01779-3; Ebbinghaus M, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0858-0; Eidan AJ, 2019, J INTERF CYTOK RES, V39, P181, DOI 10.1089/jir.2018.0134; Ernst M, 2001, J EXP MED; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Escrig A, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9071605; Eugster HP, 1998, EUR J IMMUNOL, V28, P2178, DOI 10.1002/(SICI)1521-4141(199807)28:07<2178::AID-IMMU2178>3.0.CO;2-D; Fang D, 2015, PAIN, V156, P1124, DOI 10.1097/j.pain.0000000000000158; Fang X, 2019, CLIN PSYCHOPHARM NEU, V17, P189, DOI 10.9758/cpn.2019.17.2.189; FANN MJ, 1994, P NATL ACAD SCI USA, V91, P43, DOI 10.1073/pnas.91.1.43; Farzanehfar P, 2016, NEUROCHEM RES, V41, P3161, DOI 10.1007/s11064-016-2053-3; Fasnacht N, 2008, SEMIN CELL DEV BIOL, V19, P379, DOI 10.1016/j.semcdb.2008.07.001; Fattori E, 1995, EUR J NEUROSCI, V7, P2441, DOI 10.1111/j.1460-9568.1995.tb01042.x; Feng MY, 2019, NEUROSCIENCE, V406, P109, DOI 10.1016/j.neuroscience.2019.03.003; Feng QL, 2015, EXP THER MED, V9, P1695, DOI 10.3892/etm.2015.2363; FERREIRA SH, 1993, BRIT J PHARMACOL, V110, P1227, DOI 10.1111/j.1476-5381.1993.tb13946.x; Fiore NT, 2019, NEUROSCIENCE, V416, P147, DOI 10.1016/j.neuroscience.2019.08.005; Flatters SJL, 2004, EUR J PHARMACOL, V484, P183, DOI 10.1016/j.ejphar.2003.11.013; Flatters SJL, 2003, BRAIN RES, V984, P54, DOI 10.1016/S0006-8993(03)03092-0; Fonseka TM, 2015, EXPERT OPIN INV DRUG, V24, P459, DOI 10.1517/13543784.2014.998334; Foshay KM, 2008, STEM CELLS DEV, V17, P269, DOI 10.1089/scd.2007.0098; FREI K, 1989, EUR J IMMUNOL, V19, P689, DOI 10.1002/eji.1830190418; Frydecka D, 2015, EUR ARCH PSY CLIN N, V265, P449, DOI 10.1007/s00406-014-0533-5; Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X; Galiano M, 2001, EUR J NEUROSCI, V14, P327, DOI 10.1046/j.0953-816x.2001.01647.x; Gallagher D, 2013, CELL STEM CELL, V13, P564, DOI 10.1016/j.stem.2013.10.002; Gardiner NJ, 2002, J NEUROCHEM, V83, P100, DOI 10.1046/j.1471-4159.2002.01101.x; Garver DL, 2003, NEUROPSYCHOPHARMACOL, V28, P1515, DOI 10.1038/sj.npp.1300217; Gertz K, 2012, BRAIN, V135, P1964, DOI 10.1093/brain/aws075; GIJBELS K, 1995, MOL MED, V1, P795, DOI 10.1007/BF03401894; GIJBELS K, 1990, EUR J IMMUNOL, V20, P233, DOI 10.1002/eji.1830200134; Gonzalez-Sepulveda M, 2016, J PSYCHOPHARMACOL, V30, P188, DOI 10.1177/0269881115622238; Grandbarbe L, 2003, DEVELOPMENT, V130, P1391, DOI 10.1242/dev.00374; Grande F, 2007, BIOORGAN MED CHEM, V15, P288, DOI 10.1016/j.bmc.2006.09.073; Gregg C, 2005, DEVELOPMENT, V132, P565, DOI 10.1242/dev.01592; Gu Z.J., 1996, J IMMUNOL METHODS; Guo G, 2016, STEM CELL REP, V6, P437, DOI 10.1016/j.stemcr.2016.02.005; Guptarak J, 2013, PAIN, V154, P1115, DOI 10.1016/j.pain.2013.03.026; Handel U, 2012, AM J PATHOL, V181, P163, DOI 10.1016/j.ajpath.2012.03.029; Hakkoum D, 2007, J NEUROCHEM, V100, P747, DOI 10.1111/j.1471-4159.2006.04257.x; HAMA T, 1991, NEUROSCIENCE, V40, P445, DOI 10.1016/0306-4522(91)90132-8; HAMA T, 1989, NEUROSCI LETT, V104, P340, DOI 10.1016/0304-3940(89)90600-9; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Hirota H, 1996, J EXP MED, V183, P2627, DOI 10.1084/jem.183.6.2627; Hogan D, 2003, J NEUROIMMUNOL, V137, P59, DOI 10.1016/S0165-5728(03)00038-9; Hong SS, 2015, J IMMUNOL, V195, P237, DOI 10.4049/jimmunol.1402908; Hori N, 2016, SYNAPSE, V70, P317, DOI 10.1002/syn.21902; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Hsu MP, 2015, GLIA, V63, P132, DOI 10.1002/glia.22739; Hu P, 2002, NEUROSCIENCE, V112, P23, DOI 10.1016/S0306-4522(02)00065-9; Hu ZS, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107657; Hull M, 1996, BEHAV BRAIN RES, V78, P37, DOI 10.1016/0166-4328(95)00213-8; Imai S, 2013, BRAIN, V136, P828, DOI 10.1093/brain/aws330; Inomata Y, 2003, BIOCHEM BIOPH RES CO, V302, P226, DOI 10.1016/S0006-291X(03)00127-X; INOUE M, 1995, P NATL ACAD SCI USA, V92, P8579, DOI 10.1073/pnas.92.19.8579; Irwin MR, 2017, NEUROPSYCHOPHARMACOL, V42, P129, DOI 10.1038/npp.2016.148; Irwin MR, 2016, BIOL PSYCHIAT, V80, P40, DOI 10.1016/j.biopsych.2015.05.014; Islam O, 2009, MOL BIOL CELL, V20, P188, DOI 10.1091/mbc.E08-05-0463; Ito Y, 1998, BRAIN RES, V793, P321, DOI 10.1016/S0006-8993(98)00242-X; Jazayeri JA, 2010, J INTERF CYTOK RES, V30, P865, DOI 10.1089/jir.2010.0035; Jeevakumar V, 2020, J NEUROPHYSIOL, V124, P274, DOI 10.1152/jn.00188.2020; Jung JE, 2011, STROKE, V42, P3574, DOI 10.1161/STROKEAHA.111.626648; Juttler E, 2002, NEUROSCIENTIST, V8, P268, DOI 10.1177/1073858402008003012; Kageyama R, 2009, CURR OPIN CELL BIOL, V21, P733, DOI 10.1016/j.ceb.2009.08.009; Kalueff AV, 2004, NEUROSCI LETT, V365, P106, DOI 10.1016/j.neulet.2004.04.061; Kato CD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003835; Khandaker GM, 2014, JAMA PSYCHIAT, V71, P1121, DOI 10.1001/jamapsychiatry.2014.1332; KIEFER R, 1993, EUR J NEUROSCI, V5, P775, DOI 10.1111/j.1460-9568.1993.tb00929.x; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Klein MA, 1997, GLIA, V19, P227, DOI 10.1002/(SICI)1098-1136(199703)19:3<227::AID-GLIA5>3.0.CO;2-W; Ko JS, 2016, BRAIN BEHAV IMMUN, V56, P378, DOI 10.1016/j.bbi.2016.03.003; Konig C, 2016, J NEUROSCI, V36, P9782, DOI 10.1523/JNEUROSCI.4159-15.2016; Kong XJ, 2019, BRAIN BEHAV IMMUN, V79, P159, DOI 10.1016/j.bbi.2019.01.027; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; Kotasova H, 2014, CELL MOL NEUROBIOL, V34, P1, DOI 10.1007/s10571-013-9996-6; Kwok CHT, 2020, BRAIN BEHAV IMMUN, V90, P145, DOI 10.1016/j.bbi.2020.08.004; Lacroix S, 2002, J COMP NEUROL, V454, P213, DOI 10.1002/cne.10407; Langeslag M, 2014, PFLUG ARCH EUR J PHY, V466, P2153, DOI 10.1007/s00424-014-1443-0; Langeslag M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-102; Lee HK, 2009, J NEUROCHEM, V108, P776, DOI 10.1111/j.1471-4159.2008.05826.x; Leibinger M, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20112-4; Ley EJ, 2011, J SURG RES, V170, P253, DOI 10.1016/j.jss.2011.03.006; Li XN, 2014, ACTA NEUROPSYCHIATR, V26, P170, DOI 10.1017/neu.2013.49; Liu AF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152120; Liu CC, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-76; Liu DX, 2019, PHYSIOL RES, V68, P845, DOI 10.33549/physiolres.934015; Liu QY, 2019, EXP NEUROL, V317, P226, DOI 10.1016/j.expneurol.2019.03.005; Liu Z, 2013, BRAIN INJURY, V27, P1047, DOI 10.3109/02699052.2013.794970; Liu Z, 2011, NEUROTOX RES, V19, P484, DOI 10.1007/s12640-010-9215-x; Loddick SA, 1998, J CEREBR BLOOD F MET, V18, P176, DOI 10.1097/00004647-199802000-00008; Ma SH, 2015, CELL CALCIUM, V58, P286, DOI 10.1016/j.ceca.2015.06.006; Ma SH, 2012, J PHYSIOL SCI, V62, P385, DOI 10.1007/s12576-012-0215-x; Ma WY, 2006, EXPERT OPIN THER TAR, V10, P533, DOI 10.1517/14728222.10.4.533; Maes M, 2014, EXPERT OPIN THER TAR, V18, P495, DOI 10.1517/14728222.2014.888417; Magrinelli F, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/547834; Malek N, 2015, MOL CELL NEUROSCI, V65, P1, DOI 10.1016/j.mcn.2015.02.001; Malsch P, 2014, J NEUROSCI, V34, P9845, DOI 10.1523/JNEUROSCI.5161-13.2014; Manjavachi MN, 2010, PAIN, V151, P345, DOI 10.1016/j.pain.2010.07.018; Martinez-Navarro M, 2019, NEUROPHARMACOLOGY, V148, P291, DOI 10.1016/j.neuropharm.2019.01.012; Martins-Taylor K, 2012, EPIGENETICS-US, V7, P71, DOI 10.4161/epi.7.1.18750; Marz P, 1998, P NATL ACAD SCI USA, V95, P3251, DOI 10.1073/pnas.95.6.3251; Marz P, 1999, EUR J NEUROSCI, V11, P2995, DOI 10.1046/j.1460-9568.1999.00755.x; Marz P, 1997, EUR J NEUROSCI, V9, P2765, DOI 10.1111/j.1460-9568.1997.tb01705.x; Marz P, 1999, GLIA, V26, P191, DOI 10.1002/(SICI)1098-1136(199905)26:3<191::AID-GLIA1>3.0.CO;2-#; Marz P, 1997, NEUROSCI LETT, V239, P29, DOI 10.1016/S0304-3940(97)00886-0; Melemedjian OK, 2010, J NEUROSCI, V30, P15113, DOI 10.1523/JNEUROSCI.3947-10.2010; Meng C, 2015, NEUROSCIENCE, V307, P160, DOI 10.1016/j.neuroscience.2015.08.055; Mika J, 2013, EUR J PHARMACOL, V716, P106, DOI 10.1016/j.ejphar.2013.01.072; Miller BJ, 2011, BIOL PSYCHIAT, V70, P663, DOI 10.1016/j.biopsych.2011.04.013; Mogi M, 1996, NEUROSCI LETT, V211, P13, DOI 10.1016/0304-3940(96)12706-3; Momtazmanesh S, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00892; Moon BS, 2009, EXP MOL MED, V41, P116, DOI 10.3858/emm.2009.41.2.014; Morganti-Kossmann M.C., 2002, CURR OPIN CRIT CARE, V8; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Morrison BE, 2016, NEURAL REGEN RES, V11, P878, DOI 10.4103/1673-5374.184449; Morrow JD, 2005, BRAIN BEHAV IMMUN, V19, P28, DOI 10.1016/j.bbi.2004.02.003; Moy JK, 2017, J NEUROSCI, V37, P7481, DOI 10.1523/JNEUROSCI.0220-17.2017; Muller S, 2009, STEM CELLS, V27, P431, DOI 10.1634/stemcells.2008-0234; Muller N, 2000, ANN NY ACAD SCI, V917, P456; Muller T, 1998, ACTA NEUROL SCAND, V98, P142; Murakami T, 2013, EXP THER MED, V6, P1194, DOI 10.3892/etm.2013.1296; Murphy PG, 1999, EUR J NEUROSCI, V11, P2243, DOI 10.1046/j.1460-9568.1999.00641.x; MURPHY PG, 1995, J NEUROSCI, V15, P5130; Nakamura M, 2005, CLIN REV ALLERG IMMU, V28, P197, DOI 10.1385/CRIAI:28:3:197; Nakashima K, 1999, J NEUROSCI, V19, P5429; Napoli E, 2017, STEM CELLS, V35, P1443, DOI 10.1002/stem.2636; Nelson TE, 2004, EUR J NEUROSCI, V20, P2387, DOI 10.1111/j.1460-9568.2004.03706.x; Ng A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30487-6; Niemi JP, 2017, EXP NEUROL, V296, P1, DOI 10.1016/j.expneurol.2017.06.020; NIJSTEN MWN, 1987, LANCET, V2, P921; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Obreja O, 2005, BRAIN, V128, P1634, DOI 10.1093/brain/awh490; Obreja O, 2002, PAIN, V96, P57, DOI 10.1016/S0304-3959(01)00420-1; OH YJ, 1994, NEUROREPORT, V5, P937, DOI 10.1097/00001756-199404000-00021; Okada S, 2004, J NEUROSCI RES, V76, P265, DOI 10.1002/jnr.20044; Okamoto K, 2001, EXP NEUROL, V169, P386, DOI 10.1006/exnr.2001.7677; Okuda Y, 1998, INT IMMUNOL, V10, P703, DOI 10.1093/intimm/10.5.703; Opree A, 2000, J NEUROSCI, V20, P6289, DOI 10.1523/JNEUROSCI.20-16-06289.2000; Otten U, 2000, ANN NY ACAD SCI, V917, P322; Oyanedel CN, 2015, BRAIN BEHAV IMMUN, V50, P178, DOI 10.1016/j.bbi.2015.07.001; Parish CL, 2002, J NEUROSCI, V22, P8034; Peng YP, 2005, NEUROSCI LETT, V374, P192, DOI 10.1016/j.neulet.2004.10.069; Penkowa M, 2000, GLIA, V32, P271, DOI 10.1002/1098-1136(200012)32:3<271::AID-GLIA70>3.0.CO;2-5; Peters M, 1996, IMMUNOL LETT, V54, P177, DOI 10.1016/S0165-2478(96)02669-7; Pieraut S, 2011, J NEUROSCI, V31, P13516, DOI 10.1523/JNEUROSCI.3382-11.2011; Qiu AW, 2013, NEUROENDOCRINOL LETT, V34, P529; Qiu ZH, 1998, J NEUROSCI, V18, P10445; Quarta S, 2014, J NEUROSCI, V34, P13222, DOI 10.1523/JNEUROSCI.1209-13.2014; Quarta S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-73; Quintana A, 2008, DEV NEUROBIOL, V68, P195, DOI 10.1002/dneu.20584; Radad K, 2017, CNS NEUROL DISORD-DR, V16, P740, DOI 10.2174/1871527316666170623094728; Ramer MS, 1998, PAIN, V78, P115, DOI 10.1016/S0304-3959(98)00121-3; Redwine L, 2000, J CLIN ENDOCR METAB, V85, P3597, DOI 10.1210/jc.85.10.3597; Reinhardt EL, 2016, CHRONOBIOL INT, V33, P780, DOI 10.3109/07420528.2016.1167710; Reyes TM, 1999, BRAIN RES, V851, P215, DOI 10.1016/S0006-8993(99)02189-7; Ringheim GE, 1998, MOL BRAIN RES, V55, P35, DOI 10.1016/S0169-328X(97)00356-2; Ringheim GE, 1995, J NEUROIMMUNOL, V63, P113, DOI 10.1016/0165-5728(95)00134-4; Ritter PS, 2013, MED HYPOTHESES, V81, P1031, DOI 10.1016/j.mehy.2013.09.025; Robinson R, 2020, REDOX BIOL, V34, DOI 10.1016/j.redox.2020.101574; Guerrero AR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-40; Rodriguez-Rivera NS, 2009, INT J DEV BIOL, V53, P947, DOI 10.1387/ijdb.092869nr; Rose-John S, 2002, TRENDS BIOTECHNOL, V20, P417, DOI 10.1016/S0167-7799(02)02056-5; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; Rothaug M, 2016, BBA-MOL CELL RES, V1863, P1218, DOI 10.1016/j.bbamcr.2016.03.018; Rowe RK, 2016, MOL PAIN, V12, DOI 10.1177/1744806916647055; Rudge JS, 1996, MOL CELL NEUROSCI, V7, P204, DOI 10.1006/mcne.1996.0016; Sakata H, 2012, BRAIN, V135, P3298, DOI 10.1093/brain/aws259; Samland H, 2003, J NEUROSCI RES, V73, P176, DOI 10.1002/jnr.10635; SAWADA M, 1993, NEUROSCI LETT, V160, P131, DOI 10.1016/0304-3940(93)90396-3; Schafer KH, 1999, J INTERF CYTOK RES, V19, P527, DOI 10.1089/107999099313974; Schaper F, 2015, CYTOKINE GROWTH F R, V26, P475, DOI 10.1016/j.cytogfr.2015.07.004; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Schonrock LM, 2000, NEUROSCI LETT, V294, P45, DOI 10.1016/S0304-3940(00)01543-3; Schreiber S., 2021, GASTROENTEROLOGY; Schwieler L, 2015, J PSYCHIATR NEUROSCI, V40, P126, DOI 10.1503/jpn.140126; Shaafi S, 2014, IRAN J NEUROL, V13, P70; Shan XY, 2006, STEM CELLS, V24, P1280, DOI 10.1634/stemcells.2005-0487; Shi YH, 2008, CRIT REV ONCOL HEMAT, V65, P43, DOI 10.1016/j.critrevonc.2007.06.004; Shimazaki T, 2001, J NEUROSCI, V21, P7642, DOI 10.1523/JNEUROSCI.21-19-07642.2001; Shuto T, 2001, NEUROREPORT, V12, P1081, DOI 10.1097/00001756-200104170-00043; Siau C, 2006, EXP NEUROL, V201, P507, DOI 10.1016/j.expneurol.2006.05.007; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Simeoli R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01841-5; SINGER B R, 1989, Journal of the Royal Army Medical Corps, V135, P139; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Sommer C, 2004, NEUROSCI LETT, V361, P184, DOI 10.1016/j.neulet.2003.12.007; Sommer J, 2012, J BIOL CHEM; Sordillo PP, 2016, BRAIN INJURY, V30, P1043, DOI 10.3109/02699052.2016.1163618; Spittau B, 2012, NEUROMOL MED, V14, P317, DOI 10.1007/s12017-012-8189-7; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stanke M, 2006, DEVELOPMENT, V133, P141, DOI 10.1242/dev.02189; Sterneck E, 1996, J NEUROCHEM, V67, P1365; Stoker TB, 2017, NEURAL REGEN RES, V12, P389, DOI 10.4103/1673-5374.202935; Sulistio YA, 2018, MOL NEUROBIOL, V55, P3513, DOI 10.1007/s12035-017-0594-3; Swartz KR, 2001, BRAIN RES, V896, P86, DOI 10.1016/S0006-8993(01)02013-3; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tan Y, 2013, J NEUROPATH EXP NEUR, V72, P980, DOI 10.1097/NEN.0b013e3182a79de9; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Thier M, 1999, J NEUROSCI RES, V55, P411; Torres PMM, 2001, J NEUROIMMUNOL, V117, P43, DOI 10.1016/S0165-5728(01)00303-4; TOSATO G, 1988, SCIENCE, V239, P502, DOI 10.1126/science.2829354; TOULMOND S, 1992, NEUROSCI LETT, V144, P49, DOI 10.1016/0304-3940(92)90713-H; VANDAMME J, 1987, J EXP MED, V165, P914, DOI 10.1084/jem.165.3.914; Vazquez E, 2012, ARTHRITIS RHEUM-US, V64, P2233, DOI 10.1002/art.34384; Vereyken EJF, 2007, EUR J NEUROSCI, V25, P3605, DOI 10.1111/j.1460-9568.2007.05615.x; Vezzani A, 2015, NEUROPHARMACOLOGY, V96, P70, DOI 10.1016/j.neuropharm.2014.10.027; Vgontzas AN, 2005, NEUROIMMUNOMODULAT, V12, P131, DOI 10.1159/000084844; Vgontzas AN, 1999, J CLIN ENDOCR METAB, V84, P2603, DOI 10.1210/jc.84.8.2603; Wang P, 2019, BRAIN BEHAV IMMUN, V82, P106, DOI 10.1016/j.bbi.2019.08.002; Wang XM, 2012, CYTOKINE, V59, P3, DOI 10.1016/j.cyto.2012.03.027; Wang XQ, 2009, NEUROSCI LETT, V450, P122, DOI 10.1016/j.neulet.2008.11.051; Willis EF, 2020, CELL, V180, P833, DOI 10.1016/j.cell.2020.02.013; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; WOOD JA, 1993, BRAIN RES, V629, P245, DOI 10.1016/0006-8993(93)91327-O; Xia W, 2015, NEURAL REGEN RES, V10, P610, DOI 10.4103/1673-5374.155436; Xu LP, 2018, INT J MOL MED, V41, P2037, DOI 10.3892/ijmm.2018.3418; Xu N, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00209; Xu XJ, 1997, CYTOKINE, V9, P1028, DOI 10.1006/cyto.1997.0243; Yan J, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-6; Yang G, 2017, INT J MOL MED, V39, P437, DOI 10.3892/ijmm.2017.2848; Yang LQ, 2004, SPINE, V29, P966, DOI 10.1097/00007632-200405010-00004; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yoshida K, 1996, P NATL ACAD SCI USA, V93, P407, DOI 10.1073/pnas.93.1.407; ZALCMAN S, 1994, BRAIN RES, V643, P40, DOI 10.1016/0006-8993(94)90006-X; Zhang PL, 2007, EXP NEUROL, V208, P285, DOI 10.1016/j.expneurol.2007.08.022; Zhang QJ, 2019, J NEUROCHEM, V151, P238, DOI 10.1111/jnc.14697; Zhang XL, 2020, ADV CLIN EXP MED, V29, P793, DOI 10.17219/acem/121929; Zhao D, 2019, MOL PAIN, V15, DOI 10.1177/1744806919857981; Zhong J, 1999, J NEUROSCI, V19, P4305; Zhou C, 2011, NEUROCHEM RES, V36, P1116, DOI 10.1007/s11064-011-0456-8; Zhou YQ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0607-6	286	2	2	1	3	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666	1096-0023		CYTOKINE	Cytokine	AUG	2021	144								155582	10.1016/j.cyto.2021.155582			12	Biochemistry & Molecular Biology; Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Immunology	SM6EO	WOS:000657696400003	34058569	hybrid			2022-02-06	
J	Maietta, JE; Ahmed, AO; Barchard, KA; Kuwabara, HC; Donohue, B; Ross, SR; Kinsora, TF; Allen, DN				Maietta, Julia E.; Ahmed, Anthony O.; Barchard, Kimberly A.; Kuwabara, Hana C.; Donohue, Bradley; Ross, Staci R.; Kinsora, Thomas F.; Allen, Daniel N.			Confirmatory Factor Analysis of ImPACT Cognitive Tests in High School Athletes	PSYCHOLOGICAL ASSESSMENT			English	Article						ImPACT; sport concussion; factor analysis; psychometrics	CONCUSSION ASSESSMENT; FIT INDEXES; RELIABILITY; SENSITIVITY; CONSTRUCT; VALIDITY; BATTERY	ImPACT is themost commonly utilized computerized neurocognitive assessment for the clinical management of sport concussion. The cognitive composite scores that ImPACT currently reports include Verbal Memory, Visual Memory, Visual Motor Speed, Reaction Time, and Impulse Control. However, exploratory factor analytic studies report that two or more factors may better represent ImPACT's latent structure, suggesting that the current cognitive composites may not adequately represent the cognitive constructs ImPACT assesses. The latent structure of ImPACT cognitive baseline scores was examined using exploratory (EFA) and confirmatory factor analysis (CFA) of valid baseline ImPACT scores for 36,091 high school athletes. These athletes were randomly divided into two samples. The first sample was a calibration sample used for EFA and the second sample was a cross-validation sample used for CFA to estimate the best model identified in the calibration phase, along with other models that were reported in the literature or based on theoretical considerations, including hierarchical and bifactor models. EFA identified a first-order four-factor solution consisting of Visual Memory, Visual Reaction Time, Verbal Memory, and Working Memory constructs. CFA indicated that this four-factor model provided superior fit for the data, while the current five-composite structure of ImPACT provided a poor fit for the data. The latent constructs identified in this study using CFA do not map well onto the composite scores that are currently used to interpret ImPACT performance. Future research should investigate whether interpretation of ImPACT based on the constructs identified here will be more useful for clinical decision making than current approaches.	[Maietta, Julia E.; Barchard, Kimberly A.; Kuwabara, Hana C.; Donohue, Bradley; Allen, Daniel N.] Univ Nevada, Dept Psychol, Box 455030,4505 Maryland Pkwy, Las Vegas, NV 89154 USA; [Ahmed, Anthony O.] Weill Cornell Med, Dept Psychiat, New York, NY USA; [Ross, Staci R.; Kinsora, Thomas F.] Ctr Appl Neurosci, Las Vegas, NV USA		Allen, DN (corresponding author), Univ Nevada, Dept Psychol, Box 455030,4505 Maryland Pkwy, Las Vegas, NV 89154 USA.	daniel.allen@unlv.edu		Maietta, Julia/0000-0001-5612-6321			Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; Alsalaheen B, 2016, J HEAD TRAUMA REHAB, V31, P242, DOI 10.1097/HTR.0000000000000175; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bornovalova MA, 2020, BIOL PSYCHIAT, V88, P18, DOI 10.1016/j.biopsych.2020.01.013; Brett BL, 2017, DEV NEUROPSYCHOL, V42, P70, DOI 10.1080/87565641.2016.1243114; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Byrne B. M, 2006, STRUCTURAL EQUATION, V2nd, P440; Byrne BM, 2005, J PERS ASSESS, V85, P17, DOI 10.1207/s15327752jpa8501_02; Cangur S, 2015, J MOD APPL STAT METH, V14, P152, DOI 10.22237/jmasm/1430453580; Echemendia RJ, 2020, CLIN NEUROPSYCHOL, V34, P899, DOI 10.1080/13854046.2019.1690051; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Field A., 2017, DISCOVERING STAT USI, V5th; Gaudet CE, 2021, ARCH CLIN NEUROPSYCH, V36, P561, DOI 10.1093/arclin/acaa074; Gerrard PB, 2017, ARCH CLIN NEUROPSYCH, V32, P117, DOI 10.1093/arclin/acw097; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Lovell, 2021, IMPACT ADM INT MAN 2 IMPACT ADM INT MAN 2; MacCallum RC, 2000, ANNU REV PSYCHOL, V51, P201, DOI 10.1146/annurev.psych.51.1.201; Maerlender A, 2013, CLIN NEUROPSYCHOL, V27, P290, DOI 10.1080/13854046.2012.744098; Markon KE, 2019, ANNU REV CLIN PSYCHO, V15, P51, DOI 10.1146/annurev-clinpsy-050718-095522; MARSH HW, 1988, PSYCHOL BULL, V103, P391, DOI 10.1037/0033-2909.103.3.391; Masterson CJ, 2019, J CLIN EXP NEUROPSYC, V41, P925, DOI 10.1080/13803395.2019.1641184; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P791, DOI 10.1093/arclin/act077; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Smith A., 1982, SYMBOL DIGIT MODALIT; Steiger JH, 2016, STRUCT EQU MODELING, V23, P777, DOI 10.1080/10705511.2016.1217487; Stevens J.P., 2002, APPL MULTIVARIATE ST, V4th ed.; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363; Velicer W.F, 2000, PROBLEMS SOLUTIONS H, P41, DOI DOI 10.1007/978-1-4615-4397-8_3; West SG., 2012, HDB STRUCTURAL EQUAT, P209	39	2	2	6	8	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	AUG	2021	33	8					746	755		10.1037/pas0001014			10	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	TY4RN	WOS:000683773400005	33983785				2022-02-06	
J	Makaloski, V; Widenka, H; Schonhoff, F; Spanos, K; Wyss, TR; Schmidli, J				Makaloski, Vladimir; Widenka, Hannah; Schoenhoff, Florian; Spanos, Konstantinos; Wyss, Thomas R.; Schmidli, Juerg			Efficacy and Safety of Heparinization before Deployment of Endograft for Blunt Traumatic Aortic Injury in Severely Injured Patients	ANNALS OF VASCULAR SURGERY			English	Article							MOLECULAR-WEIGHT-HEPARIN; SOLID-ORGAN INJURY; VENOUS THROMBOEMBOLISM PROPHYLAXIS; CLINICAL-PRACTICE-GUIDELINES; ENDOVASCULAR STENT-GRAFT; THORACIC AORTA; NONOPERATIVE MANAGEMENT; OPERATIVE REPAIR; EDITORS CHOICE; MULTICENTER	Background: The administration of unfractionated heparin (UFH) during endovascular repair of blunt traumatic aortic injury (BTAI) is controversial. The aim of the study is to report the early outcomes of patients undergoing thoracic endovascular aortic repair (TEVAR) for BTAI, and to assess the individualized intraoperative use and dose of UFH. Methods: This is a retrospective analysis including consecutive patients treated with TEVAR for BTAI of the descending aorta between January 1st, 2005 and December 31st, 2018. Intraoperative use and doses of UFH were analyzed. Primary outcome included a reintervention because of new onset bleeding and/or thromboembolic complication and 30-day mortality. Technical success, injury severity score (ISS), timing of treatment, and neurologic deterioration were secondary outcome. Results: Thirty-six patients with a mean age of 47 +/- 18 years, 30 males (83%), were included. Intraoperative administration of UFH was recorded in 30/36 patients (83%) with a mean dose of 4750 +/- 2180 IU. Two patients had no UFH because of extensive intracranial hemorrhage or suspected relevant liver laceration, respectively; 1 died in theatre, 1 was already anticoagulated having a mechanical aortic valve, and in 2 no information about heparin use was found. During 30 days of follow-up, 3 patients died (8%; 3/36): 1 patient with completely transected aorta died on-table and 2 on the fifth postoperative day, 1 from trauma-associated brain injury and 1 with multi organ failure. No bleeding or thromboembolic complication requiring reintervention occurred in any patient during 30 days follow-up. In 3 patients partial unintentional coverage of the left common carotid artery occurred, resulting in technical success of 89% (32/36). Mean ISS was 43 +/- 15. Thirty-five patients (97%) were severely injured having an ISS >= 25. Twenty-nine patients (81%) were treated within 24 hr and 6 patients (17%) within 1 week. No stroke or spinal cord ischemia was observed. Conclusions: Systemic heparinization in different doses during TEVAR for BTAI can be safe with no intraoperative bleeding or thromboembolic complications in early postoperative period.	[Makaloski, Vladimir; Widenka, Hannah; Schoenhoff, Florian; Wyss, Thomas R.; Schmidli, Juerg] Univ Bern, Univ Hosp Bern, Dept Cardiovasc Surg, Inselspital, CH-3010 Bern, Switzerland; [Spanos, Konstantinos] Univ Thessaly, Univ Hosp Larissa, Fac Med, Sch Hlth Sci,Vasc Surg Dept, Larisa, Greece		Makaloski, V (corresponding author), Univ Bern, Univ Hosp Bern, Dept Cardiovasc Surg, Inselspital, CH-3010 Bern, Switzerland.	vladimir.makaloski@insel.ch		Makaloski, Vladimir/0000-0001-8826-3232			Benjamin E, 2017, ANN SURG, V266, P463, DOI 10.1097/SLA.0000000000002359; Byrne JP, 2017, J TRAUMA ACUTE CARE, V82, P252, DOI 10.1097/TA.0000000000001321; Eberle BM, 2011, J TRAUMA, V70, P141, DOI 10.1097/TA.0b013e3182032f45; Erbel R, 2014, EUR HEART J, V35, P2873, DOI 10.1093/eurheartj/ehu281; Garcia-Toca M, 2010, ARCH SURG-CHICAGO, V145, P679, DOI 10.1001/archsurg.2010.114; Ho VT, 2021, J VASC SURG, V74, P71, DOI 10.1016/j.jvs.2020.12.068; Hoffer EK, 2008, J VASC INTERV RADIOL, V19, P1153, DOI 10.1016/j.jvir.2008.05.012; Hoornweg LL, 2006, J VASC SURG, V43, P1096, DOI 10.1016/j.jvs.2006.01.034; Joseph B, 2015, AM J SURG, V209, P194, DOI 10.1016/j.amjsurg.2014.03.007; Karmy-Jones R, 2011, J TRAUMA, V71, P1059, DOI 10.1097/TA.0b013e3182288783; Kenel-Pierre S, 2019, J VASC SURG, V70, P1809, DOI 10.1016/j.jvs.2019.01.065; Khoynezhad A, 2013, J VASC SURG, V57, P899, DOI 10.1016/j.jvs.2012.10.099; Kwiatt ME, 2012, J TRAUMA ACUTE CARE, V73, P625, DOI 10.1097/TA.0b013e318265cab9; Lee WA, 2011, J VASC SURG, V53, P187, DOI 10.1016/j.jvs.2010.08.027; Maldonado TS, 2013, J VASC SURG, V57, P116, DOI 10.1016/j.jvs.2012.06.101; Mattox KL, 2008, J TRAUMA, V64, P570; Murphy PB, 2016, CAN J SURG, V59, P118, DOI 10.1503/cjs.010815; Nagata K, 2016, J TRAUMA ACUTE CARE, V81, P1088, DOI 10.1097/TA.0000000000001215; Norwood SH, 2001, J AM COLL SURGEONS, V192, P161, DOI 10.1016/S1072-7515(00)00802-4; Quiroga E, 2021, ANN VASC SURG, V73, P15, DOI 10.1016/j.avsg.2020.11.009; Riambau V, 2017, EUR J VASC ENDOVASC, V53, P4, DOI 10.1016/j.ejvs.2016.06.005; Santaniello JM, 2002, J TRAUMA, V53, P442, DOI 10.1097/00005373-200209000-00008; Shahan CP, 2016, J TRAUMA ACUTE CARE, V81, P173, DOI 10.1097/TA.0000000000001058; Starnes BW, 2012, J VASC SURG, V55, P47, DOI 10.1016/j.jvs.2011.07.073; Steuer J, 2015, EUR J VASC ENDOVASC, V50, P460, DOI 10.1016/j.ejvs.2015.05.012; Tang GL, 2008, J VASC SURG, V47, P671, DOI 10.1016/j.jvs.2007.08.031; Zhang FM, 2017, J TRAUMA ACUTE CARE, V83, P690, DOI [10.1097/TA.0000000000001566, 10.1097/TA.0000000000001365]	27	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0890-5096	1615-5947		ANN VASC SURG	Ann. Vasc. Surg.	AUG	2021	75						341	348		10.1016/j.avsg.2021.01.096			8	Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Surgery; Cardiovascular System & Cardiology	TZ7CU	WOS:000684628000040	33556520				2022-02-06	
J	Oris, C; Bouillon-Minois, JB; Pinguet, J; Kahouadji, S; Durif, J; Mesle, V; Pereira, B; Schmidt, J; Sapin, V; Bouvier, D				Oris, Charlotte; Bouillon-Minois, Jean-Baptiste; Pinguet, Jeremy; Kahouadji, Samy; Durif, Julie; Mesle, Vallauris; Pereira, Bruno; Schmidt, Jeannot; Sapin, Vincent; Bouvier, Damien			Predictive Performance of Blood S100B in the Management of Patients Over 65 Years Old With Mild Traumatic Brain Injury	JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES			English	Article						Aging; Biomarker; Dementia	MINOR HEAD-INJURY; SERUM S100B; COMPUTED-TOMOGRAPHY; AGE; ADULTS; ELIMINATION; EXPRESSION; FRACTURES; PROTEINS; RECEPTOR	Background: We previously assessed the inclusion of S100B blood determination into clinical decision rules for mild traumatic brain injury (mTBI) management in the Emergency Department (ED) of Clermont-Ferrand Hospital. At the 0.10 mu g/L threshold, S100B reduced the use of cranial computed tomography (CCT) scan in adults by at least 30% with a similar to 100% sensitivity. Older patients had higher serum S100B values, resulting in lower specificity (18.7%) and decreased CCT reduction. We conducted this study to confirm the age effect on S100B concentrations, and to propose new decisional thresholds for older patients. Methods: A total of 1172 mTBI patients aged 65 and over were included. They were divided into 3 age groups: 65-79, 80-89, and >= 90 years old. S100B's performance to identify intracranial lesions (sensitivity [SE] and specificity [SP]) was assessed using the routine 0.10 mu g/L threshold and also other more efficient thresholds established for each age group. Results: S100B concentration medians were 0.18, 0.26, and 0.32 mu g/L for the 65-79, 80-89, and >= 90 years old age groups, respectively (p < .001). The most efficient thresholds were 0.11 mu g/L for the 65-79 age group and 0.15 mu g/L for the other groups. At these new thresholds, SP was respectively 28.4%, 34.3%, and 20.5% for each age group versus 24.9%, 18.2%, and 10.5% at the 0.10 mu g/L threshold. Conclusions: Adjustment of the S100B threshold is necessary in older patients' management. An increased threshold of 0.15 mu g/L is particularly interesting for patients >= 80 years old, allowing a significant increase of CCT scan reduction (29.3%).	[Oris, Charlotte; Pinguet, Jeremy; Kahouadji, Samy; Durif, Julie; Sapin, Vincent; Bouvier, Damien] Univ Hosp, Biochem & Mol Genet Dept, Clermont Ferrand, France; [Oris, Charlotte; Mesle, Vallauris; Sapin, Vincent; Bouvier, Damien] Clermont Auvergne Univ, GReD, CNRS 6293, INSERM 1103, Clermont Ferrand, France; [Bouillon-Minois, Jean-Baptiste; Schmidt, Jeannot] Univ Hosp, Adult Emergency Dept, Clermont Ferrand, France; [Pereira, Bruno] Univ Hosp, Biostat Unit DRCI Dept, Clermont Ferrand, France		Sapin, V (corresponding author), CHU Gabriel Montpied, Serv Biochim & Genet Mol, Ctr Biol, 58 Rue Montalembert, F-63000 Clermont Ferrand, France.	vsapin@chu-clermontferrand.fr					Allouchery G, 2018, CLIN CHEM LAB MED, V56, P1897, DOI 10.1515/cclm-2018-0471; Arolt V, 2003, EUR NEUROPSYCHOPHARM, V13, P235, DOI 10.1016/S0924-977X(03)00016-6; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Benavides-Piccione R, 2013, CEREB CORTEX, V23, P1798, DOI 10.1093/cercor/bhs154; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Bouvier D, 2009, ANN BIOL CLIN-PARIS, V67, P425, DOI 10.1684/abc.2009.0347; Bouvier D, 2012, CLIN CHEM, V58, P1116, DOI 10.1373/clinchem.2011.180828; Calcagnile O, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-52; Calcagnile O, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-13; COLEMAN PD, 1986, PROG BRAIN RES, V70, P227; Dickstein DL, 2007, AGING CELL, V6, P275, DOI 10.1111/j.1474-9726.2007.00289.x; DONATO R, 1985, FEBS LETT, V186, P65, DOI 10.1016/0014-5793(85)81340-5; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Donato Rosario, 2010, Cardiovasc Psychiatry Neurol, V2010, P929712, DOI 10.1155/2010/929712; Estimating the prevalence of dementia in Europe, 2019 ALZH EUR YB; Farrall AJ, 2009, NEUROBIOL AGING, V30, P337, DOI 10.1016/j.neurobiolaging.2007.07.015; Freeman SH, 2008, J NEUROPATH EXP NEUR, V67, P1205, DOI 10.1097/NEN.0b013e31818fc72f; Gardner RC, 2018, J NEUROTRAUM, V35, P2341, DOI 10.1089/neu.2018.5694; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gross S, 2010, MED SCI MONITOR, V16, pCR318; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Jehle E, 2012, ANN FR MED URGENCE, V2, P199, DOI 10.1007/s13341-012-0202-4; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Kahouadji S, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00856; Laribi S, 2014, CLIN CHEM LAB MED, V52, P527, DOI 10.1515/cclm-2013-0621; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Li JP, 2011, CLIN BIOCHEM, V44, P984, DOI 10.1016/j.clinbiochem.2011.05.014; Matias I, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00059; Michaelson MD, 2014, J CLIN ONCOL, V32, P76, DOI 10.1200/JCO.2012.48.5268; Mori T, 2010, GLIA, V58, P300, DOI 10.1002/glia.20924; Mrak RE, 2001, NEUROBIOL AGING, V22, P915, DOI 10.1016/S0197-4580(01)00293-7; Oris C, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2018-0037; Palmer AL, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00337; Park BS, 2020, CLIN NEUROL NEUROSUR, V195, DOI 10.1016/j.clineuro.2020.105902; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; PENA LA, 1995, MOL BRAIN RES, V34, P118, DOI 10.1016/0169-328X(95)00145-I; Popescu C, 2015, J Med Life, V8, P272; Riuzzi F, 2018, J CACHEXIA SARCOPENI, V9, P1255, DOI 10.1002/jcsm.12363; Rodriguez-Arellano JJ, 2016, NEUROSCIENCE, V323, P170, DOI 10.1016/j.neuroscience.2015.01.007; Schmitt A, 2005, SCHIZOPHR RES, V80, P305, DOI 10.1016/j.schres.2005.04.013; Sheng JG, 1996, NEUROBIOL AGING, V17, P359, DOI 10.1016/0197-4580(96)00037-1; Singer BR, 1998, J BONE JOINT SURG BR, V80B, P243, DOI 10.1302/0301-620X.80B2.7762; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Taipa R, 2018, NEUROPATH APPL NEURO, V44, P298, DOI 10.1111/nan.12445; Tazarourte K, 2007, EMC MED URGENCE, DOI [10.1016/S0000-0000(07)07659-0, DOI 10.1016/S0000-0000(07)07659-0]; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Unden L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0533-y; Vagberg M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135886; Vincent GK., 2010, NEXT 4 DECADES OLDER, P25; Ward MD, 2020, J APPL LAB MED, V5, P608, DOI 10.1093/jalm/jfaa039; Williams CD, 2015, AM J PREV MED, V48, P501, DOI 10.1016/j.amepre.2014.11.005; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	58	2	2	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1079-5006	1758-535X		J GERONTOL A-BIOL	J. Gerontol. Ser. A-Biol. Sci. Med. Sci.	AUG	2021	76	8					1471	1479		10.1093/gerona/glab055			9	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	UT2YY	WOS:000697988000031	33647933	Green Submitted			2022-02-06	
J	Sorenson, T; Borad, V; Schubert, W				Sorenson, ThomasJ; Borad, Vedant; Schubert, Warren			Facial Injuries Due to Cycling are Prevalent: Improved Helmet Design Offering Facial Protection is Recommended	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							US EMERGENCY-DEPARTMENTS; TRAUMATIC BRAIN-INJURIES; UNITED-STATES; BICYCLE INJURIES; CHILDREN	Purpose: Safety equipment for recreational cycling is commonly designed to protect the calvarium, but not the face, in the event of a crash. The purpose of this study is to identify the prevalence of facial injuries and their most common subcategories due to cycling injuries and to serve as an anatomical guide of what facial structures most need protection. Methods: We report a cross-sectional study of consecutive patients reported to the National Electronic Injury Surveillance System from January 1, 2010 to December 31, 2019. Patients were included in our study if they were evaluated in the emergency department (ED) for an injury due to cycling trauma. Primary outcome was injury to the face. Other variables of interest include age, sex, race, ED disposition, type of facial injury, location of facial injury, and presence of additional injuries. Descriptive and univariate statistics of the primary outcome were computed with these variables. Results: There were 138,078 total patients injured due to cycling trauma reported by National Electronic Injury Surveillance System -participating EDs during the study period and, of those, 14,326 patients experienced injury to the face, revealing a 10.4% prevalence of facial injury due to cycling trauma (14,326/138,078). Thirteen percent (1,987/14,326) of facial injuries were fractures, and the most involved structures were the nose (786/1987; 40%), orbit (459/1987; 23%), and mandible (405/1987; 20%). Compared to children, adults demonstrate a greater risk of facial fracture (23.5% versus 6.5%, P < .0001) and hospital admission after facial injury (8.9 vs 2.8%, P < .0001). Conclusions: The prevalence of facial injury in the setting of cycling trauma is over 10%, and 13% of these injuries were facial fractures. With this high prevalence, there is a need for cycling helmets that include facial protection or faceguards, and we outline the commonly fractured anatomical areas that need the most protection. (C) 2021 The American Association of Oral and Maxillofacial Surgeons.	[Sorenson, ThomasJ] Univ Minnesota, Med Sch, 420 Delaware St, Minneapolis, MN 55455 USA; [Borad, Vedant; Schubert, Warren] Univ Minnesota, Div Plast Surg, Dept Surg, Minneapolis, MN USA; [Schubert, Warren] Reg Hosp, Dept Plast & Hand Surg, St Paul, MN USA		Sorenson, T (corresponding author), Univ Minnesota, Med Sch, 420 Delaware St, Minneapolis, MN 55455 USA.	soren721@umn.edu		Sorenson, Thomas/0000-0001-6658-254X			[Anonymous], 2000, NATL ELECT INJURY SU; Bagga HS, 2015, UROLOGY, V85, P239, DOI 10.1016/j.urology.2014.07.075; Bandzar S, 2015, PEDIATRICS, V136, P658, DOI 10.1542/peds.2014-3632; Bassett DR, 2015, J PHYS ACT HEALTH, V12, P1102, DOI 10.1123/jpah.2014-0050; Benjamin T, 2019, JAMA OTOLARYNGOL, V145, P140, DOI 10.1001/jamaoto.2018.3351; Billock RM, 2015, AM J EMERG MED, V33, P1745, DOI 10.1016/j.ajem.2015.08.022; Carniol ET, 2015, OTOLARYNG HEAD NECK, V153, P957, DOI 10.1177/0194599815602668; Chen Allison J, 2014, R I Med J (2013), V97, P44; Chen WS, 2013, ACAD EMERG MED, V20, P570, DOI 10.1111/acem.12146; Cicchino JB, 2020, ACCIDENT ANAL PREV, V141, DOI 10.1016/j.aap.2020.105490; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Fischer CM, 2012, ANN EMERG MED, V60, P228, DOI 10.1016/j.annemergmed.2012.03.018; Frenkel B, 2020, J CRANIOFAC SURG, V31, P2171, DOI 10.1097/SCS.0000000000006712; Goerke D, 2020, J COMMUN HEALTH, V45, P542, DOI 10.1007/s10900-019-00773-z; Heilbronn CM, 2015, LARYNGOSCOPE, V125, P1573, DOI 10.1002/lary.25132; Hoye A, 2018, ACCIDENT ANAL PREV, V117, P85, DOI 10.1016/j.aap.2018.03.026; Hwang MJ, 2020, J ORAL MAXIL SURG, V78, DOI 10.1016/j.joms.2019.11.007; Hwang MJ, 2019, J ORAL MAXIL SURG, V77, P2055, DOI 10.1016/j.joms.2019.04.018; Lawrence LA, 2015, LARYNGOSCOPE, V125, P589, DOI 10.1002/lary.24893; McAdams RJ, 2018, ACCIDENT ANAL PREV, V118, P11, DOI 10.1016/j.aap.2018.05.019; Muthucumaru M, 2012, J PAEDIATR CHILD H, V48, P259, DOI 10.1111/j.1440-1754.2011.02233.x; Nogami S, 2021, DENT TRAUMATOL, V37, P223, DOI 10.1111/edt.12614; Olivier J, 2017, INT J EPIDEMIOL, V46, P278, DOI [10.1093/ije/dyw153, 10.1093/ije/dyw360]; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Sorenson TJ, 2021, CRANIOMAX TRAUM REC, DOI 10.1177/1943387521997237; Tom Schroeder, 2001, NEISS SAMPLE DESIGN	26	2	2	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	AUG	2021	79	8							1731.e1				8	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Dentistry, Oral Surgery & Medicine	TT0NG	WOS:000680047800020	33939961				2022-02-06	
J	Soto, PA; Vence, M; Pinero, GM; Coral, DF; Usach, V; Muraca, D; Cueto, A; Roig, A; van Raap, MBF; Setton-Avruj, CP				Soto, Paula A.; Vence, Marianela; Pinero, Gonzalo M.; Coral, Diego F.; Usach, Vanina; Muraca, Diego; Cueto, Alicia; Roig, Anna; Raap, Marcela B. Fernandez van; Setton-Avruj, Clara P.			Sciatic nerve regeneration after traumatic injury using magnetic targeted adipose-derived mesenchymal stem cells	ACTA BIOMATERIALIA			English	Article						Nanomedicine; Stem cells; Magnetic targeting; Sciatic nerve; Remyelination	IRON-OXIDE NANOPARTICLES; SPINAL-CORD-INJURY; BONE-MARROW; DRUG-DELIVERY; SCHWANN-CELLS; TISSUE; RAT; TRANSPLANTATION; BRAIN; REPAIR	Traumatic peripheral nerve injuries constitute a huge concern to public health. Nerve damage leads to a decrease or even loss of mobility of the innervated area. Adult stem cell therapies have shown some encouraging results and have been identified as promising treatment candidates for nerve regeneration. A major obstacle to that approach is securing a sufficient number of cells at the injured site to produce measurable therapeutic effects. The present work tackles this issue and demonstrates enhanced nerve re-generation ability promoted by magnetic targeted cell therapy in an in vivo Wallerian degeneration model. To this end, adipose-derived mesenchymal stem cells (AdMSC) were loaded with citric acid coated super-paramagnetic iron oxide nanoparticles (SPIONs), systemically transplanted and magnetically recruited to the injured sciatic nerve. AdMSC arrival to the injured nerve was significantly increased using magnetic targeting and their beneficial effects surpassed the regenerative properties of the stand-alone cell therapy. AdMSC-SPIONs group showed a partially conserved nerve structure with many intact myelinated axons. Also, a very remarkable restoration in myelin basic protein organization, indicative of remyelination, was observed. This resulted in an improvement in nerve conduction, demonstrating functional recovery. In summary, our results demonstrate that magnetically assisted delivery of AdMSC, using a non-invasive and non-traumatic method, is a highly promising strategy to promote cell recruitment and sciatic nerve regeneration after traumatic injury. Last but not least, our results validate magnetic targeting in vivo ex-ceeding previous reports in less complex models through cell magnetic targeting in vitro and ex vivo. Statement of significance Traumatic peripheral nerve injuries constitute a huge public health concern. They can lead to a decrease or even loss of mobility of innervated areas. Due to their complex pathophysiology, current pharmaco-logical and surgical approaches are only partially effective. Cell-based therapies have emerged as a useful tool to achieve full tissue regeneration. However, a major bottleneck is securing enough cells at injured sites. Therefore, our proposal combining biological (adipose derived mesenchymal stem cells) and nan-otechnological strategies (magnetic targeting) is of great relevance, reporting the first in vivo experiments involving "magnetic stem cell" targeting for peripheral nerve regeneration. Using a non-invasive and non traumatic method, cell recruitment in the injured nerve was improved, fostering nerve remyelination and functional recovery. (c) 2021 Published by Elsevier Ltd on behalf of Acta Materialia Inc.	[Soto, Paula A.; Pinero, Gonzalo M.; Usach, Vanina; Setton-Avruj, Clara P.] Univ Buenos Aires, Dept Quim Biol, Catedra Quim Biol Patol, Fac Farm & Bioquim, Junin 956, Buenos Aires, DF, Argentina; [Soto, Paula A.; Vence, Marianela; Pinero, Gonzalo M.; Usach, Vanina; Setton-Avruj, Clara P.] Univ Buenos Aires Buenos Aires, Inst Quim & Fis Quim Biol IQUIFIB, CONICET, Junin 956, Buenos Aires, DF, Argentina; [Coral, Diego F.; Raap, Marcela B. Fernandez van] Univ Nacl La Plata UNLP, Inst Fis La Plata IFLP CONICET, Dept Fis, Fac Ciencias Exactas, Cc 67, RA-1900 La Plata, Argentina; [Muraca, Diego] Univ Estadual Campinas, Inst Fis Gleb Wataghin, R Sergio Buarque de Holanda 777, BR-13083859 Campinas, Brazil; [Cueto, Alicia] Hosp Espanol, Serv Neurol, Ave Belgrano 2975 C1209, Buenos Aires, DF, Argentina; [Roig, Anna] ICMAB CSIC, Inst Ciencia Mat Barcelona, Bellaterra 08193, Catalonia, Spain		Setton-Avruj, CP (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fis Quim Biol IQUIFIB, CONICET, Junin 956, Buenos Aires, DF, Argentina.	setton@qb.ffyb.uba.ar	Muraca, Diego/ABG-1092-2021; Coral Coral, Diego Fernando/H-8704-2018; Muraca, Diego/K-5063-2015	Soto, Paula Andrea/0000-0002-9465-5117; Fernandez van Raap, Marcela B./0000-0001-7565-4664; Coral Coral, Diego Fernando/0000-0001-7078-2368; Muraca, Diego/0000-0002-4530-4265; Pinero, Gonzalo/0000-0001-8510-9598	CONICETConsejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP11220170101059CO, 897]; ANPCYTANPCyT [PICT 3952]; UNLPNational University of La Plata [X11/680, X11/784]; UBACYT [20020130100024]	This research was funded by CONICET (Grant numbers PIP11220170101059CO and 897) , ANPCYT (Grant number PICT 3952) , UNLP (Grant numbers X11/680 and X11/784) , and UBACYT (Grant number 20020130100024) .	Ahn YJ, 2019, INT J NANOMED, V14, P4849, DOI 10.2147/IJN.S204910; Baldari S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102087; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Carenza E, 2015, J MATER CHEM B, V3, P2538, DOI 10.1039/c4tb01895h; Carenza E, 2014, ACTA BIOMATER, V10, P3775, DOI 10.1016/j.actbio.2014.04.010; Carenza E, 2014, NANOMED-NANOTECHNOL, V10, P225, DOI 10.1016/j.nano.2013.06.005; Carriel V, 2014, NEURAL REGEN RES, V9, P1657, DOI 10.4103/1673-5374.141798; Chen FH, 2010, CHEM COMMUN, V46, P8633, DOI 10.1039/c0cc02577a; Ching RC, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1017-8; Cho H, 2013, BIOTECHNOL APPL BIOC, V60, P596, DOI 10.1002/bab.1109; Coral DF, 2018, NANOSCALE, V10, P21262, DOI 10.1039/c8nr07453d; de Sousa ME, 2016, J PHYS CHEM C, V120, P7339, DOI 10.1021/acs.jpcc.5b12330; de Sousa ME, 2013, J PHYS CHEM C, V117, P5436, DOI 10.1021/jp311556b; Fernandes M, 2018, NEURAL REGEN RES, V13, P100, DOI 10.4103/1673-5374.224378; Fernandez O, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195891; George S, 2019, STEM CELL REV REP, V15, P814, DOI 10.1007/s12015-019-09917-z; Giannaccini M, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201601429; Hoshyar N, 2016, NANOMEDICINE-UK, V11, P673, DOI 10.2217/nnm.16.5; Hur JW, 2016, J SPINAL CORD MED, V39, P655, DOI 10.1179/2045772315Y.0000000048; Hussain G, 2020, INT J BIOL SCI, V16, P116, DOI 10.7150/ijbs.35653; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029; Klingemann H, 2008, TRANSFUS MED HEMOTH, V35, P272, DOI 10.1159/000142333; Lee JS, 2010, STEM CELLS, V28, P1099, DOI 10.1002/stem.430; Li RJ, 2014, CELL BIOCHEM BIOPHYS, V68, P449, DOI 10.1007/s12013-013-9742-1; Lo Furno D, 2016, STEM CELLS DEV, V25, P1615, DOI 10.1089/scd.2016.0135; Lotfy Ahmed, 2014, International Journal of Stem Cells, V7, P135, DOI 10.15283/ijsc.2014.7.2.135; Majidi S, 2016, ARTIF CELL NANOMED B, V44, P1186, DOI 10.3109/21691401.2015.1014093; Marcus M, 2016, J NANOBIOTECHNOL, V14, DOI 10.1186/s12951-016-0190-0; Masgutov R, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00068; Matuszak J, 2018, INT J NANOMED, V13, P8443, DOI 10.2147/IJN.S179273; Mazuel F, 2016, ACS NANO, V10, P7627, DOI 10.1021/acsnano.6b02876; McIntosh K, 2006, STEM CELLS, V24, P1246, DOI 10.1634/stemcells.2005-0235; Nagaya N, 2004, AM J PHYSIOL-HEART C, V287, pH2670, DOI 10.1152/ajpheart.01071.2003; Nishida K, 2006, NEUROREPORT, V17, P1269, DOI 10.1097/01.wnr.0000227993.07799.a2; Pinero G, 2018, TRANSGENIC RES, V27, P135, DOI 10.1007/s11248-018-0062-5; Raisi A, 2014, J TRAUMA ACUTE CARE, V76, P991, DOI 10.1097/TA.0000000000000186; Saper CB, 2005, J COMP NEUROL, V493, P477, DOI 10.1002/cne.20839; Sasaki H, 2011, SPINE, V36, P933, DOI 10.1097/BRS.0b013e3181eb9fb0; Schulz A, 2014, JOVE-J VIS EXP, DOI 10.3791/51181; Shen CC, 2012, J BIOMED MATER RES A, V100A, P48, DOI 10.1002/jbm.a.33227; Slavin S, 2008, CLIN NEUROL NEUROSUR, V110, P943, DOI 10.1016/j.clineuro.2008.01.014; Stockert JC, 2018, ACTA HISTOCHEM, V120, P159, DOI 10.1016/j.acthis.2018.02.005; Sulaiman W, 2013, OCHSNER J, V13, P100; Thakor AS, 2016, J NUCL MED, V57, P1833, DOI 10.2967/jnumed.116.181362; Tukmachev D, 2015, NANOSCALE, V7, P3954, DOI 10.1039/c4nr05791k; Usach V, 2017, TRANSPLANTATION, V101, P1573, DOI 10.1097/TP.0000000000001478; Usach V, 2011, J NEUROSCI RES, V89, P1203, DOI 10.1002/jnr.22645; van Raap MBF, 2017, PHYS CHEM CHEM PHYS, V19, P7176, DOI 10.1039/c6cp08059f; Vanecek V, 2012, INT J NANOMED, V7, P3719, DOI 10.2147/IJN.S32824; Volatron J, 2017, SMALL, V13, DOI 10.1002/smll.201602030; Wang Y, 2020, ACS CHEM NEUROSCI, V11, P1359, DOI 10.1021/acschemneuro.0c00116; Wei Y, 2010, CELL PROLIFERAT, V43, P606, DOI 10.1111/j.1365-2184.2010.00710.x; Wilhelm C, 2003, BIOMATERIALS, V24, P1001, DOI 10.1016/S0142-9612(02)00440-4; Woods JT, 1941, IND ENG CHEM, V13, P0551, DOI 10.1021/i560096a013; Xia JG, 2008, J NANOSCI NANOTECHNO, V8, P6310, DOI 10.1166/jnn.2008.355; Xu C, 2020, STEM CELLS DEV, V29, P222, DOI 10.1089/scd.2019.0173; Xu W, 2012, PHYS CHEM CHEM PHYS, V14, P12687, DOI 10.1039/c2cp41357d; Zhang R, 2018, NEURAL REGEN RES, V13, P757, DOI 10.4103/1673-5374.232457; Zhang RP, 2014, MOL CELLS, V37, P650, DOI 10.14348/molcells.2014.0010; Zhao M, 2012, J DRUG TARGET, V20, P416, DOI 10.3109/1061186X.2011.651726; Zhou F., DIFFERENTIATION HUMA, DOI [10.1038/s41419-019-1772-1, DOI 10.1038/S41419-019-1772-1]; Zhou ZJ, 2020, ACS NANO, V14, P7, DOI 10.1021/acsnano.9b06842; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	64	2	2	14	14	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	AUG	2021	130						234	247		10.1016/j.actbio.2021.05.050			14	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	TP3OT	WOS:000677503800005	34082099				2022-02-06	
J	Su, H; Thompson, HJ; May, S; Dinglas, VD; Hough, CL; Hosey, MM; Hopkins, RO; Kamdar, BB; Needham, DM				Su, Han; Thompson, Hilaire J.; May, Susanne; Dinglas, Victor D.; Hough, Catherine L.; Hosey, Megan M.; Hopkins, Ramona O.; Kamdar, Biren B.; Needham, Dale M.			Association of Job Characteristics and Functional Impairments on Return to Work After ARDS	CHEST			English	Article						employment; functional ability; intensive care unit; outcomes; symptom	RESPIRATORY-DISTRESS-SYNDROME; TRAUMATIC BRAIN-INJURY; ACUTE LUNG INJURY; ONE-YEAR OUTCOMES; CRITICAL ILLNESS; COGNITIVE PERFORMANCE; PSYCHIATRIC-SYMPTOMS; SURVIVORS; HEALTH; ROSUVASTATIN	BACKGROUND: Joblessness is common after ARDS, but related risk factors are not fully understood. RESEARCH QUESTION: What is the association between survivors' pre-ARDS workload and post-ARDS functional impairment, pain, and fatigue with their return to work (RTW) status? STUDY DESIGN AND METHODS: The U.S. Occupational Information Network (O*NET) was used to determine pre-ARDS workload for participants in the ARDS Network Long-Term Outcomes Study (ALTOS). Post-ARDS functional impairment was assessed using the Mini-Mental State Examination and SF-36 Physical Functioning, Social Functioning, and Mental Health sub-scales, and categorized as either no impairments, only psychosocial impairment, physical with low psychosocial impairment, or physical with high psychosocial impairment. Post-ARDS pain and fatigue were assessed using the SF-36 pain item and Functional Assessment of Chronic Illness Therapy-Fatigue Scale fatigue scale, respectively. Generalized linear mixed modeling methods were used to evaluate associations among pre-ARDS workload, post-ARDS functional impairment, and symptoms of pain and fatigue with post-ARDS RTW. RESULTS: Pre-ARDS workload was not associated with post-ARDS RTW. However, as compared with survivors with no functional impairment, those with only psychosocial impairment (OR [CI]: 0.18 [0.06-0.50]), as well as physical impairment plus either low psychosocial impairment (0.08 [0.03-0.22]) or high psychosocial impairment (0.01 [0.003-0.05]) had lower odds of working. Pain (0.06 [0.03-0.14]) and fatigue (0.07 [0.03-0.16]) were also negatively associated with RTW. INTERPRETATION: For previously employed survivors of ARDS, post-ARDS psychosocial and physical impairments, pain, and fatigue were negatively associated with RTW, whereas pre-ARDS workload was not associated. These findings are important for designing and implementing vocational interventions for ARDS survivors.	[Su, Han; Thompson, Hilaire J.] Univ Washington, Sch Nursing, Seattle, WA 98195 USA; [Thompson, Hilaire J.] Harborview Injury Prevent & Res Ctr, Seattle, WA USA; [May, Susanne] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Dinglas, Victor D.; Hosey, Megan M.; Needham, Dale M.] Johns Hopkins Univ, Div Pulm & Crit Care Med, Sch Med, Baltimore, MD USA; [Dinglas, Victor D.; Hosey, Megan M.; Needham, Dale M.] Johns Hopkins Univ, Outcomes Crit Illness & Surg OACIS Grp, Sch Med, Baltimore, MD USA; [Hough, Catherine L.] Oregon Hlth & Sci Univ, Pulm & Crit Care Med, Portland, OR 97201 USA; [Hosey, Megan M.; Needham, Dale M.] Johns Hopkins Univ, Dept Phys Med & Rehabil, Sch Med, Baltimore, MD USA; [Hopkins, Ramona O.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Hopkins, Ramona O.] Brigham Young Univ, Psychol Dept, Provo, UT 84602 USA; [Hopkins, Ramona O.] Intermt Hlth Care, Pulm & Crit Care Med, Murray, UT USA; [Kamdar, Biren B.] Univ Calif San Diego, Div Pulm Crit Care Sleep Med & Physiol, La Jolla, CA 92093 USA		Su, H (corresponding author), Univ Washington, Sch Nursing, Seattle, WA 98195 USA.	hansu21@uw.edu	Hosey, Megan M./ABF-7208-2021	Su, Han/0000-0001-5260-8139	Hester McLaws Dissertation Research Award from University of Washington; National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [N01HR56170, R01HL091760, 3R01HL09176002S1]; NHLBIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HHSN268200536165C, HHSN268200536176C, HHSN268200536179C]; Hester McLaws Dissertation Research Award	H. S. is supported by The Hester McLaws Dissertation Research Award from University of Washington. This research was supported by the National Heart, Lung, and Blood Institute grants N01HR56170, R01HL091760, and 3R01HL09176002S1 along with funding for the ALTA, EDEN, OMEGA and SAILS trials (NHLBI contracts HHSN268200536165C to HHSN268200536176C and HHSN268200536179C) and the Hester McLaws Dissertation Research Award.	Aas RW, 2015, WORK, V53; Barsevick AM, 2006, J PAIN SYMPTOM MANAG, V31, P85, DOI 10.1016/j.jpainsymman.2005.05.015; Bienvenu OJ, 2018, INTENS CARE MED, V44, P38, DOI 10.1007/s00134-017-5009-4; Bienvenu OJ, 2015, CRIT CARE MED, V43, P642, DOI 10.1097/CCM.0000000000000752; Butt Z, 2013, J PSYCHOSOM RES, V74, P64, DOI 10.1016/j.jpsychores.2012.10.011; Cancelliere C, 2016, CHIROPR MAN THER, V24, DOI 10.1186/s12998-016-0113-z; Chan KS, 2017, THORAX, V72, P884, DOI 10.1136/thoraxjnl-2016-209400; Devlin JW, 2018, CRIT CARE MED, V46, P1532, DOI 10.1097/CCM.0000000000003259; Dinglas VD, 2016, THORAX, V71, P401, DOI 10.1136/thoraxjnl-2015-208017; Dorland HF, 2018, J CANCER SURVIV, V12, P371, DOI 10.1007/s11764-018-0676-x; Feuerstein M, 2010, J CANCER SURVIV, V4, P415, DOI 10.1007/s11764-010-0154-6; Fraser R, 2006, J VOCAT REHABIL, V25, P141; Haveraaen LA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3942-8; Heerkens Y, 2004, DISABIL REHABIL, V26, P1060, DOI 10.1080/09638280410001703530; Herr JK, 2014, J CARDIOVASC NURS, V29, P416, DOI 10.1097/JCN.0b013e31829b675e; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Hodgson CL, 2018, J CRIT CARE, V48, P21, DOI 10.1016/j.jcrc.2018.08.005; Hopkins RO, 2005, CURR OPIN CRIT CARE, V11, P369, DOI 10.1097/01.ccx.0000166399.88635.a5; Huang MX, 2016, CRIT CARE MED, V44, P954, DOI 10.1097/CCM.0000000000001621; Kamdar B.B., 2017, AM J RESP CRIT CARE, V196, P1012, DOI [DOI 10.1164/rccm.201611-2327OC, 10.1164/rccm.201611-2327OC]; Kamdar BB, 2020, THORAX, V75, P17, DOI 10.1136/thoraxjnl-2019-213803; Kamdar BB, 2018, THORAX, V73, P125, DOI 10.1136/thoraxjnl-2017-210217; Kearney J, 2020, RESUSCITATION, V146, P203, DOI 10.1016/j.resuscitation.2019.09.006; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Lombardi AV, 2014, CLIN ORTHOP RELAT R, V472, P138, DOI 10.1007/s11999-013-3099-z; Matthay MA, 2011, AM J RESP CRIT CARE, V184, P561, DOI 10.1164/rccm.201012-2090OC; Needham DM, 2016, LANCET RESP MED, V4, P203, DOI 10.1016/S2213-2600(16)00005-9; Needham Dale M, 2013, BMJ, V346, pf1532, DOI 10.1136/bmj.f1532; Needham DM, 2013, AM J RESP CRIT CARE, V188, P567, DOI 10.1164/rccm.201304-0651OC; Neufeld KJ, 2020, CHEST, V158, P999, DOI 10.1016/j.chest.2020.03.059; Newkirk LA, 2004, J GERIATR PSYCH NEUR, V17, P81, DOI 10.1177/0891988704264534; Nikayin S, 2016, GEN HOSP PSYCHIAT, V43, P23, DOI 10.1016/j.genhosppsych.2016.08.005; Norman BC, 2016, CRIT CARE MED, V44, P2003, DOI 10.1097/CCM.0000000000001849; Parker AM, 2015, CRIT CARE MED, V43, P1121, DOI 10.1097/CCM.0000000000000882; Pfoh ER, 2016, ANN AM THORAC SOC, V13, P1343, DOI 10.1513/AnnalsATS.201510-705OC; Pfoh ER, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0934-5; Rabiee A, 2016, CRIT CARE MED, V44, P1744, DOI 10.1097/CCM.0000000000001811; Rice TW, 2012, JAMA-J AM MED ASSOC, V307, P795, DOI 10.1001/jama.2012.137; Rice TW, 2011, JAMA-J AM MED ASSOC, V306, P1574, DOI 10.1001/jama.2011.1435; Righy C, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2489-3; Rothenhausler HB, 2001, GEN HOSP PSYCHIAT, V23, P88, DOI 10.1016/S0163-8343(01)00123-2; Ruhl AP, 2017, INTENS CARE MED, V43, P980, DOI 10.1007/s00134-017-4827-8; Schultz IZ, 2007, J OCCUP REHABIL, V17, P327, DOI 10.1007/s10926-007-9071-6; Spadaro S, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0554-z; Steenstra IA, 2017, J OCCUP REHABIL, V27, P369, DOI 10.1007/s10926-016-9666-x; Su H, 2021, J ADV NURS, V77, P653, DOI 10.1111/jan.14631; Truwit JD, 2014, NEW ENGL J MED, V370, P2191, DOI 10.1056/NEJMoa1401520; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Ware J., 2000, SCORE VERSION 2 SF 3; Wintermann GB, 2018, J INTENSIVE CARE, V6, DOI 10.1186/s40560-018-0295-7	51	2	2	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0012-3692	1931-3543		CHEST	Chest	AUG	2021	160	2					509	518		10.1016/j.chest.2021.03.008			10	Critical Care Medicine; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Respiratory System	TY0KI	WOS:000683472800029	33727035	Bronze			2022-02-06	
J	Tang, OY; Perla, KMR; Lim, RK; Yoon, JS; Weil, RJ; Toms, SA				Tang, Oliver Y.; Perla, Krissia M. Rivera; Lim, Rachel K.; Yoon, James S.; Weil, Robert J.; Toms, Steven A.			Interhospital competition and hospital charges and costs for patients undergoing cranial neurosurgery	JOURNAL OF NEUROSURGERY			English	Article						Herfindahl-Hirschman Index; HHI; healthcare economics; healthcare costs; health policy; perioperative outcomes; National Inpatient Sample; NIS	UNITED-STATES; CONSOLIDATION IMPLICATIONS; OUTCOMES; CARE; CRANIOTOMY; MEDICARE; SURGEON; QUALITY; IMPACT; VOLUME	OBJECTIVE Research has documented significant growth in neurosurgical expenditures and practice consolidation. The authors evaluated the relationship between interhospital competition and inpatient charges or costs in patients undergoing cranial neurosurgery. METHODS The authors identified all admissions in 2006 and 2009 from the National Inpatient Sample. Admissions were classified into 5 subspecialties: cerebrovascular, tumor, CSF diversion, neurotrauma, or functional. Hospital-specific interhospital competition levels were quantified using the Herfindahl-Hirschman Index (HHI), an economic metric ranging continuously from 0 (significant competition) to 1 (monopoly). Inpatient charges (hospital billing) were multiplied with reported cost-to-charge ratios to calculate costs (actual resource use). Multivariate regressions were used to assess the association between HHI and inpatient charges or costs separately, controlling for 17 patient, hospital, severity, and economic factors. The reported beta-coefficients reflect percentage changes in charges or costs (e.g., beta-coefficient = 1.06 denotes a +6% change). All results correspond to a standardized -0.1 change in HHI (increase in competition). RESULTS In total, 472,938 nationwide admissions for cranial neurosurgery treated at 896 unique hospitals met inclusion criteria. Hospital HHIs ranged from 0.099 to 0.724 (mean 0.298 +/- 0.105). Hospitals in more competitive markets had greater charge/cost markups (beta-coefficient = 1.10, p < 0.001) and area wage indices (beta- coefficient = 1.04, p < 0.001). Between 2006 and 2009, average neurosurgical charges and costs rose significantly ($62,098 to $77,812, p < 0.001; $21,385 to $22,389, p < 0.001, respectively). Increased interhospital competition was associated with greater charges for all admissions (beta-coefficient = 1.07, p < 0.001) as well as cerebrovascular (beta-coefficient = 1.08, p < 0.001), tumor (beta-coefficient = 1.05, p = 0.039), CSF diversion (beta-coefficient = 1.08, p < 0.001), neurotrauma (beta-coefficient = 1.07, p < 0.001), and functional neurosurgery (beta-coefficient = 1.11, p = 0.037) admissions. However, no significant associations were observed between HHI and costs, except for CSF diversion surgery (beta-coefficient = 1.03, p = 0.021). Increased competition was not associated with important clinical outcomes, such as inpatient mortality, favorable discharge disposition, or complication rates, except for lower mortality for brain tumors (OR 0.78, p = 0.026), but was related to greater length of stay for all admissions (beta-coefficient = 1.06, p < 0.001). For a sensitivity analysis adjusting for outcomes, all findings for charges and costs remained the same. CONCLUSIONS Hospitals in more competitive markets exhibited higher charges for admissions of patients undergoing an in-hospital cranial procedure. Despite this, interhospital competition was not associated with increased inpatient costs except for CSF diversion surgery. There was no corresponding improvement in outcomes with increased competition, with the exception of a potential survival benefit for brain tumor surgery.	[Tang, Oliver Y.; Perla, Krissia M. Rivera; Lim, Rachel K.; Toms, Steven A.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Yoon, James S.] Yale Sch Med, New Haven, CT USA; [Weil, Robert J.; Toms, Steven A.] Rhode Isl Hosp, Dept Neurosurg, Providence, RI USA		Toms, SA (corresponding author), Rhode Isl Hosp, Providence, RI 02903 USA.	toms@lifespan.org		Lim, Rachel/0000-0001-7711-3095			[Anonymous], Herfindahl-Hirschman Index; [Anonymous], Overview of the National (Nationwide) Inpatient Sample (NIS); Bai G, 2015, HEALTH AFFAIR, V34, P922, DOI 10.1377/hlthaff.2014.1414; Baker LC, 2014, HEALTH AFFAIR, V33, P756, DOI 10.1377/hlthaff.2013.1279; Beaulieu ND, 2020, NEW ENGL J MED, V382, P51, DOI 10.1056/NEJMsa1901383; Cerullo M, 2019, ANN SURG, V270, P681, DOI 10.1097/SLA.0000000000003481; Chang DC, 2011, J AM COLL SURGEONS, V212, P12, DOI 10.1016/j.jamcollsurg.2010.09.014; Chang V, 2016, SURGERY, V160, P1155, DOI 10.1016/j.surg.2016.05.027; Clement RC, 2013, J NEUROSURG, V118, P687, DOI 10.3171/2012.10.JNS12682; Clyde AT, 2008, HEALTH AFFAIR, V27, P1632, DOI 10.1377/hlthaff.27.6.1632; Collins S, 2019, HLTH INSURANCE COVER; Connor RA., 1998, INT J ECON BUS, V5, P159, DOI [10.1080/13571519884495, DOI 10.1080/13571519884495]; Cost-to-charge ratio files, HEALTHC COST UT PROJ; Cowan John A Jr, 2007, Clin Neurosurg, V54, P209; Curry WT, 2010, NEUROSURGERY, V66, P427, DOI 10.1227/01.NEU.0000365265.10141.8E; Davies JM, 2017, J NEUROSURG, V127, P69, DOI 10.3171/2016.7.JNS15925; Devers KJ, 2003, HEALTH SERV RES, V38, P447, DOI 10.1111/1475-6773.00124; Durand WM, 2018, SPINE J, V18, P626, DOI 10.1016/j.spinee.2017.08.256; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Englot DJ, 2012, NEUROLOGY; Goldman DP, 2010, NEW ENGL J MED, V363, P2185, DOI 10.1056/NEJMp1009501; Gourin CG, 2019, JAMA OTOLARYNGOL, V145, P939, DOI 10.1001/jamaoto.2019.2303; Greene NH, 2015, INJURY PREV, V21, P325, DOI 10.1136/injuryprev-2014-041524; Henke RM, 2013, AM J MANAG CARE, V19, pE238; Houchens R., 2015, MISSING DATA METHODS; Huppertz JW, 2017, HEALTH SERV RES, V52, P1590, DOI 10.1111/1475-6773.12549; Kessler DP, 2000, Q J ECON, V115, P577, DOI 10.1162/003355300554863; Kim DH, 2017, NEUROSURGERY, V80, pS4, DOI 10.1093/neuros/nyx008; Li H, 2014, HEALTHC AMST, V2; Ly DP, 2018, J GEN INTERN MED, V33, P1020, DOI 10.1007/s11606-018-4347-4; Medicare Payment Advisory Committee, 2018, HOSP INP OUTP SERV A HOSP INP OUTP SERV A; Mooney MA, 2019, NEUROSURGERY, V84, P1280, DOI 10.1093/neuros/nyy185; Mukamel DB, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-10; Munoz E, 2010, ANN SURG, V251, P195, DOI 10.1097/SLA.0b013e3181cbcc9a; Robinson JC, 2011, AM J MANAG CARE, V17, pE241; Sharma M, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.8.FOCUS13295; Smith ER, 2004, J NEUROSURG, V100, P90, DOI 10.3171/ped.2004.100.2.0090; Sun Y, 2019, TOOLS MORE ACCURATE; Tang O, 2019, 2019 AANS ANN SCI M; Washington CW, 2014, J NEUROSURG, V121, P482, DOI 10.3171/2014.4.JNS131100; Wright JD, 2016, JAMA SURG, V151, P612, DOI 10.1001/jamasurg.2015.5508; Wu VY, 2008, INQUIRY-J HEALTH CAR, V45, P280, DOI 10.5034/inquiryjrnl_45.03.280; Xu T, 2015, JAMA-J AM MED ASSOC, V314, P1337, DOI 10.1001/jama.2015.7492; Yoon JS, 2019, WORLD NEUROSURG, V129; Zygourakis CC, 2017, NEUROSURGERY, V81, P972, DOI 10.1093/neuros/nyx133	45	2	2	1	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	AUG	2021	132	2					361	372		10.3171/2020.6.JNS20732			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	TT9IJ	WOS:000680654900005	33007751	Bronze			2022-02-06	
J	Jewell, S; Hobson, S; Brewer, G; Rogers, M; Hartings, JA; Foreman, B; Lavrador, JP; Sole, M; Pahl, C; Boutelle, MG; Strong, AJ				Jewell, Sharon; Hobson, Stephen; Brewer, Grant; Rogers, Michelle; Hartings, Jed A.; Foreman, Brandon; Lavrador, Jose-Pedro; Sole, Michael; Pahl, Clemens; Boutelle, Martyn G.; Strong, Anthony J.			Development and Evaluation of a Method for Automated Detection of Spreading Depolarizations in the Injured Human Brain	NEUROCRITICAL CARE			English	Article						Cortical spreading depression; Brain contusion; Subdural hematoma; Subarachnoid hemorrhage; Electroencephalography; Computing methodologies	DEPRESSION; ISCHEMIA	Background Spreading depolarizations (SDs) occur in some 60% of patients receiving intensive care following severe traumatic brain injury and often occur at a higher incidence following serious subarachnoid hemorrhage and malignant hemisphere stroke (MHS); they are independently associated with worse clinical outcome. Detection of SDs to guide clinical management, as is now being advocated, currently requires continuous and skilled monitoring of the electrocorticogram (ECoG), frequently extending over many days. Methods We developed and evaluated in two clinical intensive care units (ICU) a software routine capable of detecting SDs both in real time at the bedside and retrospectively and also capable of displaying patterns of their occurrence with time. We tested this prototype software in 91 data files, each of approximately 24 h, from 18 patients, and the results were compared with those of manual assessment ("ground truth") by an experienced assessor blind to the software outputs. Results The software successfully detected SDs in real time at the bedside, including in patients with clusters of SDs. Counts of SDs by software (dependent variable) were compared with ground truth by the investigator (independent) using linear regression. The slope of the regression was 0.7855 (95% confidence interval 0.7149-0.8561); a slope value of 1.0 lies outside the 95% confidence interval of the slope, representing significant undersensitivity of 79%. R-2 was 0.8415. Conclusions Despite significant undersensitivity, there was no additional loss of sensitivity at high SD counts, thus ensuring that dense clusters of depolarizations of particular pathogenic potential can be detected by software and depicted to clinicians in real time and also be archived.	[Jewell, Sharon; Rogers, Michelle; Boutelle, Martyn G.] Imperial Coll London, Dept Bioengn, London, England; [Jewell, Sharon; Strong, Anthony J.] Kings Coll London, Acad Neurosci Ctr, Inst Psychiat, Dept Basic & Clin Neurosci, Room A1-27,Crespigny Pk,Box 41, London SE5 8AF, England; [Hobson, Stephen; Brewer, Grant; Sole, Michael] Cybula Ltd, York, N Yorkshire, England; [Hartings, Jed A.] Univ Cincinnati, Coll Med, Dept Neurosurg, Cincinnati, OH 45221 USA; [Foreman, Brandon] Univ Cincinnati, Coll Med, Dept Neurol & Rehabil Med, Cincinnati, OH 45221 USA; [Lavrador, Jose-Pedro] Kings Coll Hosp London, Dept Neurosurg, London, England; [Pahl, Clemens] Kings Coll Hosp London, Dept Intensive Care Med, London, England		Strong, AJ (corresponding author), Kings Coll London, Acad Neurosci Ctr, Inst Psychiat, Dept Basic & Clin Neurosci, Room A1-27,Crespigny Pk,Box 41, London SE5 8AF, England.	anthony.strong@kcl.ac.uk			Wellcome Trust-UK Department of Health, Health Innovation Challenge Fund [HICF-0510-080]; US Office of the Assistant Secretary of Defense for Health Affairs through the Defense Medical Research and Development Program [W81XWH-16-2-0020]; Medical Research Council (UK) Clinical Training FellowshipUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/R00112X/1]; Moberg Solutions Inc.; Cybula Ltd.	This project was funded by the Wellcome Trust-UK Department of Health, Health Innovation Challenge Fund (HICF-0510-080) grant to MGB (Chief investigator), AJS, and CP. Support was also provided by the US Office of the Assistant Secretary of Defense for Health Affairs through the Defense Medical Research and Development Program under award No. W81XWH-16-2-0020 (JAH and BF). Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense. SJ is currently funded by a Medical Research Council (UK) Clinical Training Fellowship (MR/R00112X/1). The interfacing of the Neuromonitor software with the Moberg CNS310 system was jointly funded by Moberg Solutions Inc. and Cybula Ltd.	Ayata C, 2015, PHYSIOL REV, V95, P953, DOI 10.1152/physrev.00027.2014; Carlson AP, 2019, J NEUROSURG, V131, P1773, DOI 10.3171/2018.7.JNS181478; Carlson AP, 2019, J NEUROSURG, V130, P1513, DOI 10.3171/2017.12.JNS171665; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00373; Dreier JP, 2018, ANN NEUROL, V83, P295, DOI 10.1002/ana.25147; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Dreier JP, 1998, J CEREBR BLOOD F MET, V18, P978, DOI 10.1097/00004647-199809000-00007; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Fletcher M, 2008, NEURAL NETWORKS, V21, P1076, DOI 10.1016/j.neunet.2008.06.009; Hartings JA, 2008, NEUROL RES, V30, P876, DOI 10.1179/174313208X309739; Hartings JA, 2020, JAMA NEUROL, V77, P489, DOI 10.1001/jamaneurol.2019.4476; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1857, DOI 10.1177/0271678X16653135; Hartings JA, 2014, J NEUROSURG, V120, P434, DOI 10.3171/2013.9.JNS13581; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Helbok R, 2020, NEUROCRIT CARE, V32, P306, DOI 10.1007/s12028-019-00777-6; Helbok R, 2017, J CEREBR BLOOD F MET, V37, P1871, DOI 10.1177/0271678X16651269; Hertle DN, 2012, BRAIN, V135, P2390, DOI 10.1093/brain/aws152; Hocker S, 2020, NEUROCRIT CARE, V32, P311, DOI 10.1007/s12028-019-00767-8; Kirov SA., 2017, J CEREBR BLOOD F MET, V37, P1571, DOI [DOI 10.1177/0271678X16654495, 10.1177/0271678x16654495]; Lauritzen M, 2017, J CEREBR BLOOD F MET, V37, P1553, DOI 10.1177/0271678X16657092; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Nakamura H, 2010, BRAIN, V133, P1994, DOI 10.1093/brain/awq117; Santos E, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2711-3; Shin HK, 2006, J CEREBR BLOOD F MET, V26, P1018, DOI 10.1038/sj.jcbfm.9600252; Shuttleworth CW, 2020, NEUROCRIT CARE, V32, P317, DOI 10.1007/s12028-019-00776-7; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Strong AJ, 2007, BRAIN, V130, P995, DOI 10.1093/brain/awl392	33	2	2	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2021	35	SUPPL 2		2	SI		160	175		10.1007/s12028-021-01228-x		JUL 2021	16	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WL1AZ	WOS:000678429100002	34309783	hybrid, Green Published			2022-02-06	
J	Jha, RM; Zusman, BE; Puccio, AM; Okonkwo, DO; Pease, M; Desai, SM; Leach, M; Conley, YP; Kochanek, PM				Jha, Ruchira M.; Zusman, Benjamin E.; Puccio, Ava M.; Okonkwo, David O.; Pease, Matthew; Desai, Shashvat M.; Leach, Matthew; Conley, Yvette P.; Kochanek, Patrick M.			Genetic Variants Associated With Intraparenchymal Hemorrhage Progression After Traumatic Brain Injury	JAMA NETWORK OPEN			English	Article							SULFONYLUREA RECEPTOR 1; INTRACEREBRAL HEMORRHAGE; POLYMORPHISMS; PROGESTERONE; CHANNEL; SYSTEM; EDEMA; ABCC8; ATP	IMPORTANCE Intracerebral hemorrhage progression is associated with unfavorable outcome after traumatic brain injury (TBI). No effective treatments are currently available. This secondary injury process reflects an extreme form of vasogenic edema and blood-brain barrier breakdown. The sulfonylurea receptor 1-transient receptor potential melastatin 4 (SUR1-TRPM4) cation channel is a key underlying mechanism. A phase 2 trial of SUR1-TRPM4 inhibition in contusional TBI is ongoing, and a phase 3 trial is being designed. Targeted identification of patients at increased risk for hemorrhage progression may inform prognostication, trial design (including patient selection), and ultimately treatment response. OBJECTIVE To determine whether ABCC8 (SUR1) and TRPM4 genetic variability are associated with intraparenchymal hemorrhage (IPH) progression after severe TBI, based on the putative involvement of the SUR1-TRPM4 channel in this pathophysiology. DESIGN, SETTING, AND PARTICIPANTS In this genetic association study, DNA was extracted from 416 patients with severe TBI prospectively enrolled from a level I trauma academic medical center from May 9, 2002, to August 8, 2014. Forty ABCC8 and TRPM4 single-nucleotide variants (SNVs) were genotyped (multiplex, unbiased). Data were analyzed from January 7, 2020, to May 3, 2021. MAIN OUTCOMES AND MEASURES Primary analyses addressed IPH progression at 6, 24, and 120 hours in patients without acute craniectomy (n = 321). Multivariable regressions and receiver operating characteristic curves assessed SNV and haplotype associations with progression. Spatial modeling and functional predictions were determined using standard software. RESULTS Of the 321 patients included in the analysis (mean [SD] age, 37.0 [16.3] years; 247 [76.9%] male), IPH progression occurred in 102. Four ABCC8 SNVs were associated with markedly increased odds of progression (rs2237982 [odds ratio (OR), 2.60-3.80; 95% CI, 1.14-5.90 to 1.80-8.02; P =.02 to P <.001], rs2283261 [OR, 3.37-4.77; 95% CI, 1.07-10.77 to 1.89-12.07; P =.04 to P =.001], rs3819521 [OR, 2.96-3.92; 95% CI, 1.13-7.75 to 1.42-10.87; P =.03 to P =.009], and rs8192695 [OR, 3.06-4.95; 95% CI, 1.02-9.12 to 1.67-14.68]; P =.03-.004). These are brain-specific expression quantitative trait loci (eQTL) associated with increased ABCC8 messenger RNA levels. Regulatory annotations revealed promoter and enhancer marks and strong and/or active brain-tissue transcription, directionally consistent with increased progression. Three SNVs (rs2283261, rs2237982, and rs3819521) in this cohort have been associated with intracranial hypertension. Four TRPM4 SNVs were associated with decreased IPH progression (rs3760666 [OR, 0.40-0.49; 95% CI, 0.19-0.86 to 0.27-0.89; P =.02 to P =.009], rs1477363 [OR, 0.40-0.43; 95% CI, 0.18-0.88 to 0.23-0.81; P =.02 to P =.006], rs10410857 [OR, 0.36-0.41; 95% CI, 0.20-0.67 to 0.20-0.85; P =.02 to P =.001], and rs909010 [OR, 0.27-0.40; 95% CI, 0.12-0.62 to 0.16-0.58; P =.002 to P <.001]). Significant SNVs in both genes cluster downstream, flanking exons encoding the receptor site and SUR1-TRPM4 binding interface. Adding genetic variation to clinical models improved receiver operating characteristic curve performance from 0.6959 to 0.8030 (P =.003). CONCLUSIONS AND RELEVANCE In this genetic association study, 8 ABCC8 and TRPM4 SNVs were associated with IPH progression. Spatial clustering, brain-specific eQTL, and regulatory annotations suggest biological plausibility. These findings may have important implications for neurocritical care risk stratification, patient selection, and precision medicine, including an upcoming phase 3 trial design for SUR1-TRPM4 inhibition in severe TBI.	[Jha, Ruchira M.; Desai, Shashvat M.] Barrow Neurol Inst, Dept Neurol, 240 W Thomas Rd, Phoenix, AZ 85013 USA; [Jha, Ruchira M.] Barrow Neurol Inst, Dept Neurol Surg, Phoenix, AZ 85013 USA; [Jha, Ruchira M.] Barrow Neurol Inst, Dept Neurobiol, Phoenix, AZ 85013 USA; [Zusman, Benjamin E.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Zusman, Benjamin E.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Boston, MA 02115 USA; [Puccio, Ava M.; Okonkwo, David O.; Pease, Matthew] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA; [Leach, Matthew; Kochanek, Patrick M.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA; [Conley, Yvette P.; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Clin & Translat Sci Inst, Pittsburgh, PA USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA USA		Jha, RM (corresponding author), Barrow Neurol Inst, Dept Neurol, 240 W Thomas Rd, Phoenix, AZ 85013 USA.	jha@barrowneuro.org			National Institute of Neurological Disorders and Stroke/National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS101036, 1R01NS115815-01A1]; National Institute of Nursing Research (NINR)/NIH [R00 NR013176]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P50 NS30318, 1R01NS087978]; University of Pittsburgh Institute for Clinical Research Education; NINR/NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013342]; University of Pittsburgh Clinician Scientist Training program	This study was supported by grants K23NS101036 and 1R01NS115815-01A1 from the National Institute of Neurological Disorders and Stroke/National Institutes of Health (NIH) (Dr Jha); grant R00 NR013176 from the National Institute of Nursing Research (NINR)/NIH (Dr Puccio); grant P50 NS30318 from the NIH (Dr Okonkwo); grant R01NR013342 from the NINR/NIH (Dr Conley); grant 1R01NS087978 from the NIH (Dr Kochanek); and the University of Pittsburgh Institute for Clinical Research Education and Clinician Scientist Training program.	Adatia K, 2021, NEUROCRIT CARE, V34, P312, DOI 10.1007/s12028-020-00994-4; Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Autzen HE, 2018, SCIENCE, V359, P228, DOI 10.1126/science.aar4510; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Bossers SM, 2021, JAMA NEUROL, V78, P338, DOI 10.1001/jamaneurol.2020.4596; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Carnevale JA, 2018, J NEUROSURG, V129, P1305, DOI 10.3171/2017.7.JNS17988; Cepeda S, 2020, J NEUROSURG, V132, P1623, DOI 10.3171/2019.2.JNS182025; Cepeda S, 2015, J NEUROTRAUM, V32, P1246, DOI 10.1089/neu.2014.3808; Chen MK, 2001, J NEUROSCI, V21, P6512, DOI 10.1523/JNEUROSCI.21-17-06512.2001; Edwards P, 2005, LANCET, V365, P1957; Feng Y, 2008, DIABETES CARE, V31, P1939, DOI 10.2337/dc07-2248; Jha RM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020409; Jha RM, 2019, J NEUROTRAUM, V36, P1804, DOI 10.1089/neu.2018.6124; Jha RM, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0912-9; Jha RM, 2018, CRIT CARE MED, V46, P1792, DOI 10.1097/CCM.0000000000003361; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Jha RM, 2017, LANCET NEUROL, V16, P578, DOI 10.1016/S1474-4422(17)30225-9; Jha RM, 2017, NEUROCRIT CARE, V26, P213, DOI 10.1007/s12028-016-0309-z; Jha RM, 2018, J NEUROL NEUROSUR PS, V89, P1152, DOI 10.1136/jnnp-2017-317741; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Li NN, 2017, CELL, V168, P101, DOI 10.1016/j.cell.2016.12.028; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Marchenko YV, 2008, STATA J, V8, P305, DOI 10.1177/1536867X0800800301; Marziliano N, 2015, CLIN CHIM ACTA, V451, P240, DOI 10.1016/j.cca.2015.10.003; Mathieu F, 2020, NEUROCRIT CARE, V32, P373, DOI 10.1007/s12028-019-00885-3; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Neil A, 2008, EUR HEART J, V29, P2625, DOI 10.1093/eurheartj/ehn422; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Rowell SE, 2020, JAMA-J AM MED ASSOC, V324, P961, DOI 10.1001/jama.2020.8958; Schwamm LH, 2014, NEW ENGL J MED, V371, P2522, DOI 10.1056/NEJMe1412951; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Simard JM, 2012, J CEREBR BLOOD F MET, V32, P1699, DOI 10.1038/jcbfm.2012.91; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; Sun C, 2019, BIOINFORMATICS, V35, P415, DOI 10.1093/bioinformatics/bty641; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Wan XY, 2020, J NEUROSURG, V133, P496, DOI 10.3171/2019.4.JNS183472; Ward LD, 2016, NUCLEIC ACIDS RES, V44, pD877, DOI 10.1093/nar/gkv1340; Winkler EA, 2017, J CLIN NEUROSCI, V35, P109, DOI 10.1016/j.jocn.2016.09.017; Woo SK, 2013, J BIOL CHEM, V288, P3655, DOI 10.1074/jbc.M112.428219; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yuan F, 2012, J NEUROTRAUM, V29, P2137, DOI 10.1089/neu.2011.2233; Yue JK, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.791; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1217, DOI 10.1007/s00701-019-03844-1; Zeiler FA, 2019, NAT REV NEUROL, V15, P25, DOI 10.1038/s41582-018-0105-9; Zhang DF, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/261825	53	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2574-3805			JAMA NETW OPEN	JAMA Netw. Open	JUL 26	2021	4	7								10.1001/jamanetworkopen.2021.16839			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TS2EU	WOS:000679469800001	34309670	Green Published, gold			2022-02-06	
J	Williams, JR; Nieblas-Bedolla, E; Feroze, A; Young, C; Temkin, NR; Giacino, JT; Okonkwo, DO; Manley, GT; Barber, J; Durfy, S; Markowitz, AJ; Yu, ESL; Mukherjee, P; Mac Donald, CL				Williams, John R.; Nieblas-Bedolla, Edwin; Feroze, Abdullah; Young, Christopher; Temkin, Nancy R.; Giacino, Joseph T.; Okonkwo, David O.; Manley, Geoffrey T.; Barber, Jason; Durfy, Sharon; Markowitz, Amy J.; Yu, Esther L.; Mukherjee, Pratik; Mac Donald, Christine L.		Transforming Res & Clinical Knowle	Prognostic Value of Hemorrhagic Brainstem Injury on Early Computed Tomography: A TRACK-TBI Study	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Brainstem injury; Computed tomography; Outcomes; Traumatic axonal injury	ASCENDING AROUSAL SYSTEM; DIFFUSE AXONAL INJURY; COMMON DATA ELEMENTS; SEVERE HEAD-INJURY; EXTERNAL VALIDATION; OUTCOME PREDICTION; MODERATE; MRI; CLASSIFICATION; IMPACT	Background Traumatic brainstem injury has yet to be incorporated into widely used imaging classification systems for traumatic brain injury (TBI), and questions remain regarding prognostic implications for this TBI subgroup. To address this, retrospective data on patients from the multicenter prospective Transforming Research and Clinical Knowledge in TBI study were studied. Methods Patients with brainstem and cerebrum injury (BSI+) were matched by age, sex, and admission Glasgow Coma Scale (GCS) score to patients with cerebrum injuries only. All patients had an interpretable head computed tomography (CT) scan from the first 48 hours after injury and a 6-month Glasgow Outcome Scale Extended (GOSE) score. CT scans were reviewed for brainstem lesions and, when present, characterized by location, size, and type (traumatic axonal injury, contusion, or Duret hemorrhage). Clinical, demographic, and outcome data were then compared between the two groups. Results Mann-Whitney U-tests showed no significant difference in 6-month GOSE scores in patients with BSI+ (mean 2.7) compared with patients with similar but only cerebrum injuries (mean 3.9), although there is a trend (p = 0.10). However, subclassification by brainstem lesion type, traumatic axonal injury (mean 4.0) versus Duret hemorrhage or contusion (mean 1.4), did identify a proportion of BSI+ with significantly less favorable outcome (p = 0.002). The incorporation of brainstem lesion type (traumatic axonal injury vs. contusion/Duret), along with GCS into a multivariate logistic regression model of favorable outcome (GOSE score 4-8) did show a significant contribution to the prognostication of this brainstem injury subgroup (odds ratio 0.08, 95% confidence interval 0.00-0.67, p = 0.01). Conclusions These findings suggest two groups of patients with brainstem injuries may exist with divergent recovery potential after TBI. These data support the notion that newer CT imaging classification systems may augment traditional clinical measures, such as GCS in identifying those patients with TBI and brainstem injuries that stand a higher chance of favorable outcome.	[Williams, John R.; Feroze, Abdullah; Young, Christopher; Temkin, Nancy R.; Barber, Jason; Durfy, Sharon; Mac Donald, Christine L.] Univ Washington, Harborview Med Ctr, Sch Med, Dept Neurol Surg, 325 9th Ave,Box 359924, Seattle, WA 98104 USA; [Nieblas-Bedolla, Edwin] Univ Washington, Sch Med, Seattle, WA 98195 USA; [Temkin, Nancy R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Giacino, Joseph T.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Okonkwo, David O.] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA 15213 USA; [Manley, Geoffrey T.; Markowitz, Amy J.] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Brain & Spinal Injury Ctr, Dept Neurol Surg, 1001 Potrero Ave,Bldg 1 Rm 101,Box 0899, San Francisco, CA 94143 USA; [Manley, Geoffrey T.; Markowitz, Amy J.] Univ Calif San Francisco, Ctr Trauma, 1001 Potrero Ave,Bldg 1 Rm 101,Box 0899, San Francisco, CA 94143 USA; [Yu, Esther L.; Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA		Mac Donald, CL (corresponding author), Univ Washington, Harborview Med Ctr, Sch Med, Dept Neurol Surg, 325 9th Ave,Box 359924, Seattle, WA 98104 USA.; Markowitz, AJ (corresponding author), Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Brain & Spinal Injury Ctr, Dept Neurol Surg, 1001 Potrero Ave,Bldg 1 Rm 101,Box 0899, San Francisco, CA 94143 USA.	amymarkowitz@gmail.com; cmacd@uw.edu	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Nieblas-Bedolla, Edwin/0000-0001-5879-1800	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	We would like to thank the patients and their families for their participation and support of the TRACK-TBI study. Funding for the original TRACK-TBI study was awarded to GTM by the National Institutes of Health.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Brain and Spinal Injury Center, 2014, TRANSF RES CLIN KNOW; Brown AW, 2019, BRAIN INJURY, V33, P610, DOI 10.1080/02699052.2019.1566970; Chew BG, 2012, J NEUROSURG, V117, P722, DOI 10.3171/2012.6.JNS111736; Cicuendez M, 2019, J NEURORADIOLOGY, V46, P299, DOI 10.1016/j.neurad.2018.08.001; DURET R L, 1955, Brux Med, V35, P797; Edlow BL, 2013, NEUROCRIT CARE, V19, P364, DOI 10.1007/s12028-013-9870-x; Edlow BL, 2013, J NEUROPATH EXP NEUR, V72, P505, DOI 10.1097/NEN.0b013e3182945bf6; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Gomez PA, 2014, J NEUROSURG, V121, P1314, DOI 10.3171/2014.7.JNS131874; Haghbayan H, 2017, CRIT CARE MED, V45, pe1280, DOI 10.1097/CCM.0000000000002731; Izzy S, 2017, NEUROCRIT CARE, V27, P199, DOI 10.1007/s12028-017-0399-2; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Mannion RJ, 2007, J NEUROTRAUM, V24, P128, DOI 10.1089/neu.2006.0127; Meaney D.F., 2016, YOUMANS WINNS NEUROL, V7th, P2755; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Rosenblum WI, 2015, J NEUROPATH EXP NEUR, V74, P198, DOI 10.1097/NEN.0000000000000170; Rubin R, 2020, JAMA-J AM MED ASSOC, V323, P1998, DOI 10.1001/jama.2020.8130; Schweitzer AD, 2019, RADIOGRAPHICS, V39, P1571, DOI 10.1148/rg.2019190076; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Skandsen T, 2011, J NEUROTRAUM, V28, P691, DOI 10.1089/neu.2010.1590; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008	34	2	2	2	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2021	35	2					335	346		10.1007/s12028-021-01263-8		JUL 2021	12	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WU3OH	WOS:000678429100006	34309784	Green Accepted			2022-02-06	
J	Holding, EZ; Turner, EM; Hall, TA; Leonard, S; Bradbury, KR; Williams, CN				Holding, Emily Z.; Turner, Elise M.; Hall, Trevor A.; Leonard, Skyler; Bradbury, Kathryn R.; Williams, Cydni N.			The Association Between Functional Status and Health-Related Quality of Life Following Discharge from the Pediatric Intensive Care Unit	NEUROCRITICAL CARE			English	Article						Pediatric; Critical care; Postintensive care syndrome; Outcomes; Brain injury	TRAUMATIC BRAIN-INJURY; GENERIC CORE SCALES; CHILDREN; VALIDITY; RELIABILITY; CHILDHOOD; SURVIVORS; OUTCOMES	Background Despite one third of children with acquired brain injury (ABI) experiencing new functional impairments following critical care admission, there is limited research investigating the impact of new functional impairments on overall health-related quality of life (HRQOL) or among important HRQOL domains. We aimed to investigate the association between new functional impairments, measured by the Functional Status Scale (FSS), and HRQOL in pediatric patients with ABI after critical care. Methods We conducted a secondary analysis of a prospective observational study of 275 children aged 2 months to 18 years with ABI. The primary exposure evaluated was change in FSS from baseline at hospital discharge, categorized per prior work (no change, 1-2 point increase, and >= 3 point increase). The primary outcome was overall HRQOL 6 months after hospital discharge, measured by the Pediatric Quality of Life Inventory (PedsQL) total score. Secondary outcomes were PedsQL domain scores. PedsQL total and domain scores were transformed into age-standardized z scores for analyses. Multiple linear regression models evaluated the association between FSS change category and HRQOL (overall and domain z scores) when controlling for demographic and clinical characteristics and were reported as beta-coefficients with 95% confidence intervals. Results Complete data were analyzed for 195 (71%) children, including 127 with traumatic brain injury. New functional impairment was common with 32 (16%) patients experiencing FSS increases >= 3, 50 (26%) patients with FSS increases of 1-2 points, and 113 (58%) patients with no change from prehospital baseline. The majority of children (63%) demonstrated HRQOL ratings >= 1 standard deviation below healthy age-based standards (z scores <= - 1). Regression models demonstrated older age, female sex, presence of comorbidities, and preadmission cardiopulmonary resuscitation were all significantly associated with poorer overall HRQOL (all p < 0.05). FSS increase >= 3 at discharge was significantly associated with worse overall HRQOL at follow-up (beta = - 1.07; 95% confidence interval = - 1.63 to - 0.52) when controlling for the aforementioned significant factors, and significantly improved model fit (p value for change = 0.001). Similar findings in secondary analyses were found for physical domain scores, with FSS increase showing a significant association with worse physical HRQOL scores and improvements in model fit. Change in FSS was not significantly associated with other HRQOL domain scores (emotional, social, school, psychosocial). Conclusions Many children with ABI after critical care experience new functional impairments (FSS increases) and worse HRQOL than healthy peers. FSS increase at discharge is a significant risk factor for worse HRQOL in the months after hospital discharge and improves HRQOL models beyond illness and demographic variables alone.	[Holding, Emily Z.] Dartmouth Hitchcock Med Ctr, Dept Psychiat, Lebanon, NH 03766 USA; [Turner, Elise M.] Childrens Hosp Colorado, Div Neurol, Aurora, CO USA; [Hall, Trevor A.; Leonard, Skyler] Oregon Hlth & Sci Univ, Div Pediat Psychol, Dept Pediat, Portland, OR 97201 USA; [Hall, Trevor A.; Williams, Cydni N.] Oregon Hlth & Sci Univ, Pediat Crit Care & Neurotrauma Recovery Program, Portland, OR 97201 USA; [Bradbury, Kathryn R.] Childrens Neuropsychol Serv, Boston, MA USA; [Williams, Cydni N.] Oregon Hlth & Sci Univ, Dept Pediat, Div Crit Care, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA		Holding, EZ (corresponding author), Dartmouth Hitchcock Med Ctr, Dept Psychiat, Lebanon, NH 03766 USA.	Emily_Holding@mail.harvard.edu			Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12HS022981]; National Heart Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K23HL150229]	Dr. Williams received support from the Agency for Healthcare Research and Quality (K12HS022981) for this research and is currently supported by the National Heart Lung and Blood Institute (K23HL150229). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality or National Heart Lung and Blood Institute.	Ambuehl J, 2007, SWISS MED WKLY, V137, P312; Aspesberro F, 2016, PEDIATR CRIT CARE ME, V17, pE272, DOI 10.1097/PCC.0000000000000727; Aspesberro F, 2015, INTENS CARE MED, V41, P1235, DOI 10.1007/s00134-015-3780-7; Bisegger C, 2005, SOZ PRAVENTIV MED, V50, P281, DOI 10.1007/s00038-005-4094-2; Bradbury KR, 2021, J CHILD ADOLES TRAUM, V14, P177, DOI 10.1007/s40653-020-00332-y; Brown EA, 2016, J PEDIATR PSYCHOL, V41, P244, DOI 10.1093/jpepsy/jsv090; Colville GA, 2013, PEDIATR CRIT CARE ME, V14, P446, DOI 10.1097/PCC.0b013e318290b4b5; Conlon NP, 2009, PEDIATR CRIT CARE ME, V10, P41, DOI 10.1097/PCC.0b013e31819371f6; Cunha F, 2013, PEDIATR CRIT CARE ME, V14, pE8, DOI 10.1097/PCC.0b013e31826012b4; Desai AD, 2014, JAMA PEDIATR, V168, P1114, DOI 10.1001/jamapediatrics.2014.1600; Dodd JN, 2018, PEDIATR NEUROL, V89, P58, DOI 10.1016/j.pediatrneurol.2018.09.007; Ebrahim S, 2013, PEDIATR CRIT CARE ME, V14, P10, DOI 10.1097/PCC.0b013e31825b64b3; Erickson SJ, 2010, DEV NEUROREHABIL, V13, P175, DOI 10.3109/17518420903479867; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Green L, 2013, BRAIN INJURY, V27, P872, DOI 10.3109/02699052.2013.775506; Hall TA, 2020, CLIN NEUROPSYCHOL, DOI 10.1080/13854046.2020.1797176; Hartman ME, 2020, PEDIATR NEUROL, V108, P47, DOI 10.1016/j.pediatrneurol.2020.02.003; Heneghan JA, 2017, PEDIATR CLIN N AM, V64, P1147, DOI 10.1016/j.pcl.2017.06.011; Herrup Elizabeth A, 2017, World J Crit Care Med, V6, P124, DOI 10.5492/wjccm.v6.i2.124; Knoester H, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-21; Kruse S, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0168-2; Maddux AB, 2018, PEDIATR CRIT CARE ME, V19, P1046, DOI 10.1097/PCC.0000000000001710; Manning JC, 2018, PEDIATR CRIT CARE ME, V19, P298, DOI 10.1097/PCC.0000000000001476; Mestrovic J, 2007, J PAEDIATR CHILD H, V43, P673, DOI 10.1111/j.1440-1754.2007.01185.x; Moreau JF, 2013, PEDIATR CRIT CARE ME, V14, P801, DOI 10.1097/PCC.0b013e31828aa71f; Namachivayam P, 2012, PEDIATR CRIT CARE ME, V13, P520, DOI 10.1097/PCC.0b013e31824fb989; Pinto NP, 2017, PEDIATR CRIT CARE ME, V18, pE122, DOI 10.1097/PCC.0000000000001070; Polic B, 2013, EUR J PEDIATR, V172, P85, DOI 10.1007/s00431-012-1843-0; Pollack MM, 2014, PEDIATR CRIT CARE ME, V15, P821, DOI 10.1097/PCC.0000000000000250; Pollack MM, 2014, JAMA PEDIATR, V168, P671, DOI 10.1001/jamapediatrics.2013.5316; Cordts KMP, 2020, NEUROCRIT CARE, V33, P196, DOI 10.1007/s12028-019-00883-5; Treble-Barna A, 2019, PEDIATR CRIT CARE ME, V20, pE274, DOI 10.1097/PCC.0000000000001940; Varni JW, 2011, QUAL LIFE RES, V20, P45, DOI 10.1007/s11136-010-9730-5; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; VARNI JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI DOI 10.1186/1477-7525-5-43; Watson RS, 2018, J PEDIATR-US, V198, P16, DOI 10.1016/j.jpeds.2017.12.084; Williams Cydni N, 2019, Hosp Pediatr, V9, P958, DOI 10.1542/hpeds.2019-0173; Williams CN, 2019, CURR TREAT OPTION NE, V21, DOI 10.1007/s11940-019-0586-x; Williams CN, 2018, PEDIATR NEUROL, V89, P31, DOI 10.1016/j.pediatrneurol.2018.07.013; Williams CN, 2018, NAT SCI SLEEP, V10, P225, DOI 10.2147/NSS.S174608; Williams CN, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4090083	41	2	2	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2021	35	2					347	357		10.1007/s12028-021-01271-8		JUL 2021	11	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	WU3OH	WOS:000673192500001	34272680				2022-02-06	
J	Appavu, B; Temkit, M'; Foldes, S; Burrows, BT; Kuwabara, M; Jacobson, A; Adelson, PD				Appavu, Brian; Temkit, M. 'Hamed; Foldes, Stephen; Burrows, Brian T.; Kuwabara, Michael; Jacobson, Austin; Adelson, P. David			Association of Outcomes with Model-Based Indices of Cerebral Autoregulation After Pediatric Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Pediatric neurocritical care; Multimodal neurologic monitoring; Cerebral autoregulation	CEREBROVASCULAR PRESSURE REACTIVITY; HUMAN INTRACRANIAL HYDRODYNAMICS; PERFUSION-PRESSURE; PULSE AMPLITUDE; BLOOD-FLOW; CHILDREN; THRESHOLDS; CARE	Background We investigated whether model-based indices of cerebral autoregulation (CA) are associated with outcomes after pediatric traumatic brain injury. Methods This was a retrospective analysis of a prospective clinical database of 56 pediatric patients with traumatic brain injury undergoing intracranial pressure monitoring. CA indices were calculated, including pressure reactivity index (PRx), wavelet pressure reactivity index (wPRx), pulse amplitude index (PAx), and correlation coefficient between intracranial pressure pulse amplitude and cerebral perfusion pressure (RAC). Each CA index was used to compute optimal cerebral perfusion pressure (CPP). Time of CPP below lower limit of autoregulation (LLA) or above upper limit of autoregulation (ULA) were computed for each index. Demographic, physiologic, and neuroimaging data were collected. Primary outcome was determined using Pediatric Glasgow Outcome Scale Extended (GOSE-Peds) at 12 months, with higher scores being suggestive of unfavorable outcome. Univariate and multiple linear regression with guided stepwise variable selection was used to find combinations of risk factors that can best explain the variability of GOSE-Peds scores, and the best fit model was applied to the age strata. We hypothesized that higher GOSE-Peds scores were associated with higher CA values and more time below LLA or above ULA for each index. Results At the univariate level, CPP, dose of intracranial hypertension, PRx, PAx, wPRx, RAC, percent time more than ULA derived for PAx, and percent time less than LLA derived for PRx, PAx, wPRx, and RAC were all associated with GOSE-Peds scores. The best subset model selection on all pediatric patients identified that when accounting for CPP, increased dose of intracranial hypertension and percent time less than LLA derived for wPRx were independently associated with higher GOSE-Peds scores. Age stratification of the best fit model identified that in children less than 2 years of age or 8 years of age or more, percent time less than LLA derived for wPRx represented the sole independent predictor of higher GOSE-Peds scores when accounting for CPP and dose of intracranial hypertension. For children 2 years or younger to less than 8 years of age, dose of intracranial hypertension was identified as the sole independent predictor of higher GOSE-Peds scores when accounting for CPP and percent time less than LLA derived for wPRx. Conclusions Increased dose of intracranial hypertension, PRx, wPRx, PAx, and RAC values and increased percentage time less than LLA based on PRx, wPRx, PAx, and RAC are associated with higher GOSE-Peds scores, suggestive of unfavorable outcome. Reducing intracranial hypertension and maintaining CPP more than LLA based on wPRx may improve outcomes and warrants prospective investigation.	[Appavu, Brian; Temkit, M. 'Hamed; Foldes, Stephen; Burrows, Brian T.; Jacobson, Austin; Adelson, P. David] Phoenix Childrens Hosp, Dept Neurosci, Barrow Neurol Inst, 1919 E Thomas Rd,Ambulatory Bldg B,4th Floor, Phoenix, AZ 85016 USA; [Appavu, Brian; Foldes, Stephen; Kuwabara, Michael; Adelson, P. David] Univ Arizona, Dept Child Hlth, Coll Med, 550 E Van Buren St, Phoenix, AZ 85004 USA; [Kuwabara, Michael] Phoenix Childrens Hosp, Dept Radiol, 1919 E Thomas Rd, Phoenix, AZ USA		Appavu, B (corresponding author), Phoenix Childrens Hosp, Dept Neurosci, Barrow Neurol Inst, 1919 E Thomas Rd,Ambulatory Bldg B,4th Floor, Phoenix, AZ 85016 USA.; Appavu, B (corresponding author), Univ Arizona, Dept Child Hlth, Coll Med, 550 E Van Buren St, Phoenix, AZ 85004 USA.	bappavu@phoenixchildrens.com		Appavu, Brian/0000-0002-5396-2559	United States Department of Defense Congressionally Directed Medical Research Programs Epilepsy Research Program [W81XWH-19-1-0514]	This work was funded in part by the United States Department of Defense Congressionally Directed Medical Research Programs Epilepsy Research Program (W81XWH-19-1-0514).	Akerlund CA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243427; Akhondi-Asl A, 2018, CRIT CARE MED, V46, pE1160, DOI 10.1097/CCM.0000000000003434; Appavu B, 2021, NEUROCRIT CARE, V34, P537, DOI 10.1007/s12028-020-01058-3; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; BODE H, 1988, ARCH DIS CHILD, V63, P606, DOI 10.1136/adc.63.6.606; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; CHIRON C, 1992, J NUCL MED, V33, P696; Donnelly J, 2017, CRIT CARE MED, V45, P1464, DOI 10.1097/CCM.0000000000002575; Donnelly J, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1293-6; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Lewis PM, 2015, PEDIATR CRIT CARE ME, V16, P739, DOI 10.1097/PCC.0000000000000471; Liu XY, 2017, J NEUROTRAUM, V34, P3081, DOI 10.1089/neu.2017.5003; Liu XY, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002348; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mehta A, 2010, DEV NEUROSCI-BASEL, V32, P413, DOI 10.1159/000316804; Portet S, 2020, INFECT DIS MODEL, V5, P111, DOI 10.1016/j.idm.2019.12.010; Sgouros S, 1999, J NEUROSURG, V91, P610, DOI 10.3171/jns.1999.91.4.0610; Smelewski, 2019, ACTA NEUROCHIR, V519, P2063; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Suzuki K., 1990, NAGOYA MED J, V34, P159; URSINO M, 1988, ANN BIOMED ENG, V16, P379, DOI 10.1007/BF02364625; URSINO M, 1988, ANN BIOMED ENG, V16, P403, DOI 10.1007/BF02364626; Vavilala MS, 2005, PEDIATR RES, V58, P574, DOI 10.1203/01.PDR.0000179405.30737.0F; Wintermark M, 2004, PEDIATRICS, V113, P1642, DOI 10.1542/peds.113.6.1642; Woods KS, 2021, PEDIATR CRIT CARE ME, V22, P135, DOI 10.1097/PCC.0000000000002618; Zeiler FA, 2020, BRIT J ANAESTH, V124, P440, DOI 10.1016/j.bja.2019.11.031; Zeiler FA, 2018, J NEUROTRAUM, V35, P2803, DOI 10.1089/neu.2017.5603; Zeiler FA, 2018, J NEUROTRAUM, V35, P963, DOI 10.1089/neu.2017.5241; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472	33	2	2	1	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2021	35	3					640	650		10.1007/s12028-021-01279-0		JUL 2021	11	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	XS0FS	WOS:000673192400001	34268644				2022-02-06	
J	Bianciardi, M; Izzy, S; Rosen, BR; Wald, LL; Edlow, BL				Bianciardi, Marta; Izzy, Saef; Rosen, Bruce R.; Wald, Lawrence L.; Edlow, Brian L.			Location of Subcortical Microbleeds and Recovery of Consciousness After Severe Traumatic Brain Injury	NEUROLOGY			English	Article							DOPAMINERGIC-NEURONS; CEREBRAL MICROBLEEDS; ASCENDING AROUSAL; AXONAL INJURY; SLEEP; MODULATION; ACTIVATION; WITHDRAWAL; TEMPLATE; NUCLEI	Background In patients with severe traumatic brain injury (TBI), coma is associated with impaired subcortical arousal mechanisms. However, it is unknown which nuclei involved in arousal (arousal nuclei) are implicated in coma pathogenesis and are compatible with coma recovery. Methods We mapped an atlas of arousal nuclei in the brainstem, thalamus, hypothalamus, and basal forebrain onto 3 tesla susceptibility-weighted images (SWI) in 12 patients with acute severe TBI who presented in coma and recovered consciousness within 6 months. We assessed the spatial distribution and volume of SWI microbleeds and evaluated the association of microbleed volume with the duration of unresponsiveness and functional recovery at 6 months. Results There was no single arousal nucleus affected by microbleeds in all patients. Rather, multiple combinations of microbleeds in brainstem, thalamic, and hypothalamic arousal nuclei were associated with coma and were compatible with recovery of consciousness. Microbleeds were frequently detected in the midbrain (100%), thalamus (83%), and pons (75%). Within the brainstem, the microbleed incidence was largest within the mesopontine tegmentum (e.g., pedunculotegmental nucleus, mesencephalic reticular formation) and ventral midbrain (e.g., substantia nigra, ventral tegmental area). Brainstem arousal nuclei were partially affected by microbleeds, with microbleed volume not exceeding 35% of brainstem nucleus volume on average. Compared to microbleed volume within nonarousal brainstem regions, the microbleed volume within arousal brainstem nuclei accounted for a larger proportion of variance in the duration of unresponsiveness and 6-month Glasgow Outcome Scale-Extended scores. Conclusion These results suggest resilience of arousal mechanisms in the human brain after severe TBI.	[Bianciardi, Marta; Rosen, Bruce R.; Wald, Lawrence L.; Edlow, Brian L.] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02114 USA; [Edlow, Brian L.] Massachusetts Gen Hosp, Ctr Neurotechnol & Neurorecovery, Dept Neurol, Boston, MA 02114 USA; [Izzy, Saef; Edlow, Brian L.] Harvard Med Sch, Boston, MA 02115 USA; [Bianciardi, Marta] Harvard Univ, Div Sleep Med, Boston, MA 02115 USA; [Izzy, Saef] Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA		Bianciardi, M (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02114 USA.	martab@mgh.harvard.edu	Wald, Lawrence/D-4151-2009; Bianciardi, Marta/K-6178-2016	Wald, Lawrence/0000-0001-8278-6307; Bianciardi, Marta/0000-0001-9606-6853	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIBIB-K01EB019474, NIDCD-R21DC015888, NICHD-DP2HD 101400, NINDS-R21NS109627, NINDS-RF1NS115268, NIAR01AG063982]; James S. McDonnell Foundation; Rappaport Foundation; Tiny Blue Dot Foundation	This work was funded by grants from the NIH (NIBIB-K01EB019474, NIDCD-R21DC015888, NICHD-DP2HD 101400, NINDS-R21NS109627, NINDS-RF1NS115268, NIAR01AG063982), James S. McDonnell Foundation, Rappaport Foundation, and Tiny Blue Dot Foundation.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Bianciardi M, 2018, NEUROIMAGE, V170, P222, DOI 10.1016/j.neuroimage.2017.04.070; Bianciardi M, 2015, BRAIN CONNECT, V5, P597, DOI 10.1089/brain.2015.0347; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Carrive P., 2012, HUMAN NERVOUS SYSTEM, Ved. 3; DATTA S, 1991, BRAIN RES, V566, P344, DOI 10.1016/0006-8993(91)91723-E; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Eban-Rothschild A, 2016, NAT NEUROSCI, V19, P1356, DOI 10.1038/nn.4377; Edlow BL, 2021, NAT REV NEUROL, V17, P135, DOI 10.1038/s41582-020-00428-x; Edlow BL, 2020, NEUROCRIT CARE, V33, P364, DOI 10.1007/s12028-020-01062-7; Edlow BL, 2013, J NEUROPATH EXP NEUR, V72, P505, DOI 10.1097/NEN.0b013e3182945bf6; Fischer DB, 2016, NEUROLOGY, V87, P2427, DOI 10.1212/WNL.0000000000003404; Fuller P, 2011, J COMP NEUROL, V519, P933, DOI 10.1002/cne.22559; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Griffin AD, 2019, BRAIN, V142, P3550, DOI 10.1093/brain/awz290; Izzy S, 2017, NEUROCRIT CARE, V27, P199, DOI 10.1007/s12028-017-0399-2; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; JENNETT B, 1979, J ROY COLL PHYS LOND, V13, P197; Jolly AE, 2021, BRAIN, V144, P92, DOI 10.1093/brain/awaa372; Kaur S, 2013, J NEUROSCI, V33, P7627, DOI 10.1523/JNEUROSCI.0173-13.2013; Lawrence TP, 2017, NEUROSCI LETT, V655, P143, DOI 10.1016/j.neulet.2017.06.046; Lima M.M.S., 2008, BIOSCI HYPOTHESES, V1, P9, DOI [10.1016/j.bihy.2008.01.010, DOI 10.1016/J.BIHY.2008.01.010]; Lima MMS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000513; Lu J, 2006, J NEUROSCI, V26, P193, DOI 10.1523/JNEUROSCI.2244-05.2006; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Mazwi NL, 2019, J HEAD TRAUMA REHAB, V34, pE10, DOI 10.1097/HTR.0000000000000479; Monti JM, 2008, PROG BRAIN RES, V172, P625, DOI 10.1016/S0079-6123(08)00929-1; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90219-9; Munk MHJ, 1996, SCIENCE, V272, P271, DOI 10.1126/science.272.5259.271; Nigro S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085618; Nolan AL, 2021, J NEUROTRAUM, V38, P1620, DOI 10.1089/neu.2020.7373; Olszewski J., 2014, CYTOARCHITECTURE HUM, V3rd; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; Parvizi J, 2001, COGNITION, V79, P135, DOI 10.1016/S0010-0277(00)00127-X; Pauli WM, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.63; Rosenblum WI, 2015, J NEUROPATH EXP NEUR, V74, P198, DOI 10.1097/NEN.0000000000000170; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Singh K, 2020, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01425; Snider SB, 2020, NEUROIMAGE-CLIN, V28, DOI 10.1016/j.nicl.2020.102503; Snider SB, 2020, HUM BRAIN MAPP, V41, P1520, DOI 10.1002/hbm.24892; Snider SB, 2019, NEUROLOGY, V93, pE1281, DOI 10.1212/WNL.0000000000008163; Sokoliuk R, 2021, ANN NEUROL, V89, P646, DOI 10.1002/ana.25995; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786	47	2	2	2	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JUL 13	2021	97	2					E113	E123		10.1212/WNL.0000000000012192			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UZ7ZD	WOS:000702418800016	34050005				2022-02-06	
J	Schneider, ALC; Wang, D; Gottesman, RF; Selvin, E				Schneider, Andrea L. C.; Wang, Dan; Gottesman, Rebecca F.; Selvin, Elizabeth			Prevalence of Disability Associated With Head Injury With Loss of Consciousness in Adults in the United States A Population-Based Study	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; LONG-TERM DISABILITY; LIFETIME HISTORY; NATIONAL-HEALTH; GRIP STRENGTH; OLDER-ADULTS; IMPACT; HOSPITALIZATION; EPIDEMIOLOGY; OUTCOMES	Objective To provide nationally representative prevalence estimates of disability associated with prior head injury with loss of consciousness in the United States and to examine associations between prior head injury and disability. Methods This was a cross-sectional analysis of 7,390 participants >= 40 years of age in the 2011-2014 National Health and Nutrition Examination Surveys (NHANES). Head injury with loss of consciousness was assessed by self-report. Domains of disability were assessed with a standardized structured questionnaire and measured grip strength. Logistic and linear regression models adjusted for demographic, socioeconomic/behavioral, and medical comorbidity variables were used. Multiple imputation was used to account for missing covariate data. Results Mean age of participants was 58 years; 53% were female; 71% were non-Hispanic White; and 16% had a history of head injury with loss of consciousness. Overall, participants with a history of head injury had higher prevalence of disability in at least 1 domain of functioning compared to individuals without head injury (47.4% vs 38.6%, p < 0.001), with the highest prevalence of disability in the domains of mobility and work productivity. In fully adjusted models, head injury was significantly positively associated with disability in all domains assessed on the standardized questionnaire (all p < 0.05). Participants with head injury had greater grip strength (all p < 0.05). Conclusions We found that 47.4% of individuals >= 40 years of age in the United States with a history of head injury are living with disability in at least 1 domain of functioning, corresponding to 11.4 million affected individuals. This significant burden of disability suggests that efforts are needed to improve functioning among individuals with head injury.	[Schneider, Andrea L. C.] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Wang, Dan; Gottesman, Rebecca F.; Selvin, Elizabeth] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Gottesman, Rebecca F.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA		Schneider, ALC (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA.	Andrea.Schneider@pennmedicine.upenn.edu	Gottesman, Rebecca/ABA-8468-2020	Christman Schneider, Andrea Lauren/0000-0003-0026-5052	NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K24 HL152440] Funding Source: Medline		Centers for Disease Control, TBI DATA STAT; Cetty L, 2017, INT PSYCHOGERIATR, V29, P1899, DOI 10.1017/S104161021700134X; Chen DS, 2014, J AM GERIATR SOC, V62, P850, DOI 10.1111/jgs.12800; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Courtney-Long EA, 2015, MMWR-MORBID MORTAL W, V64, P777, DOI 10.15585/mmwr.MM6429a2; Ekstrand E, 2016, TOP STROKE REHABIL, V23, P400, DOI 10.1080/10749357.2016.1168591; Grasset L, 2020, ALZHEIMERS DEMENT, V16, P853, DOI 10.1002/alz.12080; Gutierrez OM, 2011, J RENAL NUTR, V21, P140, DOI 10.1053/j.jrn.2010.03.001; Haller CS, 2017, BRAIN INJURY, V31, P319, DOI 10.1080/02699052.2016.1255777; Ilie G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0188908; Jourdan C, 2018, AM J PHYS MED REHAB, V97, P323, DOI 10.1097/PHM.0000000000000848; Kleffelgaard I, 2019, CLIN REHABIL, V33, P74, DOI 10.1177/0269215518791274; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee MC, 2018, J GERIATR PHYS THER, V41, P14, DOI 10.1519/JPT.0000000000000106; Levis B, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1476; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; McKinlay A, 2016, J INT NEUROPSYCH SOC, V22, P717, DOI 10.1017/S1355617716000497; National Center for Health Statistics, NATL HLTH NUTR EXAMI; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Plantinga LC, 2011, AM J KIDNEY DIS, V57, P212, DOI 10.1053/j.ajkd.2010.08.016; Roy D, 2020, J NEUROPSYCH CLIN N, V32, P132, DOI 10.1176/appi.neuropsych.18120379; Saunders LL, 2009, BRAIN INJURY, V23, P866, DOI 10.1080/02699050903283213; Schneider ALC, 2018, NEW ENGL J MED, V379, P1176, DOI 10.1056/NEJMc1808550; Seeman TE, 2010, AM J PUBLIC HEALTH, V100, P100, DOI 10.2105/AJPH.2008.157388; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wang YC, 2019, J HAND THER, V32, P489, DOI 10.1016/j.jht.2018.03.002; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Wilmoth K., 2017, CLIN NEUROPSYCHOL, P1; Yi HG, 2018, J HEAD TRAUMA REHAB, V33, pE24, DOI 10.1097/HTR.0000000000000352; Yue JK, 2019, NEUROL RES, V41, P609, DOI 10.1080/01616412.2019.1602312; Zajacova A, 2018, SOC SCI MED, V211, P1, DOI 10.1016/j.socscimed.2018.05.041; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	35	2	2	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JUL 13	2021	97	2					E124	E135		10.1212/WNL.0000000000012148			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	UZ7ZD	WOS:000702418800017	34039721				2022-02-06	
J	Scimeca, LM; Holbrook, L; Rhoads, T; Cerny, BM; Jennette, KJ; Resch, ZJ; Obolsky, MA; Ovsiew, GP; Soble, JR				Scimeca, Lauren M.; Holbrook, Lindsey; Rhoads, Tasha; Cerny, Brian M.; Jennette, Kyle J.; Resch, Zachary J.; Obolsky, Maximillian A.; Ovsiew, Gabriel P.; Soble, Jason R.			Examining Conners Continuous Performance Test-3 (CPT-3) Embedded Performance Validity Indicators in an Adult Clinical Sample Referred for ADHD Evaluation	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; INVALID PERFORMANCE; PROCESSING SPEED; TEST-II; ATTENTION; NEUROPSYCHOLOGISTS; SCORES	This study evaluated multiple previously-identified Continuous Performance Test-Third Edition (CPT-3) scores as embedded validity indicators (EVIs) among 201 adults undergoing neuropsychological evaluation for Attention-Deficit/Hyperactivity Disorder (ADHD) divided into valid (n = 169) and invalid (n = 32) groups based on seven criterion measures. Although 6/10 CPT-3 scores accurately detected invalidity, only two reached minimally acceptable classification accuracy of >= 0.70. The remaining four had unacceptably low accuracy (AUCs = 0.62-0.69) with 0.19-0.41 sensitivity at >= 0.90 specificity. Composite scores did not provide better classification accuracy than individual CPT-3 scores. In sum, CPT-3 individual and composite scores generally are not accurate PVTs among adults undergoing clinical evaluation for ADHD.	[Scimeca, Lauren M.; Holbrook, Lindsey; Rhoads, Tasha; Cerny, Brian M.; Jennette, Kyle J.; Resch, Zachary J.; Obolsky, Maximillian A.; Ovsiew, Gabriel P.; Soble, Jason R.] Univ Illinois, Dept Psychiat, Coll Med, Chicago, IL 60612 USA; [Scimeca, Lauren M.; Cerny, Brian M.] IIT, Dept Psychol, Chicago, IL 60616 USA; [Holbrook, Lindsey; Rhoads, Tasha; Resch, Zachary J.] Rosalind Franklin Univ Med & Sci, Dept Psychol, N Chicago, IL USA; [Obolsky, Maximillian A.] Roosevelt Univ, Dept Psychol, Chicago, IL 60605 USA; [Soble, Jason R.] Univ Illinois, Coll Med, Dept Neurol, Chicago, IL USA		Scimeca, LM (corresponding author), Univ Illinois, Dept Psychiat, Coll Med, Chicago, IL 60612 USA.	Lmscimeca@gmail.com		Soble, Jason/0000-0003-3348-8762; Rhoads, Tasha/0000-0001-9708-0083; Resch, Zachary/0000-0002-3199-6168			Abramson DA, 2020, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2020.1774378; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Baggio S, 2020, J ATTEN DISORD, V24, P840, DOI 10.1177/1087054718822060; Bailey KC, 2018, ARCH CLIN NEUROPSYCH, V33, P895, DOI 10.1093/arclin/acx111; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Boone K. B., 2002, DOT COUNTING TEST MA; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; Bracken B. A., 2005, CLIN ASSESSMENT ATTE; Busse M, 2012, CLIN NEUROPSYCHOL, V26, P675, DOI 10.1080/13854046.2012.679623; Conners C., 2014, CONNERS CONTINUOUS P; Conners C.K., 2004, CONNERS CONTINUOUS P; Critchfield E, 2019, CLIN NEUROPSYCHOL, V33, P1083, DOI 10.1080/13854046.2018.1508615; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P19, DOI 10.1080/23279095.2016.1232262; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Green P., 2003, GREENS WORD MEMORY T; Hervey AS, 2004, NEUROPSYCHOLOGY, V18, P485, DOI 10.1037/0894-4105.18.3.485; Hosmer DW, 2013, WILEY SER PROBAB ST, P153; Jennette KJ, 2021, CLIN NEUROPSYCHOL, DOI 10.1080/13854046.2021.1900398; Kofler MJ, 2013, CLIN PSYCHOL REV, V33, P795, DOI 10.1016/j.cpr.2013.06.001; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Larrabee G.L., 2012, FORENSIC NEUROPSYCHO, V2nd ed, P116; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Leib SI, 2021, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2021.1894150; LeRoy A, 2019, J ATTEN DISORD, V23, P1136, DOI 10.1177/1087054718773927; Marshall P, 2010, CLIN NEUROPSYCHOL, V24, P1204, DOI 10.1080/13854046.2010.514290; Martin PK, 2020, ARCH CLIN NEUROPSYCH, V35, P717, DOI 10.1093/arclin/acaa017; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Meyers JE, 2014, ARCH CLIN NEUROPSYCH, V29, P224, DOI 10.1093/arclin/acu001; Ord AS, 2021, CLIN NEUROPSYCHOL, V35, P1426, DOI 10.1080/13854046.2020.1751301; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Ovsiew GP, 2020, J CLIN EXP NEUROPSYC, V42, P473, DOI 10.1080/13803395.2020.1758635; Pliskin JI, 2021, ASSESSMENT, V28, P1871, DOI 10.1177/1073191120929093; Poynter K, 2019, ARCH CLIN NEUROPSYCH, V34, P1367, DOI 10.1093/arclin/acy087; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Resch ZJ, 2020, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2020.1742718; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Schroeder RW, 2019, CLIN NEUROPSYCHOL, V33, P466, DOI 10.1080/13854046.2018.1484517; Sharland MJ, 2018, CLIN NEUROPSYCHOL, V32, P98, DOI 10.1080/13854046.2017.1332240; Sherman EMS, 2020, ARCH CLIN NEUROPSYCH, V35, P735, DOI 10.1093/arclin/acaa019; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Soble JR, 2020, PSYCHOL INJ LAW, V13, P44, DOI 10.1007/s12207-019-09370-w; Soble JR, 2017, PHYS MED REH CLIN N, V28, P339, DOI 10.1016/j.pmr.2016.12.009; Sweet JJ, 2021, CLIN NEUROPSYCHOL, V35, P1053, DOI 10.1080/13854046.2021.1896036; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; Webber TA, 2020, ASSESSMENT, V27, P1399, DOI 10.1177/1073191118804874; White DJ, 2022, J ATTEN DISORD, V26, P101, DOI 10.1177/1087054720964575; White DJ, 2020, J CLIN EXP NEUROPSYC, V42, P459, DOI 10.1080/13803395.2020.1758634	50	2	2	3	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.	JUL 4	2021	46	5					347	359		10.1080/87565641.2021.1951270		JUL 2021	13	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	UU5HM	WOS:000673049700001	34256665				2022-02-06	
J	Manninen, E; Chary, K; Lapinlampi, N; Andrade, P; Paananen, T; Sierra, A; Tohka, J; Grohn, O; Pitkanen, A				Manninen, Eppu; Chary, Karthik; Lapinlampi, Niina; Andrade, Pedro; Paananen, Tomi; Sierra, Alejandra; Tohka, Jussi; Grohn, Olli; Pitkanen, Asla			Acute thalamic damage as a prognostic biomarker for post-traumatic epileptogenesis	EPILEPSIA			English	Article						EEG; epilepsy; MRI; traumatic brain injury	TRAUMATIC BRAIN-INJURY; RECEPTOR SUBUNITS; ROC CURVE; SEIZURES; EXPRESSION; SELECTION; REGULARIZATION; EPILEPSY; AREA; MRI	Objective To identify magnetic resonance imaging (MRI) biomarkers for post-traumatic epilepsy. Methods The EPITARGET (Targets and biomarkers for antiepileptogenesis, epitarget.eu) animal cohort completing T-2 relaxation and diffusion tensor MRI follow-up and 1-month-long video-electroencephalography monitoring included 98 male Sprague-Dawley rats with traumatic brain injury and 18 controls. T-2 imaging was performed on day (D) 2, D7, and D21 and diffusion tensor imaging (DTI) on D7 and D21 using a 7-Tesla Bruker PharmaScan MRI scanner. The mean and standard deviation (SD) of the T-2 relaxation rate, multiple diffusivity measures, and diffusion anisotropy at each time-point within the ventroposterolateral and ventroposteromedial thalamus were used as predictor variables in multi-variable logistic regression models to distinguish rats with and without epilepsy. Results Twenty-nine percent (28/98) of the rats with traumatic brain injury (TBI) developed epilepsy. The best-performing logistic regression model utilized the D2 and D7 T-2 relaxation time as well as the D7 diffusion tensor data. The model distinguished rats with and without epilepsy (Bonferroni-corrected p-value < .001) with a cross-validated concordance statistic of 0.74 (95% confidence interval [CI] 0.60-0.84). In a cross-validated classification test, the model exhibited 54% sensitivity and 91% specificity, enriching the epilepsy rate within the study population from the expected 29% to 71%. A model using the D2 T-2 data only resulted in a 73% enriched epilepsy rate (regression p-value .007, cross-validated concordance 0.70, 95% CI 0.56-0.80, sensitivity 29%, specificity 96%). Significance An MRI parameter set reporting on acute and subacute neuropathologic changes common to experimental and human TBI presents a diagnostic biomarker for post-traumatic epileptogenesis. Significant enrichment of the study population was achieved even when using a single time-point measurement, producing an expected epilepsy rate of 73%.	[Manninen, Eppu; Chary, Karthik; Lapinlampi, Niina; Andrade, Pedro; Paananen, Tomi; Sierra, Alejandra; Tohka, Jussi; Grohn, Olli; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland		Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland.	asla.pitkanen@uef.fi	Andrade, Pedro/N-8410-2018	Andrade, Pedro/0000-0001-9118-8341; Manninen, Eppu/0000-0002-9353-6079; Pitkanen, Asla/0000-0002-8163-5416	Sigrid Juseliuksen Saatio; Academy of FinlandAcademy of FinlandEuropean Commission [2285733-9, 272249, 273909, 275453, 284544, 312686, 316258]; FP7 Health [602102]	Sigrid Juseliuksen Saatio; Academy of Finland, Grant/Award Number: 2285733-9, 272249, 273909, 275453, 284544, 312686 and 316258; FP7 Health, Grant/Award Number: 602102	Agoston DV, 2019, J NEUROTRAUM, V36, P1724, DOI 10.1089/neu.2018.6261; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Andrade P, 2018, J NEUROSCI METH, V307, P37, DOI 10.1016/j.jneumeth.2018.06.015; Andrade P, 2017, J NEUROTRAUM, V34, P1482, DOI 10.1089/neu.2016.4675; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Benger W, 2006, INT J NEUROSCI, V116, P461, DOI 10.1080/00207450500505977; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Engel J, 2020, NEUROPHARMACOLOGY, V167, DOI 10.1016/j.neuropharm.2019.107735; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Fernandez LMJ, 2020, PHYSIOL REV, V100, P805, DOI 10.1152/physrev.00042.2018; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Garner R, 2019, EPILEPSIA, V60, P2151, DOI 10.1111/epi.16357; Golland P, 2005, LECT NOTES COMPUT SC, V3559, P501, DOI 10.1007/11503415_34; Hartwig V, 2009, INT J ENV RES PUB HE, V6, P1778, DOI 10.3390/ijerph6061778; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Huttunen H, 2013, MACH VISION APPL, V24, P1311, DOI 10.1007/s00138-012-0464-y; Huusko N, 2014, NEUROSCIENCE, V267, P30, DOI 10.1016/j.neuroscience.2014.02.026; Immonen R, 2013, J NEUROTRAUM, V30, P1305, DOI 10.1089/neu.2012.2815; Lapinlampi N, 2020, EPILEPSIA, V61, P2035, DOI 10.1111/epi.16632; Leemans A., 2009, P 17 SCI M INT SOC M, V17, P3537; Lewis JD, 2018, NEUROIMAGE, V173, P341, DOI 10.1016/j.neuroimage.2018.02.050; Manninen E, 2020, J NEUROTRAUM, V37, P2580, DOI 10.1089/neu.2019.6796; Novikov DS, 2018, J MAGN RESON, V293, P134, DOI 10.1016/j.jmr.2018.06.007; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Paz JT, 2013, NAT NEUROSCI, V16, P64, DOI 10.1038/nn.3269; Pitkanen A, 2019, NEUROBIOL DIS, V123, P42, DOI 10.1016/j.nbd.2018.05.007; Qin GS, 2008, STAT METHODS MED RES, V17, P207, DOI 10.1177/0962280207087173; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reddy SD, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010220; Schweser F, 2019, NEUROIMAGE, V200, P250, DOI 10.1016/j.neuroimage.2019.06.024; Sherman SM, 2017, COMPR PHYSIOL, V7, P713, DOI 10.1002/cphy.c160032; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Tian XF, 2019, NEUROIMAGE, V199, P273, DOI 10.1016/j.neuroimage.2019.05.070; Tohka J, 2016, NEUROINFORMATICS, V14, P279, DOI 10.1007/s12021-015-9292-3; Tomkins Oren, 2011, Cardiovasc Psychiatry Neurol, V2011, P765923, DOI 10.1155/2011/765923; Tubiv MA, 2019, NEUROBIOL DIS, V123, P115, DOI 10.1016/j.nbd.2018.05.014; van Vliet EA, 2020, NEUROBIOL DIS, V145, DOI 10.1016/j.nbd.2020.105080; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	44	2	2	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	AUG	2021	62	8					1852	1864		10.1111/epi.16986		JUL 2021	13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TU9RN	WOS:000671478900001	34245005	hybrid			2022-02-06	
J	Zhan, XH; Li, YH; Liu, YZ; Domel, AG; Alizadeh, HV; Zhou, Z; Cecchi, NJ; Raymond, SJ; Tiernan, S; Ruan, J; Barbat, S; Gevaert, O; Zeineh, MM; Grant, GA; Camarillo, DB				Zhan, Xianghao; Li, Yiheng; Liu, Yuzhe; Domel, August G.; Alizadeh, Hossein Vahid; Zhou, Zhou; Cecchi, Nicholas J.; Raymond, Samuel J.; Tiernan, Stephen; Ruan, Jesse; Barbat, Saeed; Gevaert, Olivier; Zeineh, Michael M.; Grant, Gerald A.; Camarillo, David B.			Predictive Factors of Kinematics in Traumatic Brain Injury from Head Impacts Based on Statistical Interpretation	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Traumatic brain injury; Head impact; Regression interpretation; Commonality analysis; Dominance analysis	DIFFUSE AXONAL INJURY; MODEL; CRITERIA; STRAIN	Brain tissue deformation resulting from head impacts is primarily caused by rotation and can lead to traumatic brain injury. To quantify brain injury risk based on measurements of kinematics on the head, finite element (FE) models and various brain injury criteria based on different factors of these kinematics have been developed, but the contribution of different kinematic factors has not been comprehensively analyzed across different types of head impacts in a data-driven manner. To better design brain injury criteria, the predictive power of rotational kinematics factors, which are different in (1) the derivative order (angular velocity, angular acceleration, angular jerk), (2) the direction and (3) the power (e.g., square-rooted, squared, cubic) of the angular velocity, were analyzed based on different datasets including laboratory impacts, American football, mixed martial arts (MMA), NHTSA automobile crashworthiness tests and NASCAR crash events. Ordinary least squares regressions were built from kinematics factors to the 95% maximum principal strain (MPS95), and we compared zero-order correlation coefficients, structure coefficients, commonality analysis, and dominance analysis. The angular acceleration, the magnitude and the first power factors showed the highest predictive power for the majority of impacts including laboratory impacts, American football impacts, with few exceptions (angular velocity for MMA and NASCAR impacts). The predictive power of rotational kinematics about three directions (x: posterior-to-anterior, y: left-to-right, z: superior-to-inferior) of kinematics varied with different sports and types of head impacts.	[Zhan, Xianghao; Liu, Yuzhe; Domel, August G.; Alizadeh, Hossein Vahid; Zhou, Zhou; Cecchi, Nicholas J.; Raymond, Samuel J.; Camarillo, David B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Li, Yiheng; Gevaert, Olivier] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Tiernan, Stephen] Technol Univ Dublin, Dublin, Ireland; [Ruan, Jesse; Barbat, Saeed] Ford Motor Co, 3001 Miller Rd, Dearborn, MI 48120 USA; [Zeineh, Michael M.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Grant, Gerald A.] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA		Liu, YZ (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	yuzheliu@stanford.edu	Raymond, Samuel/AAV-5908-2021; Cecchi, Nicholas J/AAC-6547-2021	Raymond, Samuel/0000-0003-2691-652X; Cecchi, Nicholas J/0000-0001-9319-4163; Zhan, Xianghao/0000-0002-7058-2603	Pac-12 Conference's Student-Athlete Health and Well-Being Initiative; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R24NS098518]; Taube Stanford Children's Concussion Initiative; Stanford Department of Bioengineering	This research was supported by the Pac-12 Conference's Student-Athlete Health and Well-Being Initiative, the National Institutes of Health (R24NS098518), Taube Stanford Children's Concussion Initiative and Stanford Department of Bioengineering. The authors also want to express their gratitude for the insights from the linear model course (STATS305A) offered by Dr. Trevor Hastie at Stanford University.	Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Bartsch AJ, 2020, ANN BIOMED ENG, V48, P2667, DOI 10.1007/s10439-020-02640-8; BUDESCU DV, 1993, PSYCHOL BULL, V114, P542, DOI 10.1037/0033-2909.114.3.542; Camarillo, 2021, COMPREHENSIVE DELINE; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Courville T, 2001, EDUC PSYCHOL MEAS, V61, P229, DOI 10.1177/0013164401612006; Donat CK, 2021, BRAIN, V144, P70, DOI 10.1093/brain/awaa336; Fahlstedt M, 2021, ANN BIOMED ENG, V49, P1097, DOI 10.1007/s10439-020-02703-w; Fahlstedt M, 2015, J BIOMECH, V48, P1331, DOI 10.1016/j.jbiomech.2015.02.057; Gabler LF, 2019, ANN BIOMED ENG, V47, P1971, DOI 10.1007/s10439-018-02179-9; Gabler LF, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038357; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; Ghazi K, 2021, J NEUROTRAUM, V38, P1023, DOI 10.1089/neu.2020.7281; Giudice JS, 2019, ANN BIOMED ENG, V47, P464, DOI 10.1007/s10439-018-02155-3; Guiza Fabian, 2017, Crit Care Med, V45, pe316, DOI 10.1097/CCM.0000000000002080; Hajiaghamemar M, 2021, J NEUROTRAUM, V38, P144, DOI 10.1089/neu.2019.6791; Hernandez F, 2019, BIOMECH MODEL MECHAN, V18, P631, DOI 10.1007/s10237-018-01106-0; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Holbourn AHS, 1943, LANCET, V2, P438; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI 10.1007/978-1-4614-7138-7_1; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kang WH, 2015, BIOMECH MODEL MECHAN, V14, P561, DOI 10.1007/s10237-014-0622-4; Kimpara, 2011, INT J AUTOMOT ENG, V2, P13, DOI [10.20485/jsaeijae.2.2_13, DOI 10.20485/JSAEIJAE.2.2_13]; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Laksari K, 2020, J NEUROTRAUM, V37, P982, DOI 10.1089/neu.2018.6340; Li XG, 2021, BIOMECH MODEL MECHAN, V20, P403, DOI 10.1007/s10237-020-01391-8; Liu Y., 2020, ARXIV PREPRINT ARXIV; Liu YZ, 2021, ANN BIOMED ENG, V49, P2791, DOI 10.1007/s10439-021-02821-z; Liu YZ, 2020, ANN BIOMED ENG, V48, P2580, DOI 10.1007/s10439-020-02629-3; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Nathans L. L., 2012, PRACTICAL ASSESS RES, V17, P1, DOI DOI 10.3102/00346543074004525; National Highway Traffic Safety Administration, 2020, DATA; O'Keeffe E, 2020, J NEUROTRAUM, V37, P347, DOI 10.1089/neu.2019.6483; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; Prunier JG, 2015, MOL ECOL, V24, P263, DOI 10.1111/mec.13029; Ray-Mukherjee J, 2014, METHODS ECOL EVOL, V5, P320, DOI 10.1111/2041-210X.12166; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Sanchez EJ, 2019, CLIN BIOMECH, V64, P82, DOI 10.1016/j.clinbiomech.2018.02.019; Sarkar Shamik, 2018, Critical Reviews in Biomedical Engineering, V46, P289, DOI 10.1615/CritRevBiomedEng.2018027249; Semmel S, 2018, MULTIPLE REGRESSION; Takahashi, 2015, SAE TECHNICAL PAPER; Takhounts E. G., 2011, PAPER; Takhounts EG, 2013, STAPP CAR CRASH J, V57, P243, DOI DOI 10.4271/2013-22-0010; Tibshirani, 1994, INTRO BOOTSTRAP, DOI [10.1201/9780429246593, DOI 10.1201/9780429246593]; Tiernan S, 2020, P I MECH ENG H, V234, P1472, DOI 10.1177/0954411920947850; Tiernan S, 2019, BRAIN INJURY, V33, P427, DOI 10.1080/02699052.2019.1566834; Tse KM, 2017, MED BIOL ENG COMPUT, V55, P641, DOI 10.1007/s11517-016-1536-3; Versace, 1971, P 15 STAPP CAR CRASH, DOI DOI 10.4271/710881; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; Wu SJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53551-1; Zhan X, IEEE T BIOMEDICAL EN, P2021; Zhan XH, 2021, J R SOC INTERFACE, V18, DOI 10.1098/rsif.2021.0260; Zhao W, 2019, J NEUROTRAUM, V36, P250, DOI 10.1089/neu.2018.5634; Zhou Zhou, 2018, Stapp Car Crash J, V62, P293	58	2	2	5	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2021	49	10			SI		2901	2913		10.1007/s10439-021-02813-z		JUL 2021	13	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	WH8FD	WOS:000671518600002	34244908	Green Submitted			2022-02-06	
J	Holth, K; Gould, KR; Hicks, AJ; Analytis, P; Feeney, TJ; Ponsford, JL				Holth, Kristian; Gould, Kate Rachel; Hicks, Amelia J.; Analytis, Penelope; Feeney, Timothy J.; Ponsford, Jennie Louise			"I've never been positive horizontal ellipsis I am now": Participant perspectives of a Positive Behaviour Support Intervention (PBS plus PLUS) for community-living individuals with ABI and their Close Others	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Early Access						Acquired brain injury; Positive Behaviour Support; qualitative research; participant perspectives; rehabilitation	TRAUMATIC BRAIN-INJURY; REPORTING QUALITATIVE RESEARCH; CHALLENGING BEHAVIOR; REHABILITATION; EXPERIENCE; PEOPLE; ADULTS	Challenging behaviours are common following moderate to severe acquired brain injury (ABI). These behaviours cause relationship and community participation difficulties and are a significant source of stress for many individuals with ABI and their close others (COs). A Positive Behaviour Support intervention, PBS + PLUS, was implemented to assist individuals with ABI to collaboratively build meaningful lives and self-regulate their behaviour. This study explored the perspectives of individuals with ABI and COs (family members, friends, and carers) who had completed an individualized 12-month PBS + PLUS intervention. Fifty-two individuals participated in semi-structured interviews, and a thematic analysis of interview transcripts identified the interrelated themes of Openness to Change, Embeddedness, Clinician Connection, and Preparedness for the Future. Participant perceptions of, and engagement with, PBS + PLUS were influenced by an attitude of openness to new ideas and by the intervention itself. Achieving contextual relevance allowed the intervention to become embedded in participants' lives, and the client-clinician relationship was central to participants' positive experiences. While most participants felt better equipped to cope with the future, some experienced difficulties transitioning to post-intervention life. These results suggest PBS + PLUS may assist individuals with ABI to lead meaningful lives and more confidently overcome behavioural challenges, while encouraging supportive and empowered COs.	[Holth, Kristian; Gould, Kate Rachel; Hicks, Amelia J.; Analytis, Penelope; Ponsford, Jennie Louise] Monash Univ, Turner Inst Brain & Mental Hlth, Sch Psychol Sci, Clayton, Vic, Australia; [Holth, Kristian; Gould, Kate Rachel; Hicks, Amelia J.; Analytis, Penelope; Ponsford, Jennie Louise] Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Richmond, Vic 3121, Australia; [Feeney, Timothy J.] Belvedere Hlth Serv, Winooski, VT USA; [Feeney, Timothy J.] Mill Sch, Winooski, VT USA		Holth, K (corresponding author), Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Richmond, Vic 3121, Australia.	kristian.holth@monash.edu	Gould, Kate Rachel/AAA-5511-2020; Ponsford, Jennie/H-8341-2014	Gould, Kate Rachel/0000-0002-3564-7408; Hicks, Amelia/0000-0002-1152-0576; Feeney, Tim/0000-0003-4208-3361; Ponsford, Jennie/0000-0003-0430-125X; Holth, Kristian/0000-0002-3264-8800; Analytis, Penelope/0000-0001-5252-9916	Transport Accident Commission [135]	This study was supported by the Transport Accident Commission [grant number 135]	Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Ardito RB, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00270; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Braun V, 2019, QUAL RES SPORT EXERC, V11, P589, DOI 10.1080/2159676X.2019.1628806; Carmichael J.J., 2021, BRAIN IMPAIR, V22, P34, DOI [https://doi.org/10.1017/BrImp.2020.6, DOI 10.1017/BRIMP.2020.6]; Carmichael JJ, 2020, BRAIN IMPAIR, V21, P191, DOI 10.1017/BrImp.2019.32; Carr EG, 2002, J POSIT BEHAV INTERV, V4, P4, DOI 10.1177/109830070200400102; Duff MC, 2012, SEMIN SPEECH LANG, V33, P44, DOI 10.1055/s-0031-1301162; Feeney TJ, 2014, NEUROREHABILITATION, V34, P709, DOI 10.3233/NRE-141088; Feeney Timothy J., 2010, Seminars in Speech and Language, V31, P145, DOI 10.1055/s-0030-1257531; Feeney TJ, 2001, J HEAD TRAUMA REHAB, V16, P61, DOI 10.1097/00001199-200102000-00008; Fisher A, 2020, DISABIL REHABIL, V42, P1305, DOI 10.1080/09638288.2018.1522551; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; Gould KR, 2021, NEUROPSYCHOL REHABIL, V31, P57, DOI 10.1080/09602011.2019.1656647; Gould KR, 2019, NEUROPSYCHOL REHABIL, V29, P376, DOI 10.1080/09602011.2017.1307767; Hammond FM, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000136; Hicks AJ, 2017, BRAIN INJURY, V31, P1312, DOI 10.1080/02699052.2017.1317361; Johnston JM, 2006, BEHAV ANALYST, V29, P51, DOI 10.1007/BF03392117; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; Ponsford J.L., ANN PHYS MED REHABIL; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Smith MJ, 2006, J HEAD TRAUMA REHAB, V21, P76, DOI 10.1097/00001199-200601000-00008; Tam S, 2015, BRAIN INJURY, V29, P813, DOI 10.3109/02699052.2015.1005134; Terry G., 2017, SAGE HDB QUALITATIVE, P17; Tincani, 2007, BEHAV ANAL TODAY, V8, P492, DOI [https://doi.org/10.1037/h0100635, DOI 10.1037/H0100635]; Toglia J., 2017, CHANGES BRAIN IMPACT, P117, DOI [10.1007/978-0-387-98188-8_6, DOI 10.1007/978-0-387-98188-8_6]; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tschuschke V, 2020, J NERV MENT DIS, V208, P56, DOI 10.1097/NMD.0000000000001111; Varney NR., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI [10.1097/00001199-199303000-00005, DOI 10.1097/00001199-199303000-00005]; Varpio L, 2017, MED EDUC, V51, P40, DOI 10.1111/medu.13124; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker M., 2006, BRAIN IMPAIR, V7, P246, DOI [10.1375/brim.7.3.246, DOI 10.1375/BRIM.7.3.246]	33	2	2	1	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.												10.1080/09602011.2021.1947326		JUL 2021	18	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	TF6DP	WOS:000670810000001	34233578				2022-02-06	
J	Liu, YZ; Domel, AG; Cecchi, NJ; Rice, E; Callan, AA; Raymond, SJ; Zhou, Z; Zhan, XH; Li, YH; Zeineh, MM; Grant, GA; Camarillo, DB				Liu, Yuzhe; Domel, August G.; Cecchi, Nicholas J.; Rice, Eli; Callan, Ashlyn A.; Raymond, Samuel J.; Zhou, Zhou; Zhan, Xianghao; Li, Yiheng; Zeineh, Michael M.; Grant, Gerald A.; Camarillo, David B.			Time Window of Head Impact Kinematics Measurement for Calculation of Brain Strain and Strain Rate in American Football	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Instrumented mouthguard; Traumatic brain injury; American football; Time window; Head impact sensor	MOUTHGUARD; SEVERITY; ACCELERATIONS; CONCUSSION; LOCATION; EXPOSURE; HELMET; SENSOR	Wearable devices have been shown to effectively measure the head's movement during impacts in sports like American football. When a head impact occurs, the device is triggered to collect and save the kinematic measurements during a predefined time window. Then, based on the collected kinematics, finite element (FE) head models can calculate brain strain and strain rate, which are used to evaluate the risk of mild traumatic brain injury. To find a time window that can provide a sufficient duration of kinematics for FE analysis, we investigated 118 on-field video-confirmed football head impacts collected by the Stanford Instrumented Mouthguard. The simulation results based on the kinematics truncated to a shorter time window were compared with the original to determine the minimum time window needed for football. Because the individual differences in brain geometry influence these calculations, we included six representative brain geometries and found that larger brains need a longer time window of kinematics for accurate calculation. Among the different sizes of brains, a pre-trigger time of 40 ms and a post-trigger time of 70 ms were found to yield calculations of brain strain and strain rate that were not significantly different from calculations using the original 200 ms time window recorded by the mouthguard. Therefore, approximately 110 ms is recommended for complete modeling of impacts for football.	[Liu, Yuzhe; Domel, August G.; Cecchi, Nicholas J.; Callan, Ashlyn A.; Raymond, Samuel J.; Zhou, Zhou; Zhan, Xianghao; Camarillo, David B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Rice, Eli] Stanford Univ, Stanford Ctr Clin Res, Stanford, CA 94305 USA; [Li, Yiheng] Stanford Univ, Dept Biomed Informat, Stanford, CA 94305 USA; [Zeineh, Michael M.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Grant, Gerald A.; Camarillo, David B.] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Grant, Gerald A.] Stanford Univ, Dept Neurol, Stanford, CA 94305 USA; [Camarillo, David B.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA		Liu, YZ (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	yuzheliu@stanford.edu	Raymond, Samuel/AAV-5908-2021; Cecchi, Nicholas J/AAC-6547-2021	Raymond, Samuel/0000-0003-2691-652X; Cecchi, Nicholas J/0000-0001-9319-4163	Pac-12 Conference's Student-Athlete Health and Well-Being Initiative; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R24NS098518]; Taube Stanford Children's Concussion Initiative	This research was supported by the Pac-12 Conference's Student-Athlete Health and Well-Being Initiative, the National Institutes of Health (R24NS098518), Taube Stanford Children's Concussion Initiative. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of funding agencies.	Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Bartsch AJ, 2020, ANN BIOMED ENG, V48, P2667, DOI 10.1007/s10439-020-02640-8; Boumis A., 2020, ARXIV201008485; Bridgman H, 2019, ANN BIOMED ENG, V47, P1725, DOI 10.1007/s10439-019-02267-4; Caccese JB, 2016, RES SPORTS MED, V24, P407, DOI 10.1080/15438627.2016.1230549; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Gabler LF, 2020, ANN BIOMED ENG, V48, P2599, DOI 10.1007/s10439-020-02654-2; Gabler LF, 2019, ANN BIOMED ENG, V47, P1971, DOI 10.1007/s10439-018-02179-9; Gabler LF, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038357; Hajiaghamemar M, 2021, J NEUROTRAUM, V38, P144, DOI 10.1089/neu.2019.6791; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hernandez F, 2019, J NEUROTRAUM, V36, P1125, DOI 10.1089/neu.2016.4758; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Holbourn AHS, 1943, LANCET, V2, P438; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; Kieffer EE, 2020, ANN BIOMED ENG, V48, P2613, DOI 10.1007/s10439-020-02647-1; King D, 2017, J NEUROSURG-PEDIATR, V19, P13, DOI 10.3171/2016.7.PEDS1684; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Knox, 2004, SAE TECHNICAL PAPER; Kuo C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199238; Kuo C, 2018, BIOMECH MODEL MECHAN, V17, P235, DOI 10.1007/s10237-017-0957-8; Kuo C, 2016, J BIOMECH, V49, P1845, DOI 10.1016/j.jbiomech.2016.04.017; Laksari K, 2020, J NEUROTRAUM, V37, P982, DOI 10.1089/neu.2018.6340; Li XG, 2021, BIOMECH MODEL MECHAN, V20, P403, DOI 10.1007/s10237-020-01391-8; Liu Y., 2020, ARXIV PREPRINT ARXIV; Liu YZ, 2020, ANN BIOMED ENG, V48, P2580, DOI 10.1007/s10439-020-02629-3; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Mihalik JP, 2020, ANN BIOMED ENG, V48, P2555, DOI 10.1007/s10439-020-02658-y; Miller Logan E., 2019, New Developments on Computational Methods and Imaging in Biomechanics and Biomedical Engineering. Lecture Notes in Computational Vision and Biomechanics (LNCVB 33), P121, DOI 10.1007/978-3-030-23073-9_8; Miller LE, 2021, ANN BIOMED ENG, V49, P1083, DOI 10.1007/s10439-020-02685-9; Motiwale S, 2016, 2016 3RD IEEE EMBS INTERNATIONAL CONFERENCE ON BIOMEDICAL AND HEALTH INFORMATICS, P204, DOI 10.1109/BHI.2016.7455870; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Myers B., 2009, SHOCK, V1, P54; O'Day KM, 2017, CLIN BIOMECH, V43, P23, DOI 10.1016/j.clinbiomech.2017.01.013; O'Keeffe E, 2020, J NEUROTRAUM, V37, P347, DOI 10.1089/neu.2019.6483; Ogden R.W., 1997, NONLINEAR ELASTIC DE; Ozga JE, 2018, BEHAV PHARMACOL, V29, P617, DOI 10.1097/FBP.0000000000000430; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Rich AM, 2019, ANN BIOMED ENG, V47, P2109, DOI 10.1007/s10439-019-02313-1; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Siegmund GP, 2014, ANN BIOMED ENG, V42, P1834, DOI 10.1007/s10439-014-1052-2; Takahashi Y., 2015, 2015011439 SAE, DOI DOI 10.4271/2015-01-1439; Takhounts E. G., 2011, PAPER; Takhounts EG, 2013, STAPP CAR CRASH J, V57, P243, DOI DOI 10.4271/2013-22-0010; Tiernan S, 2020, P I MECH ENG H, V234, P1472, DOI 10.1177/0954411920947850; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Wu LC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17864-3; Wu LC, 2016, J BIOMECH, V49, P2918, DOI 10.1016/j.jbiomech.2016.07.004; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Yanaoka T, 2017, 25 INT TECHN C ENH S; Zhan XH, 2021, ANN BIOMED ENG, V49, P2901, DOI 10.1007/s10439-021-02813-z; Zhan XH, 2021, J R SOC INTERFACE, V18, DOI 10.1098/rsif.2021.0260; Zhan XH, 2021, IEEE T BIO-MED ENG, V68, P3424, DOI 10.1109/TBME.2021.3073380; Zou H, 2007, INT J CRASHWORTHINES, V12, P341, DOI 10.1080/13588260701433024	63	2	2	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2021	49	10			SI		2791	2804		10.1007/s10439-021-02821-z		JUL 2021	14	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	WH8FD	WOS:000670165200002	34231091	Green Submitted			2022-02-06	
J	Pagella, P; Roditi, LD; Stadlinger, B; Moor, AE; Mitsiadis, TA				Pagella, Pierfrancesco; Roditi, Laura de Vargas; Stadlinger, Bernd; Moor, Andreas E.; Mitsiadis, Thimios A.			Notch signaling in the dynamics of perivascular stem cells and their niches	STEM CELLS TRANSLATIONAL MEDICINE			English	Article						dental pulp stem cells; carious teeth; mesenchymal stem cells; microenvironment; Notch ligands; Notch signaling; Notch3; pericytes; periodontal stem cells; periodontium; perivascular niche; pulp; single-cell RNA sequencing; stem cell niches; stem cells; tooth	EPITHELIAL-MESENCHYMAL INTERACTIONS; DENTAL-PULP; EXPRESSION PATTERNS; STROMAL CELLS; MOUSE; TOOTH; BRAIN; JAGGED-1	The Notch signaling pathway is a fundamental regulator of cell fate determination in homeostasis and regeneration. In this work, we aimed to determine how Notch signaling mediates the interactions between perivascular stem cells and their niches in human dental mesenchymal tissues, both in homeostatic and regenerative conditions. By single cell RNA sequencing analysis, we showed that perivascular cells across the dental pulp and periodontal human tissues all express NOTCH3, and that these cells are important for the response to traumatic injuries in vivo in a transgenic mouse model. We further showed that the behavior of perivascular NOTCH3-expressing stem cells could be modulated by cellular and molecular cues deriving from their microenvironments. Taken together, the present studies, reinforced by single-cell analysis, reveal the pivotal importance of Notch signaling in the crosstalk between perivascular stem cells and their niches in tissue homeostasis and regeneration.	[Pagella, Pierfrancesco; Mitsiadis, Thimios A.] Univ Zurich, Ctr Dent Med, Inst Oral Biol, Orofacial Dev & Regenerat, Zurich, Switzerland; [Roditi, Laura de Vargas; Moor, Andreas E.] Univ Zurich, Inst Mol Canc Res, Zurich, Switzerland; [Roditi, Laura de Vargas; Moor, Andreas E.] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [Stadlinger, Bernd] Univ Zurich, Ctr Dent Med, Clin Craniomaxillofacial & Oral Surg, Zurich, Switzerland		Mitsiadis, TA (corresponding author), Univ Zurich, Fac Med, Inst Oral Biol, Plattenstr 11, CH-8032 Zurich, Switzerland.	thimios.mitsiadis@zzm.uzh.ch	Mitsiadis, Thimios/B-5564-2016	Mitsiadis, Thimios/0000-0002-9812-9982	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [310030_197782]; University of Zurich	Swiss National Science Foundation, Grant/Award Number: 310030_197782; University of Zurich	Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Athanassiou-Papaefthymiou M, 2015, J DENT RES, V94, P1591, DOI 10.1177/0022034515606401; Blache U, 2018, EMBO REP, V19, DOI 10.15252/embr.201845964; Chen H, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay1514; Cohen B, 2010, BREAST CANCER RES TR, V123, P113, DOI 10.1007/s10549-009-0621-9; Denes BJ, 2019, J DENT RES, V98, P1357, DOI 10.1177/0022034519871448; Diekwisch TGH, 2001, INT J DEV BIOL, V45, P695; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Gopinathan G, 2019, STEM CELLS DEV, V28, P1004, DOI 10.1089/scd.2019.0124; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; He F, 2009, ARCH ORAL BIOL, V54, P216, DOI 10.1016/j.archoralbio.2008.10.003; Ho DM, 2016, CURR TOP DEV BIOL, V116, P17, DOI 10.1016/bs.ctdb.2015.12.016; Howard PS, 1998, J PERIODONTAL RES, V33, P500; Jamal M, 2015, GENES DIS, V2, P261, DOI 10.1016/j.gendis.2015.05.003; Kaltz N, 2010, EXP CELL RES, V316, P2609, DOI 10.1016/j.yexcr.2010.06.002; Kawai H, 2017, J NEUROSCI, V37, P11867, DOI 10.1523/JNEUROSCI.0001-17.2017; Koch U, 2013, DEVELOPMENT, V140, P689, DOI 10.1242/dev.080614; Kollar E J, 1986, Dev Biol (N Y 1985), V4, P297; Lane SW, 2014, NAT BIOTECHNOL, V32, P795, DOI 10.1038/nbt.2978; Liang T, 2019, J DENT RES, V98, P912, DOI 10.1177/0022034519854029; Lovschall H, 2007, INT J DEV BIOL, V51, P715, DOI 10.1387/ijdb.072393hl; Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312; Mitsiadis T A, 2011, Adv Dent Res, V23, P275, DOI 10.1177/0022034511405386; Mitsiadis TA, 1998, DEV BIOL, V204, P420, DOI 10.1006/dbio.1998.9092; Mitsiadis TA, 1997, DEVELOPMENT, V124, P1473; MITSIADIS TA, 1995, J CELL BIOL, V130, P407, DOI 10.1083/jcb.130.2.407; Mitsiadis TA, 1999, EXP CELL RES, V246, P312, DOI 10.1006/excr.1998.4285; Mitsiadis TA, 2003, EXP CELL RES, V282, P101, DOI 10.1016/S0014-4827(02)00012-5; Mitsiadis TA, 2008, EXP CELL RES, V314, P869, DOI 10.1016/j.yexcr.2007.11.001; Mitsiadis TA, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00372; Mitsiadis TA, 2009, BIRTH DEFECTS RES C, V87, P199, DOI 10.1002/bdrc.20160; Nanci A., 2013, 10 CATES ORAL HISTOL, P379; Oh M, 2020, J DENT RES, V99, P1102, DOI 10.1177/0022034520925417; Orsini G, 2018, AM J MED, V131, P1425, DOI 10.1016/j.amjmed.2018.05.042; Osathanon T, 2013, J BIOMED MATER RES A, V101, P358, DOI 10.1002/jbm.a.34332; Otabe K, 2012, CELL MED, V4, P13, DOI 10.3727/215517912X653319; Ottone C, 2014, NAT CELL BIOL, V16, P1045, DOI 10.1038/ncb3045; Pagella P, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102405; Pagella P, 2020, BIOCHEM SOC T, V48, P2729, DOI 10.1042/BST20200514; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Poulos MG, 2013, CELL REP, V4, P1022, DOI 10.1016/j.celrep.2013.07.048; Prakash N, 2002, EXP CELL RES, V278, P31, DOI 10.1006/excr.2002.5544; Rafii S, 2016, NATURE, V529, P316, DOI 10.1038/nature17040; Roguljic H, 2013, J DENT RES, V92, P709, DOI 10.1177/0022034513493434; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; Siebel C, 2017, PHYSIOL REV, V97, P1235, DOI 10.1152/physrev.00005.2017; Smith PC, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00270; Sodek J, 1992, Matrix Suppl, V1, P352; Tikhonova AN, 2019, NATURE, V569, P222, DOI 10.1038/s41586-019-1104-8; Uribe-Etxebarria V, 2017, EUR CELLS MATER, V34, P249, DOI 10.22203/eCM.v034a16; Vanlandewijck M, 2018, NATURE, V554, P475, DOI 10.1038/nature25739; Vidovic I, 2017, J DENT RES, V96, P323, DOI 10.1177/0022034516678208; Wang YY, 2014, DEVELOPMENT, V141, P307, DOI 10.1242/dev.096107; Wei KV, 2020, NATURE, V582, P259, DOI 10.1038/s41586-020-2222-z; Xu Q, 2019, J DENT RES, V98, P689, DOI 10.1177/0022034519839438; Xu XY, 2019, STEM CELL TRANSL MED, V8, P392, DOI 10.1002/sctm.18-0181; Xuan K, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaf3227; Yamada S, 2007, J BIOL CHEM, V282, P23070, DOI 10.1074/jbc.M611181200; Zhang C, 2008, J DENT RES, V87, P250, DOI 10.1177/154405910808700312	62	2	2	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2157-6564	2157-6580		STEM CELL TRANSL MED	Stem Cells Transl. Med.	OCT	2021	10	10					1433	1445		10.1002/sctm.21-0086		JUL 2021	13	Cell & Tissue Engineering	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	UT6EF	WOS:000669881100001	34227747	Green Published, gold			2022-02-06	
J	Todd, BP; Chimenti, MS; Luo, ZL; Ferguson, PJ; Bassuk, AG; Newell, EA				Todd, Brittany P.; Chimenti, Michael S.; Luo, Zili; Ferguson, Polly J.; Bassuk, Alexander G.; Newell, Elizabeth A.			Traumatic brain injury results in unique microglial and astrocyte transcriptomes enriched for type I interferon response	JOURNAL OF NEUROINFLAMMATION			English	Article						Traumatic brain injury; Microglia; Astrocytes; Type I interferon	UP-REGULATION; NEUROINFLAMMATION; NEURODEGENERATION; INFLAMMATION; MEMORY	Background Traumatic brain injury (TBI) is a leading cause of death and disability that lacks neuroprotective therapies. Following a TBI, secondary injury response pathways are activated and contribute to ongoing neurodegeneration. Microglia and astrocytes are critical neuroimmune modulators with early and persistent reactivity following a TBI. Although histologic glial reactivity is well established, a precise understanding of microglia and astrocyte function following trauma remains unknown. Methods Adult male C57BL/6J mice underwent either fluid percussion or sham injury. RNA sequencing of concurrently isolated microglia and astrocytes was conducted 7 days post-injury to evaluate cell-type-specific transcriptional responses to TBI. Dual in situ hybridization and immunofluorescence were used to validate the TBI-induced gene expression changes in microglia and astrocytes and to identify spatial orientation of cells expressing these genes. Comparative analysis was performed between our glial transcriptomes and those from prior reports in mild TBI and other neurologic diseases to determine if severe TBI induces unique states of microglial and astrocyte activation. Results Our findings revealed sustained, lineage-specific transcriptional changes in both microglia and astrocytes, with microglia showing a greater transcriptional response than astrocytes at this subacute time point. Microglia and astrocytes showed overlapping enrichment for genes related to type I interferon signaling and MHC class I antigen presentation. The microglia and astrocyte transcriptional response to severe TBI was distinct from prior reports in mild TBI and other neurodegenerative and neuroinflammatory diseases. Conclusion Concurrent lineage-specific analysis revealed novel TBI-specific transcriptional changes; these findings highlight the importance of cell-type-specific analysis of glial reactivity following TBI and may assist with the identification of novel, targeted therapies.	[Todd, Brittany P.] Univ Iowa, Med Scientist Training Program, Iowa City, IA USA; [Chimenti, Michael S.] Univ Iowa, Iowa Inst Human Genet, Bioinformat Div, Iowa City, IA USA; [Luo, Zili; Ferguson, Polly J.; Bassuk, Alexander G.; Newell, Elizabeth A.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA		Bassuk, AG; Newell, EA (corresponding author), Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA.	alexander-bassuk@uiowa.edu; elizabeth-newell@uiowa.edu		Bassuk, Alexander/0000-0002-4067-2157	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K08NS110829, R01NS098590, R01AR059730]; William McQuiston Memorial Fund	This work was supported by NIH grants K08NS110829 (EAN), R01NS098590 (AGB), and R01AR059730 (PJF). This work was also supported by the William McQuiston Memorial Fund.	Ahsan Sidra, 2017, Curr Protoc Bioinformatics, V57, DOI 10.1002/cpbi.24; Arneson D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06222-0; Barrett JP, 2020, J NEUROSCI, V40, P2357, DOI 10.1523/JNEUROSCI.2516-19.2020; Clarke LE, 2018, P NATL ACAD SCI USA, V115, pE1896, DOI 10.1073/pnas.1800165115; Cole JH, 2018, BRAIN, V141, P822, DOI 10.1093/brain/awx354; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Deczkowska A, 2018, CELL, V173, P1073, DOI 10.1016/j.cell.2018.05.003; Donato M, 2013, GENOME RES, V23, P1885, DOI 10.1101/gr.153551.112; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Early AN, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01800-w; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Guimera R.V., 2012, EMBNET J, V17, P30, DOI [10.14806/ej.17.b.286, DOI 10.14806/EJ.17.B.286]; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Itoh N, 2018, P NATL ACAD SCI USA, V115, pE302, DOI 10.1073/pnas.1716032115; Izzy S, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00307; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Karve IP, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0128-15.2016; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li Q, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201911002; Lin YC, 2016, CELL MOL NEUROBIOL, V36, P27, DOI 10.1007/s10571-015-0217-3; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Makinde HM, 2020, J SURG RES, V246, P113, DOI 10.1016/j.jss.2019.08.024; Mathys H, 2017, CELL REP, V21, P366, DOI 10.1016/j.celrep.2017.09.039; McDonough A, 2017, J NEUROSCI, V37, P8292, DOI 10.1523/JNEUROSCI.0725-17.2017; Mukherjee S, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00028; Newell EA, 2020, J NEUROTRAUM, V37, P635, DOI 10.1089/neu.2019.6675; Newell EA, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0385-17.2018; Okonechnikov K, 2016, BIOINFORMATICS, V32, P292, DOI 10.1093/bioinformatics/btv566; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Peterson AB, 2019, SURVEILLANCE REPORT; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Robinson, 2015, F1000 RES, V4, P1521, DOI DOI 10.12688/f1000research.7563.2; Rossi JL, 2015, J NEUROTRAUM, V32, P1101, DOI 10.1089/neu.2014.3611; Roy ER, 2020, J CLIN INVEST, V130, P1912, DOI 10.1172/JCI133737; Schurman LD, 2017, NEUROSCI LETT, V653, P31, DOI 10.1016/j.neulet.2017.05.032; Srinivasan K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11295; Swartzlander DB, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121109; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Trautz F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48145-w; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Walko TD, 2014, SHOCK, V41, P499, DOI 10.1097/SHK.0000000000000160; Wang ZM, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-00325-8; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Witcher KG, 2021, J NEUROSCI, V41, P1597, DOI 10.1523/JNEUROSCI.2469-20.2020; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhou YY, 2020, NAT MED, V26, P131, DOI 10.1038/s41591-019-0695-9	52	2	2	4	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	JUL 5	2021	18	1							151	10.1186/s12974-021-02197-w			15	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	TI0TU	WOS:000672496100003	34225752	Green Published, gold			2022-02-06	
J	Mahdavi, S; Hasper, E; Donders, J				Mahdavi, Seema; Hasper, Emily; Donders, Jacobus			Sluggish cognitive tempo in children with traumatic brain injuries	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						Cognitive reserve; processing speed; sluggish cognitive tempo; traumatic brain injury	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; PROCESSING SPEED; VALIDITY; RESERVE; PREDICTORS; SURVIVORS; SYMPTOMS; OUTCOMES; SCALE; MILD	This exploratory study is the first to investigate whether the construct of sluggish-cognitive tempo (SCT) is related to slowed processing speed in children with traumatic brain injury (TBI), while also considering pre-morbid and injury variables. The study evaluated SCT, as measured by the Child Behavior Checklist (CBCL), and processing speed, as assessed with the Wechsler Intelligence Scale for Children-Fourth Edition (WISC-IV Processing Speed Index), in children who sustained TBI with a wide range of injury severity. Injury variables examined included the length of coma, presence of neuroimaging findings, and time between injury and assessment. Children's cognitive reserve, as estimated by parental level of education, was a non-injury variable. The participants included 50 children, ages 6-16years, without co-morbid neurological or psychiatric conditions who underwent a neuropsychological evaluation within 1-12months after injury. Results indicated no significant correlations between SCT and any of the WISC-IV index scores. Children with a moderate-severe TBI did not differ from those with uncomplicated mild TBI on SCT but they had statistically significant lower WISC-IV Processing Speed. Although parents of children with uncomplicated mild TBI had higher levels of education as compared to parents of children with moderate-severe TBI, there was no statistically significant relationship between the level of parental education and either SCT or Processing Speed. This study suggests that SCT, as measured by the CBCL, is not a sensitive measure of sequelae of pediatric TBI.	[Mahdavi, Seema; Donders, Jacobus] Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy St SE, Grand Rapids, MI 49503 USA; [Hasper, Emily] Calvin Coll, Psychol Dept, Grand Rapids, MI 49506 USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy St SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com					Achenbach T. M., 2001, CHILD BEHAV CHECKLIS; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Anderson V., 2014, UNDERSTANDING TRAUMA, P333; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bader F, 2019, CORTEX, V119, P215, DOI 10.1016/j.cortex.2019.04.019; Barkley RA, 2014, J ABNORM CHILD PSYCH, V42, P117, DOI 10.1007/s10802-013-9824-y; Barkley RA, 2013, J CLIN CHILD ADOLESC, V42, P161, DOI 10.1080/15374416.2012.734259; Bauermeister JJ, 2012, J ABNORM CHILD PSYCH, V40, P683, DOI 10.1007/s10802-011-9602-7; Becker SP, 2016, J AM ACAD CHILD PSY, V55, P163, DOI 10.1016/j.jaac.2015.12.006; Becker SP, 2015, PSYCHOL ASSESSMENT, V27, P1037, DOI 10.1037/pas0000083; Becker SP, 2013, J PEDIATR PSYCHOL, V38, P1051, DOI 10.1093/jpepsy/jst058; Dennis M., 2006, COGNITIVE RESERVE TH, P53; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; Donders J, 2019, J INT NEUROPSYCH SOC, V25, P355, DOI 10.1017/S1355617719000109; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Fuentes A, 2010, BRAIN INJURY, V24, P995, DOI 10.3109/02699052.2010.489791; Garner AA, 2017, J ATTEN DISORD, V21, P642, DOI 10.1177/1087054714539995; Garner AA, 2010, J ABNORM CHILD PSYCH, V38, P1097, DOI 10.1007/s10802-010-9436-8; Gorman S, 2016, NEUROPSYCHOLOGY, V30, P263, DOI 10.1037/neu0000214; Graham DM, 2013, ALCOHOL CLIN EXP RES, V37, pE338, DOI 10.1111/j.1530-0277.2012.01886.x; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Hayman-Abello SE, 2003, J INT NEUROPSYCH SOC, V9, P887, DOI 10.1017/S1355617703960097; Hinshaw SP, 2002, J CONSULT CLIN PSYCH, V70, P1099, DOI 10.1037//0022-006X.70.5.1099; Jacobson LA, 2018, J ABNORM CHILD PSYCH, V46, P127, DOI 10.1007/s10802-017-0281-x; Jacobson LA, 2012, J ABNORM CHILD PSYCH, V40, P1327, DOI 10.1007/s10802-012-9643-6; Kesler SR, 2010, BRAIN IMAGING BEHAV, V4, P256, DOI 10.1007/s11682-010-9104-1; Kirkwood M.W., 2010, PRINCIPLES PRACTICE, P299; Kraus J. F., 1996, NEUROLOGY AND TRAUMA, V2, P3, DOI DOI 10.1055/s-2008-1041052; Langberg JM, 2014, J ABNORM CHILD PSYCH, V42, P91, DOI 10.1007/s10802-013-9722-3; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lee S, 2014, J ABNORM CHILD PSYCH, V42, P7, DOI 10.1007/s10802-013-9714-3; Loutfi KS, 2011, EPILEPSY BEHAV, V20, P484, DOI 10.1016/j.yebeh.2010.12.043; McBurnett K, 2014, J ABNORM CHILD PSYCH, V42, P37, DOI 10.1007/s10802-013-9801-5; Mueller Anna Katharina, 2014, J Mol Psychiatry, V2, P5, DOI 10.1186/2049-9256-2-5; Penny AM, 2009, PSYCHOL ASSESSMENT, V21, P380, DOI 10.1037/a0016600; Reeves CB, 2007, J PEDIATR PSYCHOL, V32, P1050, DOI 10.1093/jpepsy/jsm063; Richards M, 2005, ANN NEUROL, V58, P617, DOI 10.1002/ana.20637; Roebuck-Spencer T, 2018, NEUROPSYCHOLOGICAL CONDITIONS ACROSS THE LIFESPAN, P139; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Shultz EL, 2016, NEUROPSYCHOLOGY, V30, P830, DOI 10.1037/neu0000288; Silva PHR, 2019, NEUROIMAGE, V184, P761, DOI 10.1016/j.neuroimage.2018.09.080; Tamm L, 2018, CHILD NEUROPSYCHOL, V24, P82, DOI 10.1080/09297049.2016.1225707; Wechsler D, 2003, WECHSLER INTELLIGENC; Willard VW, 2013, J NEURO-ONCOL, V114, P71, DOI 10.1007/s11060-013-1149-8; Willcutt EG, 2014, J ABNORM CHILD PSYCH, V42, P21, DOI 10.1007/s10802-013-9800-6	47	2	2	1	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child	JUL 3	2021	10	3					240	246		10.1080/21622965.2019.1674653			7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	TY4EA	WOS:000683735600001	31590582				2022-02-06	
J	Barud, M; Dabrowski, W; Siwicka-Gieroba, D; Robba, C; Bielacz, M; Badenes, R				Barud, Malgorzata; Dabrowski, Wojciech; Siwicka-Gieroba, Dorota; Robba, Chiara; Bielacz, Magdalena; Badenes, Rafael			Usefulness of Cerebral Oximetry in TBI by NIRS	JOURNAL OF CLINICAL MEDICINE			English	Article						cerebral oximetry; near-infrared spectroscopy; traumatic brain injury; cerebrovascular autoregulation; intracranial pressure	NEAR-INFRARED SPECTROSCOPY; TRAUMATIC BRAIN-INJURY; OXYGEN-SATURATION; INDOCYANINE GREEN; BLOOD-FLOW; INTRACRANIAL-PRESSURE; NONINVASIVE MEASUREMENT; TISSUE OXYGENATION; PERFUSION-PRESSURE; AUTOREGULATION	Measurement of cerebral oximetry by near-infrared spectroscopy provides continuous and non-invasive information about the oxygen saturation of haemoglobin in the central nervous system. This is especially important in the case of patients with traumatic brain injuries. Monitoring of cerebral oximetry in these patients could allow for the diagnosis of inadequate cerebral oxygenation caused by disturbances in cerebral blood flow. It could enable identification of episodes of hypoxia and cerebral ischemia. Continuous bedside measurement could facilitate the rapid diagnosis of intracranial bleeding or cerebrovascular autoregulation disorders and accelerate the implementation of treatment. However, it should be remembered that the method of monitoring cerebral oximetry by means of near-infrared spectroscopy also has its numerous limitations, resulting mainly from its physical properties. This paper summarizes the usefulness of monitoring cerebral oximetry by near-infrared spectroscopy in patients with traumatic brain injury, taking into account the advantages and the disadvantages of this technique.	[Barud, Malgorzata; Dabrowski, Wojciech; Siwicka-Gieroba, Dorota] Med Univ Lublin, Dept Anaesthesiol & Intens Therapy, PL-20954 Lublin, Poland; [Robba, Chiara] Policlin San Martino, Dept Anaesthesia & Intens Care, I-16100 Genoa, Italy; [Bielacz, Magdalena] State Vocat Coll Szymon Szymonowicz, Inst Tourism & Recreat, PL-22400 Zamosc, Poland; [Badenes, Rafael] Univ Valencia, Hosp Clin Univ Valencia, Dept Anaesthesiol & Intens Care, Valencia 46010, Spain		Barud, M (corresponding author), Med Univ Lublin, Dept Anaesthesiol & Intens Therapy, PL-20954 Lublin, Poland.	gosiekbar@wp.pl; w.dabrowski5@yahoo.com; dsiw@wp.pl; kiarobba@gmail.com; magda.bielacz@gmail.com; rafaelbadenes@gmail.com		Dabrowski, Wojciech/0000-0003-0449-2375; Badenes, Rafael/0000-0001-7017-0150			Al Tayar A, 2017, J CRIT CARE, V38, P164, DOI 10.1016/j.jcrc.2016.11.006; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Baker WB, 2019, J CEREBR BLOOD F MET, V39, P1469, DOI 10.1177/0271678X19846657; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Boas DA, 2011, PHILOS T R SOC A, V369, P4407, DOI 10.1098/rsta.2011.0250; Brady KM, 2007, STROKE, V38, P2818, DOI 10.1161/STROKEAHA.107.485706; Brawanski A, 2002, J CEREBR BLOOD F MET, V22, P605, DOI 10.1097/00004647-200205000-00012; BRAZY JE, 1985, PEDIATRICS, V75, P217; Budohoski KP, 2013, J CEREBR BLOOD F MET, V33, P449, DOI 10.1038/jcbfm.2012.189; Bush B, 2019, J NEUROSURG ANESTH, V31, P269, DOI 10.1097/ANA.0000000000000607; Calderon-Arnulphi M, 2009, NEUROL RES, V31, P605, DOI 10.1179/174313209X383286; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Casati A, 2006, MINERVA ANESTESIOL, V72, P605; Davies DJ, 2015, J NEUROTRAUM, V32, P933, DOI 10.1089/neu.2014.3748; Dias C, 2016, ACTA NEUROCHIR SUPPL, V122, P143, DOI 10.1007/978-3-319-22533-3_29; Esnault P, 2015, MINERVA ANESTESIOL, V81, P876; Fellahi JL, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2013.05.004; Forcione M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22031122; Gomersall CD, 1997, CRIT CARE MED, V25, P1252, DOI 10.1097/00003246-199707000-00031; Gora F, 2002, J NEUROSURG ANESTH, V14, P218, DOI 10.1097/00008506-200207000-00008; Gupta AK, 1999, ANESTH ANALG, V88, P549, DOI 10.1097/00000539-199903000-00016; Hirasawa A, 2015, CLIN PHYSIOL FUNCT I, V35, P237, DOI 10.1111/cpf.12156; Holzschuh M, 1997, NEUROL RES, V19, P246, DOI 10.1080/01616412.1997.11740807; Hopton P, 1999, J APPL PHYSIOL, V87, P1981, DOI 10.1152/jappl.1999.87.5.1981; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Joshi B, 2012, ANESTH ANALG, V114, P503, DOI 10.1213/ANE.0b013e31823d292a; Kampfl A, 1997, ACT NEUR S, V70, P112; Keller E, 2003, NEUROIMAGE, V20, P828, DOI 10.1016/S1053-8119(03)00315-X; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; Leal-Noval SR, 2010, INTENS CARE MED, V36, P1309, DOI 10.1007/s00134-010-1920-7; Madsen PL, 1999, PROG NEUROBIOL, V58, P541, DOI 10.1016/S0301-0082(98)00093-8; Milej D, 2020, J CEREBR BLOOD F MET, V40, P1672, DOI 10.1177/0271678X19872564; Murkin J M, 2009, Br J Anaesth, V103 Suppl 1, pi3, DOI 10.1093/bja/aep299; Murkin JM, 2007, ANESTH ANALG, V104, P51, DOI 10.1213/01.ane.0000246814.29362.f4; Nagdyman N, 2008, PEDIATR ANESTH, V18, P160, DOI 10.1111/j.1460-9592.2007.02365.x; Owen-Reece H, 1999, BRIT J ANAESTH, V82, P418, DOI 10.1093/bja/82.3.418; Pellicer A, 2011, SEMIN FETAL NEONAT M, V16, P42, DOI 10.1016/j.siny.2010.05.003; Rivera-Lara L, 2017, ANESTHESIOLOGY, V126, P1187, DOI 10.1097/ALN.0000000000001625; Scheeren TWL, 2012, J CLIN MONIT COMPUT, V26, P279, DOI 10.1007/s10877-012-9348-y; SMIELEWSKI P, 1995, STROKE, V26, P2285, DOI 10.1161/01.STR.26.12.2285; Steiner LA, 2009, NEUROCRIT CARE, V10, P122, DOI 10.1007/s12028-008-9140-5; Thavasothy M, 2002, ANAESTHESIA, V57, P999, DOI 10.1046/j.1365-2044.2002.02826.x; Tsalach A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161907; Yoo KY, 2015, J NEUROSURG ANESTH, V27, P57, DOI 10.1097/ANA.0000000000000084; Yoshitani K, 2007, ANESTHESIOLOGY, V106, P458, DOI 10.1097/00000542-200703000-00009; Zavriyev AI, 2021, JTCVS TECHNIQUES, V7, P161, DOI 10.1016/j.xjtc.2021.01.023; Zheng YY, 2012, NEUROCRIT CARE, V17, P77, DOI 10.1007/s12028-012-9721-1; Zhou C, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3146814; Zuluaga MT, 2010, PEDIATR CRIT CARE ME, V11, P514, DOI 10.1097/PCC.0b013e3181c51cf1	49	2	2	3	5	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	JUL	2021	10	13							2938	10.3390/jcm10132938			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TF7WG	WOS:000670927100001	34209017	gold, Green Published			2022-02-06	
J	Davie, S; Mutch, WAC; Monterola, M; Fidler, K; Funk, DJ				Davie, Sophie; Mutch, W. Alan C.; Monterola, Marita; Fidler, Kelsi; Funk, Duane J.			The Incidence and Magnitude of Cerebral Desaturation in Traumatic Brain Injury: An Observational Cohort Study	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						cerebral saturation; neuromonitoring; traumatic brain injury; cerebral oximetry	NEAR-INFRARED SPECTROSCOPY; OXYGEN-SATURATION; OPTIMIZATION; OXIMETRY; SURGERY	Background: Cerebral ischemia in patients with traumatic brain injury (TBI) may propagate secondary neurological injury. Episodes of cerebral ischemia can be revealed through the use of cerebral oximetry monitoring. The objective of this study was to determine the incidence and severity of regional cerebral oxygen (rSO(2)) desaturation (rSO(2)<65%) in patients with severe TBI. Secondary outcomes included changes in other monitoring parameters associated with cerebral desaturation. Materials and Methods: In this single-center prospective observational cohort study, cerebral oximetry data were collected continuously for up to 72 hours in 18 adult patients with a diagnosis of severe nonpenetrating TBI who were being mechanically ventilated and undergoing intracranial pressure (ICP) monitoring an in intensive care unit in Canada. Mean arterial pressure (MAP), ICP, and cerebral perfusion pressure were collected at 5-minute intervals during the study period. Results: Twelve of 18 (67%) patients experienced an episode of cerebral desaturation. The median (interquartile range) nadir rSO(2) was 57% (51% to 62%). The duration of desaturation was 265 (57 to 1277) minutes or 8.1% (2.6% to 26.0%) of recording time. In all patients, a linear regression analysis of the area under threshold of 65% for rSO(2) was moderately correlated with the area above an ICP threshold of 20 mm Hg (R (2)=0.52; P<0.01). Similarly, there was a modest correlation between rSO(2) and MAP (R (2)=0.41; P<0.01). These relationships also held true for those patients who experienced cerebral desaturation. Patients having episodes of ICP >20 mm Hg were 6 times more likely to have a cerebral desaturation (relative risk: 6.0; 95% confidence interval: 1.3-34.7). Conclusions: Cerebral desaturations occur frequently in patients with severe TBI, and their duration can be protracted. Episodes of desaturation were moderately correlated with increased ICP and decreased MAP.	[Davie, Sophie; Mutch, W. Alan C.; Monterola, Marita; Fidler, Kelsi; Funk, Duane J.] Univ Manitoba, Max Rady Coll Med, Dept Anesthesiol & Perioperat Med, Winnipeg, MB, Canada; [Funk, Duane J.] Univ Manitoba, Max Rady Coll Med, Dept Med, Sect Crit Care, Winnipeg, MB, Canada; [Mutch, W. Alan C.] Canada North Concuss Network, Winnipeg, MB, Canada		Funk, DJ (corresponding author), Univ Manitoba, Max Rady Coll Med, Dept Anesthesiol & Perioperat Med, Winnipeg, MB, Canada.; Funk, DJ (corresponding author), Univ Manitoba, Max Rady Coll Med, Dept Med, Sect Crit Care, Winnipeg, MB, Canada.	duane.funk@umanitoba.ca			Manitoba Public Insurance; University of Manitoba Department of Anesthesiology	The authors thank Manitoba Public Insurance and the University of Manitoba Department of Anesthesiology for funding this study.	Ahn A, 2014, RESUSCITATION, V85, P522, DOI 10.1016/j.resuscitation.2013.12.007; Asim K, 2014, AM J EMERG MED, V32, P14, DOI 10.1016/j.ajem.2013.09.010; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Casati A, 2005, ANESTH ANALG, V101, P740, DOI 10.1213/01.ane.0000166974.96219.cd; Davie SN, 2012, ANESTHESIOLOGY, V116, P834, DOI 10.1097/ALN.0b013e31824c00d7; Fischer GW, 2011, J THORAC CARDIOV SUR, V141, P815, DOI 10.1016/j.jtcvs.2010.05.017; Funk DJ, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0167-y; Leal-Noval SR, 2010, INTENS CARE MED, V36, P1309, DOI 10.1007/s00134-010-1920-7; Murkin JM, 2007, ANESTH ANALG, V104, P51, DOI 10.1213/01.ane.0000246814.29362.f4; Northern Brain Injury Association, 2014, BRAIN INJ STAT; Ohmae E, 2006, NEUROIMAGE, V29, P697, DOI 10.1016/j.neuroimage.2005.08.008; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Rogers CA, 2017, BRIT J ANAESTH, V119, P384, DOI 10.1093/bja/aex182; Rosenthal G, 2014, J NEUROSURG, V120, P901, DOI 10.3171/2013.12.JNS131089; Serraino GF, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016613; Slater JP, 2009, ANN THORAC SURG, V87, P36, DOI 10.1016/j.athoracsur.2008.08.070; Taussky P, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2011.12.FOCUS11280; Viechtbauer W, 2015, J CLIN EPIDEMIOL, V68, P1375, DOI 10.1016/j.jclinepi.2015.04.014; Weigl W, 2016, J CEREBR BLOOD F MET, V36, P1825, DOI 10.1177/0271678X16667953	19	2	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2021	33	3					258	262		10.1097/ANA.0000000000000652			5	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	ST1UR	WOS:000662236600011	31633577				2022-02-06	
J	Elkbuli, A; Kinslow, K; Sen-Crowe, B; Liu, HZ; McKenney, M; Ang, D				Elkbuli, Adel; Kinslow, Kyle; Sen-Crowe, Brendon; Liu, Huazhi; McKenney, Mark; Ang, Darwin			Outcomes of resuscitative endovascular balloon occlusion of the aorta (REBOA) utilization in trauma patients with and without traumatic brain injuries: A national analysis of the American College of Surgeons Trauma Quality Improvement Program data set	SURGERY			English	Article							NONCOMPRESSIBLE TORSO HEMORRHAGE	Background: Hemorrhage remains a leading cause of death among trauma patients. Resuscitative endovascular balloon occlusion of the aorta has grown in popularity as an efficient, less invasive alternative to managing patients with noncompressible hemorrhage. The aim of this study to investigate the clinical outcomes of resuscitative endovascular balloon occlusion of the aorta use in adult civilian trauma patients with and without concomitant traumatic brain injury. Methods: This a secondary analysis of the American College of Surgeons Trauma Quality Improvement Program database from the years 2015 to 2017 of adult trauma patients with and without traumatic brain injury and who had a resuscitative endovascular balloon occlusion of the aorta. Patients who were deceased on arrival, required resuscitative thoracotomy, or had missing information regarding traumatic brain injury status were excluded. Multivariable risk adjustment was performed. The primary outcome was inpatient mortality. Results: Of 2,352,542 patients, 199 met the criteria for inclusion in the final analysis. resuscitative endovascular balloon occlusion of the aorta + traumatic brain injury patients were significantly more likely to have a lower Glasgow Coma Scale <8 (82.4% vs 54.4%, P < .001) and systolic blood pressure (89 +/- 37.4 vs 107.2 +/- 39.7; P = .002), and higher injury severity score >25 (83.5% vs 65.8%, P = .01) compared with resuscitative endovascular balloon occlusion of the aorta/non-traumatic brain injury patients. No differences in odds of inpatient mortality (62.4% vs 50.9%, P =.11) or complications (17.7% vs 11.4%, P = .21) were observed between groups. Subgroup analysis based on mechanism of injury, trauma center level, teaching hospital status, and pelvic fracture status also did not show any differences in mortality. Conclusion: Inpatient mortality with resuscitative endovascular balloon occlusion of the aorta use does not differ between patients with or without concomitant traumatic brain injury, despite those with traumatic brain injury having significantly higher injury severity and more severe hypotension on intake. (c) 2021 Elsevier Inc. All rights reserved.	[Elkbuli, Adel; Kinslow, Kyle; Sen-Crowe, Brendon; McKenney, Mark] Kendall Reg Med Ctr, Dept Surg, 11750 Bird Rd, Miami, FL 33175 USA; [Liu, Huazhi; Ang, Darwin] Ocala Reg Med Ctr, Dept Surg, Ocala, FL USA; [McKenney, Mark] Univ S Florida, Dept Surg, Tampa, FL 33620 USA; [Ang, Darwin] Univ Cent Florida, Dept Surg, Ocala, FL USA		Elkbuli, A (corresponding author), Kendall Reg Med Ctr, Dept Surg, 11750 Bird Rd, Miami, FL 33175 USA.	adel.elkbulli@hcahealthcare.com		Elkbuli, Adel/0000-0001-7730-617X			Abe T, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1577-x; Aso S, 2017, J TRAUMA ACUTE CARE, V82, P910, DOI 10.1097/TA.0000000000001345; Beyer CA, 2019, INJURY, V50, P855, DOI 10.1016/j.injury.2019.03.013; Brenner M, 2018, J AM COLL SURGEONS, V226, P730, DOI 10.1016/j.jamcollsurg.2018.01.044; Brenner Megan, 2018, Trauma Surg Acute Care Open, V3, pe000154, DOI 10.1136/tsaco-2017-000154; Brenner M, 2018, JAMA SURG, V153, P130, DOI 10.1001/jamasurg.2017.3549; Darrabie MD, 2018, J AM COLL SURGEONS, V227, P127, DOI 10.1016/j.jamcollsurg.2018.03.042; DuBose JJ, 2016, J TRAUMA ACUTE CARE, V81, P409, DOI 10.1097/TA.0000000000001079; Frohlich M, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0340-2; HUGHES CW, 1954, SURGERY, V36, P65; Johnson MA, 2017, J TRAUMA ACUTE CARE, V83, P61, DOI [10.1097/TA.0000000000001372, 10.1097/TA.0000000000001518]; Joseph B, 2019, JAMA SURG, V154, P500, DOI 10.1001/jamasurg.2019.0096; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Markov NP, 2013, SURGERY, V153, P848, DOI 10.1016/j.surg.2012.12.001; Moore LJ, 2016, AM J SURG, V212, P1222, DOI 10.1016/j.amjsurg.2016.09.027; Moore LJ, 2015, J TRAUMA ACUTE CARE, V79, P523, DOI 10.1097/TA.0000000000000809; Morrison JJ, 2012, SURG CLIN N AM, V92, P843, DOI 10.1016/j.suc.2012.05.002; Ordonez CA, 2021, SHOCK, V56, P42, DOI 10.1097/SHK.0000000000001515; Osborn LA, 2019, OPEN ACCESS EMERG M, V11, P29, DOI 10.2147/OAEM.S166087; Pieper A, 2018, J TRAUMA ACUTE CARE, V84, P449, DOI 10.1097/TA.0000000000001794; Ribeiro MAF, 2018, WORLD J EMERG SURG, V13, DOI 10.1186/s13017-018-0181-6; Tibbits EM, 2018, J TRAUMA ACUTE CARE, V85, P101, DOI 10.1097/TA.0000000000001858; Uchino H, 2016, AM J CASE REP, V17, P810, DOI 10.12659/AJCR.900267; Williams AM, 2019, J TRAUMA ACUTE CARE, V86, P415, DOI 10.1097/TA.0000000000002149; World Health Organization, INJ VIOL FACTS	25	2	2	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	JUL	2021	170	1					284	290		10.1016/j.surg.2021.01.043			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	TA5OR	WOS:000667298800043	33676729				2022-02-06	
J	Hammond, FM; Katta-Charles, S; Russell, MB; Zafonte, RD; Claassen, J; Wagner, AK; Puybasset, L; Egawa, S; Laureys, S; Diringer, M; Stevens, RD				Hammond, Flora M.; Katta-Charles, Sheryl; Russell, Mary Beth; Zafonte, Ross D.; Claassen, Jan; Wagner, Amy K.; Puybasset, Louis; Egawa, Satoshi; Laureys, Steven; Diringer, Michael; Stevens, Robert D.		Curing Coma Campaign Its Contribut	Research Needs for Prognostic Modeling and Trajectory Analysis in Patients with Disorders of Consciousness	NEUROCRITICAL CARE			English	Article						Brain injuries; Prognosis; Statistical models; Algorithms; Research; Outcome; Function; Recovery; Trajectories; Recovery science; Disorders of consciousness; Coma	TRAUMATIC BRAIN-INJURY; REHABILITATION RESEARCH; NATIONAL INSTITUTE; NEIGHBORHOOD CHARACTERISTICS; PROLONGED DISORDERS; POSITION STATEMENT; DEIDENTIFIED DATA; VEGETATIVE STATE; DECISION-MAKING; CARE	Background The current state of the science regarding the care and prognosis of patients with disorders of consciousness is limited. Scientific advances are needed to improve the accuracy, relevance, and approach to prognostication, thereby providing the foundation to develop meaningful and effective interventions. Methods To address this need, an interdisciplinary expert panel was created as part of the Coma Science Working Group of the Neurocritical Care Society Curing Coma Campaign. Results The panel performed a gap analysis which identified seven research needs for prognostic modeling and trajectory analysis ("recovery science") in patients with disorders of consciousness: (1) to define the variables that predict outcomes; (2) to define meaningful intermediate outcomes at specific time points for different endotypes; (3) to describe recovery trajectories in the absence of limitations to care; (4) to harness big data and develop analytic methods to prognosticate more accurately; (5) to identify key elements and processes for communicating prognostic uncertainty over time; (6) to identify health care delivery models that facilitate recovery and recovery science; and (7) to advocate for changes in the health care delivery system needed to advance recovery science and implement already-known best practices. Conclusion This report summarizes the current research available to inform the proposed research needs, articulates key elements within each area, and discusses the goals and advances in recovery science and care anticipated by successfully addressing these needs.	[Hammond, Flora M.; Katta-Charles, Sheryl] Indiana Univ Sch Med, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA; [Hammond, Flora M.; Katta-Charles, Sheryl] Rehabil Hosp Indiana, Indianapolis, IN 46254 USA; [Russell, Mary Beth] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Phys Med & Rehabil, Houston, TX USA; [Russell, Mary Beth] TIRR Mem Hermann, Houston, TX USA; [Zafonte, Ross D.] Harvard Univ, Harvard Med Sch, Dept Phys Med & Rehabil, 300 First Ave, Boston, MA 02129 USA; [Zafonte, Ross D.] Spaulding Rehabil Hosp, Boston, MA USA; [Zafonte, Ross D.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Zafonte, Ross D.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Claassen, Jan] Newyork Presbyterian Hosp, Dept Neurol, New York, NY USA; [Claassen, Jan] Columbia Univ, New York, NY USA; [Wagner, Amy K.] Univ Pittsburgh, Med Ctr, Dept Phys Med & Rehabil, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Med Ctr, Neurosci Ence Clin & Translat Sci Inst, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Puybasset, Louis] Sorbonne Univ, Dept Anesthesiol & Intens Care, Paris, France; [Puybasset, Louis] Grp Hosp Pitie Salpetriere, AP HP, Paris, France; [Egawa, Satoshi] TMG Asaka Med Ctr, Neurointens Care Unit, Dept Neurosurg, Saitama, Japan; [Egawa, Satoshi] TMG Asaka Med Ctr, Stroke & Epilepsy Ctr, Saitama, Japan; [Laureys, Steven] Univ Hosp Liege, Coma Sci Grp, Liege, Belgium; [Laureys, Steven] Hangzhou Normal Univ, Int Consciousness Sci Inst, Hangzhou, Peoples R China; [Diringer, Michael] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Diringer, Michael] Washington Univ, Sch Med, Dept Neurosurg, St Louis, MO USA; [Diringer, Michael] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Div Neurosci Crit Care, Baltimore, MD USA; [Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA		Hammond, FM (corresponding author), Indiana Univ Sch Med, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA.; Hammond, FM (corresponding author), Rehabil Hosp Indiana, Indianapolis, IN 46254 USA.	Flora.hammond@rhin.com			Neurocritical Care Society	The Curing Coma Campaign is supported by the Neurocritical Care Society.	Agency for Healthcare Research and Quality, 2011, 2010 NAT HEALTHC DIS 2010 NAT HEALTHC DIS; American College of Surgeons, NTDB; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Aubinet C, 2021, ANN PHYS REHABIL MED, V64, DOI 10.1016/j.rehab.2020.09.001; Bao Y, 2016, AM J PUBLIC HEALTH, V106, P1573, DOI 10.2105/AJPH.2016.303338; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Claassen J, 2019, NEW ENGL J MED, V380, P2497, DOI 10.1056/NEJMoa1812757; Comanducci A, 2020, CLIN NEUROPHYSIOL, V131, P2736, DOI 10.1016/j.clinph.2020.07.015; Corrigan JA, 2008, ARCH PHYS MED REHAB, V89, P912, DOI 10.1016/j.apmr.2007.12.027; Corrigan JD, 2012, ARCH PHYS MED REHAB, V93, P1350, DOI 10.1016/j.apmr.2012.04.028; Dijkers MP, 2018, J HEAD TRAUMA REHAB, V33, P363, DOI 10.1097/HTR.0000000000000454; Edlow BL, 2021, NAT REV NEUROL, V17, P135, DOI 10.1038/s41582-020-00428-x; Edlow BL, 2018, J HEAD TRAUMA REHAB, V33, P424, DOI 10.1097/HTR.0000000000000448; Engemann DA, 2018, BRAIN, V141, P3179, DOI 10.1093/brain/awy251; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Evans E., 2020, ARCH PHYS MED REHAB, V101, pE105, DOI [10.1016/j.apmr.2020.09.321, DOI 10.1016/J.APMR.2020.09.321]; Evans E., 2020, ARCH PHYS MED REHAB, V101, pE12, DOI [10.1016/j.apmr.2020.09.034, DOI 10.1016/J.APMR.2020.09.034]; Fins JJ, 2013, ARCH PHYS MED REHAB, V94, P1934, DOI 10.1016/j.apmr.2012.12.028; Geurts M, 2014, LANCET NEUROL, V13, P515, DOI 10.1016/S1474-4422(14)70030-4; Giacino JT, 2020, ARCH PHYS MED REHAB, V101, P1072, DOI 10.1016/j.apmr.2020.01.013; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2009, PROG BRAIN RES, V177, P33, DOI 10.1016/S0079-6123(09)17704-X; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gonzalez-Lara LE, 2021, BRAIN INJURY, V35, P200, DOI 10.1080/02699052.2020.1865565; Hammond F, 2009, J NEUROTRAUM, V26, pA83; Hammond FM, 2019, J NEUROTRAUM, V36, P1136, DOI 10.1089/neu.2018.5954; Harris K, 2020, AM J PHYS MED REHABI, V99; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kesinger MR, 2017, AM J PHYS MED REHAB, V96, P17, DOI 10.1097/PHM.0000000000000513; Kondziella D, 2020, EUR J NEUROL, V27, P741, DOI 10.1111/ene.14151; Kowalski RG, 2021, JAMA NEUROL, V78, P548, DOI 10.1001/jamaneurol.2021.0084; Kumar RG, 2018, AM J PHYS MED REHAB, V97, P236, DOI 10.1097/PHM.0000000000000838; Laskowitz D., 2016, TRANSLATIONAL RES TR; Leonardi M, 2012, BRAIN INJURY, V26, P1201, DOI 10.3109/02699052.2012.667589; Lilley EJ, 2018, JAMA SURG, V153, P44, DOI 10.1001/jamasurg.2017.3148; Mahmood SS, 2014, LANCET, V383, P999, DOI 10.1016/S0140-6736(13)61752-3; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; O'Donnell JC, 2019, NEUROSCI BIOBEHAV R, V98, P336, DOI 10.1016/j.neubiorev.2018.12.015; Olsen A, 2021, BRAIN IMAGING BEHAV, V15, P526, DOI 10.1007/s11682-020-00313-7; Povlishock JT., 2000, J NEUROTRAUM, V17, P555; Rohaut B, 2018, BRIT J ANAESTH, V120, P5, DOI 10.1016/j.bja.2017.11.007; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Soeterik SM, 2017, CLIN REHABIL, V31, P1374, DOI 10.1177/0269215517695372; Souter MJ, 2015, NEUROCRIT CARE, V23, P4, DOI 10.1007/s12028-015-0137-6; Steppacher Inga, 2018, BMC Psychol, V6, P58, DOI 10.1186/s40359-018-0272-x; Truog R, 2019, BOSTON GLOBE; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Velly L, 2018, LANCET NEUROL, V17, P317, DOI 10.1016/S1474-4422(18)30027-9; Wagner AK, 2019, NEUROPHARMACOLOGY, V145, P133, DOI 10.1016/j.neuropharm.2018.09.011; Wagner AK, 2010, EUR J PHYS REHAB MED, V46, P549; Wagner AK, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0791-5; Wagner Amy K, 2013, Pathophysiology, V20, P39, DOI 10.1016/j.pathophys.2012.02.007; Wagner AK, 2011, PM&R, V3, pS28, DOI 10.1016/j.pmrj.2011.04.013; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	62	2	2	4	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUL	2021	35	SUPPL 1		1	SI		55	67		10.1007/s12028-021-01289-y			13	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TG3ZR	WOS:000671346400006	34236623	Green Published			2022-02-06	
J	Hardin, KY; Black, C; Caldbick, K; Kelly, M; Malhotra, A; Tidd, C; Vallentin, T; Turkstra, LS				Hardin, Kathryn Y.; Black, Christine; Caldbick, Kristine; Kelly, Megan; Malhotra, Alisha; Tidd, Courtney; Vallentin, Tina; Turkstra, Lyn S.			Current Practices Among Speech-Language Pathologists for Mild Traumatic Brain Injury: A Mixed-Methods Modified Delphi Approach	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							CONCUSSION MANAGEMENT; NARRATIVE LANGUAGE; GUIDELINES; REHABILITATION; RESILIENCE; PRESCHOOL; KNOWLEDGE; STUDENTS; IDENTIFICATION; INDIVIDUALS	Purpose: The study purpose was to capture the clinical practice patterns of speech-language pathologists (SLPs) treating mild traumatic brain injury (mTBI; concussion). Study aims were to (a) characterize expert SLP practice patterns for the management of mTBI and (b) use qualitative content analysis to explore areas of quantitative variability within participants' responses. Method: Using a modified Delphi approach, SLPs completed an online survey, with Round 1 responses shaping questions for Round 2. Round 2 results were analyzed using a concurrent partially mixed-methods approach with quantitative and qualitative items. Quantitative consensus agreement levels were set prestudy at 75% agreement or higher. Topic-level items that did not reach consensus were analyzed using qualitative content analysis. Participants: SLPs engaging in a specialty mTBI-SLP networking group were invited to participate. Round 1 had nine participants (United States: 4, Canada: 5). Round 2 had 18 participants (United States: 12, Canada: 6), with a mean of 15.7 years of experience in mTBI (range: 3-33) and a mean of 7.6 clients with mTBI seen weekly (range: 1-25). Results: Nearly all topic-level practice items met quantitative consensus (42/45). Consensus areas included using conceptual frameworks, interprofessional teaming, assessment and intervention practices, goal setting, and outcomes. Functional, collaborative, and client-centered care anchored clinical practice. Areas lacking consensus included SLP roles in mTBI mental and somatic health symptoms, specific measurement tools, and intervention dosages. Qualitative themes that emerged included limited interprofessional awareness for the role of SLPs in mTBI and challenges in measurement selection. Conclusions: Study aims were met with clear consensus on clinical patterns implemented by SLPs specializing in mTBI. Results will inform both current clinical practices and future practice guidelines. High-level guidance and advocacy are needed to clarify SLP practice concerns and advance interprofessional education. Future work should address identified gaps, including targeted assessment tools and consensus on intervention methods.	[Hardin, Kathryn Y.] Univ Colorado Boulder, Dept Speech Language & Hearing Sci, Boulder, CO 80309 USA; [Black, Christine; Caldbick, Kristine; Kelly, Megan; Malhotra, Alisha; Tidd, Courtney; Vallentin, Tina; Turkstra, Lyn S.] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada		Hardin, KY (corresponding author), Univ Colorado Boulder, Dept Speech Language & Hearing Sci, Boulder, CO 80309 USA.	hardink@colorado.edu	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921			American Speech-Language-Hearing Association, 2004, PREF PRACT PATT PROF; [Anonymous], 2013, US ICF PRACT MAN US; Belanger HG, 2020, NEUROPSYCHOL REHABIL, V30, P1190, DOI 10.1080/09602011.2019.1575245; Bellerose J, 2017, NEUROPSYCHOLOGY, V31, P229, DOI 10.1037/neu0000341; Bengtsson M., 2016, PLAN PERFORM QUALITA, V2, P8, DOI [10.1016/j.npls.2016.01.001, DOI 10.1016/J.NPLS.2016.01.001]; Bialunska A, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.874; Bishop DVM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158753; Black C., 2019, 743B SLPS MCMAST U; Blyth T, 2012, BRAIN INJURY, V26, P234, DOI 10.3109/02699052.2012.654587; Bogle J, 2020, CONCUSSIONS HEARING; Brady SR, 2015, INT J QUAL METH, V14, DOI 10.1177/1609406915621381; Brain Injury Association of America, 2014, NAV INS MAZ BRAIN IN; Brown J, 2020, AM J SPEECH-LANG PAT, V29, P1389, DOI 10.1044/2020_AJSLP-19-00131; Brown J, 2019, AM J SPEECH-LANG PAT, V28, P1363, DOI 10.1044/2019_AJSLP-18-0296; Carlozzi NE, 2018, J HEAD TRAUMA REHAB, V33, P342, DOI 10.1097/HTR.0000000000000373; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chami K, 2011, J HOSP INFECT, V79, P75, DOI 10.1016/j.jhin.2011.04.014; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Cornis-Pop M, 2012, J REHABIL RES DEV, V49, pXI, DOI 10.1682/JRRD.2012.03.0048; Covington NV, 2021, AM J SPEECH-LANG PAT, V30, P974, DOI 10.1044/2020_AJSLP-20-00081; D'Hondt F, 2017, COGN AFFECT BEHAV NE, V17, P124, DOI 10.3758/s13415-016-0467-7; Dachtyl SA, 2017, AM J SPEECH-LANG PAT, V26, P716, DOI 10.1044/2017_AJSLP-16-0138; Defense and Veterans Brain Injury Center, 2019, COGNITIVE REHABILITA; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Dinnes C, 2018, COMMUN DISORD Q, V39, P490, DOI 10.1177/1525740117716416; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Duff MC, 2015, BRAIN INJURY, V29, P64, DOI 10.3109/02699052.2014.965747; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Galetto V, 2013, J NEUROLINGUIST, V26, P649, DOI 10.1016/j.jneuroling.2013.05.004; Gioia G, 2006, ACUTE CONCUSSION EVA; Goodglass H., 2001, BOSTON DIAGNOSTIC AP; Goodrich GL, 2013, J REHABIL RES DEV, V50, P757, DOI 10.1682/JRRD.2012.10.0184; Gronseth G.S., 2017, CLIN PRACTICE GUIDEL, V2017; Gutierrez ML, 2019, PATIENT-RELAT OUTCOM, V10, P67, DOI 10.2147/PROM.S171380; Hardin K. Y, 2019, SURV 14 SLPS FREQ WO; Hardin KY, 2021, AM J SPEECH-LANG PAT, V30, P894, DOI 10.1044/2020_AJSLP-20-00110; Hardin KY, 2019, SEMIN SPEECH LANG, V40, P65, DOI 10.1055/s-0038-1676452; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Helm-Estabrooks N., 2001, COGNITIVE LINGUISTIC; Hidecker MJC, 2011, DEV MED CHILD NEUROL, V53, P704, DOI 10.1111/j.1469-8749.2011.03996.x; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; Hollingsworth A., 2012, SIG 2 PERSPECTIVES N, V22, P136, DOI [10.1044/nnsld22.4.136, DOI 10.1044/NNSLD22.4.136]; Izaryk K, 2017, AM J SPEECH-LANG PAT, V26, P1225, DOI 10.1044/2017_AJSLP-16-0046; Joint Committee on Interprofessional Relations Between the American Speech-Language-Hearing Association and Division 40 (Clinical Neuropsychology) of the American Psychological Association, 2007, STRUCTURE FUNCTION I; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Ketcham C. J., 2017, CURRENT RES CONCUSSI, V4, P8, DOI [10.1055/s-0037-1603645, DOI 10.1055/S-0037-1603645]; Kontos AP, 2020, NEUROSURGERY, V87, P348, DOI 10.1093/neuros/nyz545; Kraus N, 2016, SCI REP-UK, V6, DOI 10.1038/srep39009; Krikheli L, 2020, BMJ SUPPORT PALLIAT, V10, DOI 10.1136/bmjspcare-2018-001667; Krug H., 2015, SIG 2 PERSPECTIVES N, V25, P17, DOI [10.1044/nnsld25.1.17., DOI 10.1044/NNSLD25.1.17, 10.1044/nnsld25.1.17]; LeBlanc J, 2020, BRAIN INJURY, V34, P1472, DOI 10.1080/02699052.2020.1802669; Ledbetter AK, 2019, NEUROPSYCHOL REHABIL, V29, P1226, DOI 10.1080/09602011.2017.1383272; Lee MS, 2016, APPL NEUROPSYCH-ADUL, V23, P436, DOI 10.1080/23279095.2016.1178644; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lumba-Brown A, 2020, NEUROSURGERY, V86, P2, DOI 10.1093/neuros/nyz332; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Lundine JP, 2019, AM J SPEECH-LANG PAT, V28, P1371, DOI 10.1044/2019_AJSLP-18-0295; MacDonald S., 1998, FUNCTIONAL ASSESSMEN; Management of Concussion-Mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACTICE; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Mashima P, 2019, TOP LANG DISORD, V39, P293, DOI 10.1097/TLD.0000000000000189; Mashima PA, 2021, AM J SPEECH-LANG PAT, V30, P1598, DOI 10.1044/2021_AJSLP-20-00313; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mei C, 2018, J HEAD TRAUMA REHAB, V33, P326, DOI 10.1097/HTR.0000000000000366; Meibos A, 2019, AM J AUDIOL, V28, P285, DOI 10.1044/2018_AJA-18-0141; Merritt VC, 2015, BRAIN INJURY, V29, P1325, DOI 10.3109/02699052.2015.1043948; Morrow EL, 2020, BRAIN INJURY, V34, P1590, DOI 10.1080/02699052.2020.1766114; Neils-Strunjas J, 2017, BRAIN INJURY, V31, P131, DOI 10.1080/02699052.2016.1229032; O'Brien KH, 2020, SEMIN SPEECH LANG, V41, P195, DOI 10.1055/s-0040-1701687; Ontario Neurotrauma Foundation, 2017, STAND POSTC CAR DIAG; Parrish C., 2009, SIG 2 PERSPECTIVES N, V19, P47, DOI [DOI 10.1044/NNS1D19.2.47, 10.1044/nnsld19.2.47, DOI 10.1044/NNSLD19.2.47]; Picon L. M., 2020, CONCUSSION EBOOK ASS, P89, DOI [10.1016/b978-0-323-65384-8.00008-0, DOI 10.1016/B978-0-323-65384-8.00008-0]; Picon L. M., 2017, PERSPECTIVES ASHA SP, V2, P31, DOI [10.1044/persp2.sig2.31, DOI 10.1044/PERSP2.SIG2.31]; Poellabauer C, 2015, IEEE ACCESS, V3, P1143, DOI 10.1109/ACCESS.2015.2457392; Porter KK, 2014, AM J SPEECH-LANG PAT, V23, P507, DOI 10.1044/2014_AJSLP-13-0126; Quinn B, 2000, BRAIN INJURY, V14, P1063; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Riedeman S, 2018, AM J SPEECH-LANG PAT, V27, P181, DOI 10.1044/2017_AJSLP-17-0011; Roth CR, 2015, NEUROREHABILITATION, V36, P415, DOI 10.3233/NRE-151230; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Salvatore A. P., 2019, CLIN ARCH COMMUN DIS, V4, P214, DOI [10.21849/cacd.2019.00150, DOI 10.21849/CACD.2019.00150]; Salvatore AP, 2011, J MED SPEECH-LANG PA, V19, P1; Schneider E., 2018, PERSPECTIVES ASHA SP, V3, P31, DOI [10.1044/persp3.sig2.31, DOI 10.1044/PERSP3.SIG2.31]; Schopler E., 1988, CHILDHOOD AUTISM RAT; Shariff N., 2015, J NURSING CARE, V4, P246, DOI [10.4172/2167-1168.1000246, DOI 10.4172/2167-1168.1000246,04(03)]; Silverberg ND, 2020, ARCH PHYS MED REHAB, V101, P382, DOI 10.1016/j.apmr.2019.10.179; Snow PC, 2005, PSYCHOL CRIME LAW, V11, P239, DOI 10.1080/1068316042000209323; Sohlberg MM, 2015, AM J SPEECH-LANG PAT, V24, P358, DOI 10.1044/2015_AJSLP-14-0033; Speech-Language & Audiology Canada, ROLE SPEECH LANG PAT; Speech-Language & Audiology Canada, 2019, ROLE AUD CONC MAN; Temkin-Greener H, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2014.10.013; Theadom A, 2019, NEUROPSYCHOLOGY, V33, P560, DOI 10.1037/neu0000516; Theodoroff Sarah M, 2020, Clin J Sport Med, DOI 10.1097/JSM.0000000000000874; TUROFF M, 1970, TECHNOL FORECAST SOC, V2, P149, DOI 10.1016/0099-3964(70)90004-9; Vander Werff KR, 2019, J SPEECH LANG HEAR R, V62, P2501, DOI 10.1044/2019_JSLHR-H-18-0281; Vander Werff Kathy R., 2016, Seminars in Hearing, V37, P216, DOI 10.1055/s-0036-1584409; Vargo MM, 2016, PM&R, V8, P241, DOI 10.1016/j.pmrj.2015.07.006; Wallace SJ, 2017, APHASIOLOGY, V31, P643, DOI 10.1080/02687038.2016.1186265; Williams-Butler M. A., 2019, HEALTH-LONDON, V11, P880, DOI [10.4236/health.2019.117071, DOI 10.4236/HEALTH.2019.117071]; Wong ECH, 2020, AM J SPEECH-LANG PAT, V29, P652, DOI 10.1044/2019_AJSLP-19-00118; Working Group to Develop a Clinician's Guide to Cognitive Rehabilitation in mTBI, 2017, CLIN GUID COGN REH M; Wright J, 2020, TOP LANG DISORD, V40, P6, DOI 10.1097/TLD.0000000000000198; Ylvisaker M., 2006, BRAIN IMPAIR, V7, P246, DOI [10.1375/brim.7.3.246, DOI 10.1375/BRIM.7.3.246]; Yorkston K., 2019, PERSPECTIVES ASHA SP, V4, P8, DOI 10.1044/2018_PERS-ST-2018-0001	110	2	2	2	2	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	JUL	2021	30	4					1625	1655		10.1044/2021_AJSLP-20-00311			31	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	TY1ZS	WOS:000683585400005	34038183				2022-02-06	
J	Henry, JA; Griest, S; Reavis, KM; Grush, L; Theodoroff, SM; Young, S; Thielman, EJ; Carlson, KF				Henry, James A.; Griest, Susan; Reavis, Kelly M.; Grush, Leslie; Theodoroff, Sarah M.; Young, Sarah; Thielman, Emily J.; Carlson, Kathleen F.			Noise Outcomes in Servicemembers Epidemiology (NOISE) Study: Design, Methods, and Baseline Results	EAR AND HEARING			English	Article						Auditory disorders; Epidemiology; Hearing loss; Longitudinal; Military; Tinnitus; Veterans	HEARING-LOSS; TINNITUS PREVALENCE; VETERANS; HEALTH; THRESHOLDS; IMPAIRMENT; IRAQ	Objectives: Military Service members and Veterans commonly report hearing loss and tinnitus, both of which can result in significant disability. During military service, Service members are exposed to many different types of loud noise, which is strongly associated with hearing loss and tinnitus. Other military-related exposures, such as chemicals and traumatic brain injury (TBI), are also linked with auditory problems. The purpose of the "Noise Outcomes in Servicemembers Epidemiology" (NOISE) study is to gather information from Active-Duty Service members and recently separated Veterans about their military and nonmilitary noise exposures, other relevant military and nonmilitary exposures, and potential outcomes of these exposures including tinnitus, hearing loss, and other hearing-related health concerns. Design: The NOISE study assesses lifetime noise exposures, chemical and blast exposures, TBI, physical and psychiatric comorbidities, and other military and nonmilitary exposures and outcomes that can affect auditory function. Participants undergo comprehensive in-person audiologic examinations; those who experience tinnitus undergo a complete tinnitus assessment. Exposures and select outcomes are reassessed annually by mail, and the comprehensive in-person assessment is completed every 5 years. This report presents descriptive, baseline data obtained from the first 690 participants enrolled between 2014 and 2018. Results: Some notable findings from this analysis include: (1) the prevalence of hearing loss in the sample was 8% for low frequencies (0.25 to 2 kHz), 20% for high frequencies (3 to 8 kHz), and 39% for extended high frequencies (9 to 16 kHz); (2) the prevalence of tinnitus was 53%; (3) the prevalence of both hearing loss and tinnitus was higher among those with higher age, more years of military service, greater degree of noise exposure, and exposures to blasts and/or TBI in the military; and (4) tinnitus was most prevalent among participants who serve/served in the Army relative to the other military branches. Conclusions: The NOISE study is acquiring comprehensive data on military-related auditory dysfunction. It is the first of its kind to enroll active Service members and recently separated Veterans into a longitudinal study to examine the etiology and outcomes of tinnitus and hearing loss in this population. Although these data do not necessarily represent the entire military and Veteran populations, ongoing enrollment is focused on increasing generalizability and will also provide the statistical power to conduct multivariable analyses. This will allow us to examine longitudinal associations of interest while controlling for potential confounders and other possible sources of error. These data will provide critical knowledge to refine future military hearing conservation efforts and inform efforts to develop future treatments.	[Henry, James A.; Griest, Susan; Reavis, Kelly M.; Grush, Leslie; Theodoroff, Sarah M.; Young, Sarah; Thielman, Emily J.; Carlson, Kathleen F.] Vet Affairs Portland Hlth Care Syst, VA RR&D Natl Ctr Rehabil Auditory Res NCRAR, Portland, OR USA; [Henry, James A.; Griest, Susan; Theodoroff, Sarah M.] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA; [Reavis, Kelly M.; Young, Sarah; Carlson, Kathleen F.] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA; [Carlson, Kathleen F.] Vet Affairs Hlth Care Syst, Ctr Improve Vet Involvement Care, Portland, OR USA		Henry, JA (corresponding author), VA RR&D Natl Ctr Rehabil Auditory Res NCRAR, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA.	james.henry@va.gov	Reavis, Kelly/AAU-3893-2021		Department of Defense Congressionally Directed Medical Research Program Investigator-Initiated Research AwardUnited States Department of Defense [PR121146]; Joint Warfighter Medical Research Program Award [JW160036]; U.S. Department of Veterans Affairs (VA) Rehabilitation Research and Development (RR&D) Research Career Scientist AwardUS Department of Veterans Affairs [1 IK6 RX002990-01]; VA RR&D National Center for Rehabilitative Auditory Research (VA RR&D NCRAR Center Award) at the VA Portland Health Care System in Portland, Oregon [C9230C]; Office of the Assistant Secretary of Defense for Health Affairs, through the Joint Warfighter Medical Research Program [W81XWH-17-1-0020]; U.S. Army Medical Research Acquisition Activity, Chandler Street, Fort Detrick [MD 21702-5014]	This work was supported by a Department of Defense Congressionally Directed Medical Research Program Investigator-Initiated Research Award (PR121146), a Joint Warfighter Medical Research Program Award (JW160036), and a U.S. Department of Veterans Affairs (VA) Rehabilitation Research and Development (RR&D) Research Career Scientist Award (1 IK6 RX002990-01). This material is the result of work supported with resources and the use of facilities at the VA RR&D National Center for Rehabilitative Auditory Research (VA RR&D NCRAR Center Award; C9230C) at the VA Portland Health Care System in Portland, Oregon, as well as the Department of Defense, Hearing Center of Excellence in San Antonio, Texas. The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Joint Warfighter Medical Research Program under Award No. W81XWH-17-1-0020.	AXELSSON A, 1985, British Journal of Audiology, V19, P271, DOI 10.3109/03005368509078983; Baguley D, 2013, LANCET, V382, P1600, DOI 10.1016/S0140-6736(13)60142-7; Beach EF, 2013, ANN LEIS RES, V16, P149, DOI 10.1080/11745398.2013.793157; BENDER DR, 1982, MIL MED, V147, P681; BENDER DR, 1981, MIL MED, V146, P434; Berger E.H., 2010, NOISE NAVIGATOR SOUN; Bhatt JM, 2017, LARYNGOSCOPE, V127, P466, DOI 10.1002/lary.26107; Bhatt JM, 2016, JAMA OTOLARYNGOL, V142, P959, DOI 10.1001/jamaoto.2016.1700; Bohnker BK, 2002, MIL MED, V167, P132, DOI 10.1093/milmed/167.2.132; Bramhall NF, 2017, EAR HEARING, V38, pE1, DOI 10.1097/AUD.0000000000000370; Carlson KF, 2019, AM J AUDIOL, V28, P181, DOI 10.1044/2018_AJA-TTR17-18-0042; Chia EM, 2007, EAR HEARING, V28, P187, DOI 10.1097/AUD.0b013e31803126b6; Chisolm Theresa H, 2005, Trends Amplif, V9, P111, DOI 10.1177/108471380500900303; Collee A, 2011, NOISE HEALTH, V13, P64, DOI 10.4103/1463-1741.73997; Davis AC, 2019, B WORLD HEALTH ORGAN, V97, P646, DOI 10.2471/BLT.19.224683; Department of Defense (DoD), 2020, HEAR HLTH SURV DAT R; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLIN PRACT GU; Department of Veterans Affairs Veterans Health Administration, 2010, SCREEN EV POSS TRAUM; Dobie R. A. J. B., 2004, TINNITUS THEORY MANA, p1 7; Durch, 2006, NOISE MILITARY SERVI; Folmer RL, 2011, J REHABIL RES DEV, V48, P503, DOI 10.1682/JRRD.2010.07.0138; Frayne SM, 2011, J GEN INTERN MED, V26, P33, DOI 10.1007/s11606-010-1497-4; Gasaway D.C., 1988, HEARING CONSERVATION, P243; Gordon JS, 2017, HEARING RES, V349, P21, DOI 10.1016/j.heares.2016.11.014; Government Accountability Office, 2011, IMPROVEMENTS DOD HEA; Griest S.E., 2015, MILITARY HLTH SYSTEM; Griest S.E., 2015, AUDIOLOGYNOW ANN CON; Helfer Thomas M, 2005, Am J Audiol, V14, P161, DOI 10.1044/1059-0889(2005/018); Henry JA, 2020, OTOLARYNG CLIN N AM, V53, P481, DOI 10.1016/j.otc.2020.03.002; Henry JA, 2019, MIL MED, V184, P604, DOI 10.1093/milmed/usy328; Henry JA, 2016, AM J AUDIOL, V25, P153, DOI 10.1044/2016_AJA-15-0076; Henry JA, 2015, AM J AUDIOL, V24, P66, DOI 10.1044/2014_AJA-14-0042; Johnson R.M., 1998, TINNITUS TREATMENT R, P164; Karch Stephanie J, 2016, US Army Med Dep J, P52; Kujawa SG, 2015, HEARING RES, V330, P191, DOI 10.1016/j.heares.2015.02.009; McCormack A, 2016, HEARING RES, V337, P70, DOI 10.1016/j.heares.2016.05.009; Moore BA, 2019, AM J AUDIOL, V28, P866, DOI 10.1044/2019_AJA-19-0029; Reavis K.M., 2020, PERSPECT ASHA SPEC I, V5, P959; Snow J, 2004, TINNITUS THEORY MANA, P16; Swan AA, 2017, HEARING RES, V349, P4, DOI 10.1016/j.heares.2017.01.013; Theodoroff SM, 2015, EPIDEMIOL REV, V37, P71, DOI 10.1093/epirev/mxu005; Yankaskas K, 2013, HEARING RES, V295, P3, DOI 10.1016/j.heares.2012.04.016	42	2	2	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0196-0202	1538-4667		EAR HEARING	Ear Hear.	JUL-AUG	2021	42	4					870	885		10.1097/AUD.0000000000000974			16	Audiology & Speech-Language Pathology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Otorhinolaryngology	TA7SG	WOS:000667445300011	33974792				2022-02-06	
J	Iverson, GL; Cook, NE; Howell, DR; Collings, LJ; Kusch, C; Sun, J; Virji-Babul, N; Panenka, WJ				Iverson, Grant L.; Cook, Nathan E.; Howell, David R.; Collings, Laurel J.; Kusch, Cody; Sun, Jonathan; Virji-Babul, Naznin; Panenka, William J.			Preseason Vestibular Ocular Motor Screening in Children and Adolescents	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; clinical assessments; VOMS; children	DEFICIT HYPERACTIVITY DISORDER; SPORTS-RELATED CONCUSSION; POST-CONCUSSION; RECOVERY; PERFORMANCE; RELIABILITY; YOUTH; VOMS; ABNORMALITIES; SYSTEM	Objectives: The primary purpose of this study was to examine vestibular/ocular motor screening (VOMS) test performance in a sample of healthy youth ice hockey players. A particular focus was to investigate the potential effects of age and pre-existing health conditions, including concussion history, attention-deficit/hyperactivity disorder (ADHD), learning disability (LD), headaches/migraines, and depression/anxiety on preseason baseline VOMS performance, including the near point of convergence (NPC) distance. Design: Cross-sectional cohort. Setting: Outpatient physiotherapy clinic. Participants: Three hundred eighty-seven male youth hockey players, with an average age of 11.9 years (SD = 2.2, range = 8-17), completed the VOMS and responded to self- or parent-reported demographic and medical history questionnaires during preseason baseline assessments. Independent Variables Assessed: Age, sex, and mental and physical health history including ADHD, headaches, depression, anxiety, migraine, and LD. Outcome Measure: Vestibular/ocular motor screening. Results: The large majority of boys scored within normal limits on the VOMS, ie, they reported no symptom provocation of more than 2 points on any VOMS subset (89%) and had a normal NPC distance, ie, <5 cm (78%). The individual VOMS subtests had low abnormality rates, and demographic and pre-existing health conditions, such as age, headache or migraine history, previous neurodevelopmental conditions, or mental health problems, were not associated with clinically meaningful symptom provocation during the VOMS. Conclusions: There was a low rate of abnormal findings for the individual VOMS subtests, with the exception of NPC distance, among male youth hockey players during preseason assessment.	[Iverson, Grant L.; Cook, Nathan E.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.; Cook, Nathan E.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Iverson, Grant L.; Cook, Nathan E.] Spaulding Rehabil Inst, Charlestown, MA USA; [Iverson, Grant L.; Cook, Nathan E.] MassGen Hosp Children Sport Concuss Program, Boston, MA USA; [Iverson, Grant L.] Home Base, Charlestown, MA USA; [Howell, David R.] Univ Colorado, Childrens Hosp Colorado, Sports Med Ctr, Dept Orthoped,Sch Med, Aurora, CO USA; [Collings, Laurel J.; Panenka, William J.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Collings, Laurel J.; Virji-Babul, Naznin; Panenka, William J.] British Columbia Mental Hlth & Addict Res Inst, Vancouver, BC, Canada; [Kusch, Cody] Seafair Minor Hockey Assoc, Richmond, BC, Canada; [Sun, Jonathan] Evolut Sport Therapy, Richmond, BC, Canada; [Virji-Babul, Naznin] Univ British Columbia, Dept Phys Therapy, Vancouver, BC, Canada; [Virji-Babul, Naznin] Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada; [Panenka, William J.] Univ British Columbia, Vancouver Coastal Hlth, British Columbia Prov Neuropsychiat Program, Vancouver, BC, Canada		Panenka, WJ (corresponding author), BC Childrens Hosp Res Bldg,938 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	wpanenka@mail.ubc.ca		Panenka, William/0000-0001-7143-6512; Virji-Babul, Naznin/0000-0002-8984-5848			Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; BAKER RS, 1991, SURV OPHTHALMOL, V35, P245, DOI 10.1016/0039-6257(91)90046-I; Bonfield CM, 2013, J NEUROSURG-PEDIATR, V12, P97, DOI 10.3171/2013.5.PEDS12424; Borsting Eric, 2005, Optometry, V76, P588, DOI 10.1016/j.optm.2005.07.007; Brooks BL, 2016, APPL NEUROPSYCH-CHIL, V5, P119, DOI 10.1080/21622965.2014.1003066; Bucci MP, 2014, EXP BRAIN RES, V232, P927, DOI 10.1007/s00221-013-3805-9; Cook Nathan E, 2016, PM R, V8, pS156, DOI 10.1016/j.pmrj.2016.07.032; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; DiCesare CA, 2017, BEHAV RES METHODS, V49, P258, DOI 10.3758/s13428-015-0693-x; Elbin RJ, 2018, J NEUROL PHYS THER, V42, P142, DOI 10.1097/NPT.0000000000000230; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Glaviano NR, 2015, CLIN J SPORT MED, V25, P373, DOI 10.1097/JSM.0000000000000154; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Iverson GL, 2020, J ATTEN DISORD, V24, P1095, DOI 10.1177/1087054716657410; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Khan S, 2013, NEUROREHABILITATION, V32, P437, DOI 10.3233/NRE-130866; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Littleton AC, 2015, ARCH CLIN NEUROPSYCH, V30, P683, DOI 10.1093/arclin/acv043; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Moran RN, 2018, AM J SPORT MED, V46, P1475, DOI 10.1177/0363546518756979; Mostofsky SH, 2001, NEUROLOGY, V57, P423, DOI 10.1212/WNL.57.3.423; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Murray NG, 2014, BRAIN INJURY, V28, P496, DOI 10.3109/02699052.2014.887144; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Snyder AR, 2014, CLIN NEUROPSYCHOL, V28, P1091, DOI 10.1080/13854046.2014.952667; Sufrinko AM, 2019, CLIN J SPORT MED, V29, P318, DOI 10.1097/JSM.0000000000000528; Sufrinko AM, 2017, AM J SPORT MED, V45, P1187, DOI 10.1177/0363546516685061; Worts PR, 2018, AM J SPORT MED, V46, P2004, DOI 10.1177/0363546518768750; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411	36	2	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2021	31	4					E188	E192		10.1097/JSM.0000000000000767			5	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	WN3JX	WOS:000711669500002	31233433				2022-02-06	
J	Kaufmann, D; Sollmann, N; Kaufmann, E; Veggeberg, R; Tripodis, Y; Wrobel, PP; Kochsiek, J; Martin, BM; Lin, AP; Coleman, MJ; Alosco, ML; Pasternak, O; Bouix, S; Stern, RA; Shenton, ME; Koerte, IK				Kaufmann, David; Sollmann, Nico; Kaufmann, Elisabeth; Veggeberg, Rosanna; Tripodis, Yorghos; Wrobel, Pawel P.; Kochsiek, Janna; Martin, Brett M.; Lin, Alexander P.; Coleman, Michael J.; Alosco, Michael L.; Pasternak, Ofer; Bouix, Sylvain; Stern, Robert A.; Shenton, Martha E.; Koerte, Inga K.			Age at First Exposure to Tackle Football is Associated with Cortical Thickness in Former Professional American Football Players	CEREBRAL CORTEX			English	Article						cortical thinning; repetitive head impacts; traumatic brain injury; verbal memory; visual memory	SUPERIOR FRONTAL GYRUS; SURFACE-BASED ANALYSIS; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; LONGITUDINAL CHANGES; BRAIN MATURATION; CEREBRAL-CORTEX; HIGH-SCHOOL; LATER-LIFE; ADOLESCENCE	Younger age at first exposure (AFE) to repetitive head impacts while playing American football increases the risk for later-life neuropsychological symptoms and brain alterations. However, it is not known whether AFE is associated with cortical thickness in American football players. Sixty-three former professional National Football League players (55.5 f 7.7 years) with cognitive, behavioral, and mood symptoms underwent neuroimaging and neuropsychological testing. First, the association between cortical thickness and AFE was tested. Second, the relationship between clusters of decreased cortical thickness and verbal and visual memory, and composite measures of mood/behavior and attention/psychomotor speed was assessed. AFE was positively correlated with cortical thickness in the right superior frontal cortex (cluster-wise P value [CWP] = 0.0006), the left parietal cortex (CWP = 0.0003), and the occipital cortices (right: CWP = 0.0023; left: CWP = 0.0008). A positive correlation was found between cortical thickness of the right superior frontal cortex and verbal memory (R = 0.333, P = 0.019), and the right occipital cortex and visual memory (R = 0.360, P = 0.012). In conclusion, our results suggest an association between younger AFE and decreased cortical thickness, which in turn is associated with worse neuropsychological performance. Furthermore, an association between younger AFE and signs of neurodegeneration later in life in symptomatic former American football players seems likely.	[Kaufmann, David; Sollmann, Nico; Kaufmann, Elisabeth; Wrobel, Pawel P.; Kochsiek, Janna; Koerte, Inga K.] Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat Psychosomat & Ps, cBRAIN, D-80337 Munich, Germany; [Kaufmann, David; Sollmann, Nico; Kaufmann, Elisabeth; Veggeberg, Rosanna; Wrobel, Pawel P.; Kochsiek, Janna; Lin, Alexander P.; Coleman, Michael J.; Pasternak, Ofer; Bouix, Sylvain; Shenton, Martha E.; Koerte, Inga K.] Harvard Med Sch, Brigham & Womens Hosp, Psychiat Neuroimaging Lab, 1249 Boylston St, Boston, MA 02215 USA; [Kaufmann, David] Charite, Dept Radiol, D-10117 Berlin, Germany; [Sollmann, Nico] Tech Univ Munich, Dept Diagnost & Intervent Neuroradiol, Klinikum Rechts Isar, D-81675 Munich, Germany; [Sollmann, Nico] Tech Univ Munich, TUM Neuroimaging Ctr, Klinikum Rechts Isar, D-81675 Munich, Germany; [Kaufmann, Elisabeth] Ludwig Maximilians Univ Munchen, Dept Neurol, Univ Hosp, D-81377 Munich, Germany; [Tripodis, Yorghos] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Tripodis, Yorghos; Alosco, Michael L.; Stern, Robert A.] Boston Univ, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA; [Tripodis, Yorghos; Alosco, Michael L.; Stern, Robert A.] Boston Univ, Sch Med, CTE Ctr, Boston, MA 02118 USA; [Martin, Brett M.] Boston Univ, Data Coordinating Ctr, Sch Publ Hlth, Boston, MA 02118 USA; [Lin, Alexander P.; Pasternak, Ofer; Shenton, Martha E.] Brigham & Womens Hosp, Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Lin, Alexander P.] Harvard Med Sch, Ctr Clin Spect, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; [Alosco, Michael L.; Stern, Robert A.] Boston Univ, Dept Neurol, Sch Med, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Dept Neurosurg, Sch Med, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Dept Anat & Neurobiol, Sch Med, Boston, MA 02118 USA; [Shenton, Martha E.] VA Boston Healthcare Syst, Brockton Div, Brockton, MA 02301 USA; [Koerte, Inga K.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Koerte, Inga K.] Ludwig Maximilians Univ Munchen, Grad Sch Syst Neurosci, D-82152 Munich, Germany		Koerte, IK (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Psychiat Neuroimaging Lab, 1249 Boylston St, Boston, MA 02215 USA.	lkoerte@bwh.harvard.edu	Koerte, Inga Katharina/AAW-3031-2021	Sollmann, Nico/0000-0002-8120-2223	National Institute of Neurologic Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS078337]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS100952, R01 HD090641]; German Academic Exchange Service (Deutscher Akademischer Austeuschdienst); Ludwig-Maximilians-University Munich	National Institute of Neurologic Disorders and Stroke (R01 NS078337 to PI: R.A.S.); National Institutes of Health (R01 NS100952 to I.K.K., R01 HD090641 to S.B.); the German Academic Exchange Service (Deutscher Akademischer Austeuschdienst to P.W.W.); the Ludwig-Maximilians-University Munich (P.W.W.).	Adler CM, 2018, CLIN J SPORT MED, V28, P100, DOI 10.1097/JSM.0000000000000391; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco ML, 2019, SEMIN PEDIATR NEUROL, V30, P107, DOI 10.1016/j.spen.2019.03.016; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Alosco ML, 2017, J NEUROTRAUM, V34, P772, DOI 10.1089/neu.2016.4536; Beason-Held LL, 1998, COGNITIVE BRAIN RES, V7, P111, DOI 10.1016/S0926-6410(98)00015-9; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; BOGOUSSLAVSKY J, 1987, J NEUROL NEUROSUR PS, V50, P607, DOI 10.1136/jnnp.50.5.607; Brown TT, 2012, CURR BIOL, V22, P1693, DOI 10.1016/j.cub.2012.07.002; Bryant BR, 2020, INT REV PSYCHIATR, V32, P89, DOI 10.1080/09540261.2019.1665501; Caccese JB, 2019, SPORTS MED, V49, P477, DOI 10.1007/s40279-019-01069-x; Chang WP, 2015, EXP NEUROL, V265, P180, DOI 10.1016/j.expneurol.2015.02.002; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Eskildsen SF, 2013, NEUROIMAGE, V65, P511, DOI 10.1016/j.neuroimage.2012.09.058; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fjell AM, 2009, CEREB CORTEX, V19, P2001, DOI 10.1093/cercor/bhn232; Giedd JN, 2008, J ADOLESCENT HEALTH, V42, P335, DOI 10.1016/j.jadohealth.2008.01.007; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hamsher K., 1989, MULTILINGUAL APHASIA; Hu S, 2016, J NEUROSCI, V36, P12688, DOI 10.1523/JNEUROSCI.1175-16.2016; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Kang Sung Hoon, 2019, Dement Neurocogn Disord, V18, P77, DOI 10.12779/dnd.2019.18.3.77; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Lauer J, 2017, BRAIN INJURY, V31, P1513, DOI 10.1080/02699052.2017.1341998; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lerch JP, 2008, NEUROBIOL AGING, V29, P23, DOI 10.1016/j.neurobiolaging.2006.09.013; Lerch JP, 2005, CEREB CORTEX, V15, P995, DOI 10.1093/cercor/bhh200; Leunissen I, 2014, HUM BRAIN MAPP, V35, P2459, DOI 10.1002/hbm.22341; Machielsen WCM, 2000, HUM BRAIN MAPP, V9, P156, DOI 10.1002/(SICI)1097-0193(200003)9:3<156::AID-HBM4>3.0.CO;2-Q; Marin, 1996, Semin Clin Neuropsychiatry, V1, P304; Moore DR, 2016, INT J PSYCHOPHYSIOL, V99, P85, DOI 10.1016/j.ijpsycho.2015.11.010; Nathanson JT, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967115622621; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Petermann F, 2016, Z NEUROPSYCHOL, V27, P129, DOI 10.1024/1016-264X/a000181; Plessow F, 2020, J NEUROTRAUM, V37, P1021, DOI 10.1089/neu.2019.6661; Querbes O, 2009, BRAIN, V132, P2036, DOI 10.1093/brain/awp105; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Roberts AL, 2019, AM J SPORT MED, V47, P2871, DOI 10.1177/0363546519868989; Sadeh N, 2015, HUM BRAIN MAPP, V36, P3076, DOI 10.1002/hbm.22829; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Solomon G, 2018, DEV NEUROPSYCHOL, V43, P279, DOI 10.1080/87565641.2018.1447575; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stern R., 1999, BOSTON QUALITATIVE S; Tamnes CK, 2017, J NEUROSCI, V37, P3402, DOI 10.1523/JNEUROSCI.3302-16.2017; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Thambisetty M, 2010, NEUROIMAGE, V52, P1215, DOI 10.1016/j.neuroimage.2010.04.258; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Whitford TJ, 2007, HUM BRAIN MAPP, V28, P228, DOI 10.1002/hbm.20273; Wojtowicz M, 2018, NEUROIMAGE-CLIN, V18, P377, DOI 10.1016/j.nicl.2018.01.005; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	65	2	2	7	8	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	JUL	2021	31	7					3426	3434		10.1093/cercor/bhab021			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TF6BW	WOS:000670805500020	33676369				2022-02-06	
J	Langer, LK; Alavinia, SM; Lawrence, DW; Munce, SEP; Kam, A; Tam, A; Ruttan, L; Comper, P; Bayley, MT				Langer, Laura Kathleen; Alavinia, Seyed Mohammad; Lawrence, David Wyndham; Munce, Sarah Elizabeth Patricia; Kam, Alice; Tam, Alan; Ruttan, Lesley; Comper, Paul; Bayley, Mark Theodore			Prediction of risk of prolonged postconcussion symptoms: Derivation and validation of the TRICORDRR (Toronto Rehabilitation Institute Concussion Outcome Determination and Rehab Recommendations) score	PLOS MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; HEALTH-CARE UTILIZATION; SEX-DIFFERENCES; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; SPORT HELD; DISORDERS; RESERVE; ZURICH	Background Approximately 10% to 20% of people with concussion experience prolonged post-concussion symptoms (PPCS). There is limited information identifying risk factors for PPCS in adult populations. This study aimed to derive a risk score for PPCS by determining which demographic factors, premorbid health conditions, and healthcare utilization patterns are associated with need for prolonged concussion care among a large cohort of adults with concussion. Methods and findings Data from a cohort study (Ontario Concussion Cohort study, 2008 to 2016; n = 1,330,336) including all adults with a concussion diagnosis by either primary care physician (ICD-9 code 850) or in emergency department (ICD-10 code S06) and 2 years of healthcare tracking postinjury (2008 to 2014, n = 587,057) were used in a retrospective analysis. Approximately 42.4% of the cohort was female, and adults between 18 and 30 years was the largest age group (31.0%). PPCS was defined as 2 or more specialist visits for concussionrelated symptoms more than 6 months after injury index date. Approximately 13% (73,122) of the cohort had PPCS. Total cohort was divided into Derivation (2009 to 2013, n = 417,335) and Validation cohorts (2009 and 2014, n = 169,722) based upon injury index year. Variables selected a priori such as psychiatric disorders, migraines, sleep disorders, demographic factors, and pre-injury healthcare patterns were entered into multivariable logistic regression and CART modeling in the Derivation Cohort to calculate PPCS estimates and forward selection logistic regression model in the Validation Cohort. Variables with the highest probability of PPCS derived in the Derivation Cohort were: Age > 61 years ((p) over cap = 0.54), bipolar disorder ((p) over cap = 0.52), high pre-injury primary care visits per year ((p) over cap = 0.46), personality disorders ((p) over cap = 0.45), and anxiety and depression ((p) over cap = 0.33). The area under the curve (AUC) was 0.79 for the derivation model, 0.79 for bootstrap internal validation of the Derivation Cohort, and 0.64 for the Validation model. A limitation of this study was ability to track healthcare usage only to healthcare providers that submit to Ontario Health Insurance Plan (OHIP); thus, some patients seeking treatment for prolonged symptoms may not be captured in this analysis. Conclusions In this study, we observed that premorbid psychiatric conditions, pre-injury health system usage, and older age were associated with increased risk of a prolonged recovery from concussion. This risk score allows clinicians to calculate an individual's risk of requiring treatment more than 6 months post-concussion.	[Langer, Laura Kathleen; Alavinia, Seyed Mohammad; Munce, Sarah Elizabeth Patricia; Bayley, Mark Theodore] Univ Hlth Network, KITE Res Inst, Toronto Rehabil Inst, Toronto, ON, Canada; [Alavinia, Seyed Mohammad; Tam, Alan; Bayley, Mark Theodore] Univ Toronto, Fac Med, Div Phys Med & Rehab, Toronto, ON, Canada; [Lawrence, David Wyndham; Kam, Alice; Tam, Alan; Ruttan, Lesley; Comper, Paul; Bayley, Mark Theodore] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Lawrence, David Wyndham; Comper, Paul] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Lawrence, David Wyndham] Mt Sinai Hosp, Toronto, ON, Canada; [Munce, Sarah Elizabeth Patricia] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Munce, Sarah Elizabeth Patricia; Comper, Paul] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Munce, Sarah Elizabeth Patricia; Comper, Paul] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Ruttan, Lesley] Univ Toronto Scarborough, Grad Dept Psychol Clin Sci, Toronto, ON, Canada		Langer, LK (corresponding author), Univ Hlth Network, KITE Res Inst, Toronto Rehabil Inst, Toronto, ON, Canada.	laura.langer@uhn.ca	; Alavinia, Mohammad/F-9195-2017	Langer, Laura/0000-0003-4408-355X; Bayley, Mark/0000-0001-7860-9463; Munce, Sarah/0000-0002-0595-8395; Alavinia, Mohammad/0000-0002-5503-9362	Ontario Neurotrauma Foundation [20160976031000]	This study was funded by the Ontario Neurotrauma Foundation (onf.org) MTB, grant number 20160976031000. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association A, 1994, DIAGNOSTIC STAT MANU; [Anonymous], 2016, STAT CANADA CEN; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Brook EM, 2016, PHYSICIAN SPORTSMED, V44, P20, DOI 10.1080/00913847.2016.1142834; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Center for Disease Control and Prevention (CDC), 2019, SURVEILLANCE REPORT, V2014; Center for Disease Control and Prevention (CDC) National Center for Injury Prevention and Control, 2003, REPORT C MILD TRAUMA; Chaput G, 2016, PAIN RES MANAG, V2016, DOI 10.1155/2016/2825856; Clewley D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201348; Cnossen MC, 2018, J NEUROTRAUM, V35, P2691, DOI 10.1089/neu.2017.5486; Frost J, 2015, J PRIM CARE COMMUNIT, V6, P264, DOI 10.1177/2150131915598373; Hu TN, 2017, CAN J NEUROL SCI, V44, P384, DOI 10.1017/cjn.2016.441; Huang CM, 2019, PSYCHOL LEARN MOTIV, V71, P175, DOI 10.1016/bs.plm.2019.07.006; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Langer L, 2020, J HEAD TRAUMA REHAB, V35, pE60, DOI 10.1097/HTR.0000000000000503; Lawrence DW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196062; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Lee DS, 2012, ANN INTERN MED, V156, P767, DOI 10.7326/0003-4819-156-11-201206050-00003; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Manuel DG, 2018, CAN MED ASSOC J, V190, pE871, DOI 10.1503/cmaj.170914; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Merritt VC, 2019, CLIN NEUROPSYCHOL, V33, P1016, DOI 10.1080/13854046.2018.1508616; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Ontario Neurotrauma Foundation, 2013, GUIDELINES CONCUSSIO; Ponsford J, 2019, J REHABIL MED, V51, P32, DOI 10.2340/16501977-2492; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Powers A, 2014, AM J GERIAT PSYCHIAT, V22, P1478, DOI 10.1016/j.jagp.2013.10.009; Powers AD, 2012, J PERS DISORD, V26, P524, DOI 10.1521/pedi.2012.26.4.524; Scheenen ME, 2017, J NEUROTRAUM, V34, P31, DOI 10.1089/neu.2015.4381; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Simon GE, 1999, PSYCHIATR SERV, V50, P1303, DOI 10.1176/ps.50.10.1303; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Stenberg J, 2020, ARCH PHYS MED REHAB, V101, P72, DOI 10.1016/j.apmr.2019.08.477; Stone S, 2017, SPORTS HEALTH, V9, P41, DOI 10.1177/1941738116672184; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; World Health Organization, 2016, INT STAT CLASS DIS R, V5TH; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	41	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1549-1277	1549-1676		PLOS MED	PLos Med.	JUL	2021	18	7							e1003652	10.1371/journal.pmed.1003652			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TF5PQ	WOS:000670773500001	34237056	Green Published, gold			2022-02-06	
J	Mashima, PA; Waldron-Perrine, B; MacLennan, D; Sohlberg, MM; Perla, LY; Eapen, BC				Mashima, Pauline A.; Waldron-Perrine, Brigid; MacLennan, Don; Sohlberg, McKay Moore; Perla, Lisa Y.; Eapen, Blessen C.			Interprofessional Collaborative Management of Postconcussion Cognitive Symptoms	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; SPEECH-LANGUAGE PATHOLOGY; OF-THE-LITERATURE; INCOG RECOMMENDATIONS; NEUROPSYCHOLOGICAL ASSESSMENT; DIAGNOSIS THREAT; REHABILITATION; CONCUSSION; TELEREHABILITATION; RESILIENCE	Purpose: The purpose of this clinical focus article is to illustrate an interprofessional cognitive rehabilitation approach. Invited experts representing physical medicine and rehabilitation, clinical neuropsychology/rehabilitation psychology, registered nurse care coordination, and speech-language pathology share viewpoints from their discipline to engage in collaborative interventions with the goal of enhancing treatment outcomes. Conclusions: Treating the multifactorial symptoms of concussion requires expertise from an interdisciplinary team (IDT) of professionals, contributing unique perspectives and providing integrative services to optimize rehabilitation outcomes for patients. Speech-language pathologists serve an important role on IDTs to deliver personalized, targeted therapies for prolonged or persistent postconcussion cognitive impairment.	[Mashima, Pauline A.] Univ Hawaii Manoa, Dept Commun Sci & Disorders, Honolulu, HI 96822 USA; [Waldron-Perrine, Brigid] Univ Michigan, Michigan Med, Dept Phys Med & Rehabil, Div Rehabil Psychol & Neuropsychol, Ann Arbor, MI 48109 USA; [MacLennan, Don] Minneapolis VA Hlth Care Syst, Minneapolis, MN USA; [Sohlberg, McKay Moore] Univ Oregon, Commun Disorders & Sci Program, Eugene, OR 97403 USA; [Perla, Lisa Y.] US Dept Vet Affairs, Washington, DC USA; [Eapen, Blessen C.] UCLA, David Geffen Sch Med, VA Greater Los Angeles Healthcare Syst, Los Angeles, CA 90095 USA		Mashima, PA (corresponding author), Univ Hawaii Manoa, Dept Commun Sci & Disorders, Honolulu, HI 96822 USA.	mashima@hawaii.edu					American Speech-Language-Hearing Association, 2016, COD ETH ETH COD ETH ETH; Arch JJ, 2009, PSYCHIAT CLIN N AM, V32, P525, DOI 10.1016/j.psc.2009.05.001; Armistead-Jehle P, 2016, APPL NEUROPSYCH-ADUL, V23, P264, DOI 10.1080/23279095.2015.1055564; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P290, DOI 10.1097/HTR.0000000000000070; Belanger HG, 2020, CLIN NEUROPSYCHOL, V34, P1105, DOI [10.1080/13854046.2019.1699166, 10.1080/13854046.2019.1578899]; Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P343, DOI 10.1080/13854046.2013.774438; Block CK, 2017, CLIN NEUROPSYCHOL, V31, P487, DOI 10.1080/13854046.2016.1267803; Bouwens SFM, 2009, CLIN REHABIL, V23, P310, DOI 10.1177/0269215508101744; Bradley SE, 2020, BRAIN INJURY, V34, P1031, DOI 10.1080/02699052.2020.1771770; Brown J, 2019, AM J SPEECH-LANG PAT, V28, P1363, DOI 10.1044/2019_AJSLP-18-0296; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Cherney LR, 2012, SEMIN SPEECH LANG, V33, P243, DOI 10.1055/s-0032-1320044; Chesnutt JC, 2021, AM J SPEECH-LANG PAT, V30, P1592, DOI 10.1044/2021_AJSLP-20-00315; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Clanton S, 2020, CONCUSSION ASSESSMEN, P169, DOI [10.1016/B978-0-323-65384-8.00015, DOI 10.1016/B978-0-323-65384-8.00015]; Coleman JJ, 2015, AM J SPEECH-LANG PAT, V24, P295, DOI 10.1044/2015_AJSLP-14-0028; Cornis-Pop M, 2012, J REHABIL RES DEV, V49, pXI, DOI 10.1682/JRRD.2012.03.0048; Coulon SM, 2016, AM J PREV MED, V51, P95, DOI 10.1016/j.amepre.2016.01.026; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; Ghafoori B, 2018, CLIN CASE STUD, V17, P123, DOI 10.1177/1534650118766660; Giza C, 2020, BIOMARKERS ENDOPHENO; Grant M, 2014, NEUROPSYCHOL REHABIL, V24, P661, DOI 10.1080/09602011.2014.901228; Grant M, 2012, NEUROPSYCHOL REHABIL, V22, P852, DOI 10.1080/09602011.2012.693455; Hardin KY, 2019, SEMIN SPEECH LANG, V40, P65, DOI 10.1055/s-0038-1676452; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Himle J. A., 2007, HDB EXPOSURE THERAPI, P299, DOI [10.1016/B978-012587421-2/50014-4, DOI 10.1016/B978-012587421-2/50014-4]; Interprofessional Education Collaborative, 2016, COR COMP INT COLL PR; Jarvis-Selinger S, 2008, TELEMED J E-HEALTH, V14, P720, DOI 10.1089/tmj.2007.0108; Joint Committee on Interprofessional Relations Between the American Speech -Language -Hearing Association and Division 40 (Clinical Neuropsychology) of the American Psychological Association, 2007, STRUCTURE FUNCTION I; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Kennedy M. R. T., 2017, COACHING COLL STUDEN; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; Kimble MO, 2013, J INTERPERS VIOLENCE, V28, P1672, DOI 10.1177/0886260512468319; Larrabee GJ, 2013, BEHAV SCI LAW, V31, P686, DOI 10.1002/bsl.2087; Lequerica AH, 2010, AM J PHYS MED REHAB, V89, P415, DOI 10.1097/PHM.0b013e3181d8ceb2; Lew HL, 2020, AM J PHYS MED REHAB, V99, P571, DOI 10.1097/PHM.0000000000001460; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Lumba-Brown A, 2020, NEUROSURGERY, V86, P2, DOI 10.1093/neuros/nyz332; MALEC JF, 1991, ARCH PHYS MED REHAB, V72, P138; Management of Concussion -Mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU VA DOD CLIN PRACT GU; Mashima Pauline A, 2008, Telemed J E Health, V14, P1101, DOI 10.1089/tmj.2008.0080; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCue Michael, 2010, Phys Med Rehabil Clin N Am, V21, P195, DOI 10.1016/j.pmr.2009.07.005; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P481, DOI 10.1080/09602010903529610; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Mohr DC, 2019, J MED INTERNET RES, V21, DOI 10.2196/13609; Mullally WJ, 2017, AM J MED, V130, P885, DOI 10.1016/j.amjmed.2017.04.016; Neils-Strunjas J, 2017, BRAIN INJURY, V31, P131, DOI 10.1080/02699052.2016.1229032; Oliver I, 2012, IEEE IC COMP COM NET; Pavawalla SP, 2013, J INT NEUROPSYCH SOC, V19, P305, DOI 10.1017/S135561771200135X; Perla L, 2010, NURSE LEAD, V8, P26, DOI 10.1016/j.mnl.2010.09.002; Perla LY, 2013, REHABIL NURS, V38, P231, DOI 10.1002/rnj.102; Picon L. M, 2020, CONCUSSION ASSESSMEN, DOI [10.1016/B978-0-323-65384-8.00008-0, DOI 10.1016/B978-0-323-65384-8.00008-0]; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Porter KK, 2014, AM J SPEECH-LANG PAT, V23, P507, DOI 10.1044/2014_AJSLP-13-0126; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Reivich KJ, 2011, AM PSYCHOL, V66, P25, DOI 10.1037/a0021897; Richards HJ, 2014, CLIN PSYCHOL REV, V34, P1, DOI 10.1016/j.cpr.2013.10.006; Richmond T, 2017, INT J TELEREHABILITA, V9, P63, DOI 10.5195/ijt.2017.6232; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Roy MJ, 2017, CYBERPSYCH BEH SOC N, V20, P470, DOI 10.1089/cyber.2017.0221; Sarajuuri JM, 2005, ARCH PHYS MED REHAB, V86, P2296, DOI 10.1016/j.apmr.2005.06.018; Sohlberg M., 2001, COGNITIVE REHABILITA; Sohlberg M.M., 2011, OPTIMIZING COGNITIVE; Sohlberg MM, 2016, AM J SPEECH-LANG PAT, V25, DOI 10.1044/2015_AJSLP-14-0128; Storzbach D, 2017, J HEAD TRAUMA REHAB, V32, P16, DOI 10.1097/HTR.0000000000000228; Strasser DC, 2008, ARCH PHYS MED REHAB, V89, P179, DOI 10.1016/j.apmr.2007.06.774; Stroupe KT, 2019, J GEN INTERN MED, V34, P2141, DOI 10.1007/s11606-019-05224-y; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Tapia RN, 2017, PHYS MED REH CLIN N, V28, P287, DOI 10.1016/j.pmr.2016.12.006; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Torsney K, 2003, NEUROREHABILITATION, V18, P183; Turner-Stokes L, 2009, J REHABIL MED, V41, P528, DOI 10.2340/16501977-0383; Vanderploeg RD, 2006, PSYCHOLOGICAL KNOWLEDGE IN COURT: PTSD, PAIN, AND TBI, P279, DOI 10.1007/0-387-25610-5_16; Vanderploeg RD, 2019, REHABIL PSYCHOL, V64, P1, DOI 10.1037/rep0000255; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; Veterans Health Administration, 2016, TRANS CAR MAN ILL IN TRANS CAR MAN ILL IN; Vimalananda VG, 2018, J AMBUL CARE MANAG, V41, P15, DOI 10.1097/JAC.0000000000000219; WHO, 2020, WHO TIM COVID 19; Widerstrom-Noga EG, 2009, J REHABIL RES DEV, V46, P1, DOI 10.1682/JRRD.2008.03.0038; Working Group to Develop a Clinician 's Guide to Cognitive Rehabilitation in mTBI: Application for Military Service Members and Veterans, 2016, CLIN GUID COGN REH M CLIN GUID COGN REH M; World Health Organization, 2016, GLOB DIFF EHEALTH MA; World Health Organization, 2007, INT CLASS FUNCT DIS; World Health Organization (WHO), 2010, FRAM ACT INT ED COLL; Wright J, 2021, AM J SPEECH-LANG PAT, V30, P1611, DOI 10.1044/2021_AJSLP-20-00306; Wright J, 2020, TOP LANG DISORD, V40, P6, DOI 10.1097/TLD.0000000000000198; Ylvisaker M., 2003, BRAIN IMPAIR, V4, P1, DOI [DOI 10.1375/brim.4.1.1.27031, https://doi.org/10.1375/brim.4.1.1.27031, DOI 10.1375/BRIM.4.1.1.27031]; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker M., 2006, BRAIN IMPAIR, V7, P246, DOI [10.1375/brim.7.3.246, DOI 10.1375/BRIM.7.3.246]; Ylvisaker M., 1985, CLIN MANAGEMENT NEUR, V2nd, P243	104	2	2	1	1	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	JUL	2021	30	4					1598	1610		10.1044/2021_AJSLP-20-00313			13	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	TY1ZS	WOS:000683585400003	34170743				2022-02-06	
J	McArthur, K; Krause, C; Kwon, E; Luo-Owen, X; Cochran-Yu, M; Swentek, L; Burruss, S; Turay, D; Krasnoff, C; Grigorian, A; Nahmias, J; Butt, A; Gutierrez, A; LaRiccia, A; Kincaid, M; Fiorentino, MN; Glass, N; Toscano, S; Ley, E; Lombardo, SR; Guillamondegui, OD; Bardes, JM; DeLa'O, C; Wydo, SM; Leneweaver, K; Duletzke, NT; Nunez, J; Moradian, S; Posluszny, J; Naar, L; Kaafarani, H; Kemmer, H; Lieser, MJ; Dorricott, A; Chang, GC; Nemeth, Z; Mukherjee, K				McArthur, Kaitlin; Krause, Cassandra; Kwon, Eugenia; Luo-Owen, Xian; Cochran-Yu, Meghan; Swentek, Lourdes; Burruss, Sigrid; Turay, David; Krasnoff, Chloe; Grigorian, Areg; Nahmias, Jeffry; Butt, Ahsan; Gutierrez, Adam; LaRiccia, Aimee; Kincaid, Michelle; Fiorentino, Michele N.; Glass, Nina; Toscano, Samantha; Ley, Eric; Lombardo, Sarah R.; Guillamondegui, Oscar D.; Bardes, James M.; DeLa'O, Connie; Wydo, Salina M.; Leneweaver, Kyle; Duletzke, Nicholas T.; Nunez, Jade; Moradian, Simon; Posluszny, Joseph; Naar, Leon; Kaafarani, Haytham; Kemmer, Heidi; Lieser, Mark J.; Dorricott, Alexa; Chang, Grace; Nemeth, Zoltan; Mukherjee, Kaushik			Trauma and nontrauma damage-control laparotomy: The difference is delirium (data from the Eastern Association for the Surgery of Trauma SLEEP-TIME multicenter trial)	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Trauma; damage-control laparotomy; sedation; delirium; nontrauma	CHARLSON COMORBIDITY INDEX; MECHANICALLY VENTILATED PATIENTS; PRIMARY FASCIAL CLOSURE; APACHE-II; VALIDATION; MANAGEMENT; COAGULOPATHY; PHYSIOLOGY; SEVERITY; OUTCOMES	BACKGROUND Damage-control laparotomy (DCL) has been used for traumatic and nontraumatic indications. We studied factors associated with delirium and outcome in this population. METHODS We reviewed DCL patients at 15 centers for 2 years, including demographics, Charlson Comorbidity Index (CCI), diagnosis, operations, and outcomes. We compared 30-day mortality; renal failure requiring dialysis; number of takebacks; hospital, ventilator, and intensive care unit (ICU) days; and delirium-free and coma-free proportion of the first 30 ICU days (DF/CF-ICU-30) between trauma (T) and nontrauma (NT) patients. We performed linear regression for DF/CF-ICU-30, including age, sex, CCI, achievement of primary fascial closure (PFC), small and large bowel resection, bowel discontinuity, abdominal vascular procedures, and trauma as covariates. We performed one-way analysis of variance for DF/CF-ICU-30 against traumatic brain injury severity as measured by Abbreviated Injury Scale for the head. RESULTS Among 554 DCL patients (25.8% NT), NT patients were older (58.9 +/- 15.8 vs. 39.7 +/- 17.0 years, p < 0.001), more female (45.5% vs. 22.1%, p < 0.001), and had higher CCI (4.7 +/- 3.3 vs. 1.1 +/- 2.2, p < 0.001). The number of takebacks (1.7 +/- 2.6 vs. 1.5 +/- 1.2), time to first takeback (32.0 hours), duration of bowel discontinuity (47.0 hours), and time to PFC were similar (63.2 hours, achieved in 73.5%). Nontrauma and T patients had similar ventilator, ICU, and hospital days and mortality (31.0% NT, 29.8% T). Nontrauma patients had higher rates of renal failure requiring dialysis (36.6% vs. 14.1%, p < 0.001) and postoperative abdominal sepsis (40.1% vs. 17.1%, p < 0.001). Trauma and NT patients had similar number of hours of sedative (89.9 vs. 65.5 hours, p = 0.064) and opioid infusions (106.9 vs. 96.7 hours, p = 0.514), but T had lower DF/CF-ICU-30 (51.1% vs. 73.7%, p = 0.029), indicating more delirium. Linear regression analysis indicated that T was associated with a 32.1% decrease (95% CI, 14.6%-49.5%; p < 0.001) in DF/CF-ICU-30, while achieving PFC was associated with a 25.1% increase (95% CI, 10.2%-40.1%; p = 0.001) in DF/CFICU-30. Increasing Abbreviated Injury Scale for the head was associated with decreased DF/CF-ICU-30 by analysis of variance (p < 0.001). CONCLUSION Nontrauma patients had higher incidence of postoperative abdominal sepsis and need for dialysis, while T was independently associated with increased delirium, perhaps because of traumatic brain injury.	[McArthur, Kaitlin] Loma Linda Univ, Sch Med, Div Acute Care Surg, Loma Linda, CA USA; [Krause, Cassandra; Kwon, Eugenia; Luo-Owen, Xian; Cochran-Yu, Meghan; Burruss, Sigrid; Turay, David; Mukherjee, Kaushik] Loma Linda Univ, Med Ctr, Div Acute Care Surg, Loma Linda, CA USA; [Swentek, Lourdes; Krasnoff, Chloe; Grigorian, Areg; Nahmias, Jeffry] UC Irvine, Med Ctr, Div Trauma Burns Crit Care & Acute Care Surg, Irvine, CA USA; [Grigorian, Areg; Butt, Ahsan] LAC USC Med Ctr, Div Trauma & Crit Care, Los Angeles, CA USA; [LaRiccia, Aimee; Kincaid, Michelle] Ohio Hlth Grant Med Ctr, Grant Med Ctr Trauma Serv, Columbus, OH USA; [Fiorentino, Michele N.; Glass, Nina] Rutgers New JerseyMed Sch, Div Trauma Surg Crit Care, Newark, NJ USA; [Toscano, Samantha; Ley, Eric] Cedars Sinai Med Ctr, Div Trauma, Los Angeles, CA 90048 USA; [Lombardo, Sarah R.; Guillamondegui, Oscar D.] Vanderbilt Univ, Med Ctr, Div Trauma & Surg Crit Care, Nashville, TN USA; [Bardes, James M.; DeLa'O, Connie] West Virginia Univ, Div Trauma Acute Care Surg Crit Care, Morgantown, WV 26506 USA; [Wydo, Salina M.; Leneweaver, Kyle] Cooper Univ Hlth Syst, Div Trauma, Camden, NJ USA; [Duletzke, Nicholas T.; Nunez, Jade] Univ Utah, Med Ctr, Sect Acute Care Surg, Salt Lake City, UT USA; [Moradian, Simon; Posluszny, Joseph] Northwestern Mem Hosp, Div Trauma & Crit Care Surg, Chicago, IL 60611 USA; [Naar, Leon; Kaafarani, Haytham] Massachusetts Gen Hosp, Div Trauma Emergency Surg & Surg Crit Care, Boston, MA 02114 USA; [Kemmer, Heidi; Lieser, Mark J.] Kansas City Hosp, Ctr Trauma, Res Med Ctr, Kansas City, MO USA; [Dorricott, Alexa; Chang, Grace] Mt Sinai Hosp Chicago, Chicago, IL USA; [Nemeth, Zoltan] Morristown Med Ctr, Trauma & Acute Care Ctr, Morristown, NJ USA		Mukherjee, K (corresponding author), Div Acute Care Surg, 11175 Campus St,CP 21111, Loma Linda, CA 92350 USA.	kmcarthur@students.llu.edu; ckrause@llu.edu; ekwon@llu.edu; xluoowen@llu.edu; mcochranyu@llu.edu; lourdes.swentek@gmail.com; sburruss@llu.edu; mrlturay2@yahoo.com; krasnofc@ohsu.edu; agrigori@uci.edu; jnahmias@hs.uci.edu; ahsanb@usc.edu; adam.gutierrez@med.usc.edu; aimee.lariccia@gmail.com; michelle.kincaid@ohiohealth.com; mf724@njms.rutgers.edu; ng470@njms.rutgers.edu; samantha.toscano@cshs.org; eric.ley@cshs.org; sarahlombardo.md@gmail.com; oscar.guillamondegui@vumc.org; james.bardes@hsc.wvu.edu; connie.delao@hsc.wvu.edu; wydo-salina@cooperhealth.edu; leneweaver@gmail.com; nicholas.duletzke@hsc.utah.edu; jade.nunez@hsc.utah.edu; simon.moradian@northwestern.edu; joseph.posluszny@nm.org; lnaar@mgh.harvard.edu; hkaafarani@mgh.harvard.edu; heidirkemmer@gmail.com; mark.lieser@envisionhealth.com; alexadorricott08@gmail.com; gchang55@gmail.com; zoltan.nemeth@atlantichealth.org; kmukherjee@llu.edu		Glass, Nina/0000-0002-6821-4289	 [5U54GM104942-04]	The authors declare no conflicts of interest. Research reported in this publication was supported by theNational Institute of GeneralMedical Sciences of theNational Institutes ofHealth under award number 5U54GM104942-04 (J.M.B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arabi Y, 2002, CRIT CARE, V6, P245, DOI 10.1186/cc1497; Ball CG, 2010, J GASTROINTEST SURG, V14, P1632, DOI 10.1007/s11605-010-1286-8; Becher RD, 2016, WORLD J EMERG SURG, V11, DOI 10.1186/s13017-016-0067-4; Bilimoria KY, 2013, J AM COLL SURGEONS, V217, P833, DOI 10.1016/j.jamcollsurg.2013.07.385; Bradley MJ, 2013, JAMA SURG, V148, P947, DOI 10.1001/jamasurg.2013.2514; Brillantino A, 2019, SURG INNOV, V26, P656, DOI 10.1177/1553350619857561; Burch JM, 1997, SURG CLIN N AM, V77, P779, DOI 10.1016/S0039-6109(05)70583-1; Capuzzo M, 2000, INTENS CARE MED, V26, P1779, DOI 10.1007/s001340000715; CUE JI, 1990, J TRAUMA, V30, P1007, DOI 10.1097/00005373-199008000-00010; Dessai SB, 2018, SOUTH ASIAN J CANCER, V7, P240, DOI 10.4103/sajc.sajc_241_17; Devlin JW, 2018, CRIT CARE MED, V46, P1532, DOI 10.1097/CCM.0000000000003259; Dutton William D, 2012, J Intensive Care Med, V27, P161, DOI 10.1177/0885066610396162; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Freeman AJ, 2005, ANZ J SURG, V75, P308, DOI 10.1111/j.1445-2197.2005.03373.x; Girard E, 2018, WORLD J SURG, V42, P965, DOI 10.1007/s00268-017-4262-6; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Girard TD, 2018, LANCET RESP MED, V6, P213, DOI 10.1016/S2213-2600(18)30062-6; Godat L, 2013, WORLD J EMERG SURG, V8, DOI 10.1186/1749-7922-8-53; Goussous N, 2014, INJURY, V45, P151, DOI 10.1016/j.injury.2013.01.039; Hansted AK, 2020, ACTA ANAESTH SCAND, V64, P180, DOI 10.1111/aas.13476; Hatch QM, 2011, J TRAUMA, V71, P1503, DOI 10.1097/TA.0b013e31823cd78d; Kenes MT, 2017, PHARMACOTHERAPY, V37, P1357, DOI 10.1002/phar.2021; Khan A, 2013, J TRAUMA ACUTE CARE, V75, P365, DOI 10.1097/TA.0b013e31829cb65e; Kim T, 2020, EUR J TRAUMA EMERG S, DOI 10.1007/s00068-020-01524-9; Kobayashi L, 2014, EUR J TRAUMA EMERG S, V40, P135, DOI 10.1007/s00068-014-0396-5; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Liu YM, 2016, J AM COLL SURGEONS, V223, P231, DOI 10.1016/j.jamcollsurg.2016.03.040; Marra A, 2017, SURG CLIN N AM, V97, P1215, DOI 10.1016/j.suc.2017.07.008; Miller RS, 2005, J TRAUMA, V59, P1365, DOI 10.1097/01.ta.0000196004.49422.af; Moore EE, 1996, AM J SURG, V172, P405, DOI 10.1016/S0002-9610(96)00216-4; Morgan K, 2010, J GASTROINTEST SURG, V14, P768, DOI 10.1007/s11605-010-1186-y; Perathoner A, 2010, INT J COLORECTAL DIS, V25, P767, DOI 10.1007/s00384-010-0887-8; Person Benjamin, 2009, World J Emerg Surg, V4, P41, DOI 10.1186/1749-7922-4-41; Pommerening MJ, 2014, SURGERY, V156, P431, DOI 10.1016/j.surg.2014.04.019; Regner JL, 2012, WORLD J SURG, V36, P497, DOI 10.1007/s00268-011-1203-7; Rengel KF, 2019, ANESTH ANALG, V128, P772, DOI 10.1213/ANE.0000000000004066; ROTONDO MF, 1993, J TRAUMA, V35, P375, DOI 10.1097/00005373-199309000-00008; Schmolders J, 2015, INT ORTHOP, V39, P1771, DOI 10.1007/s00264-015-2810-y; Smith SE, 2018, AM J SURG, V216, P414, DOI 10.1016/j.amjsurg.2018.04.003; St-Louis E, 2015, J TRAUMA ACUTE CARE, V78, P318, DOI 10.1097/TA.0000000000000457; Stawicki SP, 2008, INJURY, V39, P93, DOI 10.1016/j.injury.2007.06.011; STONE HH, 1983, ANN SURG, V197, P532, DOI 10.1097/00000658-198305000-00005; Tartaglia D, 2019, WORLD J EMERG SURG, V14, DOI 10.1186/s13017-019-0238-1; Vasilevskis EE, 2018, MED CARE, V56, P890, DOI 10.1097/MLR.0000000000000975; Webb Leland H, 2012, J Emerg Trauma Shock, V5, P126, DOI 10.4103/0974-2700.96480	45	2	2	2	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2021	91	1					100	107		10.1097/TA.0000000000003210			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	TC9ZM	WOS:000668996000030	34144559				2022-02-06	
J	Meyers, MC				Meyers, Michael C.			Surface-Related High School Football Game Injuries on Pad and No-Pad Fields	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						artificial surface; knee; turf; trauma	CRUCIATE LIGAMENT RECONSTRUCTION; NATURAL GRASS; MECHANISMS; SEVERITY; SPORTS; BIOMECHANICS; FATIGUE	Background: Artificial turf fields are increasingly being installed with lighter weight infill systems that incorporate a pad underlayer, which is reported to reduce surface shock and decrease injuries. At this time, the effects of a pad underlayer on football trauma are unknown. Hypothesis: Athletes would not experience differences in surface-related injuries between pad and no-pad fields. Study Design: Cohort study; Level of evidence, 2. Methods: Artificial turf fields were divided into 2 groups based on a pad underlayer or no-pad system, with 58 high schools participating across 3 states over the course of 7 seasons. Outcomes of interest included injury severity, head and knee trauma, injury category, primary type of injury, injury mechanism, anatomic location of trauma, tissue type injured, and elective imaging and surgical procedures. Data underwent multivariate analyses of variance (MANOVA) using general linear model procedures and were expressed as injury incidence rates per 10-game season. Results: Of 658 varsity games, 260 games were played on fields containing pads, and 398 games were played on no-pad fields, with 795 surface-related injuries reported. MANOVA indicated significant main effects by injury severity (F-3,F-791 = 11.436; P < .0001), knee trauma (F-9,F-785 = 2.435; P = .045), injury category (F-3,F-791 = 3.073; P < .0001), primary type of injury (F-10,F-785 = 2.660; P < .0001), injury mechanism (F-13,F-781 = 2.053; P < .001), anatomic location (F-16,F-778 = 1.592; P < .001), type of tissue injured (F-4,F-790 = 4.485; P < .0001), and elective imaging and surgical procedures (F-4,F-790 = 4.248; P < .002). Post hoc analyses indicated significantly greater incidences (P < .05) of substantial and severe injury, player-to-turf trauma, patellofemoral syndrome, neck strain, lower leg strain, and elective imaging and surgical procedures when games were played on padded turf fields. No differences in concussion rate from turf impact between pad and no-pad fields were observed. Conclusion: In contrast to conventional wisdom, the addition of a pad under an artificial turf surface increases injury rates when compared with nonpadded fields across most injury categories. At this time, findings do not support the current trend of installing lightweight padded infill systems at the high school level of play.	[Meyers, Michael C.] Idaho State Univ, Dept Human Performance & Sport Studies, Human Performance Lab, 921 South 8th Ave,Stop 8105, Pocatello, ID 83209 USA		Meyers, MC (corresponding author), Idaho State Univ, Dept Human Performance & Sport Studies, Human Performance Lab, 921 South 8th Ave,Stop 8105, Pocatello, ID 83209 USA.	meyersgroupinc@gmail.com					Ardern CL, 2015, AM J SPORT MED, V43, P848, DOI 10.1177/0363546514563282; Bahr R, 2005, BRIT J SPORT MED, V39, P324, DOI 10.1136/bjsm.2005.018341; Cimino F, 2010, AM FAM PHYSICIAN, V82, P917; DELEE JC, 1992, AM J SPORT MED, V20, P575, DOI 10.1177/036354659202000515; Dierks TA, 2007, CLIN BIOMECH, V22, P581, DOI 10.1016/j.clinbiomech.2007.01.012; ENG JJ, 1994, PHYS THER, V74, P836, DOI 10.1093/ptj/74.9.836; Ford KR, 2006, J SCI MED SPORT, V9, P433, DOI 10.1016/j.jsams.2006.03.019; Hart NH, 2016, MED SCI SPORT EXER, V48, P1379, DOI 10.1249/MSS.0000000000000897; Hewett TE, 2017, AM J SPORT MED, V45, P2654, DOI 10.1177/0363546516686080; Iacovelli JN, 2013, BRIT J SPORT MED, V47, P789, DOI 10.1136/bjsports-2012-092113; Joseph AM, 2013, J ATHL TRAINING, V48, P810, DOI 10.4085/1062-6050-48.6.03; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Knowles SB, 2009, EPIDEMIOLOGY, V20, P302, DOI 10.1097/EDE.0b013e318193107c; Krosshaug T, 2005, BRIT J SPORT MED, V39, P330, DOI 10.1136/bjsm.2005.018358; Lawrence DW, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115583653; Mair SD, 1996, AM J SPORT MED, V24, P137, DOI 10.1177/036354659602400203; Mansson O, 2011, KNEE SURG SPORT TR A, V19, P479, DOI 10.1007/s00167-010-1303-1; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McLean SG, 2010, EXERC SPORT SCI REV, V38, P192, DOI 10.1097/JES.0b013e3181f450b4; Meyers MC, 2004, AM J SPORT MED, V32, P1626, DOI 10.1177/0363546504266978; Meyers MC, 2001, INT J SPORT PSYCHOL, V32, P29; Meyers MC, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119832878; Meyers MC, 2017, AM J SPORT MED, V45, P708, DOI 10.1177/0363546516671715; Meyers MC, 2010, AM J SPORT MED, V38, P687, DOI 10.1177/0363546509352464; Milne C, 2011, BRIT J SPORT MED, V45, P945, DOI 10.1136/bjsm.2010.076943; National Federation of State High School Associations, 2018 19 NFHS ANN REP; Noyes F R, 1988, Am J Sports Med, V16 Suppl 1, pS65; Orchard J, 2002, SPORTS MED, V32, P419, DOI 10.2165/00007256-200232070-00002; Parkkari J, 2001, SPORTS MED, V31, P985, DOI 10.2165/00007256-200131140-00003; PRAGER BI, 1989, AM J SPORT MED, V17, P681, DOI 10.1177/036354658901700516; Prieske O, 2017, INT J SPORTS MED, V38, P781, DOI 10.1055/s-0043-111894; Rudicel S, 1988, Am J Sports Med, V16 Suppl 1, pS48; Shelbourne KD, 2017, AM J SPORT MED, V45, P2730, DOI 10.1177/0363546517718827; Souza TR, 2009, J AM PODIAT MED ASSN, V99, P503, DOI 10.7547/0990503; Tabachnick B. G., 1989, USING MULTIVARIATE S; Witvrouw E, 2014, BRIT J SPORT MED, V48, P411, DOI 10.1136/bjsports-2014-093450	36	2	2	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	JUL	2021	49	9					2489	2497		10.1177/0363546521990780			9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	TJ6JM	WOS:000673585500032	34247544	Green Published			2022-02-06	
J	Nelson, LD; Kramer, MD; Joyner, KJ; Patrick, CJ; Stein, MB; Temkin, N; Levin, HS; Whyte, J; Markowitz, AJ; Giacino, J; Manley, GT				Nelson, Lindsay D.; Kramer, Mark D.; Joyner, Keanan J.; Patrick, Christopher J.; Stein, Murray B.; Temkin, Nancy; Levin, Harvey S.; Whyte, John; Markowitz, Amy J.; Giacino, Joseph; Manley, Geoffrey T.		TRACK-TBI Investigators	Relationship Between Transdiagnostic Dimensions of Psychopathology and Traumatic Brain Injury (TBI): A TRACK-TBI Study	JOURNAL OF ABNORMAL PSYCHOLOGY			English	Article						traumatic brain injury; orthopedic injury; psychopathology; neurobehavioral symptoms; clinical phenotypes	BRIEF SYMPTOM INVENTORY-18; MEASUREMENT INVARIANCE; MENTAL-DISORDERS; BIFACTOR MODEL; FIT INDEXES; DSM-IV; SEQUELAE; COMMON; MILD; SEVERITY	Neuropsychiatric symptoms are common, comorbid, and often disabling for patients with traumatic brain injury (TBI). Identifying transdiagnostic symptom dimensions post-TBI may help overcome limitations of traditional psychiatric diagnoses and advance treatment development. We characterized the dimensional structure of neuropsychiatric symptoms at 2-weeks postinjury in n = 1,732 TBI patients and n = 238 orthopedic-injured trauma controls (OTC) from the Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) study. Symptoms were reported on the Brief Symptom Inventory-18, Patient Health Questionnaire-9 Depression checklist, PTSD Checklist for DSM-5, PROMIS Pain Intensity scale, and Insomnia Severity Index. We established a novel factor model of neuropsychiatric symptoms and evaluated how 3 TBI severity strata and OTC patients differed in symptom severity. The final factor model had 6 first-order factors subsumed by 2 second-order factors: Internalizing (encompassing Depression, Anxiety, and Fear) and Somatic symptoms (Sleep, Physical, Pain). Somatic symptoms fit better as a correlated factor of (vs. a lower-order factor within) Internalizing. All symptom dimensions except for Pain were more severe in 1 or more TBI subgroups, as compared to the OTC group. Milder brain injury was generally associated with more severe symptoms, whereas more general injury severity (higher level of care, e.g., emergency department, intensive care unit) was associated with more pain. The findings indicate a broad factor resembling the internalizing factor of general psychopathology in traumatically injured patients, alongside a distinct somatic symptom factor. Brain injury, especially milder brain injury, may exacerbate liabilities toward these symptoms. These neuropsychiatric dimensions may help advance more precision medicine research for TBI.	[Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA; [Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Joyner, Keanan J.; Patrick, Christopher J.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; [Stein, Murray B.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Stein, Murray B.] Univ Calif San Diego, Herbert Wertheim Sch Publ Hlth, San Diego, CA 92103 USA; [Stein, Murray B.] VA San Diego Healthcare Syst, San Diego, CA USA; [Temkin, Nancy] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Whyte, John] Einstein Healthcare Network, TBI Rehabil Res Lab, Moss Rehabil Res Inst, Elkins Pk, PA USA; [Markowitz, Amy J.] Univ Calif San Francisco, Brain & Spinal Injury Ctr, 1001 Potrero Ave Bldg 1,Room 101,Box 0899, San Francisco, CA 94143 USA; [Giacino, Joseph] Harvard Med Sch, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Boston, MA 02115 USA; [Giacino, Joseph] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA		Nelson, LD (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.; Markowitz, AJ (corresponding author), Univ Calif San Francisco, Brain & Spinal Injury Ctr, 1001 Potrero Ave Bldg 1,Room 101,Box 0899, San Francisco, CA 94143 USA.	linelson@mcw.edu; amymarkowitz@gmail.com	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Stein, Murray/0000-0001-9564-2871; Temkin, Nancy/0000-0002-6392-5292; Levin, Harvey/0000-0002-3729-3404; Nelson, Lindsay/0000-0001-5258-953X; Whyte, John/0000-0002-4381-1474	U.S. National Institute for Neurological Disorders and Stroke (NINDS) [U01 NS1365885]; One Mind; Neurotrauma Sciences LLC; NINDS Grant [R01 NS110856]; U.S. Department of Defense TBI Endpoints Development (TED) Initiative [W81XWH-14-20176]	The study was funded by the U.S. National Institute for Neurological Disorders and Stroke (NINDS) Grant U01 NS1365885, One Mind, and Neurotrauma Sciences LLC. This secondary data analysis project was supported by NINDS Grant R01 NS110856 and the U.S. Department of Defense TBI Endpoints Development (TED) Initiative (Grant W81XWH-14-20176). The article's contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health and are not necessarily endorsed by the U.S. Department of Defense or other study sponsors.	Armour C, 2016, CLIN PSYCHOL REV, V44, P60, DOI 10.1016/j.cpr.2015.12.003; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bivona U, 2019, BRAIN INJURY, V33, P1245, DOI 10.1080/02699052.2019.1641225; Bonifay W, 2017, CLIN PSYCHOL SCI, V5, P184, DOI 10.1177/2167702616657069; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Chen FF, 2007, STRUCT EQU MODELING, V14, P464, DOI 10.1080/10705510701301834; Chen FF, 2005, STRUCT EQU MODELING, V12, P471, DOI 10.1207/s15328007sem1203_7; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Davis M, 1998, BIOL PSYCHIAT, V44, P1239, DOI 10.1016/S0006-3223(98)00288-1; Derogatis LB, 2001, 18 BSI NCS PEARS INC, V1, P47; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Gignac GE, 2016, INTELLIGENCE, V55, P57, DOI 10.1016/j.intell.2016.01.006; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Greene AL, 2019, J ABNORM PSYCHOL, V128, P740, DOI 10.1037/abn0000434; Grillon C, 2006, BIOL PSYCHIAT, V60, P760, DOI 10.1016/j.biopsych.2005.11.027; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Higa-McMillan CK, 2008, J ABNORM CHILD PSYCH, V36, P1279, DOI 10.1007/s10802-008-9250-8; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hyland P, 2021, PSYCHOL MED, V51, P2422, DOI 10.1017/S003329172000104X; Hyman SE, 2010, ANNU REV CLIN PSYCHO, V6, P155, DOI 10.1146/annurev.clinpsy.3.022806.091532; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kotov R, 2017, J ABNORM PSYCHOL, V126, P454, DOI 10.1037/abn0000258; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Krueger RF, 1999, ARCH GEN PSYCHIAT, V56, P921, DOI 10.1001/archpsyc.56.10.921; Lee HCB, 2003, INT REV PSYCHIATR, V15, P359, DOI 10.1080/09540260310001606746; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; MEREDITH W, 1993, PSYCHOMETRIKA, V58, P525, DOI 10.1007/BF02294825; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Murray AL, 2013, INTELLIGENCE, V41, P407, DOI 10.1016/j.intell.2013.06.004; Nelson BD, 2015, PSYCHOL MED, V45, P2545, DOI 10.1017/S0033291715000471; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Nelson LD, 2017, J NEUROTRAUM, V34, P3158, DOI 10.1089/neu.2017.5139; Parrott JM, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.200; Petkus AJ, 2010, INT J GERIATR PSYCH, V25, P578, DOI 10.1002/gps.2377; R Core Team, 2020, R LANG ENV STAT COMP; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Recklitis CJ, 2006, PSYCHOL ASSESSMENT, V18, P22, DOI 10.1037/1040-3590.18.1.22; Rodriguez A, 2016, PSYCHOL METHODS, V21, P137, DOI 10.1037/met0000045; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Singh R, 2016, J NEUROL NEUROSUR PS, V87, P670, DOI 10.1136/jnnp-2015-311369; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tellegen A., 1985, ANXIETY ANXIETY DISO, P681; Thurmond VA, 2010, ARCH PHYS MED REHAB, V91, P1633, DOI 10.1016/j.apmr.2010.06.034; Vaidyanathan U, 2012, PSYCHOL MED, V42, P447, DOI 10.1017/S0033291711001528; Walker AK, 2013, NEUROPSYCHOPHARMACOL, V38, P1609, DOI 10.1038/npp.2013.71; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Watts AL, 2019, CLIN PSYCHOL SCI, V7, P1285, DOI 10.1177/2167702619855035; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wright AGC, 2013, J ABNORM PSYCHOL, V122, P281, DOI 10.1037/a0030133; Yoon M, 2018, STRUCT EQU MODELING, V25, P201, DOI 10.1080/10705511.2017.1387859; Zahniser E, 2019, ARCH CLIN NEUROPSYCH, V34, P1165, DOI 10.1093/arclin/acy103	62	2	2	1	1	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0021-843X	1939-1846		J ABNORM PSYCHOL	J. Abnorm. Psychol.	JUL	2021	130	5					423	434		10.1037/abn0000672			12	Psychology, Clinical; Psychiatry; Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology; Psychiatry	UL5IW	WOS:000692685500001	34110838				2022-02-06	
J	Nizamutdinov, D; Qi, XM; Berman, MH; Dougal, G; Dayawansa, S; Wu, EX; Yi, SS; Stevens, AB; Huang, JH				Nizamutdinov, Damir; Qi, Xiaoming; Berman, Marvin H.; Dougal, Gordon; Dayawansa, Samantha; Wu, Erxi; Yi, S. Stephen; Stevens, Alan B.; Huang, Jason H.			Transcranial Near Infrared Light Stimulations Improve Cognition in Patients with Dementia	AGING AND DISEASE			English	Article						transcranial near infrared light; photobiomodulation; dementia; tnir light treatment	TRAUMATIC BRAIN-INJURY; DOPAMINERGIC CELL-SURVIVAL; LASER THERAPY; MOUSE MODEL; PHOTOBIOMODULATION; APOPTOSIS; DISEASE; NEUROPROTECTION; MECHANISMS; RADIATION	Dementia is a complex syndrome with various presentations depending on the underlying pathologies. Low emission of transcranial near-infrared (tNIR) light can reach human brain parenchyma and be beneficial to a number of neurological and neurodegenerative disorders. We hereby examined the safety and potential therapeutic benefits of tNIR light stimulations in the treatment of dementia. Patients of mild to moderate dementia were randomized into active and sham treatment groups at 2:1 ratio. Active treatment consisted of low power tNIR light stimulations with an active photobiomodulation for 6 min twice daily during 8 consequent weeks. Sham treatment consisted of same treatment routine with a sham device. Neuropsychological battery was obtained before and after treatment. Analysis of variance (ANOVA) was used to analyze outcomes. Sixty subjects were enrolled. Fifty-seven subjects completed the study and had not reported health or adverse side effects during or after the treatment. Three subjects dropped out from trial for health issues unrelated to use of tNIR light treatment. Treatment with active device resulted in improvements of cognitive functions and changes were: an average increase of MMSE by 4.8 points; Logical Memory Tests I and II by similar to 3.0 points; Trail Making Tests A and B by similar to 24%; Boston Naming Test by similar to 9%; improvement of both Auditory Verbal Learning Tests in all subtest categories and overall time of performance. Many patients reported improved sleep after similar to 7 days of treatment. Caregivers noted that patients had less anxiety, improved mood, energy, and positive daily routine after similar to 14-21 days of treatment. The tNIR light treatments demonstrated safety and positive cognitive improvements in patients with dementia. Developed treatment protocol can be conveniently used at home. This study suggests that additional dementia treatment trials are warranted with a focus on mitigating caregivers' burden with tNIR light treatment of dementia patients.	[Nizamutdinov, Damir; Qi, Xiaoming; Dayawansa, Samantha; Wu, Erxi; Stevens, Alan B.; Huang, Jason H.] Baylor Scott & White Hlth, Neurosurg, Neurosci Inst, Temple, TX 76508 USA; [Nizamutdinov, Damir; Dayawansa, Samantha; Wu, Erxi; Huang, Jason H.] Texas A&M Univ, Coll Med, HSC, Neurosurg, Temple, TX 76508 USA; [Berman, Marvin H.] Quietmind Fdn, Elkins Pk, PA USA; [Dougal, Gordon] Maculume Ltd, Spennymoor, England; [Wu, Erxi] Texas A&M Univ, Coll Pharm, Dept Pharmaceut Sci, HSC, College Stn, TX USA; [Wu, Erxi; Yi, S. Stephen] Univ Texas Austin, Dept Oncol, Dell Med Sch, Austin, TX 78712 USA		Huang, JH (corresponding author), Baylor Scott & White Hlth, Dept Neurosurg, Temple, TX 76508 USA.	Jason.Huang@bswhealth.org			Clarke Brain Institute Charities Inc.	This study was supported by a research grant from Clarke Brain Institute Charities Inc. We are grateful to our team of Neurologists and Neuropsychologists under leaderships of Dr. Jeffrey W. Clark and Dr. Jared Benge for referring patients for this clinical research trial.	Ahmed I, 2011, BRAIN, V134, P979, DOI 10.1093/brain/awr028; Allen AP, 2020, AGE AGEING, V49, P52, DOI 10.1093/ageing/afz128; Assis L, 2013, LASER MED SCI, V28, P947, DOI 10.1007/s10103-012-1183-3; Berman Marvin H, 2017, J Neurol Neurosci, V8, DOI 10.21767/2171-6625.1000176; Bragin DE, 2015, J NEUROSURG, V122, P1239, DOI 10.3171/2014.8.JNS132083; Cassano P, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031404; Cipriani G, 2015, PSYCHOGERIATRICS, V15, P65, DOI 10.1111/psyg.12069; De Taboada L, 2011, J ALZHEIMERS DIS, V23, P521, DOI 10.3233/JAD-2010-100894; El Massri N, 2016, EXP BRAIN RES, V234, P3225, DOI 10.1007/s00221-016-4720-7; Grillo SL, 2013, J PHOTOCH PHOTOBIO B, V123, P13, DOI 10.1016/j.jphotobiol.2013.02.015; Hamblin MR, 2017, AIMS BIOPHYS, V4, P337, DOI 10.3934/biophy.2017.3.337; Hennessy M, 2017, J OPTICS-UK, V19, DOI 10.1088/2040-8986/19/1/013003; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Johnstone DM, 2014, NEUROSCIENCE, V274, P93, DOI 10.1016/j.neuroscience.2014.05.023; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; Karu TI, 2005, LASER SURG MED, V36, P307, DOI 10.1002/lsm.20148; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Lee HI, 2017, J BIOPHOTONICS, V10, P1502, DOI 10.1002/jbio.201600244; Liang JG, 2012, FREE RADICAL BIO MED, V53, P1459, DOI 10.1016/j.freeradbiomed.2012.08.003; Ling QZ, 2014, J CELL PHYSIOL, V229, P108, DOI 10.1002/jcp.24425; Marte A, 2017, MOL NEUROBIOL, V54, P484, DOI 10.1007/s12035-015-9659-3; Maurya PK, 2016, PROG NEURO-PSYCHOPH, V65, DOI 10.1016/j.pnpbp.2015.08.016; Meng CB, 2013, J NEUROSCI, V33, P13505, DOI 10.1523/JNEUROSCI.0918-13.2013; Moro C, 2016, BRAIN RES, V1648, P19, DOI 10.1016/j.brainres.2016.07.005; Moro C, 2014, J NEUROSURG, V120, P670, DOI 10.3171/2013.9.JNS13423; Moro C, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-40; Morries LD, 2015, NEUROPSYCH DIS TREAT, V11, P2159, DOI 10.2147/NDT.S65809; Naeser M, 2012, PROCD SOC BEHV, V61, P138, DOI 10.1016/j.sbspro.2012.10.116; Naeser MA, 2015, PHOTOMED LASER SURG, V33, P443, DOI 10.1089/pho.2015.3986; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Nawashiro H, 2012, PHOTOMED LASER SURG, V30, P231, DOI 10.1089/pho.2011.3044; Nowrangi MA, 2011, PSYCHIAT CLIN N AM, V34, P275, DOI 10.1016/j.psc.2011.02.004; Pitzschke A, 2015, PHYS MED BIOL, V60, P2921, DOI 10.1088/0031-9155/60/7/2921; Purushothuman S, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt232; Purushothuman S, 2013, BRAIN RES, V1535, P61, DOI 10.1016/j.brainres.2013.08.047; Saltmarche AE, 2017, PHOTOMED LASER SURG, V35, P432, DOI 10.1089/pho.2016.4227; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Schiffer F, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-46; Storz P, 2007, TRENDS CELL BIOL, V17, P13, DOI 10.1016/j.tcb.2006.11.003; Tedford CE, 2015, LASER SURG MED, V47, P312, DOI 10.1002/lsm.22343; Tramutola A, 2017, BRAIN RES BULL, V133, P88, DOI 10.1016/j.brainresbull.2016.06.005; WAN S, 1981, PHOTOCHEM PHOTOBIOL, V34, P679, DOI 10.1111/j.1751-1097.1981.tb09424.x; Wijesinghe P, 2016, J ALZHEIMERS DIS, V54, P1607, DOI 10.3233/JAD-160425; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Xuan WJ, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.10.108003; Zhang L, 2008, CELL PHYSIOL BIOCHEM, V22, P215, DOI 10.1159/000149799; Zhang LL, 2010, J CELL PHYSIOL, V224, P218, DOI 10.1002/jcp.22123; Zhang YO, 2003, J INVEST DERMATOL, V120, P849, DOI 10.1046/j.1523-1747.2003.12133.x	48	2	2	4	5	INT SOC AGING & DISEASE	FORT WORTH	EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA	2152-5250			AGING DIS	Aging Dis.	JUL	2021	12	4					954	963		10.14336/AD.2021.0229			10	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	TD9PE	WOS:000669649700002	34221541	Green Published, gold			2022-02-06	
J	O'Brien, WT; Pham, L; Brady, RD; Bain, J; Yamakawa, GR; Sun, MJ; Mychasiuk, R; O'Brien, TJ; Monif, M; Shultz, SR; McDonald, SJ				O'Brien, William T.; Pham, Louise; Brady, Rhys D.; Bain, Jesse; Yamakawa, Glenn R.; Sun, Mujun; Mychasiuk, Richelle; O'Brien, Terence J.; Monif, Mastura; Shultz, Sandy R.; McDonald, Stuart J.			Temporal profile and utility of serum neurofilament light in a rat model of mild traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Concussion; mTBI; Blood biomarker; NfL; Axonal injury; SIMOA; ACHI; Sensorimotor; Behaviour	BIOMARKERS	There is a widely recognized need for blood biomarkers to assist clinical decisions surrounding mild traumatic brain injury (mTBI). Serum neurofilament light (NfL), an indicator of neuroaxonal damage, is one such candidate, with early mTBI clinical investigations demonstrating significant promise. To facilitate the translation of pre-clinical mTBI findings, clinically relevant outcomes should be integrated into animal studies wherever possible. Despite this, the temporal profile and potential utility of NfL as a blood biomarker in pre-clinical mTBI is poorly understood. Here, we quantified serum NfL at 2-h, 1-, 3-, 7- and 14-days following mTBI in rats and compared these to pre-injury levels. We also investigated cumulative effects of repeat-mTBI by delivering 0, 1 or 5 mTBIs separated by 24 h. Sensorimotor performance was evaluated with the beam task at 1- and 4-h after mTBI, and serum was collected 1-day after the final procedure. We found that serum NfL levels were substantially elevated at all acute and sub-acute time-points after a single-mTBI, peaked at 1-day, and remained elevated 14-days post-injury. An mTBI dose-dependent effect on serum NfL levels was also observed, with substantially higher NfL levels found at 1-day post repeat-mTBI when compared to single-mTBI and sham-injured rats. Furthermore, NfL levels were found to be greatest in rats with the highest degree of sensorimotor impairment. In conclusion, these findings have described the temporal profile of serum NfL elevations following a single-mTBI in rats, and indicate a profile with some similarities and differences to that seen in the clinical condition. Moreover, we found that serum NfL levels were potentiated by repeat-mTBI, and that this biomarker may have utility as an indicator of injury severity. As such, future pre-clinical TBI studies may benefit from incorporating measures of serum NfL as an objective injury outcome.	[O'Brien, William T.; Brady, Rhys D.; Bain, Jesse; Yamakawa, Glenn R.; Sun, Mujun; Mychasiuk, Richelle; O'Brien, Terence J.; Monif, Mastura; Shultz, Sandy R.; McDonald, Stuart J.] Monash Univ, Dept Neurosci, Alfred Ctr, Level 6,99 Commercial Rd, Melbourne, Vic 3004, Australia; [Pham, Louise; McDonald, Stuart J.] La Trobe Univ, Dept Physiol Anat & Microbiol, Sci Dr, Bundoora, Vic 3086, Australia; [Brady, Rhys D.; Shultz, Sandy R.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, 4th Floor,Clin Sci Bldg, Parkville, Vic 3050, Australia; [O'Brien, Terence J.; Monif, Mastura] Melbourne Hlth, Dept Neurol, 300 Grattan St, Parkville, Vic 3050, Australia; [O'Brien, Terence J.; Monif, Mastura] Alfred Hlth, Dept Neurol, 55 Commercial Rd, Melbourne, Vic 3004, Australia; [Monif, Mastura] Univ Melbourne, Dept Physiol, Level 8,North Wing,Med Bldg, Parkville, Vic 3050, Australia		McDonald, SJ (corresponding author), Monash Univ, Dept Neurosci, Alfred Ctr, Level 6,99 Commercial Rd, Melbourne, Vic 3004, Australia.	william.obrien@monash.edu; l7pham@students.latrobe.edu.au; rhys.brady@monash.edu; jesse.Bain@monash.edu; glenn.yamakawa@monash.edu; mujun.Sun@monash.edu; richelle.Mychasiuk@monash.edu; terence.OBrien@monash.edu; mastura.monif@monash.edu; sandy.shultz@monash.edu; stuart.mcdonald@monash.edu	O'Brien, Terence/L-8102-2013; O'Brien, Terence/AAU-5525-2021; Monif, Mastura/L-4124-2019	McDonald, Stuart/0000-0001-5190-3179; Sun, Mujun/0000-0002-9923-9913; Yamakawa, Glenn/0000-0003-3079-6532; Monif, Mastura/0000-0001-6404-9768; O'Brien, Terence/0000-0002-7198-8621	Monash UniversityMonash University; Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	This study acknowledges research funding and support from Monash University and grants and fellowships awarded to S.R.S., T.O.B. and R. M. by the Australian National Health and Medical Research Council.	Guedes VA, 2020, NEUROLOGY, V94, pE2412, DOI 10.1212/WNL.0000000000009577; Karlsson M., 2020, J NEUROTRAUM; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDonald SJ, 2021, BIOMARK RES, V9, DOI 10.1186/s40364-020-00256-7; Pham L, 2021, NEUROBIOL DIS, V148, DOI 10.1016/j.nbd.2020.105151; Pham L, 2019, J NEUROTRAUM, V36, P2260, DOI 10.1089/neu.2018.6169; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127	10	2	2	1	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUL	2021	341								113698	10.1016/j.expneurol.2021.113698			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SU9BU	WOS:000663425900004	33727100				2022-02-06	
J	Patrick, SD; Rapport, LJ; Kanser, RJ; Hanks, RA; Bashem, JR				Patrick, Sarah D.; Rapport, Lisa J.; Kanser, Robert J.; Hanks, Robin A.; Bashem, Jesse R.			Detecting Simulated Versus Bona Fide Traumatic Brain Injury Using Pupillometry	NEUROPSYCHOLOGY			English	Article						malingering; performance validity; pupillometry; traumatic brain injury	WORD MEMORY TEST; RECOGNITION MEMORY; SYMPTOM VALIDITY; PUPIL SIZE; PERFORMANCE VALIDITY; RESPONSE-TIME; LIE DETECTION; EYE; VULNERABILITY; STRATEGIES	Objective: Pupil dilation patterns are outside of conscious control and provide information regarding neuropsychological processes related to deception, cognitive effort, and familiarity. This study examined the incremental utility of pupillometry on the Test of Memory Malingering (TOMM) in classifying individuals with verified traumatic brain injury (TBI), individuals simulating TBI, and healthy comparisons. Method: Participants were 177 adults across three groups: verified TBI (n = 53), feigned cognitive impairment due to TBI (SIM, n = 52), and heathy comparisons (HC, n = 72). Results: Logistic regression and ROC curve analyses identified several pupil indices that discriminated the groups. Pupillometry discriminated best for the comparison of greatest clinical interest, verified TBI versus simulators, adding information beyond traditional accuracy scores. Simulators showed evidence of greater cognitive load than both groups instructed to perform at their best ability (HC and TBI). Additionally, the typically robust phenomenon of dilating to familiar stimuli was relatively diminished among TBI simulators compared to TBI and HC. This finding may reflect competing, interfering effects of cognitive effort that are frequently observed in pupillary reactivity during deception. However, the familiarity effect appeared on nearly half the trials for SIM participants. Among those trials evidencing the familiarity response, selection of the unfamiliar stimulus (i.e., dilation-response inconsistency) was associated with a sizeable increase in likelihood of being a simulator. Conclusions: Taken together, these findings provide strong support for multimethod assessment: adding unique performance assessments such as biometrics to standard accuracy scores. Continued study of pupillometry will enhance the identification of simulators who are not detected by traditional performance validity test scoring metrics.	[Patrick, Sarah D.; Rapport, Lisa J.; Kanser, Robert J.; Bashem, Jesse R.] Wayne State Univ, Dept Psychol, 5057 Woodward Ave,7th Floor, Detroit, MI 48202 USA; [Hanks, Robin A.] Wayne State Univ, Dept Phys Med & Rehabil, Sch Med, Detroit, MI 48202 USA		Rapport, LJ (corresponding author), Wayne State Univ, Dept Psychol, 5057 Woodward Ave,7th Floor, Detroit, MI 48202 USA.	rapport@wayne.edu		Rapport, Lisa/0000-0001-8014-9523; Bashem, Jesse/0000-0002-0328-6388	National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90IFOO92]; Wayne State University Graduate School; NIGMS/NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25 GM 058905-21]; Blue Cross Blue Shield of Michigan Foundation [002859]; NIDILRRUnited States Department of Health & Human Services [90DPTB0006]	This research was supported by grants from the National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR 90IFOO92, Lisa J. Rapport), Wayne State University Graduate School (Robert J. Kanser), NIGMS/NIH grant R25 GM 058905-21 (Sarah D. Patrick), and Blue Cross Blue Shield of Michigan Foundation (Sarah D. Patrick, 002859.SAP), and collaboration with NIDILRR 90DPTB0006 (Robin A. Hanks).	Armstrong RA, 2018, CLIN EXP OPTOM, V101, P716, DOI 10.1111/cxo.12670; Bauer L, 2006, ARCH CLIN NEUROPSYCH, V21, P121, DOI 10.1016/j.acn.2005.06.010; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; Bodner T, 2019, J CLIN EXP NEUROPSYC, V41, P476, DOI 10.1080/13803395.2019.1579783; Boone K.B., 2013, CLIN PRACTICE FORENS; Brennan A, 2009, CLIN NEUROPSYCHOL, V23, P314, DOI 10.1080/13854040802054151; Ciuffreda Kenneth J, 2017, Concussion, V2, pCNC36, DOI 10.2217/cnc-2016-0029; Ciuffreda KJ, 2011, OPTOMETRY, V82, P337, DOI 10.1016/j.optm.2011.03.006; Cohen J., 2013, STAT POWER ANAL BEHA; Coleman RD, 1998, J CLIN EXP NEUROPSYC, V20, P201, DOI 10.1076/jcen.20.2.201.1164; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; Dionisio DP, 2001, PSYCHOPHYSIOLOGY, V38, P205, DOI 10.1017/S0048577201990717; Farah MJ, 2014, NAT REV NEUROSCI, V15, P123, DOI 10.1038/nrn3665; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; Fuermaier ABM, 2020, J CLIN EXP NEUROPSYC, V42, P285, DOI 10.1080/13803395.2019.1710468; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Gunstad J, 2001, CLIN NEUROPSYCHOL, V15, P397, DOI 10.1076/clin.15.3.397.10271; Heaver B, 2010, INT J PSYCHOPHYSIOL, V77, P306, DOI 10.1016/j.ijpsycho.2010.06.206; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hosmer DW, 2013, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118548387; Hu C, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00596; KAHNEMAN D, 1969, J EXP PSYCHOL, V79, P312, DOI 10.1037/h0026912; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; Kanser RJ, 2020, NEUROPSYCHOLOGY, V34, P308, DOI 10.1037/neu0000613; Kanser RJ, 2019, CLIN NEUROPSYCHOL, V33, P90, DOI 10.1080/13854046.2018.1440006; Kanser RJ, 2017, CLIN NEUROPSYCHOL, V31, P644, DOI 10.1080/13854046.2016.1278040; Langleben DD, 2013, PSYCHOL PUBLIC POL L, V19, P222, DOI 10.1037/a0028841; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P841, DOI 10.1080/13854040902796735; Loewenfeld IE, 1999, PUPIL ANATOMY PHYSL; Lupu T, 2018, APPL NEUROPSYCH-ADUL, V25, P532, DOI 10.1080/23279095.2017.1341410; Meyers J, 2011, CLIN NEUROPSYCHOL, V25, P477, DOI 10.1080/13854046.2011.554442; Murphy PR, 2014, HUM BRAIN MAPP, V35, P4140, DOI 10.1002/hbm.22466; Neudecker JJ, 2009, ARCH CLIN NEUROPSYCH, V24, P59, DOI 10.1093/arclin/acp008; Oliva M, 2019, COGN AFFECT BEHAV NE, V19, P366, DOI 10.3758/s13415-018-00677-w; Otero SC, 2011, PSYCHOPHYSIOLOGY, V48, P1346, DOI 10.1111/j.1469-8986.2011.01217.x; Patrick SD, 2021, CLIN NEUROPSYCHOL, V35, P1154, DOI 10.1080/13854046.2020.1716997; Porter G, 2007, Q J EXP PSYCHOL, V60, P211, DOI 10.1080/17470210600673818; Rapport LJ, 1998, J CLIN EXP NEUROPSYC, V20, P89, DOI 10.1076/jcen.20.1.89.1488; Rogers R, 2008, CLIN ASSESSMENT MALI; Rose FE, 1998, ARCH CLIN NEUROPSYCH, V13, P349, DOI 10.1016/S0887-6177(97)00025-5; Russeler J, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-37; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Sherman EMS, 2020, ARCH CLIN NEUROPSYCH, V35, P735, DOI 10.1093/arclin/acaa019; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Strauss E., 2006, COMPENDIUM COMMENTAR; Suhr J.A., 2007, ASSESSMENT MALINGERE, P287; Tabachnick B., 2018, USING MULTIVARIATE S, V7th; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; The Psychological Corporation, 2001, WECHSLER TEST ADULT; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Tomer E, 2020, APPL NEUROPSYCH-ADUL, V27, P49, DOI 10.1080/23279095.2018.1480483; Valko PO, 2016, SLEEP, V39, P1249, DOI 10.5665/sleep.5844; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X; Vo MLH, 2008, PSYCHOPHYSIOLOGY, V45, P130, DOI 10.1111/j.1469-8986.2007.00606.x; White DJ, 2020, J CLIN EXP NEUROPSYC, V42, P459, DOI 10.1080/13803395.2020.1758634; Worthington A, 2018, NEUROPSYCHOLOGIA, V118, P40, DOI 10.1016/j.neuropsychologia.2018.04.012; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7	61	2	2	0	0	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JUL	2021	35	5					472	485		10.1037/neu0000747			14	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	TP3HW	WOS:000677485500002	34014751				2022-02-06	
J	Ukwuoma, OI; Allareddy, V; Allareddy, V; Rampa, S; Rose, JA; Shein, SL; Rotta, AT				Ukwuoma, Onyinyechi I.; Allareddy, Veerajalandhar; Allareddy, Veerasathpurush; Rampa, Sankeerth; Rose, Jerri A.; Shein, Steven L.; Rotta, Alexandre T.			Trends in Head Computed Tomography Utilization in Children Presenting to Emergency Departments After Traumatic Head Injury	PEDIATRIC EMERGENCY CARE			English	Article						computed tomography; closed head injury; traumatic brain injury	UNITED-STATES; PREDICTION RULES; RADIATION-EXPOSURE; BRAIN-INJURIES; DECISION RULES; PECARN; VISITS; CT	Objectives Although closed head injuries occur commonly in children, most do not have a clinically important traumatic brain injury (ciTBI) and do not require neuroimaging. We sought to determine whether the utilization of computed tomography of the head (CT-H) in children presenting to an emergency department (ED) with a closed head injury changed after publication of validated clinical prediction rules to identify children at risk of ciTBI by the Pediatric Emergency Care Applied Research Network (PECARN). Methods We used the nationwide ED sample (2008-2013) to examine children visiting an ED after a mild closed head injury. Multiple patient and hospital characteristics were assessed. Results Of the 4,552,071 children presenting to an ED with a mild closed head injury, 1,181,659 (26.0%) underwent CT-H. Care was most commonly received at metropolitan teaching hospitals (43.5%) and varied markedly by geographic region. Overall, there were no significant changes in the nationwide rates of CT-H utilization in the period immediately after publication of the PECARN prediction rules. However, compared with metropolitan teaching hospitals, CT-H utilization increased significantly for patients treated at nonteaching hospitals and at nonmetropolitan hospitals. Conclusions There was no overall reduction in CT-H utilization after publication of the 2009 PECARN prediction rules. However, patients treated at metropolitan teaching hospitals were significantly less likely to undergo CT-H after 2009, suggesting some penetration of the PECARN tool in that setting. Further research should study patterns of CT-H utilization in nonteaching hospitals and nonmetropolitan hospitals to assess challenges for adoption of validated pediatric ciTBI prediction rules.	[Ukwuoma, Onyinyechi I.; Rose, Jerri A.; Shein, Steven L.; Rotta, Alexandre T.] Case Western Reserve Sch Med, UH Rainbow Babies & Childrens Hosp, Cleveland, OH USA; [Allareddy, Veerajalandhar] Duke Univ, Med Ctr, Duke Childrens Hosp, Durham, NC USA; [Allareddy, Veerasathpurush] Univ Illinois, Coll Dent, Dept Orthodont, Chicago, IL USA; [Rampa, Sankeerth] Rhode Isl Coll, Sch Business, Management & Mkt Dept, Providence, RI 02908 USA		Ukwuoma, OI (corresponding author), UH Rainbow Babies & Childrens Hosp, 11100 Euclid Ave,RBC 6010, Cleveland, OH 44106 USA.	Onyinyechi.Ukwuoma@UHhospitals.org; veerajalandhar-allareddy@uiowa.edu; veerasathpurush-allareddy@uiowa.edu; srampa@ric.edu; Jerri.Rose@UHhospitals.org; Steven.Shein@UHhospitals.org; alex.rotta@uhhospitals.org		Rotta, Alexandre/0000-0002-4406-2276			ABIM Foundation, CHOOS WISELY; Atabaki SM, 2016, ACAD EMERG MED, V23, P566, DOI 10.1111/acem.12923; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; CDC, ALARA LOW REAS ARCH; CDC, 2017, TRAUMATIC BRAIN INJU; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Dayan PS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2709; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; HCUP CCS. Healthcare Cost and Utilization Project (HCUP), 2017, AGENCY HEALTHCARE RE; Ide K, 2017, ACAD EMERG MED, V24, P308, DOI 10.1111/acem.13129; Ishida Y, 2013, JAMA PEDIATR, V167, P491, DOI 10.1001/jamapediatrics.2013.1448; Jennings RM, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-1349; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Kuppermann N, 2008, PEDIATR RADIOL, V38, pS670, DOI 10.1007/s00247-008-0996-5; Larson DB, 2011, RADIOLOGY, V259, P793, DOI 10.1148/radiol.11101939; Lodwick DL, 2015, PEDIATRICS, V136, pE1212, DOI 10.1542/peds.2015-1671; Mannix R, 2012, J PEDIATR-US, V160, P136, DOI 10.1016/j.jpeds.2011.06.024; Marin JR, 2014, ACAD EMERG MED, V21, P987, DOI 10.1111/acem.12458; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Menoch MJA, 2012, PEDIATRICS, V129, pE690, DOI 10.1542/peds.2011-2548; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Natale JE, 2012, ARCH PEDIAT ADOL MED, V166, P732, DOI 10.1001/archpediatrics.2012.307; Nigrovic LE, 2015, PEDIATRICS, V136, pE227, DOI 10.1542/peds.2014-3588; Nishijima DK, 2015, ANN EMERG MED, V65, P72, DOI 10.1016/j.annemergmed.2014.08.019; Osmond MH, 2017, LANCET, V390, P1487, DOI 10.1016/S0140-6736(17)32150-5; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pickering A, 2011, ARCH DIS CHILD, V96, P414, DOI 10.1136/adc.2010.202820; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008; Stiell IG, 1997, ANN EMERG MED, V30, P14, DOI 10.1016/S0196-0644(97)70104-5; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1	38	2	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	JUL	2021	37	7					E384	E390		10.1097/PEC.0000000000001618			7	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	TD3RU	WOS:000669248800016	30256318				2022-02-06	
J	Vijapur, SM; Vaughan, LE; Awan, N; DiSanto, D; McKernan, GP; Wagner, AK				Vijapur, Sushupta M.; Vaughan, Leah E.; Awan, Nabil; DiSanto, Dominic; McKernan, Gina P.; Wagner, Amy K.			Treelet transform analysis to identify clusters of systemic inflammatory variance in a population with moderate-to-severe traumatic brain injury	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Adaptive immunity; Biomarker; Chemokine; Cytokine; Glasgow outcome scale; Inflammation; Innate immunity; Soluble receptor; Traumatic brain injury; Treelet transform analysis	NECROSIS-FACTOR RECEPTORS; PROGNOSTIC BIOMARKER; OUTCOME PREDICTION; GENETIC-VARIATION; INTERFERON-GAMMA; NERVOUS-SYSTEM; CHEMOKINE; INTERLEUKIN-6; ASSOCIATION; NEUROINFLAMMATION	Background: Inflammatory cascades following traumatic brain injury (TBI) can have both beneficial and detrimental effects on recovery. Single biomarker studies do not adequately reflect the major arms of immunity and their relationships to long-term outcomes. Thus, we applied treelet transform (TT) analysis to identify clusters of interrelated inflammatory markers reflecting major components of systemic immune function for which substantial variation exists among individuals with moderate-to-severe TBI. Methods: Serial blood samples from 221 adults with moderate-to-severe TBI were collected over 1-6 months postinjury (n = 607 samples). Samples were assayed for 33 inflammatory markers using Millipore multiplex technology. TT was applied to standardized mean biomarker values generated to identify latent patterns of correlated markers. Treelet clusters (TC) were characterized by biomarkers related to adaptive immunity (TC1), innate immunity (TC2), soluble molecules (TC3), allergy immunity (TC4), and chemokines (TC5). For each TC, a score was generated as the linear combination of standardized biomarker concentrations and cluster load for each individual in the cohort. Ordinal logistic or linear regression was used to test associations between TC scores and 6- and 12-month Glasgow Outcome Scale (GOS), Disability Rating Scale (DRS), and covariates. Results: When adjusting for clinical covariates, TC5 was significantly associated with 6-month GOS (odds ratio, OR = 1.44; p-value, p = 0.025) and 6-month DRS scores (OR = 1.46; p = 0.013). TC5 relationships were attenuated when including all TC scores in the model (GOS: OR = 1.29, p = 0.163; DRS: OR = 1.33, p = 0.100). When adjusting for all TC scores and covariates, only TC3 was associated with 6- and 12-month GOS (OR = 1.32, p = 0.041; OR = 1.39, p = 0.002) and also 6- and 12-month DRS (OR = 1.38, p = 0.016; OR = 1.58, p = 0.0002). When applying TT to inflammation markers significantly associated with 6-month GOS, multivariate modeling confirmed that TC3 remained significantly associated with GOS. Biomarker cluster membership remained consistent between the GOS-specific dendrogram and overall dendrogram. Conclusions: TT effectively characterized chronic, systemic immunity among a cohort of individuals with moderate-to-severe TBI. We posit that chronic chemokine levels are effector molecules propagating cellular immune dysfunction, while chronic soluble receptors are inflammatory damage readouts perpetuated, in part, by persistent dysfunctional cellular immunity to impact neuro-recovery.	[Vijapur, Sushupta M.; Vaughan, Leah E.; Awan, Nabil; DiSanto, Dominic; McKernan, Gina P.; Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 Fifth Ave,Suite 910, Pittsburgh, PA 15213 USA; [McKernan, Gina P.] Univ Pittsburgh, Human Engn Res Labs, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Wagner, Amy K.] Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA USA		Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 Fifth Ave,Suite 910, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu		DiSanto, Dominic/0000-0002-8815-2169	DoDUnited States Department of Defense [W81XWH-071-0701]; NIDILRRUnited States Department of Health & Human Services [90DP0041, CDC R49 CCR 323155]	This work was supported, in part, by DoD W81XWH-071-0701, NIDILRR 90DP0041, & CDC R49 CCR 323155	Anderson Warren D, 2016, Drug Discov Today Dis Models, V19, P59, DOI 10.1016/j.ddmod.2017.01.003; Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; Arevalo-Martin A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02365; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barton DJ, 2016, J HEAD TRAUMA REHAB, V31, P277, DOI 10.1097/HTR.0000000000000188; Bodnar CN, 2018, NEURAL REGEN RES, V13, P1693, DOI 10.4103/1673-5374.238604; Browne KD, 2006, EXP NEUROL, V201, P301, DOI 10.1016/j.expneurol.2006.04.008; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Calcagno J, 2018, J NEUROTRAUM, V35, pA135; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; COPE AP, 1995, IMMUNOLOGY, V84, P21; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Correale J, 2004, J NEUROL, V251, P1304, DOI 10.1007/s00415-004-0649-z; Devoto C, 2017, CELL TRANSPLANT, V26, P1169, DOI 10.1177/0963689717714098; Diamond ML, 2015, EPILEPSIA, V56, P1198, DOI 10.1111/epi.13044; Diamond ML, 2014, EPILEPSIA, V55, P1109, DOI 10.1111/epi.12628; Ebert LA, 2005, MOL IMMUNOL, V42, P799, DOI 10.1016/j.molimm.2004.06.040; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Feghali Carol A., 1997, Frontiers in Bioscience (online), V2, pD12; Felt JM, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00315; Folcik VA, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-1; Frodl T, 2014, PROG NEURO-PSYCHOPH, V48, P295, DOI 10.1016/j.pnpbp.2012.12.013; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Garringer JA, 2013, J NEUROTRAUM, V30, P1415, DOI 10.1089/neu.2012.2565; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Gong Z, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1282-6; Gorst-Rasmussen A, 2012, STATA J, V12, P130, DOI 10.1177/1536867X1201200108; Gorst-Rasmussen A, 2011, AM J EPIDEMIOL, V173, P1097, DOI 10.1093/aje/kwr060; Goyal A, 2013, J NEUROTRAUM, V30, P946, DOI 10.1089/neu.2012.2579; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Grimm L.G., 1995, READING UNDERSTANDIN, P99; Gronwall C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00066; HARIRI RJ, 1994, BRAIN RES, V636, P139, DOI 10.1016/0006-8993(94)90188-0; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Helmy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039677; Hensler T, 2002, J TRAUMA, V52, P962, DOI 10.1097/00005373-200205000-00023; Hergenroeder GW, 2016, NEUROREPORT, V27, P90, DOI 10.1097/WNR.0000000000000502; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Huang DR, 2000, IMMUNOL REV, V177, P52, DOI 10.1034/j.1600-065X.2000.17709.x; JENNETT B, 1975, LANCET, V1, P480; Jeong Hey-Kyeong, 2013, Exp Neurobiol, V22, P59, DOI 10.5607/en.2013.22.2.59; Keane M.P., 2006, ENCY RESP MED, P1; Kenney MJ, 2014, COMPR PHYSIOL, V4, P1177, DOI 10.1002/cphy.c130051; Kirchhoff C, 2008, EUR J MED RES, V13, P464; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Kokiko-Cochran ON, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00672; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Kumar RG, 2019, J NEUROTRAUM, V36, P230, DOI 10.1089/neu.2018.5632; Kumar RG, 2016, BRAIN BEHAV IMMUN, V53, P183, DOI 10.1016/j.bbi.2015.12.008; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Labrenz F, 2016, BRAIN BEHAV IMMUN, V54, P17, DOI 10.1016/j.bbi.2015.11.010; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; Lee AB, 2008, ANN APPL STAT, V2, P435, DOI 10.1214/07-AOAS137; Levine SJ, 2008, J BIOL CHEM, V283, P14177, DOI 10.1074/jbc.R700052200; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Louyeau A, 2015, TRENDS IMMUNOL, V36, P569, DOI 10.1016/j.it.2015.08.006; Lundstrom W, 2012, SEMIN IMMUNOL, V24, P218, DOI 10.1016/j.smim.2012.02.005; Manek R, 2018, MOL NEUROBIOL, V55, P6112, DOI 10.1007/s12035-017-0821-y; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Mikolajczyk TP, 2016, FASEB J, V30, P1987, DOI 10.1096/fj.201500088R; Milleville K., 2020, BRAIN BEHAV IMMUN HL; Mohan K, 2002, J IMMUNOL, V168, P6420, DOI 10.4049/jimmunol.168.12.6420; Mondello S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040977; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Mortezaee K, 2018, J CELL PHYSIOL, V233, P5160, DOI 10.1002/jcp.26287; Munoz MJ, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00044; Myrga JM, 2016, J HEAD TRAUMA REHAB, V31, pE15, DOI 10.1097/HTR.0000000000000199; Needham EJ, 2019, J NEUROIMMUNOL, V332, P112, DOI 10.1016/j.jneuroim.2019.04.005; Niyonkuru C, 2013, J NEUROTRAUM, V30, P938, DOI 10.1089/neu.2012.2578; Noack M, 2014, AUTOIMMUN REV, V13, P668, DOI 10.1016/j.autrev.2013.12.004; Norden DM, 2015, NEUROPHARMACOLOGY, V96, P29, DOI 10.1016/j.neuropharm.2014.10.028; Patel JR, 2008, J NEUROSCI RES, V86, P2303, DOI 10.1002/jnr.21663; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Rancan M, 2004, J CEREBR BLOOD F MET, V24, P1110, DOI 10.1097/01.WCB.0000133470.91843.72; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rasmussen MK, 2018, LANCET NEUROL, V17, P1016, DOI 10.1016/S1474-4422(18)30318-1; Riegger T, 2009, NEUROSCIENCE, V158, P1194, DOI 10.1016/j.neuroscience.2008.08.021; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Rodney T, 2020, BEHAV BRAIN RES, V392, DOI 10.1016/j.bbr.2020.112715; Rusiecki J, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-019-1624-z; Santarsieri M., 2014, J NEUROTRAUM, V31; Santarsieri M, 2014, J NEUROTRAUM, V31, P699, DOI 10.1089/neu.2013.3177; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schmidt JA, 2020, INT J CANCER, V146, P720, DOI 10.1002/ijc.32314; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schulz J., 2018, PM R, V10, pS7; Sedger LM, 2014, CYTOKINE GROWTH F R, V25, P453, DOI 10.1016/j.cytogfr.2014.07.016; Shim R, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010064; Singhal A, 2002, J NEUROTRAUM, V19, P929, DOI 10.1089/089771502320317087; Spolski R, 2014, NAT REV DRUG DISCOV, V13, P381, DOI 10.1038/nrd4296; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stein DM, 2011, J TRAUMA, V70, P1096, DOI 10.1097/TA.0b013e318216930d; Suliman HB, 2016, PHARMACOL REV, V68, P20, DOI 10.1124/pr.115.011502; Sun Y., 2020, MATH SCI MACH LEARN; Suvannavejh GC, 2000, CELL IMMUNOL, V205, P24, DOI 10.1006/cimm.2000.1706; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00351; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Vaughan LE, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1384-1; Vijapur SM, 2020, J NEUROTRAUM, V37, P1609, DOI 10.1089/neu.2019.6780; Wagner A., 2019, J NEUROTRAUM, V36; Wagner AK, 2019, NEUROPHARMACOLOGY, V145, P133, DOI 10.1016/j.neuropharm.2018.09.011; Wagner AK, 2011, J CEREBR BLOOD F MET, V31, P1886, DOI 10.1038/jcbfm.2011.31; Walker KA, 2020, BRAIN BEHAV IMMUN, V87, P388, DOI 10.1016/j.bbi.2020.01.006; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yang Z., 2017, IN PRESS; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	115	2	2	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	JUL	2021	95						45	60		10.1016/j.bbi.2021.01.026			16	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	SN8CA	WOS:000658513000012	33524553				2022-02-06	
J	Watson, WD; Suskauer, SJ; Askin, G; Nowak, S; Baum, KT; Gerber, LM; Blackwell, LS; Koterba, CH; Hoskinson, KR; Kurowski, BG; Mclaughlin, MJ; Tlustos, SJ; Zimmerman, KO; Shah, SA				Watson, William D.; Suskauer, Stacy J.; Askin, Gulce; Nowak, Sophie; Baum, Katherine T.; Gerber, Linda M.; Blackwell, Laura S.; Koterba, Christine H.; Hoskinson, Kristen R.; Kurowski, Brad G.; Mclaughlin, Matthew J.; Tlustos, Sarah J.; Zimmerman, Kanecia O.; Shah, Sudhin A.			Cognitive Recovery During Inpatient Rehabilitation Following Pediatric Traumatic Brain Injury: A Pediatric Brain Injury Consortium Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adolescent; children; cognitive impairments; cognitive recovery; inpatient rehabilitation; minimally conscious state; posttraumatic amnesia; traumatic brain injury; unresponsive wakefulness	FUNCTIONAL INDEPENDENCE; LINGUISTIC SCALE; SOCIAL OUTCOMES; HEAD-INJURY; CHILDREN; CHILDHOOD; SEVERITY; WEEFIM; PREDICTORS; DISORDERS	Objectives: To characterize the demographics, clinical course, and predictors of cognitive recovery among children and young adults receiving inpatient rehabilitation following pediatric traumatic brain injury (TBI). Design: Retrospective observational, multicenter study. Setting: Eight acute pediatric inpatient rehabilitation facilities in the United States with specialized programs for treating patients with TBI. Participants: Children and young adults (0-21 years) with TBI (n = 234) receiving inpatient rehabilitation. Interventions: Not applicable. Main Outcome Measures: Admission and discharge status assessed by the WeeFIM Cognitive Developmental Functional Quotient (DFQ) and Cognitive and Linguistic Scale (CALS). Results: Patients admitted to pediatric inpatient rehabilitation are diverse in cognitive functioning. While the majority of patients make improvements, cognitive recovery is constrained for those admitted with the most severe cognitive impairments. Age, time since injury to rehabilitation admission, and admission WeeFIM Cognitive DFQ are significant predictors of cognitive functioning at discharge from inpatient rehabilitation. Conclusions: This work establishes a multicenter Pediatric Brain Injury Consortium and characterized the demographics and clinical course of cognitive recovery during inpatient rehabilitation of pediatric patients with TBI to aid in prospective study design.	[Watson, William D.] Columbia Univ, Vagelos Coll Phys & Surg, Dept Rehabil & Regenerat Med, New York, NY USA; [Watson, William D.; Nowak, Sophie; Shah, Sudhin A.] Blythedale Childrens Hosp, 95 Bradhurst Ave, Valhalla, NY 10595 USA; [Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Baltimore, MD USA; [Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD USA; [Askin, Gulce; Gerber, Linda M.] Weill Cornell Med, Dept Populat Hlth Sci, New York, NY USA; [Shah, Sudhin A.] Weill Cornell Med, Dept Rehabil Med, New York, NY USA; [Baum, Katherine T.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Blackwell, Laura S.] Childrens Hosp Atlanta, Dept Neuropsychol, Atlanta, GA USA; [Koterba, Christine H.; Hoskinson, Kristen R.] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Biobehav Hlth, Columbus, OH USA; [Hoskinson, Kristen R.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Kurowski, Brad G.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, Cincinnati, OH 45229 USA; [Kurowski, Brad G.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA; [Kurowski, Brad G.] Univ Cincinnati, Coll Med, Dept Neurol & Rehabil Med, Cincinnati, OH 45221 USA; [Mclaughlin, Matthew J.] Childrens Mercy Kansas City, Div Pediat Rehabil Med, Kansas City, MO USA; [Mclaughlin, Matthew J.] Univ Missouri Kansas City, Sch Med, Dept Pediat, Kansas City, MO USA; [Tlustos, Sarah J.] Univ Colorado, Childrens Hosp Colorado, Dept Rehabil, Anshutz Med Campus, Aurora, CO USA; [Tlustos, Sarah J.] Univ Colorado, Dept Phys Med & Rehabil, Anshutz Med Campus, Aurora, CO USA; [Zimmerman, Kanecia O.] Duke Univ, Med Ctr, Dept Pediat, Duke Clin Res Inst,Div Crit Care Med, Durham, NC 27710 USA		Watson, WD (corresponding author), Blythedale Childrens Hosp, 95 Bradhurst Ave, Valhalla, NY 10595 USA.	wwatson@blythedale.org					Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 2012, J HEAD TRAUMA REHAB, V27, P199, DOI 10.1097/HTR.0b013e31821a9d2b; Anderson V, 2010, J PEDIATR PSYCHOL, V35, P716, DOI 10.1093/jpepsy/jsp100; Arambula SE, 2019, EXP NEUROL, V317, P168, DOI 10.1016/j.expneurol.2019.02.016; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Crowe LM, 2013, CHILD NEUROPSYCHOL, V19, P113, DOI 10.1080/09297049.2011.651079; Crowe LM, 2012, J PEDIATR PSYCHOL, V37, P745, DOI 10.1093/jpepsy/jss070; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Davis KC, 2016, J HEAD TRAUMA REHAB, V31, pE39, DOI 10.1097/HTR.0000000000000159; Dennis M, 2014, NEUROPSYCHOL REV, V24, P389, DOI 10.1007/s11065-014-9261-x; Eilander HJ, 2016, BRAIN INJURY, V30, P1302, DOI 10.3109/02699052.2016.1170881; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Forsyth RJ, 2010, ARCH DIS CHILD, V95, P266, DOI 10.1136/adc.2008.147926; Fuentes MM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2859; Fulkerson DH, 2015, J NEUROSURG-PEDIATR, V16, P410, DOI 10.3171/2015.3.PEDS14679; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Gordon AL, 2012, PEDIATR NEUROL, V46, P339, DOI 10.1016/j.pediatrneurol.2012.02.029; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Howard I, 2005, ETHNIC DIS, V15, pS51; Hwang SY, 2019, BRAIN INJURY, V33, P1420, DOI 10.1080/02699052.2019.1641625; Keenan HT, 2006, PEDIATRICS, V117, P317, DOI 10.1542/peds.2005-0979; Kramer ME, 2013, J HEAD TRAUMA REHAB, V28, P361, DOI 10.1097/HTR.0b013e31824da031; LEVIN HS, 1979, CHILD BRAIN, V5, P281; Ley EJ, 2013, J TRAUMA ACUTE CARE, V75, P682, DOI 10.1097/TA.0b013e31829d024f; Majercik S, 2017, J TRAUMA ACUTE CARE, V82, P80, DOI 10.1097/TA.0000000000001263; Marino C, 2018, J HEAD TRAUMA REHAB, V33, pE11, DOI 10.1097/HTR.0000000000000374; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P223, DOI 10.1016/S0003-9993(96)90102-1; MCDONALD CM, 1994, ARCH PHYS MED REHAB, V75, P328, DOI 10.1016/0003-9993(94)90038-8; MSALL ME, 1994, CLIN PEDIATR, V33, P421, DOI 10.1177/000992289403300708; MSALL ME, 1994, CLIN PEDIATR, V33, P431, DOI 10.1177/000992289403300709; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Ottenbacher KJ, 2000, ARCH PHYS MED REHAB, V81, P1317, DOI 10.1053/apmr.2000.9387; Pham K, 2014, J HEAD TRAUMA REHAB, V29, pE44, DOI 10.1097/HTR.0000000000000022; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rice SA, 2005, ARCH PHYS MED REHAB, V86, P834, DOI 10.1016/j.apmr.2004.11.006; Slomine B, 2008, J HEAD TRAUMA REHAB, V23, P286, DOI 10.1097/01.HTR.0000336841.53338.2f; Slomine BS, 2019, BRAIN INJURY, V33, P1640, DOI 10.1080/02699052.2019.1658221; Slomine BS, 2016, REHABIL PSYCHOL, V61, P328, DOI 10.1037/rep0000096; Suskauer SJ, 2009, J PEDIATR REHAB MED, V2, P297, DOI 10.3233/PRM-2009-0092; Watson W, 2020, REHABIL PSYCHOL, V65, P22, DOI 10.1037/rep0000309; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yen HL, 2007, ANN ACAD MED SINGAP, V36, P62; Zonfrillo Mark R, 2018, Glob Pediatr Health, V5, p2333794X18774219, DOI 10.1177/2333794X18774219; Zonfrillo MR, 2014, J PEDIATR-US, V164, P130, DOI 10.1016/j.jpeds.2013.09.022	48	2	2	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2021	36	4			SI		253	263		10.1097/HTR.0000000000000650			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TJ9HU	WOS:000673784100011	33656473				2022-02-06	
J	Weise, KK; Galt, SJ; Hale, MH; Springer, DB; Swanson, MW				Weise, Katherine K.; Galt, Sarah J.; Hale, M. Heath; Springer, Daniel B.; Swanson, Mark W.			Pre-participation Vision Screening and Comprehensive Eye Care in National Collegiate Athletic Association Athletes	OPTOMETRY AND VISION SCIENCE			English	Article							PREPARTICIPATION PHYSICAL EVALUATION; CONVERGENCE INSUFFICIENCY; VISUAL-ACUITY; CONCUSSION; STABILIZATION; STATEMENT; CONSENSUS; RECOVERY	SIGNIFICANCE Pre-participation physical evaluation and its vision screenings have been the mainstay of medical clearance for competitive play for decades. The ability of screening to address athlete's sports-specific vision needs is unknown. METHODS Fifty-eight intercollegiate football players consented to participate in a comprehensive, sports-specific eye examination in addition to the standard pre-participation vision screening. Sensitivity, specificity, and positive and negative predictive values were determined for screening's ability to detect athletes whose vision might improve with correction, athletes who had significant ocular findings that impact safety, and either of the two conditions together. The effect no recent eye examination added to pre-participation vision screening results was evaluated for change in screening yield. Descriptive statistics of the cohort and associations with no recent comprehensive eye examination were generated. RESULTS The pre-participation vision screening was able to identify three athletes not meeting visual acuity requirements for medical clearance to play without a comprehensive assessment. A failed screening was poorly able to identify athletes who might benefit from improved acuity (sensitivity, 9.1%; specificity, 100%), have sports-specific significant ocular findings (sensitivity, 10.5%; specificity, 97.3%), or have either together (sensitivity, 7.5%; specificity, 100%). Sixty percent (33/55) of athletes reported never having a comprehensive examination or one within the last 10 years. Fifty-eight percent (34/58) had improved best-corrected visual acuity after comprehensive examination, and 81% (47/58) had improved acuity or a sports-specific significant finding. CONCLUSIONS The pre-participation vision screening was largely able to identify athletes meeting the minimum visual acuity requirement for athlete clearance. It poorly identified those who might benefit from improved vision with refractive correction and those in whom sport-specific significant eye findings were noted. Comprehensive eye care had a clear benefit for the majority of athletes tested. This benefit needs to be balanced with the potential added costs and time constraints to players and athletic department staff.	[Weise, Katherine K.; Galt, Sarah J.; Swanson, Mark W.] Univ Alabama Birmingham, Sch Optometry, Dept Optometry & Vision Sci, Birmingham, AL USA; [Hale, M. Heath] Univ Alabama Birmingham, Sch Med, Dept Athlet, Birmingham, AL USA; [Springer, Daniel B.] Univ Alabama Birmingham, Dept Athlet, Birmingham, AL USA		Weise, KK (corresponding author), Univ Alabama Birmingham, Sch Optometry, Dept Optometry & Vision Sci, Birmingham, AL USA.	kweise@uab.edu; galt.sarah@gmail.com; mhhale@uabmc.edu; dspringer@uabmc.edu; mswanson@uab.edu					Amer Acad Pediat, 2004, OPHTHALMOLOGY, V111, P600, DOI 10.1016/j.ophtha.2003.12.027; American Academy of Pediatrics, 1997, PHYS SPORTSMED; American Academy of Pediatrics American Academy of Family Physicians American College of Sports Medicine American Medical Society for Sports Medicine, 2019, PREP PHYS EV PREP PHYS EV, V5th ed; [Anonymous], 1994, Med Sci Sports Exerc, V26, pS223; [Anonymous], PREPARTICIPATION EXA, V5th; Caswell SV, 2015, PEDIATRICS, V135, P26, DOI 10.1542/peds.2014-1451; Centers for Disease Control and Prevention (CDC), VIS EYE HLTH SURV SY VIS EYE HLTH SURV SY; Cheever KM, 2018, INT J SPORTS MED, V39, P141, DOI 10.1055/s-0043-118339; Conley KM, 2014, J ATHL TRAINING, V49, P102, DOI 10.4085/1062-6050-48.6.05; D'Ath PJ, 2013, BRIT J SPORT MED, V47, P463, DOI 10.1136/bjsports-2013-092152; Dong LM, 2013, INVEST OPHTH VIS SCI, V54, P7871, DOI 10.1167/iovs.13-12403; DuPrey KM, 2017, AM J SPORT MED, V45, P2388, DOI 10.1177/0363546517705640; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Fernandes AG, 2021, BRIT J SPORT MED, V55, P584, DOI 10.1136/bjsports-2020-102706; GARRICK JG, 1980, PEDIATRICS, V66, P803; Glover DW, 1999, PHYSICIAN SPORTSMED, V27, P29, DOI 10.3810/psm.1999.08.941; GOLDBERG B, 1980, PEDIATRICS, V66, P736; Hood EA, 2019, RES SPORTS MED, V27, P467, DOI 10.1080/15438627.2018.1535434; Knishkowy B, 1997, ARCH PEDIAT ADOL MED, V151, P123, DOI 10.1001/archpedi.1997.02170390013002; Laby DM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52546-2; Lebeau JC, 2016, J SPORT EXERCISE PSY, V38, P441, DOI 10.1123/jsep.2015-0123; Lombardo J A, 2001, Clin Cornerstone, V3, P10, DOI 10.1016/S1098-3597(01)90066-3; Maron BJ, 1996, CIRCULATION, V94, P850, DOI 10.1161/01.CIR.94.4.850; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Miller SM, 2019, PEDIATR REV, V40, P108, DOI 10.1542/pir.2016-0216; National Collegiate Athletic Association (NCAA), 2020 2021 NCAA DIV 1 2020 2021 NCAA DIV 1; National Collegiate Athletic Association (NCAA), COUNT ATHL REL ACT COUNT ATHL REL ACT; National Collegiate Athletic Association (NCAA), 2013 14 SPORTS MED G; NCAA, EST PROB COMP COLL A; Ohlsson J, 2005, ACTA OPHTHALMOL SCAN, V83, P487, DOI 10.1111/j.1600-0420.2005.00516.x; Quintana C, 2020, J VESTIBUL RES-EQUIL, V30, P249, DOI 10.3233/VES-200710; Quintana CP, 2021, SPORTS MED, V51, P737, DOI 10.1007/s40279-020-01409-2; RISSER WL, 1985, J SCHOOL HEALTH, V55, P270, DOI 10.1111/j.1746-1561.1985.tb04140.x; Roberts WO, 2014, CLIN J SPORT MED, V24, P442, DOI 10.1097/JSM.0000000000000168; Rouse MW, 1999, OPTOMETRY VISION SCI, V76, P643, DOI 10.1097/00006324-199909000-00022; Swanson MW, 2017, OPTOMETRY VISION SCI, V94, P60, DOI 10.1097/OPX.0000000000000977; United States Census Bureau, INC 12 MONTHS 2018 I INC 12 MONTHS 2018 I; Vera J, 2020, EUR J SPORT SCI, V20, P407, DOI 10.1080/17461391.2019.1632385; Wajuihian Samuel Otabor, 2016, J Optom, V9, P246, DOI 10.1016/j.optom.2015.10.006; Weise KK, 2021, OPTOMETRY VISION SCI, V98, P833, DOI 10.1097/OPX.0000000000001730; Weise KK, 2017, OPTOMETRY VISION SCI, V94, P89, DOI 10.1097/OPX.0000000000000938; Zimmerman AB, 2011, EYE CONTACT LENS, V37, P153, DOI 10.1097/ICL.0b013e31820d12f4	45	2	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-5488	1538-9235		OPTOMETRY VISION SCI	Optom. Vis. Sci.	JUL	2021	98	7					764	770		10.1097/OPX.0000000000001738			7	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	TS1BM	WOS:000679391900012	34328455				2022-02-06	
J	Zavvarian, MM; Hong, J; Khazaei, M; Chio, JCT; Wang, J; Badner, A; Fehlings, MG				Zavvarian, Mohammad-Masoud; Hong, James; Khazaei, Mohamad; Chio, Jonathon Chon Teng; Wang, Jian; Badner, Anna; Fehlings, Michael G.			The Protein Kinase Inhibitor Midostaurin Improves Functional Neurological Recovery and Attenuates Inflammatory Changes Following Traumatic Cervical Spinal Cord Injury	BIOMOLECULES			English	Article						spinal cord injury; midostaurin; protein kinases; neuroprotection; neuroinflammation	ACUTE MYELOID-LEUKEMIA; VASCULAR DISRUPTION; PHASE-III; BRAIN; DRUG; ENZASTAURIN; FRACTALKINE; ACTIVATION; RILUZOLE; RECEPTOR	Traumatic spinal cord injury (SCI) impairs neuronal function and introduces a complex cascade of secondary pathologies that limit recovery. Despite decades of preclinical and clinical research, there is a shortage of efficacious treatment options to modulate the secondary response to injury. Protein kinases are crucial signaling molecules that mediate the secondary SCI-induced cellular response and present promising therapeutic targets. The objective of this study was to examine the safety and efficacy of midostaurin-a clinically-approved multi-target protein kinase inhibitor-on cervical SCI pathogenesis. High-throughput analyses demonstrated that intraperitoneal midostaurin injection (25 mg/kg) in C6/7 injured Wistar rats altered the local inflammasome and downregulated adhesive and migratory genes at 24 h post-injury. Treated animals also exhibited enhanced recovery and restored coordination between forelimbs and hindlimbs after injury, indicating the synergistic impact of midostaurin and its dimethyl sulfoxide vehicle to improve functional recovery. Furthermore, histological analyses suggested improved tissue preservation and functionality in the treated animals during the chronic phase of injury. This study serves as a proof-of-concept experiment and demonstrates that systemic midostaurin administration is an effective strategy for mitigating cervical secondary SCI damage.	[Zavvarian, Mohammad-Masoud; Hong, James; Khazaei, Mohamad; Chio, Jonathon Chon Teng; Wang, Jian; Badner, Anna; Fehlings, Michael G.] Univ Hlth Network, Krembil Brain Inst, Div Genet & Dev, Toronto, ON M5T 2S8, Canada; [Zavvarian, Mohammad-Masoud; Hong, James; Chio, Jonathon Chon Teng; Badner, Anna; Fehlings, Michael G.] Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Fehlings, Michael G.] Univ Toronto, Fac Med, Dept Surg, Toronto, ON M5T 1P5, Canada		Fehlings, MG (corresponding author), Univ Hlth Network, Krembil Brain Inst, Div Genet & Dev, Toronto, ON M5T 2S8, Canada.; Fehlings, MG (corresponding author), Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON M5S 1A8, Canada.; Fehlings, MG (corresponding author), Univ Toronto, Fac Med, Dept Surg, Toronto, ON M5T 1P5, Canada.	Mohammad.zavvarian@mail.utoronto.ca; James.hong@live.com; Mohammad.khazaei@uhnresearch.ca; Jct.chio@mail.utoronto.ca; Jian.wang@uhnresearch.ca; Anna.badner@gmail.com; Michael.Fehlings@uhn.ca	Badner, Anna/N-8035-2019	Badner, Anna/0000-0002-5244-6165; Chio, Jonathon Chon Teng/0000-0002-9914-5538; Fehlings, Michael/0000-0002-5722-6364	Ontario Graduate Scholarship (OGS)Ontario Graduate Scholarship; Crothers Family Fellowship; Unilever/Lipton Graduate Fellowship; University of Toronto Open FellowshipUniversity of Toronto	M.-M.Z. was awarded the Ontario Graduate Scholarship (OGS), Crothers Family Fellowship, Unilever/Lipton Graduate Fellowship, and the University of Toronto Open Fellowship.	Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Badhiwala JH, 2019, LANCET NEUROL, V18, P24, DOI 10.1016/S1474-4422(18)30444-7; Badner A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1243-0; Badner A, 2016, STEM CELL TRANSL MED, V5, P991, DOI 10.5966/sctm.2015-0295; Bass JJ, 2017, SCAND J MED SCI SPOR, V27, P4, DOI 10.1111/sms.12702; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bastien D, 2015, J NEUROSCI, V35, P10715, DOI 10.1523/JNEUROSCI.0498-15.2015; Bourhill T, 2017, CRIT REV ONCOL HEMAT, V112, P72, DOI 10.1016/j.critrevonc.2017.02.003; BROADWELL RD, 1982, SCIENCE, V217, P164, DOI 10.1126/science.7089551; Chio JCT, 2021, NEUROBIOL DIS, V148, DOI 10.1016/j.nbd.2020.105187; Chio JCT, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1518-0; Choi JS, 2013, EUR J PHARMACOL, V713, P39, DOI 10.1016/j.ejphar.2013.04.048; Chomarat P, 1998, Int Rev Immunol, V17, P1, DOI 10.3109/08830189809084486; Cormier Kevin W, 2017, F1000Res, V6, DOI 10.12688/f1000research.10557.1; Crump M, 2016, J CLIN ONCOL, V34, P2484, DOI 10.1200/JCO.2015.65.7171; Dooley D, 2016, STEM CELL REP, V7, P1099, DOI 10.1016/j.stemcr.2016.11.005; Dutreix C, 2014, EUR J CLIN PHARMACOL, V70, P915, DOI 10.1007/s00228-014-1675-0; Dutreix C, 2013, CANCER CHEMOTH PHARM, V72, P1223, DOI 10.1007/s00280-013-2287-6; Eldar-Finkelman H, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00032; Fehlings MG, 2017, GLOB SPINE J, V7, p116S, DOI 10.1177/2192568217706366; Fehlings Michael G, 2014, Neurosurgery, V61 Suppl 1, P36, DOI 10.1227/NEU.0000000000000412; Figley SA, 2014, J NEUROTRAUM, V31, P541, DOI 10.1089/neu.2013.3034; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Flynn JR, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00005; Freria CM, 2017, J NEUROSCI, V37, P3568, DOI 10.1523/JNEUROSCI.2841-16.2017; Gallogly MM, 2016, J BLOOD MED, V7, P73, DOI 10.2147/JBM.S100283; Gani OABSM, 2010, NAT PROD REP, V27, P489, DOI 10.1039/b923848b; Gawriluk TR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11164; Gotlib J, 2016, NEW ENGL J MED, V374, P2530, DOI 10.1056/NEJMoa1513098; Greenfeder S, 2001, RESP RES, V2, P71, DOI 10.1186/rr41; Growney JD, 2005, BLOOD, V106, P721, DOI 10.1182/blood-2004-12-4617; Gutierrez L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35978-0; Hara M, 2000, J NEUROSURG, V93, P94, DOI 10.3171/spi.2000.93.1.0094; Hatori K, 2002, J NEUROSCI RES, V69, P418, DOI 10.1002/jnr.10304; Hong J, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153762; Hong J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082167; Huang YC, 2010, TOXICOL IN VITRO, V24, P1705, DOI 10.1016/j.tiv.2010.05.015; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Hurlbert RJ, 2013, NEUROSURGERY, V72, P93, DOI 10.1227/NEU.0b013e31827765c6; Jacob SW, 2009, PHARMACOL REP, V61, P225, DOI 10.1016/S1734-1140(09)70026-X; James ND, 2018, LANCET NEUROL, V17, P905, DOI 10.1016/S1474-4422(18)30287-4; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jaworski T, 2019, NEURAL PLAST, V2019, DOI 10.1155/2019/4209475; Kasamon YL, 2018, ONCOLOGIST, V23, P1511, DOI 10.1634/theoncologist.2018-0222; Kasuya Y, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030867; Kwon BK, 2011, J NEUROTRAUM, V28, P1545, DOI 10.1089/neu.2009.1149; Lanz TV, 2013, P NATL ACAD SCI USA, V110, P14735, DOI 10.1073/pnas.1302569110; Lessard SJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05439-3; Levis M, 2017, BLOOD, V129, P3403, DOI 10.1182/blood-2017-05-782292; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Leyton L, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00132; Lima R, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10040083; Lorenz L, 2018, NATURE, V562, P128, DOI 10.1038/s41586-018-0522-3; Luskin MR, 2017, EXPERT REV HEMATOL, V10, P1033, DOI 10.1080/17474086.2017.1397510; Ma MH, 2002, J NEUROSCI RES, V68, P691, DOI 10.1002/jnr.10269; Manley PW, 2018, BIOCHEMISTRY-US, V57, P5576, DOI 10.1021/acs.biochem.8b00727; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; McClendon CL, 2014, P NATL ACAD SCI USA, V111, pE4623, DOI 10.1073/pnas.1418402111; Nagoshi N, 2015, MOLECULES, V20, P7775, DOI 10.3390/molecules20057775; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Noh KM, 2000, NEUROBIOL DIS, V7, P375, DOI 10.1006/nbdi.2000.0297; O'Shea TM, 2017, J CLIN INVEST, V127, P3265, DOI 10.1172/JCI90608; Orchard RC, 2018, NAT MICROBIOL, V3, P1109, DOI 10.1038/s41564-018-0221-8; Peter B, 2018, LEUKEMIA, V32, P1016, DOI 10.1038/leu.2017.338; Poniatowski LA, 2017, MOL NEUROBIOL, V54, P2167, DOI 10.1007/s12035-016-9787-4; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; Roufosse F, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00049; Rouleau P, 2007, J NEUROTRAUM, V24, P367, DOI 10.1089/neu.2006.0117; Sato A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-65; Schmidlin T, 2019, CELL SYST, V9, P366, DOI 10.1016/j.cels.2019.08.005; Sivasankaran R, 2004, NAT NEUROSCI, V7, P261, DOI 10.1038/nn1193; Sofroniew MV, 2018, NATURE, V557, P343, DOI 10.1038/s41586-018-0068-4; Soubeyrand M, 2014, J NEUROTRAUM, V31, P1767, DOI 10.1089/neu.2013.3319; Stansfield LC, 2017, PHARMACOTHERAPY, V37, P1586, DOI 10.1002/phar.2039; Stone RM, 2017, NEW ENGL J MED, V377, P454, DOI 10.1056/NEJMoa1614359; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Tetreault LA, 2020, GLOB SPINE J, V10, P216, DOI 10.1177/2192568219835516; Tillakaratne NJK, 2000, J NEUROSCI RES, V60, P219, DOI 10.1002/(SICI)1097-4547(20000415)60:2<219::AID-JNR11>3.0.CO;2-F; Tin A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06620-4; Turan NN, 2008, ANN VASC SURG, V22, P98, DOI 10.1016/j.avsg.2007.07.023; Vanlandewijck M, 2018, NATURE, V554, P475, DOI 10.1038/nature25739; Vestweber D, 2015, NAT REV IMMUNOL, V15, P692, DOI 10.1038/nri3908; Wang S, 2019, EXPERT OPIN THER TAR, V23, P787, DOI 10.1080/14728222.2019.1661381; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Wick W, 2010, J CLIN ONCOL, V28, P1168, DOI 10.1200/JCO.2009.23.2595; Wilcox JT, 2017, NEUROBIOL DIS, V105, P194, DOI 10.1016/j.nbd.2017.05.009; Yamasaki R, 2010, J NEUROIMMUNOL, V229, P51, DOI 10.1016/j.jneuroim.2010.07.002; Yates AG, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-020-02050-6; Zarrin AA, 2021, NAT REV DRUG DISCOV, V20, P39, DOI 10.1038/s41573-020-0082-8; Zavvarian MM, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00127; Zavvarian Mohammad-Masoud, 2020, F1000Res, V9, DOI 10.12688/f1000research.21989.1; Zhang YB, 2012, IMMUNOLOGY, V135, P268, DOI 10.1111/j.1365-2567.2011.03549.x	94	2	2	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2218-273X		BIOMOLECULES	Biomolecules	JUL	2021	11	7							972	10.3390/biom11070972			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TO1WL	WOS:000676711000001	34356596	gold, Green Published			2022-02-06	
J	Bsat, S; Chanbour, H; Bsat, A; Alomari, S; Moussalem, C; El Houshiemy, MN; Omeis, I				Bsat, Shadi; Chanbour, Hani; Bsat, Ayman; Alomari, Safwan; Moussalem, Charbel; El Houshiemy, Mohamad Nabih; Omeis, Ibrahim			Clinical utility of degradomics as predictors of complications and clinical outcome in aneurysmal subarachnoid hemorrhage	JOURNAL OF INTEGRATIVE NEUROSCIENCE			English	Article						Degradomics; Degradomes; Proteases; Aneurysm; Subarachnoid hemorrhage; Substrates; Blood-brain barrier	MYELIN BASIC-PROTEIN; ALPHA-II-SPECTRIN; NEURON-SPECIFIC ENOLASE; CEREBROSPINAL-FLUID; CEREBRAL VASOSPASM; MATRIX METALLOPROTEINASES; BREAKDOWN PRODUCTS; BRAIN-INJURY; CALPAIN; SERUM	Most of the debilitating conditions following aneurysmal subarachnoid hemorrhage result from symptomatic cerebral vasospasm and delayed cerebral ischemia. Several scales are being used, but they still lack objectivity and fail to quantify complications considered essential for prognostication routine use of biomarkers to predict complications and outcomes after aneurysmal rupture is still experimental. Degradomics were studied extensively in traumatic brain injury, but there is no discussion of these biomarkers related to aneurysmal subarachnoid hemorrhage. Degradomics involve the activation of proteases that target specific substrates and generate specific protein fragments called degradomes. While the proteolytic activities constitute the pillar of development, growth, and regeneration of tissues, dysregulated proteolysis resulting from pathological conditions like aneurysmal subarachnoid hemorrhage ends up in apoptotic processes and necrosis. To our knowledge, this is the first overview that lists a panel of degradomics with cut-off values in serum and cerebrospinal fluid, where specificity and sensitivity are only found in Kallikrein 6, Ubiquitin C Terminal Hydrolase 1 and Alpha-II-Spectrin.	[Bsat, Shadi; Moussalem, Charbel; El Houshiemy, Mohamad Nabih; Omeis, Ibrahim] Amer Univ, Dept Neurosurg, Beirut Med Ctr, Beirut 20339105, Lebanon; [Chanbour, Hani; Bsat, Ayman] Lebanese Univ, Fac Med, Beirut 20339105, Lebanon; [Alomari, Safwan] Johns Hopkins Sch Med, Dept Neurosurg, Baltimore, MD 21202 USA; [Omeis, Ibrahim] Baylor Coll Med, Dept Neurosurg, Houston, TX 77002 USA		Omeis, I (corresponding author), Amer Univ, Dept Neurosurg, Beirut Med Ctr, Beirut 20339105, Lebanon.; Omeis, I (corresponding author), Baylor Coll Med, Dept Neurosurg, Houston, TX 77002 USA.	io04@aub.edu.lb					Abou-El-Hassan H, 2017, METHODS MOL BIOL, V1598, P65, DOI 10.1007/978-1-4939-6952-4_4; Aoki K, 2002, J CLIN NEUROSCI, V9, P672, DOI 10.1054/jocn.2002.1088; Beltran PMJ, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167062; Bian L, 2020, CLIN CHIM ACTA, V502, P148, DOI 10.1016/j.cca.2019.12.014; Blomgren K, 2001, J BIOL CHEM, V276, P10191, DOI 10.1074/jbc.M007807200; Boggs JM, 2006, CELL MOL LIFE SCI, V63, P1945, DOI 10.1007/s00018-006-6094-7; Curci JA, 1998, J CLIN INVEST, V102, P1900, DOI 10.1172/JCI2182; Dittmar M, 2004, STROKE, V35, pE338, DOI 10.1161/01.STR.0000135294.08862.5d; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fields RD, 2014, NEUROSCIENTIST, V20, P426, DOI 10.1177/1073858413504465; Friedrich V, 2012, NEUROSCI LETT, V512, P6, DOI 10.1016/j.neulet.2012.01.036; Frosen J, 2012, ACTA NEUROPATHOL, V123, P773, DOI 10.1007/s00401-011-0939-3; Germano A, 2002, J NEUROTRAUM, V19, P887, DOI 10.1089/08977150260190474; Gewirtz RJ, 1999, BRAIN RES, V840, P84, DOI 10.1016/S0006-8993(99)01752-7; Goetzl EJ, 1996, J IMMUNOL, V156, P1; GOTTSCHALL PE, 1995, J NEUROSCI RES, V42, P335, DOI 10.1002/jnr.490420307; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; HALEY EC, 1992, STROKE, V23, P205, DOI 10.1161/01.STR.23.2.205; Hemmer B, 2002, NAT REV NEUROSCI, V3, P291, DOI 10.1038/nrn784; Hirashima Y, 2001, NEUROL RES, V23, P715, DOI 10.1179/016164101101199225; Horstmann S, 2006, J NEUROL SCI, V251, P82, DOI 10.1016/j.jns.2006.09.005; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Juraver-Geslin HA, 2015, GENESIS, V53, P203, DOI 10.1002/dvg.22844; Kacira T, 2007, NEUROSURGERY, V60, P674, DOI 10.1227/01.NEU.0000255394.77538.BB; Kim EM, 2010, J BIOL CHEM, V285, P16444, DOI 10.1074/jbc.M109.093799; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lad SP, 2012, J STROKE CEREBROVASC, V21, P30, DOI 10.1016/j.jstrokecerebrovasdis.2010.04.004; LAMERS KJB, 1995, ACTA NEUROL SCAND, V92, P247; Launay S, 2005, ONCOGENE, V24, P5137, DOI 10.1038/sj.onc.1208524; Lee AY, 2004, PROTEOMICS, V4, P3429, DOI 10.1002/pmic.200400979; Lee YB, 2000, BRAIN RES, V864, P220, DOI 10.1016/S0006-8993(00)02180-6; Lewis SB, 2007, J NEUROSURG, V107, P792, DOI 10.3171/JNS-07/10/0792; Lewis SB, 2010, J NEUROSCI RES, V88, P1475, DOI 10.1002/jnr.22323; Li SX, 2017, EVID-BASED COMPL ALT, V2017, P1, DOI 10.1155/2017/3514914; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Lovelock CE, 2010, NEUROLOGY, V74, P1494, DOI 10.1212/WNL.0b013e3181dd42b3; Macdonald RL, 2014, NAT REV NEUROL, V10, P44, DOI 10.1038/nrneurol.2013.246; Maddahi A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-274; Martinez-Morillo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045676; McGirt MJ, 2002, NEUROSURGERY, V51, P1128, DOI 10.1097/00006123-200211000-00005; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; Nylen K, 2007, STROKE, V38, P1489, DOI 10.1161/STROKEAHA.106.478362; Ottens AK, 2008, J NEUROCHEM, V104, P1404, DOI 10.1111/j.1471-4159.2007.05086.x; Overall CM, 2006, CANCER METAST REV, V25, P69, DOI 10.1007/s10555-006-7890-0; Papa L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31631-y; Pike BR, 2004, J CEREBR BLOOD F MET, V24, P98, DOI 10.1097/01.WCB.0000098520.11962.37; Prunell GF, 2005, J NEUROSURG, V102, P1046, DOI 10.3171/jns.2005.102.6.1046; Prunell GF, 2005, NEUROSURGERY, V56, P1082, DOI 10.1227/01.NEU.0000157966.76590.39; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Reijerkerk A, 2006, FASEB J, V20, P2550, DOI 10.1096/fj.06-6099fje; Satoh M, 2005, ACTA NEUROCHIR, V147, P187, DOI 10.1007/s00701-004-0435-9; Savickas S, 2018, BIOL CHEM, V399, P47, DOI 10.1515/hsz-2017-0187; Scarisbrick IA, 2008, CURR TOP MICROBIOL, V318, P133; Seeds NW, 1997, CELL TISSUE RES, V290, P367, DOI 10.1007/s004410050942; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; Siman R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028938; Soderholm M, 2018, STROKE, V49, P1626, DOI 10.1161/STROKEAHA.118.020660; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Suzuki H, 2010, STROKE, V41, P1783, DOI 10.1161/STROKEAHA.110.586537; Terayama R, 2004, GLIA, V48, P91, DOI 10.1002/glia.20058; THOMPSON RJ, 1983, BRAIN RES, V278, P224, DOI 10.1016/0006-8993(83)90241-X; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Vizovisek M, 2016, BIOCHIMIE, V122, P77, DOI 10.1016/j.biochi.2015.10.017; Vos PE, 2006, EUR J NEUROL, V13, P632, DOI 10.1111/j.1468-1331.2006.01332.x; Wang J, 2016, CLIN CHIM ACTA, V460, P196, DOI 10.1016/j.cca.2016.07.001; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wang LC, 2018, EXP THER MED, V15, P1510, DOI 10.3892/etm.2017.5553; Wang Z, 2012, ANN CLIN LAB SCI, V42, P14; Wasik N, 2020, ACTA NEUROCHIR, V162, P545, DOI 10.1007/s00701-019-04185-9; Wright JW, 2009, BEHAV BRAIN RES, V203, P27, DOI 10.1016/j.bbr.2009.04.014; Yong VW, 1998, TRENDS NEUROSCI, V21, P75	74	2	2	0	0	IMR PRESS	ROBINSON	112 ROBINSON RD, ROBINSON, SINGAPORE	0219-6352	1757-448X		J INTEGR NEUROSCI	J. Integr. Neurosci.	JUN 30	2021	20	2					489	497		10.31083/j.jin2002052			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TI4XD	WOS:000672804800028	34258951	gold			2022-02-06	
J	Manivannan, S; Sharouf, F; Mayo, I; Albaqer, H; Mehrez, M; Jaber, H; Nicholls, Z; Woodward, BO; Watkins, WJ; Zaben, M				Manivannan, S.; Sharouf, F.; Mayo, I.; Albaqer, H.; Mehrez, M.; Jaber, H.; Nicholls, Z.; Woodward, B. O.; Watkins, W. J.; Zaben, M.			Management of neurotrauma during COVID-19: a single centre experience and lessons for the future	BRAIN INJURY			English	Article						COVID-19; traumatic brain injury; neurosurgery	HEAD-INJURY	Introduction: Traumatic brain injury (TBI) is amongst the leading causes of morbidity and mortality worldwide. The unprecedented emergence of COVID-19 has mandated neurosurgeons to limit viral spread and spare hospital resources whilst trying to adapt management plans for TBI. We aimed to characterize how this affects decision-making on TBI management and drive strategies to cope with future expected waves. Methods: Retrospective TBI data collection from a single tertiary referral unit was performed between: 01/04/2019 - 30/06/2019 ('Pre-Epidemic') and 01/04/2020 - 30/06/20 ('Epidemic'). Demographics, mechanism of injury, TBI severity, radiological findings, alcohol/anticoagulants/antiplatelets use, and management decisions were extracted. Results: 646 TBI referrals were received in 'Pre-Epidemic' (N = 317) and 'Epidemic' (N = 280) groups. There was reduction in RTA-associated TBI (14.8 vs 9.3%; p = .04) and increase in patients on anticoagulants (14.2 vs 23.6%; p = .003) in the 'Epidemic' group. Despite similarities between other TBI-associated variables, a significantly greater proportion of patients were managed conservatively in local referring units without neurosurgical services (39.1 vs 56.8%; p < .0001), predominantly constituted by mild TBI. Conclusion: Despite COVID-19 public health measures, the burden of TBI remains eminent. Increases in local TBI management warrant vigilance from primary healthcare services to meet post-TBI needs in the community.	[Manivannan, S.] Southampton Gen Hosp, Dept Neurosurg, Southampton, Hants, England; [Sharouf, F.; Mayo, I.; Albaqer, H.; Mehrez, M.; Zaben, M.] Univ Hosp Wales, Dept Neurosurg, Cardiff, Wales; [Jaber, H.; Nicholls, Z.; Woodward, B. O.] Univ Hosp Wales, Dept Radiol, Cardiff, Wales; [Watkins, W. J.] Cardiff Univ, Coll Biomed & Life Sci, Dept Infect & Immun, Cardiff, Wales		Zaben, M (corresponding author), Cardiff Univ, Univ Hosp Wales, Neurosci & Mental Hlth Res Inst NMHRI, Sch Med, Room 4FT 80E,4th Floor,Heath Pk, Cardiff CF14 4XN, Wales.	zabenm@cardiff.ac.uk					[Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; COVIDsurg Collaborative, 2020, LANCET, V396, P27, DOI 10.1016/S0140-6736(20)31182-X; Esteban Pedro L, 2020, Bone Jt Open, V1, P617, DOI 10.1302/2633-1462.110.BJO-2020-0120.R1; Fahy Stephen, 2020, Bone Jt Open, V1, P261, DOI 10.1302/2046-3758.16.BJO-2020-0040.R1; FSSA, 2020, CLIN GUID SURG PRIOR; Hampton Matthew, 2020, Bone Jt Open, V1, P137, DOI 10.1302/2633-1462.15.BJO-2020-0028.R1; Karia Monil, 2020, Bone Jt Open, V1, P494, DOI 10.1302/2633-1462.18.BJO-2020-0074.R1; Maringe C, 2020, LANCET ONCOL, V21, P1023, DOI 10.1016/S1470-2045(20)30388-0; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Park C, 2020, ACTA ORTHOP, V91, P556, DOI 10.1080/17453674.2020.1783621; Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101623; (SBNS) SoBNS, 2020, CLIN GUIDE MANAGEMEN; Singh R, 2013, ARCH TRAUMA RES, V2, P103, DOI 10.5812/atr.13665; Singh R, 2012, DISABIL REHABIL, V34, P439, DOI 10.3109/09638288.2011.608146; Sugand, 2020, IMPACT COVID 19 ACUT; Sugand K, 2020, ACTA ORTHOP, V91, P633, DOI 10.1080/17453674.2020.1807092; WHO, 2019, COR DIS	17	2	2	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 3	2021	35	8					957	963		10.1080/02699052.2021.1934731		JUN 2021	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TS9JB	WOS:000668076800001	34184612				2022-02-06	
J	Dolma, S; Kumar, H				Dolma, Sonam; Kumar, Hemant			Neutrophil, Extracellular Matrix Components, and Their Interlinked Action in Promoting Secondary Pathogenesis After Spinal Cord Injury	MOLECULAR NEUROBIOLOGY			English	Article; Early Access						Spinal cord injury; Neutrophils; Extracellular matrix; Chondroitin sulphate proteoglycan; Matrix metalloproteinase	ACTIVATED PROTEIN-C; SULFATE PROTEOGLYCAN EXPRESSION; INFLAMMATORY RESPONSE; FUNCTIONAL RECOVERY; BARRIER DISRUPTION; TRAUMATIC BRAIN; SCAR FORMATION; P-SELECTIN; MODULATION; RECEPTOR	Secondary pathogenesis following primary mechanical damage to the spinal cord is believed to be the ultimate reason for the limitation of currently available therapies. Precisely, the complex cascade of secondary events-mediated scar formation is the sole hurdle in the recovery process due to its inhibitory effect on axonal regeneration, plasticity, and remyelination. Neutrophils initiate this secondary injury along with other extracellular matrix components such as matrix metalloproteinase (MMPs), and chondroitin sulfate proteoglycans (CSPGs). Together, they mediate inflammation, necrosis, apoptosis, lesion, and scar formation at the injury site. Activated neutrophil releases several proteases, cytokines, and chemokines that cause complete tissue destruction. Thus, neutrophil activation and infiltration in the acute phase of injury act as a roadmap for inducing tissue destruction. MMPs, are extracellular proteolytic enzymes that degrade the ECM proteins, increases vascular permeability, and are predominantly released by neutrophils. These MMPs, in turn, cleave NG2 proteoglycan, a subtype of CSPG, into the active form. This active or shed form is involved in both the fibrotic as well as glial scar formation. Since neutrophils and ECM components are closely associated with each other in pathological conditions. Herein, we emphasize the interaction of neutrophils and their influence on ECM protein expression during the acute and chronic phases to identify a promising targets for designing a therapeutic approach in spinal cord injury.	[Dolma, Sonam; Kumar, Hemant] Natl Inst Pharmaceut Educ & Res NIPER Ahmedabad, Dept Pharmacol & Toxicol, Gandhinagar, Gujarat, India		Kumar, H (corresponding author), Natl Inst Pharmaceut Educ & Res NIPER Ahmedabad, Dept Pharmacol & Toxicol, Gandhinagar, Gujarat, India.	hemantbhave@gmail.com	Kumar, Hemant/G-4576-2018	Kumar, Hemant/0000-0002-6434-0245	Department of Science and Technology, Science and Engineering Research Board (DST-SERB)Department of Science & Technology (DOST), PhilippinesDepartment of Science & Technology (India) [SRG/2020/000706]; NIPER-Ahmedabad	This work was supported by a grant from the Department of Science and Technology, Science and Engineering Research Board (DST-SERB) (SRG/2020/000706) and NIPER-Ahmedabad. The paid version of Biorender.com was utilized to prepare the illustration.	Adhipandito CF, 2019, FUTUR J PHARM SCI, V5, DOI 10.1186/s43094-019-0001-1; Ahmad G, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.556020; Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Alizadeh A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00282; Andrews EM, 2012, EXP NEUROL, V235, P174, DOI 10.1016/j.expneurol.2011.09.008; Asher RA, 2005, MOL CELL NEUROSCI, V29, P82, DOI 10.1016/j.mcn.2005.02.001; Asher RA, 2000, J NEUROSCI, V20, P2427; Avram S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/642798; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Benjamin Mina M, 2012, Exp Suppl, V103, P209, DOI 10.1007/978-3-0348-0364-9_7; Bourassa-Moreau E, 2016, J NEUROTRAUM, V33, P301, DOI 10.1089/neu.2015.3957; Bradley LM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002641; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Cho KS, 2015, NEUROCHEM RES, V40, P2242, DOI 10.1007/s11064-015-1714-y; Crocetti L, 2019, EXPERT OPIN THER PAT, V29, P555, DOI 10.1080/13543776.2019.1630379; Dang ABC, 2008, SPINE, V33, pE576, DOI 10.1097/BRS.0b013e31817ecc87; Dyck SM, 2018, NEURAL REGEN RES, V13, P2080, DOI 10.4103/1673-5374.241452; Dyck SM, 2015, STEM CELLS, V33, P2550, DOI 10.1002/stem.1979; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Farooque M, 1999, NEUROREPORT, V10, P131, DOI 10.1097/00001756-199901180-00024; Fischer T, 2019, MOLECULES, V24, DOI 10.3390/molecules24122265; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Gramegna A, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0691-x; Gris D, 2008, EXP NEUROL, V211, P259, DOI 10.1016/j.expneurol.2008.01.033; Grzywa R, 2019, BIOCHIMIE, V166, P142, DOI 10.1016/j.biochi.2019.03.005; Hamada Y, 1996, J NEUROCHEM, V66, P1525; Hesp ZC, 2018, J NEUROSCI, V38, P1366, DOI 10.1523/JNEUROSCI.3953-16.2017; Hirose K, 2000, ANN SURG, V232, P272, DOI 10.1097/00000658-200008000-00018; Hook G, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00178; Hryciw T, 2018, J NEUROTRAUM, V35, P1958, DOI 10.1089/neu.2018.5928; Hsu JYC, 2008, J NEUROSCI, V28, P13467, DOI 10.1523/JNEUROSCI.2287-08.2008; Iwamoto Satoshi, 2009, Interact Cardiovasc Thorac Surg, V8, P606, DOI 10.1510/icvts.2008.197244; Jain NB, 2015, JAMA-J AM MED ASSOC, V313, P2236, DOI 10.1001/jama.2015.6250; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Karimi-Abdolrezaee S, 2010, J NEUROSCI, V30, P1657, DOI 10.1523/JNEUROSCI.3111-09.2010; Kubota K, 2012, SPINE, V37, P1363, DOI 10.1097/BRS.0b013e31824b9e77; Kumar H, 2020, J NEUROSCI, V40, P1943, DOI 10.1523/JNEUROSCI.2035-19.2020; Kumar H, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0576-3; Kumar H, 2018, MOL NEUROBIOL, V55, P2577, DOI 10.1007/s12035-017-0509-3; Kumar H, 2017, MOL NEUROBIOL, V54, P3578, DOI 10.1007/s12035-016-9910-6; Kwon BK, 2011, J NEUROTRAUM, V28, P1545, DOI 10.1089/neu.2009.1149; Lacy Paige, 2006, Allergy Asthma Clin Immunol, V2, P98, DOI 10.1186/1710-1492-2-3-98; Lang BT, 2015, NATURE, V518, P404, DOI 10.1038/nature13974; Lau LW, 2013, NAT REV NEUROSCI, V14, P722, DOI 10.1038/nrn3550; Law SM, 2017, J INFLAMM-LOND, V14, DOI 10.1186/s12950-017-0176-1; Lee JY, 2012, BRAIN, V135, P2375, DOI 10.1093/brain/aws171; Lee JY, 2012, J NEUROCHEM, V121, P818, DOI 10.1111/j.1471-4159.2012.07731.x; Lee JY, 2014, AM J PATHOL, V184, P2985, DOI 10.1016/j.ajpath.2014.07.016; Levine JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096408; Liou JT, 2013, PAIN, V154, P2150, DOI 10.1016/j.pain.2013.06.042; Liu HQ, 2011, EXP NEUROL, V231, P236, DOI 10.1016/j.expneurol.2011.06.015; Liu NK, 2010, MOL NEUROBIOL, V41, P197, DOI 10.1007/s12035-010-8101-0; Lopez-Vales R, 2011, FASEB J, V25, P4240, DOI 10.1096/fj.11-183186; Manda-Handzlik A, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121477; Massey JM, 2008, EXP NEUROL, V209, P426, DOI 10.1016/j.expneurol.2007.03.029; Mirzaie M, 2018, INT J MOL CELL MED, V7, P8, DOI 10.22088/IJMCM.BUMS.7.1.8; Naruo S, 2003, J NEUROTRAUM, V20, P221, DOI 10.1089/08977150360547125; Neirinckx V, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0150-2; Noble LJ, 2002, J NEUROSCI, V22, P7526; Okada S, 2016, INFLAMM REGEN, V36, DOI 10.1186/s41232-016-0026-1; OKAJIMA K, 1990, THROMB HAEMOSTASIS, V63, P48; Okuno T, 2005, J BIOL CHEM, V280, P32049, DOI 10.1074/jbc.R500007200; Orr MB, 2018, NEUROTHERAPEUTICS, V15, P541, DOI 10.1007/s13311-018-0631-6; Palmer R, 2018, CLIN PHARMACOL THER, V104, P1155, DOI 10.1002/cpt.1053; Papadaki G, 2016, EUR J IMMUNOL, V46, P2542, DOI 10.1002/eji.201646542; Papayannopoulos V, 2018, NAT REV IMMUNOL, V18, P134, DOI 10.1038/nri.2017.105; Peterson SL, 2014, EXP NEUROL, V258, P35, DOI 10.1016/j.expneurol.2014.04.028; Rathore KI, 2011, J NEUROSCI, V31, P13412, DOI 10.1523/JNEUROSCI.0116-11.2011; Rink S, 2018, EXP NEUROL, V309, P148, DOI 10.1016/j.expneurol.2018.08.003; Saiwai H, 2010, AM J PATHOL, V176, P2352, DOI 10.2353/ajpath.2010.090839; Salehi B, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12010011; Sharma K, 2012, EXP NEUROL, V237, P370, DOI 10.1016/j.expneurol.2012.07.009; Shi LB, 2016, GENE, V592, P128, DOI 10.1016/j.gene.2016.07.037; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Sparano JA, 2004, J CLIN ONCOL, V22, P4683, DOI 10.1200/JCO.2004.08.054; Suberviola B, 2008, INJURY, V39, P748, DOI 10.1016/j.injury.2007.12.005; Suk K, 2016, PROG NEUROBIOL, V144, P158, DOI 10.1016/j.pneurobio.2016.08.001; Sun L, 2010, BIOCHEM BIOPH RES CO, V399, P391, DOI 10.1016/j.bbrc.2010.07.084; Taoka Y, 2000, SPINAL CORD, V38, P754, DOI 10.1038/sj.sc.3101096; Taoka Y, 1997, NEUROSCIENCE, V79, P1177, DOI 10.1016/S0306-4522(97)00011-0; Taoka Y, 1998, BRAIN RES, V799, P264, DOI 10.1016/S0006-8993(98)00459-4; Titsworth WL, 2009, GLIA, V57, P1521, DOI 10.1002/glia.20867; Trivedi A, 2006, CLIN NEUROSCI RES, V6, P283, DOI 10.1016/j.cnr.2006.09.007; Vaibhav K, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax8847; Vecino E., 2016, COMPOSITION FUNCTION, DOI [10.5772/62527, DOI 10.5772/62527]; Wang TD, 2007, J FORMOS MED ASSOC, V106, P919, DOI 10.1016/S0929-6646(08)60062-5; Waselle L, 2009, MOL CELL NEUROSCI, V42, P315, DOI 10.1016/j.mcn.2009.08.004; Watt FM, 2004, TRENDS MOL MED, V10, P577, DOI 10.1016/j.molmed.2004.10.008; Wells JEA, 2003, J NEUROSCI, V23, P10107, DOI 10.1523/jneurosci.23-31-10107.2003; Whetstone WD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170512; Wilson TJ, 2009, MOL CANCER RES, V7, P1224, DOI 10.1158/1541-7786.MCR-09-0028; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xu J, 2001, J NEUROSCI, V21, P92, DOI 10.1523/JNEUROSCI.21-01-00092.2001; Yabluchanskiy A, 2013, PHYSIOLOGY, V28, P391, DOI 10.1152/physiol.00029.2013; Zhang HQ, 2011, NEUROTHERAPEUTICS, V8, P206, DOI 10.1007/s13311-011-0038-0	98	2	2	2	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.												10.1007/s12035-021-02443-5		JUN 2021	14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SW3CX	WOS:000664397000001	34159551				2022-02-06	
J	Shura, RD; Yoash-Gantz, RE; Pickett, TC; McDonald, SD; Tupler, LA				Shura, Robert D.; Yoash-Gantz, Ruth E.; Pickett, Treven C.; McDonald, Scott D.; Tupler, Larry A.			Relations Among Performance and Symptom Validity, Mild Traumatic Brain Injury, and Posttraumatic Stress Disorder Symptom Burden in Postdeployment Veterans	PSYCHOLOGICAL INJURY & LAW			English	Article						Performance validity; Word Memory Test; Symptom validity; Personality Assessment Inventory; Veteran	PERSONALITY-ASSESSMENT INVENTORY; WORD MEMORY TEST; RESPONSE BIAS; CHRONIC PAIN; HEAD-INJURY; PREVALENCE; MMPI-2; NEUROPSYCHOLOGY; LITIGANTS; SOLDIERS	The purpose of this study was to evaluate relationships among the Word Memory Test (WMT), symptom validity test (SVT) indices of the Personality Assessment Inventory (PAI), history of mild traumatic brain injury (mTBI), and posttraumatic stress disorder (PTSD) symptom burden. Participants were postdeployment, predominantly male (88.5%) veterans (N = 417) who completed a neurocognition study that included the WMT and PAI. Correlations, chi-square analyses, and ANOVAs were used for analyses. Results of aim 1 examining relations among the two tests found that 20.4% produced invalid scores on the WMT (regardless of PAI scores), 13.8% produced an invalid PAI (regardless of WMT scores), and 4.6% were invalid on both tests. Of the 4 original PAI validity scales, only Negative Impression Management was related to WMT failure; the supplementary Malingering Index was also significant at a smaller effect size. The second aim evaluated mTBI and PTSD symptoms in relation to validity scores. History of mTBI was associated with invalid WMT scores but not PAI scores; follow-up analyses indicated that injuries sustained during deployment were significantly more likely to produce invalid WMT scores than non-deployment injuries. Contrary to hypotheses, PTSD symptom burden was related to WMT failure but not overreporting on the PAI. After dividing the sample into four groups based on valid versus invalid WMT and PAI scores, the invalid PVT valid SVT group had the highest proportion of mTBI, whereas PTSD symptom burden was highest in the groups that invalidated both measures or only the WMT. Service-connected disability status was unrelated to either type of validity. Given invalidating both types of validity measures is uncommon, the importance of sampling both types of validity is highlighted.	[Shura, Robert D.; Yoash-Gantz, Ruth E.; Tupler, Larry A.] Midatlantic Mental Illness Res Educ & Clin Ctr, Durham, NC 27710 USA; [Shura, Robert D.; Yoash-Gantz, Ruth E.] Salisbury Vet Affairs Med Ctr, Res & Acad Affairs Serv Line, Salisbury, NC 28144 USA; [Shura, Robert D.] Wake Forest Sch Med, Dept Neurol, Winston Salem, NC 27101 USA; [Pickett, Treven C.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bathesda, MD USA; [McDonald, Scott D.] Cent Virginia Vet Affairs Hlth Care Syst, Richmond, VA USA; [McDonald, Scott D.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [McDonald, Scott D.] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA; [Tupler, Larry A.] Durham Vet Affairs Med Ctr, Durham, NC USA; [Tupler, Larry A.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA		Shura, RD (corresponding author), Midatlantic Mental Illness Res Educ & Clin Ctr, Durham, NC 27710 USA.; Shura, RD (corresponding author), Salisbury Vet Affairs Med Ctr, Res & Acad Affairs Serv Line, Salisbury, NC 28144 USA.; Shura, RD (corresponding author), Wake Forest Sch Med, Dept Neurol, Winston Salem, NC 27101 USA.	Robert.Shura2@va.gov		Shura, Robert/0000-0002-9505-0080	Durham Veterans Affairs Medical Center (VAMC); Salisbury VAMC; Richmond VAMC; Mid-Atlantic Mental Illness Research, Education, and Clinical Center; Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and TreatmentUS Department of Veterans Affairs	This work was supported by resources of the Durham Veterans Affairs Medical Center (VAMC); Salisbury VAMC; Richmond VAMC; the Mid-Atlantic Mental Illness Research, Education, and Clinical Center; and the Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment. Treven C. Pickett is now at National Intrepid Center of Excellence, Walter Reed National Military Medical Center, Bethesda, MD, USA	Aase DM, 2021, ARCH CLIN NEUROPSYCH, V36, P424, DOI 10.1093/arclin/acaa053; Aikman GG, 2008, APPL NEUROPSYCHOL, V15, P176, DOI 10.1080/09084280802324283; Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P828, DOI 10.1093/arclin/acs086; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Berry DTR, 1995, PSYCHOL ASSESSMENT, V7, P517; Bowden SC, 2006, CLIN NEUROPSYCHOL, V20, P858, DOI 10.1080/13854040500246935; Brancu M, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1570; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Calhoun PS, 2000, J PERS ASSESS, V75, P338, DOI 10.1207/S15327752JPA7502_11; Carone DA, 2014, CLIN NEUROPSYCHOL, V28, P146, DOI 10.1080/13854046.2013.861019; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Copeland CT, 2016, ARCH CLIN NEUROPSYCH, V31, P18, DOI 10.1093/arclin/acv065; Critchfield E, 2019, CLIN NEUROPSYCHOL, V33, P1083, DOI 10.1080/13854046.2018.1508615; Defense and Veterans Brain Injury Center (DVBIC), 2019, TOT DOD TBI WORLDW N; Denning JH, 2019, APPL NEUROPSYCH-ADUL, V26, P1, DOI 10.1080/23279095.2017.1350684; Dismuke-Greer CE, 2019, BRAIN INJURY, V33, P198, DOI 10.1080/02699052.2018.1542508; Erdodi LA, 2019, PSYCHOL INJ LAW, V12, P155, DOI 10.1007/s12207-019-09356-8; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Gaasedelen OJ, 2019, CLIN NEUROPSYCHOL, V33, P1467, DOI 10.1080/13854046.2019.1612947; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97; Green P., 2005, GREENS WORD MEMORY T, Vrev. ed.; Green P, 2015, APPL NEUROPSYCH-ADUL, V22, P293, DOI 10.1080/23279095.2014.925903; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Haggerty KA, 2007, CLIN NEUROPSYCHOL, V21, P917, DOI 10.1080/13854040600899724; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hopwood CJ, 2007, J PERS ASSESS, V88, P43, DOI 10.1207/s15327752jpa8801_06; Ingram PB, 2020, PSYCHOL SERV, V17, P355, DOI 10.1037/ser0000339; Ivins BJ, 2003, J TRAUMA, V55, P617, DOI 10.1097/01.TA.0000052368.97573.D4; Jurick SM, 2019, ARCH CLIN NEUROPSYCH, V34, P366, DOI 10.1093/arclin/acy048; Kessler RC, 2014, JAMA PSYCHIAT, V71, P504, DOI 10.1001/jamapsychiatry.2014.28; Kucharski LT, 2007, J PERS ASSESS, V88, P25, DOI 10.1207/s15327752jpa8801_04; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Larrabee GJ, 2003, ARCH CLIN NEUROPSYCH, V18, P673, DOI 10.1016/S0887-6177(02)00157-9; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P54, DOI 10.1076/clin.17.1.54.15627; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Martindale SL, 2021, REHABIL PSYCHOL, V66, P128, DOI 10.1037/rep0000374; Martindale SL, 2018, ARCH PHYS MED REHAB, V99, P2485, DOI 10.1016/j.apmr.2018.04.029; McCaffrey R.J., 2003, J FORENSIC NEUROPSYC, V3, P45, DOI [https://doi.org/10.1300/J151v03n03_03, DOI 10.1300/J151V03N03_03]; McCormick CL, 2013, ARCH CLIN NEUROPSYCH, V28, P808, DOI 10.1093/arclin/act050; Miskey HM, 2020, J NEUROPSYCH CLIN N, V32, P161, DOI 10.1176/appi.neuropsych.17110340; Mooney SR, 2018, MIL MED, V183, pE546, DOI 10.1093/milmed/usy038; Morey L.C., 2007, PERSONALITY ASSESSME; Nelson NW, 2007, J INT NEUROPSYCH SOC, V13, P440, DOI 10.1017/S1355617707070373; Nelson NW, 2003, CLIN NEUROPSYCHOL, V17, P263, DOI 10.1076/clin.17.2.263.16511; Panayiotou A, 2010, J CLIN EXP NEUROPSYC, V32, P463, DOI 10.1080/13803390903164371; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; Sumanti M, 2006, CLIN NEUROPSYCHOL, V20, P754, DOI 10.1080/13854040500428467; Thomas KM, 2012, PSYCHOL INJ LAW, V5, P192, DOI 10.1007/s12207-011-9111-6; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Veterans Benefits Administration, 2019, ANN BEN REP FISC YEA; Wang EW, 1997, BEHAV SCI LAW, V15, P469, DOI 10.1002/(SICI)1099-0798(199723/09)15:4<469::AID-BSL279>3.0.CO;2-A; Whiteside DM, 2012, J CLIN EXP NEUROPSYC, V34, P172, DOI 10.1080/13803395.2011.630648; Whiteside DM, 2009, CLIN NEUROPSYCHOL, V23, P523, DOI 10.1080/13854040802389169; Youngjohn JR, 1997, PSYCHOL ASSESSMENT, V9, P177, DOI 10.1037/1040-3590.9.3.177	61	2	2	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	DEC	2021	14	4			SI		257	268		10.1007/s12207-021-09415-z		JUN 2021	12	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	WV8RE	WOS:000665813700001					2022-02-06	
J	O'Brien, LD; Smith, TL; Donvito, G; Cravatt, BF; Newton, J; Spiegel, S; Reeves, TM; Phillips, LL; Lichtman, AH				O'Brien, Lesley D.; Smith, Terry L.; Donvito, Giulia; Cravatt, Benjamin F.; Newton, Jason; Spiegel, Sarah; Reeves, Thomas M.; Phillips, Linda L.; Lichtman, Aron H.			Diacylglycerol Lipase-beta Knockout Mice Display a Sex-Dependent Attenuation of Traumatic Brain Injury-Induced Mortality with No Impact on Memory or Other Functional Consequences	CANNABIS AND CANNABINOID RESEARCH			English	Article; Early Access						2-arachidonylglycerol; diacylglycerol lipase-beta; endocannabinoid; endocannabinoid spatial memory; mortality; sphingolipids; traumatic brain injury	MOUSE MODEL; ENDOCANNABINOID 2-ARACHIDONOYLGLYCEROL; SPHINGOLIPID METABOLISM; INFLAMMATORY RESPONSE; PROGESTERONE; INHIBITION; RECOVERY; ALPHA; NEUROPROTECTION; ACQUISITION	Background: The endogenous cannabinoid system modulates inflammatory signaling in a variety of pathological states, including traumatic brain injury (TBI). The selective expression of diacylglycerol lipase-beta (DAGL-beta), the 2-arachidonylglycerol biosynthetic enzyme, on resident immune cells of the brain (microglia) and the role of this pathway in neuroinflammation, suggest that this enzyme may contribute to TBI-induced neuroinflammation. Accordingly, we tested whether DAGL-beta(-/-) mice would show a protective phenotype from the deleterious consequences of TBI on cognitive and neurological motor functions. Materials and Methods: DAGL-beta(-/-) and -beta(+/+) mice were subjected to the lateral fluid percussion model of TBI and assessed for learning and memory in the Morris water maze (MWM) Fixed Platform (reference memory) and Reversal (cognitive flexibility) tasks, as well as in a cued MWM task to infer potential sensorimotor/motivational deficits. In addition, subjects were assessed for motor behavior (Rotarod and the Neurological Severity Score assays) and in the light/dark box and the elevated plus maze to infer whether these manipulations affected anxiety-like behavior. Finally, we also examined whether brain injury disrupts the ceramide/sphingolipid lipid signaling system and if DAGL-beta deletion offers protection. Results: TBI disrupted all measures of neurological motor function and reduced body weight, but did not affect body temperature or performance in common assays used to infer anxiety. TBI also impaired performance in MWM Fixed Platform and Reversal tasks, but did not affect cued MWM performance. Although no differences were found between DAGL-beta(-/-) and -beta(+/+) mice in any of these measures, male DAGL-beta(-/-) mice displayed an unexpected survival-protective phenotype, which persisted at increased injury severities. In contrast, TBI did not elicit mortality in female mice regardless of genotype. TBI also produced significant changes in sphingolipid profiles (a family of lipids, members of which have been linked to both apoptotic and antiapoptotic pathways), in which DAGL-beta deletion modestly altered levels of select species. Conclusions: These findings indicate that although DAGL-beta does not play a necessary role in TBI-induced cognitive and neurological function, it appears to contribute to the increased vulnerability of male mice to TBI-induced mortality, whereas female mice show high survival rates irrespective of DAGL-beta expression.	[O'Brien, Lesley D.; Donvito, Giulia; Lichtman, Aron H.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, POB 980613, Richmond, VA 23298 USA; [Smith, Terry L.; Reeves, Thomas M.; Phillips, Linda L.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23298 USA; [Newton, Jason; Spiegel, Sarah] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Lichtman, Aron H.] Virginia Commonwealth Univ, Dept Med Chem, POB 980613, Richmond, VA 23298 USA; [Cravatt, Benjamin F.] Scripps Res Inst, Dept Mol Med, La Jolla, CA USA; [Newton, Jason] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23298 USA		Lichtman, AH (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, POB 980613, Richmond, VA 23298 USA.; Lichtman, AH (corresponding author), Virginia Commonwealth Univ, Dept Med Chem, POB 980613, Richmond, VA 23298 USA.	aron.lichtman@vcuhealth.org	Newton, Jason/AAN-8428-2020	O'Brien (nee Schurman), Lesley/0000-0002-5877-3976; Lichtman, Aron/0000-0001-5601-985X	National Institutes of Health (NIH-NCI) Cancer Center Support Grant [P30 CA016059]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [S10RR031535, NS093990, P30DA033934, DA033760, 1F31NS095628, K99HD096117, NS57758, GM043880, NS56247]; VCU School of Pharmacy; VCU Lipidomics/Metabolomics Core	This work was supported by the VCU Lipidomics/Metabolomics Core, the National Institutes of Health (NIH-NCI) Cancer Center Support Grant P30 CA016059 to the Massey Cancer Center, NIH shared resource grant (S10RR031535), NIH [Grant NS093990], and NIH [Grant P30DA033934] (to A.H.L.); NIH [Grant DA033760] (to B.F.C.); NIH [Grant 1F31NS095628] (to L.D.OB.); NIH [Grant K99HD096117] (to J.N.); NIH [Grant NS57758] (to T.M.R.); NIH [Grant GM043880] (to S.S.); and NIH [Grant NS56247] (to L.L.P.). Start-up funds from the VCU School of Pharmacy also supported this work.	Armstrong RA, 2019, FOLIA NEUROPATHOL, V57, P87, DOI 10.5114/fn.2019.85929; Barbacci DC, 2017, ACS CHEM NEUROSCI, V8, P2266, DOI 10.1021/acschemneuro.7b00189; Lopez-Rodriguez AB, 2015, PSYCHONEUROENDOCRINO, V56, P1, DOI 10.1016/j.psyneuen.2015.02.018; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Browne KD, 2006, EXP NEUROL, V201, P301, DOI 10.1016/j.expneurol.2006.04.008; Chakraborty S, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0625-x; Chen X, 2010, NEUROL RES, V32, P1097, DOI 10.1179/016164110X12681290831162; Chen X, 2009, J NEUROTRAUM, V26, P253, DOI 10.1089/neu.2007.0504; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Farfel-Becker T, 2014, HUM MOL GENET, V23, P843, DOI 10.1093/hmg/ddt468; Ferguson S, 2017, J NEUROTRAUM, V34, P1676, DOI 10.1089/neu.2016.4636; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Hait NC, 2014, NAT NEUROSCI, V17, P971, DOI 10.1038/nn.3728; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Hillard CJ, 2000, PROSTAG OTH LIPID M, V61, P3, DOI 10.1016/S0090-6980(00)00051-4; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Hsu KL, 2012, NAT CHEM BIOL, V8, P999, DOI [10.1038/NCHEMBIO.1105, 10.1038/nchembio.1105]; Janssen FJ, 2016, BIOORG MED CHEM LETT, V26, P3831, DOI 10.1016/j.bmcl.2016.06.076; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Laskowitz DT, 2007, J NEUROTRAUM, V24, P1093, DOI 10.1089/neu.2006.0192; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Ley EJ, 2013, J TRAUMA ACUTE CARE, V75, P682, DOI 10.1097/TA.0b013e31829d024f; Mecha M, 2015, BRAIN BEHAV IMMUN, V49, P233, DOI 10.1016/j.bbi.2015.06.002; Meltser I, 2008, J CLIN INVEST, V118, P1563, DOI 10.1172/JCI32796; Murray CA, 1998, J NEUROSCI, V18, P2974; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Neese SL, 2010, BRAIN RES, V1362, P93, DOI 10.1016/j.brainres.2010.09.055; Newcombe EA, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1313-3; Nguyen BM, 2014, AM SURGEON, V80, P979; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Novgorodov SA, 2018, J LIPID RES, V59, P312, DOI 10.1194/jlr.M080374; Oaks J, 2015, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00388; Ogretmen B, 2018, NAT REV CANCER, V18, P33, DOI 10.1038/nrc.2017.96; Pascual JL, 2013, AM J SURG, V206, P840, DOI 10.1016/j.amjsurg.2013.07.016; PIOMELLI D, 1996, ARACHIDONIC ACID CEL; Rossi S, 2012, MULT SCLER J, V18, P1633, DOI 10.1177/1352458512440207; Roux A, 2016, J NEUROSCI METH, V272, P19, DOI 10.1016/j.jneumeth.2016.02.004; Schaible EV, 2014, J NEUROCHEM, V129, P940, DOI 10.1111/jnc.12708; Schurman LD, 2019, J NEUROSCI, V39, P5949, DOI 10.1523/JNEUROSCI.1353-18.2019; Schurman LD, 2017, NEUROSCI LETT, V653, P31, DOI 10.1016/j.neulet.2017.05.032; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Shang JL, 2014, BRAZ J MED BIOL RES, V47, P1050, DOI 10.1590/1414-431X20143601; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Sugaya Y, 2013, J NEUROSCI, V33, P3588, DOI 10.1523/JNEUROSCI.3141-12.2013; Tanimura A, 2012, P NATL ACAD SCI USA, V109, P12195, DOI 10.1073/pnas.1204404109; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Tchantchou F, 2013, J NEUROTRAUM, V30, P565, DOI 10.1089/neu.2012.2647; Umeano Odera, 2017, World J Crit Care Med, V6, P107, DOI 10.5492/wjccm.v6.i2.107; Viader A., 2015, ELIFE, V5, P1; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Wilkerson JL, 2016, BRIT J PHARMACOL, V173, P1678, DOI 10.1111/bph.13469; Won JS, 2016, J NEUROSCI RES, V94, P990, DOI 10.1002/jnr.23873; Woods AS, 2013, ACS CHEM NEUROSCI, V4, P594, DOI 10.1021/cn300216h; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yoshida T, 2006, J NEUROSCI, V26, P4740, DOI 10.1523/JNEUROSCI.0054-06.2006; Yoshino H, 2011, J PHYSIOL-LONDON, V589, P4857, DOI 10.1113/jphysiol.2011.212225; Zhang J, 2015, J CEREBR BLOOD F MET, V35, P443, DOI 10.1038/jcbfm.2014.216	65	2	2	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2578-5125	2378-8763		CANNABIS CANNABINOID	Cannabis Cannabinoid Res.												10.1089/can.2020.0175		JUN 2021	14	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	SV0PI	WOS:000663529100001	34142866				2022-02-06	
J	Stephens, TM; Young, IM; O'Neal, CM; Dadario, NB; Briggs, RG; Teo, C; Sughrue, ME				Stephens, Tressie M.; Young, Isabella M.; O'Neal, Christen M.; Dadario, Nicholas B.; Briggs, Robert G.; Teo, Charles; Sughrue, Michael E.			Akinetic mutism reversed by inferior parietal lobule repetitive theta burst stimulation: Can we restore default mode network function for therapeutic benefit?	BRAIN AND BEHAVIOR			English	Article						default mode network; glioblastoma; right frontal tumor; theta burst stimulation; transcranial magnetic stimulation; tumor resection		Background Transcranial magnetic stimulation is a noninvasive treatment used to modulate cortical excitability. Its use over the last two decades has expanded, ranging from psychiatric disorders to traumatic brain injury and poststroke rehabilitation. Objectives We present the case of a 59-year-old male patient who presented in a decreased state of consciousness due to a right frontal glioblastoma, wherein his state was not improved by a successful surgery and could not be explained by any other condition. Due to his poor prognosis, we examine the benefits of receiving transcranial magnetic stimulation treatment to improve his akinetic mutism. Methods We utilized independent component analysis with resting-state functional magnetic resonance imaging (rsfMRI) to better understand his cortical functionality. The imaging suggested absence of the default mode network (DMN). The patient underwent five sessions of navigated intermittent theta burst stimulation to the ipsilesional inferior parietal lobule and inferior frontal gyrus, with the aim of improving his default mode network functionality. Results No other treatments resulted in an improvement of this patient's condition; however, 3 weeks following transcranial magnetic stimulation treatment, the patient was more alert and interactive, and his follow-up rsfMRI scan demonstrated a partially intact default mode network. Conclusion This case raises important questions regarding the clinical utility of transcranial magnetic stimulation to improve the connectivity of important cerebral networks and subsequent related functional recovery.	[Stephens, Tressie M.; O'Neal, Christen M.; Briggs, Robert G.] Univ Oklahoma, Hlth Sci Ctr, Dept Neurosurg, Oklahoma City, OK USA; [Young, Isabella M.] Cingulum Hlth, Sydney, NSW, Australia; [Dadario, Nicholas B.] Rutgers Robert Johnson Wood Sch Med, New Brunswick, NJ USA; [Teo, Charles; Sughrue, Michael E.] Prince Wales Private Hosp, Ctr Minimally Invas Neurosurg, Sydney, NSW, Australia		Sughrue, ME (corresponding author), Prince Wales Private Hosp, Ctr Minimally Invas Neurosurg, Suite 19,Level 7,Barker St, Randwick, NSW, Australia.	sughruevs@gmail.com		Young, Isabella M./0000-0001-7639-6679; O'Neal, Christen/0000-0001-8412-4040			Briggs RG, 2021, CANCERS, V13, DOI 10.3390/cancers13051116; Burks JD, 2017, J NEUROSURG, V126, P1795, DOI 10.3171/2016.5.JNS153006; Cardenas-Morales L, 2011, HUM BRAIN MAPP, V32, P1948, DOI 10.1002/hbm.21160; Ebke M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00792; Glover GH, 2012, NEUROIMAGE, V62, P706, DOI 10.1016/j.neuroimage.2011.10.039; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Hannawi Y, 2015, NEUROLOGY, V84, P1272, DOI 10.1212/WNL.0000000000001404; Hu ML, 2017, NEUROSCI BULL, V33, P73, DOI 10.1007/s12264-016-0090-1; Igelstrom KM, 2017, NEUROPSYCHOLOGIA, V105, P70, DOI 10.1016/j.neuropsychologia.2017.01.001; Kim DH, 2002, MAGNET RESON MED, V48, P715, DOI 10.1002/mrm.10267; Marino S, 2016, BRAIN IMAGING BEHAV, V10, P604, DOI 10.1007/s11682-015-9417-1; Padilla R, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.021022; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Shang YQ, 2020, BRAIN IMAGING BEHAV, V14, P1955, DOI 10.1007/s11682-019-00139-y; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Storti SF, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00072; Thomason ME, 2011, NEUROIMAGE, V55, P165, DOI 10.1016/j.neuroimage.2010.11.080; Threlkeld ZD, 2018, CORTEX, V106, P299, DOI 10.1016/j.cortex.2018.05.004; Van Calster L, 2017, J COGNITIVE NEUROSCI, V29, P95, DOI 10.1162/jocn_a_01025	19	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	AUG	2021	11	8							e02180	10.1002/brb3.2180		JUN 2021	7	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	WK0YR	WOS:000662723900001	34145791	Green Published, gold			2022-02-06	
J	Kochsiek, J; O'Donnell, LJ; Zhang, F; Bonke, EM; Sollmann, N; Tripodis, Y; Wiegand, TLT; Kaufmann, D; Umminger, L; Di Biase, MA; Kaufmann, E; Schultz, V; Alosco, ML; Martin, BM; Lin, AP; Coleman, MJ; Rathi, Y; Pasternak, O; Bouix, S; Stern, RA; Shenton, ME; Koerte, IK				Kochsiek, Janna; O'Donnell, Lauren J.; Zhang, Fan; Bonke, Elena M.; Sollmann, Nico; Tripodis, Yorghos; Wiegand, Tim L. T.; Kaufmann, David; Umminger, Lisa; Di Biase, Maria A.; Kaufmann, Elisabeth; Schultz, Vivian; Alosco, Michael L.; Martin, Brett M.; Lin, Alexander P.; Coleman, Michael J.; Rathi, Yogesh; Pasternak, Ofer; Bouix, Sylvain; Stern, Robert A.; Shenton, Martha E.; Koerte, Inga K.			Exposure to Repetitive Head Impacts Is Associated With Corpus Callosum Microstructure and Plasma Total Tau in Former Professional American Football Players	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						Sport-related brain injury; diffusion MR imaging; tractography; neurodegeneration; chronic traumatic encephalopathy; neuropsychological testing	TRAUMATIC BRAIN-INJURY; WHITE-MATTER; SEX-DIFFERENCES; TRACTOGRAPHY; PROTEIN	Background Exposure to repetitive head impacts (RHI) is associated with an increased risk of later-life neurobehavioral dysregulation and neurodegenerative disease. The underlying pathomechanisms are largely unknown. Purpose To investigate whether RHI exposure is associated with later-life corpus callosum (CC) microstructure and whether CC microstructure is associated with plasma total tau and neuropsychological/neuropsychiatric functioning. Study Type Retrospective cohort study. Population Seventy-five former professional American football players (age 55.2 +/- 8.0 years) with cognitive, behavioral, and mood symptoms. Field Strength/Sequence Diffusion-weighted echo-planar MRI at 3 T. Assessment Subjects underwent diffusion MRI, venous puncture, neuropsychological testing, and completed self-report measures of neurobehavioral dysregulation. RHI exposure was assessed using the Cumulative Head Impact Index (CHII). Diffusion MRI measures of CC microstructure (i.e., free-water corrected fractional anisotropy (FA), trace, radial diffusivity (RD), and axial diffusivity (AD)) were extracted from seven segments of the CC (CC1-7), using a tractography clustering algorithm. Neuropsychological tests were selected: Trail Making Test Part A (TMT-A) and Part B (TMT-B), Controlled Oral Word Association Test (COWAT), Stroop Interference Test, and the Behavioral Regulation Index (BRI) from the Behavior Rating Inventory of Executive Function, Adult version (BRIEF-A). Statistical Tests Diffusion MRI metrics were tested for associations with RHI exposure, plasma total tau, neuropsychological performance, and neurobehavioral dysregulation using generalized linear models for repeated measures. Results RHI exposure was associated with increased AD of CC1 (correlation coefficient (r) = 0.32, P < 0.05) and with increased plasma total tau (r = 0.34, P < 0.05). AD of the anterior CC1 was associated with increased plasma total tau (CC1: r = 0.30, P < 0.05; CC2: r = 0.29, P < 0.05). Higher trace, AD, and RD of CC1 were associated with better performance (P < 0.05) in TMT-A (trace, r = 0.33; AD, r = 0.31; and RD, r = 0.28) and TMT-B (trace, r = 0.31; RD, r = 0.34). Higher FA and AD of CC2 were associated with better performance (P < 0.05) in TMT-A (FA, r = 0.36; AD, r = 0.28), TMT-B (FA, r = 0.36; AD, r = 0.27), COWAT (FA, r = 0.36; AD, r = 0.32), and BRI (AD, r = 0.29). Data Conclusion These results suggest an association among RHI exposure, CC microstructure, plasma total tau, and clinical functioning in former professional American football players. Technical Efficacy Stage: 1	[Kochsiek, Janna; Bonke, Elena M.; Sollmann, Nico; Kaufmann, David; Umminger, Lisa; Di Biase, Maria A.; Kaufmann, Elisabeth; Schultz, Vivian; Lin, Alexander P.; Coleman, Michael J.; Rathi, Yogesh; Pasternak, Ofer; Bouix, Sylvain; Shenton, Martha E.; Koerte, Inga K.] Harvard Med Sch, Brigham & Womens Hosp, Psychiat Neuroimaging Lab, Boston, MA 02115 USA; [Kochsiek, Janna; Bonke, Elena M.; Sollmann, Nico; Wiegand, Tim L. T.; Kaufmann, David; Umminger, Lisa; Kaufmann, Elisabeth; Schultz, Vivian; Koerte, Inga K.] Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat Psychosomat & Ps, cBRAIN, Munich, Germany; [O'Donnell, Lauren J.; Zhang, Fan] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Lab Math Imaging, Boston, MA 02115 USA; [O'Donnell, Lauren J.; Zhang, Fan; Rathi, Yogesh; Pasternak, Ofer; Shenton, Martha E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; [Bonke, Elena M.; Koerte, Inga K.] Ludwig Maximilians Univ Munchen, Grad Sch Syst Neurosci, Munich, Germany; [Sollmann, Nico; Schultz, Vivian] Tech Univ Munich, Sch Med, Dept Diagnost & Intervent Neuroradiol, Klinikum Rechts Isar, Munich, Germany; [Sollmann, Nico] Tech Univ Munich, TUM Neuroimaging Ctr, Klinikum Rechts Isar, Munich, Germany; [Sollmann, Nico] Univ Hosp Ulm, Dept Diagnost & Intervent Radiol, Ulm, Germany; [Tripodis, Yorghos] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Tripodis, Yorghos; Alosco, Michael L.; Stern, Robert A.] Boston Univ, Alzheimers Dis Ctr, Boston, MA 02215 USA; [Tripodis, Yorghos; Alosco, Michael L.; Stern, Robert A.] Boston Univ, Sch Med, CTE Ctr, Boston, MA 02118 USA; [Kaufmann, David] Charite, Dept Radiol, Berlin, Germany; [Kaufmann, David] Univ Augsburg, Univ Hosp Augsburg, Dept Radiol, Augsburg, Germany; [Di Biase, Maria A.; Shenton, Martha E.; Koerte, Inga K.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02115 USA; [Kaufmann, Elisabeth] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Neurol, Munich, Germany; [Alosco, Michael L.; Stern, Robert A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Martin, Brett M.] Boston Univ, Sch Publ Hlth, Data Coordinating Ctr, Boston, MA USA; [Lin, Alexander P.] Harvard Med Sch, Ctr Clin Spect, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Anat, Boston, MA 02118 USA		Koerte, IK (corresponding author), 1249 Boylston St, Boston, MA 02215 USA.	ikoerte@bwh.harvard.edu	Koerte, Inga Katharina/AAW-3031-2021	Sollmann, Nico/0000-0002-8120-2223; Bonke, Elena/0000-0002-8547-7283; O'Donnell, Lauren Jean/0000-0003-0197-7801	National Institute of Neurologic Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS078337]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS100952, R01 HD090641]; Projekt DEAL	This study was funded by the National Institute of Neurologic Disorders and Stroke (R01 NS078337, R.A. Stern). This work was also supported by research grants from NIH (R01 NS100952, I.K. Koerte; R01 HD090641, S. Bouix). Plasma total tau assays were provided by Quanterix (Billerica, MA, USA). Open Access funding enabled and organized by Projekt DEAL.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; Alosco ML, 2017, J NEUROTRAUM, V34, P772, DOI 10.1089/neu.2016.4536; Amlien IK, 2013, RADIOLOGY, V266, P295, DOI 10.1148/radiol.12120319; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Banks WA, 2017, J ALZHEIMERS DIS, V55, P411, DOI 10.3233/JAD-160542; Bendlin BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037720; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Dage JL, 2016, ALZHEIMERS DEMENT, V12, P1226, DOI 10.1016/j.jalz.2016.06.001; Dolle JP, 2018, EXP NEUROL, V300, P121, DOI 10.1016/j.expneurol.2017.11.001; Farell M, 2019, CLIN NEUROPATHOL, V38, P51, DOI 10.5414/NP301130; Freshwater SM, 1878, STROOP COLOR WORD TE; Goldberg E, 2005, PSYCHIAT CLIN N AM, V28, P567, DOI 10.1016/j.psc.2005.05.005; Guo T, 2017, ACTA NEUROPATHOL, V133, P665, DOI 10.1007/s00401-017-1707-9; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Katz DI, 2021, NEUROLOGY, V96, P848, DOI 10.1212/WNL.0000000000011850; Kawata K, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.581781; KING AI, 1995, J NEUROTRAUM, V12, P651, DOI 10.1089/neu.1995.12.651; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Laing KK, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa132; Liao R, 2017, NEUROIMAGE-CLIN, V15, P819, DOI 10.1016/j.nicl.2017.06.027; Makris N, 1999, NEUROIMAGE, V9, P18, DOI 10.1006/nimg.1998.0384; Michalicova A, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.570045; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Norton I, 2017, CANCER RES, V77, pE101, DOI 10.1158/0008-5472.CAN-17-0332; O'Donnell LJ, 2007, IEEE T MED IMAGING, V26, P1562, DOI 10.1109/TMI.2007.906785; Popoola Olusegun, 2019, Case Rep Psychiatry, V2019, P5925191, DOI 10.1155/2019/5925191; Reddy CP, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00166; Reitan RM, 1992, TRAIL MAKING TEST MA; ROTH R, 2005, CHILD NEUROPSYCHOL, V6, P235; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stenset V, 2011, NEUROBIOL AGING, V32, P581, DOI 10.1016/j.neurobiolaging.2009.04.014; Taghdiri F, 2019, NEUROLOGY, V92, pE2717, DOI 10.1212/WNL.0000000000007608; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Xu JS, 2013, HUM BRAIN MAPP, V34, P1044, DOI 10.1002/hbm.21491	40	2	2	7	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	DEC	2021	54	6					1819	1829		10.1002/jmri.27774		JUN 2021	11	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	XE2TY	WOS:000662028000001	34137112	Green Published, hybrid			2022-02-06	
J	Ribeiro, TN; Delgado-Garcia, LM; Porcionatto, MA				Ribeiro, Tais Novaki; Delgado-Garcia, Lina Maria; Porcionatto, Marimelia A.			Notch1 and Galectin-3 Modulate Cortical Reactive Astrocyte Response After Brain Injury	FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY			English	Article						neurogenic program; astrocyte reactivation; traumatic brain injury; dedifferentiation; neurogenic signaling pathway; NICD; Jagged; Hes5	PERIINFARCT AREA; STEM-CELLS; ACTIVATION; SURFACE; DIFFERENTIATION; PROLIFERATION; ASTROGLIOSIS; GLIOSIS; DELTA; PCR	After a brain lesion, highly specialized cortical astrocytes react, supporting the closure or replacement of the damaged tissue, but fail to regulate neural plasticity. Growing evidence indicates that repair response leads astrocytes to reprogram, acquiring a partially restricted regenerative phenotype in vivo and neural stem cells (NSC) hallmarks in vitro. However, the molecular factors involved in astrocyte reactivity, the reparative response, and their relation to adult neurogenesis are poorly understood and remain an area of intense investigation in regenerative medicine. In this context, we addressed the role of Notch1 signaling and the effect of Galectin-3 (Gal3) as underlying molecular candidates involved in cortical astrocyte response to injury. Notch signaling is part of a specific neurogenic microenvironment that maintains NSC and neural progenitors, and Gal3 has a preferential spatial distribution across the cortex and has a central role in the proliferative capacity of reactive astrocytes. We report that in vitro scratch-reactivated cortical astrocytes from C57Bl/6J neonatal mice present nuclear Notch1 intracellular domain (NICD1), indicating Notch1 activation. Colocalization analysis revealed a subpopulation of reactive astrocytes at the lesion border with colocalized NICD1/Jagged1 complexes compared with astrocytes located far from the border. Moreover, we found that Gal3 increased intracellularly, in contrast to its extracellular localization in non-reactive astrocytes, and NICD1/Gal3 pattern distribution shifted from diffuse to vesicular upon astrocyte reactivation. In vitro, Gal3(-/-) reactive astrocytes showed abolished Notch1 signaling at the lesion core. Notch1 receptor, its ligands (Jagged1 and Delta-like1), and Hes5 target gene were upregulated in C57Bl/6J reactive astrocytes, but not in Gal3(-/-) reactive astrocytes. Finally, we report that Gal3(-/-) mice submitted to a traumatic brain injury model in the somatosensory cortex presented a disrupted response characterized by the reduced number of GFAP reactive astrocytes, with smaller cell body perimeter and decreased NICD1 presence at the lesion core. These results suggest that Gal3 might be essential to the proper activation of Notch signaling, facilitating the cleavage of Notch1 and nuclear translocation of NICD1 into the nucleus of reactive cortical astrocytes. Additionally, we hypothesize that reactive astrocyte response could be dependent on Notch1/Jagged1-Hes5 signaling activation following brain injury.	[Ribeiro, Tais Novaki; Delgado-Garcia, Lina Maria; Porcionatto, Marimelia A.] Univ Fed Sao Paulo, Dept Biochem, Lab Mol Neurobiol, Sao Paulo, Brazil		Porcionatto, MA (corresponding author), Univ Fed Sao Paulo, Dept Biochem, Lab Mol Neurobiol, Sao Paulo, Brazil.	marimelia.porcionatto@unifesp.br			Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2018/12605-8, 2018/05846-9, 2016/190848, 2016/25737-4, 2015/19231-8]; Coordination for the Improvement of Higher Education Personnel (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]; National Council for Scientific and Technological Development (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [465656/2014-5, 309679/2018-4]; IBRO LARC Exchange Fellowships program	This work was supported by the Sao Paulo Research Foundation (FAPESP) grant nos. 2018/12605-8, 2018/05846-9, 2016/190848, 2016/25737-4, and 2015/19231-8, Coordination for the Improvement of Higher Education Personnel (CAPES; Financial Code 001), and the National Council for Scientific and Technological Development (CNPq), grant nos. 465656/2014-5 and 309679/2018-4. LD-G received a grant from IBRO LARC Exchange Fellowships program.	Ables JL, 2010, J NEUROSCI, V30, P10484, DOI 10.1523/JNEUROSCI.4721-09.2010; Acaz-Fonseca E, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0166-6; Al-Dalahmah O, 2020, GLIA, V68, P435, DOI 10.1002/glia.23730; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Caberoy NB, 2012, J CELL PHYSIOL, V227, P401, DOI 10.1002/jcp.22955; de Oliveira FL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21409-7; dos Santos SN, 2017, ONCOTARGET, V8, P49484, DOI 10.18632/oncotarget.17718; Elola MT, 2015, BIOCHEM J, V469, P1, DOI 10.1042/BJ20150461; Engler A, 2018, CELL REP, V22, P992, DOI 10.1016/j.celrep.2017.12.094; Escartin C, 2021, NAT NEUROSCI, V24, P312, DOI 10.1038/s41593-020-00783-4; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Grandbarbe L, 2003, DEVELOPMENT, V130, P1391, DOI 10.1242/dev.00374; Heng J, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000696; Hsu DK, 2000, AM J PATHOL, V156, P1073, DOI 10.1016/S0002-9440(10)64975-9; Jia JY, 2020, DEV CELL, V52, P69, DOI 10.1016/j.devcel.2019.10.025; Johannes L, 2018, J CELL SCI, V131, DOI 10.1242/jcs.208884; John S, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00139; Kang HG, 2016, ONCOTARGET, V7, P68229, DOI 10.18632/oncotarget.11920; Kobayashi T, 2014, CURR TOP DEV BIOL, V110, P263, DOI 10.1016/B978-0-12-405943-6.00007-5; Lakshminarayan R, 2014, NAT CELL BIOL, V16, P592, DOI 10.1038/ncb2970; LaVoie MJ, 2003, J BIOL CHEM, V278, P34427, DOI 10.1074/jbc.M302659200; Lebkuechner I, 2015, J NEUROCHEM, V135, P234, DOI 10.1111/jnc.13213; LeComte MD, 2015, P NATL ACAD SCI USA, V112, P8726, DOI 10.1073/pnas.1501029112; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magnusson JP, 2020, ELIFE, V9, DOI 10.7554/eLife.59733; Magnusson JP, 2014, SCIENCE, V346, P237, DOI 10.1126/science.346.6206.237; Manderfield LJ, 2012, CIRCULATION, V125, P314, DOI 10.1161/CIRCULATIONAHA.111.047159; Mundim MV, 2019, MOL CELL NEUROSCI, V94, P1, DOI 10.1016/j.mcn.2018.10.004; Nabi IR, 2015, J CELL SCI, V128, P2213, DOI 10.1242/jcs.151159; Nakajima K, 2014, NEOPLASIA, V16, P939, DOI 10.1016/j.neo.2014.09.005; Nangia-Makker P, 2018, GLYCOBIOLOGY, V28, P172, DOI 10.1093/glycob/cwy001; Newlaczyl AU, 2011, CANCER LETT, V313, P123, DOI 10.1016/j.canlet.2011.09.003; Nguyen JV, 2011, P NATL ACAD SCI USA, V108, P1176, DOI 10.1073/pnas.1013965108; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Nomura K, 2017, J IMMUNOL, V198, P4792, DOI 10.4049/jimmunol.1502532; Pekny M, 2019, NEUROSCI LETT, V689, P45, DOI 10.1016/j.neulet.2018.07.021; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Petrovic J, 2014, DEVELOPMENT, V141, P2313, DOI 10.1242/dev.108100; Puigdellivol M, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00162; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Rotshenker S, 2009, J MOL NEUROSCI, V39, P99, DOI 10.1007/s12031-009-9186-7; Santopolo G, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9071732; Shimada IS, 2012, J NEUROSCI, V32, P7926, DOI 10.1523/JNEUROSCI.4303-11.2012; Shimada IS, 2011, STROKE, V42, P3231, DOI 10.1161/STROKEAHA.111.623280; Sirko S, 2015, GLIA, V63, P2340, DOI 10.1002/glia.22898; Srejovic I, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10050798; Stanley P, 2014, NAT CELL BIOL, V16, P506, DOI 10.1038/ncb2983; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Venkatesan C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-32; Verkhratsky A, 2021, PFLUG ARCH EUR J PHY, V473, P753, DOI 10.1007/s00424-020-02465-3; Verkhratsky A, 2017, BRAIN PATHOL, V27, P629, DOI 10.1111/bpa.12537; Verkhratsky A, 2016, NEUROBIOL DIS, V85, P254, DOI 10.1016/j.nbd.2015.03.025; Verkhratsky A, 2012, ASN NEURO, V4, DOI 10.1042/AN20120010; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Yang H, 2009, CELL MOL NEUROBIOL, V29, P455, DOI 10.1007/s10571-008-9337-3; Yip PK, 2017, SCI REP-UK, V7, DOI 10.1038/srep41689; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zamboni M, 2020, CELL STEM CELL, V27, P605, DOI 10.1016/j.stem.2020.07.006; Zhang YM, 2015, NEUROSCI LETT, V603, P12, DOI 10.1016/j.neulet.2015.07.009; Zhong JH, 2018, J NEUROSURG, V129, P732, DOI 10.3171/2016.11.JNS162121	63	2	2	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-634X			FRONT CELL DEV BIOL	Front. Cell. Dev. Biol.	JUN 16	2021	9								649854	10.3389/fcell.2021.649854			16	Cell Biology; Developmental Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Developmental Biology	TB7MI	WOS:000668129000001	34222228	gold, Green Published			2022-02-06	
J	Wei, PJ; Wang, K; Luo, C; Huang, YC; Misilimu, D; Wen, HM; Jin, P; Li, CH; Gong, Y; Gao, YQ				Wei, Pengju; Wang, Ke; Luo, Chen; Huang, Yichen; Misilimu, Dilidaer; Wen, Huimei; Jin, Peng; Li, Chuhua; Gong, Ye; Gao, Yanqin			Cordycepin confers long-term neuroprotection via inhibiting neutrophil infiltration and neuroinflammation after traumatic brain injury	JOURNAL OF NEUROINFLAMMATION			English	Article						White matter injury; Neutrophil; Microglia; macrophage; Blood-brain barrier; Traumatic brain injury	WHITE-MATTER; BARRIER; PROTECTS; DAMAGE; MICE; INFLAMMATION; DYNAMICS; MODELS; STROKE	BackgroundThe secondary injury caused by traumatic brain injury (TBI), especially white matter injury (WMI), is highly sensitive to neuroinflammation, which further leads to unfavored long-term outcomes. Although the cross-talk between the three active events, immune cell infiltration, BBB breakdown, and proinflammatory microglial/macrophage polarization, plays a role in the vicious cycle, its mechanisms are not fully understood. It has been reported that cordycepin, an extract from Cordyceps militaris, can inhibit TBI-induced neuroinflammation although the long-term effects of cordycepin remain unknown. Here, we report our investigation of cordycepin's long-term neuroprotective function and its underlying immunological mechanism.MethodsTBI mice model was established with a controlled cortical impact (CCI) method. Cordycepin was intraperitoneally administered twice daily for a week. Neurological outcomes were assessed by behavioral tests, including grid walking test, cylinder test, wire hang test, and rotarod test. Immunofluorescence staining, transmission electron microscopy, and electrophysiology recording were employed to assess histological and functional lesions. Quantitative-PCR and flow cytometry were used to detect neuroinflammation. The tracers of Sulfo-NHS-biotin and Evans blue were assessed for the blood-brain barrier (BBB) leakage. Western blot and gelatin zymography were used to analyze protein activity or expression. Neutrophil depletion in vivo was performed via using Ly6G antibody intraperitoneal injection.ResultsCordycepin administration ameliorated long-term neurological deficits and reduced neuronal tissue loss in TBI mice. Meanwhile, the long-term integrity of white matter was also preserved, which was revealed in multiple dimensions, such as morphology, histology, ultrastructure, and electrical conductivity. Cordycepin administration inhibited microglia/macrophage pro-inflammatory polarization and promoted anti-inflammatory polarization after TBI. BBB breach was attenuated by cordycepin administration at 3 days after TBI. Cordycepin suppressed the activities of MMP-2 and MMP-9 and the neutrophil infiltration at 3 days after TBI. Moreover, neutrophil depletion provided a cordycepin-like effect, and cordycepin administration united with neutrophil depletion did not show a benefit of superposition.ConclusionsThe long-term neuroprotective function of cordycepin via suppressing neutrophil infiltration after TBI, thereby preserving BBB integrity and changing microglia/macrophage polarization. These findings provide significant clinical potentials to improve the quality of life for TBI patients.	[Wei, Pengju; Wang, Ke; Luo, Chen; Huang, Yichen; Misilimu, Dilidaer; Wen, Huimei; Jin, Peng; Gong, Ye; Gao, Yanqin] Fudan Univ, Dept Crit Care Med & Neurosurg, State Key Lab Med Neurobiol, MOE Frontiers Ctr Brain Sci,Huashan Hosp, Shanghai 200032, Peoples R China; [Wei, Pengju; Wang, Ke; Luo, Chen; Huang, Yichen; Misilimu, Dilidaer; Wen, Huimei; Jin, Peng; Gong, Ye; Gao, Yanqin] Fudan Univ, Inst Brain Sci, Shanghai 200032, Peoples R China; [Li, Chuhua] South China Normal Univ, Sch Life Sci, Guangzhou 510631, Peoples R China		Gong, Y; Gao, YQ (corresponding author), Fudan Univ, Dept Crit Care Med & Neurosurg, State Key Lab Med Neurobiol, MOE Frontiers Ctr Brain Sci,Huashan Hosp, Shanghai 200032, Peoples R China.; Gong, Y; Gao, YQ (corresponding author), Fudan Univ, Inst Brain Sci, Shanghai 200032, Peoples R China.	gong_ye@fudan.edu.cn; yqgao@shmu.edu.cn	Gao, Yanqin/I-6790-2016	Gao, Yanqin/0000-0002-4915-9819; , Pengju/0000-0003-0979-4321	Chinese Key R&D Plan of the State Ministry of Science and Technology [2017YFC1308403, 2018YFC1312604]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81870971, 82071311, 81971232, 81771419]; Shanghai Municipal Science and Technology Major Project [2018SHZDZX01]; ZJLab	This project was supported by the Chinese Key R&D Plan of the State Ministry of Science and Technology (2017YFC1308403, 2018YFC1312604), National Natural Science Foundation of China grants (81870971, 82071311, 81971232, 81771419), and Project Supported by Shanghai Municipal Science and Technology Major Project (No.2018SHZDZX01) and ZJLab.	Abe N, 2018, GLIA, V66, P2158, DOI 10.1002/glia.23469; Abrahamson EE, 2020, EXP NEUROL, V328, DOI 10.1016/j.expneurol.2020.113257; Alam A, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-02005-x; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Bernstein DL, 2020, J CEREBR BLOOD F MET, V40, P1953, DOI 10.1177/0271678X19882264; Cai ZL, 2013, EUR J PHARMACOL, V714, P249, DOI 10.1016/j.ejphar.2013.05.049; Cao ZP, 2018, PHYSIOL BEHAV, V184, P135, DOI 10.1016/j.physbeh.2017.11.026; Cheng YJ, 2017, METAB BRAIN DIS, V32, P1133, DOI 10.1007/s11011-017-0003-7; Dong ZSW, 2019, EUR J PHARMACOL, V853, P325, DOI 10.1016/j.ejphar.2019.04.015; Dorhoi A, 2013, J CLIN INVEST, V123, P4836, DOI 10.1172/JCI67604; Edwards DN, 2020, J CEREBR BLOOD F MET, V40, P1695, DOI 10.1177/0271678X19880161; Eyolfson E, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01994-z; Filley CM, 2018, J ALZHEIMERS DIS, V65, P345, DOI 10.3233/JAD-180287; Goldim Mariana Pereira de Souza, 2019, Curr Protoc Immunol, V126, pe83, DOI 10.1002/cpim.83; Green AR, 2002, CLIN EXP PHARMACOL P, V29, P1030, DOI 10.1046/j.1440-1681.2002.03767.x; Hajiaghamemar M, 2019, EXP NEUROL, V318, P101, DOI 10.1016/j.expneurol.2019.04.019; Han YY, 2019, J NEUROCHEM, V151, P79, DOI 10.1111/jnc.14826; Haruwaka K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13812-z; James S.L., 2019, LANCET NEUROL, V18, P56, DOI [10.1016/S1474-4422(18)30415-0, DOI 10.1016/S1474-4422(18)30415-0]; Kang LJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16191-y; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kong LL, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-112; Kumari R, 2020, NEUROCHEM INT, V139, DOI 10.1016/j.neuint.2020.104790; Lee J, 2019, CNS NEUROSCI THER, V25, P1290, DOI 10.1111/cns.13266; Li K, 2020, PHARMACOL THERAPEUT, V207, DOI 10.1016/j.pharmthera.2019.107465; Li PY, 2013, ANN NEUROL, V74, P458, DOI 10.1002/ana.23815; Lorenzini L, 2020, MOLECULES, V25, DOI 10.3390/molecules25030503; Ma L, 2015, NUTR RES, V35, P431, DOI 10.1016/j.nutres.2015.04.011; Manwani B, 2011, BRAIN BEHAV IMMUN, V25, P1689, DOI 10.1016/j.bbi.2011.06.015; Mao LL, 2021, CNS NEUROSCI THER, V27, P113, DOI 10.1111/cns.13534; McDonald S, 2019, BRAIN IMAGING BEHAV, V13, P819, DOI 10.1007/s11682-018-9906-0; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Ning YL, 2013, J CEREBR BLOOD F MET, V33, P1789, DOI 10.1038/jcbfm.2013.127; Pelisch N, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-02037-3; Qin P, 2019, MOLECULES, V24, DOI 10.3390/molecules24122231; Ramos CDL, 2005, J LEUKOCYTE BIOL, V78, P167, DOI 10.1189/jlb.0404237; Sandsmark DK, 2019, NEURON, V103, P367, DOI 10.1016/j.neuron.2019.06.002; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Shi H, 2015, CNS NEUROSCI THER, V21, P374, DOI 10.1111/cns.12366; Shi YJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10523; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Tan L, 2021, PHYTOTHER RES, V35, P1284, DOI 10.1002/ptr.6890; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang XL, 2020, IMMUNOPHARM IMMUNOT, V42, P119, DOI 10.1080/08923973.2020.1728310; Wong YY, 2010, J BIOL CHEM, V285, P2610, DOI 10.1074/jbc.M109.071159; Xu MY, 2019, CNS NEUROSCI THER, V25, P734, DOI 10.1111/cns.13102; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; Yang H, 2021, J CEREBR BLOOD F MET, V41, P958, DOI 10.1177/0271678X20942613; Yang RR, 2020, INFLAMMATION, V43, P752, DOI 10.1007/s10753-019-01162-3; Yang Y, 2015, BRAIN RES, V1623, P30, DOI 10.1016/j.brainres.2015.04.024; Yuan J, 2016, BRAIN RES BULL, V127, P171, DOI 10.1016/j.brainresbull.2016.09.010; Zhang J, 2019, J CEREBR BLOOD F MET, V39, P1394, DOI 10.1177/0271678X18785480	53	2	2	18	20	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	JUN 15	2021	18	1							137	10.1186/s12974-021-02188-x			17	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	SW6AV	WOS:000664597300002	34130727	Green Published, Green Submitted, gold			2022-02-06	
J	Barretto, TA; Park, E; Telliyan, T; Liu, E; Gallagher, D; Librach, C; Baker, A				Barretto, Tanya A.; Park, Eugene; Telliyan, Tamar; Liu, Elaine; Gallagher, Denis; Librach, Clifford; Baker, Andrew			Vascular Dysfunction after Modeled Traumatic Brain Injury Is Preserved with Administration of Umbilical Cord Derived Mesenchymal Stromal Cells and Is Associated with Modulation of the Angiogenic Response	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						angiogenic response; blood-brain barrier dysfunction; mesenchymal stromal cells; pericytes; traumatic brain injury	CONTROLLED CORTICAL IMPACT; FLUID PERCUSSION INJURY; CEREBRAL-BLOOD-FLOW; AXONAL INJURY; NEUROVASCULAR UNIT; CORPUS-CALLOSUM; STEM-CELLS; BARRIER; PERICYTES; PERMEABILITY	Vascular dysfunction arising from blood-brain barrier (BBB) breakdown after traumatic brain injury (TBI) can adversely affect neuronal health and behavioral outcome. Pericytes and endothelial cells of the neurovascular unit (NVU) function collectively to maintain strict regulation of the BBB through tight junctions. Secondary injury mechanisms, such as pro-angiogenic signals that contribute to pericyte loss, can prolong and exacerbate primary vascular injury. Human umbilical cord perivascular cells (HUCPVCs) are a source of mesenchymal stromal cells (MSCs) that have been shown to reduce vascular dysfunction after neurotrauma. We hypothesized that the perivascular properties of HUCPVCs can reduce vascular dysfunction after modeled TBI by preserving the pericyte-endothelial interactions. Rats were subjected to a moderate fluid percussion injury (FPI) and intravenously infused with 1,500,000 HUCPVCs post-injury. At acute time points (24 h and 48 h) quantitative polymerase chain reaction (qPCR) analysis demonstrated that the gene expression of angiopoietin-2 was increased with FPI and reduced with HUCPVCs. Immunofluorescent assessment of RECA-1 (endothelial cells) and platelet-derived growth factor receptors (PDGFR-beta) (pericytes) revealed that capillary and pericyte densities as well as the co-localization of the two cells were decreased with FPI and preserved with HUCPVC administration. These acute HUCPVC-mediated protective effects were associated with less permeability to Evan's blue dye and increased expression of the tight junction occludin, suggesting less vascular leakage. Further, at 4 weeks post-injury, HUCPVC administration was associated with reduced anxiety and decreased beta-amyloid precursor protein (beta-APP) accumulation. In summary, HUCPVCs promoted pericyte-endothelial barrier function that was associated with improved long-term outcome.	[Barretto, Tanya A.; Park, Eugene; Telliyan, Tamar; Liu, Elaine; Baker, Andrew] St Michaelss Hosp, Keenan Res Ctr, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Barretto, Tanya A.; Baker, Andrew] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Librach, Clifford] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada; [Librach, Clifford] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Baker, Andrew] Univ Toronto, Dept Crit Care, St Michaels Hosp, Toronto, ON, Canada; [Baker, Andrew] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; [Gallagher, Denis; Librach, Clifford] CReATe Fertil Ctr, Toronto, ON, Canada		Barretto, TA (corresponding author), St Michaelss Hosp, Keenan Res Ctr, 30 Bond St, Toronto, ON M5B 1W8, Canada.	tanya.barretto@mail.utoronto.ca			Physicians' Services Incorporated (PSI) Foundation [15-13]	This work was supported by the Physicians' Services Incorporated (PSI) Foundation (15-13).	Ai JL, 2007, J NEUROTRAUM, V24, P960, DOI 10.1089/neu.2006.0224; Al Ahmad A, 2009, J CELL PHYSIOL, V218, P612, DOI 10.1002/jcp.21638; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Badner A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1243-0; Baker AJ, 2002, J NEUROTRAUM, V19, P587, DOI 10.1089/089771502753754064; Baksh D, 2007, STEM CELLS, V25, P1384, DOI 10.1634/stemcells.2006-0709; Balabanov R, 1996, MICROVASC RES, V52, P127, DOI 10.1006/mvre.1996.0049; Barretto TA, 2020, STEM CELLS DEV, V29, P198, DOI 10.1089/scd.2019.0135; Bazzigaluppi P, 2019, HYPERTENSION, V74, P1041, DOI 10.1161/HYPERTENSIONAHA.119.13187; Bhowmick S, 2019, EXP NEUROL, V317, P260, DOI 10.1016/j.expneurol.2019.03.014; Brickler TR, 2018, J NEUROSCI, V38, P9618, DOI 10.1523/JNEUROSCI.0914-18.2018; Brown RC, 2005, BIOCHEM BIOPH RES CO, V327, P1114, DOI 10.1016/j.bbrc.2004.12.123; Brown RC, 2003, J CELL SCI, V116, P693, DOI 10.1242/jcs.00264; Dore-Duffy P, 2007, NEUROL RES, V29, P395, DOI 10.1179/016164107X204729; Eilken HM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01738-3; Ekmark-Lewen S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-44; Ennis J, 2008, METHOD CELL BIOL, V86, P121, DOI 10.1016/S0091-679X(08)00007-1; Feng YX, 2007, THROMB HAEMOSTASIS, V97, P99, DOI 10.1160/TH06-05-0277; Fernandez-Klettl F, 2015, J CEREBR BLOOD F MET, V35, P883, DOI 10.1038/jcbfm.2015.60; Gallagher D, 2019, BIOL PSYCHIAT, V86, P712, DOI 10.1016/j.biopsych.2019.07.015; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Hill J, 2014, J NEUROIMMUNE PHARM, V9, P591, DOI 10.1007/s11481-014-9557-x; Hong SH, 2013, STEM CELLS DEV, V22, P2425, DOI 10.1089/scd.2012.0552; Hong S, 2013, J CELL BIOL, V201, P131, DOI 10.1083/jcb.201211054; Hori S, 2004, J NEUROCHEM, V89, P503, DOI 10.1111/j.1471-4159.2004.02343.x; Hoshino S, 2003, NEUROL MED-CHIR, V43, P165, DOI 10.2176/nmc.43.165; Huang EYK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086354; Jackson S, 2017, NEURO-ONCOLOGY, V19, P1173, DOI 10.1093/neuonc/nox058; Jiang Y, 2012, J NEUROTRAUM, V29, P2332, DOI 10.1089/neu.2012.2362; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Kobeissy F. H, 2015, BRAIN NEUROTRAUMA MO; Kumar N, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000469; Nasser M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00895; Ng I, 2003, Ann Acad Med Singap, V32, pS63; Ngwenya LB, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/4209821; Park E, 2017, J NEUROTRAUM, V34, P2801, DOI 10.1089/neu.2016.4560; Park E, 2013, NEUROBIOL DIS, V52, P150, DOI 10.1016/j.nbd.2012.12.002; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Paterno R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0762-x; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Reslan S, 2014, REHABIL PSYCHOL, V59, P453, DOI 10.1037/a0037186; Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166; Sarugaser Rahul, 2009, V482, P269, DOI 10.1007/978-1-59745-060-7_17; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Smyth LCD, 2018, J CHEM NEUROANAT, V92, P48, DOI 10.1016/j.jchemneu.2018.06.001; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Sweeney M, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00154; Sweeney MD, 2016, NAT NEUROSCI, V19, P771, DOI 10.1038/nn.4288; Vawda R, 2019, STEM CELL TRANSL MED, V8, P639, DOI 10.1002/sctm.18-0192; Villasenor R, 2017, J CEREBR BLOOD F MET, V37, P3683, DOI 10.1177/0271678X17697340; Wu HT, 2012, BRAIN RES, V1486, P121, DOI 10.1016/j.brainres.2012.09.039; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Yuan HT, 2009, MOL CELL BIOL, V29, P2011, DOI 10.1128/MCB.01472-08	58	2	2	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2021.0158		JUN 2021	16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SO8WT	WOS:000659255900001	33899499				2022-02-06	
J	Shi, J; Du, XP; Cavagnaro, MJ; Li, N				Shi, Jian; Du, Xianping; Cavagnaro, Maria Jose; Li, Na			A Bibliometric Analysis and Visualization of the Top-Cited Publications in Mild Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						mild traumatic brain injury; top-cited publications; bibliometric analysis; visualization; neurotrauma	CONCUSSION	Background: For measuring their impact in scientific research, the citation count of the publications is used in the bibliometric analysis, though still in the bibliometric analysis, there is no comprehensive summary of mild traumatic brain injury (mTBI) research. This article intends to provide the physicians and the neuroscientists with a reference guide to assess the most influential publications written on this subject through a macroscopic view of the research activities on mTBI. Methods: The database of the Web of Science was used to compile the 100 top-ranking publications on mTBI. The selected publications were evaluated on the basis of the several categorizations including the type of the publications, number of citations, country of origin, and year of publication. Results: Between 1946 and 2020, the 13,040 publications that were published were included in the database. The least cited publications received 274 citations, while the most cited received 1,748. Altogether, 71 publications were from the USA while 29 were from other countries. Among all the institutions, the University of Pittsburgh Medical Center led the list with six publications. Around 100 papers, mostly on the clinical studies in the categories of neurology and neurosciences, were published in 54 different journals. Conclusions: This study provides both a transverse section summary and historical retrospect for the clinical advances of mTBI, and the publications of important observations that contributed a significant impact on the treatment and prevention of mTBI had been identified.	[Shi, Jian] Cent South Univ, Xiangya Hosp 3, Dept Spine Surg, Changsha, Peoples R China; [Du, Xianping] Rutgers State Univ, Dept Mech & Aerosp Engn, Piscataway, NJ USA; [Cavagnaro, Maria Jose] Univ Arizona, Coll Med, Tucson, AZ USA; [Li, Na] Cent South Univ, Xiangya Hosp 3, Dept Radiol, Changsha, Peoples R China		Li, N (corresponding author), Cent South Univ, Xiangya Hosp 3, Dept Radiol, Changsha, Peoples R China.	lina2864@csu.edu.cn			Science and Technology Innovation Program of Hunan Province [2020RC2015]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2020TQ0364]; Natural Science Foundation of HunanNatural Science Foundation of Hunan Province [2020JJ5865]	Funding was provided by the Science and Technology Innovation Program of Hunan Province (2020RC2015), the China Postdoctoral Science Foundation (2020TQ0364), and Natural Science Foundation of Hunan (2020JJ5865).	Aksnes DW, 2006, J AM SOC INF SCI TEC, V57, P169, DOI 10.1002/asi.20262; Azer SA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009889; Brandt JS, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.18007; De Bellis N., 2009, BIBLIOMETRICS CITATI; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hui ZY, 2013, ORTHOPEDICS, V36, pE1225, DOI 10.3928/01477447-20130920-11; Kulkarni AV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000403; LABAND DN, 1994, JAMA-J AM MED ASSOC, V272, P147; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Li L, 2018, WORLD NEUROSURG, V113, pE82, DOI 10.1016/j.wneu.2018.01.164; Manyangu G, 2021, EUR J PREV CARDIOL, V28, P1303, DOI 10.1177/2047487319854827; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Oelrich B, 2007, EUR UROL, V52, P1238, DOI 10.1016/j.eururo.2007.06.050; Pantziarka P, 2019, FUTURE ONCOL, V15, P3597, DOI 10.2217/fon-2019-0233; Tripathi RS, 2011, BMC ANESTHESIOL, V11, DOI 10.1186/1471-2253-11-24	15	2	2	4	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 9	2021	12								687796	10.3389/fneur.2021.687796			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SW4SG	WOS:000664506300001	34177789	gold, Green Published			2022-02-06	
J	Opeyemi, OM; Rogers, MB; Firek, BA; Janesko-Feldman, K; Vagni, V; Mullett, SJ; Wendell, SG; Nelson, BP; New, LA; Mario, E; Kochanek, PM; Bayir, H; Clark, RSB; Morowitz, MJ; Simon, DW				Opeyemi, Oluwasinmisola M.; Rogers, Matthew B.; Firek, Brian A.; Janesko-Feldman, Keri; Vagni, Vincent; Mullett, Steven J.; Wendell, Stacy G.; Nelson, Brittany P.; New, Lee Ann; Marino, Eliana; Kochanek, Patrick M.; Bayir, Hulya; Clark, Robert S. B.; Morowitz, Michael J.; Simon, Dennis W.			Sustained Dysbiosis and Decreased Fecal Short-Chain Fatty Acids after Traumatic Brain Injury and Impact on Neurologic Outcome	JOURNAL OF NEUROTRAUMA			English	Article						gut-brain axis; microbiome; short-chain fatty acids; traumatic brain injury	CONTROLLED CORTICAL IMPACT; MULTIPLE BODY SITES; GUT MICROBIOTA; VALPROIC ACID; MICROGLIAL ACTIVATION; DIETARY FIBER; LESION SIZE; T-CELLS; METABOLITES; MODEL	Traumatic brain injury (TBI) alters microbial populations present in the gut, which may impact healing and tissue recovery. However, the duration and impact of these changes on outcome from TBI are unknown. Short-chain fatty acids (SCFAs), produced by bacterial fermentation of dietary fiber, are important signaling molecules in the microbiota gut-brain axis. We hypothesized that TBI would lead to a sustained reduction in SCFA producing bacteria, fecal SCFAs concentration, and administration of soluble SCFAs would improve functional outcome after TBI. Adult mice (n = 10) had the controlled cortical impact (CCI) model of TBI performed (6 m/sec, 2-mm depth, 50-msec dwell). Stool samples were collected serially until 28 days after CCI and analyzed for SCFA concentration by high-performance liquid chromatography-mass spectrometry/mass spectrometry and microbiome analyzed by 16S gene sequencing. In a separate experiment, mice (n = 10/group) were randomized 2 weeks before CCI to standard drinking water or water supplemented with the SCFAs acetate (67.5 mM), propionate (25.9 mM), and butyrate (40 mM). Morris water maze performance was assessed on post-injury Days 14-19. Alpha diversity remained stable until 72 h, at which point a decline in diversity was observed without recovery out to 28 days. The taxonomic composition of post-TBI fecal samples demonstrated depletion of bacteria from Lachnospiraceae, Ruminococcaceae, and Bacteroidaceae families, and enrichment of bacteria from the Verrucomicrobiaceae family. Analysis from paired fecal samples revealed a reduction in total SCFAs at 24 h and 28 days after TBI. Acetate, the most abundant SCFA detected in the fecal samples, was reduced at 7 days and 28 days after TBI. SCFA administration improved spatial learning after TBI versus standard drinking water. In conclusion, TBI is associated with reduced richness and diversity of commensal microbiota in the gut and a reduction in SCFAs detected in stool. Supplementation of soluble SCFAs improves spatial learning after TBI.	[Opeyemi, Oluwasinmisola M.; Janesko-Feldman, Keri; Vagni, Vincent; Nelson, Brittany P.; New, Lee Ann; Kochanek, Patrick M.; Bayir, Hulya; Clark, Robert S. B.; Simon, Dennis W.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Rogers, Matthew B.; Firek, Brian A.; Morowitz, Michael J.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Mullett, Steven J.; Wendell, Stacy G.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Kochanek, Patrick M.; Bayir, Hulya; Clark, Robert S. B.; Simon, Dennis W.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Kochanek, Patrick M.; Bayir, Hulya; Clark, Robert S. B.; Simon, Dennis W.] Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15260 USA; [Kochanek, Patrick M.; Bayir, Hulya; Clark, Robert S. B.; Simon, Dennis W.] Univ Pittsburgh, UPMC Childrens Hosp Pittsburgh, Neurosci Inst, Pittsburgh, PA USA; [Bayir, Hulya] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Clark, Robert S. B.] Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA USA; [Morowitz, Michael J.] Univ Pittsburgh, Ctr Microbiome & Med, Pittsburgh, PA USA; [Marino, Eliana] Monash Univ, Dept Biochem, Melbourne, Vic, Australia		Simon, DW (corresponding author), Childrens Hosp Pittsburgh, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	dennis.simon2@chp.edu	Marino, Eliana/C-5135-2011	Marino, Eliana/0000-0001-5371-8778; Opeyemi, Oluwasinmisola/0000-0002-9869-6418	National Institutes of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21 NS115173]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIHS10OD023402]; UPMC Children's Hospital of Pittsburgh	Drs. Simon, Morowitz and Clark received funding from National Institutes of Neurological Disorders and Stroke, grant number R21 NS115173. Dr. Wendell is supported by NIH grant number NIHS10OD023402. Drs. Simon and Morowitz's work was also supported by the UPMC Children's Hospital of Pittsburgh.	Arun P, 2010, J NEUROTRAUM, V27, P293, DOI 10.1089/neu.2009.0994; Bambakidis T, 2016, J NEUROTRAUM, V33, P1514, DOI 10.1089/neu.2015.4163; Boets E, 2015, NUTRIENTS, V7, P8916, DOI 10.3390/nu7115440; Brand A, 1997, CELL MOL BIOL, V43, P645; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; da Fonseca DM, 2015, CELL, V163, P354, DOI 10.1016/j.cell.2015.08.030; Daglas M, 2019, CELL REP, V29, P1178, DOI 10.1016/j.celrep.2019.09.046; Dash PK, 2009, NEUROSCIENCE, V163, P1, DOI 10.1016/j.neuroscience.2009.06.028; David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; Deehan EC, 2020, CELL HOST MICROBE, V27, P389, DOI 10.1016/j.chom.2020.01.006; Deelchand DK, 2009, J NEUROCHEM, V109, P46, DOI 10.1111/j.1471-4159.2009.05895.x; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Houlden A, 2016, BRAIN BEHAV IMMUN, V57, P10, DOI 10.1016/j.bbi.2016.04.003; Jenkins LW, 2002, J NEUROTRAUM, V19, P715, DOI 10.1089/08977150260139101; Jepsen CH, 2014, J TRAUMA ACUTE CARE, V77, P292, DOI 10.1097/TA.0000000000000333; Katzenberger RJ, 2015, FLY, V9, P68, DOI 10.1080/19336934.2015.1085623; Kim CH, 2018, IMMUNOLOGY, V154, P220, DOI 10.1111/imm.12930; Kitsios GD, 2017, J CRIT CARE, V38, P84, DOI 10.1016/j.jcrc.2016.09.029; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Kokiko-Cochran ON, 2008, NEUROSCI LETT, V436, P27, DOI 10.1016/j.neulet.2008.02.046; Korley FK, 2018, J NEUROTRAUM, V35, P1185, DOI 10.1089/neu.2017.5581; Li HX, 2016, BRAIN RES, V1642, P70, DOI 10.1016/j.brainres.2016.03.031; Lindefeldt M, 2019, NPJ BIOFILMS MICROBI, V5, DOI 10.1038/s41522-018-0073-2; Louis P, 2017, ENVIRON MICROBIOL, V19, P29, DOI 10.1111/1462-2920.13589; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Marino E, 2017, NAT IMMUNOL, V18, P552, DOI 10.1038/ni.3713; Mehta NM, 2010, JPEN-PARENTER ENTER, V34, P38, DOI 10.1177/0148607109348065; Montonye DR, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01085; Mukherjee S, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00028; Nicholson SE, 2019, SHOCK, V52, P240, DOI 10.1097/SHK.0000000000001211; Nikolian VC, 2018, CRIT CARE MED, V46, pE59, DOI 10.1097/CCM.0000000000002800; Nikolian VC, 2017, J TRAUMA ACUTE CARE, V83, P1066, DOI 10.1097/TA.0000000000001612; Orhan N, 2016, BRAIN RES, V1631, P113, DOI 10.1016/j.brainres.2015.11.038; Petersen C, 2014, CELL MICROBIOL, V16, P1024, DOI 10.1111/cmi.12308; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rogers MB, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0211-0; Romick-Rosendale LE, 2018, BIOL BLOOD MARROW TR, V24, P2418, DOI 10.1016/j.bbmt.2018.07.030; Rothhammer V, 2018, NATURE, V557, P724, DOI 10.1038/s41586-018-0119-x; Russell WR, 2011, AM J CLIN NUTR, V93, P1062, DOI 10.3945/ajcn.110.002188; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Simon DW, 2020, BRAIN RES, V1747, DOI 10.1016/j.brainres.2020.147056; Simon DW, 2018, J NEUROTRAUM, V35, P130, DOI 10.1089/neu.2017.5093; Thaiss CA, 2016, NATURE, V540, P544, DOI 10.1038/nature20796; Treangen TJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02757; Urban RJ, 2020, J NEUROTRAUM, V37, P1037, DOI 10.1089/neu.2019.6688; Vojinovic D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13721-1; Wolahan SM, 2018, J NEUROSCI RES, V96, P688, DOI 10.1002/jnr.24085; Yamashiro K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171521; Yap YA, 2020, ADV EXP MED BIOL; Yeh A, 2016, SHOCK, V46, P649, DOI 10.1097/SHK.0000000000000691; Zhu CS, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8060113	55	2	2	8	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 15	2021	38	18					2610	2621		10.1089/neu.2020.7506		JUN 2021	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	US2IV	WOS:000658437400001	33957773				2022-02-06	
J	Currie, GR; Lee, R; Black, AM; Palacios-Derflingher, L; Hagel, BE; Emery, CA; Marshall, DA				Currie, Gillian R.; Lee, Raymond; Black, Amanda M.; Palacios-Derflingher, Luz; Hagel, Brent E.; Emery, Carolyn A.; Marshall, Deborah A.			An Economic Evaluation of Disallowing Body Checking in 11- to 12-Year-Old Ice Hockey Leagues	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article; Early Access						cost-effectiveness; hockey; injury prevention	SPORT PARTICIPATION; INJURY; CONCUSSION; RISK; PROGRAM; CALGARY	Background: After a national policy change in 2013 disallowing body checking in Pee Wee ice hockey games, the rate of injury was reduced by 50% in Alberta. However, the effect on associated health care costs has not been examined previously. Hypothesis: A national policy removing body checking in Pee Wee (ages 11-12 years) ice hockey games will reduce injury rates, as well as costs. Study Design: Cost-effectiveness analysis alongside cohort study. Methods: A cost-effectiveness analysis was conducted alongside a cohort study comparing rates of game injuries in Pee Wee hockey games in Alberta in a season when body checking was allowed (2011-2012) with a season when it was disallowed after a national policy change (2013-2014). The effectiveness measure was the rate of game injuries per 1000 player-hours. Costs were estimated based on associated health care use from both the publicly funded health care system and privately paid health care cost perspectives. Probabilistic sensitivity analysis was conducted using bootstrapping. Results: Disallowing body checking significantly reduced the rate of game injuries (-2.21; 95% CI [-3.12, -1.31] injuries per 1000 player-hours). We found no statistically significant difference in public health care system (-$83; 95% CI [-$386, $220]) or private health care costs (-$70; 95% CI [-$198, $57]) per 1000 player-hours. The probability that the policy of disallowing body checking was dominant (with both fewer injuries and lower costs) from the perspective of the public health care system and privately paid health care was 78% and 92%, respectively. Conclusion: Given the significant reduction in injuries, combined with lower public health care system and private costs in the large majority of iterations in the probabilistic sensitivity analysis, our findings support the policy change disallowing body checking in ice hockey in 11- and 12-year-old ice hockey leagues.	[Currie, Gillian R.; Lee, Raymond; Palacios-Derflingher, Luz; Hagel, Brent E.; Emery, Carolyn A.; Marshall, Deborah A.] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada; [Currie, Gillian R.; Hagel, Brent E.; Emery, Carolyn A.] Univ Calgary, Cumming Sch Med, Dept Paediat, Calgary, AB, Canada; [Currie, Gillian R.; Black, Amanda M.; Hagel, Brent E.; Emery, Carolyn A.; Marshall, Deborah A.] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Currie, Gillian R.; Hagel, Brent E.; Emery, Carolyn A.; Marshall, Deborah A.] Univ Calgary, OBrien Inst Publ Hlth, Calgary, AB, Canada; [Black, Amanda M.; Palacios-Derflingher, Luz; Hagel, Brent E.; Emery, Carolyn A.] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Emery, Carolyn A.; Marshall, Deborah A.] Univ Calgary, McCaig Inst Bone & Joint Hlth, Cumming Sch Med, Calgary, AB, Canada		Marshall, DA (corresponding author), Univ Calgary, Cumming Sch Med, Hlth Res Innovat Ctr, Room 3C56,3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	damarsha@ucalgary.ca					Alberta Government , 2017, SOMB MED PRIC LIST 0; Alberta Interactive Health Data Application, 2013, HOSP AMB CAR CAS APP; Black AM, 2017, BRIT J SPORT MED, V51, P1767, DOI 10.1136/bjsports-2016-097392; Drummond M., 2005, METHODS EC EVALUATIO; Emery CA, 2009, PAED CHILD HEALT-CAN, V14, P439, DOI 10.1093/pch/14.7.439; Emery CA, 2006, CLIN J SPORT MED, V16, P20, DOI 10.1097/01.jsm.0000184638.72075.b7; Emery C, 2020, BRIT J SPORT MED, V54, P414, DOI 10.1136/bjsports-2019-101092; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Hupperets MDW, 2010, AM J SPORT MED, V38, P2194, DOI 10.1177/0363546510373470; Lacny S, 2014, BRIT J SPORT MED, V48, P1299, DOI 10.1136/bjsports-2014-093493; Marshall DA, 2016, BRIT J SPORT MED, V50, P1388, DOI 10.1136/bjsports-2015-095666; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Mckay CD, 2014, CAN J PUBLIC HEALTH, V105, pE445, DOI 10.17269/cjph.105.4653; Michaels-Igbokwe C, 2019, INJURY PREV, V25, P340, DOI 10.1136/injuryprev-2018-042846; Parachute, 2015, COST INJ CAN; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Polinder S, 2012, ACCIDENT ANAL PREV, V45, P211, DOI 10.1016/j.aap.2011.07.004; *SMARTRISK, 2009, EC BURD INJ CAN; Verhagen EALM, 2005, BRIT J SPORT MED, V39, P111, DOI 10.1136/bjsm.2003.011031	21	2	2	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health											19417381211021551	10.1177/19417381211021551		JUN 2021	7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	SQ9CC	WOS:000660645000001	34096399	hybrid			2022-02-06	
J	Boehme, NA; Hedberg-Buenz, A; Tatro, N; Bielecki, M; Castonguay, WC; Scheetz, TE; Anderson, MG; Dutca, LM				Boehme, Nickolas A.; Hedberg-Buenz, Adam; Tatro, Nicole; Bielecki, Michael; Castonguay, William C.; Scheetz, Todd E.; Anderson, Michael G.; Dutca, Laura M.			Axonopathy precedes cell death in ocular damage mediated by blast exposure	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; RETINAL GANGLION-CELLS; EXPERIMENTAL RODENT MODEL; OPTIC NEUROPATHY; COMPLEMENT-SYSTEM; MOUSE MODEL; MICE; PATHOPHYSIOLOGY; DEGENERATION; EXPRESSION	Traumatic brain injuries (TBI) of varied types are common across all populations and can cause visual problems. For military personnel in combat settings, injuries from blast exposures (bTBI) are prevalent and arise from a myriad of different situations. To model these diverse conditions, we are one of several groups modeling bTBI using mice in varying ways. Here, we report a refined analysis of retinal ganglion cell (RGC) damage in male C57BL/6J mice exposed to a blast-wave in an enclosed chamber. Ganglion cell layer thickness, RGC density (BRN3A and RBPMS immunoreactivity), cellular density of ganglion cell layer (hematoxylin and eosin staining), and axon numbers (paraphenylenediamine staining) were quantified at timepoints ranging from 1 to 17-weeks. RNA sequencing was performed at 1-week and 5-weeks post-injury. Earliest indices of damage, evident by 1-week post-injury, are a loss of RGC marker expression, damage to RGC axons, and increase in glial markers expression. Blast exposure caused a loss of RGC somas and axons-with greatest loss occurring by 5-weeks post-injury. While indices of glial involvement are prominent early, they quickly subside as RGCs are lost. The finding that axonopathy precedes soma loss resembles pathology observed in mouse models of glaucoma, suggesting similar mechanisms.	[Boehme, Nickolas A.; Hedberg-Buenz, Adam; Castonguay, William C.; Anderson, Michael G.; Dutca, Laura M.] Ctr Prevent & Treatment Visual Loss, Iowa City VA Healthcare Syst, 601 Hwy 6, Iowa City, IA 52772 USA; [Boehme, Nickolas A.; Tatro, Nicole; Bielecki, Michael; Scheetz, Todd E.; Anderson, Michael G.; Dutca, Laura M.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA; [Hedberg-Buenz, Adam; Castonguay, William C.; Anderson, Michael G.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA USA; [Tatro, Nicole; Scheetz, Todd E.; Anderson, Michael G.] Univ Iowa, Inst Vis Res, Iowa City, IA USA		Dutca, LM (corresponding author), Ctr Prevent & Treatment Visual Loss, Iowa City VA Healthcare Syst, 601 Hwy 6, Iowa City, IA 52772 USA.; Dutca, LM (corresponding author), Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA.	laura-dutca@uiowa.edu	Anderson, Michael/B-4580-2009	Anderson, Michael/0000-0001-5730-6105	Career Development/Capacity Building Award from the U.S. Department of Veterans Affairs Rehabilitation Research and Development (RR&D) Service (LMD) [IK2RX002003]; U.S. Department of Veterans Affairs, RRDUS Department of Veterans Affairs [T32 DK112751-01, I01RX001481]; NIH/NEI Center [P30 EY025580]; University of Iowa Carver College of Medicine	The authors thank Carly J. van der Heide, Ph.D. for providing the protocol to quantify BRN3A<SUP>+</SUP> cells, Addison Woll for help with the RNA extraction, and the Iowa Central Microscopy Research Facility at The University of Iowa Carver College of Medicine for technical help. We also acknowledge Christine Blaumueller, Ph.D. of the Scientific Editing and Research Communication Core at The University of Iowa Carver College of Medicine for critical reading of the manuscript and advice on the logic, flow, and presentation of the science. This research was supported by Career Development/Capacity Building Award IK2RX002003 from the U.S. Department of Veterans Affairs Rehabilitation Research and Development (RR&D) Service (LMD), Training Grant T32 DK112751-01 (AH-B), and I01RX001481 from the U.S. Department of Veterans Affairs, RR&D (MGA), and an NIH/NEI Center Support Grant to The University of Iowa (P30 EY025580). The RNA-Seq results were obtained by the Genomics Division of the Iowa Institute of Human Genetics, which is supported in part by The University of Iowa Carver College of Medicine. The authors are solely responsible for the content and writing of the paper.	Alawieh A, 2018, J NEUROSCI, V38, P2519, DOI 10.1523/JNEUROSCI.2197-17.2018; Allen RS, 2018, J NEUROTRAUM, V35, P2104, DOI 10.1089/neu.2017.5394; Armstrong RA, 2018, CLIN EXP OPTOM, V101, P716, DOI 10.1111/cxo.12670; Bartsch S, 1997, BRAIN RES, V762, P231, DOI 10.1016/S0006-8993(97)00484-8; Bastakis GG, 2019, DEV NEUROBIOL, V79, P819, DOI 10.1002/dneu.22710; Bergersen K, 2017, BRAIN INJURY, V31, P279, DOI 10.1080/02699052.2016.1255779; Bernardo-Colon A, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00719; Bray ER, 2019, NEURON, V103, P642, DOI 10.1016/j.neuron.2019.05.044; Bricker-Anthony C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131921; Bricker-Anthony C, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0192-5; Burke EG, 2019, NEURAL REGEN RES, V14, P593, DOI 10.4103/1673-5374.247463; Capo-Aponte JE, 2017, OPTOMETRY VISION SCI, V94, P7, DOI 10.1097/OPX.0000000000000825; Carlson SW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00532; Carlson SW, 2016, J NEUROTRAUM, V33, P113, DOI 10.1089/neu.2014.3839; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Cernak I., 2015, BRAIN NEUROTRAUMA MO; Choi JH, 2015, CLIN EXP OPHTHALMOL, V43, P239, DOI 10.1111/ceo.12407; Danias J, 2003, INVEST OPHTH VIS SCI, V44, P5151, DOI 10.1167/iovs.02-1101; Das M, 2019, REV NEUROSCIENCE, V30, P305, DOI 10.1515/revneuro-2018-0015; Diel RJ, 2021, BRIT J OPHTHALMOL, V105, P751, DOI 10.1136/bjophthalmol-2020-316417; Dinet V, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01178; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DRAGER UC, 1981, INVEST OPHTH VIS SCI, V20, P285; Duan X, 2015, NEURON, V85, P1244, DOI 10.1016/j.neuron.2015.02.017; Dutca LM, 2014, INVEST OPHTH VIS SCI, V55, P8330, DOI 10.1167/iovs.14-15468; Eastlake K, 2020, CURR EYE RES, V45, P339, DOI 10.1080/02713683.2019.1648831; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Evans LP, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.12.7; Evans LP, 2020, J NEUROTRAUM, V37, P1463, DOI 10.1089/neu.2019.6725; Evans LP, 2018, ANN CLIN TRANSL NEUR, V5, P240, DOI 10.1002/acn3.523; Galindo-Romero C, 2011, EXP EYE RES, V92, P377, DOI 10.1016/j.exer.2011.02.008; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Griffin AD, 2019, BRAIN, V142, P3550, DOI 10.1093/brain/awz290; Guilmatre A, 2014, DEV NEUROBIOL, V74, P113, DOI 10.1002/dneu.22128; Guley NH, 2016, J NEUROTRAUM, V33, P403, DOI 10.1089/neu.2015.3886; Guley NM, 2019, EXP EYE RES, V182, P109, DOI 10.1016/j.exer.2019.03.013; Hammad A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1066-z; Harper MM, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03374; Harper MM, 2019, INVEST OPHTH VIS SCI, V60, P4159, DOI 10.1167/iovs.19-27565; Harper MM, 2019, INVEST OPHTH VIS SCI, V60, P2716, DOI 10.1167/iovs.18-26353; Harper MM, 2014, INVEST OPHTH VIS SCI, V55, P1350, DOI 10.1167/iovs.13-13692; Hedberg-Buenz A, 2016, EXP EYE RES, V146, P386, DOI 10.1016/j.exer.2015.07.020; Hedberg-Buenz A, 2016, EXP EYE RES, V146, P370, DOI 10.1016/j.exer.2015.09.011; Hernandez A, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0408-1; Hickman TT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28924-7; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Jiang YD, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-96; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Koehn D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132804; Konan LM, 2019, J NEUROTRAUM, V36, P2117, DOI 10.1089/neu.2018.6260; Kossmann T, 1997, J NEUROIMMUNOL, V73, P63, DOI 10.1016/S0165-5728(96)00164-6; Krukowski K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123753; Li L, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00109; Li T, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1524-2; Liao Y, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz114; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Mac Nair CE, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0558-y; Magone MT, 2014, J REHABIL RES DEV, V51, P71, DOI 10.1682/JRRD.2013.01.0008; Mahan MY, 2019, WORLD NEUROSURG, V128, pE434, DOI 10.1016/j.wneu.2019.04.170; Manek R, 2018, MOL NEUROBIOL, V55, P6112, DOI 10.1007/s12035-017-0821-y; Mao M, 2011, INVEST OPHTH VIS SCI, V52, P2679, DOI 10.1167/iovs.10-5993; Mead B, 2016, EXP EYE RES, V151, P96, DOI 10.1016/j.exer.2016.08.006; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; Mohlin C, 2017, MOL IMMUNOL, V89, P84, DOI 10.1016/j.molimm.2017.05.028; Monteiro P, 2017, NAT REV NEUROSCI, V18, P147, DOI 10.1038/nrn.2016.183; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Naguib S, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104695; Nuesi R, 2020, DATA BRIEF, V30, DOI 10.1016/j.dib.2020.105649; Nuschke AC, 2015, EXP EYE RES, V141, P111, DOI 10.1016/j.exer.2015.06.006; Piehler T, 2018, MIL MED, V183, P269, DOI 10.1093/milmed/usx158; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Quigley HA, 2011, EXP EYE RES, V92, P299, DOI 10.1016/j.exer.2011.01.006; Rashid Khalid, 2019, Front Immunol, V10, P1975, DOI 10.3389/fimmu.2019.01975; Resource TGO, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI [10.1093/NAR/GKY1055, DOI 10.1093/NAR/GKY1055, 10.1093/nar/gky1055]; Rheaume BA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05134-3; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez AR, 2014, J COMP NEUROL, V522, P1411, DOI 10.1002/cne.23521; Roselli F, 2018, J NEUROTRAUM, V35, P226, DOI 10.1089/neu.2017.5168; Sanes JR, 2015, ANNU REV NEUROSCI, V38, P221, DOI 10.1146/annurev-neuro-071714-034120; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schlamp CL, 2013, MOL VIS, V19, P1387; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Silverman SM, 2018, ANNU REV VIS SCI, V4, P45, DOI 10.1146/annurev-vision-091517-034425; Singman EL, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0069-2; Smith RS, 2002, RES METH MUT M SER, P265; Song HL, 2018, BEHAV BRAIN RES, V347, P148, DOI 10.1016/j.bbr.2018.03.007; Stasi K, 2006, INVEST OPHTH VIS SCI, V47, P1024, DOI 10.1167/iovs.05-0830; Struebing FL, 2018, J NEUROTRAUM, V35, P118, DOI 10.1089/neu.2017.5104; Subirada PV, 2018, EUR J NEUROSCI, V47, P1429, DOI 10.1111/ejn.13965; Tao WS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12225-6; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Tran NM, 2019, NEURON, V104, P1039, DOI 10.1016/j.neuron.2019.11.006; Tsai T, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00931; Vecino E, 2016, PROG RETIN EYE RES, V51, P1, DOI 10.1016/j.preteyeres.2015.06.003; Vest V, 2019, J NEUROTRAUM, V36, P1646, DOI 10.1089/neu.2018.6046; Vidal-Sanz M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00235; Vogel EW, 2017, J NEUROTRAUM, V34, P1063, DOI 10.1089/neu.2016.4578; Wang WH, 2018, J NEUROTRAUM, V35, P2306, DOI 10.1089/neu.2018.5688; Williams PA, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0091-6; Xu HP, 2016, EUR J PHARMACOL, V787, P94, DOI 10.1016/j.ejphar.2016.03.001; Yasuda M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093258; Yin TC, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0220-16.2016; Yin TC, 2014, CELL REP, V8, P1731, DOI 10.1016/j.celrep.2014.08.030; Zarei K, 2016, SCI REP-UK, V6, DOI 10.1038/srep26559	110	2	2	3	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	JUN 3	2021	11	1							11774	10.1038/s41598-021-90412-2			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ST1UL	WOS:000662236000069	34083587	gold, Green Published			2022-02-06	
J	Qiu, CX; Albayram, O; Kondo, A; Wang, B; Kim, N; Arai, K; Tsai, CY; Bassal, MA; Herbert, MK; Washida, K; Angeli, P; Kozono, S; Stucky, JE; Baxley, S; Lin, YM; Sun, Y; Rotenberg, A; Caldarone, BJ; Bigio, EH; Chen, XC; Tenen, DG; Zeidel, M; Lo, EH; Zhou, XZ; Lu, KP				Qiu, Chenxi; Albayram, Onder; Kondo, Asami; Wang, Bin; Kim, Nami; Arai, Ken; Tsai, Cheng-Yu; Bassal, Mahmoud A.; Herbert, Megan K.; Washida, Kazuo; Angeli, Peter; Kozono, Shingo; Stucky, Joseph E.; Baxley, Sean; Lin, Yu-Min; Sun, Yan; Rotenberg, Alexander; Caldarone, Barbara J.; Bigio, Eileen H.; Chen, Xiaochun; Tenen, Daniel G.; Zeidel, Mark; Lo, Eng H.; Zhou, Xiao Zhen; Lu, Kun Ping			Cis P-tau underlies vascular contribution to cognitive impairment and dementia and can be effectively targeted by immunotherapy in mice	SCIENCE TRANSLATIONAL MEDICINE			English	Article							PROLYL ISOMERASE PIN1; BRAIN-INJURY; ALZHEIMERS-DISEASE; GENE-EXPRESSION; PHOSPHORYLATED TAU; MOUSE MODEL; PATHOGENESIS; ANTIBODY; DEFICITS; REVEAL	Compelling evidence supports vascular contributions to cognitive impairment and dementia (VCID) including Alzheimer's disease (AD), but the underlying pathogenic mechanisms and treatments are not fully understood. Cis P-tau is an early driver of neurodegeneration resulting from traumatic brain injury, but its role in VCID remains unclear. Here, we found robust cis P-tau despite no tau tangles in patients with VCID and in mice modeling key aspects of clinical VCID, likely because of the inhibition of its isomerase Pin1 by DAPK1. Elimination of cis P-tau in VCID mice using cis-targeted immunotherapy, brain-specific Pin1 overexpression, or DAPK1 knockout effectively rescues VCID-like neurodegeneration and cognitive impairment in executive function. Cis mAb also prevents and ameliorates progression of AD-like neurodegeneration and memory loss in mice. Furthermore, single-cell RNA sequencing revealed that young VCID mice display diverse cortical cell type-specific transcriptomic changes resembling old patients with AD, and the vast majority of these global changes were recovered by cis-targeted immunotherapy. Moreover, purified soluble cis P-tau was sufficient to induce progressive neurodegeneration and brain dysfunction by causing axonopathy and conserved transcriptomic signature found in VCID mice and patients with AD with early pathology. Thus, cis P-tau might play a major role in mediating VCID and AD, and antibody targeting it may be useful for early diagnosis, prevention, and treatment of cognitive impairment and dementia after neurovascular insults and in AD.	[Qiu, Chenxi; Albayram, Onder; Kondo, Asami; Wang, Bin; Kim, Nami; Tsai, Cheng-Yu; Herbert, Megan K.; Angeli, Peter; Kozono, Shingo; Stucky, Joseph E.; Baxley, Sean; Lin, Yu-Min; Zhou, Xiao Zhen; Lu, Kun Ping] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Translat Therapeut, Boston, MA 02215 USA; [Qiu, Chenxi; Albayram, Onder; Kondo, Asami; Wang, Bin; Kim, Nami; Tsai, Cheng-Yu; Bassal, Mahmoud A.; Herbert, Megan K.; Angeli, Peter; Kozono, Shingo; Stucky, Joseph E.; Baxley, Sean; Lin, Yu-Min; Tenen, Daniel G.; Zeidel, Mark; Zhou, Xiao Zhen; Lu, Kun Ping] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Qiu, Chenxi; Albayram, Onder; Kondo, Asami; Wang, Bin; Kim, Nami; Tsai, Cheng-Yu; Bassal, Mahmoud A.; Herbert, Megan K.; Angeli, Peter; Kozono, Shingo; Stucky, Joseph E.; Baxley, Sean; Lin, Yu-Min; Tenen, Daniel G.; Zhou, Xiao Zhen; Lu, Kun Ping] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Canc Res Inst, Boston, MA 02215 USA; [Qiu, Chenxi; Wang, Bin; Zhou, Xiao Zhen; Lu, Kun Ping] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Albayram, Onder] Med Univ South Carolina, Dept Med, Div Cardiol, Charleston, SC 29425 USA; [Arai, Ken; Washida, Kazuo; Lo, Eng H.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Charlestown, MA 02129 USA; [Arai, Ken; Washida, Kazuo; Lo, Eng H.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA 02129 USA; [Bassal, Mahmoud A.; Tenen, Daniel G.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Bassal, Mahmoud A.; Tenen, Daniel G.] Harvard Med Sch, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Sun, Yan; Rotenberg, Alexander] Harvard Med Sch, Childrens Hosp Boston, Dept Neurol, Boston, MA 02115 USA; [Caldarone, Barbara J.] Harvard Med Sch, Harvard NeuroDiscovery Ctr, NeuroBehav Lab, Boston, MA 02115 USA; [Bigio, Eileen H.] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Chen, Xiaochun] Fujian Med Univ Union Hosp, Fujian Key Lab Mol Neurol, Fuzhou 350001, Fujian, Peoples R China; [Lu, Kun Ping] Harvard Med Sch, Program Neurosci, Boston, MA 02115 USA		Zhou, XZ; Lu, KP (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Translat Therapeut, Boston, MA 02215 USA.; Zhou, XZ; Lu, KP (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA.; Zhou, XZ; Lu, KP (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Canc Res Inst, Boston, MA 02215 USA.; Zhou, XZ; Lu, KP (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Lu, KP (corresponding author), Harvard Med Sch, Program Neurosci, Boston, MA 02115 USA.	xzhou@bidmc.harvard.edu; klu@bidmc.harvard.edu	; Herbert, Megan/E-6348-2015	Bassal, Mahmoud Adel/0000-0003-4322-2968; Herbert, Megan/0000-0003-1599-4362	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AG055559, R01AG046319, U01NS096835, 2T32AG000222-26]; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG013854]; Alzheimer's AssociationAlzheimer's Association [DVT-14-322623]; Alzheimer's Research UKAlzheimer's Research UK (ARUK); Weston Brain Institute [MCDN-15-368711]; Thome Memorial Foundation in Alzheimer's Disease Drug Discovery Research; National Football League	C.Q. and O.A. are Alzheimer's Association Research Fellows, C.-Y.T. is a National Science Council Postdoctoral Fellow from Taiwan, and P.A. is supported by an NIH Training Grant 2T32AG000222-26 to C.-Y.T. E.H.B. is supported by NIA P30 AG013854 to E.H.B. This work was supported by NIH grants R01AG055559 to K.P.L., E.H.L. and X.Z.Z. and R01AG046319, U01NS096835, Alzheimer's Association (DVT-14-322623), Alzheimer's Research UK and Weston Brain Institute (MCDN-15-368711), Thome Memorial Foundation in Alzheimer's Disease Drug Discovery Research to K.P.L, and National Football League grant to W. Meehan, K.P.L., and X.Z.Z. and gift donations from the Owens Family Foundation to X.Z.Z. and K.P.L.	Albayram O, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01068-4; [Anonymous], 2019, SAFETY TOLERABILITY; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Balczon R, 2017, FASEB J, V31, P2785, DOI 10.1096/fj.201601042RR; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Clavaguera F, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a024372; Congdon EE, 2018, NAT REV NEUROL, V14, P399, DOI 10.1038/s41582-018-0013-z; Coulthard MG, 2012, AM J PATHOL, V181, P1493, DOI 10.1016/j.ajpath.2012.06.043; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Elliott LT, 2018, NATURE, V562, P210, DOI 10.1038/s41586-018-0571-7; Ferrer I, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00112; Gao TS, 2016, BIOINFORMATICS, V32, P3543, DOI 10.1093/bioinformatics/btw495; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; Han XP, 2018, CELL, V172, P1091, DOI 10.1016/j.cell.2018.02.001; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Kalish BT, 2018, P NATL ACAD SCI USA, V115, pE1051, DOI 10.1073/pnas.1717871115; Kim BM, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.216; Kisler K, 2017, NAT REV NEUROSCI, V18, P419, DOI 10.1038/nrn.2017.48; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; KRAUS DW, 1986, SCIENCE, V232, P90, DOI 10.1126/science.232.4746.90; Lai JJ, 2020, IMMUNITY, V52, P123, DOI 10.1016/j.immuni.2019.11.013; Li JH, 2003, J IMMUNOL, V171, P1526, DOI 10.4049/jimmunol.171.3.1526; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu KP, 2016, JAMA NEUROL, V73, P1356, DOI 10.1001/jamaneurol.2016.2027; Lu PJ, 1999, NATURE, V399, P784; Mathys H, 2019, NATURE, V570, P332, DOI 10.1038/s41586-019-1195-2; McEwan WA, 2017, P NATL ACAD SCI USA, V114, P574, DOI 10.1073/pnas.1607215114; Nakamura K, 2012, CELL, V149, P232, DOI 10.1016/j.cell.2012.02.016; Pluta R, 2018, J ALZHEIMERS DIS, V66, P429, DOI 10.3233/JAD-180772; Polydoro M, 2014, ACTA NEUROPATHOL, V127, P257, DOI 10.1007/s00401-013-1215-5; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Rosenmann H, 2006, ARCH NEUROL-CHICAGO, V63, P1459, DOI 10.1001/archneur.63.10.1459; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Ryo A, 2002, MOL CELL BIOL, V22, P5281, DOI 10.1128/MCB.22.15.5281-5295.2002; Sarabi AS, 2008, J NEUROSCI RES, V86, P2912, DOI 10.1002/jnr.21734; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Saunders A, 2018, CELL, V174, P1015, DOI 10.1016/j.cell.2018.07.028; Shibata M, 2007, STROKE, V38, P2826, DOI 10.1161/STROKEAHA.107.490151; Sultan A, 2011, J BIOL CHEM, V286, P4566, DOI 10.1074/jbc.M110.199976; Tu WH, 2010, CELL, V140, P222, DOI 10.1016/j.cell.2009.12.055; Tuo QZ, 2017, MOL PSYCHIATR, V22, P1520, DOI 10.1038/mp.2017.171; Venkat P, 2015, EXP NEUROL, V272, P97, DOI 10.1016/j.expneurol.2015.05.006; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Wegmann S, 2015, EMBO J, V34, P3028, DOI 10.15252/embj.201592748; Wolock S. L., 2018, 357368 BIORXIV; Zemva J, 2014, CNS NEUROL DISORD-DR, V13, P322, DOI 10.2174/18715273113126660141	51	2	2	8	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	1946-6234	1946-6242		SCI TRANSL MED	Sci. Transl. Med.	JUN 2	2021	13	596							eaaz7615	10.1126/scitranslmed.aaz7615			15	Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	SO1HA	WOS:000658729500002	34078745	Green Accepted			2022-02-06	
J	Anderson, EN; Morera, AA; Kour, S; Cherry, JD; Ramesh, N; Gleixner, A; Schwartz, JC; Ebmeier, C; Old, W; Donnelly, CJ; Cheng, JP; Kline, AE; Kofler, J; Stein, TD; Pandey, UB				Anderson, Eric N.; Morera, Andres A.; Kour, Sukhleen; Cherry, Jonathan D.; Ramesh, Nandini; Gleixner, Amanda; Schwartz, Jacob C.; Ebmeier, Christopher; Old, William; Donnelly, Christopher J.; Cheng, Jeffrey P.; Kline, Anthony E.; Kofler, Julia; Stein, Thor D.; Pandey, Udai Bhan			Traumatic injury compromises nucleocytoplasmic transport and leads to TDP-43 pathology	ELIFE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; NUCLEAR-PORE COMPLEXES; FRONTOTEMPORAL LOBAR DEGENERATION; MOTOR-NEURON DISEASE; BRAIN-INJURY; HEAD-INJURY; ALZHEIMERS-DISEASE; PHASE-TRANSITION; DROSOPHILA MODEL; STRESS GRANULES	Traumatic brain injury (TBI) is a predisposing factor for many neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), Parkinson's disease (PD), and chronic traumatic encephalopathy (CTE). Although defects in nucleocytoplasmic transport (NCT) is reported ALS and other neurodegenerative diseases, whether defects in NCT occur in TBI remains unknown. We performed proteomic analysis on Drosophila exposed to repeated TBI and identified resultant alterations in several novel molecular pathways. TBI upregulated nuclear pore complex (NPC) and nucleocytoplasmic transport (NCT) proteins as well as alter nucleoporin stability. Traumatic injury disrupted RanGAP1 and NPC protein distribution in flies and a rat model and led to coaggregation of NPC components and TDP-43. In addition, trauma-mediated NCT defects and lethality are rescued by nuclear export inhibitors. Importantly, genetic upregulation of nucleoporins in vivo and in vitro triggered TDP-43 cytoplasmic mislocalization, aggregation, and altered solubility and reduced motor function and lifespan of animals. We also found NUP62 pathology and elevated NUP62 concentrations in postmortem brain tissues of patients with mild or severe CTE as well as co-localization of NUP62 and TDP-43 in CTE. These findings indicate that TBI leads to NCT defects, which potentially mediate the TDP-43 pathology in CTE.	[Anderson, Eric N.; Kour, Sukhleen; Ramesh, Nandini; Pandey, Udai Bhan] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat, Med Ctr, Pittsburgh, PA 15213 USA; [Morera, Andres A.; Schwartz, Jacob C.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ USA; [Cherry, Jonathan D.; Stein, Thor D.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Cherry, Jonathan D.; Stein, Thor D.] Boston VA Healthcare Syst, Boston, MA USA; [Gleixner, Amanda; Donnelly, Christopher J.] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA USA; [Gleixner, Amanda; Donnelly, Christopher J.] Univ Pittsburgh, LiveLike Lou Ctr ALS Res, Brain Inst, Sch Med, Pittsburgh, PA USA; [Ebmeier, Christopher; Old, William] Univ Colorado, Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Cheng, Jeffrey P.; Kline, Anthony E.] Univ Pittsburgh, Phys Med & Rehabil, Pittsburgh, PA USA; [Cheng, Jeffrey P.; Kline, Anthony E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15260 USA; [Kline, Anthony E.] Univ Pittsburgh, Crit Care Med, Pittsburgh, PA 15260 USA; [Kofler, Julia] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Pandey, Udai Bhan] Univ Pittsburgh, Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15260 USA		Pandey, UB (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat, Med Ctr, Pittsburgh, PA 15213 USA.	udai@pitt.edu	Schwartz, Jacob/J-6477-2012	Schwartz, Jacob/0000-0002-5205-564X; Donnelly, Christopher/0000-0002-2383-9015	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21 AG064940, R01 NS081303, R21 NS098379, U54 NS115266, R01 NS084967, R56 NS113810, 1R00 NS082376]; Robert Packard Center for ALS Research, Johns Hopkins University	National Institute of Neurological Disorders and Stroke R21 AG064940 Christopher J Donnelly Udai Bhan Pandey; National Institute of Neurological Disorders and Stroke R01 NS081303 Udai Bhan Pandey; National Institute of Neurological Disorders and Stroke R21 NS098379 Christopher J Donnelly Udai Bhan Pandey; National Institute of Neurological Disorders and Stroke U54 NS115266 Thor Stein; National Institute of Neurological Disorders and Stroke R01 NS084967 Anthony E Kline; National Institute of Neurological Disorders and Stroke R56 NS113810 Anthony E Kline; National Institute of Neurological Disorders and Stroke 1R00 NS082376 Jacob Schwartz; Robert Packard Center for ALS Research, Johns Hopkins University Udai Bhan Pandey; The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Anderson EN, 2018, HUM MOL GENET, V27, P1366, DOI 10.1093/hmg/ddy047; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Arai T, 2009, ACTA NEUROPATHOL, V117, P125, DOI 10.1007/s00401-008-0480-1; Arnold ES, 2013, P NATL ACAD SCI USA, V110, pE736, DOI 10.1073/pnas.1222809110; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Bakthavachalu B, 2018, NEURON, V98, P754, DOI 10.1016/j.neuron.2018.04.032; Basel-Vanagaite L, 2006, ANN NEUROL, V60, P214, DOI 10.1002/ana.20902; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; BISCHOFF FR, 1995, P NATL ACAD SCI USA, V92, P1749, DOI 10.1073/pnas.92.5.1749; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Boer J, 1998, MOL CELL BIOL, V18, P1236, DOI 10.1128/MCB.18.3.1236; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Boyce M, 2011, P NATL ACAD SCI USA, V108, P3141, DOI 10.1073/pnas.1010045108; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Calabretta S, 2015, TRENDS BIOCHEM SCI, V40, P662, DOI 10.1016/j.tibs.2015.08.012; Cantu D, 2016, NEUROLOGY, V86; Chang JC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180828; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Cherry JD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185541; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Choksi DK, 2014, HUM MOL GENET, V23, P1025, DOI 10.1093/hmg/ddt498; Chou CC, 2018, NAT NEUROSCI, V21, P228, DOI 10.1038/s41593-017-0047-3; Conicella AE, 2016, STRUCTURE, V24, P1537, DOI 10.1016/j.str.2016.07.007; Cook CN, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abb3774; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; Diaper DC, 2013, HUM MOL GENET, V22, P1539, DOI 10.1093/hmg/ddt005; Dickmanns A, 2015, INT REV CEL MOL BIO, V320, P171, DOI 10.1016/bs.ircmb.2015.07.010; Eftekharzadeh B, 2018, NEURON, V99, P925, DOI 10.1016/j.neuron.2018.07.039; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Floch AG, 2014, METHOD CELL BIOL, V122, P1, DOI 10.1016/B978-0-12-417160-2.00001-1; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gasset-Rosa F, 2019, NEURON, V102, P339, DOI 10.1016/j.neuron.2019.02.038; Gasset-Rosa F, 2017, NEURON, V94, P48, DOI 10.1016/j.neuron.2017.03.027; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Grima JC, 2017, NEURON, V94, P93, DOI 10.1016/j.neuron.2017.03.023; Harris MA, 2013, OCCUP ENVIRON MED, V70, P839, DOI 10.1136/oemed-2013-101444; Hetzer M, 2002, NAT CELL BIOL, V4, pE177, DOI 10.1038/ncb0702-e177; HOLT GD, 1987, J CELL BIOL, V104, P1157, DOI 10.1083/jcb.104.5.1157; Huang CY, 2017, J NEUROIMMUNOL, V313, P61, DOI 10.1016/j.jneuroim.2017.10.011; Hutten S, 2020, SEMIN CELL DEV BIOL, V99, P151, DOI 10.1016/j.semcdb.2019.05.020; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Jensen K, 2013, JOVE-J VIS EXP, DOI 10.3791/50245; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Katzenberger RJ, 2015, JOVE-J VIS EXP, DOI 10.3791/52905; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Kusano A, 2001, DEV CELL, V1, P351, DOI 10.1016/S1534-5807(01)00042-9; Lattante S, 2013, HUM MUTAT, V34, P812, DOI 10.1002/humu.22319; Li B, 2014, TRAFFIC, V15, P347, DOI 10.1111/tra.12150; Lin DH, 2019, ANNU REV BIOCHEM, V88, P725, DOI 10.1146/annurev-biochem-062917-011901; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Mann JR, 2019, NEURON, V102, P321, DOI 10.1016/j.neuron.2019.01.048; McGurk L, 2018, MOL CELL, V71, P703, DOI 10.1016/j.molcel.2018.07.002; McKee AC, 2018, HAND CLINIC, V158, P297, DOI 10.1016/B978-0-444-63954-7.00028-8; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nofrini V, 2016, EUR J HUM GENET, V24, P1388, DOI 10.1038/ejhg.2016.25; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Peters TL, 2013, AMYOTROPH LAT SCL FR, V14, P267, DOI 10.3109/21678421.2012.754043; Polymenidou M, 2012, BRAIN RES, V1462, P3, DOI 10.1016/j.brainres.2012.02.059; Pujol G, 2002, BIOCHEM BIOPH RES CO, V294, P354, DOI 10.1016/S0006-291X(02)00492-8; Roth P, 2003, J CELL BIOL, V163, P701, DOI 10.1083/jcb.200304046; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/NMETH.2212, 10.1038/nmeth.2212]; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Schachtrup C, 2015, NAT NEUROSCI, V18, P1077, DOI 10.1038/nn.4054; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Solmaz SR, 2011, CELL, V147, P590, DOI 10.1016/j.cell.2011.09.034; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Srivastava AK, 2018, NEUROMETHODS, V139, P1, DOI 10.1007/978-1-4939-8564-7_1; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Tajiri N, 2016, CNS NEUROSCI THER, V22, P306, DOI 10.1111/cns.12501; Tamir S, 2017, J NEUROL SCI, V381, P715, DOI 10.1016/j.jns.2017.08.2015; Tan XL, 2018, J NEUROTRAUM, V5, P12; Taylor KM, 2016, PARKINSONISM RELAT D, V23, P57, DOI 10.1016/j.parkreldis.2015.12.005; Tyanova S, 2015, PROTEOMICS, V15, P1453, DOI 10.1002/pmic.201400449; Tylicka M, 2014, CHILD NERV SYST, V30, P1191, DOI 10.1007/s00381-014-2409-4; Uryu K, 2008, J NEUROPATH EXP NEUR, V67, P555, DOI 10.1097/NEN.0b013e31817713b5; Vanacore N, 2006, PARKINSONISM RELAT D, V12, P327, DOI 10.1016/j.parkreldis.2005.11.007; vanDeursen J, 1996, EMBO J, V15, P5574, DOI 10.1002/j.1460-2075.1996.tb00942.x; Wang HK, 2015, NEUROSCIENCE, V300, P94, DOI 10.1016/j.neuroscience.2015.05.013; Wiesner D, 2018, EXP NEUROL, V299, P15, DOI 10.1016/j.expneurol.2017.09.011; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wu XS, 2001, P NATL ACAD SCI USA, V98, P3191, DOI 10.1073/pnas.051631598; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yao XL, 2008, J NEUROCHEM, V104, P353, DOI 10.1111/j.1471-4159.2007.04970.x; Zeng XJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0316-4; Zhang K, 2018, CELL, V173, P958, DOI 10.1016/j.cell.2018.03.025; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106; Zhu YP, 2016, J MOL CELL BIOL, V8, P2, DOI 10.1093/jmcb/mjv033	105	2	2	5	7	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	JUN 1	2021	10								e67587	10.7554/eLife.67587			30	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	SN6DR	WOS:000658378500001	34060470	Green Published, gold			2022-02-06	
J	Berlin, RS; Dalena, MM; Oleck, NC; Halsey, JN; Luthringer, M; Hoppe, IC; Lee, EDS; Granick, MS				Berlin, Ryan S.; Dalena, Margaret M.; Oleck, Nicholas C.; Halsey, Jordan N.; Luthringer, Margaret; Hoppe, Ian C.; Lee, Edward S.; Granick, Mark S.			Facial Fractures and Mixed Dentition - What Are the Implications of Dentition Status in Pediatric Facial Fracture Management?	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Facial fractures and dentition status; mixed dentition; pediatric facial fractures; surgical treatment during mixed dentition	MIDFACIAL FRACTURES; MANDIBLE FRACTURES; INJURIES; PATTERNS; CHILDREN	Introduction: The stage of maturation of the pediatric facial skeleton at the time of injury has a significant impact on both facial fracture patterns and management strategies. For instance, the relative prominence of the pediatric cranium during the early years of life affords protection to the structures of the midface, whereas delayed aeration of the frontal sinuses may predispose younger patients to frontal bone fractures. The dentition status of a pediatric patient may have similar implications in the setting of facial fracture. In this study, the authors examine the effect of dentition status on facial fracture patterns and management strategies at an urban, level 1 trauma center. Methods: A retrospective chart review was performed for all cases of facial fracture occurring in the pediatric patient population at a level 1 trauma center (University Hospital in Newark, NJ) between 2002 and 2014. A database including patient demographics, facial fracture, and concomitant injury patterns, and operative management data was constructed and analyzed. Results: A total of 72 patients with mixed dentition met inclusion criteria for our study and were compared against patients with primary (n = 35) and permanent (n = 349) dentition. The mean age at presentation was 9.2 years, with a male predominance of 68%. The most common fracture etiology was pedestrian struck accident (n = 23), fall (n = 21), motor vehicle collision (n = 12), and assault (n = 9). The most frequently identified facial fractures were that of the orbit (n = 31), mandible (n = 21), nasal bone (n = 19), and frontal sinus (n = 14). Additionally, 8 Le Fort and 4 nasoorbitoethmoid fractures were identified. Twenty-one patients (29%) required operative management for 1 or more facial fractures. Operative intervention was required in 38% of mandibular fractures, with 6 patients requiring only maxillomandibular fixation and 2 requiring open reduction and internal fixation with titanium plating. Nine cases of orbital fracture (29%) were managed operatively - 4 with absorbable plates, 3 with Medpor implants, and 8 with titanium plating. Management of all nasal fractures requiring operative intervention was accomplished through closed reduction. Concomitant injuries included traumatic brain injury (TBI) (n = 35), skull fracture (n = 24), intracranial hemorrhage (ICH) (n = 20), and long bone fracture (n = 12). Seventeen patients required admission to the intensive care unit. Patients with mixed dentition were significantly more likely to sustain frontal sinus and Le Fort fractures (P < 0.01), as well as skull fracture, ICH, and TBI (P < 0.01) as compared to those with permanent dentition. Conclusions: The dentition status of a pediatric patient may have significant implications in both patterns of injury and operative management strategies in the setting of acute facial trauma. Our study finds that Le Fort and frontal sinus fractures were significantly more common in patients with mixed dentition. Severe concomitant injuries such as ICH and TBI were also significantly more likely in this cohort. A patient's dentition status may also play a role in the decision for ridged fixation of mandibular and orbital fractures, as well as the method of maxillomandibular fixation in maxillary and mandibular alveolar fracture.	[Berlin, Ryan S.; Dalena, Margaret M.; Oleck, Nicholas C.; Halsey, Jordan N.; Luthringer, Margaret; Lee, Edward S.; Granick, Mark S.] Rutgers New Jersey Med Sch, Dept Surg, Div Plast & Reconstruct Surg, Newark, NJ USA; [Hoppe, Ian C.] Univ Mississippi, Med Ctr, Dept Surg, Div Plast & Reconstruct Surg, Jackson, MS 39216 USA		Halsey, JN (corresponding author), 185 S Orange Ave, Newark, NJ 07103 USA.	jordan.halsey88@gmail.com		Luthringer, Margaret/0000-0001-7342-5163			Araki T, 2017, NEUROL MED-CHIR, V57, P82, DOI 10.2176/nmc.ra.2016-0191; Bilgen F, 2019, J CRANIOFAC SURG, V30, P2368, DOI 10.1097/SCS.0000000000005896; Boyette JR, 2014, OTOLARYNG CLIN N AM, V47, P747, DOI 10.1016/j.otc.2014.06.008; Braun TL, 2017, SEMIN PLAST SURG, V31, P118, DOI 10.1055/s-0037-1601380; Cakabay T, 2018, J CRANIOFAC SURG, V29, P1334, DOI 10.1097/SCS.0000000000004550; Centers for Disease Control and Prevention, 2015, INJURY PREVENTION CO; Chocron Y, 2019, J CRANIOFAC SURG, V30, P2111, DOI 10.1097/SCS.0000000000006002; Ferreira P, 2004, BRIT J ORAL MAX SURG, V42, P501, DOI 10.1016/j.bjoms.2004.06.006; Filinte GT, 2015, ULUS TRAVMA ACIL CER, V21, P509, DOI 10.5505/tjtes.2015.23922; Gart MS, 2014, PLAST RECONSTR SURG, V134, P1345, DOI 10.1097/PRS.0000000000000719; Goth S, 2012, J CRANIOFAC SURG, V23, P47, DOI 10.1097/SCS.0b013e318240c8ab; Grunwaldt L, 2011, PLAST RECONSTR SURG, V128, P1263, DOI 10.1097/PRS.0b013e318230c8cf; Haug RH, 2000, ORAL SURG ORAL MED O, V90, P126, DOI 10.1067/moe.2000.107974; IIZUKA T, 1995, ARCH OTOLARYNGOL, V121, P1366; KABAN LB, 1977, PLAST RECONSTR SURG, V59, P15, DOI 10.1097/00006534-197701000-00002; Kao R, 2019, LARYNGOSCOPE INVEST, V4, P597, DOI 10.1002/lio2.315; Lopez J, 2019, PLAST RECONSTR SURG, V143, P211, DOI 10.1097/PRS.0000000000005106; Macmillan A, 2018, J ORAL MAXIL SURG, V76, P1044, DOI 10.1016/j.joms.2017.11.039; Naran S, 2014, PLAST RECONSTR SURG, V133, P364, DOI 10.1097/01.prs.0000436842.07871.b6; National Highway Traffic Safety Administration, 2018, TRAFF SAF FACTS; Owusu JA, 2016, JAMA FACIAL PLAST SU, V18, P37, DOI 10.1001/jamafacial.2015.1456; Smartt JM, 2005, PLAST RECONSTR SURG, V116, p28E, DOI 10.1097/01.prs.0000173445.10908.f8; Vu AT, 2015, J CRANIOFAC SURG, V26, P776, DOI 10.1097/SCS.0000000000001276; Vyas RM, 2008, J CRANIOFAC SURG, V19, P339, DOI 10.1097/SCS.0b013e31814fb5e3; Yu J, 2011, J CRANIOFAC SURG, V22, P1247, DOI 10.1097/SCS.0b013e31821c6955	25	2	2	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JUN	2021	32	4					1370	1375		10.1097/SCS.0000000000007424			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	SS2TX	WOS:000661595100056	33427769				2022-02-06	
J	Fung, FW; Wang, Z; Parikh, DS; Jacobwitz, M; Vala, L; Donnelly, M; Topjian, AA; Xiao, R; Abend, NS				Fung, France W.; Wang, Zi; Parikh, Darshana S.; Jacobwitz, Marin; Vala, Lisa; Donnelly, Maureen; Topjian, Alexis A.; Xiao, Rui; Abend, Nicholas S.			Electrographic Seizures and Outcome in Critically Ill Children	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; CONTINUOUS VIDEO-EEG; NONCONVULSIVE SEIZURES; STATUS EPILEPTICUS; CONSENSUS STATEMENT; TERMINOLOGY; VERSION; ADULTS; COMMON; RISK	Objective To determine the association between electroencephalographic seizure (ES) and electroencephalographic status epilepticus (ESE) exposure and unfavorable neurobehavioral outcomes in critically ill children with acute encephalopathy. Methods This was a prospective cohort study of acutely encephalopathic critically ill children undergoing continuous EEG monitoring (CEEG). ES exposure was assessed as (1) no ES/ESE, (2) ES, or (3) ESE. Outcomes assessed at discharge included the Glasgow Outcome Scale-Extended Pediatric Version (GOS-E-Peds), Pediatric Cerebral Performance Category (PCPC), and mortality. Unfavorable outcome was defined as a reduction in GOS-E-Peds or PCPC score from preadmission to discharge. Stepwise selection was used to generate multivariate logistic regression models that assessed associations between ES exposure and outcomes while adjusting for multiple other variables. Results Among 719 consecutive critically ill patients, there was no evidence of ES in 535 patients (74.4%), ES occurred in 140 patients (19.5%), and ESE in 44 patients (6.1%). The final multivariable logistic regression analyses included ES exposure, age dichotomized at 1 year, acute encephalopathy category, initial EEG background category, comatose at CEEG initiation, and Pediatric Index of Mortality 2 score. There was an association between ESE and unfavorable GOS-E-Peds (odds ratio 2.21, 95% confidence interval 1.07-4.54) and PCPC (odds ratio 2.17, 95% confidence interval 1.05-4.51) but not mortality. There was no association between ES and unfavorable outcome or mortality. Conclusions Among acutely encephalopathic critically ill children, there was an association between ESE and unfavorable neurobehavioral outcomes, but no association between ESE and mortality. ES exposure was not associated with unfavorable neurobehavioral outcomes or mortality.	[Fung, France W.; Abend, Nicholas S.] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Fung, France W.; Abend, Nicholas S.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Wang, Zi; Xiao, Rui] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA; [Topjian, Alexis A.; Abend, Nicholas S.] Univ Penn, Perelman Sch Med, Dept Anesthesia & Crit Care, Philadelphia, PA 19104 USA; [Xiao, Rui; Abend, Nicholas S.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Fung, France W.; Parikh, Darshana S.; Jacobwitz, Marin; Abend, Nicholas S.] Childrens Hosp Philadelphia, Dept Pediat, Div Neurol, Philadelphia, PA 19104 USA; [Vala, Lisa; Donnelly, Maureen; Abend, Nicholas S.] Childrens Hosp Philadelphia, Dept Neurodiagnost, Philadelphia, PA 19104 USA; [Topjian, Alexis A.] Childrens Hosp Philadelphia, Dept Anesthesia & Crit Care Med, Philadelphia, PA 19104 USA		Fung, FW (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA.	fungf@email.chop.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U54-HD086984, K02NS096058]; Wolfson Family Foundation	NIH K02NS096058, the Wolfson Family Foundation, and NIH U54-HD086984.	Abend NS, 2011, NEUROLOGY, V76, P1071, DOI 10.1212/WNL.0b013e318211c19e; Abend NS, 2017, J CLIN NEUROPHYSIOL, V34, P534, DOI 10.1097/WNP.0000000000000424; Abend NS, 2013, NEUROLOGY, V81, P383, DOI 10.1212/WNL.0b013e31829c5cfe; Abend NS, 2013, SEIZURE-EUR J EPILEP, V22, P467, DOI 10.1016/j.seizure.2013.03.008; Abend NS, 2011, J CLIN NEUROPHYSIOL, V28, P15, DOI 10.1097/WNP.0b013e3182051123; Abend NS, 2010, NEUROCRIT CARE, V12, P382, DOI 10.1007/s12028-010-9337-2; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Beniczky S, 2013, EPILEPSIA, V54, P28, DOI 10.1111/epi.12270; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Claassen J, 2014, ANN NEUROL, V75, P771, DOI 10.1002/ana.24166; Claassen J, 2013, ANN NEUROL, V74, P53, DOI 10.1002/ana.23859; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; Fung FW, 2020, NEUROLOGY, V95, pE1599, DOI 10.1212/WNL.0000000000010421; Fung FW, 2020, EPILEPSIA, V61, P498, DOI 10.1111/epi.16448; Fung FW, 2019, EPILEPSIA, V60, P2095, DOI 10.1111/epi.16341; Fung FW, 2019, J CLIN NEUROPHYSIOL, V36, P349, DOI 10.1097/WNP.0000000000000591; Greiner HM, 2012, PEDIATRICS, V129, pE748, DOI 10.1542/peds.2011-2067; Gwer S, 2012, ARCH DIS CHILD, V97, P343, DOI 10.1136/archdischild-2011-300935; Harris ML, 2016, J CHILD NEUROL, V31, P1546, DOI 10.1177/0883073816664670; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P87, DOI 10.1097/WNP.0000000000000166; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P96, DOI 10.1097/WNP.0000000000000165; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI 10.1097/WNP.0b013e3182784729; Isaeva E, 2010, EUR J NEUROSCI, V31, P1446, DOI 10.1111/j.1460-9568.2010.07179.x; Karnam HB, 2009, EXP NEUROL, V217, P378, DOI 10.1016/j.expneurol.2009.03.028; Kirkham FJ, 2012, INTENS CARE MED, V38, P853, DOI 10.1007/s00134-012-2529-9; Lambrechtsen FACP, 2008, EPILEPSIA, V49, P615, DOI 10.1111/j.1528-1167.2007.01465.x; Lee JW, 2016, J CLIN NEUROPHYSIOL, V33, P133, DOI 10.1097/WNP.0000000000000230; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McCoy B, 2011, EPILEPSIA, V52, P1973, DOI 10.1111/j.1528-1167.2011.03291.x; Payne ET, 2014, BRAIN, V137, P1429, DOI 10.1093/brain/awu042; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Fernandez IS, 2017, EPILEPSIA, V58, P420, DOI 10.1111/epi.13653; Sanchez SM, 2013, J CLIN NEUROPHYSIOL, V30, P156, DOI 10.1097/WNP.0b013e31827eda27; Schreiber JM, 2012, NEUROCRIT CARE, V17, P31, DOI 10.1007/s12028-012-9715-z; Slater A, 2003, INTENS CARE MED, V29, P278, DOI 10.1007/s00134-002-1601-2; Srinivasakumar P, 2015, PEDIATRICS, V136, pE1302, DOI 10.1542/peds.2014-3777; Topjian AA, 2016, PEDIATR CRIT CARE ME, V17, P547, DOI 10.1097/PCC.0000000000000740; Topjian AA, 2014, CRIT CARE MED, V42, P1518, DOI 10.1097/CCM.0000000000000216; Topjian AA, 2013, CRIT CARE MED, V41, P215, DOI 10.1097/CCM.0b013e3182668035; van Rooij LGM, 2010, PEDIATRICS, V125, pE358, DOI 10.1542/peds.2009-0136; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Wagenman KL, 2014, NEUROLOGY, V82, P396, DOI 10.1212/WNL.0000000000000082; Williams K, 2011, EPILEPSIA, V52, P1130, DOI 10.1111/j.1528-1167.2011.03070.x; Williams RP, 2016, EPILEPSIA, V57, P786, DOI 10.1111/epi.13354; Witzman S, 2020, J CLIN NEUROPHYSIOL, V37, P455, DOI 10.1097/WNP.0000000000000639; Yang A, 2015, SEIZURE-EUR J EPILEP, V25, P104, DOI 10.1016/j.seizure.2014.09.013; YOUNKIN DP, 1986, ANN NEUROL, V20, P513, DOI 10.1002/ana.410200412	48	2	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JUN 1	2021	96	22					E2749	E2760		10.1212/WNL.0000000000012032			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UZ7UN	WOS:000702406800016	33893203				2022-02-06	
J	Huber, CM; Patton, DA; Jain, D; Master, CL; Margulies, SS; Mcdonald, CC; Arbogast, KB				Huber, Colin M.; Patton, Declan A.; Jain, Divya; Master, Christina L.; Margulies, Susan S.; Mcdonald, Catherine C.; Arbogast, Kristy B.			Variations in Head Impact Rates in Male and Female High School Soccer	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						HEAD INJURIES; CONCUSSION; PEDIATRIC SPORTS MEDICINE; INJURY PREVENTION; FOOTBALL (SOCCER)	CONTACT; EPIDEMIOLOGY; CONCUSSIONS; INJURIES; EXPOSURE	Introduction Repetitive head impacts in soccer have been linked to short-term neurophysiological deficits, and female soccer players have higher concussion rates than males. These findings have inspired investigation into gender differences in head impact exposure and how head impact rate contributes to the cumulative effect of head impact exposure on neurological outcomes. Various periods of exposure have been used to calculate head impact rates, including head impacts per season, game, and player-hour. Purpose The aim of this study was to apply different methodological approaches to quantify and compare head impact rates by gender for two seasons of high school varsity soccer. Methods Video review was used to confirm all events recorded by a headband-mounted impact sensor and calculate playing time for all players. Impact rates were calculated per athlete exposure (presence and participation) and per player-hour (scheduled game time, individual play time, and absolute time). Results Impact rates per athlete exposure ranged from 2.5 to 3.2 for males and from 1.4 to 1.6 for females, and impact rates per player-hour ranged from 2.7 to 3.8 for males and from 1.0 to 1.6 for females. The exposure calculation method significantly affected head impact rates; however, regardless of approach, the head impact rate for males was higher, up to threefold, than for females. Individual head impact exposure varied substantially within a team with one in five players experiencing no impacts. Conclusions Overall, the gender differences found in this study indicate that males experience higher head impact exposure compared with females. Future studies are needed to understand potential clinical implications of variability in head impact exposure and reconcile higher female concussion rates with the reduced head impact rates presented herein.	[Huber, Colin M.; Jain, Divya] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Huber, Colin M.; Patton, Declan A.; Jain, Divya; Master, Christina L.; Mcdonald, Catherine C.; Arbogast, Kristy B.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Master, Christina L.] Childrens Hosp Philadelphia, Sports Med & Performance Ctr, Philadelphia, PA 19104 USA; [Master, Christina L.; Mcdonald, Catherine C.; Arbogast, Kristy B.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Margulies, Susan S.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Margulies, Susan S.] Emory Univ, Atlanta, GA 30322 USA; [Mcdonald, Catherine C.] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA		Arbogast, KB (corresponding author), 2716 South St, Philadelphia, PA 19146 USA.	chuber3@seas.upenn.edu; pattonda@email.chop.edu; jdivya@seas.upenn.edu; masterc@email.chop.edu; susan.margulies@gatech.edu; mcdonalc@upenn.edu; ARBOGAST@email.chop.edu		HUBER, COLIN/0000-0002-0045-5940; McDonald, Catherine/0000-0003-3856-8542	Shipley School administration; National Institute of Neurologic Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS097549]; Pennsylvania Department of Health	The authors thank the students and parents from the Shipley School for their participation. The authors appreciate the support from the Shipley School administration and athletic department: Steve Piltch, Michael Turner, Mark Duncan, Katelyn Taylor, Dakota Carroll, Kimberly Shaud, and Kayleigh Jenkins.; Research reported in this publication was supported by National Institute of Neurologic Disorders and Stroke of the National Institutes of Health under award number R01NS097549 and the Pennsylvania Department of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health and the Pennsylvania Department of Health.	Campolettano ET, 2016, J NEUROSURG-PEDIATR, V18, P536, DOI 10.3171/2016.5.PEDS1696; Chrisman SPD, 2019, CLIN J SPORT MED, V29, P3, DOI 10.1097/JSM.0000000000000497; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Goldsberry BK., 2020, MUCH FOOTBALL IS EVE, P1; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Haran FJ, 2013, INT J SPORTS MED, V34, P350, DOI 10.1055/s-0032-1304647; Huber CM, 2021, J BIOMECH ENG-T ASME, V143, DOI 10.1115/1.4048574; Kawata K, 2016, INT J SPORTS MED, V37, P405, DOI 10.1055/s-0035-1569290; Kelley ME, 2019, J NEUROSURG-PEDIATR, V23, P381, DOI 10.3171/2018.9.PEDS18314; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Kerr ZY, 2011, CLIN PEDIATR, V50, P594, DOI 10.1177/0009922810390513; King D, 2016, SPORTS MED, V46, P151, DOI 10.1007/s40279-015-0423-7; Knowles SB, 2006, AM J EPIDEMIOL, V164, P1209, DOI 10.1093/aje/kwj337; Kuo C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199238; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Mackay DF, 2019, NEW ENGL J MED, V381, P1801, DOI 10.1056/NEJMoa1908483; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Miller LE, 2020, RES SPORTS MED, V28, P55, DOI 10.1080/15438627.2019.1590833; Nevins D., 2019, ATHLETIC TRAINING SP, V11, P174, DOI [10.3928/19425864-20180802-02, DOI 10.3928/19425864-20180802-02]; Nguyen JVK, 2019, SPORTS MED, V49, P1575, DOI 10.1007/s40279-019-01135-4; Oeur RA., 2016, 34 INT C BIOMECHANIC, P4; Patton DA, 2020, AM J SPORT MED, V48, P1246, DOI 10.1177/0363546520906406; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Reynolds BB, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117701708; Rich AM, 2019, ANN BIOMED ENG, V47, P2109, DOI 10.1007/s10439-019-02313-1; Sandmo SB, 2020, SCAND J MED SCI SPOR, V30, P193, DOI 10.1111/sms.13562; Saunders TD, 2020, CLIN BIOMECH, V74, P14, DOI 10.1016/j.clinbiomech.2020.02.003; Triax Technologies, 2014, LAB VALIDATION SIM G; Tyson AM, 2018, J APPL BIOMECH, V34, P320, DOI 10.1123/jab.2017-0256; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vollavanh LR, 2018, J APPL BIOMECH, V34, P396, DOI 10.1123/jab.2017-0231	35	2	2	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	JUN	2021	53	6					1245	1251		10.1249/MSS.0000000000002567			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	SB4ZD	WOS:000650003400016	33986230				2022-02-06	
J	Liu, N; Sun, HY; Li, XZ; Cao, W; Peng, AN; Dong, SY; Yu, ZX				Liu, Na; Sun, Haiyan; Li, Xuezhong; Cao, Wei; Peng, Aini; Dong, Suyan; Yu, Zhixin			Downregulation of lncRNA KCNQ1OT1 relieves traumatic brain injury induced neurological deficits via promoting "M2" microglia polarization	BRAIN RESEARCH BULLETIN			English	Article						Traumatic brain injury; Microglia; KCNQ1OT1; ceRNA; miR-873-5p	LONG NONCODING RNA; EXPRESSION; PROGNOSIS	Background: Microglia-induced neuroinflammation is one of the main characteristics of traumatic brain injury (TBI). Presently, we aim to investigate the role of long non-coding RNA (lncRNA) KCNQ1 overlapping transcript 1 (KCNQ1OT1) in TBI-induced neurological deficits and the related mechanism. Methods: An in-vivo TBI model was established in mice, and in-vitro experiments were carried out on BV2 microglia. Then the neurological functions, microglial activation, inflammatory cytokines, and proteins were detected. Results: Our data indicated that KCNQ1OT1 was markedly overexpressed in the cerebral tissues of TBI mice, accompanied by a higher level of the cytokines (including IL-1 beta, IL-6, and TNF alpha). However, knocking down KCNQ1OT1 relieved neurological deficits, neuron loss, and blood-brain barrier damage. Besides, overexpressing miR-873-5p enhanced the "M2'' polarization of microglia by repressing the TRAF6-mediated p38 and NF-kappa B pathways. In contrast, downregulating KCNQ1OT1 repressed microglial neuroinflammation by attenuating the "M1'' polarization of microglia and promoting "M2'' polarization of microglia, and inactivating the p38 and NF-kappa B pathway. Conclusions: Mechanistically, KCNQ1OT1 functioned as a competitive endogenous RNA (ceRNA) by sponging miR-873-5p, which targeted the 3' untranslated region (UTR) of TRAF6. Overall, our data confirmed that downregulating lncRNA KCNQ1OT1 exerted neuroprotective effects on TBI mice by modulating the miR-873-5p-TRAF6-p38/NF-kappa B axis.	[Liu, Na; Li, Xuezhong; Cao, Wei; Peng, Aini; Dong, Suyan] First Peoples Hosp Zhenjiang, Dept Neurol, 8 Dianli Rd, Zhenjiang 212000, Jiangsu, Peoples R China; [Sun, Haiyan] Jilin Prov FAW Gen Hosp, Dept Neurol, Changchun 130000, Jilin, Peoples R China; [Yu, Zhixin] First Peoples Hosp Zhenjiang, ICU, Zhenjiang 212000, Jiangsu, Peoples R China		Liu, N (corresponding author), First Peoples Hosp Zhenjiang, Dept Neurol, 8 Dianli Rd, Zhenjiang 212000, Jiangsu, Peoples R China.	liunaln005@163.com		Liu, Na/0000-0001-5763-2808	National Science foundation of Jiangsu Province [BK20160547]	This work was supported by National Science foundation of Jiangsu Province (BK20160547) .	Bhalala O.G., 2015, BRAIN NEUROTRAUMA MO; Chen CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115694; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Crupi R, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9040297; Cui Y, 2018, CELL BIOL INT, V42, P1632, DOI 10.1002/cbin.11060; Di Padova F, 2018, EXPERT OPIN THER TAR, V22, P401, DOI 10.1080/14728222.2018.1464139; Di Pietro V, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00429; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Dou Y, 2018, CURR NEUROPHARMACOL, V16, P1306, DOI 10.2174/1570159X16666180412094655; Fu TM, 2018, P NATL ACAD SCI USA, V115, P1783, DOI 10.1073/pnas.1721788115; Ge XT, 2019, J NEUROTRAUM, V36, P1291, DOI 10.1089/neu.2018.5728; Ge YT, 2019, IMMUNOPHARM IMMUNOT, V41, P549, DOI 10.1080/08923973.2019.1666406; Gu SX, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040732; Henry RJ, 2019, NEUROTHERAPEUTICS, V16, P216, DOI 10.1007/s13311-018-0665-9; Ji W, 2018, NEUROCHEM RES, V43, P1863, DOI 10.1007/s11064-018-2602-z; Jiang XH, 2020, MOL THER-NUCL ACIDS, V19, P179, DOI 10.1016/j.omtn.2019.10.036; Jiao J, 2020, CHINA COMMUN, V17, P1, DOI 10.23919/J.CC.2020.07.001; Li GQ, 2019, PATHOL RES PRACT, V215, P34, DOI 10.1016/j.prp.2018.10.008; Li ZX, 2019, NEUROPSYCH DIS TREAT, V15, P1671, DOI 10.2147/NDT.S206624; Li ZJ, 2019, INT IMMUNOPHARMACOL, V67, P268, DOI 10.1016/j.intimp.2018.12.001; Liu FY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1388-x; Long XB, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01761-0; Morris Nunez J., 2008, JOVE-J VIS EXP, P897, DOI [10.3791/897, DOI 10.3791/897]; Mussa BM, 2019, J PHYSIOL SCI, V69, P981, DOI 10.1007/s12576-019-00718-0; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Qiao CX, 2019, BIOCHEM BIOPH RES CO, V508, P217, DOI 10.1016/j.bbrc.2018.11.100; Shao HF, 2019, EUR REV MED PHARMACO, V23, P4341, DOI 10.26355/eurrev_201905_17940; Shi R, 2018, NEUROCHEM RES, V43, P1529, DOI 10.1007/s11064-018-2567-y; Su XQ, 2020, BRAIN RES BULL, V158, P1, DOI [10.1016/j.brainresbull.2020.02.000, 10.1016/j.brainresbull.2020.02.009]; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Wang CF, 2017, J NEUROTRAUM, V34, P2100, DOI 10.1089/neu.2016.4642; Wang X, 2018, IEEE INT CONF ASAP, P25; Wang ZL, 2020, ONCOTARGETS THER, V13, P1037, DOI 10.2147/OTT.S213168; Wheble JLC, 2016, J ROY ARMY MED CORPS, V162, P87, DOI 10.1136/jramc-2015-000472; Wu YY, 2020, BIOCHEM CELL BIOL, V98, P338, DOI 10.1139/bcb-2019-0271; Xiao X, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0501-0; Yang YX, 2019, NEUROCHEM RES, V44, P811, DOI 10.1007/s11064-018-02714-z; Yi M, 2019, CELL CYCLE, V18, P2332, DOI 10.1080/15384101.2019.1647024; Yi M, 2020, INFLAMMATION, V43, P1832, DOI 10.1007/s10753-020-01257-2; Zhang L, 2019, MOL THER-NUCL ACIDS, V17, P754, DOI 10.1016/j.omtn.2019.07.013; Zhang YM, 2019, J CELL BIOCHEM, V120, P17584, DOI 10.1002/jcb.29025; Zhong JJ, 2016, BRAIN RES, V1646, P589, DOI 10.1016/j.brainres.2016.07.002; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59	43	2	2	4	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	JUN	2021	171						91	102		10.1016/j.brainresbull.2021.03.004			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RQ2QP	WOS:000642265100011	33713751				2022-02-06	
J	Morrow, EL; Patel, NN; Duff, MC				Morrow, Emily L.; Patel, Nirav N.; Duff, Melissa C.			Disability and the COVID-19 Pandemic: A Survey of Individuals With Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; traumatic; COVID-19; Rehabilitation	REHABILITATION; SUPPORT; INTERVENTIONS; SEQUELAE; VIOLENCE; MODEL	Objectives: To identify the consequences of the coronavirus 2019 (COVID-19) pandemic for individuals with traumatic brain injury (TBI), with particular attention to unique effects for individuals with chronic disability. Design: Individuals with and without a history of TBI completed a web-based survey. Setting: Participants were recruited from the Vanderbilt Brain Injury Patient Registry in Nashville, TN, and completed the survey from their homes between May and June 2020, during social distancing related to the COVID-19 pandemic. Participants: Participants (NZ47) in the chronic phase of moderate-severe TBI (>6mo postinjury) and 51 noninjured comparison (NC) peers completed the survey. Interventions: Not applicable. Main Outcome Measures: Participants, or respondents, answered a mix of multiple choice and free text questions about how the COVID-19 pandemic has affected their work, education, medical care, social communication, sources of information and decision making, and mental and physical well-being. Individuals with TBI also answered questions about how TBI has affected their experiences of the pandemic. Results: As a group, respondents with TBI reported less pandemic-related behavior change (eg, daily habits, virtual social visits, and masking) than NC peers. Both NCs and respondents with TBI identified health care providers as trusted sources of public health information. One-third of individuals with TBI indicated that brain injury has made coping with the pandemic more difficult, and respondents identified mental health challenges and social isolation as key barriers. Conclusions: These results suggest that health care providers should look for ways to provide tailored education and reduce social isolation for individuals with disability during the ongoing COVID-19 pandemic. We discuss several direct suggestions from participant responses. Archives of Physical Medicine and Rehabilitation 2021;102:1075-83 (c) 2021 by the American Congress of Rehabilitation Medicine	[Morrow, Emily L.; Patel, Nirav N.; Duff, Melissa C.] Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, 1215 21st Ave South, Nashville, TN 37232 USA		Morrow, EL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, 1215 21st Ave South, Nashville, TN 37232 USA.	emily.l.morrow@vanderbilt.edu		Morrow, Emily/0000-0003-4629-2283	National Institutes of Health, National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 110661]	Supported by National Institutes of Health, National Institute of Neurological Disorders and Stroke (grant no. R01 110661 to M.C.D.) .	Alund NN, 2020, NASHVILLE TENNE 0511; [Anonymous], 2015, C TRAUM BRAIN INJ US; [Anonymous], 2020, NEWS 4 NASHVILL 0512; Armitage R, 2020, LANCET PUBLIC HEALTH, V5, pE257, DOI 10.1016/S2468-2667(20)30076-1; Bethel JW, 2011, AM J PREV MED, V40, P139, DOI 10.1016/j.amepre.2010.10.020; Bloodworth DM, 2007, AM J PHYS MED REHAB, V86, P770, DOI 10.1097/PHM.0b013e31813e0439; Boyle CA, 2020, DISABIL HEALTH J, V13, DOI 10.1016/j.dhjo.2020.100943; Centers for Disease Control and Prevention, CDCS DISASTER PLANNI; Chiaravalloti ND, 2021, J NEUROL, V268, P1598, DOI 10.1007/s00415-020-10160-7; Courtenay K, 2020, IRISH J PSYCHOL MED, V37, P231, DOI 10.1017/ipm.2020.45; Dahdah MN, 2016, ARCH PHYS MED REHAB, V97, P1821, DOI 10.1016/j.apmr.2016.05.005; Dwyer C., 2020, NATL PUBLIC RADIO; Ehde DM, 2013, ARCH PHYS MED REHAB, V94, pS30, DOI 10.1016/j.apmr.2012.10.025; Eisenman David P, 2009, Disaster Med Public Health Prep, V3, P33, DOI 10.1097/DMP.0b013e318193be89; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Gormley M, 2019, BRAIN INJURY, V33, P1567, DOI 10.1080/02699052.2019.1658222; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Lebrasseur A, 2021, DISABIL HEALTH J, V14, DOI 10.1016/j.dhjo.2020.101014; Leocani L, 2020, EUR J NEUROL, V27, pE50, DOI 10.1111/ene.14320; Lund EM, 2020, REHABIL PSYCHOL, V65, P199, DOI 10.1037/rep0000347; MacDonald S, 2017, BRAIN INJURY, V31, P1760, DOI 10.1080/02699052.2017.1379613; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McIsaac Kathryn E, 2016, CMAJ Open, V4, pE746, DOI 10.9778/cmajo.20160072; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ramage AE, 2020, AM J SPEECH-LANG PAT, V29, P1821, DOI 10.1044/2020_AJSLP-20-00147; Rigon A, 2019, J INT NEUROPSYCH SOC, V25, P285, DOI 10.1017/S1355617718001108; Scheel AM, 2021, PERSPECT PSYCHOL SCI, V16, P744, DOI 10.1177/1745691620966795; Shapiro LT, 2020, J HEAD TRAUMA REHAB, V35, P439, DOI 10.1097/HTR.0000000000000571; St Ivany A, 2016, FAM COMMUNITY HEALTH, V39, P129, DOI 10.1097/FCH.0000000000000094; Stojanov A, 2020, MULT SCLER RELAT DIS, V45, DOI 10.1016/j.msard.2020.102407; Stubbs JL, 2020, LANCET PUBLIC HEALTH, V5, pE19, DOI 10.1016/S2468-2667(19)30188-4; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; United Nations Human Rights Office of the High Commissioner, 2020, COVID 19 RIGHTS PERS, P1; World Health Organization (WHO), DIS CONS COVID 19 OU; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Ylvisaker M., 2003, BRAIN IMPAIR, V4, P1, DOI [DOI 10.1375/brim.4.1.1.27031, https://doi.org/10.1375/brim.4.1.1.27031, DOI 10.1375/BRIM.4.1.1.27031]; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker M, 2003, ASHA S, V23, P59; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104	41	2	2	2	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2021	102	6					1075	1083		10.1016/j.apmr.2021.01.064			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	SM2ZC	WOS:000657477200004	33529614	Green Published, Bronze			2022-02-06	
J	Pilipovic, K; Bumber, JR; Dolenec, P; Grzeta, N; Jankovic, T; Kriz, J; Zupan, G				Pilipovic, Kristina; Bumber, Jelena Rajic; Dolenec, Petra; Grzeta, Nika; Jankovic, Tamara; Kriz, Jasna; Zupan, Gordana			Long-Term Effects of Repetitive Mild Traumatic Injury on the Visual System in Wild-Type and TDP-43 Transgenic Mice	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						brain injuries; traumatic; diffuse axonal injury; geniculate bodies; mice; nerve degeneration; neurofilament proteins; neuroglia; optic tract; superior colliculi; synaptophysin; TDP-43 proteinopathies	ENGINEERED ROTATIONAL ACCELERATION; FRONTOTEMPORAL LOBAR DEGENERATION; HEAD IMPACT MODEL; TAR-DNA-BINDING; FLUORO-JADE-C; BRAIN-INJURY; MOUSE MODEL; NEUROFILAMENT-LIGHT; SUPERIOR COLLICULUS; PATHOLOGY	Little is known about the impairments and pathological changes in the visual system in mild brain trauma, especially repetitive mild traumatic brain injury (mTBI). The goal of this study was to examine and compare the effects of repeated head impacts on the neurodegeneration, axonal integrity, and glial activity in the optic tract (OT), as well as on neuronal preservation, glial responses, and synaptic organization in the lateral geniculate nucleus (LGN) and superior colliculus (SC), in wild-type mice and transgenic animals with overexpression of human TDP-43 mutant protein (TDP-43(G348C)) at 6 months after repeated closed head traumas. Animals were also assessed in the Barnes maze (BM) task. Neurodegeneration, axonal injury, and gliosis were detected in the OT of the injured animals of both genotypes. In the traumatized mice, myelination of surviving axons was mostly preserved, and the expression of neurofilament light chain was unaffected. Repetitive mTBI did not induce changes in the LGN and the SC, nor did it affect the performance of the BM task in the traumatized wild-type and TDP-43 transgenic mice. Differences in neuropathological and behavioral assessments between the injured wild-type and TDP-43(G348C) mice were not revealed. Results of the current study suggest that repetitive mTBI was associated with chronic damage and inflammation in the OT in wild-type and TDP-43(G348C) mice, which were not accompanied with behavioral problems and were not affected by the TDP-43 genotype, while the LGN and the SC remained preserved in the used experimental conditions.	[Pilipovic, Kristina; Bumber, Jelena Rajic; Dolenec, Petra; Grzeta, Nika; Jankovic, Tamara; Zupan, Gordana] Univ Rijeka, Fac Med, Dept Basic & Clin Pharmacol & Toxicol, Brace Branchetta 20, Rijeka 51000, Croatia; [Kriz, Jasna] Univ Laval, Fac Med, Dept Psychiat & Neurosci, Quebec City, PQ G1V 0A6, Canada		Zupan, G (corresponding author), Univ Rijeka, Fac Med, Dept Basic & Clin Pharmacol & Toxicol, Brace Branchetta 20, Rijeka 51000, Croatia.	kristina.pilipovic@medri.uniri.hr; jelena.rajic@medri.uniri.hr; petra.dolenec@medri.uniri.hr; nika.grzeta@medri.uniri.hr; tamara.jankovic@medri.uniri.hr; jasna.kriz@fmed.ulaval.ca; gordana.zupan@medri.uniri.hr	Dolenec, Petra/AAV-1118-2021; Pilipovic, Kristina/Q-5974-2018	Dolenec, Petra/0000-0002-9960-0385; Pilipovic, Kristina/0000-0002-7129-1621	Croatian Science Foundation [IP-2016-06-4602]	This work was fully funded by the Croatian Science Foundation under the project number IP-2016-06-4602 to G.Z.	Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Armstrong RA, 2017, CLIN NEUROPATHOL, V36, P66, DOI 10.5414/NP300991; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bashir A, 2020, EXP NEUROL, V324, DOI 10.1016/j.expneurol.2019.113116; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Block ML, 2007, BIOCHEM SOC T, V35, P1127, DOI 10.1042/BST0351127; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bumber JR, 2021, J NEUROPATH EXP NEUR, V80, P2, DOI 10.1093/jnen/nlaa130; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chen HZ, 2017, J NEUROTRAUM, V34, P2291, DOI 10.1089/neu.2016.4870; Cheng WH, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-018-0461-0; Cheng WH, 2018, EXP NEUROL, V301, P26, DOI 10.1016/j.expneurol.2017.12.007; Chidlow G, 2009, EXP EYE RES, V88, P426, DOI 10.1016/j.exer.2008.10.015; Costanza A, 2011, NEUROPATH APPL NEURO, V37, P570, DOI 10.1111/j.1365-2990.2011.01186.x; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Das M, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1499-z; Desai A, 2020, J NEUROTRAUM, V37, P286, DOI 10.1089/neu.2019.6602; Ellis EM, 2016, J NEUROPHYSIOL, V116, P602, DOI 10.1152/jn.00227.2016; Franz CK, 2019, J NEUROPHYSIOL, V122, P1174, DOI 10.1152/jn.00572.2018; Gangolli M, 2019, J NEUROTRAUM, V36, P735, DOI 10.1089/neu.2018.5700; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Gazdzinski LM, 2020, J NEUROTRAUM, V37, P1818, DOI 10.1089/neu.2020.6992; Gendron TF, 2010, NEUROPATH APPL NEURO, V36, P97, DOI [10.1111/j.1365-2990.2010.01060.x, 10.1111/j.1365-2990.2009.01060.x]; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Guedes VA, 2020, NEUROLOGY, V94, pE2412, DOI 10.1212/WNL.0000000000009577; Haar CV, 2019, EXP NEUROL, V317, P87, DOI 10.1016/j.expneurol.2019.02.012; Haber M, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0164-17.2017; Hall ANB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159442; Hanrahan F, 2016, TRANSLATIONAL RES TR; Hatanpaa KJ, 2008, J NEUROPATH EXP NEUR, V67, P271, DOI 10.1097/NEN.0b013e31816a12a6; Heyburn L, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00766; Heyburn L, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00680; Higashi S, 2007, BRAIN RES, V1184, P284, DOI 10.1016/j.brainres.2007.09.048; HOFBAUER A, 1985, J COMP NEUROL, V234, P465, DOI 10.1002/cne.902340405; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kerschensteiner D, 2017, VISUAL NEUROSCI, V34, DOI 10.1017/S0952523817000062; Khodanovich MY, 2017, SCI REP-UK, V7, DOI 10.1038/srep46686; Kokotos AC, 2019, J NEUROCHEM, V151, P28, DOI 10.1111/jnc.14797; Kumar S, 2021, MOL NEURODEGENER, V16, DOI 10.1186/s13024-020-00420-5; Lancon JA, 1998, ANAT REC, V253, P13, DOI 10.1002/(SICI)1097-0185(199802)253:1<13::AID-AR8>3.0.CO;2-F; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Laverse E, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa137; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Liu EY, 2019, CELL REP, V27, P1409, DOI 10.1016/j.celrep.2019.04.003; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; May PJ, 2006, PROG BRAIN RES, V151, P321, DOI 10.1016/S0079-6123(05)51011-2; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Moisse K, 2009, BRAIN RES, V1296, P176, DOI 10.1016/j.brainres.2009.07.023; Moisse K, 2009, BRAIN RES, V1249, P202, DOI 10.1016/j.brainres.2008.10.021; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Ratti A, 2016, J NEUROCHEM, V138, P95, DOI 10.1111/jnc.13625; Ruijter JM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-2; Saykally JN, 2018, J NEUROTRAUM, V35, P139, DOI 10.1089/neu.2017.5070; Schirmer L, 2013, BRAIN PATHOL, V23, P2, DOI 10.1111/j.1750-3639.2012.00608.x; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Sen N, 2017, NEUROCHEM INT, V111, P103, DOI 10.1016/j.neuint.2017.01.019; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Sophie Su Y., 2016, TRANSLATIONAL RES TR; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Swarup V, 2011, BRAIN, V134, P2610, DOI 10.1093/brain/awr159; Tarsa L, 2002, P NATL ACAD SCI USA, V99, P1012, DOI 10.1073/pnas.022575999; Tenkova Tatyana I., 2007, V399, P31, DOI 10.1007/978-1-59745-504-6_3; Thammisetty SS, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1350-y; THIEL G, 1993, BRAIN PATHOL, V3, P87, DOI 10.1111/j.1750-3639.1993.tb00729.x; Tzekov R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153608; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Underhill HR, 2011, NEUROIMAGE, V54, P2052, DOI 10.1016/j.neuroimage.2010.10.065; Uryu K, 2008, J NEUROPATH EXP NEUR, V67, P555, DOI 10.1097/NEN.0b013e31817713b5; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang J, 2015, J CEREBR BLOOD F MET, V35, P443, DOI 10.1038/jcbfm.2014.216	88	2	2	2	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	JUN	2021	22	12							6584	10.3390/ijms22126584			20	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	SY6CY	WOS:000665974900001	34205342	gold, Green Published			2022-02-06	
J	Yao, L; Baker, JL; Schiff, ND; Purpura, KP; Shoaran, M				Yao, Lin; Baker, Jonathan L.; Schiff, Nicholas D.; Purpura, Keith P.; Shoaran, Mahsa			Predicting task performance from biomarkers of mental fatigue in global brain activity	JOURNAL OF NEURAL ENGINEERING			English	Article						vigilance task; ECoG; mental fatigue; machine learning; non-human primates; traumatic brain injury	WEARABLE EEG SYSTEM; AROUSAL REGULATION; EYE-MOVEMENTS; STIMULATION; DROWSINESS; ATTENTION; DISORDERS; AMPLITUDE; TOOL	Objective. Detection and early prediction of mental fatigue (i.e. shifts in vigilance), could be used to adapt neuromodulation strategies to effectively treat patients suffering from brain injury and other indications with prominent chronic mental fatigue. Approach. In this study, we analyzed electrocorticography (ECoG) signals chronically recorded from two healthy non-human primates (NHP) as they performed a sustained attention task over extended periods of time. We employed a set of spectrotemporal and connectivity biomarkers of the ECoG signals to identify periods of mental fatigue and a gradient boosting classifier to predict performance, up to several seconds prior to the behavioral response. Main results. Wavelet entropy and the instantaneous amplitude and frequency were among the best single features across sessions in both NHPs. The classification performance using higher order spectral-temporal (HOST) features was significantly higher than that of conventional spectral power features in both NHPs. Across the 99 sessions analyzed, average F1 scores of 77.5% +/- 8.2% and 91.2% +/- 3.6%, and accuracy of 79.5% +/- 8.9% and 87.6% +/- 3.9% for the classifier were obtained for each animal, respectively. Significance. Our results here demonstrate the feasibility of predicting performance and detecting periods of mental fatigue by analyzing ECoG signals, and that this general approach, in principle, could be used for closed-loop control of neuromodulation strategies.	[Yao, Lin] Zhejiang Univ, Frontiers Sci Ctr Brain & Brain Machine Integrat, Hangzhou 310000, Zhejiang, Peoples R China; [Yao, Lin] Zhejiang Univ, Coll Comp Sci, Hangzhou 310000, Zhejiang, Peoples R China; [Yao, Lin; Shoaran, Mahsa] Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY 14850 USA; [Baker, Jonathan L.; Schiff, Nicholas D.; Purpura, Keith P.] Weill Cornell Med, Feil Family Brain & Mind Res Inst, New York, NY 10021 USA; [Shoaran, Mahsa] Swiss Fed Inst Technol EPFL, Inst Elect Engn, CH-1202 Geneva, Switzerland; [Shoaran, Mahsa] Swiss Fed Inst Technol EPFL, Ctr Neuroprosthet, CH-1202 Geneva, Switzerland		Yao, L (corresponding author), Zhejiang Univ, Frontiers Sci Ctr Brain & Brain Machine Integrat, Hangzhou 310000, Zhejiang, Peoples R China.; Yao, L (corresponding author), Zhejiang Univ, Coll Comp Sci, Hangzhou 310000, Zhejiang, Peoples R China.; Yao, L (corresponding author), Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY 14850 USA.	ly329@zju.edu.cn; job2037@cornell.edu; mahsa.shoaran@epfl.ch		Shoaran, Mahsa/0000-0002-6426-4799	National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS-067249]; Daedalus Fund for Innovation from Weill Cornell Medicine; Cornell University; EPFL; National Key R&D Program of China [2018YFA0701400]; Zhejiang Lab [2019KE0AD01]	The animal experiments conducted at Weill Cornell Medicine were supported by the National Institute of Neurological Disorders and Stroke (NINDS) under R01-NS-067249 and this study was supported under a Daedalus Fund for Innovation from Weill Cornell Medicine, funding from Cornell University, and EPFL. This work was partially supported by the grants from National Key R&D Program of China (2018YFA0701400) and Zhejiang Lab (2019KE0AD01).	Acharya UR, 2015, KNOWL-BASED SYST, V88, P85, DOI 10.1016/j.knosys.2015.08.004; Angjelichinoski M, 2019, J NEURAL ENG, V16, DOI 10.1088/1741-2552/ab1a1f; Baker JL, 2016, J NEUROPHYSIOL, V116, P2383, DOI 10.1152/jn.01129.2015; Balandong RP, 2018, IEEE ACCESS, V6, P22908, DOI 10.1109/ACCESS.2018.2811723; Barwick F, 2012, CLIN NEUROPHYSIOL, V123, P278, DOI 10.1016/j.clinph.2011.06.027; Benjamin AS, 2018, FRONT COMPUT NEUROSC, V12, DOI 10.3389/fncom.2018.00056; Bondar IV., 2019, NEUROSCI BEHAV PHYSL, V49, P996, DOI [10.1007/s11055-019-00829-6, DOI 10.1007/S11055-019-00829-6]; Borghini G, 2014, NEUROSCI BIOBEHAV R, V44, P58, DOI 10.1016/j.neubiorev.2012.10.003; Chavez M, 2003, IEEE T BIO-MED ENG, V50, P571, DOI 10.1109/TBME.2003.810696; Cimenser A, 2011, P NATL ACAD SCI USA, V108, P8832, DOI 10.1073/pnas.1017041108; Corsi-Cabrera M, 2003, INT J PSYCHOPHYSIOL, V50, P213, DOI 10.1016/S0167-8760(03)00168-5; Davies DR., 1982, PSYCHOL VIGILANCE; Dimitrakopoulos GN, 2018, IEEE T NEUR SYS REH, V26, P740, DOI 10.1109/TNSRE.2018.2791936; Donahue CJ, 2018, P NATL ACAD SCI USA, V115, pE5183, DOI 10.1073/pnas.1721653115; Eoh HJ, 2005, INT J IND ERGONOM, V35, P307, DOI 10.1016/j.ergon.2004.09.006; Ezzyat Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02753-0; Correa AG, 2014, MED ENG PHYS, V36, P244, DOI 10.1016/j.medengphy.2013.07.011; Gonzalez-Trejo E, 2019, IEEE T HUM-MACH SYST, V49, P589, DOI 10.1109/THMS.2019.2931011; Harvy J, 2019, IEEE T NEUR SYS REH, V27, P358, DOI 10.1109/TNSRE.2019.2893949; HIKOSAKA O, 1985, J NEUROPHYSIOL, V53, P292, DOI 10.1152/jn.1985.53.1.292; HJORTH B, 1970, ELECTROEN CLIN NEURO, V29, P306, DOI 10.1016/0013-4694(70)90143-4; Huang DF, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00235; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Iwasaki M, 2005, CLIN NEUROPHYSIOL, V116, P878, DOI 10.1016/j.clinph.2004.11.001; Jain A, 1997, IEEE T PATTERN ANAL, V19, P153, DOI 10.1109/34.574797; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kinomura S, 1996, SCIENCE, V271, P512, DOI 10.1126/science.271.5248.512; Kuhlmann L, 2018, BRAIN, V141, P2619, DOI 10.1093/brain/awy210; Li G, 2015, IEEE SENS J, V15, P7169, DOI 10.1109/JSEN.2015.2473679; Lin CT, 2014, IEEE T BIOMED CIRC S, V8, P165, DOI 10.1109/TBCAS.2014.2316224; Little S, 2016, J NEUROL NEUROSUR PS, V87, P1388, DOI 10.1136/jnnp-2016-313518; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Mennes M, 2010, PSYCHOPHYSIOLOGY, V47, P1142, DOI 10.1111/j.1469-8986.2010.01015.x; Monteiro TG, 2019, IEEE T HUM-MACH SYST, V49, P599, DOI 10.1109/THMS.2019.2938156; MUNOZ DP, 1992, J NEUROPHYSIOL, V67, P1000, DOI 10.1152/jn.1992.67.4.1000; Munoz DP, 2003, J NEUROPHYSIOL, V90, P503, DOI 10.1152/jn.00192.2003; Paeye C, 2016, J VISION, V16, DOI 10.1167/16.10.15; Paus T, 1997, J COGNITIVE NEUROSCI, V9, P392, DOI 10.1162/jocn.1997.9.3.392; Paus T, 2000, PROG BRAIN RES, V126, P65; Pfurtscheller G., 1992, INDUCED RHYTHMS BRAI, P117; Phillips KA, 2014, AM J PRIMATOL, V76, P801, DOI 10.1002/ajp.22281; Posner, 1978, CHRONOMETRIC EXPLORA; Provenza NR, 2019, J NEURAL ENG, V16, DOI 10.1088/1741-2552/ab2c58; Provenza NR, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00152; Purpura KP, 2003, J NEUROPHYSIOL, V90, P3455, DOI 10.1152/jn.00011.2003; Rosso OA, 2001, J NEUROSCI METH, V105, P65, DOI 10.1016/S0165-0270(00)00356-3; Sahayadhas A, 2012, SENSORS-BASEL, V12, P16937, DOI 10.3390/s121216937; Sallet J, 2013, J NEUROSCI, V33, P12255, DOI 10.1523/JNEUROSCI.5108-12.2013; Sarter M, 2006, BRAIN RES REV, V51, P145, DOI 10.1016/j.brainresrev.2005.11.002; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2013, J NEUROPHYSIOL, V109, P1152, DOI 10.1152/jn.00317.2011; Schiff ND., 2019, ANN BRAIN IN INV M W; Schiff ND, 2008, ANN NY ACAD SCI, V1129, P105, DOI 10.1196/annals.1417.029; Shabani H, 2016, BIOMED ENG LETT, V6, P196, DOI 10.1007/s13534-016-0223-5; Shoaib M, 2016, 2016 IEEE 18TH INTERNATIONAL CONFERENCE ON E-HEALTH NETWORKING, APPLICATIONS AND SERVICES (HEALTHCOM), P111; Shoaran M, 2018, IEEE J EM SEL TOP C, V8, P693, DOI 10.1109/JETCAS.2018.2844733; Slater JD, 2017, J NEUROPSYCH CLIN N, V29, P236, DOI 10.1176/appi.neuropsych.16060120; Steinborn MB, 2012, ACTA PSYCHOL, V139, P65, DOI 10.1016/j.actpsy.2011.10.010; Sun FT, 2008, NEUROTHERAPEUTICS, V5, P68, DOI 10.1016/j.nurt.2007.10.069; Thorpy Michael J., 2010, ENCY SLEEP SLEEP DIS, V3rd; Tort ABL, 2010, J NEUROPHYSIOL, V104, P1195, DOI 10.1152/jn.00106.2010; Trejo L., 2015, PSYCHOLOGY, V6, P572, DOI [10.4236/psych.2015.65055, DOI 10.4236/PSYCH.2015.65055]; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Wang DD, 2018, J NEUROSCI, V38, P4556, DOI 10.1523/JNEUROSCI.0431-18.2018; Wascher E, 2014, BIOL PSYCHOL, V96, P57, DOI 10.1016/j.biopsycho.2013.11.010; Wichmann T, 2018, J NEURAL TRANSM, V125, P419, DOI 10.1007/s00702-017-1736-5; Yao L, 2020, INT CONF ACOUST SPEE, P1259, DOI 10.1109/ICASSP40776.2020.9053358; Yao L, 2020, CLIN NEUROPHYSIOL, V131, P274, DOI 10.1016/j.clinph.2019.09.021; Yao L, 2018, BIOMED CIRC SYST C, P315; Zheng J, 2019, NEURON, V102, P887, DOI 10.1016/j.neuron.2019.03.025; Zhu BZ, 2019, CEPHALALGIA, V39, P1143, DOI 10.1177/0333102419839975	71	2	2	1	8	IOP Publishing Ltd	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1741-2560	1741-2552		J NEURAL ENG	J. Neural Eng.	JUN	2021	18	3							036001	10.1088/1741-2552/abc529			14	Engineering, Biomedical; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Neurosciences & Neurology	QT9EB	WOS:000626889000001	33108778				2022-02-06	
J	Jia, XY; Chang, XB; Bai, LJ; Wang, YL; Dong, DB; Gan, SQ; Wang, S; Li, X; Yang, XF; Sun, YX; Li, TH; Xiong, F; Niu, X; Yan, H				Jia, Xiaoyan; Chang, Xuebin; Bai, Lijun; Wang, Yulin; Dong, Debo; Gan, Shuoqiu; Wang, Shan; Li, Xuan; Yang, Xuefei; Sun, Yinxiang; Li, Tianhui; Xiong, Feng; Niu, Xuan; Yan, Hao			A Longitudinal Study of White Matter Functional Network in Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						compensatory mechanism; fMRI; mild traumatic brain injury; resting-state functional connectivity; white matter functional networks	CONNECTIVITY; ORGANIZATION; ASSOCIATION; DYSFUNCTION; INTEGRITY; SEVERITY; PATHWAYS; RECOVERY; TRACTS; REST	Some patients after mild traumatic brain injury (mTBI) experience microstructural damages in the long-distance white matter (WM) connections, which disrupts the functional connectome of large-scale brain networks that support cognitive function. Patterns of WM structural damage following mTBI were well documented using diffusion tensor imaging (DTI). However, the functional organization of WM and its association with gray matter functional networks (GM-FNs) and its DTI metrics remain unknown. The present study adopted resting-state functional magnetic resonance imaging to explore WM functional properties in mTBI patients (108 acute patients, 48 chronic patients, 46 healthy controls [HCs]). Eleven large-scale WM functional networks (WM-FNs) were constructed by the k-means clustering algorithm of voxel-wise WM functional connectivity (FC). Compared with HCs, acute mTBI patients observed enhanced FC between inferior fronto-occipital fasciculus (IFOF) WM-FN and primary sensorimotor WM-FNs, and cortical primary sensorimotor GM-FNs. Further, acute mTBI patients showed increased DTI metrics (mean diffusivity, axial diffusivity, and radial diffusivity) in deep WM-FNs and higher-order cognitive WM-FNs. Moreover, mTBI patients demonstrated full recovery of FC and partial recovery of DTI metrics in the chronic stage. Additionally, enhanced FC between IFOF WM-FN and anterior cerebellar GM-FN was correlated with impaired information processing speed. Our findings provide novel evidence for functional and structural alteration of WM-FNs in mTBI patients. Importantly, the convergent damage of the IFOF network might imply its crucial role in our understanding of the pathophysiology mechanism of mTBI patients.	[Jia, Xiaoyan; Bai, Lijun; Gan, Shuoqiu; Wang, Shan; Li, Xuan; Yang, Xuefei; Li, Tianhui; Xiong, Feng] Xi An Jiao Tong Univ, Dept Biomed Engn, Xian, Peoples R China; [Chang, Xuebin; Dong, Debo] Univ Elect Sci & Technol China, Clin Hosp Chengdu Brain Sci Inst, Sch Life Sci & Technol, Chengdu, Peoples R China; [Wang, Yulin] Vrije Univ Brussel, Dept Expt & Appl Psychol, Brussels, Belgium; [Wang, Yulin] Univ Ghent, Dept Data Anal, Ghent, Belgium; [Dong, Debo] Res Ctr Julich, Inst Neurosci & Med, Brain & Behav INM 7, Julich, Germany; [Sun, Yinxiang; Niu, Xuan] Xi An Jiao Tong Univ, Dept Med Imaging, Affiliated Hosp 1, Xian, Peoples R China; [Yan, Hao] Xian Int Studies Univ, Key Lab Artificial Intelligence & Cognit Neurosci, Wen Yuan Nan Rd, Xian 710128, Shaanxi, Peoples R China; [Yan, Hao] Xidian Univ, Dept Linguist, Xian, Peoples R China		Yan, H (corresponding author), Xian Int Studies Univ, Key Lab Artificial Intelligence & Cognit Neurosci, Wen Yuan Nan Rd, Xian 710128, Shaanxi, Peoples R China.	haoyan@xisu.edu.cn	Niu, Xuan/AAD-7351-2022		National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771914, 82071993]; National Social Science Foundation of China [20BYY097]; Humanities and Social Science Foundation of Ministry of Education of ChinaMinistry of Education, China [19YJC740100]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [RW180178, Xjj 2018229, xzy022019045]	This study was supported by the National Science Foundation of China (grant number 81771914, 82071993), the National Social Science Foundation of China (grant number 20BYY097), the Humanities and Social Science Foundation of Ministry of Education of China (grant number 19YJC740100), and the Fundamental Research Funds for the Central Universities (grant number RW180178, Xjj 2018229, xzy022019045).	ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; Antonakakis M, 2017, NEUROSCIENCE, V356, P275, DOI 10.1016/j.neuroscience.2017.05.032; ARNETT JA, 1995, PSYCHOL ASSESSMENT, V7, P220; Bai LJ, 2020, HUM BRAIN MAPP, V41, P4431, DOI 10.1002/hbm.25135; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bharath RD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00513; Brandstack N, 2013, RADIOLOGY, V267, P231, DOI 10.1148/radiol.12112570; Dall'Acqua P, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00280; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Ding ZH, 2018, P NATL ACAD SCI USA, V115, P595, DOI 10.1073/pnas.1711567115; Ding ZH, 2016, MAGN RESON IMAGING, V34, P8, DOI 10.1016/j.mri.2015.10.003; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Fabri M, 2011, BRAIN RES, V1370, P99, DOI 10.1016/j.brainres.2010.11.039; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Forkel SJ, 2014, CORTEX, V56, P73, DOI 10.1016/j.cortex.2012.09.005; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gawryluk JR, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-56; Harman-Smith YE, 2013, J CLIN EXP NEUROPSYC, V35, P785, DOI 10.1080/13803395.2013.824554; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Ji GJ, 2019, HUM BRAIN MAPP, V40, P1253, DOI 10.1002/hbm.24444; Jiang YC, 2019, HUM BRAIN MAPP, V40, P3113, DOI 10.1002/hbm.24584; Jiang YC, 2019, NEUROIMAGE, V190, P172, DOI 10.1016/j.neuroimage.2018.04.018; Joy S, 2004, ARCH CLIN NEUROPSYCH, V19, P759, DOI 10.1016/j.acn.2003.09.009; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Lange RT, 2021, J NEUROTRAUM, V38, P63, DOI 10.1089/neu.2019.6852; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mac Donald CL, 2019, BRAIN COMMUN, V1, DOI 10.1093/braincomms/fcz031; Martino J, 2010, CORTEX, V46, P691, DOI 10.1016/j.cortex.2009.07.015; Marussich L, 2017, NEUROIMAGE, V146, P1128, DOI 10.1016/j.neuroimage.2016.10.005; Palacios EM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz6892; Peer M, 2017, J NEUROSCI, V37, P6394, DOI 10.1523/JNEUROSCI.3872-16.2017; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Robertson CS, 2013, J NEUROTRAUM, V30, P765, DOI 10.1089/neu.2012.2431; Sadeghniiat-Haghighi K, 2014, QUAL LIFE RES, V23, P533, DOI 10.1007/s11136-013-0489-3; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Sours C, 2015, BRAIN CONNECT, V5, P442, DOI 10.1089/brain.2014.0333; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Vascak M, 2018, CEREB CORTEX, V28, P1625, DOI 10.1093/cercor/bhx058; Weathers F. W., 1994, PTSD CHECKLIST CIVIL, P10; Wolf JA, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00043; Wu TL, 2016, MAGN RESON IMAGING, V34, P1235, DOI 10.1016/j.mri.2016.07.001; Wu X, 2017, NEUROIMAGE, V152, P371, DOI 10.1016/j.neuroimage.2017.02.074; Yan CG, 2016, NEUROINFORMATICS, V14, P339, DOI 10.1007/s12021-016-9299-4; Yeh PH, 2017, HUM BRAIN MAPP, V38, P352, DOI 10.1002/hbm.23365; Yin B, 2019, FRONT NEURAL CIRCUIT, V13, DOI 10.3389/fncir.2019.00028	50	2	2	8	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2021	38	19					2686	2697		10.1089/neu.2021.0017		MAY 2021	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	YH9QT	WOS:000656636800001	33906419	Green Submitted			2022-02-06	
J	Fedorchak, G; Rangnekar, A; Onks, C; Loeffert, AC; Loeffert, J; Olympia, RP; DeVita, S; Leddy, J; Haider, MN; Roberts, A; Rieger, J; Uhlig, T; Monteith, C; Middleton, F; Zuckerman, SL; Lee, TM; Yeates, KO; Mannix, R; Hicks, S				Fedorchak, Gregory; Rangnekar, Aakanksha; Onks, Cayce; Loeffert, Andrea C.; Loeffert, Jayson; Olympia, Robert P.; DeVita, Samantha; Leddy, John; Haider, Mohammad N.; Roberts, Aaron; Rieger, Jessica; Uhlig, Thomas; Monteith, Chuck; Middleton, Frank; Zuckerman, Scott L.; Lee, Timothy; Yeates, Keith Owen; Mannix, Rebekah; Hicks, Steven			Saliva RNA biomarkers predict concussion duration and detect symptom recovery: a comparison with balance and cognitive testing	JOURNAL OF NEUROLOGY			English	Article						traumatic brain injury; microRNA; spit; return to play; prognosis; mTBI	TRAUMATIC BRAIN-INJURY; MICRORNA EXPRESSION; EARLY INTERVENTION; HEAD-INJURY; IMPACT; KNOWLEDGE	Objective The goals of this study were to assess the ability of salivary non-coding RNA (ncRNA) levels to predict post-concussion symptoms lasting >= 21 days, and to examine the ability of ncRNAs to identify recovery compared to cognition and balance. Methods RNA sequencing was performed on 505 saliva samples obtained longitudinally from 112 individuals (8-24-years-old) with mild traumatic brain injury (mTBI). Initial samples were obtained <= 14 days post-injury, and follow-up samples were obtained >= 21 days post-injury. Computerized balance and cognitive test performance were assessed at initial and follow-up time-points. Machine learning was used to define: (1) a model employing initial ncRNA levels to predict persistent post-concussion symptoms (PPCS) >= 21 days post-injury; and (2) a model employing follow-up ncRNA levels to identify symptom recovery. Performance of the models was compared against a validated clinical prediction rule, and balance/cognitive test performance, respectively. Results An algorithm using age and 16 ncRNAs predicted PPCS with greater accuracy than the validated clinical tool and demonstrated additive combined utility (area under the curve (AUC) 0.86; 95% CI 0.84-0.88). Initial balance and cognitive test performance did not differ between PPCS and non-PPCS groups (p > 0.05). Follow-up balance and cognitive test performance identified symptom recovery with similar accuracy to a model using 11 ncRNAs and age. A combined model (ncRNAs, balance, cognition) most accurately identified recovery (AUC 0.86; 95% CI 0.83-0.89). Conclusions ncRNA biomarkers show promise for tracking recovery from mTBI, and for predicting who will have prolonged symptoms. They could provide accurate expectations for recovery, stratify need for intervention, and guide safe return-to-activities.	[Loeffert, Andrea C.; Hicks, Steven] Penn State Coll Med, Dept Pediat, Hershey, PA 17033 USA; [Onks, Cayce; Loeffert, Jayson] Penn State Coll Med, Dept Family Med, Hershey, PA 17033 USA; [Olympia, Robert P.] Penn State Coll Med, Dept Emergency Med, Hershey, PA 17033 USA; [Fedorchak, Gregory; Rangnekar, Aakanksha; DeVita, Samantha; Rieger, Jessica; Uhlig, Thomas] Quadrant Biosci, Syracuse, NY 13210 USA; [Leddy, John; Haider, Mohammad N.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, UBMD Orthopaed & Sports Med, Buffalo, NY 14214 USA; [Zuckerman, Scott L.; Lee, Timothy] Vanderbilt Univ, Med Ctr, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA; [Monteith, Chuck] Colgate Univ, Hamilton, NY 13346 USA; [Mannix, Rebekah] Harvard Med Sch, Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA; [Middleton, Frank] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA; [Roberts, Aaron] Adena Bone & Joint Ctr, Dept Adena Reg Med Ctr, Chillicothe, OH 45601 USA; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Alberta Childrens Hosp, Dept Psychol,Res Inst, Calgary, AB T2N 1N4, Canada		Hicks, S (corresponding author), Penn State Coll Med, Dept Pediat, Hershey, PA 17033 USA.	shicks1@pennstatehealth.psu.edu					Atif H, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519832286; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bazarian JJ, 2001, CLIN PEDIATR, V40, P207, DOI 10.1177/000992280104000405; Beaumont A, 1999, NEUROL RES, V21, P742, DOI 10.1080/01616412.1999.11741008; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Brooks BL, 2016, J INT NEUROPSYCH SOC, V22, P379, DOI 10.1017/S1355617715001368; Chiu EC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216450; Conway FN, 2020, CLIN J SPORT MED, V30, P203, DOI 10.1097/JSM.0000000000000557; Dontje ML, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195424; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hicks SD, 2020, CLIN TRANSL MED, V10, DOI 10.1002/ctm2.197; Hicks SD, 2018, J NEUROTRAUM, V35, P64, DOI 10.1089/neu.2017.5111; Higgins KL, 2017, ARCH CLIN NEUROPSYCH, V32, P259, DOI 10.1093/arclin/acw108; Howell DR, 2018, AM J SPORT MED, V46, P3254, DOI 10.1177/0363546518796830; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; Johnson JJ, 2018, JAMA PEDIATR, V172, P65, DOI 10.1001/jamapediatrics.2017.3884; Johnson K., 2013, APPL PREDICTIVE MODE, V26, DOI [10.1007/978-1-4614-6849-3, DOI 10.1007/978-1-4614-6849-3]; LaRocca D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0207785; Lathan C, 2013, MIL MED, V178, P365, DOI 10.7205/MILMED-D-12-00438; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Pasinetti Giulio M, 2012, Am J Neurodegener Dis, V1, P88; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Rizzo JR, 2021, BRAIN INJURY, V35, P426, DOI 10.1080/02699052.2021.1878554; Rogelj B, 2004, REV NEUROSCIENCE, V15, P185; Sullivan KA, 2012, BRAIN INJURY, V26, P1098, DOI 10.3109/02699052.2012.666367; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	36	2	2	1	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	NOV	2021	268	11					4349	4361		10.1007/s00415-021-10566-x		MAY 2021	13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WF2PS	WOS:000653663400001	34028616	Green Published, hybrid			2022-02-06	
J	Banman, CJ; Schneider, KJ; Cluff, T; Peters, RM				Banman, Christopher J.; Schneider, Kathryn J.; Cluff, Tyler; Peters, Ryan M.			Altered Vestibular Balance Function in Combat Sport Athletes	JOURNAL OF NEUROTRAUMA			English	Article						balance; combat sports; electrical vestibular stimulation; electromyography; reflex; vestibular system	TRAUMATIC BRAIN-INJURY; BLAST EXPOSURE; STIMULATION; RESPONSES; HEAD; DYSFUNCTION; CONCUSSION; PERCEPTION; PATTERNS; NERVE	Combat sports pose a risk for accumulative injuries to the nervous system, yet fighters have remained an understudied population. Here, our purpose was to determine whether repetitive blows to the head have an effect on vestibular balance reflexes in combat sports athletes. We compared lower-limb muscle responses evoked with electrical vestibular stimuluation (EVS) between fighters (boxing/muay thai) and non-fighter controls. Each participant received stochastic vestibular stimulation (0-25 Hz, +/- 3 mA) over their mastoid processes while they stood relaxed with their head to the left or right. Surface electromyography was recorded from the medial gastrocnemius and soleus muscles bilaterally. Short and medium latency response (SLR/MLR) peaks were significantly delayed in the fighter group compared to controls. SLR and MLR peak amplitudes were also significantly lower in fighters. Fighter-estimated cumulative repetitive head impact (RHI) events demonstrated strong positive correlations with the timing of SLR and MLR peaks. Cumulative RHI events also negatively correlated with peak MLR amplitude and response gain at frequencies above 5 Hz. Our results provide evidence of a progressive vestibular impairment in combat sports athletes, potentially resulting from blows to the head accumulated in sparring practice and competitive bouts throughout their careers. Taken together, EVS-based vestibular assessments may provide a valuable clinical diagnostic tool and help better inform "return-to-play" and career-length decisions for not only combat sports athletes, but potentially other populations at risk of RHIs.	[Banman, Christopher J.; Schneider, Kathryn J.; Cluff, Tyler; Peters, Ryan M.] Univ Calgary, Fac Kinesiol, Kinesiol B Room 135,2500 Univ Dr Northwest, Calgary, AB T2N 1N4, Canada; [Schneider, Kathryn J.; Cluff, Tyler; Peters, Ryan M.] Univ Calgary, Fac Kinesiol, Hotchkiss Brain Inst, Calgary, AB, Canada; [Schneider, Kathryn J.] Univ Calgary, Alberta Childrens Hosp, Fac Kinesiol, Res Inst Child & Maternal Hlth,Cumming Sch Med, Calgary, AB, Canada; [Schneider, Kathryn J.] Univ Calgary, Sport Injury Prevent Res Ctr, Fac Kinesiol, Calgary, AB, Canada; [Schneider, Kathryn J.] Univ Calgary, Fac Kinesiol, Sport Med Ctr, Calgary, AB, Canada; [Schneider, Kathryn J.] Evidence Sport & Spinal Therapy, Calgary, AB, Canada		Peters, RM (corresponding author), Univ Calgary, Fac Kinesiol, Kinesiol B Room 135,2500 Univ Dr Northwest, Calgary, AB T2N 1N4, Canada.	ryan.peters1@ucalgary.ca			University of Calgary; Natural Sciences Research Council Wearable Technology and Research Collaboration (NSERC We-TRAC) PostGraduate Scholarship	This research was funded by start-up funding provided by the University of Calgary to R.M.P., as well as a Natural Sciences Research Council Wearable Technology and Research Collaboration (NSERC We-TRAC) PostGraduate Scholarship awarded to C.J.B.	Akin FW, 2017, BRAIN INJURY, V31, P1188, DOI 10.1080/02699052.2017.1288928; Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Aw ST, 2008, NEUROLOGY, V71, P1776, DOI 10.1212/01.wnl.0000335971.43443.d9; BERGSTROM B, 1973, ACTA OTO-LARYNGOL, V76, P173, DOI 10.3109/00016487309121496; Bernick C, 2020, NEUROLOGY, V94, pE232, DOI 10.1212/WNL.0000000000008817; BRITTON TC, 1993, EXP BRAIN RES, V94, P143; Caccese JB, 2020, J NEUROTRAUM, V37, P2656, DOI 10.1089/neu.2020.7001; Cohen JT, 2002, ISRAEL MED ASSOC J, V4, P559; Dakin CJ, 2007, J PHYSIOL-LONDON, V583, P1117, DOI 10.1113/jphysiol.2007.133264; Dakin CJ, 2011, EXP BRAIN RES, V209, P345, DOI 10.1007/s00221-011-2549-7; Dakin CJ, 2010, J NEUROPHYSIOL, V103, P1048, DOI 10.1152/jn.00881.2009; Dalton BH, 2014, EXP GERONTOL, V60, P120, DOI 10.1016/j.exger.2014.09.020; Fitzpatrick RC, 2004, J APPL PHYSIOL, V96, P2301, DOI 10.1152/japplphysiol.00008.2004; Franke LM, 2012, J REHABIL RES DEV, V49, P985, DOI 10.1682/JRRD.2011.12.0250; Gattu R, 2016, BRAIN INJURY, V30, P1501, DOI 10.1080/02699052.2016.1219056; Gensberger KD, 2016, J NEUROSCI, V36, P9097, DOI 10.1523/JNEUROSCI.4239-15.2016; GOLDBERG JM, 1984, J NEUROPHYSIOL, V51, P1236, DOI 10.1152/jn.1984.51.6.1236; Halliday DM, 1995, PROG BIOPHYS MOL BIO, V64, P237, DOI 10.1016/S0079-6107(96)00009-0; Heroux ME, 2014, J APPL PHYSIOL, V116, P140, DOI 10.1152/japplphysiol.00906.2013; Hwang S, 2017, J NEUROTRAUM, V34, P8, DOI 10.1089/neu.2015.4238; Hwang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088132; Ishiyama G, 2009, SEMIN NEUROL, V29, P491, DOI 10.1055/s-0029-1241039; Jahn K, 2003, BRAIN, V126, P1579, DOI 10.1093/brain/awg163; Khosravi-Hashemi N, 2019, J PHYSIOL-LONDON, V597, P5231, DOI 10.1113/JP278642; Kwan A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09738-1; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Pavlik AE, 1999, EXP BRAIN RES, V124, P273, DOI 10.1007/s002210050623; PETERKA RJ, 1995, EXP BRAIN RES, V105, P101; Peterka RJ, 2012, IEEE ENG MED BIO, P6137, DOI 10.1109/EMBC.2012.6347394; Peters RM, 2016, EXP GERONTOL, V82, P50, DOI 10.1016/j.exger.2016.05.014; Peters RM, 2015, J NEUROPHYSIOL, V114, P264, DOI 10.1152/jn.00114.2015; Phillips C, 2016, JARO-J ASSOC RES OTO, V17, P19, DOI 10.1007/s10162-015-0544-6; Ralston JD, 2020, MED DEVICES-EVID RES, V13, P411, DOI 10.2147/MDER.S279521; Raphan T, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00096; Rauch SD, 2001, ANN NY ACAD SCI, V942, P220; RICHTER E, 1980, ACTA OTO-LARYNGOL, V90, P199, DOI 10.3109/00016488009131716; ROSENBERG JR, 1989, PROG BIOPHYS MOL BIO, V53, P1, DOI 10.1016/0079-6107(89)90004-7; ROSENHALL U, 1973, ACTA OTO-LARYNGOL, V76, P208, DOI 10.3109/00016487309121501; Shin W, 2014, AM J NEURORADIOL, V35, P285, DOI 10.3174/ajnr.A3676; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; Wardman DL, 2003, J PHYSIOL-LONDON, V551, P1033, DOI 10.1113/jphysiol.2003.045971	46	2	2	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2021	38	16					2291	2300		10.1089/neu.2020.7432		MAY 2021	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TY0QY	WOS:000653278800001	33752455				2022-02-06	
J	Doppmann, P; Meuli, L; Sollid, SJM; Filipovic, M; Knapp, J; Exadaktylos, A; Albrecht, R; Pietsch, U				Doppmann, Pascal; Meuli, Lorenz; Sollid, Stephen J. M.; Filipovic, Miodrag; Knapp, Jurgen; Exadaktylos, Aristomenis; Albrecht, Roland; Pietsch, Urs			End-tidal to arterial carbon dioxide gradient is associated with increased mortality in patients with traumatic brain injury: a retrospective observational study	SCIENTIFIC REPORTS			English	Article							VENTILATION; ANESTHESIA; MODERATE; DIFFERENCE; MANAGEMENT; PRESSURE; CHILDREN; PCO2	Early definitive airway protection and normoventilation are key principles in the treatment of severe traumatic brain injury. These are currently guided by end tidal CO2 as a proxy for PaCO2. We assessed whether the difference between end tidal CO2 and PaCO2 at hospital admission is associated with in-hospital mortality. We conducted a retrospective observational cohort study of consecutive patients with traumatic brain injury who were intubated and transported by Helicopter Emergency Medical Services to a Level 1 trauma center between January 2014 and December 2019. We assessed the association between the CO2 gap-defined as the difference between end tidal CO2 and PaCO2-and in-hospital mortality using multivariate logistic regression models. 105 patients were included in this study. The mean +/- SD CO2 gap at admission was 1.64 +/- 1.09 kPa and significantly greater in non-survivors than survivors (2.26 +/- 1.30 kPa vs. 1.42 +/- 0.92 kPa, p<.001). The correlation between EtCO2 and PaCO2 at admission was low (Pearson's r=.287). The mean CO2 gap after 24 h was only 0.64 +/- 0.82 kPa, and no longer significantly different between non-survivors and survivors. The multivariate logistic regression model showed that the CO2 gap was independently associated with increased mortality in this cohort and associated with a 2.7-fold increased mortality for every 1 kPa increase in the CO2 gap (OR 2.692, 95% CI 1.293 to 5.646, p=.009). This study demonstrates that the difference between EtCO2 and PaCO2 is significantly associated with in-hospital mortality in patients with traumatic brain injury. EtCO2 was significantly lower than PaCO2, making it an unreliable proxy for PaCO2 when aiming for normocapnic ventilation. The CO2 gap can lead to iatrogenic hypoventilation when normocapnic ventilation is aimed and might thereby increase in-hospital mortality.	[Doppmann, Pascal; Filipovic, Miodrag; Albrecht, Roland; Pietsch, Urs] Cantonal Hosp St, Dept Anaesthesiol & Intens Care Med, Rorschacher Str 95, CH-9007 Gallen St Gallen, Switzerland; [Meuli, Lorenz] Univ Hosp Zurich, Dept Vasc Surg, Zurich, Switzerland; [Sollid, Stephen J. M.] Norwegian Air Ambulance Fdn, Oslo, Norway; [Knapp, Jurgen] Univ Bern, Bern Univ Hosp, Dept Anaesthesiol & Pain Med, Inselspital, Bern, Switzerland; [Exadaktylos, Aristomenis; Albrecht, Roland; Pietsch, Urs] Univ Bern, Bern Univ Hosp, Dept Emergency Med, Inselspital, Freiburgstr, CH-3010 Bern, Switzerland; [Albrecht, Roland; Pietsch, Urs] Swiss Air Ambulance, Rega RettungsFlugwacht Guarde Aerienne, Postfach 1414, CH-8058 Zurich, Switzerland		Pietsch, U (corresponding author), Cantonal Hosp St, Dept Anaesthesiol & Intens Care Med, Rorschacher Str 95, CH-9007 Gallen St Gallen, Switzerland.; Pietsch, U (corresponding author), Univ Bern, Bern Univ Hosp, Dept Emergency Med, Inselspital, Freiburgstr, CH-3010 Bern, Switzerland.; Pietsch, U (corresponding author), Swiss Air Ambulance, Rega RettungsFlugwacht Guarde Aerienne, Postfach 1414, CH-8058 Zurich, Switzerland.	urs.pietsch@kssg.ch					Abdelmalik PA, 2019, TRANSFUSION, V59, P1529, DOI 10.1111/trf.15171; Belpomme V, 2005, AM J EMERG MED, V23, P852, DOI 10.1016/j.ajem.2005.04.011; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bouma G J, 1995, New Horiz, V3, P384; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Checketts MR, 2016, ANAESTHESIA, V71, P470, DOI 10.1111/anae.13421; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Fiorentino M, 2019, J TRAUMA ACUTE CARE, V87, P1156, DOI 10.1097/TA.0000000000002440; FLETCHER R, 1984, BRIT J ANAESTH, V56, P109, DOI 10.1093/bja/56.2.109; Frerk C, 2015, BRIT J ANAESTH, V115, P827, DOI 10.1093/bja/aev371; Fujimoto S, 2019, RESP CARE, V64, P1208, DOI 10.4187/respcare.06094; Harve-Rytsala H, 2021, ACTA ANAESTH SCAND, V65, P534, DOI 10.1111/aas.13751; Hiller J, 2010, ANAESTH INTENS CARE, V38, P302, DOI 10.1177/0310057X1003800212; Katayama Y, 2013, JAPANESE J NEUROSURG, V22, P831, DOI [10.7887/jcns.22.831, DOI 10.7887/JCNS.22.831]; Law Grace T. S., 2009, Hong Kong Medical Journal, V15, P440; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; NUNN JF, 1960, J APPL PHYSIOL, V15, P383, DOI 10.1152/jappl.1960.15.3.383; Ogoh S, 2019, J APPL PHYSIOL, V127, P1197, DOI 10.1152/japplphysiol.00057.2019; Onodi C, 2017, ANAESTHESIA, V72, P1357, DOI 10.1111/anae.13969; Prause G, 1997, RESUSCITATION, V35, P145, DOI 10.1016/S0300-9572(97)00043-9; Price J, 2020, EMERG MED J, V37, P674, DOI 10.1136/emermed-2019-209077; SHANKAR KB, 1989, CAN J ANAESTH, V36, P124, DOI 10.1007/BF03011432; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Steiner LA, 2005, ACTA NEUROCHIR, V147, P477, DOI 10.1007/s00701-005-0510-x; Suominen PK, 2007, ASAIO J, V53, P670, DOI 10.1097/MAT.0b013e3181569bf3; Volovici V, 2019, J NEUROTRAUM, V36, P3183, DOI 10.1089/neu.2019.6474; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Warner KJ, 2009, J TRAUMA, V66, P26, DOI 10.1097/TA.0b013e3181957a25; Yang JT, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.9448; Yosefy C, 2004, EMERG MED J, V21, P557, DOI 10.1136/emj.2003.005819	30	2	2	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	MAY 17	2021	11	1							10391	10.1038/s41598-021-89913-x			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SN6XS	WOS:000658431900015	34001982	Green Accepted, gold, Green Published			2022-02-06	
J	Chen, KY; Tsai, TY; Chang, CF; Ou, JC; Tsai, YR; Ma, HP; Chiu, WT; Tsai, SH; Liao, KH; Lin, JW; Lin, CM; Wu, JCC; Chiang, YH				Chen, Kai-Yun; Tsai, Tung-Yao; Chang, Cheng-Fu; Ou, Ju-Chi; Tsai, Yan-Rou; Ma, Hon-Ping; Chiu, Wen-Ta; Tsai, Shin-Han; Liao, Kuo-Hsing; Lin, Jia-Wei; Lin, Chien-Min; Wu, John Chung-Che; Chiang, Yung-Hsiao			Worsening of Dizziness Impairment Is Associated with Bone Marrow Kinase on Chromosome X Level in Patients after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; BMX; dizziness; traumatic brain injury	TYROSINE KINASE; ETK/BMX; BALANCE; BIOMARKERS; MANAGEMENT; DISORDERS; DIAGNOSIS; ETK; SRC	Over 2 million people suffer from mild traumatic brain injury (mTBI) each year. Predicting symptoms of mTBI and the characterization of those symptoms has been challenging. Biomarkers that correlate clinical symptoms to disease outcome are desired to improve understanding of the disease and optimize patient care. Bone marrow kinase on chromosome X (BMX), a member of the TEC family of nonreceptor tyrosine kinases, is up-regulated after traumatic neural injury in a rat model of mTBI. The aim of this investigation was to determine whether BMX serum concentrations can effectively be used to predict outcomes after mTBI in a clinical setting. A total of 63 patients with mTBI (Glasgow Coma Score [GCS] between 13 and 15) were included. Blood samples taken at the time of hospital admission were analyzed for BMX. Data collected included demographic and clinical variables. Outcomes were assessed using the Dizziness Handicap Inventory (DHI) questionnaire at baseline and 6 weeks postinjury. The participant was asssigned to the case group if the subject's complaints of dizziness became worse at the sixth week assessment; otherwise, the participant was assigned to the control group. A receiver operating characteristic curve was constructed to explore BMX level. Significant associations were found between serum levels of BMX and dizziness. Areas under the curve for prediction of change in DHI postinjury were 0.76 for total score, 0.69 for physical score, 0.65 for emotional score, and 0.66 for functional score. Specificities were between 0.69 and 0.77 for total score and emotional score, respectively. Therefore, BMX demonstrates potential as a candidate serum biomarker of exacerbating dizziness post-mTBI.	[Chen, Kai-Yun; Tsai, Yan-Rou; Tsai, Shin-Han; Chiang, Yung-Hsiao] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Neural Regenerat Med, Taipei, Taiwan; [Chen, Kai-Yun; Tsai, Yan-Rou; Tsai, Shin-Han; Chiang, Yung-Hsiao] Taipei Med Univ, Ctr Neurotrauma & Neuroregenerat, Taipei, Taiwan; [Tsai, Tung-Yao; Ou, Ju-Chi; Ma, Hon-Ping; Tsai, Shin-Han] Taipei Med Univ, Shuang Ho Hosp, Dept Emergency Med, New Taipei, Taiwan; [Chang, Cheng-Fu; Lin, Jia-Wei; Lin, Chien-Min; Wu, John Chung-Che; Chiang, Yung-Hsiao] Taipei Med Univ, Coll Med, Dept Surg, Taipei, Taiwan; [Chang, Cheng-Fu; Chiu, Wen-Ta; Wu, John Chung-Che; Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, 250 Wu Xing St, Taipei 110, Taiwan; [Tsai, Shin-Han] Taipei Med Univ, Coll Publ Hlth & Nutr, Taipei, Taiwan; [Liao, Kuo-Hsing] Wan Fang Hosp, Dept Neurosurg, Taipei, Taiwan; [Lin, Jia-Wei; Lin, Chien-Min] Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, New Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Canc Ctr, Translat Res Lab, Taipei, Taiwan		Wu, JCC (corresponding author), Taipei Med Univ Hosp, Dept Neurosurg, 250 Wu Xing St, Taipei 110, Taiwan.	dr.jcwu@gmail.com					Agrawal Y, 2009, ARCH INTERN MED, V169, P938, DOI 10.1001/archinternmed.2009.66; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Chen KY, 2012, CELL TRANSPLANT, V21, P345, DOI 10.3727/096368911X582741; Chen RY, 2001, NAT CELL BIOL, V3, P439, DOI 10.1038/35074500; Chen XY, 2004, ONCOGENE, V23, P1854, DOI 10.1038/sj.onc.1207308; Cogan AM, 2014, OTJR-OCCUP PART HEAL, V34, P150, DOI 10.3928/15394492-20140617-01; Conn JM, 2003, INJURY PREV, V9, P117, DOI 10.1136/ip.9.2.117; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Flanagan S, 1999, MT SINAI J MED, V66, P152; Freeman M., 2014, J INT NEUROPSYCHOL S, V5, P1; Gurley JM, 2013, NEUROREHABILITATION, V32, P519, DOI 10.3233/NRE-130874; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Lee LF, 2001, MOL CELL BIOL, V21, P8385, DOI 10.1128/MCB.21.24.8385-8397.2001; Neuhauser HK, 2005, NEUROLOGY, V65, P898, DOI 10.1212/01.wnl.0000175987.59991.3d; Qiu Y, 2000, ONCOGENE, V19, P5651, DOI 10.1038/sj.onc.1203958; Tsai YT, 2000, MOL CELL BIOL, V20, P2043, DOI 10.1128/MCB.20.6.2043-2054.2000; Wang YJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/293687; Wu JCC, 2013, J SURG RES, V179, P138, DOI 10.1016/j.jss.2012.09.013; Wu JCC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039226; Wu YM, 2001, J BIOL CHEM, V276, P17672, DOI 10.1074/jbc.M010964200; Yardley L, 1998, BRIT J GEN PRACT, V48, P1131; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	27	2	2	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2021	38	10					1445	1449		10.1089/neu.2014.3691			5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RZ6DB	WOS:000648685300010	25747875				2022-02-06	
J	Liu, XL; Gao, CC; Qi, M; Han, YL; Zhou, ML; Zheng, LR				Liu, Xi-lin; Gao, Chao-Chao; Qi, Min; Han, Yan-ling; Zhou, Meng-liang; Zheng, Lan-rong			Expression of FOXO transcription factors in the brain following traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						Traumatic brain injury; Foxo1; Foxo3a; Foxo4; Expression	INFLAMMATORY RESPONSE; OXIDATIVE STRESS; HEMORRHAGE; PATHWAY	Traumatic brain injury (TBI) is a substantial clinical and social problem worldwide, causing high morbidity and mortality along with significant economic and medical costs. Forkhead box O transcription factors (FOXOs) have been found to play a critical role in the regulation of cell functions, such as nutrient metabolism, programmed cell death, and tumor suppression. In the central nervous system, FOXOs are reported to be pivotal regulators of learning and memory, neurite outgrowth, and axonal degeneration. However, the role of FOXOs in TBI is still unknown. Here, we investigate changes in the expression of FOXOs in the acute stage following TBI. First, we evaluated the expression of FOXO proteins in the brains of humans after TBI. A TBI model was then established in mice, and the ipsilateral cerebral cortex was collected at 3 h, 6 h, 9 h, 12 h, 24 h, and 72 h post-TBI. The dynamic expression of Foxo proteins was observed. Neuron-specific localization of Foxos was detected by double immunofluorescence staining. Following TBI, FOXO proteins in the brains of humans were significantly increased. In mice, Foxo protein levels generally peaked at 24 h. By examining co-localization with neurons, the proportion of Foxo(+) neurons was found to increase following TBI and peak at 24 h. This study reveals the timedependent and neuron-specific expression of Foxos following TBI in mice, providing insight to enhance understanding of the role of Foxos in TBI.	[Liu, Xi-lin; Zheng, Lan-rong] Wannan Med Coll, Grad Sch, Wuhu 241002, Anhui, Peoples R China; [Liu, Xi-lin; Zheng, Lan-rong] Wannan Med Coll, Sch Basic Med Sci, Dept Pathol, 22 West Wenchang Rd, Wuhu 241002, Anhui, Peoples R China; [Gao, Chao-Chao; Han, Yan-ling] Nanjing Med Univ, Jinling Hosp, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China; [Qi, Min] Wannan Med Coll, Yijishan Hosp, Dept Neurosurg, Wuhu 241001, Anhui, Peoples R China; [Han, Yan-ling; Zhou, Meng-liang] Nanjing Med Univ, Dept Neurosurg, Jinling Hosp, Sch Med, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China		Zheng, LR (corresponding author), Wannan Med Coll, Sch Basic Med Sci, Dept Pathol, 22 West Wenchang Rd, Wuhu 241002, Anhui, Peoples R China.; Zhou, ML (corresponding author), Nanjing Med Univ, Dept Neurosurg, Jinling Hosp, Sch Med, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	mengliangzhou@yahoo.com; zhenglanrong@qq.com		gao, chao-chao/0000-0002-0506-7226	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771292, 81571162]	This work was supported by grants from the National Natural Science Foundation of China (No. 81771292 and No. 81571162).	Davila D, 2008, MOL BIOL CELL, V19, P2014, DOI 10.1091/mbc.E07-08-0811; de la Torre-Ubieta L, 2010, GENE DEV, V24, P799, DOI 10.1101/gad.1880510; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Eslami M, 2020, NEUROL RES, V42, P91, DOI 10.1080/01616412.2019.1709139; Gardner AJ, 2016, HAND CLINIC, V138, P207, DOI 10.1016/B978-0-12-802973-2.00012-4; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Hoekman MFM, 2006, GENE EXPR PATTERNS, V6, P134, DOI 10.1016/j.modgep.2005.07.003; Hu W, 2019, PROG NEUROBIOL, V181, DOI 10.1016/j.pneurobio.2019.101645; Kapoor S, 2013, J NEUROSCI, V33, P17398, DOI 10.1523/JNEUROSCI.2756-13.2013; Li ZY, 2016, NEUROSCI LETT, V629, P131, DOI 10.1016/j.neulet.2016.06.013; Ma X, 2020, INT J MOL SCI, V21; Maegele M, 2020, LANCET NEUROL, V19, P637, DOI 10.1016/S1474-4422(20)30208-8; Maiese K, 2018, CURR NEUROVASC RES, V15, P81, DOI 10.2174/1567202615666180319151244; Maiese K, 2009, MED RES REV, V29, P395, DOI 10.1002/med.20139; Oh H, 2019, METHODS MOL BIOL, V1890, P239, DOI 10.1007/978-1-4939-8900-3_20; Polter A, 2009, BIOL PSYCHIAT, V65, P150, DOI 10.1016/j.biopsych.2008.08.005; Salman M., 2020, DIS MODEL MECH, V13; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Singh V, 2020, INFLAMMATION, V43, P1589, DOI 10.1007/s10753-020-01242-9; Sun LQ, 2018, BEHAV BRAIN RES, V337, P271, DOI 10.1016/j.bbr.2017.08.042; Wang TY, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01835-z; Webb AE, 2016, AGING CELL, V15, P673, DOI 10.1111/acel.12479; Weckbach S, 2012, J NEUROTRAUM, V29, P1233, DOI 10.1089/neu.2011.2169; Ye ZN, 2018, BEHAV BRAIN RES, V339, P19, DOI 10.1016/j.bbr.2017.11.011; Zhao P., 2020, J CELL MOL MED, V24; Zhao PZ, 2020, J CELL MOL MED, V24, P8466, DOI 10.1111/jcmm.15406	26	2	2	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAY 14	2021	753								135882	10.1016/j.neulet.2021.135882			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RN3ER	WOS:000640234700001	33838260				2022-02-06	
J	Stewart, AN; Lowe, JL; Glaser, EP; Mott, CA; Shahidehpour, RK; McFarlane, KE; Bailey, WM; Zhang, B; Gensel, JC				Stewart, Andrew N.; Lowe, John L.; Glaser, Ethan P.; Mott, Caitlin A.; Shahidehpour, Ryan K.; McFarlane, Katelyn E.; Bailey, William M.; Zhang, Bei; Gensel, John C.			Acute inflammatory profiles differ with sex and age after spinal cord injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Acute inflammation; Aging; Gender; Macrophage phenotype; Neurotrauma; P2y12 receptor; Sex as a biological variable	GENDER-RELATED DIFFERENCES; LEVEL NEUROPATHIC PAIN; FUNCTIONAL RECOVERY; MEDIATOR PRODUCTION; FEMALE RATS; MACROPHAGES; MICROGLIA; COMPLEMENT; ACTIVATION; REPAIR	Background Sex and age are emerging as influential variables that affect spinal cord injury (SCI) recovery. Despite a changing demographic towards older age at the time of SCI, the effects of sex or age on inflammation remain to be elucidated. This study determined the sex- and age-dependency of the innate immune response acutely after SCI. Methods Male and female mice of ages 4- and 14-month-old received T9 contusion SCI and the proportion of microglia, monocyte-derived macrophages (MDM), and neutrophils surrounding the lesion were determined at 3- and 7-day post-injury (DPI) using flow cytometry. Cell counts of microglia and MDMs were obtained using immunohistochemistry to verify flow cytometry results at 3-DPI. Microglia and MDMs were separately isolated using fluorescence-activated cell sorting (FACS) at 3-day post-injury (DPI) to assess RNA expression of 27 genes associated with activation, redox, and debris metabolism/clearance. Results Flow cytometry revealed that being female and older at the time of injury significantly increased MDMs relative to other phagocytes, specifically increasing the ratio of MDMs to microglia at 3-DPI. Cell counts using immunohistochemistry revealed that male mice have more total microglia within SCI lesions that can account for a lower MDM/microglia ratio. With NanoString analyses of 27 genes, only 1 was differentially expressed between sexes in MDMs; specifically, complement protein C1qa was increased in males. No genes were affected by age in MDMs. Only 2 genes were differentially regulated in microglia between sexes after controlling for false discovery rate, specifically CYBB (NOX2) as a reactive oxygen species (ROS)-associated marker as well as MRC1 (CD206), a gene associated with reparative phenotypes. Both genes were increased in female microglia. No microglial genes were differentially regulated between ages. Differences between microglia and MDMs were found in 26 of 27 genes analyzed, all expressed higher in MDMs with three exceptions. Specifically, C1qa, cPLA2, and CD86 were expressed higher in microglia. Conclusions These findings indicate that inflammatory responses to SCI are sex-dependent at both the level of cellular recruitment and gene expression.	[Stewart, Andrew N.; Lowe, John L.; Glaser, Ethan P.; Mott, Caitlin A.; McFarlane, Katelyn E.; Bailey, William M.; Zhang, Bei; Gensel, John C.] Univ Kentucky, Coll Med, Dept Physiol, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; [Lowe, John L.] Georgetown Coll, Sci Honors Program, Georgetown, KY 40324 USA; [Shahidehpour, Ryan K.] Univ Kentucky, Coll Med, Dept Neurosci, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; [Zhang, Bei] Weill Cornell Med, Brain & Mind Res Inst, New York, NY 10021 USA		Gensel, JC (corresponding author), Univ Kentucky, Coll Med, Dept Physiol, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA.	Gensel.1@uky.edu		, John/0000-0001-8980-108X	Craig H. Neilson Foundation [465079]; National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS091582, F32NS111241]; National Institute on Alcohol Abuse and AlcoholismUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [T32AA027488]; National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA177558]	Funding support provided by the Craig H. Neilson Foundation under award #465079, the National IDnstitute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) under Awards: R01NS091582 and F32NS111241, as well as, the National Institute on Alcohol Abuse and Alcoholism training grant T32AA027488 and National Cancer Institute grant P30CA177558.	Baker AE, 2004, ENDOCRINOLOGY, V145, P5021, DOI 10.1210/en.2004-0619; Bianchi VE, 2019, J ENDOCR SOC, V3, P91, DOI 10.1210/js.2018-00186; Bonofiglio D, 2005, CLIN CANCER RES, V11, P6139, DOI 10.1158/1078-0432.CCR-04-2453; Budh CN, 2003, SPINAL CORD, V41, P122, DOI 10.1038/sj.sc.3101407; Calippe B, 2010, J IMMUNOL, V185, P1169, DOI 10.4049/jimmunol.0902383; da Costa MG, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02664; Datto JP, 2015, J NEUROTRAUM, V32, P1146, DOI 10.1089/neu.2014.3702; Datto JP., 2016, DATASET PAPERS SCI, V2016, P6276348, DOI [10.1155/2016/6276348, DOI 10.1155/2016/6276348]; Detloff MR, 2008, EXP NEUROL, V212, P337, DOI 10.1016/j.expneurol.2008.04.009; Doran SJ, 2019, J NEUROTRAUM, V36, P1040, DOI 10.1089/neu.2018.6019; Emamhadi M, 2016, ARCH BONE JT SURG-AB, V4, P56; Farooque M, 2006, SPINAL CORD, V44, P182, DOI 10.1038/sj.sc.3101816; Fenn AM, 2014, J NEUROSCI, V34, P8904, DOI 10.1523/JNEUROSCI.1146-14.2014; Foryst-Ludwig A., 2008, PLOS GENET, V4, DOI [10.1371/journal.pgen.1000108, DOI 10.1371/journal.pgen.1000108]; Fraser D, 2015, J IMMUNOL, V194; Fujita Y, 2003, COMP BIOCHEM PHYS C, V136, P85, DOI 10.1016/S1532-0456(03)00194-7; Galvan MD, 2008, J NEUROSCI, V28, P13876, DOI 10.1523/JNEUROSCI.2823-08.2008; Gaudet AD, 2017, EXP NEUROL, V295, P46, DOI 10.1016/j.expneurol.2017.05.011; Gensel JC, 2019, J NEUROTRAUM, V36, P2372, DOI 10.1089/neu.2018.6207; Gensel JC, 2017, SCI REP-UK, V7, DOI 10.1038/srep40144; Gensel JC, 2015, BRAIN RES, V1619, P1, DOI 10.1016/j.brainres.2014.12.045; Gensel JC, 2009, J NEUROSCI, V29, P3956, DOI 10.1523/JNEUROSCI.3992-08.2009; Greenhalgh AD, 2014, J NEUROSCI, V34, P6316, DOI 10.1523/JNEUROSCI.4912-13.2014; Gwak YS, 2009, NEUROSCIENCE, V161, P895, DOI 10.1016/j.neuroscience.2009.03.055; Hains BC, 2006, J NEUROSCI, V26, P4308, DOI 10.1523/JNEUROSCI.0003-06.2006; Harrison M, 2013, NEUROIMAGE, V68, P22, DOI 10.1016/j.neuroimage.2012.11.048; Hauben E, 2002, EUR J NEUROSCI, V16, P1731, DOI 10.1046/j.1460-9568.2002.02241.x; Honjoh K, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00525; Hooshmand MJ, 2014, IMMUN AGEING, V11, DOI 10.1186/1742-4933-11-15; Kipp M, 2009, FRONT NEUROENDOCRIN, V30, P188, DOI 10.1016/j.yfrne.2009.04.004; Kopper TJ, 2018, J NEUROSCI RES, V96, P969, DOI 10.1002/jnr.24114; McFarlane K, 2020, J NEUROTRAUM, V37, P1983, DOI 10.1089/neu.2019.6931; Nscisc, 2020, 2019 ANN STAT REP SP; Peterson SL, 2014, EXP NEUROL, V258, P35, DOI 10.1016/j.expneurol.2014.04.028; Qiao F, 2006, AM J PATHOL, V169, P1039, DOI 10.2353/ajpath.2006.060248; Rettew JA, 2008, BIOL REPROD, V78, P432, DOI 10.1095/biolreprod.107.063545; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Smith JA, 2011, NEUROCHEM RES, V36, P1587, DOI 10.1007/s11064-010-0336-7; Stewart AN, 2021, EXP NEUROL, V337, DOI 10.1016/j.expneurol.2021.113597; Stewart AN, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00802; Stewart AN, 2019, NEURAL REGEN RES, V14, P1895, DOI 10.4103/1673-5374.259606; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; von Leden RE, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0933-3; Walker CL, 2019, J NEUROTRAUM, V36, P1974, DOI 10.1089/neu.2018.6233; Wang X, 2015, GLIA, V63, P635, DOI 10.1002/glia.22774; Werhagen L, 2004, SPINAL CORD, V42, P665, DOI 10.1038/sj.sc.3101641; Yoon M, 2010, PPAR RES, V2010, DOI 10.1155/2010/584296; Zhang B, 2019, BRAIN BEHAV IMMUN, V76, P139, DOI 10.1016/j.bbi.2018.11.013; Zhang B, 2016, NEUROBIOL AGING, V47, P157, DOI 10.1016/j.neurobiolaging.2016.07.029; Zhang B, 2015, EXP NEUROL, V273, P83, DOI 10.1016/j.expneurol.2015.08.001	50	2	2	3	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	MAY 13	2021	18	1							113	10.1186/s12974-021-02161-8			16	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	SL5QA	WOS:000656971500002	33985529	Green Published, gold			2022-02-06	
J	Abayazid, F; Ding, K; Zimmerman, K; Stigson, H; Ghajari, M				Abayazid, Fady; Ding, Ke; Zimmerman, Karl; Stigson, Helena; Ghajari, Mazdak			A New Assessment of Bicycle Helmets: The Brain Injury Mitigation Effects of New Technologies in Oblique Impacts	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Traumatic brain injury; Helmets; Rotational motion; Oblique impacts; Standards	HEAD; TRANSPORT	New helmet technologies have been developed to improve the mitigation of traumatic brain injury (TBI) in bicycle accidents. However, their effectiveness under oblique impacts, which produce more strains in the brain in comparison with vertical impacts adopted by helmet standards, is still unclear. Here we used a new method to assess the brain injury prevention effects of 27 bicycle helmets in oblique impacts, including helmets fitted with a friction-reducing layer (MIPS), a shearing pad (SPIN), a wavy cellular liner (WaveCel), an airbag helmet (Hovding) and a number of conventional helmets. We tested whether helmets fitted with the new technologies can provide better brain protection than conventional helmets. Each helmeted headform was dropped onto a 45 degrees inclined anvil at 6.3 m/s at three locations, with each impact location producing a dominant head rotation about one anatomical axes of the head. A detailed computational model of TBI was used to determine strain distribution across the brain and in key anatomical regions, the corpus callosum and sulci. Our results show that, in comparison with conventional helmets, the majority of helmets incorporating new technologies significantly reduced peak rotational acceleration and velocity and maximal strain in corpus callosum and sulci. Only one helmet with MIPS significantly increased strain in the corpus collosum. The helmets fitted with MIPS and WaveCel were more effective in reducing strain in impacts producing sagittal rotations and a helmet fitted with SPIN in coronal rotations. The airbag helmet was effective in reducing brain strain in all impacts, however, peak rotational velocity and brain strain heavily depended on the analysis time. These results suggest that incorporating different impact locations in future oblique impact test methods and designing helmet technologies for the mitigation of head rotation in different planes are key to reducing brain injuries in bicycle accidents.	[Abayazid, Fady; Ding, Ke; Zimmerman, Karl; Ghajari, Mazdak] Imperial Coll, Dyson Sch Design Engn, London, England; [Zimmerman, Karl] Imperial Coll London, Hammersmith Hosp, Dept Brain Sci, Computat Cognit & Clin Neuroimaging Lab, London, England; [Stigson, Helena] Folksam Insurance Grp, Stockholm, Sweden; [Stigson, Helena] Chalmers Univ Technol, Vehicle Safety Div, Dept Appl Mech, Gothenburg, Sweden; [Stigson, Helena] Karolinska Inst, Dept Clin Neurosci, Div Insurance Med, S-17177 Stockholm, Sweden		Abayazid, F (corresponding author), Imperial Coll, Dyson Sch Design Engn, London, England.	fa1016@ic.ac.uk	Zimmerman, Karl/AAL-4988-2020	Zimmerman, Karl/0000-0003-1239-3414	Imperial College President's PhD Scholarship; Folksam Insurance Group; Road Safety Trust	We would like to acknowledge the financial support from the Imperial College President's PhD Scholarship. The experimental helmet impact tests in this study were funded by Folksam Insurance Group and the Road Safety Trust, an independent grant-giving trust aiming to reduce the number of people killed or injured on the UK roads through providing independent funding for vital research and practical interventions into new approaches to road safety.	Aare Magnus, 2003, Traffic Inj Prev, V4, P240, DOI 10.1080/15389580309879; Administration U. S. D. of T. N. H. T. S., 2011, BICYCLISTS OTHER CYC; [Anonymous], TRANSPORT SECRETARYS; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bian KW, 2020, BIOMECH MODEL MECHAN, V19, P2323, DOI 10.1007/s10237-020-01341-4; Bland ML, 2020, ANN BIOMED ENG, V48, P2783, DOI 10.1007/s10439-020-02620-y; Bland ML, 2020, ANN BIOMED ENG, V48, P47, DOI 10.1007/s10439-019-02330-0; Bliven E, 2019, ACCIDENT ANAL PREV, V124, P58, DOI 10.1016/j.aap.2018.12.017; Bottlang M, 2020, ANN BIOMED ENG, V48, P68, DOI 10.1007/s10439-019-02328-8; Bourdet N, 2012, P I MECH ENG P-J SPO, V226, P282, DOI 10.1177/1754337112442326; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Coleman H., 2018, TRAFF SAF FACTS; Cripton PA, 2014, ACCIDENT ANAL PREV, V70, P1, DOI 10.1016/j.aap.2014.02.016; Deck C, 2019, J SAFETY RES, V71, P67, DOI 10.1016/j.jsr.2019.09.003; DeMarco AL, 2020, ANN BIOMED ENG, V48, P58, DOI 10.1007/s10439-019-02422-x; DeVore GR, 2017, J ULTRAS MED, V36, P459, DOI 10.7863/ultra.16.03025; Dodds N, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027845; Donat CK, 2021, BRAIN, V144, P70, DOI 10.1093/brain/awaa336; European Committe for Standardization, 1997, EUR QUAL AW, P1; Fahlstedt M, 2021, ANN BIOMED ENG, V49, P1097, DOI 10.1007/s10439-020-02703-w; Fahlstedt M, 2016, ACCIDENT ANAL PREV, V91, P135, DOI 10.1016/j.aap.2016.02.025; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Halldin P, 2001, INT J CRASHWORTHINES, V6, P53, DOI 10.1533/cras.2001.0162; Halldin P., 2003, IMPROVED HELMET DESI, P1; Hamer M, 2008, PREV MED, V46, P9, DOI 10.1016/j.ypmed.2007.03.006; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Holbourn AHS, 1943, LANCET, V2, P438; Hubbard RP., 2010, SAE TECH PAP SER, V1, P3836; Khosroshahi SF, 2019, J BIOMECH, V97, DOI 10.1016/j.jbiomech.2019.109376; Kleiven, 2005, P IRCOBI C PRAG CZEC, P21; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kurt M, 2017, ANN BIOMED ENG, V45, P1148, DOI 10.1007/s10439-016-1732-1; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meng S., 2018, P IRCOBI C ATH GREEC, P454; Mills NJ, 2009, INT J IMPACT ENG, V36, P913, DOI 10.1016/j.ijimpeng.2008.12.011; Mills NJ, 1996, INT J CRASHWORTHINES, V2, P7; Moller NC, 2011, PREV MED, V53, P172, DOI 10.1016/j.ypmed.2011.06.007; Murphy A., 2019, REPORTED ROAD CASUAL, V1; Nightingale RW, 1996, J BIOMECH, V29, P307, DOI 10.1016/0021-9290(95)00056-9; Nilsson P, 2017, ACCIDENT ANAL PREV, V100, P30, DOI 10.1016/j.aap.2016.12.020; Ommaya A.K., 1967, 11 STAPP CAR CRASH C, DOI [10.4271/670906, DOI 10.4271/670906]; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Perez E., 2014, P INT CYCL SAF C GOT, P1; Pintar, 1990, P 34 STAPP CAR CRASH, V902309, P55; Pintar FA., 1990, SAE TECH PAP; Rizzi M, 2013, P INT RES COUNC BIOM; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Siegkas P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39953-1; Stigson H., 2017, P INT RES COUNCIL BI, P13; Takhounts EG, 2013, STAPP CAR CRASH J, V57, P243, DOI DOI 10.4271/2013-22-0010; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Trotta A, 2018, J BIOMECH, V75, P28, DOI 10.1016/j.jbiomech.2018.05.003; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; Wen LM, 2008, PREV MED, V46, P29, DOI 10.1016/j.ypmed.2007.08.009; Yoganandan N., 2009, J BIOMECH ENG-T ASME, V111, P250	55	2	2	2	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2021	49	10			SI		2716	2733		10.1007/s10439-021-02785-0		MAY 2021	18	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering	WH8FD	WOS:000648839400003	33973128	hybrid, Green Published			2022-02-06	
J	Sloley, SS; Main, BS; Winston, CN; Harvey, AC; Kaganovich, A; Korthas, HT; Caccavano, AP; Zapple, DN; Wu, JY; Partridge, JG; Cookson, MR; Vicini, S; Burns, MP				Sloley, Stephanie S.; Main, Bevan S.; Winston, Charisse N.; Harvey, Alex C.; Kaganovich, Alice; Korthas, Holly T.; Caccavano, Adam P.; Zapple, David N.; Wu, Jian-young; Partridge, John G.; Cookson, Mark R.; Vicini, Stefano; Burns, Mark P.			High-frequency head impact causes chronic synaptic adaptation and long-term cognitive impairment in mice	NATURE COMMUNICATIONS			English	Article							TRAUMATIC BRAIN-INJURY; MOUSE MODEL; NMDA RECEPTORS; NEUROBEHAVIORAL CHANGES; POTASSIUM CHANNELS; PYRAMIDAL NEURONS; AXONAL INJURY; MILD; MEMANTINE; EXCITABILITY	Repeated head impact exposure can cause memory and behavioural impairments but the physiological changes in the brain are not well understood. Here, the authors reveal synaptic adaptations as a potential mechanism for early abnormal behavioural events observed after mild and high-frequency head impact. Repeated head impact exposure can cause memory and behavioral impairments. Here, we report that exposure to non-damaging, but high frequency, head impacts can alter brain function in mice through synaptic adaptation. High frequency head impact mice develop chronic cognitive impairments in the absence of traditional brain trauma pathology, and transcriptomic profiling of mouse and human chronic traumatic encephalopathy brain reveal that synapses are strongly affected by head impact. Electrophysiological analysis shows that high frequency head impacts cause chronic modification of the AMPA/NMDA ratio in neurons that underlie the changes to cognition. To demonstrate that synaptic adaptation is caused by head impact-induced glutamate release, we pretreated mice with memantine prior to head impact. Memantine prevents the development of the key transcriptomic and electrophysiological signatures of high frequency head impact, and averts cognitive dysfunction. These data reveal synapses as a target of high frequency head impact in human and mouse brain, and that this physiological adaptation in response to head impact is sufficient to induce chronic cognitive impairment in mice.	[Sloley, Stephanie S.; Winston, Charisse N.; Korthas, Holly T.; Caccavano, Adam P.; Wu, Jian-young; Partridge, John G.; Vicini, Stefano; Burns, Mark P.] Georgetown Univ, Med Ctr, Interdisciplinary Program Neurosci, Washington, DC 20007 USA; [Sloley, Stephanie S.; Main, Bevan S.; Winston, Charisse N.; Harvey, Alex C.; Korthas, Holly T.; Zapple, David N.; Wu, Jian-young; Burns, Mark P.] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA; [Kaganovich, Alice; Cookson, Mark R.] Natl & Nstitute Aging, Lab Neurogenet, Bethesda, MD USA; [Caccavano, Adam P.; Partridge, John G.; Vicini, Stefano] Georgetown Univ, Med Ctr, Dept Pharmacol & Physiol, Washington, DC 20007 USA		Burns, MP (corresponding author), Georgetown Univ, Med Ctr, Interdisciplinary Program Neurosci, Washington, DC 20007 USA.; Burns, MP (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA.	mark.burns@georgetown.edu	Caccavano, Adam/I-2223-2015	Caccavano, Adam/0000-0002-6819-533X	National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS107370, UG3NS106941]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK117508]; Intramural Research Program of the NIH, National Institute on Aging (NIA); NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R03AG061645]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS041218]; Advanced Rehabilitation Research and Training Fellowship - Department of Health and Human Services [90AR5005]; Mouse Behavior Core in the Georgetown University Neuroscience Department	These authors contributed equally: Mark R. Cookson, Stefano Vicini, Mark P. Burns. We thank all past and present members of the Burns lab for valuable discussions. This work was supported by the National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) (R01NS107370 and UG3NS106941 to M.P.B.), the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (R01DK117508 to S.V.), the Intramural Research Program of the NIH, National Institute on Aging (NIA) (M.R.C.), and the NIA (R03AG061645 to J.-Y.W.). NINDS also supported the Neural Injury and Plasticity Training Grant housed in the Center for Neural Injury and Recovery (CNIR) at Georgetown University (T32NS041218 to S.S.S, C.N.W., and H.T.K). Funding was also provided by the Advanced Rehabilitation Research and Training Fellowship funded by the Department of Health and Human Services (90AR5005 awarded to B.S.M). This research was supported by the Mouse Behavior Core in the Georgetown University Neuroscience Department. Graphical illustrations and schematics throughout the manuscript were made using BioRender (https://biorender.com/).We also thank Ashley Bolte and Ruchelle Buenaventura for their support with bioinformatic coding and visualization of sequencing studies, and also Dr. Patricia Foley, Dr. Robin Tucker, and all of the Division of Comparative Medicine (DCM) team at Georgetown University.	Albensi BC, 2000, EXP NEUROL, V162, P385, DOI 10.1006/exnr.1999.7338; Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Arneson D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06222-0; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Bugay V, 2020, J NEUROTRAUM, V37, P248, DOI 10.1089/neu.2018.6333; Castranio EL, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0569-2; Castranio EL, 2017, NEUROBIOL DIS, V105, P1, DOI 10.1016/j.nbd.2017.05.006; Cho H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65916-y; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Czerniawski J, 2011, J NEUROSCI, V31, P11200, DOI 10.1523/JNEUROSCI.2211-11.2011; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Deng P, 2011, J NEUROTRAUM, V28, P1173, DOI 10.1089/neu.2010.1683; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Effgen GB, 2017, J NEUROTRAUM, V34, P934, DOI 10.1089/neu.2016.4528; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Ford NC, 2016, NEUROSCIENCE, V339, P502, DOI 10.1016/j.neuroscience.2016.10.027; Gao HB, 2017, BRAIN RES, V1657, P1, DOI 10.1016/j.brainres.2016.11.028; Giza CC, 2001, J ATHL TRAINING, V36, P228; Glasgow NG, 2017, J NEUROSCI, V37, P9686, DOI 10.1523/JNEUROSCI.1173-17.2017; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Greer JE, 2012, J NEUROSCI, V32, P6682, DOI 10.1523/JNEUROSCI.0881-12.2012; Hanell A, 2015, J NEUROTRAUM, V32, P1590, DOI 10.1089/neu.2014.3592; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; Humphries ESA, 2015, J BIOMOL SCREEN, V20, P1055, DOI 10.1177/1087057115601677; Jimenez-Mateos Eva M, 2009, Int J Physiol Pathophysiol Pharmacol, V1, P180; Johnson JW, 2015, CURR OPIN PHARMACOL, V20, P54, DOI 10.1016/j.coph.2014.11.006; Kanayama G, 1996, METHOD FIND EXP CLIN, V18, P105; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Karimi SA, 2021, HIPPOCAMPUS, V31, P156, DOI 10.1002/hipo.23270; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Le Meur K, 2007, J PHYSIOL-LONDON, V580, P373, DOI 10.1113/jphysiol.2006.123570; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Li SJ, 2017, PROG NEUROBIOL, V157, P79, DOI 10.1016/j.pneurobio.2017.01.001; Lin AP, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0094-5; Logan SM, 2007, J NEUROPHYSIOL, V98, P2693, DOI 10.1152/jn.00462.2007; Longhi L, 2011, J CEREBR BLOOD F MET, V31, P1919, DOI 10.1038/jcbfm.2011.42; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lovero KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066171; Lozovaya NA, 2004, J PHYSIOL-LONDON, V558, P451, DOI 10.1113/jphysiol.2004.063792; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Main BS, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0249-5; Main BS, 2017, JOVE-J VIS EXP, DOI 10.3791/55713; Masse IO, 2019, JOVE-J VIS EXP, DOI 10.3791/59585; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Mei ZR, 2018, BEHAV BRAIN RES, V340, P195, DOI 10.1016/j.bbr.2017.04.017; Meng QY, 2017, EBIOMEDICINE, V16, P184, DOI 10.1016/j.ebiom.2017.01.046; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Moojen VKM, 2012, BRAIN RES, V1466, P82, DOI 10.1016/j.brainres.2012.05.041; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Neustadtl AL, 2017, NEUROREPORT, V28, P618, DOI 10.1097/WNR.0000000000000811; Nichols J, 2015, CNS NEUROSCI THER, V21, P193, DOI 10.1111/cns.12351; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Partridge JG, 2000, J NEUROPHYSIOL, V84, P1422, DOI 10.1152/jn.2000.84.3.1422; Partridge JG, 2014, J PHYSIOL-LONDON, V592, P2721, DOI 10.1113/jphysiol.2014.272773; Partridge JG, 2009, J NEUROPHYSIOL, V102, P3038, DOI 10.1152/jn.00272.2009; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Queenan BN, 2016, NEUROSCIENCE, V315, P206, DOI 10.1016/j.neuroscience.2015.12.017; Reimand J, 2019, NAT PROTOC, V14, P482, DOI 10.1038/s41596-018-0103-9; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Rodriguez GA, 2013, LEARN MEMORY, V20, P256, DOI 10.1101/lm.030031.112; Rosi S, 2012, HIPPOCAMPUS, V22, P544, DOI 10.1002/hipo.20920; Saab BJ, 2011, PHARMACOLOGY, V88, P284, DOI 10.1159/000332829; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Santschi LA, 2003, BRAIN RES, V962, P78, DOI 10.1016/S0006-8993(02)03846-5; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Seo JS, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.56; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; SHOHAMI E, 1994, ACTA NEUROCHIR, P443; Stenzel-Poore MP, 2003, LANCET, V362, P1028, DOI 10.1016/S0140-6736(03)14412-1; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Ting JT, 2014, METHODS MOL BIOL, V1183, P221, DOI 10.1007/978-1-4939-1096-0_14; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Umschwief G, 2010, J CEREBR BLOOD F MET, V30, P616, DOI 10.1038/jcbfm.2009.234; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Xiao K, 2018, J PHYSIOL-LONDON, V596, P4729, DOI 10.1113/JP275970; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Yokobori S, 2013, TRANSL STROKE RES, V4, P25, DOI 10.1007/s12975-012-0226-1	102	2	2	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2041-1723			NAT COMMUN	Nat. Commun.	MAY 10	2021	12	1							2613	10.1038/s41467-021-22744-6			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UD6HG	WOS:000687305500020	33972519	gold, Green Published			2022-02-06	
J	Farzaneh, N; Williamson, CA; Gryak, J; Najarian, K				Farzaneh, Negar; Williamson, Craig A.; Gryak, Jonathan; Najarian, Kayvan			A hierarchical expert-guided machine learning framework for clinical decision support systems: an application to traumatic brain injury prognostication	NPJ DIGITAL MEDICINE			English	Article							COMPUTED-TOMOGRAPHY; PREDICTION; MODEL; CLASSIFICATION; PROGESTERONE; VALIDATION	Prognosis of the long-term functional outcome of traumatic brain injury is essential for personalized management of that injury. Nonetheless, accurate prediction remains unavailable. Although machine learning has shown promise in many fields, including medical diagnosis and prognosis, such models are rarely deployed in real-world settings due to a lack of transparency and trustworthiness. To address these drawbacks, we propose a machine learning-based framework that is explainable and aligns with clinical domain knowledge. To build such a framework, additional layers of statistical inference and human expert validation are added to the model, which ensures the predicted risk score's trustworthiness. Using 831 patients with moderate or severe traumatic brain injury to build a model using the proposed framework, an area under the receiver operating characteristic curve (AUC) and accuracy of 0.8085 and 0.7488 were achieved, respectively, in determining which patients will experience poor functional outcomes. The performance of the machine learning classifier is not adversely affected by the imposition of statistical and domain knowledge "checks and balances". Finally, through a case study, we demonstrate how the decision made by a model might be biased if it is not audited carefully.	[Farzaneh, Negar; Gryak, Jonathan; Najarian, Kayvan] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Williamson, Craig A.; Najarian, Kayvan] Univ Michigan, Michigan Ctr Integrat Res Crit Care, Ann Arbor, MI 48109 USA; [Williamson, Craig A.] Univ Michigan, Dept Neurol Surg, Ann Arbor, MI 48109 USA; [Williamson, Craig A.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Gryak, Jonathan; Najarian, Kayvan] Univ Michigan, Michigan Inst Data Sci, Ann Arbor, MI 48109 USA; [Najarian, Kayvan] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Najarian, Kayvan] Univ Michigan, Dept Elect Engn & Comp Sci, Ann Arbor, MI 48109 USA		Farzaneh, N (corresponding author), Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.	negarf@umich.edu		Gryak, Jonathan/0000-0002-5125-7741	National Institute of Health (NIH) Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (F31)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [LM012946-01]	N.F. was supported by National Institute of Health (NIH) Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (F31) No. LM012946-01.	Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Bhandari Shilpa, 2020, SNTA '20: Proceedings of the 3rd International Workshop on Systems and Network Telemetry and Analytics, P19, DOI 10.1145/3391812.3396274; Bi Y, 2020, MOL THER-NUCL ACIDS, V22, P362, DOI 10.1016/j.omtn.2020.08.022; Caruana R, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1721, DOI 10.1145/2783258.2788613; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Committee on Medical Aspect of Automotive Safety, 1971, JAMA-J AM MED ASSOC, V215, P277; Deepika A, 2016, J NEUROSCI RURAL PRA, V7, pS1, DOI 10.4103/0976-3147.196473; Duan Rui, 2016, AMIA Annu Symp Proc, V2016, P1764; Elshawi R, 2019, BMC MED INFORM DECIS, V19, DOI 10.1186/s12911-019-0874-0; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fogel AL, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-017-0012-2; Geurts M, 2014, LANCET NEUROL, V13, P515, DOI 10.1016/S1474-4422(14)70030-4; Goldstein FC, 2017, J NEUROTRAUM, V34, P115, DOI 10.1089/neu.2015.4313; Hemphill JC, 2009, EMERG MED CLIN N AM, V27, P27, DOI 10.1016/j.emc.2008.08.009; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; JANSEN T, 2020, P 30 MED INF EUR C, P307; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P417, DOI 10.1097/TA.0000000000000372; Kell D.B., 2017, WHAT WE NEED BUILD E; Kelly CJ, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1426-2; Lee S.-I, 2018, EXPLAINABLE MACHINE, DOI [10.1101/331769v1.abstract, DOI 10.1101/331769V1.ABSTRACT]; Lundberg S. M., 2018, ARXIV PREPRINT ARXIV; Lundberg SM., 2017, ADV NEURALINFOR MATI, DOI DOI 10.5555/3295222.3295230; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Majdan M, 2017, J NEUROSCI RURAL PRA, V8, P20, DOI 10.4103/0976-3147.193543; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Matsuo K, 2019, J NEUROTRAUM, DOI 10.1089/neu.2018.6276; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Moore NA, 2013, BRIT J NEUROSURG, V27, P340, DOI 10.3109/02688697.2012.754402; Ogura K, 2020, DEV PREDICTION MODEL, DOI [10.1101/2020.08.18.20176180v1, DOI 10.1101/2020.08.18.20176180V1]; Paulus JK, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-0304-9; Paulus JK, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.117.003823; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rajkomar A, 2019, NEW ENGL J MED, V380, P1347, DOI 10.1056/NEJMra1814259; Rau Cheng-Shyuan, 2018, PLoS One, V13, pe0207192, DOI 10.1371/journal.pone.0207192; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Ribeiro MT, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1135, DOI 10.1145/2939672.2939778; Rizoli S, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0098-x; Rosi J, 2017, J CLIN NEUROSCI, V42, P122, DOI 10.1016/j.jocn.2017.03.012; Sakr S., COMPUT INTELL-US, DOI [10.1038/s41746-021-00445-0, DOI 10.1038/S41746-021-00445-0]; Stenberg M, 2017, BRAIN INJURY, V31, P351, DOI 10.1080/02699052.2016.1261303; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TEASDALE G, 1974, LANCET, V2, P81; Tourani R., 2020, P 2020 KDD WORKSH CA, P23; Vellido A, 2020, NEURAL COMPUT APPL, V32, P18069, DOI 10.1007/s00521-019-04051-w; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Williamson C. A., 2018, INTRACEREBRAL HEMORR, P95, DOI [10.1007/978-3-319-77063-5, DOI 10.1007/978-3-319-77063-5]; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304	49	2	2	3	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2398-6352			NPJ DIGIT MED	npj Digit. Med.	MAY 7	2021	4	1							78	10.1038/s41746-021-00445-0			9	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Medical Informatics	RZ0GG	WOS:000648278400001	33963275	gold, Green Published			2022-02-06	
J	Arif, H; Troyer, EA; Paulsen, JS; Vaida, F; Wilde, EA; Bigler, ED; Hesselink, JR; Yang, TT; Tymofiyeva, O; Wade, O; Max, JE				Arif, Hattan; Troyer, Emily A.; Paulsen, Jane S.; Vaida, Florin; Wilde, Elisabeth A.; Bigler, Erin D.; Hesselink, John R.; Yang, Tony T.; Tymofiyeva, Olga; Wade, Owen; Max, Jeffrey E.			Long-Term Psychiatric Outcomes in Adults with History of Pediatric Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						adolescent TBI; child TBI; long-term psychiatric outcome; psychiatric disorder; traumatic brain injury	HEAD-INJURIES; CHILDREN; DISORDERS; ADOLESCENTS; RELIABILITY; PREDICTORS; CHILDHOOD; SCHEDULE; TBI	The objective of the study was to compare psychiatric outcomes in adults with and without history of pediatric traumatic brain injury (TBI). Youth ages 6 to 14 years hospitalized for TBI from 1992 to 1994 were assessed at baseline and at 3, 6, 12, and 24 months post-injury. In the current study, psychiatric assessments were repeated at 24 years post-injury with the same cohort, now adults ages 29 to 39 years. A control group of healthy adults also was recruited for one-time cross-sectional assessments. Outcome measures included: 1) presence of a psychiatric disorder since the 24-month assessment not present before the TBI ("novel psychiatric disorder," NPD), or in the control group, the presence of a psychiatric disorder that developed after the mean age of injury of the TBI group plus 2 years; and 2) Time-to-Event for onset of an NPD during the same time periods. In the TBI group, NPDs were significantly more common, and presence of a current NPD was significantly predicted by presence of a pre-injury lifetime psychiatric disorder and by abnormal day-of-injury computed tomography (CT) scan. Compared with controls, the TBI group also had significantly shorter Time-to-Event for onset of any NPD. These findings demonstrate that long-term psychiatric outcomes in adults previously hospitalized for pediatric TBI are significantly worse when compared with adult controls without history of pediatric TBI, both in terms of prevalence and earlier onset of NPD. Further, in the TBI group, long-term NPD outcome is predicted independently by presence of pre-injury psychiatric disorder and abnormal day-of-injury CT scan.	[Arif, Hattan; Troyer, Emily A.; Max, Jeffrey E.] Univ Calif San Diego, Dept Psychiat, 5755 Oberlin Dr,Suite 301, San Diego, CA 92121 USA; [Vaida, Florin] Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92103 USA; [Hesselink, John R.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Paulsen, Jane S.] Univ Iowa, Dept Neurosci, Iowa City, IA USA; [Paulsen, Jane S.] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Paulsen, Jane S.; Wade, Owen; Max, Jeffrey E.] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Paulsen, Jane S.] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; [Wilde, Elisabeth A.] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol & Neurosci, Provo, UT 84602 USA; [Yang, Tony T.] Univ Calif San Francisco, Dept Psychiat, Div Child & Adolescent Psychiat, Weill Inst Neurosci, San Francisco, CA USA; [Tymofiyeva, Olga] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Max, Jeffrey E.] Rady Childrens Hosp San Diego, San Diego, CA USA		Max, JE (corresponding author), Univ Calif San Diego, Dept Psychiat, 5755 Oberlin Dr,Suite 301, San Diego, CA 92121 USA.	jmax@health.ucsd.edu	Paulsen, Jane/ABG-1815-2021		Big Blue Sky Foundation; National Institute of Child Health and DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R-01 HD088438]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH018399]; National Center for Complementary and Integrative Health [R21AT009173, R61AT009864]; National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI Grant [UL1TR001872]	This study was funded by a gift from Big Blue Sky Foundation. Drs. Max, Vaida, Wilde, and Hesselink receive support from the National Institute of Child Health and Development (R-01 HD088438). Dr. Troyer receives support through the National Institute of Mental Health (T32MH018399). Dr. Tymofiyeva and Dr. Yang receive support through the National Center for Complementary and Integrative Health (R21AT009173, R61AT009864), and the National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI Grant Number UL1TR001872.	American Psychiatric Association, 2000, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890423349; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Andreasen N.C., 1994, PSYCHAT EPIDEMIOLOGY, P349; ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; CHAMBERS WJ, 1985, ARCH GEN PSYCHIAT, V42, P696; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Eisenberg, 1987, NEUROBEHAVIORAL RECO, P215; ENGEL GL, 1979, GEN HOSP PSYCHIAT, V1, P156, DOI 10.1016/0163-8343(79)90062-8; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Guinn AS, 2019, INJURY PREV, V25, P514, DOI 10.1136/injuryprev-2018-042927; Hessen E, 2008, BRAIN INJURY, V22, P39, DOI 10.1080/02699050701846179; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Hoover H.D., 1986, MANUAL SCH ADM IOWA; Huang MX, 2020, J NEUROTRAUM, V37, P994, DOI 10.1089/neu.2019.6417; Jonsson CA, 2004, BRAIN INJURY, V18, P921, DOI 10.1080/02699050410001671900; Kendler KS, 2017, PSYCHOL MED, V47, P925, DOI 10.1017/S0033291716003032; Kessler RC, 2010, SLEEP, V33, P1539, DOI 10.1093/sleep/33.11.1539; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Last CG, 1996, J AM ACAD CHILD PSY, V35, P1502, DOI 10.1097/00004583-199611000-00019; LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Max J.E., 2021, J NEUROPSYCHIATRY CL; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 1998, J AM ACAD CHILD PSY, V37, P297, DOI 10.1097/00004583-199803000-00015; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; Max JE, 1997, NEUROCASE, V3, P119; Max JE, 1998, J NEUROPSYCH CLIN N, V10, P290, DOI 10.1176/jnp.10.3.290; Max JE, 1997, J NERV MENT DIS, V185, P394, DOI 10.1097/00005053-199706000-00006; Max JE, 2014, PSYCHIAT CLIN N AM, V37, P125, DOI 10.1016/j.psc.2013.11.003; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; Max JE, 2012, J AM ACAD CHILD PSY, V51, P1208, DOI 10.1016/j.jaac.2012.08.026; Merikangas Kathleen Ries, 2009, Dialogues Clin Neurosci, V11, P7; MILLER IW, 1994, FAM PROCESS, V33, P53, DOI 10.1111/j.1545-5300.1994.00053.x; Morissette MP, 2020, FAM MED COMMUNITY HE, V8, DOI 10.1136/fmch-2020-000390; Nybo T, 1999, BRAIN INJURY, V13, P759; ORVASCHEL H, 1982, J AM ACAD CHILD PSY, V21, P392, DOI 10.1016/S0002-7138(09)60944-4; Prinz R., 1987, ADV BEHAV ASSESSMENT, P57; Rosema S, 2014, J NEUROTRAUM, V31, P899, DOI 10.1089/neu.2013.3226; Ryan NP, 2019, J NEUROTRAUM, V36, P2895, DOI 10.1089/neu.2018.6308; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Ryan NP, 2013, INT J DEV NEUROSCI, V31, P811, DOI 10.1016/j.ijdevneu.2013.10.002; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; SPARROW SS, 1985, J PEDIATR PSYCHOL, V10, P215, DOI 10.1093/jpepsy/10.2.215; TEASDALE G, 1974, LANCET, V2, P81; Tuerk C, 2020, HUM BRAIN MAPP, V41, P561, DOI 10.1002/hbm.24822; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Zamani A, 2019, EXP NEUROL, V314, P34, DOI 10.1016/j.expneurol.2019.01.007	61	2	2	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2021	38	11					1515	1525		10.1089/neu.2020.7238		MAY 2021	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	SL0LA	WOS:000648009100001	33765846				2022-02-06	
J	Sun, YX; Wang, S; Gan, SQ; Niu, X; Yin, B; Bai, GH; Yang, XF; Jia, XY; Bai, LJ; Zhang, M				Sun, Yingxiang; Wang, Shan; Gan, Shuoqiu; Niu, Xuan; Yin, Bo; Bai, Guanghui; Yang, Xuefei; Jia, Xiaoyan; Bai, Lijun; Zhang, Ming			Serum Neuron-Specific Enolase Levels Associated with Connectivity Alterations in Anterior Default Mode Network after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cognitive function; graph theory; mild traumatic brain injury; serum biomarkers	WORKING-MEMORY; FUNCTIONAL CONNECTIVITY; INDEPENDENT COMPONENT; PREFRONTAL CORTEX; SALIENCE NETWORK; HEAD-INJURY; INFLAMMATION; FLUCTUATIONS; BIOMARKERS; DEFICITS	Mild traumatic brain injury (mTBI) is the most prevalent neurological insult and leads to long-lasting cognitive impairment. Neuroimaging studies have discovered abnormalities in brain network connectivity following mTBI as the underlying neural basis of cognitive deficits. However, the pathophysiologic mechanisms involved in imaging alterations remain elusive. Proteins neuron-specific enolase (NSE) and ubiquitin C terminal hydrolase 1 are reliable markers for neuronal cell-body damage, both of which have been demonstrated to be increased in serum following mTBI. Therefore, we conducted a longitudinal study to examine relationships between abnormal brain network connectivity and serum neuronal biomarkers and their associations with cognitive recovery following mTBI. Sixty patients were followed-up at 1 week and 3 months post-injury and 41 controls were recruited. Resting-state functional magnetic resonance imaging was used to build a functional connectivity matrix within large-scale intrinsic networks, and their topological properties were analyzed using graph theory measures. We found that, compared with controls, mTBI patients showed significant decreases in a number of nodal characteristics in default mode network (DMN), salience network, and executive network (p < 0.05, false discovery rate corrected) at 3 months post-injury. Linear regression analysis found elevated serum NSE in acute phase could predict lower efficiency and degree centrality of anterior DMN at 3 months post-injury. In addition, efficiency and degree centrality of anterior DMN were negatively associated with working memory. Our study showed neuronal injury was associated with alterations in brain network connectivity after mTBI. These findings can facilitate capability to predict the brain functional outcomes and cognitive recovery in mTBI.	[Sun, Yingxiang; Gan, Shuoqiu; Niu, Xuan; Zhang, Ming] Xi An Jiao Tong Univ, Dept Med Imaging, Affiliated Hosp 1, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China; [Wang, Shan; Gan, Shuoqiu; Yang, Xuefei; Jia, Xiaoyan; Bai, Lijun] Xi An Jiao Tong Univ, Dept Biomed Engn, 28,Xianning West Rd, Xian 710049, Shaanxi, Peoples R China; [Yin, Bo] Wenzhou Med Univ, Affiliated Hosp 2, Dept Neurosurg, Wenzhou, Peoples R China; [Bai, Guanghui] Wenzhou Med Univ, Affiliated Hosp 2, Dept Radiol, Wenzhou, Peoples R China; Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China		Zhang, M (corresponding author), Xi An Jiao Tong Univ, Dept Med Imaging, Affiliated Hosp 1, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China.; Bai, LJ (corresponding author), Xi An Jiao Tong Univ, Dept Biomed Engn, 28,Xianning West Rd, Xian 710049, Shaanxi, Peoples R China.	bailijun@xjtu.edu.cn; yingxian0320@foxmail.com	Niu, Xuan/AAD-7351-2022		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771914, 82071993, 82071879, 81871331]; Zhejiang Natural Science FoundationNatural Science Foundation of Zhejiang Province [LY15H090016]; Wenzhou Municipal Sci-Tech Bureau [Y20140577]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [xjj2018229, xzy022019045]	This work was supported by the National Natural Science Foundation of China (grant nos.81771914, 82071993, 82071879 and 81871331); Zhejiang Natural Science Foundation (grant nos. LY15H090016); Wenzhou Municipal Sci-Tech Bureau (grant no. Y20140577) and the Fundamental Research Funds for the Central Universities (grant nos. xjj2018229, xzy022019045).	Akamatsu Y, 2020, NEUROTHERAPEUTICS, V17, P446, DOI 10.1007/s13311-020-00840-7; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; ARNETT JA, 1995, PSYCHOL ASSESSMENT, V7, P220; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Chaves ML, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-6; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Harman-Smith YE, 2013, J CLIN EXP NEUROPSYC, V35, P785, DOI 10.1080/13803395.2013.824554; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Herculano-Houzel S, 2011, BRAIN BEHAV EVOLUT, V78, P22, DOI 10.1159/000327318; Hou WS, 2019, BRAIN CONNECT, V9, P475, DOI 10.1089/brain.2018.0629; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Jilka SR, 2014, J NEUROSCI, V34, P10798, DOI 10.1523/JNEUROSCI.0518-14.2014; Jolly AE, 2020, BRAIN, V143, P1158, DOI 10.1093/brain/awaa067; Kasahara M, 2011, BRAIN INJURY, V25, P1170, DOI 10.3109/02699052.2011.608210; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Lyoo IK, 2011, ARCH GEN PSYCHIAT, V68, P701, DOI 10.1001/archgenpsychiatry.2011.70; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Menon Vinod, 2010, Brain Struct Funct, V214, P655, DOI 10.1007/s00429-010-0262-0; Merzagora ACR, 2014, BRAIN IMAGING BEHAV, V8, P446, DOI 10.1007/s11682-013-9258-8; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Perlstein WM, 2003, NEUROSCI LETT, V342, P191, DOI 10.1016/S0304-3940(03)00226-X; Qin PM, 2011, NEUROIMAGE, V57, P1221, DOI 10.1016/j.neuroimage.2011.05.028; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Raichle ME, 2011, BRAIN CONNECT, V1, P3, DOI 10.1089/brain.2011.0019; Schrepf A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04648-0; Schroeter ML, 2015, J NEUROTRAUM, V32, P1380, DOI 10.1089/neu.2013.3163; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Stranjalis G, 2008, J TRAUMA, V65, P789, DOI 10.1097/TA.0b013e3181469e26; Sun YX, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01120; THOMPSON RJ, 1983, BRAIN RES, V278, P224, DOI 10.1016/0006-8993(83)90241-X; Thompson WH, 2016, NEUROIMAGE-CLIN, V12, P1004, DOI 10.1016/j.nicl.2016.05.005; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; von Wild KRH, 2008, ACT NEUR S, V101, P55; Wang JH, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3389/fnhum.2015.00386, 10.3389/fnhum.2015.00458]; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049	62	2	2	3	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2021	38	11					1495	1505		10.1089/neu.2020.7372		MAY 2021	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SL0LA	WOS:000647966500001	33687275				2022-02-06	
J	Ge, XT; Zhu, LY; Li, WZ; Sun, J; Chen, FL; Ping, L; Zhang, JN				Ge, Xintong; Zhu, Luoyun; Li, Wenzhu; Sun, Jian; Chen, Fanglian; Ping Lei; Zhang, Jianning			Red Cell Distribution Width to Platelet Count Ratio: A Promising Routinely Available Indicator of Mortality for Acute Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						platelet; prognostic model; red cell distribution width; traumatic brain injury		Prognosis evaluation is crucial for the effective management of patients with acute traumatic brain injury (TBI). However, there is still a lack of routinely available blood indicators for mortality risk in clinical practice. To investigate whether blood red cell distribution width to platelet count ratio (RPR) correlates with hospital mortality of TBI, clinical data of 2220 patients with TBI were extracted from two large intensive care unit cohorts (MIMIC-III and eICU Database), and were integratively analyzed using our developed method named MeDICS. We found that higher RPR can be observed among non-survivors than survivors of TBI (p < 0.001). It had a moderately good prognostic performance for mortality with an area under receiver-operating characteristic curve (AUC) of 0.7367, which was greater than that of Glasgow Coma Scale (GCS; AUC = 0.6022). Besides, the nomogram consisting of RPR, GCS, and other risk factors was developed, where 10-fold cross-validation was performed to protect it against overfitting. A Harrell's C-index of 0.8523 was determined, suggesting an improved prognostic value based on RPR. The in vivo experiments further confirmed the association between RPR and neuro-outcome after TBI. It indicated that the continuous change in RPR post-injury is attributed to the development of inflammation, which emphasized the importance of controlling inflammatory response in clinical treatment. Taken together, RPR is a promising routinely available predictor of mortality for acute TBI. The nomogram generated from it can be used in resource-limited settings, thus be proposed as a prognosis evaluation aid for patients with TBI in all levels of medical system.	[Ge, Xintong; Sun, Jian] Tianjin Med Univ Gen Hosp, Dept Neurosurg, 154 Anshan Rd, Tianjin 300052, Peoples R China; [Zhu, Luoyun] Tianjin Med Univ Gen Hosp, Dept Med Examinat, Tianjin, Peoples R China; [Li, Wenzhu; Ping Lei] Tianjin Med Univ Gen Hosp, Dept Geriatr, 154 Anshan Rd, Tianjin 300052, Peoples R China; [Ge, Xintong; Chen, Fanglian; Zhang, Jianning] Tianjin Neurol Inst, Key Lab Injuries Variat & Regenerat Nervous Syst, Tianjin, Peoples R China; [Ge, Xintong; Chen, Fanglian; Zhang, Jianning] Tianjin Neurol Inst, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin, Peoples R China; [Li, Wenzhu; Ping Lei] Tianjin Geriatr Inst, Lab Neurotrauma & Neurodegenerat Disorders, Tianjin, Peoples R China		Zhang, JN (corresponding author), Tianjin Med Univ Gen Hosp, Dept Neurosurg, 154 Anshan Rd, Tianjin 300052, Peoples R China.; Ping, L (corresponding author), Tianjin Med Univ Gen Hosp, Dept Geriatr, 154 Anshan Rd, Tianjin 300052, Peoples R China.	leiping1974@163.com; jnzhang@tmu.edu.cn	Ge, Xintong/X-4889-2019	Ge, Xintong/0000-0001-7153-952X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [82071394, 82072166, 81930031]; Natural Science Foundation of Tianjin Municipal Science and Technology Commission [18JCQNJC81100]	This research was supported by grants from National Natural Science Foundation of China (No. 82071394, 82072166, and 81930031) and Natural Science Foundation of Tianjin Municipal Science and Technology Commission (No. 18JCQNJC81100).	Assinger A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01687; Celik T, 2016, CARDIOL J, V23, P84, DOI 10.5603/CJ.a2015.0070; Cetinkaya E, 2014, WORLD J GASTROENTERO, V20, P14450, DOI 10.3748/wjg.v20.i39.14450; Czeiter E, 2020, EBIOMEDICINE, V56, DOI 10.1016/j.ebiom.2020.102785; Ding YY, 2019, SCAND J GASTROENTERO, V54, P81, DOI 10.1080/00365521.2018.1558786; Dolmans RGF, 2020, WORLD NEUROSURG, V136, pE60, DOI 10.1016/j.wneu.2019.10.086; Fletcher-Sandersjoo A, 2021, NEUROCRIT CARE, V34, P635, DOI 10.1007/s12028-020-01037-8; Frankel M, 2019, J NEUROTRAUM, V36, P2863, DOI 10.1089/neu.2018.5809; Ge XT, 2020, MOL THER, V28, P503, DOI 10.1016/j.ymthe.2019.11.017; Ge XT, 2018, J NEUROSCI METH, V308, P162, DOI 10.1016/j.jneumeth.2018.07.021; Ge XT, 2018, BRAIN RES, V1697, P10, DOI 10.1016/j.brainres.2018.06.008; Ge XT, 2019, J NEUROTRAUM, V36, P1291, DOI 10.1089/neu.2018.5728; Ge XT, 2016, BRAIN RES, V1650, P31, DOI 10.1016/j.brainres.2016.07.015; Ghaffari S, 2008, ANTIOXID REDOX SIGN, V10, P1923, DOI 10.1089/ars.2008.2142; Guo F, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.12.006; Huang S, 2018, FASEB J, V32, P512, DOI 10.1096/fj.201700673R; Leger M, 2013, NAT PROTOC, V8, P2531, DOI 10.1038/nprot.2013.155; Levi M, 2016, SEMIN THROMB HEMOST, V42, P252, DOI 10.1055/s-0035-1570080; Lippi Giuseppe, 2014, Clin Chem Lab Med, V52, pe197, DOI 10.1515/cclm-2014-0353; Lorente L, 2021, ACTA NEUROL BELG, V121, P715, DOI 10.1007/s13760-020-01409-z; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Murray GD, 2018, J NEUROSURG, V128, P1621, DOI 10.3171/2017.12.JNS172782; Qiu L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13151-3; Ripoche J, 2011, CLIN RES HEPATOL GAS, V35, P353, DOI 10.1016/j.clinre.2011.02.012; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Sadaka Farid, 2018, J Clin Med Res, V10, P9, DOI 10.14740/jocmr3173w; Salvagno GL, 2015, CRIT REV CL LAB SCI, V52, P86, DOI 10.3109/10408363.2014.992064; Shahim P, 2020, NEUROLOGY, V95, pE623, DOI 10.1212/WNL.0000000000009985; Shi KB, 2019, CELL MOL IMMUNOL, V16, P523, DOI 10.1038/s41423-019-0213-5; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Sun P, 2016, ONCOTARGET, V7, P42650, DOI 10.18632/oncotarget.9516; Taefi A, 2015, HEPATOL INT, V9, P454, DOI 10.1007/s12072-015-9638-9; Tekin YK, 2020, BRAZ J CARDIOV SURG, V35, P175, DOI 10.21470/1678-9741-2019-0348; Unden L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0533-y; Xie SY, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012342; Xu X, 2018, NEUROBIOL DIS, V117, P15, DOI 10.1016/j.nbd.2018.05.016; Yuan Q, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-017-0471-0; Zhang JN, 2018, BLOOD, V131, P2001, DOI 10.1182/blood-2017-11-784108; Zhang YL, 2017, NATURE, V548, P52, DOI 10.1038/nature23282	39	2	2	4	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2020.7481		MAY 2021	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RW8ZW	WOS:000646809700001	33719580				2022-02-06	
J	Jabbarli, R; He, SQ; Oppong, MD; Herten, A; Chihi, M; Pierscianek, D; Dammann, P; Sure, U; Wrede, KH				Jabbarli, Ramazan; He, Shi-Qing; Oppong, Marvin Darkwah; Herten, Annika; Chihi, Mehdi; Pierscianek, Daniela; Dammann, Philipp; Sure, Ulrich; Wrede, Karsten H.			Size does matter: The role of decompressive craniectomy extent for outcome after aneurysmal subarachnoid hemorrhage	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						decompressive craniectomy; intracranial aneurysm; outcome research; subarachnoid hemorrhage; surface		Background and purpose In previous studies in patients with traumatic brain injury and ischemic stroke, the size of decompressive craniectomy (DC) was reported to be paramount with regard to patient outcomes. We aimed to identify the impact of DC size on treatment results in individuals with aneurysmal subarachnoid hemorrhage (SAH). Methods The extent of DC in 232 patients with SAH who underwent bifrontal or hemicraniectomy between January 2003 and December 2015 was analyzed using semi-automated surface measurements. The study endpoints were course of intracranial pressure (ICP) treatment after DC, occurrence of cerebral infarcts, in-hospital mortality, and unfavorable outcome at 6 months (defined as modified Rankin scale score >3). The associations of DC size with the study endpoints were adjusted for DC timing, patient age, clinical and radiographic severity of SAH, aneurysm location, and treatment modality. Results The mean DC surface area was 100.9 (+/- 45.8) cm(2). In multivariate analysis, a large DC (>105 cm(2)) was independently associated with a lower risk of cerebral infarcts (adjusted odds ratio [aOR] 0.30, 95% confidence interval [CI] 0.16-0.56), in-hospital mortality (aOR 0.28, 95% CI 0.14-0.56) and unfavorable outcome (aOR 0.51, 95% CI 0.27-0.98). Moreover, SAH patients with a small DC size (<75 cm(2)) were more likely to require prolonged (>3 days, aOR 3.60, 95% CI 1.37-9.42) and enhanced (aOR 2.31, 95% CI 1.12-4.74) postoperative ICP treatment. Conclusion This is the first study showing the impact of DC size on postoperative ICP control and patient outcome in the context of SAH; specifically, a large craniectomy flap (>105 cm(2)) might lead to better outcomes in SAH patients requiring decompressive surgery.	[Jabbarli, Ramazan; He, Shi-Qing; Oppong, Marvin Darkwah; Herten, Annika; Chihi, Mehdi; Pierscianek, Daniela; Dammann, Philipp; Sure, Ulrich; Wrede, Karsten H.] Univ Hosp Essen, Dept Neurosurg & Spine Surg, D-45147 Essen, Germany; [He, Shi-Qing] Univ South China, Hengyang Med Coll, Affiliated Nanhua Hosp, Dept Neurosurg, Hengyang, Hunan, Peoples R China		Jabbarli, R (corresponding author), Univ Hosp Essen, Dept Neurosurg & Spine Surg, D-45147 Essen, Germany.	ramazan.jabbarli@uk-essen.de	Wrede, Karsten/AAZ-2154-2020; Oppong, Marvin Darkwah/AAP-7231-2020	Wrede, Karsten/0000-0001-7076-3503; Oppong, Marvin Darkwah/0000-0003-1021-5024; Jabbarli, Ramazan/0000-0002-8356-6629	China: Clinical Medical Research General Instruction Project of Hunan Provincial Health Commission [20201971]; Clinical Medical Technology Innovation Guiding Project of Hunan Province [2020SK51907]	Shi-Qing He was funded by the following research grants from China: Clinical Medical Research General Instruction Project of Hunan Provincial Health Commission (20201971), and Clinical Medical Technology Innovation Guiding Project of Hunan Province (2020SK51907).	Alotaibi NM, 2017, J NEUROSURG, V127, P1315, DOI 10.3171/2016.9.JNS161383; Buhler D, 2015, STROKE, V46, P819, DOI 10.1161/STROKEAHA.114.007703; Buschmann U, 2007, ACTA NEUROCHIR, V149, P59, DOI 10.1007/s00701-006-1069-x; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; D'Ambrosio AL, 2005, NEUROSURGERY, V56, P12, DOI 10.1227/01.NEU.0000144820.38439.63; Fisher C M, 1977, Neurosurgery, V1, P245; Hambock M, 2020, ACTA NEUROCHIR, V162, P745, DOI 10.1007/s00701-020-04243-7; Harris L, 2020, ACTA NEUROCHIR, V162, P2019, DOI 10.1007/s00701-020-04448-w; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Holsgrove DT, 2014, ACTA NEUROCHIR SUPPL, V119, P53, DOI 10.1007/978-3-319-02411-0_9; Jabbarli R., 2020, BRAIN COMMUN, V2; Jabbarli R, 2019, NEUROLOGY, V93, pE458, DOI 10.1212/WNL.0000000000007862; Jabbarli R, 2017, WORLD NEUROSURG, V98, P689, DOI 10.1016/j.wneu.2016.12.012; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Li G, 2008, CHIN J TRAUMATOL, V11, P253, DOI 10.1016/S1008-1275(08)60052-8; Miller K, 2016, WORLD NEUROSURG, V95, P441, DOI 10.1016/j.wneu.2016.08.061; Molyneux AJ, 2002, J NEURORADIOLOGY, V29, P74; Oppong MD, 2020, CLIN NEUROL NEUROSUR, V199, DOI 10.1016/j.clineuro.2020.106252; Oppong MD, 2019, J NEUROSURG, V131, P1473, DOI 10.3171/2018.7.JNS181119; Oppong MD, 2018, ACTA NEUROCHIR, V160, P1393, DOI 10.1007/s00701-018-3549-1; Otani N, 2008, CEREBROVASC DIS, V26, P612, DOI 10.1159/000165115; Rashidi A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228009; Reid P, 2018, WORLD NEUROSURG, V119, pE922, DOI 10.1016/j.wneu.2018.08.005; Sahuquillo J, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub3; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; Schur S, 2020, WORLD NEUROSURG, V137, pE430, DOI 10.1016/j.wneu.2020.01.232; Sedney CL, 2014, J NEUROSCI RURAL PRA, V5, P212, DOI 10.4103/0976-3147.133555; Smith ER, 2002, NEUROSURGERY, V51, P117, DOI 10.1097/00006123-200207000-00018; Steiner T, 2013, CEREBROVASC DIS, V35, P93, DOI 10.1159/000346087; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; Wirtz C R, 1997, Neurosurg Focus, V2, pE3	35	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	JUL	2021	28	7					2200	2207		10.1111/ene.14835		MAY 2021	8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SP5WQ	WOS:000646321600001	33760316	hybrid			2022-02-06	
J	Ristola, M; Fedele, C; Hagman, S; Sukki, L; Kapucu, FE; Mzezewa, R; Hyvarinen, T; Kallio, P; Priimagi, A; Narkilahti, S				Ristola, Mervi; Fedele, Chiara; Hagman, Sanna; Sukki, Lassi; Kapucu, Fikret Emre; Mzezewa, Ropafadzo; Hyvarinen, Tanja; Kallio, Pasi; Priimagi, Arri; Narkilahti, Susanna			Directional Growth of Human Neuronal Axons in a Microfluidic Device with Nanotopography on Azobenzene-Based Material	ADVANCED MATERIALS INTERFACES			English	Article						azobenzene; human pluripotent stem cells; light&#8208; responsive materials; microfluidics; surface relief gratings; topographic guidance		Axonal dysfunction and degeneration are important pathological features of central nervous system (CNS) diseases and traumas, such as Alzheimer's disease, traumatic brain injury, ischemic stroke and spinal cord injury. Engineered microfluidic chips combined with human pluripotent stem cell (hPSC)-derived neurons provide valuable tools for targeted in vitro research on axons to improve understanding of disease mechanisms and enhance drug development. Here, a polydimethylsiloxane (PDMS) microfluidic chip integrated with a light patterned substrate is utilized to achieve both isolated and unidirectional axonal growth of hPSC-derived neurons. The isolation of axons from somas and dendrites and robust axonal outgrowth to adjacent, axonal compartment, is achieved by optimized cross-sectional area and length of PDMS microtunnels in the microfluidic device. In the axonal compartment, the photoinscribed nanotopography on a thin film of azobenzene-containing molecular glass efficiently guides the growth of axons. Integration of nanotopographic patterns with a compartmentalized microfluidic chip creates a human neuron-based model that supports superior axonal alignment in an isolated microenvironment. The practical utility of the chip by studying oxygen-glucose deprivation-induced damage for the isolated and aligned axons is demonstrated here. The created chip model represents a sophisticated platform and a novel tool for enhanced and long-term axon-targeted in vitro studies.	[Ristola, Mervi; Hagman, Sanna; Kapucu, Fikret Emre; Mzezewa, Ropafadzo; Hyvarinen, Tanja; Narkilahti, Susanna] Tampere Univ, Fac Med & Hlth Technol, Neuro Grp, Arvo Ylpon Katu 34, Tampere 33520, Finland; [Fedele, Chiara; Priimagi, Arri] Tampere Univ, Smart Photon Mat Grp, Fac Engn & Nat Sci, Korkeakoulunkatu 10, Tampere 33720, Finland; [Sukki, Lassi; Kallio, Pasi] Tampere Univ, Micro & Nanosyst Res Grp, Fac Med & Hlth Technol, Korkeakoulunkatu 10, Tampere 33720, Finland		Narkilahti, S (corresponding author), Tampere Univ, Fac Med & Hlth Technol, Neuro Grp, Arvo Ylpon Katu 34, Tampere 33520, Finland.	susanna.narkilahti@tuni.fi	Fedele, Chiara/AAQ-7550-2021; Kallio, Pasi/G-4260-2014; Priimagi, Arri/E-7319-2012	Sukki, Lassi/0000-0001-9181-7355; Hyvarinen, Tanja/0000-0002-8723-8817; kapucu, emre/0000-0002-4557-6885; Kallio, Pasi/0000-0002-2890-6782; Priimagi, Arri/0000-0002-5945-9671; Hagman, Sanna/0000-0002-3950-7736; Narkilahti, Susanna/0000-0002-7602-4418	Academy of FinlandAcademy of FinlandEuropean Commission [296415, 312414, 312411, 332693, 330707]; Business Finland (Human Spare Parts project); Finnish Cultural FoundationFinnish Cultural FoundationFinnish IT center for science; Emil Aaltonen Foundation; Orion Research Foundation; Paivikki and Sakari Sohlberg Foundation; Orion foundation; Instrumentarium Science Foundation	The authors thank Arla Tanner and Anniina Brofeldt for assistance in the microtunnel dimension testing experiments, Marlitt Viehrig for assistance in the manufacturing of the microfluidic devices and Hanna Makela and Eija Hannuksela for technical assistance with cell maintenance. Prof. Eero Castren and the Neuronal Cell Culture Unit at the University of Helsinki are acknowledged for providing the primary rat cortical culture. The work was supported by the Imaging Facility and iPS Cells Facility (Faculty of Medicine and Health Technology, Tampere University). The authors also thank Biocenter Finland for the support of Imaging and iPS cells facilities. This work was supported by the Academy of Finland (grants 296415, MR; 312414, SN; 312411, PK; 332693, FEK; and 330707, SH), Business Finland (Human Spare Parts project, SN and PK), the Finnish Cultural Foundation (CF, SH). AP and CF also gratefully acknowledge Emil Aaltonen Foundation for financial support. F.E.K. also acknowledges Orion Research Foundation for financial support, S.H. for The Paivikki and Sakari Sohlberg Foundation, and R.M. for Orion foundation and Instrumentarium Science Foundation.	Aebersold M.J., 1982, TRAC-TREND ANAL CHEM, V78, P60; Avior Y, 2016, NAT REV MOL CELL BIO, V17, P170, DOI 10.1038/nrm.2015.27; Baac HW, 2004, MAT SCI ENG C-BIO S, V24, P209, DOI 10.1016/j.msec.2003.09.009; Barille R, 2011, COLLOID SURFACE B, V88, P63, DOI 10.1016/j.colsurfb.2011.06.005; Bennani OR, 2015, NEW J CHEM, V39, P9162, DOI 10.1039/c5nj01299f; Bigler RL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00676-w; Campenot RB, 1996, J CELL BIOL, V135, P701, DOI 10.1083/jcb.135.3.701; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; Cartoni R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184672; Chan LY, 2013, BIOMATERIALS, V34, P382, DOI 10.1016/j.biomaterials.2012.09.033; Chang VY, 2019, ADV OPT MATER, V7, DOI 10.1002/adom.201900091; Clemons TD, 2018, RSC ADV, V8, P9661, DOI 10.1039/c7ra12693j; Czaniecki C, 2019, P NATL ACAD SCI USA, V116, P14280, DOI 10.1073/pnas.1900576116; Denton KR, 2016, METHODS MOL BIOL, V1353, P309, DOI 10.1007/7651_2014_167; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Dworak BJ, 2009, LAB CHIP, V9, P404, DOI 10.1039/b806689b; Egawa N, 2017, TRANSL STROKE RES, V8, P14, DOI 10.1007/s12975-016-0495-1; Farkhondeh A, 2019, DRUG DISCOV TODAY, V24, P992, DOI 10.1016/j.drudis.2019.01.007; Fedele C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71567-w; Fonck E, 2009, STROKE, V40, P2552, DOI 10.1161/STROKEAHA.108.528091; Habibey R, 2015, LAB CHIP, V15, P4578, DOI 10.1039/c5lc01027f; Halldorsson S, 2015, BIOSENS BIOELECTRON, V63, P218, DOI 10.1016/j.bios.2014.07.029; Hemmila S, 2012, APPL SURF SCI, V258, P9864, DOI 10.1016/j.apsusc.2012.06.044; Hongisto H, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0738-4; Hyvarinen T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53647-8; Hyvarinen T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53414-9; Jiang XL, 1998, APPL PHYS LETT, V72, P2502, DOI 10.1063/1.121400; Juntunen M, 2020, STEM CELLS INT, V2020, DOI 10.1155/2020/8841026; Kamande JW, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00084; Kiamehr M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153773; Kirby R, 2014, J MATER CHEM C, V2, P841, DOI 10.1039/c3tc32034k; Lappalainen RS, 2010, REGEN MED, V5, P749, DOI 10.2217/RME.10.58; Lee N, 2014, MOL CELLS, V37, P497, DOI 10.14348/molcells.2014.0137; Lesniak A, 2019, SMALL, V15, DOI 10.1002/smll.201803758; Letournel F., 2018, OPEN BIOMED ENG J, V12, P92, DOI DOI 10.2174/1874120701812010092; Lu X, 2012, J NEUROSCI METH, V209, P35, DOI 10.1016/j.jneumeth.2012.05.021; MacInnis BL, 2002, SCIENCE, V295, P1536, DOI 10.1126/science.1064913; Mertens J, 2016, NAT REV NEUROSCI, V17, P424, DOI 10.1038/nrn.2016.46; Narula U, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176868; Neto E, 2016, J NEUROSCI, V36, P11573, DOI 10.1523/JNEUROSCI.1748-16.2016; Park J, 2014, J NEUROSCI METH, V221, P166, DOI 10.1016/j.jneumeth.2013.09.018; Park J, 2009, BIOMED MICRODEVICES, V11, P1145, DOI 10.1007/s10544-009-9331-7; Park JW, 2006, NAT PROTOC, V1, P2128, DOI 10.1038/nprot.2006.316; Pelkonen A, 2020, BIOSENS BIOELECTRON, V168, DOI 10.1016/j.bios.2020.112553; Peyrin JM, 2011, LAB CHIP, V11, P3663, DOI 10.1039/c1lc20014c; Puspoki Z, 2016, ADV ANAT EMBRYOL CEL, V219, P69, DOI 10.1007/978-3-319-28549-8_3; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; Rianna C, 2016, ADV FUNCT MATER, V26, P7572, DOI 10.1002/adfm.201602577; Ristola M, 2019, J MICROMECH MICROENG, V29, DOI 10.1088/1361-6439/ab16a7; ROCHON P, 1995, APPL PHYS LETT, V66, P136, DOI 10.1063/1.113541; Sahu Madhusmita Priyadarshini, 2019, Neuronal Signal, V3, pNS20180207, DOI 10.1042/NS20180207; Salvadores N, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00451; Sandoe J, 2013, NAT NEUROSCI, V16, P780, DOI 10.1038/nn.3425; Siddique R, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0676; Simitzi C, 2017, ACTA BIOMATER, V51, P21, DOI 10.1016/j.actbio.2017.01.023; Skottman H, 2010, IN VITRO CELL DEV-AN, V46, P206, DOI 10.1007/s11626-010-9286-2; Sleigh JN, 2019, NAT REV NEUROL, V15, P691, DOI 10.1038/s41582-019-0257-2; Song LQ, 2016, COLLOID SURFACE B, V148, P49, DOI 10.1016/j.colsurfb.2016.08.041; Sundaramoorthy V, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008343; Tan KKB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27653-1; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor AM, 2003, LANGMUIR, V19, P1551, DOI 10.1021/la026417v; Taylor AM, 2010, NEURON, V66, P57, DOI 10.1016/j.neuron.2010.03.022; Toivanen M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00606; Vapaavuori J, 2015, J MATER CHEM C, V3, P11011, DOI 10.1039/c5tc01776a; Wu HI, 2010, LAB CHIP, V10, P647, DOI 10.1039/b918217a	66	2	2	16	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2196-7350			ADV MATER INTERFACES	Adv. Mater. Interfaces	JUN	2021	8	11							2100048	10.1002/admi.202100048		MAY 2021	14	Chemistry, Multidisciplinary; Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Materials Science	SP6MF	WOS:000646173800001		hybrid			2022-02-06	
J	Algahtany, M; McFaull, S; Chen, L; Zhang, SD; Saarela, O; Alqahtani, F; Cusimano, MD				Algahtany, Mubarak; McFaull, Steven; Chen, Ling; Zhang, Shudong; Saarela, Olli; Alqahtani, Feras; Cusimano, Michael D.			The Changing Etiology and Epidemiology of Traumatic Spinal Injury: A Population-Based Study	WORLD NEUROSURGERY			English	Article						Elderly; Epidemiology; Falls; Incidence; Injury prevention; Ontario; Spinal cord injury; Traumatic brain injury; Traumatic spinal injury	CORD-INJURY; UNITED-STATES; PREVALENCE; FRACTURES; TRENDS; INFRASTRUCTURE; ONTARIO; CANADA; ADULTS; BRAIN	-OBJECTIVE: No previous large population-based studies of traumatic spinal injury (TSI) rates, trends, and patterns exist. We aimed to fill this knowledge gap on TSI epidemiology using a population-based study of 13 million people. -METHODS: This is a descriptive cross-sectional cohort study that analyzes a national, mandatory reporting database for all emergency departments and ambulatory care centers in Ontario over 15 years. Demographics of TSI, trends in the TSI rate, etiology, transfer, disposition, comorbidities, and associated traumatic brain injury or spinal cord injury were analyzed. -RESULTS: There were 167,357 TSI-related emergency department visits resulting in 70,684 hospitalizations and 376 deaths. The overall rate of TSI significantly increased from 66.94 to 118.61 per 100,000. Female patients had greater rates of TSI. Older patients had greater rates of TSI, especially related to falls. Fall was found to be the commonest mechanism of TSI, whereas motor vehicle collisions scaled down to the third commonest mechanism of TSI. Sport-related TSI had the greatest percentage of increase in the rate over all mechanisms (221%, P < 0.001). TSI with associated traumatic brain injury comprised 6% of the cohort but had the greatest percentage increase (91%) in the rate compared to all other TSI forms. -CONCLUSIONS: The rate of TSI continues to rise in Ontario as the population ages. The rise is primarily attributed to a shift in the epidemiology and etiology of TSI from a younger male population toward an older female population, with falls as the primary injury mechanism. Establishing preventive measures to address this shift is essential.	[Algahtany, Mubarak] King Khalid Univ, Div Neurosurg, Dept Surg, Abha, Saudi Arabia; [Algahtany, Mubarak; Alqahtani, Feras] King Khalid Univ, Coll Med, Abha, Saudi Arabia; [Algahtany, Mubarak; Chen, Ling; Zhang, Shudong; Cusimano, Michael D.] St Michaels Hosp, Div Neurosurg, Dept Surg, Toronto, ON, Canada; [Algahtany, Mubarak; Chen, Ling; Zhang, Shudong; Cusimano, Michael D.] Keenan Res Ctr, Li KaShing Knowledge Inst, Injury Prevent Res Off, Toronto, ON, Canada; [McFaull, Steven] Publ Hlth Agcy Canada, Injury Sect, Hlth Surveillance & Epidemiol Div, Ottawa, ON, Canada; [Saarela, Olli; Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada		Algahtany, M (corresponding author), King Khalid Univ, Div Neurosurg, Dept Surg, Abha, Saudi Arabia.; Algahtany, M (corresponding author), King Khalid Univ, Coll Med, Abha, Saudi Arabia.; Algahtany, M (corresponding author), St Michaels Hosp, Div Neurosurg, Dept Surg, Toronto, ON, Canada.; Algahtany, M (corresponding author), Keenan Res Ctr, Li KaShing Knowledge Inst, Injury Prevent Res Off, Toronto, ON, Canada.	mbalgahtany@kku.edu.sa					Barbara-Bataller E, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0491-4; Brau RH, 2018, P R HEALTH SCI J, V37, P67; Brubacher JR, 2014, AM J PUBLIC HEALTH, V104, pE89, DOI 10.2105/AJPH.2014.302068; Couris CM, 2010, SPINAL CORD, V48, P39, DOI 10.1038/sc.2009.77; DeVivo MJ, 2012, SPINAL CORD, V50, P365, DOI 10.1038/sc.2011.178; Dryden DM, 2003, CAN J NEUROL SCI, V30, P113, DOI 10.1017/S0317167100053373; Fu TS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145469; Fu WW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175868; Furlan JC, 2013, CAN J NEUROL SCI, V40, P456, DOI 10.1017/S0317167100014530; Hagen EM, 2009, SPINAL CORD, V47, P367, DOI 10.1038/sc.2008.118; Harris MA, 2013, INJURY PREV, V19, P303, DOI 10.1136/injuryprev-2012-040561; Hu R, 1996, SPINE, V21, P492, DOI 10.1097/00007632-199602150-00016; Jain NB, 2015, JAMA-J AM MED ASSOC, V313, P2236, DOI 10.1001/jama.2015.6250; Jawa RS, 2017, J AM GERIATR SOC, V65, P909, DOI 10.1111/jgs.14669; Katsuura Y, 2016, J ORTHOP, V13, P383, DOI 10.1016/j.jor.2016.06.019; Kattail D, 2009, J TRAUMA, V67, P936, DOI 10.1097/TA.0b013e3181a8b431; Krueger H, 2013, CHRON DIS INJ CAN, V33, P113; Kumar R, 2018, WORLD NEUROSURG, V113, pE345, DOI 10.1016/j.wneu.2018.02.033; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Lefio A, 2018, REV PANAM SALUD PUBL, V42, DOI [10.26633/RPSP.2018.60, 10.26633/rpsp.2018.60]; Lenehan B, 2012, SPINE, V37, P321, DOI 10.1097/BRS.0b013e31822e5ff8; Leucht P, 2009, INJURY, V40, P166, DOI 10.1016/j.injury.2008.06.040; Liu P, 2012, SPINE, V37, P1310, DOI 10.1097/BRS.0b013e3182474d8b; Majdan M, 2016, EUR SPINE J, V25, P62, DOI 10.1007/s00586-015-3985-z; Munce SEP, 2013, SPINAL CORD, V51, P64, DOI 10.1038/sc.2012.81; Niemi-Nikkola V, 2018, SPINE, V43, pE45, DOI 10.1097/BRS.0000000000002214; Noonan VK, 2012, NEUROEPIDEMIOLOGY, V38, P219, DOI 10.1159/000336014; Passias PG, 2018, WORLD NEUROSURG, V110, pE427, DOI 10.1016/j.wneu.2017.11.011; Pickett GE, 2006, SPINE, V31, P799, DOI 10.1097/01.brs.0000207258.80129.03; Pickett W, 2003, J TRAUMA, V55, P1070, DOI 10.1097/01.TA.0000034228.18541.D1; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rahimi-Movaghar V, 2013, NEUROEPIDEMIOLOGY, V41, P65, DOI 10.1159/000350710; Robertson A, 2002, SPINE, V27, P2825, DOI 10.1097/00007632-200212150-00019; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Smith E, 2018, NEUROEPIDEMIOLOGY, V51, P19, DOI 10.1159/000488146; Staton C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144971; Tafida MA, 2018, J ORTHOP SCI, V23, P273, DOI 10.1016/j.jos.2017.10.013; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tee JW, 2013, GLOB SPINE J, V3, P75, DOI 10.1055/s-0033-1337124; Teschke K, 2012, AM J PUBLIC HEALTH, V102, P2336, DOI 10.2105/AJPH.2012.300762; Tricco AC, 2017, JAMA-J AM MED ASSOC, V318, P1687, DOI 10.1001/jama.2017.15006; Van Den Berg M, 2011, J NEUROTRAUM, V28, P469, DOI 10.1089/neu.2010.1608; Wang HW, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005220; Yang NP, 2008, INJURY, V39, P443, DOI 10.1016/j.injury.2007.12.007	44	2	2	3	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2021	149						E116	E127		10.1016/j.wneu.2021.02.066			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	RU9LH	WOS:000645460900015	33631390				2022-02-06	
J	Bedard, G; Lawrence, DW				Bedard, Gillian; Lawrence, David Wyndham			Does Concussion Affect Perception-Action Coupling Behavior? Action Boundary Perception as a Biomarker for Concussion	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; action boundary; perception	VISUAL GUIDANCE; INJURY; CALIBRATION; RISK; PLAY	Background: After a concussion, athletes may be at increased risk of musculoskeletal injuries. Altered perception of action boundaries (ABP), or the limits of one's action capabilities, is one possible mechanism for this increase in injury risk after concussion. Objective: To evaluate differences in symptoms, neurocognitive, vestibular/oculomotor, and action boundary function between subjects with no concussion history (NoHx) and concussion history (ConcHX). Design: Cross-sectional study. Setting: Laboratory at the University of Pittsburgh. Participants: ConcHx (n = 22; age: 21.8 +/- 3.0 years, height: 174.0 +/- 8.3 cm, and mass: 77.8 +/- 14.8 kg) and NoHx athletes (n = 24; age: 21.6 +/- 2.0 years, height: 176.0 +/- 10.0 cm, and mass: 72.0 +/- 15.3 kg). Intervention: Immediate Postconcussion Assessment and Cognitive Testing (ImPACT) and Post-Concussion Symptom Scale (PCSS), Vestibular-Ocular Motor Screening (VOMS) tool, and the Perception-Action Coupling Task (PACT). The PACT measures the accuracy of ABP. Main Outcome Measures: Neurocognitive domain scores, PCSS, VOMS subdomain symptom gain, ABP accuracy, and actualization. Results: ConcHx reported 2.7 +/- 1.5 previous concussions occurring on average 263.8 +/- 228.9 days prior. ConcHx was higher on several VOMS items including vertical/horizontal saccades (P = 0.001; P = 0.05), vertical/horizontal vestibular-ocular reflex (P < 0.001; P = 0.04), and visual motion sensitivity (P < 0.001). Average PACT movement time (P = 0.01) and reaction time (P = 0.01) were longer in ConcHx. Conclusions: These findings provide preliminary support for impaired vestibular/oculomotor function and ABP in ConcHx compared with NoHx. The current results may enhance our understanding of the mechanisms for increased musculoskeletal injury risk after concussion.	[Bedard, Gillian; Lawrence, David Wyndham] Univ Toronto, Fac Med, Toronto, ON, Canada; [Lawrence, David Wyndham] Univ Hlth Network UHN, Toronto Rehabil Inst, Toronto, ON, Canada		Lawrence, DW (corresponding author), Univ Toronto, Fac Kinesiol & Phys Educ, David L Maclntosh Sport Med Clin, 100 Devonshire Pl,4th Floor, Toronto, ON M5S 2C9, Canada.	dw.lawrence@mail.utoronto.ca					Baker CS, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12252; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Connaboy C, 2019, AEROSP MED HUM PERF, V90, P77, DOI 10.3357/AMHP.5190.2019; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Craig CM, 2006, NATURWISSENSCHAFTEN, V93, P97, DOI 10.1007/s00114-005-0071-0; Daviaux Y, 2016, NEUROSCIENCE, V339, P32, DOI 10.1016/j.neuroscience.2016.09.033; Daviaux Y, 2016, PSYCHOL RES-PSYCH FO, V80, P224, DOI 10.1007/s00426-015-0653-1; Daviaux Y, 2014, EXP BRAIN RES, V232, P2243, DOI 10.1007/s00221-014-3915-z; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Fajen BR, 2005, PERCEPTION, V34, P717, DOI 10.1068/p5405; Fernandez-Ruiz J, 2000, COGNITIVE BRAIN RES, V9, P223, DOI 10.1016/S0926-6410(99)00057-9; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gibson J. J., 1979, ECOLOGICAL APPROACH; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; Herman DC., 2016, SPORTS MED, V44, P742; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Le Runigo C, 2005, HUM MOVEMENT SCI, V24, P429, DOI 10.1016/j.humov.2005.06.008; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Mark LS, 1997, J EXP PSYCHOL HUMAN, V23, P1365, DOI 10.1037/0096-1523.23.5.1365; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Michelet T, 2010, J NEUROPHYSIOL, V104, P119, DOI 10.1152/jn.00819.2009; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Pijpers JR, 2007, J SPORT SCI, V25, P97, DOI 10.1080/02640410600630894; Powers KC, 2014, BRAIN INJURY, V28, P465, DOI 10.3109/02699052.2014.888759; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Smith J, 2010, ECOL PSYCHOL, V22, P119, DOI 10.1080/10407411003720080; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; van Andel S, 2017, HUM MOVEMENT SCI, V51, P59, DOI 10.1016/j.humov.2016.11.004; WARREN WH, 1984, J EXP PSYCHOL HUMAN, V10, P683, DOI 10.1037/0096-1523.10.5.683; Witt JK, 2016, J APPL RES MEM COGN, V5, P69, DOI 10.1016/j.jarmac.2015.07.008; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	34	2	2	2	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2021	31	3					289	294		10.1097/JSM.0000000000000741			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	SO2PJ	WOS:000658818900015	33882544				2022-02-06	
J	Bruce, JM; Thelen, J; Meeuwisse, W; Hutchison, MG; Rizos, J; Comper, P; Echemendia, RJ				Bruce, Jared M.; Thelen, Joanie; Meeuwisse, Willem; Hutchison, Michael G.; Rizos, John; Comper, Paul; Echemendia, Ruben J.			Use of the Sport Concussion Assessment Tool 5 (SCAT5) in professional hockey, part 2: which components differentiate concussed and non-concussed players?	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							HISTORY; DIAGNOSIS	Objectives To examine the utility of Sport Concussion Assessment Tool (SCAT5) subcomponents in differentiating physician diagnosed concussed players from controls. Methods We evaluated 1924 professional hockey players at training camp using the National Hockey League (NHL) Modified SCAT5 prior to the 2018-2019 season. Over the course of the season, 314 English-speaking players received SCAT5 evaluations within 1 day of a suspected concussive event. Of these players, 140 (45%) were subsequently diagnosed with concussion by their team physicians. Results Concussed players reported more symptoms (Concussed M=8.52, SD=4.78; Control M=3.32, SD=3.97), and recalled fewer words than Controls on both the Immediate Memory (Concussed M=19.34, SD=4.06; Control M=21.53, SD=2.94) and Delayed Recall (Concussed z=-0.91; Control z=-0.09) tasks during the acute evaluation. Concussed players also made more errors than Controls on the mBESS and were more likely to report double vision and exhibit clinician-observed balance problems than controls. There were no between-group differences on the Concentration component of the SCAT5. Stepwise regression revealed that symptom report and list learning tasks both accounted for independent variance in identifying players diagnosed with concussion. Conclusions These findings provide support for use of the SCAT5 to assist in identifying concussed professional hockey players. When examining SCAT5 subtests, both symptom report and the 10-item word list accounted for independent variance in identifying concussion status in this sample of professional hockey players. The mBESS also differentiated Concussed players and Controls. The Concentration component of the SCAT5 did not significantly differentiate Concussed players and Controls.	[Bruce, Jared M.] Univ Missouri, Dept Biomed & Hlth Informat, Kansas City Sch Med, Kansas City, MO USA; [Thelen, Joanie] Natl Hockey League, New York, NY USA; [Thelen, Joanie] Univ Missouri, Kansas City, MO 64110 USA; [Meeuwisse, Willem] Natl Hockey League, Calgary, AB, Canada; [Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Rizos, John] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Comper, Paul] Univ Hlth Network, Dept Family & Community Med, Toronto, ON, Canada; [Echemendia, Ruben J.] Univ Orthoped Ctr, Concuss Care Clin, State Coll, PA USA; [Echemendia, Ruben J.] Univ Missouri, Dept Psychol, Kansas City, MO USA		Echemendia, RJ (corresponding author), UOC Concuss Care Clin, State Coll, PA 16801 USA.	rechemendia@comcast.net		Echemendia, Ruben/0000-0001-6116-8462; Thelen, Joan/0000-0003-1802-9111	NFL (NFL-Long) through Boston Children's Hospital; GenzymeSanofi-AventisGenzyme Corporation	RJE is a paid consultant for the NHL and co-\-chair of the NHL/NHLPA Concussion Subcommittee. He is also a paid consultant for Major League Soccer and Princeton University Athletic Medicine. He has a financial interest in EyeGuide and is chair of their Scientific Advisory Board and is currently a co-PI for a grant funded by the NFL (NFL-Long) through Boston Children's Hospital and occasionally provides expert testimony in matters related to MTBI and sports concussion. JT is a part-time employee of the NHL. WM is Medical Director for the NHL and an employee of the NHL. MGH is a member of the NHL/NHLPA Concussion Subcommittee and a consultant to the NHLPA, for which he receives remuneration. JR is a member of the NHL/NHLPA Concussion Subcommittee and a paid medical/physician consultant to the NHLPA. PC is co-chair of the NHL/NHLPA Concussion Subcommittee and a paid consultant to the NHLPA. JMB is a part-time employee of the NHL. He receives grant funding from Genzyme and is a consultant to Med-IQ and Sporting KC.	Asken BM, 2020, ARCH CLIN NEUROPSYCH, V35, P291, DOI 10.1093/arclin/acz007; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Bailey CM, 2014, OXFORD HDB SPORTS RE; Bruce JM, 2004, NEUROLOGY, V63, P1516; Davis GA, 2019, BRIT J SPORT MED, V53, P1299, DOI 10.1136/bjsports-2018-099727; Downey RI, 2018, BRAIN INJURY, V32, P1345, DOI 10.1080/02699052.2018.1484166; Echemendia R, BJSM; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Echemendia RJ, 2018, BRIT J SPORT MED, V52, P1149, DOI 10.1136/bjsports-2016-097090; Ellis M, 2018, J NEUROSURG-PEDIATR, V21, P401, DOI 10.3171/2017.9.PEDS17392; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Hurtubise JM, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2017-000312; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; Norheim N, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000412; Piland SG, 2010, J ATHL TRAINING, V45, P273, DOI 10.4085/1062-6050-45.3.273; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Register-Mihalik JK, 2009, SPORTS HEALTH, V1, P61, DOI 10.1177/1941738108325920; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Snegireva N, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aaef44; Spielberger CD, 1985, SO PSYCHOL, V2, P6	27	2	2	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	MAY	2021	55	10					557	565		10.1136/bjsports-2020-102072			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	SB9TI	WOS:000650327000014	32847812	Bronze			2022-02-06	
J	Chuck, CC; Martin, TJ; Kalagara, R; Shaaya, E; Kheirbek, T; Cielo, D				Chuck, Carlin C.; Martin, Thomas J.; Kalagara, Roshini; Shaaya, Elias; Kheirbek, Tareq; Cielo, Deus			Emergency medical services protocols for traumatic brain injury in the United States: A call for standardization	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury; Prehospital care; Emergency medical services; Hyperventilation; Protocol development; Tranexamic acid	RAPID-SEQUENCE INTUBATION; TIDAL CARBON-DIOXIDE; PREHOSPITAL MANAGEMENT; HEAD-INJURY; HYPERVENTILATION; HYPOTENSION; ARTERIAL; GUIDELINES; PRESSURE; HYPOXIA	Background: Traumatic brain injury (TBI) with acute elevation in intracranial pressure (ICP) is a neurologic emergency associated with significant morbidity and mortality. In addition to indicated trauma resuscitation, emergency department (ED) management includes empiric administration of hyperosmolar agents, rapid diagnostic imaging, anticoagulation reversal, and early neurosurgical consultation. Despite optimization of in-hospital care, patient outcomes may be worsened by variation in prehospital management. In this study, we evaluate geographic variation between emergency medical services (EMS) protocols for patients with suspected TBI. Methods: We performed a cross-sectional analysis of statewide EMS protocols in the United States in December 2020 and included all complete protocols published on government websites. Outcome measures were defined to include protocols or orders for the following interventions, given TBI: (1) hyperventilation and end-tidal capnography (EtCO2) goals, (2) administration of hyperosmolar agents, (3) tranexamic acid (TXA) administration for isolated head injury, (4) non-invasive management including head-of-bed elevation, and (5) hemodynamic goals. Results: We identified 32 statewide protocols including Washington, D.C., 4 of which did not include specific guidance for TBI. Of 28 states providing ventilatory guidance, 22/28 (78.6%) recommend hyperventilation, with 17/22 (77.3%) restricting hyperventilation to signs of acute herniation. The remaining 6 states prohibited hyperventilation. Regarding EtCO2 goals among states permitting hyperventilation, 17/22 (77.3%) targeted an EtCO2 of < 35 mmHg, while 5/22 (22.7%) provided no guide EtCO2 for hyperventilation. Rhode Island was the only state identified that included hypertonic saline (3%), and Delaware was the only state that allowed TXA in the setting of isolated TBI with GCS <= 12. Only 15/32 (46.9%) identified states recommend head-of-bed elevation. For blood pressure goals, 12/28 (42.9%) of states set minimum systolic blood pressure at 90 mmHg, while 10/28 (35.7%) set other SBP goals. The remaining 6/28 (21.4%) did not provide TBI-specific SBP goals. Conclusions: There is wide variation among civilian prehospital protocols for traumatic brain injury. Pre hospital care within the first "golden hour" may dramatically affect patient outcomes. Neurocritical care providers should be mindful of geographic variation in local protocols when designing and evaluating quality improvement interventions and should aim to standardize prehospital care protocols. (c) 2021 Elsevier Ltd. All rights reserved.	[Chuck, Carlin C.; Martin, Thomas J.] Brown Univ, Warren Alpert Med Sch, 222 Richmond St,Box G-9313, Providence, RI 02912 USA; [Kalagara, Roshini] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Kheirbek, Tareq] Brown Univ, Dept Surg, Warren Alpert Med Sch, Providence, RI 02912 USA; [Shaaya, Elias; Cielo, Deus] Brown Univ, Dept Neurosurg, Warren Alpert Med Sch, Providence, RI 02912 USA		Chuck, CC (corresponding author), Brown Univ, Warren Alpert Med Sch, 222 Richmond St,Box G-9313, Providence, RI 02912 USA.	carlin_chuck@brown.edu	Martin, Thomas Joseph/ABC-6485-2021; Kheirbek, Tareq/AAL-6616-2020; Shaaya, Elias/ABA-4907-2021	Martin, Thomas Joseph/0000-0002-6194-2830; Kheirbek, Tareq/0000-0002-6758-9150; Chuck, Carlin/0000-0001-5735-2654; Kalagara, Roshini/0000-0002-2607-0408			Alarcon JD, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009986.pub2; Alnemari AM, 2017, WORLD NEUROSURG, V106, P509, DOI 10.1016/j.wneu.2017.07.009; Belpomme V, 2005, AM J EMERG MED, V23, P852, DOI 10.1016/j.ajem.2005.04.011; Berlot G, 2009, EUR J EMERG MED, V16, P312, DOI 10.1097/MEJ.0b013e32832d3aa1; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; Bossers SM, 2021, JAMA NEUROL, V78, P338, DOI 10.1001/jamaneurol.2020.4596; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Chuck C, 2020, J COLL EMERG MED SER, V3, P22, DOI [10.30542/JCEMS.2020.03.01.06, DOI 10.30542/JCEMS.2020.03.01.06]; Davis CS, 2014, ACAD EMERG MED, V21, P1173, DOI 10.1111/acem.12485; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Dumont TM, 2010, J NEUROTRAUM, V27, P1233, DOI 10.1089/neu.2009.1216; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Godoy DA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00250; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Hoogmartens O, 2014, PREHOSP EMERG CARE, V18, P265, DOI 10.3109/10903127.2013.856506; Kupas DF, 2015, PREHOSP EMERG CARE, V19, P292, DOI 10.3109/10903127.2014.964891; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; NASEMSO.org Model EMS, 2021, CLIN GUID, P1145; Pandrich MJ, 2020, NEUROSURG REV, V43, P69, DOI 10.1007/s10143-018-0988-3; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Rostykus P, 2016, PREHOSP EMERG CARE, V20, P524, DOI 10.3109/10903127.2015.1128031; Rowell SE, 2020, JAMA-J AM MED ASSOC, V324, P961, DOI 10.1001/jama.2020.8958; RUSSELL GB, 1994, J TRAUMA, V36, P317, DOI 10.1097/00005373-199403000-00006; RUSSELL GB, 1992, J NEUROSURG ANESTH, V4, P245, DOI 10.1097/00008506-199210000-00003; Schierhout G, 2000, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD000566, 10.1002/14651858. CD000566]; Spaite DW, 2019, JAMA SURG, V154, DOI 10.1001/jamasurg.2019.1152; Spaite DW, 2017, ANN EMERG MED, V70, P522, DOI 10.1016/j.annemergmed.2017.03.027; Spaite DW, 2014, ACAD EMERG MED, V21, P818, DOI 10.1111/acem.12411; Stiver SI, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E5; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; Thomas SH, 2002, J TRAUMA, V52, P47, DOI 10.1097/00005373-200201000-00010	35	2	2	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2021	52	5					1145	1150		10.1016/j.injury.2021.01.008			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	RX4BJ	WOS:000647170200008	33487407				2022-02-06	
J	Cone, JT; Benjamin, ER; Alfson, DB; Demetriades, D				Cone, Jennifer T.; Benjamin, Elizabeth R.; Alfson, Daniel B.; Demetriades, Demetrios			Isolated severe blunt traumatic brain injury: effect of obesity on outcomes	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; blunt trauma; body mass index; obesity; TQIP; Trauma Quality Improvement Program	BODY-MASS-INDEX; RISK-FACTORS; VENOUS THROMBOEMBOLISM; CARDIOVASCULAR RISK; MORBID-OBESITY; MORTALITY; PARADOX; IMPACT; COMPLICATIONS; LONG	OBJECTIVE Obesity has been widely reported to confer significant morbidity and mortality in both medical and surgical patients. However, contemporary data indicate that obesity may confer protection after both critical illness and certain types of major surgery. The authors hypothesized that this "obesity paradox" may apply to patients with isolated severe blunt traumatic brain injuries (TBIs). METHODS The Trauma Quality Improvement Program (TQIP) database was queried for patients with isolated severe blunt TBI (head Abbreviated Injury Scale [AIS] score 3-5, all other body areas AIS < 3). Patient data were divided based on WHO classification levels for BMI: underweight (< 18.5 kg/m(2)), normal weight (18.5-24.9 kg/m(2)), overweight (25.0-29.9 kg/m(2)), obesity class 1 (30.0-34.9 kg/m(2)), obesity class 2 (35.0-39.9 kg/m(2)), and obesity class 3 (>= 40.0 kg/m2). The role of BMI in patient outcomes was assessed using regression models. RESULTS In total, 103,280 patients were identified with isolated severe blunt TBI. Data were excluded for patients aged < 20 or > 89 years or with BMI < 10 or > 55 kg/m(2) and for patients who were transferred from another treatment center or who showed no signs of life upon presentation, leaving data from 38,446 patients for analysis. Obesity was not found to confer a survival advantage on univariate analysis. On multivariate analysis, underweight patients as well as obesity class 1 and 3 patients had a higher rate of mortality (OR 1.86, 95% CI 1.48-2.34; OR 1.18, 95% CI 1.01-1.37; and OR 1.41, 95% CI 1.03-1.93, respectively). Increased obesity class was associated with an increased risk of respiratory complications (obesity class 1: OR 1.19, 95% CI 1.03-1.37; obesity class 2: OR 1.30, 95% CI 1.05-1.62; obesity class 3: OR 1.55, 95% CI 1.18-2.05) and thromboembolic complications (overweight: OR 1.43, 95% CI 1.16-1.76; obesity class 1: OR 1.45, 95% CI 1.11-1.88; obesity class 2: OR 1.55, 95% CI 1.05-2.29) despite a decreased risk of overall complications (obesity class 2: OR 0.82, 95% CI 0.73-0.92; obesity class 3: OR 0.83, 95% CI 0.72-0.97). Underweight patients had a significantly increased risk of overall complications (OR 1.39, 95% CI 1.24-1.57). CONCLUSIONS Although there was an obesity-associated decrease in overall complications, the study data did not demonstrate a paradoxical protective effect of obesity on mortality after isolated severe blunt TBI. Obese patients with isolated severe blunt TBI are at increased risk of respiratory and venous thromboembolic complications. However, underweight patients appear to be at highest risk after severe blunt TBI, with significantly increased risks of morbidity and mortality.	[Cone, Jennifer T.] Univ Chicago, Dept Surg, Sect Trauma & Acute Care Surg, Chicago, IL 60637 USA; [Benjamin, Elizabeth R.; Alfson, Daniel B.; Demetriades, Demetrios] Univ Southern Calif, LAC USC Med Ctr, Dept Surg, Div Trauma Emergency Surg & Surg Crit Care, Los Angeles, CA 90007 USA		Benjamin, ER (corresponding author), Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90007 USA.	elizabeth.benjamin@med.usc.edu					Abramowitz MK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194697; Ageno W, 2008, CIRCULATION, V117, P93, DOI 10.1161/CIRCULATIONAHA.107.709204; Arabi YM, 2013, CRIT CARE, V17, DOI 10.1186/cc12680; Aune D, 2016, CIRCULATION, V133, P639, DOI 10.1161/CIRCULATIONAHA.115.016801; Benjamin ER, 2017, AM J SURG, V214, P899, DOI 10.1016/j.amjsurg.2017.01.023; Brown CVR, 2005, J TRAUMA, V59, P1048, DOI 10.1097/01.ta.0000189047.65630.c5; Caan BJ, 2017, CANCER EPIDEM BIOMAR, V26, P1008, DOI [10.1158/1055-9965.EPI-17-0200, 10.1158/1055-9965.epi-17-0200]; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; CHOBAN PS, 1991, J TRAUMA, V31, P1253, DOI 10.1097/00005373-199109000-00009; Davenport DL, 2009, J VASC SURG, V49, P140, DOI 10.1016/j.jvs.2008.08.052; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Diaz JJ, 2009, J TRAUMA, V66, P226, DOI 10.1097/TA.0b013e31815eb776; Ditillo M, 2014, J TRAUMA ACUTE CARE, V76, P176, DOI 10.1097/TA.0b013e3182ab0d7c; Duane TM, 2006, J TRAUMA, V61, P1218, DOI 10.1097/01.ta.0000241022.43088.e1; Evans DC, 2011, AM SURGEON, V77, P1003; Galyfos G, 2017, J VASC SURG, V65, P1193, DOI 10.1016/j.jvs.2016.09.032; Glance LG, 2014, ANN SURG, V259, P576, DOI 10.1097/SLA.0000000000000330; Gruberg L, 2005, AM J CARDIOL, V95, P439, DOI 10.1016/j.amjcard.2004.10.007; Gruberg L, 2002, J AM COLL CARDIOL, V39, P578, DOI 10.1016/S0735-1097(01)01802-2; HARRIS T, 1988, JAMA-J AM MED ASSOC, V259, P1520; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hutagalung R, 2011, INTENS CARE MED, V37, P1793, DOI 10.1007/s00134-011-2321-2; Liu T, 2013, INJURY, V44, P1145, DOI 10.1016/j.injury.2012.10.038; Lv WY, 2017, INTERACT CARDIOV TH, V25, P633, DOI 10.1093/icvts/ivx191; Mohamed-Ali V, 1999, AM J PHYSIOL-ENDOC M, V277, pE971, DOI 10.1152/ajpendo.1999.277.6.E971; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Mullen JT, 2008, ANN SURG ONCOL, V15, P2164, DOI 10.1245/s10434-008-9990-2; Mullen JT, 2009, ANN SURG, V250, P166, DOI 10.1097/SLA.0b013e3181ad8935; Neville AL, 2004, ARCH SURG-CHICAGO, V139, P983, DOI 10.1001/archsurg.139.9.983; Newell MA, 2007, J AM COLL SURGEONS, V204, P1056, DOI 10.1016/j.jamcollsurg.2006.12.042; Olufajo OA, 2016, J TRAUMA ACUTE CARE, V81, P71, DOI 10.1097/TA.0000000000001046; Perka C, 2000, ARCH ORTHOP TRAUM SU, V120, P267, DOI 10.1007/s004020050462; Rios-Diaz AJ, 2017, AM J SURG, V214, P385, DOI 10.1016/j.amjsurg.2016.05.006; Valentijn TM, 2013, WORLD J SURG, V37, P2560, DOI 10.1007/s00268-013-2162-y; Valentijn TM, 2013, SURG-J R COLL SURG E, V11, P169, DOI 10.1016/j.surge.2013.02.003; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867; Young T, 2004, JAMA-J AM MED ASSOC, V291, P2013, DOI 10.1001/jama.291.16.2013	37	2	2	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAY	2021	134	5					1667	1674		10.3171/2020.3.JNS193458			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RZ6HW	WOS:000648699900004	32534488	Bronze			2022-02-06	
J	Dickerson, RN; Crawford, CN; Tsiu, MK; Bujanowski, CE; Van Matre, ET; Swanson, JM; Filiberto, DM; Minard, G				Dickerson, Roland N.; Crawford, Christin N.; Tsiu, Melissa K.; Bujanowski, Cara E.; Van Matre, Edward T.; Swanson, Joseph M.; Filiberto, Dina M.; Minard, Gayle			Augmented Renal Clearance Following Traumatic Injury in Critically Ill Patients Requiring Nutrition Therapy	NUTRIENTS			English	Article						trauma; injury; kidney; creatinine; creatinine clearance; nutrition; augmented renal clearance; enteral nutrition; parenteral nutrition; protein	GLOMERULAR-FILTRATION-RATE; CREATININE CLEARANCE; FUNCTIONAL RESERVE; ANTIBIOTIC EXPOSURE; ACUTE HYPOCALCEMIA; SERUM CREATININE; KIDNEY-FUNCTION; SEPTIC PATIENTS; DOSING REGIMEN; BRAIN-INJURY	The intent of this study was to ascertain the prevalence of augmented renal clearance (ARC) in patients with traumatic injuries who require nutrition therapy and identify factors associated with ARC. Adult patients admitted to the trauma intensive care unit from January 2015 to September 2016 who received enteral or parenteral nutrition therapy and had a 24 h urine collection within 4 to 14 days after injury were retrospectively evaluated. Patients with a serum creatinine concentration > 1.5 mg/dL, required dialysis, or had an incomplete urine collection were excluded. ARC was defined as a measured creatinine clearance > 149 mL/min/1.73 m(2). Two hundred and three patients were evaluated. One hundred and two (50%) exhibited ARC. A greater proportion of patients with ARC were male (86% vs. 67%; p = 0.004), had traumatic brain injury (33% vs. 9%; p = 0.001), a higher injury severity score (30 +/- 11 vs. 26 +/- 12; p = 0.015), were younger (36 +/- 15 vs. 54 +/- 17 years; p = 0.001), had a lower serum creatinine concentration (0.7 +/- 2 vs. 0.9 +/- 0.2 mg/dL; p = 0.001) and were more catabolic (nitrogen balance of -10.8 +/- 13.0 vs. -6.2 +/- 9.2 g/d; p = 0.004). The multivariate analysis revealed African American race and protein intake were also associated with ARC. Half of critically ill patients with traumatic injuries experience ARC. Patients with multiple risk factors for ARC should be closely evaluated for dosing of renally-eliminated electrolytes, nutrients, and medications.	[Dickerson, Roland N.; Van Matre, Edward T.; Swanson, Joseph M.] Univ Tennessee, Hlth Sci Ctr, Coll Pharm, Dept Clin Pharm & Translat Sci, Memphis, TN 38163 USA; [Crawford, Christin N.] JPS Hlth Network, Dept Pharm, Ft Worth, TX 76104 USA; [Tsiu, Melissa K.] Methodist Charlton Hosp, Dept Pharm, Dallas, TX 75237 USA; [Bujanowski, Cara E.] Huntsville Dist Mem Hosp, Dept Pharm, Huntsville, AL 35801 USA; [Filiberto, Dina M.; Minard, Gayle] Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Surg, Memphis, TN 38163 USA		Dickerson, RN (corresponding author), Univ Tennessee, Hlth Sci Ctr, Coll Pharm, Dept Clin Pharm & Translat Sci, Memphis, TN 38163 USA.	rdickerson@uthsc.edu; CCrawfor04@jpshealth.org; meltsiu@gmail.com; cebujanowski@gmail.com; edward.vanmatre@uthsc.edu; jswanson@uthsc.edu; dfiliber@uthsc.edu; gminard@uthsc.edu		Van Matre, Edward/0000-0001-9125-9509; Dickerson, Roland/0000-0002-2086-6317			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Baptista JP, 2012, INT J ANTIMICROB AG, V39, P420, DOI 10.1016/j.ijantimicag.2011.12.011; Barletta Jeffrey F, 2017, J Trauma Acute Care Surg, V82, P665, DOI 10.1097/TA.0000000000001387; Barletta JF, 2016, J TRAUMA ACUTE CARE, V81, P1115, DOI 10.1097/TA.0000000000001211; BENGOA JM, 1983, AM J CLIN NUTR, V38, P264, DOI 10.1093/ajcn/38.2.264; BOSCH JP, 1983, AM J MED, V75, P943, DOI 10.1016/0002-9343(83)90873-2; Brown KA, 2006, JPEN-PARENTER ENTER, V30, P209, DOI 10.1177/0148607106030003209; Buckley CT, 2021, NUTR CLIN PRACT, V36, P212, DOI 10.1002/ncp.10546; Carrie C, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2621-4; Carrie C, 2019, ANAESTH CRIT CARE PA, V38, P371, DOI 10.1016/j.accpm.2018.12.004; Carrie C, 2018, J CRIT CARE, V48, P66, DOI 10.1016/j.jcrc.2018.08.026; Carrie C, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2117-7; Carrie C, 2018, INT J ANTIMICROB AG, V51, P443, DOI 10.1016/j.ijantimicag.2017.11.013; Claus BOM, 2013, J CRIT CARE, V28, P695, DOI 10.1016/j.jcrc.2013.03.003; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cogle S. V., 2017, Journal of Pharmacy and Nutrition Sciences, V7, P106; Conil JM, 2007, BRIT J CLIN PHARMACO, V63, P583, DOI 10.1111/j.1365-2125.2006.02807.x; Conil JM, 2007, INT J CLIN PHARM TH, V45, P133; Dickerson RN, 2001, JPEN-PARENTER ENTER, V25, P152, DOI 10.1177/0148607101025003152; Dickerson RN, 2008, NUTRITION, V24, P536, DOI 10.1016/j.nut.2008.02.008; Dickerson RN, 2007, JPEN-PARENTER ENTER, V31, P228, DOI 10.1177/0148607107031003228; Dickerson RN, 2005, JPEN-PARENTER ENTER, V29, P436, DOI 10.1177/0148607105029006436; Dickerson RN, 2015, JPEN-PARENTER ENTER, V39, P282, DOI 10.1177/0148607113506939; Dickerson RN, 2014, NUTR CLIN PRACT, V29, P786, DOI 10.1177/0884533614542439; Dickerson RN, 2013, JPEN-PARENTER ENTER, V37, P506, DOI 10.1177/0148607112458526; Dickerson RN, 2013, JPEN-PARENTER ENTER, V37, P342, DOI 10.1177/0148607112466894; Dickerson RN, 2012, J TRAUMA ACUTE CARE, V73, P549, DOI 10.1097/TA.0b013e318256de1b; Dickerson RN, 2009, JPEN-PARENTER ENTER, V33, P646, DOI 10.1177/0148607109335307; Doig GS, 2015, INTENS CARE MED, V41, P1197, DOI 10.1007/s00134-015-3827-9; FLISER D, 1993, J AM SOC NEPHROL, V3, P1371; HEYMSFIELD SB, 1983, AM J CLIN NUTR, V37, P478, DOI 10.1093/ajcn/37.3.478; Jacobs A, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.02534-17; Johnston CT, 2017, JPEN-PARENTER ENTER, V41, P796, DOI 10.1177/0148607115602885; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lindsey KA, 2010, NUTRITION, V26, P784, DOI 10.1016/j.nut.2009.08.013; Lipman J, 2003, ANESTH ANALG, V97, P1149, DOI 10.1213/01.ANE.0000077077.54084.B0; LOIRAT P, 1978, NEW ENGL J MED, V299, P915, DOI 10.1056/NEJM197810262991703; Minkute R, 2013, J CLIN PHARM THER, V38, P462, DOI 10.1111/jcpt.12088; Minville V, 2011, CRIT CARE, V15, DOI 10.1186/cc10013; Morbitzer KA, 2019, CRIT CARE MED, V47, P800, DOI 10.1097/CCM.0000000000003716; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; Ronco C, 2017, INTENS CARE MED, V43, P917, DOI 10.1007/s00134-017-4691-6; Sacks G S, 1994, Nutr Clin Pract, V9, P105, DOI 10.1177/0115426594009003105; Sacks GS, 1997, NUTRITION, V13, P303; Sharma A, 2014, NEPHRON CLIN PRACT, V127, P94, DOI 10.1159/000363721; Sharpe JP, 2015, J TRAUMA ACUTE CARE, V78, P468, DOI 10.1097/TA.0000000000000562; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Udy A, 2010, ANESTH ANALG, V111, P1505, DOI 10.1213/ANE.0b013e3181f7107d; Udy AA, 2017, J NEUROTRAUM, V34, P137, DOI 10.1089/neu.2015.4328; Udy AA, 2014, CRIT CARE MED, V42, P520, DOI 10.1097/CCM.0000000000000029; Udy AA, 2013, CRIT CARE, V17, DOI 10.1186/cc12544; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	52	2	2	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2072-6643		NUTRIENTS	Nutrients	MAY	2021	13	5							1681	10.3390/nu13051681			13	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	ST3ZI	WOS:000662385500001	34063391	Green Published, gold			2022-02-06	
J	Dragan, B; Adamik, B; Burzynska, M; Dragan, SL; Gozdzik, W				Dragan, Barbara; Adamik, Barbara; Burzynska, Malgorzata; Dragan, Szymon Lukasz; Gozdzik, Waldemar			Platelet Receptor Activity for Predicting Survival in Patients with Intracranial Bleeding	JOURNAL OF CLINICAL MEDICINE			English	Article						platelet aggregation; intracranial hemorrhages; craniocerebral trauma; aneurysm; ruptured; platelet function tests; survival rate	TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; COAGULATION TESTS; DYSFUNCTION; PROGRESSION; IMPACT; COAGULOPATHY	Blood coagulation disorders in patients with intracranial bleeding as a result of head injuries or ruptured aneurysms are a diagnostic and therapeutic problem and appropriate assessments are needed to limit CNS damage and to implement preventive measures. The aim of the study was to monitor changes in platelet aggregation and to assess the importance of platelet dysfunction for predicting survival. Platelet receptor function analysis was performed using the agonists arachidonic acid (ASPI), adenosine diphosphate (ADP), collagen (COL), thrombin receptor activating protein (TRAP), ristocetin (RISTO) upon admission to the ICU and on days 2, 3, and 5. On admission, the ASPI, ADP, COL, TRAP, and RISTO tests indicated there was reduced platelet aggregation, despite there being a normal platelet count. In 'Non-survivors', the platelet response to all agonists was suppressed throughout the study period, while in 'Survivors' it improved. Measuring platelet function in ICU patients with intracranial bleeding is a strong predictor related to outcome: patients with impaired platelet aggregation had a lower 28-day survival rate compared to patients with normal platelet aggregation (log-rank test p = 0.014). The results indicated that measuring platelet aggregation can be helpful in the early detection, diagnosis, and treatment of bleeding disorders.	[Dragan, Barbara; Adamik, Barbara; Burzynska, Malgorzata; Gozdzik, Waldemar] Wroclaw Med Univ, Dept Anaesthesiol & Intens Therapy, Borowska 213, PL-50556 Wroclaw, Poland; [Dragan, Szymon Lukasz] Wroclaw Med Univ, Dept Regenerat & Restorat Med Orthopaed, Borowska 213, PL-50556 Wroclaw, Poland		Dragan, B (corresponding author), Wroclaw Med Univ, Dept Anaesthesiol & Intens Therapy, Borowska 213, PL-50556 Wroclaw, Poland.	barbara.dragan@umed.wroc.pl; barbara.adamik@umed.wroc.pl; malgorzata.burzynska@umed.wroc.pl; s.dragan@umed.wroc.pl; waldemar.gozdzik@umed.wroc.pl	; Adamik, Barbara/H-8696-2016	Dragan, Barbara/0000-0003-3108-4211; Adamik, Barbara/0000-0002-0541-841X; Burzynska, Malgorzata/0000-0003-2318-7130; Gozdzik, Waldemar/0000-0001-8668-1641	Wroclaw Medical University (Poland) [STM.A170.17.042]	This research was funded by Wroclaw Medical University (Poland), grant number STM.A170.17.042.	Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Castellino FJ, 2014, J TRAUMA ACUTE CARE, V76, P1169, DOI 10.1097/TA.0000000000000216; Claassen J, 2002, STROKE, V33, P1225, DOI 10.1161/01.STR.0000015624.29071.1F; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Davenport R, 2011, CRIT CARE MED, V39, P2652, DOI 10.1097/CCM.0b013e3182281af5; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Manoel ALD, 2015, NEUROCRIT CARE, V22, P34, DOI 10.1007/s12028-014-0026-4; Frontera JA, 2017, NEUROCRIT CARE, V26, P48, DOI 10.1007/s12028-016-0292-4; Haas T, 2015, BRIT J ANAESTH, V114, P217, DOI 10.1093/bja/aeu303; Hanke AA, 2010, EUR J MED RES, V15, P214; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; He QG, 2019, NEUROPSYCH DIS TREAT, V15, P3443, DOI 10.2147/NDT.S229284; Ingall T, 2000, STROKE, V31, P1054, DOI 10.1161/01.STR.31.5.1054; Kornblith LZ, 2018, J TRAUMA ACUTE CARE, V85, P873, DOI 10.1097/TA.0000000000002025; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Lawrence T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012197; Levi M, 2006, CRIT CARE, V10, DOI 10.1186/cc4975; Lindblad C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00015; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Oved JH, 2021, J THROMB HAEMOST, V19, P248, DOI 10.1111/jth.15113; Perez P, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1062-z; Ramsey MT, 2016, J TRAUMA ACUTE CARE, V80, P726, DOI 10.1097/TA.0000000000001017; Rivero-Arias Oliver, 2010, Cost Eff Resour Alloc, V8, P6, DOI 10.1186/1478-7547-8-6; Schnuriger B, 2010, J TRAUMA, V68, P881, DOI 10.1097/TA.0b013e3181d3cc58; Schweizer TA, 2012, J NEUROL SCI, V316, P137, DOI 10.1016/j.jns.2012.01.003; Solomon C, 2011, THROMB HAEMOSTASIS, V106, P322, DOI 10.1160/TH11-03-0175; Toth O, 2006, THROMB HAEMOSTASIS, V96, P781, DOI 10.1160/TH06-05-0242; Wohlauer MV, 2012, J AM COLL SURGEONS, V214, P739, DOI 10.1016/j.jamcollsurg.2012.01.050; Yuan Q, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-017-0471-0	32	2	2	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	MAY	2021	10	10							2205	10.3390/jcm10102205			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SI5NA	WOS:000654869700001	34069736	gold, Green Published			2022-02-06	
J	Engelhardt, J; Brauge, D; Loiseau, H				Engelhardt, J.; Brauge, D.; Loiseau, H.			Second Impact Syndrome. Myth or reality?	NEUROCHIRURGIE			English	Article						Second impact syndrome; Talk and deteriorate; Mild brain injury	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; ACUTE SUBDURAL-HEMATOMA; HIGH-SCHOOL SPORTS; 2ND-IMPACT SYNDROME; SUBSTANCE-P; TRIGEMINOCARDIAC REFLEX; FOOTBALL PLAYERS; CEREBRAL EDEMA; UNITED-STATES	Introduction. - Second impact syndrome (SIS) is a devastating condition occurring in sport-induced mild brain injury. SIS is drastically defined by anamnestic, clinical and radiological criteria, which is unusual in the field of cranial traumatology. The purpose of this study was to provide a literature review of this syndrome. Material and methods. - We conducted a literature review of all published studies on PubMed. The keywords were "second impact syndrome and catastrophic head injury", "second impact syndrome and sport", "repeat concussion and catastrophic brain injury", "catastrophic head injury and concussion", "catastrophic head injury", "concussion and second impact syndrome", "concussion and repetitive head injury". Results. - Eighty-two full-text articles were assessed for eligibility. Finally, 41 studies were included in qualitative synthesis and 21 were included in quantitative synthesis. Discussion. - The number of cases reported in the literature was extremely small compared to the population at risk, i.e., the number of athletes exposed to repeated concussions. SIS was similar to talk and die syndrome, with which it shares certain characteristics. If we consider SIS according to "talk and deteriorate tables", it opens up interesting perspectives because they are specific in children and adolescents. Taking into account the scarcity of this syndrome, one may question whether athlete-intrinsic features may be involved in at least some cases of SIS. On a pathophysiological level, many explanations remained unsatisfactory because they were unable to explain all the clinical phenomena and observed lesions. Triggering the trigeminocardiac reflex is a crucial element in explaining the sequence of clinical events. Its association with a state of neurogenic inflammation provides an almost complete explanation for this particular condition. Finally, on a practical level, a concussion occurring during the playing of a sport must be considered as any other injury before allowing a return to play. (C) 2020 Published by Elsevier Masson SAS.	[Engelhardt, J.] Univ Bordeaux, Dept Neurosurg, Hop Pellegrin, F-33076 Bordeaux, France; [Brauge, D.] Univ Toulouse, Dept Neurosurg, Hop Pierre Paul Riquet, Pl Dr Baylac TSA 40031, F-31059 Toulouse, France; [Loiseau, H.] Univ Bordeaux, Dept Neurosurg, Hop Pellegrin, EA 7435 IMOTION Imagerie Mol & Therapies Innovant, 146 Rue Leo Saignat,Case 127, F-33076 Bordeaux, France		Loiseau, H (corresponding author), Univ Bordeaux, Dept Neurosurg, Hop Pellegrin, EA 7435 IMOTION Imagerie Mol & Therapies Innovant, 146 Rue Leo Saignat,Case 127, F-33076 Bordeaux, France.	hugues.loiseau@chu-bordeaux.fr					Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; Adler RH, 2011, PM&R, V3, pS468, DOI 10.1016/j.pmrj.2011.08.006; Albano AW, 2016, SPORTS HEALTH, V8, P465, DOI 10.1177/1941738116662025; Bailes JE, 2017, J NEUROSURG-PEDIATR, V19, P116, DOI 10.3171/2016.8.PEDS16355; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Bey T, 2009, WEST J EMERG MED, V10, P6; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Boden BP, 2013, AM J SPORT MED, V41, P1108, DOI 10.1177/0363546513478572; BOLLINGER O, 1891, INT BEITRAGE WEISSEN, P457; Bonfield CM, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.2.FOCUS1558; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Byard RW, 2009, FORENSIC SCI MED PAT, V5, P36, DOI 10.1007/s12024-008-9063-7; Cantu RC, 2000, NEUROSURGERY, V47, P673, DOI 10.1097/00006123-200009000-00029; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; Chowdhury T, 2015, J NEUROSURG ANESTH, V27, P136, DOI 10.1097/ANA.0000000000000065; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Corrigan F, 2012, CNS NEUROSCI THER, V18, P513, DOI 10.1111/j.1755-5949.2012.00332.x; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Duhaime AC, 2007, PROG BRAIN RES, V161, P293, DOI 10.1016/S0079-6123(06)61020-0; FEKETE JF, 1968, CAN MED ASSOC J, V99, P1234; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Greco T, 2019, EXP NEUROL, V317, P206, DOI 10.1016/j.expneurol.2019.01.012; HAAS DC, 1988, J NEUROSURG, V68, P181, DOI 10.3171/jns.1988.68.2.0181; HAAS DC, 1975, ARCH NEUROL-CHICAGO, V32, P727, DOI 10.1001/archneur.1975.00490530049003; Hebert O, 2016, J SCI MED SPORT, V19, P789, DOI 10.1016/j.jsams.2015.12.517; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kersey RD, 1998, J ATHL TRAINING, V33, P264; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Kors EE, 2001, ANN NEUROL, V49, P753, DOI 10.1002/ana.1031; Kucera KL, 2017, MMWR-MORBID MORTAL W, V65, P1465, DOI 10.15585/mmwr.mm6552a2; LANG DA, 1994, J NEUROSURG, V80, P675, DOI 10.3171/jns.1994.80.4.0675; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Litt David W., 1995, Journal of Athletic Training, V30, P69; Logan SM, 2001, J ATHL TRAINING, V36, P433; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Marmarou A, 2006, ACTA NEUROCHIR SUPPL, V96, P24; Marmarou A, 2000, ACT NEUR S, V76, P349; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; MCQUILLEN JB, 1988, AM J FOREN MED PATH, V9, P12, DOI 10.1097/00000433-198803000-00004; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Metting Z, 2010, J NEUROTRAUM, V27, P2183, DOI 10.1089/neu.2010.1395; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Miele VJ, 2004, MED SCI SPORT EXER, V36, P1852, DOI 10.1249/01.MSS.0000145470.16938.7A; Mori T, 2006, ACTA NEUROCHIR SUPPL, V96, P40; Mueller FO, 2001, J ATHL TRAINING, V36, P312; Narayana S, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00538; Navarro JC, 2012, J NEUROTRAUM, V29, P322, DOI 10.1089/neu.2011.1979; PICKLES W, 1950, NEW ENGL J MED, V242, P607, DOI 10.1056/NEJM195004202421602; Potts MA, 2012, PM&R, V4, P530, DOI 10.1016/j.pmrj.2012.01.015; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Randolph C, 2009, J INT NEUROPSYCH SOC, V15, P512, DOI 10.1017/S135561770909064X; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; REILLY PL, 1975, LANCET, V2, P375; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Sakas DE, 1997, NEUROSURGERY, V41, P661, DOI 10.1097/00006123-199709000-00031; Sakas DE, 1997, MED HYPOTHESES, V48, P431, DOI 10.1016/S0306-9877(97)90042-6; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Schaller B, 2004, J NEUROL, V251, P658, DOI 10.1007/s00415-004-0458-4; Schallmo MS, 2017, J BONE JOINT SURG AM, V99, P1314, DOI 10.2106/JBJS.16.01573; Schneider R., 1973, HEAD NECK INJURIES F, P35; Scramstad C, 2017, CAN J NEUROL SCI, V44, P207, DOI 10.1017/cjn.2016.325; SHELL D, 1993, PHYSICIAN SPORTSMED, V21, P74, DOI 10.1080/00913847.1993.11710364; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; SNOEK JW, 1984, BRAIN, V107, P15, DOI 10.1093/brain/107.1.15; Sorby-Adams AJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081788; Squier W, 2012, CHILD NERV SYST, V28, P2005, DOI 10.1007/s00381-012-1870-1; Stam AH, 2009, J NEUROL NEUROSUR PS, V80, P1125, DOI 10.1136/jnnp.2009.177279; Stovitz SD, 2017, CURR SPORT MED REP, V16, P50, DOI 10.1249/JSR.0000000000000326; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Tator C, 2019, **DROPPED REF**, P1; Thomas M, 2011, PEDIATRICS, V128, pE1, DOI 10.1542/peds.2010-2743; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Veevers AE, 2009, J FORENSIC SCI, V54, P1466, DOI 10.1111/j.1556-4029.2009.01201.x; Vink R, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00304; Weinstein E, 2013, J NEUROSURG-PEDIATR, V11, P331, DOI 10.3171/2012.11.PEDS12343; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; Yang JZ, 2017, AM J PUBLIC HEALTH, V107, P1916, DOI 10.2105/AJPH.2017.304056; Yard EE, 2009, J ATHL TRAINING, V44, P645, DOI 10.4085/1062-6050-44.6.645; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171; Yengo-Kahn AM, 2017, WORLD NEUROSURG, V106, DOI 10.1016/J.WNEU.2017.07.072; Zacest AC, 2010, ACTA NEUROCHIR SUPPL, V106, P211, DOI 10.1007/978-3-211-98811-4_39; Zador Z, 2007, PROG BRAIN RES, V161, P185, DOI 10.1016/S0079-6123(06)61012-1; Zuckerman SL, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12279	109	2	2	0	0	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0028-3770	1773-0619		NEUROCHIRURGIE	Neurochirurgie	MAY	2021	67	3					265	275		10.1016/j.neuchi.2019.12.007			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	RU4GM	WOS:000645106900010	32169407				2022-02-06	
J	Goh, SC; Saw, AE; Kountouris, A; Orchard, JW; Saw, R				Goh, Sherwin C.; Saw, Anna E.; Kountouris, Alex; Orchard, John W.; Saw, Richard			Neurocognitive changes associated with concussion in elite cricket players are distinct from changes due to post-match with no head impact	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Sports; Head injury; Traumatic brain injury; Neuropsychology; Neuropsychological tests; Cognitive science	COGNITIVE FUNCTION; BASE-LINE; RELIABILITY; PERFORMANCE; EXERCISE; COGSPORT; TESTS	Objectives: Determine intra-individual changes in CogSport performance in elite cricket players diagnosed with concussion, and differentiate this from changes which may be attributed to post-match with no head impact. Design: Retrospective observational study of elite Australian male and female cricket players with diagnosed concussion and prospective cohort study of cricket players with no head impact post-match. Methods: CogSport performance relative to an individual's baseline was compared between 46 cricket players diagnosed with concussion following a head impact sustained during a match, and 84 cricket players who played a match during which they had no head impact. Results: CogSport performance post-match for players diagnosed with concussion was slower for detection speed (p < 0.001), identification speed (p = 0.007), and one back speed (p = 0.011). No changes in one card learning speed or any accuracy measures were observed. CogSport performance post-match with no head impact was faster but less accurate for one card learning (both p < 0.001). No changes in the other three test components were observed. Conclusions: Slower performance in three of four CogSport tasks (detection, identification, one back) may be indicative of concussion, as these intra-individual changes were not observed in players post-match with no head impact. The fourth task, one card learning, may not be a useful indicator of concussion as it was not observed to change with concussion yet was susceptible to change post-match with no head impact. CogSport may have clinical utility in assisting the clinical diagnosis of concussion in elite male and female cricket players. (c) 2020 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Goh, Sherwin C.] Brisbane Sports & Exercise Med Specialists, Brisbane, Qld, Australia; [Saw, Anna E.; Kountouris, Alex; Orchard, John W.; Saw, Richard] Cricket Australia, Melbourne, Vic, Australia		Goh, SC (corresponding author), Brisbane Sports & Exercise Med Specialists, Brisbane, Qld, Australia.	Sherwingohpublic@gmail.com					[Anonymous], 2017, BR J SPORTS MED; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Covassin T, 2007, BRIT J SPORT MED, V41, P370, DOI 10.1136/bjsm.2006.032334; Falleti MG, 2006, J CLIN EXP NEUROPSYC, V28, P1095, DOI 10.1080/13803390500205718; Farnsworth JL, 2017, J ATHL TRAINING, V52, P826, DOI 10.4085/1062-6050-52.6.03; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Gardner A, 2012, APPL NEUROPSYCH-ADUL, V19, P90, DOI 10.1080/09084282.2011.643945; Green SL, 2019, J CONCUSSION, V3, P1; Grego F, 2005, INT J SPORTS MED, V26, P27, DOI 10.1055/s-2004-817915; Haddad M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00612; Hill T, 2019, SPORTS HEALTH, V11, P180, DOI 10.1177/1941738118811315; Lee JH, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117727261; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Putukian M, 2017, J ATHL TRAINING, V52, P236, DOI 10.4085/1062-6050-52.1.08; Rahman-Filipiak AAM, 2013, NEUROPSYCHOL REV, V23, P314, DOI 10.1007/s11065-013-9241-6; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Schmit C, 2017, SPORTS MED, V47, P1289, DOI 10.1007/s40279-016-0657-z; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742	23	2	2	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	MAY	2021	24	5					420	424		10.1016/j.jsams.2020.10.005			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	RK4GS	WOS:000638256500002	33160856				2022-02-06	
J	Hetzer, SM; Guilhaume-Correa, F; Day, D; Bedolla, A; Evanson, NK				Hetzer, Shelby M.; Guilhaume-Correa, Fernanda; Day, Dylan; Bedolla, Alicia; Evanson, Nathan K.			Traumatic Optic Neuropathy Is Associated with Visual Impairment, Neurodegeneration, and Endoplasmic Reticulum Stress in Adolescent Mice	CELLS			English	Article						traumatic optic neuropathy; head trauma; adolescent head trauma; ER stress; mice	RETINAL GANGLION-CELLS; LATERAL GENICULATE-NUCLEUS; BRAIN-INJURY; AXONAL INJURY; NERVE; MODEL; IMPACT; NEUROINFLAMMATION; MICRODIALYSIS; MECHANISMS	Traumatic brain injury (TBI) results in a number of impairments, often including visual symptoms. In some cases, visual impairments after head trauma are mediated by traumatic injury to the optic nerve, termed traumatic optic neuropathy (TON), which has few effective options for treatment. Using a murine closed-head weight-drop model of head trauma, we previously reported in adult mice that there is relatively selective injury to the optic tract and thalamic/brainstem projections of the visual system. In the current study, we performed blunt head trauma on adolescent C57BL/6 mice and investigated visual impairment in the primary visual system, now including the retina and using behavioral and histologic methods at new time points. After injury, mice displayed evidence of decreased optomotor responses illustrated by decreased optokinetic nystagmus. There did not appear to be a significant change in circadian locomotor behavior patterns, although there was an overall decrease in locomotor behavior in mice with head injury. There was evidence of axonal degeneration of optic nerve fibers with associated retinal ganglion cell death. There was also evidence of astrogliosis and microgliosis in major central targets of optic nerve projections. Further, there was elevated expression of endoplasmic reticulum (ER) stress markers in retinas of injured mice. Visual impairment, histologic markers of gliosis and neurodegeneration, and elevated ER stress marker expression persisted for at least 30 days after injury. The current results extend our previous findings in adult mice into adolescent mice, provide direct evidence of retinal ganglion cell injury after head trauma and suggest that axonal degeneration is associated with elevated ER stress in this model of TON.	[Hetzer, Shelby M.; Day, Dylan; Bedolla, Alicia; Evanson, Nathan K.] Univ Cincinnati, Coll Med, Neurosci Grad Program, Cincinnati, OH 45267 USA; [Guilhaume-Correa, Fernanda] Virginia Polytech Inst & State Univ, Translat Biol Med & Hlth, Roanoke, VA 24016 USA; [Evanson, Nathan K.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, Cincinnati, OH 45229 USA; [Evanson, Nathan K.] Univ Cincinnati, Dept Pediat, Cincinnati, OH 45229 USA		Evanson, NK (corresponding author), Univ Cincinnati, Coll Med, Neurosci Grad Program, Cincinnati, OH 45267 USA.; Evanson, NK (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, Cincinnati, OH 45229 USA.; Evanson, NK (corresponding author), Univ Cincinnati, Dept Pediat, Cincinnati, OH 45229 USA.	canslesy@mail.uc.edu; fergc92@vt.edu; dylanday1@gmail.com; bedollam@mail.uc.edu; Nathan.evanson@cchmc.org		Hetzer, Shelby/0000-0002-6497-378X; Evanson, Nathan/0000-0003-2474-9764	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD001097]; Procter Award; Division of Pediatric Rehabilitation Medicine at Cincinnati Children's Hospital Medical Center	This work was supported by the National Institutes of Health (NIH grant HD001097 (N.K.E.)) and by a Procter Award and the Division of Pediatric Rehabilitation Medicine at Cincinnati Children's Hospital Medical Center (N.K.E.). The funding entities played no role in the design, execution, analysis, or interpretation of the results.	Abdejalil J, 2005, VISION RES, V45, P1439, DOI 10.1016/j.visres.2004.12.015; Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Llompart-Pou JA, 2010, NEUROCRIT CARE, V13, P211, DOI 10.1007/s12028-010-9399-1; Athanasiou D, 2013, FEBS LETT, V587, P2008, DOI 10.1016/j.febslet.2013.05.020; Bashir A, 2020, EXP NEUROL, V324, DOI 10.1016/j.expneurol.2019.113116; Bernardo-Colon A, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00719; BUNT SM, 1983, J COMP NEUROL, V213, P94, DOI 10.1002/cne.902130109; Cansler SM, 2020, J NEUROSCI RES, V98, P571, DOI 10.1002/jnr.24543; Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851; Cekanaviciute E, 2014, GLIA, V62, P1227, DOI 10.1002/glia.22675; Chan JW, 2019, INVEST OPHTH VIS SCI, V60, P2005, DOI 10.1167/iovs.18-26094; Chen HZ, 2017, J NEUROTRAUM, V34, P2291, DOI 10.1089/neu.2016.4870; Cook MW, 1996, ARCH OTOLARYNGOL, V122, P389; CRUNELLI V, 1987, J PHYSIOL-LONDON, V384, P587, DOI 10.1113/jphysiol.1987.sp016471; Cui Q, 2015, NEUROSCIENCE, V284, P845, DOI 10.1016/j.neuroscience.2014.11.002; Desai A, 2020, J NEUROTRAUM, V37, P286, DOI 10.1089/neu.2019.6602; Eletto D, 2014, J CELL SCI, V127, P3649, DOI 10.1242/jcs.153643; Evanson NK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197346; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; Fitch MT, 2008, CNS REGENERATION: BASIC SCIENCE AND CLINICAL ADVANCES, 2ND EDITION, P59, DOI 10.1016/B978-012373994-0.50005-1; Ford RL, 2012, J AAPOS, V16, P413, DOI 10.1016/j.jaapos.2012.04.009; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Glimcher P.W., 2001, INT ENCY SOCIAL BEHA, P5205; Guilhaume-Correa F, 2020, J NEUROSCI RES, V98, P557, DOI 10.1002/jnr.24535; Harrington ME, 1997, NEUROSCI BIOBEHAV R, V21, P705, DOI 10.1016/S0149-7634(96)00019-X; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Heitz FD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045182; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hu Y, 2012, NEURON, V73, P445, DOI 10.1016/j.neuron.2011.11.026; Jang SH, 2015, J NEURO-OPHTHALMOL, V35, P270, DOI 10.1097/WNO.0000000000000249; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Keating CE, 2020, J NEUROTRAUM, V37, P1918, DOI 10.1089/neu.2019.6738; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; Kranz P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.369; Kroeger H, 2019, FEBS J, V286, P399, DOI 10.1111/febs.14522; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Loov C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033090; McColl TJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00372; Mead B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110612; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Namdar I, 2020, J MOL NEUROSCI, V70, P365, DOI 10.1007/s12031-019-01422-9; Ohlsson M, 2003, J NEUROTRAUM, V20, P895, DOI 10.1089/089771503322385827; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Perri ER, 2016, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00080; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Quina LA, 2005, J NEUROSCI, V25, P11595, DOI 10.1523/JNEUROSCI.2837-05.2005; Reid R.C., 2013, FUNDAMENTAL NEUROSCI, V4th ed., P577; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Sen N, 2017, NEUROCHEM INT, V111, P103, DOI 10.1016/j.neuint.2017.01.019; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Singman EL, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0069-2; STEINSAPIR KD, 1994, SURV OPHTHALMOL, V38, P487, DOI 10.1016/0039-6257(94)90145-7; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Swanson MW, 2017, OPTOMETRY VISION SCI, V94, P60, DOI 10.1097/OPX.0000000000000977; Tao WS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12225-6; Tavender TJ, 2010, ANTIOXID REDOX SIGN, V13, P1177, DOI 10.1089/ars.2010.3230; Thaung C, 2002, NEUROSCI LETT, V325, P21, DOI 10.1016/S0304-3940(02)00223-9; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Ullmann JFP, 2012, BRAIN BEHAV EVOLUT, V79, P26, DOI 10.1159/000332802; VanderWall K.B., 2018, 429282 BIORXIV, DOI [10.1101/429282, DOI 10.1101/429282]; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Wang JQ, 2013, J NEUROPATH EXP NEUR, V72, P768, DOI 10.1097/NEN.0b013e31829d8d9d; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Willie JT, 2012, J NEUROTRAUM, V29, P1908, DOI 10.1089/neu.2012.2404; Xu LY, 2015, EXP NEUROL, V273, P168, DOI 10.1016/j.expneurol.2015.08.014; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Yu-Wai-Man Patrick, 1800, Taiwan J Ophthalmol, V5, P3; Zelinsky DG, 2010, PM&R, V2, P852, DOI 10.1016/j.pmrj.2010.06.012; Zhang SX, 2014, EXP EYE RES, V125, P30, DOI 10.1016/j.exer.2014.04.015; Zhang Z, 2019, REDOX BIOL, V25, DOI 10.1016/j.redox.2018.11.005	76	2	2	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2073-4409		CELLS-BASEL	Cells	MAY	2021	10	5							996	10.3390/cells10050996			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	SI2TN	WOS:000654679000001	33922788	Green Published, gold			2022-02-06	
J	Johnson, RS; Scott, KH; Lynall, RC				Johnson, Rachel S.; Scott, Kendall H.; Lynall, Robert C.			A Proposal for Complex Gait Evaluation Using Dual-Task Gait Termination Time	JOURNAL OF SPORT REHABILITATION			English	Article						reaction time; gait analysis; concussion; orthopedic injury; rehabilitation	SUPRASPINATUS TENDON THICKNESS; ROTATOR CUFF TENDINOPATHY; ACROMIO-HUMERAL DISTANCE; SUBACROMIAL SPACE WIDTH; DIAGNOSTIC-ACCURACY; IMPINGEMENT; RELIABILITY; POSITION; ELITE; TRANSLATION	Context: Gait termination time (GTT) has been used to predict falls in older adults but has not been explored in the sport rehabilitation setting. The incorporation of a concurrent cognitive task as a complex measure of gait in this clinical population could lead to better health-related outcomes. Objective: To compare the effect of planned and unplanned gait termination with and without a concurrent cognitive task on reaction time (RT), gait velocity, and GTT. Design: Cross-sectional. Setting: Laboratory. Participants: Twenty young adults (females 60.0%, age 20.1 [0.9] y, height 169.5 [8.8] cm, mass 67.4 [10.8] kg). Intervention: Participants completed 6 planned and 6 unplanned gait termination trials on an instrumented gait mat with and without a cognitive task. Main Outcome Measures: The authors measured RT (s), gait velocity (m/s), GTT (s), and normalized GTT (s(2)/m). A 2 (motor) x 2 (cognitive) repeated-measures analysis of variance (alpha = .05) was used; significant interaction effects were explored using Bonferroni-corrected t tests (alpha < .008). Results: Participants walked more slowly during dual-task trials compared with single-task trials (F-1,F-19 = 4.401, P = .050). Participants walked significantly more slowly with a cognitive task during planned (P < .001, mean difference = -0.184m/s, 95% CI, -0.256 to -0.111) and unplanned (P = .001, mean difference = -0.111m/s, 95% CI, -0.173 to -0.050) gait termination. Participants walked significantly more slowly (P < .001, mean difference = -0.142m/s, 95% CI, -0.210 to -0.075) when performing the most difficult task, unplanned termination with a cognitive task, than when performing the least difficult task, planned termination with no cognitive task. We observed a cognitive task main effect such that adding a cognitive task increased RT (F-1,F-19 = 16.375, P = .001, mean difference = -0.118 s, 95% CI, -0.178 to -0.057) and slowed normalized GTT (F-1,F-19 = 5.655, P = .028, mean difference = -0.167 s(2)/m, 95% CI, -0.314 to -0.020). Conclusions: Overall, participants displayed more conservative gait strategies and slower RT, normalized GTT, and gait velocity as task difficulty increased. More investigation is needed to truly understand the clinical meaningfulness of these measures in athletic injuries.	[Johnson, Rachel S.; Scott, Kendall H.; Lynall, Robert C.] Univ Georgia, UGA Biomech Lab, Athens, GA 30602 USA; [Johnson, Rachel S.; Lynall, Robert C.] Univ Georgia, UGA Concuss Res Lab, Athens, GA 30602 USA; [Johnson, Rachel S.; Lynall, Robert C.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA		Johnson, RS (corresponding author), Univ Georgia, UGA Biomech Lab, Athens, GA 30602 USA.	Rachel.johnson1@uga.edu	Lynall, Robert/M-2888-2014	Lynall, Robert/0000-0002-0785-6640	Fonds de Recherche QuebecSante (FRQS)	These authors and any research foundation with which they are affiliated did not receive any financial payments or other benefits from any commercial entity related to the subject of this article. F.C.L.d.O. received a postdoctoral fellowship from the Fonds de Recherche QuebecSante (FRQS).	Alqunaee M, 2012, ARCH PHYS MED REHAB, V93, P229, DOI 10.1016/j.apmr.2011.08.035; Beaton DE, 2005, J BONE JOINT SURG AM, V87A, P1038, DOI 10.2106/JBJS.D.02060; Bey MJ, 2007, CLIN BIOMECH, V22, P767, DOI 10.1016/j.clinbiomech.2007.04.006; Cools AM, 2010, BRIT J SPORT MED, V44, P678, DOI 10.1136/bjsm.2009.070128; de Oliveira FCL, 2017, J ELECTROMYOGR KINES, V35, P100, DOI 10.1016/j.jelekin.2017.06.002; de Witte PB, 2014, CLIN BIOMECH, V29, P26, DOI 10.1016/j.clinbiomech.2013.10.014; Desmeules F, 2004, CLIN J SPORT MED, V14, P197, DOI 10.1097/00042752-200407000-00002; Durand Marie-Jose, 2005, J Hand Ther, V18, P34, DOI 10.1197/j.jht.2004.10.010; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Graichen H, 2005, J BIOMECH, V38, P755, DOI 10.1016/j.jbiomech.2004.05.020; Hebert LJ, 2003, J MAGN RESON IMAGING, V18, P72, DOI 10.1002/jmri.10327; Hertel R, 1996, J Shoulder Elbow Surg, V5, P307, DOI 10.1016/S1058-2746(96)80058-9; Hinterwimmer S, 2003, MED SCI SPORT EXER, V35, P2055, DOI 10.1249/01.MSS.0000099089.49700.53; Kalra N, 2010, J ORTHOP SPORT PHYS, V40, P633, DOI 10.2519/jospt.2010.3155; Leong HT, 2012, J SCI MED SPORT, V15, P284, DOI 10.1016/j.jsams.2011.11.259; de Oliveira FCL, 2019, CLIN BIOMECH, V61, P16, DOI 10.1016/j.clinbiomech.2018.11.005; Maenhout A, 2015, J ATHL TRAINING, V50, P281, DOI 10.4085/1062-6050-49.3.92; Maenhout A, 2013, CLIN J SPORT MED, V23, P178, DOI 10.1097/JSM.0b013e31825b6995; Maenhout A, 2012, AM J SPORT MED, V40, P2105, DOI 10.1177/0363546512454530; McCreesh KM, 2015, BRIT J SPORT MED, V49, P298, DOI 10.1136/bjsports-2012-092063; McCreesh KM, 2016, J CLIN ULTRASOUND, V44, P159, DOI 10.1002/jcu.22318; Michener LA, 2015, KNEE SURG SPORT TR A, V23, P363, DOI 10.1007/s00167-013-2542-8; Michener LA, 2009, ARCH PHYS MED REHAB, V90, P1898, DOI 10.1016/j.apmr.2009.05.015; Miller CA, 2008, ARCH PHYS MED REHAB, V89, P1162, DOI 10.1016/j.apmr.2007.10.046; Navarro-Ledesma S, 2018, CLIN BIOMECH, V53, P101, DOI 10.1016/j.clinbiomech.2018.02.013; Navarro-Ledesma S, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1498-0; NEER CS, 1983, CLIN ORTHOP RELAT R, P70; Pijls BG, 2010, J CLIN ULTRASOUND, V38, P128, DOI 10.1002/jcu.20674; Seitz AL, 2011, J CLIN ULTRASOUND, V39, P146, DOI 10.1002/jcu.20783; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Siegel LB, 1999, AM FAM PHYSICIAN, V59, P1843; Silva RT, 2010, BRIT J SPORT MED, V44, P407, DOI 10.1136/bjsm.2008.046284; Thomas SJ, 2013, J SPORT REHABIL, V22, P216, DOI 10.1123/jsr.22.3.216; Vanderstukken F, 2020, BRAZ J PHYS THER, V24, P273, DOI 10.1016/j.bjpt.2019.04.006; Vanderstukken F, 2019, J SPORT SCI, V37, P484, DOI 10.1080/02640414.2018.1507238; Wang HK, 2005, SCAND J MED SCI SPOR, V15, P29, DOI 10.1111/j.1600-0838.2004.00408.x	36	2	2	2	4	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	MAY	2021	30	4					525	537		10.1123/jsr.2020-0080			13	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	RQ5YK	WOS:000642494100001	32963127				2022-02-06	
J	Komoltsev, IG; Frankevich, SO; Shirobokova, NI; Volkova, AA; Levshina, IP; Novikova, MR; Manolova, AO; Gulyaeva, NV				Komoltsev, Ilia G.; Frankevich, Stepan O.; Shirobokova, Natalia, I; Volkova, Aleksandra A.; Levshina, Irina P.; Novikova, Margarita R.; Manolova, Anna O.; Gulyaeva, Natalia, V			Differential early effects of traumatic brain injury on spike-wave discharges in Sprague-Dawley rats	NEUROSCIENCE RESEARCH			English	Article						Traumatic brain injury; Epileptiform activity; Spike-wave discharges; Epileptogenesis; Anxiety behavior; Neuroinflammation; Hippocampus; Neocortex	METHYL-D-ASPARTATE; ANIMAL-MODELS; HIPPOCAMPAL; EPILEPSY; NEUROINFLAMMATION; SEIZURES; DIAZEPAM; LESIONS	Unprovoked seizures in the late period of traumatic brain injury (TBI) occur in almost 20% of humans and experimental animals, psychiatric comorbidities being common in both situations. The aim of the study was to evaluate epileptiform activity in the early period of TBI induced by lateral fluid percussion brain injury in adult male Srague-Dawley rats and to reveal potential behavioral and pathomorphological correlates of early electrophysiological alterations. One week after TBI the group of animals was remarkably heterogeneous regarding the incidence of bifrontal 7-Hz spikes and spike-wave discharges (SWDs). It consisted of 3 typical groups: a) rats with low baseline and high post-craniotomy SWD level; b)with constantly low both baseline and post-craniotomy SWD levels; c) constantly high both baseline and post craniotomy SWD levels. Rats with augmented SWD occurrence after TBI demonstrated freezing episodes accompanying SWDs as well as increased anxiety-like behavior (difficulty of choosing). The discharges were definitely associated with sleep phases. The incidence of SWDs positively correlated with the area of glial activation in the neocortex but not in the hippocampus.The translational potential of the data is revealing new pathophysiological links between epileptiform activity appearance, direct cortical and distant hippocampal damage and anxiety-like behavior, putative early predictors of late posttraumatic pathology. ? 2020 Elsevier B.V. and Japan Neuroscience Society. All rights reserved.	[Komoltsev, Ilia G.; Frankevich, Stepan O.; Shirobokova, Natalia, I; Volkova, Aleksandra A.; Levshina, Irina P.; Novikova, Margarita R.; Manolova, Anna O.; Gulyaeva, Natalia, V] Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, Lab Funct Biochem Nervous Syst, 5A Butlerov Str, Moscow 117485, Russia; [Komoltsev, Ilia G.; Gulyaeva, Natalia, V] Healthcare Dept Moscow, Moscow Res & Clin Ctr Neuropsychiat, 43 Donskaya Str, Moscow 115419, Russia		Gulyaeva, NV (corresponding author), Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, Lab Funct Biochem Nervous Syst, Butlerov St 5A, Moscow 117485, Russia.	komoltsev.ilia@gmail.com; stepan.frankevich@yandex.ru; mr.brightside144@mail.ru; aleksandra.al.volkova@gmail.com; ilevshina@mail.ru; mrnovikova.ihna@mail.ru; anna.tishkina@phystech.edu; nata_gul@mail.ru	Novikova, Margarita/AAC-2331-2022; Komoltsev, Ilia/V-1327-2018	Komoltsev, Ilia/0000-0002-4918-6411	Russian Foundation for Basic Research (RFBR)Russian Foundation for Basic Research (RFBR) [160400855, 19-015-00258, 18-315-00146]	Supported by Russian Foundation for Basic Research (RFBR) grants 160400855, 19-015-00258 (NG; electrophysiological and behavioral analysis) and 18-315-00146 (IK; histological analysis) .	Aniol VA, 2013, EPILEPSY BEHAV, V26, P196, DOI 10.1016/j.yebeh.2012.12.006; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Aronica E, 2017, MODELS OF SEIZURES AND EPILEPSY, 2ND EDITION, P139, DOI 10.1016/B978-0-12-804066-9.00011-0; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bagetta G, 1996, NEUROSCIENCE, V71, P613, DOI 10.1016/0306-4522(95)00502-1; Bailey KR, 2009, FRONT NEUROSCI, P77; Becker A, 1997, PHARMACOL RES, V35, P27, DOI 10.1006/phrs.1996.0116; BENARI Y, 1980, BRAIN RES, V191, P79, DOI 10.1016/0006-8993(80)90316-9; BENARI Y, 1978, EUR J PHARMACOL, V52, P419, DOI 10.1016/0014-2999(78)90302-3; Bernert H, 1996, P NATL ACAD SCI USA, V93, P5235, DOI 10.1073/pnas.93.11.5235; Blumcke I, 2017, NEW ENGL J MED, V377, P1648, DOI 10.1056/NEJMoa1703784; Bragin A, 2016, EPILEPSIA, V57, P735, DOI 10.1111/epi.13359; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Christensen J, 2015, SEMIN NEUROL, V35, P218, DOI 10.1055/s-0035-1552923; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; DiSabato DJ, 2016, J NEUROCHEM, V139, P136, DOI 10.1111/jnc.13607; File Sandra E, 2004, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0803s26; Forcelli PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081401; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Gulyaeva NV, 2019, BIOCHEMISTRY-MOSCOW+, V84, P1306, DOI 10.1134/S0006297919110087; Gulyaeva NV, 2010, NEUROCHEM J+, V4, P84, DOI 10.1134/S1819712410020029; Gulyaeva NV, 2019, NEUROCHEM RES, V44, P1306, DOI 10.1007/s11064-018-2662-0; Gupta PK, 2014, J NEUROTRAUM, V31, P1439, DOI 10.1089/neu.2013.3221; Gurkoff GG, 2013, J NEUROTRAUM, V30, P292, DOI 10.1089/neu.2012.2463; Hesdorffer DC, 2012, ANN NEUROL, V72, P184, DOI 10.1002/ana.23601; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Kirk J, 2012, IDENTITY STUD SOC SC, P1; Kostopoulos GK, 2000, CLIN NEUROPHYSIOL, V111, pS27, DOI 10.1016/S1388-2457(00)00399-0; Leresche N, 2012, PFLUG ARCH EUR J PHY, V463, P201, DOI 10.1007/s00424-011-1009-3; LERNERNATOLI M, 1991, NEUROSCI LETT, V122, P174, DOI 10.1016/0304-3940(91)90851-J; Lescot T, 2010, J NEUROTRAUM, V27, P463, DOI 10.1089/neu.2009.0982-C; Malmgren K, 2012, EPILEPSIA, V53, P19, DOI 10.1111/j.1528-1167.2012.03610.x; Malykhin NV, 2010, J PSYCHIATR NEUROSCI, V35, P337, DOI 10.1503/jpn.100002; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meeren HKM, 2002, J NEUROSCI, V22, P1480, DOI 10.1523/JNEUROSCI.22-04-01480.2002; Pagni C.A., 2005, ACTA NEUROCHIR S, DOI [10.1007/3-211-27577-0-3, DOI 10.1007/3-211-27577-0-3]; Pearce PS, 2014, EPILEPSY BEHAV, V32, P121, DOI 10.1016/j.yebeh.2014.01.004; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Pitkanen A, 2017, MODELS OF SEIZURES AND EPILEPSY, 2ND EDITION, P661, DOI 10.1016/B978-0-12-804066-9.00046-8; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Rodgers KM, 2015, J NEUROSCI, V35, P9194, DOI 10.1523/JNEUROSCI.0919-15.2015; RODGERS RJ, 1995, PHARMACOL BIOCHEM BE, V52, P297, DOI 10.1016/0091-3057(95)00138-M; RUTH RE, 1982, EXP NEUROL, V76, P508, DOI 10.1016/0014-4886(82)90120-0; Saletti P.G., 2019, NEUROBIOL DIS, DOI [10.1016/j.nbd.2018, DOI 10.1016/J.NBD.2018]; SEMBA K, 1984, NEUROSCIENCE, V12, P761, DOI 10.1016/0306-4522(84)90168-4; Shaw FZ, 2007, J NEUROPHYSIOL, V97, P238, DOI 10.1152/jn.00340.2006; Shaw FZ, 2004, J NEUROPHYSIOL, V91, P63, DOI 10.1152/jn.00487.2003; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Sitnikova E., 2010, EPILEPSY RES; Sonuga-Barke EJS, 2016, J CHILD PSYCHOL PSYC, V57, P321, DOI 10.1111/jcpp.12496; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tran LD, 2006, J NEUROTRAUM, V23, P1330, DOI 10.1089/neu.2006.23.1330; Vezzani A., 2012, GLIA NEURONAL INTERA, P1	58	2	2	1	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	MAY	2021	166						42	54		10.1016/j.neures.2020.05.005			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RT8JI	WOS:000644701700005	32461140				2022-02-06	
J	Korgaonkar, MS; Williamson, T; Bryant, RA				Korgaonkar, Mayuresh S.; Williamson, Thomas; Bryant, Richard A.			Neural activity during response inhibition in mild traumatic brain injury and posttraumatic stress disorder	NEUROBIOLOGY OF STRESS			English	Article						Mild traumatic brain injury; Posttraumatic stress disorder; Response inhibition; Functional magnetic resonance imaging; Evoked response potential	ADOLESCENT EARTHQUAKE SURVIVORS; COGNITIVE-CONTROL; WORKING-MEMORY; TASK; PTSD; ACTIVATION; ATTENTION; SYMPTOMS; NETWORKS; VETERANS	Mild traumatic brain injury (mTBI) is often characterized by deficits in response inhibition, which can contribute to marked social and occupational dysfunction. mTBI often occurs in the context of psychologically traumatic events. This can cause posttraumatic stress disorder (PTSD), which also impedes response inhibition. The overlap or distinction in these inhibitory deficits in mTBI and PTSD is unclear. This study aimed to assess behavioral, neurophysiological, and neuroimaging indices of response inhibition in mTBI by also assessing these parameters in healthy controls (HC) and PTSD participants. Participants with mTBI (without PTSD) (n = 46), PTSD (without mTBI) (n = 41), and HC (n = 40) were assessed during a response inhibition task (the Go/NoGo task) during neuropsychological testing and separate functional magnetic imaging and event-related potentials sessions. PTSD symptom severity was assessed with the Clinician-Administered PTSD Scale. Both mTBI and PTSD participants performed more omission errors on the Go/NoGo task and were associated with greater N2 amplitude, greater left inferior parietal activation and reduced connectivity of the left inferior parietal cluster and left angular gyrus compared to HC. There were no differences between mTBI and PTSD on any of these measures. These findings highlight that both mTBI and PTSD contribute to neural dysfunction during response inhibition, and arguably these occur due to distinct mechanisms. In the context of the common comorbidity between these two conditions, strategies to address response inhibition deficits in mTBI may need to consider causative factors underpinning neurological insult of mTBI and psychological effects associated with PTSD.	[Korgaonkar, Mayuresh S.; Williamson, Thomas; Bryant, Richard A.] Westmead Inst Med Res, Brain Dynam Ctr, Westmead, NSW, Australia; [Korgaonkar, Mayuresh S.] Univ Sydney, Fac Med & Hlth, Sch Hlth Sci, Sydney, NSW, Australia; [Williamson, Thomas; Bryant, Richard A.] Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia		Bryant, RA (corresponding author), Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia.	r.bryant@unsw.edu.au		Williamson, Thomas/0000-0002-8338-0605	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1073041]	This study was supported by the National Health and Medical Research Council Program Grant (1073041). The study sponsor had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Breukelaar IA, 2018, HUM BRAIN MAPP, V39, P5028, DOI 10.1002/hbm.24342; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carrion VG, 2008, DEPRESS ANXIETY, V25, P514, DOI 10.1002/da.20346; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Depue BE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/691505; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; Dunst B, 2014, INTELLIGENCE, V42, P22, DOI 10.1016/j.intell.2013.09.005; Etkin Amit, 2013, Dialogues Clin Neurosci, V15, P419; Falconer E, 2008, J PSYCHIATR NEUROSCI, V33, P413; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huster RJ, 2013, INT J PSYCHOPHYSIOL, V87, P217, DOI 10.1016/j.ijpsycho.2012.08.001; Jovanovic T, 2013, CORTEX, V49, P1884, DOI 10.1016/j.cortex.2012.08.011; Karr JE, 2014, NEUROPSYCHOL REV, V24, P428, DOI 10.1007/s11065-014-9271-8; Krivitzky LS, 2011, J INT NEUROPSYCH SOC, V17, P1143, DOI 10.1017/S1355617711001226; Larson MJ, 2012, J INT NEUROPSYCH SOC, V18, P323, DOI 10.1017/S1355617711001779; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; Maki-Marttunen V, 2015, J NEUROTRAUM, V32, P272, DOI 10.1089/neu.2014.3557; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nguyen AT, 2016, INT J PSYCHOPHYSIOL, V107, P63, DOI 10.1016/j.ijpsycho.2016.07.002; Niendam TA, 2012, COGN AFFECT BEHAV NE, V12, P241, DOI 10.3758/s13415-011-0083-5; Olff M, 2014, NEUROBIOL LEARN MEM, V112, P114, DOI 10.1016/j.nlm.2014.01.003; Picton TW, 2007, CEREB CORTEX, V17, P826, DOI 10.1093/cercor/bhk031; Sadeh N, 2015, HUM BRAIN MAPP, V36, P3076, DOI 10.1002/hbm.22829; Scheibel RS, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00352; Scheibel RS, 2009, J NEUROTRAUM, V26, P1447, DOI 10.1089/neu.2008.0736; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Shomstein S, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00038; Shu IW, 2014, PSYCHIAT RES-NEUROIM, V224, P58, DOI 10.1016/j.pscychresns.2014.07.010; Shucard JL, 2008, BIOL PSYCHOL, V79, P223, DOI 10.1016/j.biopsycho.2008.05.005; Smith JL, 2008, CLIN NEUROPHYSIOL, V119, P704, DOI 10.1016/j.clinph.2007.11.042; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Spadoni AD, 2018, CURR TOP BEHAV NEURO, V38, P163, DOI 10.1007/7854_2017_35; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Stephens JA, 2018, J NEUROTRAUM, V35, P241, DOI 10.1089/neu.2017.5237; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Swick D, 2011, NEUROIMAGE, V56, P1655, DOI 10.1016/j.neuroimage.2011.02.070; Swick D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-102; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Wu JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep08844; Wu JH, 2010, NEUROSCI LETT, V486, P117, DOI 10.1016/j.neulet.2010.07.040; Xu B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14867-y; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zhao WX, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.966; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	59	2	2	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	2352-2895			NEUROBIOL STRESS	Neurobiol. Stress	MAY	2021	14								100308	10.1016/j.ynstr.2021.100308			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SU4AG	WOS:000663082000002	33665241	Green Published, gold			2022-02-06	
J	Lefevre-Dognin, C; Cogne, M; Perdrieau, V; Granger, A; Heslot, C; Azouvi, P				Lefevre-Dognin, C.; Cogne, M.; Perdrieau, V; Granger, A.; Heslot, C.; Azouvi, P.			Definition and epidemiology of mild traumatic brain injury	NEUROCHIRURGIE			English	Article						Concussion; Mild traumatic brain injury; Epidemiology	POPULATION; PREVALENCE; PROGNOSIS; TRENDS	Background/objectives. - The definition of mild traumatic brain injury (mTBI), also known as concussion, has been a matter of controversy, which makes comparison between studies difficult. Incidence varies greatly from one country to another. The present article reviews definitions and epidemiology. Methods. - Literature review. Results. - According to the Mild TBI Committee of the American Congress of Rehabilitation Medicine, revised by the World Health Organization (WHO), mTBI is defined by a Glasgow Coma Scale score between 13 and 15 at 30 minutes post-injury, and one or more of the following symptoms: <30 min loss of consciousness; <24 hours post-traumatic amnesia (PTA); impaired mental state at time of accident (confusion, disorientation, etc.); and/or transient neurological deficit. If a focal lesion is found on computed tomography (CT) or magnetic resonance imaging (MRI), the term "complicated mild TBI" has been proposed. Incidence of mTBI is 200-300/100,000 persons per year for hospitalized patients and probably twice as high if non-hospitalized patients are included. However, a few recent populationbased studies reported a much higher rate (>700/100,000). A changing pattern of epidemiology has been found in high-income countries, related to a decrease in road -accident injuries in young adults, while conversely the proportion of falls has increased with population aging. Conclusion. - Mild TBI is a major public health concern, the epidemiology of which has greatly changed in the last twenty years. (C) 2020 Published by Elsevier Masson SAS.	[Lefevre-Dognin, C.; Perdrieau, V; Granger, A.; Heslot, C.; Azouvi, P.] Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, 104 Blvd Raymond Poincare, F-92380 Garches, France; [Lefevre-Dognin, C.; Heslot, C.; Azouvi, P.] Univ Versailles St Quentin En Yvelines, EA 4047 HANDIReSP, Montigny Le Bretonneux, France; [Cogne, M.] Rennes Univ Hosp, Rehabil Med Unit, 2 Rue Henri le Guilloux, F-35000 Rennes, France; [Cogne, M.] INRIA, Hybrid Team, Campus Univ Beaulieu, F-35042 Rennes, France		Lefevre-Dognin, C (corresponding author), Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, 104 Blvd Raymond Poincare, F-92380 Garches, France.	Clemence.lefevre@aphp.fr					Andelic N, 2013, LANCET NEUROL, V12, P28, DOI 10.1016/S1474-4422(12)70294-6; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Cancelliere C, 2017, J HEAD TRAUMA REHAB, V32, pE37, DOI 10.1097/HTR.0000000000000260; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2001, J REHABIL MED, P28; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kolakowsky-Hayner SA, 2001, BRAIN INJURY, V15, P53, DOI 10.1080/02699050150209138; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; Stephenson S, 2005, ACCIDENT ANAL PREV, V37, P825, DOI 10.1016/j.aap.2005.03.024; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901	24	2	2	5	9	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0028-3770	1773-0619		NEUROCHIRURGIE	Neurochirurgie	MAY	2021	67	3					218	221		10.1016/j.neuchi.2020.02.002			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	RU4GM	WOS:000645106900002	32387427				2022-02-06	
J	Maietta, JE; Barchard, KA; Kuwabara, HC; Donohue, BD; Ross, SR; Kinsora, TF; Allen, DN				Maietta, Julia E.; Barchard, Kimberly A.; Kuwabara, Hana C.; Donohue, Bradley D.; Ross, Staci R.; Kinsora, Thomas F.; Allen, Daniel N.			Influence of Special Education, ADHD, Autism, and Learning Disorders on ImPACT Validity Scores in High School Athletes	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Sports medicine; Neurodevelopmental disorders; Return to sport; Neuropsychological tests; Athletic injuries; Youth sports	IMMEDIATE POST-CONCUSSION; LINE NEUROCOGNITIVE PERFORMANCE; COGNITIVE TESTING IMPACT; MULTIVARIATE BASE RATES; PREVALENCE; SYMPTOMS; CHILDREN; HISTORY; UTILITY	Objective: The Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) is commonly used to assist with post-concussion return-to-play decisions for athletes. Additional investigation is needed to determine whether embedded indicators used to determine the validity of scores are influenced by the presence of neurodevelopmental disorders (NDs). Method: This study examined standard and novel ImPACT validity indicators in a large sample of high school athletes (n = 33,772) with or without self-reported ND. Results: Overall, 7.1% of athletes' baselines were judged invalid based on standard ImPACT validity criteria. When analyzed by group (healthy, ND), there were significantly more invalid ImPACT baselines for athletes with an ND diagnosis or special education history (between 9.7% and 54.3% for standard and novel embedded validity criteria) when compared to athletes without NDs. ND history was a significant predictor of invalid baseline performance above and beyond other demographic characteristics (i.e., age, sex, and sport), although it accounted for only a small percentage of variance. Multivariate base rates are presented stratified for age, sex, and ND. Conclusions: These data provide evidence of higher than normal rates of invalid baselines in athletes who report ND (based on both the standard and novel embedded validity indicators). Although ND accounted for a small percentage of variance in the prediction of invalid performance, negative consequences (e.g., extended time out of sports) of incorrect decision-making should be considered for those with neurodevelopmental conditions. Also, reasons for the overall increase noted here, such as decreased motivation, "sandbagging", or disability-related cognitive deficit, require additional investigation.	[Maietta, Julia E.; Barchard, Kimberly A.; Kuwabara, Hana C.; Donohue, Bradley D.; Allen, Daniel N.] Univ Nevada, Dept Psychol, Box 455030,4505 Maryland Pkwy, Las Vegas, NV 89154 USA; [Ross, Staci R.; Kinsora, Thomas F.] Ctr Appl Neurosci, Las Vegas, NV USA		Allen, DN (corresponding author), Univ Nevada, Dept Psychol, Box 455030,4505 Maryland Pkwy, Las Vegas, NV 89154 USA.	daniel.allen@unlv.edu		Maietta, Julia/0000-0001-5612-6321; Allen, Daniel/0000-0003-4868-2242			Abeare CA, 2018, JAMA NEUROL, V75, P697, DOI 10.1001/jamaneurol.2018.0031; Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Brett BL, 2017, DEV NEUROPSYCHOL, V42, P70, DOI 10.1080/87565641.2016.1243114; Brooks BL, 2013, PRACT RESOUR MENT, P75, DOI 10.1016/B978-0-12-386934-0.00002-X; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Chafetz M, 2011, CLIN NEUROPSYCHOL, V25, P1239, DOI 10.1080/13854046.2011.586785; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Cook NE, 2019, CHILD NEUROPSYCHOL, V25, P836, DOI 10.1080/09297049.2018.1543389; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Gardner RM, 2017, PHYSICIAN SPORTSMED, V45, P1, DOI 10.1080/00913847.2017.1248221; Gaudet CE, 2017, CLIN NEUROPSYCHOL, V31, P43, DOI 10.1080/13854046.2016.1220622; Higgins KL, 2017, ARCH CLIN NEUROPSYCH, V32, P259, DOI 10.1093/arclin/acw108; Holdnack J.A., 2019, HDB PSYCHOL ASSESSME, P103; Inman TH, 2002, ARCH CLIN NEUROPSYCH, V17, P1, DOI 10.1016/S0887-6177(00)00073-1; Iverson GL, 1996, J CLIN EXP NEUROPSYC, V18, P38, DOI 10.1080/01688639608408260; Kaye S, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00396; Kerr ZY, 2015, J ATHL TRAINING, V50, P1174, DOI 10.4085/1062-6050-50.11.11; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Lippa SM, 2018, CLIN NEUROPSYCHOL, V32, P391, DOI 10.1080/13854046.2017.1406146; Lovell M. R, 2018, IMPACT ADM INTERPRET; Manderino LM, 2018, ARCH CLIN NEUROPSYCH, V33, P596, DOI 10.1093/arclin/acx102; Manderino L, 2018, CLIN J SPORT MED, V28, P111, DOI 10.1097/JSM.0000000000000433; Manderino LM, 2019, CLIN NEUROPSYCHOL, V33, P1455, DOI 10.1080/13854046.2018.1539191; Mayes SD, 2006, LEARN INDIVID DIFFER, V16, P145, DOI 10.1016/j.lindif.2005.07.004; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; Parke EM, 2020, J ATTEN DISORD, V24, P1227, DOI 10.1177/1087054715576343; Peltonen K, 2019, CHILD NEUROPSYCHOL, V25, P336, DOI 10.1080/09297049.2018.1474865; Poysophon P, 2018, SPORTS HEALTH, V10, P317, DOI 10.1177/1941738117751387; Raab CA, 2020, ARCH CLIN NEUROPSYCH, V35, P283, DOI 10.1093/arclin/acz001; Rabinowitz AR, 2015, DEV NEUROPSYCHOL, V40, P29, DOI 10.1080/87565641.2014.1001066; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Salinas CM, 2016, APPL NEUROPSYCH-CHIL, V5, P264, DOI 10.1080/21622965.2015.1052814; Schatz P, 2017, SPORT EXERC PERFORM, V6, P243, DOI 10.1037/spy0000100; Schatz P, 2014, J ATHL TRAINING, V49, P659, DOI 10.4085/1062-6050-49.3.37; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Vickery CD, 2004, ARCH CLIN NEUROPSYCH, V19, P37, DOI 10.1016/S0887-6177(02)00170-1; Walton SR, 2018, MED SCI SPORT EXER, V50, P1377, DOI 10.1249/MSS.0000000000001592; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	45	2	2	1	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAY	2021	27	5					461	471		10.1017/S1355617720001149			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	SD6WJ	WOS:000651515000006	33292913				2022-02-06	
J	Martindale, SL; Ord, AS; Lad, SS; Miskey, HM; Taber, KH; Rowland, JA				Martindale, Sarah L.; Ord, Anna S.; Lad, Sagar S.; Miskey, Holly M.; Taber, Katherine H.; Rowland, Jared A.			Differential Effects of Deployment and Nondeployment Mild TBI on Neuropsychological Outcomes	REHABILITATION PSYCHOLOGY			English	Article						cognition; TBI; attention; PTSD; concussion	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; SERVICE MEMBERS; PERFORMANCE VALIDITY; IRAQI FREEDOM; VETERANS; ASSOCIATIONS; CONCUSSION; PTSD; METAANALYSIS	Objective: Mild traumatic brain injury (TBI) that occurs in a deployment environment is characteristically different from mild TBI that occurs outside of deployment. This study evaluated differential and interaction effects of deployment and nondeployment mild TBI on cognitive and behavioral health outcomes. Research Method: Combat veterans (N = 293) who passed performance-validity measures completed the Mid-Atlantic MIRECC Assessment of TBI (MMA-TBI), Clinician-Administered Posttraumatic Stress Disorder (PTSD) Scale (CAPS-5), a neuropsychological assessment battery, and self-report questionnaires. A 2 x 2 x 2 analysis of variance (ANOVA) was conducted to evaluate the main and interaction effects across mild TBI groups and PTSD diagnosis. Results: Deployment TBI was associated with poorer outcomes on several cognitive tests: Wechsler Adult Intelligence Scale, 4th edition (WAIS-IV); Working Memory Index (WMI; p = .018); Trail Making Test A (TMT-A; p < .001); and Trail Making Test B (TMT-B; p = .002). Deployment TBI and PTSD were also associated with increased PTSD, depressive, and neurobehavioral symptoms; pain interference; and poorer sleep quality. Nondeployment TBI had no effect on cognitive performance and was associated only with poorer sleep quality. PTSD had the strongest associations with symptom measures and deployment TBI with cognitive outcomes. There were no significant interaction effects after adjusting for multiple comparisons. Conclusions: Remote outcomes associated with mild deployment TBI are different from those associated with nondeployment mild TBI and are robust beyond PTSD. This suggests that the environment surrounding a TBI event influences cognitive and symptom sequelae. Veterans who experience mild TBI during deployment may report changes in cognition, but most will continue to function within the expected range.	[Martindale, Sarah L.; Ord, Anna S.; Lad, Sagar S.; Miskey, Holly M.; Taber, Katherine H.; Rowland, Jared A.] WG Bill Hefner VA Healthcare Syst, 1601 Brenner Ave 11M, Salisbury, NC 28144 USA; [Martindale, Sarah L.] Wake Forest Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27101 USA; [Ord, Anna S.; Lad, Sagar S.; Miskey, Holly M.] Wake Forest Sch Med, Dept Neurol, Winston Salem, NC 27101 USA; [Taber, Katherine H.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Rowland, Jared A.] Wake Forest Sch Med, Dept Neurobiol, Winston Salem, NC 27101 USA		Martindale, SL (corresponding author), WG Bill Hefner VA Healthcare Syst, 1601 Brenner Ave 11M, Salisbury, NC 28144 USA.	Sarah.Martindale-Supak@va.gov	Martindale, Sarah L/O-8553-2018	Martindale, Sarah L/0000-0002-0059-3454; Lad, PsyD, Sagar/0000-0002-1278-8355; Ord, Anna/0000-0003-3373-2016	Department of Defense Chronic Effects of Neurotrauma Consortium (CENC) Award [W81XWH-13-2-0095]; Department of Veterans Affairs CENC AwardUS Department of Veterans Affairs [I01 CX001135]	This work was supported by grant funding from a Department of Defense Chronic Effects of Neurotrauma Consortium (CENC) Award (W81XWH-13-2-0095) and a Department of Veterans Affairs CENC Award (I01 CX001135). This work was also supported by resources of the Salisbury Veterans Affairs Medical Center; the Mid-Atlantic Mental Illness Research Education and Clinical Center (MIRECC); and the Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness, Research, and Treatment (MIRT). The views, opinions, and/or findings contained in this article are those of the authors and should not be construed as an official U.S. Department of Veterans Affairs or U.S. Department of Defense position, policy, or decision, unless so designated by other official documentation. We thank the veterans and service members who participated in this research. We would also like to thank Mary Peoples; David J. Curry, Alana M. Higgins, Christine Sortino, and G. Melissa Evans, for their contributions to this project. For a comprehensive list of publications from the present study, please contact the corresponding author.	Amtmann D, 2010, PAIN, V150, P173, DOI 10.1016/j.pain.2010.04.025; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Boone K., 2002, THE B TEST; Bramoweth AD, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0401-4; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; Busse M, 2012, CLIN NEUROPSYCHOL, V26, P675, DOI 10.1080/13854046.2012.679623; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Cooper DB, 2018, J HEAD TRAUMA REHAB, V33, P81, DOI 10.1097/HTR.0000000000000375; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Defense and Veterans Brain Injury Center, 2019, DOD NUMB TRAUM BRAIN; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Green P, 2004, TEST MANUAL MEDICAL; Hamsher K., 1989, MULTILINGUAL APHASIA; Haran FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079595; Heaton R., 2004, PSYCHOL ASSESS RESOU; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson KM, 2013, J WOMENS HEALTH, V22, P267, DOI 10.1089/jwh.2012.3755; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Kocsis JD, 2009, J REHABIL RES DEV, V46, P667, DOI 10.1682/JRRD.2008.08.0100; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Martindale SL, 2020, NEUROPSYCHOLOGY, V34, P735, DOI 10.1037/neu0000672; Martindale SL, 2018, ARCH PHYS MED REHAB, V99, P2485, DOI 10.1016/j.apmr.2018.04.029; Martindale SL, 2017, NEUROPSYCHOLOGY, V31, P93, DOI 10.1037/neu0000312; Mattson EK, 2019, NEUROPSYCHOLOGY, V33, P913, DOI 10.1037/neu0000560; Neipert L, 2014, BRAIN INJURY, V28, P1667, DOI 10.3109/02699052.2014.947623; Nelson N.W., 2015, BRAIN NEUROTRAUMA MO, P451; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Regasa LE, 2019, J HEAD TRAUMA REHAB, V34, P21, DOI 10.1097/HTR.0000000000000417; Reitan R, 1985, HALSTEAD REITAN NEUR; Riley E, 2019, NEUROPSYCHOLOGY, V33, P534, DOI 10.1037/neu0000529; Roebuck-Spencer TM, 2012, CLIN NEUROPSYCHOL, V26, P473, DOI 10.1080/13854046.2011.650214; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rowland JA, 2020, J NEUROTRAUM, V37, P1797, DOI 10.1089/neu.2019.6972; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Shandera-Ochsner AL, 2013, CLIN NEUROPSYCHOL, V27, P881, DOI 10.1080/13854046.2013.802017; Shura RD, 2020, CLIN NEUROPSYCHOL, V34, P1025, DOI 10.1080/13854046.2019.1635209; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vasterling JJ, 2018, J INT NEUROPSYCH SOC, V24, P311, DOI 10.1017/S1355617717001059; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wrocklage KM, 2016, J INT NEUROPSYCH SOC, V22, P399, DOI 10.1017/S1355617716000059	62	2	2	2	2	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2021	66	2					128	138		10.1037/rep0000374			11	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	TF3LK	WOS:000670616800003	33382338				2022-02-06	
J	McKay, A; Trevena-Peters, J; Ponsford, J				McKay, Adam; Trevena-Peters, Jessica; Ponsford, Jennie			The Use of Atypical Antipsychotics for Managing Agitation After Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Agitated Behavior Scale (ABS); agitation; antipsychotics; posttraumatic amnesia (PTA); rehabilitation; traumatic brain injury (TBI); violence	PHARMACOLOGICAL MANAGEMENT; BEHAVIOR; REHABILITATION; RECOVERY; PATIENT; RECOMMENDATIONS; OUTCOMES; SCALE	Objective: This study examined the use of antipsychotics for managing agitation during posttraumatic amnesia (PTA) after traumatic brain injury (TBI) and its relationship with agitated behavior. Design: Observational prospective study with correlational design. Setting: Inpatient rehabilitation hospital for TBI. Participants: A total of 125 consecutive admissions who were in PTA and had moderate-severe TBI. Measures: Antipsychotic use was compared with agitation levels as measured by the total scores on the Agitated Behavior Scale (ABS). Results: Atypical antipsychotics were used in one-third of participants to manage agitation. Antipsychotic use was more common in participants with high levels of global agitation; however, there were many on antipsychotics who had mild or even no agitation according to the ABS. Uncontrolled observational data found no reduction in agitation after antipsychotic commencement or dose increase. Conclusions: Antipsychotics are commonly used to manage agitation after TBI despite limited evidence of efficacy. Agitation should be formally monitored in PTA to ensure antipsychotics are used to manage more severe agitation and for evaluating treatment response. Research is needed to understand why prescribers are using antipsychotics when agitation is mild or below clinical thresholds.	[McKay, Adam; Trevena-Peters, Jessica; Ponsford, Jennie] Monash Univ, Turner Inst, Melbourne, Vic, Australia; [McKay, Adam; Trevena-Peters, Jessica; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [McKay, Adam; Trevena-Peters, Jessica; Ponsford, Jennie] Epworth HealthCare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [McKay, Adam] Epworth HealthCare, Dept Psychol, Melbourne, Vic, Australia; [Ponsford, Jennie] Natl Trauma Res Inst, Melbourne, Vic, Australia		McKay, A (corresponding author), Monash Univ, Turner Inst, Clayton, Vic 3800, Australia.; McKay, A (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia.	adam.mckay@monash.edu; jessica.trevenapeters@gmail.com; jennie.ponsford@monash.edu					Bayley M., 2019, EVIDENCE BASED REV M, V13, P1; Beaulieu C, 2008, J HEAD TRAUMA REHAB, V23, P304, DOI 10.1097/01.HTR.0000336843.60961.b7; Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Bogner JA, 2000, J HEAD TRAUMA REHAB, V15, P656, DOI 10.1097/00001199-200002000-00005; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; Bogner J, 2015, ARCH PHYS MED REHAB, V96, pS274, DOI 10.1016/j.apmr.2015.04.020; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; Folweiler KA, 2017, J NEUROTRAUM, V34, P451, DOI 10.1089/neu.2016.4417; Francisco GE, 2007, BRAIN INJURY, V21, P1007, DOI 10.1080/02699050701559558; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P917, DOI 10.1016/S0003-9993(97)90050-2; GEFFEN G, 1994, AUST OCCUP THER J, V41, P31, DOI DOI 10.1111/J.1440-1630.1994.TB01809.X; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; Harmsen M, 2004, BRAIN INJURY, V18, P787, DOI 10.1080/02699050410001671757; Hicks AJ, 2018, J NEUROTRAUM, V35, P2755, DOI 10.1089/neu.2018.5738; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Janzen S, 2014, BRAIN INJURY, V28, P318, DOI 10.3109/02699052.2013.860478; Kadyan V, 2004, AM J PHYS MED REHAB, V83, P747, DOI 10.1097/01.PHM.0000140790.30468.F4; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Lequerica AH, 2007, J HEAD TRAUMA REHAB, V22, P177, DOI 10.1097/01.HTR.0000271118.96780.bc; MCNENY R, 1995, NEUROREHABILITATION, V5, P211, DOI 10.3233/NRE-1995-5304; McNett M, 2012, BRAIN INJURY, V26, P1155, DOI 10.3109/02699052.2012.667587; Mehta S, 2018, BRAIN INJURY, V32, P287, DOI 10.1080/02699052.2017.1419377; Mortimer DS, 2017, J NEUROSCI NURS, V49, P25, DOI 10.1097/JNN.0000000000000253; Mysiw WJ, 1997, ARCH PHYS MED REHAB, V78, P213, DOI 10.1016/S0003-9993(97)90266-5; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nash RP, 2019, PSYCHOSOMATICS, V60, P139, DOI 10.1016/j.psym.2018.11.009; Noe E, 2007, BEHAV NEUROL, V18, P7, DOI 10.1155/2007/529076; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; Perreault M., 2017, CRIT CARE, V21, P219, DOI [10.1186/s13054-017-1630-4, DOI 10.1186/S13054-017-1630-4]; Phelps TI, 2015, J NEUROTRAUM, V32, P590, DOI 10.1089/neu.2014.3711; Pisa FE, 2015, BRAIN INJURY, V29, P508, DOI 10.3109/02699052.2014.992474; Plantier D, 2016, ANN PHYS REHABIL MED, V59, P42, DOI 10.1016/j.rehab.2015.10.003; Ponsford J., 2018, NEUROPSYCHOL REHABIL, V30, P1; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Sandel ME, 1996, ARCH PHYS MED REHAB, V77, P617, DOI 10.1016/S0003-9993(96)90306-8; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; Shores E A, 1995, Appl Neuropsychol, V2, P167; Silver JM., 2004, NEUROPSYCHIATRY TRAU, P313; Singh R, 2014, BRAIN INJURY, V28, P336, DOI 10.3109/02699052.2013.873142; Waldron-Perrine B, 2008, REHABIL PSYCHOL, V53, P426, DOI 10.1037/a0013530; Williamson D, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029604	43	2	2	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2021	36	3			SI		149	155		10.1097/HTR.0000000000000614			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	SM4ZF	WOS:000657614900005	32898031				2022-02-06	
J	O'Neil-Pirozzi, TM; Lequerica, AH; Chiaravalloti, ND; Juengst, SB; Newman, JK				O'Neil-Pirozzi, Therese M.; Lequerica, Anthony H.; Chiaravalloti, Nancy D.; Juengst, Shannon B.; Newman, Jody K.			Cognitive-Communication Predictors of Employment Outcomes 1 and 5 Years Posttraumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognition; communication; comprehension; employment; expression; memory; problem solving; return to work; social interaction; traumatic brain injury	JOB STABILITY; WORK; RETURN; SEVERITY; RECOVERY; DURATION; MODERATE; AMNESIA; ABILITY; SKILLS	Objective: To examine changes in functional memory, problem solving, comprehension, expression, and social communication over the first 2 years posttraumatic brain injury (TBI) and the ability of each to predict return to work (RTW) outcomes at 1 year and 5 years postinjury. Design: Secondary analysis of data from a multicenter longitudinal cohort study. Setting: Acute inpatient rehabilitation facilities and community follow-up. Participants: A total of 3543 individuals between 16 and 60 years of age who were competitively employed at the time of TBI and had completed year 1, year 2, and year 5 postinjury follow-ups. Main Outcome Measures: Year 1 and year 5 RTW status (+/- competitively employed) at the time of study completion. Results: Greater function across each of the 5 cognitive-communication abilities was associated with RTW success at 1 year and 5 years post-TBI. At discharge, these 5 abilities showed comparable odds of predicting later employment. At year 1 and year 2 follow-ups, independence with problem solving was the most predictive of employment 5 years post-TBI, followed by social interaction, memory, expression, and comprehension. Conclusions: An increased rehabilitation focus on functional memory, problem solving, comprehension, expression, and social interaction post-TBI has the potential to improve RTW outcomes.	[O'Neil-Pirozzi, Therese M.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Dept Commun Sci & Disorders, 70 Forsyth Bldg,Room 103,360HuntingtonAve, Boston, MA 02132 USA; [Lequerica, Anthony H.; Chiaravalloti, Nancy D.] Kessler Fdn, Ctr Traumat Brain Injury Res, E Hanover, NJ USA; [Lequerica, Anthony H.; Chiaravalloti, Nancy D.] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA; [Juengst, Shannon B.] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Newman, Jody K.] Craig Hosp, Res Dept, Englewood, CO USA		O'Neil-Pirozzi, TM (corresponding author), Northeastern Univ, Dept Commun Sci & Disorders, 70 Forsyth Bldg,Room 103,360HuntingtonAve, Boston, MA 02132 USA.	t.oneil-pirozzi@neu.edu; a.lequerica@kesslerfoundation.org; n.chiaravalloti@kesslerfoundation.org; Shannon.Juengst@UTSouthwestern.edu; JNewman@CraigHospital.org			National Institute of Disability, Independent Living, and Rehabilitation Research (NIDILRR) [90DPTB0011, 90DPTB0003, 90DPTB0013-01-00, 90DPTB0007]	This work was funded by grants from the National Institute of Disability, Independent Living, and Rehabilitation Research (NIDILRR) to Spaulding/Harvard Traumatic Brain Injury Model System (90DPTB0011); Northern New Jersey Traumatic Brain Injury System (90DPTB0003); North Texas TBI Model System (UTSW; 90DPTB0013-01-00); and Rocky Mountain Regional Brain Injury System, Craig Hospital (90DPTB0007). NIDILRR is a center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS).	[Anonymous], 1997, GUID UN DAT SET MED; Arnould A, 2016, ANN PHYS REHABIL MED, V59, P18, DOI 10.1016/j.rehab.2015.09.002; Athanasou J., 2008, INT J DISABIL MANAG, V3, P54; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Bureau of Labor Statistics, 2018, EMPL MAJ IND SECT; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Douglas JM, 2016, J SPEECH LANG HEAR R, V59, P511, DOI 10.1044/2015_JSLHR-L-15-0025; Frey K., 2020, INT COGN COMM DIS C; Gauthier S, 2018, J COMMUN DISORD, V73, P77, DOI 10.1016/j.jcomdis.2018.04.003; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Groswasser Z, 1999, NEUROPSYCHOL REHABIL, V9, P493, DOI 10.1080/096020199389545; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Hendricks CT, 2017, J BURN CARE RES, V38, pE359, DOI 10.1097/BCR.0000000000000388; Inoue T, 2018, WORK, V60, P393, DOI 10.3233/WOR-182747; Isaki E, 2000, BRAIN INJURY, V14, P441; Kelly M, 2017, J HEAD TRAUMA REHAB, V32, pE55, DOI 10.1097/HTR.0000000000000269; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Larkins BM, 2004, BRAIN INJURY, V18, P691, DOI 10.1080/02699050310001617389; Meulenbroek P, 2016, J VOCAT REHABIL, V44, P15, DOI 10.3233/JVR-150777; Meulenbroek P, 2016, DISABIL REHABIL, V38, P452, DOI 10.3109/09638288.2015.1044621; Murphy L, 2006, BRAIN INJURY, V20, P1119, DOI 10.1080/02699050600664335; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; O'Neil-Pirozzi TM, 2018, J HEAD TRAUMA REHAB, V33, P237, DOI 10.1097/HTR.0000000000000365; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Purohit M, 2014, ARCH PHYS MED REHAB, V95, P1342, DOI 10.1016/j.apmr.2014.01.029; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Unal I, 2017, COMPUT MATH METHOD M, V2017, DOI 10.1155/2017/3762651; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737	33	2	2	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2021	36	3			SI		196	204		10.1097/HTR.0000000000000641			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	SM4ZF	WOS:000657614900014	33528176	Green Accepted			2022-02-06	
J	Parekh, SM; Fernandes, GS; Moses, JP; Fuller, CW; Scammell, BE; Batt, ME; Zhang, WY; Doherty, M				Parekh, Sanjay M.; Fernandes, Gwen S.; Moses, Jonathan P.; Fuller, Colin W.; Scammell, Brigitte E.; Batt, Mark E.; Zhang, Weiya; Doherty, Michael			Postural Control Deficits After Repetitive Soccer Heading	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; mild traumatic brain injury; subconcussion; football	LINE DRAWING ATLAS; PROFESSIONAL FOOTBALL; KNEE OSTEOARTHRITIS; WIDESPREAD PAIN; RISK; PREVALENCE; INJURIES; LEVEL; CHONDROCALCINOSIS; MENISCECTOMY	Objective: To determine the acute effects of repetitive soccer heading on postural control. Design: Prospective study; participants were divided into 2 groups: a soccer heading group and a control group. Setting: Biomechanics laboratory. Participants: One hundred sixty participants, including youth (age = 13.0 +/- 0.8 years), high school (age = 17.2 +/- 1.0 years), and collegiate (age = 20.2 +/- 1.3 years) male and female soccer players, participated in this study. Interventions: Participants in the soccer heading group performed 12 soccer headers (initial velocity = 11.2 m/s). Postural control testing was performed both before (PRE) and immediately after (POST) the purposeful soccer headers. Control participants performed postural control testing PRE and POST a 15-minute wait period. During postural control testing, participants were asked to stand on the MobileMat (Tekscan Inc, Boston, Massachusetts) for two 2-minute intervals with their hands on their hips and their feet together with one eyes-open and one eyes-closed trial. Main Outcome Measures: Using the center-of-pressure data, 95% area, sway velocity, and ApEn were calculated. Multilevel linear models were used to analyze the effects of age, sex, group, condition, and concussion history simultaneously. Results: Participants in the soccer heading group had significantly higher sway velocity POST than participants in the control group after controlling for age, sex, concussion history, condition, and PRE (t = -3.002; P = 0.003; 95% confidence interval, -0.482 to -0.100). There were no significant differences from PRE to POST for 95% area, M/L ApEn, and A/P ApEn. Conclusions: Repetitive soccer heading does not affect most postural control measures, even among youth athletes. However, sway velocity increased after heading relative to control participants independent of age, sex, and concussion history.	[Parekh, Sanjay M.; Fernandes, Gwen S.; Zhang, Weiya; Doherty, Michael] Univ Nottingham, Acad Rheumatol, Sch Med, Div Rheumatol Orthopaed & Dermatol, Nottingham, England; [Parekh, Sanjay M.; Fernandes, Gwen S.; Moses, Jonathan P.; Fuller, Colin W.; Scammell, Brigitte E.; Batt, Mark E.; Zhang, Weiya; Doherty, Michael] Queens Med Ctr, Arthrit Res UK Ctr Sport Exercise & Osteoarthrit, Nottingham, England; [Fernandes, Gwen S.; Scammell, Brigitte E.; Zhang, Weiya; Doherty, Michael] Nottingham City Hosp, Arthrit Res UK Pain Ctr, Nottingham, England; [Moses, Jonathan P.; Scammell, Brigitte E.; Batt, Mark E.] Nottingham Univ Hosp NHS Trust, Queens Med Ctr, Nottingham, England; [Fuller, Colin W.] Colin Fuller Consultancy Ltd, East Leake, England		Zhang, WY (corresponding author), Nottingham City Hosp, Arthrit Res UK Pain Ctr, Nottingham, England.; Zhang, WY (corresponding author), Nottingham City Hosp, Acad Rheumatol, Clin Sci Bldg, Nottingham NG5 1PB, England.	weiya.zhang@nottingham.ac.uk		Fernandes, Gwen Sascha/0000-0003-0203-7053; Doherty, Michael/0000-0002-5763-8326; Parekh, Sanjay/0000-0002-4249-0891	Arthritis Research UK Centre for Sport, Exercise and OsteoarthritisVersus Arthritis [20194]; FIFA Medical Assessment and Research Centre (F-MARC); Professional Football Association (PFA)	This study was funded by Arthritis Research UK Centre for Sport, Exercise and Osteoarthritis (Grant 20194). The study was also funded by the FIFA Medical Assessment and Research Centre (F-MARC) and the Professional Football Association (PFA).	Arden N, 2006, BEST PRACT RES CL RH, V20, P3, DOI 10.1016/j.berh.2005.09.007; Arliani GG, 2014, CLINICS, V69, P589, DOI 10.6061/clinics/2014(09)03; BISHAY M, 1992, BRIT MED J, V305, P477, DOI 10.1136/bmj.305.6851.477; Braun HJ, 2012, BONE, V51, P278, DOI 10.1016/j.bone.2011.11.019; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; DOHERTY M, 1982, LANCET, V1, P1207; Drawer S, 2002, BRIT J SPORT MED, V36, P446, DOI 10.1136/bjsm.36.6.446; Drawer S, 2001, BRIT J SPORT MED, V35, P402, DOI 10.1136/bjsm.35.6.402; Ekstrand J, 2011, BRIT J SPORT MED, V45, P553, DOI 10.1136/bjsm.2009.060582; Elleuch M. H., 2008, Annales de Readaptation et de Medecine Physique, V51, P174, DOI 10.1016/j.annrmp.2008.01.003; Fernandes GS, 2018, BRIT J SPORT MED, V52, P678, DOI 10.1136/bjsports-2017-097503; FIFA, 2007, BIG COUNT 2006 FACTS; Fuller CW, 2004, AM J SPORT MED, V32, p43S, DOI 10.1177/0363546503261248; Fuller CW, 2006, BRIT J SPORT MED, V40, P151, DOI 10.1136/bjsm.2005.021048; HADLER NM, 1992, ANN INTERN MED, V116, P598, DOI 10.7326/0003-4819-116-7-598; Hawkins RD, 1999, BRIT J SPORT MED, V33, P196, DOI 10.1136/bjsm.33.3.196; Heidari B, 2011, CASP J INTERN MED, V2, P249; Hugman BJ, 2005, PFA 1 FOOTBALL LEAGU; Hunt IM, 1999, RHEUMATOLOGY, V38, P275, DOI 10.1093/rheumatology/38.3.275; Ingham SL, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-57; Krajnc Z, 2010, WIEN KLIN WOCHENSCHR, V122, P40, DOI 10.1007/s00508-010-1341-1; Kuijt MTK, 2012, J SCI MED SPORT, V15, P480, DOI 10.1016/j.jsams.2012.02.008; LEDINGHAM J, 1993, ANN RHEUM DIS, V52, P520, DOI 10.1136/ard.52.7.520; Macfarlane GJ, 1996, J RHEUMATOL, V23, P1628; Mandelbaum BR, 2005, AM J SPORT MED, V33, P1003, DOI 10.1177/0363546504272261; McMillan G, 2005, OCCUP ENVIRON MED, V62, P567, DOI 10.1136/oem.2004.017137; Muraki S, 2012, ARTHRITIS RHEUM-US, V64, P1447, DOI 10.1002/art.33508; Muthuri SG, 2011, OSTEOARTHR CARTILAGE, V19, P1286, DOI 10.1016/j.joca.2011.07.015; Nagaosa Y, 2000, ANN RHEUM DIS, V59, P587, DOI 10.1136/ard.59.8.587; Neame RL, 2003, ANN RHEUM DIS, V62, P513, DOI 10.1136/ard.62.6.513; PARTRIDGE RE, 1968, ANN RHEUM DIS, V27, P559, DOI 10.1136/ard.27.6.559; Rees F, 2012, ARTHRIT CARE RES, V64, P533, DOI 10.1002/acr.21586; Roddy E, 2012, JOINT BONE SPINE, V79, P425, DOI 10.1016/j.jbspin.2012.03.013; Roemer FW, 2014, BEST PRACT RES CL RH, V28, P31, DOI 10.1016/j.berh.2014.02.002; ROOS H, 1994, AM J SPORT MED, V22, P219, DOI 10.1177/036354659402200211; ROSENBERG TD, 1988, J BONE JOINT SURG AM, V70A, P1479, DOI 10.2106/00004623-198870100-00006; Silverwood V, 2015, OSTEOARTHR CARTILAGE, V23, P507, DOI 10.1016/j.joca.2014.11.019; Suri P, 2012, PM&R, V4, pS10, DOI 10.1016/j.pmrj.2012.01.007; THUN M, 1987, BRIT J IND MED, V44, P611; Tran G, 2016, BRIT J SPORT MED, V50, P1459, DOI 10.1136/bjsports-2016-096142; Turner AP, 2000, BRIT J SPORT MED, V34, P332, DOI 10.1136/bjsm.34.5.332; von Porat A, 2004, ANN RHEUM DIS, V63, P269, DOI 10.1136/ard.2003.008136; Walden M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3042; Wilkinson CE, 2005, ANN RHEUM DIS, V64, P1467, DOI 10.1136/ard.2004.033282; Zhang W, 2008, ARTHRITIS RHEUM, V58, P137, DOI 10.1002/art.23237; Zhang W, 2011, ANN RHEUM DIS, V70, P563, DOI 10.1136/ard.2010.139105	46	2	2	2	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2021	31	3					281	288		10.1097/JSM.0000000000000742			8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	SO2PJ	WOS:000658818900014	31157625	Green Published			2022-02-06	
J	Tarudji, AW; Gee, CC; Romereim, SM; Convertine, AJ; Kievit, FM				Tarudji, Aria W.; Gee, Connor C.; Romereim, Sarah M.; Convertine, Anthony J.; Kievit, Forrest M.			Antioxidant thioether core-crosslinked nanoparticles prevent the bilateral spread of secondary injury to protect spatial learning and memory in a controlled cortical impact mouse model of traumatic brain injury	BIOMATERIALS			English	Article						Traumatic brain injury; Nanomedicine; Neuroinflammation; Reactive oxygen species; Morris water maze		The secondary phase of traumatic brain injury (TBI) is partly caused by the release of excess reactive oxygen species (ROS) from the primary injury. However, there are currently no therapies that have been shown to reduce the secondary spread of injury beyond the primary insult. Nanoparticles offer the ability to rapidly accumulate and be retained in injured brain for improved target engagement. Here, we utilized systemically administered antioxidant thioether core-cross-linked nanoparticles (NP1) that scavenge and inactivate ROS to reduce this secondary spread of injury in a mild controlled cortical impact (CCI) mouse model of TBI. We found that NP1 treatment protected CCI mice from injury induced learning and memory deficits observed in the Morris water maze (MWM) test at 1-month post-CCI. This protection was likely a result of NP1-mediated reduction in oxidative stress in the ipsilateral hemisphere as determined by immunofluorescence imaging of markers of oxidative stress and the spread of neuroinflammation into the contralateral hippocampus as determined by immunofluorescence imaging of activated microglia and neuron-astrocyte-microglia triad formation. These data suggest NP1-mediated reduction in post-traumatic oxidative stress correlates with the reduction in the spread of injury to the contralateral hippocampus to protect spatial memory and learning in CCI mice. Therefore, these materials may offer an improved treatment strategy to reduce the secondary spread of TBI.	[Tarudji, Aria W.; Gee, Connor C.; Romereim, Sarah M.; Kievit, Forrest M.] Univ Nebraska Lincoln, Dept Biol Syst Engn, 200LW Chase Hall, Lincoln, NE 68583 USA; [Convertine, Anthony J.] Missouri Univ Sci & Technol, Dept Mat Sci & Engn, 223 McNutt Hall, Rolla, MO 65409 USA		Kievit, FM (corresponding author), Univ Nebraska Lincoln, 228 LW Chase Hall,3605 Fair St, Lincoln, NE 68583 USA.	fkievit2@unl.edu		Tarudji, Aria/0000-0002-3887-0648; Kievit, Forrest/0000-0002-9847-783X; Gee, Connor/0000-0002-5205-7557	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20GM103480]; Nebraska Settlement Biomedical Research Development Funds; National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS109488]	F.K. acknowledges support from an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health (P20GM103480), the Nebraska Settlement Biomedical Research Development Funds, and the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (R01NS109488).	Adibhatla RM, 2010, ANTIOXID REDOX SIGN, V12, P125, DOI [10.1089/ars.2009.2668, 10.1089/ARS.2009.2668]; Alluri H, 2018, METHODS MOL BIOL, V1717, P37, DOI 10.1007/978-1-4939-7526-6_4; Ayoub AE, 2003, J NEUROSCI, V23, P7759; Bailey ZS, 2020, J NEUROTRAUM, V37, P1452, DOI 10.1089/neu.2016.4644; Baker EW, 2019, J NEUROTRAUM, V36, P61, DOI 10.1089/neu.2017.5551; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Beckhauser T.F., 2016, J EXP NEUROSCI, V10s1; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Bharadwaj VN, 2020, TISSUE ENG PT A, V26, P688, DOI 10.1089/ten.tea.2020.0040; Bharadwaj VN, 2018, NANOMED-NANOTECHNOL, V14, P2155, DOI 10.1016/j.nano.2018.06.004; Bharadwaj VN, 2016, SCI REP-UK, V6, DOI 10.1038/srep29988; Bony BA, 2020, ACS OMEGA, V5, P16220, DOI 10.1021/acsomega.0c01890; Braun M, 2017, J IMMUNOL, V198, P3615, DOI 10.4049/jimmunol.1601948; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Cerbai F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045250; Cruz LJ, 2016, J CONTROL RELEASE, V223, P31, DOI 10.1016/j.jconrel.2015.12.029; Cunningham CL, 2013, J NEUROSCI, V33, P4216, DOI 10.1523/JNEUROSCI.3441-12.2013; Di Pietro V, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9030260; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; DUVDEVANI R, 1995, J NEUROTRAUM, V12, P65, DOI 10.1089/neu.1995.12.65; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Foote C.S., 1971, 23 INT C PUR APPL CH, P129; Gerlai RT, 2002, BRAIN RES BULL, V57, P3, DOI 10.1016/S0361-9230(01)00630-X; Ghosh N, 2018, IMMUNITY AND INFLAMMATION IN HEALTH AND DISEASE: EMERGING ROLES OF NUTRACEUTICALS AND FUNCTIONAL FOODS IN IMMUNE SUPPORT, P45, DOI 10.1016/B978-0-12-805417-8.00004-4; Goff HD, 1997, INT DAIRY J, V7, P363, DOI 10.1016/S0958-6946(97)00040-X; Gruenbaum SE, 2016, CNS DRUGS, V30, P791, DOI 10.1007/s40263-016-0355-2; Hall ED, 2019, NEUROPHARMACOLOGY, V145, P247, DOI 10.1016/j.neuropharm.2018.08.005; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jahn-Eimermacher A, 2011, BEHAV BRAIN RES, V221, P271, DOI 10.1016/j.bbr.2011.03.007; Janatpour ZC, 2019, J NEUROTRAUM, V36, P3115, DOI 10.1089/neu.2019.6376; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jullienne A, 2018, J NEUROTRAUM, V35, P1646, DOI 10.1089/neu.2017.5547; Kim S., 2017, CONCUSSION, V2; Kinder HA, 2019, J NEUROTRAUM, V36, P2810, DOI 10.1089/neu.2019.6405; Klima D, 2019, PERCEPT MOTOR SKILL, V126, P50, DOI 10.1177/0031512518809203; Kumar A, 2016, BRAIN BEHAV IMMUN, V58, P291, DOI 10.1016/j.bbi.2016.07.158; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Lana D, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00296; Lana D, 2017, EXP GERONTOL, V96, P46, DOI 10.1016/j.exger.2017.06.006; Lana D, 2016, EXP GERONTOL, V83, P71, DOI 10.1016/j.exger.2016.07.011; Lana D, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00322; Leconte C, 2020, J NEUROTRAUM, V37, P1342, DOI 10.1089/neu.2019.6679; Li W, 2016, BRAIN RES, V1646, P53, DOI 10.1016/j.brainres.2016.05.036; Liu YL, 2017, ACTA PHARMACOL SIN, V38, P1445, DOI 10.1038/aps.2017.103; Loane D, 2014, NEUROTHERAPEUTICS, V11, P857, DOI 10.1007/s13311-014-0298-6; Lutton EM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03309-4; Mao X, 2020, J NEUROTRAUM, V37, P1331, DOI 10.1089/neu.2019.6510; Megjhani M, 2015, BIOINFORMATICS, V31, P2190, DOI 10.1093/bioinformatics/btv109; Miller DM, 2015, EXP NEUROL, V264, P103, DOI 10.1016/j.expneurol.2014.11.008; Miller HA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52622-7; Minogue AM, 2017, PROG NEURO-PSYCHOPH, V79, P15, DOI 10.1016/j.pnpbp.2017.02.008; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; O'Grady KP, 2018, ACS BIOMATER SCI ENG, V4, P1251, DOI 10.1021/acsbiomaterials.6b00804; O'Keeffe E, 2020, J NEUROTRAUM, V37, P347, DOI 10.1089/neu.2019.6483; OMAR BA, 1990, FREE RADICAL BIO MED, V9, P465, DOI 10.1016/0891-5849(90)90123-Z; OMAR BA, 1990, FREE RADICAL BIO MED, V9, P473, DOI 10.1016/0891-5849(90)90124-2; Osier ND, 2015, J NEUROTRAUM, V32, P1861, DOI 10.1089/neu.2014.3680; Pekny M, 2016, BBA-MOL BASIS DIS, V1862, P483, DOI 10.1016/j.bbadis.2015.11.014; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Sato K, 2001, TETRAHEDRON, V57, P2469, DOI 10.1016/S0040-4020(01)00068-0; Schwartzberg LS, 2018, ADV THER, V35, P754, DOI 10.1007/s12325-018-0707-z; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Smith SL, 1998, J NEUROTRAUM, V15, P707, DOI 10.1089/neu.1998.15.707; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Ugolini F, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00372; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Xu JL, 2016, ADV FUNCT MATER, V26, P4124, DOI 10.1002/adfm.201504416; Xu Y, 2016, IEEE J-STSP, V10, P115, DOI 10.1109/JSTSP.2015.2505660; Yoo D, 2017, ACS NANO, V11, P8600, DOI 10.1021/acsnano.7b03426; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	77	2	2	9	14	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	MAY	2021	272								120766	10.1016/j.biomaterials.2021.120766			12	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	RP8NN	WOS:000641980000002	33819812				2022-02-06	
J	Wilmoth, K; Curcio, N; Tarkenton, T; Meredith-Duliba, T; Tan, A; Didehbani, N; Hynan, LS; Miller, SM; Bell, KR; Cullum, CM				Wilmoth, Kristin; Curcio, Nicholas; Tarkenton, Tahnae; Meredith-Duliba, Tawny; Tan, Alexander; Didehbani, Nyaz; Hynan, Linda S.; Miller, Shane M.; Bell, Kathleen R.; Cullum, C. Munro			Utility of Brief Psychological Measures for Prediction of Prolonged Symptom Clearance in Concussed Student Athletes	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Concussion; Athletes; Sports; Adolescent psychology; Psychological screening inventory; Neuropsychological rehabilitation	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; POSTCONCUSSION SYNDROME; SLEEP DISTURBANCE; RECOVERY; CHILDREN; ANXIETY	Objective: Variability in recovery time following sport-related concussion (SRC) is poorly understood. We explored the utility of brief mood, anxiety, and sleep questionnaires as postinjury predictors of SRC symptom clearance in adolescents. Method: At initial visit 0-2 weeks postinjury, concussed athletes aged 12-18 years self-reported injury/medical factors (prior concussion, loss of consciousness, amnesia, and concussion symptom severity) and were administered psychological symptom measures. At 3 months, medical record review determined return-to-play (RTP) date. Subjects were divided into two datasets, with the first utilized for developing cutoff scores and then validated with the second dataset. Results: A total of 64% of the 141 participants had early RTP (within 21 days postinjury), and 23% had late RTP (postinjury day 30 or later). The Generalized Anxiety Disorder Screener (GAD-7, M = 2.1, SD = 3.1) was the only significant predictor (p = .001), with a 1.4-fold [95% CI 1.2-1.8] increased risk for every point. No other factors in the full model discriminated recovery groups (ps > .05). Receiver operating characteristic curve analysis derived a GAD-7 cut score >= 3 (sensitivity= 56.7%, specificity = 74.2%, AUCs = 0.63-0.79, ps < .001). Conclusions: Postconcussion anxiety symptoms may help identify individuals at increased risk for prolonged recovery.	[Wilmoth, Kristin] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Wilmoth, Kristin] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Curcio, Nicholas; Tarkenton, Tahnae; Meredith-Duliba, Tawny; Didehbani, Nyaz; Hynan, Linda S.; Cullum, C. Munro] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX USA; [Tan, Alexander] Childrens Healthcare Atlanta, Dept Neuropsychol, Atlanta, GA USA; [Hynan, Linda S.] Univ Texas Southwestern Med Ctr Dallas, Dept Populat & Data Sci Biostat, Dallas, TX 75390 USA; [Miller, Shane M.] Univ Texas Southwestern Med Ctr Dallas, Dept Orthopaed Surg, Dallas, TX 75390 USA; [Miller, Shane M.] Texas Scottish Rite Hosp Children, Dept Sports Med, Dallas, TX 75219 USA; [Bell, Kathleen R.] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Cullum, C. Munro] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Cullum, C. Munro] Univ Texas Southwestern Med Ctr Dallas, Dept Neurotherapeut & Neurol Surg, Dallas, TX 75390 USA		Cullum, CM (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Munro.Cullum@UTSouthwestern.edu		Tan, Alexander/0000-0001-5198-4618	Peter O'Donnell Jr.; Brain Institute; Texas Institute for Brain Injury and Repair at the University of Texas Southwestern Medical Center	This work was supported by the Peter O'Donnell Jr. Brain Institute and the Texas Institute for Brain Injury and Repair at the University of Texas Southwestern Medical Center.	Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bramley H, 2017, CLIN PEDIATR, V56, P1280, DOI 10.1177/0009922816681603; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chorney DB, 2008, J PEDIATR PSYCHOL, V33, P339, DOI 10.1093/jpepsy/jsm105; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Covassin T, 2017, SPORT EXERC PERFORM, V6, P220, DOI 10.1037/spy0000105; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Hixson KM, 2017, J SPORT REHABIL, V26, P588, DOI 10.1123/jsr.2016-0122; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Krzanowski WJ, 2009, MONOGR STAT APPL PRO, V111, P1; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lees-Haley PR, 2001, ARCH CLIN NEUROPSYCH, V16, P689, DOI 10.1016/S0887-6177(00)00092-5; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Menard S, 2002, APPL LOGISTIC REGRES, V106; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Murdaugh DL, 2018, ARCH PHYS MED REHAB, V99, P960, DOI 10.1016/j.apmr.2018.01.005; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Thomas DJ, 2018, CLIN J SPORT MED, V28, P56, DOI 10.1097/JSM.0000000000000413; Tiirikainen K, 2019, PSYCHIAT RES, V272, P30, DOI 10.1016/j.psychres.2018.12.004; Weber ML, 2018, AM J SPORT MED, V46, P1742, DOI 10.1177/0363546518765145; Wilmoth K, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519830421	33	2	2	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2021	36	3					430	436		10.1093/arclin/acz061			7	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	TB2DI	WOS:000667754500014	31768516				2022-02-06	
J	Zirovich, MD; Pangarkar, SS; Manh, C; Chen, L; Vangala, S; Elashoff, DA; Izuchukwu, IS				Zirovich, Milena D.; Pangarkar, Sanjog S.; Manh, Christina; Chen, Lucia; Vangala, Sitaram; Elashoff, David A.; Izuchukwu, Ifeoma Stella			Botulinum Toxin Type A for the Treatment of Post-traumatic Headache: A Randomized, Placebo-Controlled, Cross-over Study	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; CHRONIC MIGRAINE; DOUBLE-BLIND; CONTROLLED PHASE; ONABOTULINUMTOXINA; CONVERSION	Introduction: Botulinum toxin type A (BoNT/A) is an approved treatment for chronic migraine and has been shown to be effective in reducing number, days, and severity of headache in other headache disorders. Whether botulinum toxin is a safe and effective treatment specifically for post-traumatic headache (PTH), however, is unknown. This study sought to determine whether treatment with BoNT/A improved symptoms of PTH in military veterans. Materials and Methods: Forty subjects with PTH were randomized to receive treatment of either BoNT/A or a saline placebo. Sixteen weeks post-treatment or at return to baseline headache severity, subjects were crossed over to receive treatment with the other medication than previously treated with in the first session. Subjects recorded number of headaches, number of headache days, and headache pain severity in daily diaries. Outcome measures included change in the weekly number of headaches, number of headache days per week, and headache pain severity compared to baseline, and the change in number of headaches and number of headaches days at baseline compared to the rating scores averaged across weeks 6-11. Results: The number of headaches per week significantly decreased by 2.24 (43.3%) with BoNT/A treatment (P < .001) and significantly increased by 1.28 (35.1%) with placebo (P = .02) at the end of the 16 weeks and the difference between groups was also significant (P < .001). The number of headache days per week also significantly decreased by 2.24 (44.4%) at the end of 16 weeks with BoNT/A treatment (P < .001), was not significantly changed with placebo, and the difference between the two groups was significant (P < .001). Both the change in number of headaches and number of headache days averaged across weeks 6-11 compared to baseline were significantly decreased in the BoNT/A group (1.6 and 1.4, respectively) compared to a significant increase of 0.3 in number of weekly headaches and a nonsignificant decrease of 0.1 in number of headache days for the placebo group (P = .048 and P = .005, respectively). Headache pain severity was significantly reduced by 0.06 with botulinum toxin treatment (P = .02) and was not significantly increased by 0.04 in the placebo group with a significant difference between groups (P = .006). Conclusions: Treatment with BoNT/A clinically and significantly improved the frequency and pain severity of PTH compared to placebo in military veterans. Limitations of the study include subject dropout, adherence to documenting variables daily in the dairy, and only one treatment of BoNT/A. Strengths include the cross-over study design, which demonstrated that BoNT/A was effective regardless of treatment order. This dataset is the first prospective study to evaluate BoNT/A as an intervention for symptoms of PTH and provides evidence that larger-scale and multiple treatment studies evaluating BoNT/A for this headache type are warranted.	[Zirovich, Milena D.; Pangarkar, Sanjog S.; Manh, Christina] VA Greater Los Angeles Healthcare Serv, Phys Med & Rehabil Serv, Los Angeles, CA 90073 USA; [Zirovich, Milena D.; Pangarkar, Sanjog S.; Izuchukwu, Ifeoma Stella] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Chen, Lucia; Vangala, Sitaram; Elashoff, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med Stat Core, Los Angeles, CA 90024 USA; [Elashoff, David A.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Izuchukwu, Ifeoma Stella] VA Greater Los Angeles Healthcare Serv, Internal Med Serv, Los Angeles, CA 90073 USA; [Elashoff, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Clin Translat Sci Inst, Los Angeles, CA 90024 USA		Zirovich, MD (corresponding author), VA Greater Los Angeles Healthcare Serv, Phys Med & Rehabil Serv, Los Angeles, CA 90073 USA.; Zirovich, MD (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.				Ipsen BiopharmaceuticalsIpsen [Zirovich0002]	This study was funded by Ipsen Biopharmaceuticals with an unrestricted grant and study medication (grant ID: Zirovich0002).	Andreou AP, 2018, EUR J NEUROL, V25, P1069, DOI 10.1111/ene.13657; [Anonymous], AUTHOR IS DEP DEFENS; Aoki KR, 2003, HEADACHE, V43, pS9; Aurora SK, 2010, CEPHALALGIA, V30, P793, DOI 10.1177/0333102410364676; Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; Blumenfeld AM, 2004, DERMATOL CLIN, V22, P167, DOI 10.1016/S0733-8635(03)00105-0; Dashtipour K, 2016, MOV DISORD CLIN PRAC, V3, P109, DOI 10.1002/mdc3.12235; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Diener HC, 2010, CEPHALALGIA, V30, P804, DOI 10.1177/0333102410364677; Do TP, 2018, ACTA NEUROL SCAND, V137, P442, DOI 10.1111/ane.12906; Dodick DW, 2010, HEADACHE, V50, P921, DOI 10.1111/j.1526-4610.2010.01678.x; Durham PL, 2004, HEADACHE, V44, P35, DOI 10.1111/j.1526-4610.2004.04007.x; Fabrizio KS, 2010, NURS CLIN N AM, V45, P569, DOI 10.1016/j.cnur.2010.06.003; Hagen C, 1999, LEVELS COGNITIVE FUN; JENSEN MP, 1994, PAIN, V58, P387, DOI 10.1016/0304-3959(94)90133-3; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Lippert-Gruner M, 2012, NEUROL NEUROCHIR POL, V46, P591, DOI 10.5114/ninp.2012.32109; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; Luvisetto S, 2015, TOXINS, V7, P3818, DOI 10.3390/toxins7093818; Porta Mauro, 2005, J Headache Pain, V6, P325, DOI 10.1007/s10194-005-0222-x; Santoro A, 2017, NEUROL SCI, V38, P1779, DOI 10.1007/s10072-017-3054-y; Scaglione F, 2016, TOXINS, V8, DOI 10.3390/toxins8030065; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Silberstein SD, 2015, J NEUROL NEUROSUR PS, V86, P996, DOI 10.1136/jnnp-2013-307149; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Weathers F.W., 1993, ANN CONV INT SOC TRA; Yerry JA, 2015, HEADACHE, V55, P395, DOI 10.1111/head.12495; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	28	2	2	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAY-JUN	2021	186	5-6					493	499		10.1093/milmed/usaa391			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TF9TQ	WOS:000671057600020	33241323	hybrid			2022-02-06	
J	Spronk, I; Polinder, S; Bonsel, GJ; Janssen, MF; Haagsma, JA				Spronk, I.; Polinder, S.; Bonsel, G. J.; Janssen, M. F.; Haagsma, J. A.			The relation between EQ-5D and fatigue in a Dutch general population sample: an explorative study	HEALTH AND QUALITY OF LIFE OUTCOMES			English	Article							QUALITY-OF-LIFE; HEALTH-STATUS; BOLT-ON; EUROQOL; IMPACT; PREVALENCE; DIMENSIONS; VERSION; TARIFF; STATE	Background Fatigue negatively influences health-related quality of life. It is questionable whether fatigue is sufficiently covered by the EQ-5D. This study investigated whether fatigue is covered by the existing domains of the EQ-5D. Methods A Dutch general population sample completed the EQ-5D (3L and 5L version) and the Rivermead Post-Concussion Symptoms Questionnaire (RPQ), of which the fatigue item was used. Outcomes were compared between participants with and without a chronic health condition. Convergent validity was assessed, and multivariate regression analyses was used to predict the RPQ fatigue item from the EQ-5D-3L and EQ-5D-5L domains separately. Results 3027 people completed the survey, of whom 52% had >= 1 chronic health condition. Fatigue was reported by 48% of the participants. Fatigue was moderately correlated to the EQ-5D domains 'pain/discomfort', 'usual activities', and 'anxiety/depression' for the 3L (r = 0.379-0.426) and 5L version (r = 0.411-0.469). For the 5L, also a moderate correlation with 'mobility' (r = 0.335) was observed. The remaining correlations were weak. All EQ-5D-3L and 5L domains except for 'mobility' were significantly associated with the RPQ fatigue item (unstandardized Beta = - 0.20-0.67; p < 0.01 to p = 0.04). Comparable outcomes were found for participants with and without >= 1 chronic health condition. Conclusions The extent to which fatigue is covered by the EQ-5D domains is small to moderate, with the EQ-5D-5L being slightly more sensitive to capture fatigue compared to the EQ-5D-3L. An extra fatigue item for the EQ-5D may add value, as fatigue is not fully captured by the existing domains, both in people with and without a chronic health condition.	[Spronk, I.; Polinder, S.; Bonsel, G. J.; Haagsma, J. A.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Spronk, I.] Maasstad Hosp, Assoc Dutch Burn Ctr, Rotterdam, Netherlands; [Bonsel, G. J.] EuroQol Grp Execut Off, Rotterdam, Netherlands; [Janssen, M. F.] Erasmus MC, Dept Psychiat, Sect Med Psychol & Psychotherapy, Rotterdam, Netherlands		Spronk, I (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.; Spronk, I (corresponding author), Maasstad Hosp, Assoc Dutch Burn Ctr, Rotterdam, Netherlands.	i.spronk@erasmusmc.nl		Spronk, Inge/0000-0001-9571-576X	EuroQol [20180330]	This study was funded by EuroQol (Grant Number: 20180330).	Basu N, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0662-y; Brazier J, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18340; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Brooks RG, 2015, EUROQOL WORKING PAPE; Buchholz I, 2018, PHARMACOECONOMICS, V36, P645, DOI 10.1007/s40273-018-0642-5; Cohen J., 2013, STAT POWER ANAL BEHA; Coons SJ, 2000, PHARMACOECONOMICS, V17, P13, DOI 10.2165/00019053-200017010-00002; Cullen W, 2002, IRISH J MED SCI, V171, P10, DOI 10.1007/BF03168931; De Smedt D, 2013, INT J CARDIOL, V167, P2294, DOI 10.1016/j.ijcard.2012.06.025; Dellenmark-Blom M, 2019, QUAL LIFE RES, V28, P1389, DOI 10.1007/s11136-019-02119-7; Devlin NJ, 2004, QUAL LIFE RES, V13, P1265, DOI 10.1023/B:QURE.0000037495.00959.9b; Efthymiadou O, 2019, HEALTH POLICY, V123, P159, DOI 10.1016/j.healthpol.2018.12.003; Finch AP, 2019, VALUE HEALTH, V22, P50, DOI 10.1016/j.jval.2018.07.001; Finch AP, 2018, EUR J HEALTH ECON, V19, P557, DOI 10.1007/s10198-017-0902-x; Fiteni F, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5579-3; Fortier-Brochu E, 2010, J PSYCHOSOM RES, V69, P475, DOI 10.1016/j.jpsychores.2010.05.005; Kluthcovsky ACGC, 2012, SUPPORT CARE CANCER, V20, P1901, DOI 10.1007/s00520-011-1293-7; Gold JI, 2009, CLIN J PAIN, V25, P407, DOI 10.1097/AJP.0b013e318192bfb1; Gudex C, 2005, EQ 5D CONCEPTS METHO, P19; Guyatt GH., 1996, QUALITY LIFE PHARMAC, P41; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Hoffmeyer-Zlotnik JHP, 2003, ADV CROSS NATL COMP, DOI DOI 10.1007/978-1-4419-9186-7_10; Janssen MF, 2013, QUAL LIFE RES, V22, P1717, DOI 10.1007/s11136-012-0322-4; Janssen MF, 2018, PHARMACOECONOMICS, V36, P675, DOI 10.1007/s40273-018-0623-8; Jelsma J, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0046-0; Kaarlola A, 2004, INTENS CARE MED, V30, P2245, DOI 10.1007/s00134-004-2471-6; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Krabbe PFM, 1999, J CLIN EPIDEMIOL, V52, P293, DOI 10.1016/S0895-4356(98)00163-2; Lamers LM, 2006, HEALTH ECON, V15, P1121, DOI 10.1002/hec.1124; Longworth L, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18090; Perneger TV, 2011, INT J QUAL HEALTH C, V23, P52, DOI 10.1093/intqhc/mzq068; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rupp I, 2004, ARTHRIT RHEUM-ARTHR, V51, P578, DOI 10.1002/art.20539; Shah K, 2016, IMPORTANT ASPECTS HL; Spronk I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197507; Swinburn P, 2013, VALUE HEALTH, V16, P1156, DOI 10.1016/j.jval.2013.10.003; van't Leven M, 2010, EUR J PUBLIC HEALTH, V20, P251, DOI 10.1093/eurpub/ckp113; Versteegh MM, 2016, VALUE HEALTH, V19, P343, DOI 10.1016/j.jval.2016.01.003; Volksgezondheidenzorg.info, 2020, AANTAL MENSEN MET CH; Voormolen DC, 2019, BRAIN INJURY, V33, P1078, DOI 10.1080/02699052.2019.1607557; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Yang YL, 2015, VALUE HEALTH, V18, P52, DOI 10.1016/j.jval.2014.09.004	42	2	2	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1477-7525		HEALTH QUAL LIFE OUT	Health Qual. Life Outcomes	APR 29	2021	19	1							135	10.1186/s12955-021-01771-3			11	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	RV1XL	WOS:000645633500001	33926461	gold, Green Published			2022-02-06	
J	Yamamoto, R; Fujishima, S; Sasaki, J; Gando, S; Saitoh, D; Shiraishi, A; Kushimoto, S; Ogura, H; Abe, T; Mayumi, T; Kotani, J; Nakada, T; Shiino, Y; Tarui, T; Okamoto, K; Sakamoto, Y; Shiraishi, SI; Takuma, K; Tsuruta, R; Masuno, T; Takeyama, N; Yamashita, N; Ikeda, H; Ueyama, M; Hifumi, T; Yamakawa, K; Hagiwara, A; Otomo, Y				Yamamoto, Ryo; Fujishima, Seitaro; Sasaki, Junichi; Gando, Satoshi; Saitoh, Daizoh; Shiraishi, Atsushi; Kushimoto, Shigeki; Ogura, Hiroshi; Abe, Toshikazu; Mayumi, Toshihiko; Kotani, Joji; Nakada, Taka-aki; Shiino, Yasukazu; Tarui, Takehiko; Okamoto, Kohji; Sakamoto, Yuichiro; Shiraishi, Shin-Ichiro; Takuma, Kiyotsugu; Tsuruta, Ryosuke; Masuno, Tomohiko; Takeyama, Naoshi; Yamashita, Norio; Ikeda, Hiroto; Ueyama, Masashi; Hifumi, Toru; Yamakawa, Kazuma; Hagiwara, Akiyoshi; Otomo, Yasuhiro		Japanese Assoc Acute Med JAAM Fou; Sepsis Trauma FORECAST Study Grp	Hyperoxemia during resuscitation of trauma patients and increased intensive care unit length of stay: inverse probability of treatment weighting analysis	WORLD JOURNAL OF EMERGENCY SURGERY			English	Article						Hyperoxemia; Hyperoxia; Trauma; Critically ill; ICU length of stay; Mortality		Background Information on hyperoxemia among patients with trauma has been limited, other than traumatic brain injuries. This study aimed to elucidate whether hyperoxemia during resuscitation of patients with trauma was associated with unfavorable outcomes. Methods A post hoc analysis of a prospective observational study was carried out at 39 tertiary hospitals in 2016-2018 in adult patients with trauma and injury severity score (ISS) of > 15. Hyperoxemia during resuscitation was defined as PaO2 of >= 300 mmHg on hospital arrival and/or 3 h after arrival. Intensive care unit (ICU)-free days were compared between patients with and without hyperoxemia. An inverse probability of treatment weighting (IPW) analysis was conducted to adjust patient characteristics including age, injury mechanism, comorbidities, vital signs on presentation, chest injury severity, and ISS. Analyses were stratified with intubation status at the emergency department (ED). The association between biomarkers and ICU length of stay were then analyzed with multivariate models. Results Among 295 severely injured trauma patients registered, 240 were eligible for analysis. Patients in the hyperoxemia group (n = 58) had shorter ICU-free days than those in the non-hyperoxemia group [17 (10-21) vs 23 (16-26), p < 0.001]. IPW analysis revealed the association between hyperoxemia and prolonged ICU stay among patients not intubated at the ED [ICU-free days = 16 (12-22) vs 23 (19-26), p = 0.004], but not among those intubated at the ED [18 (9-20) vs 15 (8-23), p = 0.777]. In the hyperoxemia group, high inflammatory markers such as soluble RAGE and HMGB-1, as well as low lung-protective proteins such as surfactant protein D and Clara cell secretory protein, were associated with prolonged ICU stay. Conclusions Hyperoxemia until 3 h after hospital arrival was associated with prolonged ICU stay among severely injured trauma patients not intubated at the ED.	[Yamamoto, Ryo; Sasaki, Junichi] Keio Univ, Dept Emergency & Crit Care Med, Sch Med, Tokyo, Japan; [Fujishima, Seitaro] Keio Univ, Ctr Gen Med Educ, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan; [Gando, Satoshi] Sapporo Higashi Tokushukai Hosp, Dept Acute & Crit Care Med, Sapporo, Hokkaido, Japan; [Gando, Satoshi] Hokkaido Univ, Div Acute & Crit Care Med, Dept Anesthesiol & Crit Care Med, Grad Sch Med, Sapporo, Hokkaido, Japan; [Saitoh, Daizoh] Natl Def Med Coll, Res Inst, Div Traumatol, Tokorozawa, Saitama, Japan; [Shiraishi, Atsushi] Kameda Med Ctr, Emergency & Trauma Ctr, Kameda, Japan; [Kushimoto, Shigeki] Tohoku Univ, Div Emergency & Crit Care Med, Grad Sch, Sendai, Miyagi, Japan; [Ogura, Hiroshi] Osaka Univ, Dept Traumatol & Acute Crit Med, Grad Sch Med, Osaka, Japan; [Abe, Toshikazu] Juntendo Univ, Dept Gen Med, Tokyo, Japan; [Abe, Toshikazu] Univ Tsukuba, Hlth Serv Res & Dev Ctr, Tsukuba, Ibaraki, Japan; [Mayumi, Toshihiko] Univ Occupat & Environm Hlth, Sch Med, Dept Emergency Med, Kitakyushu, Fukuoka, Japan; [Kotani, Joji] Kobe Univ, Dept Surg Related, Div Disaster & Emergency Med, Grad Sch Med, Kobe, Hyogo, Japan; [Nakada, Taka-aki] Chiba Univ, Dept Emergency & Crit Care Med, Grad Sch Med, Chiba, Japan; [Shiino, Yasukazu] Kawasaki Med Sch, Dept Acute Med, Kurashiki, Okayama, Japan; [Tarui, Takehiko] Kyorin Univ, Dept Trauma & Crit Care Med, Sch Med, Tokyo, Japan; [Okamoto, Kohji] Kitakyushu City Yahata Hosp, Ctr Gastroenterol & Liver Dis, Dept Surg, Kitakyushu, Fukuoka, Japan; [Sakamoto, Yuichiro] Saga Univ Hosp, Emergency & Crit Care Med, Saga, Japan; [Shiraishi, Shin-Ichiro] Aizu Chuo Hosp, Dept Emergency & Crit Care Med, Aizu Wakamatsu, Fukushima, Japan; [Takuma, Kiyotsugu] Kawasaki Municipal Kawasaki Hosp, Emergency & Crit Care Ctr, Kawasaki, Kanagawa, Japan; [Tsuruta, Ryosuke] Yamaguchi Univ, Adv Med Emergency & Crit Care Ctr, Ube, Yamaguchi, Japan; [Masuno, Tomohiko] Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo, Japan; [Takeyama, Naoshi] Aichi Med Univ Hosp, Adv Crit Care Ctr, Nagakute, Aichi, Japan; [Yamashita, Norio] Kurume Univ Hosp, Adv Emergency Med Serv Ctr, Kurume, Fukuoka, Japan; [Ikeda, Hiroto] Teikyo Univ, Dept Emergency Med, Sch Med, Tokyo, Japan; [Ueyama, Masashi] Japan Community Healthcare Org, Dept Trauma, Crit Care Med, Chukyo Hosp, Nagoya, Aichi, Japan; [Ueyama, Masashi] Japan Community Healthcare Org, Burn Ctr, Chukyo Hosp, Nagoya, Aichi, Japan; [Hifumi, Toru] St Lukes Int Hosp, Dept Emergency & Crit Care Med, Tokyo, Japan; [Yamakawa, Kazuma] Osaka Gen Med Ctr, Div Trauma & Surg Crit Care, Osaka, Japan; [Hagiwara, Akiyoshi] Ctr Hosp Natl Ctr Global Hlth & Med, Tokyo, Japan; [Otomo, Yasuhiro] Tokyo Med & Dent Univ, Hosp Med, Trauma & Acute Crit Care Ctr, Tokyo, Japan		Fujishima, S (corresponding author), Keio Univ, Ctr Gen Med Educ, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	fujishim@keio.jp; jaam-6@bz04.plala.or.jp	Abe, Toshikazu/ABH-1639-2021; Fujishima, Seitaro/G-6155-2011	Fujishima, Seitaro/0000-0001-8823-8440	Japanese Association for Acute Medicine [2014-01]	This study was supported by the Japanese Association for Acute Medicine (grant number 2014-01).	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Angelos Mark G, 2011, Resuscitation, V82 Suppl 2, pS48, DOI 10.1016/S0300-9572(11)70151-4; Angus DC, 2020, NEW ENGL J MED, V382, P1054, DOI 10.1056/NEJMe2000800; Asfar P, 2017, LANCET RESP MED, V5, P180, DOI 10.1016/S2213-2600(17)30046-2; Austin PC, 2017, STAT METHODS MED RES, V26, P1654, DOI 10.1177/0962280215584401; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Baekgaard JS, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03274-x; Barbateskovic M, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012631.pub2; Barrot L, 2020, NEW ENGL J MED, V382, P999, DOI 10.1056/NEJMoa1916431; Bezerra FS, 2019, INTENS CARE MED EXP, V7, DOI 10.1186/s40635-019-0233-6; BISSONNETTE B, 1991, CAN J ANAESTH, V38, P654, DOI 10.1007/BF03008204; Broeckaert F, 2000, ANN NY ACAD SCI, V923, P68; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chu DK, 2018, LANCET, V391, P1693, DOI 10.1016/S0140-6736(18)30479-3; Damiani E, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0711-x; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Dias-Freitas F, 2016, RESP MED, V119, P23, DOI 10.1016/j.rmed.2016.08.010; Diringer MN, 2008, CURR OPIN CRIT CARE, V14, P167, DOI 10.1097/MCC.0b013e3282f57552; Du J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33828-7; Fisher AB, 2008, AM J PHYSIOL-LUNG C, V295, pL1066, DOI 10.1152/ajplung.90486.2008; Gando S, 2020, J THROMB HAEMOST, V18, P2232, DOI 10.1111/jth.14931; Girardis M, 2016, JAMA-J AM MED ASSOC, V316, P1583, DOI 10.1001/jama.2016.11993; Helmerhorst HJF, 2015, CRIT CARE MED, V43, P1508, DOI 10.1097/CCM.0000000000000998; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kawaguchi T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175129; Locy ML, 2012, ANTIOXID REDOX SIGN, V17, P1407, DOI 10.1089/ars.2011.4377; Moore L, 2006, J TRAUMA, V61, P718, DOI 10.1097/01.ta.0000197906.28846.87; Naylor JF, 2020, AM J EMERG MED, V38, P709, DOI 10.1016/j.ajem.2019.06.005; Palmer E, 2019, AM J RESP CRIT CARE, V200, P1373, DOI 10.1164/rccm.201904-0849OC; Patel JK, 2018, RESUSCITATION, V127, P83, DOI 10.1016/j.resuscitation.2018.04.008; Raj R, 2013, CRIT CARE, V17, DOI 10.1186/cc12856; REINHART K, 1991, CHEST, V99, P690, DOI 10.1378/chest.99.3.690; Roberts BW, 2018, CIRCULATION, V137, P2114, DOI 10.1161/CIRCULATIONAHA.117.032054; Sinclair SE, 2004, CRIT CARE MED, V32, P2496, DOI 10.1097/01.CCM.0000148231.04642.8D; Sutton ADJ, 2014, ANAESTH INTENS CARE, V42, P730, DOI 10.1177/0310057X1404200608; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Wang CH, 2014, RESUSCITATION, V85, P1142, DOI 10.1016/j.resuscitation.2014.05.021; Watson NA, 2000, EUR J ANAESTH, V17, P152, DOI 10.1046/j.1365-2346.2000.00640.x; Yamamoto R, 2020, AM J SURG, V220, P1485, DOI 10.1016/j.amjsurg.2020.07.017; Yamamoto R, 2020, J INTENSIVE CARE, V8, DOI 10.1186/s40560-020-00477-w; Young P, 2020, INTENS CARE MED, V46, P17, DOI 10.1007/s00134-019-05857-x; Zhang F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14667-4	42	2	2	1	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-7922			WORLD J EMERG SURG	World J. Emerg. Surg.	APR 29	2021	16	1							19	10.1186/s13017-021-00363-2			9	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	RV1XG	WOS:000645633000001	33926507	Green Published, gold			2022-02-06	
J	Aaron, SE; Hamner, JW; Ozturk, ED; Hunt, DL; Iaccarino, MA; Meehan, WP; Howell, DR; Tan, CO				Aaron, Stacey E.; Hamner, Jason W.; Ozturk, Erin D.; Hunt, Danielle L.; Iaccarino, Mary Alexis; Meehan, William P., III; Howell, David R.; Tan, Can Ozan			Cerebrovascular Neuroprotection after Acute Concussion in Adolescents	ANNALS OF NEUROLOGY			English	Article								Objective To assess acute cerebrovascular function in concussed adolescents (14-21 years of age), whether it is related to resting cerebral hemodynamics, and whether it recovers chronically. Methods Cerebral vasoreactivity and autoregulation, based on middle cerebral artery blood flow velocity, was assessed in 28 concussed participants (<= 14 days of injury) and 29 matched controls. The participants in the concussion group returned for an 8-week follow-up assessment. Over the course of those 8-weeks, participants recorded aerobic exercise frequency and duration. Results Between groups, demographic, clinical, and hemodynamic variables were not significantly different. Vasoreactivity was significantly higher in the concussed group (p = 0.02). Within the concussed group, 60% of the variability in resting cerebral blood flow velocity was explained by vasoreactivity and two components of autoregulation - falling slope and effectiveness of autoregulation (adjusted R-2 = 0.60, p < 0.001). Moreover, lower mean arterial pressure, lower responses to increases in arterial pressure, and lower vasoreactivity were significantly associated with larger symptom burden (adjusted R-2 = 0.72, p < 0.01). By the 8-week timepoint, symptom burden, but not vasoreactivity, improved in all but four concussed participants (p < 0.01). 8-week change in vasoreactivity was positively associated with aerobic exercise volume (adjusted R-2 = 0.19, p = 0.02). Interpretation Concussion resulted in changes in cerebrovascular regulatory mechanisms, which in turn explained the variability in resting cerebral blood flow velocity and acute symptom burden. Furthermore, these alterations persisted chronically despite symptom resolution, but was positively modified by aerobic exercise volume. These findings provide a mechanistic framework for further investigation into underlying cerebrovascular related symptomatology. ANN NEUROL 2021	[Aaron, Stacey E.; Iaccarino, Mary Alexis; Tan, Can Ozan] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Aaron, Stacey E.; Hamner, Jason W.; Ozturk, Erin D.; Tan, Can Ozan] Spaulding Rehabil Hosp, Boston, MA USA; [Aaron, Stacey E.] Univ Kansas, Dept Phys Therapy & Rehabil Sci, Kansas City, KS 66103 USA; [Hunt, Danielle L.; Meehan, William P., III; Howell, David R.] Boston Childrens Hosp, Boston, MA USA; [Iaccarino, Mary Alexis] MassGen Children, Sports Concuss Program, Boston, MA USA; [Iaccarino, Mary Alexis; Tan, Can Ozan] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Howell, David R.] Univ Colorado, Sch Med, Aurora, CO USA; [Howell, David R.] Childrens Hosp Colorado, Aurora, CO USA		Tan, CO (corresponding author), 1575 Cambridge St, Cambridge, MA 02138 USA.	cotan@mgh.harvard.edu	Tan, Can Ozan/E-2598-2016; Hamner, J. W./B-4607-2017	Tan, Can Ozan/0000-0001-9673-9907; Hamner, J. W./0000-0002-5819-2362; Aaron, Stacey/0000-0002-2532-8278	Eunice Kennedy Shriver National Institute of Child Health & Human Development grant [R03HD094560]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03NS106444]	This work was funded by the Eunice Kennedy Shriver National Institute of Child Health & Human Development grant R03HD094560 to D.R.H and National Institute of Neurological Disorders and Stroke grant R03NS106444 to C.O.T.	Albalawi T, 2017, J NEUROTRAUM, V34, P2700, DOI 10.1089/neu.2017.5060; Babcock L, 2015, J PEDIATR REHAB MED, V8, P285, DOI 10.3233/PRM-150347; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Brooks BL, 2019, BRAIN INJURY, V33, P233, DOI 10.1080/02699052.2018.1540798; Churchill NW, 2019, J NEUROTRAUM, V36, P1518, DOI 10.1089/neu.2018.6024; Coverdale NS, 2020, BRAIN IMAGING BEHAV, V14, P2438, DOI 10.1007/s11682-019-00194-5; Di Battista AP, 2018, J NEUROIMMUNOL, V319, P1, DOI 10.1016/j.jneuroim.2018.03.002; FRIEDMAN JH, 1981, J AM STAT ASSOC, V76, P817, DOI 10.2307/2287576; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Hamer J, 2020, J NEUROTRAUM, V37, P1197, DOI 10.1089/neu.2019.6800; Hamner JW, 2019, J PHYSIOL-LONDON, V597, P1553, DOI 10.1113/JP277321; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Howell DR, 2019, MED SCI SPORT EXER, V51, P647, DOI 10.1249/MSS.0000000000001829; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kraus N, 2017, NEUROSCI LETT, V646, P21, DOI 10.1016/j.neulet.2017.03.008; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Lin CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149109; MARKWALDER TM, 1984, J CEREBR BLOOD F MET, V4, P368, DOI 10.1038/jcbfm.1984.54; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McQuire JC, 1998, J NEUROSURG, V89, P526, DOI 10.3171/jns.1998.89.4.0526; Orr CA, 2016, J NEUROTRAUM, V33, P803, DOI 10.1089/neu.2014.3721; Ozturk ED, 2018, J PHYSIOL ANTHROPOL, V37, DOI 10.1186/s40101-018-0164-z; Rickards CA, 2007, AM J PHYSIOL-REG I, V293, pR243, DOI 10.1152/ajpregu.00087.2007; Rose SC, 2017, BRAIN INJURY, V31, P260, DOI 10.1080/02699052.2016.1235285; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Tan CO, 2014, EXP PHYSIOL, V99, P3, DOI 10.1113/expphysiol.2013.072355; Tan CO, 2012, J APPL PHYSIOL, V113, P1194, DOI 10.1152/japplphysiol.00783.2012; Wang Y, 2020, NEUROPSYCHOL REV, DOI 10.1007/s11065-020-09451-7; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Wang Y, 2015, DEV NEUROPSYCHOL, V40, P40, DOI 10.1080/87565641.2014.979927	35	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	JUL	2021	90	1					43	51		10.1002/ana.26082		APR 2021	9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SU3QS	WOS:000644905700001	33855730				2022-02-06	
J	Bretzin, AC; Covassin, T; Wiebe, DJ; Stewart, W				Bretzin, Abigail C.; Covassin, Tracey; Wiebe, Douglas J.; Stewart, William			Association of Sex With Adolescent Soccer Concussion Incidence and Characteristics	JAMA NETWORK OPEN			English	Article							EPIDEMIOLOGY	IMPORTANCE Because of the negative consequences of concussion, considerable research efforts have been directed toward understanding the risk factors for sport-related concussion (SRC) and its outcomes to better inform strategies for risk reduction. Girls are suggested to have an increased risk of concussion, warranting exploration into sex-dependent variations in concussion presentation and management, with the potential that this information might inform sex-specific rules directed toward risk reduction within sports. OBJECTIVE To compare sex-associated differences in epidemiology and concussion management in adolescent soccer players within a prospective, longitudinal high school injury surveillance project. DESIGN, SETTING, AND PARTICIPANTS This prospective, longitudinal cohort study assessed male and female soccer athletes from all high schools in the Michigan High School Athletic Association (MHSAA) during academic years 2016-2017 to 2018-2019. EXPOSURES Sport-related concussion captured in the MHSAA Head Injury Reporting System. MAIN OUTCOMES AND MEASURES Outcomes included details regarding each documented SRC event, including injury mechanism, immediate management, and return-to-play time. Multiple comparisons were made between male and female athletes regarding SRC risk, mechanism, short-term management, and outcomes. RESULTS A total of 43 741 male and 39 637 female soccer athletes participated in MHSAA soccer during the 3 consecutive academic years of study (2016-2017: n = 751 schools; 2017-2018: n = 750 schools; and 2018-2019: n = 747 schools). During the 3 years of surveillance, 1507 of the 83 378 soccer athletes (1.8%) were reported to have SRC during soccer participation, including 557 boys (37.0%) and 950 girls (63.0%). Documented SRC risk in female soccer participants was greater than in male soccer participants (risk ratio, 1.88; 95% CI, 1.69-2.09; P < .001). Male soccer athletes most often sustained SRC from contact with another player (48.4%), whereas SRCs in female soccer players recorded in the Head Injury Reporting System were most often from nonplayer contact events (41.9%; P < .001). Adolescent male soccer players with a documented SRC were more likely to be removed from play on the day of injury (odds ratio, 1.54; 95% CI, 1.15-2.06; P = .004). Although the overall median time to return to play was 11 days (interquartile range [IQR], 7-15 days), male athletes typically returned 2 days earlier than female athletes (median, 10 [IQR, 7-14] days vs 12 [IQR, 7-16] days; Peto test P < .001). CONCLUSIONS AND RELEVANCE In this cohort study, sex-associated differences were revealed among adolescent soccer athletes in SRC risk, mechanism of injury, immediate management, and outcomes in injuries documented in a statewide injury reporting system. Thus, consideration might be given to sex-specific approaches to participation and concussion management in the sport.	[Bretzin, Abigail C.; Wiebe, Douglas J.] Univ Penn, Penn Injury Sci Ctr, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA; [Covassin, Tracey] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA; [Stewart, William] Queen Elizabeth Univ Hosp, Dept Neuropathol, 1345 Govan Rd, Glasgow G51 4TF, Lanark, Scotland; [Stewart, William] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland		Stewart, W (corresponding author), Queen Elizabeth Univ Hosp, Dept Neuropathol, 1345 Govan Rd, Glasgow G51 4TF, Lanark, Scotland.	william.stewart@glasgow.ac.uk		Bretzin, Abigail/0000-0003-3730-2849; Stewart, William/0000-0003-2199-2582	Football Association; Professional Footballers Association; NHS Research Scotland; Penn Injury Science Center [R49CE03083]; Brain Injury Training Grant [NS043126]	This work was supported by The Football Association (Dr Stewart), The Professional Footballers Association (Dr Stewart), NHS Research Scotland (Dr Stewart), Penn Injury Science Center grant R49CE03083 (Drs Bretzin and Wiebe), and Brain Injury Training Grant NS043126 (Dr Bretzin).	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Ashton J, 2021, SCI MED FOOTBALL, V5, P181, DOI 10.1080/24733938.2020.1846769; Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Bretzin AC, 2018, AM J SPORT MED, V46, P2263, DOI 10.1177/0363546518778251; Bretzin AC, 2017, SPORTS HEALTH, V9, P168, DOI 10.1177/1941738116678615; Caccese JB, 2018, SPORT BIOMECH, V17, P462, DOI 10.1080/14763141.2017.1360385; Chandran A, 2020, RES SPORTS MED, V28, P42, DOI 10.1080/15438627.2019.1590834; Charek DB, 2020, J HEAD TRAUMA REHAB, V35, P85, DOI 10.1097/HTR.0000000000000476; Covassin T, 2018, AM J SPORT MED, V46, P2270, DOI 10.1177/0363546518780225; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Dolle JP, 2018, EXP NEUROL, V300, P121, DOI 10.1016/j.expneurol.2017.11.001; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Howell DR, 2020, CLIN J SPORT MED, V30, pS42, DOI 10.1097/JSM.0000000000000570; Huggins RA, 2019, J ATHL TRAINING, V54, P1129, DOI 10.4085/1062-6050-12-19; Kerr ZY, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2180; Kerr ZY, 2019, J NEUROTRAUM, V36, P2073, DOI 10.1089/neu.2017.5319; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kunz M., 2007, FIFA MAGAZINE, V7, P11, DOI DOI 10.1080/13673882.2007.9680857; Lee EB, 2019, ACTA NEUROPATHOL, V138, P389, DOI 10.1007/s00401-019-02030-y; Ling DI, 2020, CLIN ORTHOP RELAT R, V478, P1469, DOI 10.1097/CORR.0000000000000995; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Mackay DF, 2019, NEW ENGL J MED, V381, P1801, DOI 10.1056/NEJMoa1908483; Mansell J, 2005, J ATHL TRAINING, V40, P310; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGuine TA, 2018, J ATHL TRAINING, V53, P1017, DOI 10.4085/1062-6050-209-18; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Pierpoint Lauren A, 2018, Inj Epidemiol, V5, P29, DOI 10.1186/s40621-018-0159-6; Putukian M, 2019, AM J SPORT MED, V47, P1236, DOI 10.1177/0363546519830100; Putukian M, 2019, BRIT J SPORT MED, V53, P1332, DOI 10.1136/bjsports-2018-100232; Smith DH, 2020, NAT REV NEUROL, V16, P457, DOI 10.1038/s41582-020-0382-y; Terwilliger VK, 2016, J NEUROTRAUM, V33, P761, DOI 10.1089/neu.2015.4082; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Wallace C, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000433; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Zuckerman Scott L, 2016, Neurosurgery, V63 Suppl 1, P102, DOI 10.1227/NEU.0000000000001280; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	40	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2574-3805			JAMA NETW OPEN	JAMA Netw. Open	APR 27	2021	4	4							e218191	10.1001/jamanetworkopen.2021.8191			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV1QD	WOS:000645614400007	33904911	Green Published, Green Accepted, gold			2022-02-06	
J	Di Sapia, R; Moro, F; Montanarella, M; Iori, V; Micotti, E; Tolomeo, D; Wang, KKW; Vezzani, A; Ravizza, T; Zanier, ER				Di Sapia, Rossella; Moro, Federico; Montanarella, Marica; Iori, Valentina; Micotti, Edoardo; Tolomeo, Daniele; Wang, Kevin K. W.; Vezzani, Annamaria; Ravizza, Teresa; Zanier, Elisa R.			In-depth characterization of a mouse model of post-traumatic epilepsy for biomarker and drug discovery	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article							TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; SPATIAL MEMORY; SEIZURES; SEGMENTATION; PROTECTION; PRECISION; RISK	Post-traumatic epilepsy (PTE) accounts for 5% of all epilepsies and 10-20% of the acquired forms. The latency between traumatic brain injury (TBI) and epilepsy onset in high-risk patients offers a therapeutic window for intervention to prevent or improve the disease course. However, progress towards effective treatments has been hampered by the lack of sensitive prognostic biomarkers of PTE, and of therapeutic targets. There is therefore a pressing clinical need for preclinical PTE models suitable for biomarker discovery and drug testing. We characterized in-depth a model of severe TBI induced by controlled cortical impact evolving into PTE in CD1 adult male mice. To identify sensitive measures predictive of PTE development and severity, TBI mice were longitudinally monitored by video-electrocorticography (ECoG), examined by MRI, and tested for sensorimotor and cognitive deficits and locomotor activity. At the end of the video-ECoG recording mice were killed for brain histological analysis. PTE occurred in 58% of mice with frequent motor seizures (one seizure every other day), as determined up to 5 months post-TBI. The weight loss of PTE mice in 1 week after TBI correlated with the number of spontaneous seizures at 5 months. Moreover, the recovery rate of the sensorimotor deficit detected by the SNAP test before the predicted time of epilepsy onset was significantly lower in PTE mice than in those without epilepsy. Neuroscore, beam walk and cognitive deficit were similar in all TBI mice. The increase in the contusion volume, the volume of forebrain regions contralateral to the lesioned hemisphere and white matter changes over time assessed by MRI were similar in PTE and no-PTE mice. However, brain histology showed a more pronounced neuronal cell loss in the cortex and hippocampus contralateral to the injured hemisphere in PTE than in no-PTE mice. The extensive functional and neuropathological characterization of this TBI model, provides a tool to identify sensitive measures of epilepsy development and severity clinically useful for increasing PTE prediction in high-risk TBI patients. The high PTE incidence and spontaneous seizures frequency in mice provide an ideal model for biomarker discovery and for testing new drugs.	[Di Sapia, Rossella; Iori, Valentina; Vezzani, Annamaria; Ravizza, Teresa] Ist Ric Farmacol Mario Negri IRCCS, Dept Neurosci, Lab Expt Neurol, Via Mario Negri 2, I-20156 Milan, Italy; [Moro, Federico; Montanarella, Marica; Zanier, Elisa R.] Ist Ric Farmacol Mario Negri IRCCS, Dept Neurosci, Lab Acute Brain Injury & Therapeut Strategies, Via Mario Negri 2, I-20156 Milan, Italy; [Micotti, Edoardo; Tolomeo, Daniele] Ist Ric Farmacol Mario Negri IRCCS, Dept Neurosci, Lab Biol Neurodegenerat Disorders, Via Mario Negri 2, I-20156 Milan, Italy; [Wang, Kevin K. W.] Univ Florida, Program Neurotrauma Neuroprote & Biomarkers Res, Dept Emergency Med Psychiat Neurosci & Chem, Gainesville, FL USA		Ravizza, T (corresponding author), Ist Ric Farmacol Mario Negri IRCCS, Dept Neurosci, Lab Expt Neurol, Via Mario Negri 2, I-20156 Milan, Italy.; Zanier, ER (corresponding author), Ist Ric Farmacol Mario Negri IRCCS, Dept Neurosci, Lab Acute Brain Injury & Therapeut Strategies, Via Mario Negri 2, I-20156 Milan, Italy.	teresa.ravizza@marionegri.it; elisa.zanier@marionegri.it	moro, federico/K-5644-2016; Di Sapia, Rossella/ABF-8823-2021; Moro, Federico/AAG-1731-2021	moro, federico/0000-0002-2682-5583; Di Sapia, Rossella/0000-0001-7481-5198; Moro, Federico/0000-0002-2682-5583; Wang, Kevin/0000-0002-9343-6473; Zanier, Elisa/0000-0002-3011-8718; Vezzani, Annamaria/0000-0003-0573-6175	Office of the Assistant Secretary of Defense for Health Affairs; Defense Health Agency J9, Research and Development Directorate [W81XWH-19-1-0733]; Citizen United for Research in Epilepsy (CURE) Post-Traumatic Epilepsy initiative [W81XWH-15-2-0069]	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs and the Defense Health Agency J9, Research and Development Directorate, through the (Epilepsy Research Program) under Award No. W81XWH-19-1-0733. Salaries of RDS, FM, TR and ERZ were also supported by the Citizen United for Research in Epilepsy (CURE) Post-Traumatic Epilepsy initiative under Award No. W81XWH-15-2-0069. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense.	Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bai J, 2012, MAGN RESON IMAGING, V30, P789, DOI 10.1016/j.mri.2012.02.010; Bernhardt BC, 2015, ANN NEUROL, V77, P436, DOI 10.1002/ana.24341; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Brady RD, 2019, NEUROBIOL DIS, V123, P8, DOI 10.1016/j.nbd.2018.08.007; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Butler CR, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00163; Conrad CD, 1997, BRAIN RES, V759, P76, DOI 10.1016/S0006-8993(97)00236-9; Dellu F, 2000, NEUROBIOL LEARN MEM, V73, P31, DOI 10.1006/nlme.1999.3919; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Frigerio F, 2018, BRAIN, V141, P3130, DOI 10.1093/brain/awy247; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Gupta RK, 2005, EPILEPSIA, V46, P1465, DOI 10.1111/j.1528-1167.2005.01205.x; Hong SJ, 2017, NEUROLOGY, V88, P734, DOI 10.1212/WNL.0000000000003632; Hudak AM, 2004, J HEAD TRAUMA REHAB, V19, P290, DOI 10.1097/00001199-200407000-00003; Hung C, 2012, CURR TREAT OPTION NE, V14, P293, DOI 10.1007/s11940-012-0178-5; Hunt RF, 2013, NAT NEUROSCI, V16, P692, DOI 10.1038/nn.3392; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Hutchinson E, 2005, ILAR J, V46, P148, DOI 10.1093/ilar.46.2.148; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kilkenny C, 2010, J PHARMACOL PHARMACO, V1, P94, DOI 10.4103/0976-500X.72351; Klein P, 2020, NEUROPHARMACOLOGY, V168, DOI 10.1016/j.neuropharm.2019.107762; Klein P, 2017, EPILEPSY BEHAV, V72, P188, DOI 10.1016/j.yebeh.2017.05.024; Lapinlampi N, 2020, EPILEPSIA, V61, P2035, DOI 10.1111/epi.16632; Mazzini L, 2003, EPILEPSIA, V44, P569, DOI 10.1046/j.1528-1157.2003.34902.x; Moro F, 2021, BRIT J ANAESTH, V126, P256, DOI 10.1016/j.bja.2020.08.027; Palacios EM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz6892; Palacios EM, 2017, AM J NEURORADIOL, V38, P537, DOI 10.3174/ajnr.A5025; Paxinos G., 2008, MOUSE BRAIN STEREOTA; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Pischiutta F, 2016, CRIT CARE MED, V44, pE1118, DOI 10.1097/CCM.0000000000001864; Pischiutta F, 2014, NEUROPHARMACOLOGY, V79, P119, DOI 10.1016/j.neuropharm.2013.11.001; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Sammali E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07274-w; Sawilowsky SS, 2009, J MOD APPL STAT METH, V8, P597, DOI 10.22237/jmasm/1257035100; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seo Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49311-w; Shandra O., 2020, J VIS EXP, V156, P60360; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Thompson K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009900.pub2; Tubiv MA, 2019, NEUROBIOL DIS, V123, P115, DOI 10.1016/j.nbd.2018.05.014; Verellen Rebecca M, 2010, Therapy, V7, P527, DOI 10.2217/thy.10.57; Wang HZ, 2013, IEEE T PATTERN ANAL, V35, P611, DOI 10.1109/TPAMI.2012.143; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zanier ER, 2016, J NEUROTRAUM, V33, P1060, DOI 10.1089/neu.2015.4041; Zanier ER, 2014, NEUROTHERAPEUTICS, V11, P679, DOI 10.1007/s13311-014-0277-y; Zanier ER, 2013, CNS NEUROSCI THER, V19, P695, DOI 10.1111/cns.12128; Zanier ER, 2011, CRIT CARE MED, V39, P2501, DOI 10.1097/CCM.0b013e31822629ba; Zhang H, 2007, LECT NOTES COMPUT SC, V4792, P211; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zhu BY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13170-w	61	2	2	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	APR 26	2021	9	1							76	10.1186/s40478-021-01165-y			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RU2WP	WOS:000645010900002	33902685	Green Published, gold			2022-02-06	
J	Mansour, RF; Aljehane, NO				Mansour, Romany F.; Aljehane, Nojood O.			An optimal segmentation with deep learning based inception network model for intracranial hemorrhage diagnosis	NEURAL COMPUTING & APPLICATIONS			English	Article						Deep learning; Kapur&#8217; s thresholding; EHO algorithm; Inception network; Intracranial hemorrhages	CT	Traumatic Brain Injury (TBI) leads to intracranial hemorrhages (ICH), which is a severe illness resulted in death if it is not properly diagnosed and treated in the earlier stage. Presently, computer tomography (CT) images are widely used by radiologists to identify and locate the regions of ICH. But it is a tedious task and mainly depends on the professional radiologists. This paper develops new deep learning (DL)-based ICH diagnosis and classification (DL-ICH) model using optimal image segmentation with Inception Network. The proposed DL-ICH model involves preprocessing, segmentation, feature extraction, and classification. Firstly, the input data undergo format conversion where the NIfTI files are converted into JPEG format. Next, Kapur's thresholding with an elephant herd optimization (EHO) algorithm called KT-EHO is employed for image segmentation. Then, DL based Inception v4 network is applied as a feature extractor to extract a useful set of features and a multilayer perceptron (MLP) is used for classification. An extensive set of simulations takes place to ensure the effective diagnostic performance of the DL-ICH model and the results are investigated under diverse dimensions. The experimental results achieved better accuracy rate.	[Mansour, Romany F.] New Valley Univ, Dept Math, Fac Sci, El Kharga 72511, Egypt; [Aljehane, Nojood O.] Tabuk Univ, Coll Comp Sci & Informat Technol, Tabuk, Saudi Arabia		Mansour, RF (corresponding author), New Valley Univ, Dept Math, Fac Sci, El Kharga 72511, Egypt.	romanyf@sci.nvu.edu.eg; noaljohani@ut.edu.sa	Mansour, Romany F./AAB-6085-2021; Aljehane, Nojood/ABG-8816-2021	Mansour, Romany F./0000-0001-5857-8495; 			Chang PD, 2018, AM J NEURORADIOL, V39, P1609, DOI 10.3174/ajnr.A5742; Chilamkurthy S, 2018, LANCET, V392, P2388, DOI 10.1016/S0140-6736(18)31645-3; Danilov G, 2020, STUD HEALTH TECHNOL, V272, P370, DOI 10.3233/SHTI200572; Davis V, 2017, 2017 IEEE INTERNATIONAL CONFERENCE ON ADVANCES IN COMPUTING, COMMUNICATION AND CONTROL (ICAC3); Francis, 2019, INT J COMPUT INF SCI, V6; Grewal M, 2018, I S BIOMED IMAGING, P281, DOI 10.1109/ISBI.2018.8363574; Heidari AA, 2019, SOFT COMPUT, V23, P7941, DOI 10.1007/s00500-018-3424-2; Hssayeni MD, 2020, DATA, V5, DOI 10.3390/data5010014; Jnawali K, 2018, PROC SPIE, V10575, DOI 10.1117/12.2293725; Karki M, 2020, ARTIF INTELL MED, V106, DOI 10.1016/j.artmed.2020.101850; Karolin M., 2019, 2019 International Conference on Communication and Signal Processing (ICCSP), P0058, DOI 10.1109/ICCSP.2019.8698013; Kuo WC, 2018, LECT NOTES COMPUT SC, V11072, P715, DOI 10.1007/978-3-030-00931-1_82; Li YH, 2012, J MED SYST, V36, P1259, DOI 10.1007/s10916-010-9587-8; Prevedello LM, 2017, RADIOLOGY, V285, P923, DOI 10.1148/radiol.2017162664; Rajinikanth V, 2017, PATTERN RECOGN LETT, V94, P87, DOI 10.1016/j.patrec.2017.05.028; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tekchandani H, 2020, COMPUT METH PROG BIO, V194, DOI 10.1016/j.cmpb.2020.105478; Ye H, 2019, EUR RADIOL, V29, P6191, DOI 10.1007/s00330-019-06163-2; Yuh EL, 2008, J NEUROTRAUM, V25, P1163, DOI 10.1089/neu.2008.0590	19	2	2	5	6	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0941-0643	1433-3058		NEURAL COMPUT APPL	Neural Comput. Appl.	OCT	2021	33	20					13831	13843		10.1007/s00521-021-06020-8		APR 2021	13	Computer Science, Artificial Intelligence	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	WL7HG	WOS:000642374900002					2022-02-06	
J	Anderson, TN; Farrell, DH; Rowell, SE				Anderson, Taylor N.; Farrell, David H.; Rowell, Susan E.			Fibrinolysis in Traumatic Brain Injury: Diagnosis, Management, and Clinical Considerations	SEMINARS IN THROMBOSIS AND HEMOSTASIS			English	Article						traumatic brain injury; fibrinolysis; coagulopathy; intracranial hemorrhage; thromboelastography		Posttraumatic coagulopathy involves disruption of both the coagulation and fibrinolytic pathways secondary to tissue damage, hypotension, and inflammatory upregulation. This phenomenon contributes to delayed complications after traumatic brain injury (TBI), including intracranial hemorrhage progression and systemic disseminated intravascular coagulopathy. Development of an early hyperfibrinolytic state may result in uncontrolled bleeding and is associated with increased mortality in patients with TBI. Although fibrinolytic assays are not routinely performed in the assessment of posttraumatic coagulopathy, circulating biomarkers such as D-dimer and fibrin degradation products have demonstrated potential utility in outcome prediction. Unfortunately, the relatively delayed nature of these tests limits their clinical utility. In contrast, viscoelastic tests are able to provide a rapid global assessment of coagulopathy, although their ability to reliably identify disruptions in the fibrinolytic cascade remains unclear. Limited evidence supports the use of hypertonic saline, cryoprecipitate, and plasma to correct fibrinolytic disruption; however, some studies suggest more harm than benefit. Recently, early use of tranexamic acid in patients with TBI and confirmed hyperfibrinolysis has been proposed as a strategy to further improve clinical outcomes. Moving forward, further delineation of TBI phenotypes and the clinical implications of fibrinolysis based on phenotypic variation is needed. In this review, we summarize the clinical aspects of fibrinolysis in TBI, including diagnosis, treatment, and clinical correlates, with identification of targeted areas for future research efforts.	[Anderson, Taylor N.; Farrell, David H.] Oregon Hlth & Sci Univ, Sch Med, Div Trauma Crit Care & Acute Care Surg, Portland, OR 97201 USA; [Rowell, Susan E.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA		Anderson, TN (corresponding author), Oregon Hlth & Sci Univ, Sch Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	andertay@ohsu.edu		Anderson, Taylor/0000-0002-8608-8343			Abdelmalik PA, 2016, NEUROCRIT CARE, V24, P361, DOI 10.1007/s12028-015-0191-0; Ahammad J, 2020, INT J LAB HEMATOL, V42, P180, DOI 10.1111/ijlh.13148; Albert Venencia, 2019, Hematol Oncol Stem Cell Ther, V12, P32, DOI 10.1016/j.hemonc.2018.09.005; Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bardehle S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00354; Barrett CD, 2019, J TRAUMA ACUTE CARE, V86, P101, DOI 10.1097/TA.0000000000002092; Barrett CD, 2018, J AM COLL SURGEONS, V227, pS275, DOI 10.1016/j.jamcollsurg.2018.07.567; Bayir A, 2006, NEUROL INDIA, V54, P363, DOI 10.4103/0028-3886.28106; Briens A, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.1; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; Chang R, 2017, SURGERY, V161, P538, DOI 10.1016/j.surg.2016.08.023; Chapman MP, 2016, J TRAUMA ACUTE CARE, V80, P16, DOI 10.1097/TA.0000000000000885; Chapman MP, 2013, J TRAUMA ACUTE CARE, V75, P961, DOI 10.1097/TA.0b013e3182aa9c9f; Chen HS, 2020, AM J EMERG MED, V38, P364, DOI 10.1016/j.ajem.2019.158499; Cheng R., 2017, AUSTIN J CEREBROVASC, V4, P1073; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Condron M, 2018, J TRAUMA ACUTE CARE, V85, P888, DOI 10.1097/TA.0000000000002040; Conti A, 2004, J NEUROTRAUM, V21, P854, DOI 10.1089/0897715041526212; Cooper, 2014, J CRIT CARE, V29; Cotton BA, 2012, J TRAUMA ACUTE CARE, V73, P365, DOI 10.1097/TA.0b013e31825c1234; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Di Battista AP, 2016, SHOCK, V46, P96, DOI 10.1097/SHK.0000000000000642; Diebel ME, 2018, J TRAUMA ACUTE CARE, V84, P75, DOI 10.1097/TA.0000000000001726; Etemadrezaie H, 2007, CLIN NEUROL NEUROSUR, V109, P166, DOI 10.1016/j.clineuro.2006.09.001; Fair KA, 2021, J NEUROTRAUM, V38, P960, DOI 10.1089/neu.2018.6234; Folkerson LE, 2015, SURGERY, V158, P655, DOI 10.1016/j.surg.2015.02.029; Gando S, 2018, THROMB J, V16, DOI 10.1186/s12959-018-0167-3; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; Griemert EV, 2019, ANN NEUROL, V85, P667, DOI 10.1002/ana.25458; Halaweish I, 2015, J AM COLL SURGEONS, V220, P809, DOI 10.1016/j.jamcollsurg.2015.01.057; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hayakawa M, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1811-1; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Hunt BJ, 1996, J CLIN PATHOL, V49, P958, DOI 10.1136/jcp.49.12.958; Karri J, 2017, SHOCK, V48, P644, DOI 10.1097/SHK.0000000000000912; Karri JV, 2014, J SURG RES, V190, P655, DOI 10.1016/j.jss.2014.01.055; Kashuk JL, 2010, ANN SURG, V252, P434, DOI 10.1097/SLA.0b013e3181f09191; KAUFMAN HH, 1980, NEUROSURGERY, V7, P445, DOI 10.1227/00006123-198011000-00003; Kushimoto S, 2001, NEUROSURGERY, V49, P1084, DOI 10.1097/00006123-200111000-00011; Kwaan HC, 2020, SEMIN THROMB HEMOST, V46, P116, DOI 10.1055/s-0039-3402428; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Leeper CM, 2018, J TRAUMA ACUTE CARE, V85, P12, DOI 10.1097/TA.0000000000001836; Maegele M, 2020, SEMIN THROMB HEMOST, V46, P155, DOI 10.1055/s-0040-1702178; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Mahmood A, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2073-6; McNeil JS, 2017, ANESTHESIOLOGY, V127, P892, DOI 10.1097/ALN.0000000000001742; Medcalf RL, 2017, J THROMB HAEMOST, V15, P2089, DOI 10.1111/jth.13849; Medcalf RL, 2020, SEMIN THROMB HEMOST, V46, P176, DOI 10.1055/s-0040-1702170; Meizoso JP, 2018, J TRAUMA ACUTE CARE, V84, P426, DOI 10.1097/TA.0000000000001792; Meizoso JP, 2017, J AM COLL SURGEONS, V224, P575, DOI 10.1016/j.jamcollsurg.2016.12.018; MINER ME, 1982, J PEDIATR-US, V100, P687, DOI 10.1016/S0022-3476(82)80565-9; Moore EE, 2015, J TRAUMA ACUTE CARE, V78, pS65, DOI 10.1097/TA.0000000000000634; Moore HB, 2017, J SURG RES, V220, P438, DOI 10.1016/j.jss.2017.04.028; Moore HB, 2016, J AM COLL SURGEONS, V222, P347, DOI 10.1016/j.jamcollsurg.2016.01.006; Moore HB, 2014, J TRAUMA ACUTE CARE, V77, P811, DOI 10.1097/TA.0000000000000341; Morrison JJ, 2013, JAMA SURG, V148, P218, DOI 10.1001/jamasurg.2013.764; Mosnier LO, 2001, THROMB HAEMOSTASIS, V85, P5; Muradashvili N, 2013, BRAIN INJURY, V27, P1508, DOI 10.3109/02699052.2013.823562; Nakae R, 2019, ACTA NEUROCHIR, V161, P1943, DOI 10.1007/s00701-019-04010-3; Nakae R, 2016, J NEUROTRAUM, V33, P688, DOI 10.1089/neu.2015.4039; Napolitano LM, 2013, J TRAUMA ACUTE CARE, V74, P1575, DOI 10.1097/TA.0b013e318292cc54; Nascimento B, 2016, BRIT J ANAESTH, V117, P775, DOI 10.1093/bja/aew343; Nekludov M, 2007, J NEUROTRAUM, V24, P174, DOI 10.1089/neu.2006.0173; Niego B, 2014, J CEREBR BLOOD F MET, V34, P1283, DOI 10.1038/jcbfm.2014.99; Niego B, 2012, BLOOD, V119, P4752, DOI 10.1182/blood-2011-07-369512; Peiniger S, 2011, CRIT CARE, V15, DOI 10.1186/cc10048; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Pezold M, 2012, SURGERY, V151, P48, DOI 10.1016/j.surg.2011.06.023; Rao A, 2017, NEUROSURGERY, V64, P182, DOI 10.1093/neuros/nyx210; Reust DL, 2010, ANESTH ANALG, V110, P694, DOI 10.1213/ANE.0b013e3181c7eb27; Rhind SG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-5; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Samuels JM, 2019, J TRAUMA ACUTE CARE, V86, P686, DOI 10.1097/TA.0000000000002173; Scarpelini S, 2009, BRAZ J MED BIOL RES, V42, P1210, DOI 10.1590/S0100-879X2009001200015; Schochl H, 2014, SHOCK, V41, P44, DOI 10.1097/SHK.0000000000000093; Shibahashi K, 2019, NEUROL MED-CHIR, V59, P371, DOI 10.2176/nmc.oa.2019-0062; Spinella PC, 2011, J TRAUMA, V71, pS343, DOI 10.1097/TA.0b013e318227ef2d; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Stolla M, 2019, TRANSFUSION, V59, P1522, DOI 10.1111/trf.15169; Sugimoto K, 2017, J NEUROTRAUM, V34, P3245, DOI 10.1089/neu.2017.5240; Sugiyama K, 2020, BLOOD TRANSFUS-ITALY, V18, P6, DOI 10.2450/2019.0198-18; Sumislawski JJ, 2018, J TRAUMA ACUTE CARE, V85, P907, DOI 10.1097/TA.0000000000002048; Tan TS, 2002, ANAESTHESIA, V57, P644, DOI 10.1046/j.1365-2044.2002.02603.x; Tian HL, 2010, NEUROSURG REV, V33, P359, DOI 10.1007/s10143-010-0251-z; Tong WS, 2012, BRAIN INJURY, V26, P1136, DOI 10.3109/02699052.2012.666437; van Gent JAN, 2020, ACTA NEUROCHIR, V162, P329, DOI 10.1007/s00701-019-04111-z; Wada T, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1808-9; Walker PF, 2020, BMC EMERG MED, V20, DOI 10.1186/s12873-020-00335-w; Wu GJ, 2019, BLOOD ADV, V3, P729, DOI 10.1182/bloodadvances.2018025429; Yuan Q, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-017-0471-0; Yuan Q, 2016, J NEUROTRAUM, V33, P1279, DOI 10.1089/neu.2015.4205; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20; Zhang DF, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/261825; Zhang JN, 2018, BLOOD, V131, P2001, DOI 10.1182/blood-2017-11-784108; Zhang LM, 2019, WORLD NEUROSURG, V132, pE21, DOI 10.1016/j.wneu.2019.09.024; Zhang LM, 2017, WORLD NEUROSURG, V104, P381, DOI 10.1016/j.wneu.2017.04.140; Zhang XY, 2020, J CLIN LAB ANAL, V34, DOI 10.1002/jcla.23216; Zhao ZL, 2020, SEMIN THROMB HEMOST, V46, P167, DOI 10.1055/s-0039-3402427	104	2	2	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0094-6176	1098-9064		SEMIN THROMB HEMOST	Semin. Thromb. Hemost.	JUL	2021	47	05					527	537		10.1055/s-0041-1722970		APR 2021	11	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	TC0DV	WOS:000641548400001	33878779				2022-02-06	
J	Mallah, K; Couch, C; Alshareef, M; Borucki, D; Yang, XF; Alawieh, A; Tomlinson, S				Mallah, Khalil; Couch, Christine; Alshareef, Mohammed; Borucki, Davis; Yang, Xiaofeng; Alawieh, AliL; Tomlinson, Stephen			Complement mediates neuroinflammation and cognitive decline at extended chronic time points after traumatic brain injury	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Traumatic brain injury; Complement inhibition; Cognitive decline		Traumatic brain injury (TBI) can result in progressive cognitive decline occurring for years after the initial insult, and for which there is currently no pharmacological treatment. An ongoing chronic inflammatory response after TBI is thought to be an important factor in driving this cognitive decline. Here, we investigate the role of complement in neuroinflammation and cognitive decline for up to 6 months after murine TBI. Male C57BL/6 mice were subjected to open head injury using a controlled cortical impact device. At 2 months post TBI, mice were moved to large cages with an enriched environment to simulate rehabilitation therapy, and assigned to one of three treatment groups: 1. vehicle (PBS), 2. CR2Crry (3 doses over 1 week), 3. CR2Crry (continuous weekly dose until the end of the study). The study was terminated at 6 months post-TBI for all groups. Motor and cognitive function was analyzed, with histopathological analysis of brain tissue. Measured at 6 months after TBI, neither of the complement inhibition paradigms improved motor performance. However, mice receiving continuous CR2Crry treatment showed improved spatial learning and memory compared to both mice receiving only 3 doses and to mice receiving vehicle control. Analysis of brain sections at 6 months after injury revealed ongoing complement activation in the control group, with reduced complement activation and C3 deposition in the continuous CR2Crry treatment group. The ipsilateral hemisphere of continuously treated animals also showed a decrease in microglia/macrophage and astrocyte activation compared to vehicle. There was also increased astrocytosis in the contralateral hippocampus of vehicle treated vs. naive mice, which was reduced in mice continuously treated with CR2Crry. This study demonstrates continued complement mediated neuroinflammation at extended chronic time points after TBI, and extends the potential treatment window for complement inhibition, which has previously been shown to improve outcomes after murine TBI.	[Mallah, Khalil; Couch, Christine; Alshareef, Mohammed; Borucki, Davis; Yang, Xiaofeng; Alawieh, AliL; Tomlinson, Stephen] Med Univ South Carolina, Dept Microbiol & Immunol, 173 Ashley Ave,BSB 204,MSC 504, Charleston, SC 29425 USA; [Couch, Christine] Med Univ South Carolina, Coll Hlth Profess, Dept Hlth Sci & Res, Charleston, SC 29425 USA; [Alshareef, Mohammed] Med Univ South Carolina, Dept Neurol Surg, Charleston, SC 29425 USA; [Borucki, Davis] Med Univ South Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Borucki, Davis] Med Univ South Carolina, Med Scientist Training Program, Charleston, SC 29425 USA; [Alawieh, AliL] Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA; [Tomlinson, Stephen] Ralph Johnson VA Med Ctr, Charleston, SC 29401 USA		Alawieh, A; Tomlinson, S (corresponding author), Med Univ South Carolina, Dept Microbiol & Immunol, 173 Ashley Ave,BSB 204,MSC 504, Charleston, SC 29425 USA.; Alawieh, A (corresponding author), Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA.	ali.mostafa.alawieh@emory.edu; tomlinss@musc.edu		Couch, Christine/0000-0002-2667-4746; tomlinson, stephen/0000-0002-6281-2122	Department of Veterans AffairsUS Department of Veterans Affairs [1BX004256, 1RX001141, IK6BX005235]; National Institute of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32AI132164]; NIH National Center for Advancing Translational Sciences (NCATS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1 TR001451, UL1 TR001450]; Neurosurgery Research and Education Foundation (NREF) Research Fellowship Grant	This work was supported by grants from the Department of Veterans Affairs (1BX004256, 1RX001141 and IK6BX005235) to S.T, the National Institute of Health (NIH) (T32AI132164) to KM, the NIH National Center for Advancing Translational Sciences (NCATS) (TL1 TR001451 and UL1 TR001450) to CC, and Neurosurgery Research and Education Foundation (NREF) Research Fellowship Grant to MA.	Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Alawieh A, 2021, J NEUROSCI, V41, P1830, DOI 10.1523/JNEUROSCI.1734-20.2020; Alawieh A, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6459; Alawieh A, 2018, J NEUROSCI, V38, P2519, DOI 10.1523/JNEUROSCI.2197-17.2018; Andrey P, 2005, J NEUROSCI METH, V145, P233, DOI 10.1016/j.jneumeth.2005.01.006; Atkinson C, 2005, J CLIN INVEST, V115, P2444, DOI 10.1172/JCI25208; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Biederman J, 2015, J NERV MENT DIS, V203, P813, DOI 10.1097/NMD.0000000000000375; Biot E, 2016, PLANT J, V87, P230, DOI 10.1111/tpj.13189; Bonetto A, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.101; Boulos ME, 2018, J NEUROSCI, V38, P7201, DOI 10.1523/JNEUROSCI.1011-18.2018; Caballero-Garrido E, 2017, BEHAV BRAIN RES, V331, P282, DOI 10.1016/j.bbr.2017.05.042; Carnevale JA, 2018, J NEUROSURG, V129, P1305, DOI 10.3171/2017.7.JNS17988; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Darwish H, 2012, BRAIN INJURY, V26, P1763, DOI [10.3109/02699052.2012.741452, 10.3109/02699052.2011.635362]; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Gao M, 2021, STEM CELL RES THER, V12, DOI 10.1186/s13287-021-02186-z; Gurfein BT, 2012, MOL MED, V18, P606, DOI 10.2119/molmed.2012.00053; Habbas S, 2015, CELL, V163, P1730, DOI 10.1016/j.cell.2015.11.023; Henry RJ, 2020, J NEUROSCI, V40, P2960, DOI 10.1523/JNEUROSCI.2402-19.2020; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Huang YX, 2008, J IMMUNOL, V181, P8068, DOI 10.4049/jimmunol.181.11.8068; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; KACZOROWSKI SL, 1995, J CEREBR BLOOD F MET, V15, P860, DOI 10.1038/jcbfm.1995.107; Krukowski K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123753; Leinhase I, 2006, EXP NEUROL, V199, P454, DOI 10.1016/j.expneurol.2006.01.033; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Marschner L, 2019, BEHAV BRAIN RES, V365, P222, DOI 10.1016/j.bbr.2018.02.040; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Neher MD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-95; Nguyen TP, 2018, J ALZHEIMERS DIS, V66, P717, DOI 10.3233/JAD-180586; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Patil SS, 2009, BEHAV BRAIN RES, V198, P58, DOI 10.1016/j.bbr.2008.10.029; Popovitz J, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00006; Rancan M, 2003, J CEREBR BLOOD F MET, V23, P1070, DOI 10.1097/01.WCB.0000084250.20114.2C; Ruseva MM, 2015, P NATL ACAD SCI USA, V112, P14319, DOI 10.1073/pnas.1513698112; Santello M, 2019, NAT NEUROSCI, V22, P154, DOI 10.1038/s41593-018-0325-8; Seibenhener ML, 2015, JOVE-J VIS EXP, DOI 10.3791/52434; Song HB, 2003, J CLIN INVEST, V111, P1875, DOI 10.1172/JCI200317348; Tureyen K, 2004, J NEUROSCI METH, V139, P203, DOI 10.1016/j.jneumeth.2004.04.029	45	2	2	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	APR 20	2021	9	1							72	10.1186/s40478-021-01179-6			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	RP6AO	WOS:000641809800001	33879257	gold, Green Published			2022-02-06	
J	Mack, CD; Solomon, G; Covassin, T; Theodore, N; Cardenas, J; Sills, A				Mack, Christina D.; Solomon, Gary; Covassin, Tracey; Theodore, Nicholas; Cardenas, Javier; Sills, Allen			Epidemiology of Concussion in the National Football League, 2015-2019	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; American football; National Football League; epidemiology		Background: Concussion in American football, and specifically the National Football League (NFL) is a major area of interest and key focus for injury prevention. Complete and accurate characterization of when, how, and to whom these injuries occur can facilitate injury reduction efforts. Existing studies of concussion in the NFL use publicly available data, potentially limiting data quality and the inferences that can be made. Hypothesis: Concussion incidence in the NFL decreased across the 2015-2019 seasons. Study Design: Descriptive epidemiology study. Methods: Concussion incidence, including counts, one-season risk, and rates per game and player-plays, among active NFL players from 2015 to 2019 is described by year, season, play type, and roster position. Results: A total 1302 concussions were identified from 2015 to 2019 among 1004 players. Of these, 80% occurred in NFL games. The average annual incidence of in-season game concussions changed over the study period, from 230.7 per season (2015-2017) to 177.0 per season (2018-2019); this represented a 23% decrease in game settings (P < 0.01). Practice concussions fluctuated across the years of the study from 38 to 67 per season (average = 50.8/season). There were 70.6 concussions per 100 preseason games, which was slightly higher than the regular season rate per game of 61.7. Overall, there were 790 regular season game concussions across 4,657,243 player-plays and 114,428 player-games during the 5-year study. In regular season games, the majority of concussions were sustained on running and passing plays (n = 119/season), and the highest average rate per play occurred on kickoffs (0.69/100 plays). Defensive secondary (cornerbacks, safeties, and generic defensive backs) and offensive line incurred the most concussions, and the highest rates of concussion were among tight ends and wide receivers. Conclusion and Relevance: Concussions in the NFL are a key focus for player safety. Concussion reduction strategies were implemented before 2018, after which there was a sustained 2-year decrease in concussion incidence, providing a new benchmark from which to work toward further injury reduction.	[Mack, Christina D.] IQVIA, Res Triangle Pk, NC USA; [Solomon, Gary; Sills, Allen] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Nashville, TN 37212 USA; [Solomon, Gary; Sills, Allen] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA; [Covassin, Tracey; Sills, Allen] Natl Football League Player Hlth & Safety Dept, New York, NY USA; [Covassin, Tracey] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA; [Theodore, Nicholas] Johns Hopkins Univ, Sch Med, Dept Neurol Surg, Baltimore, MD USA; [Cardenas, Javier] Barrow Neurol Inst, Dept Neurol, Phoenix, AZ 85013 USA		Mack, CD (corresponding author), IQVIA Real World Solut, 4820 Emperor Blvd, Durham, NC 27703 USA.	christina.mack@IQVIA.com					Bailey AM, 2020, ANN BIOMED ENG, V48, P2531, DOI 10.1007/s10439-020-02627-5; Beachy G, 2014, J ATHL TRAINING, V49, P493, DOI 10.4085/1062-6050-49.2.19; Beaudouin Florian, 2019, Sports Med Int Open, V3, pE6, DOI 10.1055/a-0808-2551; Bedard G, 2021, CLIN J SPORT MED, V31, P289, DOI 10.1097/JSM.0000000000000741; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Camp CL, 2018, AM J SPORT MED, V46, P1997, DOI 10.1177/0363546518773048; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Clark MD, 2017, AM J SPORT MED, V45, P929, DOI 10.1177/0363546516677793; Coffey N, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-017-0118-8; Cosgrave M, 2019, PHYS THER SPORT, V35, P99, DOI 10.1016/j.ptsp.2018.11.010; Dai JB, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118815448; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dreyer NA, 2019, SPORTS HEALTH, V11, P440, DOI 10.1177/1941738119854759; Ellenbogen RG, 2018, BRIT J SPORT MED, V52, P894, DOI 10.1136/bjsports-2018-099203; Hannah T, 2019, CUREUS, V11, DOI 10.7759/cureus.6252; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Houck Z, 2016, AM J SPORT MED, V44, P2269, DOI 10.1177/0363546516645070; Hutchinson MR., 2014, ANN ORTHOP RHEUMATOL, V2, P1022; Kent R, 2020, J BIOMECH, V99, DOI 10.1016/j.jbiomech.2019.109551; Lawrence DW, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115583653; Lessley DJ, 2018, AM J SPORT MED, V46, P3502, DOI 10.1177/0363546518804498; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Mack C, 2020, NEUROSURGERY, V87, P312, DOI 10.1093/neuros/nyz481; Mack C, 2020, CURR SPORT MED REP, V19, P168, DOI 10.1249/JSR.0000000000000711; Mack C, 2019, J ATHL TRAINING, V54, P852, DOI 10.4085/1062-6050-181-19; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McNeel C, 2020, J SCI MED SPORT, V23, P125, DOI 10.1016/j.jsams.2019.10.010; Myer GD, 2014, J ORTHOP SPORT PHYS, V44, P164, DOI 10.2519/jospt.2014.5298; Nathanson JT, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967115622621; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Padaki AS, 2016, AM J SPORT MED, V44, P2263, DOI 10.1177/0363546516634679; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Putukian M, 2019, AM J SPORT MED, V47, P1236, DOI 10.1177/0363546519830100; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Schallmo MS, 2017, J BONE JOINT SURG AM, V99, P1314, DOI 10.2106/JBJS.16.01573; Teramoto M, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117740862; Teramoto M, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115620365; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	43	2	2	1	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	SEP	2021	13	5					423	430	19417381211011446	10.1177/19417381211011446		APR 2021	8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	UI2DO	WOS:000643482500001	33872087				2022-02-06	
J	Park, G; Suh, JH; Han, SJ				Park, Gahee; Suh, Jee Hyun; Han, Soo Jeong			Transcranial direct current stimulation for balance and gait in repetitive mild traumatic brain injury in rats	BMC NEUROSCIENCE			English	Article						TDCS; Mild traumatic brain injury; Balance; Motor evoked potential		Background Balance impairment and lack of postural orientation are serious problems in patients with repetitive mild traumatic brain injury (mTBI). Objective To investigate whether anodal transcranial direct current stimulation (tDCS) over the primary motor cortex (M1) can improve balance control and gait in repetitive mTBI rat models. Methods In this prospective animal study, 65 repetitive mTBI rats were randomly assigned to two groups: the tDCS group and the control group. To create repetitive mTBI model rats, we induced mTBI in the rats for 3 consecutive days. The tDCS group received one session of anodal tDCS over the M1 area 24 h after the third induced mTBI, while the control group did not receive tDCS treatment. Motor-evoked potential (MEP), foot-fault test, and rotarod test were evaluated before mTBI, before tDCS and after tDCS. The Mann-Whitney U test and Wilcoxon signed rank test were used to assess the effects of variables between the two groups. Results Anodal tDCS over the M1 area significantly improved the amplitude of MEP in the tDCS group (p = 0.041). In addition, rotarod duration was significantly increased in the tDCS group (p = 0.001). The foot-fault ratio was slightly lower in the tDCS group, however, this was not statistically significant. Conclusion Anodal tDCS at the M1 area could significantly improve the amplitude of MEP and balance function in a repetitive mTBI rat model. We expect that anodal tDCS would have the potential to improve balance in patients with repetitive mTBI.	[Park, Gahee; Suh, Jee Hyun; Han, Soo Jeong] Ewha Womans Univ, Coll Med, Dept Rehabil Med, 1071 An Yang Cheon Ro, Seoul 07985, South Korea; [Suh, Jee Hyun] Bundang Jesaeng Gen Hosp, Dept Rehabil Med, 20,Seohyeon Ro 180 Beon Gil, Seongnam Si 13590G, Gyeonggi Do, South Korea		Suh, JH (corresponding author), Ewha Womans Univ, Coll Med, Dept Rehabil Med, 1071 An Yang Cheon Ro, Seoul 07985, South Korea.	suhtwins@hanmail.net			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2059711]	This study was supported and funded by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2059711). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa EH, 2016, J MOTOR BEHAV, V48, P5, DOI 10.1080/00222895.2015.1024824; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; Barth JT, 2001, J ATHL TRAINING, V36, P253; Batra NA, 2008, BIOL PSYCHIAT, V63, P1178, DOI 10.1016/j.biopsych.2007.10.007; Bodnar CN, 2019, J NEUROTRAUM, V36, P1683, DOI 10.1089/neu.2018.6127; BRAMMER DW, 1991, LAB ANIM SCI, V41, P432; Cambiaghi M, 2010, EUR J NEUROSCI, V31, P704, DOI 10.1111/j.1460-9568.2010.07092.x; Grecco LAC, 2017, DEV NEUROREHABIL, V20, P142, DOI 10.3109/17518423.2016.1139639; Degani AM, 2017, BRAIN INJURY, V31, P49, DOI 10.1080/02699052.2016.1225982; Deliagina TG, 2007, PHYSIOL BEHAV, V92, P148, DOI 10.1016/j.physbeh.2007.05.023; Du XC, 2020, CELL BIOSCI, V10, DOI 10.1186/s13578-020-00393-4; Ellenbroek B, 2016, DIS MODEL MECH, V9, P1079, DOI 10.1242/dmm.026120; Epperson CN, 2002, ARCH GEN PSYCHIAT, V59, P851, DOI 10.1001/archpsyc.59.9.851; Ferrucci R, 2008, NEUROLOGY, V71, P493, DOI 10.1212/01.wnl.0000317060.43722.a3; Fregni F, 2006, MOVEMENT DISORD, V21, P1693, DOI 10.1002/mds.21012; Grecco LAC, 2014, BRAZ J PHYS THER, V18, P419, DOI 10.1590/bjpt-rbf.2014.0053; Grunhaus L, 2003, INT J NEUROPSYCHOPH, V6, P371, DOI 10.1017/S1461145703003705; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Ikoma K, 1996, NEUROLOGY, V46, P1371, DOI 10.1212/WNL.46.5.1371; Jacobs JV, 2007, J NEURAL TRANSM, V114, P1339, DOI 10.1007/s00702-007-0657-0; Karayannidou A, 2009, J PHYSIOL-LONDON, V587, P3795, DOI 10.1113/jphysiol.2009.170183; Kaski D, 2013, NEUROREHAB NEURAL RE, V27, P864, DOI 10.1177/1545968313496328; Kim HJ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1372946; Kim HJ, 2017, PEERJ, V5, DOI 10.7717/peerj.2818; Kim SJ, 2010, J KOREAN MED SCI, V25, P1499, DOI 10.3346/jkms.2010.25.10.1499; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Lang N, 2005, EUR J NEUROSCI, V22, P495, DOI 10.1111/j.1460-9568.2005.04233.x; Luft AR, 2001, EXP BRAIN RES, V140, P112, DOI 10.1007/s002210100805; Mallinson AI, 1998, AM J OTOL, V19, P814; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Maruta J, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.548220; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nomura T, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00317; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Powers KC, 2014, GAIT POSTURE, V39, P728, DOI 10.1016/j.gaitpost.2013.10.005; Rogers DC, 1997, STROKE, V28, P2060, DOI 10.1161/01.STR.28.10.2060; Russell M, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00104; Saeys W, 2015, DISABIL REHABIL, V37, P1857, DOI 10.3109/09638288.2014.982834; Saha DC, 2007, J AM ASSOC LAB ANIM, V46, P74; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Schatz P, 2011, CLIN NEUROPSYCHOL, V25, P1042, DOI 10.1080/13854046.2011.556669; Smith MJ, 1999, NEUROLOGY, V53, P2069, DOI 10.1212/WNL.53.9.2069; de Moura MCDS, 2019, SOMATOSENS MOT RES, V36, P122, DOI 10.1080/08990220.2019.1624517; Steiner KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163598; Sussman D, 2017, NEUROSCI LETT, V650, P52, DOI 10.1016/j.neulet.2017.04.026; Tang YP, 1997, J NEUROTRAUM, V14, P851, DOI 10.1089/neu.1997.14.851; Tiwari HS, 2015, NEUROSCI LETT, V589, P121, DOI 10.1016/j.neulet.2015.01.038; VanItallie TB, 2019, METABOLISM, V100, DOI 10.1016/j.metabol.2019.07.007; Wood TA, 2019, AM J PHYS MED REHAB, V98, P566, DOI 10.1097/PHM.0000000000001152; WOOLSEY CN, 1950, RES PUBL ASSOC RES N, V30, P238; Yoon KJ, 2016, J NEUROL SCI, V362, P314, DOI 10.1016/j.jns.2016.02.005; Yosephi MH, 2018, BRAIN STIMUL, V11, P1239, DOI 10.1016/j.brs.2018.07.044	56	2	2	5	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	APR 17	2021	22	1							26	10.1186/s12868-021-00633-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RO1ZE	WOS:000640845500001	33865318	gold, Green Published			2022-02-06	
J	Crichton, A; Ignjatovic, V; Babl, FE; Oakley, E; Greenham, M; Hearps, S; Delzoppo, C; Beauchamp, MH; Guerguerian, AM; Boutis, K; Hubara, E; Hutchison, J; Anderson, V				Crichton, Alison; Ignjatovic, Vera; Babl, Franz E.; Oakley, Ed; Greenham, Mardee; Hearps, Stephen; Delzoppo, Carmel; Beauchamp, Miriam H.; Guerguerian, Anne-Marie; Boutis, Kathy; Hubara, Evyatar; Hutchison, Jamie; Anderson, Vicki			Interleukin-8 Predicts Fatigue at 12 Months Post-Injury in Children with Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						children; fatigue; Glasgow Coma Scale; serum biomarkers; traumatic brain injury		Despite many children experiencing fatigue after childhood brain injury, little is known about the predictors of this complaint. To date, traditional indices of traumatic brain injury (TBI) severity have not predicted reliably persisting fatigue (up to three years post-injury). This study aimed to establish whether persisting fatigue is predicted by serum biomarker concentrations in child TBI. We examined whether acute serum biomarker expression would improve prediction models of 12-month fatigue based on injury severity. Blood samples were collected from 87 children (1-17 years at injury) sustaining mild to severe TBI (Glasgow Coma Scale [GCS] range 3-15; mean 12.43; classified as mild TBI [n = 50, 57%] vs. moderate/severe TBI [n = 37, 43%]), and presenting to the emergency departments (ED) and pediatric intensive care units (PICU) at one of three tertiary pediatric hospitals (Royal Children's Hospital (RCH); Hospital for Sick Children (HSC), Toronto; St Justine Children's Hospital (SJH), Montreal). Six serum biomarker concentrations were measured within 24 h of injury (interleukin-6, interleukin-8 [IL-8], soluble vascular cell adhesion molecule [SVCAM], S100 calcium binding protein B [S100B], neuron specific enolase [NSE], and soluble neural cell adhesion molecule [sNCAM]). Fatigue at 12 months post-injury was measured using the Pediatric Quality of Life Inventory Multidimensional Fatigue Scale (parent report), classified as present/absent using previously derived cut-points. At 12 months post-injury, 22% of participants experienced fatigue. A model including IL-8 was the best serum biomarker for estimating the probability of children experiencing fatigue at 12 months post-injury. The IL-8 also significantly improved predictive models of fatigue based on severity.	[Crichton, Alison; Ignjatovic, Vera; Babl, Franz E.; Oakley, Ed; Greenham, Mardee; Hearps, Stephen; Delzoppo, Carmel; Anderson, Vicki] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Crichton, Alison] Monash Univ, Fac Med Nursing & Hlth Sci, Sch Clin Sci, Dept Paediat, Melbourne, Vic, Australia; [Ignjatovic, Vera; Babl, Franz E.; Oakley, Ed] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Greenham, Mardee; Anderson, Vicki] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia; [Babl, Franz E.; Oakley, Ed; Delzoppo, Carmel; Anderson, Vicki] Royal Childrens Hosp, Melbourne, Vic, Australia; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Beauchamp, Miriam H.] Ste Justine Hosp, Res Ctr, Montreal, PQ, Canada; [Guerguerian, Anne-Marie; Hubara, Evyatar; Hutchison, Jamie] Hosp Sick Children SickKids, Crit Care Med, Toronto, ON, Canada; [Boutis, Kathy] Hosp Sick Children SickKids, Paediat Emergency Med, Toronto, ON, Canada; [Guerguerian, Anne-Marie; Hutchison, Jamie] Hosp Sick Children Res Inst, Neurosci & Mental Hlth Res Program, Toronto, ON, Canada; [Guerguerian, Anne-Marie; Hutchison, Jamie] Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada; [Boutis, Kathy] Univ Toronto, Dept Paediat, Toronto, ON, Canada		Crichton, A (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Cictoria 3052, Australia.	ali.crichton@mcri.edu.au		Hearps, Stephen/0000-0003-2984-1172			Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; ALOISI F, 1992, J IMMUNOL, V149, P2358; Anderson JS, 1997, J NERV MENT DIS, V185, P359, DOI 10.1097/00005053-199706000-00001; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Anderson V, 2012, DISABIL REHABIL, V34, P1639, DOI 10.3109/09638288.2012.656789; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Bandyopadhyay S, 2005, ACAD EMERG MED, V12, P732, DOI 10.1197/j.aem.2005.02.017; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Beers SR, 2007, J NEUROTRAUM, V24, P97, DOI 10.1089/neu.2006.0055; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Crichton A, 2018, J HEAD TRAUMA REHAB, V33, P200, DOI 10.1097/HTR.0000000000000330; Crichton A, 2018, J INT NEUROPSYCH SOC, V24, P224, DOI 10.1017/S1355617717000893; Crichton AJ, 2017, J HEAD TRAUMA REHAB, V32, P107, DOI 10.1097/HTR.0000000000000248; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Eddy L, 2007, J SPEC PEDIATR NURS, V12, P105, DOI 10.1111/j.1744-6155.2007.00099.x; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Eiser C, 2001, QUAL LIFE RES, V10, P347, DOI 10.1023/A:1012253723272; Ewing-Cobbs L, 2014, J PEDIATR PSYCHOL, V39, P653, DOI 10.1093/jpepsy/jsu018; Falk AC, 2013, SCAND J CARING SCI, V27, P51, DOI 10.1111/j.1471-6712.2012.00999.x; Greenham M, 2018, DEV NEUROPSYCHOL, V43, P312, DOI 10.1080/87565641.2018.1440557; Haqqani AS, 2007, J NEUROTRAUM, V24, P54, DOI 10.1089/neu.2006.0079; Holland AA, 2014, CHILD NEUROPSYCHOL, V20, P71, DOI 10.1080/09297049.2012.748888; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Jonsson CCA, 2014, INT J REHABIL RES, V37, P317, DOI 10.1097/MRR.0000000000000073; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Lo TYM, 2010, J NEUROTRAUM, V27, P2139, DOI 10.1089/neu.2010.1387; Lo TYM, 2009, J NEUROTRAUM, V26, P1479, DOI [10.1089/neu.2008.0753, 10.1089/neu.2008-0753]; Lugones M, 2018, NEUROSCI BIOBEHAV R, V87, P206, DOI 10.1016/j.neubiorev.2018.02.006; MacAllister WS, 2009, MULT SCLER J, V15, P1502, DOI 10.1177/1352458509345902; MCCLAIN CJ, 1987, J LAB CLIN MED, V110, P48; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Nijhof SL, 2011, PEDIATRICS, V127, pE1169, DOI 10.1542/peds.2010-1147; NITTA T, 1992, NEUROSURG REV, V15, P203, DOI 10.1007/BF00345934; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Panepinto JA, 2014, PEDIATR BLOOD CANCER, V61, P171, DOI 10.1002/pbc.24776; Papa L, 2017, J NEUROTRAUM, V34, P2187, DOI 10.1089/neu.2017.5030; Papa L, 2016, SPORTS MED ARTHROSC, V24, P108, DOI 10.1097/JSA.0000000000000117; Ponsford J, 2015, J HEAD TRAUMA REHAB, V30, P277, DOI 10.1097/HTR.0000000000000049; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Pranzatelli MR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00557; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Shen JH, 2006, SLEEP MED REV, V10, P63, DOI 10.1016/j.smrv.2005.05.004; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; StataCorp, 2017, STATA STAT SOFTWARE; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Upton P, 2008, QUAL LIFE RES, V17, P895, DOI 10.1007/s11136-008-9350-5; Varni JW, 2010, INT J PEDIATR OBES, V5, P34, DOI 10.3109/17477160903111706; Varni JW, 2004, J RHEUMATOL, V31, P2494; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Whitsett SF, 2008, J PEDIATR ONCOL NURS, V25, P86, DOI 10.1177/1043454208315546; Wilkinson AA, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0925-6; Wilkinson AA, 2016, PEDIATR CRIT CARE ME, V17, P638, DOI 10.1097/PCC.0000000000000752; Wilkinson J, 2018, NEUROPSYCHOL REV, V28, P73, DOI 10.1007/s11065-018-9370-z; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zhang L, 2011, J CELL PHYSIOL, V226, P1694, DOI 10.1002/jcp.22500; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	70	2	2	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2021	38	8					1151	1163		10.1089/neu.2018.6083			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	RJ3OX	WOS:000637508500020	31880977	Green Submitted			2022-02-06	
J	Rasmussen, MS; Andelic, N; Pripp, AH; Nordenmark, TH; Soberg, HL				Rasmussen, Mari S.; Andelic, Nada; Pripp, Are H.; Nordenmark, Tonje H.; Soberg, Helene L.			The effectiveness of a family-centred intervention after traumatic brain injury: A pragmatic randomised controlled trial	CLINICAL REHABILITATION			English	Article						Traumatic brain injury; rehabilitation interventions; family; health related quality of life; randomised controlled trial		Objectives: To determine the effectiveness of a family-centred intervention for patients with traumatic brain injury and family members. Design: Open-labelled, two-armed randomised controlled trial. Settings: Outpatient clinic and family residences. Participants: Sixty-one patients (33 women) with traumatic brain injury, with mean (SD) age 43.8 (12.2), and 63 family members (33 women), with mean (SD) age 42.6 (11.3), were assign to intervention (n = 30 families) and control group (n = 31 families). Intervention: An eight-session single-family intervention to improve individual and family functioning. Outcome measures: Self-reported questionnaires at start-of-treatment, median (IQR) 11.4 (8.4, 15.9) months post-injury, and at two follow-ups, 2.7 (2.3, 3.8) and 9.2 (8.2, 9.9) months after start-of-treatment. Primary outcome measures were the SF-36 Mental Component Summary (MCS) and Caregiver Burden Scale (CGB). Secondary outcome measures were the Family Adaptability and Cohesion Evaluation Scale (FACES) and Quality of Life after Brain Injury Questionnaire (QOLIBRI). Group differences were analysed with linear mixed-model analysis for repeated measurements. Results: No significant between-group differences were found. The intervention group significantly improved on the MCS, the CGB and FACES in the treatment period, whereas the controls did not. The mean (SD) MCS change in the treatment period was 2.4 (1.1) points P = 0.028 in the intervention group. Mean (SE) MCS scores were 47.9 (1.26) and 47.3 (1.27) in the intervention and control group at last follow-up. Conclusions: Receiving an eight-session family intervention, in addition to specialised rehabilitation for the patients, was not superior to rehabilitation at a specialised traumatic brain injury outpatient clinic.	[Rasmussen, Mari S.; Andelic, Nada; Nordenmark, Tonje H.; Soberg, Helene L.] Oslo Univ Hosp, Dept Phys Med & Rehabil, PB 4950 Nydalen, N-0424 Oslo, Norway; [Rasmussen, Mari S.; Andelic, Nada] Univ Oslo, Fac Med, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Inst Hlth & Soc, Oslo, Norway; [Pripp, Are H.] Oslo Univ Hosp, Oslo Ctr Biostat & Epidemiol Res Support Serv, Oslo, Norway; [Nordenmark, Tonje H.] Univ Oslo, Dept Psychol, Oslo, Norway; [Soberg, Helene L.] OsloMet Oslo Metropolitan Univ, Fac Hlth Sci, Dept Physiotherapy, Oslo, Norway		Rasmussen, MS (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, PB 4950 Nydalen, N-0424 Oslo, Norway.	m.s.rasmussen@studmed.uio.no		Rasmussen, Mari Storli/0000-0003-2794-4768	DAM Foundation, Norway [2016/FO77196]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by the DAM Foundation, Norway, under Grant no. 2016/FO77196. The trial funders played no role in the study design, data collection, analysis or interpretation, manuscript writing or decision to submit the article for publication.	Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; [Anonymous], 2008, ABBREVIATED INJURY S; Bakas T, 2017, STROKE, V48, pE122, DOI 10.1161/STROKEAHA.117.016052; Bannon SM, 2020, PSYCHOSOMATICS, V61, P518, DOI 10.1016/j.psym.2020.04.003; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bragstad LK, 2020, CLIN REHABIL, V34, P1056, DOI 10.1177/0269215520929737; de Goumoens Veronique, 2018, JBI Database System Rev Implement Rep, V16, P2330, DOI 10.11124/JBISRIR-2017-003846; Donovan J, 2014, CHIROPR MAN THER, V22, DOI 10.1186/s12998-014-0038-3; Elmstahl S, 1996, ARCH PHYS MED REHAB, V77, P177, DOI 10.1016/S0003-9993(96)90164-1; Essock SM, 2003, SCHIZOPHRENIA BULL, V29, P115, DOI 10.1093/oxfordjournals.schbul.a006981; Hagen C, 1979, LEVELS COGNITIVE FUN; Howe EI, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.561400; JENNETT B, 1975, LANCET, V1, P480; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kreitzer N, 2018, ARCH PHYS MED REHAB, V99, P2342, DOI 10.1016/j.apmr.2018.04.016; Lefebvre Helene, 2007, J Trauma Nurs, V14, P100; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Manskow US, 2017, NEUROREHABILITATION, V40, P211, DOI 10.3233/NRE-161406; Manskow US, 2014, BRAIN INJURY, V28, P672; Mayo NE, 2011, AGE AGEING, V40, P718, DOI 10.1093/ageing/afr061; Moher D, 2010, BMJ-BRIT MED J, V340, DOI [10.1136/bmj.c869, 10.1016/j.ijsu.2011.10.001, 10.1016/j.jclinepi.2010.03.004]; Norup A, 2017, NEUROPSYCHOL REHABIL, V27, P196, DOI 10.1080/09602011.2015.1076484; Olson D, 2011, J MARITAL FAM THER, V37, P64, DOI 10.1111/j.1752-0606.2009.00175.x; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Rasmussen MS., 2019, COGENT MED, V6; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Stejskal TM, 2012, NEUROREHABILITATION, V31, P75, DOI 10.3233/NRE-2012-0776; Stevens Lillian Flores, 2016, Top Spinal Cord Inj Rehabil, V22, P49, DOI 10.1310/sci2201-49; Testa JA, 2006, J HEAD TRAUMA REHAB, V21, P236, DOI 10.1097/00001199-200605000-00004; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson L, 2017, J NEUROTRAUM, V34, P59, DOI 10.1089/neu.2015.4287; Winter L, 2016, BRAIN INJURY, V30, P373, DOI 10.3109/02699052.2016.1144080; Yu AM, 2018, PEDIATR RES, V84, P393, DOI 10.1038/s41390-018-0019-7	38	2	2	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	OCT	2021	35	10					1428	1441	02692155211010369	10.1177/02692155211010369		APR 2021	14	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	WC6KV	WOS:000646010200001	33858221	Green Published			2022-02-06	
J	You, WD; Zhu, YR; Wei, AQ; Du, J; Wang, YD; Zheng, PD; Tu, MD; Wang, H; Wen, L; Yang, XF				You, Wendong; Zhu, Yuanrun; Wei, Anqi; Du, Juan; Wang, Yadong; Zheng, Peidong; Tu, Mengdi; Wang, Hao; Wen, Liang; Yang, Xiaofeng			Traumatic Brain Injury Induces Gastrointestinal Dysfunction and Dysbiosis of Gut Microbiota Accompanied by Alterations of Bile Acid Profile	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						bile acids; dysbiosis; gastrointestinal dysfunction; gut microbiota; traumatic brain injury		Gastrointestinal dysfunction is a common peripheral organ complication after traumatic brain injury (TBI), yet the underlying mechanism remains unknown. TBI has been demonstrated to cause gut microbiota dysbiosis in animal models, although the impacts of gut microbiota dysbiosis on gastrointestinal dysfunction were not examined. Bile acids are key metabolites between gut microbiota and host interactions. Therefore, the aim of this study was to investigate the mechanistic links between them by detecting the alterations of gut microbiota and bile acid profile after TBI. For that, we established TBI in mice using a lateral fluid percussion injury model. Gut microbiota was examined by 16S rRNA sequencing, and bile acids were profiled by ultra-performance liquid chromatography-tandem mass spectrometry. Our results showed that TBI caused intestinal inflammation and gut barrier impairment. Alterations of gut microbiota and bile acid profile were observed. The diversity of gut microbiota experienced a time dependent change from 1 h to 7 days post-injury. Levels of bile acids in feces and plasma were decreased after TBI, and the decrease was more significant in secondary bile acids, which may contribute to intestinal inflammation. Specific bacterial taxa such as Staphylococcus and Lachnospiraceae that may contribute to the bile acid metabolic changes were identifed. In conclusion, our study suggested that TBI-induced gut microbiota dysbiosis may contribute to gastrointestinal dysfunction via altering bile acid profile. Gut microbiota may be a potential treatment target for TBI-induced gastrointestinal dysfunction.	[You, Wendong; Zhu, Yuanrun; Wei, Anqi; Wang, Yadong; Zheng, Peidong; Tu, Mengdi; Wang, Hao; Wen, Liang; Yang, Xiaofeng] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Emergency & Trauma Ctr, Hangzhou, Zhejiang, Peoples R China; [Du, Juan] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China; [Wang, Hao; Wen, Liang; Yang, Xiaofeng] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China		Wen, L; Yang, XF (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	wenliang@zju.edu.cn; zjcswk@zju.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81971159, 82000489]; Natural Science Foundation of Zhejiang ProvinceNatural Science Foundation of Zhejiang Province [Y19H030059]	This study was supported by the National Natural Science Foundation of China (No. 81971159, No. 82000489) and the Natural Science Foundation of Zhejiang Province (No. Y19H030059).	Bansal V, 2010, J TRAUMA, V68, P1059, DOI 10.1097/TA.0b013e3181d87373; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; BAZAN NG, 1995, J NEUROTRAUM, V12, P791, DOI 10.1089/neu.1995.12.791; Biagioli M, 2017, J IMMUNOL, V199, P718, DOI 10.4049/jimmunol.1700183; Chen HW, 2019, CELL, V177, P1217, DOI 10.1016/j.cell.2019.03.036; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Cook AM, 2008, NUTR CLIN PRACT, V23, P608, DOI 10.1177/0884533608326060; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; de Vos WM, 2012, NUTR REV, V70, pS45, DOI 10.1111/j.1753-4887.2012.00505.x; Feighery L, 2008, J TRAUMA, V64, P131, DOI 10.1097/TA.0b013e3181568d9f; Fung TC, 2017, NAT NEUROSCI, V20, P145, DOI 10.1038/nn.4476; Gaddam Samson Sujit Kumar, 2015, Handb Clin Neurol, V127, P205, DOI 10.1016/B978-0-444-52892-6.00014-3; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hang CH, 2005, WORLD J GASTROENTERO, V11, P1149, DOI 10.3748/wjg.v11.i8.1149; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Houlden A, 2016, BRAIN BEHAV IMMUN, V57, P10, DOI 10.1016/j.bbi.2016.04.003; Huang KZ, 2018, PEDIATR RES, V83, P1031, DOI 10.1038/pr.2018.14; Jia W, 2018, NAT REV GASTRO HEPAT, V15, P111, DOI 10.1038/nrgastro.2017.119; Kakiyama G, 2013, J HEPATOL, V58, P949, DOI 10.1016/j.jhep.2013.01.003; Kaur N, 2011, GUT MICROBES, V2, P211, DOI 10.4161/gmic.2.4.17863; Lavelle A, 2020, NAT REV GASTRO HEPAT, V17, P223, DOI 10.1038/s41575-019-0258-z; Ma EL, 2017, BRAIN BEHAV IMMUN, V66, P56, DOI 10.1016/j.bbi.2017.06.018; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mayer EA, 2015, J CLIN INVEST, V125, P926, DOI 10.1172/JCI76304; Nicholson SE, 2019, SHOCK, V52, P240, DOI 10.1097/SHK.0000000000001211; Ohland CL, 2010, AM J PHYSIOL-GASTR L, V298, pG807, DOI 10.1152/ajpgi.00243.2009; Park AJ, 2013, NEUROGASTROENT MOTIL, V25, P733, DOI 10.1111/nmo.12153; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; Ridlon JM, 2015, ACTA PHARM SIN B, V5, P99, DOI 10.1016/j.apsb.2015.01.006; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Sharon G, 2016, CELL, V167, P915, DOI 10.1016/j.cell.2016.10.027; Simon DW, 2020, BRAIN RES, V1747, DOI 10.1016/j.brainres.2020.147056; Tan M, 2011, BRIT J NEUROSURG, V25, P2, DOI 10.3109/02688697.2010.522745; Treangen TJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02757; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Wang WJ, 2018, BRIT J PHARMACOL, V175, P469, DOI 10.1111/bph.14095; Wen L., 2019, J VIS EXP, V19; Wen L, 2018, J NEUROTRAUM, V35, P2330, DOI 10.1089/neu.2017.5540; Winston JA, 2020, GUT MICROBES, V11, P158, DOI 10.1080/19490976.2019.1674124; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhu CS, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8060113	43	2	2	6	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2020.7526		APR 2021	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RN3QF	WOS:000640266300001	33677989				2022-02-06	
J	Schindler, AG; Baskin, B; Juarez, B; Lee, SJ; Hendrickson, R; Pagulayan, K; Zweifel, LS; Raskind, MA; Phillips, PEM; Peskind, ER; Cook, DG				Schindler, Abigail G.; Baskin, Britahny; Juarez, Barbara; Janet Lee, Suhjung; Hendrickson, Rebecca; Pagulayan, Kathleen; Zweifel, Larry S.; Raskind, Murray A.; Phillips, Paul E. M.; Peskind, Elaine R.; Cook, David G.			Repetitive blast mild traumatic brain injury increases ethanol sensitivity in male mice and risky drinking behavior in male combat veterans	ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH			English	Article						addiction; alcohol; AUDIT&#8208; C; blast; traumatic brain injury; Veteran		Background Mild traumatic brain injury (mTBI) is common in civilians and highly prevalent among military service members. mTBI can increase health risk behaviors (e.g., sensation seeking, impulsivity) and addiction risk (e.g., for alcohol use disorder (AUD)), but how mTBI and substance use might interact to promote addiction risk remains poorly understood. Likewise, potential differences in single vs. repetitive mTBI in relation to alcohol use/abuse have not been previously examined. Methods Here, we examined how a history of single (1x) or repetitive (3x) blast exposure (blast-mTBI) affects ethanol (EtOH)-induced behavioral and physiological outcomes using an established mouse model of blast-mTBI. To investigate potential translational relevance, we also examined self-report responses to the Alcohol Use Disorders Identification Test-Consumption questions (AUDIT-C), a widely used measure to identify potential hazardous drinking and AUD, and used a novel unsupervised machine learning approach to investigate whether a history of blast-mTBI affected drinking behaviors in Iraq/Afghanistan Veterans. Results Both single and repetitive blast-mTBI in mice increased the sedative properties of EtOH (with no change in tolerance or metabolism), but only repetitive blast potentiated EtOH-induced locomotor stimulation and shifted EtOH intake patterns. Specifically, mice exposed to repetitive blasts showed increased consumption "front-loading" (e.g., a higher rate of consumption during an initial 2-h acute phase of a 24-h alcohol access period and decreased total daily intake) during an intermittent 2-bottle choice condition. Examination of AUDIT-C scores in Iraq/Afghanistan Veterans revealed an optimal 3-cluster solution: "low" (low intake and low frequency), "frequent" (low intake and high frequency), and "risky" (high intake and high frequency), where Veterans with a history of blast-mTBI displayed a shift in cluster assignment from "frequent" to "risky," as compared to Veterans who were deployed to Iraq/Afghanistan but had no lifetime history of TBI. Conclusions Together, these results offer new insight into how blast-mTBI may give increase AUD risk and highlight the increased potential for adverse health risk behaviors following repetitive blast-mTBI.	[Schindler, Abigail G.; Baskin, Britahny; Janet Lee, Suhjung; Peskind, Elaine R.; Cook, David G.] VA Puget Sound Hlth Care Syst, VA Northwest Geriatr Res Educ & Clin Ctr, Seattle, WA USA; [Schindler, Abigail G.; Hendrickson, Rebecca; Pagulayan, Kathleen; Raskind, Murray A.] VA Puget Sound Hlth Care Syst, VA Northwest Mental Illness Res Educ & Clin Ctr, Seattle, WA USA; [Schindler, Abigail G.; Baskin, Britahny; Juarez, Barbara; Hendrickson, Rebecca; Pagulayan, Kathleen; Zweifel, Larry S.; Raskind, Murray A.; Phillips, Paul E. M.; Peskind, Elaine R.; Cook, David G.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Schindler, Abigail G.; Baskin, Britahny; Zweifel, Larry S.; Phillips, Paul E. M.; Cook, David G.] Univ Washington, Grad Program Neurosci, Seattle, WA 98195 USA; [Zweifel, Larry S.; Phillips, Paul E. M.; Cook, David G.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Cook, David G.] Univ Washington, Dept Med, Seattle, WA USA		Schindler, AG (corresponding author), VA Puget Sound Hlth Care Syst, S182,1660 South Columbian Way, Seattle, WA 98108 USA.	aschind@u.washington.edu	Pagulayan, Kati/AAR-9225-2020		University of WashingtonUniversity of Washington; U.S. Department of Veterans AffairsUS Department of Veterans Affairs [B77421, IK2CX001774]; Burroughs Wellcome FundBurroughs Wellcome Fund [1019873]; Biomedical Laboratory Research and Development, VA Office of Research and Development [1IK2BX003258, 5I01BX002311]	University of Washington; U.S. Department of Veterans Affairs, Grant/Award Number: #B77421 and IK2CX001774; Burroughs Wellcome Fund, Grant/Award Number: 1019873; Biomedical Laboratory Research and Development, VA Office of Research and Development, Grant/Award Number: 1IK2BX003258 and 5I01BX002311	Adams RS, 2012, J HEAD TRAUMA REHAB, V27, P349, DOI 10.1097/HTR.0b013e318268db94; Bradley KA, 1998, ALCOHOL CLIN EXP RES, V22, P1842, DOI 10.1097/00000374-199811000-00034; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Crawford EF, 2013, DRUG ALCOHOL DEPEN, V132, P101, DOI 10.1016/j.drugalcdep.2013.01.012; Dawson DA, 2005, ALCOHOL CLIN EXP RES, V29, P844, DOI 10.1097/01.ALC.0000164374.32229.A2; Defense and Veterans Brain Injury Center (DVBIC), 2019, DOD NUMB TRAUM BRAIN; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; First MB, 1995, STRUCTURED CLIN INTE; Fox J, 2007, MOUSE BIOMEDICAL RES; Fucich EA, 2019, J NEUROTRAUM, V36, P1847, DOI 10.1089/neu.2018.5854; Goldstein LE, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0064-3; Gowin JL, 2017, AM J PSYCHIAT, V174, P1094, DOI 10.1176/appi.ajp.2017.16101180; Grossbard J, 2017, PSYCHIAT SERV, V68, P48, DOI 10.1176/appi.ps.201500290; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hendrickson RC, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0908-5; Hoerster KD, 2012, AM J PREV MED, V43, P483, DOI 10.1016/j.amepre.2012.07.029; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Krukowski K, 2020, J NEUROTRAUM, V37, P1370, DOI 10.1089/neu.2019.6827; Lim YW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125130; Logsdon AF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66113-7; Lowing JL, 2014, J NEUROTRAUM, V31, P1700, DOI 10.1089/neu.2013.3286; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Miller SC, 2013, AM J PSYCHIAT, V170, P383, DOI 10.1176/appi.ajp.2012.12010126; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Muelbl MJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28062-0; Nawarawong NN, 2019, EUR J NEUROSCI, V50, P2101, DOI 10.1111/ejn.14281; Olson-Madden JH, 2012, J HEAD TRAUMA REHAB, V27, P370, DOI 10.1097/HTR.0b013e318268d496; Perez-Garcia G, 2019, NEUROPHARMACOLOGY, V145, P220, DOI 10.1016/j.neuropharm.2018.09.023; Perez-Garcia G, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0357-17.2018; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Sajja VSSS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15075; Sajja VSSS, 2013, J NEUROSCI RES, V91, P593, DOI 10.1002/jnr.23179; Salling MC, 2018, J NEUROSCI, V38, P6207, DOI 10.1523/JNEUROSCI.0550-18.2018; Santiago PN, 2010, PSYCHIAT SERV, V61, P575, DOI 10.1176/ps.2010.61.6.575; Schindler AG, 2017, NEUROBIOL DIS, V106, P23, DOI 10.1016/j.nbd.2017.06.004; Schindler AG, 2021, J NEUROTRAUM, V38, P940, DOI 10.1089/neu.2020.7061; Seal KH, 2011, DRUG ALCOHOL DEPEN, V116, P93, DOI 10.1016/j.drugalcdep.2010.11.027; Seidl JNT, 2015, J CLIN EXP NEUROPSYC, V37, P84, DOI 10.1080/13803395.2014.989817; Stahre MA, 2009, AM J PREV MED, V36, P208, DOI 10.1016/j.amepre.2008.10.017; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Teng SX, 2015, BRAIN BEHAV IMMUN, V45, P145, DOI 10.1016/j.bbi.2014.11.006; Trivedi RB, 2020, J GEN INTERN MED, V35, P112, DOI 10.1007/s11606-019-05307-w; Vonder Haar C, 2019, EUR J NEUROSCI, V50, P2134, DOI 10.1111/ejn.14123; Wenger JW, 2018, EXAMINATION RECENT D; Wilcox MV, 2014, NEUROPSYCHOPHARMACOL, V39, P579, DOI 10.1038/npp.2013.230	51	2	2	3	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0145-6008	1530-0277		ALCOHOL CLIN EXP RES	Alcoholism (NY)	MAY	2021	45	5					1051	1064		10.1111/acer.14605		APR 2021	14	Substance Abuse	Science Citation Index Expanded (SCI-EXPANDED)	Substance Abuse	SD0WV	WOS:000638271700001	33760264				2022-02-06	
J	Yang, FJ; Chen, LW; Wang, HP; Zhang, JH; Shen, YD; Qiu, YQ; Qu, ZW; Li, J; Xu, WD				Yang, Fangjing; Chen, Liwen; Wang, Haipeng; Zhang, Jionghao; Shen, Yundong; Qiu, Yanqun; Qu, Zhiwei; Li, Jie; Xu, Wendong			Combined contralateral C7 to C7 and L5 to S1 cross nerve transfer for treating limb hemiplegia after stroke	BRITISH JOURNAL OF NEUROSURGERY			English	Article; Early Access						Motor dysfunction; nerve transfer; spastic hemiplegia; stroke		Background Contralateral C7 to C7 cross nerve transfer has been proved to be safe and effective for patients with spastic arm paralysis due to stroke and traumatic brain injury. For the lower limb, contralateral L5 to S1 cross nerve transfer serves as a novel surgical approach. In many cases, patients with hemiplegia have both upper and lower limb dysfunction and hope to restore all limb functions within one operation. To cope with this demand, we performed combined contralateral C7 to C7 and L5 to S1 cross nerve transfer in two cases successfully. Case description Two patients were enrolled in this study. The first patient is a 36-year-old woman who had spasticity and hemiplegia in both upper and lower limbs on the left side after a right cerebral hemorrhage 14 years prior. The second patient is a 64-year-old man who suffered from permanent muscle weakness in his right limbs, especially the leg, after a left cerebral hemorrhage 7 years prior. Both patients underwent the combined nerve transfer to improve upper and lower limb motor functions simultaneously. During the 10-month follow-up after surgery, the limb functions of both patients improved significantly. Conclusions This study demonstrates the safety and benefits of combined contralateral C7 to C7 and L5 to S1 cross nerve transfer for hemiplegic patients after stroke. This novel combined surgical approach could provide an optimal choice for patients suffering from both upper and lower limb dysfunction, to reduce hospital stay while reducing financial burden.	[Yang, Fangjing; Shen, Yundong; Qiu, Yanqun; Xu, Wendong] Fudan Univ, Huashan Hosp, Dept Hand Surg, Shanghai, Peoples R China; [Chen, Liwen; Shen, Yundong; Qiu, Yanqun; Li, Jie; Xu, Wendong] Jingan Dist Ctr Hosp, Dept Hand & Upper Extrem Surg, Shanghai, Peoples R China; [Chen, Liwen; Wang, Haipeng; Zhang, Jionghao; Shen, Yundong; Qiu, Yanqun; Qu, Zhiwei; Li, Jie; Xu, Wendong] Shanghai Clin Med Ctr Limb Funct Reconstruct, Shanghai, Peoples R China; [Wang, Haipeng; Zhang, Jionghao; Qu, Zhiwei] Jingan Dist Ctr Hosp, Dept Orthoped, Shanghai, Peoples R China; [Xu, Wendong] Fudan Univ, Huashan Hosp, Natl Clin Res Ctr Aging & Med, Shanghai, Peoples R China; [Xu, Wendong] Shanghai Key Lab Peripheral Nerve & Microsurg, Shanghai, Peoples R China		Xu, WD (corresponding author), Fudan Univ, Huashan Hosp, Dept Hand Surg, Shanghai, Peoples R China.; Xu, WD (corresponding author), Jingan Dist Ctr Hosp, Dept Hand & Upper Extrem Surg, Shanghai, Peoples R China.; Xu, WD (corresponding author), Shanghai Clin Med Ctr Limb Funct Reconstruct, Shanghai, Peoples R China.; Xu, WD (corresponding author), Fudan Univ, Huashan Hosp, Natl Clin Res Ctr Aging & Med, Shanghai, Peoples R China.; Xu, WD (corresponding author), Shanghai Key Lab Peripheral Nerve & Microsurg, Shanghai, Peoples R China.	wendongxu@fudan.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81972157, 81525009]; Shanghai Top Priority Clinical Medicine Center Construction Project [2017ZZ01006]; Chinese Academy of Medical Sciences Research Fund [2018RU007]	This work was supported by National Natural Science Foundation of China [81972157, 81525009], Shanghai Top Priority Clinical Medicine Center Construction Project [2017ZZ01006], and Chinese Academy of Medical Sciences Research Fund [2018RU007].	Arya K. N., 2014, Annals of Physical and Rehabilitation Medicine, V57, P696, DOI 10.1016/j.rehab.2014.06.003; Barss TS, 2020, J NEUROPHYSIOL, V123, P158, DOI 10.1152/jn.00433.2019; Cook DJ, 2012, NATURE, V483, P213, DOI 10.1038/nature10841; Danner SM, 2016, J PHYSIOL-LONDON, V594, P6947, DOI 10.1113/JP272787; Darmohray DM, 2019, NEURON, V102, P217, DOI 10.1016/j.neuron.2019.01.038; Dimyan MA, 2011, NAT REV NEUROL, V7, P76, DOI 10.1038/nrneurol.2010.200; Harnie J, 2019, ELIFE, V8, DOI 10.7554/eLife.50134; Hua XY, 2015, NEUROSURGERY, V76, P187, DOI 10.1227/NEU.0000000000000590; Hurteau MF, 2018, J NEUROSCI, V38, P4104, DOI 10.1523/JNEUROSCI.3288-17.2018; Kalladka D, 2014, STEM CELLS CLONING, V7, P31, DOI 10.2147/SCCAA.S38003; Katoozian L, 2018, J NATL MED ASSOC, V110, P547, DOI 10.1016/j.jnma.2018.01.008; Kaupp C, 2018, J NEUROPHYSIOL, V119, P1095, DOI 10.1152/jn.00570.2017; Krucoff MO, 2019, NEUROSURGERY, V84, P30, DOI 10.1093/neuros/nyy128; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; Lin DJ, 2018, STROKE, V49, P3107, DOI 10.1161/STROKEAHA.118.021359; Lundstrom E, 2010, J REHABIL MED, V42, P296, DOI 10.2340/16501977-0509; Midha R, 2019, J NEUROSURG, V130, P675, DOI 10.3171/2018.11.JNS181520; Naghavi M, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l94; Qiu YQ, 2019, WORLD NEUROSURG, V121, P12, DOI 10.1016/j.wneu.2018.09.118; Sakai K, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011968.pub3; Spasticity LS., 2017, FRONT NEUROL, V8, P404; Wang GB, 2019, J STROKE CEREBROVASC, V28, P2140, DOI 10.1016/j.jstrokecerebrovasdis.2019.04.006; Wang JH, 2016, STROKE, V47, P929, DOI 10.1161/STROKEAHA.115.012466; Wilson TJ, 2019, NEUROTHERAPEUTICS, V16, P26, DOI 10.1007/s13311-018-0664-x; Xu WD, 2011, MICROSURG, V31, P404, DOI 10.1002/micr.20877; Yu BF, 2020, MICROSURG, V40, P234, DOI 10.1002/micr.30470; Zhang ZG, 2019, NAT REV NEUROL, V15, P193, DOI 10.1038/s41582-018-0126-4; Zheng MX, 2018, NEW ENGL J MED, V378, P22, DOI 10.1056/NEJMoa1615208	28	2	2	1	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.												10.1080/02688697.2021.1910764		APR 2021	4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RL5IT	WOS:000639007400001	33843383				2022-02-06	
J	Bailey, ZS; Leung, LY; Yang, XF; Cardiff, K; Gilsdorf, J; Shear, D; Kochanek, PM				Bailey, Zachary S.; Leung, Lai Yee; Yang, Xiaofang; Cardiff, Katherine; Gilsdorf, Janice; Shear, Deborah; Kochanek, Patrick M.			Prehospital Whole Blood Resuscitation Reduces Fluid Requirement While Maintaining Critical Physiology in a Model of Penetrating Traumatic Brain Injury and Hemorrhage: Implications on Resource-Limited Combat Casualty Care	SHOCK			English	Article						Brain tissue oxygen tension; cerebral edema; cerebral perfusion pressure; intracranial pressure; neuroresuscitation	HYPOTENSIVE RESUSCITATION; CRYSTALLOID RESUSCITATION; HYPEROSMOLAR THERAPY; TISSUE OXYGEN; SHOCK; EDEMA; TRANSFUSION; DEATH; PATHOPHYSIOLOGY; GUIDELINES	Prehospital resuscitation using whole blood (WB) is the standard of care for hemorrhagic shock (HS) but there is no consensus recommendation for resuscitation in the presence of traumatic brain injury (TBI) due to a lack of sufficient evidence. In order to evaluate the optimal resuscitation strategies for TBI+HS, Sprague-Dawley rats were randomized into four groups based on resuscitation fluid and prehospital mean arterial pressure (MAP) threshold (n = 9-10/group): Lactated Ringer's (LR)-60 mm Hg (LR60), LR-70 mm Hg (LR70), WB-60 mm Hg (WB60), WB-70 mm Hg (WB70). All groups received a frontal penetrating ballistic-like brain injury followed by a 35-min period of HS. During the prehospital phase, rats received an initial bolus of resuscitation fluid (WB or LR) followed by LR as needed to maintain MAP above the designated threshold for 90 min. During the in-hospital phase, rats received definitive resuscitation with shed WB. Physiological parameters were recorded continuously and cerebral edema was measured at 3 and 24 h postinjury. The WB60 group demonstrated a significantly lower prehospital fluid requirement compared WB70, LR60, and LR70 (P < 0.05). Compared to the respective LR groups, both the WB60 and WB70 groups also demonstrated improved MAP, cerebral perfusion pressure, brain tissue oxygen tension, and cerebral edema. The edema benefits were observed at 3 h, but not 24 h postinjury, and were localized to the injury site. Together, these results provide evidence that prehospital WB resuscitation and lower MAP resuscitation thresholds can reduce the prehospital fluid requirement while still maintaining critical cerebral physiology in a model of HS and concomitant TBI.	[Bailey, Zachary S.; Leung, Lai Yee; Yang, Xiaofang; Cardiff, Katherine; Gilsdorf, Janice; Shear, Deborah] Walter Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect Branch, Silver Spring, MD USA; [Leung, Lai Yee] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Crit Care Med, Sch Med, Pittsburgh, PA USA		Bailey, ZS (corresponding author), 503 Robert Grant Ave,Room 2W12, Silver Spring, MD 20910 USA.	Zachary.s.bailey5.civ@mail.mil			Combat Casualty Care Research Program, United States Army Medical Research and Development Command	This work was supported by Combat Casualty Care Research Program, United States Army Medical Research and Development Command. The authors thank Christina LaValle for statistical consultation and review.	Albreiki M, 2018, EUR J TRAUMA EMERG S, V44, P191, DOI 10.1007/s00068-017-0862-y; Brockman EC, 2013, J CEREBR BLOOD F MET, V33, P1457, DOI 10.1038/jcbfm.2013.104; Cap AP, 2018, MIL MED, V183, P44, DOI 10.1093/milmed/usy120; CAPONE AC, 1995, J AM COLL SURGEONS, V180, P49; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cohn SM, 2011, WORLD J SURG, V35, P430, DOI 10.1007/s00268-010-0875-8; Cooper DJ, 2013, J NEUROTRAUM, V30, P512, DOI 10.1089/neu.2012.2573; Cotton BA, 2006, SHOCK, V26, P115, DOI 10.1097/01.shk.0000209564.84822.f2; Cunningham TL, 2014, J NEUROTRAUM, V31, P505, DOI 10.1089/neu.2013.2965; Eastridge BJ, 2019, TRANSFUSION, V59, P1423, DOI 10.1111/trf.15161; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Eastridge BJ, 2011, J TRAUMA, V71, pS4, DOI 10.1097/TA.0b013e318221147b; Farrokh S, 2019, CURR OPIN CRIT CARE, V25, P105, DOI 10.1097/MCC.0000000000000585; Feinstein AJ, 2005, J AM COLL SURGEONS, V201, P536, DOI 10.1016/j.jamcollsurg.2005.05.031; Freeman W David, 2015, Continuum (Minneap Minn), V21, P1299, DOI 10.1212/CON.0000000000000235; Gantner D, 2014, CURR OPIN CRIT CARE, V20, P385, DOI 10.1097/MCC.0000000000000114; Godoy DA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00250; Gross T, 2012, ACTA ANAESTH SCAND, V56, P1163, DOI 10.1111/j.1399-6576.2012.02724.x; Jha RM, 2018, J NEUROTRAUM, V35, P2125, DOI 10.1089/neu.2016.4696; Joint Trauma System Committee on Tactical Combat Casualty Care, 2019, DEPLOYEDMEDICINE; Jones DG, 2018, BMC SURG, V18, DOI 10.1186/s12893-018-0427-y; Kasotakis G, 2013, J TRAUMA ACUTE CARE, V74, P1215, DOI 10.1097/TA.0b013e3182826e13; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Knapp JM, 2005, AACN ADV CRIT CARE, V16, P199, DOI 10.1097/00044067-200504000-00011; Kochanek PM, 2019, NEUROSURGERY, V84, P1169, DOI 10.1093/neuros/nyz051; Kudo D, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-016-0202-z; Leung Lai Yee, 2015, J Trauma Acute Care Surg, V79, pS130, DOI 10.1097/TA.0000000000000785; Leung LY, 2013, J NEUROTRAUM, V30, P1288, DOI 10.1089/neu.2012.2715; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Li T, 2011, ANESTHESIOLOGY, V114, P111, DOI 10.1097/ALN.0b013e3181fe3fe7; Lin GS, 2013, INJURY, V44, P1811, DOI 10.1016/j.injury.2013.02.009; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Morrison CA, 2011, J TRAUMA, V70, P652, DOI 10.1097/TA.0b013e31820e77ea; Murdock AD, 2014, SHOCK, V41, P62, DOI 10.1097/SHK.0000000000000134; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Otten EJ, 2017, WILD ENVIRON MED, V28, pS117, DOI 10.1016/j.wem.2017.02.008; Plesnila N, 2011, CRIT CARE MED, V39, P592, DOI 10.1097/CCM.0b013e31820a4f50; Rehn M, 2018, TRANSFUSION MED, V28, P277, DOI 10.1111/tme.12483; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Rosomoff HL, 1996, CRIT CARE MED, V24, pS48; Shackelford SA, 2017, JAMA-J AM MED ASSOC, V318, P1581, DOI 10.1001/jama.2017.15097; Shear DA, 2011, J NEUROTRAUM, V28, P2185, DOI 10.1089/neu.2011.1916; Sheth KN, 2016, LANCET NEUROL, V15, P1160, DOI 10.1016/S1474-4422(16)30196-X; Stainsby D, 2006, TRANSFUS MED REV, V20, P273, DOI 10.1016/j.tmrv.2006.05.002; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Van Wyck D., 2017, JOINT TRAUMA SYSTEM; Vespa PM, 2016, JAMA NEUROL, V73, P504, DOI 10.1001/jamaneurol.2016.0251; Wang N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1085-4; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Witherspoon B, 2017, NURS CLIN N AM, V52, P249, DOI 10.1016/j.cnur.2017.01.002; Yan EB, 2014, J NEUROTRAUM, V31, P618, DOI 10.1089/neu.2013.3087; Yu YH, 2009, RESUSCITATION, V80, P1424, DOI 10.1016/j.resuscitation.2009.08.024; YUAN XQ, 1992, SURG GYNECOL OBSTET, V174, P305	56	2	2	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	APR	2021	55	4					545	553		10.1097/SHK.0000000000001662			9	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	SV3LX	WOS:000663725100015	32925600				2022-02-06	
J	Chhuom, TW; Thompson, HJ				Chhuom, Tiffany W.; Thompson, Hilaire J.			Older Spousal Dyads and the Experience of Recovery in the Year After Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE NURSING			English	Article						aged; caregiving; head injury; recovery; rehabilitation; social support; nursing	CAREGIVERS	BACKGROUND: Significant others of older persons with traumatic brain injury (TBI) may be more likely to face increased caregiving responsibilities, leading to increased relationship challenges. Relatively little is known about this cohort. The study aimed to describe the impact of experiencing a mild/moderate TBI on the older adult as well as the significant other in the year post injury. DESIGN AND METHODS: This is a multiple-case study using data from a larger parent study. Qualitative content analysis of interviews conducted at 1, 3, 6, and 12 months post injury with 3 dyads was performed (24 interviews) and included cross-case and cross-time comparisons. RESULTS: Dyads that included persons 65 years and older with a mild-moderate TBI and their significant others were enrolled (N = 3/6 individuals). The identified themes were struggling to accept limitations and acceptance, gratitude, fear and concern, frustration/anger/guilt/resentment, broader social support, emotional coping, and the presence or absence of broader social support. CONCLUSIONS: Feelings of hope, gratitude, and acceptance serve as vital ways for couples to continue toward a path of recovery and healing. Lack of social support was a stressor, creating a barrier to recovery. Significant others tended to focus on others versus self-care needs. Nurses should integrate social support and self-care into the assessment of the spousal dyad after TBI. These findings can also inform the development of support groups and case management models for both patients after TBI and their significant others.	[Thompson, Hilaire J.] Univ Washington, Sch Nursing, Seattle, WA 98195 USA; [Thompson, Hilaire J.] Harborview Injury Prevent & Res Ctr, Core Fac, Seattle, WA USA; [Chhuom, Tiffany W.] SUNY Buffalo, Sch Social Work, Buffalo, NY USA; [Chhuom, Tiffany W.] Univ Seattle, Addict Studies, Grad Certificate Program Mental Hlth Counseling, Seattle, WA USA		Thompson, HJ (corresponding author), Univ Washington, Sch Nursing, Seattle, WA 98195 USA.; Thompson, HJ (corresponding author), Harborview Injury Prevent & Res Ctr, Core Fac, Seattle, WA USA.	tiffchhuom@gmail.com; hilairet@uw.edu			National Institutes of Health, National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR025015]; Building Academic Geriatric Nursing Capacity Program	This work was supported, in part, by grants from the National Institutes of Health, National Center for Research Resources (KL2RR025015), and the Building Academic Geriatric Nursing Capacity Program (fellowships to H. J.T.).	Anderson MI, 2013, J HEAD TRAUMA REHAB, V28, P453, DOI 10.1097/HTR.0b013e31825d6087; Bremer P, 2015, HEALTH POLICY, V119, P1459, DOI 10.1016/j.healthpol.2015.09.014; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Cheng C, 2018, INT J OLDER PEOPLE N, V13, DOI 10.1111/opn.12208; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Gervasio AH, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199706000-00003; Herrmann LL, 2019, RES GERONTOL NURS, V12, P227, DOI 10.3928/19404921-20190610-01; Kratz AL, 2017, NEUROPSYCHOL REHABIL, V27, P16, DOI 10.1080/09602011.2015.1051056; Manskow US, 2015, J HEAD TRAUMA REHAB, V30, P411, DOI 10.1097/HTR.0000000000000085; Saban KL, 2015, REHABIL NURS, V40, P277, DOI 10.1002/rnj.182; Thompson HJ, 2020, J NEUROSCI NURS, V52, P46, DOI 10.1097/JNN.0000000000000498; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wade SL, 2010, NEUROREHABILITATION, V27, P63, DOI 10.3233/NRE-2010-0581; Yin RK, 2003, CASE STUDY RES DESIG	14	2	2	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	APR	2021	53	2					57	62		10.1097/JNN.0000000000000569			6	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	SK9ED	WOS:000656520900003	33538455				2022-02-06	
J	Dhillon, NS; Sutandi, A; Vishwanath, M; Lim, MM; Cao, H; Si, D				Dhillon, Navjodh Singh; Sutandi, Agustinus; Vishwanath, Manoj; Lim, Miranda M.; Cao, Hung; Si, Dong			A Raspberry Pi-Based Traumatic Brain Injury Detection System for Single-Channel Electroencephalogram	SENSORS			English	Article						traumatic brain injury (TBI); machine learning (ML); electroencephalogram (EEG); raspberry pi (RPI)		Traumatic Brain Injury (TBI) is a common cause of death and disability. However, existing tools for TBI diagnosis are either subjective or require extensive clinical setup and expertise. The increasing affordability and reduction in the size of relatively high-performance computing systems combined with promising results from TBI related machine learning research make it possible to create compact and portable systems for early detection of TBI. This work describes a Raspberry Pi based portable, real-time data acquisition, and automated processing system that uses machine learning to efficiently identify TBI and automatically score sleep stages from a single-channel Electroencephalogram (EEG) signal. We discuss the design, implementation, and verification of the system that can digitize the EEG signal using an Analog to Digital Converter (ADC) and perform real-time signal classification to detect the presence of mild TBI (mTBI). We utilize Convolutional Neural Networks (CNN) and XGBoost based predictive models to evaluate the performance and demonstrate the versatility of the system to operate with multiple types of predictive models. We achieve a peak classification accuracy of more than 90% with a classification time of less than 1 s across 16-64 s epochs for TBI vs. control conditions. This work can enable the development of systems suitable for field use without requiring specialized medical equipment for early TBI detection applications and TBI research. Further, this work opens avenues to implement connected, real-time TBI related health and wellness monitoring systems.	[Dhillon, Navjodh Singh; Sutandi, Agustinus; Si, Dong] Univ Washington, Comp & Software Syst, Bothell, WA 98011 USA; [Vishwanath, Manoj; Cao, Hung] Univ Calif Irvine, Dept Elect Engn & Comp Sci, Irvine, CA 92697 USA; [Lim, Miranda M.] VA Portland Hlth Care Syst, Portland, OR 97239 USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA; [Cao, Hung] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA		Si, D (corresponding author), Univ Washington, Comp & Software Syst, Bothell, WA 98011 USA.; Cao, H (corresponding author), Univ Calif Irvine, Dept Elect Engn & Comp Sci, Irvine, CA 92697 USA.; Cao, H (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA.	navjodh@uw.edu; sutandia@uw.edu; manojv@uci.edu; lmir@ohsu.edu; hungcao@uci.edu; dongsi@uw.edu		Cao, Hung/0000-0003-4197-7208	VA Portland Health Care System, VA Career Development Award [1K2 BX002712]; NSF CAREER AwardNational Science Foundation (NSF)NSF - Office of the Director (OD) [1917105]; Graduate Research Award of Computing and Software Systems division; University ofWashington BothellUniversity of Washington [74-0525]	The data in this work was supported with resources and the use of facilities at the VA Portland Health Care System, VA Career Development Award #1K2 BX002712 to M.M.L. Interpretations and conclusions are those of the authors and do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. H.C. is funded by the NSF CAREER Award #1917105. D.S. was funded by the Graduate Research Award of Computing and Software Systems division and the startup fund 74-0525 of the University ofWashington Bothell.	Albert B, 2016, WORLD AUTOMAT CONG; [Anonymous], CYTON BIOSENSING BOA; [Anonymous], MCP3008 ANALOG DIGIT; [Anonymous], scipy.signal.welch. SciPy v1.6.1 Reference Guide; [Anonymous], BRAINHAT RASPBERRY P; [Anonymous], TBI: Get the Facts|Concussion|Traumatic Brain Injury; [Anonymous], TRAUMATIC BRAIN INJU; [Anonymous], MCP4725 DIGITAL ANAL; [Anonymous], XGBOOST PARAMETERS X; [Anonymous], dmlc/xgboost; Arif R, 2018, INT CONF CIRC SYST S, P271, DOI 10.1109/ICSIGSYS.2018.8372771; Byrom B, 2018, CLIN PHARMACOL THER, V104, P59, DOI 10.1002/cpt.1077; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Konstantinidis E.I., 2015, 5 EAI INT C WIR MOB, DOI [10.4108/eai.14-10-2015.2261698, DOI 10.4108/EAI.14-10-2015.2261698]; Lee Bruce, 2005, NeuroRx, V2, P372; Lim MM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007092; Modarres MH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38102-4; Modarres Mo H., 2017, Neurobiology of Sleep and Circadian Rhythms, V2, P59, DOI 10.1016/j.nbscr.2016.06.001; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Storzbach D., 2013, VA EVIDENCE BASED SY; Sutandi A., 2020, P 2020 IEEE SIGN PRO, V16, P1; Vishwanath M, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20072027; Zgallai W., 2019, P ADV SCI ENG TECHN, DOI [10.1109/ICASET.2019.8714373, DOI 10.1109/ICASET.2019.8714373]	27	2	2	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1424-8220		SENSORS-BASEL	Sensors	APR	2021	21	8							2779	10.3390/s21082779			13	Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering; Instruments & Instrumentation	RT9WE	WOS:000644803400001	33920805	Green Published, gold, Green Submitted			2022-02-06	
J	Hunzinger, KJ; Costantini, KM; Swanik, CB; Buckley, TA				Hunzinger, Katherine J.; Costantini, Katelyn M.; Swanik, C. Buz; Buckley, Thomas A.			Diagnosed concussion is associated with increased risk for lower extremity injury in community rugby players	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Musculoskeletal injury; Sex differences; Mild traumatic brain injury		Objectives: To determine (1) the association between lifetime diagnosed concussion and lower extremity musculoskeletal injury (LE-MSI) among community rugby union players and (2) the sex specific risk of LE-MSI given concussion history among males and females. Design: Retrospective survey. Methods: 1037 (59.0% male, (612/1037), age: 31.6 +/- 11.3 years) rugby players (10.1 +/- 8.1 years played) completed an online survey to ascertain injury history. A chi-squared test of association was performed between concussion and LE-MSI; significant outcomes were followed-up with an odds ratio. A binary logistic regression with any LE-MSI (yes/no) as the outcome and concussion (yes/no) and sex (male/female) as predictors was performed to determine if there was a sex by concussion interaction. Results: There was an overall significant association between concussion and any LE-MSI(chi(1)= 13.055, p < 0.001, OR =2.30 [95%CI: 1.45, 3.65]). Both male (OR =2.21) and females (OR = 2.49) had significant associations for concussion and LE-MSI, but there were no differences between sex for risk of LE-MSI (R-2 =0.024, p =0.999). Conclusions: Community rugby players with a history of concussion are >2 x more likely to also experience an LE-MSI than those without a history of concussion. There were no differences in the odds of LE-MSI between males and females with a history of diagnosed concussion. In line with current World Rugby injury prevention programs, future research should aim to reduce LE-MSI incidence to maximize player safety and wellness through targeted injury prevention and teams should utilize a conservative return to play protocols following concussion. (C) 2020 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Hunzinger, Katherine J.; Costantini, Katelyn M.; Swanik, C. Buz; Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE 19716 USA; [Hunzinger, Katherine J.; Swanik, C. Buz; Buckley, Thomas A.] Univ Delaware, Interdisciplinary Program Biomech & Movement Sci, Newark, DE 19716 USA		Buckley, TA (corresponding author), Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE 19716 USA.; Buckley, TA (corresponding author), Univ Delaware, Interdisciplinary Program Biomech & Movement Sci, Newark, DE 19716 USA.	TBuckley@UDel.edu	Hunzinger, Katherine J./AAJ-6332-2020; Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150; Hunzinger, Katherine/0000-0002-4599-8543; Costantini, Katelyn/0000-0002-6007-0276	University of Delaware Unidel Distinguished Graduate Scholars Fellowship	Research reported in this manuscript was supported by the University of Delaware Unidel Distinguished Graduate Scholars Fellowship.	Almeida SA, 1999, MED SCI SPORT EXER, V31, P1807, DOI 10.1097/00005768-199912000-00017; Attwood MJ, 2018, BRIT J SPORT MED, V52, P368, DOI 10.1136/bjsports-2017-098005; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Cosgrave M, 2019, PHYS THER SPORT, V35, P99, DOI 10.1016/j.ptsp.2018.11.010; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Davies MAM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12130-y; Eagle SR, 2020, SPORTS MED, V50, P15, DOI 10.1007/s40279-019-01144-3; English Professional Rugby Injury Surveillance Project Steering Group, 2018, PROF RUGB FESS RUGB; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Gallo V, 2020, J NEUROL NEUROSUR PS, V91, P455, DOI 10.1136/jnnp-2019-321170; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; Hind K, 2020, SPORTS MED, V50, P2051, DOI 10.1007/s40279-020-01310-y; Houston MN, 2018, BRAIN INJURY, V32, P1353, DOI 10.1080/02699052.2018.1512718; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Hunzinger Katherine J, 2020, BMJ Mil Health, DOI 10.1136/bmjmilitary-2020-001589; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Lynall RC, 2017, J ATHL TRAINING, V52, P1028, DOI 10.4085/1062-6050-52.11.22; McPherson AL, 2020, SPORTS MED, V50, P1203, DOI 10.1007/s40279-020-01262-3; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Neogi T, 2013, OSTEOARTHR CARTILAGE, V21, P1145, DOI 10.1016/j.joca.2013.03.018; Oldham JR, 2020, MED SCI SPORT EXER, V52, P2279, DOI 10.1249/MSS.0000000000002385; Roberts SP, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003998; Swanik C, 2015, J ATHL TRAINING, V50, P1100, DOI 10.4085/1062-6050-50.10.08; USA Rugby, US RUGB MEMB STATS; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1; Willigenburg NW, 2016, AM J SPORT MED, V44, P753, DOI 10.1177/0363546515622389; World Rugby, 2017, WORLD RUGB YEAR REV; Yeomans C, 2018, SPORTS MED, V48, P837, DOI 10.1007/s40279-017-0838-4	29	2	2	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	APR	2021	24	4					368	372		10.1016/j.jsams.2020.10.013			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	QL3QL	WOS:000620994500010	33176983				2022-02-06	
J	Lewinska, P; Galas, A				Lewinska, Paulina; Galas, Andrzej			Use of structure-from-motion algorithms for geomorphological analyses of simple volcanic structures: A case study of Chilcayoc Chico and four other volcanoes of the Andahua Group, Peru	JOURNAL OF SOUTH AMERICAN EARTH SCIENCES			English	Article						Chilcayoc chico volcano; Scoria cones; Structure-from-Motion; Photogrammetry; Point cloud; Peru; Andes		The Chilcayoc Chico volcano is classified as a scoria cone and a part of the Quaternary Andahua Group, southern Peru. In 2017, we performed detailed geological and morphological surveys, including a collection of 163 photographs that allowed for the creation of a 3D model based on Structure-from-Motion (SfM) algorithms. We compare the results of morphometric analyses of cone parameters (basal diameter, height, crater diameter) obtained in different ways: 1:50 000 scale map, satellite based DEM (from SRTM and ASTER missions), and from 3D SfM based models in order to evaluate data source quality. We concluded that maps and DEM based data is not detailed enough to bring any meaningful concussions for evaluation of age of small volcanic cones and more detailed 3D models, are necessary. We propose a method for fast image and spatial data gathering for SfM of volcanic cones. Models of Chilcayoc Chico show shelf-like structures within the crater that indicate that the cone was formed by multiple consecutive volcanic activities. We identified at least four, Strombolian or Hawaiian-type eruptive (3 Strombolian style eruption dominated episodes and 1 effusive style eruption). Evidences of effusive activity were observed, eruption dynamics became subsequently less explosive until culminating in a final effusive eruption phase. This is in contrast to previous studies that suggested that Chilcayoc Chico is a long-lived scoria cone with the sign of slight shifts of the active vents within the crater. We also provided a similar analysis of other cones from the area (Chilcayoc, Chilcayoc Grande, Jechapita, Puca Mauras) in order to estimate their relative age.	[Lewinska, Paulina] AGH Univ Sci & Technol, Fac Min Surveying & Environm Engn, Krakow, Poland; [Lewinska, Paulina] Univ York, Dept Comp Sci, York YO10 5DD, N Yorkshire, England; [Galas, Andrzej] Polish Acad Sci, Mineral & Energy Econ Res Inst, Krakow, Poland		Lewinska, P (corresponding author), AGH Univ Sci & Technol, Fac Min Surveying & Environm Engn, Krakow, Poland.	lewinska.paulina@gmail.com; agalas@min-pan.krakow.pl	Lewinska, Paulina/O-4126-2019; Galas, Andrzej/A-7078-2017	Lewinska, Paulina/0000-0002-8141-754X; Galas, Andrzej/0000-0003-0083-3769	AGH University of Science and Technology [11.11.150.005, 16.16.150.545]	We would like to thank prof. Karoly Nemeth and all other reviewers of the manuscript for their work and time in improving its quality and all valuable input. This work was supported by AGH University of Science and Technology statutory funding 11.11.150.005, 16.16.150.545.	Abrams M, 2000, INT J REMOTE SENS, V21, P847, DOI 10.1080/014311600210326; Apollo M, 2021, CURR ISSUES TOUR, V24, P1970, DOI 10.1080/13683500.2020.1812541; Bemis SP, 2014, J STRUCT GEOL, V69, P163, DOI 10.1016/j.jsg.2014.10.007; Borowski L, 2018, 2018 BALTIC GEODETIC CONGRESS (BGC-GEOMATICS 2018), P62, DOI 10.1109/BGC-Geomatics.2018.00018; Cabrera M, 2000, C PER GEOL RES SOC G, P186; Carrera-Hernandez J., 2018, REV MEX CIENC GEOL, V33, P122, DOI [10.22201/cgeo.20072902-.2016.1, DOI 10.22201/CGEO.20072902-.2016.1]; Coltelli M, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9030192; del Soldato M, 2018, GEOGR FIS DIN QUAT, V41, P51, DOI 10.4461/GFDQ.2018.41.4; Delacour A, 2007, B VOLCANOL, V69, P581, DOI 10.1007/s00445-006-0096-z; Derrien A, 2015, GEOPHYS RES LETT, V42, P6959, DOI 10.1002/2015GL064820; Di Traglia F, 2009, J VOLCANOL GEOTH RES, V180, P89, DOI 10.1016/j.jvolgeores.2008.10.020; Di Traglia F, 2014, GEOMORPHOLOGY, V219, P152, DOI 10.1016/j.geomorph.2014.05.002; Doniz J, 2008, J VOLCANOL GEOTH RES, V173, P185, DOI 10.1016/j.jvolgeores.2007.12.046; Doniz-Paez J, 2015, GEOMORPHOLOGY, V228, P432, DOI 10.1016/j.geomorph.2014.10.004; Ely JC, 2017, EARTH SURF PROC LAND, V42, P877, DOI 10.1002/esp.4044; Farquharson JI, 2015, J VOLCANOL GEOTH RES, V304, P336, DOI 10.1016/j.jvolgeores.2015.09.004; Fonstad MA, 2013, EARTH SURF PROC LAND, V38, P421, DOI 10.1002/esp.3366; Fornaciai A, 2012, J VOLCANOL GEOTH RES, V217, P56, DOI 10.1016/j.jvolgeores.2011.12.012; Furukawa Y, 2010, PROC CVPR IEEE, P1434, DOI 10.1109/CVPR.2010.5539802; Galas A.Nemeth, J VOLCANOL GEOTH RES; Galas A, 2018, GEOHERITAGE, V10, P707, DOI 10.1007/s12371-018-0307-y; Galas A, 2014, J S AM EARTH SCI, V56, P301, DOI 10.1016/j.jsames.2014.09.012; Galas A, 2011, ANN SOC GEOL POL, V81, P1; Gocal J, 2009, ENG IND GEODESY 2, P340; Godoy B, 2018, J S AM EARTH SCI, V84, P184, DOI 10.1016/j.jsames.2018.03.013; Gomez C., 2012, HIST 3D TOPOGRAPHIC; Gruszczynski W, 2017, ISPRS J PHOTOGRAMM, V126, P168, DOI 10.1016/j.isprsjprs.2017.02.015; Guilbaud MN, 2012, B VOLCANOL, V74, P1187, DOI 10.1007/s00445-012-0594-0; Harwin S, 2012, REMOTE SENS-BASEL, V4, P1573, DOI 10.3390/rs4061573; Hengl T, 2009, DEV SOIL SCI, V33, P1; Hoempler A, 1962, B SOC GEOLOGICA PERU, V37, P59; James MR, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL054245; James MR, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002289; James MR, 2016, J GLACIOL, V62, P159, DOI 10.1017/jog.2016.27; James MR, 2014, EARTH SURF PROC LAND, V39, P1413, DOI 10.1002/esp.3609; Kavanagh J.L., 2017, REV ANALOGUE NUMERIC, DOI [10.5194/se-2017-40, DOI 10.5194/SE-2017-40]; Kawiecka R, 2018, J APPL ENG SCI, V8, P65, DOI 10.2478/jaes-2018-0020; Kereszturi G., 2012, NEMETH; Kereszturi G, 2013, B VOLCANOL, V75, DOI 10.1007/s00445-013-0734-1; Kervyn M, 2012, GEOMORPHOLOGY, V136, P59, DOI 10.1016/j.geomorph.2011.04.009; Kolzenburg S, 2016, IEEE T GEOSCI REMOTE, V54, P6687, DOI 10.1109/TGRS.2016.2587798; Lewinska Paulina, 2018, E3S Web of Conferences, V49, DOI 10.1051/e3sconf/20184900067; Lewinska P, 2021, MEASUREMENT, V168, DOI 10.1016/j.measurement.2020.108327; Maas H.-G., 2010, HE CRYOSPHERE DISCUS, V38, DOI [10.5194/tcd-4-2415-2010., DOI 10.5194/TCD-4-2415-2010]; Maciuk K, 2019, MEASUREMENT, V147, DOI 10.1016/j.measurement.2019.07.071; Maciuk K, 2016, GEOD VESTN, V60, P455, DOI 10.15292/geodetski-vestnik.2016.03.455-466; Manrique N, 2019, B VOLCANOL, V82, DOI 10.1007/s00445-019-1335-4; Marsella M, 2014, REMOTE SENS-BASEL, V6, P12166, DOI 10.3390/rs61212166; Martin U, 2006, J VOLCANOL GEOTH RES, V155, P104, DOI 10.1016/j.jvolgeores.2006.02.012; Midgley NG, 2017, GEOMORPHOLOGY, V282, P18, DOI 10.1016/j.geomorph.2017.01.008; Nakano T, 2014, INT ARCH PHOTOGRAMM, V40-8, P71, DOI 10.5194/isprsarchives-XL-8-71-2014; Nemeth K, 2015, INT J EARTH SCI, V104, P2131, DOI 10.1007/s00531-015-1243-6; Nemeth K, 2011, CENT EUR J GEOSCI, V3, P102, DOI 10.2478/s13533-011-0008-4; Nemeth K, 2010, GEOL SOC AM SPEC PAP, V470, P43, DOI 10.1130/2010.2470(04); Piermattei L, 2015, EARTH SURF PROC LAND, V40, P1791, DOI 10.1002/esp.3756; Quincey D.J., 2016, STRUCTURE MOTION GEO; Rodriguez-Gonzalez A, 2011, GEOMORPHOLOGY, V134, P249, DOI 10.1016/j.geomorph.2011.06.033; Ryan JC, 2015, CRYOSPHERE, V9, P1, DOI 10.5194/tc-9-1-2015; Samaniego P, 2016, J VOLCANOL GEOTH RES, V323, P110, DOI 10.1016/j.jvolgeores.2016.04.038; Silva De, 1991, VOLCANOES CENTRAL AN; Smith IEM, 2017, GEOL SOC SPEC PUBL, V446, P1, DOI 10.1144/SP446.14; Swanson E., 2004, INGEMMET B A, V137, P19; TAKADA A, 1994, J GEOPHYS RES-SOL EA, V99, P13563, DOI 10.1029/94JB00494; Tarolli P, 2014, GEOMORPHOLOGY, V216, P295, DOI 10.1016/j.geomorph.2014.03.008; Travelletti J, 2012, ISPRS J PHOTOGRAMM, V70, P39, DOI 10.1016/j.isprsjprs.2012.03.007; Ulusoy I, 2017, TURK JEOL BULT, V60, P223; Ureta G, 2019, IAVCEI 5 INT VOL GEO; Valentine GA, 2008, J VOLCANOL GEOTH RES, V177, P857, DOI 10.1016/j.jvolgeores.2008.01.050; Vespermann D., 2000, ENCY VOLCANOES, P683; Walter TR, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12121961; Wessling R.B., 1999, WORLD WIDE 30 M RESO; Westoby MJ, 2012, GEOMORPHOLOGY, V179, P300, DOI 10.1016/j.geomorph.2012.08.021; Worner G, 2018, ELEMENTS, V14, P237, DOI 10.2138/gselements.14.4.237; WOOD CA, 1980, J VOLCANOL GEOTH RES, V7, P387, DOI 10.1016/0377-0273(80)90040-2; WOOD CA, 1980, J VOLCANOL GEOTH RES, V8, P137, DOI 10.1016/0377-0273(80)90101-8	75	2	2	4	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0895-9811	1873-0647		J S AM EARTH SCI	J. South Am. Earth Sci.	APR	2021	107								103058	10.1016/j.jsames.2020.103058			12	Geosciences, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Geology	RJ5SI	WOS:000637661400001					2022-02-06	
J	Lorente, L; Martin, MM; Perez-Cejas, A; Gonzalez-Rivero, AF; Argueso, M; Ramos, L; Sole-Violan, J; Caceres, JJ; Jimenez, A; Garcia-Marin, V				Lorente, L.; Martin, M. M.; Perez-Cejas, A.; Gonzalez-Rivero, A. F.; Argueso, M.; Ramos, L.; Sole-Violan, J.; Caceres, J. J.; Jimenez, A.; Garcia-Marin, V.			Serum caspase-3 levels during the first week of traumatic brain injury	MEDICINA INTENSIVA			English	Article						Caspase-3; Patients; Mortality; Traumatic; Brain injury		Objective: Confluence between the intrinsic and extrinsic apoptosis pathways is reached at Patients; the point of caspase-3 activation, which induces death cell. Higher serum caspase-3 levels have Mortality; been recorded on day 1 of traumatic brain injury (TBI) in 30-day non-survivors compared to Traumatic; survivors. The objectives of this study therefore were to determine whether serum caspase-3 Brain injury levels are persistently higher in non-survivors than in survivors, and whether these levels may be used to predict 30-day mortality. Design: A prospective observational study was carried out. Setting: Six Spanish Intensive Care Units. Patients: Patients with severe isolated TBI (defined as Glasgow Coma Scale <9 points and non-cranial Injury Severity Score <10 points). Interventions: Serum caspase-3 concentrations were measured on days 1, 4 and 8 of TBI. Main variables of interest: Thirty-day mortality was considered as the study endpoint. Results: In comparison with non-survivors (n= 34), 30-day survivors (n= 90) showed lower serum caspase-3 levels on days 1 (p= 0.001), 4 (p< 0.001) and 8 (p< 0.001) of TBI. Analysis of the ROC curves showed serum caspase-3 concentrations on days 1, 4 and 8 of TBI to have an AUC (95% CI) in predicting 30-day mortality of 0.70 (0.61-0.78; p= 0.001), 0.83 (0.74-0.89; p < 0.001) and 0.87 (0.79-0.93; p < 0.001), respectively. Conclusions: The novel findings of our study were that serum caspase-3 levels during the first week of TBI were lower in survivors and could predict 30-day mortality. (C) 2019 Elsevier Espana, S.L.U. y SEMICYUC. All rights reserved.	[Lorente, L.] Hosp Univ Canarias, Intens Care Unit, San Cristobal la Laguna, Santa Cruz De T, Spain; [Martin, M. M.] Hosp Univ Nuestra Senora Candelaria, Intens Care Unit, Santa Cruz De Tenerife, Spain; [Perez-Cejas, A.; Gonzalez-Rivero, A. F.] Hosp Univ Canarias, Dept Lab, San Cristobal la Laguna, Santa Cruz De T, Spain; [Argueso, M.] Univ Valencia, Hosp Clin, Intens Care Unit, Valencia, Spain; [Ramos, L.] Hosp Gen La Palma, Intens Care Unit, Brena Alta, La Palma, Spain; [Sole-Violan, J.] CIBERES, Hosp Univ Dr Negrin, Intens Care Unit, Las Palmas Gran Canaria, Spain; [Caceres, J. J.] Hosp Insular, Intens Care Unit, Las Palmas Gran Canaria, Spain; [Jimenez, A.] Hosp Univ Canarias, Res Unit, San Cristobal la Laguna, Santa Cruz De T, Spain; [Garcia-Marin, V.] Hosp Univ Canarias, Dept Neurosurg, San Cristobal la Laguna, Santa Cruz De T, Spain		Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, San Cristobal la Laguna, Santa Cruz De T, Spain.	lorentemartin@msn.com		Jimenez-Sosa, Alejandro/0000-0001-8732-2616	Fundacion DISA a la Investigacion Medica [OA18/011]	This study was supported by a grant (OA18/011) from Fundacion DISA a la Investigacion Medica 2017 (Santa Cruz de Tenerife. Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson EE, 2006, EXP NEUROL, V197, P437, DOI 10.1016/j.expneurol.2005.10.011; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cavallucci V, 2011, CURR PHARM DESIGN, V17, P215, DOI 10.2174/138161211795049705; Chico-Fernandez M, 2019, MED INTENSIVA; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; Eberspacher E, 2006, ANESTH ANALG, V103, P1527, DOI 10.1213/01.ane.0000247803.30582.2d; Fang J, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01006; Glushakov AO, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103151; Glushakova OY, 2018, J NEUROTRAUM, V35, P157, DOI 10.1089/neu.2017.4999; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Harter L, 2001, J NEUROIMMUNOL, V121, P76, DOI 10.1016/S0165-5728(01)00409-X; Hentze H, 2001, BIOCHEM BIOPH RES CO, V283, P1111, DOI 10.1006/bbrc.2001.4918; Jia F, 2009, J NEUROTRAUM, V26, P243, DOI 10.1089/neu.2008.0670; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kunz A, 2010, BEST PRACT RES-CLIN, V24, P495, DOI 10.1016/j.bpa.2010.10.001; Lorente L, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0485-z; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Nathoo N, 2004, J NEUROSURG, V101, P233, DOI 10.3171/jns.2004.101.2.0233; Nik Amir, 2018, Bull Emerg Trauma, V6, P141, DOI 10.29252/beat-060208; Rovegno M, 2012, MED INTENSIVA, V36, P37, DOI 10.1016/j.medin.2011.06.008; Saykally JN, 2012, NEUROSCIENCE, V223, P305, DOI 10.1016/j.neuroscience.2012.07.070; Servia L, 2019, MED INTENSIVA, V43, P26, DOI 10.1016/j.medin.2017.11.008; Shah SA, 2006, EXP GERONTOL, V41, P1201, DOI 10.1016/j.exger.2006.07.006; Song Y, 2019, CHEM-BIOL INTERACT, V304, P173, DOI 10.1016/j.cbi.2019.03.013; Soustiel JF, 2005, J NEUROTRAUM, V22, P345, DOI 10.1089/neu.2005.22.345; TEASDALE G, 1974, LANCET, V2, P81; Uzan M, 2006, ACTA NEUROCHIR, V148, P1157, DOI 10.1007/s00701-006-0887-1; Wang K, 2014, CHINESE MED J-PEKING, V127, P1964, DOI 10.3760/cma.j.issn.0366-6999.20120638; Yamagami K, 2019, WORLD NEUROSURG	33	2	2	0	0	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	0210-5691	1578-6749		MED INTENSIVA	Med. Intensiv.	APR	2021	45	3					131	137		10.1016/j.medin.2019.09.005			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RJ1EG	WOS:000637344600001	31677852				2022-02-06	
J	Skrifvars, MB; Bailey, M; Moore, E; Martensson, J; French, C; Presneill, J; Nichol, A; Little, L; Duranteau, J; Huet, O; Haddad, S; Arabi, YM; McArthur, C; Cooper, DJ; Bendel, S; Bellomo, R				Skrifvars, Markus B.; Bailey, Michael; Moore, Elizabeth; Martensson, Johan; French, Craig; Presneill, Jeffrey; Nichol, Alistair; Little, Lorraine; Duranteau, Jacques; Huet, Olivier; Haddad, Samir; Arabi, Yaseen M.; McArthur, Colin; Cooper, David James; Bendel, Stepani; Bellomo, Rinaldo		Erythropoietin Traumatic Brain Inj; Australian New Zealand Intensive C	A Post Hoc Analysis of Osmotherapy Use in the Erythropoietin in Traumatic Brain Injury Study-Associations With Acute Kidney Injury and Mortality	CRITICAL CARE MEDICINE			English	Article						acute kidney injury; critical care; intracranial pressure; mannitol; renal insufficiency; traumatic brain injury	HYPERTONIC SALINE; INTRACRANIAL HYPERTENSION; MANNITOL; MANAGEMENT; SERUM; EPIDEMIOLOGY; CHLORIDE	OBJECTIVES: Mannitol and hypertonic saline are used to treat raised intracerebral pressure in patients with traumatic brain injury, but their possible effects on kidney function and mortality are unknown. DESIGN: A post hoc analysis of the erythropoietin trial in traumatic brain injury (ClinicalTrials.gov NCT00987454) including daily data on mannitol and hypertonic saline use. SETTING: Twenty-nine university-affiliated teaching hospitals in seven countries. PATIENTS: A total of 568 patients treated in the ICU for 48 hours without acute kidney injury of whom 43 (7%) received mannitol and 170 (29%) hypertonic saline. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We categorized acute kidney injury stage according to the Kidney Disease Improving Global Outcome classification and defined acute kidney injury as any Kidney Disease Improving Global Outcome stage-based changes from the admission creatinine. We tested associations between early (first 2 d) mannitol and hypertonic saline and time to acute kidney injury up to ICU discharge and death up to 180 days with Cox regression analysis. Subsequently, acute kidney injury developed more often in patients receiving mannitol (35% vs 10%; p < 0.001) and hypertonic saline (23% vs 10%; p < 0.001). On competing risk analysis including factors associated with acute kidney injury, mannitol (hazard ratio, 2.3; 95% CI, 1.2-4.3; p = 0.01), but not hypertonic saline (hazard ratio, 1.6; 95% CI, 0.9-2.8; p = 0.08), was independently associated with time to acute kidney injury. In a Cox model for predicting time to death, both the use of mannitol (hazard ratio, 2.1; 95% CI, 1.1- 4.1; p = 0.03) and hypertonic saline (hazard ratio, 1.8; 95% CI, 1.02-3.2; p = 0.04) were associated with time to death. CONCLUSIONS: In this post hoc analysis of a randomized controlled trial, the early use of mannitol, but not hypertonic saline, was independently associated with an increase in acute kidney injury. Our findings suggest the need to further evaluate the use and choice of osmotherapy in traumatic brain injury.	[Skrifvars, Markus B.; Bailey, Michael; Nichol, Alistair; Little, Lorraine; Cooper, David James; Bellomo, Rinaldo] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Skrifvars, Markus B.] Helsinki Univ Hosp, Dept Anaesthesiol, Div Intens Care, Intens Care & Pain Med, Helsinki, Finland; [Skrifvars, Markus B.] Univ Helsinki, Helsinki, Finland; [Skrifvars, Markus B.] Helsinki Univ Hosp, Dept Emergency Care & Serv, Helsinki, Finland; [Bailey, Michael; Bellomo, Rinaldo] Univ Melbourne, Ctr Integrated Crit Care, Melbourne, Vic, Australia; [Moore, Elizabeth] Monash Univ, Sch Publ Hlth & Prevent Med, Transfus Res Unit, Melbourne, Vic, Australia; [Martensson, Johan] Karolinska Inst, Dept Physiol & Pharmacol, Sect Anaesthesia & Intens Care, Stockholm, Sweden; [French, Craig] Western Hlth, Dept Intens Care, Melbourne, Vic, Australia; [Presneill, Jeffrey] Royal Melbourne Hosp, Dept Intens Care, Melbourne, Vic, Australia; [Nichol, Alistair] Univ Coll Dublin, Sch Med & Med Sci, Dublin, Ireland; [Nichol, Alistair] St Vincents Univ Hosp, Dublin, Ireland; [Nichol, Alistair; Cooper, David James] Alfred, Dept Intens Care & Hyperbar Med, Melbourne, Vic, Australia; [Duranteau, Jacques] Univ Paris Sud XI, Hop Univ Paris Sud HUPS, Dept Anaesthesia & Intens Care, Paris, France; [Huet, Olivier] Univ Bretagne Occidental, Dept Anesthesie Reanimat, Hop Cavale Blanche, CHRU Brest, Blvd Tanguy Prigent, Brest, France; [Haddad, Samir; Arabi, Yaseen M.] King Saud Bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia; [Haddad, Samir; Arabi, Yaseen M.] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [McArthur, Colin] Auckland City Hosp, Dept Crit Care Med, Auckland, New Zealand; [Bendel, Stepani] Kuopio Univ Hosp, Dept Anesthesiol & Intens Care, Kuopio, Finland; [Bendel, Stepani] Univ Eastern Finland, Kuopio, Finland; [Bellomo, Rinaldo] Austin Hlth, Dept Intens Care, Melbourne, Vic, Australia		Skrifvars, MB (corresponding author), Monash Univ, Australian & New Zealand Intens Care Res Ctr, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia.; Skrifvars, MB (corresponding author), Helsinki Univ Hosp, Dept Anaesthesiol, Div Intens Care, Intens Care & Pain Med, Helsinki, Finland.; Skrifvars, MB (corresponding author), Univ Helsinki, Helsinki, Finland.; Skrifvars, MB (corresponding author), Helsinki Univ Hosp, Dept Emergency Care & Serv, Helsinki, Finland.	markus.skrifvars@hus.fi		Nichol, Alistair/0000-0002-4689-1238	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [545902]; Transport Accident Commission of Victoria [D162]	Erythropoietin trial in traumatic brain injury was supported, in part, by grants from the National Health and Medical Research Council of Australia (grant 545902) and the Transport Accident Commission of Victoria (grant D162).	Anstey JR, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6399; Boone Myles Dustin, 2015, Surg Neurol Int, V6, P177, DOI 10.4103/2152-7806.170248; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Castillo LB, 2009, CRIT CARE RESUSC, V11, P151; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Doi K, 2003, AM J MED, V115, P593, DOI 10.1016/S0002-9343(03)00425-X; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Fink Matthew E, 2012, Continuum (Minneap Minn), V18, P640, DOI 10.1212/01.CON.0000415432.84147.1e; GERBER JG, 1979, AM J PHYSIOL, V237, pF441, DOI 10.1152/ajprenal.1979.237.6.F441; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; Kim MY, 2014, J NEUROSURG, V120, P1340, DOI 10.3171/2013.12.JNS13888; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lin SY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002032; MANNINEN PH, 1987, CAN J ANAESTH, V34, P442, DOI 10.1007/BF03014345; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Nichol A, 2015, TRIALS, V16, DOI 10.1186/s13063-014-0528-6; Nomani AZ, 2014, RENAL FAILURE, V36, P1169, DOI 10.3109/0886022X.2014.926758; Oddo M, 2018, INTENS CARE MED, V44, P449, DOI 10.1007/s00134-018-5086-z; Pettila V, 2009, CRIT CARE RESUSC, V11, P94; Presneill Jeffrey, 2014, Trials, V15, P501, DOI 10.1186/1745-6215-15-501; Raj R, 2018, CRIT CARE MED, V46, pE302, DOI 10.1097/CCM.0000000000002959; Rein JL, 2019, AM J PHYSIOL-RENAL, V316, pF587, DOI 10.1152/ajprenal.00130.2018; Robba C, 2021, CRIT CARE MED, V49, P112, DOI 10.1097/CCM.0000000000004673; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; See EJ, 2019, KIDNEY INT, V95, P160, DOI 10.1016/j.kint.2018.08.036; Shawkat H, 2012, BJA EDUC, V12, P82, DOI 10.1093/bjaceaccp/mkr063; Skrifvars MB, 2019, ACTA ANAESTH SCAND, V63, P200, DOI 10.1111/aas.13244; Sovik S, 2019, INTENS CARE MED, V45, P407, DOI 10.1007/s00134-019-05535-y; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Suetrong B, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1499-7; Wakai A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub5	35	2	2	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	APR	2021	49	4					E394	E403		10.1097/CCM.0000000000004853			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RL9VX	WOS:000639312200005	33566466	Green Published, hybrid			2022-02-06	
J	Stippler, M; Keith, S; Nelton, EB; Parsons, CS; Singleton, J; Bilello, LA; Tibbles, CD; Davis, RB; Edlow, JA; Rosen, CL				Stippler, Martina; Keith, Stacey; Nelton, Emmalin B.; Parsons, Charles S.; Singleton, Jennifer; Bilello, Leslie A.; Tibbles, Carrie D.; Davis, Roger B.; Edlow, Jonathan A.; Rosen, Carlo L.			Pathway-Based Reduction of Repeat Head Computed Tomography for Patients With Complicated Mild Traumatic Brain Injury: Implementation and Outcomes	NEUROSURGERY			English	Article						CT; Mild TBI; Radiology; Traumatic brain injury; Triage	GUIDELINES	BACKGROUND: Routine follow-up head imaging in complicated mild traumatic brain injury (cmTBI) patients has not been shown to alter treatment, improve outcomes, or identify patients in need of neurosurgical intervention. We developed a follow-up head computed tomography (CT) triage algorithm for cmTBI patients to decrease the number of routine follow-up head CT scans obtained in this population. OBJECTIVE: To report our experience with protocol implications and patient outcome. METHODS: Data on all cmTBI patients presenting from July 1, 2018 to June 31, 2019, to our level 1, tertiary, academic medical center were collected prospectively and analyzed retrospectively. Descriptive analysis was performed. RESULTS: Of the 178 patients enrolled, 52 (29%) received a follow-up head CT. A total of 27 patients (15%) were scanned because of initial presentation and triaged to the group to receive a routine follow-up head CT. A total of 151 patients (85%) were triaged to the group without routine follow-up head CT scan. Protocol adherence was 89% with 17 violations. CONCLUSION: Utilizing this protocol, we were able to safely decrease the use of routine follow-up head CT scans in cmTBI patients by 71% without any missed injuries or delayed surgery. Adoption of the protocol was high among all services managing TBI patients.	[Stippler, Martina; Nelton, Emmalin B.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Neurosurg, Boston, MA 02215 USA; [Keith, Stacey; Parsons, Charles S.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Acute Care Trauma & Crit Care, Boston, MA 02215 USA; [Singleton, Jennifer] Univ Colorado, UC Hlth Highlands Ranch Hosp, Dept Emergency Med, Sch Med, Aurora, CO USA; [Bilello, Leslie A.; Tibbles, Carrie D.; Edlow, Jonathan A.; Rosen, Carlo L.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Davis, Roger B.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Gen Med, Boston, MA 02215 USA		Stippler, M (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Neurosurg, 110 Francis St, Boston, MA 02215 USA.	mstipple@bidmc.harvard.edu			NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR002541] Funding Source: Medline		Bullock M Ross, 2006, Neurosurgery, V58, pS7; Bullock MR, 2006, NEUROSURGERY S, V58, pSi; Carlson AP, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10182; CDC, 2015, CTR DIS CONTR PREV R; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Joseph B, 2015, JAMA SURG, V150, P866, DOI 10.1001/jamasurg.2015.1134; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P984, DOI 10.1097/TA.0000000000000428; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Kobayashi L, 2017, J TRAUMA ACUTE CARE, V82, P827, DOI 10.1097/TA.0000000000001414; Levy AS, 2014, WORLD NEUROSURG, V82, pE319, DOI 10.1016/j.wneu.2013.11.008; Martin GE, 2018, J TRAUMA ACUTE CARE, V84, P483, DOI 10.1097/TA.0000000000001767; Pruitt P, 2017, AM J EMERG MED, V35, P255, DOI 10.1016/j.ajem.2016.10.064; Soleman J, 2017, SWISS MED WKLY, V147, DOI 10.4414/smw.2017.14398; Stippler M, 2017, WORLD NEUROSURG, V105, P265, DOI 10.1016/j.wneu.2017.05.008; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162	15	2	2	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	APR	2021	88	4					773	778		10.1093/neuros/nyaa504			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RJ0VD	WOS:000637320800042	33469647	Green Published			2022-02-06	
J	Sullivan, DR; Miller, MW; Wolf, EJ; Logue, MW; Robinson, ME; Fortier, CB; Fonda, JR; Wang, DJJ; Milberg, WP; McGlinchey, RE; Salat, DH				Sullivan, Danielle R.; Miller, Mark W.; Wolf, Erika J.; Logue, Mark W.; Robinson, Meghan E.; Fortier, Catherine B.; Fonda, Jennifer R.; Wang, Danny J. J.; Milberg, William P.; McGlinchey, Regina E.; Salat, David H.			Cerebral perfusion is associated with blast exposure in military personnel without moderate or severe TBI	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						ASL; blast; cerebral blood flow; CBF; mTBI; mild traumatic brain injury; perfusion; veterans		Due to the use of improvised explosive devices, blast exposure and mild traumatic brain injury (mTBI) have become hallmark injuries of the Iraq and Afghanistan wars. Although the mechanisms of the effects of blast on human neurobiology remain active areas of investigation, research suggests that the cerebrovasculature may be particularly vulnerable to blast via molecular processes that impact cerebral blood flow. Given that recent work suggests that blast exposure, even without a subsequent TBI, may have negative consequences on brain structure and function, the current study sought to further understand the effects of blast exposure on perfusion. One hundred and eighty military personnel underwent pseudo-continuous arterial spin labeling (pCASL) imaging and completed diagnostic and clinical interviews. Whole-brain analyses revealed that with an increasing number of total blast exposures, there was significantly increased perfusion in the right middle/superior frontal gyri, supramarginal gyrus, lateral occipital cortex, and posterior cingulate cortex as well as bilateral anterior cingulate cortex, insulae, middle/superior temporal gyri and occipital poles. Examination of other neurotrauma and clinical variables such as close-range blast exposures, mTBI, and PTSD yielded no significant effects. These results raise the possibility that perfusion may be an important neural marker of brain health in blast exposure.	[Sullivan, Danielle R.; Miller, Mark W.; Wolf, Erika J.; Logue, Mark W.] VA Boston Healthcare Syst, Natl Ctr PTSD, 116B-2,150 S Huntington Ave, Boston, MA 02130 USA; [Sullivan, Danielle R.; Miller, Mark W.; Wolf, Erika J.; Fonda, Jennifer R.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Logue, Mark W.] Boston Univ, Sch Med, Biomed Genet, Boston, MA 02118 USA; [Logue, Mark W.] Boston Univ, Sch Med, Dept Biostat, Boston, MA 02118 USA; [Robinson, Meghan E.] Baylor Coll Med, Core Adv MRI, Houston, TX 77030 USA; [Robinson, Meghan E.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Fortier, Catherine B.; Fonda, Jennifer R.; Milberg, William P.; McGlinchey, Regina E.; Salat, David H.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, Boston, MA USA; [Fortier, Catherine B.; Fonda, Jennifer R.; Milberg, William P.; McGlinchey, Regina E.; Salat, David H.] VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr GRECC, Boston, MA USA; [Fortier, Catherine B.; Fonda, Jennifer R.; Milberg, William P.; McGlinchey, Regina E.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Wang, Danny J. J.] Univ Southern Calif, Keck Sch Med, Mark & Mary Stevens Neuroimaging & Informat Inst, Lab FMRI Technol LOFT, Los Angeles, CA 90007 USA; [Wang, Danny J. J.] Univ Southern Calif, Dept Neurol, Los Angeles, CA 90007 USA; [Salat, David H.] VA Boston Healthcare Syst, Neuroimaging Res Vet Ctr, Boston, MA USA; [Salat, David H.] Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA		Sullivan, DR (corresponding author), VA Boston Healthcare Syst, Natl Ctr PTSD, 116B-2,150 S Huntington Ave, Boston, MA 02130 USA.	drsulliv@bu.edu	Fonda, Jennifer R./ABG-2890-2021; Fortier, Catherine/AAS-2163-2021; Wang, Danny JJ/O-2482-2018	Fonda, Jennifer R./0000-0001-9482-2918; Fortier, Catherine/0000-0002-8953-9904; Wang, Danny JJ/0000-0002-0840-7062; Sullivan, Danielle R./0000-0002-0141-5887	CSRD VA [IK2 CX001772] Funding Source: Medline		Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Alosco ML, 2016, J HEAD TRAUMA REHAB, V31, P360, DOI 10.1097/HTR.0000000000000201; Alsop DC, 2008, NEUROIMAGE, V42, P1267, DOI 10.1016/j.neuroimage.2008.06.006; Bakker A, 2012, NEURON, V74, P467, DOI 10.1016/j.neuron.2012.03.023; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Beason-Held LL, 2013, J NEUROSCI, V33, P18008, DOI 10.1523/JNEUROSCI.1402-13.2013; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Benedictus MR, 2017, EUR RADIOL, V27, P1169, DOI 10.1007/s00330-016-4450-z; Bernbaum M, 2015, J CEREBR BLOOD F MET, V35, P1610, DOI 10.1038/jcbfm.2015.92; Bir C, 2012, MAGN RESON IMAGING, V30, P527, DOI 10.1016/j.mri.2011.12.003; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Brickman AM, 2009, PSYCHIAT RES-NEUROIM, V172, P117, DOI 10.1016/j.pscychresns.2008.11.006; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chao LL, 2010, ALZ DIS ASSOC DIS, V24, P19, DOI 10.1097/WAD.0b013e3181b4f736; Chappell MA, 2011, MAGN RESON MED, V65, P1173, DOI 10.1002/mrm.22641; Chappell MA, 2009, IEEE T SIGNAL PROCES, V57, P223, DOI 10.1109/TSP.2008.2005752; Clark AL, 2017, NEUROIMAGE-CLIN, V14, P308, DOI 10.1016/j.nicl.2016.12.017; Deibler AR, 2008, AM J NEURORADIOL, V29, P1235, DOI 10.3174/ajnr.A1033; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Groves AR, 2009, NEUROIMAGE, V45, P795, DOI 10.1016/j.neuroimage.2008.12.027; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huang CR, 2003, NEUROIMAGE, V19, P1137, DOI 10.1016/S1053-8119(03)00168-X; Ito H, 2003, J CEREBR BLOOD F MET, V23, P665, DOI 10.1097/01.WCB.0000067721.64998.F5; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johnson KA, 2007, J NEUROL NEUROSUR PS, V78, P240, DOI 10.1136/jnnp.2006.096800; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kapogiannis D, 2011, LANCET NEUROL, V10, P187, DOI 10.1016/S1474-4422(10)70277-5; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Luckhaus C, 2008, NEUROIMAGE, V40, P495, DOI 10.1016/j.neuroimage.2007.11.053; McGlinchey RE, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1556; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller DR, 2017, BRAIN IMAGING BEHAV, V11, P1129, DOI 10.1007/s11682-016-9593-7; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; Onetti Y, 2015, AM J PHYSIOL-HEART C, V308, pH862, DOI 10.1152/ajpheart.00001.2015; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Ponto LLB, 2016, J NEUROPSYCH CLIN N, V28, P89, DOI 10.1176/appi.neuropsych.15050106; Promjunyakul N, 2015, NEUROIMAGE-CLIN, V8, P224, DOI 10.1016/j.nicl.2015.04.012; Robinson ME, 2017, J NEUROTRAUM, V34, pS53, DOI 10.1089/neu.2016.4709; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Salat DH, 2017, BRAIN INJURY, V31, P1204, DOI 10.1080/02699052.2017.1327672; Shi YL, 2016, J CEREBR BLOOD F MET, V36, P1653, DOI 10.1177/0271678X16662891; Simard JM, 2014, J NEUROTRAUM, V31, P1292, DOI 10.1089/neu.2013.3016; Sojkova J, 2008, J NUCL MED, V49, P1465, DOI 10.2967/jnumed.108.051946; Sosa MAG, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-018-0647-5; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Sullivan DR, 2019, J NEUROTRAUM, V36, P3264, DOI 10.1089/neu.2019.6489; Sullivan DR, 2019, J HEAD TRAUMA REHAB, V34, pE18, DOI 10.1097/HTR.0000000000000449; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Wang Z, 2013, NEUROIMAGE-CLIN, V2, P630, DOI 10.1016/j.nicl.2013.04.014; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Wu WC, 2007, MAGN RESON MED, V58, P1020, DOI 10.1002/mrm.21403; Xekardaki A, 2015, RADIOLOGY, V274, P490, DOI 10.1148/radiol.14140680; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	67	2	2	4	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	APR	2021	41	4					886	900		10.1177/0271678X20935190			15	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	QZ5OS	WOS:000630775900016	32580671	Green Published			2022-02-06	
J	Tsai, SHL; Goyal, A; Alvi, MA; Kerezoudis, P; Yolcu, YU; Wahood, W; Habermann, EB; Burns, TC; Bydon, M				Tsai, Sung Huang Laurent; Goyal, Anshit; Alvi, Mohammed Ali; Kerezoudis, Panagiotis; Yolcu, Yagiz Ugur; Wahood, Waseem; Habermann, Elizabeth B.; Burns, Terry C.; Bydon, Mohamad			Hospital volume-outcome relationship in severe traumatic brain injury: stratified analysis by level of trauma center	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; head trauma; surgery; hospital volume; outcome analysis; volume-outcome relationship; National Trauma Data Bank; mortality; length of stay; ICU days	SURGEON VOLUME; PATIENT OUTCOMES; MORTALITY	OBJECTIVE The nature of the volume-outcome relationship in cases with severe traumatic brain injury (TBI) remains unclear, with considerable interhospital variation in patient outcomes. The objective of this study was to understand the state of the volume-outcome relationship at different levels of trauma centers in the United States. METHODS The authors queried the National Trauma Data Bank for the years 2007?2014 for patients with severe TBI. Case volumes for each level of trauma center organized into quintiles (Q1?Q5) served as the primary predictor. Analyzed outcomes included in-hospital mortality, total hospital length of stay (LOS), and intensive care unit (ICU) stay. Multivariable regression models were performed for in-hospital mortality, overall complications, and total hospital and ICU LOSs to adjust for possible confounders. The analysis was stratified by level designation of the trauma center. Statistical significance was established at p < 0.001 to avoid a type I error due to a large sample size. RESULTS A total of 122,445 patients were included. Adjusted analysis did not demonstrate a significant relationship between increasing hospital volume of severe TBI cases and in-hospital mortality, complications, and nonhome hospital discharge disposition among level I?IV trauma centers. However, among level II trauma centers, hospital LOS was longer for the highest volume quintile (adjusted mean difference [MD] for Q5: 2.83 days, 95% CI 1.40?4.26 days, p < 0.001, reference = Q1). For level III and IV trauma centers, both hospital LOS and ICU LOS were longer for the highest volume quintile (adjusted MD for Q5: LOS 4.6 days, 95% CI 2.3?7.0 days, p < 0.001; ICU LOS 3.2 days, 95% CI 1.6?4.8 days, p < 0.001). CONCLUSIONS Higher volumes of severe TBI cases at a lower level of trauma center may be associated with a longer LOS. These results may assist policymakers with target interventions for resource allocation and point to the need for careful decision in with severe TBI.	[Tsai, Sung Huang Laurent] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Tsai, Sung Huang Laurent; Goyal, Anshit; Alvi, Mohammed Ali; Kerezoudis, Panagiotis; Yolcu, Yagiz Ugur; Wahood, Waseem; Bydon, Mohamad] Mayo Clin, Neuroinformat Lab, Rochester, MN USA; [Goyal, Anshit; Alvi, Mohammed Ali; Kerezoudis, Panagiotis; Yolcu, Yagiz Ugur; Wahood, Waseem; Burns, Terry C.; Bydon, Mohamad] Mayo Clin, Dept Neurol Surg, Rochester, MN USA; [Habermann, Elizabeth B.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Tsai, Sung Huang Laurent] Chang Gung Mem Hosp, Dept Orthoped Surg, Keelung, Taiwan		Bydon, M (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	bydon.mohamad@mayo.edu	Alvi, Mohammed Ali/AAE-1490-2019	Alvi, Mohammed Ali/0000-0002-7131-079X; Tsai, Sung Huang Laurent/0000-0002-6993-5416; Wahood, Waseem/0000-0002-2963-4096; Habermann, Elizabeth/0000-0002-1140-003X			Alali AS, 2017, NEUROSURGERY, V80, P534, DOI 10.1093/neuros/nyw098; American College of Surgeons, 2014, RESOURCES OPTIMAL CA, V6; Caputo LM, 2014, INJURY, V45, P478, DOI 10.1016/j.injury.2013.09.038; Clark DE, 2010, J AM COLL SURGEONS, V211, P224, DOI 10.1016/j.jamcollsurg.2010.03.033; Giwa F, 2018, AM J SURG, V215, P155, DOI 10.1016/j.amjsurg.2017.03.022; Glance LG, 2004, J TRAUMA, V56, P682, DOI 10.1097/01.TA.0000053469.92142.40; Goka EA, 2017, ANN VASC SURG, V45, P271, DOI 10.1016/j.avsg.2017.04.031; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; Hata T, 2016, ANN SURG, V263, P664, DOI 10.1097/SLA.0000000000001437; Hsu RCJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016833; Kim YJ, 2014, J CLIN NURS, V23, P301, DOI 10.1111/jocn.12129; Leow JJ, 2018, EUR UROL FOCUS, V4, P775, DOI 10.1016/j.euf.2017.03.008; London JA, 2003, J TRAUMA, V54, P16, DOI 10.1097/00005373-200301000-00003; Melfa G, 2018, G CHIR, V39, P5, DOI 10.11138/gchir/2018.39.1.005; Minei JP, 2014, ANN SURG, V260, P456, DOI 10.1097/SLA.0000000000000873; Panaich SS, 2016, WORLD J CARDIOL, V8, P302, DOI 10.4330/wjc.v8.i4.302; Phillips P, 2017, EUR J VASC ENDOVASC, V53, P77, DOI 10.1016/j.ejvs.2016.10.007; Preston L, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009252; Shi HY, 2014, J NEUROSURG, V121, P1323, DOI 10.3171/2014.8.JNS131526; Tepas JJ, 2013, J TRAUMA ACUTE CARE, V74, P143, DOI 10.1097/TA.0b013e3182788b5a; Wada T, 2017, INJURY, V48, P1423, DOI 10.1016/j.injury.2017.05.003; Weinheimer KT, 2017, ARTHROSCOPY, V33, P1273, DOI 10.1016/j.arthro.2017.03.005	22	2	2	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	APR	2021	134	4					1303	1315		10.3171/2020.1.JNS192115			13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	YJ2FN	WOS:000744351600004	32168482	Bronze			2022-02-06	
J	Wang, DY; Hong, MY; Pei, J; Gao, YH; Zheng, Y; Xu, X				Wang, Da-Yong; Hong, Ming-Yan; Pei, Jian; Gao, Yun-He; Zheng, Yu; Xu, Xiang			ER stress mediated-autophagy contributes to neurological dysfunction in traumatic brain injury via the ATF6 UPR signaling pathway	MOLECULAR MEDICINE REPORTS			English	Article						traumatic brain injury; activating transcription factor 6; endoplasmic reticulum stress; autophagy; autophagic flux; neurological dysfunction		A major public health problem, traumatic brain injury (TBI) can cause severe neurological impairment. Although autophagy is closely associated with the pathogenesis of TBI, the role of autophagy in neurological deficits is unclear. The purpose of the present study was to investigate the molecular mechanisms of endoplasmic reticulum (ER) stress-induced autophagy and its detrimental effects on neurological outcomes following TBI. A rat model of TBI was established by controlled cortical impact. ER stress activation, autophagy induction and autophagic flux dysfunction were examined in the damaged hippocampus post-TBI. Pharmacological inhibition of ER stress significantly blocked post-traumatic autophagy activation, as evidenced by decreased conversion of microtubule-associated protein 1 light chain 3 (LC3)-I to LC3-II and Beclin-1 expression levels in the hippocampus region. Short hairpin RNA-mediated activating transcription factor 6 knockdown significantly prevented ER stress-mediated autophagy stimulation via targeting essential autophagic genes, including autophagy related (ATG)3, ATG9 and ATG12. Furthermore, neurological scores, foot fault test and Morris water maze were used to evaluate the neurological functions of TBI rats. The results revealed that the blockage of ER stress or autophagy attenuated TBI-induced traumatic damage and functional outcomes. In conclusion, these findings provided new insights into the molecular mechanisms of ER stress-induced autophagy and demonstrated its potential role in neurological deficiency following TBI.	[Wang, Da-Yong; Hong, Ming-Yan; Pei, Jian; Gao, Yun-He; Zheng, Yu; Xu, Xiang] Tangshan Gongren Hosp, Dept Neurosurg, 7 Wenhua Rd, Tangshan 063000, Hebei, Peoples R China		Xu, X (corresponding author), Tangshan Gongren Hosp, Dept Neurosurg, 7 Wenhua Rd, Tangshan 063000, Hebei, Peoples R China.	13832810397@139.com			Natural Science Foundation of Hebei ProvinceNatural Science Foundation of Hebei Province [16397747D]; Health and Family Planning Commission Project of Hebei Province [20171358]	The present study was supported by the Natural Science Foundation of Hebei Province (grant no. 16397747D) and the Health and Family Planning Commission Project of Hebei Province (grant no. 20171358).	Adhami F, 2007, AUTOPHAGY, V3, P42, DOI 10.4161/auto.3412; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Cai Y, 2016, AUTOPHAGY, V12, P225, DOI 10.1080/15548627.2015.1121360; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Evans TD, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aag2298; Feldmann LK, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20123048; Feng Y, 2017, NEUROCHEM RES, V42, P3296, DOI 10.1007/s11064-017-2372-z; Gao Y, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00095; Hood KN, 2018, J NEUROSCI, V38, P2372, DOI 10.1523/JNEUROSCI.1756-17.2018; Hylin MJ, 2018, DEV NEUROSCI-BASEL, V40, P175, DOI 10.1159/000488343; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Iurlaro R, 2016, FEBS J, V283, P2640, DOI 10.1111/febs.13598; Jin YC, 2017, WORLD NEUROSURG, V100, P351, DOI 10.1016/j.wneu.2017.01.033; Komatsu M, 2012, PHARMACOL RES, V66, P457, DOI 10.1016/j.phrs.2012.07.004; Li D, 2019, MED SCI MONITOR, V25, P1871, DOI 10.12659/MSM.915727; Li D, 2018, BRAIN RES, V1688, P15, DOI 10.1016/j.brainres.2017.10.018; Li ZW, 2012, BBA-REV CANCER, V1826, P13, DOI 10.1016/j.bbcan.2012.02.001; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Namba T, 2007, BIOCHEM BIOPH RES CO, V355, P543, DOI 10.1016/j.bbrc.2007.02.004; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Pavlovic D, 2019, PITUITARY, V22, P270, DOI 10.1007/s11102-019-00957-9; Rashid HO, 2015, AUTOPHAGY, V11, P1956, DOI 10.1080/15548627.2015.1091141; Sharma M, 2017, J GEN VIROL, V98, P1027, DOI 10.1099/jgv.0.000792; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Sprenkle NT, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0183-y; Su YC, 2016, INT J NEUROSCI, V126, P681, DOI 10.3109/00207454.2015.1059836; Sun LQ, 2014, MOL MED REP, V9, P77, DOI 10.3892/mmr.2013.1787; Sun LQ, 2018, BEHAV BRAIN RES, V337, P271, DOI 10.1016/j.bbr.2017.08.042; Sun XF, 2018, BIOCHEM BIOPH RES CO, V505, P45, DOI 10.1016/j.bbrc.2018.09.047; Sun XL, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109144; Wang CF, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1248; Wang J, 2014, AUTOPHAGY, V10, P766, DOI 10.4161/auto.27954; Wang L, 2015, TRANSL STROKE RES, V6, P50, DOI 10.1007/s12975-014-0362-x; Whalen MJ, 1999, J NEUROTRAUM, V16, P583, DOI 10.1089/neu.1999.16.583; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Wolf MS, 2019, NEUROBIOL DIS, V122, P9, DOI 10.1016/j.nbd.2018.04.018; Xu KB, 2018, CHEM-BIOL INTERACT, V286, P96, DOI 10.1016/j.cbi.2018.02.028; Yin Y, 2017, AGEING RES REV, V34, P3, DOI 10.1016/j.arr.2016.08.008; Yu Z, 2017, J CEREBR BLOOD F MET, V37, P1069, DOI 10.1177/0271678X16650218; Zeng XJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0316-4; Zeng ZQ, 2020, J CELL PHYSIOL, V235, P1973, DOI 10.1002/jcp.29173; Zhang Q, 2015, INT J BIOL SCI, V11, P559, DOI 10.7150/ijbs.10690; Zhang ZY, 2016, NEUROCHEM RES, V41, P409, DOI 10.1007/s11064-016-1844-x; Zhao MF, 2016, MOL MED REP, V13, P13, DOI 10.3892/mmr.2015.4551; Zhou Y, 2016, CELL BIOL TOXICOL, V32, P141, DOI 10.1007/s10565-016-9323-3	49	2	2	1	4	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	APR	2021	23	4							247	10.3892/mmr.2021.11886			9	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	QK8JN	WOS:000620626300001	33537827				2022-02-06	
J	Weyer-Jamora, C; Brie, MS; Luks, TL; Smith, EM; Braunstein, SE; Villanueva-Meyer, JE; Bracci, PM; Chang, SS; Hervey-Jumper, SL; Taylor, JW				Weyer-Jamora, Christina; Brie, Melissa S.; Luks, Tracy L.; Smith, Ellen M.; Braunstein, Steve E.; Villanueva-Meyer, Javier E.; Bracci, Paige M.; Chang, Susan; Hervey-Jumper, Shawn L.; Taylor, Jennie W.			Cognitive impact of lower-grade gliomas and strategies for rehabilitation	NEURO-ONCOLOGY PRACTICE			English	Article						cognitive outcomes; cognitive rehabilitation; low-grade glioma; neurocognitive outcomes; primary brain tumor	TIME PRESSURE MANAGEMENT; BRAIN-TUMOR PATIENTS; NEUROCOGNITIVE FUNCTION; PROCESSING SPEED; WORKING-MEMORY; DYSFUNCTION; ATTENTION; SURGERY; EFFICACY; DEFICITS	Outcomes for patients with lower-grade gliomas (LrGGs) continue to improve with advances in molecular characterization and treatment. However, cognitive sequela from the tumor and its treatment leave a significant impact on health-related quality of life for these patients. Several factors affect each patient's cognition, such as tumor location, treatment, medication, and comorbidities. However, impairments of processing speed, attention, concentration, working memory, and executive function are common across LrGG patients. Cognitive rehabilitation strategies, well established in traumatic brain injury and stroke populations, are based on neural plasticity and functional reorganization. Adapting these strategies for implementation in patients with brain tumors is an active area of research. This article provides an overview of cognitive domains commonly impaired in LrGG patients and evidence for the use of cognitive rehabilitation strategies to address these impairments with the goal of improving health-related quality of life in this patient population.	[Weyer-Jamora, Christina; Brie, Melissa S.; Smith, Ellen M.; Chang, Susan; Hervey-Jumper, Shawn L.; Taylor, Jennie W.] Univ Calif San Francisco, Dept Neurol Surg, 400 Parnassus Ave,A808, San Francisco, CA 94143 USA; [Weyer-Jamora, Christina; Brie, Melissa S.] Zuckerberg San Francisco Gen Hosp, Dept Psychiat & Behav Sci, San Francisco, CA USA; [Luks, Tracy L.; Villanueva-Meyer, Javier E.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Braunstein, Steve E.] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94143 USA; [Bracci, Paige M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Taylor, Jennie W.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA		Taylor, JW (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 400 Parnassus Ave,A808, San Francisco, CA 94143 USA.	Jennie.Taylor@ucsf.edu			Sheri Sobrato Brisson Brain Cancer Fund; Robert Wood Johnson FoundationRobert Wood Johnson Foundation (RWJF) [74259]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08 110919-01]	This work was supported by the LoGlio Collective [to all authors]; the Sheri Sobrato Brisson Brain Cancer Fund [to C.W.J., S.C, and S.H.J.]; the Robert Wood Johnson Foundation [grant number 74259 to S.H.J.]; and the National Institute of Neurological Disorders and Stroke [grant number K08 110919-01 to S.H.J.]	Anderson V, 2002, PRINCIPLES FRONTAL L, P504; Antonsson M, 2018, ACTA NEUROL SCAND, V137, P469, DOI 10.1111/ane.12887; Armstrong TS, 2012, NEURO-ONCOLOGY, V14, P65, DOI 10.1093/neuonc/nos210; Baddeley AD, 2002, EUR PSYCHOL, V7, P85, DOI 10.1027//1016-9040.7.2.85; Bartolo M, 2012, J NEURO-ONCOL, V107, P537, DOI 10.1007/s11060-011-0772-5; Barzilai O, 2019, J NEUROSURG, V130, P426, DOI 10.3171/2017.9.JNS17658; Bogdanova Y, 2016, J HEAD TRAUMA REHAB, V31, P419, DOI 10.1097/HTR.0000000000000203; Boone M, 2016, J NEURO-ONCOL, V129, P123, DOI 10.1007/s11060-016-2152-7; Brissart H, 2013, NEUROCASE, V19, P553, DOI 10.1080/13554794.2012.701644; Buckner JC, 2016, NEW ENGL J MED, V374, P1344, DOI 10.1056/NEJMoa1500925; Cairncross G, 2013, J CLIN ONCOL, V31, P337, DOI 10.1200/JCO.2012.43.2674; Chang Susan M, 2016, Am Soc Clin Oncol Educ Book, V35, P75, DOI 10.14694/EDBK_158869; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cochereau J, 2016, ACTA NEUROCHIR, V158, P305, DOI 10.1007/s00701-015-2674-3; Cohen R.A., 2014, NEUROPSYCHOLOGY ATTE; Coomans MB, 2019, CURR OPIN ONCOL, V31, P540, DOI 10.1097/CCO.0000000000000581; Correa DD, 2018, J NEURO-ONCOL, V136, P613, DOI 10.1007/s11060-017-2692-5; Correa DD, 2007, J NEURO-ONCOL, V81, P175, DOI 10.1007/s11060-006-9212-3; Dixon R.A., 1999, COGNITIVE NEUROREHAB, P59; Douw L, 2009, LANCET NEUROL, V8, P810, DOI 10.1016/S1474-4422(09)70204-2; Duffau H, 2018, CURR OPIN ONCOL, V30, P383, DOI 10.1097/CCO.0000000000000483; Elliott M, 2014, BRAIN INJURY, V28, P1610, DOI 10.3109/02699052.2014.934921; Esposito R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040231; Fasotti L, 2000, NEUROPSYCHOL REHABIL, V10, P47, DOI 10.1080/096020100389291; Fawcett JW, 2001, BRAIN DAMAGE BRAIN R, P289; Francis DR, 2002, APHASIOLOGY, V16, P243, DOI 10.1080/02687040143000564; Gehring K, 2009, J CLIN ONCOL, V27, P3712, DOI 10.1200/JCO.2008.20.5765; Goldberg E., 2009, NEW EXECUTIVE BRAIN; Habets EJJ, 2018, EUR J CANCER, V100, P104, DOI 10.1016/j.ejca.2018.05.014; Harris RJ, 2014, J NEURO-ONCOL, V116, P373, DOI 10.1007/s11060-013-1304-2; Haskins E., 2014, COGNITIVE REHABILITA; Hassler MR, 2010, J NEURO-ONCOL, V97, P109, DOI 10.1007/s11060-009-0006-2; Hendriks EJ, 2018, HUM BRAIN MAPP, V39, P2064, DOI 10.1002/hbm.23986; Hoffermann M, 2017, J CLIN NEUROSCI, V36, P31, DOI 10.1016/j.jocn.2016.10.030; Johnstone B, 2009, REHABILITATION OF NEUROPSYCHOLOGICAL DISORDERS: A PRACTICAL GUIDE FOR REHABILITATION PROFESSIONALS, P1; KAIL R, 1994, ACTA PSYCHOL, V86, P199, DOI 10.1016/0001-6918(94)90003-5; KATZ DI, 2006, COGNITIVE REHABILITA; Kesler SR, 2017, J NEURO-ONCOL, V131, P565, DOI 10.1007/s11060-016-2328-1; Khan F, 2014, J REHABIL MED, V46, P754, DOI 10.2340/16501977-1840; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Klein M, 2002, LANCET, V360, P1361, DOI 10.1016/S0140-6736(02)11398-5; Kolb B, 1998, ANNU REV PSYCHOL, V49, P43, DOI 10.1146/annurev.psych.49.1.43; Koziol L. F., 2009, SUBCORTICAL STRUCTUR; Krasny-Pacini A, 2014, DISABIL REHABIL, V36, P105, DOI 10.3109/09638288.2013.777807; Kurtz MM, 2007, CURR PSYCHIATRY REV, V3, P213, DOI 10.2174/157340007781369702; Leeper HE, 2018, NEURO-ONCOL PRACT, V5, P3, DOI 10.1093/nop/npx034; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lilja A, 1992, NEUROPSYCHOLOGY, V6, P315; Locke Dona E C, 2008, J Support Oncol, V6, P383; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Luu P, 2007, BRAIN RES, V1179, P89, DOI 10.1016/j.brainres.2007.03.092; Maddy K. M., 2014, Annals of Physical and Rehabilitation Medicine, V57, P254, DOI 10.1016/j.rehab.2014.03.002; Maschio M, 2015, J NEURO-ONCOL, V125, P419, DOI 10.1007/s11060-015-1933-8; Miotto EC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105987; Miotto EC, 2013, CLIN NEUROL NEUROSUR, V115, P309, DOI 10.1016/j.clineuro.2012.05.024; Miotto EC, 2011, ARQ NEURO-PSIQUIAT, V69, P596, DOI 10.1590/S0004-282X2011000500005; Molinaro AM, 2019, NAT REV NEUROL, V15, P405, DOI 10.1038/s41582-019-0220-2; National Institute for Clinical Excellence Great Britain National Health Service, 2004, IMPROVING SUPPORTIVE; Ng JCH, 2019, J NEURO-ONCOL, V141, P167, DOI 10.1007/s11060-018-03023-9; Nokia MS, 2012, EUR J NEUROSCI, V36, P3521, DOI 10.1111/ejn.12007; Noll KR, 2016, J NEURO-ONCOL, V128, P323, DOI 10.1007/s11060-016-2114-0; Noll KR, 2017, PSYCHO-ONCOLOGY, V26, P617, DOI 10.1002/pon.4046; Nwachukwu CR, 2015, J NEURO-ONCOL, V121, P599, DOI 10.1007/s11060-014-1673-1; O'Neil-Pirozzi TM, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000181; O'Neil-Pirozzi TM, 2010, J HEAD TRAUMA REHAB, V25, P43, DOI 10.1097/HTR.0b013e3181bf24b1; Perna R, 2012, APPL NEUROPSYCH-ADUL, V19, P263, DOI 10.1080/09084282.2012.670147; Prosperini L, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/481574; Pulsifer MB, 2018, INT J RADIAT ONCOL, V102, P391, DOI 10.1016/j.ijrobp.2018.05.069; Racine CA, 2015, NEUROSURGERY, V77, P371, DOI 10.1227/NEU.0000000000000779; Raisa N., 2019, MNJ MALANG NEUROL J, V5, P92, DOI [DOI 10.21776/UB.MNJ.2019.005.02.9, 10.21776/ub.mnj.2019.005.02.9]; Reichenberg A, 2007, PSYCHOL BULL, V133, P833, DOI 10.1037/0033-2909.133.5.833; Richard NM, 2019, J NEURO-ONCOL, V142, P565, DOI 10.1007/s11060-019-03130-1; Richardson JTE, 2001, CLIN NEUROPSYCHOLOGI; Santini B, 2012, J NEURO-ONCOL, V108, P319, DOI 10.1007/s11060-012-0817-4; Satoer D, 2014, J NEURO-ONCOL, V116, P153, DOI 10.1007/s11060-013-1275-3; Schatz J, 2000, NEUROPSYCHOLOGY, V14, P189, DOI 10.1037//0894-4105.14.2.189; Scheibel RS, 1996, J NEURO-ONCOL, V30, P61; Scott JG, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P149, DOI 10.1007/978-0-387-76978-3_6; Scott JG, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P219, DOI 10.1007/978-0-387-76978-3_10; Sherer M, 1997, CANCER, V80, P250, DOI 10.1002/(SICI)1097-0142(19970715)80:2<250::AID-CNCR13>3.3.CO;2-T; Simmons-Mackie N, 2010, ARCH PHYS MED REHAB, V91, P1814, DOI 10.1016/j.apmr.2010.08.026; Skeel RL, 2009, REHABILITATION NEURO, P47; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Sohlberg MM, 2003, J MED SPEECH-LANG PA, V11, pXIX; Sohlberg MM, 2001, ANN NY ACAD SCI, V931, P359; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; Stamenova V, 2019, NEUROPSYCHOL REHABIL, V29, P1569, DOI 10.1080/09602011.2018.1438294; Stoecklein VM, 2020, NEURO-ONCOLOGY, V22, P1388, DOI 10.1093/neuonc/noaa044; Strangman GE, 2008, ARCH PHYS MED REHAB, V89, P974, DOI 10.1016/j.apmr.2008.02.011; Stuss Donald T, 2002, PRINCIPLES FRONTAL L; Talacchi A, 2011, J NEURO-ONCOL, V103, P541, DOI 10.1007/s11060-010-0417-0; Taphoorn MJB, 2003, SEMIN ONCOL, V30, P45, DOI 10.1053/j.seminoncol.2003.11.023; Tranel D, 2007, J CLIN EXP NEUROPSYC, V29, P319, DOI 10.1080/13803390600701376; Turner S, 2006, APHASIOLOGY, V20, P483, DOI 10.1080/02687030600589991; van den Bent MJ, 2011, LANCET ONCOL, V12, P583, DOI 10.1016/S1470-2045(11)70057-2; van den Bent MJ, 2017, LANCET, V390, P1645, DOI 10.1016/S0140-6736(17)31442-3; van den Bent MJ, 2013, J CLIN ONCOL, V31, P344, DOI 10.1200/JCO.2012.43.2229; van der Linden SD, 2018, J NEURO-ONCOL, V137, P523, DOI 10.1007/s11060-017-2738-8; van Kessel E, 2017, J NEURO-ONCOL, V134, P9, DOI 10.1007/s11060-017-2503-z; van Lonkhuizen PJC, 2019, EUR J CANCER CARE, V28, DOI 10.1111/ecc.13088; van Loon EMP, 2015, J REHABIL MED, V47, P481, DOI 10.2340/16501977-1975; Wefel JS, 2016, NEURO-ONCOLOGY, V18, P1656, DOI 10.1093/neuonc/now165; Wefel JS, 2011, LANCET ONCOL, V12, P703, DOI 10.1016/S1470-2045(10)70294-1; Wefel JS, 2004, BRIT J CANCER, V90, P1691, DOI 10.1038/sj.bjc.6601772; WHYTE J, 1992, ARCH PHYS MED REHAB, V73, P1094; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P1, DOI 10.1017/CBO9780511581083; Winans-Mitrik RL, 2014, AM J SPEECH-LANG PAT, V23, P330, DOI 10.1044/2014_AJSLP-13-0102; Winkens I, 2009, ARCH PHYS MED REHAB, V90, P1672, DOI 10.1016/j.apmr.2009.04.016; Yang S, 2014, ANN REHABIL MED-ARM, V38, P726, DOI 10.5535/arm.2014.38.6.726; Yu ZZ, 2017, CHINESE MED J-PEKING, V130, P1491, DOI 10.4103/0366-6999.207465; Zucchella C, 2013, J NEURO-ONCOL, V114, P93, DOI 10.1007/s11060-013-1153-z	114	2	2	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2054-2577	2054-2585		NEURO-ONCOL PRACT	Neuro-Oncol. Pract.	APR	2021	8	2					117	128		10.1093/nop/npaa072			12	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	RY0ZE	WOS:000647645700003	33898046	Green Published			2022-02-06	
J	He, B; Chen, W; Zeng, JS; Tong, WS; Zheng, P				He, Bin; Chen, Wei; Zeng, Jingsong; Tong, Wusong; Zheng, Ping			Long noncoding RNA NKILA transferred by astrocyte-derived extracellular vesicles protects against neuronal injury by upregulating NLRX1 through binding to mir-195 in traumatic brain injury	AGING-US			English	Article						traumatic brain injury; long noncoding RNA NKILA; microRNA-195; NLRX1; extracellular vesicles		The study aims to investigate the effects of long noncoding RNA (lncRNA) transmitted nuclear factor-KB interacting lncRNA (NKILA)-containing astrocyte-derived small extracellular vesicles (EVs) on traumatic brain injury (TBI). TBI was modeled in vitro by exposing human neurons to mechanical injury and in vivo by controlled cortical impact in a mouse model. The gain- and loss-function approaches were conducted in injured neurons to explore the role of NKILA, microRNA-195 (miR-195) and nucleotide-binding leucine-rich repeat containing family member X1 (NLRX1) in neuronal injury. EVs extracted from NKILA-overexpressing astrocytes were used to treat injured neurons. It was revealed that NKILA was downregulated in injured neurons. Astrocyte coculture participated in the upregulation of NKILA in injured neurons. Additionally, NKILA could competitively bind to miR-195 that directly targeted NLRX1. Next, the upregulation of NLRX1 or NKILA relived neuronal injury by promoting neuronal proliferation but inhibiting apoptosis. Astrocyte-derived EVs transferred NKILA into neurons, which led to the downregulation of miR-195, upregulation of NLRX1, increased cell proliferation, and decreased cell apoptosis. The in vivo experiments validated that NKILA-containing EVs promoted brain recovery following TBI. Collectively, astrocyte-derived EVs carrying NKILA was found to alleviate neuronal injury in TBI by competitively binding to miR-195 and upregulating NLRX1.	[He, Bin; Chen, Wei] Shanghai Univ Med & Hlth Sci, Dept Neurosurg, Shanghai 201318, Peoples R China; [Zeng, Jingsong; Tong, Wusong; Zheng, Ping] Shanghai Pudong New Area People, Dept Neurosurg, Shanghai 201200, Peoples R China		Zheng, P (corresponding author), Shanghai Pudong New Area People, Dept Neurosurg, Shanghai 201200, Peoples R China.	zhengp@unimelb.edu.au		Chen, Wei/0000-0001-7438-3241	Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81701231]; Natural Science Foundation of ShanghaiNatural Science Foundation of Shanghai [16ZR1431500]; Shanghai Pudong New Area People's Hospital Project [E18-11]	This work was supported by Natural Science Foundation of China (81701231) and Natural Science Foundation of Shanghai (16ZR1431500) and Shanghai Pudong New Area People's Hospital Project (E18-11).	Andelic N, 2013, LANCET NEUROL, V12, P28, DOI 10.1016/S1474-4422(12)70294-6; Brickler T, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6373506; Chen W, 2020, J TISSUE ENG REGEN M, V14, P412, DOI 10.1002/term.3002; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Dickens AM, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai7696; Didiot MC, 2016, MOL THER, V24, P1836, DOI 10.1038/mt.2016.126; Fruhbeis C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001604; Geng JF, 2018, INT J BIOCHEM CELL B, V99, P133, DOI 10.1016/j.biocel.2018.03.021; Guescini M, 2010, J NEURAL TRANSM, V117, P1, DOI 10.1007/s00702-009-0288-8; Guitart K, 2016, GLIA, V64, P896, DOI 10.1002/glia.22963; He JF, 2011, J BIOCHEM MOL TOXIC, V25, P404, DOI 10.1002/jbt.20396; Hong Y, 2017, J NEUROSCI, V37, P9550, DOI 10.1523/JNEUROSCI.1418-17.2017; Hu G, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.114; Huang S, 2018, FASEB J, V32, P512, DOI 10.1096/fj.201700673R; Ke S, 2018, AGING-US, V10, P56, DOI 10.18632/aging.101359; Lafourcade C, 2016, J EXP NEUROSCI, V10, P1, DOI 10.4137/JEN.S39916; Lang HL, 2017, ONCOL REP, V38, P785, DOI 10.3892/or.2017.5742; Li HY, 2016, MOL IMMUNOL, V76, P90, DOI 10.1016/j.molimm.2016.06.013; Linnerbauer M, 2020, NEURON, V108, P608, DOI 10.1016/j.neuron.2020.08.012; Liu Y, 2018, BIOMED PHARMACOTHER, V98, P856, DOI 10.1016/j.biopha.2017.12.079; Liu Y, 2018, INT J LOW EXTR WOUND, V17, P144, DOI 10.1177/1534734618794856; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Ni HQ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00014; Reza-Zaldivar EE, 2019, NEURAL REGEN RES, V14, P1626, DOI 10.4103/1673-5374.255978; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rufino-Ramos D, 2017, J CONTROL RELEASE, V262, P247, DOI 10.1016/j.jconrel.2017.07.001; Shi GD, 2013, GLIA, V61, P504, DOI 10.1002/glia.22451; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sun YX, 2013, NEUROL SCI, V34, P345, DOI 10.1007/s10072-012-1007-z; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Theus MH, 2017, J IMMUNOL, V199, P3547, DOI 10.4049/jimmunol.1700251; Torrente D, 2014, NEUROSCI LETT, V565, P2, DOI 10.1016/j.neulet.2013.12.058; Upadhya R, 2020, J CONTROL RELEASE, V323, P225, DOI 10.1016/j.jconrel.2020.04.017; Verkhratsky A, 2016, EMBO J, V35, P239, DOI 10.15252/embj.201592705; Wang CF, 2017, J NEUROTRAUM, V34, P2100, DOI 10.1089/neu.2016.4642; Wu DP, 2017, CELL PHYSIOL BIOCHEM, V42, P2453, DOI 10.1159/000480209; Wu Zhenyu, 2018, Front Immunol, V9, P3066, DOI 10.3389/fimmu.2018.03066; Yao XL, 2017, J NEUROIMMUNOL, V310, P38, DOI 10.1016/j.jneuroim.2017.06.006; Yoon JH, 2012, MOL CELL, V47, P648, DOI 10.1016/j.molcel.2012.06.027; You Y, 2020, J EXTRACELL VESICLES, V9, DOI 10.1080/20013078.2019.1706801; Zhang HS, 2018, INT J MOL MED, V41, P3203, DOI 10.3892/ijmm.2018.3567; Zhang PJ, 2017, CNS NEUROL DISORD-DR, V16, P724, DOI 10.2174/1871527316666170124164306; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770; Zhao YJ, 2018, ONCOL REP, V39, P1197, DOI 10.3892/or.2018.6207; Zhong JJ, 2016, BRAIN RES, V1646, P589, DOI 10.1016/j.brainres.2016.07.002	46	2	2	0	2	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1945-4589			AGING-US	Aging-US	MAR 31	2021	13	6					8127	8145					19	Cell Biology; Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Geriatrics & Gerontology	RH1CF	WOS:000635963500029	33686956	Green Published, gold			2022-02-06	
J	Cho, MJ; Jang, SH				Cho, Min Jye; Jang, Sung Ho			Relationship between post-traumatic amnesia and white matter integrity in traumatic brain injury using tract-based spatial statistics	SCIENTIFIC REPORTS			English	Article								This study used tract-based spatial statistics to examine the relationship between post-traumatic amnesia (PTA) and white matter integrity in patients with a traumatic brain injury (TBI). Forty-seven patients with TBI in the chronic stage and 47 age- and sex-matched normal control subjects were recruited to the study. Correlation coefficients were calculated to observe the relationships among the PTA duration, white matter fractional anisotropy (FA) values, and mini-mental state examination (MMSE) results in the patient group. Both before and after Benjamini-Hochberg (BH) corrections, FA values of 46 of the 48 regions of interests of the patient group were lower than those of the control group. The FA values of column and body of fornix, left crus of fornix, left uncinate fasciculus, right hippocampus part of cingulum, left medial lemniscus, right superior cerebellar peduncle, left superior cerebellar peduncle, and left posterior thalamic radiation (after BH correction: the uncinate fasciculus and right hippocampus part of cingulum) in the patient group were negatively correlated with PTA duration. PTA duration was related to the injury severity of eight neural structures, each of which is involved in the cognitive functioning of patients with TBI. Therefore, PTA duration can indicate injury severity of the above neural structures in TBI patients.	[Cho, Min Jye; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Namku 705717, Daegu, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Namku 705717, Daegu, South Korea.	strokerehab@hanmail.net			Medical Research Center Program [2015R1A5A2009124]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning	This work was supported by the Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Alm KH, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00343; Anjari M, 2007, NEUROIMAGE, V35, P1021, DOI 10.1016/j.neuroimage.2007.01.035; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2009, J HEAD TRAUMA REHAB, V24, P76, DOI 10.1097/HTR.0b013e31819c2190; BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Bubb EJ, 2018, NEUROSCI BIOBEHAV R, V92, P104, DOI 10.1016/j.neubiorev.2018.05.008; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Formisano R, 2004, ACTA NEUROCHIR, V146, P457, DOI 10.1007/s00701-004-0225-4; Funahashi S, 2013, J PHYSIOL-PARIS, V107, P471, DOI 10.1016/j.jphysparis.2013.05.001; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; Group TCmW, 2009, J REHABIL RES DEV, V46; HASLAM C, 1994, BRAIN INJURY, V8, P519, DOI 10.3109/02699059409151004; HASLAM C, 1995, NEUROPSYCHOLOGY, V9, P599, DOI 10.1037/0894-4105.9.4.599; Jang SH, 2014, NEURORADIOLOGY, V56, P965, DOI 10.1007/s00234-014-1419-y; Lee SJ, 2020, STROKE, V51, pE246, DOI 10.1161/STROKEAHA.120.029996; Kim E, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091318; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Liu YW, 2007, RADIOLOGY, V242, P518, DOI 10.1148/radiol.2422051698; MANDLEBERG IA, 1976, J NEUROL NEUROSUR PS, V39, P1001, DOI 10.1136/jnnp.39.10.1001; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1127, DOI 10.1136/jnnp.38.11.1127; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; Matsuura T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56485-w; McDonald S, 2019, BRAIN IMAGING BEHAV, V13, P819, DOI 10.1007/s11682-018-9906-0; McFarland K, 2001, CLIN NEUROPSYCHOL, V15, P59, DOI 10.1076/clin.15.1.59.1916; Metoki A, 2017, BRAIN STRUCT FUNCT, V222, P4187, DOI 10.1007/s00429-017-1458-3; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; O'Phelan KH, 2018, J NEUROTRAUM, V35, P739, DOI 10.1089/neu.2016.4944; OLSON CL, 1974, J AM STAT ASSOC, V69, P894, DOI 10.2307/2286159; Owens JA, 2018, BRAIN INJURY, V32, P776, DOI 10.1080/02699052.2018.1451656; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Ryan NP, 2018, PSYCHOL MED, V48, P679, DOI 10.1017/S0033291717002057; Schwarz CG, 2014, NEUROIMAGE, V94, P65, DOI 10.1016/j.neuroimage.2014.03.026; Senova S, 2020, J NEUROL NEUROSUR PS, V91, P547, DOI 10.1136/jnnp-2019-322375; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; SHORES EA, 1989, J NEUROL NEUROSUR PS, V52, P126, DOI 10.1136/jnnp.52.1.126-a; Sigurdardottir S, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000039; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Subramaniam K, 2018, SCHIZOPHR RES, V193, P276, DOI 10.1016/j.schres.2017.06.062; Tate RL, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.074989; Van der Werf YD, 2003, NEUROPSYCHOLOGIA, V41, P1330, DOI 10.1016/S0028-3932(03)00059-9; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Xiong KL, 2014, BRAIN RES, V1591, P86, DOI 10.1016/j.brainres.2014.10.030; Yiannakkaras C, 2019, J INTEGR NEUROSCI, V18, P95, DOI 10.31083/j.jin.2019.02.144; Yin B, 2019, FRONT NEURAL CIRCUIT, V13, DOI 10.3389/fncir.2019.00028; Zalesky A, 2011, MAGN RESON IMAGING, V29, P111, DOI 10.1016/j.mri.2010.06.027	50	2	2	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	MAR 25	2021	11	1							6898	10.1038/s41598-021-86439-0			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RG7GF	WOS:000635701800013	33767378	Green Published, gold			2022-02-06	
J	Gwarzo, IH; Perez-Patron, M; Xu, XH; Radcliff, T; Horney, J				Gwarzo, Ibrahim H.; Perez-Patron, Maria; Xu, Xiaohui; Radcliff, Tiffany; Horney, Jennifer			Traumatic Brain Injury Related Hospitalizations: Factors Associated with In-hospital Mortality among Elderly Patients Hospitalized with a TBI	BRAIN INJURY			English	Article						Traumatic brain injury; hospitalization; elderly; mortality; texas; disparities		Background: This study aims to describe TBI-related hospitalizations for the whole population and identify factors associated with in-hospital mortality among elderly (>= 65 years) patients hospitalized with TBI in Texas. Methods: Using Texas Hospital Discharge Data from 2012 to 2014, TBI-related hospitalizations were identified using International Classification of Diseases - Ninth Revision - Clinical Modification (ICD-9-CM) codes. Rates for age and gender were estimated using U.S. Census data. Univariate and multivariate analyses were used to identify factors associated with in-hospital mortality among those aged at least 65 years. Results: There were 51,419 TBI-related hospitalizations from 2012 to 2014 in Texas. Falls were the leading cause of TBI-related hospitalizations 6235 (36.64%), 6595 (38.40%), and 5412 (37.59%) for 2012, 2013, and 2014, respectively. Males had higher rates of hospitalizations while rates were highest for those above 80 years of age. Compared to Whites, Hispanics had 1.18 higher adjusted odds of in-hospital mortality [OR = 1.18: 95% CI (1.01-1.40)]. Similarly, adjusted odds of in-hospital mortality were higher among males [OR = 1.55: 95% CI (1.36-1.77)]. Conclusion: This study provided evidence of demographic disparities in the burden and outcome of TBI in Texas, findings could serve as a foundation for targeted TBI prevention interventions.	[Horney, Jennifer] Univ Delaware, Epidemiol, Newark, DE USA		Gwarzo, IH (corresponding author), Texas A&M Univ, Epidemiol & Biostat, 221 Adriance Lab Rd, College Stn, TX 77843 USA.	rahim9@tamu.edu	Gwarzo, Ibrahim/AAM-4685-2021	Gwarzo, Ibrahim/0000-0002-0794-179X			[Anonymous], 1997, RECOMMENDATIONS REPO, V46; Bazarian JJ, 2003, ACAD EMERG MED, V10, P1209, DOI 10.1197/S1069-6563(03)00491-3; Berkow, 1995, MERCK MANUAL GERIATR, P65; BOWMAN S, 2007, MED CARE, V1; Census Bureau, 2019, QUICKFACTS TEX; Centers for Disease Control and Prevention, 2015, NATL CENT INJ PREV C, V2, P1; Chen L., 2019, MED EXPANSION TEXAS; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; ELIXHAUSER A, 1998, MED CARE, V1; FAUL M, 2003, EPILEPSIA, V44; Fletcher AE, 2007, BRAIN INJURY, V21, P691, DOI 10.1080/02699050701426873; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; HINGSON R, 1987, J STUD ALCOHOL, V48, P212, DOI 10.15288/jsa.1987.48.212; Hofman K, 2005, AM J PUBLIC HEALTH, V95, P13, DOI 10.2105/AJPH.2004.039354; Houry D, 2016, AM J LIFESTYLE MED, V10, P74, DOI 10.1177/1559827615600137; Injury Epidemiology  Surveillance Branch Environmental Epidemiology & Disease Registries Section Department of State Health Services (e):, 2012, SURVEILLANCE BRANCH; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Krishnamoorthy V, 2015, J TRAUMA NURS, V22, P204, DOI 10.1097/JTN.0000000000000135; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Lagbas C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/143092; Li WJ, 2006, AM J PUBLIC HEALTH, V96, P1192, DOI 10.2105/AJPH.2005.083055; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; NEVITT M, 1989, JAMA-J AM MED ASSOC, V261; Nyam TTE, 2019, WORLD NEUROSURG, V122, pE740, DOI 10.1016/j.wneu.2018.10.130; Onose C., 2015, J MED LIFE, V8; Ostermann RC, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-0975-y; Pandit V, 2014, J SURG RES, V190, P634, DOI 10.1016/j.jss.2014.04.039; Peterson AB, 2014, SURVEILLANCE REPORT; Ramanathan DM, 2012, J NEUROTRAUM, V29, P1371, DOI 10.1089/neu.2011.2197; Redeker N S, 1995, Am J Crit Care, V4, P370; Salim A, 2010, J TRAUMA, V68, P211, DOI 10.1097/TA.0b013e3181a0e659; SHI L, 2000, MED CARE RES REV, V57; Sorenson SB, 2011, AM J PUBLIC HEALTH, V101, pS353, DOI 10.2105/AJPH.2010.300029; Texas administrative code, 2011, HOSP DISCH DAT; Texas D., 2014, TEXAS MOTOR VEHICLE; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tieves Kelly S, 2005, WMJ, V104, P22; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; VINSON D, 2003, J STUD ALCOHOL, V64	42	2	2	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR 16	2021	35	5					554	562		10.1080/02699052.2021.1890822		MAR 2021	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RO8QM	WOS:000630930300001	33749412				2022-02-06	
J	Keenan, HT; Clark, AE; Holubkov, R; Cox, CS; Ewing-Cobbs, L				Keenan, Heather T.; Clark, Amy E.; Holubkov, Richard; Cox, Charles S., Jr.; Ewing-Cobbs, Linda			Trajectories of Children's Executive Function After Traumatic Brain Injury	JAMA NETWORK OPEN			English	Article							BEHAVIOR RATING INVENTORY; YOUNG-CHILDREN; ACADEMIC-ACHIEVEMENT; COGNITIVE PREDICTORS; SOCIAL COMPETENCE; RECOVERY; TBI; AGE	This cohort study uses data from pediatric trauma centers to assess the recovery of children's executive function after experiencing mild-to-severe traumatic brain injury. Question What is the 3-year trajectory of recovery of executive function after mild-to-severe traumatic brain injury in children? Findings In this longitudinal cohort study of 559 children with mild, moderate, or severe traumatic brain injury or orthopedic injury, patterns of recovery differed by injury severity, age at injury, and executive function assessed. Overall, growth curve models showed children's functioning worsening most sharply from baseline to 12 months; children with severe traumatic brain injury showed a secondary worsening between 24 and 36 months on some subscales. Meaning Results suggest that changes in the recovery of children's executive function over time will require repeated assessments in order to tailor interventions. Importance Executive functions are critical for school and social success. Although these functions are adversely affected by pediatric traumatic brain injury (TBI), recovery patterns are not well established. Objective To examine 3-year trajectories of selected children's executive functions after TBI. Design, Setting, and Participants This prospective cohort study was conducted from January 22, 2013, to September 30, 2015, with 3-year follow-up at the level I pediatric trauma centers Primary Children's Hospital in Salt Lake City, Utah and Children's Memorial Hermann Hospital in Houston, Texas. Study participants included children aged 2 to 15 years with TBI or orthopedic injury (OI) who were treated at the participating hospitals. Children were consecutively recruited and stratified by injury severity and age group. A total of 625 children consented and completed a baseline survey; 559 (89%) children completed at least 1 follow-up and composed the analysis cohort. It was hypothesized that recovery would differ by injury severity, age at injury, and sex. Data analyses were performed from June to October 2019. Main Outcomes and Measures Growth curve models examined the pattern of change in the Emotional Control, Inhibit, Working Memory, and Plan-Organize subscales of the Behavior Rating Inventory of Executive Function (BRIEF) or BRIEF-Preschool. For all BRIEF subscales, higher scores indicate worse symptoms, and a score of 65 or greater represents clinical impairment. Results A total of 559 children (mean [SD] age, 8.6 [4.4] years; 356 boys [64%], 328 non-Hispanic White children [59%]) were included in the study: 155 (28%) children had mild TBI, 162 (29%) had complicated mild or moderate TBI, 90 (16%) had severe TBI, and 152 (27%) had OI. Growth curve trajectories varied by BRIEF subscale and injury severity. Overall, children with TBI did not return to their preinjury baseline, with a stepwise worsening of each outcome at 36 months by TBI severity compared with OI. Among children with severe TBI, trajectories accelerated fastest, indicating increased problems, from injury to 12 months for the Emotional Control (9.0 points; 95% CI, 6.0-11.9 points), Inhibit (3.6 points; 95% CI, 1.6-5.6 points), and Working Memory (7.0 points; 95% CI, 4.1-9.9 points) subscales. Their trajectories plateaued, with a secondary acceleration before 36 months for the Emotional Control and Working Memory subscales. Children with mild TBI had worse 36-month scores on all subscales except Inhibit compared with OI. Recovery patterns were similar for boys and girls. Conclusions and Relevance In this longitudinal cohort study of children with TBI, trajectory analysis revealed that some children worsen after a recovery plateau, suggesting a need for longitudinal reassessment beyond 1 year postinjury.	[Keenan, Heather T.; Clark, Amy E.; Holubkov, Richard] Univ Utah, Dept Pediat, Div Crit Care, Salt Lake City, UT 84158 USA; [Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch Houston, Dept Pediat Surg, Houston, TX 77030 USA; [Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Pediat, Houston, TX 77030 USA; [Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Childrens Learning Inst, Houston, TX 77030 USA		Keenan, HT (corresponding author), Univ Utah, Dept Pediat, 295 Chipeta Way,POB 581289, Salt Lake City, UT 84158 USA.	heather.keenan@hsc.utah.edu			Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01/CE002188]; National Institute of Health/Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24HD072984]	This study was supported by grant U01/CE002188 from the Centers for Disease Control and Prevention under Cooperative Agreement (Drs Keenan and Ewing-Cobbs). This study was supported by grant K24HD072984 from the National Institute of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development (Dr Keenan).	Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V, 2017, J NEUROTRAUM, V34, P2261, DOI 10.1089/neu.2016.4692; Arnett AB, 2013, J INT NEUROPSYCH SOC, V19, P881, DOI 10.1017/S1355617713000635; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Casey BJ, 2015, ANNU REV PSYCHOL, V66, P295, DOI 10.1146/annurev-psych-010814-015156; Chavez-Arana C, 2018, J PEDIATR PSYCHOL, V43, P928, DOI 10.1093/jpepsy/jsy013; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Durber CM, 2017, NEUROPSYCHOLOGY, V31, P499, DOI 10.1037/neu0000351; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Faber J, 2016, BRAIN INJURY, V30, P1635, DOI 10.1080/02699052.2016.1199910; Fosco WD, 2019, J ADOLESCENCE, V76, P37, DOI 10.1016/j.adolescence.2019.08.008; Fulton JB, 2012, NEUROPSYCHOLOGY, V26, P314, DOI 10.1037/a0027973; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Gennarelli TA., 2008, ABBREVIATED INJURY S; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Grissom NM, 2019, NEUROPSYCHOPHARMACOL, V44, P86, DOI 10.1038/s41386-018-0179-5; Keenan HT, 2018, J NEUROTRAUM, V35, P286, DOI 10.1089/neu.2017.5265; Krasny-Pacini A, 2017, ANN PHYS REHABIL MED, V60, P74, DOI 10.1016/j.rehab.2016.06.001; Le Fur C, 2020, ANN PHYS REHABIL MED, V63, P270, DOI 10.1016/j.rehab.2019.09.003; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Morgan PL, 2019, CHILD DEV, V90, P1802, DOI 10.1111/cdev.13095; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Resch C, 2019, NEUROPSYCHOLOGIA, V124, P236, DOI 10.1016/j.neuropsychologia.2018.12.004; Romine CB, 2005, APPL NEUROPSYCHOL, V12, P190, DOI 10.1207/s15324826an1204_2; Runyan DK, 1998, PEDIATRICS, V101, P12, DOI 10.1542/peds.101.1.12; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; TEASDALE G, 1974, LANCET, V2, P81; Toplak ME, 2013, J CHILD PSYCHOL PSYC, V54, P131, DOI 10.1111/jcpp.12001; U.S. Department of Health & Human Services, POV GUID; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Zelazo PD., 2016, EXECUTIVE FUNCTION I	40	2	2	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2574-3805			JAMA NETW OPEN	JAMA Netw. Open	MAR 19	2021	4	3							e212624	10.1001/jamanetworkopen.2021.2624			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QZ1BO	WOS:000630470300005	33739432	Green Published, gold			2022-02-06	
J	Ko, IG; Jin, JJ; Hwang, L; Kim, SH; Kim, CJ; Jeon, JW; Chung, JY; Han, JH				Ko, Il-Gyu; Jin, Jun-Jang; Hwang, Lakkyong; Kim, Sang-Hoon; Kim, Chang-Ju; Jeon, Jung Won; Chung, Jun-Young; Han, Jin Hee			Adenosine A(2A) receptor agonist polydeoxyribonucleotide ameliorates short-term memory impairment by suppressing cerebral ischemia-induced inflammation via MAPK pathway	PLOS ONE			English	Article							EXERCISE IMPROVES MEMORY; TRAUMATIC BRAIN-INJURY; REPERFUSION INJURY; STROKE MECHANISMS; HYPOXIC-ISCHEMIA; DOWN-REGULATION; ACTIVATION; APOPTOSIS; POTENTIATION; HIPPOCAMPUS	Cerebral ischemia causes tissue death owing to occlusion of the cerebral blood vessels, and cerebral ischemia activates mitogen-activated protein kinase (MAPK) and induces secretion of pro-inflammatory cytokines. Adenosine A(2A) receptor agonist, polydeoxyribonucleotide (PDRN), suppresses the secretion of pro-inflammatory cytokines and exhibits anti-inflammatory effect. In the current study, the therapeutic effect of PDRN on cerebral ischemia was evaluated using gerbils. For the induction of cerebral ischemia, the common carotid arteries were exposed, and then aneurysm clips were used to occlude the common carotid arteries bilaterally for 7 minutes. In the PDRN-treated groups, the gerbils were injected intraperitoneally with 0.3 mL of saline containing 8 mg/kg PDRN, per a day for 7 days following cerebral ischemia induction. In order to confirm the participation of the adenosine A(2A) receptor in the effects mediated by PDRN, 8 mg/kg 7-dimethyl-1-propargylxanthine (DMPX), adenosine A(2A) receptor antagonist, was treated with PDRN. In the current study, induction of ischemia enhanced the levels of pro-inflammatory cytokines and increased phosphorylation of MAPK signaling factors in the hippocampus and basolateral amygdala. However, treatment with PDRN ameliorated short-term memory impairment by suppressing the production of pro-inflammatory cytokines and inactivation of MAPK signaling factors in cerebral ischemia. Furthermore, PDRN treatment enhanced the concentration of cyclic adenosine-3,5'-monophosphate (cAMP) as well as phosphorylation of cAMP response element-binding protein (p-CREB). Co-treatment of DMPX and PDRN attenuated the therapeutic effect of PDRN on cerebral ischemia. Based on these findings, PDRN may be developed as the primary treatment in cerebral ischemia.	[Ko, Il-Gyu; Jin, Jun-Jang; Hwang, Lakkyong; Kim, Sang-Hoon; Kim, Chang-Ju] Kyung Hee Univ, Dept Physiol, Coll Med, Seoul, South Korea; [Jeon, Jung Won] Kyung Hee Univ, Dept Internal Med, Kyung Hee Univ Hosp Gangdong, Coll Med, Seoul, South Korea; [Chung, Jun-Young] Kyung Hee Univ, Dept Anesthesiol & Pain Med, Kyung Hee Univ Hosp Gangdong, Coll Med, Seoul, South Korea; [Han, Jin Hee] Kyung Hee Univ, Dept Anesthesiol & Pain Med, Kyung Hee Med Ctr, Coll Med, Seoul, South Korea		Han, JH (corresponding author), Kyung Hee Univ, Dept Anesthesiol & Pain Med, Kyung Hee Med Ctr, Coll Med, Seoul, South Korea.	esthesi@khu.ac.kr	Kim, Chang-Ju/M-4216-2017	Kim, Chang-Ju/0000-0003-4749-5795; HAN, JIN-HEE/0000-0003-0399-1148; Hwang, Lakkyong/0000-0001-5173-1258	National Research Foundation of KoreaNational Research Foundation of Korea [NRF-2017R1D1A1B03032827]	Jin Hee Han NRF-2017R1D1A1B03032827 National Research Foundation of Korea Research fund support	Aden U, 2003, STROKE, V34, P739, DOI 10.1161/01.STR.0000060204.67672.8B; Ahmad M, 2010, TRANSL STROKE RES, V1, P74, DOI 10.1007/s12975-010-0023-7; An J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091847; Brea D, 2009, CEREBROVASC DIS, V27, P48, DOI 10.1159/000200441; Chen F, 2014, PROG NEUROBIOL, V115, P246, DOI 10.1016/j.pneurobio.2013.12.007; Chera S, 2011, DEV GROWTH DIFFER, V53, P186, DOI 10.1111/j.1440-169X.2011.01250.x; Cho CH, 2019, INT NEUROUROL J, V23, pS11, DOI 10.5213/inj.1938040.020; Cho JW, 2018, INT NEUROUROL J, V22, pS156, DOI 10.5213/inj.1836224.112; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Erfani S, 2015, NEUROPEPTIDES, V49, P63, DOI 10.1016/j.npep.2014.12.004; Fann DYW, 2018, MOL NEUROBIOL, V55, P1082, DOI 10.1007/s12035-017-0394-9; Fontinha BM, 2008, NEUROPHARMACOLOGY, V54, P924, DOI 10.1016/j.neuropharm.2008.01.011; Giambelluca MS, 2017, J LEUKOCYTE BIOL, V102, P829, DOI 10.1189/jlb.2VMA1216-517R; Hwang L, 2019, ANIM CELLS SYST, V23, P371, DOI 10.1080/19768354.2019.1688185; Jeon JW, 2014, ANIM CELLS SYST, V18, P399, DOI 10.1080/19768354.2014.983968; Jeon SJ, 2011, NEUROCHEM RES, V36, P2259, DOI 10.1007/s11064-011-0550-y; Jiang MJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0167-6; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Ko IG, 2019, J EXERC REHABIL, V15, P504, DOI 10.12965/jer.1938316.158; Ko IG, 2018, J EXERC REHABIL, V14, P327, DOI 10.12965/jer.1836248.124; Ko IG, 2018, LIFE SCI, V203, P12, DOI 10.1016/j.lfs.2018.04.009; Ko IG, 2009, PHARMACOL BIOCHEM BE, V91, P629, DOI 10.1016/j.pbb.2008.10.009; Kong LL, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-112; Kovalska M, 2012, NEUROCHEM RES, V37, P1568, DOI 10.1007/s11064-012-0752-y; Kwakkel G, 2004, RESTOR NEUROL NEUROS, V22, P281; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lambertsen KL, 2012, J CEREBR BLOOD F MET, V32, P1677, DOI 10.1038/jcbfm.2012.88; Lee JM, 2018, J EXERC REHABIL, V14, P713, DOI 10.12965/jer.36394.197; Lee SH, 2016, J EXERC REHABIL, V12, P69, DOI 10.12965/jer.1632586.293; Melani A, 2014, INT REV NEUROBIOL, V119, P309, DOI 10.1016/B978-0-12-801022-8.00013-1; Meng XB, 2018, MOLECULES, V23, DOI 10.3390/molecules23092401; Milne GR, 2011, THESCIENTIFICWORLDJO, V11, P320, DOI 10.1100/tsw.2011.22; Naderi Y, 2017, BEHAV PHARMACOL, V28, P214, DOI 10.1097/FBP.0000000000000297; Park JH, 2016, INT NEUROUROL J, V20, P107, DOI 10.5213/inj.1632532.266; Pedata F, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/805198; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Shin MS, 2019, INT NEUROUROL J, V23, P116, DOI 10.5213/inj.1938103.052; Tebano MT, 2008, J NEUROCHEM, V104, P279, DOI 10.1111/j.1471-4159.2007.05046.x; Wang T, 2019, AM J TRANSL RES, V11, P5967; Yang CH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081638; Yoon S, 2019, ANN REHABIL MED-ARM, V43, P204, DOI 10.5535/arm.2019.43.2.204; Zamani M, 2013, J Neurosci Rural Pract, V4, P164, DOI 10.4103/0976-3147.112753; Zhou YQ, 2019, BRIT J PHARMACOL, V176, P2250, DOI 10.1111/bph.14673	43	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248689	10.1371/journal.pone.0248689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	WOS:000631029700028	33735236	Green Published, gold			2022-02-06	
J	Richter, S; Winzeck, S; Kornaropoulos, EN; Das, T; Vande Vyvere, T; Verheyden, J; Williams, GB; Correia, MM; Menon, DK; Newcombe, VFJ				Richter, Sophie; Winzeck, Stefan; Kornaropoulos, Evgenios N.; Das, Tilak; Vande Vyvere, Thijs; Verheyden, Jan; Williams, Guy B.; Correia, Marta M.; Menon, David K.; Newcombe, Virginia F. J.		Collaborative European NeuroTrauma	Neuroanatomical Substrates and Symptoms Associated With Magnetic Resonance Imaging of Patients With Mild Traumatic Brain Injury	JAMA NETWORK OPEN			English	Article							DIFFUSION TENSOR; OUTCOME PREDICTION; CENTER-TBI; MRI; CONCUSSION; TISSUE; CARE	This multicenter cohort study assesses neuroanatomical substrates in patients with mild traumatic brain injury and the optimal timing for magnetic resonance imaging. Question What neuroanatomical changes are associated with symptoms after mild traumatic brain injury (mTBI), and when is the optimal time for acute imaging? Findings In this multicenter cohort study, 81 patients with mTBI underwent advanced magnetic resonance imaging within 72 hours and 2 to 3 weeks after injury. White matter volume and integrity evolved during that window in tandem with symptoms and were most closely associated with clinical recovery if imaging was performed within 72 hours. Meaning These findings suggest that white matter injury is associated with symptoms after mTBI and could, if detected early, help select patients at risk of poor outcome for clinical follow-up or interventional trials. Importance Persistent symptoms after mild traumatic brain injury (mTBI) represent a major public health problem. Objective To identify neuroanatomical substrates of mTBI and the optimal timing for magnetic resonance imaging (MRI). Design, Setting, and Participants This prospective multicenter cohort study encompassed all eligible patients from the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study (December 19, 2014, to December 17, 2017) and a local cohort (November 20, 2012, to December 19, 2013). Patients presented to the hospital within 24 hours of an mTBI (Glasgow Coma Score, 13-15), satisfied local criteria for computed tomographic scanning, and underwent MRI scanning less than 72 hours (MR1) and 2 to 3 weeks (MR2) after injury. In addition, 104 control participants were enrolled across all sites. Data were analyzed from January 1, 2019, to December 31, 2020. Exposure Mild TBI. Main Outcomes and Measures Volumes and diffusion parameters were extracted via automated bespoke pipelines. Symptoms were measured using the Rivermead Post Concussion Symptoms Questionnaire in the short term and the extended Glasgow Outcome Scale at 3 months. Results Among the 81 patients included in the analysis (73 CENTER-TBI and 8 local), the median age was 45 (interquartile range [IQR], 24-59; range, 14-85) years, and 57 (70.4%) were male. Structural sequences were available for all scans; diffusion data, for 73 MR1 and 79 MR2 scans. After adjustment for multiple comparisons between scans, visible lesions did not differ significantly, but cerebral white matter volume decreased (MR2:MR1 ratio, 0.98; 95% CI, 0.96-0.99) and ventricular volume increased (MR2:MR1 ratio, 1.06; 95% CI, 1.02-1.10). White matter volume was within reference limits on MR1 scans (patient to control ratio, 0.99; 95% CI, 0.97-1.01) and reduced on MR2 scans (patient to control ratio, 0.97; 95% CI, 0.95-0.99). Diffusion parameters changed significantly between scans in 13 tracts, following 1 of 3 trajectories. Symptoms measured by Rivermead Post Concussion Symptoms Questionnaire scores worsened in the progressive injury phenotype (median, +5.00; IQR, +2.00 to +5.00]), improved in the minimal change phenotype (median, -4.50; IQR, -9.25 to +1.75), and were variable in the pseudonormalization phenotype (median, 0.00; IQR, -6.25 to +9.00) (P = .02). Recovery was favorable for 33 of 65 patients (51%) and was more closely associated with MR1 than MR2 (area under the curve, 0.87 [95% CI, 0.78-0.96] vs 0.75 [95% CI, 0.62-0.87]; P = .009). Conclusions and Relevance These findings suggest that advanced MRI reveals potential neuroanatomical substrates of mTBI in white matter and is most strongly associated with odds of recovery if performed within 72 hours, although future validation is required.	[Richter, Sophie; Winzeck, Stefan; Kornaropoulos, Evgenios N.; Menon, David K.; Newcombe, Virginia F. J.] Univ Cambridge, Univ Div Anaesthesia, Addenbrookes Hosp, Dept Med, Hills Rd,POB 93, Cambridge CB2 0QQ, England; [Winzeck, Stefan] Imperial Coll London, Dept Comp, BioMedIA, London, England; [Das, Tilak] Addenbrookes Hosp, Dept Radiol, Cambridge, England; [Vande Vyvere, Thijs] Univ Hosp, Dept Radiol, Antwerp, Belgium; [Vande Vyvere, Thijs] Univ Antwerp, Antwerp, Belgium; [Vande Vyvere, Thijs; Verheyden, Jan] Icometrix, Res & Dev, Leuven, Belgium; [Williams, Guy B.] Univ Cambridge, Wolfson Brain Imaging Ctr, Dept Clin Neurosci, Cambridge, England; [Correia, Marta M.] Univ Cambridge, MRC Med Res Council, Cognit & Brain Sci Unit, Cambridge, England		Richter, S (corresponding author), Univ Cambridge, Univ Div Anaesthesia, Addenbrookes Hosp, Dept Med, Hills Rd,POB 93, Cambridge CB2 0QQ, England.		Vande Vyvere, Thijs/AAB-5180-2022; Posti, Jussi P./Y-2908-2019	Vande Vyvere, Thijs/0000-0003-4032-5443; Posti, Jussi P./0000-0002-5925-5193; Takala, Riikka/0000-0001-6342-0043; Richter, Sophie/0000-0003-3272-484X; Das, Tilak/0000-0003-0655-412X	European Commission from the European Union 7th Framework program [602150]; Hannelore Kohl Stiftung; NeuroTrauma Sciences, LLC; Integra Neurosciences; European Union 7th Framework programEuropean Commission [FP7-270259-TBIcare]; NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); NIHR Cambridge Clinical Research FacilityGeneral Electric; Cambridge University Hospitals NHS (National Health Service) Foundation Trust; University of Cambridge - NIHR; Wellcome Trust PhD FellowshipWellcome Trust; NIHR Senior Investigator Award; Academy of Medical Sciences/The Health Foundation (UK)	The Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) was supported by European Commission grant 602150 from the European Union 7th Framework program, the Hannelore Kohl Stiftung, NeuroTrauma Sciences, LLC, and Integra Neurosciences. Cambridge data collection was supported in part by grant FP7-270259-TBIcare from the European Union 7th Framework program. Both studieswere supported by infrastructure provided by the NIHR Cambridge Biomedical Research Centre and the NIHR Cambridge Clinical Research Facility, which is a partnership between Cambridge University Hospitals NHS (National Health Service) Foundation Trust and the University of Cambridge, funded by the NIHR; by aWellcome Trust PhD Fellowship (Dr Richter); by an NIHR Senior Investigator Award (Dr Menon); and by the Academy of Medical Sciences/The Health Foundation (UK) (Dr Newcombe).	Aitchison J, 2005, 2 COMP DAT AN WORKSH; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Benjamini Y., 1995, J ROY STAT SOC, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Einarsen CE, 2019, J NEUROTRAUM, V36, P3172, DOI 10.1089/neu.2018.6360; Grover H, 2018, AM J NEURORADIOL, V39, P2200, DOI 10.3174/ajnr.A5903; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hunter LE, 2019, J NEUROTRAUM, V36, P1222, DOI 10.1089/neu.2018.5838; Hutchinson EB, 2018, J NEUROSCI RES, V96, P612, DOI 10.1002/jnr.24065; Jeurissen B, 2014, NEUROIMAGE, V103, P411, DOI 10.1016/j.neuroimage.2014.07.061; Karlsen RH, 2019, J NEUROSCI RES, V97, P568, DOI 10.1002/jnr.24383; Kassambara A., 2018, DATANOVIA; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Korley FK, 2019, ACAD EMERG MED, DOI 10.1111/acem.13844; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Ledig C, 2015, MED IMAGE ANAL, V21, P40, DOI 10.1016/j.media.2014.12.003; Lunter CM, 2019, EMERG MED AUSTRALAS, V31, P355, DOI 10.1111/1742-6723.13163; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Manjon JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073021; Mikolic A, 2021, J NEUROTRAUM, V38, P196, DOI 10.1089/neu.2020.7074; Mustafi SM, 2018, J NEUROTRAUM, V35, P2653, DOI 10.1089/neu.2017.5158; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Newcombe VFJ, 2016, NEUROREHAB NEURAL RE, V30, P49, DOI 10.1177/1545968315584004; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Reuben A, 2014, EMERG MED J, V31, P72, DOI 10.1136/emermed-2012-201667; Richter S, 2019, J NEUROTRAUM, V36, P2743, DOI 10.1089/neu.2018.6216; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Theadom A, 2017, ARCH PHYS MED REHAB, V98, P1560, DOI 10.1016/j.apmr.2017.01.010; Thomas AW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178360; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Vande Vyvere T, 2019, J NEUROTRAUM, V36, P1080, DOI 10.1089/neu.2018.6061; Veenith TV, 2014, J CEREBR BLOOD F MET, V34, P1622, DOI 10.1038/jcbfm.2014.123; Veenith TV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065941; Veraart J, 2016, NEUROIMAGE, V142, P384, DOI 10.1016/j.neuroimage.2016.08.016; Veraart J, 2016, MAGN RESON MED, V76, P301, DOI 10.1002/mrm.25866; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Wang ZN, 2021, J NEUROTRAUM, V38, P464, DOI 10.1089/neu.2018.6196; Wasserthal J, 2018, NEUROIMAGE, V183, P239, DOI 10.1016/j.neuroimage.2018.07.070; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yin B, 2019, FRONT NEURAL CIRCUIT, V13, DOI 10.3389/fncir.2019.00028; Yue JK, 2018, NEUROL RES, V40, P972, DOI 10.1080/01616412.2018.1505416; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	49	2	2	2	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2574-3805			JAMA NETW OPEN	JAMA Netw. Open	MAR 18	2021	4	3							e210994	10.1001/jamanetworkopen.2021.0994			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QZ1AR	WOS:000630467900002	33734414	gold, Green Published			2022-02-06	
J	Grassner, L; Petr, O; Warner, FM; Dedeciusova, M; Mathis, AM; Pinggera, D; Gsellmann, S; Meiners, LC; Freigang, S; Mokry, M; Resch, A; Kretschmer, T; Rossmann, T; Navarro, FR; Gruber, A; Spendel, M; Winkler, PA; Marhold, F; Sherif, C; Wais, JP; Rossler, K; Pfisterer, W; Muhlbauer, M; Trivik-Barrientos, FA; Rath, S; Voldrich, R; Krska, L; Lipina, R; Kerekanic, M; Fiedler, J; Kasik, P; Priban, V; Tichy, M; Krupa, P; Cesak, T; Kroupa, R; Callo, A; Haninec, P; Pohlodek, D; Krahulik, D; Sejkorova, A; Sames, M; Dvorak, J; Suchomel, P; Tomas, R; Klener, J; Juran, V; Smrcka, M; Linzer, P; Kaiser, M; Hrabovsky, D; Jancalek, R; Kalin, V; Bozinov, O; Niggli, C; Serra, C; Guatta, R; Kuhlen, DE; Wanderer, S; Marbacher, S; Lave, A; Schaller, K; Esculier, C; Raabe, A; Kramer, JLK; Thome, C; Netuka, D				Grassner, Lukas; Petr, Ondra; Warner, Freda M.; Dedeciusova, Michaela; Mathis, Andrea Maria; Pinggera, Daniel; Gsellmann, Sina; Meiners, Laura C.; Freigang, Sascha; Mokry, Michael; Resch, Alexandra; Kretschmer, Thomas; Rossmann, Tobias; Navarro, Francisco Ruiz; Gruber, Andreas; Spendel, Mathias; Winkler, Peter A.; Marhold, Franz; Sherif, Camillo; Wais, Jonathan P.; Roessler, Karl; Pfisterer, Wolfgang; Muehlbauer, Manfred; Trivik-Barrientos, Felipe A.; Rath, Sebastian; Voldrich, Richard; Krska, Lukas; Lipina, Radim; Kerekanic, Martin; Fiedler, Jiri; Kasik, Petr; Priban, Vladimir; Tichy, Michal; Krupa, Petr; Cesak, Tomas; Kroupa, Robert; Callo, Andrej; Haninec, Pavel; Pohlodek, Daniel; Krahulik, David; Sejkorova, Alena; Sames, Martin; Dvorak, Josef; Suchomel, Petr; Tomas, Robert; Klener, Jan; Juran, Vilem; Smrcka, Martin; Linzer, Petr; Kaiser, Miroslav; Hrabovsky, Dusan; Jancalek, Radim; Kaelin, Vincens; Bozinov, Oliver; Niggli, Cedric; Serra, Carlo; Guatta, Ramona; Kuhlen, Dominique E.; Wanderer, Stefan; Marbacher, Serge; Lave, Alexandre; Schaller, Karl; Esculier, Clarinde; Raabe, Andreas; Kramer, John L. K.; Thome, Claudius; Netuka, David			Trends and outcomes for non-elective neurosurgical procedures in Central Europe during the COVID-19 pandemic	SCIENTIFIC REPORTS			English	Article								The world currently faces the novel severe acute respiratory syndrome coronavirus 2 pandemic. Little is known about the effects of a pandemic on non-elective neurosurgical practices, which have continued under modified conditions to reduce the spread of COVID-19. This knowledge might be critical for the ongoing second coronavirus wave and potential restrictions on health care. We aimed to determine the incidence and 30-day mortality rate of various non-elective neurosurgical procedures during the COVID-19 pandemic. A retrospective, multi-centre observational cohort study among neurosurgical centres within Austria, the Czech Republic, and Switzerland was performed. Incidence of neurosurgical emergencies and related 30-day mortality rates were determined for a period reflecting the peak pandemic of the first wave in all participating countries (i.e. March 16th-April 15th, 2020), and compared to the same period in prior years (2017, 2018, and 2019). A total of 4,752 emergency neurosurgical cases were reviewed over a 4-year period. In 2020, during the COVID-19 pandemic, there was a general decline in the incidence of non-elective neurosurgical cases, which was driven by a reduced number of traumatic brain injuries, spine conditions, and chronic subdural hematomas. Thirty-day mortality did not significantly increase overall or for any of the conditions examined during the peak of the pandemic. The neurosurgical community in these three European countries observed a decrease in the incidence of some neurosurgical emergencies with 30-day mortality rates comparable to previous years (2017-2019). Lower incidence of neurosurgical cases is likely related to restrictions placed on mobility within countries, but may also involve delayed patient presentation.	[Grassner, Lukas; Petr, Ondra; Pinggera, Daniel; Thome, Claudius] Med Univ Innsbruck, Dept Neurosurg, Anichstr 35,MZA 3rd Floor, A-6020 Innsbruck, Austria; [Warner, Freda M.; Kramer, John L. K.] Univ British Columbia, Int Collaborat Repair Discoveries ICORD, Vancouver, BC, Canada; [Dedeciusova, Michaela; Voldrich, Richard; Netuka, David] Charles Univ Prague, Cent Mil Hosp, Med Fac 1, Dept Neurosurg & Neuro Oncol, Prague, Czech Republic; [Mathis, Andrea Maria; Esculier, Clarinde; Raabe, Andreas] Bern Univ Hosp, Dept Neurosurg, Inselspital Bern, Bern, Switzerland; [Gsellmann, Sina; Meiners, Laura C.] Landeskrankenhaus Feldkirch, Dept Neurosurg, Feldkirch, Austria; [Freigang, Sascha; Mokry, Michael] Med Univ Graz, Dept Neurosurg, Graz, Austria; [Resch, Alexandra; Kretschmer, Thomas] Klinikum Klagenfurt, Dept Neurosurg & Neurorestaurat, Klagenfurt, Austria; [Rossmann, Tobias; Navarro, Francisco Ruiz; Gruber, Andreas] Kepler Univ Hosp GmbH, Johannes Kepler Univ, Dept Neurosurg, Linz, Austria; [Spendel, Mathias; Winkler, Peter A.] Paracelsus Med Univ, Dept Neurosurg, Christian Doppler Clin, Salzburg, Austria; [Marhold, Franz; Sherif, Camillo] Karl Landsteiner Univ Hlth Sci, Univ Hosp St, Dept Neurosurg, St Polten, Austria; [Wais, Jonathan P.; Roessler, Karl] Med Univ Vienna, Dept Neurosurg, Vienna, Austria; [Pfisterer, Wolfgang; Muehlbauer, Manfred] Klin Donaustadt, Dept Neurosurg, Vienna, Austria; [Trivik-Barrientos, Felipe A.; Rath, Sebastian] Wiener Neustadt Gen Hosp, Dept Neurosurg, Wiener Neustadt, Austria; [Krska, Lukas; Lipina, Radim] Univ Hosp Ostrava, Dept Neurosurg, Ostrava, Czech Republic; [Kerekanic, Martin; Fiedler, Jiri] Ceske Budejovice Hosp, Dept Neurosurg, Ceske Budejovice, Czech Republic; [Kasik, Petr; Priban, Vladimir] Pilsen Univ Hosp, Dept Neurosurg, Motol, Czech Republic; [Tichy, Michal] Motol Univ Hosp, Dept Neurosurg, Motol, Czech Republic; [Krupa, Petr; Cesak, Tomas] Univ Hosp Hradec Kralove, Dept Neurosurg, Hradec Kralove, Czech Republic; [Kroupa, Robert] Municipal Hosp Ostrava Fifejdy, Unit Neurosurg, Ostrava Fifejdy, Czech Republic; [Callo, Andrej; Haninec, Pavel] Univ Hosp Kralovske Vinohrady, Dept Neurosurg, Prague, Czech Republic; [Pohlodek, Daniel; Krahulik, David] Univ Hosp Olomouc, Dept Neurosurg, Olomouc, Czech Republic; [Sejkorova, Alena; Sames, Martin] Usti Labem Hosp, Dept Neurosurg, Prague, Czech Republic; [Dvorak, Josef; Suchomel, Petr] Liberec Hosp, Dept Neurosurg, Prague, Czech Republic; [Tomas, Robert; Klener, Jan] Homolka Hosp, Unit Neurosurg, Prague, Czech Republic; [Juran, Vilem; Smrcka, Martin] Univ Hosp Brno, Dept Neurosurg, Prague, Czech Republic; [Juran, Vilem; Smrcka, Martin; Hrabovsky, Dusan; Jancalek, Radim] Masaryk Univ, Prague, Czech Republic; [Linzer, Petr] Zlin Hosp, Unit Neurosurg, Prague, Czech Republic; [Kaiser, Miroslav] Pardubice Hosp, Unit Neurosurg, Prague, Czech Republic; [Hrabovsky, Dusan; Jancalek, Radim] St Annes Univ Hosp Brno, Dept Neurosurg, Prague, Czech Republic; [Kaelin, Vincens; Bozinov, Oliver] Kantonspital, Dept Neurosurg, St Gallen, Switzerland; [Niggli, Cedric; Serra, Carlo] Univ Zurich Hosp, Clin Neurosci Ctr, Dept Neurosurg, Zurich, Switzerland; [Guatta, Ramona; Kuhlen, Dominique E.] Neuroctr Southern Switzerland, Clin Neurosurg, Lugano, Switzerland; [Wanderer, Stefan; Marbacher, Serge] Kantonspital Aarau, Dept Neurosurg, Aarau, Switzerland; [Lave, Alexandre; Schaller, Karl] Geneva Univ Hosp, Dept Neurosurg, Geneva, Switzerland		Grassner, L (corresponding author), Med Univ Innsbruck, Dept Neurosurg, Anichstr 35,MZA 3rd Floor, A-6020 Innsbruck, Austria.	Lukas.grassner@googlemail.com	Jancalek, Radim/AAP-9193-2020; Smrcka, Martin/AAM-8872-2021; Marbacher, Serge/E-7784-2013; serra, carlo/AAB-8742-2022; Kretschmer, Thomas/AAW-1331-2020	Jancalek, Radim/0000-0001-6834-6567; Smrcka, Martin/0000-0002-9191-8700; Marbacher, Serge/0000-0001-6305-7571; serra, carlo/0000-0002-7305-550X; Kretschmer, Thomas/0000-0002-0419-6720; fiedler, jiri/0000-0001-7886-6021; Marhold, Franz/0000-0001-8338-8060; Tomas, Robert/0000-0001-6619-9938			Aminian A, 2020, ANN SURG, V272, pE27, DOI 10.1097/SLA.0000000000003925; Arnaout O, 2020, NEUROSURGERY, V87, pE173, DOI 10.1093/neuros/nyaa146; Beyrouti R, 2020, J NEUROL NEUROSUR PS, V91, P889, DOI 10.1136/jnnp-2020-323586; BRINDLE M, 2020, LIEBIGS ANN CHEM, DOI DOI 10.1097/SLA.0000000000003992; Bryan AF, 2020, ANN SURG, V272, pE161, DOI 10.1097/SLA.0000000000003995; Carrabba G, 2020, LANCET, V395, pE76, DOI 10.1016/S0140-6736(20)30927-2; Chen R, 2020, CAN J ANESTH, V67, P655, DOI 10.1007/s12630-020-01630-7; COVIDSurg Collaborative, 2020, BRIT J SURG, V107, P1097, DOI 10.1002/bjs.11646; De Filippo O, 2020, NEW ENGL J MED, V383, P88, DOI 10.1056/NEJMc2009166; Germano A, 2020, WORLD NEUROSURG, V139, pE812, DOI 10.1016/j.wneu.2020.04.181; Iacobucci G, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1106; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jarman MP, 2020, ANN SURG, V272, pE226, DOI 10.1097/SLA.0000000000004126; Jean WC, 2020, ACTA NEUROCHIR, V162, P1229, DOI 10.1007/s00701-020-04342-5; Jindal V, 2020, MED ONCOL, V37, DOI 10.1007/s12032-020-01382-w; Lei SQ, 2020, ECLINICALMEDICINE, V21, DOI 10.1016/j.eclinm.2020.100331; Leung K, 2020, LANCET, V395, P1382, DOI 10.1016/S0140-6736(20)30746-7; Lin EE, 2020, JAMA SURG, V155, P775, DOI 10.1001/jamasurg.2020.2588; Liu KM, 2020, J NEUROL NEUROSUR PS, V91, P669, DOI 10.1136/jnnp-2020-323177; Livingston EH, 2020, JAMA-J AM MED ASSOC, V323, P2254, DOI 10.1001/jama.2020.7903; Lurie N, 2020, NEW ENGL J MED, V382, P1969, DOI 10.1056/NEJMp2005630; Muhammad S, 2020, NEUROSURGERY, V87, pE220, DOI 10.1093/neuros/nyaa184; Panciani PP, 2020, NEUROSURGERY, V87, pE167, DOI 10.1093/neuros/nyaa140; Pearce N, 2020, INT J EPIDEMIOL, V49, P1059, DOI 10.1093/ije/dyaa108; Perin A, 2020, J NEURO-ONCOL, V148, P203, DOI 10.1007/s11060-020-03496-7; PINGGERA D, 2020, EUR, DOI DOI 10.1007/s00068-020-01445-7; Placella G, 2020, INJURY, V51, P1403, DOI 10.1016/j.injury.2020.04.012; Pleasure SJ, 2020, JAMA NEUROL, V77, P679, DOI 10.1001/jamaneurol.2020.1065; ROBINSON RG, 1984, J NEUROSURG, V61, P263, DOI 10.3171/jns.1984.61.2.0263; Ross SW, 2020, J AM COLL SURGEONS, V230, P1080, DOI 10.1016/j.jamcollsurg.2020.03.019; Service BC, 2020, J BONE JOINT SURG AM, V102, DOI 10.2106/JBJS.20.00599; Subramaniam A, 2020, INDIAN J CRIT CARE M, V24, P926, DOI 10.5005/jp-journals-10071-23640; Tsermoulas G, 2020, WORLD NEUROSURG, V139, P519, DOI 10.1016/j.wneu.2020.05.108; Zhong Q, 2020, BRIT J ANAESTH, V124, P670, DOI 10.1016/j.bja.2020.03.007; Zoia C, 2020, ACTA NEUROCHIR, V162, P1221, DOI 10.1007/s00701-020-04305-w; Zubair AS, 2020, JAMA NEUROL, V77, P1018, DOI 10.1001/jamaneurol.2020.2065	36	2	2	2	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	MAR 17	2021	11	1							6171	10.1038/s41598-021-85526-6			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ1RI	WOS:000630511700015	33731753	Green Published, gold			2022-02-06	
J	Sharma, R; Zamani, A; Dill, LK; Sun, M; Chu, E; Robinson, MJ; O'Brien, TJ; Shultz, SR; Semple, BD				Sharma, Rishabh; Zamani, Akram; Dill, Larissa K.; Sun, Mujun; Chu, Erskine; Robinson, Marcus J.; O'Brien, Terence J.; Shultz, Sandy R.; Semple, Bridgette D.			A systemic immune challenge to model hospital-acquired infections independently regulates immune responses after pediatric traumatic brain injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Traumatic brain injury; Infection; Lipopolysaccharide; Inflammation; Sickness behavior; Neurotrauma; Pediatric; Juvenile; Immune responses		BackgroundTraumatic brain injury (TBI) is a major cause of disability in young children, yet the factors contributing to poor outcomes in this population are not well understood. TBI patients are highly susceptible to nosocomial infections, which are mostly acquired within the first week of hospitalization, and such infections may modify TBI pathobiology and recovery. In this study, we hypothesized that a peripheral immune challenge such as lipopolysaccharide (LPS)-mimicking a hospital-acquired infection-would worsen outcomes after experimental pediatric TBI, by perpetuating the inflammatory immune response.MethodsThree-week-old male mice received either a moderate controlled cortical impact or sham surgery, followed by a single LPS dose (1 mg/kg i.p.) or vehicle (0.9% saline) at 4 days post-surgery, then analysis at 5 or 8 days post-injury (i.e., 1 or 4 days post-LPS).ResultsLPS-treated mice exhibited a time-dependent reduction in general activity and social investigation, and increased anxiety, alongside substantial body weight loss, indicating transient sickness behaviors. Spleen-to-body weight ratios were also increased in LPS-treated mice, indicative of persistent activation of adaptive immunity at 4 days post-LPS. TBI + LPS mice showed an impaired trajectory of weight gain post-LPS, reflecting a synergistic effect of TBI and the LPS-induced immune challenge. Flow cytometry analysis demonstrated innate immune cell activation in blood, brain, and spleen post-LPS; however, this was not potentiated by TBI. Cytokine protein levels in serum, and gene expression levels in the brain, were altered in response to LPS but not TBI across the time course. Immunofluorescence analysis of brain sections revealed increased glia reactivity due to injury, but no additive effect of LPS was observed.ConclusionsTogether, we found that a transient, infection-like systemic challenge had widespread effects on the brain and immune system, but these were not synergistic with prior TBI in pediatric mice. These findings provide novel insight into the potential influence of a secondary immune challenge to the injured pediatric brain, with future studies needed to elucidate the chronic effects of this two-hit insult.	[Sharma, Rishabh; Zamani, Akram; Dill, Larissa K.; Sun, Mujun; Chu, Erskine; O'Brien, Terence J.; Shultz, Sandy R.; Semple, Bridgette D.] Monash Univ, Alfred Ctr, Cent Clin Sch, Dept Neurosci, Level 6,99 Commercial Rd, Melbourne, Vic 3004, Australia; [Dill, Larissa K.; O'Brien, Terence J.; Shultz, Sandy R.; Semple, Bridgette D.] Alfred Hlth, Dept Neurol, Prahran, Vic, Australia; [Robinson, Marcus J.] Monash Univ, Dept Immunol & Pathol, Cent Clin Sch, Melbourne, Vic, Australia; [O'Brien, Terence J.; Shultz, Sandy R.; Semple, Bridgette D.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia		Semple, BD (corresponding author), Monash Univ, Alfred Ctr, Cent Clin Sch, Dept Neurosci, Level 6,99 Commercial Rd, Melbourne, Vic 3004, Australia.; Semple, BD (corresponding author), Alfred Hlth, Dept Neurol, Prahran, Vic, Australia.	Bridgette.Semple@monash.edu	O'Brien, Terence/L-8102-2013; O'Brien, Terence/AAU-5525-2021	Sharma, Rishabh/0000-0001-6832-9468; Sun, Mujun/0000-0002-9923-9913; O'Brien, Terence/0000-0002-7198-8621	National Health and Medical Research Council of Australia (NHMRC)National Health and Medical Research Council of Australia; Monash UniversityMonash University	This study was supported by funding from the National Health and Medical Research Council of Australia (NHMRC) in the form of fellowships to BDS, SRS, and TOB, with additional funding provided by Monash University.	Abdullah A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1354-7; Alharfi IM, 2014, J NEUROTRAUM, V31, P452, DOI [10.1089/neu.2013.2904, 10.1089/NEU.2013.2904]; Aly NYA, 2008, MED PRIN PRACT, V17, P373, DOI 10.1159/000141500; Anderson CV, 1996, J NEUROTRAUM, V13, P35, DOI 10.1089/neu.1996.13.35; Andraweera N, 2016, AUST HEALTH REV, V40, P114, DOI 10.1071/AH15062; Bang Jin Hyuk, 2015, Korean J Neurotrauma, V11, P81, DOI 10.13004/kjnt.2015.11.2.81; Barrett JP, 2020, J NEUROSCI, V40, P2357, DOI 10.1523/JNEUROSCI.2516-19.2020; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Berg BM, 2004, BRAIN BEHAV IMMUN, V18, P149, DOI 10.1016/S0889-1591(03)00113-2; Bian YQ, 2013, BEHAV BRAIN RES, V253, P253, DOI 10.1016/j.bbr.2013.07.028; Biesmans S, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/271359; Bubalo N, 2014, FASEB J, V28; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Campos-Pires R, 2019, BRIT J ANAESTH, V123, P60, DOI 10.1016/j.bja.2019.02.032; Cazareth J, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-132; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Corrigan F, 2017, BRAIN BEHAV IMMUN, V64, P124, DOI 10.1016/j.bbi.2017.04.006; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; DeMaster D, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.832; Denes A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-164; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Dziedzic T, 2004, CRIT CARE, V8, P266, DOI 10.1186/cc2828; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Fu HQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106331; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Glance LG, 2011, ARCH SURG-CHICAGO, V146, P794, DOI 10.1001/archsurg.2011.41; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; Hambleton J, 1996, P NATL ACAD SCI USA, V93, P2774, DOI 10.1073/pnas.93.7.2774; Hamele M, 2016, J NEUROTRAUM, V33, P832, DOI 10.1089/neu.2015.4004; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; Henry CJ, 2009, BRAIN BEHAV IMMUN, V23, P309, DOI 10.1016/j.bbi.2008.09.002; Henry CJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-15; Henry RJ, 2020, J NEUROSCI, V40, P2960, DOI 10.1523/JNEUROSCI.2402-19.2020; Hoogland ICM, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00110; Hoogland ICM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0332-6; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Izzy S, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00307; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; KENT S, 1992, TRENDS PHARMACOL SCI, V13, P24, DOI 10.1016/0165-6147(92)90012-U; Kim KK, 2013, ENDOCRINOL METAB, V28, P214, DOI 10.3803/EnM.2013.28.3.214; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; Kourbeti IS, 2011, BRIT J NEUROSURG, V25, P9, DOI 10.3109/02688697.2010.500411; Liao CC, 2014, MAYO CLIN PROC, V89, P163, DOI 10.1016/j.mayocp.2013.09.019; Lindsey HM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01296; Liu ZJ, 2015, CNS NEUROSCI THER, V21, P320, DOI 10.1111/cns.12361; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Makinde HM, 2017, J IMMUNOL, V199, P3583, DOI 10.4049/jimmunol.1700896; Malaeb SN, 2014, PEDIATR RES, V76, P363, DOI 10.1038/pr.2014.106; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Mishra SK, 2017, MOL CELL NEUROSCI, V78, P25, DOI 10.1016/j.mcn.2016.11.008; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Norden DM, 2016, GLIA, V64, P300, DOI 10.1002/glia.22930; Pandya A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28189-0; Pennypacker KR, 2015, J CEREBR BLOOD F MET, V35, P186, DOI 10.1038/jcbfm.2014.212; Potts Mathew B, 2006, NeuroRx, V3, P143; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Ritzel RM, 2018, J NEUROTRAUM, V35, P1419, DOI 10.1089/neu.2017.5399; Robinson MJ, 2020, CELL REP, V30, P1530, DOI 10.1016/j.celrep.2020.01.009; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Seifert HA, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1239-9; Semple BD, 2017, J NEUROSCI, V37, P7864, DOI 10.1523/JNEUROSCI.0982-17.2017; Semple BD, 2017, BEHAV BRAIN RES, V319, P48, DOI 10.1016/j.bbr.2016.10.045; Semple BD, 2016, METHODS MOL BIOL, V1462, P325, DOI 10.1007/978-1-4939-3816-2_18; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Sharma R, 2019, BRAIN BEHAV IMMUN, V79, P63, DOI 10.1016/j.bbi.2019.04.034; Shen Y, 2016, J CELL BIOL, V215, P719, DOI 10.1083/jcb.201605046; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shuman EK, 2018, INFECT DIS CLIN N AM, V32, P885, DOI 10.1016/j.idc.2018.07.002; Sun MJ, 2018, BRAIN BEHAV IMMUN, V69, P618, DOI 10.1016/j.bbi.2018.01.007; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; Takashiba S, 1999, INFECT IMMUN, V67, P5573, DOI 10.1128/IAI.67.11.5573-5578.1999; Tateda K, 1996, INFECT IMMUN, V64, P769, DOI 10.1128/IAI.64.3.769-774.1996; Thompson WL, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-35; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Valencic L., 2015, SANAMED, V10, P185, DOI [10.5937/sanamed1503185V, DOI 10.5937/SANAMED1503185V]; Vezzani A, 2016, ACTA NEUROPATHOL, V131, P211, DOI 10.1007/s00401-015-1481-5; Walsh S, 2017, NEUROTOXICOLOGY, V61, P64, DOI 10.1016/j.neuro.2016.03.011; Wang KC, 2013, NEUROSCIENCE, V234, P146, DOI 10.1016/j.neuroscience.2012.12.049; Wang YB, 2018, J NEUROTRAUM, V35, P105, DOI 10.1089/neu.2017.5024; Webster KM, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112979; Webster KM, 2019, J COMP NEUROL, V527, P1102, DOI 10.1002/cne.24589; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Wohleb ES, 2012, PSYCHONEUROENDOCRINO, V37, P1491, DOI 10.1016/j.psyneuen.2012.02.003; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zamani A, 2020, BRAIN RES BULL, V156, P43, DOI 10.1016/j.brainresbull.2019.12.015; Zanier ER, 2016, J NEUROTRAUM, V33, P1060, DOI 10.1089/neu.2015.4041; Zanier Elisa R, 2015, Intensive Care Med Exp, V3, P39, DOI 10.1186/s40635-015-0039-0; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	97	2	2	1	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	MAR 17	2021	18	1							72	10.1186/s12974-021-02114-1			23	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	QZ8CK	WOS:000630948500001	33731173	Green Published, gold			2022-02-06	
J	Postupna, N; Rose, SE; Gibbons, LE; Coleman, NM; Hellstern, LL; Ritchie, K; Wilson, AM; Cudaback, E; Li, XW; Melief, EJ; Beller, AE; Miller, JA; Nolan, AL; Marshall, DA; Walker, R; Montine, TJ; Larson, EB; Crane, PK; Ellenbogen, RG; Lein, ES; Dams-O'Connor, K; Keene, CD				Postupna, Nadia; Rose, Shannon E.; Gibbons, Laura E.; Coleman, Natalie M.; Hellstern, Leanne L.; Ritchie, Kayla; Wilson, Angela M.; Cudaback, Eiron; Li, Xianwu; Melief, Erica J.; Beller, Allison E.; Miller, Jeremy A.; Nolan, Amber L.; Marshall, Desiree A.; Walker, Rod; Montine, Thomas J.; Larson, Eric B.; Crane, Paul K.; Ellenbogen, Richard G.; Lein, Edward S.; Dams-O'Connor, Kristen; Keene, C. Dirk			The Delayed Neuropathological Consequences of Traumatic Brain Injury in a Community-Based Sample	FRONTIERS IN NEUROLOGY			English	Article						chronic traumatic encephalopathy; histelide; Adult Changes in Thought study; amyloid&#8211; beta; traumatic brain injury; immunohistochemistry; hyperphosphorylated tau		The late neuropathological effects of traumatic brain injury have yet to be fully elucidated, particularly with respect to community-based cohorts. To contribute to this critical gap in knowledge, we designed a multimodal neuropathological study, integrating traditional and quantitative approaches to detect pathologic changes in 532 consecutive brain autopsies from participants in the Adult Changes in Thought (ACT) study. Diagnostic evaluation including assessment for chronic traumatic encephalopathy (CTE) and quantitative immunoassay-based methods were deployed to examine levels of pathological (hyperphosphorylated) tau (pTau) and amyloid (A) beta in brains from ACT participants with (n = 107) and without (n = 425) history of remote TBI with loss of consciousness (w/LOC). Further neuropathological assessments included immunohistochemistry for alpha-synuclein and phospho-TDP-43 pathology and astro- (GFAP) and micro- (Iba1) gliosis, mass spectrometry analysis of free radical injury, and gene expression evaluation (RNA sequencing) in a smaller sub-cohort of matched samples (49 cases with TBI and 49 non-exposed matched controls). Out of 532 cases, only 3 (0.6%-none with TBI w/LOC history) showed evidence of the neuropathologic signature of chronic traumatic encephalopathy (CTE). Across the entire cohort, the levels of pTau and A beta showed expected differences for brain region (higher levels in temporal cortex), neuropathological diagnosis (higher in participants with Alzheimer's disease), and APOE genotype (higher in participants with one or more APOE epsilon 4 allele). However, no differences in PHF-tau or A beta(1-42) were identified by Histelide with respect to the history of TBI w/LOC. In a subset of TBI cases with more carefully matched control samples and more extensive analysis, those with TBI w/LOC history had higher levels of hippocampal pTau but no significant differences in A beta, alpha-synuclein, pTDP-43, GFAP, Iba1, or free radical injury. RNA-sequencing also did not reveal significant gene expression associated with any measure of TBI exposure. Combined, these findings suggest long term neuropathological changes associated with TBI w/LOC may be subtle, involve non-traditional pathways of neurotoxicity and neurodegeneration, and/or differ from those in autopsy cohorts specifically selected for neurotrauma exposure.	[Postupna, Nadia; Rose, Shannon E.; Coleman, Natalie M.; Hellstern, Leanne L.; Ritchie, Kayla; Wilson, Angela M.; Cudaback, Eiron; Li, Xianwu; Melief, Erica J.; Beller, Allison E.; Nolan, Amber L.; Marshall, Desiree A.; Keene, C. Dirk] Univ Washington, Sch Med, Dept Lab Med & Pathol, Seattle, WA 98195 USA; [Gibbons, Laura E.; Crane, Paul K.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Miller, Jeremy A.; Lein, Edward S.] Allen Inst Brain Sci, Seattle, WA USA; [Walker, Rod; Larson, Eric B.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA; [Montine, Thomas J.] Stanford Univ, Sch Med, Dept Pathol, Palo Alto, CA 94304 USA; [Ellenbogen, Richard G.; Lein, Edward S.; Keene, C. Dirk] Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA		Keene, CD (corresponding author), Univ Washington, Sch Med, Dept Lab Med & Pathol, Seattle, WA 98195 USA.; Keene, CD (corresponding author), Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA.	cdkeene@uw.edu			Department of Defense Congressionally Directed Medical Research Program GrantUnited States Department of Defense [W81XWH-17-1-0330]; NIH/NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG061028, U01NS086625, U01AG006781, P50AG005136]; Paul Allen Family Foundation; Nancy and Buster Alvord Endowment	This work was funded by a Department of Defense Congressionally Directed Medical Research Program Grant #W81XWH-17-1-0330, NIH/NIA Grants R01AG061028, U01NS086625 (Late Effects of TBI study), U01AG006781 (Adult Changes in Thought Study), P50AG005136 (UW Alzheimer's Disease Research Center), a grant from the Paul Allen Family Foundation, and the Nancy and Buster Alvord Endowment.	Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Adnan A, 2013, BRAIN INJURY, V27, P1415, DOI 10.3109/02699052.2013.823659; American Psychiatric Association, 1994, TASK FORC DSM IDIAGN; [Anonymous], 2015, C TRAUM BRAIN INJ US; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P139, DOI 10.1097/01.HTR.0000319930.69343.64; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bieniek KF, 2020, BRAIN PATHOL, V30, P63, DOI 10.1111/bpa.12757; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Caselli RJ, 2010, NEUROSCI LETT, V473, P168, DOI 10.1016/j.neulet.2010.02.016; Centers for Disease Control and Prevention, 2019, TBI GET THE FACTS; Centers for Disease Control and Prevention, 2014, TRAUMATIC BRAIN INJU; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Cholerton B, 2013, J ALZHEIMERS DIS, V36, P699, DOI 10.3233/JAD-130281; Coughlin D, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0779-1; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Deutsch MB, 2015, DEMENT GERIATR COGN, V39, P143, DOI 10.1159/000369787; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Forrest SL, 2019, J NEUROPATH EXP NEUR, V78, P398, DOI 10.1093/jnen/nlz017; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Helmes E, 2011, BRAIN INJURY, V25, P338, DOI 10.3109/02699052.2011.556104; HIXSON JE, 1990, J LIPID RES, V31, P545; Huang CH, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1187-0; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jawaid A, 2009, NEURODEGENER DIS, V6, P219, DOI 10.1159/000258704; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kalkonde YV, 2012, ALZHEIMERS DEMENT, V8, P204, DOI 10.1016/j.jalz.2011.03.011; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; KATZMAN R, 1989, ANN NEUROL, V25, P317, DOI 10.1002/ana.410250402; Kenney K, 2018, J NEUROPATH EXP NEUR, V77, P50, DOI 10.1093/jnen/nlx101; King A, 2010, NEUROPATHOLOGY, V30, P408, DOI 10.1111/j.1440-1789.2009.01085.x; Koga S, 2016, J NEUROPATH EXP NEUR, V75, P963, DOI 10.1093/jnen/nlw073; Kok E, 2009, ANN NEUROL, V65, P650, DOI 10.1002/ana.21696; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; Lee SH, 2018, MOVEMENT DISORD, V33, P262, DOI 10.1002/mds.27252; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Li W, 2016, J NEUROL, V263, P1280, DOI 10.1007/s00415-016-8093-4; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; McKee AC, 2020, SEMIN NEUROL, V40, P359, DOI 10.1055/s-0040-1713632; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Mez J, 2020, ANN NEUROL, V87, P116, DOI 10.1002/ana.25611; Miller JA, 2017, ELIFE, V6, DOI 10.7554/eLife.31126; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Mondello S, 2013, NEUROLOGY, V80, P1662, DOI 10.1212/WNL.0b013e3182904d43; Montine TJ, 2005, ANTIOXID REDOX SIGN, V7, P269, DOI 10.1089/ars.2005.7.269; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Mosconi L, 2017, NEUROLOGY, V89, P1382, DOI 10.1212/WNL.0000000000004425; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1263, DOI 10.1097/00005072-199912000-00007; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Noy S, 2016, J NEUROPATH EXP NEUR, V75, P1145, DOI 10.1093/jnen/nlw092; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; OMeara ES, 1997, AM J EPIDEMIOL, V146, P373, DOI 10.1093/oxfordjournals.aje.a009290; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Postupna N, 2015, J NEUROPATH EXP NEUR, V74, P100, DOI 10.1097/NEN.0000000000000153; Rabinovici GD, 2017, JAMA-J AM MED ASSOC, V318, P338, DOI 10.1001/jama.2017.9353; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; RASMUSSON DX, 1995, BRAIN INJURY, V9, P213, DOI 10.3109/02699059509008194; Riedel BC, 2016, J STEROID BIOCHEM, V160, P134, DOI 10.1016/j.jsbmb.2016.03.012; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith DH, 2019, NAT REV NEUROL, V15, P179, DOI 10.1038/s41582-018-0114-8; Sonnen JA, 2009, J ALZHEIMERS DIS, V18, P703, DOI 10.3233/JAD-2009-1180; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Sugarman MA, 2019, ALZHEIMERS DEMENT, V15, P686, DOI 10.1016/j.jalz.2018.12.015; Suhanov AV, 2006, EUR J NEUROL, V13, P990, DOI 10.1111/j.1468-1331.2006.01391.x; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Weiner MW, 2017, NEUROLOGY, V89, P1923, DOI 10.1212/WNL.0000000000004608; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; WILLIAMS DB, 1991, NEUROLOGY, V41, P1554, DOI 10.1212/WNL.41.10.1554; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Xu W, 2015, J NEUROL NEUROSUR PS, V86, P1299, DOI 10.1136/jnnp-2015-310548; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zhang J, 2015, J CEREBR BLOOD F MET, V35, P706, DOI 10.1038/jcbfm.2014.247	102	2	2	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAR 16	2021	12								624696	10.3389/fneur.2021.624696			18	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	RF3GO	WOS:000634730400001	33796061	gold, Green Published			2022-02-06	
J	Lesniak, A; Poznanski, P; Religa, P; Nawrocka, A; Bujalska-Zadrozny, M; Sacharczuk, M				Lesniak, Anna; Poznanski, Piotr; Religa, Piotr; Nawrocka, Agata; Bujalska-Zadrozny, Magdalena; Sacharczuk, Mariusz			Loss of Brain-Derived Neurotrophic Factor (BDNF) Resulting From Congenital- Or Mild Traumatic Brain Injury-Induced Blood-Brain Barrier Disruption Correlates With Depressive-Like Behaviour	NEUROSCIENCE			English	Article						blood-brain barrier; brain-derived neurotrophic factor; chronic mild stress; mild traumatic brain injury; depressive-like behaviour; HA; LA mice		neurotrophic factor (BDNF) plays an important role in processes associated with neuroplasticity and neuroprotection. Evidence suggests that decreased BDNF levels in the central nervous system (CNS) represent a mechanism underlying the development of mood disorders. We hypothesize that both congenital and traumatic brain injury (mTBI)-induced blood-brain barrier (BBB) breakdown are responsible for brain BDNF depletion that contributes to the development of depressive-like symptoms. We employed a mouse model of innate differences in BBB integrity with high (HA) and low (LA) permeability. Depressive-like behaviours were determined under chronic mild stress (CMS) conditions or following mTBI using the tail suspension test (TST). Microvascular leakage of the BBB was evaluated using the Evans Blue Dye (EBD) extravasation method. BDNF concentrations in the brain and plasma were measured using the ELISA. Control HA mice with congenitally high BBB permeability showed exacerbated depressive-like behaviours compared with LA mice. In LA mice, with normal BBB function, mTBI, but not CMS, facilitated depressive-like behaviours, which correlated with enhanced BDNF efflux from the brain. In addition, mTBI triggered upregulation of the Bdnf gene in LA mice to compensate for BDNF loss. No alterations in BDNF levels were observed in mTBI and CMS-exposed HA mice. Moreover, CMS did not induce BBB damage or affect depressive-like behaviours in HA mice despite downregulating Bdnf gene expression. To conclude, BDNF efflux through the mTBI-disrupted BBB is strongly linked to the development of depressive-like behaviours, while the depressive phenotype in mice with congenital BBB dysfunction is independent of BDNF leakage. (c) 2021 IBRO. Published by Elsevier Ltd. All rights reserved.	[Lesniak, Anna; Bujalska-Zadrozny, Magdalena; Sacharczuk, Mariusz] Med Univ Warsaw, Fac Pharm, Ctr Preclin Res & Technol, Dept Pharmacodynam,Lab Med Div, Warsaw, Poland; [Poznanski, Piotr; Religa, Piotr; Nawrocka, Agata; Sacharczuk, Mariusz] Polish Acad Sci, Inst Genet & Anim Biotechnol, Dept Expt Genom, Jastrzebiec, Poland		Sacharczuk, M (corresponding author), Mariusz Sacharczuk Inst Genet & Anim Biotechnol J, Dept Expt Genom, Postepu 36A, PL-05552 Magdalenka, Poland.	m.sacharczuk@ighz.pl	Poznanski, Piotr/AAZ-1709-2020	Poznanski, Piotr/0000-0002-1321-2235	 [STAT/MARSAC/2019/01];  [FW3/N/2019]	This work was funded by statutory grants no. STAT/MARSAC/2019/01 (S.I.I.3) and FW3/N/2019. Centre for Preclinical Research and Technology infrastructure was used to quantify the extent of BBB damage in HA and LA mice. We also wish to thank Shanti Diwakarla for her editing services, Anna Bobrowska and Irmina Bienkowska for their technical support and animal husbandry.	aan het Rot M, 2009, CAN MED ASSOC J, V180, P305, DOI 10.1503/cmaj.080697; AYENSU WK, 1995, PHYSIOL BEHAV, V57, P165, DOI 10.1016/0031-9384(94)00204-I; Blaszczyki JW, 2010, ACTA NEUROBIOL EXP, V70, P398; Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309; Cheng YY, 2018, BRAIN BEHAV IMMUN, V69, P556, DOI 10.1016/j.bbi.2018.02.003; Colzato LS, 2011, PSYCHONEUROENDOCRINO, V36, P1562, DOI 10.1016/j.psyneuen.2011.04.010; Delis F, 2013, BEHAV NEUROSCI, V127, P95, DOI 10.1037/a0030750; Demir S, 2015, NEUROPSYCH DIS TREAT, V11, P2253, DOI 10.2147/NDT.S89470; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P419, DOI 10.1177/1545968315600525; FAWCETT J, 1993, INT CLIN PSYCHOPHARM, V8, P217, DOI 10.1097/00004850-199300840-00002; Gajkowska B, 2011, FOLIA NEUROPATHOL, V49, P311; Gourley SL, 2012, P NATL ACAD SCI USA, V109, P20714, DOI 10.1073/pnas.1208342109; Gudmundsson P, 2007, AM J GERIAT PSYCHIAT, V15, P832, DOI 10.1097/JGP.0b013e3180547091; Hammen C, 2009, DEPRESS ANXIETY, V26, P718, DOI 10.1002/da.20571; Haruwaka K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13812-z; Huang YL, 2020, NEURAL REGEN RES, V15, P1150, DOI 10.4103/1673-5374.270414; Hue CD, 2015, J CEREBR BLOOD F MET, V35, P1191, DOI 10.1038/jcbfm.2015.38; James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409; Kosson A, 2014, ACTA NEUROBIOL EXP, V74, P26; Lesniak A, 2017, BEHAV BRAIN RES, V326, P209, DOI 10.1016/j.bbr.2017.03.015; Liu W, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/6871089; Lutfy K, 1996, PHARMACOL BIOCHEM BE, V54, P495, DOI 10.1016/0091-3057(95)02285-6; Menard C, 2017, NAT NEUROSCI, V20, P1752, DOI 10.1038/s41593-017-0010-3; Murakami S, 2005, NEUROSCI RES, V53, P129, DOI 10.1016/j.neures.2005.06.008; Murray CJL, GLOBAL BURDEN DIS CO; Nabeshima Toshitaka, 2013, Exp Neurobiol, V22, P235, DOI 10.5607/en.2013.22.4.235; Ninan I, 2014, NEUROPHARMACOLOGY, V76, P684, DOI 10.1016/j.neuropharm.2013.04.011; Notaras M, 2016, MOL PSYCHIATR, V21, P730, DOI 10.1038/mp.2015.152; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; PANOCKA I, 1986, BRAIN RES, V397, P156, DOI 10.1016/0006-8993(86)91380-6; PANOCKA I, 1986, BRAIN RES, V397, P152, DOI 10.1016/0006-8993(86)91379-X; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Poznanski P, 2020, ADDICT BIOL, V25, DOI 10.1111/adb.12683; Poznanski P, 2017, NEUROPHARMACOLOGY, V118, P90, DOI 10.1016/j.neuropharm.2017.03.016; Qin YH, 2019, PSYCHONEUROENDOCRINO, V107, P59, DOI 10.1016/j.psyneuen.2019.05.007; Ragan AR, 2013, STRESS, V16, P571, DOI 10.3109/10253890.2013.807244; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Reinhart V, 2015, NEUROBIOL DIS, V77, P220, DOI 10.1016/j.nbd.2015.03.011; Romero IA, 2003, NEUROSCI LETT, V344, P112, DOI 10.1016/S0304-3940(03)00348-3; Rosas-Vidal LE, 2018, NEUROPSYCHOPHARMACOL, V43, P2636, DOI 10.1038/s41386-018-0176-8; Roszkowski M, 2016, J CEREBR BLOOD F MET, V36, P1304, DOI 10.1177/0271678X16647739; Sacharczuk M, 2014, ADDICT BIOL, V19, P643, DOI 10.1111/adb.12030; Sacharczuk M, 2012, J ENVIRON PATHOL TOX, V31, P167, DOI 10.1615/JEnvironPatholToxicolOncol.v31.i2.80; Sacharczuk M, 2009, ACTA NEUROBIOL EXP, V69, P459; Santha P, 2016, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00088; Schaaf MJM, 1998, BRAIN RES, V813, P112, DOI 10.1016/S0006-8993(98)01010-5; Schaaf MJM, 1997, J NEUROSCI RES, V48, P334, DOI 10.1002/(SICI)1097-4547(19970515)48:4<334::AID-JNR5>3.3.CO;2-F; Schroeter ML, 2008, J AFFECT DISORDERS, V111, P271, DOI 10.1016/j.jad.2008.03.005; Schwarz MJ, 1998, NEUROSCI LETT, V253, P201, DOI 10.1016/S0304-3940(98)00655-7; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Steiner J, 2008, NEUROSCIENCE, V154, P496, DOI 10.1016/j.neuroscience.2008.03.060; Suchanek R, 2013, J NEUROPSYCH CLIN N, V25, P88, DOI 10.1176/appi.neuropsych.11100234; Sun MM, 2013, PSYCHIAT GENET, V23, P124, DOI 10.1097/YPG.0b013e328360c866; Sunbul EA, 2016, PSYCHIAT INVEST, V13, P121, DOI 10.4306/pi.2016.13.1.121; Verhagen M, 2010, MOL PSYCHIATR, V15, P260, DOI 10.1038/mp.2008.109; Willner P, 2017, NEUROBIOL STRESS, V6, P78, DOI 10.1016/j.ynstr.2016.08.002; Xu GM, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00032; Yang B, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.95; Zhang JC, 2016, CURR NEUROPHARMACOL, V14, P721, DOI 10.2174/1570159X14666160119094646	63	2	2	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	MAR 15	2021	458						1	10		10.1016/j.neuroscience.2021.01.013			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QP7MK	WOS:000624016900001	33465406				2022-02-06	
J	Shah, EJ; Huttemann, M; Sanderson, TH; Gurdziel, K; Ruden, DM				Shah, Ekta J.; Huttemann, Maik; Sanderson, Thomas H.; Gurdziel, Katherine; Ruden, Douglas M.			Inhibiting Mitochondrial Cytochrome c Oxidase Downregulates Gene Transcription After Traumatic Brain Injury in Drosophila	FRONTIERS IN PHYSIOLOGY			English	Article						traumatic brain injury; sex-differences; gene expression; near-infrared light; mitochondria		Traumatic brain injuries (TBIs) caused by a sudden impact to the head alter behavior and impair physical and cognitive function. Besides the severity, type and area of the brain affected, the outcome of TBI is also influenced by the patient's biological sex. Previous studies reporting mitochondrial dysfunction mainly focused on exponential reactive oxygen species (ROS) generation, increased mitochondrial membrane potential, and altered mitochondrial dynamics as a key player in the outcome to brain injury. In this study, we evaluated the effect of a near-infrared (NIR) light exposure on gene expression in a Drosophila TBI model. NIR interacts with cytochrome c oxidase (COX) of the electron transport chain to reduce mitochondrial membrane potential hyperpolarization, attenuate ROS generation, and apoptosis. We subjected w(1118) male and female flies to TBI using a high-impact trauma (HIT) device and subsequently exposed the isolated fly brains to a COX-inhibitory wavelength of 750 nm for 2 hours (hr). Genome-wide 3 '-mRNA-sequencing of fly brains revealed that injured w(1118) females exhibit greater changes in transcription compared to males at 1, 2, and 4 hours (hr) after TBI. Inhibiting COX by exposure to NIR downregulates gene expression in injured females but has minimal effect in injured males. Our results suggest that mitochondrial COX modulation with NIR alters gene expression in Drosophila following TBI and the response to injury and NIR exposure varies by biological sex.	[Shah, Ekta J.; Ruden, Douglas M.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Huttemann, Maik] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI USA; [Sanderson, Thomas H.] Univ Michigan, Sch Med, Dept Emergency Med, Ann Arbor, MI USA; [Gurdziel, Katherine] Wayne State Univ, Off Vice President Res, Detroit, MI 48202 USA; [Ruden, Douglas M.] Wayne State Univ, Inst Environm Hlth Sci, Detroit, MI 48202 USA; [Ruden, Douglas M.] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48202 USA		Ruden, DM (corresponding author), Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA.; Gurdziel, K (corresponding author), Wayne State Univ, Off Vice President Res, Detroit, MI 48202 USA.; Ruden, DM (corresponding author), Wayne State Univ, Inst Environm Hlth Sci, Detroit, MI 48202 USA.; Ruden, DM (corresponding author), Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48202 USA.	gurdziel@wayne.edu; douglas.ruden@gmail.com	Ruden, Douglas/ABE-1418-2021; Sanderson, Thomas/K-6656-2012	Sanderson, Thomas/0000-0003-0112-8164; Huttemann, Maik/0000-0001-6310-7081	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01ES012933, 5P30ES020957, 1UG3OD023285]; Office of the Vice President for Research at Wayne State University	This work was funded by the National Institutes of Health [Grant Nos. 5R01ES012933 (DR), 5P30ES020957 (DR), and 1UG3OD023285 (DR)]. In addition, the Office of the Vice President for Research at Wayne State University supports KG and provided pilot funds for DR.	Allen NJ, 2009, NATURE, V457, P675, DOI 10.1038/457675a; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anesti V, 2006, BBA-BIOENERGETICS, V1757, P692, DOI 10.1016/j.bbabio.2006.04.013; Bartolak-Suki E, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081812; Begum R, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0073; Boldogh IR, 2006, BBA-MOL CELL RES, V1763, P450, DOI 10.1016/j.bbamcr.2006.02.014; Castellani RJ, 2019, J ALZHEIMERS DIS, V67, P447, DOI 10.3233/JAD-180721; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Chung WS, 2015, NAT NEUROSCI, V18, P1539, DOI 10.1038/nn.4142; Ciuffreda KJ., 2016, ADV OPHTHALMOL OPTOM, V1, P307, DOI [10.1016/j.yaoo.2016.03.013, DOI 10.1016/J.YAOO.2016.03.013]; Collins-Praino LE, 2017, BRAIN BEHAV IMMUN, V60, P369, DOI 10.1016/j.bbi.2016.09.027; Conley YP, 2014, J NEUROTRAUM, V31, P34, DOI 10.1089/neu.2013.2855; Carneiro AMC, 2019, PHOTOBIOMOD PHOTOMED, V37, P657, DOI 10.1089/photob.2019.4683; Dale Horne M.K, 2018, TRAUMATIC BRAIN INJU; Breda CND, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101255; Demarest TG, 2015, J BIOENERG BIOMEMBR, V47, P173, DOI 10.1007/s10863-014-9583-7; Dinet V, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01178; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Edwards G, 2019, J NEUROTRAUM, DOI 10.1089/neu.2018.6348; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Fitzpatrick MO, 1998, BRIT J NEUROSURG, V12, P313; Fresno C, 2013, BIOINFORMATICS, V29, P2810, DOI 10.1093/bioinformatics/btt487; Giacci MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104565; Griffin GD, 2011, MIL MED, V176, P364, DOI 10.7205/MILMED-D-10-00021; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Hamblin MR, 2018, J NEUROSCI RES, V96, P731, DOI 10.1002/jnr.24190; Hennessy M, 2017, J OPTICS-UK, V19, DOI 10.1088/2040-8986/19/1/013003; Henry RJ, 2020, J NEUROSCI, V40, P2960, DOI 10.1523/JNEUROSCI.2402-19.2020; Hetru C, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000232; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; KARU TI, 1995, DOKL AKAD NAUK+, V342, P693; Katzenberger RJ, 2016, G3-GENES GENOM GENET, V6, P4151, DOI 10.1534/g3.116.036194; Katzenberger RJ, 2015, JOVE-J VIS EXP, DOI 10.3791/52905; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Khuman J, 2012, J NEUROTRAUM, V29, P408, DOI 10.1089/neu.2010.1745; Kim Susan, 2017, Concussion, V2, pCNC48, DOI 10.2217/cnc-2017-0013; Klocke D, 2011, BEILSTEIN J NANOTECH, V2, P186, DOI 10.3762/bjnano.2.22; Leitgeb J, 2011, J TRAUMA, V71, P1620, DOI 10.1097/TA.0b013e318226ea0e; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Moreira MS, 2009, J PHOTOCH PHOTOBIO B, V97, P145, DOI 10.1016/j.jphotobiol.2009.09.002; Morries LD, 2015, NEUROPSYCH DIS TREAT, V11, P2159, DOI 10.2147/NDT.S65809; Moskal N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13781-3; Muir R, 2016, BIOESSAYS, V38, P150, DOI 10.1002/bies.201500105; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; Petersen AJ, 2013, GENETICS, V194, P133, DOI 10.1534/genetics.113.150854; Petersen AJ, 2012, P NATL ACAD SCI USA, V109, pE656, DOI 10.1073/pnas.1110470109; Plesnila N, 2016, CURR OPIN PHARMACOL, V26, P110, DOI 10.1016/j.coph.2015.10.008; Quirk BJ, 2012, PHOTOMED LASER SURG, V30, P523, DOI 10.1089/pho.2012.3261; Reddy PH, 2009, CNS SPECTRUMS, V14, P8, DOI 10.1017/S1092852900024901; Poiani GDR, 2018, TRIALS, V19, DOI 10.1186/s13063-017-2414-5; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; dos Santos JGRP, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2632-5; Saatman K.E.S.G., 2009, HDB NEUROCHEMISTRY M; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sanderson TH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21869-x; Sanderson TH, 2013, MOL NEUROBIOL, V47, P9, DOI 10.1007/s12035-012-8344-z; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sen AK, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00175; Shah EJ, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00511; Shah EJ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00409; Shahpasand K, 2012, J NEUROSCI, V32, P2430, DOI 10.1523/JNEUROSCI.5927-11.2012; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Strubakos CD, 2020, J CEREBR BLOOD F MET, V40, P833, DOI 10.1177/0271678X19845149; Swanson LC, 2020, G3-GENES GENOM GENET, V10, P3109, DOI 10.1534/g3.120.401377; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; van Alphen B., 2018, BIORXIV PREPRINT, DOI [10.1101/422535, DOI 10.1101/422535]; Ventura-Clapier R, 2017, CLIN SCI, V131, P803, DOI 10.1042/CS20160485; Vos M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078562; Walker MA, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/164309; Watts LT, 2016, NEURAL REGEN RES, V11, P1403, DOI 10.4103/1673-5374.191205; Weinrich TW, 2017, NEUROBIOL AGING, V60, P34, DOI 10.1016/j.neurobiolaging.2017.08.016; West C, 2017, CELL, V169, P188, DOI 10.1016/j.cell.2017.03.032; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Zhang Q, 2014, J CEREBR BLOOD F MET, V34, P1391, DOI 10.1038/jcbfm.2014.95	83	2	2	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-042X			FRONT PHYSIOL	Front. Physiol.	MAR 15	2021	12								628777	10.3389/fphys.2021.628777			13	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	RE6QG	WOS:000634275500001	33790803	gold, Green Published			2022-02-06	
J	Stubbs, JL; Thornton, AE; Gicas, KM; O'Connor, TA; Livingston, EM; Lu, HY; Mehta, AK; Lang, DJ; Vertinsky, AT; Field, TS; Heran, MK; Leonova, O; Sahota, CS; Buchanan, T; Barr, AM; MacEwan, GW; Rauscher, A; Honer, WG; Panenka, WJ				Stubbs, Jacob L.; Thornton, Allen E.; Gicas, Kristina M.; O'Connor, Tiffany A.; Livingston, Emily M.; Lu, Henri Y.; Mehta, Amiti K.; Lang, Donna J.; Vertinsky, Alexandra T.; Field, Thalia S.; Heran, Manraj K.; Leonova, Olga; Sahota, Charanveer S.; Buchanan, Tari; Barr, Alasdair M.; MacEwan, G. William; Rauscher, Alexander; Honer, William G.; Panenka, William J.			Characterizing Traumatic Brain Injury and Its Association with Losing Stable Housing in a Community-based Sample : Caracterisation d'une lesion cerebrale traumatique et de son association avec la perte d'un logement stable dans un echantillon communautaire	CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE			English	Article; Early Access						traumatic brain injury; homeless; precarious housing; marginally housed	POSTTRAUMATIC AMNESIA; YOUNG-ADULTS; HOMELESS; HEALTH; COHORT; RELIABILITY; PREVALENCE; VALIDITY	Objective: Traumatic brain injury (TBI) is increasingly recognized as a common and impactful health determinant in homeless and precariously housed populations. We sought to describe the history of TBI in a precariously housed sample and evaluate how TBI was associated with the initial loss and lifetime duration of homelessness and precarious housing. Method: We characterized the prevalence, mechanisms, and sex difference of lifetime TBI in a precariously housed sample. We also examined the impact of TBI severity and timing on becoming and staying homeless or precariously housed; 285 precariously housed participants completed the Brain Injury Screening Questionnaire in addition to other health assessments. Results: A history of TBI was reported in 82.1% of the sample, with 64.6% reporting > 1 TBI, and 21.4% reporting a moderate or severe TBI. Assault was the most common mechanism of injury overall, and females reported significantly more traumatic brain injuries due to physical abuse than males (adjusted OR = 1.26, 95% CI = 1.14 to 1.39, P < 0.0001). The first moderate or severe TBI was significantly closer to the first experience of homelessness (b = 2.79, P = 0.003) and precarious housing (b = 2.69, P < 0.0001) than was the first mild TBI. In participants who received their first TBI prior to becoming homeless or precariously housed, traumatic brain injuries more proximal to the initial loss of stable housing were associated with a longer lifetime duration of homelessness (RR = 1.04, 95% CI = 1.02 to 1.06, P < 0.0001) and precarious housing (RR = 1.03, 95% CI = 1.01 to 1.04, P < 0.0001). Conclusions: These findings demonstrate the high prevalence of TBI in this vulnerable population, and that aspects of TBI severity and timing are associated with the loss and lifetime duration of stable housing.	[Stubbs, Jacob L.; Gicas, Kristina M.; Mehta, Amiti K.; Leonova, Olga; Buchanan, Tari; MacEwan, G. William; Honer, William G.; Panenka, William J.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Stubbs, Jacob L.; Thornton, Allen E.; Gicas, Kristina M.; O'Connor, Tiffany A.; Livingston, Emily M.; Lu, Henri Y.; Mehta, Amiti K.; Lang, Donna J.; Buchanan, Tari; Barr, Alasdair M.; Honer, William G.; Panenka, William J.] British Columbia Mental Hlth & Subst Use Serv Res, Vancouver, BC, Canada; [Thornton, Allen E.; O'Connor, Tiffany A.; Livingston, Emily M.; Lu, Henri Y.; Sahota, Charanveer S.] Simon Fraser Univ, Dept Psychol, Burnaby, BC, Canada; [Gicas, Kristina M.] York Univ, Dept Psychol, Toronto, ON, Canada; [Lang, Donna J.; Vertinsky, Alexandra T.; Heran, Manraj K.] Univ British Columbia, Dept Radiol, Vancouver, BC, Canada; [Field, Thalia S.] Univ British Columbia, Div Neurol, Vancouver, BC, Canada; [Barr, Alasdair M.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC, Canada; [Rauscher, Alexander] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada; [Panenka, William J.] Univ British Columbia, British Columbia Neuropsychiat Program, Vancouver, BC, Canada		Panenka, WJ (corresponding author), BC Childrens Hosp Res Inst, Room A3-123,3rd Floor,938 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	wpanenka@mail.ubc.ca	Field, Thalia/P-4103-2019	Field, Thalia/0000-0002-1176-0633; Barr, Alasdair/0000-0002-3407-1574	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [CBG-101827, MOP-137103]; British Columbia Mental Health and Substance Use Services (an Agency of the Provincial Health Services Authority); William and Ada Isabelle Steel Fund; Jack Bell Chair in Schizophrenia; Canada Research ChairsCanada Research ChairsCGIAR; Michael Smith Foundation for Health ResearchMichael Smith Foundation for Health Research; Heart and Stroke Foundation of CanadaHeart & Stroke Foundation of Canada; Vancouver Coastal Health Research Institute	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by the Canadian Institutes of Health Research (CBG-101827, MOP-137103), and the British Columbia Mental Health and Substance Use Services (an Agency of the Provincial Health Services Authority) as well as the William and Ada Isabelle Steel Fund. WGH was supported by the Jack Bell Chair in Schizophrenia, AR is supported by Canada Research Chairs, and TSF is supported by the Michael Smith Foundation for Health Research, the Heart and Stroke Foundation of Canada, and the Vancouver Coastal Health Research Institute.	Argintaru N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-577; Barbic SP, 2018, CAN J PUBLIC HEALTH, V109, P204, DOI 10.17269/s41997-018-0087-9; Barnes SM, 2015, J HEALTH CARE POOR U, V26, P92, DOI 10.1353/hpu.2015.0010; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Bymaster A, 2017, J HEALTH CARE POOR U, V28, P582, DOI 10.1353/hpu.2017.0041; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Centers for Disease Control and Prevention, 2015, REPORT C TRAUMATIC B; Corrigan JD, 2018, INJURY PREV, V24, P396, DOI 10.1136/injuryprev-2017-042371; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Fazel S, 2014, LANCET, V384, P1529, DOI 10.1016/S0140-6736(14)61132-6; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gaetz S., 2013, STATE HOMELESSNESS C; Gerber G.J., 2016, CANADIAN J COMMUNITY, V35, P69, DOI DOI 10.7870/CJCMH-2016-034; Haag H., 2019, TRAUMA VIOLENCE ABUS; Honer WG, 2017, CAN J PSYCHIAT, V62, P482, DOI 10.1177/0706743717693781; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Hwang SW, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4036; Jones AA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008876; Kovacs-Burns K, 2012, CANADIAN DEFINITION; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, P1986, DOI 10.2105/AJPH.2014.302087; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; Nikoo M, 2017, J HEAD TRAUMA REHAB, V32, pE19, DOI 10.1097/HTR.0000000000000262; Oddy M, 2012, BRAIN INJURY, V26, P1058, DOI 10.3109/02699052.2012.667595; Palepu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075133; R Core Team, 2020, R LANG ENV STAT COMP; Roberts CM, 2016, J HEAD TRAUMA REHAB, V31, pE71, DOI 10.1097/HTR.0000000000000154; Russell LM, 2013, AM J PUBLIC HEALTH, V103, pS211, DOI 10.2105/AJPH.2013.301485; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Schmitt T, 2017, J NEUROTRAUM, V34, P3301, DOI 10.1089/neu.2017.5076; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Sherer M, 2015, ARCH PHYS MED REHAB, V96, P652, DOI 10.1016/j.apmr.2014.10.024; Stergiopoulos V, 2015, JAMA-J AM MED ASSOC, V313, P905, DOI 10.1001/jama.2015.1163; Stubbs JL, 2020, LANCET PUBLIC HEALTH, V5, pE19, DOI 10.1016/S2468-2667(19)30188-4; Svoboda T, 2014, EMERG MED J, V31, P571, DOI 10.1136/emermed-2012-201761; To MJ, 2015, J HEAD TRAUMA REHAB, V30, P270, DOI 10.1097/HTR.0000000000000044; Topolovec-Vranic Jane, 2014, CMAJ Open, V2, pE69, DOI 10.9778/cmajo.20130046; Vila-Rodriguez F, 2013, AM J PSYCHIAT, V170, P1413, DOI 10.1176/appi.ajp.2013.12111439; Waclawik K., 2019, FRONTIERS PUBLIC HLT, V7, P1	40	2	2	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0706-7437	1497-0015		CAN J PSYCHIAT	Can. J. Psychiat.-Rev. Can. Psychiat.											07067437211000665	10.1177/07067437211000665		MAR 2021	9	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	SO2ZN	WOS:000658845300001	33719613				2022-02-06	
J	Hu, LC; Liu, J; Xue, H; Panayi, AC; Xie, XD; Lin, Z; Wang, TT; Xiong, Y; Hu, YQ; Yan, CC; Chen, L; Abududilibaier, A; Zhou, W; Mi, BB; Liu, GH				Hu, Liangcong; Liu, Jing; Xue, Hang; Panayi, Adriana C.; Xie, Xudong; Lin, Ze; Wang, Tiantian; Xiong, Yuan; Hu, Yiqiang; Yan, Chengcheng; Chen, Lang; Abududilibaier, Abudula; Zhou, Wu; Mi, Bobin; Liu, Guohui			miRNA-92a-3p regulates osteoblast differentiation in patients with concomitant limb fractures and TBI via IBSP/PI3K-AKT inhibition	MOLECULAR THERAPY-NUCLEIC ACIDS			English	Article							TRAUMATIC BRAIN-INJURY; BONE-FORMATION; CALLUS FORMATION; PROLIFERATION; BIOGENESIS; RESORPTION; MICRORNAS; IBSP	Patients who sustain concomitant fractures and traumatic brain injury (TBI) are known to have significantly quicker fracture-healing rates than patients with isolated fractures. The mechanisms underlying this phenomenon have yet to be identified. In the present study, we found that the upregulation of microRNA-92a-3p (miRNA-92a-3p) induced by TBI correlated with a decrease in integrin binding sialoprotein (IBSP) expression in callus formation. In vitro, overexpressing miRNA-92a3p inhibited IBSP expression and accelerated osteoblast differentiation, whereas silencing of miRNA-92a-3p inhibited osteoblast activity. A decrease in IBSP facilitated osteoblast differentiation via the Phosphatidylinositol 3-kinase/threonine kinase 1 (PI3K/AKT) signaling pathway. Through luciferase assays, we found evidence that IBSP is a miRNA-92a-3p target gene that negatively regulates osteoblast differentiation. Moreover, the present study confirmed that pre-injection of agomiR92a-3p leads to increased bone formation. Collectively, these results indicate that miRNA-92a-3p overexpression may be a key factor underlying the improved fracture healing observed in TBI patients. Upregulation of miRNA-92a-3p may therefore be a promising therapeutic strategy for promoting fracture healing and preventing nonunion.	[Hu, Liangcong; Liu, Jing; Xue, Hang; Xie, Xudong; Lin, Ze; Xiong, Yuan; Hu, Yiqiang; Yan, Chengcheng; Chen, Lang; Abududilibaier, Abudula; Zhou, Wu; Mi, Bobin; Liu, Guohui] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Orthoped, 1277 Jiefang Ave, Wuhan 430022, Peoples R China; [Panayi, Adriana C.] Harvard Med Sch, Div Plast Surg, Brigham & Womens Hosp, Boston, MA 02215 USA; [Wang, Tiantian] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Emergency, 1277 Jiefang Ave, Wuhan 430022, Peoples R China		Zhou, W; Mi, BB; Liu, GH (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Orthoped, 1277 Jiefang Ave, Wuhan 430022, Peoples R China.	2016XH0120@hust.edu.cn; mibobin@hust.edu.cn; liuguohui@hust.edu.cn	Panayi, Adriana C./AAF-1817-2020	Panayi, Adriana C./0000-0003-4053-9855	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81772345]; National Key Research & Development Program of China [2018YFC2001502, 2018YFB1105705]; National Health Commission of the People's Republic of China [ZX-01-018, ZX-01-C2016153]; Health Commission of Hubei Province [WJ2019Z009]	This research was supported by grants (no. 81772345) from the National Natural Science Foundation of China, National Key Research & Development Program of China (nos. 2018YFC2001502 and 2018YFB1105705), National Health Commission of the People's Republic of China (nos. ZX-01-018 and ZX-01-C2016153), and the Health Commission of Hubei Province (no. WJ2019Z009).	Adeloye D, 2016, B WORLD HEALTH ORGAN, V94, P510, DOI 10.2471/BLT.15.163121; Arik M, 2019, EKLEM HAST CERRAHISI, V30, P267, DOI 10.5606/ehc.2019.66041; Ayari H, 2012, ADV MED SCI-POLAND, V57, P334, DOI 10.2478/v10039-012-0056-0; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boudiffa M, 2010, J BONE MINER RES, V25, P2393, DOI 10.1002/jbmr.245; Bouleftour W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095144; Brady RD, 2016, SCI REP-UK, V6, DOI 10.1038/srep34491; Cadosch D, 2009, J BONE JOINT SURG AM, V91A, P282, DOI 10.2106/JBJS.G.01613; CALANDRIELLO B, 1964, Bull Hosp Joint Dis, V25, P170; Curtin P, 2009, BIOCHEMISTRY-US, V48, P6876, DOI 10.1021/bi900066b; Perez DD, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60212-1; Deng S, 2019, BIOMED PHARMACOTHER, V110, P602, DOI 10.1016/j.biopha.2018.11.103; Edwards KA, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00348; Eijken M, 2006, MOL CELL ENDOCRINOL, V248, P87, DOI 10.1016/j.mce.2005.11.034; Fan Y, 2017, CELL METAB, V25, P661, DOI 10.1016/j.cmet.2017.01.001; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; GARLAND DE, 1988, CLIN ORTHOP RELAT R, P86; Golinvaux NS, 2020, J HAND SURG-AM, V45, DOI 10.1016/j.jhsa.2019.10.012; Guntur AR, 2011, J ENDOCRINOL, V211, P123, DOI 10.1530/JOE-11-0175; Guo J, 2017, J CELL PHYSIOL, V232, P3158, DOI 10.1002/jcp.25769; Han YY, 2018, DRUG DES DEV THER, V12, P137, DOI 10.2147/DDDT.S148457; He SX, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20192743; Hu K, 2016, J CLIN INVEST, V126, P509, DOI 10.1172/JCI82585; Huang XQ, 2020, LIFE SCI, V254, DOI 10.1016/j.lfs.2020.117809; Iffland PH, 2017, ANNU REV PATHOL-MECH, V12, P547, DOI 10.1146/annurev-pathol-052016-100138; KERR JM, 1993, GENOMICS, V17, P408, DOI 10.1006/geno.1993.1340; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lee SY, 2020, MOL THER, V28, P142, DOI 10.1016/j.ymthe.2019.08.014; Li CJ, 2015, J CLIN INVEST, V125, P1509, DOI 10.1172/JCI77716; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Lin ZP, 2019, J BONE MINER METAB, V37, P264, DOI 10.1007/s00774-018-0935-y; Liu CJ, 2005, J BIOL CHEM, V280, P2788, DOI 10.1074/jbc.M412604200; Liu Y, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20201165; Locher RJ, 2015, J MUSCULOSKEL NEURON, V15, P309; LoRusso PM, 2016, J CLIN ONCOL, V34, P3803, DOI 10.1200/JCO.2014.59.0018; Lu S, 2020, WORLD NEUROSURG, V133, P227, DOI 10.1016/j.wneu.2019.09.136; Luo H, 2019, EFORT OPEN REV, V4, P513, DOI 10.1302/2058-5241.4.180054; Luo ZW, 2019, NANOSCALE, V11, P20884, DOI 10.1039/c9nr02791b; Maiden MJ, 2020, AM J RESP CRIT CARE, V201, P167, DOI 10.1164/rccm.201903-0673OC; Mao GP, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1004-0; Marie PJ, 2012, CURR OSTEOPOROS REP, V10, P190, DOI 10.1007/s11914-012-0109-0; Nepal Sarthak, 2015, Lancet, V385 Suppl 2, pS7, DOI 10.1016/S0140-6736(15)60802-9; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521, DOI 10.1302/0301-620X.69B4.3611150; Polito F, 2020, MOL BIOL REP, V47, P2941, DOI 10.1007/s11033-020-05386-7; Rauch A, 2019, NAT GENET, V51, P716, DOI 10.1038/s41588-019-0359-1; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Seemann R, 2018, J MUSCULOSKEL NEURON, V18, P32; Singleton Q, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010063; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Treiber T, 2019, NAT REV MOL CELL BIO, V20, P5, DOI 10.1038/s41580-018-0059-1; Wang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062936; Wang L, 2018, TRAFFIC INJ PREV, V19, P749, DOI 10.1080/15389588.2018.1487061; Wang RK, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2377-4; Xiong Y, 2019, MOL THER-NUCL ACIDS, V17, P223, DOI 10.1016/j.omtn.2019.06.001; Xue H, 2019, CARBOHYD POLYM, V226, DOI 10.1016/j.carbpol.2019.115302; Yang AJ, 2018, CELL PHYSIOL BIOCHEM, V48, P361, DOI 10.1159/000491742; Yang TY, 2012, J BONE JOINT SURG BR, V94B, P227, DOI 10.1302/0301-620X.94B2.28193; Zhang Wei, 2019, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V33, P1467, DOI 10.7507/1002-1892.201903073	60	2	2	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2162-2531			MOL THER-NUCL ACIDS	Mol. Ther.-Nucl. Acids	MAR 5	2021	23						1345	1359		10.1016/j.omtn.2021.02.008			15	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	WA8DO	WOS:000703114200001	33717654	hybrid, Green Published			2022-02-06	
J	Schiweck, J; Murk, K; Ledderose, J; Munster-Wandowski, A; Ornaghi, M; Vida, I; Eickholt, BJ				Schiweck, Juliane; Murk, Kai; Ledderose, Julia; Muenster-Wandowski, Agnieszka; Ornaghi, Marta; Vida, Imre; Eickholt, Britta J.			Drebrin controls scar formation and astrocyte reactivity upon traumatic brain injury by regulating membrane trafficking	NATURE COMMUNICATIONS			English	Article								The brain of mammals lacks a significant ability to regenerate neurons and is thus particularly vulnerable. To protect the brain from injury and disease, damage control by astrocytes through astrogliosis and scar formation is vital. Here, we show that brain injury in mice triggers an immediate upregulation of the actin-binding protein Drebrin (DBN) in astrocytes, which is essential for scar formation and maintenance of astrocyte reactivity. In turn, DBN loss leads to defective astrocyte scar formation and excessive neurodegeneration following brain injuries. At the cellular level, we show that DBN switches actin homeostasis from ARP2/3-dependent arrays to microtubule-compatible scaffolds, facilitating the formation of RAB8-positive membrane tubules. This injury-specific RAB8 membrane compartment serves as hub for the trafficking of surface proteins involved in astrogliosis and adhesion mediators, such as beta 1-integrin. Our work shows that DBN-mediated membrane trafficking in astrocytes is an important neuroprotective mechanism following traumatic brain injury in mice. Reactive astrocytes control tissue damage following traumatic brain injury. Here the authors show that Drebrin (DBN) regulates scar formation and astrocyte reactivity in mice. Astrocytic DBN plays its neuroprotective role through the mediation of membrane trafficking.	[Schiweck, Juliane; Murk, Kai; Ledderose, Julia; Ornaghi, Marta; Eickholt, Britta J.] Charite, Inst Biochem, Berlin, Germany; [Muenster-Wandowski, Agnieszka; Vida, Imre] Charite, Inst Anat, Berlin, Germany; [Eickholt, Britta J.] Charite, NeuroCure Cluster Excellence, Berlin, Germany		Murk, K; Eickholt, BJ (corresponding author), Charite, Inst Biochem, Berlin, Germany.; Eickholt, BJ (corresponding author), Charite, NeuroCure Cluster Excellence, Berlin, Germany.	kai.murk@charite.de; britta.eickholt@charite.de	Vida, Imre/F-8275-2012; Munster-Wandowski, Agnieszka/Q-5690-2016	Vida, Imre/0000-0003-3214-2233; Munster-Wandowski, Agnieszka/0000-0002-5401-0218; Eickholt, Britta/0000-0001-7873-8687; Murk, Kai/0000-0002-6573-4529; Schiweck, Juliane/0000-0001-9319-899X	Projekt DEAL	Open Access funding enabled and organized by Projekt DEAL.	Alekseeva O S, 2015, Zh Evol Biokhim Fiziol, V51, P313; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Aoki C, 2005, J COMP NEUROL, V483, P383, DOI 10.1002/cne.20449; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Barkers RA, 2018, NATURE, V557, P329, DOI 10.1038/s41586-018-0087-1; Berginski Matthew E, 2013, F1000Res, V2, P68, DOI 10.12688/f1000research.2-68.v1; Bowman SL, 2016, J CELL BIOL, V214, P797, DOI 10.1083/jcb.201512068; Butkevich E, 2004, CURR BIOL, V14, P650, DOI 10.1016/j.cub.2004.03.063; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Delevoye C, 2016, CURR BIOL, V26, P1, DOI 10.1016/j.cub.2015.11.020; Delevoye C, 2014, CELL REP, V6, P445, DOI 10.1016/j.celrep.2014.01.002; Demir K, 2013, CELL REP, V4, P1224, DOI 10.1016/j.celrep.2013.08.008; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Dun XP, 2012, MOL CELL NEUROSCI, V49, P341, DOI 10.1016/j.mcn.2012.01.006; Elizondo DM, 2019, IMMUNOLOGY, V156, P136, DOI 10.1111/imm.13010; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Frik J, 2018, EMBO REP, V19, DOI 10.15252/embr.201745294; Gautreau A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016832; Ginosyan AA, 2019, MOL BIOL CELL, V30, P646, DOI 10.1091/mbc.E18-10-0639; Grigoriev I, 2011, CURR BIOL, V21, P967, DOI 10.1016/j.cub.2011.04.030; Grintsevich EE, 2010, J MOL BIOL, V398, P542, DOI 10.1016/j.jmb.2010.03.039; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Hara M, 2017, NAT MED, V23, P818, DOI 10.1038/nm.4354; Hariri M, 2000, MOL BIOL CELL, V11, P255, DOI 10.1091/mbc.11.1.255; Hattula K, 2006, J CELL SCI, V119, P4866, DOI 10.1242/jcs.03275; He JT, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20193510; Hiroyasu S, 2016, FASEB J, V30, P2298, DOI 10.1096/fj.201500160R; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Koganezawa N, 2017, MOL CELL NEUROSCI, V84, P85, DOI 10.1016/j.mcn.2017.01.004; Kreis P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08420-w; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Li B, 2017, P NATL ACAD SCI USA, V114, pE3642, DOI 10.1073/pnas.1619266114; Li ZW, 2019, STRUCTURE, V27, P27, DOI 10.1016/j.str.2018.10.011; Lucas CH, 2014, NEUROSCI LETT, V558, P97, DOI 10.1016/j.neulet.2013.10.037; Martinet W, 2009, CIRC RES, V104, P304, DOI 10.1161/CIRCRESAHA.108.188318; Menzel-Severing J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28596-3; Mikati MA, 2013, J BIOL CHEM, V288, P19926, DOI 10.1074/jbc.M113.472647; Morizawa YM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00037-1; Murk K, 2013, J CELL SCI, V126, P3873, DOI 10.1242/jcs.125146; Naslavsky N, 2018, J CELL SCI, V131, DOI 10.1242/jcs.216499; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; North HA, 2015, J NEUROSCI, V35, P3725, DOI 10.1523/JNEUROSCI.4546-14.2015; Pannasch U, 2013, TRENDS NEUROSCI, V36, P405, DOI 10.1016/j.tins.2013.04.004; Pasqualin C, 2015, AM J PHYSIOL-CELL PH, V308, pC237, DOI 10.1152/ajpcell.00259.2014; Peranen J, 2011, CYTOSKELETON, V68, P527, DOI 10.1002/cm.20529; Puthenveedu MA, 2010, CELL, V143, P761, DOI 10.1016/j.cell.2010.10.003; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; Robel S, 2011, J NEUROSCI, V31, P12471, DOI 10.1523/JNEUROSCI.2696-11.2011; Robel S, 2009, GLIA, V57, P1630, DOI 10.1002/glia.20876; Ryan TA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01024; Sakane A, 2016, MOL BIOL CELL, V27, P3095, DOI 10.1091/mbc.E16-05-0332; Sakane A, 2012, J BIOL CHEM, V287, P42455, DOI 10.1074/jbc.M112.383653; Sasaki S, 2011, J NEUROPATH EXP NEUR, V70, P349, DOI 10.1097/NEN.0b013e3182160690; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Schiweck J, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00261; Schrotter S, 2016, J BIOL CHEM, V291, P10239, DOI 10.1074/jbc.M115.700138; Shafaq-Zadah M, 2016, NAT CELL BIOL, V18, P54, DOI 10.1038/ncb3287; Shandra O, 2019, J NEUROSCI, V39, P1944, DOI 10.1523/JNEUROSCI.1067-18.2018; Simonetti B, 2019, CURR OPIN CELL BIOL, V56, P22, DOI 10.1016/j.ceb.2018.08.006; Sirko S, 2015, GLIA, V63, P2340, DOI 10.1002/glia.22898; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sun W, 2017, J NEUROSCI, V37, P4493, DOI 10.1523/JNEUROSCI.3199-16.2017; Sun ZQ, 2016, J CELL BIOL, V215, P445, DOI 10.1083/jcb.201609037; Tabdanov ED, 2018, CELL REP, V25, P328, DOI 10.1016/j.celrep.2018.09.030; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Vacca B, 2014, HUM MOL GENET, V23, P2834, DOI 10.1093/hmg/ddt670; van Weering JRT, 2014, SEMIN CELL DEV BIOL, V31, P40, DOI 10.1016/j.semcdb.2014.03.015; Wang JTH, 2014, METHODSX, V1, P36, DOI 10.1016/j.mex.2014.05.002; Wang J, 2015, J NEUROSCI METH, V240, P67, DOI 10.1016/j.jneumeth.2014.11.001; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Wiley CA, 2016, J NEUROTRAUM, V33, P1866, DOI 10.1089/neu.2015.4272; Willmes CG, 2017, SCI REP-UK, V7, DOI 10.1038/srep42652; Wittenmayer N, 2009, P NATL ACAD SCI USA, V106, P13564, DOI 10.1073/pnas.0905819106; Worth DC, 2013, J CELL BIOL, V202, P793, DOI 10.1083/jcb.201303005; Wu LZ, 2014, DEV CELL, V30, P378, DOI 10.1016/j.devcel.2014.07.005; Xu WD, 2006, J BIOL CHEM, V281, P11826, DOI 10.1074/jbc.M510141200; Yang YJ, 2011, GLIA, V59, P200, DOI 10.1002/glia.21089; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	83	2	2	3	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2041-1723			NAT COMMUN	Nat. Commun.	MAR 5	2021	12	1							1490	10.1038/s41467-021-21662-x			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QU6TH	WOS:000627413200001	33674568	Green Published, gold			2022-02-06	
J	Holikova, K; Laakso, H; Salo, R; Shatillo, A; Nurmi, A; Bares, M; Vanicek, J; Michaeli, S; Mangia, S; Sierra, A; Grohn, O				Holikova, Klara; Laakso, Hanne; Salo, Raimo; Shatillo, Artem; Nurmi, Antti; Bares, Martin; Vanicek, Jiri; Michaeli, Shalom; Mangia, Silvia; Sierra, Alejandra; Grohn, Olli			RAFF-4, Magnetization Transfer and Diffusion Tensor MRI of Lysophosphatidylcholine Induced Demyelination and Remyelination in Rats	FRONTIERS IN NEUROSCIENCE			English	Article						myelin; demyelination; remyelination; MRI; diffusion; rotating frame relaxation	MYELIN; RELAXATION; CONTRAST; T-2; CNS	Remyelination is a naturally occurring response to demyelination and has a central role in the pathophysiology of multiple sclerosis and traumatic brain injury. Recently we demonstrated that a novel MRI technique entitled Relaxation Along a Fictitious Field (RAFF) in the rotating frame of rank n (RAFFn) achieved exceptional sensitivity in detecting the demyelination processes induced by lysophosphatidylcholine (LPC) in rat brain. In the present work, our aim was to test whether RAFF4, along with magnetization transfer (MT) and diffusion tensor imaging (DTI), would be capable of detecting the changes in the myelin content and microstructure caused by modifications of myelin sheets around axons or by gliosis during the remyelination phase after LPC-induced demyelination in the corpus callosum of rats. We collected MRI data with RAFF4, MT and DTI at 3 days after injection (demyelination stage) and at 38 days after injection (remyelination stage) of LPC (n = 12) or vehicle (n = 9). Cell density and myelin content were assessed by histology. All MRI metrics detected differences between LPC-injected and control groups of animals in the demyelination stage, on day 3. In the remyelination phase (day 38), RAFF4, MT parameters, fractional anisotropy, and axial diffusivity detected signs of a partial recovery consistent with the remyelination evident in histology. Radial diffusivity had undergone a further increase from day 3 to 38 and mean diffusivity revealed a complete recovery correlating with the histological assessment of cell density attributed to gliosis. The combination of RAFF4, MT and DTI has the potential to differentiate between normal, demyelinated and remyelinated axons and gliosis and thus it may be able to provide a more detailed assessment of white matter pathologies in several neurological diseases.	[Holikova, Klara; Vanicek, Jiri] Masaryk Univ, St Annes Univ Hosp Brno, Dept Med Imaging, Brno, Czech Republic; [Holikova, Klara; Bares, Martin; Vanicek, Jiri] Masaryk Univ, Fac Med, Brno, Czech Republic; [Laakso, Hanne; Salo, Raimo; Sierra, Alejandra; Grohn, Olli] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Kuopio, Finland; [Shatillo, Artem; Nurmi, Antti] Charles River Labs, Kuopio, Finland; [Bares, Martin] Masaryk Univ, St Annes Univ Hosp Brno, Dept Neurol 1, Brno, Czech Republic; [Bares, Martin] Univ Minnesota, Sch Med, Dept Neurol, Minneapolis, MN 55455 USA; [Michaeli, Shalom; Mangia, Silvia] Univ Minnesota, Ctr Magnet Resonance Res, Minneapolis, MN USA		Grohn, O (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Kuopio, Finland.	olli.grohn@uef.fi	Bares, Martin/E-3700-2012	Bares, Martin/0000-0001-6846-6809; Salo, Raimo/0000-0003-3610-236X	European Union's Horizon 2020 Research and Innovation Programme Under the Marie Sklodowska-Curie GrantSKA South Africa [691110]; Academy of FinlandAcademy of FinlandEuropean Commission	This project was received funding from the European Union's Horizon 2020 Research and Innovation Programme Under the Marie Sklodowska-Curie Grant Agreement No. 691110 (MICROBRADAM) and Academy of Finland.	Armstrong RC, 2016, NEUROPHARMACOLOGY, V110, P654, DOI 10.1016/j.neuropharm.2015.04.029; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Benjamini Y., 1995, J ROY STAT SOC, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Chenevert TL, 2000, JNCI-J NATL CANCER I, V92, P2029, DOI 10.1093/jnci/92.24.2029; Dula AN, 2010, MAGN RESON MED, V63, P902, DOI 10.1002/mrm.22267; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Hakkarainen H, 2016, MAGN RESON MED, V75, P161, DOI 10.1002/mrm.25590; Heath F, 2018, DEV NEUROBIOL, V78, P136, DOI 10.1002/dneu.22552; HIRANO A, 1989, DEV NEUROSCI-BASEL, V11, P112, DOI 10.1159/000111892; Laitinen T, 2010, NEUROIMAGE, V51, P521, DOI 10.1016/j.neuroimage.2010.02.077; Leemans A., 2009, PROC INT SOC MAG RES, V17; Lehto LJ, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00433; Liimatainen T, 2015, MAGN RESON MED, V73, P254, DOI 10.1002/mrm.25129; Liimatainen T, 2011, J MAGN RESON, V209, P269, DOI 10.1016/j.jmr.2011.01.022; Liimatainen T, 2010, MAGN RESON MED, V64, P983, DOI 10.1002/mrm.22372; Luo T, 2019, J MAGN RESON IMAGING, V49, P1750, DOI 10.1002/jmri.26328; Mangia S, 2011, MAGN RESON IMAGING, V29, P1346, DOI 10.1016/j.mri.2011.04.002; Nasrabady SE, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0515-3; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Oluich LJ, 2012, J NEUROSCI, V32, P8317, DOI 10.1523/JNEUROSCI.1053-12.2012; Pfeiffer F, 2019, BRAIN PATHOL, V29, P675, DOI 10.1111/bpa.12748; Podbielska M, 2013, BRAIN SCI, V3, P1282, DOI 10.3390/brainsci3031282; PRINEAS JW, 1979, ANN NEUROL, V5, P22, DOI 10.1002/ana.410050105; Raine C., 1984, MYELIN, P1, DOI 10.1007/978-1-4757-1830-0_1; Saab AS, 2017, CURR OPIN NEUROBIOL, V47, P104, DOI 10.1016/j.conb.2017.09.013; Satzer D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116788; Seifert AC, 2017, NEUROIMAGE, V163, P358, DOI 10.1016/j.neuroimage.2017.09.054; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Tozer DJ, 2005, MAGN RESON MED, V53, P1415, DOI 10.1002/mrm.20479; van Zijl PCM, 2018, NEUROIMAGE, V168, P222, DOI 10.1016/j.neuroimage.2017.04.045; WAXMAN SG, 1979, J NEUROL SCI, V44, P45, DOI 10.1016/0022-510X(79)90221-1; Wilhelm MJ, 2012, P NATL ACAD SCI USA, V109, P9605, DOI 10.1073/pnas.1115107109; WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113; Woodruff RH, 1999, GLIA, V25, P216, DOI 10.1002/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L; Zhao C, 2005, J NEUROL SCI, V233, P87, DOI 10.1016/j.jns.2005.03.008	36	2	2	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	MAR 4	2021	15								625167	10.3389/fnins.2021.625167			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QY3WP	WOS:000629974200001	33746698	gold, Green Published			2022-02-06	
J	Wang, ZY; Wang, HC; Becker, R; Rufo, J; Yang, SJ; Mace, BE; Wu, MX; Zou, J; Laskowitz, DT; Huang, TJ				Wang, Zeyu; Wang, Haichen; Becker, Ryan; Rufo, Joseph; Yang, Shujie; Mace, Brian E.; Wu, Mengxi; Zou, Jun; Laskowitz, Daniel T.; Huang, Tony Jun			Acoustofluidic separation enables early diagnosis of traumatic brain injury based on circulating exosomes	MICROSYSTEMS & NANOENGINEERING			English	Article							UNITED-STATES; PARTICLE; BLOOD; CELLS; CARE	Traumatic brain injury (TBI) is a global cause of morbidity and mortality. Initial management and risk stratification of patients with TBI is made difficult by the relative insensitivity of screening radiographic studies as well as by the absence of a widely available, noninvasive diagnostic biomarker. In particular, a blood-based biomarker assay could provide a quick and minimally invasive process to stratify risk and guide early management strategies in patients with mild TBI (mTBI). Analysis of circulating exosomes allows the potential for rapid and specific identification of tissue injury. By applying acoustofluidic exosome separation-which uses a combination of microfluidics and acoustics to separate bioparticles based on differences in size and acoustic properties-we successfully isolated exosomes from plasma samples obtained from mice after TBI. Acoustofluidic isolation eliminated interference from other blood components, making it possible to detect exosomal biomarkers for TBI via flow cytometry. Flow cytometry analysis indicated that exosomal biomarkers for TBI increase in the first 24 h following head trauma, indicating the potential of using circulating exosomes for the rapid diagnosis of TBI. Elevated levels of TBI biomarkers were only detected in the samples separated via acoustofluidics; no changes were observed in the analysis of the raw plasma sample. This finding demonstrated the necessity of sample purification prior to exosomal biomarker analysis. Since acoustofluidic exosome separation can easily be integrated with downstream analysis methods, it shows great potential for improving early diagnosis and treatment decisions associated with TBI.	[Wang, Zeyu; Rufo, Joseph; Yang, Shujie; Wu, Mengxi; Huang, Tony Jun] Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27708 USA; [Wang, Haichen; Mace, Brian E.; Laskowitz, Daniel T.] Duke Univ, Dept Neurol, Durham, NC 27708 USA; [Becker, Ryan] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA; [Mace, Brian E.] Duke Univ, Dept Geriatr, Durham, NC 27708 USA; [Zou, Jun] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77840 USA		Huang, TJ (corresponding author), Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27708 USA.; Laskowitz, DT (corresponding author), Duke Univ, Dept Neurol, Durham, NC 27708 USA.	danl@neuro.duke.edu; tony.huang@duke.edu	Huang, Tony Jun/A-1546-2009; Yang, Shujie/AAC-8573-2019; Wu, Mengxi/R-1398-2018	Huang, Tony Jun/0000-0003-1205-3313; Yang, Shujie/0000-0003-2626-3397; Wu, Mengxi/0000-0003-0086-5349	United States Army Medical Research Acquisition Activity [W81XWH-18-1-0242]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UG3TR002978, R01GM132603, R01GM135486, R33CA223908, R01GM127714, R01HD086325]; National Science FoundationNational Science Foundation (NSF) [ECCS-1807601]; Duke Human Vaccine Institute Flow Cytometry Facility; Shared Materials Instrumentation Facility from Duke University	We acknowledge support from the United States Army Medical Research Acquisition Activity (W81XWH-18-1-0242), National Institutes of Health (UG3TR002978, R01GM132603, R01GM135486, R33CA223908, R01GM127714, and R01HD086325), and National Science Foundation (ECCS-1807601). We also acknowledge support from the Duke Human Vaccine Institute Flow Cytometry Facility and the Shared Materials Instrumentation Facility from Duke University.	Afzal M, 2020, ZOOL J LINN SOC-LOND, V188, P809; Baasch T, 2020, PHYS REV APPL, V14, DOI 10.1103/PhysRevApplied.14.024052; Baudoin M, 2020, ANNU REV FLUID MECH, V52, P205, DOI [10.1146/annurev-fluid-010719-060154, 10.1146/annurev-fluid-010719060154]; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Bode WN, 2020, MICROMACHINES-BASEL, V11, DOI 10.3390/mi11030292; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Bussiere V, 2019, ANAL CHEM, V91, P13978, DOI 10.1021/acs.analchem.9b03521; Collins DJ, 2015, LAB CHIP, V15, P3439, DOI 10.1039/c5lc00614g; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cox L, 2019, PHYS REV APPL, V12, DOI 10.1103/PhysRevApplied.12.064055; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fushimi T, 2019, APPL PHYS LETT, V115, DOI 10.1063/1.5113467; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Goetzl L, 2018, ANN CLIN TRANSL NEUR, V5, P4, DOI 10.1002/acn3.499; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kadimisetty K, 2018, BIOSENS BIOELECTRON, V109, P156, DOI 10.1016/j.bios.2018.03.009; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Laskowitz DT, 2010, J NEUROTRAUM, V27, P1983, DOI 10.1089/neu.2010.1396; Li DR, 2012, LEGAL MED-TOKYO, V14, P84, DOI 10.1016/j.legalmed.2011.12.007; Li P, 2019, ANAL CHEM, V91, P757, DOI 10.1021/acs.analchem.8b03786; Liu XL, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18113796; Ma ZC, 2020, ADV MATER, V32, DOI 10.1002/adma.201904181; Manek R, 2018, MOL NEUROBIOL, V55, P6112, DOI 10.1007/s12035-017-0821-y; Olofsson K, 2018, LAB CHIP, V18, P2466, DOI 10.1039/c8lc00537k; Olson D, 2011, THER HYPOTHERMIA TEM, V1, DOI 10.1089/ther.2011.0014; Ozcelik A, 2018, NAT METHODS, V15, P1021, DOI 10.1038/s41592-018-0222-9; Reboud J, 2012, P NATL ACAD SCI USA, V109, P15162, DOI 10.1073/pnas.1206055109; Rekker K, 2014, CLIN BIOCHEM, V47, P135, DOI 10.1016/j.clinbiochem.2013.10.020; Saeidi D, 2019, J ACOUST SOC AM, V145, P3311, DOI 10.1121/1.5110303; Schneider A, 2013, CELL TISSUE RES, V352, P33, DOI 10.1007/s00441-012-1428-2; Shaglwf Z, 2019, J ACOUST SOC AM, V145, P945, DOI 10.1121/1.5090499; Nguyen TD, 2020, SENSOR ACTUAT B-CHEM, V318, DOI 10.1016/j.snb.2020.128143; Tayebi M, 2020, ANAL CHEM, V92, P10733, DOI 10.1021/acs.analchem.0c02006; Taylor DD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0503; Tian ZH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14553-0; Tian ZH, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau6062; Van Assche D, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60338-2; Wang TY, 2013, LAB CHIP, V13, P4190, DOI 10.1039/c3lc50783a; Wang ZY, 2020, J MOL DIAGN, V22, P50, DOI 10.1016/j.jmoldx.2019.08.004; Wang ZY, 2019, LAB CHIP, V19, P4021, DOI 10.1039/c9lc00498j; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Winston Charisse N, 2016, Alzheimers Dement (Amst), V3, P63, DOI 10.1016/j.dadm.2016.04.001; Wu MX, 2019, MICROSYST NANOENG, V5, DOI 10.1038/s41378-019-0064-3; Wu MX, 2017, P NATL ACAD SCI USA, V114, P10584, DOI 10.1073/pnas.1709210114; Xiong Y, 2017, NEURAL REGEN RES, V12, P19, DOI 10.4103/1673-5374.198966; Yeo LY, 2014, ANNU REV FLUID MECH, V46, P379, DOI 10.1146/annurev-fluid-010313-141418; Zhang ML, 2018, ACS SENSORS, V3, P1584, DOI 10.1021/acssensors.8b00412; Zhang PR, 2020, ANNU REV ANAL CHEM, V13, P17, DOI 10.1146/annurev-anchem-090919-102205; Zhang SP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05297-z; Zhao Z, 2016, LAB CHIP, V16, P489, DOI 10.1039/c5lc01117e	50	2	2	1	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2055-7434			MICROSYST NANOENG	Microsyst. Nanoeng.	MAR 3	2021	7	1							20	10.1038/s41378-021-00244-3			11	Nanoscience & Nanotechnology; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Instruments & Instrumentation	QS7XE	WOS:000626107800002	34567734	Green Published, gold			2022-02-06	
J	Liu, XS; Xie, YX; Wan, XD; Wu, JL; Fan, ZZ; Yang, LJ				Liu, Xiaosong; Xie, Yingxin; Wan, Xiangdong; Wu, Jianliang; Fan, Zhenzeng; Yang, Lijun			Protective Effects of Aquaporin-4 Deficiency on Longer-term Neurological Outcomes in a Mouse Model	NEUROCHEMICAL RESEARCH			English	Article						Traumatic brain injury (TBI); Aquaporin-4 (AQP4); Glymphatic system; Inflammation		Traumatic brain injury (TBI) has been a crucial health problem, with more than 50 million patients worldwide each year. Glymphatic system is a fluid exchange system that relies on the polarized water channel aquaporin-4 (AQP4) at the astrocytes, accounting for the clearance of abnormal proteins and metabolites from brain tissues. However, the dysfunction of glymphatic system and alteration of AQP4 polarization during the progression of TBI remain unclear. AQP4(-/-) and Wild Type (WT) mice were used to establish the TBI mouse model respectively. Brain edema and Evans blue extravasation were conducted 24 h post-injury to evaluate the acute TBI. Morris water maze (MWM) was used to establish the long-term cognitive functions of AQP4(-/-) and WT mice post TBI. Western-blot and qRT-PCR assays were performed to demonstrate protective effects of AQP4 deficiency to blood-brain barrier (BBB) integrity and amyloid-beta clearance. The inflammation of cerebral tissues post TBI was estimated by ELISA assay. AQP4 deficiency alleviated the brain edema and neurological deficit in TBI mice. AQP4-knockout led to improved cognitive outcomes in mice post TBI. The BBB integrity and cerebral amyloid-beta clearance were protected by AQP4 deficiency in TBI mice. AQP4 deficiency ameliorated the TBI-induced inflammation. AQP4 deficiency improved longer-term neurological outcomes in a mouse model of TBI.	[Liu, Xiaosong; Wan, Xiangdong; Wu, Jianliang; Fan, Zhenzeng; Yang, Lijun] Hebei Med Univ, Dept Neurosurg, Hosp 2, 215 Heping Rd, Shijiazhuang 050000, Hebei, Peoples R China; [Xie, Yingxin] Hebei Med Univ, Dept Doppler Ultrasound, Hosp 2, 215 Heping Rd, Shijiazhuang 050000, Hebei, Peoples R China		Yang, LJ (corresponding author), Hebei Med Univ, Dept Neurosurg, Hosp 2, 215 Heping Rd, Shijiazhuang 050000, Hebei, Peoples R China.	yanglijun1981@163.com			Natural Science Foundation of Hebei Province, ChinaNatural Science Foundation of Hebei Province [H2018206325, H2020206543]	The study was supported by the Natural Science Foundation of Hebei Province, China (H2018206325 and H2020206543).	Araki T, 2017, NEUROL MED-CHIR, V57, P82, DOI 10.2176/nmc.ra.2016-0191; Araki Y, 2021, NEUROSURG REV, V44, P2785, DOI 10.1007/s10143-020-01459-0; Ayton S, 2014, FREE RADICAL BIO MED, V69, P331, DOI 10.1016/j.freeradbiomed.2014.01.041; Benveniste H, 2019, GERONTOLOGY, V65, P106, DOI 10.1159/000490349; Biswas S, 2021, CHEMOSPHERE, V270, DOI 10.1016/j.chemosphere.2020.129438; Bomyea J, 2017, J HEAD TRAUMA REHAB, V32, pE35, DOI 10.1097/HTR.0000000000000278; Donnelly JE, 2017, CHILD NERV SYST, V33, P1735, DOI 10.1007/s00381-017-3523-x; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gatson JW, 2013, J NEUROSURG, V118, P1336, DOI 10.3171/2013.2.JNS121771; Gluchowska K, 2021, BIOCHEM BIOPH RES CO, V540, P8, DOI 10.1016/j.bbrc.2020.12.067; Goodman JR, 2020, J CEREBR BLOOD F MET, V40, P1724, DOI 10.1177/0271678X19874134; He XF, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00144; Hubbard JA, 2018, BRAIN RES BULL, V136, P118, DOI 10.1016/j.brainresbull.2017.02.011; Iliff J, 2019, J PHYSIOL-LONDON, V597, P4417, DOI 10.1113/JP277635; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Katada R, 2014, FASEB J, V28, P705, DOI 10.1096/fj.13-231274; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Marklund N, 2014, J NEUROTRAUM, V31, P42, DOI 10.1089/neu.2013.2964; Mestre H, 2018, ELIFE, V7, DOI 10.7554/eLife.40070; Miles SR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184265; Miszczuk D, 2016, MOL NEUROBIOL, V53, P7010, DOI 10.1007/s12035-015-9578-3; Mortensen KN, 2019, J NEUROSCI, V39, P6365, DOI 10.1523/JNEUROSCI.1974-18.2019; Noggle CA, 2010, APPL NEUROPSYCHOL, V17, P123, DOI 10.1080/09084281003709009; Oberholzer Michael, 2019, Med Sci (Basel), V7, DOI 10.3390/medsci7030047; Plog BA, 2018, ANNU REV PATHOL-MECH, V13, P379, DOI 10.1146/annurev-pathol-051217-111018; Popernack ML, 2015, J PEDIATR HEALTH CAR, V29, pE1, DOI 10.1016/j.pedhc.2014.09.003; Shi S, 2016, J ALZHEIMERS DIS, V50, P859, DOI 10.3233/JAD-150963; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Stein DM, 2017, CRIT CARE CLIN, V33, P1, DOI 10.1016/j.ccc.2016.08.008; Wang YB, 2018, J NEUROTRAUM, V35, P105, DOI 10.1089/neu.2017.5024; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003; Yuan F, 2016, J NEUROCHEM, V136, P581, DOI 10.1111/jnc.13423; Zeiler FA, 2020, BRIT J ANAESTH, V124, P440, DOI 10.1016/j.bja.2019.11.031	35	2	2	2	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	JUN	2021	46	6					1380	1389		10.1007/s11064-021-03272-7		MAR 2021	10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	RV2KJ	WOS:000624381600001	33651262				2022-02-06	
J	Andelic, N; Roe, C; Tenovuo, O; Azouvi, P; Dawes, H; Majdan, M; Ranta, J; Howe, EI; Wiegers, EJA; Tverdal, C; Borgen, I; Forslund, MV; Kleffelgaard, I; Dahl, HM; Jacob, L; Cogne, M; Lu, J; von Steinbuechel, N; Zeldovich, M				Andelic, Nada; Roe, Cecilie; Tenovuo, Olli; Azouvi, Philippe; Dawes, Helen; Majdan, Marek; Ranta, Jukka; Howe, Emilie I.; Wiegers, Eveline J. A.; Tverdal, Cathrine; Borgen, Ida; Forslund, Marit V.; Kleffelgaard, Ingerid; Dahl, Hilde M.; Jacob, Louis; Cogne, Melanie; Lu, Juan; von Steinbuechel, Nicole; Zeldovich, Marina		CENTER-TBI Participants	Unmet Rehabilitation Needs after Traumatic Brain Injury across Europe: Results from the CENTER-TBI Study	JOURNAL OF CLINICAL MEDICINE			English	Article						rehabilitation needs; traumatic brain injury; disability; outcome	SERVICE UTILIZATION; HEALTH-CARE; CHAINED EQUATIONS; MULTIPLE INJURIES; MENTAL-HEALTH; HEAD-INJURY; SEVERITY; PREDICTORS; DISABILITY; DEFINITION	This study aims to assess rehabilitation needs and provision of rehabilitation services for individuals with moderate-to-severe disability and investigate factors influencing the probability of receiving rehabilitation within six months after traumatic brain injury (TBI). Overall, the analyses included 1206 individuals enrolled in the CENTER-TBI study with severe-to-moderate disability. Impairments in five outcome domains (daily life activities, physical, cognition, speech/language, and psychological) and the use of respective rehabilitation services (occupational therapy, physiotherapy, cognitive and speech therapies, and psychological counselling) were recorded. Sociodemographic and injury-related factors were used to investigate the probability of receiving rehabilitation. Physiotherapy was the most frequently provided rehabilitation service, followed by speech and occupational therapy. Psychological counselling was the least frequently accessed service. The probability of receiving a rehabilitative intervention increased for individuals with greater brain injury severity (odds ratio (OR) 1.75, CI 95%: 1.27-2.42), physical (OR 1.92, CI 95%: 1.21-3.05) and cognitive problems (OR 4.00, CI 95%: 2.34-6.83) but decreased for individuals reporting psychological problems (OR 0.57, CI 95%: 1.21-3.05). The study results emphasize the need for more extensive prescription of rehabilitation services for individuals with disability. Moreover, targeted rehabilitation programs, which aim to improve outcomes, should specifically involve psychological services to meet the needs of individuals recovering from TBI.	[Andelic, Nada; Roe, Cecilie; Howe, Emilie I.; Borgen, Ida; Forslund, Marit V.; Kleffelgaard, Ingerid] Oslo Univ Hosp, Dept Phys Med & Rehabil, N-0424 Oslo, Norway; [Andelic, Nada; Roe, Cecilie] Univ Oslo, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Fac Med, Inst Hlth & Soc, N-0373 Oslo, Norway; [Roe, Cecilie; Howe, Emilie I.; Tverdal, Cathrine; Dahl, Hilde M.] Univ Oslo, Inst Clin Med, Fac Med, N-0318 Oslo, Norway; [Tenovuo, Olli] Univ Turku, Turku Univ Hosp, Turku Brain Injury Ctr, Turku 20500, Finland; [Tenovuo, Olli] Univ Turku, Clin Neurosci, Turku 20500, Finland; [Azouvi, Philippe] Hop Raymond Poincare, AP HP, GH Paris Saclay, F-92380 Garches, France; [Azouvi, Philippe] Univ Paris Saclay, UVSQ, INSERM, CESP,UMR 1018,Team DevPsy, F-94807 Villejuif, France; [Dawes, Helen] Oxford Brookes Univ Oxford, Oxford Inst Nursing Midwifery & Allied Hlth Res, Ctr Movement Occupat & Rehabil Sci, Oxford OX3 0BP, England; [Dawes, Helen] Oxford Hlth NHS Fdn Trust, Oxford Hlth Biomed Res Ctr, Oxford OX3 7JX, England; [Majdan, Marek] Trnava Univ, Fac Hlth Sci & Social Work, Inst Global Hlth & Epidemiol, Dept Publ Hlth, Trnava 91843, Slovakia; [Ranta, Jukka] VTT Tech Res Ctr Finland Ltd, FI-02044 Espoo, Finland; [Wiegers, Eveline J. A.] Univ Med Ctr, Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Tverdal, Cathrine] Oslo Univ Hosp, Dept Neurosurg, N-0424 Oslo, Norway; [Borgen, Ida] Univ Oslo, Fac Social Sci, Dept Psychol, N-0424 Oslo, Norway; [Dahl, Hilde M.] Oslo Univ Hosp, Dept Child Neurol, N-0424 Oslo, Norway; [Jacob, Louis] Univ Versailles St Quentin En Yvelines, Fac Med, F-78035 Versailles, France; [Jacob, Louis] Univ Barcelona, CIBERSAM, Parc Sanitari St Joan Deu, Res & Dev Unit, Barcelona 08830, Spain; [Cogne, Melanie] Univ Hosp Rennes, Phys & Rehabil Med Dept, 2 Rue Henri Le Guilloux, F-35000 Rennes, France; [Lu, Juan] Univ Richmond, Virginia Commonwealth, Div Epidemiol, Dept Family Med & Populat Hlth, Richmond, VA 23173 USA; [von Steinbuechel, Nicole; Zeldovich, Marina] Univ Med Ctr Gottingen, Inst Med Psychol & Med Sociol, D-37073 Gottingen, Germany		Andelic, N (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, N-0424 Oslo, Norway.; Andelic, N (corresponding author), Univ Oslo, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Fac Med, Inst Hlth & Soc, N-0373 Oslo, Norway.; Zeldovich, M (corresponding author), Univ Med Ctr Gottingen, Inst Med Psychol & Med Sociol, D-37073 Gottingen, Germany.	NADAND@ous-hf.no; CEROEE@ous-hf.no; olli.tenovuo@pp.inet.fi; philippe.azouvi@aphp.fr; hdawes@brookes.ac.uk; mmajdan@truni.sk; Jukka.Ranta@vtt.fi; emihow@ous-hf.no; e.wiegers@erasmusmc.nl; UXTVEC@ous-hf.no; idmbor@ous-hf.no; mavfor@ous-hf.no; UXINFF@ous-hf.no; hilde@legesiden.no; louis.jacob.contacts@gmail.com; melaniecogne@hotmail.fr; juan.lu@vcuhealth.org; nvsteinbuechel@med.uni-goettingen.de; marina.zeldovich@med.uni-goettingen.de	Jacob, Louis/AAL-3956-2020; Posti, Jussi P./Y-2908-2019	Jacob, Louis/0000-0003-1071-1239; Posti, Jussi P./0000-0002-5925-5193; Howe, Emilie Isager/0000-0003-1587-5873; Dahl, Hilde Margrete/0000-0003-2634-2589; Zeldovich, Marina/0000-0003-0172-9904; Tverdal, Cathrine/0000-0002-1094-3825	European Union 7th Framework program (EC) [247 602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA); Elizabeth Casson Trust; NIHR Oxford Health Biomedical Research Centre	The data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Union 7th Framework program (EC grant 247 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA) and from Integra LifeSciences Corporation (USA). Helen Dawes is supported by the Elizabeth Casson Trust and the NIHR Oxford Health Biomedical Research Centre.	Althubaiti A, 2016, J MULTIDISCIP HEALTH, V9, P211, DOI 10.2147/JMDH.S104807; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th; Andelic N, 2020, J REHABIL MED, V52, DOI 10.2340/16501977-2662; Andelic N, 2014, PM&R, V6, P1013, DOI 10.1016/j.pmrj.2014.05.005; Andelic N, 2014, J NEUROTRAUM, V31, P1313, DOI 10.1089/neu.2013.3292; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Arnould A, 2016, ANN PHYS REHABIL MED, V59, P18, DOI 10.1016/j.rehab.2015.09.002; Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BAMBER D, 1975, J MATH PSYCHOL, V12, P387, DOI 10.1016/0022-2496(75)90001-2; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Cnossen MC, 2017, J REHABIL MED, V49, P395, DOI 10.2340/16501977-2216; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Gennarelli TA., 2008, ABBREVIATED INJURY S; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Heinze G, 2017, TRANSPL INT, V30, P6, DOI 10.1111/tri.12895; Heymans M., **DATA OBJECT**; Jacob L, 2020, NEUROREHAB NEURAL RE, V34, P814, DOI 10.1177/1545968320946038; Jennekens N, 2010, J CLIN NURS, V19, P1198, DOI 10.1111/j.1365-2702.2009.03114.x; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Johnstone B, 2002, J RURAL HEALTH, V18, P109, DOI 10.1111/j.1748-0361.2002.tb00882.x; Jourdan C, 2015, BRAIN INJURY, V29, P701, DOI 10.3109/02699052.2015.1004646; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Mandrekar JN, 2010, J THORAC ONCOL, V5, P1315, DOI 10.1097/JTO.0b013e3181ec173d; Mayhew D, 2019, ANAESTHESIA, V74, P373, DOI 10.1111/anae.14569; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Phillips VL, 2004, J HEAD TRAUMA REHAB, V19, P217, DOI 10.1097/00001199-200405000-00003; Ponsford J, 2021, J NEUROTRAUM, V38, P1060, DOI 10.1089/neu.2020.7299; Pradat-Diehl P., 2012, Annals of Physical and Rehabilitation Medicine, V55, P546, DOI 10.1016/j.rehab.2012.07.002; Prang KH, 2012, BRAIN INJURY, V26, P1611, DOI 10.3109/02699052.2012.698790; R Core Team, 2021, R LANG ENV STAT COMP; Rathmann K, 2020, REHABILITATION, V59, P223, DOI 10.1055/a-1119-2905; Rubin D., 1987, MULTIPLE IMPUTATION; Sauerbrei W, 2007, STAT MED, V26, P5512, DOI 10.1002/sim.3148; Schumacher R, 2016, BRAIN INJURY, V30, P1186, DOI 10.1080/02699052.2016.1183821; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Soberg HL, 2008, J REHABIL MED, V40, P340, DOI 10.2340/16501977-0174; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Sveen U, 2016, EUR J PHYS REHAB MED, V52, P650; Ta'eed G, 2015, NEUROPSYCHOL REHABIL, V25, P841, DOI 10.1080/09602011.2014.990043; TEASDALE G, 1974, LANCET, V2, P81; Turner-Stokes L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub3; van Buuren S, 2011, J STAT SOFTW, V45, P1; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Voormolen DC, 2018, J NEUROTRAUM, V35, P1233, DOI 10.1089/neu.2017.5257; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Wilson L, 2017, J NEUROTRAUM, V34, P59, DOI 10.1089/neu.2015.4287	57	2	2	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	MAR	2021	10	5							1035	10.3390/jcm10051035			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QV8UR	WOS:000628240000001	33802336	gold, Green Published			2022-02-06	
J	Bogdanov, S; Brookes, N; Epps, A; Naismith, SL; Teng, A; Lah, S				Bogdanov, Stefan; Brookes, Naomi; Epps, Adrienne; Naismith, Sharon L.; Teng, Arthur; Lah, Suncica			Fatigue in Children With Moderate or Severe Traumatic Brain Injury Compared With Children With Orthopedic Injury: Characteristics and Associated Factors	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adolescence; brain injuries; child; fatigue; sleep		Objective: To characterize fatigue in children with moderate or severe traumatic brain injury (TBI) and to identify associated factors. Setting: Urban tertiary pediatric healthcare facility. Participants: Children aged 5 to 15 years with a moderate TBI (n = 21), severe TBI (n = 23), or an orthopedic injury (OI; n = 38). Design: Case-control study. Main Measures: (i) Pediatric Quality of Life Inventory Multidimensional Fatigue Scale (PedsQL-MFS), completed by parents and children; (ii) Sleep Disturbance Scale for Children, completed by parents. Data on injury-specific factors and other factors of interest were also collected. Results: The 2 TBI groups did not differ on any of the fatigue outcomes (child or parent ratings). Relative to the OI group, parents rated children in both TBI groups as experiencing greater fatigue. However, on self-ratings, only children with moderate TBI endorsed greater fatigue. Sleep was commonly associated with fatigue, with child sleep disturbance and child sleep hygiene associated with parent-rated and self-rated child fatigue, respectively. Individually, there were no cases of "normal" fatigue coinciding with severe sleep disturbance. However, there were several cases of severe fatigue coinciding with normal sleep. Additional factors associated with fatigue were older age at injury, longer time since injury, and/or greater internalizing difficulties. Conclusion: Children with moderate and severe TBI experience greater fatigue than OI controls. Parent and child ratings of fatigue appear to be associated with different factors, indicating that fatigue management may require a broad range of treatments.	[Bogdanov, Stefan; Lah, Suncica] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Brookes, Naomi; Epps, Adrienne] Sydney Childrens Hosp, Rehab2Kids Rehabil Unit, Randwick, NSW, Australia; [Teng, Arthur] Sydney Childrens Hosp, Dept Sleep Med, Randwick, NSW, Australia; [Naismith, Sharon L.] Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia; [Naismith, Sharon L.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia; [Teng, Arthur] Univ New South Wales, Sch Paediat & Womens Hlth, Kensington, NSW, Australia; [Lah, Suncica] Macquarie Univ, ARC Ctr Excellence Cognit & Its Disorders, Macquarie Pk, NSW, Australia		Bogdanov, S (corresponding author), Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia.	sbog4215@uni.sydney.edu.au; Naomi.Brookes@health.nsw.gov.au; adrienne.epps@health.nsw.gov.au; sharon.naismith@sydney.edu.au; arthur.teng@health.nsw.gov.au; suncica.lah@sydney.edu.au		Naismith, Sharon/0000-0001-9076-2778			Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Achenbach T. M., 2000, MANUAL ASEBA PRESCHO, V30; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Bogdanov S, 2019, J HEAD TRAUMA REHAB, V34, P122, DOI 10.1097/HTR.0000000000000426; Bruni O, 1996, J SLEEP RES, V5, P251, DOI 10.1111/j.1365-2869.1996.00251.x; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Colville GA, 2019, PEDIATR CRIT CARE ME, V20, pE98, DOI 10.1097/PCC.0000000000001794; Crichton A, 2018, J HEAD TRAUMA REHAB, V33, P200, DOI 10.1097/HTR.0000000000000330; Crichton A, 2018, J INT NEUROPSYCH SOC, V24, P224, DOI 10.1017/S1355617717000893; Crichton AJ, 2017, J HEAD TRAUMA REHAB, V32, P107, DOI 10.1097/HTR.0000000000000248; DeLuca J, 2005, ISS CLIN COGN NEUROP, P1; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0939; Ferreira VR, 2009, SLEEP MED, V10, P457, DOI 10.1016/j.sleep.2008.03.018; Fischer JT, 2018, NEUROPSYCHOLOGY, V32, P161, DOI 10.1037/neu0000420; Harsh JR, 2002, SLEEP, V25, pA316; Henderson JA, 2010, J PSYCHOPATHOL BEHAV, V32, P271, DOI 10.1007/s10862-009-9143-3; Hicks CL, 2001, PAIN, V93, P173, DOI 10.1016/S0304-3959(01)00314-1; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Lah S, 2021, NEUROPSYCHOL REHABIL, V31, P345, DOI 10.1080/09602011.2019.1693404; Leavitt VM, 2010, PM&R, V2, P332, DOI 10.1016/j.pmrj.2010.03.027; LeBourgeois MK, 2005, PEDIATRICS, V115, P257, DOI 10.1542/peds.2004-0815H; Lewandowski AS, 2011, J PEDIATR PSYCHOL, V36, P780, DOI 10.1093/jpepsy/jsq119; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Rogers V.E., 2017, AUSTIN PEDIAT, V4, P1, DOI [10.26420/austinpediatr.2017.1056, DOI 10.26420/AUSTINPEDIATR.2017.1056]; Saez-Francas N, 2012, PSYCHIAT RES, V200, P748, DOI 10.1016/j.psychres.2012.04.041; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Spruyt K, 2011, SLEEP MED REV, V15, P19, DOI 10.1016/j.smrv.2010.07.005; Stores G, 2013, DEV MED CHILD NEUROL, V55, P797, DOI 10.1111/dmcn.12163; Storfer-Isser A, 2013, J SLEEP RES, V22, P707, DOI 10.1111/jsr.12059; Vandeleur M, 2017, J PEDIATR-US, V182, P170, DOI 10.1016/j.jpeds.2016.11.069; Varni JW, 2004, J RHEUMATOL, V31, P2494; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Young JL, 2007, PSYCHOPHARMACOL BULL, V40, P118; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	49	2	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2021	36	2			SI		E108	E117		10.1097/HTR.0000000000000585			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RH9OM	WOS:000636539100009	32769830				2022-02-06	
J	Chen, H; Li, Y; Jiang, B; Zhu, GM; Rezaii, PG; Lu, G; Wintermark, M				Chen, Hui; Li, Ying; Jiang, Bin; Zhu, Guangming; Rezaii, Paymon Garakani; Lu, Gang; Wintermark, Max			Demographics and clinical characteristics of acute traumatic brain injury patients in the different Neuroimaging Radiological Interpretation System (NIRIS) categories	JOURNAL OF NEURORADIOLOGY			English	Article						Traumatic brain injury; TBI; Computed tomography; CT; Demographics; Clinical characteristics	GLASGOW COMA SCALE; PROGNOSTIC VALUE; UNITED-STATES; CLASSIFICATION; VALIDATION; PREDICTION; VISITS; IMPACT; MILD; CT	Purpose. - To characterize the demographics, clinical and imaging findings, and outcomes of traumatic brain injury (TBI) patients in each of NeuroImaging Radiological Interpretation System (NIRIS) categories. Material and methods. - We considered all consecutive patients transported to Stanford Hospital's emergency department by ambulance or helicopter between November 2015 and April 2017. We retained adult patients (> 18 years old) for whom a trauma alert was triggered and who underwent a non-contrast head computer tomography (CT) because of suspected TBI. We reviewed the non-contrast CT scans in these patients for the NIH TBI common data elements (CDEs). We recorded, then assessed differences in terms of demographics, clinical characteristics, imaging CDEs, and outcomes in patients from the different NIRIS categories. Results. - In all, 1152 patients were included in this study. Patients with NIRIS 0 imaging findings were significantly younger than patients in other NIRIS categories (P < 0.001). Motor vehicle accidents and falls from height were the most common mechanisms of injury across NIRIS categories. GCS scores decreased with increasing NIRIS category imaging findings and were significantly lower in patients with NIRIS 4 imaging findings (P < 0.001). Significant differences in NIRIS categories were observed for all imaging CDEs (P < 0.001), in agreement with the definition of the different NIRIS categories. Mortality increased progressively with increasing NIRIS severity. Conclusions. - TBI patients in different NIRIS categories have different clinical characteristics, hospital courses and outcomes. This natural history assessment of patients from different NIRIS categories could thus serve as a reference standard for future TBI clinical trials. (c) 2019 Elsevier Masson SAS. All rights reserved.	[Chen, Hui; Li, Ying; Jiang, Bin; Zhu, Guangming; Rezaii, Paymon Garakani; Wintermark, Max] Stanford Univ, Sch Med, Dept Radiol, Neuroradiol Sect, 300 Pasteur Dr,Grant-S047, Palo Alto, CA 94305 USA; [Chen, Hui] Beijing Chaoyang Integrat Med Emergency Med Ctr, Encephalopathy Ctr, Beijing 100122, Peoples R China; [Li, Ying] PLA Army Gen Hosp, Dept Neurol, Beijing 100700, Peoples R China; [Lu, Gang] Beijing Chaoyang Integrat Med Emergency Med Ctr, Dept Reparat & Reconstruct Surg, Beijing 100122, Peoples R China		Wintermark, M (corresponding author), Stanford Univ, Sch Med, Dept Radiol, Neuroradiol Sect, 300 Pasteur Dr,Grant-S047, Palo Alto, CA 94305 USA.	max.wintermark@gmail.com	Chen, Hui/AAD-7653-2019; Chen, Hui/AAU-9464-2021	Chen, Hui/0000-0002-4479-0185; 	National Natural Science Foundations of ChinaNational Natural Science Foundation of China (NSFC) [81771273]	Dr. Hui Chen is supported by a grant from the National Natural Science Foundations of China (Grant No. 81771273).	[Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; Bragge P, 2016, J NEUROTRAUM, V33, P1461, DOI 10.1089/neu.2015.4233; Brophy GM, 2013, J NEUROTRAUM, V30, P1484, DOI 10.1089/neu.2012.2524; CDC, 2016, TRAUMATIC BRAIN INJU; Faul M, EPIDEMIOLOGY TRAUMAT; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Hawryluk GWJ, 2016, NEUROSURG CLIN N AM, V27, P375, DOI 10.1016/j.nec.2016.05.002; Howard RB, 2017, J NEUROTRAUM, V34, P1915, DOI 10.1089/neu.2015.4179; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laskowski RA, 2015, BRAINNEUROTRAUMA MOL; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P42, DOI 10.1017/S0317167100006296; Saika A, 2015, ACTA NEUROCHIR, V157, P1323, DOI 10.1007/s00701-015-2469-6; Stanford Health Care LPCsHS, 2016, TRAUMA GUIDLINES; Stead LG, 2009, NEUROCRIT CARE, V10, P50, DOI 10.1007/s12028-008-9145-0; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; van Dijck JT, 2018, J NEUROSURG SCI, V62, P153, DOI 10.23736/S0390-5616.17.04255-2; Wintermark M, 2018, J NEUROTRAUM, V35, P2665, DOI 10.1089/neu.2017.5311; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304	31	2	2	1	1	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0150-9861	1773-0406		J NEURORADIOLOGY	J. Neuroradiol.	MAR	2021	48	2					104	111		10.1016/j.neurad.2019.07.002			8	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	RB3VX	WOS:000632043500006	31323305				2022-02-06	
J	Chitturi, J; Santhakumar, V; Kannurpatti, SS				Chitturi, Jyothsna; Santhakumar, Vijayalakshmi; Kannurpatti, Sridhar S.			Traumatic brain injury metabolome and mitochondrial impact after early stage Ru360 treatment	MITOCHONDRION			English	Article						Traumatic brain injury; Mitochondria; Metabolomics; Oxidative stress; Ru360; Calcium uniporter	CALCIUM HOMEOSTASIS; GLUCOSE-METABOLISM; N-ACETYLASPARTATE; CA2+ UNIPORTER; NEUROPROTECTION; METABOANALYST; DYSFUNCTION; RELEVANCE; INFLUX; TOOL	Ru360, a mitochondrial Ca2+ uptake inhibitor, was tested in a unilateral fluid percussion TBI model in developing rats (P31). Vehicle and Ru360 treated TBI rats underwent sensorimotor behavioral monitoring between 24 and 72 h, thereafter which 185 brain metabolites were analyzed postmortem using LC/MS. Ru360 treatment after TBI improved sensorimotor behavioral recovery, upregulated glycolytic and pentose phosphate pathways, mitigated oxidative stress and prevented NAD+ depletion across both hemispheres. While neural viability improved ipsilaterally, it reduced contralaterally. Ru360 treatment, overall, had a global impact with most benefit near the strongest injury impact areas, while perturbing mitochondrial oxidative energetics in the milder TBI impact areas.	[Chitturi, Jyothsna; Kannurpatti, Sridhar S.] Rutgers New Jersey Med Sch, Dept Radiol, Adm Complex Bldg 5 ADMC5,30 Bergen St Room 575, Newark, NJ 07101 USA; [Santhakumar, Vijayalakshmi] Rutgers New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, MSB H-512,185 S Orange Ave, Newark, NJ 07103 USA; [Santhakumar, Vijayalakshmi] Univ Calif Riverside, Mol Cell & Syst Biol, Spieth 1308,3401 Watkins Dr, Riverside, CA 92521 USA		Kannurpatti, SS (corresponding author), Rutgers New Jersey Med Sch, Dept Radiol, Adm Complex Bldg 5 ADMC5,30 Bergen St Room 575, Newark, NJ 07101 USA.	jc2248@njms.rutgers.edu; santhavi@njms.rutgers.edu; kannursr@njms.rutgers.edu		Santhakumar, Vijayalakshmi/0000-0001-6278-4187	New Jersey Commission for Brain injury research [CBIR15IRG010]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS097750]	Acknowledgements This study was supported by funding from the New Jersey Commission for Brain injury research (CBIR15IRG010; SK) and National Institutes of Health (R01NS097750; VS) . Sample preparation and the LC/MS measurements were performed at the Proteomics and Metabolomics Core Facility at Weill Cornell Medicine, NY.	Aoyama K, 2013, INT J MOL SCI, V14, P21021, DOI 10.3390/ijms141021021; Bai KW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155393; Bas-Orth C, 2020, J CEREBR BLOOD F MET, V40, P2225, DOI 10.1177/0271678X19887777; Budd SL, 1996, J NEUROCHEM, V67, P2282; Chitturi J, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00431; Chitturi J, 2019, J NEUROTRAUM, V36, P1264, DOI 10.1089/neu.2018.6100; Chitturi J, 2018, NEUROCHEM INT, V120, P75, DOI 10.1016/j.neuint.2018.08.003; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Demougeot C, 2001, J NEUROCHEM, V77, P408, DOI 10.1046/j.1471-4159.2001.00285.x; Ferreira GC, 2017, NEUROCHEM RES, V42, P1661, DOI 10.1007/s11064-017-2288-7; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Fluegge D, 2012, NAT NEUROSCI, V15, P754, DOI 10.1038/nn.3074; Giorgi C, 2012, MITOCHONDRION, V12, P77, DOI 10.1016/j.mito.2011.07.004; Jones LL, 2010, PROG LIPID RES, V49, P61, DOI 10.1016/j.plipres.2009.08.004; Kannurpatti SS, 2008, J CEREBR BLOOD F MET, V28, P772, DOI 10.1038/sj.jcbfm.9600574; Kannurpatti SS, 2017, J CEREBR BLOOD F MET, V37, P381, DOI 10.1177/0271678X16680637; Kannurpatti SS, 2015, NMR BIOMED, V28, P1579, DOI 10.1002/nbm.3421; Kannurpatti SS, 2000, NEUROCHEM RES, V25, P1527, DOI 10.1023/A:1026602100160; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; LEGENDRE P, 1993, J NEUROSCI, V13, P674; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; Martano G, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1083-9; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Moffett John R, 2013, Front Neuroenergetics, V5, P11, DOI 10.3389/fnene.2013.00011; Murugan M, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00019; Nordengen K, 2015, BRAIN STRUCT FUNCT, V220, P899, DOI 10.1007/s00429-013-0691-7; Osteen CL, 2004, NEUROSCIENCE, V128, P305, DOI 10.1016/j.neuroscience.2004.06.034; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Parent M, 2019, J NEUROTRAUM, V36, P601, DOI 10.1089/neu.2018.5741; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Prins ML, 2017, CHILD NERV SYST, V33, P1711, DOI 10.1007/s00381-017-3518-7; Prins ML, 2016, J CHILD NEUROL, V31, P28, DOI 10.1177/0883073814549244; Prins ML, 2001, J NEUROTRAUM, V18, P31, DOI 10.1089/089771501750055758; Robertson CL, 2013, J NEUROTRAUM, V30, P2066, DOI 10.1089/neu.2013.3007; Sanganahalli BG, 2013, J CEREBR BLOOD F MET, V33, P1115, DOI 10.1038/jcbfm.2013.61; Sanganahalli BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063317; Strokin M, 2016, NEUROCHEM RES, V41, P1250, DOI 10.1007/s11064-015-1819-3; Tang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096944; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xia JG, 2010, BIOINFORMATICS, V26, P2342, DOI 10.1093/bioinformatics/btq418; Xia JG, 2010, NUCLEIC ACIDS RES, V38, pW71, DOI 10.1093/nar/gkq329; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yokobori S, 2014, CNS NEUROL DISORD-DR, V13, P606, DOI 10.2174/187152731304140702112805; Zhang MM, 2016, J AGR FOOD CHEM, V64, P7921, DOI 10.1021/acs.jafc.6b03592; Zhao LT, 2015, BIOCHEM BIOPH RES CO, V461, P537, DOI 10.1016/j.bbrc.2015.04.066	51	2	2	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1567-7249	1872-8278		MITOCHONDRION	Mitochondrion	MAR	2021	57						192	204		10.1016/j.mito.2021.01.003			13	Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Genetics & Heredity	RY1HX	WOS:000647668600009	33484870				2022-02-06	
J	Erdodi, L; Korcsog, K; Considine, C; Casey, J; Scoboria, A; Abeare, C				Erdodi, Laszlo; Korcsog, Kassandra; Considine, Ciaran; Casey, Joseph; Scoboria, Alan; Abeare, Christopher			Introducing the ImPACT-5: An Empirically Derived Multivariate Validity Composite	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						embedded validity indicators; football; ImPACT; performance validity; sport-concussion		Objective: To create novel Immediate Post-Concussion and Cognitive Testing (ImPACT)-based embedded validity indicators (EVIs) and to compare the classification accuracy to 4 existing EVIImPACT. Method: The ImPACT was administered to 82 male varsity football players during preseason baseline cognitive testing. The classification accuracy of existing EVIImPACT was compared with a newly developed index (ImPACT-5A and B). The ImPACT-5A represents the number of cutoffs failed on the 5 ImPACT composite scores at a liberal cutoff (0.85 specificity); ImPACT-5B is the sum of failures on conservative cutoffs (>= 0.90 specificity). Results: ImPACT-5A >= 1 was sensitive (0.81), but not specific (0.49) to invalid performance, consistent with EVIImPACT developed by independent researchers (0.68 sensitivity at 0.73-0.75 specificity). Conversely, ImPACT-5B >= 3 was highly specific (0.98), but insensitive (0.22), similar to Default EVIImPACT (0.04 sensitivity at 1.00 specificity). ImPACT-5A >= 3 or ImPACT-5B >= 2 met forensic standards of specificity (0.91-0.93) at 0.33 to 0.37 sensitivity. Also, the ImPACT-5s had the strongest linear relationship with clinically meaningful levels of invalid performance of existing EVIImPACT. Conclusions: The ImPACT-5s were superior to the standard EVIImPACT and comparable to existing aftermarket EVIImPACT, with the flexibility to optimize the detection model for either sensitivity or specificity. The wide range of ImPACT-5 cutoffs allows for a more nuanced clinical interpretation.	[Erdodi, Laszlo; Korcsog, Kassandra; Casey, Joseph; Scoboria, Alan; Abeare, Christopher] Univ Windsor, Dept Psychol, 401 Sunset, Windsor, ON N9B 3P4, Canada; [Considine, Ciaran] Vanderbilt Univ, Sch Med, Dept Neurol, Nashville, TN 37212 USA		Abeare, C (corresponding author), Univ Windsor, Dept Psychol, 401 Sunset, Windsor, ON N9B 3P4, Canada.	Laszlo.Erdodi@uwindsor.ca; korcsog@uwindsor.ca; ciaran.considine@vumc.org; jecasey@uwindsor.ca; scoboria@uwindsor.ca; cabeare@uwindsor.ca		Abeare, Christopher/0000-0002-7163-7434	Collaborative Research Grant from the University of Windsor	This research was supported in part by a Collaborative Research Grant from the University of Windsor awarded to C. Abeare (PI), A. Scoboria, L. Erdodi, and the Concussion Research Group.	Abeare C, 2019, PSYCHOL INJ LAW, V12, P170, DOI 10.1007/s12207-019-09353-x; Abeare C, 2019, J HEAD TRAUMA REHAB, V34, pE20, DOI 10.1097/HTR.0000000000000451; Abeare CA, 2018, JAMA NEUROL, V75, P697, DOI 10.1001/jamaneurol.2018.0031; Abeare CA, 2017, J CLIN EXP NEUROPSYC, V39, P738, DOI 10.1080/13803395.2016.1259396; An KY, 2019, J CLIN EXP NEUROPSYC, V41, P15, DOI 10.1080/13803395.2018.1483488; An KY, 2017, CLIN NEUROPSYCHOL, V31, P193, DOI 10.1080/13854046.2016.1217046; Barth JT, 1989, MILD HEAD INJURY, P257; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Broglio SP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00252; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; D'Lauro C, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118760854; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Erdodi L.A., 2017, PSYCHOL NEUROSCIENCE, V10, P325, DOI [10.1037/pne0000103, DOI 10.1037/PNE0000103, https://doi.org//10.1037/pne0000103, DOI https://doi.org/10.1037/pne0000103]; Erdodi L A., 2019, ASSESSMENT FEIGNED C; Erdodi LA, 2020, ARCH CLIN NEUROPSYCH, V35, P188, DOI 10.1093/arclin/acz032; Erdodi LA, 2019, PSYCHOL INJ LAW, V12, P155, DOI 10.1007/s12207-019-09356-8; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P307, DOI 10.1007/s12207-018-9337-7; Erdodi LA, 2019, APPL NEUROPSYCH-ADUL, V26, P155, DOI 10.1080/23279095.2017.1384925; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P327, DOI 10.1080/23279095.2017.1298600; Erdodi LA, 2018, ARCH CLIN NEUROPSYCH, V33, P845, DOI 10.1093/acn/acx110; Erdodi LA, 2017, J CLIN EXP NEUROPSYC, V39, P369, DOI 10.1080/13803395.2016.1230181; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2014, PSYCHOL INJ LAW, V7, P255, DOI 10.1007/s12207-014-9197-8; Gaudet CE, 2017, CLIN NEUROPSYCHOL, V31, P43, DOI 10.1080/13854046.2016.1220622; Gioia GA., 2012, PEDIAT FORENSIC NEUR, P205; Giza CC, 2001, J ATHL TRAINING, V36, P228; Glassmire DM, 2019, PSYCHOL ASSESSMENT, V31, P120, DOI 10.1037/pas0000650; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Higgins KL, 2017, ARCH CLIN NEUROPSYCH, V32, P259, DOI 10.1093/arclin/acw108; Johnson SC, 2012, CLIN NEUROPSYCHOL, V26, P1230, DOI 10.1080/13854046.2012.709886; Kerr ZY, 2015, J ATHL TRAINING, V50, P1174, DOI 10.4085/1062-6050-50.11.11; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lichtenstein JD, 2019, PSYCHOL INJ LAW, V12, P127, DOI 10.1007/s12207-019-09354-w; Lichtenstein JD, 2014, AM J SPORT MED, V42, P479, DOI 10.1177/0363546513509225; Lovell M, 2000, IMPACT IMMEDIATE POS; Nakayama Y, 2014, AM J SPORT MED, V42, P2000, DOI 10.1177/0363546514535901; Nelson LD, 2015, AM J SPORT MED, V43, P2018, DOI 10.1177/0363546515587714; Poynter K, 2019, ARCH CLIN NEUROPSYCH, V34, P1367, DOI 10.1093/arclin/acy087; Rai JK, 2021, APPL NEUROPSYCH-ADUL, V28, P185, DOI 10.1080/23279095.2019.1613994; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Rogers R., 2008, CLIN ASSESSMENT MALI; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Shura RD, 2020, CLIN NEUROPSYCHOL, V34, P1025, DOI 10.1080/13854046.2019.1635209; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Tyson BT, 2018, EPILEPSY BEHAV, V87, P39, DOI 10.1016/j.yebeh.2018.08.010; Zuccato BG, 2018, PSYCHOL ASSESSMENT, V30, P1491, DOI 10.1037/pas0000596	50	2	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2021	36	2			SI		103	113		10.1097/HTR.0000000000000576			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RH9OM	WOS:000636539100008	32472832				2022-02-06	
J	Ferris, LM; Kontos, AP; Eagle, SR; Elbin, RJ; Collins, MW; Mucha, A; Clugston, JR; Port, NL				Ferris, Lyndsey M.; Kontos, Anthony P.; Eagle, Shawn R.; Elbin, R. J.; Collins, Michael W.; Mucha, Anne; Clugston, James R.; Port, Nicholas L.			Predictive Accuracy of the Sport Concussion Assessment Tool 3 and Vestibular/Ocular-Motor Screening, Individually and In Combination: A National Collegiate Athletic Association-Department of Defense Concussion Assessment, Research and Education Consortium Analysis	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						head injuries; concussion; clinical assessment; grading scales; vestibular system; oculomotor system; VOMS; SCAT		Background: Vestibular and ocular symptoms in sport-related concussions are common. The Vestibular/Ocular-Motor Screening (VOMS) tool is a rapid, free, pen-and-paper tool that directly assesses these symptoms and shows consistent utility in concussion identification, prognosis, and management. However, a VOMS validation study in the acute concussion period of a large sample is lacking. Purpose: To examine VOMS validity among collegiate student-athletes, concussed and nonconcussed, from the multisite National Collegiate Athletic Association-Department of Defense Concussion Assessment, Research and Education (CARE) Consortium. A secondary aim was to utilize multidimensional machine learning pattern classifiers to deduce the additive power of the VOMS in relation to components of the Sport Concussion Assessment Tool 3 (SCAT3). Study Design: Cohort study (diagnosis); Level of evidence, 3. Methods: Preseason and acute concussion assessments were analyzed for 419 student-athletes. Variables in the analysis included the VOMS, Balance Error Scoring System, Standardized Assessment of Concussion, and SCAT3 symptom evaluation score. Descriptive statistics were calculated for all tools, including Kolmogorov-Smirnov significance and Cohen d effect size. Correlations between tools were analyzed with Spearman r, and predictive accuracy was evaluated through an Ada Boosted Tree machine learning model's generated receiver operating characteristic curves. Results: Total VOMS scores and SCAT3 symptom scores demonstrated significant increases in the acute concussion time frame (Cohen d = 1.23 and 1.06; P < .0001), whereas the Balance Error Scoring System lacked clinical significance (Cohen d = 0.17). Incorporation of VOMS into the full SCAT3 significantly boosted overall diagnostic ability by 4.4% to an area under the curve of 0.848 (P < .0001) and produced a 9% improvement in test sensitivity over the existing SCAT3 battery. Conclusion: The results from this study highlight the relevance of the vestibular and oculomotor systems to concussion and the utility of the VOMS tool. Given the 3.8 million sports-related and 45,121 military-related concussions per year, the addition of VOMS to the SCAT3 is poised to identify up to an additional 304,000 athletes and 3610 servicemembers annually who are concussed, thereby improving concussion assessment and diagnostic rates. Health care providers should consider the addition of VOMS to their concussion assessment toolkits, as its use can positively affect assessment and management of concussions, which may ultimately improve outcomes for this complex and common injury.	[Ferris, Lyndsey M.; Kontos, Anthony P.; Eagle, Shawn R.; Elbin, R. J.; Collins, Michael W.; Mucha, Anne; Clugston, James R.; Port, Nicholas L.] Indiana Univ, Bloomington, IN 47405 USA; [Ferris, Lyndsey M.; Port, Nicholas L.] Indiana Univ, Sch Optometry, 800 E Atwater Ave, Bloomington, IN 47405 USA; [Kontos, Anthony P.; Eagle, Shawn R.; Collins, Michael W.] Univ Pittsburgh, Pittsburgh, PA USA; [Elbin, R. J.] Univ Arkansas, Fayatteville, AR USA; [Mucha, Anne] UPMC Ctr Rehab Serv, Pittsburgh, PA USA; [Clugston, James R.] Univ Florida, Gainesville, FL USA		Port, NL (corresponding author), Indiana Univ, Sch Optometry, 800 E Atwater Ave, Bloomington, IN 47405 USA.	nport@indiana.edu					[Anonymous], 2019, MATLAB STAT MACHINE; [Anonymous], 2019, DEFENSE VETERANS BRA; Appel R., 2013, JMLR WORKSHOP C P, DOI DOI 10.5555/3042817.3043003; Bakker A, 2019, EDUC STUD MATH, V102, P1, DOI 10.1007/s10649-019-09908-4; Bergeron MF, 2019, MED SCI SPORT EXER, V51, P1362, DOI 10.1249/MSS.0000000000001903; Bixenmann B, 2014, INT J PHYS MED REHAB, V2, P6; Bland JM, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2622; Boshra R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53751-9; Broglio SP, 2019, SPORTS MED, V49, P1977, DOI 10.1007/s40279-019-01155-0; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Caccese JB, 2016, J SPORT REHABIL, V25, P133, DOI 10.1123/jsr.2014-0281; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Childs C, 2018, EYE BRAIN, V10, P101, DOI 10.2147/EB.S183042; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Debacker J, 2018, HAND CLINIC, V158, P145, DOI 10.1016/B978-0-444-63954-7.00015-X; Defense and Veterans Brain Injury Center, 2018, DOD WORLDW TBI NUMB, P2001; Doupe P, 2019, VALUE HEALTH, V22, P808, DOI 10.1016/j.jval.2019.02.012; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Franke LM, 2012, J REHABIL RES DEV, V49, P985, DOI 10.1682/JRRD.2011.12.0250; Garcia GGP, 2019, J NEUROTRAUM, V36, P1571, DOI 10.1089/neu.2018.6098; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Hoffer ME, 2017, LARYNGOSCOPE INVEST, V2, P157, DOI 10.1002/lio2.74; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; KWAPIL KJ, 2003, BRAIN IMPAIR, V4, P155; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Leigh RJ, 2015, NEUROLOGY EYE MOVEME; Main KL, 2017, NEUROIMAGE-CLIN, V16, P1, DOI 10.1016/j.nicl.2017.06.031; MASSOF RW, 1987, APPL OPTICS, V26, P1395, DOI 10.1364/AO.26.001395; Matsuo K, 2019, J NEUROTRAUM, DOI 10.1089/neu.2018.6276; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moran RN, 2018, AM J SPORT MED, V46, P1475, DOI 10.1177/0363546518756979; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Onate JA, 2007, J ATHL TRAINING, V42, P446; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Ponsford JL, 2016, J NEUROTRAUM, V33, P997, DOI 10.1089/neu.2015.4025; Putukian M, 2017, J ATHL TRAINING, V52, P236, DOI 10.4085/1062-6050-52.1.08; Rahn C, 2015, CLIN J SPORT MED, V25, P248, DOI 10.1097/JSM.0000000000000141; Rice ME, 2005, LAW HUMAN BEHAV, V29, P615, DOI 10.1007/s10979-005-6832-7; Salati M, 2016, CURR SURG REP, V4, DOI 10.1007/s40137-016-0158-x; Skora W, 2018, ANN AGR ENV MED, V25, P665, DOI 10.26444/aaem/81138; Suchoff I B, 1999, J Am Optom Assoc, V70, P301; Szczupak M., TRAUMATIC BRAIN INJU, V2020, P151; Truong JQ, 2016, BRAIN INJURY, V30, P1372, DOI 10.1080/02699052.2016.1192220; Truong JQ, 2016, BRAIN INJURY, V30, P1378, DOI 10.1080/02699052.2016.1195922; Wallace B, 2016, EYE BRAIN, V8, P153, DOI 10.2147/EB.S82670; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411; Zimmer A, 2013, J ATHL TRAINING, V48, P659, DOI 10.4085/1062-6050-48.5.06	60	2	2	2	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	MAR	2021	49	4					1040	1048		10.1177/0363546520988098			9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	QX3QM	WOS:000629261000022	33600216				2022-02-06	
J	Khattar, NK; McCallum, AP; Fortuny, EM; White, AC; Ball, TJ; Adams, SW; Meyer, KS; Wei, G; John, KD; Bak, E; Sieg, EP; Ding, DL; James, RF				Khattar, Nicolas K.; McCallum, Abigail P.; Fortuny, Enzo M.; White, Andrew C.; Ball, Tyler J.; Adams, Shawn W.; Meyer, Kimberly S.; Wei, George; John, Kevin D.; Bak, Esther; Sieg, Emily P.; Ding, Dale; James, Robert F.			Minimally Invasive Endoscopy for Acute Subdural Hematomas: A Report of 3 Cases	OPERATIVE NEUROSURGERY			English	Article						Subdural hematoma; Minimally invasive; Endoscopic evacuation; Apollo; Artemis		BACKGROUND: Acute subdural hematomas (aSDHs) occur in approximately 10% to 20% of all closed head injury and represent a significant cause of morbidity and mortality in traumatic brain injury patients. Conventional craniotomy is an invasive intervention with the potential for excess blood loss and prolonged postoperative recovery time. OBJECTIVE: To evaluate the outcomes of minimally invasive endoscopy for evacuation of aSDHs in a pilot feasibility study. METHODS: We retrospectively reviewed the records of consecutive patients with aSDHs who underwent surgical treatment at our institution with minimally invasive endoscopy using the Apollo/Artemis Neuro Evacuation Device (Penumbra, Alameda, California) between April 2015 and July 2018. RESULTS: The study cohort comprised three patients. The Glasgow Coma Scale on admission was 15 for all 3 patients, median preoperative hematoma volume was 49.5 cm(3) (range 44-67.8 cm(3)), median postoperative degree of hematoma evacuation was 88% (range 84%-89%), and median modified Rankin Scale at discharge was 1 (range 0-3). CONCLUSION: Endoscopic evacuation of aSDHs can be a safe and effective alternative to craniotomy in appropriately selected patients. Further studies are needed to refine the selection criteria for endoscopic aSDH evacuation and evaluate its long-term outcomes.	[Khattar, Nicolas K.; McCallum, Abigail P.; Fortuny, Enzo M.; Ball, Tyler J.; Adams, Shawn W.; Meyer, Kimberly S.; Wei, George; John, Kevin D.; Bak, Esther; Sieg, Emily P.; Ding, Dale] Univ Louisville, Sch Med, Dept Neurol Surg, Louisville, KY 40292 USA; [White, Andrew C.] Univ Louisville, Sch Med, Dept Radiol, Louisville, KY 40292 USA; [James, Robert F.] Indiana Univ Sch Med, IU Hlth Phys Neurosurg, Dept Neurol Surg, Indianapolis, IN 46202 USA		James, RF (corresponding author), IU Hlth Neurosci Ctr, Goodman Hall,Suite 5100,362 W 15th St, Indianapolis, IN 46202 USA.	rfjames@iu.edu					Agha RA, 2018, INT J SURG, V60, P279, DOI 10.1016/j.ijsu.2018.10.031; Alagoz F, 2017, TURK NEUROSURG, V27, P187, DOI 10.5137/1019-5149.JTN.15177-15.2; Fiorella D, 2016, STROKE, V47, P1399, DOI 10.1161/STROKEAHA.115.011415; Fomchenko EI, 2018, CURR TREAT OPTION NE, V20, DOI 10.1007/s11940-018-0518-1; Frontera JA, 2011, CRIT CARE MED, V39, P1619, DOI 10.1097/CCM.0b013e3182186ed6; Hanley DF, 2019, LANCET, V393, P1021, DOI 10.1016/S0140-6736(19)30195-3; Hanley DF, 2016, LANCET NEUROL, V15, P1226, DOI 10.1016/S1474-4422(16)30234-4; Ichimura S, 2019, J CLIN NEUROSCI, V61, P311, DOI 10.1016/j.jocn.2018.11.043; Karibe H, 2017, NEUROL MED-CHIR, V57, P418, DOI 10.2176/nmc.st.2017-0058; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; Karnjanasavitree Worawach, 2018, Asian J Neurosurg, V13, P1158, DOI 10.4103/ajns.AJNS_199_18; Kawasaki T, 2018, ACTA NEUROCHIR, V160, P241, DOI 10.1007/s00701-017-3399-2; Kellner CP, 2018, J NEUROINTERV SURG, V10, P771, DOI 10.1136/neurintsurg-2017-013719; Khattar NK, 2019, WORLD NEUROSURG, V129, pE35, DOI 10.1016/j.wneu.2019.04.164; Labib MA, 2017, NEUROSURGERY, V80, P515, DOI 10.1227/NEU.0000000000001316; Liu XM, 2018, WORLD NEUROSURG, V120, pE1024, DOI 10.1016/j.wneu.2018.08.219; Marion DW, 2006, NEUROSURGERY, V58, P655; Matsumoto H, 2018, SURG INNOV, V25, P455, DOI 10.1177/1553350618785270; Miki Koichi, 2016, No Shinkei Geka, V44, P455, DOI 10.11477/mf.1436203310; Phan K, 2017, WORLD NEUROSURG, V101, P677, DOI 10.1016/j.wneu.2017.03.024; Przybylowski CJ, 2015, J CLIN NEUROSCI, V22, P1727, DOI 10.1016/j.jocn.2015.05.015; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Senft C, 2009, NEUROL RES, V31, P1012, DOI 10.1179/174313209X409034; Spiotta AM, 2015, OPER NEUROSURG, V11, P243, DOI 10.1227/NEU.0000000000000698; Won SY, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17421; Xia ZW, 2018, WORLD NEUROSURG, V115, P266, DOI 10.1016/j.wneu.2018.04.181; Yan KX, 2017, NEUROL RES, V39, P803, DOI 10.1080/01616412.2017.1321709; Yokosuka K, 2015, J NEUROSURG, V123, P1065, DOI 10.3171/2014.10.JNS14915	28	2	2	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2332-4252	2332-4260		OPER NEUROSURG	Oper. Neurosurg.	MAR	2021	20	3					310	315		10.1093/ons/opaa390			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RJ0VQ	WOS:000637322100044	33372226				2022-02-06	
J	Khokhar, BR; Lindberg, MA; Walker, WC				Khokhar, Bilal R.; Lindberg, Megan A.; Walker, William C.			Post-mTBI Pain Interference in a US Military Population: A Chronic Effects of Neurotrauma Consortium Study	MILITARY MEDICINE			English	Article								Introduction Chronic pain is a significant problem for service members and veterans with mild traumatic brain injury (mTBI). While the root cause of pain is not clearly understood, comorbidities may contribute to how their pain disrupts their functional status, a construct termed "pain interference." The purpose of this study is to examine the associations between mTBI, other comorbidities, and pain interference. Materials and Methods The sample comprised participants with mTBI(s) from The Chronic Effects of Neurotrauma Consortium multicenter observational study. Potential concussive events were identified using a modified Ohio State University traumatic brain injury (TBI) Identification interview and then further with a structured interview. Pain interference was measured with the TBI quality-of-life pain interference score, which was categorized into insignificant, moderate, and high pain interference. Comorbidities of interest included anxiety, depression, post-traumatic stress disorder, insomnia, and arthritis. Multivariable relationships were analyzed using logistic regression. Results The analysis sample included 346 participants with mTBI(s). In adjusted analysis, those with high pain interference were more likely to have history of >= 3 TBIs (odds ratio (OR) 3.1, 95% confidence interval [CI] 1.4, 6.9) and to have clinical levels of post-traumatic stress disorder (OR 5.4, 95% CI 1.9, 15.7), depression (OR 2.5, 95% CI, 1.0, 6.1), anxiety (OR 4.9, 95% CI, 2.0, 11.7), and sleep disturbances (OR 6.1, 95% CI 2.0, 19.0) versus those with insignificant pain interference. Conclusion These results identify clinical features of veterans and service members with mTBI(s) who are at highest risk for pain-related disability. These findings also demonstrate the need to consider mental health and sleep problems in their pain evaluation and treatment approach.	[Khokhar, Bilal R.; Lindberg, Megan A.] Def & Vet Brain Injury Ctr, Silver Spring, MD 20910 USA; [Walker, William C.] Vet Affairs Med Ctr, Dept Phys Med & Rehabil, Hunter Holmes McGuire Dept, Richmond, VA 23249 USA; [Walker, William C.] Def & Vet Brain Injury Ctr, Richmond, VA 23249 USA; [Walker, William C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23284 USA		Khokhar, BR (corresponding author), Def & Vet Brain Injury Ctr, Silver Spring, MD 20910 USA.			Khokhar, Bilal/0000-0003-0143-1390	U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); U.S. Department of Veterans Affairs Chronic Effects of Neurotrauma ConsortiumUS Department of Veterans Affairs [W81XWH-13-2-0095]; U.S. Army Medical Research Acquisition Activity, Fort Detrick MD	This material is based upon work supported by the U.S. Army Medical Research and Material Command and from the U.S. Department of Veterans Affairs Chronic Effects of Neurotrauma Consortium under Award No. W81XWH-13-2-0095. The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the views of the U.S. Government, or the U.S. Department of Veterans Affairs, and no official endorsement should be inferred.	Aase DM, 2018, PSYCHIAT RES, V268, P460, DOI 10.1016/j.psychres.2018.08.019; Aili K, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2310-5; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Dieter JN, 2019, NEUROSCI INSIGHTS, V14, DOI 10.1177/1179069519892933; Fear NT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-797; Han CS, 2015, PSYCHIAT INVEST, V12, P1, DOI 10.4306/pi.2015.12.1.1; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hoot MR, 2018, BRAIN INJURY, V32, P1169, DOI 10.1080/02699052.2018.1482427; Khoury S, 2018, PROG NEURO-PSYCHOPH, V87, P224, DOI 10.1016/j.pnpbp.2017.06.007; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lavigne G, 2015, PAIN, V156, pS75, DOI 10.1097/j.pain.0000000000000111; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Palacios-Cena M, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0730-5; Phillips KM, 2016, J REHABIL RES DEV, V53, P413, DOI 10.1682/JRRD.2014.05.0126; Powell MA, 2015, J TRAUMA STRESS, V28, P322, DOI 10.1002/jts.22027; Romesser J, 2012, J REHABIL RES DEV, V49, P1127, DOI 10.1682/JRRD.2010.12.0238; Salaffi F, 2018, PAIN RES MANAG, V2018, DOI 10.1155/2018/8564215; Seal KH, 2016, J REHABIL RES DEV, V53, P185, DOI 10.1682/JRRD.2014.12.0301; Silverberg ND, 2016, J HEAD TRAUMA REHAB, V31, P388, DOI 10.1097/HTR.0000000000000198; Stojanovic MP, 2016, PAIN MED, V17, P2017, DOI 10.1093/pm/pnw042; Stratton KJ, 2014, J REHABIL RES DEV, V51, P1189, DOI 10.1682/JRRD.2014.04.0111; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Walker WC, 2016, BRAIN INJURY, V30, P1469, DOI 10.1080/02699052.2016.1219061; Walker WC, 2017, J HEAD TRAUMA REHAB, V32, pE16, DOI 10.1097/HTR.0000000000000251; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Wasserberg J, 2002, BMJ-BRIT MED J, V325, P454, DOI 10.1136/bmj.325.7362.454	30	2	2	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2021	186	3-4					E293	E299		10.1093/milmed/usaa249			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RJ0VH	WOS:000637321200016	33007066	hybrid			2022-02-06	
J	Konduru, SS; Wallace, EP; Pfammatter, JA; Rodrigues, PV; Jones, MV; Maganti, RK				Konduru, Sai Sruthi; Wallace, Eli P.; Pfammatter, Jesse A.; Rodrigues, Paulo, V; Jones, Mathew, V; Maganti, Rama K.			Sleep-wake characteristics in a mouse model of severe traumatic brain injury: Relation to posttraumatic epilepsy	EPILEPSIA OPEN			English	Article						NREM delta power; posttraumatic epilepsy; sleep spindles; sleep-wake disturbances; Traumatic brain injury	CONTROLLED CORTICAL IMPACT; SLOW-WAVE; SEIZURES; DISTURBANCES; WAKEFULNESS; POPULATION; PLASTICITY; DYNAMICS; PATTERNS	Study objectivesTraumatic brain injury (TBI) results in sequelae that include posttraumatic epilepsy (PTE) and sleep-wake disturbances. Here, we sought to determine whether sleep characteristics could predict development of PTE in a model of severe TBI. MethodsFollowing controlled cortical impact (CCI) or sham injury (craniotomy only), CD-1 mice were implanted with epidural electroencephalography (EEG) and nuchal electromyography (EMG) electrodes. Acute (1st week) and chronic (months 1, 2, or 3) 1-week-long video-EEG recordings were performed after the injury to examine epileptiform activity. High-amplitude interictal events were extracted from EEG using an automated method. After scoring sleep-wake patterns, sleep spindles and EEG delta power were derived from nonrapid eye movement (NREM) sleep epochs. Brain CTs (computerized tomography) were performed in sham and CCI cohorts to quantify the brain lesions. We then employed a no craniotomy (NC) control to perform 1-week-long EEG recordings at week 1 and month 1 after surgery. ResultsPosttraumatic seizures were seen in the CCI group only, whereas interictal epileptiform activity was seen in CCI or sham. Sleep-wake disruptions consisted of shorter wake or NREM bout lengths and shorter duration or lower power for spindles in CCI and sham. NREM EEG delta power increased in CCI and sham groups compared with NC though the CCI group with posttraumatic seizures had lower power at a chronic time point compared with those without. Follow-up brain CTs showed a small lesion in the sham injury group suggesting a milder form of TBI that may account for their interictal activity and sleep changes. SignificanceIn our TBI model, tracking changes in NREM delta power distinguishes between CCI acutely and animals that will eventually develop PTE, but further work is necessary to identify sleep biomarkers of PTE. Employing NC controls together with sham controls should be considered in future TBI studies.	[Konduru, Sai Sruthi; Wallace, Eli P.; Rodrigues, Paulo, V; Maganti, Rama K.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurol, 1685 Highland Ave,7142 MFCB, Madison, WI 53705 USA; [Wallace, Eli P.; Pfammatter, Jesse A.; Jones, Mathew, V] Univ Wisconsin, Dept Neurosci, Sch Med & Publ Hlth, Madison, WI 53705 USA; [Wallace, Eli P.] Univ Wisconsin, Cellular & Mol Pathol Grad Program, Sch Med & Publ Hlth, Madison, WI 53705 USA		Maganti, RK (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurol, 1685 Highland Ave,7142 MFCB, Madison, WI 53705 USA.	maganti@neurology.wisc.edu		Maganti, Rama/0000-0001-5472-1645; Pfammatter, Jesse/0000-0001-8352-2979	Department of DefenseUnited States Department of Defense [PRMRP:161864]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21NS104612-01A1]	This work is supported by the Department of Defense Grant PRMRP:161864 (PI: RM) and National Institutes of Health Grant Number R21NS104612-01A1 (PI:RM).	Andrade P, 2017, CLIN NEUROPHYSIOL, V128, pe246; Andrade P, 2017, J NEUROTRAUM, V34, P1482, DOI 10.1089/neu.2016.4675; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Bhalerao U, 2013, BRAIN INJURY, V27, P767, DOI 10.3109/02699052.2013.793396; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Boly M, 2017, BRAIN, V140, P1026, DOI 10.1093/brain/awx017; Bragin A, 2016, EPILEPSIA, V57, P735, DOI 10.1111/epi.13359; Buchele F, 2016, J NEUROTRAUM, V33, P1171, DOI 10.1089/neu.2015.4001; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; D'Ambrosio R, 2009, BRAIN, V132, P2805, DOI 10.1093/brain/awp217; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Gupta PK, 2014, J NEUROTRAUM, V31, P1439, DOI 10.1089/neu.2013.3221; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Hazra A, 2014, J NEUROSCI RES, V92, P1434, DOI 10.1002/jnr.23430; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Jakubcakova V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040625; Kelly KM, 2015, EPILEPSY RES, V117, P104, DOI 10.1016/j.eplepsyres.2015.09.009; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kochanek PM, 2006, J CEREBR BLOOD F MET, V26, P565, DOI 10.1038/sj.jcbfm.9600218; Lim MM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007092; Lucke-Wold BP, 2015, SEIZURE-EUR J EPILEP, V33, P13, DOI 10.1016/j.seizure.2015.10.002; Luttjohann A, 2009, PHYSIOL BEHAV, V98, P579, DOI 10.1016/j.physbeh.2009.09.005; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Mantua J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00328; Modarres M, 2016, SLEEP CIRCADIAN RHYT, V1; Olson E, 2016, J NEUROTRAUM, V33, P734, DOI 10.1089/neu.2015.4085; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Pfammatter Jesse A, 2019, Epilepsia Open, V4, P110, DOI 10.1002/epi4.12303; Pfammatter JA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207158; Rowe RK, 2014, SLEEP, V37, P743, DOI 10.5665/sleep.3582; Rowe RK, 2014, BRAIN INJURY, V28, P504, DOI 10.3109/02699052.2014.888768; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Sabir M, 2015, BRAIN BEHAV IMMUN, V47, P118, DOI 10.1016/j.bbi.2014.12.023; Salinsky M, 2015, J HEAD TRAUMA REHAB, V30, pE65, DOI 10.1097/HTR.0000000000000057; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Skopin MD, 2015, J NEUROTRAUM, V32, P289, DOI 10.1089/neu.2014.3664; Soltani S, 2019, FRONT SYST NEUROSCI, V13, DOI 10.3389/fnsys.2019.00051; Taylor JA, 2019, J NEUROSCI, V39, P4829, DOI 10.1523/JNEUROSCI.1167-18.2019; Thomasy HE, 2019, J NEUROTRAUM, V36, P802, DOI 10.1089/neu.2018.5810; Thomasy HE, 2016, NEUROBIOL SLEEP CIRC, P1; Tononi G, 2014, NEURON, V81, P12, DOI 10.1016/j.neuron.2013.12.025; Uygun DS, 2019, SLEEP, V42, DOI 10.1093/sleep/zsy218; Vyazovskiy VV, 2004, ARCH ITAL BIOL, V142, P511; Wallace E, 2015, BRAIN RES, V1615, P116, DOI 10.1016/j.brainres.2015.04.037; Willie JT, 2012, J NEUROTRAUM, V29, P1908, DOI 10.1089/neu.2012.2404; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	51	2	2	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2470-9239		EPILEPSIA OPEN	Epilepsia Open	MAR	2021	6	1					181	194		10.1002/epi4.12462			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RZ4FW	WOS:000648553600020	33681661	Green Submitted, Green Published, gold			2022-02-06	
J	Kontos, AP; Monti, K; Eagle, SR; Thomasma, E; Holland, CL; Thomas, D; Bitzer, HB; Mucha, A; Collins, MW				Kontos, Anthony P.; Monti, Katrina; Eagle, Shawn R.; Thomasma, Eliot; Holland, Cyndi L.; Thomas, Drew; Bitzer, Hannah B.; Mucha, Anne; Collins, Michael W.			Test-retest reliability of the Vestibular Ocular Motor Screening (VOMS) tool and modified Balance Error Scoring System (mBESS) in US military personnel	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Mild traumatic brain injury; Vestibular-ocular motor screening; Balance; MACE-2		The Military Acute Concussion Evaluation 2 (MACE 2), which includes the Vestibular-Ocular Motor Screening (VOMS) tool and the single-leg stance component of the modified Balance Error Scoring System (mBESS), was introduced in 2018 as an assessment of acute mTBI in US military personnel. However, the reliability of the VOMS and mBESS in this population has not been established. Objectives: The primary purpose of this study was to examine the reliability of the VOMS across a 6-month period in healthy, uninjured US Army Special Operations Command (USASOC) personnel. Design: Active duty/heathy military personnel (n = 108) completed the VOMS and mBESS at baseline and follow-up 6 months later (+/- 1 month). Method: Cronbach's alpha was used to examine the internal consistency of the VOMS and mBESS at both time points. Two-way mixed intra-class correlation coefficients (ICC) with consistency agreement were used to evaluate test-retest reliability. Results: VOMS demonstrated excellent internal consistency (alpha = 0.99), whereas, the mBESS demonstrated poor internal consistency (alpha = 0.29). Test-retest reliability of VOMS items was moderate-to-good with ICCs ranging from 0.60 to 0.81. Test-retest reliability was moderate for mBESS total score (ICC = 0.59) and double-leg stance (ICC = 0.73), while single-leg (ICC = 0.49) and tandem (ICC = 0.02) stances were poor. Conclusions: The findings suggest that VOMS has high internal consistency and moderate-to-good test-retest reliability. mBESS has poor internal consistency and poor-to-moderate test-retest reliability. The results suggest that VOMS is a reliable addition to the MACE-2, whereas, mBESS single-leg stance is less reliable. As such, mBESS double-leg stance may be a more reliable measure of balance in this population. (C) 2020 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Kontos, Anthony P.; Eagle, Shawn R.; Holland, Cyndi L.; Bitzer, Hannah B.; Collins, Michael W.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA 15260 USA; [Monti, Katrina] 1st Special Forces Grp Airborne, Washington, DC USA; [Thomasma, Eliot] Baylor Univ, Keller Army Community Hosp, Div Sports PT Fellowship 1, Waco, TX 76798 USA; [Thomas, Drew] Geneva Fdn, Tacoma, WA USA; [Mucha, Anne] Ctr Rehabil Serv, Pittsburgh, PA USA		Kontos, AP (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA 15260 USA.	akontos@pitt.edu		Bitzer, Hannah/0000-0002-7232-6056; Monti, Katrina/0000-0001-5526-4757	United States Department of Defense Congressional Directed Medical Research Programs Clinical and Rehabilitative Medicine Research Program Neurosensory and Rehabilitation Research Award-Clinical Trial Option [MR141293]	This research was funded by the United States Department of Defense Congressional Directed Medical Research Programs Clinical and Rehabilitative Medicine Research Program Neurosensory and Rehabilitation Research Award-Clinical Trial Option (MR141293).	Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Buckley TA, 2018, CLIN J SPORT MED, V28, P174, DOI 10.1097/JSM.0000000000000426; Corwin DJ, 2020, MED SCI SPORT EXER, V52, P542, DOI 10.1249/MSS.0000000000002163; Defense and Veterans Brain Injury Center, 2017, DOD WORLDW NUMB TB1; Eagle SR, 2019, MED SCI SPORT EXER, V51, P1619, DOI 10.1249/MSS.0000000000001974; Kontos AP, 2019, J HEAD TRAUMA REHAB, V34, P394, DOI 10.1097/HTR.0000000000000536; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Moran RN, 2018, AM J SPORT MED, V46, P1475, DOI 10.1177/0363546518756979; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; National Academies of Sciences Medicine., 2019, DIAGNOSIS ASSESSMENT; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; Oldham JR, 2018, MED SCI SPORT EXER, V50, P1162, DOI 10.1249/MSS.0000000000001540; Schatz P, 2017, BRIT J SPORT MED, V51, pA78; Storzbach D., 2013, VA EVIDENCE BASED SY; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683	18	2	2	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	MAR	2021	24	3					264	268		10.1016/j.jsams.2020.08.012			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	QC1QP	WOS:000614608900009	32951978	Bronze			2022-02-06	
J	MacDarby, L; Healy, M; Curley, G; McHugh, JC				MacDarby, Laura; Healy, Martina; Curley, Gerard; McHugh, John C.			EEG in the Pediatric Intensive Care Unit: An Irish Experience	JOURNAL OF CLINICAL NEUROPHYSIOLOGY			English	Article; Proceedings Paper	Meeting of the European-Society-of-Pediatric-and-Neonatal-Intensive-Care	JUN 18-21, 2019	Salzburg, AUSTRIA	European Soc Pediat & Neonatal Intens Care		Critical care; Electroencephalography; Nonconvulsive status epilepticus; Pediatrics; Seizures	CRITICALLY-ILL CHILDREN; TRAUMATIC BRAIN-INJURY; ELECTROGRAPHIC SEIZURES; NONCONVULSIVE SEIZURES; CONSENSUS STATEMENT; STATUS EPILEPTICUS; ELECTROENCEPHALOGRAPHY; PROGNOSTICATION; PREVALENCE; PATTERNS	Introduction: Evidence for continuous EEG monitoring in the pediatric intensive care unit (PICU) is increasing. However, 24/7 access to EEG is not routinely available in most centers, and clinical management is often informed by more limited EEG resources. The experience of EEG was reviewed in a tertiary PICU where 24/7 EEG cover is unavailable. Methods: Retrospective EEG and clinical review of 108 PICU patients. Correlations were carried out between EEG and clinical variables including mortality. The role of EEG in clinical decision making was documented. Results: One hundred ninety-six EEGs were carried out in 108 PICU patients over 2.5 years (434 hours of recording). After exclusion of 1 outlying patient with epileptic encephalopathy, 136 EEGs (median duration, 65 minutes; range, 20 minutes to 4 hours 40 minutes) were included. Sixty-two patients (57%) were less than 12 months old. Seizures were detected in 18 of 107 patients (17%); 74% of seizures were subclinical; 72% occurred within the first 30 minutes of recording. Adverse EEG findings were associated with high mortality. Antiepileptic drug use was high in the studied population irrespective of EEG seizure detection. Prevalence of epileptiform discharges and EEG seizures diminished with increasing levels of sedation. Conclusions: EEG provides important diagnostic information in a large proportion of PICU patients. In the absence of 24/7 EEG availability, empirical antiepileptic drug utilization is high.	[MacDarby, Laura; Healy, Martina] Childrens Hlth Ireland Crumlin CHI Crumlin, Dept Anesthesia & Crit Care, Dublin, Ireland; [Curley, Gerard] Beaumont Hosp, Dept Anesthesia & Crit Care, Dublin, Ireland; [McHugh, John C.] CHI Crumlin, Clin Neurophysiol Dept, Dublin, Ireland		McHugh, JC (corresponding author), Childrens Hlth Ireland Crumlin, Cooley Rd, Dublin D12 N512, Ireland.	drjohnmchugh@gmail.com			National Children's Research Center	The National Children's Research Center awarded the first author her registration fees to complete a medical research doctorate at The Royal College of Surgeons, Ireland. This funding is ongoing.	Abend NS, 2011, NEUROLOGY, V76, P1071, DOI 10.1212/WNL.0b013e318211c19e; Abend NS, 2009, NEUROLOGY, V72, P1931, DOI 10.1212/WNL.0b013e3181a82687; Abend NS, 2015, J CLIN NEUROPHYSIOL, V32, P486, DOI 10.1097/WNP.0000000000000198; Abend NS, 2015, J CLIN NEUROPHYSIOL, V32, P257, DOI 10.1097/WNP.0000000000000170; Abend NS, 2013, J CLIN NEUROPHYSIOL, V30, P134, DOI 10.1097/WNP.0b013e3182872af9; Abend NS, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-012-0330-3; Abend NS, 2011, NEUROCRIT CARE, V15, P70, DOI 10.1007/s12028-010-9380-z; Alvarez V, 2013, CRIT CARE, V17, DOI 10.1186/cc12879; Chong DJ, 2005, J CLIN NEUROPHYSIOL, V22, P79, DOI 10.1097/01.WNP.0000158699.78529.AF; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Claassen J, 2013, ANN NEUROL, V74, P53, DOI 10.1002/ana.23859; Friedman D, 2009, ANESTH ANALG, V109, P506, DOI 10.1213/ane.0b013e3181a9d8b5; Gollwitzer S, 2015, CLIN NEUROPHYSIOL, V126, P1514, DOI 10.1016/j.clinph.2014.10.215; Gutierrez-Colina AM, 2012, PEDIATR NEUROL, V46, P158, DOI 10.1016/j.pediatrneurol.2011.12.009; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P87, DOI 10.1097/WNP.0000000000000166; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P96, DOI 10.1097/WNP.0000000000000165; Horn J, 2014, CURR OPIN CRIT CARE, V20, P280, DOI 10.1097/MCC.0000000000000085; Hosain SA, 2005, PEDIATR NEUROL, V32, P162, DOI 10.1016/j.pediatrneurol.2004.09.008; Hyllienmark L, 2007, EUR J PAEDIATR NEURO, V11, P70, DOI 10.1016/j.ejpn.2006.11.005; Jette N, 2006, ARCH NEUROL-CHICAGO, V63, P1750, DOI 10.1001/archneur.63.12.1750; Kilbride RD, 2009, ARCH NEUROL-CHICAGO, V66, P723, DOI 10.1001/archneurol.2009.100; Kuratani J, 2016, J CLIN NEUROPHYSIOL, V33, P320, DOI 10.1097/WNP.0000000000000321; Lin JJ, 2017, PEDIATR CRIT CARE ME, V18, P249, DOI 10.1097/PCC.0000000000001067; McHugh JC, 2009, IRISH J MED SCI, V178, P263, DOI 10.1007/s11845-009-0317-5; Payne ET, 2014, BRAIN, V137, P1429, DOI 10.1093/brain/awu042; Rossetti AO, 2018, J CLIN NEUROPHYSIOL, V35, P359, DOI 10.1097/WNP.0000000000000467; Rossetti AO, 2016, LANCET NEUROL, V15, P597, DOI 10.1016/S1474-4422(16)00015-6; Fernandez IS, 2017, EPILEPSIA, V58, P420, DOI 10.1111/epi.13653; Sanchez SM, 2013, EPILEPSIA, V54, P1419, DOI 10.1111/epi.12261; Sanchez SM, 2013, J CLIN NEUROPHYSIOL, V30, P156, DOI 10.1097/WNP.0b013e31827eda27; Sansevere AJ, 2017, J CLIN NEUROPHYSIOL, V34, P421, DOI 10.1097/WNP.0000000000000379; Shahwan A, 2010, EPILEPSIA, V51, P1198, DOI 10.1111/j.1528-1167.2009.02517.x; Towne AR, 2000, NEUROLOGY, V54, P340, DOI 10.1212/WNL.54.2.340; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vlachy J, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00303; Wagenman KL, 2014, NEUROLOGY, V82, P396, DOI 10.1212/WNL.0000000000000082; Westover MB, 2015, CLIN NEUROPHYSIOL, V126, P463, DOI 10.1016/j.clinph.2014.05.037; Williams K, 2011, EPILEPSIA, V52, P1130, DOI 10.1111/j.1528-1167.2011.03070.x	39	2	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0736-0258	1537-1603		J CLIN NEUROPHYSIOL	J. Clin. Neurophysiol.	MAR	2021	38	2					130	134		10.1097/WNP.0000000000000673			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	SL0TP	WOS:000656629200009	31834039				2022-02-06	
J	McGeary, DD; Penzien, DB; Resick, PA; McGeary, CA; Jaramillo, CA; Eapen, BC; Young-McCaughan, S; Nabity, PS; Moring, JC; Houle, TT; Keane, TM; Peterson, AL				McGeary, Donald D.; Penzien, Donald B.; Resick, Patricia A.; McGeary, Cindy A.; Jaramillo, Carlos A.; Eapen, Blessen C.; Young-McCaughan, Stacey; Nabity, Paul S.; Moring, John C.; Houle, Timothy T.; Keane, Terence M.; Peterson, Alan L.		Consortium Alleviate PTSD	Study design for a randomized clinical trial of cognitive-behavioral therapy for posttraumatic headache	CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS			English	Article						Headache; PTSD; Polymorbidity; Traumatic brain injury; Veterans		Posttraumatic headache (PTH) is a common debilitating condition arising from head injury and is highly prevalent among military service members and veterans with traumatic brain injury (TBI). Diagnosis and treatment for PTH is still evolving, and surprisingly little is known about the putative mechanisms that drive these headaches. This manuscript describes the design of a randomized clinical trial of two nonpharmacological (i.e., behavioral) interventions for posttraumatic headache. Design of this trial required careful consideration of PTH diagnosis and inclusion criteria, which was challenging due to the lack of standard clinical characteristics in PTH unique from other types of headaches. The treatments under study differed in clinical focus and dose (i.e., number of treatment sessions), but the trial was designed to balance the treatments as well as possible. Finally, while the primary endpoints for pain research can vary from assessments of pain intensity to objective and subjective functional measures, this trial of PTH interventions chose carefully to establish clinically relevant endpoints and to maximize the opportunity to detect significant differences between groups with two primary outcomes. All these issues are discussed in this manuscript.	[McGeary, Donald D.; McGeary, Cindy A.; Young-McCaughan, Stacey; Nabity, Paul S.; Moring, John C.; Peterson, Alan L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat & Behav Sci, San Antonio, TX 78229 USA; [Penzien, Donald B.] Wake Forest Univ, Dept Psychiat & Behav Med, Winston Salem, NC USA; [Penzien, Donald B.] Wake Forest Univ, Dept Neurol, Winston Salem, NC USA; [Resick, Patricia A.] Duke Univ, Dept Psychiat & Behav Sci, Med Ctr, Durham, NC USA; [McGeary, Donald D.; Jaramillo, Carlos A.; Peterson, Alan L.] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [McGeary, Donald D.; Jaramillo, Carlos A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Rehabil Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Eapen, Blessen C.] Greater Angeles Vet Hlth Care Syst, Los Angeles, CA USA; [Eapen, Blessen C.] Univ Calif Los Angeles, David Geffen Sch Med, PM&R, Los Angeles, CA USA; [Houle, Timothy T.] Massachusetts Gen Hosp, Dept Anaesthesia, Boston, MA USA; [Peterson, Alan L.] Univ Texas San Antonio, Dept Psychol, San Antonio, TX USA; [Keane, Terence M.] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA USA; [Keane, Terence M.] Boston Univ, Dept Psychiat, Sch Med, Boston, MA USA		McGeary, DD (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat & Behav Sci, San Antonio, TX 78229 USA.; McGeary, DD (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Rehabil Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	mcgeary@uthscsa.edu; penzien@gmail.com; patricia.resick@duke.edu; mcgearyc@uthscsa.edu; jaramilloc3@uthscsa.edu; blessen.eapen2@va.gov; youngs1@uthscsa.edu; nabity@uthscsa.edu; moringgj@uthscsa.edu; thoule1@mgh.harvard.edu; Terence.Keane@va.gov; petersona3@uthscsa.edu	Penzien, Donald B/H-9693-2017	Penzien, Donald B/0000-0003-4913-7158	U.S. Department of Defense, Defense Health Program, Psychological Health and Traumatic Brain Injury Research Program (PH/TBI RP) [W81XWH-13-2-0065]; U.S. Department of Veterans Affairs, Office of Research & Development, Clinical Science Research & Development Service [I01CX001136-01]	This research was supported by Consortium to Alleviate PTSD award numbers W81XWH-13-2-0065 from the U.S. Department of Defense, Defense Health Program, Psychological Health and Traumatic Brain Injury Research Program (PH/TBI RP), and I01CX001136-01 from the U.S. Department of Veterans Affairs, Office of Research & Development, Clinical Science Research & Development Service.	A. P. Association, 2013, DIAGNOSTIC STAT MANU; ANDREW ME, 1992, INT J BIOMED COMPUT, V31, P17, DOI 10.1016/0020-7101(92)90050-3; [Anonymous], 2018, Cephalalgia, V38, P1, DOI 10.1177/0333102417738202; Arcaya MC, 2017, HEALTH PSYCHOL, V36, P411, DOI 10.1037/hea0000433; Ashina H, 2018, CEPHALALGIA, V38, P353, DOI 10.1177/0333102416684344; Ashina H, 2019, NAT REV NEUROL, V15, P607, DOI 10.1038/s41582-019-0243-8; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Becker WJ, 2019, CAN J NEUROL SCI, V46, P3, DOI 10.1017/cjn.2018.359; Ben Barnes J, 2019, MIL MED, V184, pE218, DOI 10.1093/milmed/usy226; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; BOHN MJ, 1995, J STUD ALCOHOL, V56, P423, DOI 10.15288/jsa.1995.56.423; Bourn LE, 2016, J PSYCHOSOM RES, V82, P35, DOI 10.1016/j.jpsychores.2016.01.009; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Bree D, 2018, CEPHALALGIA, V38, P246, DOI 10.1177/0333102416681571; Bryan CJ, 2014, J AFFECT DISORDERS, V159, P15, DOI 10.1016/j.jad.2014.02.021; Buysse DJ, 2010, SLEEP, V33, P781, DOI 10.1093/sleep/33.6.781; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Chong CD, 2018, HEADACHE, V58, P53, DOI 10.1111/head.13223; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Devilly GJ, 2000, J BEHAV THER EXP PSY, V31, P73, DOI 10.1016/S0005-7916(00)00012-4; Eckner JT, 2017, CLIN J SPORT MED, V27, P266, DOI 10.1097/JSM.0000000000000346; Farmer Carrie M, 2016, Rand Health Q, V6, P12; Galovski TE, 2009, J TRAUMA STRESS, V22, P197, DOI 10.1002/jts.20418; Holtkamp MD, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0572-x; Howard L, 2020, CURR OPIN NEUROL, V33, P316, DOI 10.1097/WCO.0000000000000815; Hundert AS, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.3452; Jaramillo CA, 2016, HEADACHE, V56, P528, DOI 10.1111/head.12726; Johnson DC, 2011, MIL MED, V176, P161, DOI 10.7205/MILMED-D-10-00258; Joiner TE, 2002, BEHAV RES THER, V40, P471, DOI 10.1016/S0005-7967(01)00017-1; Kamins J, 2018, HEADACHE, V58, P811, DOI 10.1111/head.13312; Kind S, 2019, CURR PAIN HEADACHE R, V23, DOI 10.1007/s11916-019-0828-3; Kleiman SE, 2020, PSYCHOL SERV, V17, P187, DOI 10.1037/ser0000306; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Langdon R, 2018, PEDIATR ANN, V47, pE61, DOI 10.3928/19382359-20180131-01; Leung A, 2018, MOL PAIN, V14, DOI 10.1177/1744806918810297; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lucas S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0520-1; MARTIN NJ, 1990, HEADACHE, V30, P729, DOI 10.1111/j.1526-4610.1990.hed3011729.x; MARTIN NJ, 1993, HEADACHE, V33, P244, DOI 10.1111/j.1526-4610.1993.hed3305244.x; Martindale SL, 2018, ARCH PHYS MED REHAB, V99, P2485, DOI 10.1016/j.apmr.2018.04.029; Martinson SJ, 2019, B ENTOMOL RES, V109, P141, DOI [10.1017/S0007485318000184, 10.1080/02699052.2018.1492741]; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Minen M, 2019, HEADACHE, V59, P151, DOI 10.1111/head.13455; MORIN CM, 1993, PSYCHOL AGING, V8, P463, DOI 10.1037/0882-7974.8.3.463; Nelson NW, 2020, NEUROPSYCHOLOGY, V34, P116, DOI 10.1037/neu0000594; Nock MK, 2007, PSYCHOL ASSESSMENT, V19, P309, DOI 10.1037/1040-3590.19.3.309; O'Neal Mary Angela, 2017, Pract Neurol, V17, P191, DOI 10.1136/practneurol-2016-001589; Park E, 2020, IBRO REP, V8, P18, DOI 10.1016/j.ibror.2019.12.001; Penzien D.B., 2013, STRUCTURED DIAGNOSTI; Penzien DB, 2005, HEADACHE, V45, pS110, DOI 10.1111/j.1526-4610.2005.4502004.x; Porter JK, 2019, PHARMACOECON-OPEN, V3, P411, DOI 10.1007/s41669-018-0105-0; Rains JC, 2005, HEADACHE, V45, pS92, DOI 10.1111/j.1526-4610.2005.4502003.x; Ropacki S, 2018, ARCH PHYS MED REHAB, V99, P952, DOI 10.1016/j.apmr.2017.12.035; Roper LS, 2017, J PAIN RES, V10, P1991, DOI 10.2147/JPR.S129808; Sauro KM, 2010, HEADACHE, V50, P383, DOI 10.1111/j.1526-4610.2009.01544.x; Selim A, 2009, QUAL LIFE RES, V18, P43, DOI 10.1007/s11136-008-9418-2; Seng EK, 2017, HEADACHE, V57, P593, DOI 10.1111/head.13021; SIMONS DJ, 1946, PSYCHOSOM MED, V8, P227, DOI 10.1097/00006842-194607000-00001; Smelt AFH, 2014, CEPHALALGIA, V34, P29, DOI 10.1177/0333102413497599; Sobell LC, 2003, J STUD ALCOHOL, V64, P858, DOI 10.15288/jsa.2003.64.858; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stewart WF, 2003, HEADACHE, V43, P258, DOI 10.1046/j.1526-4610.2003.03050.x; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Turner JA, 2016, PAIN, V157, P2434, DOI 10.1097/j.pain.0000000000000635; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Wachen J.S., 2019, CURR TREAT OPT PSYCH, V6, P107, DOI [10.1007/s40501-019-00169-9, DOI 10.1007/S40501-019-00169-9]; Ware JE, 2000, MED CARE, V38, P73; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486; Yu L, 2012, BEHAV SLEEP MED, V10, P6, DOI 10.1080/15402002.2012.636266	76	2	2	0	2	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA		2451-8654		CONT CLIN TRIAL COMM	Contemp. Clin. Trials Commun.	MAR	2021	21								100699	10.1016/j.conctc.2021.100699			11	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	RH5RT	WOS:000636276300015	33490706	gold, Green Published			2022-02-06	
J	Miner, DG; Harper, BA; Glass, SM				Miner, Daniel G.; Harper, Brent A.; Glass, Stephen M.			Validity of Postural Sway Assessment on the Biodex BioSway (TM) Compared With the NeuroCom Smart Equitest	JOURNAL OF SPORT REHABILITATION			English	Article						balance; postural control; posturography	RELIABILITY	Context: Current tools for sideline assessment of balance following a concussion may not be sufficiently sensitive to identify impairments, which may place athletes at risk for future injury. Quantitative field-expedient balance assessments are becoming increasingly accessible in sports medicine and may improve sensitivity to enable clinicians to more readily detect these subtle deficits. Objective: To determine the validity of the postural sway assessment on the Biodex BioSway (TM) compared with the gold standard NeuroCom Smart Equitest System. Design: Cross-sectional cohort study. Setting: Clinical research laboratory. Participants: Forty-nine healthy adults (29 females: 24.34 [2.45] y, height 163.65 [7.57] cm, mass 63.64 [7.94] kg; 20 males: 26.00 [3.70] y, height 180.11 [7.16] cm, mass 82.97 [12.78] kg). Intervention(s): The participants completed the modified clinical test of sensory interaction in balance on the Biodex BioSway (TM) with 2 additional conditions (head shake and firm surface; head shake and foam surface) and the Sensory Organization Test and Head Shake Sensory Organization Test on the NeuroCom Smart Equitest. Main Outcome Measures: Interclass correlation coefficient and Bland-Altman limits of agreement for Sway Index, equilibrium ratio, and area of 95% confidence ellipse. Results: Fair-good reliability (interclass correlation coefficient = .48-.65) was demonstrated for the stance conditions with eyes open on a firm surface. The Head Shake Sensory Interaction and Balance Test condition on a firm surface resulted in fair reliability (interclass correlation coefficient = .50-.59). The authors observed large ranges for limits of agreement across outcome measures, indicating that the systems should not be used interchangeably. Conclusions: The authors observed fair reliability between BioSway (TM) and NeuroCom, with better agreement between systems with the assessment of postural sway on firm/static surfaces. However, the agreement of these systems may improve by incorporating methods that mitigate the floor effect in an athletic population (eg, including a head shake condition). BioSway (TM) may provide a surrogate field-expedient measurement tool.	[Miner, Daniel G.] Radford Univ, Radford Univ Carilion, Dept Phys Therapy, Roanoke, VA 24013 USA; [Glass, Stephen M.] Radford Univ, Dept Phys Therapy, Radford, VA 24142 USA; [Harper, Brent A.] Chapman Univ, Dept Phys Therapy, Orange, CA USA		Miner, DG (corresponding author), Radford Univ, Radford Univ Carilion, Dept Phys Therapy, Roanoke, VA 24013 USA.	dminer1@radford.edu		Miner, Danny/0000-0003-0877-8119; Glass, Stephen/0000-0001-6263-527X			Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Clark S, 2008, J ORTHOP SPORT PHYS, V38, P262, DOI 10.2519/jospt.2008.2406; Corwin DJ, 2020, MED SCI SPORT EXER, V52, P542, DOI 10.1249/MSS.0000000000002163; Dewan Birendra M, 2019, Biomed Res Int, V2019, P8185710, DOI 10.1155/2019/8185710; Hinman MR, 2000, J SPORT REHABIL, V9, P240, DOI 10.1123/jsr.9.3.240; Imhoff Sarah, 2016, J Sports Med (Hindawi Publ Corp), V2016, P5127374, DOI 10.1155/2016/5127374; Mancini M, 2010, EUR J PHYS REHAB MED, V46, P239; Paniccia M, 2018, SPORTS HEALTH, V10, P175, DOI 10.1177/1941738117741651; Schmitz R, 1998, J SPORT REHABIL, V7, P95, DOI 10.1123/jsr.7.2.95; Wrisley DM, 2004, ARCH PHYS MED REHAB, V85, P335, DOI 10.1016/j.apmr.2003.03.005	10	2	2	1	1	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	MAR	2021	30	3					516	520		10.1123/jsr.2020-0227			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	RQ5UF	WOS:000642483100001	32882681	Bronze			2022-02-06	
J	Munoz, ER; Caccese, JB; Wilson, BE; Shuler, KT; Santos, FV; Caban, CT; Jeka, JJ; Langford, D; Hudson, MB				Munoz, Eric R.; Caccese, Jaclyn B.; Wilson, Brittany E.; Shuler, Kyle T.; Santos, Fernando, V; Caban, Carolina T.; Jeka, John J.; Langford, Dianne; Hudson, Matthew B.			Effects of purposeful soccer heading on circulating small extracellular vesicle concentration and cargo	JOURNAL OF SPORT AND HEALTH SCIENCE			English	Article						Biomarker; Concussion; MicroRNA; Repetitive head impact exposure; Soccer heading	TRAUMATIC BRAIN-INJURY; WHITE-MATTER; EXPRESSION; MICRORNAS; CONCUSSION; BIOMARKERS; EXOSOMES; PATHOGENESIS; DYSFUNCTION; MECHANISM	Background: Considering the potential cumulative effects of repetitive head impact (HI) exposure, we need sensitive biomarkers to track short- and long-term effects. Circulating small extracellular vesicles (sEVs) (<200 nm) traffic biological molecules throughout the body and may have diagnostic value as biomarkers for disease. The purpose of this study was to identify the microRNA (miRNA) profile in circulating sEVs derived from human plasma following repetitive HI exposure. Methods: Healthy adult (ages 18-35 years) soccer players were randomly assigned to 1 of 3 groups: the HI group performed 10 standing headers, the leg impact group performed 10 soccer ball trapping maneuvers over 10 min, and the control group did not participate in any soccer drills. Plasma was collected before testing and 24 h afterward, and sEVs were isolated and characterized via nanoparticle tracking analysis. Next-generation sequencing was utilized to identify candidate microRNAs isolated from sEVs, and candidate microRNAs were analyzed via quantitative polymerase chain reaction. In silico target prediction was performed using TargetScan (Version 7.0; targetscan.org) and miRWalk (http://mirwalk.umm.uni-heidelberg.de/) programs, and target validation was performed using luciferase reporter vectors with a miR-7844-5p mimic in human embryonic kidney (HEK) 293T/17 cells. Results: Plasma sEV concentration and size were not affected across time and group following repetitive HI exposure. After 24 h, the HI read count from next-generation sequencing showed a 4-fold or greater increase in miR-92b-5p, miR-423-5p, and miR-24-3p and a 3-fold or greater decrease in miR-7844-5p, miR-144-5p, miR-221-5p, and miR-22-3p. Analysis of quantitative polymerase chain reaction revealed that leg impact did not alter the candidate miRNA levels. To our knowledge, miR-7844-5p is a previously unknown miRNA. We identified 8 miR-7844-5p mRNA targets: protein phosphatase 1 regulatory inhibitor subunit 1B (PPP1R1B), LIM and senescent cell antigen-like domains 1 (LIMS1), autophagy-related 12 (ATG12), microtubule-associated protein 1 light chain 3 beta (MAP1LC3B), integrin subunit alpha-1 (ITGA1), mitogen-activated protein kinase 1 (MAPK1), glycogen synthase kinase 3 beta (GSK3B), and mitogen-activated protein kinase 8 (MAPK8). Conclusion: Collectively, these data indicate repetitive HI exposure alters plasma sEV miRNA content, but not sEV size or number. Furthermore, for the first time we demonstrate that previously unknown miR-7844-5p targets mRNAs known to be involved in mitochondrial apoptosis, autophagy regulation, mood disorders, and neurodegenerative disease.	[Munoz, Eric R.; Wilson, Brittany E.; Shuler, Kyle T.; Santos, Fernando, V; Jeka, John J.; Hudson, Matthew B.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE 19713 USA; [Caccese, Jaclyn B.] Ohio State Univ, Sch Hlth & Rehabil Sci, Coll Med, Columbus, OH 43210 USA; [Caban, Carolina T.; Langford, Dianne] Temple Univ, Lewis Katz Sch Med, Dept Neurosci, Philadelphia, PA 19140 USA		Hudson, MB (corresponding author), Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE 19713 USA.	mbhudson@udel.edu	Caccese, Jaclyn B./AAH-4571-2020	Caccese, Jaclyn B./0000-0003-2329-3603; Santos, Fernando/0000-0002-8637-792X; Munoz, Eric/0000-0003-0010-7513	National Institutes of Health (NIH)-National Institute of Neurological Disorders and Stroke (NINDS) R01 [NS102157-01]; National Institutes of Health (NIH)-National Institute of General Medical Sciences (NIGMS) P20 [GM113125-01]	This study was supported by National Institutes of Health (NIH)-National Institute of Neurological Disorders and Stroke (NINDS) R01 (NS102157-01) and National Institutes of Health (NIH)-National Institute of General Medical Sciences (NIGMS) P20 (GM113125-01). Graphical abstract and VideoSlides illustrations were created with BioRender.com.	Alosco ML, 2016, ALZHEIMERS DEMENT, V7, P33; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beal MF, 1998, BBA-BIOENERGETICS, V1366, P211, DOI 10.1124/jpet.112.192138; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Bhattacharyya M, 2013, MOL BIOSYST, V9, P457, DOI 10.1039/c2mb25434d; Caccese JB, 2019, MED SCI SPORT EXER, V51, P1355, DOI 10.1249/MSS.0000000000001905; Caccese JB, 2018, SPORT BIOMECH, V17, P462, DOI 10.1080/14763141.2017.1360385; Caccese JB, 2018, RES SPORTS MED, V26, P64, DOI 10.1080/15438627.2017.1393756; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Devoto C, 2020, J NEUROTRAUM, V37, P2482, DOI 10.1089/neu.2019.6933; Di Pietro V, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00290; Dorminy M, 2015, BRAIN INJURY, V29, P1158, DOI 10.3109/02699052.2015.1035324; Ercole A, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0614-3; Everaert C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01617-3; Gardiner C, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19671; Giotopoulou N, 2015, CLIN EXP METASTAS, V32, P255, DOI 10.1007/s10585-015-9701-x; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Guo F, 2018, BRAIN PATHOL, V28, P3, DOI 10.1111/bpa.12545; Gupta A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-68; Hazelton I, 2018, J NEUROTRAUM, V35, P639, DOI 10.1089/neu.2017.5049; Higgins MJ, 2009, P I MECH ENG P-J SPO, V223, P117, DOI 10.1243/17543371JSET15; Huber BR, 2016, PHYS MED REH CLIN N, V27, P503, DOI 10.1016/j.pmr.2015.12.007; Hudson MB, 2014, AM J PHYSIOL-CELL PH, V307, pC314, DOI 10.1152/ajpcell.00395.2013; Hudson MB, 2014, AM J PHYSIOL-CELL PH, V306, pC551, DOI 10.1152/ajpcell.00266.2013; Hwang S, 2017, J NEUROTRAUM, V34, P8, DOI 10.1089/neu.2015.4238; Johnson JJ, 2018, JAMA PEDIATR, V172, P65, DOI 10.1001/jamapediatrics.2017.3884; Jope RS, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00016; Jovicic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054222; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau P, 2013, EMBO MOL MED, V5, P1613, DOI 10.1002/emmm.201201974; Li SH, 2005, J CELL SCI, V118, P2913, DOI 10.1242/jcs.02422; Liang XQ, 2007, CIRC RES, V100, P527, DOI 10.1161/01.RES.0000259041.37059.8c; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103948; Ma WB, 2016, CELL BIOCHEM FUNCT, V34, P511, DOI 10.1002/cbf.3224; Mackay DF, 2019, NEW ENGL J MED, V381, P1801, DOI 10.1056/NEJMoa1908483; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; Meder B, 2011, MOL CELL BIOL, V31, P3424, DOI 10.1128/MCB.05269-11; Momen-Heravi F, 2018, PHARMACOL THERAPEUT, V192, P170, DOI 10.1016/j.pharmthera.2018.08.002; Mondello S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040977; Ozdemir AY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058232; Papa L, 2019, J NEUROTRAUM, V36, P1343, DOI 10.1089/neu.2018.6072; Patz S, 2013, J NEUROTRAUM, V30, P1232, DOI 10.1089/neu.2012.2596; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rearden A, 2008, J NEUROSCI RES, V86, P2535, DOI 10.1002/jnr.21701; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Rubinstein AD, 2011, MOL CELL, V44, P698, DOI 10.1016/j.molcel.2011.10.014; Satoh J, 2010, J PHARMACOL SCI, V114, P269, DOI 10.1254/jphs.10R11FM; Shah R, 2018, NEW ENGL J MED, V379, P958, DOI 10.1056/NEJMra1704286; Siminska D, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082445; Svingos AM, 2019, BRAIN INJURY, V33, P1, DOI 10.1080/02699052.2019.1573379; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tarnutzer AA, 2017, BRIT J SPORT MED, V51, P1592, DOI 10.1136/bjsports-2016-096593; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thompson AG, 2016, NAT REV NEUROL, V12, P346, DOI 10.1038/nrneurol.2016.68; Tyagi Vineet, 2016, Surg Neurol Int, V7, P78, DOI 10.4103/2152-7806.189296; Wahid F, 2010, BBA-MOL CELL RES, V1803, P1231, DOI 10.1016/j.bbamcr.2010.06.013; Wang X, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0099-8; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; Xu WY, 2013, INT J ONCOL, V42, P757, DOI 10.3892/ijo.2012.1742; Yang YQ, 2005, J AM SOC NEPHROL, V16, P1966, DOI 10.1681/ASN.2004121112; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127	64	2	2	2	3	SHANGHAI UNIV SPORT	SHANGHAI	EDITORIAL BOARD, 650 QINGYUANHUAN RD, SHANGHAI, 200438, PEOPLES R CHINA	2095-2546	2213-2961		J SPORT HEALTH SCI	J. Sport Health Sci.	MAR	2021	10	2					122	130		10.1016/j.jshs.2020.11.006			9	Hospitality, Leisure, Sport & Tourism; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Sport Sciences	QY5AT	WOS:000630052900003	33189894	gold, Green Published			2022-02-06	
J	Parthiban, JKBC; Sundaramahalingam, S; Rao, JB; Nannaware, VP; Rathwa, VN; Nasre, VY; Prahlad, ST				Parthiban, Jutty K. B. C.; Sundaramahalingam, Shanthanam; Rao, J. Balaparameswara; Nannaware, Vaishali Pralhad; Rathwa, Vishnu Najarubhai; Nasre, Vaibhav Yogesh; Prahlad, Shantigrama Thirumalachar			Basal Cisternostomy-A Microsurgical Cerebro Spinal Fluid Let Out Procedure and Treatment Option in the Management of Traumatic Brain Injury. Analysis of 40 Consecutive Head Injury Patients Operated with and without Bone Flap Replacement Following Cisternostomy in a Tertiary Care Centre in India	NEUROLOGY INDIA			English	Article						Basal cisternostomy; cerebral oedema; decompressive craniectomy; neurotrauma; traumatic brain injury	DECOMPRESSIVE CRANIECTOMY	Background: Decompressive craniectomy (DC) is considered the gold standard blanket surgical procedure for all medically intractable cerebral oedema in Traumatic Brain Injury (TBI). It's only proven fact is that it reduces Intra Cerebral Pressure (ICP) by providing space for the oedematous brain. Attempts are being made to find additional or alternative procedures to improve outcomes in TBI. Basal Cisternostomy is one such technique proposed to bring such a change in world literature. Aim: To analyse the validity of Basal Cisternostomy in TBI patients Materials and Methods: A total of 40 patients who underwent Basal Cisternostomy (BC) in TBI admitted in the senior author's unit between January 2016 and April 2019 were analysed retrospectively. All surgeries were performed by single surgeon with microsurgical expertise. Outcome was assessed according to Glasgow outcome scale (GOS). Results were analysed using SPSS software. Results: In severe TBI, Basal Cisternostomy group showed 77.8% favourable outcome while Decompressive Craniectomy in addition to Basal Cisternostomy group showed 72.7% only. While favourable GOS was seen in 82% (33/40), the unfavourable outcome was noticed in 12.5% (5/40) and death in 5% (2/40) in this series. Hydrocephalus was seen in 12.5% (5/40). Patients operated earlier from the time of injury showed better results than those who got operated later irrespective of severity of neurological status. ICU stay and hospital stay duration and its validity could not be assessed. Conclusion: Basal Cisternostomy is an effective procedure in Traumatic Brain Injury patients that not only improves outcome but also reduces the need for Decompressive Craniectomy as a blanket procedure and thus avoiding its associated complications.	[Parthiban, Jutty K. B. C.; Sundaramahalingam, Shanthanam; Rao, J. Balaparameswara; Nannaware, Vaishali Pralhad; Rathwa, Vishnu Najarubhai; Nasre, Vaibhav Yogesh; Prahlad, Shantigrama Thirumalachar] Kovai Med Ctr & Hosp, Dept Neurosurg, 99 Avinashi Rd, Coimbatore 641014, Tamil Nadu, India		Parthiban, JKBC (corresponding author), Kovai Med Ctr & Hosp, Dept Neurosurg, 99 Avinashi Rd, Coimbatore 641014, Tamil Nadu, India.	juttyparthiban@gmail.com					Bulat M, 2011, BRAIN RES REV, V65, P99, DOI 10.1016/j.brainresrev.2010.08.002; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cherian I, 2019, WORLD NEUROSURG, V131, P385, DOI 10.1016/j.wneu.2019.07.082; Cherian I, 2018, J NEUROSCI RES, V96, P744, DOI 10.1002/jnr.24145; Cherian Iype, 2013, Asian J Neurosurg, V8, P132, DOI 10.4103/1793-5482.121684; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Giammattei L, 2020, ACTA NEUROCHIR, V162, P469, DOI 10.1007/s00701-020-04222-y; Giammattei L, 2018, WORLD NEUROSURG, V116, P322, DOI 10.1016/j.wneu.2018.05.176; Giammattei L, 2018, WORLD NEUROSURG, V109, P460, DOI 10.1016/j.wneu.2017.10.085; Grindlinger GA, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3251-9; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Masoudi Mohammad Sadegh, 2016, Bull Emerg Trauma, V4, P161; Oreskovic D, 2010, BRAIN RES REV, V64, P241, DOI 10.1016/j.brainresrev.2010.04.006	16	2	2	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	MAR-APR	2021	69	2					328	333		10.4103/0028-3886.314535			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RW0MR	WOS:000646219200016	33904445				2022-02-06	
J	Ponsford, J; Harrison-Felix, C; Ketchum, JM; Spitz, G; Miller, AC; Corrigan, JD				Ponsford, Jennie; Harrison-Felix, Cynthia; Ketchum, Jessica M.; Spitz, Gershon; Miller, A. Cate; Corrigan, John D.			Outcomes 1 and 2 Years After Moderate to Severe Traumatic Brain Injury: An International Comparative Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; traumatic; Outcomes; Rehabilitation		Objective: This study compared traumatic brain injury (TBI) outcomes from 2 cohorts: the National Institute on Disability, Independent Living, and Rehabilitation Research Traumatic Brain Injury Model Systems (TBIMS) in the United States and Longitudinal Head Injury Outcome Study conducted in Victoria, Australia, by the Monash Epworth Rehabilitation Research Centre (MERRC). Design: Cohort study with 1- and 2-year follow-up. Setting: Acute trauma care and inpatient rehabilitation with follow-up. Participants: Patients (N= 1056) with moderate-severe TBI admitted in 2000-2012 to inpatient rehabilitation after motor vehicle-related collisions, who completed follow-up, were matched using 1:2 matching algorithm based on age at injury, days of posttraumatic amnesia, and years education, resulting in groups of 352 (MERRC) and 704 patients (TBIMS). Intervention: The cohorts had received acute trauma care and inpatient rehabilitation for a median 38 (MERRC) or 33 days (TBIMS). The MERRC group also had routine access to community-based support and rehabilitation for return to work or school, attendant care, and home help as justified, funded by an accident compensation system, whereas the TBIMS cohort had variable access to these services. Main Outcome Measures: Outcomes were assessed 1 and 2 years post injury in terms of employment, living situation, marital status, and Glasgow Outcome Scale-Extended (GOS-E) scores. Results: At 2 years post injury, MERRC participants were more likely to be competitively employed. At both 1 and 2 years post injury, MERRC participants were more likely to be married and living independently. On GOS-E, the TBIMS group had higher percentages of patients inLower Severe Disability/Vegetative State and Upper Good Recovery than MERRC participants, whereas the MERRC cohort had higher percentages of Lower Moderate Disability than TBIMS. Conclusions: Findings may suggest that routine provision of community-based supports could confer benefits for long-term TBI outcomes. Further studies documenting rehabilitation services are needed to explore this. (C) 2020 by the American Congress of Rehabilitation Medicine	[Ponsford, Jennie; Spitz, Gershon] Monash Univ, Turner Inst Brain & Mental Hlth, Sch Psychol Sci, Melbourne, Vic, Australia; [Ponsford, Jennie; Spitz, Gershon] Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Harrison-Felix, Cynthia; Ketchum, Jessica M.] Craig Hosp, Res Dept, Englewood, CO USA; [Miller, A. Cate] Dept Hlth & Human Serv HHS, Natl Inst Disabil Independent Living & Rehabil Re, Adm Community Living ACL, Washington, DC USA; [Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA		Ponsford, J (corresponding author), Monash Univ, Sch Psychol Sci, 18 Innovat Walk, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu			National Institute on Disability, Independent Living, and Rehabilitation Research, a center within the Administration for Community Living of the US Department of Health and Human Services; Transport Accident Commission; National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DPTB0001]; Traumatic Brain Injury Model Systems National Data and Statistical Center [90DP0084]	The Traumatic Brain Injury Model System Centers program is funded by the National Institute on Disability, Independent Living, and Rehabilitation Research, a center within the Administration for Community Living of the US Department of Health and Human Services. The Monash Epworth Rehabilitation Research Centre Longitudinal Head Injury Outcome Study is funded by the Transport Accident Commission. Representatives from Transport Accident Commission were not involved in the collection, data analysis, preparation or review of the paper.; Supported by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) to Ohio State University (grant no. 90DPTB0001) and the Traumatic Brain Injury Model Systems National Data and Statistical Center (grant no. 90DP0084). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this publication do not necessarily represent the policy of NIDILRR, ACL, or HHS, and you should not assume endorsement by the Federal Government.	AccessEconomics,, 2009, EC COST SCI TBI AUST; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Burkner PC, 2018, R J, V10, P395; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P122, DOI 10.1097/HTR.0000000000000012; Dijkers MP, 2018, J HEAD TRAUMA REHAB, V33, P363, DOI 10.1097/HTR.0000000000000454; Ho DE, 2011, J STAT SOFTW, V42; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; National Data and Statistical Center, TRAUMATIC BRAIN INJU; Ponsford J, 1999, NEUROPSYCHOL REHABIL, V9, P517, DOI 10.1080/096020199389563; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Spitz G, 2019, J NEUROTRAUM, V36, P2533, DOI 10.1089/neu.2018.5850; Walker WC, 2018, J NEUROTRAUM, V35, P1587, DOI 10.1089/neu.2017.5359	18	2	2	1	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2021	102	3					371	377		10.1016/j.apmr.2020.09.387			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	RC1JV	WOS:000632559000004	33190797				2022-02-06	
J	Rosenbloom, C; Broman, D; Chu, W; Chatterjee, R; Kryger, KO				Rosenbloom, Craig; Broman, Daniel; Chu, Wing; Chatterjee, Robin; Okholm Kryger, Katrine			Sport-related concussion practices of medical team staff in elite football in the United Kingdom, a pilot study	SCIENCE AND MEDICINE IN FOOTBALL			English	Article; Early Access						Soccer; assessment; strategy; doctor; physiotherapist; therapist		Objectives: To explore sport-related concussion (SRC) awareness, behaviours, and attitudes of medical team staff working in elite football in the United Kingdom. Including usage and awareness of the FA concussion guidelines, concussion education rates of players and coaching staff, and collection of baseline concussion assessments. Methods: Cross-sectional questionnaire study distributed online by organisations including or representing medical staff working in elite football in the United Kingdom. Results: 120 responses were gathered. High awareness rates of the FA guidelines were found (97%) with variable rates of player and coaching staff concussion education. Baseline concussion assessments were collected by 78%. Of those, 99% collected SCAT5 with low rates of other neuro-psychometric testing (17%). Confidence of pitch-side SRC recognition was high (93% feeling very confident or confident). Introduction of a 'concussion' substitute was seen as strongly positive for player welfare (85% strongly agreeing or agreeing). Conclusions: Awareness of FA concussion guidelines, and collection of SCAT5 baseline testing was high. Player and coaching staff concussion education rates were low, as was the use of neuro-psychometric testing beyond the use of the SCAT5. There was strong support the introduction of a 'concussion' substitute being a positive thing for player welfare.	[Rosenbloom, Craig] Tech Directorate, Football Assoc, Burton Upon Trent, England; [Rosenbloom, Craig; Okholm Kryger, Katrine] Queen Mary Univ London, Sport & Exercise Med, London, England; [Broman, Daniel] Isokinet Med Grp, London, England; [Chu, Wing] St Marys Hosp, Imperial Coll Healthcare NHS Trust, London, England; [Chatterjee, Robin] Inst Sport Exercise & Hlth, London, England; [Chatterjee, Robin] British Assoc Sport & Exercise Med, 3 Jetstream Dr, Doncaster, England; [Okholm Kryger, Katrine] St Marys Univ, Fac Sport Hlth & Appl Sci, London, England; [Okholm Kryger, Katrine] Univ Southern Denmark, Dept Sports Sci & Clin Biomech, Odense, Denmark		Rosenbloom, C (corresponding author), Tech Directorate, Football Assoc, Burton Upon Trent, England.	craig.rosenbloom@thefa.com		Chatterjee, Robin/0000-0002-4858-3642; Okholm Kryger, Katrine/0000-0003-0924-6181; Rosenbloom, Craig/0000-0001-6166-209X			Abraham KJ, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024607; Anderson LC, 2005, J MED ETHICS, V31, P88, DOI 10.1136/jme.2002.000836; Anderson L, 2013, INT REV SOCIOL SPORT, V48, P238, DOI 10.1177/1012690211435031; Bahr R, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094826; Bizzini M, 2015, BRIT J SPORT MED, V49, P577, DOI 10.1136/bjsports-2015-094765; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Broglio SP., 2010, J SPORTS SCI MED, V9; Cash DE., 2019, EFFECTS PRESEASON CO; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P870, DOI 10.1136/bjsports-2017-097508; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Ekstrand J, 2011, BRIT J SPORT MED, V45, P553, DOI 10.1136/bjsm.2009.060582; Fuller GW, 2017, J SCI MED SPORT, V20, P246, DOI 10.1016/j.jsams.2016.07.008; Gouttebarge V, 2019, BMJ OPEN SPORT EXERC, V5, DOI 10.1136/bmjsem-2018-000490; Gouttebarge V, 2017, PHYSICIAN SPORTSMED, V45, P443, DOI 10.1080/00913847.2017.1376572; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Hagglund M, 2013, BRIT J SPORT MED, V47, P738, DOI 10.1136/bjsports-2013-092215; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Junge A, 2015, BRIT J SPORT MED, V49, P599, DOI 10.1136/bjsports-2014-094469; Kroshus E, 2017, J ATHL TRAINING, V52, P1041, DOI 10.4085/1062-6050-52.11.17; Kurowski BG, 2015, J TRAUMA ACUTE CARE, V79, pS21, DOI 10.1097/TA.0000000000000675; Lovell M., 2001, PITTSBURGH NEUROHEAL; Mathema P, 2016, CLIN J SPORT MED, V26, P320, DOI 10.1097/JSM.0000000000000256; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Niederer D, 2018, BRAIN INJURY, V32, P1096, DOI 10.1080/02699052.2018.1483032; Nilsson M, 2013, CLIN J SPORT MED, V23, P255, DOI 10.1097/JSM.0b013e31827ee6f8; O'Leary F, 2020, BMJ OPEN SPORT EXERC, V6, DOI 10.1136/bmjsem-2019-000695; Onate JA., 2009, ATHLETIC TRAINING SP, V1, DOI [DOI 10.3928/19425864-20090427-07, 10.3928/19425864-20090427-07]; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; Partridge B, 2014, J BIOETHIC INQ, V11, P65, DOI 10.1007/s11673-013-9491-2; Patricios JS, 2018, BRIT J SPORT MED, V52, P635, DOI 10.1136/bjsports-2018-099079; Polsky S, 1998, J CONTEMP HEALTH LAW, V14; Price J, 2012, BRIT J SPORT MED, V46, P1000, DOI 10.1136/bjsports-2011-090687; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; The Football Association, 2015, FA CONC GUID; The International Football Association Board, 2020, IFAB AGR IMPL SUBST; Tsao J, 2014, ATHLETIC INSIGHT, V6; Turner M, 2021, BRIT J SPORT MED, V55, P539, DOI 10.1136/bjsports-2020-102108; Williams JM, 2016, J SPORT HEALTH SCI, V5, P197, DOI 10.1016/j.jshs.2015.01.009	40	2	2	3	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2473-3938	2473-4446		SCI MED FOOTBALL	Sci. Med. Football												10.1080/24733938.2021.1892174		MAR 2021	9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	QP4ZJ	WOS:000623845300001					2022-02-06	
J	Ross, AJ; Ross, BJ; Zeoli, TC; Brown, SM; Mulcahey, MK				Ross, Austin J.; Ross, Bailey J.; Zeoli, Tyler C.; Brown, Symone M.; Mulcahey, Mary K.			Injury Profile of Mixed Martial Arts Competitions in the United States	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						martial arts; medical aspects of sports; epidemiology; general sports trauma		Background: The popularity of mixed martial arts (MMA) continues to grow in the United States. Although prior work has provided valuable insight concerning injuries in the sport, much of the available literature is limited by factors such as small sample sizes, varying athlete demographics, and inconsistent data collection methods. Purpose: To report injury rates and types in MMA and analyze potential variance between competition and match variables. Study Design: Descriptive epidemiology study. Methods: We performed a retrospective review of injuries sustained by fighters during MMA contests between 2018 and 2019 using ringside physician postmatch injury reports from Wisconsin and Arizona. The prevalence of overall injuries and specific injury types was compared by location (Arizona vs Wisconsin), competition level (amateur vs professional), match result (decisions vs any other result), and match winners versus losers. Results: In 503 contests, 285 (57%) had at least 1 injury. In these 285 matches, participants experienced 401 injuries: 197 (49%) in professional bouts and 204 (51%) in amateur bouts. The match injury rate was higher in professional bouts than in amateur contests (68% vs 51%; P < .001). Amateur fighters had more contusions and hematomas (31% vs 22%; P < .001), while professional fighters had more lacerations (39% vs 23%; P < .001). Losers exhibited a higher match injury rate than winners (48% vs 24%; P < .001). Winners experienced a higher proportion of fractures (19% vs 9%; P = .005), and losers experienced more concussions (17% vs 2%; P < .001). Conclusion: Professional fighters and losers of MMA bouts exhibited higher injury rates relative to amateurs and winners. The prevalence of specific injury types varied by competition level, match result, and match winners versus losers. The results of this study may be used to better understand the current injury profile in MMA and to develop targeted strategies for injury prevention.	[Ross, Austin J.; Ross, Bailey J.; Zeoli, Tyler C.; Brown, Symone M.; Mulcahey, Mary K.] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Ross, Austin J.; Ross, Bailey J.; Zeoli, Tyler C.; Brown, Symone M.; Mulcahey, Mary K.] Tulane Univ, Sch Med, Dept Orthopaed Surg, New Orleans, LA 70112 USA		Mulcahey, MK (corresponding author), Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA.	Mary.mulcahey.md@gmail.com					Bledsoe GH, 2006, J SPORT SCI MED, V5, P136; Buse GJ, 2006, BRIT J SPORT MED, V40, P169, DOI 10.1136/bjsm.2005.021295; Curran-Sills G, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000348; Fares MY, 2019, PHYSICIAN SPORTSMED, V47, P205, DOI 10.1080/00913847.2018.1546108; Fossman S., INT SPORTS COMBAT FE; Hutchison MG, 2014, AM J SPORT MED, V42, P1352, DOI 10.1177/0363546514526151; Jensen AR, 2017, SPORTS HEALTH, V9, P64, DOI 10.1177/1941738116664860; Kordi R, 2004, BRIT J SPORT MED, V38, P678, DOI 10.1136/bjsm.2004.011643; Lockwood J, 2018, TRAUMA, V20, P245, DOI 10.1177/1460408617740902; Luekenhoff T., 2019, ASS BOXING COMMISSIO; Lystad RP, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967113518492; McClain R, 2014, CLIN J SPORT MED, V24, P497, DOI 10.1097/JSM.0000000000000078; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Ngai KM, 2008, BRIT J SPORT MED, V42, P686, DOI 10.1136/bjsm.2007.044891; Petrisor BA, 2019, SPORTS HEALTH, V11, P432, DOI 10.1177/1941738119849112; Rainey Charles E, 2009, N Am J Sports Phys Ther, V4, P190; Scoggin James F 3rd, 2010, Am J Orthop (Belle Mead NJ), V39, P247; Scoggin JF, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114522184; Seidenberg PH, 2011, CURR SPORT MED REP, V10, P147, DOI 10.1249/JSR.0b013e31821cc952; United States Mixed Martial Arts Federation, MIX MART ARTS RUL AM; Zazryn TR, 2003, BRIT J SPORT MED, V37, P448, DOI 10.1136/bjsm.37.5.448; Zazryn TR, 2009, CLIN J SPORT MED, V19, P20, DOI 10.1097/JSM.0b013e31818f1582	22	2	2	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	MAR	2021	9	3							2325967121991560	10.1177/2325967121991560			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	RE9AT	WOS:000634442200001	33855092	gold, Green Published			2022-02-06	
J	Ruet, A; Bayen, E; Jourdan, C; Vallat-Azouvi, C; Azerad, S; Grimaldi, L; Meaude, L; Charanton, J; Azouvi, P				Ruet, Alexis; Bayen, Eleonore; Jourdan, Claire; Vallat-Azouvi, Claire; Azerad, Sylvie; Grimaldi, Lamiae; Meaude, Layide; Charanton, James; Azouvi, Philippe			Potential for recovery between 4 and 8 years after a severe traumatic brain injury. Data from the PariS-TBI longitudinal study	ANNALS OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Traumatic brain injury; Outcome assessment; Mood; Adult; Longitudinal study		Background: Severe traumatic brain injury (TBI) is a leading cause of complex and persistent disability. Yet, long-term change in global functioning and determinants of this change remain unclear. Objectives: This study aimed to assess change in global functioning in the long-term after severe TBI and factors associated with the change. Methods: This was a prospective observational study of an inception cohort of adults with severe TBI in the Paris area (PariS-TBI). Outcome was assessed at 1, 4 and 8 years post-injury. For the included participants (n = 257), change in global outcome between 4 and 8 years was evaluated with the Glasgow Outcome Scale Extended (GOSE) score, and its association with pre-injury, injury-related and post-injury variables was tested with univariate and multivariable analyses. Results: More than half of the 73 participants evaluated at both 4 and 8 years showed global improvement (of at least one point) in GOSE score and an improvement in mood, executive function, and subjective complaints. On univariate analysis, none of the pre-injury, injury or post-injury variables were associated with GOSE score change between 4 and 8 years, except for GOSE score at 4 years (rho = -0.24, P = 0.04). On multivariable analysis, probability of increased GOSE score was associated with more years of education (odds ratio 1.18 [95% confidence interval 1.02-1.37], P = 0.03). The change in GOSE score was significantly correlated with change in Hospital Anxiety Depression Scale score between 4 and 8 years (rho = -0.42, P < 0.001). Conclusions: Most participants with severe TBI in the present sample showed a late improvement (4 to 8 years post-injury) in global functioning. Of the socio-demographic and injury-related factors, only more years of education was associated with improvement in global functioning. Decreased anxiety and depression symptoms were associated with improved global functioning. Targeting interventions to enhance resilience may be the most effective in the long-term after severe TBI. (C) 2020 Elsevier Masson SAS. All rights reserved.	[Bayen, Eleonore] Sorbonne Univ, Hop Pitie Salpetriere, AP HP, Dept Reeduc Neurol,Fac Med, Paris, France; [Vallat-Azouvi, Claire] Hop Raymond Poincare, Antenne UEROS SAMSAH92 UGECAM IDF, Garches, France; [Vallat-Azouvi, Claire; Azouvi, Philippe] Univ Versailles St Quentin, EA4047, HANDIReSP, Montigny Le Bretonneux, France; [Vallat-Azouvi, Claire] Lab Psychopathol & Neuropsychol, EA 2027, Paris, France; [Azerad, Sylvie; Grimaldi, Lamiae; Meaude, Layide] Hop Ambroise Pare, AP HP, Unite Rech Clin, Boulogne, France; [Grimaldi, Lamiae] LA SER, Paris, France; [Grimaldi, Lamiae] Pasteur Inst, Pharmacoepidemiol & Infect Dis Unit, Paris, France; [Charanton, James] Ctr Ressources Francilien Traumatisme Cranien CRP, Paris, France; [Jourdan, Claire] CHU Lapeyronie, Dept Med Phys & Readaptat, Montpellier, France; [Azouvi, Philippe] Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, Garches, France; [Ruet, Alexis] CHU Caen, Caen, Normandie, France		Ruet, A (corresponding author), CHU Caen, Serv Med Phys & Readaptat, Ave Cote Nacre, F-14000 Caen, France.	alexis.ruet@gmail.com	RUET, Alexis/L-8726-2015	RUET, Alexis/0000-0002-5080-5734	French Ministry of Health (Programme hospitalier de recherche clinique) [AOM04084]; AP-HP (Departement de la recherche clinique et du developpement) - Institut de recherche en sante publique (IRESP)	The first part of this study and the 8-year evaluation were funded by a grant from the French Ministry of Health (Programme hospitalier de recherche clinique 2004 and 2012, AOM04084) and sponsored by AP-HP (Departement de la recherche clinique et du developpement). The second part of this study (4-year outcome) was funded by a grant from the Institut de recherche en sante publique (IRESP).	Andelic N, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1018; Andersson E, 2017, ACTA ANAESTH SCAND, V61, P502, DOI 10.1111/aas.12880; Azouvi P, 2015, NEUROPSYCHOL REHABIL, V25, P864, DOI 10.1080/09602011.2014.990907; Bayen E, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00320; Bayen E, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000079; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Chesnel C, 2018, CLIN REHABIL, V32, P692, DOI 10.1177/0269215517734294; Connelly J, 2006, DISABIL REHABIL, V28, P629, DOI 10.1080/09638280500276513; Dams-O'Connor K, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000073; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Fayol P., 2004, Annales de Readaptation et de Medecine Physique, V47, P142, DOI 10.1016/j.annrmp.2004.01.004; Forslund MV, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00219; Forslund MV, 2017, BRAIN INJURY, V31, P329, DOI 10.1080/02699052.2016.1255778; Gorgoraptis N, 2019, NEUROREHABILITATION, V44, P321, DOI 10.3233/NRE-182618; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; JENNETT B, 1975, LANCET, V1, P480; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Jourdan C, 2018, AM J PHYS MED REHAB, V97, P323, DOI 10.1097/PHM.0000000000000848; Jourdan C, 2017, J HEAD TRAUMA REHAB, V32, pE26, DOI 10.1097/HTR.0000000000000276; Jourdan C, 2016, J HEAD TRAUMA REHAB, V31, pE42, DOI 10.1097/HTR.0000000000000147; Jourdan C, 2015, BRAIN INJURY, V29, P701, DOI 10.3109/02699052.2015.1004646; Kreutzer JS, 2018, BRAIN INJURY, V32, P963, DOI 10.1080/02699052.2018.1468577; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2486, DOI 10.1016/j.apmr.2013.06.021; R Core Team, 2021, R LANG ENV STAT COMP; Ruet A, 2018, DISABIL REHABIL, V40, P2200, DOI 10.1080/09638288.2017.1327992; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Vallat-Azouvi C, 2018, J NEUROSCI RES, V96, P601, DOI 10.1002/jnr.24180; Wardlaw C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00563; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	35	2	2	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	1877-0657	1877-0665		ANN PHYS REHABIL MED	Ann. Phys. Rehabil. Med.	MAR	2021	64	2							101422	10.1016/j.rehab.2020.07.005			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	RE5JA	WOS:000634189000005	32763484				2022-02-06	
J	Stein, MB; Yuh, E; Jain, S; Okonkwo, DO; Mac Donald, CL; Levin, H; Giacino, JT; Dikmen, S; Vassar, MJ; Diaz-Arrastia, R; Robertson, CS; Nelson, LD; McCrea, M; Sun, XY; Temkin, N; Taylor, SR; Markowitz, AJ; Manley, GT; Mukherjee, P				Stein, Murray B.; Yuh, Esther; Jain, Sonia; Okonkwo, David O.; Mac Donald, Christine L.; Levin, Harvey; Giacino, Joseph T.; Dikmen, Sureyya; Vassar, Mary J.; Diaz-Arrastia, Ramon; Robertson, Claudia S.; Nelson, Lindsay D.; McCrea, Michael; Sun, Xiaoying; Temkin, Nancy; Taylor, Sabrina R.; Markowitz, Amy J.; Manley, Geoffrey T.; Mukherjee, Pratik		TRACK TBI Investigators	Smaller Regional Brain Volumes Predict Posttraumatic Stress Disorder at 3 Months After Mild Traumatic Brain Injury	BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING			English	Article							HIPPOCAMPAL VOLUME; GEOMETRICALLY ACCURATE; CORTICAL THICKNESS; COGNITIVE-ABILITY; CONNECTIVITY; AFGHANISTAN; RESILIENCE; VETERANS; RISK	BACKGROUND: Brain volumes in regions such as the hippocampus and amygdala have been associated with risk for the development of posttraumatic stress disorder (PTSD). The objective of this study was to determine whether a set of regional brain volumes, measured by magnetic resonance imaging at 2 weeks following mild traumatic brain injury, were predictive of PTSD at 3 and 6 months after injury. METHODS: Using data from TRACK-TBI (Transforming Research and Clinical Knowledge in TBI), we included patients (N = 421) with Glasgow Coma Scale scores 13?15 assessed after evaluation in the emergency department and at 2 weeks, 3 months, and 6 months after injury. Probable PTSD diagnosis (PTSD Checklist for DSM-5 score, $33) was the outcome. FreeSurfer 6.0 was used to perform volumetric analysis of threedimensional T1-weighted magnetic resonance images at 3T obtained 2 weeks post injury. Brain regions selected a priori for volumetric analyses were insula, hippocampus, amygdala, superior frontal cortex, rostral and caudal anterior cingulate, and lateral and medial orbitofrontal cortices. RESULTS: Overall, 77 (18.3%) and 70 (16.6%) patients had probable PTSD at 3 and 6 months. A composite volume derived as the first principal component incorporating 73.8% of the variance in insula, superior frontal cortex, and rostral and caudal cingulate contributed to the prediction of 3-month (but not 6-month) PTSD in multivariable models incorporating other established risk factors. CONCLUSIONS: Results, while needing replication, provide support for a brain reserve hypothesis of PTSD and proof of principle for how prediction of at-risk individuals might be accomplished to enhance prognostic accuracy and enrich clinical prevention trials for individuals at the highest risk of PTSD following mild traumatic brain injury.	[Stein, Murray B.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Stein, Murray B.; Jain, Sonia; Sun, Xiaoying] Univ Calif San Diego, Herbert Wertheim Sch Publ Hlth & Human Longev Sci, La Jolla, CA 92093 USA; [Stein, Murray B.] VA San Diego Healthcare Syst, San Diego, CA USA; [Yuh, Esther; Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Vassar, Mary J.; Taylor, Sabrina R.; Manley, Geoffrey T.; Mukherjee, Pratik] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Yuh, Esther] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Vassar, Mary J.; Taylor, Sabrina R.; Markowitz, Amy J.; Manley, Geoffrey T.] Zuckerberg San Francisco Gen Hosp & Trauma Ctr, Brain & Spinal Cord Injury Ctr, San Francisco, CA USA; [Okonkwo, David O.] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Mac Donald, Christine L.; Dikmen, Sureyya; Temkin, Nancy] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Levin, Harvey; Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Giacino, Joseph T.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Giacino, Joseph T.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Nelson, Lindsay D.; McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Nelson, Lindsay D.; McCrea, Michael] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA		Stein, MB (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.; Stein, MB (corresponding author), Univ Calif San Diego, Herbert Wertheim Sch Publ Hlth & Human Longev Sci, La Jolla, CA 92093 USA.	mstein@health.ucsd.edu; amymarkowitz@gmail.com	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Levin, Harvey/0000-0002-3729-3404; Badjatia, Neeraj/0000-0003-1509-9034; Stein, Murray/0000-0001-9564-2871; Hemphill, Claude/0000-0003-4019-7525	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01NS086090]; U.S. Department of DefenseUnited States Department of Defense [W81XWH-14-2-0176]; Abbott LaboratoriesAbbott Laboratories; One Mind; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); National Football League Players Association	This research was supported by the National Institutes of Health (Grant No. U01NS086090 [to GTM] ) and U.S. Department of Defense (Grant No. W81XWH-14-2-0176 [to GTM] ) . Abbott Laboratories provided funding for addin TRACK-TBI clinical studies. One Mind provided funding for TRACK-TBI patients' stipends and support to clinical sites.; EY had a patent pending for USPTO No. 62/269,778. GTM received grants from the National Institute of Neurological Disorders and Stroke during the conduct of the study and research funding from the U.S. Department of Energy, grants from the Department of Defense, research funding from Abbott Laboratories, grants from the National Football League Scientific Advisory Board, and research funding from One Mind outside the submitted work. In addition, GTM had a patent issued for Interpretation and Quantification of Emergency Features on Head Computed Tomography. He served for 2 seasons as an unaffiliated neurologic consultant for home games of the Oakland Raiders; he was compensated $1500 per game for 6 games during the 2017 season but received no compensation for this work during the 2018 season. MBS received personal fees from Acadia Pharmaceuticals, Amgen, Aptinyx, Bionomics, GW Pharma, and Janssen and personal fees and stock options from Oxeia Biopharmaceuticals outside the submitted work. RD-A received personal fees and research funding from Neural Analytics Inc. and travel reimbursement from Brain Box Solutions Inc. outside the submitted work. Dana Goldman received personal fees from Amgen, Avanir Pharmaceuticals, Acadia Pharmaceuticals, Aspen Health Strategy Group, and Celgene outside the submitted work. Natalie Kreitzer received personal fees from Portola outside the submitted work. PM received grants from GE Healthcare and nonfinancial support from GE-NFL Head Health Initiative outside the submitted work. In addition, PM had a patent pending for USPTO No. 62/269,778. Jonathan Rosand received personal fees from Boehringer Ingelheim and New Beta Innovations outside the submitted work. Ross Zafonte received royalties from Oakstone for an educational CD (Physical Medicine and Rehabilitation: a Comprehensive Review) and Demos publishing for serving as coeditor of Brain Injury Medicine. Ross Zafonte serves or served on the scientific advisory boards of Myomo, Oxeia Biopharma, BioDirection, and ElMindA. He also evaluates patients in the MGH Brain and Body-TRUST Program, which is funded by the National Football League Players Association. Ross Zafonte served on the Mackey White Committee. All other authors report no biomedical financial interests or potential conflicts of interest.	Akiki TJ, 2018, NEUROIMAGE, V176, P489, DOI 10.1016/j.neuroimage.2018.05.005; Albrecht JS, 2020, J HEAD TRAUMA REHAB, V35, pE352, DOI 10.1097/HTR.0000000000000551; Atwoli L, 2015, CURR OPIN PSYCHIATR, V28, P307, DOI 10.1097/YCO.0000000000000167; Benjamini Y., 1995, J ROY STAT SOC, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolsinger J, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00693; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Chen LW, 2018, DEPRESS ANXIETY, V35, P1018, DOI 10.1002/da.22833; Daskalakis NP, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0898-7; Dickie EW, 2013, PSYCHOL MED, V43, P645, DOI 10.1017/S0033291712001328; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Gurvits TV, 1996, BIOL PSYCHIAT, V40, P1091, DOI 10.1016/S0006-3223(96)00229-6; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Kaplan GB, 2018, J NEUROTRAUM, V35, P210, DOI 10.1089/neu.2016.4953; King AP, 2016, DEPRESS ANXIETY, V33, P289, DOI 10.1002/da.22481; Koch SBJ, 2016, DEPRESS ANXIETY, V33, P592, DOI 10.1002/da.22478; Koenen KC, 2009, AM J PSYCHIAT, V166, P50, DOI 10.1176/appi.ajp.2008.08030343; Kremen WS, 2007, ARCH GEN PSYCHIAT, V64, P361, DOI 10.1001/archpsyc.64.3.361; Kunimatsu A, 2020, J MAGN RESON IMAGING, V52, P380, DOI 10.1002/jmri.26929; Logue MW, 2018, BIOL PSYCHIAT, V83, P244, DOI 10.1016/j.biopsych.2017.09.006; Lopez KC, 2017, J NEUROTRAUM, V34, P16, DOI 10.1089/neu.2015.4323; Miller DR, 2017, BIOL PSYCHIAT-COGN N, V2, P363, DOI 10.1016/j.bpsc.2016.12.006; O'Doherty DCM, 2015, PSYCHIAT RES-NEUROIM, V232, P1, DOI 10.1016/j.pscychresns.2015.01.002; Pietrzak RH, 2015, JAMA PSYCHIAT, V72, P396, DOI 10.1001/jamapsychiatry.2014.2470; Polimanti R, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.3447; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Sorensen HJ, 2016, J AFFECT DISORDERS, V196, P148, DOI 10.1016/j.jad.2016.02.037; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Stern Y, 2020, ALZHEIMERS DEMENT, V16, P1305, DOI 10.1016/j.jalz.2018.07.219; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Woodward SH, 2009, ARCH GEN PSYCHIAT, V66, P1373, DOI 10.1001/archgenpsychiatry.2009.160; Wrocklage KM, 2017, EUR NEUROPSYCHOPHARM, V27, P515, DOI 10.1016/j.euroneuro.2017.02.010; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	41	2	2	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2451-9022	2451-9030		BIOL PSYCHIAT-COGN N	Biol. Psychiat.-Cogn. Neurosci. Neuroimag.	MAR	2021	6	3					352	359		10.1016/j.bpsc.2020.10.008			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	QV8RK	WOS:000628231300002	33386283				2022-02-06	
J	Sulimai, N; Brown, J; Lominadze, D				Sulimai, Nurul; Brown, Jason; Lominadze, David			Fibrinogen Interaction with Astrocyte ICAM-1 and PrP(C) Results in the Generation of ROS and Neuronal Death	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						apoptosis; pro-inflammatory markers; neuron; NO; proximity ligation; ROS		Many neuroinflammatory diseases, like traumatic brain injury (TBI), are associated with an elevated level of fibrinogen and short-term memory (STM) impairment. We found that during TBI, extravasated fibrinogen deposited in vasculo-astrocyte interfaces, which was associated with neurodegeneration and STM reduction. The mechanisms of this fibrinogen-astrocyte interaction and its functional role in neurodegeneration are still unclear. Cultured mouse brain astrocytes were treated with fibrinogen in the presence or absence of function-blocking antibody or peptide against its astrocyte receptors intercellular adhesion molecule-1 (ICAM-1) or cellular prion protein (PrP(C)), respectively. Fibrinogen interactions with astrocytic ICAM-1 and PrP(C) were characterized. The expression of pro-inflammatory markers, generations of reactive oxygen species (ROS) and nitric oxide (NO) in astrocytes, and neuronal death caused by astrocyte-conditioned medium were assessed. Data showed a strong association between fibrinogen and astrocytic ICAM-1 or PrP(C), overexpression of pro-inflammatory cytokines and overproduction of ROS and NO, resulting in neuronal apoptosis and death. These effects were reduced by blocking the function of astrocytic ICAM-1 and PrP(C), suggesting that fibrinogen association with its astrocytic receptors induce the release of pro-inflammatory cytokines, resulting in oxidative stress, and ultimately neuronal death. This can be a mechanism of neurodegeneration and the resultant STM reduction seen during TBI.	[Sulimai, Nurul; Brown, Jason; Lominadze, David] Univ S Florida, Dept Surg, Morsani Coll Med, Tampa, FL 33612 USA; [Lominadze, David] Univ S Florida, Dept Mol Pharmacol & Physiol, Morsani Coll Med, Tampa, FL 33612 USA		Lominadze, D (corresponding author), Univ S Florida, Dept Surg, Morsani Coll Med, Tampa, FL 33612 USA.; Lominadze, D (corresponding author), Univ S Florida, Dept Mol Pharmacol & Physiol, Morsani Coll Med, Tampa, FL 33612 USA.	nurulsulimai@usf.edu; jasonb3@usf.edu; dlominadze@usf.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL146832]	This work was supported by the NIH grant #HL146832.	Adamec E, 2001, BRAIN RES PROTOC, V7, P193, DOI 10.1016/S1385-299X(01)00072-1; BROSNAN CF, 1995, NEUROLOGY, V45, pS16, DOI 10.1212/WNL.45.6_Suppl_6.S16; Capra F, 2000, J INFECT DIS, V181, P425, DOI 10.1086/315265; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Charkviani M, 2020, J NEUROPHYSIOL, V124, P536, DOI 10.1152/jn.00224.2020; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Clark DPQ, 2019, NEUROCHEM RES, V44, P1410, DOI 10.1007/s11064-019-02721-8; Clark VD, 2018, BRAIN RES, V1699, P158, DOI 10.1016/j.brainres.2018.08.023; Colombo E, 2016, TRENDS IMMUNOL, V37, P608, DOI 10.1016/j.it.2016.06.006; Coltinho AS, 2007, NEUROBIOL DIS, V26, P282, DOI 10.1016/j.nbd.2007.01.005; Davalos D, 2012, SEMIN IMMUNOPATHOL, V34, P43, DOI 10.1007/s00281-011-0290-8; Fiala M, 2002, EUR J CLIN INVEST, V32, P360, DOI 10.1046/j.1365-2362.2002.00994.x; Genius J, 2000, FREE RADICAL BIO MED, V29, P515, DOI 10.1016/S0891-5849(00)00343-9; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Hsiao TW, 2013, ACTA BIOMATER, V9, P7200, DOI 10.1016/j.actbio.2013.02.047; Hubbard AK, 2000, FREE RADICAL BIO MED, V28, P1379, DOI 10.1016/S0891-5849(00)00223-9; Ishii T, 2017, AGING CELL, V16, P39, DOI 10.1111/acel.12523; Jang E, 2013, J IMMUNOL, V191, P5204, DOI 10.4049/jimmunol.1301637; Jenkins DR, 2018, J NEUROTRAUM, V35, P2259, DOI 10.1089/neu.2017.5291; Jensen T, 2007, THROMB HAEMOSTASIS, V97, P822, DOI 10.1160/TH07-01-0039; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; LANGUINO LR, 1993, CELL, V73, P1423, DOI 10.1016/0092-8674(93)90367-Y; Lassmann H, 2010, EXP NEUROL, V225, P2, DOI 10.1016/j.expneurol.2009.10.009; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Lee SJ, 2000, J IMMUNOL, V165, P4658, DOI 10.4049/jimmunol.165.8.4658; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Lominadze D, 2005, AM J PHYSIOL-HEART C, V288, pH1257, DOI 10.1152/ajpheart.00856.2004; Marchant RE, 2002, CURR PROTEIN PEPT SC, V3, P249, DOI 10.2174/1389203023380611; Merlini M, 2019, NEURON, V101, P1099, DOI 10.1016/j.neuron.2019.01.014; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Muller N, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01251; Muradashvili N, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070077; Muradashvili N, 2016, J PHYSIOL-LONDON, V594, P5941, DOI 10.1113/JP272558; Muradashvili N, 2015, METAB BRAIN DIS, V30, P411, DOI 10.1007/s11011-014-9550-3; Muradashvili N, 2012, J CEREBR BLOOD F MET, V32, P150, DOI 10.1038/jcbfm.2011.144; Onodera T, 2017, P JPN ACAD B-PHYS, V93, P155, DOI 10.2183/pjab.93.010; Pahatouridis D, 2010, BRAIN INJURY, V24, P1189, DOI 10.3109/02699052.2010.490510; Park KJ, 2014, J CEREBR BLOOD F MET, V34, P357, DOI 10.1038/jcbfm.2013.216; Park MS, 2014, J EXERC REHABIL, V10, P148, DOI 10.12965/jer.140109; Paul J, 2007, J EXP MED, V204, P1999, DOI 10.1084/jem.20070304; POTSCHKA M, 1987, ANAL BIOCHEM, V162, P47, DOI 10.1016/0003-2697(87)90009-1; Ryu JK, 2018, NAT IMMUNOL, V19, P1212, DOI 10.1038/s41590-018-0232-x; Salazar SV, 2017, BIOCHEM BIOPH RES CO, V483, P1143, DOI 10.1016/j.bbrc.2016.09.062; Schneider B, 2003, P NATL ACAD SCI USA, V100, P13326, DOI 10.1073/pnas.2235648100; SHRIKANT P, 1995, J IMMUNOL, V155, P1489; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Sun YR, 2011, BRIT J NEUROSURG, V25, P363, DOI 10.3109/02688697.2011.552650; Tarassishin L, 2014, GLIA, V62, P999, DOI 10.1002/glia.22657; Tehranian R, 2008, J NEUROTRAUM, V25, P755, DOI 10.1089/neu.2007.0441; Tennent GA, 2007, BLOOD, V109, P1971, DOI 10.1182/blood-2006-08-040956; Tyagi N, 2008, MOL CELL BIOCHEM, V307, P13, DOI 10.1007/s11010-007-9579-2; Vasse M, 1996, HAEMOSTASIS, V26, P331; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Yates RL, 2017, ANN NEUROL, V82, P259, DOI 10.1002/ana.24997; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	58	2	2	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	MAR	2021	22	5							2391	10.3390/ijms22052391			16	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	QV9XX	WOS:000628316000001	33673626	gold, Green Published			2022-02-06	
J	Tabibkhooei, A; Hatam, J; Mokhtari, M; Abolmaali, M				Tabibkhooei, A.; Hatam, J.; Mokhtari, M.; Abolmaali, M.			COVID-19-associated spontaneous subacute subdural haematoma: report of two cases	NEW MICROBES AND NEW INFECTIONS			English	Article						Coronavirus; coronavirus disease 2019; subdural haematoma		Since March 2020, the pandemic of coronavirus disease 2019 (COVID-19) has become a threat to global health. Several kinds of coronavirusassociated disorders, including vascular involvements with neurological symptoms, have been reported worldwide. Here, we describe two individuals with COVID-19 with no history of traumatic brain injury nor of vascular injuries, who developed spontaneous subdural haematoma in a subacute process. Both individuals became lethargic and unresponsive during admission in the intensive care unit. Both have undergone emergent craniotomy with acceptable outcome. The first patient improved significantly and was discharged a week after surgery. However, the second individual had no improvement on her consciousness and died 3 days after surgery. Haemorrhagic events, including subdural haematoma, can happen during COVID-19 infection with several possible mechanisms. Brain imaging and further neurological evaluation must be performed in any individuals with COVID-19 who show signs of alteration in their state of consciousness. (c) 2021 The Authors. Published by Elsevier Ltd.	[Tabibkhooei, A.; Hatam, J.] Iran Univ Med Sci, Rasoul Akram Hosp, Dept Neurosurg, Tehran, Iran; [Mokhtari, M.] Iran Univ Med Sci, Rasoul Akram Hosp, Dept Neurol, Tehran, Iran; [Abolmaali, M.] Khatam Alanbia Hosp, Shefa Neurosci Res Ctr, Tehran, Iran		Abolmaali, M (corresponding author), Iran Univ Med Sci, Tehran, Iran.	dr.meysam.a@gmail.com	mokhtari, mahisa/AAS-5600-2021	mokhtari, mahisa/0000-0002-3522-0287			Altschul DJ, 2020, CLIN NEUROL NEUROSUR, V198, DOI 10.1016/j.clineuro.2020.106112; Cheruiyot I, 2021, NEUROL SCI, V42, P25, DOI 10.1007/s10072-020-04870-z; Dorgalaleh A, 2020, SEMIN THROMB HEMOST, V46, P815, DOI 10.1055/s-0040-1713434; FOTUHI M, 2020, J ALZHEIM DIS; Gogia B, 2020, CUREUS, V12, DOI 10.7759/cureus.10159; Li YN, 2020, STROKE VASC NEUROL, V5, P279, DOI 10.1136/svn-2020-000431; Parry AH, 2020, ACAD RADIOL, V27, P1329, DOI 10.1016/j.acra.2020.05.024; Poyiadji N, 2020, RADIOLOGY, V296, pE119, DOI 10.1148/radiol.2020201187; Rothstein A, 2020, STROKE, V51, pE219, DOI 10.1161/STROKEAHA.120.030995; Sharifi-Razavi A, 2020, NEW MICROB NEW INFEC, V35, DOI 10.1016/j.nmni.2020.100669; Stawicki SP, 2020, J GLOB INFECT DIS, V12, P47, DOI 10.4103/jgid.jgid_86_20; Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768	12	2	2	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND		2052-2975		NEW MICROB NEW INFEC	New Microbes New Infect.	MAR	2021	40								100848	10.1016/j.nmni.2021.100848			4	Infectious Diseases; Microbiology	Emerging Sources Citation Index (ESCI)	Infectious Diseases; Microbiology	TV5DC	WOS:000681742700002	33614040	Green Published, gold			2022-02-06	
J	Toida, C; Muguruma, T; Gakumazawa, M; Shinohara, M; Abe, T; Takeuchi, I; Morimura, N				Toida, Chiaki; Muguruma, Takashi; Gakumazawa, Masayasu; Shinohara, Mafumi; Abe, Takeru; Takeuchi, Ichiro; Morimura, Naoto			Age- and Severity-Related In-Hospital Mortality Trends and Risks of Severe Traumatic Brain Injury in Japan: A Nationwide 10-Year Retrospective Study	JOURNAL OF CLINICAL MEDICINE			English	Article						pediatric patient; severely injured patients; in-hospital mortality; traumatic brain injury; injury prevention		Traumatic brain injury (TBI) is the major cause of mortality and morbidity in severely-injured patients worldwide. This retrospective nationwide study aimed to evaluate the age- and severity-related in-hospital mortality trends and mortality risks of patients with severe TBI from 2009 to 2018 to establish effective injury prevention measures. We retrieved information from the Japan Trauma Data Bank dataset between 2009 and 2018. The inclusion criteria for this study were patients with severe TBI defined as those with an Injury Severity Score >= 16 and TBI. In total, 31,953 patients with severe TBI (32.6%) were included. There were significant age-related differences in characteristics, mortality trend, and mortality risk in patients with severe TBI. The in-hospital mortality trend of all patients with severe TBI significantly decreased but did not improve for patients aged <= 5 years and with a Glasgow Coma Scale (GCS) score between 3 and 8. Severe TBI, age >= 65 years, fall from height, GCS score 3-8, and urgent blood transfusion need were associated with a higher mortality risk, and mortality risk did not decrease after 2013. Physicians should consider specific strategies when treating patients with any of these risk factors to reduce severe TBI mortality.	[Toida, Chiaki; Morimura, Naoto] Univ Tokyo, Dept Disaster Med Management, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan; [Toida, Chiaki; Muguruma, Takashi; Gakumazawa, Masayasu; Shinohara, Mafumi; Abe, Takeru; Takeuchi, Ichiro] Yokohama City Univ, Grad Sch Med, Dept Emergency Med, Minami Ku, 4-57 Urafunecho, Yokohama, Kanagawa 2320024, Japan		Toida, C (corresponding author), Univ Tokyo, Dept Disaster Med Management, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.; Toida, C (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Emergency Med, Minami Ku, 4-57 Urafunecho, Yokohama, Kanagawa 2320024, Japan.	toida-ygc@umin.ac.jp; mgrmtks@gmail.com; gakumazawa-tuk@umin.ac.jp; shinoharamafumi@yahoo.co.jp; abet@yokohama-cu.ac.jp; takeqq@yokohama-cu.ac.jp; molimula-tky@umin.ac.jp		chiaki, Toida/0000-0003-4551-4841			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barratt H, 2010, EMERG MED J, V27, P173, DOI 10.1136/emj.2009.075382; Brain Trauma Foundation, GUIDELINES MANAGEMEN, V4th; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; Cheng PX, 2020, J SAFETY RES, V72, P93, DOI 10.1016/j.jsr.2019.12.013; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Gomez PA, 2018, ACTA NEUROCHIR, V160, P2291, DOI 10.1007/s00701-018-3705-7; Hung KL, 2020, BIOMED J, V43, P240, DOI 10.1016/j.bj.2020.03.008; Jalali R, 2014, CRIT CARE RES PRACT, V2014, DOI 10.1155/2014/289803; Kimura A, 2012, WORLD J SURG, V36, P813, DOI 10.1007/s00268-012-1498-z; Kojima M, 2019, ANN EMERG MED, V73, P281, DOI 10.1016/j.annemergmed.2018.09.034; Lazaridis C, 2016, NEW ENGL J MED, V374, P1384, DOI 10.1056/NEJMc1600339; Lichte P, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0159-8; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Lindfors M, 2018, ACTA NEUROCHIR, V160, P2107, DOI 10.1007/s00701-018-3670-1; Moore EE, 2017, TRAUMA; Patel HC, 2010, ACTA NEUROCHIR, V152, P1353, DOI 10.1007/s00701-010-0666-x; Peden M, 2008, WORLD REPORT CHILD I; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; Shibahashi K, 2018, WORLD NEUROSURG, V120, pE667, DOI 10.1016/j.wneu.2018.08.142; Shibahashi K, 2018, WORLD NEUROSURG, V114, pE350, DOI 10.1016/j.wneu.2018.02.183; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x	27	2	2	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	MAR	2021	10	5							1072	10.3390/jcm10051072			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QV9EK	WOS:000628265300001	33806639	Green Published, gold			2022-02-06	
J	Wilson, JE; Shinall, MC; Leath, TC; Wang, L; Harrell, FE; Wilson, LD; Nordness, MF; Rakhit, S; de Riesthal, MR; Duff, MC; Pandharipande, PP; Patel, MB				Wilson, Jo Ellen; Shinall, Myrick C., Jr.; Leath, Taylor C.; Wang, Li; Harrell, Frank E., Jr.; Wilson, Laura D.; Nordness, Mina F.; Rakhit, Shayan; de Riesthal, Michael R.; Duff, Melissa C.; Pandharipande, Pratik P.; Patel, Mayur B.			Worse Than Death: Survey of Public Perceptions of Disability Outcomes After Hypothetical Traumatic Brain Injury	ANNALS OF SURGERY			English	Article						decision-making; Extended Glasgow Outcome Score (GOSE); health utilities; outcomes; quality of life; traumatic brain injury		Objective: The aim of this study was to determine the health utility states of the most commonly used traumatic brain injury (TBI) clinical trial endpoint, the Extended Glasgow Outcome Scale (GOSE). Summary Background Data: Health utilities represent the strength of one's preferences under conditions of uncertainty. There are insufficient data to indicate how an individual would value levels of disability after a TBI. Methods: This was a cross-sectional web-based online convenience sampling adaptive survey. Using a standard gamble approach, participants evaluated their preferences for GOSE health states 1 year after a hypothetical TBI. The categorical GOSE was studied from vegetative state (GOSE2) to upper good recovery (GOSE8). Median (25th percentile, 75th percentile) health utility values for different GOSE states after TBI, ranging from -1 (worse than death) to 1 (full health), with 0 as reference (death). Results: Of 3508 eligible participants, 3235 (92.22%) completed the survey. Participants rated lower GOSE states as having lower utility, with some states rated as worse than death, though the relationship was nonlinear and intervals were unequal between health states. Over 75% of participants rated a vegetative state (GOSE2, absence of awareness and bedridden) and about 50% rated lower severe disability (GOSE3, housebound needing all-day assistance) as conditions worse than death. Conclusions: In the largest investigation of public perceptions about post-TBI disability, we demonstrate unequally rated health states, with some states perceived as worse than death. Although limited by selection bias, these results may guide future comparative-effectiveness research and shared medical decision-making after neurologic injury.	[Wilson, Jo Ellen; Shinall, Myrick C., Jr.; Pandharipande, Pratik P.; Patel, Mayur B.] Vanderbilt Univ, Med Ctr, Crit Illness Brain Dysfunct & Survivorship CIBS C, Nashville, TN 37232 USA; [Wilson, Jo Ellen] Vanderbilt Univ, Med Ctr, Dept Psychiat & Behav Sci, Div Gen Psychiat, Nashville, TN USA; [Wilson, Jo Ellen] Vanderbilt Univ, Med Ctr, Dept Surg, Div Gen Surg,Sect Surg Sci, Nashville, TN USA; [Leath, Taylor C.; Nordness, Mina F.; Rakhit, Shayan; Patel, Mayur B.] Vanderbilt Univ, Med Ctr, Div Trauma Emergency Gen Surg & Surg Crit Care, Dept Surg,Sect Surg Sci, Nashville, TN 37232 USA; [Leath, Taylor C.; Nordness, Mina F.; Rakhit, Shayan; Patel, Mayur B.] Vanderbilt Univ, Med Ctr, Div Trauma Emergency Gen Surg & Surg Crit Care, Dept Neurosurg,Sect Surg Sci, Nashville, TN 37232 USA; [Leath, Taylor C.; Nordness, Mina F.; Rakhit, Shayan; Patel, Mayur B.] Vanderbilt Univ, Med Ctr, Vanderbilt Brain Inst, Nashville, TN 37232 USA; [Wang, Li; Harrell, Frank E., Jr.] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Wilson, Laura D.] Univ Tulsa, Oxley Coll Hlth Sci, Dept Commun Sci & Disorders, Tulsa, OK 74104 USA; [Wilson, Laura D.; de Riesthal, Michael R.; Duff, Melissa C.; Patel, Mayur B.] Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, Nashville, TN 37232 USA; [Pandharipande, Pratik P.] Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Div Anesthesiol Crit Care Med, Nashville, TN USA; [Pandharipande, Pratik P.; Patel, Mayur B.] Vanderbilt Univ, Med Ctr, Ctr Hlth Serv Res, Nashville, TN 37232 USA; [Pandharipande, Pratik P.; Patel, Mayur B.] US Dept Vet Affairs, Nashville Vet Affairs VA Med Ctr, Geriatr Res Educ & Clin Ctr, Nashville, TN 37228 USA; [Pandharipande, Pratik P.; Patel, Mayur B.] US Dept Vet Affairs, Tennessee Valley Healthcare Syst, Nashville, TN 37228 USA		Patel, MB (corresponding author), Vanderbilt Univ, Med Ctr, Crit Illness Brain Dysfunct & Survivorship CIBS C, Nashville, TN 37232 USA.; Patel, MB (corresponding author), Vanderbilt Univ, Med Ctr, Div Trauma Emergency Gen Surg & Surg Crit Care, Dept Surg,Sect Surg Sci, Nashville, TN 37232 USA.; Patel, MB (corresponding author), Vanderbilt Univ, Med Ctr, Div Trauma Emergency Gen Surg & Surg Crit Care, Dept Neurosurg,Sect Surg Sci, Nashville, TN 37232 USA.; Patel, MB (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Brain Inst, Nashville, TN 37232 USA.; Patel, MB (corresponding author), Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, Nashville, TN 37232 USA.; Patel, MB (corresponding author), Vanderbilt Univ, Med Ctr, Ctr Hlth Serv Res, Nashville, TN 37232 USA.; Patel, MB (corresponding author), US Dept Vet Affairs, Nashville Vet Affairs VA Med Ctr, Geriatr Res Educ & Clin Ctr, Nashville, TN 37228 USA.; Patel, MB (corresponding author), US Dept Vet Affairs, Tennessee Valley Healthcare Syst, Nashville, TN 37228 USA.	mayur.b.patel@vumc.org			REDCap; Vanderbilt Institute for Clinical and Translational Research award CTSA [UL1 RR024975/UL1 TR000445/UL1 TR002243, VR12073]; NIH CTSA program [UL1TR000445, U24TR001579, 5 U24TR00157902]; Vanderbilt Clinical and Translational Research Scholars' Award [1KL2TR002245]; Vanderbilt Clinical Oncology Research Career Development Award [K12CA090625]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM120484, HL111111]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG035117]; Vanderbilt Faculty Scholars Program	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: FEH, LW, and this project's study design, data collection, analysis, and interpretation were supported by REDCap and Vanderbilt Institute for Clinical and Translational Research award CTSA grant UL1 RR024975/UL1 TR000445/UL1 TR002243 NCRR/NCATS/NIH and VR12073 to TCL mentored by MBP. ResearchMatch has been funded in part by the NIH CTSA program and is funded by grants UL1TR000445, U24TR001579, and 5 U24TR00157902. JEW was supported by the Vanderbilt Clinical and Translational Research Scholars' Award (1KL2TR002245). MCS was supported by the Vanderbilt Clinical Oncology Research Career Development Award (K12CA090625). JEW, PPP, and MBP were supported by the National Institutes of Health (GM120484 and HL111111). MBP and PPP were supported by NIH R01AG058639. PPP was supported by NIH AG035117. MBP received salary support from the Vanderbilt Faculty Scholars Program. All authors declare no other relationships or activities that could appear to have influenced the submitted work.	Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Aloizos S, 2015, TURK NEUROSURG, V25, P552, DOI 10.5137/1019-5149.JTN.9685-14.4; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Aoki N, 1998, MED DECIS MAKING, V18, P357, DOI 10.1177/0272989X9801800401; Attenhofer K., 2018, UTILITY WEIGHTED MOD; Barnato AE, 2007, J GEN INTERN MED, V22, P338, DOI 10.1007/s11606-006-0088-x; Bell KR, 2011, ARCH PHYS MED REHAB, V92, P1552, DOI 10.1016/j.apmr.2011.05.018; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Chaisinanunkul N, 2015, STROKE, V46, P2238, DOI 10.1161/STROKEAHA.114.008547; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corso PS, 2008, AM J PUBLIC HEALTH, V98, P1094, DOI 10.2105/AJPH.2007.119826; Dijkland SA, 2018, STROKE, V49, P965, DOI 10.1161/STROKEAHA.117.020194; Faigle R, 2016, STROKE, V47, P964, DOI 10.1161/STROKEAHA.115.011712; Fried TR, 2007, J GEN INTERN MED, V22, P495, DOI 10.1007/s11606-007-0104-9; Gold M., 1996, COST EFFECTIVENESS H; Goodlin SJ, 1999, JAMA-J AM MED ASSOC, V282, P2333, DOI 10.1001/jama.282.24.2333; Gregson BA, 2015, HEALTH TECHNOL ASSES, V19, DOI 10.3310/hta19700; Haines KL, 2018, AM J HOSP PALLIAT ME, V35, P1081, DOI 10.1177/1049909117753377; Hanchate A, 2009, ARCH INTERN MED, V169, P493, DOI 10.1001/archinternmed.2008.616; Harrell FE, 2015, SPRINGER SER STAT, P311, DOI 10.1007/978-3-319-19425-7_13; Hmisc: Harrell Miscellaneous, R package. version 3.17-4. (2016) [Computer Program]; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Koskinen LOD, 2015, NEUROCRIT CARE, V22, P26, DOI 10.1007/s12028-014-0030-8; Kosty J, 2012, J NEUROTRAUM, V29, P1322, DOI 10.1089/neu.2011.2222; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Lilley EJ, 2018, JAMA SURG, V153, P44, DOI 10.1001/jamasurg.2017.3148; Lin CM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/529580; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Livingston DH, 2009, J TRAUMA, V67, P341, DOI 10.1097/TA.0b013e3181a5cc34; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; McCauley SR, 2013, J NEUROTRAUM, V30, P1506, DOI 10.1089/neu.2013.2925; Mitchell SL, 2003, JAMA-J AM MED ASSOC, V290, P73, DOI 10.1001/jama.290.1.73; Newgard CD, 2015, ANN EMERG MED, V66, P30, DOI 10.1016/j.annemergmed.2014.12.004; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Olivecrona Z, 2015, BRAIN INJURY, V29, P446, DOI 10.3109/02699052.2014.989403; Pennington CR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146487; Printz C, 2012, CTS-CLIN TRANSL SCI, V5, P434; Schnurr PP, 1998, J NERV MENT DIS, V186, P522, DOI 10.1097/00005053-199809000-00002; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Shaw JW, 2005, MED CARE, V43, P203, DOI 10.1097/00005650-200503000-00003; Sox HC BM, 2007, MED DECIS MAKING, V2nd; Stover JF, 2014, J NEUROTRAUM, V31, P1599, DOI 10.1089/neu.2014.3344; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; Virnig BA, 2000, J AM GERIATR SOC, V48, P1117, DOI 10.1111/j.1532-5415.2000.tb04789.x; Wallston K.A., 2002, PASTORAL PSYCHOL, V50, P359, DOI [DOI 10.1023/A:1014413720710, https://doi.org/10.1023/A:1014413720710]; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson R, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-21; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256	60	2	2	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	MAR	2021	273	3					500	506		10.1097/SLA.0000000000003389			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	QB1FY	WOS:000613888300034	31972638				2022-02-06	
J	Varner, CE; Thompson, C; Wit, K; Borgundvaag, B; Houston, R; McLeod, S				Varner, Catherine E.; Thompson, Cameron; Wit, Kerstin; Borgundvaag, Bjug; Houston, Reaves; McLeod, Shelley			A randomized trial comparing prescribed light exercise to standard management for emergency department patients with acute mild traumatic brain injury	ACADEMIC EMERGENCY MEDICINE			English	Article								Background There is a paucity of effective management strategies to prevent prolonged symptoms following mild traumatic brain injury (mTBI), and emerging evidence suggesting possible benefits of exercise. The objective of this trial was to determine whether adult patients presenting to the emergency department (ED) with a diagnosis of acute mTBI prescribed light exercise were less likely to develop persistent postconcussion symptoms (PCS). Methods This was a randomized controlled trial conducted in three Canadian EDs. Consecutive, adult (18-64 years) ED patients with an mTBI sustained within the preceding 48 hours were eligible for enrollment. The intervention group received discharge instructions prescribing 30 minutes of daily light exercise, and the control group was given standard mTBI instructions advising gradual return to exercise following symptom resolution. The primary outcome was the proportion of patients with PCS at 30 days, defined as the presence of three or more symptoms on the Rivermead Post-concussion Symptoms Questionnaire (RPQ). Results A total of 367 patients were enrolled (control group, n = 184; intervention, n = 183). Median age was 32 years and 201 (57.6%) were female. There was no difference in the proportion of patients with PCS at 30 days (control, 13.4% vs intervention, 14.6%; increment 1.2%, 95% confidence interval [CI] = -6.2 to 8.5). There were no differences in median change of RPQ scores, median number of return health care provider visits, median number of missed school or work days, or unplanned return ED visits within 30 days. Participants in the control group reported fewer minutes of light exercise at 7 days (30 vs 35; increment 5, 95% CI = 2 to 15). Conclusion In this trial of prescribed early light exercise for acute mTBI, there were no differences in recovery or health care utilization outcomes. Results suggest that early light exercise may be encouraged as tolerated at ED discharge following mTBI, but this guidance is not sufficient to prevent PCS.	[Varner, Catherine E.; Thompson, Cameron; Borgundvaag, Bjug; Houston, Reaves; McLeod, Shelley] Sinai Hlth, Schwartz Reisman Emergency Med Inst, Toronto, ON, Canada; [Varner, Catherine E.; Borgundvaag, Bjug; McLeod, Shelley] Univ Toronto, Dept Family & Community Med, 206-600 Univ Ave, Toronto, ON M5G 1X5, Canada; [Wit, Kerstin] McMaster Univ, Dept Med, Hamilton, ON, Canada		Varner, CE (corresponding author), Sinai Hlth, Schwartz Reisman Emergency Med Inst, Toronto, ON, Canada.; Varner, CE (corresponding author), Univ Toronto, Dept Family & Community Med, 206-600 Univ Ave, Toronto, ON M5G 1X5, Canada.	catherine.varner@sinaihealth.ca	McLeod, Shelley/AAE-9636-2019	McLeod, Shelley/0000-0003-2686-6307; Varner, Catherine/0000-0002-9696-1329	Workplace Safety and Insurance Board of Ontario; Canadian Association of Emergency Physicians	This project was supported by grants from the Workplace Safety and Insurance Board of Ontario and the Canadian Association of Emergency Physicians.	Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Andersen RE, 1997, ANN INTERN MED, V127, P395, DOI 10.7326/0003-4819-127-5-199709010-00010; [Anonymous], 2013, BRAIN INJURY ADVICE; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Centers for Disease Control and Prevention, WHAT EXP CONC; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Eliyahu L, 2016, ACAD EMERG MED, V23, P531, DOI 10.1111/acem.12924; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Geneen LJ, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011279.pub2; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Hayden J A, 2005, Cochrane Database Syst Rev, pCD000335; Itoh T, 2011, J NEURAL TRANSM, V118, P193, DOI 10.1007/s00702-010-0495-3; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Madhok DY, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10050269; Marshall S., 2018, GUIDELINE CONCUSSION, V3rd; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Morrison L, 2019, CAN J EMERG MED, V21, P784, DOI 10.1017/cem.2019.22; Plass AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210138; Ponsford J, 2019, J REHABIL MED, V51, P32, DOI 10.2340/16501977-2492; Rainville James, 2004, Spine J, V4, P106, DOI 10.1016/S1529-9430(03)00174-8; RELANDER M, 1972, BMJ-BRIT MED J, V4, P777, DOI 10.1136/bmj.4.5843.777; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1186/1741-7015-8-18]; Scorza KA, 2012, AM FAM PHYSICIAN, V85, P123; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Sveen U, 2010, SCAND J OCCUP THER, V17, P225, DOI 10.3109/11038120903171295; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Thornton JS, 2016, CLIN J SPORT MED, V26, P259, DOI 10.1097/JSM.0000000000000363; Valentine V, 2012, AM FAM PHYSICIAN, V85, P100; Varner CE, 2017, ACAD EMERG MED, V24, P75, DOI 10.1111/acem.13073; Voormolen DC, 2018, J NEUROTRAUM, V35, P1233, DOI 10.1089/neu.2017.5257; Wise EK, 2012, ARCH PHYS MED REHAB, V93, P1319, DOI 10.1016/j.apmr.2012.05.009; Yue JK, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00343	36	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	MAY	2021	28	5					493	501		10.1111/acem.14215		FEB 2021	9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	SD7WD	WOS:000623098600001	33481332				2022-02-06	
J	LeBlond, E; Smith-Paine, J; Narad, M; Wade, SL; Gardis, M; Naresh, M; Makoroff, K; Rhine, T				LeBlond, Elizabeth; Smith-Paine, Julia; Narad, Megan; Wade, Shari L.; Gardis, Molly; Naresh, Mhadhu; Makoroff, Kathi; Rhine, Tara			Understanding the relationship between family functioning and health-related quality of life in very young children with moderate-to-severe TBI	CLINICAL NEUROPSYCHOLOGIST			English	Article						Traumatic brain injury; quality of life; pediatric; family functioning; acquired brain injury		Objective: To investigate the relationship of pre-injury and concurrent family functioning with health-related quality of life (HR QoL) following traumatic brain injury (TBI) or orthopedic injury (OI) in very young children. Method: Prospective enrollment of children ages 0-4 years who presented to the emergency department after sustaining either acute TBI or OI. This is a sub-analysis of children who completed at least one post-injury follow-up visit. At time of study enrollment, parents rated pre-injury family functioning (Family Assessment Device-General Functioning Scale) and the child's HR QoL (Pediatric Quality of Life Inventory(TM)). Family functioning and HR QoL were assessed at one and six months post-injury. Mixed models were used to examine family functioning as a moderator of a child's HR QoL following injury. Results: Data were analyzed for 42 children with TBI and 24 children with OI. For both groups, better pre-injury family functioning was significantly associated with better HR QoL over time. A triple interaction of injury type by time since injury by concurrent family functioning indicated that children with TBI and poor family functioning had significantly worse HR QoL at six months post-injury relative to other groups. Conclusion: Despite a small sample size, current results underscore the importance of family functioning to recovery following early childhood TBI and support the need for continued research and development of interventions to improve outcomes in this population.	[LeBlond, Elizabeth; Wade, Shari L.] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [LeBlond, Elizabeth; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Rehabil Med, Cincinnati, OH 45229 USA; [Smith-Paine, Julia; Narad, Megan] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, Cincinnati, OH 45229 USA; [Narad, Megan; Gardis, Molly] Univ Cincinnati Hlth, Cincinnati, OH USA; [Wade, Shari L.; Makoroff, Kathi; Rhine, Tara] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Naresh, Mhadhu; Makoroff, Kathi; Rhine, Tara] Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, Cincinnati, OH 45229 USA		Rhine, T (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,ML 2008, Cincinnati, OH 45229 USA.	tara.rhine@cchmc.org			National Center for Advancing Translational Sciences of the National Institutes of Health-Award [KL2 TR001426-01]	Funding for this research was provided by the National Center for Advancing Translational Sciences of the National Institutes of Health-Award Number KL2 TR001426-01. The authors have no conflicts of interest to disclose. No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the authors(s) or upon any organization with which the author(s) is/are associated.	Aguilar JM, 2019, J HEAD TRAUMA REHAB, V34, P65, DOI 10.1097/HTR.0000000000000443; Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Aitken ME, 2004, ARCH PHYS MED REHAB, V85, P567, DOI 10.1016/j.apmr.2003.06.018; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Antonini TN, 2014, BEHAV THER, V45, P455, DOI 10.1016/j.beth.2014.02.003; Avraham JB, 2019, INJURY PREV, V25, P136, DOI 10.1136/injuryprev-2017-042435; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Camara-Costa H, 2020, QUAL LIFE RES, V29, P515, DOI 10.1007/s11136-019-02305-7; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; DeMatteo CA, 2014, BRAIN INJURY, V28, P114, DOI 10.3109/02699052.2013.848380; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gerber P, 2007, CHILD NERV SYST, V23, P499, DOI 10.1007/s00381-006-0267-4; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Gerring JP, 2012, J NEUROTRAUM, V29, P621, DOI 10.1089/neu.2011.2234; Graves JM, 2015, AM J PUBLIC HEALTH, V105, pE35, DOI 10.2105/AJPH.2015.302744; IBM Corp. Released, 2017, IBM SPSS STAT WINDOW; Ilmer EC, 2016, EUR J PAEDIATR NEURO, V20, P131, DOI 10.1016/j.ejpn.2015.09.003; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Keenan HT, 2006, PEDIATRICS, V117, P317, DOI 10.1542/peds.2005-0979; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kirk S, 2015, CHILD CARE HLTH DEV, V41, P303, DOI 10.1111/cch.12173; Labrell F, 2018, BRAIN INJURY, V32, P1780, DOI 10.1080/02699052.2018.1524931; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Micklewright JL, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI 10.1017/S1355617711001792; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Narad ME, 2015, J DEV BEHAV PEDIATR, V36, P700, DOI 10.1097/DBP.0000000000000208; Odetola FO, 2015, INT J INJ CONTROL SA, V22, P260, DOI 10.1080/17457300.2014.925937; Papa Linda, 2008, Expert Opin Med Diagn, V2, P937, DOI 10.1517/17530059.2.8.937; Potter JL, 2011, REHABIL PSYCHOL, V56, P351, DOI 10.1037/a0025445; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Sander, 2014, HDB NEUROPSYCHOLOGY, P311, DOI [https://doi.org/10.1007/978-1-4939-0784-7_16, DOI 10.1007/978-1-4939-0784-7_16]; Sluys KP, 2015, QUAL LIFE RES, V24, P2689, DOI 10.1007/s11136-015-1002-y; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; Varni JW, 2011, QUAL LIFE RES, V20, P45, DOI 10.1007/s11136-010-9730-5; Vinchon M, 2005, J NEUROSURG, V102, P380, DOI 10.3171/ped.2005.102.4.0380; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2017, J AM ACAD CHILD PSY, V56, P930, DOI 10.1016/j.jaac.2017.09.413; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; WALDER AD, 1995, INTENS CARE MED, V21, P606, DOI 10.1007/BF01700170; Woods DT, 2011, DEV NEUROREHABIL, V14, P274, DOI 10.3109/17518423.2011.586371; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	58	2	2	1	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JUL 4	2021	35	5			SI		868	884		10.1080/13854046.2021.1881163		FEB 2021	17	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	SV7PS	WOS:000622234600001	33634733				2022-02-06	
J	Gravesteijn, BY; Sewalt, CA; Venema, E; Nieboer, D; Steyerberg, EW				Gravesteijn, Benjamin Yael; Sewalt, Charlie Aletta; Venema, Esmee; Nieboer, Daan; Steyerberg, Ewout W.		CENTER-TBI Collaborators	Missing Data in Prediction Research: A Five-Step Approach for Multiple Imputation, Illustrated in the CENTER-TBI Study	JOURNAL OF NEUROTRAUMA			English	Article						imputation; missing data; prediction; traumatic brain injury; tutorial		In medical research, missing data is common. In acute diseases, such as traumatic brain injury (TBI), even well-conducted prospective studies may suffer from missing data in baseline characteristics and outcomes. Statistical models may simply drop patients with any missing values, potentially leaving a selected subset of the original cohort. Imputation is widely accepted by methodologists as an appropriate way to deal with missing data. We aim to provide practical guidance on handling missing data for prediction modeling. We hereto propose a five-step approach, centered around single and multiple imputation: 1) explore the missing data patterns; 2) choose a method of imputation; 3) perform imputation; 4) assess diagnostics of the imputation; and 5) analyze the imputed data sets. We illustrate these five steps with the estimation and validation of the IMPACT (International Mission on Prognosis and Analysis of Clinical Trials in Traumatic Brain Injury) prognostic model in 1375 patients from the CENTER-TBI database, included in 53 centers across 17 countries, with moderate or severe TBI in the prospective European CENTER-TBI study. Future prediction modeling studies in acute diseases may benefit from following the suggested five steps for optimal statistical analysis and interpretation, after maximal effort has been made to minimize missing data.	[Gravesteijn, Benjamin Yael; Sewalt, Charlie Aletta; Venema, Esmee; Nieboer, Daan; Steyerberg, Ewout W.] Erasmus MC, Dept Publ Hlth, Postbus 2040, NL-3000 CA Rotterdam, Netherlands; [Steyerberg, Ewout W.] Leiden Univ Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands		Gravesteijn, BY (corresponding author), Erasmus MC, Dept Publ Hlth, Postbus 2040, NL-3000 CA Rotterdam, Netherlands.	b.gravesteijn@erasmusmc.nl	Vande Vyvere, Thijs/AAB-5180-2022; Sahuquillo, Juan/B-3577-2008; Posti, Jussi P./Y-2908-2019; Ercole, Ari/B-6288-2009; Raj, Rahul/K-7693-2012; Gomez, Pedro/E-2411-2014	Vande Vyvere, Thijs/0000-0003-4032-5443; Sahuquillo, Juan/0000-0003-0713-5875; Posti, Jussi P./0000-0002-5925-5193; Ercole, Ari/0000-0001-8350-8093; Van Essen, Thomas/0000-0003-4657-5283; Gravesteijn, Benjamin/0000-0001-8096-5803; Sanchez-Porras, Renan/0000-0002-9084-8114; Rossi, Sandra/0000-0002-9963-8121; van der Naalt, Joukje/0000-0001-9873-2418; Radoi, Andreea/0000-0002-0677-3544; Coles, Jonathan/0000-0003-4013-679X; Sakowitz, Oliver/0000-0003-3248-6335; Newcombe, Virginia/0000-0001-6044-9035; Kondziella, Daniel/0000-0001-5562-9808; Zeiler, Frederick/0000-0003-1737-0510; Raj, Rahul/0000-0003-4243-9591; Takala, Riikka/0000-0001-6342-0043; Stewart, William/0000-0003-2199-2582; Gomez, Pedro/0000-0002-4185-5238	European UnionEuropean Commission [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA)	Data used in preparation of this article were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Union 7th Framework program (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), the OneMind (USA), and the Integra LifeSciences Corporation (USA). The funder had no role in the study design, enrollment, collection of data, writing, or publication decisions.	Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Buuren, 2018, FLEXIBLE IMPUTATION; Collins GS, 2015, ANN INTERN MED, V162, P55, DOI [10.7326/M14-0697, 10.1002/bjs.9736, 10.1111/dme.12654, 10.1038/bjc.2014.639, 10.1016/j.jclinepi.2014.11.010, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594]; COX DR, 1958, BIOMETRIKA, V45, P562, DOI 10.1093/biomet/45.3-4.562; DERKSEN S, 1992, BRIT J MATH STAT PSY, V45, P265, DOI 10.1111/j.2044-8317.1992.tb00992.x; Dijkland SA, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6401; Ebrahim G.J., 2007, J TROPICAL PEDIAT, V53, P294; Efron B., 1993, INTRO BOOTSTRAP; Foks KA, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3527; Hughes RA, 2019, INT J EPIDEMIOL, V48, P1294, DOI 10.1093/ije/dyz032; Kontopantelis E, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-016-0281-5; Kunzmann K, 2021, J NEUROTRAUM, V38, P455, DOI 10.1089/neu.2019.6858; Lee KJ, 2012, EMERG THEMES EPIDEMI, V9, DOI 10.1186/1742-7622-9-3; Leisman DE, 2020, CRIT CARE MED, V48, P623, DOI 10.1097/CCM.0000000000004246; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Madley-Dowd P, 2019, J CLIN EPIDEMIOL, V110, P63, DOI 10.1016/j.jclinepi.2019.02.016; Majdan M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0068-9; Mercaldo SF, 2020, BIOSTATISTICS, V21, P236, DOI 10.1093/biostatistics/kxy040; MISLEVY RJ, 1991, J EDUC STAT, V16, P150; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Mustillo S, 2012, SOCIOL METHOD RES, V41, P335, DOI 10.1177/0049124112452392; Nielson JL, 2021, J NEUROTRAUM, V38, P2530, DOI 10.1089/neu.2019.6702; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perkins NJ, 2018, AM J EPIDEMIOL, V187, P568, DOI 10.1093/aje/kwx348; Richter S, 2019, J NEUROTRAUM, V36, P2743, DOI 10.1089/neu.2018.6216; Riley RD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001380; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Rubin D.B., 2004, MULTIPLE IMPUTATION; Sauerbrei W., 2013, OPEN J STAT, V3, P79, DOI [10.4236/ojs.2013.32011, DOI 10.4236/OJS.2013.32011]; Schomaker M, 2018, STAT MED, V37, P2252, DOI 10.1002/sim.7654; Seaman SR, 2013, STAT METHODS MED RES, V22, P278, DOI 10.1177/0962280210395740; Shmueli G, 2010, STAT SCI, V25, P289, DOI 10.1214/10-STS330; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW., 2019, CLIN PREDICTION MODE, V2nd ed; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Steyerberg EW, 2019, STAT MED, V38, P4290, DOI 10.1002/sim.8296; Steyerberg EW, 2016, J CLIN EPIDEMIOL, V69, P245, DOI 10.1016/j.jclinepi.2015.04.005; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Sullivan TR, 2015, AM J EPIDEMIOL, V182, P528, DOI 10.1093/aje/kwv100; TEASDALE G, 1974, LANCET, V2, P81; Von Hippel P, 2013, EFFICIENCY GAINS USI; von Hippel PT, 2007, SOCIOL METHODOL, V37, P83, DOI 10.1111/j.1467-9531.2007.00180.x; Wahlby Ulrika, 2002, AAPS PharmSci, V4, pE27; White IR, 2010, STAT MED, V29, P2920, DOI 10.1002/sim.3944; Wood AM, 2008, STAT MED, V27, P3227, DOI 10.1002/sim.3177	48	2	2	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2021	38	13					1842	1857		10.1089/neu.2020.7218		FEB 2021	16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SU3SJ	WOS:000624609300001	33470157				2022-02-06	
J	Almeida, MF; Piehler, T; Carstens, KE; Zhao, ML; Samadi, M; Dudek, SM; Norton, CJ; Parisian, CM; Farizatto, KLG; Bahr, BA				Almeida, Michael F.; Piehler, Thuvan; Carstens, Kelly E.; Zhao, Meilan; Samadi, Mahsa; Dudek, Serena M.; Norton, Christopher J.; Parisian, Catherine M.; Farizatto, Karen L. G.; Bahr, Ben A.			Distinct and dementia-related synaptopathy in the hippocampus after military blast exposures	BRAIN PATHOLOGY			English	Article						Alzheimer&#8208; type synaptopathogenesis; mild traumatic brain injury; NBDP; NCAM breakdown products; neurotrauma; synaptic decline		Explosive shockwaves, and other types of blast exposures, are linked to injuries commonly associated with military service and to an increased risk for the onset of dementia. Neurological complications following a blast injury, including depression, anxiety, and memory problems, often persist even when brain damage is undetectable. Here, hippocampal explants were exposed to the explosive 1,3,5-trinitro-1,3,5-triazinane (RDX) to identify indicators of blast-induced changes within important neuronal circuitries. Highly controlled detonations of small, 1.7-gram RDX spherical charges reduced synaptic markers known to be downregulated in cognitive disorders, but without causing overt neuronal loss or astroglial responses. In the absence of neuromorphological alterations, levels of synaptophysin, GluA1, and synapsin IIb were significantly diminished within 24 hr, and these synaptic components exhibited progressive reductions following blast exposure as compared to their stable maintenance in control explants. In contrast, labeling of the synapsin IIa isoform remained unaltered, while neuropilar staining of other markers decreased, including synapsin IIb and neural cell adhesion molecule (NCAM) isoforms, along with evidence of NCAM proteolytic breakdown. NCAM(180) displayed a distinct decline after the RDX blasts, whereas NCAM(140) and NCAM(120) exhibited smaller or no deterioration, respectively. Interestingly, the extent of synaptic marker reduction correlated with AT8-positive tau levels, with tau pathology stochastically found in CA1 neurons and their dendrites. The decline in synaptic components was also reflected in the size of evoked postsynaptic currents recorded from CA1 pyramidals, which exhibited a severe and selective reduction. The identified indicators of blast-mediated synaptopathy point to the need for early biomarkers of explosives altering synaptic integrity with links to dementia risk, to advance strategies for both cognitive health and therapeutic monitoring.	[Almeida, Michael F.; Norton, Christopher J.; Parisian, Catherine M.; Farizatto, Karen L. G.; Bahr, Ben A.] Univ N Carolina, Biotechnol Res & Training Ctr, Pembroke, NC 28372 USA; [Piehler, Thuvan] US Army, Res Lab, Aberdeen Proving Ground, MD USA; [Carstens, Kelly E.; Zhao, Meilan; Samadi, Mahsa; Dudek, Serena M.] NIEHS, Neurobiol Lab, POB 12233, Res Triangle Pk, NC 27709 USA; [Carstens, Kelly E.] US EPA, Ctr Computat Toxicol & Exposure, Res Triangle Pk, NC 27711 USA; [Samadi, Mahsa] Imperial Coll London, Fac Med Ctr, London, England		Bahr, BA (corresponding author), Univ N Carolina, Biotechnol Res & Training Ctr, Pembroke, NC 28372 USA.	bahr@uncp.edu	Almeida, Michael Fernandes de/ABB-6908-2021	Almeida, Michael F/0000-0002-0188-2717	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R25GM077634]; Intramural Research Program of the National Institute of Environmental Health Sciences, National Institutes of Health [Z01 ES100221]; U.S. Army Research LaboratoryUnited States Department of DefenseUS Army Research Laboratory (ARL); U.S. Army Research Office [W911NF-14-2-0087]	National Institutes of Health, Grant/Award Number: 5R25GM077634; Intramural Research Program of the National Institute of Environmental Health Sciences, National Institutes of Health,, Grant/Award Number: Z01 ES100221 (SMD); U.S. Army Research Laboratory and the U.S. Army Research Office, Grant/Award Number: W911NF-14-2-0087 (BAB)	Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Bahr BA, 2002, EXP NEUROL, V174, P37, DOI 10.1006/exnr.2001.7852; BAHR BA, 1993, BRAIN RES, V628, P286, DOI 10.1016/0006-8993(93)90966-Q; Bahr BA, 2000, J NEUROSCI RES, V59, P827, DOI 10.1002/(SICI)1097-4547(20000315)59:6<827::AID-JNR15>3.0.CO;2-Q; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Bendiske J, 2002, J NEUROPATH EXP NEUR, V61, P640, DOI 10.1093/jnen/61.7.640; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Bernath E, 2006, NEUROBIOL AGING, V27, P624, DOI 10.1016/j.neurobiolaging.2005.02.013; Bisaz R, 2013, LEARN MEMORY, V20, P183, DOI 10.1101/lm.030064.112; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Brennaman LH, 2010, ADV EXP MED BIOL, V663, P299, DOI 10.1007/978-1-4419-1170-4_19; Brix KA, 2017, J NEUROTRAUM, V34, pS18, DOI 10.1089/neu.2017.5222; Budinich CS, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/378307; Carlson SW, 2016, J NEUROTRAUM, V33, P113, DOI 10.1089/neu.2014.3839; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Chen KP, 2018, BRAIN RES, V1699, P117, DOI 10.1016/j.brainres.2018.08.015; Counts SE, 2012, NEURODEGENER DIS, V10, P216, DOI 10.1159/000333122; Department of Defense (DoD), DAT WORLDW NUMB TRAU; Dickstein DL, 2021, MOL PSYCHIATR, V26, P5940, DOI 10.1038/s41380-020-0674-z; Effgen GB, 2016, J NEUROTRAUM, V33, P1901, DOI 10.1089/neu.2015.4327; Ekstrom AD, 2018, HIPPOCAMPUS, V28, P680, DOI 10.1002/hipo.22750; Farizatto KLG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42934-z; Fish L., 2018, PROTECTING WARFIGHTE; Gitler D, 2008, J NEUROSCI, V28, P10835, DOI 10.1523/JNEUROSCI.0924-08.2008; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; HAN HQ, 1991, NATURE, V349, P697, DOI 10.1038/349697a0; Hoffman KB, 1998, BRAIN RES, V811, P152, DOI 10.1016/S0006-8993(98)00907-X; Hoyt DB, 2004, J TRAUMA, V57, P410, DOI 10.1097/00005373-200408000-00038; Hwang J, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184432; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Kohl C, 2013, STRESS, V16, P647, DOI 10.3109/10253890.2013.840824; Korotkov A, 2020, BRAIN PATHOL, V30, P897, DOI 10.1111/bpa.12865; Larson ME, 2017, P NATL ACAD SCI USA, V114, pE4648, DOI 10.1073/pnas.1704698114; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; Montagrin A, 2018, HIPPOCAMPUS, V28, P672, DOI 10.1002/hipo.22797; Murray HC, 2016, NEUROSCIENCE, V330, P359, DOI 10.1016/j.neuroscience.2016.06.003; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Rachmany L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03792-9; Sawyer TW, 2018, J NEUROTRAUM, V35, P174, DOI 10.1089/neu.2016.4961; Schoch KM, 2013, J NEUROCHEM, V125, P909, DOI 10.1111/jnc.12144; Shichi K, 2011, J PHARMACOL EXP THER, V338, P701, DOI 10.1124/jpet.110.178079; Smith M, 2016, EXP NEUROL, V286, P107, DOI 10.1016/j.expneurol.2016.10.002; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Vicente JS., 2002, J MOL BIOL BIOTECHNO, V3, P1; Viswaprakash N, 2015, J NEUROSCI RES, V93, P1442, DOI 10.1002/jnr.23589; Weber MT, 2019, BRAIN PATHOL, V29, P437, DOI 10.1111/bpa.12677; Williamson V., 2009, INVISIBLE WOUNDS PSY; Wisniewski ML, 2011, BBA-MOL BASIS DIS, V1812, P1664, DOI 10.1016/j.bbadis.2011.09.011; Yeh PH, 2017, HUM BRAIN MAPP, V38, P352, DOI 10.1002/hbm.23365; Zander NE, 2015, J NEUROSCI RES, V93, P1353, DOI 10.1002/jnr.23594	51	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1015-6305	1750-3639		BRAIN PATHOL	Brain Pathol.	MAY	2021	31	3							e12936	10.1111/bpa.12936		FEB 2021	13	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	SI9AO	WOS:000621233500001	33629462	Green Published, gold			2022-02-06	
J	Ferrazzano, P; Yeske, B; Mumford, J; Kirk, G; Bigler, ED; Bowen, K; O'Brien, N; Rosario, B; Beers, SR; Rathouz, P; Bell, MJ; Alexander, AL				Ferrazzano, Peter; Yeske, Benjamin; Mumford, Jeanette; Kirk, Gregory; Bigler, Erin D.; Bowen, Katherine; O'Brien, Nicole; Rosario, Bedda; Beers, Sue R.; Rathouz, Paul; Bell, Michael J.; Alexander, Andrew L.		ADAPT MRI Biomarkers Investigators	Brain Magnetic Resonance Imaging Volumetric Measures of Functional Outcome after Severe Traumatic Brain Injury in Adolescents	JOURNAL OF NEUROTRAUMA			English	Article						cognitive function; corpus callosum; MRI; severe adolescent brain injury; traumatic brain injury; ventricle-to-brain ratio		Adolescent traumatic brain injury (TBI) is a major public health concern, resulting in >35,000 hospitalizations in the United States each year. Although neuroimaging is a primary diagnostic tool in the clinical assessment of TBI, our understanding of how specific neuroimaging findings relate to outcome remains limited. Our study aims to identify imaging biomarkers of long-term neurocognitive outcome after severe adolescent TBI. Twenty-four adolescents with severe TBI (Glasgow Coma Scale <= 8) enrolled in the ADAPT (Approaches and Decisions after Pediatric TBI) study were recruited for magnetic resonance imaging (MRI) scanning 1-2 years post-injury at 13 participating sites. Subjects underwent outcome assessments similar to 1-year post-injury, including the Wechsler Abbreviated Scale of Intelligence (IQ) and the Pediatric Glasgow Outcome Scale-Extended (GOSE-Peds). A typically developing control cohort of 38 age-matched adolescents also underwent scanning and neurocognitive assessment. Brain-image segmentation was performed on T-1-weighted images using Freesurfer. Brain and ventricular cerebrospinal fluid volumes were used to compute a ventricle-to-brain ratio (VBR) for each subject, and the corpus callosum cross-sectional area was determined in the midline for each subject. The TBI group demonstrated higher VBR and lower corpus callosum area compared to the control cohort. After adjusting for age and sex, VBR was significantly related with GOSE-Peds score in the TBI group (n = 24, p = 0.01, cumulative odds ratio = 2.18). After adjusting for age, sex, intracranial volume, and brain volume, corpus callosum cross-sectional area correlated significantly with IQ score in the TBI group (partial cor = 0.68, n = 18, p = 0.007) and with PSI (partial cor = 0.33, p = 0.02). No association was found between VBR and IQ or between corpus callosum and GOSE-Peds. After severe adolescent TBI, quantitative MRI measures of VBR and corpus callosum cross-sectional area are associated with global functional outcome and neurocognitive outcomes, respectively.	[Ferrazzano, Peter; Yeske, Benjamin; Kirk, Gregory; Alexander, Andrew L.] Univ Wisconsin, Waisman Ctr, Madison, WI USA; [Alexander, Andrew L.] Univ Wisconsin, Waisman Ctr Brain Imaging Lab, Madison, WI USA; [Ferrazzano, Peter] Univ Wisconsin, Dept Pediat, Madison, WI USA; [Alexander, Andrew L.] Univ Wisconsin, Dept Med Phys, 1530 Med Sci Ctr, Madison, WI 53706 USA; [Alexander, Andrew L.] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Mumford, Jeanette] Univ Wisconsin, Ctr Hlth Minds, Madison, WI USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Dept Neurol, Salt Lake City, UT USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Bowen, Katherine] Seattle Childrens Hosp, Seattle, WA USA; [O'Brien, Nicole] Ohio State Univ, Dept Pediat, Div Crit Care Med, Nationwide Childrens Hosp, Columbus, OH 43210 USA; [Rosario, Bedda] Univ Pittsburgh, Sch Med, Dept Epidemiol, Pittsburgh, PA USA; [Beers, Sue R.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Rathouz, Paul] Univ Texas Austin, Dell Med Sch, Dept Populat Hlth, Austin, TX 78712 USA; [Bell, Michael J.] Childrens Natl Med Ctr, Dept Pediat, Washington, DC 20010 USA		Ferrazzano, P (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Div Pediat Crit Care Med, Dept Pediat, 1500 Highland Ave,Waisman Ctr T517, Madison, WI 53705 USA.	ferrazzano@pediatrics.wisc.edu			National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 NS081041, K08NS078113, R01NS092870]; National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD090256]	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number U01 NS081041 (Bell), K08NS078113, and R01NS092870 (Ferrazzano), and was also supported, in part, by a core grant to the University of Wisconsin Waisman Center from the National Institute of Child Health and Human Development (U54HD090256). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson V, 2012, J NEUROTRAUM, V29, P143, DOI 10.1089/neu.2011.2012; Andronikou S, 2015, PEDIATR RADIOL, V45, P1016, DOI 10.1007/s00247-014-3255-y; Babikian T, 2018, J NEUROTRAUM, V35, P1637, DOI 10.1089/neu.2017.5366; BARKOVICH AJ, 1988, AM J NEURORADIOL, V9, P487; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Bell MJ, 2017, CHILD NERV SYST, V33, P1663, DOI 10.1007/s00381-017-3530-y; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bigler ED, 2006, AM J PHYS MED REHAB, V85, P793, DOI 10.1097/01.phm.0000237873.26250.e1; Bigler ED, 2016, J CHILD NEUROL, V31, P1302, DOI 10.1177/0883073816654143; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Boger-Megiddo I, 2006, J AUTISM DEV DISORD, V36, P733, DOI 10.1007/s10803-006-0121-2; Brezova V, 2014, NEUROIMAGE-CLIN, V5, P128, DOI 10.1016/j.nicl.2014.03.012; Carrion VG, 2009, PSYCHIAT RES-NEUROIM, V172, P226, DOI 10.1016/j.pscychresns.2008.07.008; Cascio C, 2006, AM J PSYCHIAT, V163, P2157, DOI 10.1176/appi.ajp.163.12.2157; Catroppa C, 2008, J CHILD NEUROL, V23, P486, DOI 10.1177/0883073807309773; Cole JH, 2018, BRAIN, V141, P822, DOI 10.1093/brain/awx354; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dennis EL, 2018, HUM BRAIN MAPP, V39, P3759, DOI 10.1002/hbm.24209; Dennis EL, 2017, NEUROIMAGE-CLIN, V15, P125, DOI 10.1016/j.nicl.2017.03.014; Dennis EL, 2016, J NEUROTRAUM, V33, P840, DOI 10.1089/neu.2015.4012; Dennis M, 2014, NEUROPSYCHOL REV, V24, P389, DOI 10.1007/s11065-014-9261-x; Dennis M, 2013, NEUROSCI BIOBEHAV R, V37, P2760, DOI 10.1016/j.neubiorev.2013.09.010; Douglas David B, 2018, Med Sci (Basel), V7, DOI 10.3390/medsci7010002; Drijkoningen D, 2017, J NEUROTRAUM, V34, P1022, DOI 10.1089/neu.2016.4500; Drijkoningen D, 2015, HUM BRAIN MAPP, V36, P4897, DOI 10.1002/hbm.22958; Dubovsky EC, 2001, AM J NEURORADIOL, V22, P190; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Ewing-Cobbs L, 2012, INT J DEV NEUROSCI, V30, P247, DOI 10.1016/j.ijdevneu.2011.07.004; Faul M, 2010, TRAUMATIC BRAIN INJU; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Ferrazzano PA, 2019, J NEUROSURG-PEDIATR, V23, P471, DOI 10.3171/2018.10.PEDS18374; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Gale SD, 2010, J HEAD TRAUMA REHAB, V25, P15, DOI 10.1097/HTR.0b013e3181c39960; Ghosh A, 2009, BRAIN INJURY, V23, P228, DOI 10.1080/02699050802672789; Goldsmith W, 2004, AM J FOREN MED PATH, V25, P89, DOI 10.1097/01.paf.0000127407.28071.63; Green REA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00067; Hagmann C, 2016, J CHILD NEUROL, V31, P300, DOI 10.1177/0883073815591214; Harris TC, 2019, ANN BIOMED ENG, V47, P1941, DOI 10.1007/s10439-018-02148-2; Hayakawa K, 1996, ACTA RADIOL, V37, P830; Hiess RK, 2015, J AUTISM DEV DISORD, V45, P3107, DOI 10.1007/s10803-015-2468-8; ICHISE M, 1994, J NUCL MED, V35, P217; Irimia A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00530; Jacobson SW, 2017, ALCOHOL CLIN EXP RES, V41, P965, DOI 10.1111/acer.13363; Johnson SC, 1996, NEUROPSYCHOLOGY, V10, P408, DOI 10.1037/0894-4105.10.3.408; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Katramados AM, 2018, NEUROIMAG CLIN N AM, V28, P649, DOI 10.1016/j.nic.2018.06.007; Keightley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00139; Kelly CE, 2019, DEV MED CHILD NEUROL, V61, P820, DOI 10.1111/dmcn.14084; KISHORE PRS, 1978, NEURORADIOLOGY, V16, P261, DOI 10.1007/BF00395266; Konigs M, 2018, BRAIN IMAGING BEHAV, V12, P29, DOI 10.1007/s11682-017-9673-3; Lee R, 2014, PEDIATR NEUROL, V51, P669, DOI 10.1016/j.pediatrneurol.2014.07.028; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; Mandalis A, 2007, DEV NEUROPSYCHOL, V32, P683, DOI 10.1080/87565640701376045; Martola J, 2008, ACTA RADIOL, V49, P570, DOI 10.1080/02841850802039898; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Molteni E, 2019, EUR J NEUROL, V26, P1183, DOI 10.1111/ene.13963; Okonkwo OC, 2010, ALZHEIMERS DEMENT, V6, P404, DOI 10.1016/j.jalz.2010.02.003; Panigrahy A, 2005, PEDIATR RADIOL, V35, P1199, DOI 10.1007/s00247-005-1577-5; Porto L, 2011, EUR J PAEDIATR NEURO, V15, P493, DOI 10.1016/j.ejpn.2011.06.004; Preis S, 2000, COGNITIVE BRAIN RES, V10, P37, DOI 10.1016/S0926-6410(00)00020-3; Rashid A, 2017, CHILD NERV SYST, V33, P965, DOI 10.1007/s00381-017-3412-3; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; ROBERSON FC, 1979, SURG NEUROL, V12, P161; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Shashi V, 2004, NEUROIMAGE, V21, P1399, DOI 10.1016/j.neuroimage.2003.12.004; Slawik H, 2009, J NEUROTRAUM, V26, P1891, DOI 10.1089/neu.2009.0942; Smitherman E, 2016, J NEUROTRAUM, V33, P35, DOI 10.1089/neu.2014.3801; Stivaros SM, 2016, PEDIATR RADIOL, V46, P73, DOI 10.1007/s00247-015-3444-3; Stopa EG, 2001, EXP NEUROL, V167, P40, DOI 10.1006/exnr.2000.7545; Tasker RC, 2005, PEDIATR RES, V58, P302, DOI 10.1203/01.PDR.0000169965.08854.25; Tasker RC, 2010, DEV NEUROSCI-BASEL, V32, P374, DOI 10.1159/000316806; Tomaiuolo F, 2012, BRAIN RES BULL, V87, P373, DOI 10.1016/j.brainresbull.2012.01.008; Treble-Barna A, 2017, J NEUROTRAUM, V34, P1919, DOI 10.1089/neu.2016.4840; Treble-Barna A, 2017, J NEUROTRAUM, V34, P353, DOI 10.1089/neu.2016.4476; Verger K, 2001, BRAIN INJURY, V15, P211; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Wintermark M, 2018, BRIT J RADIOL, V91, DOI 10.1259/bjr.20170505; Wright KL, 2020, J NEUROTRAUM, V37, P2188, DOI 10.1089/neu.2019.6691; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	93	2	2	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2021	38	13					1799	1808		10.1089/neu.2019.6918		FEB 2021	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SU3SJ	WOS:000624025700001	33487126				2022-02-06	
J	Huijben, JA; Dixit, A; Stocchetti, N; Maas, AIR; Lingsma, HF; van der Jagt, M; Nelson, D; Citerio, G; Wilson, L; Menon, DK; Ercole, A				Huijben, Jilske A.; Dixit, Abhishek; Stocchetti, Nino; Maas, Andrew I. R.; Lingsma, Hester F.; van der Jagt, Mathieu; Nelson, David; Citerio, Giuseppe; Wilson, Lindsay; Menon, David K.; Ercole, Ari		CTR-TBI Investigators Participants	Use and impact of high intensity treatments in patients with traumatic brain injury across Europe: a CENTER-TBI analysis	CRITICAL CARE			English	Article							DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL-PRESSURE; MANAGEMENT; THERAPY; RELIABILITY; VALIDITY; SCALE; LEVEL	Purpose: To study variation in, and clinical impact of high Therapy Intensity Level (TIL) treatments for elevated intracranial pressure (ICP) in patients with traumatic brain injury (TBI) across European Intensive Care Units (ICUs). Methods: We studied high TIL treatments (metabolic suppression, hypothermia (<35 degrees C), intensive hyperventilation (PaCO2 < 4 kPa), and secondary decompressive craniectomy) in patients receiving ICP monitoring in the ICU stratum of the CENTER-TBI study. A random effect logistic regression model was used to determine between-centre variation in their use. A propensity score-matched model was used to study the impact on outcome (6-months Glasgow Outcome Score-extended (GOSE)), whilst adjusting for case-mix severity, signs of brain herniation on imaging, and ICP. Results: 313 of 758 patients from 52 European centres (41%) received at least one high TIL treatment with significant variation between centres (median odds ratio =2.26). Patients often transiently received high TIL therapies without escalation from lower tier treatments. 38% of patients with high TIL treatment had favourable outcomes (GOSE >= 5). The use of high TIL treatment was not significantly associated with worse outcome (285 matched pairs, OR 1.4, 95% CI [1.0-2.0]). However, a sensitivity analysis excluding high TIL treatments at day 1 or use of metabolic suppression at any day did reveal a statistically significant association with worse outcome. Conclusion: Substantial between-centre variation in use of high TIL treatments for TBI was found and treatment escalation to higher TIL treatments were often not preceded by more conventional lower TIL treatments. The significant association between high TIL treatments after day 1 and worse outcomes may reflect aggressive use or unmeasured confounders or inappropriate escalation strategies.	[Huijben, Jilske A.; Lingsma, Hester F.] Univ Med Ctr Rotterdam, Ctr Med Decis Sci, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands; [Dixit, Abhishek; Menon, David K.; Ercole, Ari] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Stocchetti, Nino] Univ Milan, Dept Pathophysiol & Transplants, Milan, Italy; [Stocchetti, Nino] Fdn IRCCS Ca Granda, Osped Maggiore Policlin, Milan, Italy; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium; [van der Jagt, Mathieu] Univ Med Ctr Rotterdam, Dept Intens Care Adults, Erasmus MC, Rotterdam, Netherlands; [Nelson, David] Karolinska Inst, Dept Physiol & Pharmacol, Sect Perioperat Med & Intens Care, Stockholm, Sweden; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Citerio, Giuseppe] ASST Monza, San Gerardo Hosp, Neurointens Care, Monza, Italy; [Wilson, Lindsay] Univ Stirling, Div Psychol, Stirling, Scotland		Huijben, JA (corresponding author), Univ Med Ctr Rotterdam, Ctr Med Decis Sci, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands.	j.a.huijben@erasmusmc.nl	Posti, Jussi P./Y-2908-2019; Ercole, Ari/B-6288-2009; Sahuquillo, Juan/B-3577-2008; Gomez, Pedro/E-2411-2014; Raj, Rahul/K-7693-2012; van der Jagt, Mathieu/G-1905-2017	Posti, Jussi P./0000-0002-5925-5193; Ercole, Ari/0000-0001-8350-8093; Sahuquillo, Juan/0000-0003-0713-5875; Gomez, Pedro/0000-0002-4185-5238; Sakowitz, Oliver/0000-0003-3248-6335; Nelson, David/0000-0003-2530-8207; Zeiler, Frederick/0000-0003-1737-0510; Van Essen, Thomas/0000-0003-4657-5283; Sanchez-Porras, Renan/0000-0002-9084-8114; Dark, Paul/0000-0003-3309-0164; Radoi, Andreea/0000-0002-0677-3544; Dixit, Abhishek/0000-0001-9543-5901; Newcombe, Virginia/0000-0001-6044-9035; Takala, Riikka/0000-0001-6342-0043; Raj, Rahul/0000-0003-4243-9591; van der Jagt, Mathieu/0000-0003-2566-8325; Huijben, Jilske (Antonia)/0000-0002-2892-5406; Kondziella, Daniel/0000-0001-5562-9808; Coles, Jonathan/0000-0003-4013-679X; Rossi, Sandra/0000-0002-9963-8121	European Commission 7th Framework program [602150]	This research is funded by the European Commission 7th Framework program (602150). The funder had no role in the design of the study and collection, analysis, interpretation of data and in writing the manuscript.	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Bonow RH, 2019, NEUROCRIT CARE, V30, P157, DOI 10.1007/s12028-018-0590-0; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cnossen MC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1816-9; Cooper DJ, 2018, JAMA-J AM MED ASSOC, V320, P2211, DOI 10.1001/jama.2018.17075; Cooper DJ, 2011, MED J AUSTRALIA, V194, P437, DOI 10.5694/j.1326-5377.2011.tb03053.x; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cnossen MC, 2017, CRIT CARE MED, V45, P660, DOI 10.1097/CCM.0000000000002263; Doiron D, 2017, INT J EPIDEMIOL, V46, P1372, DOI 10.1093/ije/dyx180; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Neumann JO, 2008, INTENS CARE MED, V34, P1676, DOI 10.1007/s00134-008-1123-7; Roberts I, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000033.pub2; Shore PM, 2006, CRIT CARE MED, V34, P1981, DOI 10.1097/01.CCM.0000220765.22184.ED; Steyerberg EW, 2019, LANCET NEUROLOGY; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; van Buuren S, 2011, J STAT SOFTW, V45, P1; Zuercher P, 2016, J NEUROTRAUM, V33, P1768, DOI 10.1089/neu.2015.4266	22	2	2	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1364-8535	1466-609X		CRIT CARE	Crit. Care	FEB 23	2021	25	1							78	10.1186/s13054-020-03370-y			13	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QO5TF	WOS:000623203900002	33622371	Green Published, Green Submitted, gold			2022-02-06	
J	Giza, CC; McCrea, M; Huber, D; Cameron, KL; Houston, MN; Jackson, JC; McGinty, G; Pasquina, P; Broglio, SP; Brooks, A; DiFiori, J; Duma, S; Harezlak, J; Goldman, J; Guskiewicz, K; McAllister, TW; McArthur, D; Meier, TB; Mihalik, JP; Nelson, LD; Rowson, S; Gill, J				Giza, Christopher C.; McCrea, Michael; Huber, Daniel; Cameron, Kenneth L.; Houston, Megan N.; Jackson, Jonathan C.; McGinty, Gerald; Pasquina, Paul; Broglio, Steven P.; Brooks, Alison; DiFiori, John; Duma, Stefan; Harezlak, Jaroslaw; Goldman, Joshua; Guskiewicz, Kevin; McAllister, Thomas W.; McArthur, David; Meier, Timothy B.; Mihalik, Jason P.; Nelson, Lindsay D.; Rowson, Steven; Gill, Jessica		CARE Consortium Investigators	Assessment of Blood Biomarker Profile After Acute Concussion During Combative Training Among US Military Cadets A Prospective Study From the NCAA and US Department of Defense CARE Consortium	JAMA NETWORK OPEN			English	Article							NEUROCHEMICAL AFTERMATH; UNITED-STATES; BRAIN-INJURY; MILD; S100B	Importance Validation of protein biomarkers for concussion diagnosis and management in military combative training is important, as these injuries occur outside of traditional health care settings and are generally difficult to diagnose. Objective To investigate acute blood protein levels in military cadets after combative training-associated concussions. Design, Setting, and Participants This multicenter prospective case-control study was part of a larger cohort study conducted by the National Collegiate Athletic Association and the US Department of Defense Concussion Assessment Research and Education (CARE) Consortium from February 20, 2015, to May 31, 2018. The study was performed among cadets from 2 CARE Consortium Advanced Research Core sites: the US Military Academy at West Point and the US Air Force Academy. Cadets who incurred concussions during combative training (concussion group) were compared with cadets who participated in the same combative training exercises but did not incur concussions (contact-control group). Clinical measures and blood sample collection occurred at baseline, the acute postinjury point (<6 hours), the 24- to 48-hour postinjury point, the asymptomatic postinjury point (defined as the point at which the cadet reported being asymptomatic and began the return-to-activity protocol), and 7 days after return to activity. Biomarker levels and estimated mean differences in biomarker levels were natural log (ln) transformed to decrease the skewness of their distributions. Data were collected from August 1, 2016, to May 31, 2018, and analyses were conducted from March 1, 2019, to January 14, 2020. Exposure Concussion incurred during combative training. Main Outcomes and Measures Proteins examined included glial fibrillary acidic protein, ubiquitin C-terminal hydrolase-L1, neurofilament light chain, and tau. Quantification was conducted using a multiplex assay (Simoa; Quanterix Corp). Clinical measures included the Sport Concussion Assessment Tool-Third Edition symptom severity evaluation, the Standardized Assessment of Concussion, the Balance Error Scoring System, and the 18-item Brief Symptom Inventory. Results Among 103 military service academy cadets, 67 cadets incurred concussions during combative training, and 36 matched cadets who engaged in the same training exercises did not incur concussions. The mean (SD) age of cadets in the concussion group was 18.6 (1.3) years, and 40 cadets (59.7%) were male. The mean (SD) age of matched cadets in the contact-control group was 19.5 (1.3) years, and 25 cadets (69.4%) were male. Compared with cadets in the contact-control group, those in the concussion group had significant increases in glial fibrillary acidic protein (mean difference in ln values, 0.34; 95% CI, 0.18-0.50; P < .001) and ubiquitin C-terminal hydrolase-L1 (mean difference in ln values, 0.97; 95% CI, 0.44-1.50; P < .001) levels at the acute postinjury point. The glial fibrillary acidic protein level remained high in the concussion group compared with the contact-control group at the 24- to 48-hour postinjury point (mean difference in ln values, 0.22; 95% CI, 0.06-0.38; P = .007) and the asymptomatic postinjury point (mean difference in ln values, 0.21; 95% CI, 0.05-0.36; P = .01). The area under the curve for all biomarkers combined, which was used to differentiate cadets in the concussion and contact-control groups, was 0.80 (95% CI, 0.68-0.93; P < .001) at the acute postinjury point. Conclusions and Relevance This study's findings indicate that blood biomarkers have potential for use as research tools to better understand the pathobiological changes associated with concussion and to assist with injury identification and recovery from combative training-associated concussions among military service academy cadets. These results extend the previous findings of studies of collegiate athletes with sport-associated concussions.	[Giza, Christopher C.; McArthur, David] Univ Calif Los Angeles, UCLA Steve Tisch BrainSPORT Program, Dept Neurosurg, 300 Stein Plaza,Rm 531 Wasserman, Los Angeles, CA 90095 USA; [Giza, Christopher C.] Univ Calif Los Angeles, Dept Pediat, UCLA Steve Tisch BrainSPORT Program, Los Angeles, CA 90024 USA; [McCrea, Michael; Huber, Daniel; Meier, Timothy B.; Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Cameron, Kenneth L.; Houston, Megan N.] Keller Army Community Hosp, West Point, NY USA; [Cameron, Kenneth L.; Pasquina, Paul] Uniformed Serv Univ Hlth Sci, Dept Phys Med & Rehabil, Bethesda, MD USA; [Jackson, Jonathan C.; McGinty, Gerald] US Air Force Acad, Colorado Springs, CO 80840 USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA; [Brooks, Alison] Univ Wisconsin, Sch Med & Publ Hlth, Dept Orthoped & Rehabil, Madison, WI 53706 USA; [DiFiori, John] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA; [Duma, Stefan; Rowson, Steven] Virginia Tech, Dept Biomed Engn, Blacksburg, VA USA; [Harezlak, Jaroslaw] Indiana Univ, Sch Publ Health Bloomington, Dept Epidemiol & Biostat, Bloomington, IN 47405 USA; [Goldman, Joshua] Univ Calif Los Angeles, Dept Family Med, UCLA Steve Tisch BrainSPORT Program, Los Angeles, CA USA; [Guskiewicz, Kevin; Mihalik, Jason P.] Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27515 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Gill, Jessica] NINR, NIH, Bethesda, MD 20892 USA		Giza, CC (corresponding author), Univ Calif Los Angeles, UCLA Steve Tisch BrainSPORT Program, Dept Neurosurg, 300 Stein Plaza,Rm 531 Wasserman, Los Angeles, CA 90095 USA.	cgiza@mednet.ucla.edu	Harezlak, Jaroslaw/P-8557-2014	Harezlak, Jaroslaw/0000-0002-3070-7686	Grand Alliance Concussion Assessment, Research, and Education Consortium; National Collegiate Athletic Association; US Department of DefenseUnited States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-14-2-0151]	This study was supported by the Grand Alliance Concussion Assessment, Research, and Education Consortium, the National Collegiate Athletic Association, the US Department of Defense, and grant W81XWH-14-2-0151 from the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program.	Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; Di Battista AP, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01367; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Gaetani L, 2019, J NEUROL NEUROSUR PS, V90, P870, DOI 10.1136/jnnp-2018-320106; Gill J, 2018, BRAIN INJURY, V32, P1277, DOI 10.1080/02699052.2018.1471738; Gill J, 2018, NEUROLOGY, V91, pE1385, DOI 10.1212/WNL.0000000000006321; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; Kenney Kimbra, 2018, Brain Inj, V32, P1276, DOI 10.1080/02699052.2018.1483530; Koh SXT, 2014, SPORTS MED, V44, P369, DOI 10.1007/s40279-013-0119-9; Lippa SM, 2019, J NEUROTRAUM, V36, P2190, DOI 10.1089/neu.2018.6269; McCrea M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.19771; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; Neselius S, 2015, KNEE SURG SPORT TR A, V23, P2536, DOI 10.1007/s00167-014-3066-6; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Stuart JI, 2018, MIL MED, V183, pE378, DOI 10.1093/milmed/usx107; Vandenbroucke JP, 2014, INT J SURG, V12, P1500, DOI 10.1016/j.ijsu.2014.07.014; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0; Zetterberg H, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.037143; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277	27	2	2	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2574-3805			JAMA NETW OPEN	JAMA Netw. Open	FEB 22	2021	4	2							e2037731	10.1001/jamanetworkopen.2020.37731			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QM7KE	WOS:000621953200004	33616662	Green Published, gold			2022-02-06	
J	Bilodeau, V; Saavedra-Mitjans, M; Frenette, AJ; Burry, L; Albert, M; Bernard, F; Williamson, DR				Bilodeau, Veronique; Saavedra-Mitjans, Mar; Frenette, Anne Julie; Burry, Lisa; Albert, Martin; Bernard, Francis; Williamson, David R.			Safety of dexmedetomidine for the control of agitation in critically ill traumatic brain injury patients: a descriptive study	JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS			English	Article						agitation; critical care; dexmedetomidine; traumatic brain injury		Background Behavioural disturbances such as agitation are common following traumatic brain injury and can interfere with treatments, cause self-harm and delay rehabilitation. As there is a lack of evidence on the optimal approach to manage agitation in recovering TBI patients, various pharmacological agents are used including antipsychotics, anticonvulsants and sedative agents. Among sedatives, the safety and efficacy of dexmedetomidine to control agitation in traumatic brain injury patients is not well documented. Objective To describe the safety, use and efficacy of dexmedetomidine for the management of agitation following traumatic brain injury in the intensive care unit. Methods Medical records of all patients admitted to the intensive care unit of the Hopital Sacre-Coeur de Montreal for a traumatic brain injury who received dexmedetomidine for agitation between 1 January 2017 and 31 December 2017 were reviewed. Patients who received dexmedetomidine for indications other than agitation were excluded. Data on dexmedetomidine prescription practices and safety were extracted. Frequency of agitation and concomitant psychoactive medication use was explored over a period starting two days prior to the initiation of dexmedetomidine to six days after or discontinuation, whichever came first. Results We identified 41 patients in whom dexmedetomidine was initiated. Dexmedetomidine was started on median ICU day 3 (25(th)-75(th) percentiles: 2-7) and had a median treatment duration of 3 days (25(th)-75(th) percentiles: 3-6) and a mean average rate of 0.62 mcg/kg/h (SD 0.25). Although hypotension (76%) and bradycardia (54%) were common, only one patient required intervention. The proportion of patients with at least one episode of agitation decreased from 100% on day 0, to 88%, 69% and 63% on days 1, 2 and 3 of dexmedetomidine, respectively. The decrease was statistically significant difference between days 0 and 2 as well as between days 0 and 3. Concomitant use of propofol and benzodiazepines also decreased over the course of dexmedetomidine treatment. Conclusion Dexmedetomidine use was safe and associated with a reduction in agitation in traumatic brain injury patients in the 96 hours following its initiation.	[Bilodeau, Veronique; Saavedra-Mitjans, Mar; Frenette, Anne Julie; Williamson, David R.] Univ Montreal, Fac Pharm, Montreal, PQ, Canada; [Saavedra-Mitjans, Mar; Frenette, Anne Julie; Williamson, David R.] Hop Sacre Coeur Montreal, Res Ctr, Montreal, PQ, Canada; [Frenette, Anne Julie; Williamson, David R.] Hop Sacre Coeur Montreal, Pharm Dept, Montreal, PQ, Canada; [Burry, Lisa] Mt Sinai Hosp, Pharm Dept, Toronto, ON, Canada; [Burry, Lisa] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Albert, Martin; Bernard, Francis] Hop Sacre Coeur Montreal, Dept Crit Care, Montreal, PQ, Canada; [Albert, Martin; Bernard, Francis] Univ Montreal, Fac Med, Dept Med, Montreal, PQ, Canada		Williamson, DR (corresponding author), Univ Montreal, Fac Pharm, Montreal, PQ, Canada.	david.williamson@umontreal.ca		Williamson, David/0000-0003-3360-4831	Faculty of Pharmacy of the University of Montreal; FRQ--S research career grant	This study was supported by a summer student research grant from the Faculty of Pharmacy of the University of Montreal. No other external funding was used. David Williamson is supported by an FRQ--S research career grant.	Arciniegas David B, 2011, Dialogues Clin Neurosci, V13, P325; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; Bogner J, 2015, ARCH PHYS MED REHAB, V96, pS274, DOI 10.1016/j.apmr.2015.04.020; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Devlin JW, 2018, CRIT CARE MED, V46, P1532, DOI 10.1097/CCM.0000000000003259; Dupuis S, 2019, CAN J ANESTH, V66, P318, DOI 10.1007/s12630-018-01289-1; Frenette AJ, 2016, INTENS CARE MED, V42, P122, DOI 10.1007/s00134-015-3964-1; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P924, DOI 10.1016/S0003-9993(97)90051-4; Gagnon DJ, 2017, J CRIT CARE, V37, P119, DOI 10.1016/j.jcrc.2016.09.006; Ganau M, 2018, MINERVA ANESTESIOL, V84, P632, DOI 10.23736/S0375-9393.18.12294-2; Humble SS, 2016, BRAIN INJURY, V30, P1266, DOI 10.1080/02699052.2016.1187289; Jakob SM, 2012, JAMA-J AM MED ASSOC, V307, P1151, DOI 10.1001/jama.2012.304; Keating GM, 2015, DRUGS, V75, P1119, DOI 10.1007/s40265-015-0419-5; Larsen LK, 2019, ACTA ANAESTH SCAND, V63, P352, DOI 10.1111/aas.13270; Luaute J, 2016, ANN PHYS REHABIL MED, V59, P58, DOI 10.1016/j.rehab.2015.11.001; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; Pajoumand M, 2016, J TRAUMA ACUTE CARE, V81, P345, DOI 10.1097/TA.0000000000001069; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; Pasin L, 2014, J CARDIOTHOR VASC AN, V28, P1459, DOI 10.1053/j.jvca.2014.03.010; Perreault M, 2017, CRIT CARE, V21, P219; Pisa FE, 2015, BRAIN INJURY, V29, P508, DOI 10.3109/02699052.2014.992474; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Reade MC, 2016, JAMA-J AM MED ASSOC, V315, P1460, DOI 10.1001/jama.2016.2707; Reade MC, 2014, NEW ENGL J MED, V370, P444, DOI 10.1056/NEJMra1208705; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Singh R, 2014, BRAIN INJURY, V28, P336, DOI 10.3109/02699052.2013.873142; Tang JF, 2011, NEUROCRIT CARE, V15, P175, DOI 10.1007/s12028-009-9315-8; Williamson D, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029604; Williamson DR, 2020, PILOT FEASIBILITY ST, V6, DOI 10.1186/s40814-020-00736-5; Zhang J, 2019, DRUG DES DEV THER, V13, P2853, DOI 10.2147/DDDT.S207016	31	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-4727	1365-2710		J CLIN PHARM THER	J. Clin. Pharm. Ther.	AUG	2021	46	4					1020	1026		10.1111/jcpt.13389		FEB 2021	7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	TF1CY	WOS:000619601400001	33606290				2022-02-06	
J	Heyburn, L; Abutarboush, R; Goodrich, S; Urioste, R; Batuure, A; Wheel, J; Wilder, DM; Arun, P; Ahlers, ST; Long, JSB; Sajja, VS				Heyburn, Lanier; Abutarboush, Rania; Goodrich, Samantha; Urioste, Rodrigo; Batuure, Andrew; Wheel, Jaimena; Wilder, Donna M.; Arun, Peethambaran; Ahlers, Stephen T.; Long, Joseph B.; Sajja, Venkatasivasai Sujith			Repeated Low-Level Blast Acutely Alters Brain Cytokines, Neurovascular Proteins, Mechanotransduction, and Neurodegenerative Markers in a Rat Model	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						blast wave-induced neurotrauma; blood-brain barrier; Piezo2 channel; TAR DNA-bindingprotein 43 (TDP-43); repetitive blast		Exposure to the repeated low-level blast overpressure (BOP) periodically experienced by military personnel in operational and training environments can lead to deficits in behavior and cognition. While these low-intensity blasts do not cause overt changes acutely, repeated exposures may lead to cumulative effects in the brain that include acute inflammation, vascular disruption, and other molecular changes, which may eventually contribute to neurodegenerative processes. To identify these acute changes in the brain following repeated BOP, an advanced blast simulator was used to expose rats to 8.5 or 10 psi BOP once per day for 14 days. At 24 h after the final BOP, brain tissue was collected and analyzed for inflammatory markers, astrogliosis (GFAP), tight junction proteins (claudin-5 and occludin), and neurodegeneration-related proteins (A beta 40/42, pTau, TDP-43). After repeated exposure to 8.5 psi BOP, the change in cytokine profile was relatively modest compared to the changes observed following 10 psi BOP, which included a significant reduction in several inflammatory markers. Reduction in the tight junction protein occludin was observed in both groups when compared to controls, suggesting cerebrovascular disruption. While repeated exposure to 8.5 psi BOP led to a reduction in the Alzheimer's disease (AD)-related proteins amyloid-beta (A beta)40 and A beta 42, these changes were not observed in the 10 psi group, which had a significant reduction in phosphorylated tau. Finally, repeated 10 psi BOP exposures led to an increase in GFAP, indicating alterations in astrocytes, and an increase in the mechanosensitive ion channel receptor protein, Piezo2, which may increase brain sensitivity to injury from pressure changes from BOP exposure. Overall, cumulative effects of repeated low-level BOP may increase the vulnerability to injury of the brain by disrupting neurovascular architecture, which may lead to downstream deleterious effects on behavior and cognition.	[Heyburn, Lanier; Urioste, Rodrigo; Batuure, Andrew; Wheel, Jaimena; Wilder, Donna M.; Arun, Peethambaran; Long, Joseph B.; Sajja, Venkatasivasai Sujith] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA; [Abutarboush, Rania; Goodrich, Samantha; Ahlers, Stephen T.] Naval Med Res Ctr, Neurotrauma Dept, Operat & Undersea Med Directorate, Silver Spring, MD USA		Sajja, VS (corresponding author), Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA.	venkatasivasaisujith.sajja.ctr@mail.mil		Sajja, Sujith/0000-0002-1992-9501	Defense Health Program [602115HP.3720.001]	This work was supported/funded by work unit number 602115HP.3720.001.A1317 as a part of the ``Exposure Standards for Repeated Blast'' program funded by the Defense Health Program managed by Joint Program Committee 5.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; De Gasperi Rita, 2012, Front Neurol, V3, P177, DOI 10.3389/fneur.2012.00177; DeKosky ST, 2017, BRAIN INJURY, V31, P1177, DOI 10.1080/02699052.2017.1312528; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Duckworth J., 2018, 7 STAT OF THE SCI M, P15; Edwards KA, 2020, BRAIN INJURY, V34, P1213, DOI 10.1080/02699052.2020.1797171; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Eonta SE, 2020, MIL MED, V185, pE513, DOI 10.1093/milmed/usz185; Ferrari LF, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0068-4; Gill J, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000186; Gill J, 2017, BRAIN BEHAV IMMUN, V65, P90, DOI 10.1016/j.bbi.2017.02.015; Gu M, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2075463; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Heyburn L, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00766; Heyburn L, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00680; Hubbard WB, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5175249; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Iacono D, 2020, J NEUROPATH EXP NEUR, V79, P144, DOI 10.1093/jnen/nlz122; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Kamimori Gary H, 2018, Mil Med, V183, P28, DOI 10.1093/milmed/usx186; Kamnaksh A., 2014, TRANSL PROTEOM, V3, P22, DOI [10.1016/j.trprot.2013.11.001, DOI 10.1016/J.TRPROT.2013.11.001]; Kawoos U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167510; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Perez-Polo JR, 2015, J NEUROSCI RES, V93, P549, DOI 10.1002/jnr.23513; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Rios JD, 2019, MOL VIS, V25, P283; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Rusiecki J, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-019-1624-z; Sajja Venkata Siva Sai S, 2012, Biomed Sci Instrum, V48, P374; Sajja VSSS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00891; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Sajja VS, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73643-7; Sajja VS, 2018, NEUROMETHODS, V139, P123, DOI 10.1007/978-1-4939-8564-7_8; Schrenk-Siemens K, 2015, NAT NEUROSCI, V18, P10, DOI 10.1038/nn.3894; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Shin KC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42492-4; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Simard JM, 2014, J NEUROTRAUM, V31, P1292, DOI 10.1089/neu.2013.3016; Sosa MAG, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0483-z; Szczot M, 2017, CELL REP, V21, P2760, DOI 10.1016/j.celrep.2017.11.035; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Valiyaveettil M, 2013, NEUROSCI LETT, V539, P1, DOI 10.1016/j.neulet.2013.01.028; Yamamoto S, 2018, MOLECULES, V23, DOI 10.3390/molecules23020245; Yang H, 2016, ONCOTARGET, V7, P44630, DOI 10.18632/oncotarget.10134; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; Zhang MM, 2019, CELL REP, V26, P1419, DOI 10.1016/j.celrep.2019.01.056; Zhang TX, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01712-z; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	56	2	2	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	FEB 19	2021	15								636707	10.3389/fncel.2021.636707			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QS4GZ	WOS:000625859700001	33679327	Green Published, gold			2022-02-06	
J	Liu, H; He, JC; Wu, Y; Du, Y; Jiang, YH; Chen, CZ; Yu, ZY; Zhong, JJ; Wang, ZG; Cheng, CJ; Sun, XC; Huang, ZJ				Liu, Han; He, Junchi; Wu, Yue; Du, Yang; Jiang, Yinghua; Chen, Chengzhi; Yu, Zhanyang; Zhong, Jianjun; Wang, Zhigang; Cheng, Chongjie; Sun, Xiaochuan; Huang, Zhijian			Endothelial Regulation by Exogenous Annexin A1 in Inflammatory Response and BBB Integrity Following Traumatic Brain Injury	FRONTIERS IN NEUROSCIENCE			English	Article						annexin A1; blood&#8211; brain barrier; inflammation; RhoA; traumatic brain injury		Background and Target Following brain trauma, blood-brain barrier (BBB) disruption and inflammatory response are critical pathological steps contributing to secondary injury, leading to high mortality and morbidity. Both pathologies are closely associated with endothelial remodeling. In the present study, we concentrated on annexin A1 (ANXA1) as a novel regulator of endothelial function after traumatic brain injury. Methods After establishing controlled cortical impact (CCI) model in male mice, human recombinant ANXA1 (rANXA1) was administered intravenously, followed by assessments of BBB integrity, brain edema, inflammatory response, and neurological deficits. Result Animals treated with rANXA1 (1 mu g/kg) at 1 h after CCI exhibited optimal BBB protection including alleviated BBB disruption and brain edema, as well as endothelial junction proteins loss. The infiltrated neutrophils and inflammatory cytokines were suppressed by rANXA1, consistent with decreased adhesive and transmigrating molecules from isolated microvessels. Moreover, rANXA1 attenuated the neurological deficits induced by CCI. We further found that the Ras homolog gene family member A (RhoA) inhibition has similar effect as rANXA1 in ameliorating brain injuries after CCI, whereas rANXA1 suppressed CCI-induced RhoA activation. Conclusion Our findings suggest that the endothelial remodeling by exogenous rANXA1 corrects BBB disruption and inflammatory response through RhoA inhibition, hence improving functional outcomes in CCI mice.	[Liu, Han; He, Junchi; Wu, Yue; Jiang, Yinghua; Zhong, Jianjun; Cheng, Chongjie; Sun, Xiaochuan; Huang, Zhijian] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing, Peoples R China; [Liu, Han; Wang, Zhigang] Shandong Univ, Qilu Hosp, Dept Neurosurg, Qingdao Campus, Qingdao, Peoples R China; [Du, Yang] Cent South Univ, Xiangya Hosp, Dept Neurol, Changsha, Peoples R China; [Du, Yang; Jiang, Yinghua; Yu, Zhanyang] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02115 USA; [Du, Yang; Jiang, Yinghua; Yu, Zhanyang] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA; [Chen, Chengzhi] Chongqing Med Univ, Innovat Ctr Social Risk Governance Hlth, Res Ctr Med & Social Dev, Dept Occupat & Environm Hlth,Sch Publ Hlth & Mana, Chongqing, Peoples R China		Sun, XC; Huang, ZJ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing, Peoples R China.	sunxch1445@qq.com; zhijian@cqmu.edu.cn		, Chuanzhong/0000-0001-7425-4749	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571159]; National Natural Science Foundation for Youth of ChinaNational Natural Science Foundation of China (NSFC) [81601072]	The research leading to these results has received funding from National Natural Science Foundation of China (No. 81571159) and National Natural Science Foundation for Youth of China (No. 81601072).	Bose A, 2018, MOL NEUROBIOL, V55, P6558, DOI 10.1007/s12035-017-0861-3; Corvol H, 2018, J CYST FIBROS, V17, P190, DOI 10.1016/j.jcf.2017.11.003; Cristante E, 2013, P NATL ACAD SCI USA, V110, P832, DOI 10.1073/pnas.1209362110; Delbary-Gossart S, 2016, BRAIN, V139, P1762, DOI 10.1093/brain/aww074; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Gattringer T, 2020, TRANSL STROKE RES, V11, P402, DOI 10.1007/s12975-019-00741-8; Girol AP, 2013, J IMMUNOL, V190, P5689, DOI 10.4049/jimmunol.1202030; Heemskerk N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10493; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; Huang B, 2012, NEUROBIOL DIS, V46, P204, DOI 10.1016/j.nbd.2012.01.008; Huang ZJ, 2016, J NEUROCHEM, V136, P1017, DOI 10.1111/jnc.13491; HUBAISHY I, 1995, BIOCHEMISTRY-US, V34, P14527, DOI 10.1021/bi00044a031; IKEBUCHI NW, 1990, J BIOL CHEM, V265, P3392; Lee DBN, 2004, AM J PHYSIOL-RENAL, V287, pF481, DOI 10.1152/ajprenal.00175.2003; Liu J, 2018, THERANOSTICS, V8, P6053, DOI 10.7150/thno.30305; Liu SX, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101770; Luh C, 2019, TRANSL STROKE RES, V10, P534, DOI 10.1007/s12975-018-0677-0; Marmarou A, 2003, ACT NEUR S, V86, P7; McArthur S, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0043-0; Muller WA, 2013, VET PATHOL, V50, P7, DOI 10.1177/0300985812469883; Rao JL, 2017, SCI REP-UK, V7, DOI 10.1038/srep39727; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Su SC, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M110.157271; Subramanian P, 2016, CURR OPIN HEMATOL, V23, P36, DOI 10.1097/MOH.0000000000000198; Sugimoto MA, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/8239258; Terry S, 2010, PHYSIOLOGY, V25, P16, DOI 10.1152/physiol.00034.2009; Tornero D, 2013, BRAIN, V136, P3561, DOI 10.1093/brain/awt278; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Wang ZF, 2020, TRANSL STROKE RES, V11, P1103, DOI 10.1007/s12975-020-00789-x; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wu JC, 2020, TRANSL STROKE RES, V11, P720, DOI 10.1007/s12975-019-00771-2; Zemmar A, 2014, J NEUROSCI, V34, P8685, DOI 10.1523/JNEUROSCI.3817-13.2014; Zhang C, 2020, TRANSL STROKE RES, V11, P799, DOI 10.1007/s12975-019-00758-z; Zhang WT, 2016, NEUROBIOL DIS, V91, P37, DOI 10.1016/j.nbd.2016.02.020; Zhao S, 2017, NEUROSCI LETT, V643, P125, DOI 10.1016/j.neulet.2016.12.006	36	2	2	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	FEB 18	2021	15								627110	10.3389/fnins.2021.627110			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QR4CA	WOS:000625157300001	33679307	Green Published, gold			2022-02-06	
J	Lira, M; Zamorano, P; Cerpa, W				Lira, Matias; Zamorano, Pedro; Cerpa, Waldo			Exo70 intracellular redistribution after repeated mild traumatic brain injury	BIOLOGICAL RESEARCH			English	Article						Hippocampus; Exocyst; Exo70; Compartmentalization; Redistribution; Traumatic brain injury	EXOCYST COMPLEX; PLASMA-MEMBRANE; RECEPTOR TRAFFICKING; CRYSTAL-STRUCTURE; AMPA RECEPTORS; EXOCYTOSIS; PHOSPHORYLATION; NEURONS; MIGRATION; GLUTAMATE	Background Exo70 is a subunit of the greater exocyst complex, a collection of proteins that oversees cellular membrane addition and polarized exocytosis by acting as a tethering intermediate between the plasma membrane and newly synthesized secretory vesicles. Although Exo70 function has been implicated in several developmental events including cytokinesis and the establishment of cell polarity, its role in neuropathologies is poorly understood. On the other hand, traumatic brain injury is the result of mechanical external force including contusion, fast acceleration, and expansive waves that produce temporal or permanent cognitive damage and triggers physical and psychosocial alterations including headache, memory problems, attention deficits, difficulty thinking, mood swings, and frustration. Traumatic brain injury is a critical health problem on a global scale, constituting a major cause of deaths and disability among young adults. Trauma-related cellular damage includes redistribution of N-methyl-D-aspartate receptors outside of the synaptic compartment triggering detrimental effects to neurons. The exocyst has been related to glutamate receptor constitutive trafficking/delivery towards synapse as well. This work examines whether the exocyst complex subunit Exo70 participates in traumatic brain injury and if it is redistributed among subcellular compartments Results Our analysis shows that Exo70 expression is not altered upon injury induction. By using subcellular fractionation, we determined that Exo70 is redistributed from microsomes fraction into the synaptic compartment after brain trauma. In the synaptic compartment, we also show that the exocyst complex assembly and its interaction with GluN2B are increased. Finally, we show that the Exo70 pool that is redistributed comes from the plasma membrane. Conclusions The present findings position Exo70 in the group of proteins that could modulate GluN2B synaptic availability in acute neuropathology like a traumatic brain injury. By acting as a nucleator factor, Exo70 is capable of redirecting the ensembled complex into the synapse. We suggest that this redistribution is part of a compensatory mechanism by which Exo70 is able to maintain GluN2B partially on synapses. Hence, reducing the detrimental effects associated with TBI pathophysiology.	[Lira, Matias; Cerpa, Waldo] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Av Libertador Bernardo OHiggins 340, Santiago, Chile; [Cerpa, Waldo] Univ Magallanes, Ctr Excelencia Biomed Magallanes CEBIMA, Punta Arenas, Chile; [Zamorano, Pedro] Univ Antofagasta, Dept Biomed, Antofagasta, Chile; [Zamorano, Pedro] Univ Antofagasta, Inst Antofagasta, Antofagasta, Chile		Cerpa, W (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Av Libertador Bernardo OHiggins 340, Santiago, Chile.; Cerpa, W (corresponding author), Univ Magallanes, Ctr Excelencia Biomed Magallanes CEBIMA, Punta Arenas, Chile.	wcerpa@bio.puc.cl		Cerpa, Waldo/0000-0001-7344-0144	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT [1190620]; Center for Excellence in Science and Technology [AFB 170005, PFB 12/2007]; Sociedad Quimica y Minera de Chile (SQM);  [BMBF 20150065]	This work has been supported by grants: BMBF 20150065 (PCI) to PZ and WC; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) 1190620 to WC, Center for Excellence in Science and Technology (AFB 170005, PFB 12/2007), Sociedad Quimica y Minera de Chile (SQM) for special grant "The role of lithium on human health and disease" to WC.	Ahmed SM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07467-5; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Bell JD, 2009, CELL DEATH DIFFER, V16, P1665, DOI 10.1038/cdd.2009.106; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Brymora A, 2001, J BIOL CHEM, V276, P29792, DOI 10.1074/jbc.C100320200; Carlson SW, 2018, J NEUROTRAUM, V35, P2827, DOI 10.1089/neu.2017.5509; Carlson SW, 2016, J NEUROTRAUM, V33, P113, DOI 10.1089/neu.2014.3839; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Carvajal FJ, 2018, BBA-MOL BASIS DIS, V1864, P2010, DOI 10.1016/j.bbadis.2018.03.019; Carvajal FJ, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/2701526; Chen M, 2018, J ALZHEIMERS DIS, V66, P751, DOI 10.3233/JAD-180726; Chernyshova Y, 2011, J NEUROSCI, V31, P3522, DOI 10.1523/JNEUROSCI.3109-10.2011; Coulter ME, 2020, GENET MED, V22, P1040, DOI 10.1038/s41436-020-0758-9; Dennis SH, 2011, J NEUROSCI, V31, P11941, DOI 10.1523/JNEUROSCI.1183-11.2011; Dupraz S, 2009, J NEUROSCI, V29, P13292, DOI 10.1523/JNEUROSCI.3907-09.2009; Essis SA, 2015, BRAIN RES, V1624, P349, DOI 10.1016/j.brainres.2015.07.055; Fruhmesser A, 2013, EUR J HUM GENET, V21, P1177, DOI 10.1038/ejhg.2013.18; Fujita A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079689; Gerges NZ, 2006, EMBO J, V25, P1623, DOI 10.1038/sj.emboj.7601065; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Guo W, 1999, J BIOL CHEM, V274, P23558, DOI 10.1074/jbc.274.33.23558; Guo W, 2000, TRENDS CELL BIOL, V10, P251, DOI 10.1016/S0962-8924(00)01754-2; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hamburger ZA, 2006, J MOL BIOL, V356, P9, DOI 10.1016/j.jmb.2005.09.099; Heider MR, 2012, TRAFFIC, V13, P898, DOI 10.1111/j.1600-0854.2012.01353.x; Heise C, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00212; Hsu SC, 1996, NEURON, V17, P1209, DOI 10.1016/S0896-6273(00)80251-2; Ibrahim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21793; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Johnstone VPA, 2015, J NEUROTRAUM, V32, P1333, DOI 10.1089/neu.2014.3785; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Letinic K, 2009, P NATL ACAD SCI USA, V106, P11342, DOI 10.1073/pnas.0904244106; Lipschutz JH, 2002, CURR BIOL, V12, pR212, DOI 10.1016/S0960-9822(02)00753-4; Lira M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9112402; Lira M, 2019, MOL NEUROBIOL, V56, P4620, DOI 10.1007/s12035-018-1378-0; Liu JL, 2007, MOL BIOL CELL, V18, P4483, DOI 10.1091/mbc.E07-05-0461; Lu HZ, 2016, CELL REP, V15, P2012, DOI 10.1016/j.celrep.2016.04.073; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mao L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13923-7; Martin-Urdiroz M, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00024; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; Mira RG, 2020, BIOCHEM BIOPH RES CO, V528, P514, DOI 10.1016/j.bbrc.2020.05.160; Moore BA, 2007, J MOL BIOL, V371, P410, DOI 10.1016/j.jmb.2007.05.018; Nada S, 2003, J BIOL CHEM, V278, P47610, DOI 10.1074/jbc.M303873200; Park Y, 2013, J CEREBR BLOOD F MET, V33, P1642, DOI 10.1038/jcbfm.2013.121; Parsons MP, 2014, NEURON, V82, P279, DOI 10.1016/j.neuron.2014.03.030; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Picco A, 2017, CELL, V168, P400, DOI 10.1016/j.cell.2017.01.004; Pommereit D, 2007, J CELL SCI, V120, P2694, DOI 10.1242/jcs.03475; Ren JQ, 2012, DEV CELL, V22, P967, DOI 10.1016/j.devcel.2012.03.005; Risling TE, 2012, CAN VET J, V53, P299; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rossi G, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201904161; Sabella SA, 2018, BRAIN INJURY, V32, P926, DOI 10.1080/02699052.2018.1469168; Sandoval M, 2013, BRAIN RES, V1520, P1, DOI 10.1016/j.brainres.2013.04.049; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Smalla K-H, 2013, CYTOSKELETON IMAGING, V79, P265; Smolders K, 2015, SCI REP-UK, V5, DOI 10.1038/srep10917; Spaethling JM, 2008, J NEUROTRAUM, V25, P1207, DOI 10.1089/neu.2008.0532; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; Vega IE, 2001, J NEUROSCI, V21, P3839, DOI 10.1523/JNEUROSCI.21-11-03839.2001; Wang HY, 2002, MOL BIOL CELL, V13, P515, DOI 10.1091/mbc.01-11-0542; Wang SF, 2019, J BIOL CHEM, V294, P19988, DOI 10.1074/jbc.RA119.010821; Wen J, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-100; Whyte JRC, 2002, J CELL SCI, V115, P2627; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Wu B, 2015, J CELL SCI, V128, P2957, DOI 10.1242/jcs.156398; Yeaman C, 2001, J CELL BIOL, V155, P593, DOI 10.1083/jcb.200107088; Zhang BL, 2011, BRAIN RES, V1382, P165, DOI 10.1016/j.brainres.2011.01.065; Zhang CH, 2016, P NATL ACAD SCI USA, V113, pE41, DOI 10.1073/pnas.1521248112; Zhao YT, 2013, DEV CELL, V26, P266, DOI 10.1016/j.devcel.2013.07.007	77	2	2	1	3	SOC BIOLGIA CHILE	SANTIAGO	CASILLA 16164, SANTIAGO 9, CHILE	0716-9760	0717-6287		BIOL RES	Biol. Res.	FEB 16	2021	54	1							5	10.1186/s40659-021-00329-3			13	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	QI3ND	WOS:000618885000001	33593425	gold, Green Published			2022-02-06	
J	Beydoun, HA; Butt, C; Beydoun, MA; Hossain, S; Eid, SM; Zonderman, AB				Beydoun, Hind A.; Butt, Catherine; Beydoun, May A.; Hossain, Sharmin; Eid, Shaker M.; Zonderman, Alan B.			Cross-sectional study of major procedure codes among hospitalized patients with traumatic brain injury by level of injury severity in the 2004 to 2014 Nationwide Inpatient Sample	MEDICINE			English	Article						hospital; injury; procedure; traumatic brain injury	UNITED-STATES; MANAGEMENT; MORTALITY; DEATHS; NEUROPROTECTION; REHABILITATION; MODERATE; OUTCOMES; TRENDS	Despite its public health significance, TBI management across US healthcare institutions and patient characteristics with an emphasis on utilization and outcomes of TBI-specific procedures have not been evaluated at the national level. We aimed to characterize top 10 procedure codes among hospitalized adults with TBI as primary diagnosis by injury severity. A Cross-sectional study was conducted using 546, 548 hospitalization records from the 2004 to 2014 Nationwide Inpatient Sample were analyzed. Data elements of interest included injury, patient, hospital characteristics, procedures, in-hospital death and length of stay. Ten top procedure codes were "Closure of skin and subcutaneous tissue of other sites", "Insertion of endotracheal tube", "Continuous invasive mechanical ventilation for less than 96 consecutive hours", "Venous catheterization (not elsewhere classified)", "Continuous invasive mechanical ventilation for 96 consecutive hours or more", "Transfusion of packed cells", "Incision of cerebral meninges", "Serum transfusion (not elsewhere classified)", "Temporary tracheostomy", and "Arterial catherization". Prevalence rates ranged between 3.1% and 15.5%, with variations according to injury severity and over time. Whereas "Closure of skin and subcutaneous tissue of other sites" was associated with fewer in-hospital deaths and shorter hospitalizations, "Temporary tracheostomy" was associated with fewer in-hospital deaths among moderate-to-severe TBI patients, and "Continuous invasive mechanical ventilation for less than 96 consecutive hours" was associated with shorter hospitalizations among severe TBI patients. Other procedures were associated with worse outcomes. Nationwide, the most frequently reported hospitalization procedure codes among TBI patients aimed at homeostatic stabilization and differed in prevalence, trends, and outcomes according to injury severity.	[Beydoun, Hind A.] Ft Belvoir Community Hosp, Dept Res Programs, 9300 DeWitt Loop, Ft Belvoir, VA 22060 USA; [Butt, Catherine] Def & Vet Brain Injury Ctr, Intrepid Spirit Ctr, Ft Belvoir, VA USA; [Beydoun, May A.; Hossain, Sharmin; Zonderman, Alan B.] NIA, Lab Epidemiol & Populat Sci, NIH, IRP, Bethesda, MD 20892 USA; [Beydoun, Hind A.; Eid, Shaker M.] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA		Beydoun, HA (corresponding author), Ft Belvoir Community Hosp, Dept Res Programs, 9300 DeWitt Loop, Ft Belvoir, VA 22060 USA.	Hind.a.Baydoun.civ@mail.mil			National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); Johns Hopkins University School of Medicine in Baltimore, Maryland	The manuscript was supported in part by the Intramural Research Program of the National Institute on Aging and Johns Hopkins University School of Medicine in Baltimore, Maryland.	Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Anghinah R, 2018, ARQ NEURO-PSIQUIAT, V76, P100, DOI [10.1590/0004-282X20170196, 10.1590/0004-282x20170196]; Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; Asemota AO, 2013, J NEUROTRAUM, V30, P67, DOI 10.1089/neu.2012.2605; Brandel MG, 2017, J NEUROTRAUM, V34, P1005, DOI 10.1089/neu.2016.4504; Chaudhry R, 2017, NEUROCRIT CARE, V26, P232, DOI 10.1007/s12028-016-0330-2; Dawodu ST, 2015, TRAUMATIC BRAIN INJU; Desai M, 2018, J NEUROSURG SCI, V62, P563, DOI 10.23736/S0390-5616.18.04476-4; Faul M, 2010, TRAUMATIC BRAIN INJU; Fetta J, 2017, J NEUROSCI NURS, V49, P235, DOI 10.1097/JNN.0000000000000298; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Geeraerts T, 2018, ANAESTH CRIT CARE PA, V37, P171, DOI 10.1016/j.accpm.2017.12.001; Hammad A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1097-5; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; Hassan A, 2017, AM SURGEON, V83, P541; Hoffman H, 2019, NEUROCRIT CARE, V30, P666, DOI 10.1007/s12028-018-0656-z; Hoffman H, 2018, WORLD NEUROSURG, V118, pE880, DOI 10.1016/j.wneu.2018.07.089; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; Marehbian J, 2017, NEUROCRIT CARE, V27, P430, DOI 10.1007/s12028-017-0408-5; Nosaka N, 2017, ACTA MED OKAYAMA, V71, P1, DOI 10.18926/AMO/54819; Pujari R, 2018, J NEUROSURG SCI, V62, P584, DOI 10.23736/S0390-5616.18.04533-2; Rosenbaum BP, 2014, J CLIN NEUROSCI, V21, P1874, DOI 10.1016/j.jocn.2014.05.006; Scerrati A, 2018, J NEUROSURG SCI, V62, P574, DOI 10.23736/S0390-5616.18.04462-4; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sheriff FG, 2015, SEMIN NEUROL, V35, P42, DOI 10.1055/s-0035-1544238; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Swanson TM, 2017, PUBLIC HEALTH REP, V132, P251, DOI 10.1177/0033354916687748; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor CA, 2015, J HEAD TRAUMA REHAB, V30, P150, DOI 10.1097/HTR.0000000000000105; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Zhu CR, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011671	33	2	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	FEB 12	2021	100	6							e24438	10.1097/MD.0000000000024438			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RN9VG	WOS:000640700100029	33578536	gold, Green Published			2022-02-06	
J	Karton, C; Post, A; Laflamme, Y; Kendall, M; Cournoyer, J; Robidoux, MA; Gilchrist, MD; Hoshizaki, TB				Karton, Clara; Post, Andrew; Laflamme, Yannick; Kendall, Marshall; Cournoyer, Janie; Robidoux, Michael A.; Gilchrist, Michael D.; Hoshizaki, T. Blaine			Exposure to brain trauma in six age divisions of minor ice hockey	JOURNAL OF BIOMECHANICS			English	Article						Brain trauma exposure; Injury prevention; Minor ice hockey; Objective measurements; Risk mitigation strategies	WHITE-MATTER ALTERATIONS; HEAD IMPACTS; FOOTBALL PLAYERS; DYNAMIC-RESPONSE; VIDEO ANALYSIS; CONCUSSION; INJURY; RISK; CHILDREN; RECONSTRUCTION	Acute and chronic neurological risks associated with brain trauma sustained in professional ice hockey has generated concern for youth participants. Minor hockey is a different game when compared to elite players presenting distinctive risk factors for each age division. Objective measures of brain trauma exposure were documented for six divisions in minor ice hockey; U7, U9, U11, U13, U15, U18. Game video analysis, physical reconstruction and computational modelling was employed to capture the event conditions, frequency of impacts, frequency of high strain magnitude (>0.17) impacts, and cumulative trauma. The results showed proportional differences in the event conditions; event type, closing velocity, and head impact location, informing the improvement of age appropriate protection, testing protocols, and safety standards. Frequency of events were highest for U7 when players were learning to skate, and again in U18 as game physicality increases. No significant difference was observed in frequency of high magnitude impacts across age divisions. A peak in high magnitude impacts was empirically observed at both U7 and U15 where skill development in skating and body checking, respectively, were most prominent. Finally, a cumulative trauma metric incorporating frequency and magnitude of impacts provided a detailed analysis of trauma exposure provides for a targeted approach to managing injury risk specific to age division. Objective measures of brain trauma exposure identified in the current study are important to inform strategy, guide legislation and initiate policy for safe play in minor ice hockey. (c) 2020 Elsevier Ltd. All rights reserved.	[Karton, Clara; Post, Andrew; Laflamme, Yannick; Kendall, Marshall; Cournoyer, Janie; Robidoux, Michael A.; Hoshizaki, T. Blaine] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada; [Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland		Karton, C (corresponding author), Univ Ottawa, 200 Lees Ave,Block A106, Ottawa, ON K1N 6N5, Canada.	ckarton@uottawa.ca			Natural Science and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC)	The authors acknowledge financial contributions from Natural Science and Engineering Research Council of Canada (NSERC) and Sport Maska Inc. Thank you to the many University of Ottawa students who assisted in this project's data collection and analysis.	Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beckwith J, 2018, ANN BIOMED ENG, V46, P819, DOI 10.1007/s10439-018-1999-5; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Chen W, 2020, STRUCT CONCRETE, DOI 10.1002/suco.201900389; Clark JM, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4040605; CORTES N, 2017, VIDEO ANAL VERIFICAT, V45, P2379, DOI DOI 10.1177/0363546517706703; Cournoyer J, 2019, SPORT BIOMECH, DOI 10.1080/14763141.2019.1600004; Dawson L, 2020, J BIOMECH ENG-T ASME, V142, DOI 10.1115/1.4045808; Declan P., 2017, BRIT J SPORT MED, V51, P371; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Fryar Cheryl D, 2012, Vital Health Stat 11, P1; Gilchrist, 2013, P INT RES COUNC BIOM; Gilchrist, 2016, TRAUM BRAIN INJ CLIN; Gioia GA, 2015, BRAIN INJURY, V29, P195, DOI 10.3109/02699052.2014.965210; Giza C.C, 2014, SPORTS NEUROL, V20, P1570; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hockey Canada, 2018 2019 ANN REP; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki, 2020, J CONCUSSION, DOI [10.1177/2059700220911285., DOI 10.1177/2059700220911285]; Hoshizaki T.B., 2012, P INT RES COUNC BIOM; Hoshizaki T.B., 2013, J NEUROL PSYCHAIT, V5, P181; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Juliusson PB, 2013, ANN HUM BIOL, V40, P220, DOI 10.3109/03014460.2012.759276; Karton C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-54874-9; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Koncan D, 2020, COMPUT METHOD BIOMEC, V23, P500, DOI 10.1080/10255842.2020.1741555; Kontos AP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1633; Krolikowski M., 2014, J UNDERGRADUATE RES, V4, P6; Krolikowski MP, 2017, AM J SPORT MED, V45, P468, DOI 10.1177/0363546516669701; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Lin AP, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0094-5; Mayinger MC, 2018, BRAIN IMAGING BEHAV, V12, P44, DOI 10.1007/s11682-017-9672-4; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McMunn L., 2019, P AM SOC TEST MAT 6; Mihalik JP, 2012, ANN BIOMED ENG, V40, P141, DOI 10.1007/s10439-011-0405-3; Mihalik JP, 2010, MED SCI SPORT EXER, V42, P1431, DOI 10.1249/MSS.0b013e3181d2521a; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; NELLHAUS G, 1968, PEDIATRICS, V41, P106; Oeur RA, 2019, P I MECH ENG P-J SPO, V233, P258, DOI 10.1177/1754337118819337; Oeur RA, 2015, J NEUROSURG, V123, P415, DOI 10.3171/2014.10.JNS14440; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Post A., 2019, 42 CAN MED BIOL ENG; Post A, 2018, SPORTS ENG, V21, P235, DOI 10.1007/s12283-018-0263-4; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Post A, 2014, J NEUROSURG, V120, P453, DOI 10.3171/2013.10.JNS131101; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Public Health Agency of Canada, 2019, UND AW SPORTS REL CO; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Reed N, 2010, INT J SPORTS MED, V31, P826, DOI 10.1055/s-0030-1263103; Rousseau P., 2014, THESIS U OTTAWA CANA; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Ruhe A, 2014, BRIT J SPORT MED, V48, P102, DOI 10.1136/bjsports-2012-091609; Sollmann N, 2018, NEUROIMAGE-CLIN, V17, P642, DOI 10.1016/j.nicl.2017.11.020; Stamm J.M., 2015, AM ACAD NEUROL, V84, P1; Stazyk K, 2017, BRAIN INJURY, V31, P631, DOI 10.1080/02699052.2017.1283533; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; USA Hockey, MEMB STAT 2019 20 FI; Walsh ES, 2018, SPORTS ENG, V21, P479, DOI 10.1007/s12283-018-0286-x; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	79	2	2	2	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	FEB 12	2021	116									10.1016/j.jbiomech.2020.110203			10	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	QR0HU	WOS:000624896800010	33412437				2022-02-06	
J	Karelina, K; Schneiderman, K; Shah, S; Fitzgerald, J; Cruz, RV; Oliverio, R; Whitehead, B; Yang, JZ; Weil, ZM				Karelina, Kate; Schneiderman, Katarina; Shah, Sarthak; Fitzgerald, Julie; Cruz, Ruth Velazquez; Oliverio, Robin; Whitehead, Bailey; Yang, Jingzhen; Weil, Zachary M.			Moderate Intensity Treadmill Exercise Increases Survival of Newborn Hippocampal Neurons and Improves Neurobehavioral Outcomes after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						anxiety; exercise; learning and memory; neurogenesis; traumatic brain injury		Physician-prescribed rest after traumatic brain injury (TBI) is both commonplace and an increasingly scrutinized approach to TBI treatment. Although this practice remains a standard of patient care for TBI, research of patient outcomes reveals little to no benefit of prescribed rest after TBI, and in some cases prolonged rest has been shown to interfere with patient well-being. In direct contrast to the clinical advice regarding physical activity after TBI, animal models of brain injury consistently indicate that exercise is neuroprotective and promotes recovery. Here, we assessed the effect of low and moderate intensity treadmill exercise on functional outcome and hippocampal neural proliferation after brain injury. Using the controlled cortical impact (CCI) mouse model of TBI, we show that 10 days of moderate intensity treadmill exercise initiated after CCI reduces anxiety-like behavior, improves hippocampus-dependent spatial memory, and promotes hippocampal proliferation and newborn neuronal survival. Pathophysiological measures including lesion volume and axon degeneration were not altered by exercise. Taken together, these data reveal that carefully titrated physical activity may be a safe and effective approach to promoting recovery after brain injury.	[Karelina, Kate; Cruz, Ruth Velazquez; Oliverio, Robin; Whitehead, Bailey; Weil, Zachary M.] West Virginia Univ, Rockefeller Neurosci Inst, Dept Neurosci, POB 9303,108 Biomed Rd BMRC 322, Morgantown, WV 26506 USA; [Schneiderman, Katarina; Shah, Sarthak; Fitzgerald, Julie] Ohio State Univ, Dept Neurosci, Wexner Med Ctr, Columbus, OH 43210 USA; [Yang, Jingzhen] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Columbus, OH USA		Karelina, K (corresponding author), West Virginia Univ, Rockefeller Neurosci Inst, Dept Neurosci, POB 9303,108 Biomed Rd BMRC 322, Morgantown, WV 26506 USA.	ekaterina.weil@hsc.wvu.edu		Oliverio, Robin/0000-0002-9927-8939	National Institute of General Medical Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104942]; National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS104177]	Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award number U54GM104942, and the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number P30NS104177.	Archer T, 2012, NEUROTOX RES, V21, P418, DOI 10.1007/s12640-011-9297-0; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Bellenchi GC, 2013, J NEUROCHEM, V124, P159, DOI 10.1111/jnc.12084; Ben Abdallah NMB, 2010, NEUROBIOL AGING, V31, P151, DOI 10.1016/j.neurobiolaging.2008.03.002; Berlin AA, 2006, PSYCHOSOM MED, V68, P224, DOI 10.1097/01.psy.0000204628.73273.23; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chauhan NB, 2010, J NEUROSCI METH, V190, P1, DOI 10.1016/j.jneumeth.2010.04.004; Chen MJ, 2009, HIPPOCAMPUS, V19, P962, DOI 10.1002/hipo.20579; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chin LM, 2015, ARCH PHYS MED REHAB, V96, P754, DOI 10.1016/j.apmr.2014.11.009; Chio CC, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0867-9; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; DeMatteo C, 2015, CLIN PEDIATR, V54, P152, DOI 10.1177/0009922814558256; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Dixon C.E., 2016, CONTROLLED CORTICAL; Driver S, 2009, BRAIN INJURY, V23, P203, DOI 10.1080/02699050802695574; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Gil-Gomez JA, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-30; Giza CC, 2018, JAMA NEUROL, V75, P399, DOI 10.1001/jamaneurol.2018.0006; Goldshtrom Y, 2010, J BODYW MOV THER, V14, P336, DOI 10.1016/j.jbmt.2009.06.002; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2012, J NEUROTRAUM, V29, P1426, DOI 10.1089/neu.2011.2229; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Gu YL, 2014, NEUROSCI LETT, V570, P86, DOI 10.1016/j.neulet.2014.04.004; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; Hood KN, 2018, J NEUROSCI, V38, P2372, DOI 10.1523/JNEUROSCI.1756-17.2018; Itoh T, 2011, J NEURAL TRANSM, V118, P1263, DOI 10.1007/s00702-011-0629-2; Itoh T, 2011, J NEURAL TRANSM, V118, P193, DOI 10.1007/s00702-010-0495-3; Jacotte-Simancas A, 2015, J NEUROTRAUM, V32, P739, DOI 10.1089/neu.2014.3502; Karelina K, 2015, NEUROSCIENCE, V285, P292, DOI 10.1016/j.neuroscience.2014.10.053; Kim DH, 2010, PHYSIOL BEHAV, V101, P660, DOI 10.1016/j.physbeh.2010.09.021; Ko IG, 2019, J EXERC REHABIL, V15, P504, DOI 10.12965/jer.1938316.158; Ko IG, 2018, J EXERC REHABIL, V14, P327, DOI 10.12965/jer.1836248.124; Komada Munekazu, 2008, J Vis Exp, DOI 10.3791/1088; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Lal A., 2017, BRIT J SPORT MED, V51, pA83; Leasure JL, 2008, NEUROSCIENCE, V156, P456, DOI 10.1016/j.neuroscience.2008.07.041; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Lee YSC, 2014, NEUROREHABILITATION, V35, P57, DOI 10.3233/NRE-141100; Lerman I, 2002, J APPL PHYSIOL, V92, P2245, DOI 10.1152/japplphysiol.01045.2001; Li FW, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00186; Liu YF, 2009, J PHYSIOL-LONDON, V587, P3221, DOI 10.1113/jphysiol.2009.173088; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Luo L, 2019, BEHAV BRAIN RES, V362, P323, DOI 10.1016/j.bbr.2018.11.037; Ma CL, 2017, BEHAV BRAIN RES, V317, P332, DOI 10.1016/j.bbr.2016.09.067; Marques-Aleixo I, 2012, PROG NEUROBIOL, V99, P149, DOI 10.1016/j.pneurobio.2012.08.002; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; McLeod TCV, 2017, J ATHL TRAINING, V52, P262, DOI 10.4085/1052-6050-51.6.06; Mychasiuk R, 2016, EUR J NEUROSCI, V44, P2407, DOI 10.1111/ejn.13360; Paterno R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0762-x; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Pin-Barre C, 2017, STROKE, V48, P2855, DOI 10.1161/STROKEAHA.117.017962; Riggio S, 2011, NEUROL CLIN, V29, P35, DOI 10.1016/j.ncl.2010.10.008; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Shen XF, 2013, INT J MOL SCI, V14, P21598, DOI 10.3390/ijms141121598; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Strohle A, 2009, J NEURAL TRANSM, V116, P777, DOI 10.1007/s00702-008-0092-x; Svensson M, 2016, NEUROBIOL STRESS, V5, P8, DOI 10.1016/j.ynstr.2016.09.002; Svensson M, 2015, NEUROREHAB NEURAL RE, V29, P577, DOI 10.1177/1545968314562108; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z; Voloboueva LA, 2011, J NEUROSCI RES, V89, P1989, DOI 10.1002/jnr.22768; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Wise EK, 2012, ARCH PHYS MED REHAB, V93, P1319, DOI 10.1016/j.apmr.2012.05.009; Wogensen E, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/830871; Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008; Wu CW, 2008, J APPL PHYSIOL, V105, P1585, DOI 10.1152/japplphysiol.90775.2008; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; Yuan TF, 2015, STEM CELL REV REP, V11, P706, DOI 10.1007/s12015-015-9603-y; Zhang LY, 2020, MED SCI SPORT EXER, V52, P1699, DOI 10.1249/MSS.0000000000002318; Zhang LY, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-46; Zhang Pengyue, 2012, Front Biosci (Elite Ed), V4, P2476; Zhang Q, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.854; Zhao Y, 2017, NEUROCHEM RES, V42, P389, DOI 10.1007/s11064-016-2081-z; Zhao ZR, 2015, J NEUROTRAUM, V32, P1347, DOI 10.1089/neu.2014.3739	90	2	2	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2021	38	13					1858	1869		10.1089/neu.2020.7389		FEB 2021	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SU3SJ	WOS:000617988400001	33470170				2022-02-06	
J	Ajayi, PT; Garavito, DMN; Reyna, VF				Ajayi, Peter T.; Garavito, David M. N.; Reyna, Valerie F.			Socioeconomic status and concussion reporting: The distinct and mediating roles of gist processing, knowledge, and attitudes	JOURNAL OF BEHAVIORAL DECISION MAKING			English	Article						concussions; fuzzy&#8208; trace theory; gist; risky decision making; socioeconomic status		Improving health outcomes for concussed athletes and others requires self-reporting symptoms; not reporting risks second-impact syndrome and death. However, concussions in adolescents and young adults are often underreported. We treat reporting as a risky decision, extending predictions of fuzzy-trace theory (FTT). We hypothesize that low SES indirectly interferes with the development of cognitive skills that reduce unhealthy risky decision making. Specifically, we expect that SES may be related to intentions to report a concussion because low SES delays development of cognitive gist processing that reduces risk-taking. Adolescents in high-school and young adults in college (n = 1211) answered questions about concussion knowledge, concussion attitudes, and cognitive scales based on FTT: categorical thinking and endorsement of gist principles about risk. Overall, for each of the two age groups, and for athletes as well as nonathletes, SES was associated with reporting intentions, and this association was mediated by the three psychological predictors we tested: gist processing, concussion knowledge, and concussion attitudes. Results are consistent with lower SES reducing opportunities for normative cognitive development, the latter characterized by developmental increases in gist processing about risk. Hence, consistent with hypotheses, gist processing, concussion knowledge, and healthier attitudes about concussions were each associated with greater intentions to report concussions. Although educational initiatives currently focus on rote knowledge and healthy attitudes, future interventions to reduce concussion underreporting could benefit from explaining the gist of risk, especially to low SES youth, adapting successful FTT-based risk-reduction curricula from other domains.	[Ajayi, Peter T.; Garavito, David M. N.; Reyna, Valerie F.] Cornell Univ, Human Neurosci Inst, Dept Human Dev, Ithaca, NY USA		Garavito, DMN (corresponding author), Cornell Univ, Dept Human Dev, Ithaca, NY 14853 USA.	dmg345@cornell.edu		Garavito, David/0000-0003-4903-9486; Reyna, Valerie/0000-0003-2851-5797; Ajayi, Peter/0000-0002-2378-5758	Office of Engagement Initiatives at Cornell University; National Institute of Food and AgricultureUnited States Department of Agriculture (USDA)National Institute of Food and Agriculture [NYC-321407]; National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR014368, R21NR016905]	Office of Engagement Initiatives at Cornell University; National Institute of Food and Agriculture, Grant/Award Number: NYC-321407; National Institute of Nursing Research, Grant/Award Numbers: R01NR014368, R21NR016905	Adler NE, 2008, ANNU REV PUBL HEALTH, V29, P235, DOI 10.1146/annurev.publhealth.29.020907.090852; Agler R, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01984; Ajayi PT, 2021, J BEHAV DECIS MAKING, V34, P639, DOI 10.1002/bdm.2235; Amso Dima, 2017, Policy Insights Behav Brain Sci, V4, P139, DOI 10.1177/2372732217721933; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; ARTHUR W, 1994, EDUC PSYCHOL MEAS, V54, P394, DOI 10.1177/0013164494054002013; Baker DP, 2011, AIDS BEHAV, V15, P1319, DOI 10.1007/s10461-010-9717-9; Blalock SJ, 2016, HEALTH PSYCHOL, V35, P781, DOI 10.1037/hea0000384; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Chaloupka F., 2014, SPATIAL DEMOGRAPHY, V2, P55, DOI [DOI 10.1007/BF03354904, https://doi.org/10.1007/BF03354904]; Chandran A, 2020, J ATHL TRAINING, V55, P1027, DOI 10.4085/1062-6050-232-19; Chinn N.R., 2016, BMJ OPEN SPORT EXERC, V2, P000118, DOI [10.1136/bmjsem-2016-000118, DOI 10.1136/BMJSEM-2016-000118]; Cho YH, 2018, HEALTH EDUC J, V77, P778, DOI 10.1177/0017896918765024; Covassin T, 2010, OPEN ACCESS J SPORTS, V1, P55; Cusimano MD, 2017, SAGE OPEN MED, V5, DOI [10.1177/2050312117694794, 10.1177/2050312117699799]; Donnell Z, 2018, J SAFETY RES, V64, P163, DOI 10.1016/j.jsr.2017.12.001; Duncan GJ, 2012, WIRES COGN SCI, V3, P377, DOI 10.1002/wcs.1176; Eilertsen T, 2016, SCAND J PSYCHOL, V57, P399, DOI 10.1111/sjop.12324; Ensminger ME, 2000, J ADOLESCENT RES, V15, P392, DOI 10.1177/0743558400153005; Evans GW, 2013, CHILD DEV PERSPECT, V7, P43, DOI 10.1111/cdep.12013; Evans GW, 2010, ANN NY ACAD SCI, V1186, P174, DOI 10.1111/j.1749-6632.2009.05336.x; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Foster CA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215030; Frieden T.R., 2014, NATL CTR INJURY PREV; Fritz MS, 2007, PSYCHOL SCI, V18, P233, DOI 10.1111/j.1467-9280.2007.01882.x; Fujita K, 2009, PSYCHOL SCI, V20, P799, DOI 10.1111/j.1467-9280.2009.02372.x; Gamino JF, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00924; Garavito D.M.N., 2020, INTENTIONS REPORT CO; Garavito DMN, 2019, APPL COGNITIVE PSYCH, V33, P646, DOI 10.1002/acp.3481; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Geisner IM, 2012, J CHILD ADOLES SUBST, V21, P156, DOI 10.1080/1067828X.2012.662433; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Gianaros PJ, 2007, SOC COGN AFFECT NEUR, V2, P161, DOI 10.1093/scan/nsm013; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gottfredson LS, 2004, J PERS SOC PSYCHOL, V86, P174, DOI 10.1037/0022-3514.86.1.174; Gottfried AW, 2003, MON PARENT, P189; Grasset L, 2019, NEUROLOGY, V93, pE1890, DOI 10.1212/WNL.0000000000008463; Guo G, 2000, DEMOGRAPHY, V37, P431, DOI 10.1353/dem.2000.0005; Haarbauer-Krupa J, 2018, J PEDIATR-US, V197, P241, DOI 10.1016/j.jpeds.2018.01.075; Hackman DA, 2010, NAT REV NEUROSCI, V11, P651, DOI 10.1038/nrn2897; Hatch SL, 2007, AM J COMMUN PSYCHOL, V40, P313, DOI 10.1007/s10464-007-9134-z; Hayes, 2018, INTRO MEDIATION MODE; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Johnson SB, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3075; Kaufman JS, 2001, AM J EPIDEMIOL, V154, P291, DOI 10.1093/aje/154.4.291; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Kim P., 2018, HDB LIFE COURSE HLTH, P463, DOI [10.1007/978-3-319-47143-3_19, DOI 10.1007/978-3-319-47143-3_19]; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Kwak Y, 2015, COGNITIVE DEV, V36, P20, DOI 10.1016/j.cogdev.2015.08.001; Lag T, 2014, J BEHAV DECIS MAKING, V27, P95, DOI 10.1002/bdm.1788; Lin AC, 2015, SPORTS HEALTH, V7, P124, DOI 10.1177/1941738115571570; Lindau M., 2016, STRESS CONCEPTS COGN, P153; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Luby J, 2013, JAMA PEDIATR, V167, P1135, DOI 10.1001/jamapediatrics.2013.3139; Mani A, 2013, SCIENCE, V341, P976, DOI 10.1126/science.1238041; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McEwen Bruce S, 2017, Chronic Stress (Thousand Oaks), V1, DOI 10.1177/2470547017692328; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mills B, 2008, PSYCHOL SCI, V19, P429, DOI 10.1111/j.1467-9280.2008.02104.x; Mirtcheva DM, 2009, J SCHOOL HEALTH, V79, P485, DOI 10.1111/j.1746-1561.2009.00438.x; Moore JC., 2000, J OFF STAT, V16, P331; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Peters E, 2006, PSYCHOL SCI, V17, P407, DOI 10.1111/j.1467-9280.2006.01720.x; Preacher KJ, 2011, PSYCHOL METHODS, V16, P93, DOI 10.1037/a0022658; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Raffington L, 2018, DEV PSYCHOL, V54, P1232, DOI 10.1037/dev0000529; Rahimi-Golkhandan S., 2017, NEBRASKA S MOTIVATIO; Raizada Rajeev D S, 2010, Front Hum Neurosci, V4, P3, DOI 10.3389/neuro.09.003.2010; Register-Mihalik JK, 2019, J SCI MED SPORT, V22, P509, DOI 10.1016/j.jsams.2018.11.003; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Reyna VF, 2008, MED DECIS MAKING, V28, P829, DOI 10.1177/0272989X08327069; Reyna VF, 2006, PSYCHOL SCI, P1, DOI 10.1111/j.1529-1006.2006.00026.x; Reyna VF, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.1912441117; Reyna VF, 2015, CHILD DEV PERSPECT, V9, P122, DOI 10.1111/cdep.12117; Reyna VF, 2014, J EXP PSYCHOL GEN, V143, P1627, DOI 10.1037/a0036717; Reyna VF, 2014, PSYCHOL SCI, V25, P76, DOI 10.1177/0956797613497022; Reyna VF, 2012, JUDGM DECIS MAK, V7, P332; Reyna VF, 2011, DEV REV, V31, P180, DOI 10.1016/j.dr.2011.07.004; Reyna VF, 2011, J EXP PSYCHOL LEARN, V37, P1125, DOI 10.1037/a0023943; Reyna VF, 2009, PSYCHOL BULL, V135, P943, DOI 10.1037/a0017327; Reyna VF, 2003, RISK ANAL, V23, P325, DOI 10.1111/1539-6924.00332; Rindermann H, 2010, LEARN INDIVID DIFFER, V20, P544, DOI 10.1016/j.lindif.2010.07.002; Rivers SE, 2008, DEV REV, V28, P107, DOI 10.1016/j.dr.2007.11.002; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Salmon DM, 2021, INT J SPORTS SCI COA, V16, P54, DOI 10.1177/1747954120961200; Sandi Carmen, 2007, Neural Plasticity, V2007, DOI 10.1055/2007/78970; Scharf T., 2003, INT J EMERGENCY MANA, V1, P278, DOI DOI 10.1504/IJEM.2003.003297; Sinayev A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00532; Singh-Manoux A, 2005, AM J EPIDEMIOL, V161, P831, DOI 10.1093/aje/kwi109; Stelzl I, 1995, INTELLIGENCE, V21, P279, DOI 10.1016/0160-2896(95)90018-7; Swartz JR, 2017, MOL PSYCHIATR, V22, P209, DOI 10.1038/mp.2016.82; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Teasdale TW, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002321; Thomas M, 2011, PEDIATRICS, V128, pE1, DOI 10.1542/peds.2010-2743; von Stumm S, 2015, INTELLIGENCE, V48, P30, DOI 10.1016/j.intell.2014.10.002; Wallace J, 2017, J SCHOOL HEALTH, V87, P665, DOI 10.1111/josh.12543; Waltzman D, 2020, MMWR-MORBID MORTAL W, V69, P870, DOI 10.15585/mmwr.mm6927a4; Webbe FM, 2003, CLIN SPORT MED, V22, P577, DOI 10.1016/S0278-5919(02)00103-5; Weller JA, 2014, PSYCHOL AGING, V29, P271, DOI 10.1037/a0036623; White CM, 2015, RISK ANAL, V35, P1407, DOI 10.1111/risa.12369; Wilhelms EA, 2013, J MED PHILOS, V38, P268, DOI 10.1093/jmp/jht018; Williams DR, 2016, HEALTH PSYCHOL, V35, P407, DOI 10.1037/hea0000242; Williams DR, 2010, ANN NY ACAD SCI, V1186, P69, DOI 10.1111/j.1749-6632.2009.05339.x; Zuckerman SL, 2017, J NEUROSURG-PEDIATR, V19, P652, DOI 10.3171/2017.1.PEDS16611	113	2	2	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-3257	1099-0771		J BEHAV DECIS MAKING	J. Behav. Decis. Mak.	DEC	2021	34	5					639	656		10.1002/bdm.2235		FEB 2021	18	Psychology, Applied	Social Science Citation Index (SSCI)	Psychology	WR4PD	WOS:000616419600001					2022-02-06	
J	Wang, YQ; Han, Y; Chen, M; Wang, HZ				Wang, Yongqiang; Han, Yong; Chen, Min; Wang, Hangzhou			Three-pillar expansive craniotomy: a new surgical technique for cerebral decompression in children	CHILDS NERVOUS SYSTEM			English	Article						Enlarging craniotomy; Medical refractory cerebral edema; Head injury; Cerebral stroke		Purpose The aim of this study is to conduct a retrospective review of data obtained in all consecutive patients who had undergone cerebral decompression using the 3-pillar expansive craniotomy (3PEC) in our hospital between 2016 and 2020. Methods and results We developed a novel craniotomy technique using expansion cranioplasty in patients with traumatic brain injury or stroke, which could relieve intracranial hypertension, maintain cerebral protection, and avoid subsequent cranial repair. Sixteen patients aged 2-18 years old underwent the 3PEC. Two patients, who presented very severe neurological conditions at the admission, died. All surviving patients showed good neurological outcome. None of the survived patients presented with bone flap resorption or sinking flap syndrome. Conclusion The role of decompressive craniectomy has been recently questioned in the pediatric population by the use of decompressive craniotomy. In this limited study of children patients experiencing stroke or traumatic brain injury, 3PEC was proved useful in reducing intracranial pressure (ICP), thus, questioning the role of decompressive craniectomy in children. The technique effectively reduces postoperative complications and eliminates subsequent cranioplasty procedures otherwise introduced by traditional decompressive craniectomy.	[Wang, Yongqiang; Han, Yong; Chen, Min; Wang, Hangzhou] Soochow Univ, Childrens Hosp, Dept Neurosurg, 92 Zhongnan St, Suzhou 215006, Jiangsu, Peoples R China		Wang, HZ (corresponding author), Soochow Univ, Childrens Hosp, Dept Neurosurg, 92 Zhongnan St, Suzhou 215006, Jiangsu, Peoples R China.	13771843695@163.com			Science and education program of Suzhou [KJXW2017023]	The study was supported by the Science and education program of Suzhou (KJXW2017023).	Abode-Iyamah KO, 2018, WORLD NEUROSURG, V118, pE414, DOI 10.1016/j.wneu.2018.06.204; Adeleye A Olufemi, 2011, Surg Neurol Int, V2, P150, DOI 10.4103/2152-7806.86227; Ashayeri K, 2016, NEUROSURGERY, V79, P525, DOI 10.1227/NEU.0000000000001366; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Frassanito P, 2019, CHILD NERV SYST, V35, P1459, DOI 10.1007/s00381-019-04193-1; Frassanito P, 2017, CHILD NERV SYST, V33, P1759, DOI 10.1007/s00381-017-3541-8; Goettler CE, 2007, J TRAUMA, V62, P777, DOI 10.1097/TA.0b013e31802ee55e; Gutman Matthew J, 2017, Surg Neurol Int, V8, P130, DOI 10.4103/sni.sni_460_16; Horsfall HL, 2020, NEUROSURG REV, V43, P1493, DOI 10.1007/s10143-019-01180-7; Kano T, 2012, NEUROL MED-CHIR, V52, P816, DOI 10.2176/nmc.52.816; Karl M., 2015, BRIT J NEUROSURG, V29, P314, DOI [10.3109/02688697.2015.1012047, DOI 10.3109/02688697.2015.1012047]; Khanna R, 2016, J NEUROSURG, V125, P674, DOI 10.3171/2015.6.JNS15706; Ko K, 2007, NEUROSURGERY, V60, P255, DOI 10.1227/01.NEU.0000255380.64969.81; Nobre MC, 2018, WORLD NEUROSURG, V120, pE269, DOI 10.1016/j.wneu.2018.08.048; Peethambaran AK, 2015, NEUROL INDIA, V63, P895, DOI 10.4103/0028-3886.170081; Schmidt JH, 2007, J NEUROSURG, V107, P678, DOI 10.3171/JNS-07/09/0678; Stoner KE, 2016, WORLD NEUROSURG, V96, P101, DOI 10.1016/j.wneu.2016.08.095; Yokota H, 2019, CHILD NERV SYST, V35, P1491, DOI 10.1007/s00381-019-04177-1	18	2	2	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	MAY	2021	37	5					1723	1728		10.1007/s00381-021-05073-3		FEB 2021	6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	RV2QW	WOS:000616072800002	33559054				2022-02-06	
J	Raiders, S; Han, T; Scott-Hewitt, N; Kucenas, S; Lew, D; Logan, MA; Singhvi, A				Raiders, Stephan; Han, Taeho; Scott-Hewitt, Nicole; Kucenas, Sarah; Lew, Deborah; Logan, Mary A.; Singhvi, Aakanksha			Engulfed by Glia: Glial Pruning in Development, Function, and Injury across Species	JOURNAL OF NEUROSCIENCE			English	Article						glia; phagocytosis; neuronal pruning; model organisms	PROGRAMMED CELL-DEATH; CENTRAL-NERVOUS-SYSTEM; FOCAL ADHESION KINASE; EAR SUPPORTING CELLS; SYNAPSE ELIMINATION; MICROGLIAL PHAGOCYTOSIS; ALPHA-V-BETA-5 INTEGRIN; PIGMENT EPITHELIUM; DEGENERATING AXONS; RETINAL DYSTROPHY	Phagocytic activity of glial cells is essential for proper nervous system sculpting, maintenance of circuitry, and long-term brain health. Glial engulfment of apoptotic cells and superfluous connections ensures that neuronal connections are appropriately refined, while clearance of damaged projections and neurotoxic proteins in the mature brain protects against inflammatory insults. Comparative work across species and cell types in recent years highlights the striking conservation of pathways that govern glial engulfment. Many signaling cascades used during developmental pruning are re-employed in the mature brain to "fine tune" synaptic architecture and even clear neuronal debris following traumatic events. Moreover, the neuronglia signaling events required to trigger and perform phagocytic responses are impressively conserved between invertebrates and vertebrates. This review offers a compare-and-contrast portrayal of recent findings that underscore the value of investigating glial engulfment mechanisms in a wide range of species and contexts.	[Raiders, Stephan; Singhvi, Aakanksha] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Raiders, Stephan; Singhvi, Aakanksha] Univ Washington, Mol & Cellular Biol Grad Program, Seattle, WA 98195 USA; [Han, Taeho] Univ Calif San Francisco, UCSF Weill Inst Neurosci, San Francisco, CA 94158 USA; [Scott-Hewitt, Nicole] Boston Childrens Hosp, FM Kirby Ctr Neurobiol, Boston, MA 02115 USA; [Scott-Hewitt, Nicole] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Kucenas, Sarah] Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; [Lew, Deborah] Fordham Univ, Dept Biol Sci, Bronx, NY 10458 USA; [Logan, Mary A.] Oregon Hlth & Sci Univ, Jungers Ctr, Dept Neurol, Portland, OR 97239 USA		Singhvi, A (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.; Singhvi, A (corresponding author), Univ Washington, Mol & Cellular Biol Grad Program, Seattle, WA 98195 USA.	asinghviv@fredhutch.org		Kucenas, Sarah/0000-0002-1950-751X; Logan, Mary/0000-0001-6577-4574; Raiders, Stephan/0000-0002-2394-9193	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32T32AG066574, R01 NS114222, R01MH119349]; Glenn Foundation for Medical Research; Simons Foundation/SFARI [488574]; Anderson Foundation; Marco J. Heidner Foundation Pilot Fund; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 NS107771, R01-EY026215, R01 NS117934, R01 NS072212]; Ken and Ginger Harrison Term Professor Award; Sigma-Xi; Pew Charitable Trusts; Burroughs Welcome FundBurroughs Wellcome Fund; National Institutes of Health-T32: Training in Molecular NeurodegenerationUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; University of Virginia Brain Institute; AFAR Junior Faculty Grant	This work was supported by National Institute of Health T32T32AG066574 to SR (AS laboratory); Glenn Foundation for Medical Research and AFAR Junior Faculty Grant, Simons Foundation/SFARI Grant 488574, National Institute of Health R01 NS114222, and Anderson Foundation and the Marco J. Heidner Foundation Pilot Fund to A.S.; National Institutes of Health R21 NS107771, National Institutes of Health R01 NS117934, and Ken and Ginger Harrison Term Professor Award to M.A.L.; National Institutes of Health R01-EY026215 and Sigma-Xi grants in aid to D.L. (Silvia Finnemann laboratory); Pew Charitable Trusts, National Institute of Mental Health R01MH119349, and Burroughs Welcome Fund to T.H. (Anna Molofsky laboratory); National Institutes of Health-T32: Training in Molecular Neurodegeneration to N.S.-H. (Beth Stevens laboratory); and University of Virginia Brain Institute and National Institutes of Health R01 NS072212 to S.K. We apologize to those whose work was not cited, due to either space constraints or our oversight.	Allen NJ, 2017, NEURON, V96, P697, DOI 10.1016/j.neuron.2017.09.056; Anderson SR, 2019, CELL REP, V27, P2002, DOI 10.1016/j.celrep.2019.04.062; Aronica E, 2007, NEUROBIOL DIS, V26, P497, DOI 10.1016/j.nbd.2007.01.015; Arya R, 2015, SEMIN CELL DEV BIOL, V39, P12, DOI 10.1016/j.semcdb.2015.02.001; Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; Bacaj T, 2008, SCIENCE, V322, P744, DOI [10.1126/science.1163074, 10.1126/science.1161473]; BAIRATI A, 1963, J ULTRA MOL STRUCT R, V9, P484, DOI 10.1016/S0022-5320(63)80080-5; Bishop DL, 2004, NEURON, V44, P651, DOI 10.1016/j.neuron.2004.10.026; Brown GC, 2014, NAT REV NEUROSCI, V15, P209, DOI 10.1038/nrn3710; Burbridge TJ, 2014, NEURON, V84, P1049, DOI 10.1016/j.neuron.2014.10.051; Burda JE, 2017, CELL RES, V27, P726, DOI 10.1038/cr.2017.37; Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Calabrese B, 2006, PHYSIOLOGY, V21, P38, DOI 10.1152/physiol.00042.2005; Cantera R, 1996, DEV GENES EVOL, V206, P277, DOI 10.1007/s004270050052; Chung WS, 2015, NAT NEUROSCI, V18, P1539, DOI 10.1038/nn.4142; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Corty Megan M, 2013, J Cell Biol, V203, P395, DOI 10.1083/jcb.201306099; Cunningham ME, 2020, J PERIPHER NERV SYST, V25, P143, DOI 10.1111/jns.12373; Darabid H, 2014, NAT REV NEUROSCI, V15, P703, DOI 10.1038/nrn3821; Di Pierdomenico J, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00014; Doherty J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001985; Doherty J, 2009, J NEUROSCI, V29, P4768, DOI 10.1523/JNEUROSCI.5951-08.2009; DOWLING JE, 1962, J CELL BIOL, V14, P73, DOI 10.1083/jcb.14.1.73; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; Etchegaray JI, 2016, J NEUROSCI, V36, P3170, DOI 10.1523/JNEUROSCI.1912-15.2016; Eyo UB, 2017, GLIA, V65, P5, DOI 10.1002/glia.23006; Eyo UB, 2015, J NEUROSCI, V35, P2417, DOI 10.1523/JNEUROSCI.3279-14.2015; Eyo UB, 2014, J NEUROSCI, V34, P10528, DOI 10.1523/JNEUROSCI.0416-14.2014; Feng W, 2002, J BIOL CHEM, V277, P17016, DOI 10.1074/jbc.M107876200; Ferrari S, 2011, CURR GENOMICS, V12, P238, DOI 10.2174/138920211795860107; Filipello F, 2018, IMMUNITY, V48, P979, DOI 10.1016/j.immuni.2018.04.016; Finneman SC, 2001, J EXP MED, V194, P1289, DOI 10.1084/jem.194.9.1289; Finnemann SC, 2003, EMBO J, V22, P4143, DOI 10.1093/emboj/cdg416; Fourgeaud L, 2016, NATURE, V532, P240, DOI 10.1038/nature17630; Freeman MR, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020552; Fu AKY, 2016, P NATL ACAD SCI USA, V113, pE2705, DOI 10.1073/pnas.1604032113; Gadani SP, 2015, NEURON, V85, P703, DOI 10.1016/j.neuron.2015.01.013; Golshani P, 1998, J NEUROPHYSIOL, V80, P143, DOI 10.1152/jn.1998.80.1.143; Goodman M, 2009, P NATL ACAD SCI USA, V106, P20824, DOI 10.1073/pnas.0911239106; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Gunner G, 2019, NAT NEUROSCI, V22, P1075, DOI 10.1038/s41593-019-0419-y; Gyorffy BA, 2018, P NATL ACAD SCI USA, V115, P6303, DOI 10.1073/pnas.1722613115; Hakim-Mishnaevski K, 2019, CELL REP, V29, P1438, DOI 10.1016/j.celrep.2019.09.086; Harms KJ, 2007, BRAIN RES, V1184, P65, DOI 10.1016/j.brainres.2006.02.094; Haruwaka K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13812-z; He JC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00912; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Herculano-Houzel S, 2014, GLIA, V62, P1377, DOI 10.1002/glia.22683; Hidalgo A, 2011, GLIA, V59, P1296, DOI 10.1002/glia.21092; Hilu-Dadia R, 2020, CURR OPIN IMMUNOL, V62, P62, DOI 10.1016/j.coi.2019.11.010; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hooks BM, 2006, NEURON, V52, P281, DOI 10.1016/j.neuron.2006.07.007; Hrvatin S, 2018, NAT NEUROSCI, V21, P120, DOI 10.1038/s41593-017-0029-5; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; Huberman AD, 2007, CURR OPIN NEUROBIOL, V17, P73, DOI 10.1016/j.conb.2007.01.005; Hughes AN, 2020, NAT NEUROSCI, V23, P1055, DOI 10.1038/s41593-020-0654-2; Inada H, 2006, GENETICS, V172, P2239, DOI 10.1534/genetics.105.050013; Jay TR, 2019, GLIA, V67, P1873, DOI 10.1002/glia.23664; Jiruska P, 2010, J NEUROSCI, V30, P5690, DOI 10.1523/JNEUROSCI.0535-10.2010; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Koeppen J, 2018, J NEUROSCI, V38, P5710, DOI 10.1523/JNEUROSCI.3618-17.2018; Kohno H, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0408-3; Kulkarni S, 2017, P NATL ACAD SCI USA, V114, pE3709, DOI 10.1073/pnas.1619406114; Kurant E, 2008, CELL, V133, P498, DOI 10.1016/j.cell.2008.02.052; Lakkaraju A, 2020, PROG RETIN EYE RES, V78, DOI 10.1016/j.preteyeres.2020.100846; Lau SF, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107530; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lee YI, 2016, P NATL ACAD SCI USA, V113, pE479, DOI 10.1073/pnas.1519156113; Leeson HC, 2018, STEM CELLS, V36, P1764, DOI 10.1002/stem.2894; Lehrman EK, 2018, NEURON, V100, P120, DOI 10.1016/j.neuron.2018.09.017; Lemke G, 2019, NAT REV IMMUNOL, V19, P539, DOI 10.1038/s41577-019-0167-y; Lew DS, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01463; Li T, 2020, EMBO J, V39, DOI 10.15252/embj.2019104136; Li Y, 2012, DEV CELL, V23, P1189, DOI 10.1016/j.devcel.2012.10.027; Lin L, 2017, CELL, V170, P158, DOI 10.1016/j.cell.2017.06.018; Logan MA, 2017, CURR OPIN NEUROBIOL, V47, P162, DOI 10.1016/j.conb.2017.10.008; Lu TY, 2014, P NATL ACAD SCI USA, V111, P12544, DOI 10.1073/pnas.1403450111; Lu ZJ, 2011, NAT CELL BIOL, V13, P1076, DOI 10.1038/ncb2299; Luchena C, 2018, MEDIAT INFLAMM, V2018, P1; Lutz AB, 2017, P NATL ACAD SCI USA, V114, pE8072, DOI 10.1073/pnas.1710566114; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Mackay DS, 2010, MOL VIS, V16, P369; Madry C, 2018, NEURON, V97, P299, DOI 10.1016/j.neuron.2017.12.002; Makinson CD, 2017, NEURON, V93, P1165, DOI 10.1016/j.neuron.2017.01.031; Mangahas PM, 2005, SEMIN CELL DEV BIOL, V16, P295, DOI 10.1016/j.semcdb.2004.12.005; Mao YY, 2012, MOL BIOL CELL, V23, P1104, DOI 10.1091/mbc.E11-10-0840; Martin M, 2012, J BIOL CHEM, V287, P33733, DOI 10.1074/jbc.M112.341339; Mazzoni F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38363-z; McLaughlin CN, 2019, DEV CELL, V48, P506, DOI 10.1016/j.devcel.2018.12.019; Miyamoto A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12540; Monzack EL, 2015, CELL DEATH DIFFER, V22, P1995, DOI 10.1038/cdd.2015.48; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Morizawa YM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00037-1; Musashe DT, 2016, CELL REP, V16, P1838, DOI 10.1016/j.celrep.2016.07.022; Nandrot E, 2000, NEUROBIOL DIS, V7, P586, DOI 10.1006/nbdi.2000.0328; Nedergaard M, 2012, GLIA, V60, P1013, DOI 10.1002/glia.22288; Neher JJ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00027; Neniskyte U, 2017, NAT REV NEUROSCI, V18, P658, DOI 10.1038/nrn.2017.110; Nguyen PT, 2020, CELL, V182, P388, DOI 10.1016/j.cell.2020.05.050; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Paidassi H, 2008, J IMMUNOL, V180, P2329, DOI 10.4049/jimmunol.180.4.2329; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Paz JT, 2013, NAT NEUROSCI, V16, P64, DOI 10.1038/nn.3269; Paz JT, 2010, J NEUROSCI, V30, P5465, DOI 10.1523/JNEUROSCI.5083-09.2010; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Pinault Didier, 2005, Thalamus & Related Systems, V3, P181, DOI 10.1017/S1472928807000209; Pomeshchik Y, 2015, BRAIN BEHAV IMMUN, V44, P68, DOI 10.1016/j.bbi.2014.08.002; Punal VM, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000492; Purice MD, 2017, ELIFE, V6, DOI 10.7554/eLife.23611; Raiders S, 2020, BIORXIV, DOI [10.1101/2020.11.11.378893, DOI 10.1101/2020.11.11.378893]; Ravizza T, 2006, NEUROBIOL DIS, V24, P128, DOI 10.1016/j.nbd.2006.06.003; Riccomagno MM, 2015, ANNU REV CELL DEV BI, V31, P779, DOI 10.1146/annurev-cellbio-100913-013038; Roche SL, 2014, J NEUROSCI, V34, P12904, DOI 10.1523/JNEUROSCI.1725-14.2014; Sapar ML, 2018, CELL REP, V24, P2273, DOI 10.1016/j.celrep.2018.07.095; Schafer DP, 2016, ELIFE, V5, DOI 10.7554/eLife.15224; Schafer DP, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020545; Schafer DP, 2013, CURR OPIN NEUROBIOL, V23, P1034, DOI 10.1016/j.conb.2013.09.012; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Scharfman HE, 2007, CURR NEUROL NEUROSCI, V7, P348, DOI 10.1007/s11910-007-0053-z; SCHULTER G, 1973, Z ANAT ENTWICKLUNGS, V141, P251, DOI 10.1007/BF00519046; Scott-Hewitt N, 2020, EMBO J, V39, DOI 10.15252/embj.2020105380; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Segawa K, 2011, P NATL ACAD SCI USA, V108, P19246, DOI 10.1073/pnas.1114799108; Shacham-Silverberg V, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1155-z; Silverman SM, 2019, J EXP MED, V216, P1925, DOI 10.1084/jem.20190009; Silverman SM, 2018, ANNU REV VIS SCI, V4, P45, DOI 10.1146/annurev-vision-091517-034425; Singhvi A, 2019, ANNU REV NEUROSCI, V42, P149, DOI 10.1146/annurev-neuro-070918-050314; Singhvi A, 2016, CELL, V165, P936, DOI 10.1016/j.cell.2016.03.026; Sipe GO, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10905; Smith CJ, 2016, GLIA, V64, P1138, DOI 10.1002/glia.22987; Smith IW, 2013, J NEUROSCI, V33, P17724, DOI 10.1523/JNEUROSCI.3339-13.2013; Smrz D, 2007, J BIOL CHEM, V282, P10487, DOI 10.1074/jbc.M611090200; Song JW, 2008, J NEUROSCI, V28, P8993, DOI 10.1523/JNEUROSCI.0720-08.2008; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Takeuchi Y, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0345-16.2017; Takeuchi Y, 2014, J NEUROSCI, V34, P1258, DOI 10.1523/JNEUROSCI.3865-13.2014; Tasdemir-Yilmaz OE, 2014, GENE DEV, V28, P20, DOI 10.1101/gad.229518.113; THANOS S, 1992, BRAIN RES, V588, P21, DOI 10.1016/0006-8993(92)91340-K; Tremblay ME, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0314-8; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Vainchtein ID, 2018, SCIENCE, V359, P1269, DOI 10.1126/science.aal3589; Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283; Verkhratsky A., 2013, GLIAL PHYSL PATHOPHY; Verkhratsky A, 2016, CURR OPIN PHARMACOL, V26, P74, DOI 10.1016/j.coph.2015.09.011; Vezzani A, 2015, COLD SPRING HARB PER, V6; Vilalta A, 2018, FEBS J, V285, P3566, DOI 10.1111/febs.14323; von Bartheld CS, 2016, J COMP NEUROL, V524, P3865, DOI 10.1002/cne.24040; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wallace SW, 2016, CELL REP, V15, P550, DOI 10.1016/j.celrep.2016.03.051; Wan GQ, 2013, SEMIN CELL DEV BIOL, V24, P448, DOI 10.1016/j.semcdb.2013.03.009; Wang C, 2020, SCIENCE, V367, P688, DOI 10.1126/science.aaz2288; Wang XC, 2016, CELL MOL LIFE SCI, V73, P2221, DOI 10.1007/s00018-016-2196-z; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Watts RJ, 2004, CURR BIOL, V14, P678, DOI 10.1016/j.cub.2004.03.035; Weil M, 1997, CURR BIOL, V7, P281, DOI 10.1016/S0960-9822(06)00125-4; Weinhard L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03566-5; Werneburg S, 2020, IMMUNITY, V52, P167, DOI 10.1016/j.immuni.2019.12.004; Wilton DK, 2019, ANNU REV NEUROSCI, V42, P107, DOI 10.1146/annurev-neuro-070918-050306; Winfree LM, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.40; Wu HH, 2009, NAT NEUROSCI, V12, P1534, DOI 10.1038/nn.2446; Yoshida A, 2016, GENES BRAIN BEHAV, V15, P429, DOI 10.1111/gbb.12260; Yoshida M, 2009, NEUROSCI RES, V64, P118, DOI 10.1016/j.neures.2009.02.002; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; Zhao L, 2015, EMBO MOL MED, V7, P1179, DOI 10.15252/emmm.201505298; Zhao XF, 2018, CELL REP, V22, P2080, DOI 10.1016/j.celrep.2018.02.004; Zhu YL, 2019, CELL, V179, P74, DOI 10.1016/j.cell.2019.08.001; Ziegenfuss JS, 2012, NAT NEUROSCI, V15, P979, DOI 10.1038/nn.3135	174	2	2	3	4	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474	1529-2401		J NEUROSCI	J. Neurosci.	FEB 3	2021	41	5					823	833		10.1523/JNEUROSCI.1660-20.2020			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QF2XQ	WOS:000616763400003	33468571	Green Published, Bronze			2022-02-06	
J	Arciniega, H; Shires, J; Furlong, S; Kilgore-Gomez, A; Cerreta, A; Murray, NG; Berryhill, ME				Arciniega, Hector; Shires, Jorja; Furlong, Sarah; Kilgore-Gomez, Alexandrea; Cerreta, Adelle; Murray, Nicholas G.; Berryhill, Marian E.			Impaired visual working memory and reduced connectivity in undergraduates with a history of mild traumatic brain injury	SCIENTIFIC REPORTS			English	Article							DEFAULT-MODE NETWORK; WHITE-MATTER ABNORMALITIES; SHORT-TERM-MEMORY; SURFACE-BASED ANALYSIS; FUNCTIONAL CONNECTIVITY; COGNITIVE IMPAIRMENT; UNITED-STATES; EEG; PERFORMANCE; CONCUSSION	Mild traumatic brain injury (mTBI), or concussion, accounts for 85% of all TBIs. Yet survivors anticipate full cognitive recovery within several months of injury, if not sooner, dependent upon the specific outcome/measure. Recovery is variable and deficits in executive function, e.g., working memory (WM) can persist years post-mTBI. We tested whether cognitive deficits persist in otherwise healthy undergraduates, as a conservative indicator for mTBI survivors at large. We collected WM performance (change detection, n-back tasks) using various stimuli (shapes, locations, letters; aurally presented numbers and letters), and wide-ranging cognitive assessments (e.g., RBANS). We replicated the observation of a general visual WM deficit, with preserved auditory WM. Surprisingly, visual WM deficits were equivalent in participants with a history of mTBI (mean 4.3 years post-injury) and in undergraduates with recent sports-related mTBI (mean 17 days post-injury). In seeking the underlying mechanism of these behavioral deficits, we collected resting state fMRI (rsfMRI) and EEG (rsEEG). RsfMRI revealed significantly reduced connectivity within WM-relevant networks (default mode, central executive, dorsal attention, salience), whereas rsEEG identified no differences (modularity, global efficiency, local efficiency). In summary, otherwise healthy current undergraduates with a history of mTBI present behavioral deficits with evidence of persistent disconnection long after full recovery is expected.	[Arciniega, Hector; Shires, Jorja; Kilgore-Gomez, Alexandrea; Cerreta, Adelle; Murray, Nicholas G.; Berryhill, Marian E.] Univ Nevada, Dept Psychol, Program Cognit & Brain Sci, 1664 N Virginia St,MS 296, Reno, NV 89557 USA; [Arciniega, Hector; Shires, Jorja; Kilgore-Gomez, Alexandrea; Cerreta, Adelle; Murray, Nicholas G.; Berryhill, Marian E.] Univ Nevada, Dept Psychol, Program Integrat Neurosci, 1664 N Virginia St,MS 296, Reno, NV 89557 USA; [Arciniega, Hector] Harvard Med Sch, Brigham & Womens Hosp, Psychiat Neuroimaging Lab, Boston, MA 02215 USA; [Murray, Nicholas G.] Univ Nevada, Sch Community Hlth Sci, Reno, NV 89557 USA; [Furlong, Sarah] Univ North Carolina Chapel Hill, Dept Psychol & Neurosci, Chapel Hill, NC 27599 USA		Arciniega, H (corresponding author), Univ Nevada, Dept Psychol, Program Cognit & Brain Sci, 1664 N Virginia St,MS 296, Reno, NV 89557 USA.; Arciniega, H (corresponding author), Univ Nevada, Dept Psychol, Program Integrat Neurosci, 1664 N Virginia St,MS 296, Reno, NV 89557 USA.; Arciniega, H (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Psychiat Neuroimaging Lab, Boston, MA 02215 USA.	harciniega@bwh.harvard.edu			NSFNational Science Foundation (NSF) [OIA 1632738, OIA 1632849]; NIGMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM103650]; Tahoe Institute for Rural Health Research; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F99 NS113419, K00 NS113419-02]	This material is based upon work supported in part by several funding sources including NSF OIA 1632849 (MB), NSF OIA 1632738 (MB), NIGMS P20GM103650 (MB), the Tahoe Institute for Rural Health Research (MB), NINDS F99 NS113419 (HA), and NINDS K00 NS113419-02 (HA). The research from the presented projects were submitted in fulfillment of the requirements for the degree of Doctor of Philosophy in Neuroscience at the University of Nevada, Reno. The content is solely the responsibility of the authors and does not represent the official views of any funding agency.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Alosco ML, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00440; Anderson DE, 2019, CLIN NEUROPHYSIOL, V130, P1243, DOI 10.1016/j.clinph.2019.04.714; Arciniega H., 2020, J CLIN TRANSL RES, V5, P169, DOI [10.18053/jctres.05.202004.003, DOI 10.18053/JCTRES.05.202004.003]; Arciniega H, 2019, ATTEN PERCEPT PSYCHO, V81, P2597, DOI 10.3758/s13414-019-01774-9; Barry RJ, 2017, BIOL PSYCHOL, V129, P293, DOI 10.1016/j.biopsycho.2017.09.010; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Belouchrani A, 1997, IEEE T SIGNAL PROCES, V45, P434, DOI 10.1109/78.554307; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Broadway JM, 2019, CORTEX, V120, P240, DOI 10.1016/j.cortex.2019.06.011; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Cameron KL, 2012, J NEUROTRAUM, V29, P1313, DOI 10.1089/neu.2011.2168; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Catani M, 2005, BRAIN, V128, P2224, DOI 10.1093/brain/awh622; Cerreta AGB, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.570030; Chen AC, 2013, P NATL ACAD SCI USA, V110, P19944, DOI 10.1073/pnas.1311772110; Chien HY, 2016, AUTISM RES, V9, P1058, DOI 10.1002/aur.1607; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Cohen JR, 2016, J NEUROSCI, V36, P12083, DOI 10.1523/JNEUROSCI.2965-15.2016; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; De Monte VE., 2005, BRAIN IMPAIR, V6, P109, DOI [10.1375/brim.2005.6.2.109, DOI 10.1375/BRIM.2005.6.2.109]; de Munck JC, 2009, NEUROIMAGE, V47, P69, DOI 10.1016/j.neuroimage.2009.04.029; de Pasquale F, 2016, CEREB CORTEX, V26, P4015, DOI 10.1093/cercor/bhv185; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Disbrow EA, 2014, J PARKINSON DIS, V4, P453, DOI 10.3233/JPD-130341; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Eagle SR, 2020, J NEUROSURG-PEDIATR, V26, P165, DOI 10.3171/2020.2.PEDS2025; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fox CJ, 2009, HUM BRAIN MAPP, V30, P1637, DOI 10.1002/hbm.20630; Fox PT, 2012, NEUROIMAGE, V61, P407, DOI 10.1016/j.neuroimage.2011.12.051; Furlong S, 2021, J CLIN CHILD ADOLESC, V50, P746, DOI 10.1080/15374416.2020.1796680; Gasser T, 2003, J CLIN NEUROPHYSIOL, V20, P273, DOI 10.1097/00004691-200307000-00007; GESCHWIN.N, 1965, BRAIN, V88, P585, DOI 10.1093/brain/88.3.585; Geschwind N, 2010, NEUROPSYCHOL REV, V20, P128, DOI 10.1007/s11065-010-9131-0; Ghaderi AH, 2019, INT J NEUROSCI, V129, P904, DOI 10.1080/00207454.2019.1586688; Gordon EM, 2014, HUM BRAIN MAPP, V35, P1004, DOI 10.1002/hbm.22230; Gosselin N, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12253; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Hudac CM, 2018, INT J PSYCHOPHYSIOL, V132, P135, DOI 10.1016/j.ijpsycho.2017.09.020; Iverson GL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218997; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Jiang YH, 2000, J EXP PSYCHOL LEARN, V26, P683, DOI 10.1037/0278-7393.26.3.683; Jiang Y, 2016, PAIN, V157, P1970, DOI 10.1097/j.pain.0000000000000606; Johnson B, 2020, BRAIN IMAGING BEHAV, V14, P110, DOI 10.1007/s11682-018-9982-1; Kobeissy F. H, 2015, BRAIN NEUROTRAUMA MO; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Li FF, 2020, CNS NEUROSCI THER, V26, P1083, DOI 10.1111/cns.13430; Lin F, 2016, J AM GERIATR SOC, V64, P1293, DOI 10.1111/jgs.14132; Lopez-Calderon J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00213; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Mann B, 2012, J FORENSIC PSYCHI PS, V23, P744, DOI 10.1080/14789949.2012.720838; Maurer U, 2015, BRAIN TOPOGR, V28, P127, DOI 10.1007/s10548-014-0361-y; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; Mencarelli L, 2019, HUM BRAIN MAPP, V40, P3810, DOI 10.1002/hbm.24633; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Miller DR, 2017, BRAIN IMAGING BEHAV, V11, P1129, DOI 10.1007/s11682-016-9593-7; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Mouzon B, 2019, J NEUROTRAUM, V36, P576, DOI 10.1089/neu.2018.5720; Mueller ST, 2014, J NEUROSCI METH, V222, P250, DOI 10.1016/j.jneumeth.2013.10.024; Murray N, 2020, J ATHL TRAINING, V55, P109, DOI 10.4085/1062-6050-187-19; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Ortiz E, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/186353; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Power JD, 2015, NEUROIMAGE, V105, P536, DOI 10.1016/j.neuroimage.2014.10.044; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Rajesh A, 2017, J NEUROTRAUM, V34, P3280, DOI 10.1089/neu.2017.5047; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Saad ZS, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P1510; Samuelson KW, 2009, J INT NEUROPSYCH SOC, V15, P853, DOI 10.1017/S1355617709990282; Santangelo V, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00233; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Shackman AJ, 2010, NEUROIMAGE, V51, P1319, DOI 10.1016/j.neuroimage.2010.03.037; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Sosin DM, 1996, BRAIN INJURY, V10, P47; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Sporns O, 2013, CURR OPIN NEUROBIOL, V23, P162, DOI 10.1016/j.conb.2012.11.015; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Tang AC, 2005, NEUROIMAGE, V25, P539, DOI 10.1016/j.neuroimage.2004.11.027; Taylor CA, 2015, J HEAD TRAUMA REHAB, V30, P150, DOI 10.1097/HTR.0000000000000105; Terwilliger VK, 2016, J NEUROTRAUM, V33, P761, DOI 10.1089/neu.2015.4082; Tessitore A, 2012, NEUROLOGY, V79, P2226, DOI 10.1212/WNL.0b013e31827689d6; Thompson JM, 2008, CAN FAM PHYSICIAN, V54, P1549; Todd JJ, 2005, COGN AFFECT BEHAV NE, V5, P144, DOI 10.3758/CABN.5.2.144; Todd JJ, 2005, PSYCHOL SCI, V16, P965, DOI 10.1111/j.1467-9280.2005.01645.x; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Toth B, 2017, HUM BRAIN MAPP, V38, P4019, DOI 10.1002/hbm.23645; Toth SL, 2010, ISR J PSYCHIATR REL, V47, P5; van der Horn HJ, 2016, HUM BRAIN MAPP, V37, P1645, DOI 10.1002/hbm.23126; van Eijck MM, 2018, BRAIN INJURY, V32, P395, DOI 10.1080/02699052.2018.1429018; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vatansever D, 2017, HUM BRAIN MAPP, V38, P41, DOI 10.1002/hbm.23341; Vinck M, 2011, NEUROIMAGE, V55, P1548, DOI 10.1016/j.neuroimage.2011.01.055; Wammes JD, 2017, BRAIN COGNITION, V111, P112, DOI 10.1016/j.bandc.2016.11.004; Ward AM, 2015, NEUROBIOL AGING, V36, P265, DOI 10.1016/j.neurobiolaging.2014.06.028; Warden DL, 2005, NEW ENGL J MED, V353, P633; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; Winkler I, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/035013; Winkler I, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-30; Woods SP, 2006, ARCH CLIN NEUROPSYCH, V21, P413, DOI 10.1016/j.acn.2006.06.002; Yakushev I, 2013, NEUROIMAGE, V79, P184, DOI 10.1016/j.neuroimage.2013.04.069; Zhang QS, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00244	126	2	2	3	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	FEB 2	2021	11	1							2789	10.1038/s41598-021-80995-1			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG6PP	WOS:000617706100026	33531546	Green Published, gold			2022-02-06	
J	Babl, FE; Tavender, E; Ballard, DW; Borland, ML; Oakley, E; Cotterell, E; Halkidis, L; Goergen, S; Davis, GA; Perry, D; Anderson, V; Barlow, KM; Barnett, P; Bennetts, S; Bhamjee, R; Cole, J; Craven, J; Haskell, L; Lawton, B; Lithgow, A; Mullen, G; O'Brien, S; Paproth, M; Wilson, CL; Ring, J; Wilson, A; Leo, GS; Dalziel, SR				Babl, Franz E.; Tavender, Emma; Ballard, Dustin W.; Borland, Meredith L.; Oakley, Ed; Cotterell, Elizabeth; Halkidis, Lambros; Goergen, Stacy; Davis, Gavin A.; Perry, David; Anderson, Vicki; Barlow, Karen M.; Barnett, Peter; Bennetts, Scott; Bhamjee, Roisin; Cole, Joanne; Craven, John; Haskell, Libby; Lawton, Ben; Lithgow, Anna; Mullen, Glenda; O'Brien, Sharon; Paproth, Michelle; Wilson, Catherine L.; Ring, Jenny; Wilson, Agnes; Leo, Grace S. Y.; Dalziel, Stuart R.		Paediat Res Emergency Dept Intl Co	Australian and New Zealand Guideline for Mild to Moderate Head Injuries in Children	EMERGENCY MEDICINE AUSTRALASIA			English	Article						child; guideline; head injury; traumatic brain injury		Objective Children frequently present with head injuries to acute care settings. Although international paediatric clinical practice guidelines for head injuries exist, they do not address all considerations related to triage, imaging, observation versus admission, transfer, discharge and follow-up of mild to moderate head injuries relevant to the Australian and New Zealand context. The Paediatric Research in Emergency Departments International Collaborative (PREDICT) set out to develop an evidence-based, locally applicable, practical clinical guideline for the care of children with mild to moderate head injuries presenting to acute care settings. Methods A multidisciplinary Guideline Working Group (GWG) developed 33 questions in three key areas - triage, imaging and discharge of children with mild to moderate head injuries presenting to acute care settings. We identified existing high-quality guidelines and from these guidelines recommendations were mapped to clinical questions. Updated literature searches were undertaken, and key new evidence identified. Recommendations were created through either adoption, adaptation or development of de novo recommendations. The guideline was revised after a period of public consultation. Results The GWG developed 71 recommendations (evidence-informed = 35, consensus-based = 17, practice points = 19), relevant to the Australian and New Zealand setting. The guideline is presented as three documents: (i) a detailed Full Guideline summarising the evidence underlying each recommendation; (ii) a Guideline Summary; and (iii) a clinical Algorithm: Imaging and Observation Decision-making for Children with Head Injuries. Conclusions The PREDICT Australian and New Zealand Guideline for Mild to Moderate Head Injuries in Children provides high-level evidence and practical guidance for front line clinicians.	[Babl, Franz E.; Oakley, Ed; Barnett, Peter] Royal Childrens Hosp, Emergency Dept, Melbourne, Vic, Australia; [Babl, Franz E.; Tavender, Emma; Oakley, Ed; Davis, Gavin A.; Anderson, Vicki; Barnett, Peter; Wilson, Catherine L.] Murdoch Childrens Res Inst, Clin Sci, Melbourne, Vic, Australia; [Babl, Franz E.; Tavender, Emma; Oakley, Ed; Anderson, Vicki; Barnett, Peter] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Babl, Franz E.; Tavender, Emma; Oakley, Ed; Anderson, Vicki; Barnett, Peter] Univ Melbourne, Ctr Integrated Crit Care, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia; [Ballard, Dustin W.] Kaiser Permanente, Clin Res Emergency Serv & Treatment CREST Network, Oakland, CA USA; [Ballard, Dustin W.] Kaiser Permanente, Div Res, Oakland, CA USA; [Borland, Meredith L.; O'Brien, Sharon] Perth Childrens Hosp, Emergency Dept, Perth, WA, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Med, Div Emergency Med, Perth, WA, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Med, Div Paediat, Perth, WA, Australia; [Borland, Meredith L.; O'Brien, Sharon] Curtin Univ, Sch Nursing, Perth, WA, Australia; [Cotterell, Elizabeth] Univ New England, Sch Rural Med, Armidale, NSW, Australia; [Halkidis, Lambros] Cairns Hosp, Emergency Dept, Cairns, Qld, Australia; [Goergen, Stacy] Monash Hlth, Monash Hlth Imaging, Melbourne, Vic, Australia; [Goergen, Stacy] Monash Univ, Sch Clin Sci, Dept Surg, Melbourne, Vic, Australia; [Goergen, Stacy] Monash Univ, Sch Clin Sci, Dept Neurosurg, Melbourne, Vic, Australia; [Davis, Gavin A.] Cabrini Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Perry, David] Starship Childrens Hosp, Radiol Dept, Auckland, New Zealand; [Anderson, Vicki] Royal Childrens Hosp, Psychol Serv, Melbourne, Vic, Australia; [Barlow, Karen M.; Lawton, Ben] Univ Queensland, Child Hlth Res Ctr, Brisbane, Qld, Australia; [Barlow, Karen M.] Childrens Hlth Queensland, Neurosci Unit, Queensland Paediat Rehabil Serv, Brisbane, Qld, Australia; [Bennetts, Scott] Ambulance Victoria, Clin Effectiveness, Melbourne, Vic, Australia; [Bhamjee, Roisin] Univ Melbourne, Dept Gen Practice, Melbourne, Vic, Australia; [Cole, Joanne] Tauranga Hosp, Emergency Dept, Tauranga, New Zealand; [Craven, John] Women & Childrens Hosp, Emergency Dept, Adelaide, SA, Australia; [Craven, John] SA Ambulance, MedSTAR, Adelaide, SA, Australia; [Craven, John] Flinders Med Ctr, Emergency Dept, Adelaide, SA, Australia; [Haskell, Libby; Dalziel, Stuart R.] Starship Childrens Hosp, Childrens Emergency Dept, Auckland, New Zealand; [Lawton, Ben] Queensland Childrens Hosp, Emergency Dept, Brisbane, Qld, Australia; [Lawton, Ben; Leo, Grace S. Y.] Dont Forget Bubbles, Sydney, NSW, Australia; [Lawton, Ben] Logan Hosp, Emergency Dept, Logan, Qld, Australia; [Lithgow, Anna] Royal Darwin Hosp, Emergency Dept, Darwin, NT, Australia; [Mullen, Glenda; Leo, Grace S. Y.] Sydney Childrens Hosp, Emergency Dept, Sydney, NSW, Australia; [Ring, Jenny; Wilson, Agnes] Hlth Res Consulting, Sydney, NSW, Australia; [Leo, Grace S. Y.] Univ New South Wales, Sch Women & Childrens Hlth, Sydney, NSW, Australia; [Dalziel, Stuart R.] Univ Auckland, Dept Surg, Auckland, New Zealand; [Dalziel, Stuart R.] Univ Auckland, Dept Paediat Child & Youth Hlth, Auckland, New Zealand		Babl, FE (corresponding author), Univ Melbourne, Dept Paediat, Emergency Res, Flemington Rd, Parkville, Vic 3052, Australia.	franz.babl@rch.org.au	Barlow, Karen/C-1323-2014	Barlow, Karen/0000-0003-2612-8507; Cotterell, Elizabeth/0000-0001-8469-8394; Tavender, Emma/0000-0002-7230-712X; Goergen, Stacy/0000-0001-9668-6809	National Health and Medical Research Council (NHMRC) Centre of Research Excellence grants for Paediatric Emergency Medicine, Canberra, AustraliaNational Health and Medical Research Council of Australia [GNT1058560/GNT1171228]; Royal Children's Hospital Foundation, Melbourne, Australia; Victorian Government's Operational Infrastructure programme; NHMRC Practitioner Fellowship, Canberra, Australia; Health Research Council of New ZealandHealth Research Council of New Zealand [HRC13/556]; Cure Kids New Zealand	The PREDICT Australian and New Zealand Guideline for Mild to Moderate Head Injuries in Children was developed with funding support from the National Health and Medical Research Council (NHMRC) Centre of Research Excellence grants for Paediatric Emergency Medicine (GNT1058560/GNT1171228), Canberra, Australia, administered by the Murdoch Children's Research Institute, and from the Royal Children's Hospital Foundation, Melbourne, Australia. The project was also supported by the Victorian Government's Operational Infrastructure programme. FEB's time was part funded by an NHMRC Practitioner Fellowship, Canberra, Australia and a grant from the Royal Children's Hospital Foundation, Melbourne, Australia. SRD's time was part funded by the Health Research Council of New Zealand (HRC13/556) and Cure Kids New Zealand.	Astrand R, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0574-x; Babl FE, 2021, J NEUROSURG-PEDIATR, V27, P196, DOI 10.3171/2020.7.PEDS2090; Babl FE, 2018, ANN EMERG MED, V71, P703, DOI 10.1016/j.annemergmed.2018.01.015; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Badawy MK, 2017, ACAD EMERG MED, V24, P595, DOI 10.1111/acem.13168; Borland ML, 2019, ANN EMERG MED, V74, P1, DOI 10.1016/j.annemergmed.2018.11.035; Bressan S, 2020, J PAEDIATR CHILD H, V56, P1891, DOI 10.1111/jpc.15073; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Crowe LM, 2018, ARCH PHYS MED REHAB, V99, P1360, DOI 10.1016/j.apmr.2017.12.026; Da Dalt L, 2018, ITAL J PEDIATR, V44, DOI 10.1186/s13052-017-0442-0; Dalton S, 2009, EMERG MED AUSTRALAS, V21, P67, DOI 10.1111/j.1742-6723.2008.01148.x; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Dawson J., LIVING GUIDELINE DIA; DeMatteo C, 2020, BMJ OPEN SPORT EXERC, V6, DOI 10.1136/bmjsem-2019-000667; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Fervers B, 2006, INT J QUAL HEALTH C, V18, P167, DOI 10.1093/intqhc/mzi108; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Holmes JF, 2011, ANN EMERG MED, V58, P315, DOI 10.1016/j.annemergmed.2011.03.060; Institute of Medicine, 2011, CLIN PRACT GUID WE C; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kochar A, 2020, EMERG MED J, V37, P127, DOI 10.1136/emermed-2018-208154; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lee LK, 2011, J PEDIATR-US, V158, P1003, DOI 10.1016/j.jpeds.2010.11.036; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; National Health and Medical Research Council, 2018, GUID GUID AD AD STAR; National Institute for Health and Care Excellence, 2014, HEAD INJ ASS EARL MA; Notarangelo LD., ITAL J PEDIAT; O'Brien S, 2019, J PAEDIATR CHILD H, V55, P42, DOI 10.1111/jpc.14104; O'Neill JA, 2017, REHABIL PSYCHOL, V62, P300, DOI 10.1037/rep0000155; Ontario Neurotrauma Foundation, 2014, GUID DIAGN MAN PED C; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pfeiffer H, 2020, EMERG MED J, V37, P119, DOI 10.1136/emermed-2019-208893; Phillips N, 2020, EMERG MED AUSTRALAS, V32, P240, DOI 10.1111/1742-6723.13396; Ryan ME, 2014, J AM COLL RADIOL, V11, P939, DOI 10.1016/j.jacr.2014.07.017; Schonfeld D, 2013, ANN EMERG MED, V62, P597, DOI 10.1016/j.annemergmed.2013.06.020; Schunemann HJ, 2017, J CLIN EPIDEMIOL, V81, P101, DOI 10.1016/j.jclinepi.2016.09.009; Singh S, 2020, ACAD EMERG MED, V27, P832, DOI 10.1111/acem.13942; TEASDALE G, 1974, LANCET, V2, P81; Wieteska, 2017, ADV PAEDIAT LIFE SUP; Wilson A., 2021, EMERG MED AUSTRALAS, DOI [10.1111/1742-6723.13716, DOI 10.1111/1742]; Wilson CL, 2020, EMERG MED J, V37, P686, DOI 10.1136/emermed-2020-209719; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	43	2	2	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-6731	1742-6723		EMERG MED AUSTRALAS	Emerg. Med. Australas.	APR	2021	33	2					214	231		10.1111/1742-6723.13722		FEB 2021	18	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	QY0PX	WOS:000613806800001	33528896				2022-02-06	
J	Ma, JY; Hong, G; Ha, E; Hong, H; Kim, J; Joo, Y; Yoon, S; Lyoo, IK; Kim, J				Ma, Jiyoung; Hong, Gahae; Ha, Eunji; Hong, Haejin; Kim, Jinsol; Joo, Yoonji; Yoon, Sujung; Lyoo, In Kyoon; Kim, Jungyoon			Hippocampal cerebral blood flow increased following low-pressure hyperbaric oxygenation in firefighters with mild traumatic brain injury and emotional distress	NEUROLOGICAL SCIENCES			English	Article						Hyperbaric oxygenation; Perfusion MRI; Limbic system; Firefighters; Mild traumatic brain injury; Emotional distress	THERAPY	Background Recent evidence suggests that hyperbaric oxygenation (HBO), which has been used as an effective treatment for certain types of tissue injury, may change neural activities in the human brain and subsequently improve symptoms of psychiatric disorders. To scrutinize the neural mechanism of HBO in the human brain, we investigated whether 20 sessions of HBO changed regional cerebral blood flow (rCBF) of the limbic system in firefighters with mild traumatic brain injury (mTBI) and subjective emotional distress. Methods Twenty firefighters with mTBI and mild emotional distress were treated with HBO at a relatively low pressure of 1.3 atmospheres absolute for 45 min a day for 20 consecutive days (the mild emotional distress group). The rCBF of the limbic system was measured using an arterial spin labeling perfusion magnetic resonance imaging before and after the HBO. Analyses were performed on the data from fourteen individuals who completed the study and 14 age- and sex-matched healthy firefighters (the comparison group). Results Firefighters in the mild emotional distress group showed increase rCBF following HBO in a cluster encompassing the right hippocampal and parahippocampal regions (peak t = 4.31; cluster size = 248 mm(3))(post-hoc analysis, z = 5.92, p < 0.001) that had lower rCBF relative to the comparison group at baseline (post-hoc analysis, t = -2.20, p = 0.04). Conclusion The current study demonstrated that low-pressure HBO might increase rCBF of the hippocampal and parahippocampal regions, suggesting a potential underpinning mechanism of HBO in the human brain.	[Ma, Jiyoung; Hong, Gahae; Ha, Eunji; Hong, Haejin; Kim, Jinsol; Joo, Yoonji; Yoon, Sujung; Lyoo, In Kyoon; Kim, Jungyoon] Ewha Womans Univ, Ewha Brain Inst, Seoul, South Korea; [Ma, Jiyoung] Univ Utah, Diagnost Neuroimaging, Salt Lake City, UT USA; [Ha, Eunji; Hong, Haejin; Kim, Jinsol; Yoon, Sujung; Lyoo, In Kyoon; Kim, Jungyoon] Ewha Womans Univ, Dept Brain & Cognit Sci, Seoul, South Korea; [Joo, Yoonji; Lyoo, In Kyoon] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul, South Korea; [Lyoo, In Kyoon] Univ Utah, Dept Psychiat, Salt Lake City, UT USA		Kim, J (corresponding author), Ewha Womans Univ, Ewha Brain Inst, Seoul, South Korea.; Kim, J (corresponding author), Ewha Womans Univ, Dept Brain & Cognit Sci, Seoul, South Korea.	jungyoon.kimm@ewha.ac.kr		Kim, Jungyoon/0000-0002-6204-5170	National Research Foundation of Korea - Korean government (Ministry of Science and ICT) [NRF-2020M3E5D9080555, 2020R1F1A1077421]; Field-oriented Support of Fire Fighting Technology Research and Development Program - National Fire Agency of Korea [MPSS-Fire Fighting Safety-2016-86]	This research was supported by the National Research Foundation of Korea grant funded by the Korean government (Ministry of Science and ICT, NRF-2020M3E5D9080555 to In Kyoon Lyoo and 2020R1F1A1077421 to Jungyoon Kim) and by the Field-oriented Support of Fire Fighting Technology Research and Development Program funded by the National Fire Agency of Korea (MPSS-Fire Fighting Safety-2016-86 to Jungyoon Kim).	Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Apfel BA, 2011, BIOL PSYCHIAT, V69, P541, DOI 10.1016/j.biopsych.2010.09.044; Aslan S, 2010, MAGN RESON IMAGING, V28, P928, DOI 10.1016/j.mri.2010.03.037; Banoujaafar H, 2014, J CEREBR BLOOD F MET, V34, P1681, DOI 10.1038/jcbfm.2014.133; Solana AB, 2016, BRAIN IMAGING BEHAV, V10, P373, DOI 10.1007/s11682-015-9404-6; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Camporesi EM, 2014, UNDERSEA HYPERBAR M, V41, P247; Chen XY, 2016, NEUROCHEM RES, V41, P3032, DOI 10.1007/s11064-016-2022-x; Coles JP, 2006, J CEREBR BLOOD F MET, V26, P48, DOI 10.1038/sj.jcbfm.9600179; Collin G, 2014, CEREB CORTEX, V24, P2258, DOI 10.1093/cercor/bht064; Daugherty WP, 2004, J NEUROSURG, V101, P499, DOI 10.3171/jns.2004.101.3.0499; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Du X, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00004; Efrati S, 2014, EXPERT REV NEUROTHER, V14, P233, DOI 10.1586/14737175.2014.884928; Grieve SM, 2011, NEUROIMAGE, V55, P868, DOI 10.1016/j.neuroimage.2010.12.087; Han PF, 2018, BRAIN RES, V1700, P41, DOI 10.1016/j.brainres.2018.07.010; Harch PG, 2007, BRAIN RES, V1174, P120, DOI 10.1016/j.brainres.2007.06.105; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Huang L, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-21; Janik R, 2016, BBA-MOL BASIS DIS, V1862, P957, DOI 10.1016/j.bbadis.2015.10.023; Jarcho JM, 2009, CLIN PHARMACOL THER, V86, P352, DOI 10.1038/clpt.2009.126; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Lim SW, 2017, WORLD NEUROSURG, V100, P128, DOI 10.1016/j.wneu.2016.12.118; Lin KC, 2012, J TRAUMA ACUTE CARE, V72, P650, DOI 10.1097/TA.0b013e31823c575f; Liu Meng-Qi, 2017, Nan Fang Yi Ke Da Xue Xue Bao, V37, P1242; Liu WC, 2016, CRIT CARE MED, V44, pE25, DOI 10.1097/CCM.0000000000001299; Maes M, 2009, METAB BRAIN DIS, V24, P27, DOI 10.1007/s11011-008-9118-1; Mayberg HS, 2002, AM J PSYCHIAT, V159, P728, DOI 10.1176/appi.ajp.159.5.728; Miller RS, 2015, JAMA INTERN MED, V175, P43, DOI 10.1001/jamainternmed.2014.5479; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palzur E, 2008, BRAIN RES, V1221, P126, DOI 10.1016/j.brainres.2008.04.078; Sapolsky RM, 2003, NEUROCHEM RES, V28, P1735, DOI 10.1023/A:1026021307833; Singh K, 2016, EXP NEUROL, V275, P427, DOI 10.1016/j.expneurol.2015.07.016; Sun L, 2014, NEUROREPORT, V25, P718, DOI 10.1097/WNR.0000000000000181; Wang F, 2016, NEUROL SCI, V37, P693, DOI 10.1007/s10072-015-2460-2; Xu F, 2015, NEUROIMAGE, V110, P39, DOI 10.1016/j.neuroimage.2015.01.046; Zhang L, 2006, MED HYPOTHESES, V66, P1205, DOI 10.1016/j.mehy.2005.11.041; Zhou ZW, 2007, J NEUROSURG, V106, P687, DOI 10.3171/jns.2007.106.4.687	38	2	2	3	4	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	OCT	2021	42	10					4131	4138		10.1007/s10072-021-05094-5		FEB 2021	8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UQ8HB	WOS:000614018400003	33532950				2022-02-06	
J	Wang, A; Zhou, GW; Kawai, K; O'Brien, M; Shearer, AE; Brodsky, JR				Wang, Alicia; Zhou, Guangwei; Kawai, Kosuke; O'Brien, Michael; Shearer, A. Eliot; Brodsky, Jacob R.			Benign Paroxysmal Positional Vertigo in Children and Adolescents With Concussion	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; dizziness; BPPV; pediatric; vestibular; vertigo; postconcussion syndrome		Background: Dizziness after concussion is primarily attributed to effects on the brain, but traumatic inner ear disorders can also contribute. Benign paroxysmal positional vertigo (BPPV) is a common vestibular disorder that can result from minor head trauma and can be easily diagnosed and rapidly treated in an office setting. The role of BPPV in pediatric postconcussive dizziness has not been well-studied. Purpose: To evaluate the prevalence and clinical features of BPPV in a group of pediatric patients with concussion and prolonged dizziness after concussion. Study Design: Case-control study. Methods: Retrospective review of 102 patients seen within the past 3 years in a pediatric multidisciplinary concussion clinic for evaluation of postconcussive dizziness. Results: BPPV was diagnosed in 29.4% (30/102) of patients with postconcussion syndrome and dizziness. All patients with BPPV were treated with repositioning maneuvers, except for 5 patients who had spontaneous resolution of symptoms. Patients were evaluated at an average of 18.8 weeks (SD, 16.4 weeks) after the injury. BPPV was diagnosed at similar rates regardless of gender or age group (children vs adolescents). The mean Post-Concussion Symptom Scale (PCSS) score did not differ significantly between patients with (58.3 [SD, 22.5]) or without BPPV (55.8 [SD, 29.4]; P = 0.39). The PCSS "balance problems or dizziness" subscore also did not differ between patients with (3.3 [SD, 1.7]) or without BPPV (2.8 [SD, 1.6]; P = 0.13). Conclusion: BPPV is fairly common in pediatric concussion, occurring in one-third of the patients studied. BPPV is often not diagnosed and treated until many weeks after the injury. Increased awareness of the evaluation and management of BPPV among pediatric concussion providers may help expedite resolution of dizziness and hasten overall recovery in affected patients.	[Wang, Alicia; Zhou, Guangwei; Kawai, Kosuke; Shearer, A. Eliot; Brodsky, Jacob R.] Boston Childrens Hosp, Dept Otolaryngol & Commun Enhancement, 300 Longwood Ave, Boston, MA 02115 USA; [Zhou, Guangwei; Kawai, Kosuke; O'Brien, Michael; Shearer, A. Eliot; Brodsky, Jacob R.] Harvard Med Sch, Boston, MA 02115 USA; [O'Brien, Michael] Boston Childrens Hosp, Div Sports Med, Boston, MA USA		Brodsky, JR (corresponding author), Boston Childrens Hosp, Dept Otolaryngol & Commun Enhancement, 300 Longwood Ave, Boston, MA 02115 USA.	jacob.brodsky@childrens.harvard.edu		Wang, Alicia/0000-0003-4137-8547			Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Balatsouras DG, 2017, ANN OTO RHINOL LARYN, V126, P54, DOI 10.1177/0003489416674961; Bhattacharyya N, 2008, OTOLARYNG HEAD NECK, V139, pS47, DOI 10.1016/j.otohns.2008.08.022; Brodsky JR, 2018, OTOLARYNG HEAD NECK, V159, P365, DOI 10.1177/0194599818770618; Brodsky JR, 2018, OTOL NEUROTOL, V39, P344, DOI 10.1097/MAO.0000000000001673; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Jahn K, 2015, CURR OPIN NEUROL, V28, P78, DOI 10.1097/WCO.0000000000000157; Katsarkas A, 1999, ACTA OTO-LARYNGOL, V119, P745, DOI 10.1080/00016489950180360; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Neuhauser HK, 2009, SEMIN NEUROL, V29, P473, DOI 10.1055/s-0029-1241043; O'Reilly RC., 2020, MANUAL PEDIAT BALANC, V2nd ed; Parnes LS, 2003, CAN MED ASSOC J, V169, P681; von Brevern M, 2007, J NEUROL NEUROSUR PS, V78, P710, DOI 10.1136/jnnp.2006.100420; World Health Organization, 2012, INT STAT CLASS DIS R; Zhou GW, 2015, OTOLARYNG HEAD NECK, V152, P1133, DOI 10.1177/0194599815576720	19	2	2	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	JUL	2021	13	4					380	386	1941738120970515	10.1177/1941738120970515		FEB 2021	7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	TC4GB	WOS:000620299500001	33528343	hybrid, Green Published			2022-02-06	
J	Alkaslasi, MR; Cho, NE; Dhillon, NK; Shelest, O; Haro-Lopez, PS; Linaval, NT; Ghoulian, J; Yang, AR; Vit, JP; Avalos, P; Ley, EJ; Thomsen, GM				Alkaslasi, Mor R.; Cho, Noell E.; Dhillon, Navpreet K.; Shelest, Oksana; Haro-Lopez, Patricia S.; Linaval, Nikhil T.; Ghoulian, Josh; Yang, Audrey R.; Vit, Jean-Philippe; Avalos, Pablo; Ley, Eric J.; Thomsen, Gretchen M.			Poor Corticospinal Motor Neuron Health Is Associated with Increased Symptom Severity in the Acute Phase Following Repetitive Mild TBI and Predicts Early ALS Onset in Genetically Predisposed Rodents	BRAIN SCIENCES			English	Article						amyotrophic lateral sclerosis; traumatic brain injury; concussion; corticospinal motor neurons; chronic traumatic encephalopathy		Traumatic brain injury (TBI) is a well-established risk factor for several neurodegenerative disorders including Alzheimer's disease and Parkinson's disease, however, a link between TBI and amyotrophic lateral sclerosis (ALS) has not been clearly elucidated. Using the SOD1(G93A) rat model known to recapitulate the human ALS condition, we found that exposure to mild, repetitive TBI lead ALS rats to experience earlier disease onset and shortened survival relative to their sham counterparts. Importantly, increased severity of early injury symptoms prior to the onset of ALS disease symptoms was linked to poor health of corticospinal motor neurons and predicted worsened outcome later in life. Whereas ALS rats with only mild behavioral injury deficits exhibited no observable changes in corticospinal motor neuron health and did not present with early onset or shortened survival, those with more severe injury-related deficits exhibited alterations in corticospinal motor neuron health and presented with significantly earlier onset and shortened lifespan. While these studies do not imply that TBI causes ALS, we provide experimental evidence that head injury is a risk factor for earlier disease onset in a genetically predisposed ALS population and is associated with poor health of corticospinal motor neurons.	[Alkaslasi, Mor R.; Cho, Noell E.; Shelest, Oksana; Haro-Lopez, Patricia S.; Avalos, Pablo; Thomsen, Gretchen M.] Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Los Angeles, CA 90048 USA; [Dhillon, Navpreet K.; Linaval, Nikhil T.; Ghoulian, Josh; Yang, Audrey R.; Ley, Eric J.] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA; [Vit, Jean-Philippe] Cedars Sinai Med Ctr, Biobehav Res Core, Los Angeles, CA 90048 USA		Thomsen, GM (corresponding author), Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Los Angeles, CA 90048 USA.	mor.alkaslasi@cshs.org; noell.cho@cshs.org; navpreet.dhillon@cshs.org; roksana.elder@cshs.org; patricia.harolopez@cshs.org; nikhil.linaval@cshs.org; josh.ghoulian@cshs.org; audrey.yang@cshs.org; Jean-Philippe.Vit@cshs.org; pablo.avalos@cshs.org; eric.ley@cshs.org; GMThomsen@hotmail.com		Yang, Audrey/0000-0002-2910-2823	ALS Finding a Cure(R), a program of The Leandro P. Rizzuto Foundation	This work was funded by ALS Finding a Cure (R), (Grant Title: "Traumatic Brain Injury and its Potential Link to ALS") a program of The Leandro P. Rizzuto Foundation.	Anderson EN, 2018, HUM MOL GENET, V27, P1366, DOI 10.1093/hmg/ddy047; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Becker LA, 2017, NATURE, V544, P367, DOI 10.1038/nature22038; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Browne SE, 2006, NEUROBIOL DIS, V22, P599, DOI 10.1016/j.nbd.2006.01.001; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; DALAKAS MC, 1987, ANN NEUROL, V22, P580, DOI 10.1002/ana.410220504; Dupuis L, 2011, LANCET NEUROL, V10, P75, DOI 10.1016/S1474-4422(10)70224-6; Evans TM, 2015, NEUROSCIENCE, V298, P410, DOI 10.1016/j.neuroscience.2015.04.041; Feddermann-Demont N, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.630; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Genc B, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020502; Gitler AD, 2011, PRION, V5, P179, DOI 10.4161/pri.5.3.17230; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Granatiero V, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020036; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Jara JH, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0896-4; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kwee LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032768; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Lehman EJ, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt188; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Martin LJ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00635; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Menon P, 2015, CLIN NEUROPHYSIOL, V126, P803, DOI 10.1016/j.clinph.2014.04.023; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Ozdinler PH, 2011, J NEUROSCI, V31, P4166, DOI 10.1523/JNEUROSCI.4184-10.2011; Palamiuc L, 2015, EMBO MOL MED, V7, P526, DOI 10.15252/emmm.201404433; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Schmidt S, 2010, J NEUROL SCI, V291, P22, DOI 10.1016/j.jns.2010.01.011; Steyn FJ, 2018, J NEUROL NEUROSUR PS, V89, P1016, DOI 10.1136/jnnp-2017-317887; Thomsen GM, 2018, STEM CELLS, V36, P1122, DOI 10.1002/stem.2825; Thomsen GM, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0059-14.2015; Thomsen GM, 2017, J TRAUMA ACUTE CARE, V82, P1039, DOI 10.1097/TA.0000000000001443; Thomsen GM, 2016, J TRAUMA ACUTE CARE, V81, P1070, DOI 10.1097/TA.0000000000001248; Thomsen GM, 2014, J NEUROSCI, V34, P15587, DOI 10.1523/JNEUROSCI.2037-14.2014; Vaisman N, 2009, J NEUROL SCI, V279, P26, DOI 10.1016/j.jns.2008.12.027; Vascak M, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00157; Wang HK, 2015, NEUROSCIENCE, V300, P94, DOI 10.1016/j.neuroscience.2015.05.013; Wang MD, 2017, NEUROTOXICOLOGY, V61, P101, DOI 10.1016/j.neuro.2016.06.015; Wolozin B, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-56; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254	51	2	2	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	FEB	2021	11	2							160	10.3390/brainsci11020160			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QN1YD	WOS:000622263100001	33530492	Green Published, gold			2022-02-06	
J	Anderson, M; Petit, KM; Wallace, J; Covassin, T; Beidler, E				Anderson, Morgan; Petit, Kyle M.; Wallace, Jessica; Covassin, Tracey; Beidler, Erica			Factors Associated With Concussion Nondisclosure in Collegiate Student-Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						coach influence; pressure; reporting behavior	REPORTING BEHAVIORS; KNOWLEDGE; SYMPTOMS; INJURIES; SUPPORT; FEMALE; SEX	Context: Mandated concussion education has aimed to improve student-athlete knowledge; however, some collegiate student-athletes continue to not disclose concussion. Concussion knowledge may not be the only factor influencing reporting, as student-athlete sex, sport, and pressure from external stakeholders (eg, coaches, teammates, fans, parents or family) have all been documented as influencing collegiate concussionreporting behavior. Objective: To examine factors associated with concussion nondisclosure in collegiate student-athletes. Design: Cross-sectional study. Setting: Four National Collegiate Athletic Association Division I and two Division II universities. Patients or Other Participants: A total of 1125 collegiate student-athletes completed the survey, and 741 provided viable responses and were included for data analysis. Main Outcome Measure(s): We used a 10- to 15-minute electronic or paper-and-pencil survey that asked about personal and sport demographics, diagnosed concussions and nondisclosed concussion history, concussion knowledge, and level of agreement regarding pressure to play after a head impact experienced during collegiate sport participation. Significant univariable factors were entered into a multivariable logistic regression analysis. Results: Sex (P =.005), sport-risk type (P<.001), diagnosed concussion history (P<.001), concussion knowledge (P =.017), and pressure from coaches (P<.001), teammates (P<.001), fans (P = .024), and parents or family (P =.003) were factors associated with concussion nondisclosure in individual univariable logistic regressions. After we conducted multivariable analyses, male sex (P =.001), high concussionrisk sport participation (P =.048), diagnosed concussion history (P,.001), increased concussion knowledge (P =.013), and experiencing pressure from coaches to continue playing after sustaining a hit to the head (P =.002) were factors associated with concussion nondisclosure in collegiate student-athletes. Conclusions: Our results suggest that concussion-education programs should go beyond the identification of signs and symptoms to include the dangers of continuing to play, long-term consequences, and transparency about concussion protocols. Comprehensive concussion-education programs should involve coaches and athletes to improve the reporting culture.y	[Anderson, Morgan; Petit, Kyle M.; Covassin, Tracey] Michigan State Univ, E Lansing, MI 48824 USA; [Wallace, Jessica] Univ Alabama, Tuscaloosa, AL USA; [Beidler, Erica] Duquesne Univ, 118 Hlth Sci Bldg,600 Forbes Ave, Pittsburgh, PA 15282 USA		Beidler, E (corresponding author), Duquesne Univ, 118 Hlth Sci Bldg,600 Forbes Ave, Pittsburgh, PA 15282 USA.	johnsone1@duq.edu		Anderson, Morgan/0000-0001-9170-6663			Ajzen I, 2011, BASIC APPL SOC PSYCH, V33, P101, DOI 10.1080/01973533.2011.568834; [Anonymous], 2013, 2013 14 NCAA SPORTS; Baugh CM, 2019, J NEUROTRAUM, V36, P2065, DOI 10.1089/neu.2018.6161; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Beidler E, 2018, J ATHL TRAINING, V53, P866, DOI 10.4085/1062-6050-266-17; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Covassin T, 2014, J ATHL TRAINING, V49, P462, DOI 10.4085/1062-6059-49.2.03; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Frieden TR, 2010, AM J PUBLIC HEALTH, V100, P590, DOI 10.2105/AJPH.2009.185652; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Glanz K, 2008, HLTH BEHAV HLTH ED T, V4, P23; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDonald T, 2016, J TRAUMA NURS, V23, P241, DOI 10.1097/JTN.0000000000000227; Milroy JJ, 2019, J CONCUSSION, V3, DOI [10.1177/2059700219894104, DOI 10.1177/2059700219894104]; O'Connor S, 2020, PHYSICIAN SPORTSMED, V48, P186, DOI 10.1080/00913847.2019.1671141; Piana LE, 2020, PHYSICIAN SPORTSMED, V48, P46, DOI 10.1080/00913847.2019.1624657; Register-Mihalik JK, 2019, J SCI MED SPORT, V22, P509, DOI 10.1016/j.jsams.2018.11.003; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Sanderson J, 2017, COMMUN SPORT, V5, P267, DOI 10.1177/2167479515623455; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	30	2	2	0	2	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	FEB	2021	56	2					157	163		10.4085/1062-6050-0102-20			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	QK3AH	WOS:000620252800005	33596598	gold, Green Published			2022-02-06	
J	Babl, FE; Lyttle, MD; Phillips, N; Kochar, A; Dalton, S; Cheek, JA; Furyk, J; Neutze, J; Bressan, S; Williams, A; Hearps, SJC; Oakley, E; Davis, GA; Dalziel, SR; Borland, ML				Babl, Franz E.; Lyttle, Mark D.; Phillips, Natalie; Kochar, Amit; Dalton, Sarah; Cheek, John A.; Furyk, Jeremy; Neutze, Jocelyn; Bressan, Silvia; Williams, Amanda; Hearps, Stephen J. C.; Oakley, Ed; Davis, Gavin A.; Dalziel, Stuart R.; Borland, Meredith L.		Paediat Res Emergency Dept Int	Mild traumatic brain injury in children with ventricular shunts: a PREDICT study	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						ventricular shunt; traumatic brain injury; child; hydrocephalus; trauma	HEAD-INJURY; COMPUTED-TOMOGRAPHY; DECISION RULES; HYDROCEPHALUS; HEMATOMA; CHALICE; PECARN; CATCH	OBJECTIVE Current clinical decision rules (CDRs) guiding the use of CT scanning in pediatric traumatic brain injury (TBI) assessment generally exclude children with ventricular shunts (VSs). There is limited evidence as to the risk of abnormalities found on CT scans or clinically important TBI (ciTBI) in this population. The authors sought to determine the frequency of these outcomes and the presence of CDR predictor variables in children with VSs. METHODS The authors undertook a planned secondary analysis on children with VSs included in a prospective external validation of 3 CDRs for TBI in children presenting to 10 emergency departments in Australia and New Zealand. They analyzed differences in presenting features, management and acute outcomes (TBI on CT and ciTBI) between groups with and without VSs, and assessed the presence of CDR predictors in children with a VS. RESULTS A total of 35 of 20,137 children (0.2%) with TBI had a VS; only 2 had a Glasgow Coma Scale score < 15. Overall, 49% of patients with a VS underwent CT scanning compared with 10% of those without a VS. One patient had a finding of TBI on CT scanning, with positive predictor variables on CDRs. This patient had a ciTBI. No patient required neurosurgery. For children with and without a VS, the frequency of ciTBI was 2.9% (95% CI 0.1%-14.9%) compared with 1.4% (95% CI 1.2%-1.6%) (difference 1.5% [95% CI -4.0% to 7.0%]), and TBI on CT 2.9% (95% CI 0.1%-14.9%) compared with 2.0% (95% CI 1.8%-2.2%) (difference 0.9%, 95% CI -4.6% to 6.4%). CONCLUSIONS The authors' data provide further support that the risk of TBI is similar for children with and without a VS.	[Babl, Franz E.; Cheek, John A.; Oakley, Ed] Royal Childrens Hosp, Emergency Dept, Melbourne, Vic, Australia; [Babl, Franz E.; Lyttle, Mark D.; Cheek, John A.; Bressan, Silvia; Williams, Amanda; Hearps, Stephen J. C.; Oakley, Ed; Davis, Gavin A.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Lyttle, Mark D.] Bristol Royal Hosp Children, Emergency Dept, Bristol, Avon, England; [Lyttle, Mark D.] Univ West England, Fac Hlth & Life Sci, Bristol, Avon, England; [Borland, Meredith L.] Perth Childrens Hosp, Emergency Dept, Perth, WA, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Med, Div Emergency Med, Perth, WA, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Med, Div Paediat, Perth, WA, Australia; [Phillips, Natalie] Univ Queensland, Queensland Childrens Hosp, Emergency Dept, South Brisbane, Qld, Australia; [Phillips, Natalie] Univ Queensland, Child Hlth Res Ctr, Fac Med, South Brisbane, Qld, Australia; [Kochar, Amit] Womens & Childrens Hosp, Emergency Dept, Adelaide, SA, Australia; [Dalton, Sarah] Childrens Hosp Westmead, Emergency Dept, Sydney, NSW, Australia; [Cheek, John A.] Monash Med Ctr, Emergency Dept, Melbourne, Vic, Australia; [Furyk, Jeremy] Townsville Hosp, Emergency Dept, Townsville, Qld, Australia; [Furyk, Jeremy] Univ Hosp Geelong, Emergency Dept, Geelong, Vic, Australia; [Furyk, Jeremy] Deakin Univ, Fac Hlth, Sch Med, Geelong, Vic, Australia; [Neutze, Jocelyn] KidzFirst Middlemore Hosp, Emergency Dept, Auckland, New Zealand; [Bressan, Silvia] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Dalziel, Stuart R.] Starship Childrens Hlth, Emergency Dept, Auckland, New Zealand; [Dalziel, Stuart R.] Univ Auckland, Dept Surg, Auckland, New Zealand; [Dalziel, Stuart R.] Univ Auckland, Dept Paediat Child & Youth Hlth, Auckland, New Zealand; [Babl, Franz E.; Cheek, John A.; Oakley, Ed] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Pediat, Melbourne, Vic, Australia		Babl, FE (corresponding author), Univ Melbourne, Parkville, Vic, Australia.	franz.babl@rch.org.au		Hearps, Stephen/0000-0003-2984-1172	National Health and Medical Research Council (NHMRC), Canberra, AustraliaNational Health and Medical Research Council of Australia [GNT1046727, GNT1058560]; Murdoch Children's Research Institute, Melbourne, Australia; Emergency Medicine Foundation Brisbane, Australia [EMPJ-11162]; Perpetual Philanthropic Services, Australia [2012/1140]; Auckland Medical Research Foundation [3112011]; A + Trust (Auckland District Health Board), Auckland, New Zealand; WA Health Targeted Research Funds 2013, Perth, Australia; Townsville Hospital and Health Service Private Practice Research and Education Trust Fund, Townsville, Australia; Victorian Government's Infrastructure Support Program, Melbourne, Australia; Royal Children's Hospital Foundation, Melbourne, Australia; NHMRC Practitioner FellowshipNational Health and Medical Research Council of Australia; Health Research Council of New ZealandHealth Research Council of New Zealand [HRC13/556]; Cure Kids New Zealand	The study was funded by grants from the National Health and Medical Research Council (NHMRC; project grant GNT1046727, Centre of Research Excellence for Paediatric Emergency Medicine GNT1058560), Canberra, Australia; the Murdoch Children's Research Institute, Melbourne, Australia; the Emergency Medicine Foundation (EMPJ-11162), Brisbane, Australia; Perpetual Philanthropic Services (2012/1140), Australia; Auckland Medical Research Foundation (No. 3112011) and the A + Trust (Auckland District Health Board), Auckland, New Zealand; WA Health Targeted Research Funds 2013, Perth, Australia; and the Townsville Hospital and Health Service Private Practice Research and Education Trust Fund, Townsville, Australia. The study was supported by the Victorian Government's Infrastructure Support Program, Melbourne, Australia. F.E.B.'s time was funded in part by a grant from the Royal Children's Hospital Foundation, Melbourne, Australia, and an NHMRC Practitioner Fellowship. S.R.D.'s time was funded by the Health Research Council of New Zealand (HRC13/556) and Cure Kids New Zealand. The funders had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.	AOKI N, 1988, SURG NEUROL, V29, P22, DOI 10.1016/0090-3019(88)90118-8; Astrand R, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0574-x; Babl Franz, 2006, Emerg Med Australas, V18, P143, DOI 10.1111/j.1742-6723.2006.00823.x; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Babl FE, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-148; Da Dalt L, 2018, ITAL J PEDIATR, V44, DOI 10.1186/s13052-017-0442-0; DAVIS RL, 1994, ANN EMERG MED, V24, P640, DOI 10.1016/S0196-0644(94)70273-X; Dewan MC, 2019, J NEUROSURG, V130, P1065, DOI 10.3171/2017.10.JNS17439; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Holmedal LJ, 2007, PEDIATR RADIOL, V37, P1209, DOI 10.1007/s00247-007-0625-8; Kahle KT, 2016, LANCET, V387, P788, DOI 10.1016/S0140-6736(15)60694-8; Krishnamurthy S, 2013, AM J NEURORADIOL, V34, P695, DOI 10.3174/ajnr.A3334; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Nigrovic LE, 2013, ANN EMERG MED, V61, P389, DOI 10.1016/j.annemergmed.2012.08.030; Okazaki T, 2005, PEDIATR NEUROSURG, V41, P241, DOI 10.1159/000087481; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Park DB, 2016, PEDIATR EMERG CARE, V32, P585, DOI 10.1097/PEC.0000000000000760; Shu EBS, 2000, PEDIATR NEUROSURG, V32, P176, DOI 10.1159/000028930	21	2	2	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	FEB	2021	27	2					196	202		10.3171/2020.7.PEDS2090			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	QE1EC	WOS:000615948400003	33254139				2022-02-06	
J	Camarano, JG; Ratliff, HT; Korst, GS; Hrushka, JM; Jupiter, DC				Camarano, Joseph G.; Ratliff, Hunter T.; Korst, Genevieve S.; Hrushka, Jaron M.; Jupiter, Daniel C.			Predicting in-hospital mortality after traumatic brain injury: External validation of CRASH-basic and IMPACT-core in the national trauma data bank	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury; Prognosis; Mortality; Prediction models; External validation		Background: Traumatic brain injury (TBI) prognostic prediction models offer value to individualized treatment planning, systematic outcome assessments and clinical research design but require continuous external validation to ensure generalizability to different settings. The Corticosteroid Randomization After Significant Head Injury (CRASH) and International Mission on Prognosis and Analysis on Clinical Trials in TBI (IMPACT) models are widely available but lack robust assessments of performance in a current national sample of patients. The purpose of this study is to assess the performance of the CRASH-Basic and IMPACT-Core models in predicting in-hospital mortality using a nationwide retrospective cohort from the National Trauma Data Bank (NTDB). Methods: The 2016 NTDB was used to analyze an adult cohort with moderate-severe TBI (Glasgow Coma Scale [GCS] <= 12, head Abbreviated Injury Scale of 2-6). Observed in-hospital mortality or discharge to hospice was compared to the CRASH-Basic and IMPACT-Core models' predicted probability of 14-day or 6-month mortality, respectively. Performance measures included discrimination (area under the receiver operating characteristic curve [AUC]) and calibration (calibration plots and Brier scores). Further sensitivity analysis included patients with GCS <= 14 and considered patients discharged to hospice to be alive at 14-days. Results: A total of 26,228 patients were included in this study. Both models demonstrated good ability in differentiating between patients who died and those who survived, with IMPACT demonstrating a marginally greater AUC (0.863; 95% CI: 0.858 - 0.867) than CRASH (0.858; 0.854 - 0.863); p < 0.001. On calibration, IMPACT overpredicted at lower scores and underpredicted at higher scores but had good calibration-in-the-large (indicating no systemic over/underprediction), while CRASH consistently under-predicted mortality. Brier scores were similar (0.152 for IMPACT, 0.162 for CRASH; p < 0.001). Both models showed slight improvement in performance when including patients with GCS <= 14. Conclusion: Both CRASH-Basic and IMPACT-Core accurately predict in-hospital mortality following moderate-severe TBI, and IMPACT-Core performs well beyond its original GCS cut-off of 12, indicating potential utility for mild TBI (GCS 13-15). By demonstrating validity in the NTDB, these models appear generalizable to new data and offer value to current practice in diverse settings as well as to large-scale research de sign.Introduction (C) 2020 Elsevier Ltd. All rights reserved.	[Camarano, Joseph G.; Ratliff, Hunter T.; Korst, Genevieve S.; Hrushka, Jaron M.] Univ Texas Med Branch, Sch Med, Galveston, TX 77555 USA; [Jupiter, Daniel C.] Univ Texas Med Branch, Dept Prevent Med & Populat Hlth, Galveston, TX 77555 USA; [Jupiter, Daniel C.] Univ Texas Med Branch, Dept Orthopaed Surg & Rehabil, Galveston, TX 77555 USA		Camarano, JG (corresponding author), 6130 Lago Mar Blvd,Apartment 2112, Texas City, TX 77591 USA.	jgcamara@utmb.edu; htratlif@utmb.edu; gekorst@utmb.edu; jmhrushk@utmb.edu; dajupite@utmb.edu		Hrushka, Jaron/0000-0003-4556-1023; Ratliff, Hunter/0000-0003-4978-1998			Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Carney NA, 2003, J TRAUMA, V54, pS236, DOI 10.1097/00005373-200306001-00002; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cowley Laura E, 2019, Diagn Progn Res, V3, P16, DOI 10.1186/s41512-019-0060-y; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Elahi C, 2021, J NEUROSURG, V134, P1285, DOI 10.3171/2020.2.JNS192512; Elwyn G, 2006, BMJ-BRIT MED J, V333, P417, DOI 10.1136/bmj.38926.629329.AE; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Finkelstein E.A., 2006, INCIDENCE EC BURDEN, DOI [10.1093/acprof:oso/9780195179484.001.0001, DOI 10.1093/ACPROF:OSO/9780195179484.001.0001]; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell, 2019, REGRESSION MODELING, P1; Hashmi ZG, 2018, JAMA SURG, V153, P852, DOI 10.1001/jamasurg.2018.0483; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lopez-Raton M, 2014, J STAT SOFTW, V61, P1; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maeda Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221791; Majdan M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0068-9; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Moskowitz J, 2018, MDM POLICY PRACT, V3; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Quinn T, 2017, NEUROCRIT CARE, V27, P154, DOI 10.1007/s12028-017-0427-2; R Development Core Team 3.0.1A language and environment for statistical computing, 2013, R FOUND STAT COMPUT, P2; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Sacks GD, 2016, ANN SURG, V264, P889, DOI 10.1097/SLA.0000000000001750; Stein DG, 2017, NEW THERAPEUTICS FOR TRAUMATIC BRAIN INJURY: PREVENTION OF SECONDARY BRAIN DAMAGE AND ENHANCEMENT OF REPAIR AND REGENERATION, P3, DOI 10.1016/B978-0-12-802686-1.00001-8; Steyerberg E.W., 2020, IMPACT PROGNOSTIC CA; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Sun H, 2016, J NEUROTRAUM, V33, P1535, DOI 10.1089/neu.2015.4164; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; The MRC CRASH Trial Collaborators, 2020, CRASH PROGN MOD PRED; Tucker B, 2017, J EMERG MED, V53, P18, DOI 10.1016/j.jemermed.2017.02.010; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; Volovici V, 2019, J NEUROTRAUM, V36, P3183, DOI 10.1089/neu.2019.6474; Young FB, 2005, STROKE, V36, P597, DOI 10.1161/01.STR.0000154856.42135.85	48	2	2	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	FEB	2021	52	2					147	153		10.1016/j.injury.2020.10.051			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	QB5ZC	WOS:000614217000005	33070947				2022-02-06	
J	Guzeldag, S; Yilmaz, G; Tuna, M; Altuntas, M; Ozdemir, M				Guzeldag, Seda; Yilmaz, Gokhan; Tuna, Merva; Altuntas, Mukerrem; Ozdemir, Mustafa			Measuring the Optic Nerve Sheath Diameter with Ultrasound in Acute Middle Cerebral Artery Stroke Patients	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Optic Nerve Sheath Diameter; Thrombolytic Therapy; Middle Cerebral Artery Infarction; Stroke	INTRACRANIAL-PRESSURE; ISCHEMIC-STROKE; ULTRASONOGRAPHY; INFARCTION; EDEMA	Background: Measurement of the optic nerve sheath diameter (ONSD) with ultrasound enables non-invasive and indirect assessment of increased intracranial pressure (ICP). Although most of the studies were employed with traumatic brain injury patients, its increasingly popular in acute ischemic stroke (AIS) studies. Objectives: Evaluating whether using ONSD as a follow-up measurement would help monitor the thrombolytic therapy (TT) effectiveness and determine the high-risk patients for malignant middle cerebral artery (MCA) syndrome. Methods: This prospective observational study was conducted between August 1, 2019, and February 1, 2020, in a tertiary hospital. Forty-four patients were eligible. We determined the TT moment as the time when the first ocular ultrasound measurement would be made (time 0). Also, we decided on the 24th h after the treatment as the time to perform the second ocular ultrasound measurement (time 24). The National Institute of Health Stroke Scale (NIHSS), the Glasgow Coma Scale (GCS), and the Alberta Stroke Program Early Computed Tomography (ASPECT) scores were evaluated blindly at the time-0 and the time-24. The cut-off value of ONSD was 0.55 mm. Results: There was no difference in ONSD results before and after the TT (p = 0.414). But, patients with an equal or higher value than cut-off had an increased risk for complications such as malignant-MCA, bleeding, seizure, etc. (p = 0.05). Malignant-MCA was observed in four patients with higher ONSD values. At the time-24, NIHSS decreased, GCS and ASPECT scores increased. Finally, ONSD was positively correlated with the NIHSS and negatively correlated with the GCS at the time-24. Conclusions: Monitoring ONSD values in both the emergency department and the intensive care unit may be useful in the early diagnosis of MCA stroke complications and the follow-up of TT's effectiveness.	[Guzeldag, Seda] Kayseri City Hosp, Dept Neurointens Care, Kayseri, Turkey; [Yilmaz, Gokhan; Altuntas, Mukerrem] Kayseri City Hosp, Dept Emergency Med, Kayseri, Turkey; [Tuna, Merva] Kayseri City Hosp, Dept Neurol, Kayseri, Turkey; [Ozdemir, Mustafa] Kayseri City Hosp, Dept Radiol, Kayseri, Turkey		Guzeldag, S (corresponding author), Kayseri City Hosp, Neurointens Care Unit, Kayseri, Turkey.	guzeldagseda@gmail.com	YILMAZ, Gokhan/R-8086-2019; Yilmaz, Gokhan/AAV-5219-2020	YILMAZ, Gokhan/0000-0002-7621-553X; guzeldag, seda/0000-0002-9122-7213; Altuntas, Mukerrem/0000-0001-5775-3909			Albert AF, 2017, J STROKE CEREBROVASC, V26, P2671, DOI 10.1016/j.jstrokecerebrovasdis.2017.06.041; Amini A, 2013, AM J EMERG MED, V31, P236, DOI 10.1016/j.ajem.2012.06.025; Avci M, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55080413; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Brain Trauma F, 2008, J NEUROTRAUM, V25, P276; Cardim D, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00764; Dubourg J, 2011, INTENS CARE MED, V37, P1059, DOI 10.1007/s00134-011-2224-2; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; FLETCHER AP, 1976, STROKE, V7, P135, DOI 10.1161/01.STR.7.2.135; Geeraerts T, 2008, INTENS CARE MED, V34, P2062, DOI 10.1007/s00134-008-1149-x; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Hansen HC, 1996, SURG RADIOL ANAT, V18, P323, DOI 10.1007/BF01627611; HAYREH SS, 1968, DOC OPHTHALMOL, V24, P289, DOI 10.1007/BF02550944; Kellie George, 1824, Trans Med Chir Soc Edinb, V1, P84; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Lochner P, 2020, J NEUROL, V267, P2713, DOI 10.1007/s00415-020-09906-0; Manno EM, 1997, CRIT CARE CLIN, V13, P79, DOI 10.1016/S0749-0704(05)70297-9; Manouchehrifar M, 2018, AM J EMERG MED, V36, P2064, DOI 10.1016/j.ajem.2018.08.041; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; MEYER JOHN S., 1965, P200; Monro A, 1783, LOND MED J, V4, P113; Moretti R, 2009, NEUROCRIT CARE, V11, P406, DOI 10.1007/s12028-009-9250-8; Moretti R, 2009, J NEUROSURG ANESTH, V21, P16, DOI 10.1097/ANA.0b013e318185996a; Murtha LA, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00124; Murtha LA, 2015, J CEREBR BLOOD F MET, V35, P592, DOI 10.1038/jcbfm.2014.230; Nabeta HW, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu093; Salahuddin N, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0267-1; Sangani Shruti V, 2015, Indian J Radiol Imaging, V25, P173, DOI 10.4103/0971-3026.155869; Soldatos T, 2008, CRIT CARE, V12, DOI 10.1186/cc6897; Tanne D, 2001, DRUGS, V61, P1439, DOI 10.2165/00003495-200161100-00007; Ueda T, 2015, J NEUROIMAGING, V25, P927, DOI 10.1111/jon.12246; Wang CX, 2007, PROG NEUROBIOL, V83, P140, DOI 10.1016/j.pneurobio.2007.07.006; WHITE OB, 1979, STROKE, V10, P743, DOI 10.1161/01.STR.10.6.743; Yayan J, 2013, CLIN INTERV AGING, V8, P963, DOI 10.2147/CIA.S48269	35	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	FEB	2021	30	2							105523	10.1016/j.jstrokecerebrovasdis.2020.105523			7	Neurosciences; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	PT2AM	WOS:000608421600028	33307289				2022-02-06	
J	Hubbard, WB; Dong, JF; Cruz, MA; Rumbaut, RE				Hubbard, W. Brad; Dong, Jing-fei; Cruz, Miguel A.; Rumbaut, Rolando E.			Links between thrombosis and inflammation in traumatic brain injury	THROMBOSIS RESEARCH			English	Article						Platelets; Biomarkers; Blood-brain barrier dysfunction; Blast injury; Mild TBI; Fibrinogen; Coagulopathy; Hemostasis; von Willebrand factor; Extracellular vesicles	RAT-LIVER	Traumatic brain injury (TBI) continues to be a major healthcare problem and there is much to be explored regarding the secondary pathobiology to identify early predictive markers and new therapeutic targets. While documented changes in thrombosis and inflammation in major trauma have been well described, growing evidence suggests that isolated TBI also results in systemic alterations in these mechanisms. Here, we review recent experimental and clinical findings that demonstrate how blood-brain barrier dysfunction, systemic immune response, inflammation, platelet activation, and thrombosis contribute significantly to the pathogenesis of TBI. Despite advances in the links between thrombosis and inflammation, there is a lack of treatment options aimed at both processes and this could be crucial to treating vascular injury, local and systemic inflammation, and secondary ischemic events following TBI. With emerging evidence of newly-identified roles for platelets, leukocytes, the coagulation system and extracellular vesicles in processes of inflammation and thrombosis, there is a growing need to characterize these mechanisms within the context of TBI and whether these changes persist into the chronic phase of injury. Importantly, this review defines areas in need of further research to advance the field and presents a roadmap to identify new diagnostic and treatment options for TBI.	[Hubbard, W. Brad] Lexington VA Healthcare Syst, Lexington, KY USA; [Hubbard, W. Brad] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Lexington, KY USA; [Dong, Jing-fei] Bloodworks Res Inst, Seattle, WA USA; [Dong, Jing-fei] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; [Cruz, Miguel A.; Rumbaut, Rolando E.] Michael E DeBakey VA Med Ctr, Ctr Translat Res Inflammatory Dis CTRID, Houston, TX USA; [Cruz, Miguel A.; Rumbaut, Rolando E.] Baylor Coll Med, Houston, TX 77030 USA		Hubbard, WB (corresponding author), Lexington VA Med Ctr, 1101 Vet Dr, Lexington, KY 40502 USA.	bradhubbard@uky.edu			Department of Veterans Affairs Biomedical Laboratory Research & Development (BLRD) ServiceUS Department of Veterans Affairs; BLR&D Career Development Award from the Department of Veterans AffairsUS Department of Veterans Affairs [IK2 BX004618]; BLR&D Merit Review Award from the Department of Veterans AffairsUS Department of Veterans Affairs [I01 BX002551]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21NS087296, R01HL152200]	The meeting that inspired this review was supported by a field-based meeting award from the Department of Veterans Affairs Biomedical Laboratory Research & Development (BLR&D) Service. This work was supported by BLR&D Career Development Award Number [grant number IK2 BX004618] from the Department of Veterans Affairs awarded to WBH. RER was supported by BLR&D Merit Review Award [grant number I01 BX002551] from the Department of Veterans Affairs, JFD was supported by the NIH [grant numbers R21NS087296; R01HL152200]. The content is solely the responsibility of the authors and does not represent the official views of National Institutes of Health, Department of Veterans Affairs or the United States government.	Abbott NJ, 2013, J INHERIT METAB DIS, V36, P437, DOI 10.1007/s10545-013-9608-0; Albert-Weissenberger C, 2019, J NEUROIMMUNOL, V326, P9, DOI 10.1016/j.jneuroim.2018.10.011; Albert-Weissenberger C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00269; ANDERSON ME, 1980, J BIOL CHEM, V255, P9530; Posada-Duque RA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00231; Arthur JF, 2008, PLATELETS, V19, P1, DOI 10.1080/09537100701817224; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; BACH R, 1988, BIOCHEMISTRY-US, V27, P4227, DOI 10.1021/bi00412a004; Bailey ZS, 2016, METHODS MOL BIOL, V1462, P119, DOI 10.1007/978-1-4939-3816-2_8; Begonja AJ, 2005, BLOOD, V106, P2757, DOI 10.1182/blood-2005-03-1047; Bianco F, 2005, J IMMUNOL, V174, P7268, DOI 10.4049/jimmunol.174.11.7268; Bolton-Hall AN, 2019, J NEUROTRAUM, V36, P1203, DOI 10.1089/neu.2018.6096; Boudreau LH, 2014, BLOOD, V124, P2173, DOI 10.1182/blood-2014-05-573543; Brown AC, 2019, BIOCONJUGATE CHEM, V30, P1951, DOI 10.1021/acs.bioconjchem.9b00360; Brown LS, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00282; Brown SB, 2000, J BIOL CHEM, V275, P5987, DOI 10.1074/jbc.275.8.5987; Bryckaert M, 2015, CELL MOL LIFE SCI, V72, P307, DOI 10.1007/s00018-014-1743-8; Cairns CB, 1997, J TRAUMA, V42, P532, DOI 10.1097/00005373-199703000-00023; Canobbio I, 2019, RES PRACT THROMB HAE, V3, P564, DOI 10.1002/rth2.12254; Cavallucci V, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.511; Cekic C, 2016, NAT REV IMMUNOL, V16, P177, DOI 10.1038/nri.2016.4; Chang R, 2016, BLOOD, V128, P1043, DOI 10.1182/blood-2016-01-636423; Chen XR, 2017, J NEUROINFLAMM, V14, DOI [10.1186/s12974-017-0917-3, 10.1186/s12974-018-1151-3]; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Chio CC, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0867-9; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Chou A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061616; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Daglas M, 2019, CELL REP, V29, P1178, DOI 10.1016/j.celrep.2019.09.046; Dale GL, 2006, J THROMB HAEMOST, V4, P2664, DOI 10.1111/j.1538-7836.2006.02211.x; Darbousset R, 2012, BLOOD, V120, P2133, DOI 10.1182/blood-2012-06-437772; Davizon P, 2010, SEMIN THROMB HEMOST, V36, P857, DOI 10.1055/s-0030-1267039; De Meyer SF, 2016, STROKE, V47, P1165, DOI 10.1161/STROKEAHA.115.011238; De Oliveira CO, 2007, J NEUROTRAUM, V24, P1331, DOI 10.1089/neu.2006.0159; deKroon AIPM, 1997, BBA-BIOMEMBRANES, V1325, P108, DOI 10.1016/S0005-2736(96)00240-4; Delvaeye M, 2009, BLOOD, V114, P2367, DOI 10.1182/blood-2009-05-199208; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; DEVAUX PF, 1992, ANNU REV BIOPH BIOM, V21, P417, DOI 10.1146/annurev.bb.21.060192.002221; Doherty CP, 2016, J NEUROPATH EXP NEUR, V75, P656, DOI 10.1093/jnen/nlw036; Dong J.F., 2020, BLOOD; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Duan SM, 2006, GLIA, V54, P738, DOI 10.1002/glia.20397; EDDLESTON M, 1993, J CLIN INVEST, V92, P349, DOI 10.1172/JCI116573; Fan KQ, 2019, CELL, V179, P864, DOI 10.1016/j.cell.2019.10.001; Farell M, 2019, CLIN NEUROPATHOL, V38, P51, DOI 10.5414/NP301130; Fasipe TA, 2018, STROKE, V49, P2536, DOI 10.1161/STROKEAHA.118.022888; Ferrari D, 1997, NEUROPHARMACOLOGY, V36, P1295, DOI 10.1016/S0028-3908(97)00137-8; FLECK RA, 1990, THROMB RES, V59, P421, DOI 10.1016/0049-3848(90)90148-6; Folkerson LE, 2018, AM J EMERG MED, V36, P38, DOI 10.1016/j.ajem.2017.06.057; FOX JEB, 1991, J BIOL CHEM, V266, P13289; Galvagno SM, 2017, J TRAUMA ACUTE CARE, V83, P668, DOI 10.1097/TA.0000000000001584; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Goyal K, 2018, INDIAN J CRIT CARE M, V22, P632, DOI 10.4103/ijccm.IJCCM_156_18; Hammad A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1066-z; Han XJ, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00210; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Heemskerk JWM, 1997, BLOOD, V90, P2615, DOI 10.1182/blood.V90.7.2615.2615_2615_2625; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; Hopp S, 2016, ANN NEUROL, V79, P970, DOI 10.1002/ana.24655; HOVIUS R, 1990, BIOCHIM BIOPHYS ACTA, V1021, P217, DOI 10.1016/0005-2736(90)90036-N; Hubbard WB, 2019, J NEUROTRAUM, V36, P1252, DOI 10.1089/neu.2018.5990; Hubbard WB, 2018, J NEUROSCI RES, V96, P1677, DOI 10.1002/jnr.24271; Hubbard WB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28848-2; Hubbard WB, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5175249; Jackson SP, 2019, BLOOD, V133, P906, DOI 10.1182/blood-2018-11-882993; Jamous MA, 2020, OPEN ACCESS EMERG M, V12, P81, DOI 10.2147/OAEM.S239881; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jenkins DR, 2018, J NEUROTRAUM, V35, P2259, DOI 10.1089/neu.2017.5291; Jiang RC, 2018, JAMA NEUROL, V75, P1338, DOI 10.1001/jamaneurol.2018.2030; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Karasu E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00721; Kazanis I, 2015, EXP NEUROL, V269, P75, DOI 10.1016/j.expneurol.2015.03.018; Keaney J, 2015, FEBS J, V282, P4067, DOI 10.1111/febs.13412; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kiouptsi Klytaimnistra, 2020, Subcell Biochem, V94, P437, DOI 10.1007/978-3-030-41769-7_18; Kramer TJ, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1550-0; Kumar MA, 2019, J NEUROTRAUM, V36, P222, DOI 10.1089/neu.2018.5696; Kuriakose M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26813-7; Langen UH, 2019, ANNU REV CELL DEV BI, V35, P591, DOI 10.1146/annurev-cellbio-100617-062608; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; LASH LH, 1985, ARCH BIOCHEM BIOPHYS, V240, P583, DOI 10.1016/0003-9861(85)90065-7; Lee Bruce, 2005, NeuroRx, V2, P372; Lee K, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/207247; Leiter O, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00747; Leiter O, 2019, PROG NEUROBIOL, V183, DOI 10.1016/j.pneurobio.2019.101695; Li AE, 1999, CIRC RES, V85, P304, DOI 10.1161/01.RES.85.4.304; Liu YWY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1173-x; Lok J, 2011, ACTA NEUROCHIR SUPPL, V111, P63, DOI 10.1007/978-3-7091-0693-8_11; Lu DY, 2004, J NEUROTRAUM, V21, P1756, DOI 10.1089/neu.2004.21.1756; Maeda T, 1997, ACT NEUR S, V70, P102; Makinde HM, 2017, J IMMUNOL, V199, P3583, DOI 10.4049/jimmunol.1700896; MANSOOR MA, 1992, ANAL BIOCHEM, V200, P218, DOI 10.1016/0003-2697(92)90456-H; Martin C, 2007, J THROMB HAEMOST, V5, P1363, DOI 10.1111/j.1538-7836.2007.02536.x; Martin GE, 2018, SHOCK, V50, P551, DOI 10.1097/SHK.0000000000001056; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Memon AA, 2018, BRIT J HAEMATOL, V181, P378, DOI 10.1111/bjh.15206; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Mojiri A, 2019, MICROCIRCULATION, V26, DOI 10.1111/micc.12510; Morales D, 2006, J NEUROTRAUM, V23, P976, DOI 10.1089/neu.2006.23.976; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Muldoon LL, 2013, J CEREBR BLOOD F MET, V33, P13, DOI 10.1038/jcbfm.2012.153; Muradashvili N, 2015, METAB BRAIN DIS, V30, P411, DOI 10.1007/s11011-014-9550-3; Muradashvili N, 2013, BRAIN INJURY, V27, P1508, DOI 10.3109/02699052.2013.823562; Murugan M, 2020, BRAIN BEHAV IMMUN, V88, P340, DOI 10.1016/j.bbi.2020.03.029; Nag S, 2011, NEUROPATH APPL NEURO, V37, P3, DOI 10.1111/j.1365-2990.2010.01138.x; Nagao RJ, 2019, ADV SCI, V6, DOI 10.1002/advs.201901725; Nakae R, 2019, ACTA NEUROCHIR, V161, P1943, DOI 10.1007/s00701-019-04010-3; NESHEIM ME, 1983, J BIOL CHEM, V258, P5386; Niemela J, 2008, EUR J IMMUNOL, V38, P2718, DOI 10.1002/eji.200838437; O'Keeffe E, 2020, J NEUROTRAUM, V37, P347, DOI 10.1089/neu.2019.6483; OSTERUD B, 1977, P NATL ACAD SCI USA, V74, P5260, DOI 10.1073/pnas.74.12.5260; Pearlstein DP, 2002, ARTERIOSCL THROM VAS, V22, P566, DOI 10.1161/01.ATV.0000012262.76205.6A; Phillis JW, 2006, BRAIN RES REV, V52, P201, DOI 10.1016/j.brainresrev.2006.02.002; Ploplis VA, 2014, J NEUROTRAUM, V31, P1672, DOI 10.1089/neu.2013.3302; Ponto LLB, 2016, J NEUROPSYCH CLIN N, V28, P89, DOI 10.1176/appi.neuropsych.15050106; Praeger AJ, 2012, CRIT CARE RESUSC, V14, P10; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; RUF W, 1991, J BIOL CHEM, V266, P16256; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sahyouni R, 2017, J CONCUSSION, V1; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Samuels JM, 2019, J TRAUMA ACUTE CARE, V86, P686, DOI 10.1097/TA.0000000000002173; Sandsmark DK, 2019, NEURON, V103, P367, DOI 10.1016/j.neuron.2019.06.002; Savjani RR, 2017, J NEUROTRAUM, V34, P3107, DOI 10.1089/neu.2017.5022; Schmitt A, 2001, EXP HEMATOL, V29, P1295, DOI 10.1016/S0301-472X(01)00733-0; Schwarzmaier SM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-32; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Sen P, 2011, BLOOD, V117, P3199, DOI 10.1182/blood-2010-09-310706; Shi J, 2008, J THROMB HAEMOST, V6, P1167, DOI 10.1111/j.1538-7836.2008.03010.x; Shi JL, 2003, BLOOD, V101, P2628, DOI 10.1182/blood-2002-07-1951; Shi KB, 2019, CELL MOL IMMUNOL, V16, P523, DOI 10.1038/s41423-019-0213-5; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Skotak M, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01015; Skrifvars MB, 2017, INTENS CARE MED, V43, P419, DOI 10.1007/s00134-016-4655-2; Smeding L, 2012, SHOCK, V37, P449, DOI 10.1097/SHK.0b013e31824c3238; Stephens JA, 2018, J NEUROTRAUM, V35, P241, DOI 10.1089/neu.2017.5237; Stoll G, 2019, NAT REV NEUROL, V15, P473, DOI 10.1038/s41582-019-0221-1; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; SVENNERHOLM L, 1968, J LIPID RES, V9, P570; SVENNERHOLM L, 1972, BRAIN RES, V47, P457, DOI 10.1016/0006-8993(72)90652-X; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00351; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Vaibhav K, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax8847; Valladolid C, 2020, BLOOD ADV, V4, P1340, DOI 10.1182/bloodadvances.2020001500; Veksler R, 2020, BRAIN, V143, P1826, DOI 10.1093/brain/awaa140; Visavadiya NP, 2016, REDOX BIOL, V8, P59, DOI 10.1016/j.redox.2015.12.011; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Ware JB, 2020, BRAIN, V143, P1625, DOI 10.1093/brain/awaa166; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; Wu YG, 2018, BLOOD, V132, P1075, DOI 10.1182/blood-2018-03-841932; Xiong Y, 1998, J NEUROTRAUM, V15, P531, DOI 10.1089/neu.1998.15.531; Xu X, 2020, J THROMB HAEMOST, V18, P3154, DOI 10.1111/jth.15096; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; Yuan Q, 2017, NEUROSCIENCE, V348, P114, DOI 10.1016/j.neuroscience.2017.02.020; Zhang JN, 2018, BLOOD, V131, P2001, DOI 10.1182/blood-2017-11-784108; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhao Z, 2019, HAEMATOLOGICA; Zhao ZL, 2020, HAEMATOLOGICA, V105, P209, DOI 10.3324/haematol.2018.214932; Zhao ZL, 2016, BLOOD, V127, P2763, DOI [10.1182/blood-2015-12688838, 10.1182/blood-2015-12-688838]; Zhou Y, 2018, BLOOD, V131, P563, DOI 10.1182/blood-2017-08-801738; ZWAAL RFA, 1977, NATURE, V268, P358, DOI 10.1038/268358a0	175	2	2	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0049-3848	1879-2472		THROMB RES	Thromb. Res.	FEB	2021	198						62	71		10.1016/j.thromres.2020.10.041			10	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	QE2PJ	WOS:000616053200012	33290884				2022-02-06	
J	Lynch, KR; Jackson, DB				Lynch, Kellie R.; Jackson, Dylan B.			Firearm exposure and the health of high-risk intimate partner violence victims	SOCIAL SCIENCE & MEDICINE			English	Article						Gun violence; Intimate partner violence; Health correlates; Trauma	POSTTRAUMATIC-STRESS-DISORDER; SLEEP QUALITY INDEX; TRAUMATIC BRAIN-INJURY; PHYSICAL HEALTH; SOCIOECONOMIC-STATUS; MENTAL-HEALTH; WOMEN; SYMPTOMS; ASSOCIATION; COMORBIDITY	Rationale: The negative physical and mental health consequences of intimate partner violence (IPV) have been well-documented, as those who are exposed to trauma experience more physical health issues. Further, an abuser's direct access to a firearm drastically increases the risk for fatality, which can exacerbate ongoing stress and trauma in an abusive relationship. However, very little research has investigated the intersection of exposure to firearms and adverse health outcomes in the context of IPV. Objective. This study investigates the sensitivity of firearm exposure in IPV contexts by examining if abusive partner firearm ownership-regardless of actual use of a gun in the abuse-is associated with negative health outcomes. Methods. The research team administered questionnaires to IPV victims (N = 215) from six domestic violence shelters across rural and urban locations in a single state. Results. Having an abusive partner who owned a firearm was associated with significantly worse physical health-above and beyond IPV experienced in the relationship. Even so, IPV involving firearms was not significantly associated with physical health beyond partner firearm ownership. The relationship between partner firearm ownership and negative health outcomes was primarily attenuated by sleep disturbances among victims. Conclusions. The results provide initial information about the role that firearms play in adverse victim health beyond injuries (e.g., gunshot wounds) and fatalities.	[Lynch, Kellie R.] Univ Texas San Antonio, Dept Criminol & Criminal Justice, 501 W Cesar Chavez Blvd, San Antonio, TX 78207 USA; [Jackson, Dylan B.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA		Lynch, KR (corresponding author), Univ Texas San Antonio, Dept Criminol & Criminal Justice, 501 W Cesar Chavez Blvd, San Antonio, TX 78207 USA.	Kellie.Lynch@utsa.edu; dylan.jackson@jhu.edu			Office for the Vice President for Research at the University of Texas at San Antonio as part of the Grants for Research Advancement and Transformation program	This research was funded by the Office for the Vice President for Research at the University of Texas at San Antonio as part of the Grants for Research Advancement and Transformation program.	ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6; Beydoun HA, 2012, SOC SCI MED, V75, P959, DOI 10.1016/j.socscimed.2012.04.025; Bonomi AE, 2009, ARCH INTERN MED, V169, P1692, DOI 10.1001/archinternmed.2009.292; Breiding MJ, 2008, ANN EPIDEMIOL, V18, P538, DOI 10.1016/j.annepidem.2008.02.005; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Campbell JC, 2003, AM J PUBLIC HEALTH, V93, P1089, DOI 10.2105/AJPH.93.7.1089; Coker AL, 2000, ARCH FAM MED, V9, P451, DOI 10.1001/archfami.9.5.451; Coker AL, 2005, J WOMENS HEALTH, V14, P829, DOI 10.1089/jwh.2005.14.829; Cooper AA, 2011, P AM MATH SOC, V139, P2933, DOI 10.1090/S0002-9939-2010-10714-1; Dillon Gina, 2013, Int J Family Med, V2013, P313909, DOI 10.1155/2013/313909; Dirkzwager AJE, 2007, PSYCHOSOM MED, V69, P435, DOI 10.1097/PSY.0b013e318052e20a; Dobie DJ, 2006, J GEN INTERN MED, V21, pS58, DOI 10.1111/j.1525-1497.2006.00376.x; Gagnon KL, 2017, J TRAUMA DISSOCIATIO, V18, P635, DOI 10.1080/15299732.2016.1252001; Gallegos A.M., 2019, TRAUMA VIOLENCE ABUS; Germain A, 2005, J ANXIETY DISORD, V19, P233, DOI 10.1016/j.janxdis.2004.02.001; Golding JM, 1999, J FAM VIOLENCE, V14, P99, DOI 10.1023/A:1022079418229; Grinshteyn E, 2019, PREV MED, V123, P20, DOI 10.1016/j.ypmed.2019.02.026; Gruenewald J, 2012, J QUANT CRIMINOL, V28, P141, DOI 10.1007/s10940-011-9155-5; Haag H., 2019, TRAUMA VIOLENCE ABUS; Hemenway D, 2013, NEW ENGL J MED, V368, P2033, DOI 10.1056/NEJMsb1302631; Jackson DB, 2020, SLEEP HEALTH, V6, P723, DOI 10.1016/j.sleh.2020.04.013; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Jacobsen WC, 2019, J RES CRIME DELINQ, V56, P651, DOI 10.1177/0022427819829794; Karlson KB, 2012, SOCIOL METHODOL, V42, P286, DOI 10.1177/0081175012444861; Kendall-Tackett K, 2003, WOMEN THER, V26, P45, DOI 10.1300/J015v26n01_03; Kendall-Tackett KA, 2000, CHILD ABUSE NEGLECT, V24, P799, DOI 10.1016/S0145-2134(00)00136-8; Kendall-Tackett K, 2009, PSYCHOL TRAUMA-US, V1, P35, DOI 10.1037/a0015128; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Lalley-Chareczko L, 2017, J INTERPERS VIOLENCE, V32, P2471, DOI 10.1177/0886260515592651; Little R. J., 2019, STAT ANAL MISSING DA, V793; Logan T K, 2007, Violence Vict, V22, P546, DOI 10.1891/088667007782312168; Logan TK, 2018, VIOLENCE VICTIMS, V33, P399, DOI 10.1891/0886-6708.VV-D-17-00134; Lynch KR, 2018, J INTERPERS VIOLENCE, V33, P686, DOI 10.1177/0886260515613344; Mason SM, 2013, DIABETES CARE, V36, P1159, DOI 10.2337/dc12-1082; Mason SM, 2012, ANN EPIDEMIOL, V22, P562, DOI 10.1016/j.annepidem.2012.05.003; Matthews KA, 2011, ANNU REV PSYCHOL, V62, P501, DOI 10.1146/annurev.psych.031809.130711; McEwen BS, 2006, METABOLISM, V55, pS20, DOI 10.1016/j.metabol.2006.07.008; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; Mollborn S, 2020, SOC SCI MED, V265, DOI 10.1016/j.socscimed.2020.113182; Muller CJ, 2014, INT J EPIDEMIOL, V43, P962, DOI 10.1093/ije/dyu029; Niles B.L., 2000, PL S STRESS, P213; PEARLIN LI, 1989, J HEALTH SOC BEHAV, V30, P241, DOI 10.2307/2136956; Peleg T, 2006, CNS SPECTRUMS, V11, P589, DOI 10.1017/S109285290001364X; Pigeon WR, 2011, J WOMENS HEALTH, V20, P1923, DOI 10.1089/jwh.2011.2781; Resnick HS, 1997, BEHAV MED, V23, P65, DOI 10.1080/08964289709596730; Rothman Emily F, 2005, J Am Med Womens Assoc (1972), V60, P62; Sanchez SE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152199; Sareen J, 2007, PSYCHOSOM MED, V69, P242, DOI 10.1097/PSY.0b013e31803146d8; Smith ME, 2020, SOC SCI MED, V246, DOI 10.1016/j.socscimed.2019.112587; Sorenson SB, 2004, AM J PUBLIC HEALTH, V94, P1412, DOI 10.2105/AJPH.94.8.1412; Sorenson SB, 2018, TRAUMA VIOLENCE ABUS, V19, P431, DOI 10.1177/1524838016668589; Sorenson SB, 2017, J WOMENS HEALTH, V26, P249, DOI 10.1089/jwh.2016.5832; Spencer CM, 2020, TRAUMA VIOLENCE ABUS, V21, P527, DOI 10.1177/1524838018781101; Stark E., 2009, COERCIVE CONTROL ENT; StataCorp, 2017, STATA STAT SOFTWARE, V15; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Sullivan TP, 2017, VIOLENCE GEND, V4, P31, DOI 10.1089/vio.2016.0024; Thoits PA, 2010, J HEALTH SOC BEHAV, V51, pS41, DOI 10.1177/0022146510383499; Tolman R M, 1999, Violence Vict, V14, P25; Van Houdenhove B., 2009, TRAUMA PHYS HLTH UND; Walker R, 2011, J INTERPERS VIOLENCE, V26, P2004, DOI 10.1177/0886260510372932; Werner KB, 2016, PSYCHIAT RES, V240, P234, DOI 10.1016/j.psychres.2016.04.039; Wiebe DJ, 2003, ANN EMERG MED, V42, P405, DOI 10.1016/S0196-0644(03)00509-2; Williams D R, 1997, J Health Psychol, V2, P335, DOI 10.1177/135910539700200305; Woods SJ, 2008, J MIDWIFERY WOM HEAL, V53, P538, DOI 10.1016/j.jmwh.2008.07.004; Woods SJ, 2010, J TRAUMA STRESS, V23, P141, DOI 10.1002/jts.20495	68	2	2	1	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-9536	1873-5347		SOC SCI MED	Soc. Sci. Med.	FEB	2021	270								113644	10.1016/j.socscimed.2020.113644			8	Public, Environmental & Occupational Health; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Biomedical Social Sciences	QL8WO	WOS:000621361500010	33385621				2022-02-06	
J	Maerlender, A; Smith, E; Brolinson, PG; Crisco, J; Urban, J; Ajamil, A; Rowson, S; Campolettano, ET; Gellner, RA; Bellamkonda, S; Kieffer, E; Kelley, ME; Jones, D; Powers, A; Beckwith, J; Stitzel, J; Greenwald, RM; Duma, S				Maerlender, Arthur; Smith, Eric; Brolinson, P. Gunnar; Crisco, Joseph; Urban, Jillian; Ajamil, Amaris; Rowson, Steven; Campolettano, Eamon T.; Gellner, Ryan A.; Bellamkonda, Srinidhi; Kieffer, Emily; Kelley, Mireille E.; Jones, Derek; Powers, Alex; Beckwith, Jonathan; Stitzel, Joel; Greenwald, Richard M.; Duma, Stefan			Neuropsychological Change After a Single Season of Head Impact Exposure in Youth Football	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Youth football; Head impact exposure; Neuropsychological test; Cognition; NIH Toolbox; Reliable change	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; CLINICAL-SIGNIFICANCE; NEUROLOGIC FUNCTION; CONCUSSION; CB; ACCELERATION; SPORTS; COHORT; TERM	Objectives: Head impact exposure (HIE) in youth football is a public health concern. The objective of this study was to determine if one season of HIE in youth football was related to cognitive changes. Method: Over 200 participants (ages 9-13) wore instrumented helmets for practices and games to measure the amount of HIE sustained over one season. Pre- and post-season neuropsychological tests were completed. Test score changes were calculated adjusting for practice effects and regression to the mean and used as the dependent variables. Regression models were calculated with HIE variables predicting neuropsychological test score changes. Results: For the full sample, a small effect was found with season average rotational values predicting changes in list-learning such that HIE was related to negative score change: standardized beta (beta) = -.147, t(205) = -2.12, and p = .035. When analyzed by age clusters (9-10, 11-13) and adding participant weight to models, the R (2) values increased. Splitting groups by weight (median split), found heavier members of the 9-10 cohort with significantly greater change than lighter members. Additionaly, significantly more participants had clinically meaningful negative changes: X (2) = 10.343, p = .001. Conclusion: These findings suggest that in the 9-10 age cluster, the average seasonal level of HIE had inverse, negative relationships with cognitive change over one season that was not found in the older group. The mediation effects of age and weight have not been explored previously and appear to contribute to the effects of HIE on cognition in youth football players.	[Maerlender, Arthur] Univ Nebraska, Lincoln, NE 68588 USA; [Smith, Eric; Brolinson, P. Gunnar; Rowson, Steven; Campolettano, Eamon T.; Gellner, Ryan A.; Kieffer, Emily; Duma, Stefan] Virginia Polytech Inst & State Univ, Ctr Injury Biomech, Blacksburg, VA 24060 USA; [Urban, Jillian; Kelley, Mireille E.; Jones, Derek; Stitzel, Joel] Wake Forest Univ, Sch Biomed Engn & Sci, Winston Salem, NC 27109 USA; [Ajamil, Amaris; Beckwith, Jonathan; Greenwald, Richard M.] Simbex Inc, Lebanon, NH 03766 USA; [Brolinson, P. Gunnar] Edward Via Coll Osteopath Med, Dept Family & Sports Med, Blacksburg, VA 24060 USA; [Crisco, Joseph; Bellamkonda, Srinidhi] Brown Univ, Dept Orthoped, Providence, RI 02912 USA; [Powers, Alex] Wake Forest Baptist Med Ctr, Dept Neurosurg, Winston Salem, NC 27157 USA		Maerlender, A (corresponding author), Univ Nebraska, Ctr Brain Biol & Behav, Lincoln, NE 68588 USA.	amaerlender2@unl.edu	Rowson, Steven/B-1270-2012	Rowson, Steven/0000-0002-3227-0596; Crisco, Joseph/0000-0002-8786-0905	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094410]	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number R01NS094410. We would like to thank the youth, parents, and coaches for their time and effort participating in this project; also, thanks to Tina Strates for database assistance.	Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Brennan JH, 2017, SPORTS MED, V47, P469, DOI 10.1007/s40279-016-0582-1; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Carlozzi NE, 2015, ARCH CLIN NEUROPSYCH, V30, P359, DOI 10.1093/arclin/acv031; Carlozzi NE, 2013, MONOGR SOC RES CHILD, V78, P88, DOI 10.1111/mono.12036; Carman AJ, 2015, NAT REV NEUROL, V11, P230, DOI 10.1038/nrneurol.2015.30; Casey BJ, 2010, J AM ACAD CHILD PSY, V49, P1189, DOI 10.1016/j.jaac.2010.08.017; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Chelune GJ, 2003, PREDICTION IN FORENSIC AND NEUROPSYCHOLOGY, P123; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Heilbronner RL, 2010, CLIN NEUROPSYCHOL, V24, P1267, DOI 10.1080/13854046.2010.526785; Institute of Medicine (IOM) and National Research Council (NRC), 2014, SPORTS RELATED CONCU; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Johnson EK, 2006, REHABIL COUNS BULL, V50, P35, DOI 10.1177/00343552060500010501; Kelley ME, 2017, J NEUROTRAUM, V34, P1939, DOI 10.1089/neu.2016.4812; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kuczmarski RJ., 2002, ADV DATA, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; National Institutes of Health and Northwestern University, 2017, NIH TOOLB ASS NEUR B; Nauman EA, 2015, DEV NEUROPSYCHOL, V40, P85, DOI 10.1080/87565641.2015.1016161; Rose SC, 2019, J NEUROTRAUM, V36, P2803, DOI 10.1089/neu.2019.6519; Rose SC, 2019, J HEAD TRAUMA REHAB, V34, P87, DOI 10.1097/HTR.0000000000000441; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P791, DOI 10.1093/arclin/act077; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Slotkin J., 2017, NIH TOOLBOX EQUIVALE; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tarnutzer AA, 2017, BRIT J SPORT MED, V51, P1592, DOI 10.1136/bjsports-2016-096593; Temkin NR, 1999, J INT NEUROPSYCH SOC, V5, P357, DOI 10.1017/S1355617799544068; Tsushima WT, 2016, APPL NEUROPSYCH-CHIL, V5, P149, DOI 10.1080/21622965.2015.1052813; Tulsky DS, 2017, REHABIL PSYCHOL, V62, P413, DOI 10.1037/rep0000174; Tulsky DS, 2013, MONOGR SOC RES CHILD, V78, P70, DOI 10.1111/mono.12035; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004; Zelazo PD, 2013, MONOGR SOC RES CHILD, V78, P16, DOI 10.1111/mono.12032	58	2	2	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	FEB	2021	27	2					113	123	PII S1355617720000685	10.1017/S1355617720000685			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	QF3VS	WOS:000616826300001	32762785	Green Submitted, Green Accepted			2022-02-06	
J	Matsushima, K; Leichtle, SW; Wild, J; Young, K; Chang, G; Demetriades, D				Matsushima, Kazuhide; Leichtle, Stefan W.; Wild, Jeffrey; Young, Katelyn; Chang, Grace; Demetriades, Demetrios		EAST ACT-TBI Multictr Study Grp	Anticoagulation therapy in patients with traumatic brain injury: An Eastern Association for the Surgery of Trauma multicenter prospective study	SURGERY			English	Article; Proceedings Paper	32nd Annual Scientific Assembly of the Eastern-Association-for-the-Surgery-of-Trauma (EAST)	JAN 15-19, 2019	Austin, TX	Eastern Assoc Surg Trauma			ANTITHROMBOTIC THERAPY; INTRACRANIAL HEMORRHAGE; ATRIAL-FIBRILLATION; WARFARIN; STROKE; THROMBOEMBOLISM; MORTALITY; RISK	Background: Trauma care providers often face a dilemma regarding anticoagulation therapy initiation in patients with traumatic brain injury owing to the associated risks of traumatic brain injury progression. The aims of this study were the following: (1) to describe the current practice of anticoagulation therapy in traumatic brain injury patients and their outcomes and (2) to identify factors associated with the progression of traumatic brain injury after anticoagulation therapy. Methods: In this multicenter prospective observational study, we included computed tomography -proven traumatic brain injury patients who received anticoagulation therapy within 30 days of hospital admission. Our primary outcome was the incidence of clinically significant progression of traumatic brain injury after anticoagulation therapy initiation. Results: A total of 168 patients were enrolled more than 22 months. Atrial fibrillation and venous thromboembolism were the most common pre-injury and post-injury anticoagulation therapy indications, respectively. Overall, 16 patients (9.6%) experienced clinically significant traumatic brain injury progression after anticoagulation therapy, out of which 9 (5.4%) patients subsequently required neurosurgical interventions. Between patients with clinical progression of traumatic brain injury and patients who showed no such progression, there were no significant differences in the baseline demographics and severity of traumatic brain injury. However, anticoagulation therapy was initiated significantly earlier in patients of the deterioration group than those of the nodeterioration group (4.5 days vs 11 days, P = .015). In a multiple logistic regression model, patients who received anticoagulation therapy later after injury had significantly lower risk of clinically significant traumatic brain injury progression (odds ratio: 0.915 for each day, 95% confidence interval: 0.841-0.995, P = .037). Conclusion: Our results suggest that early anticoagulation therapy is associated with higher risk of traumatic brain injury progression, thus a balance between bleeding and thromboembolic risks should be carefully evaluated in each case before initiating anticoagulation therapy. (C) 2020 Elsevier Inc. All rights reserved.	[Matsushima, Kazuhide; Demetriades, Demetrios] LAC USC Med Ctr, Div Acute Care Surg, Los Angeles, CA USA; [Leichtle, Stefan W.] VCU Med Ctr, Div Acute Care Surg Serv, Richmond, VA USA; [Wild, Jeffrey; Young, Katelyn] Geisinger Med Ctr, Sect Trauma & Emergency Gen Surg, Danville, PA 17822 USA; [Chang, Grace] Div Trauma & Surg Crit Care, Mt Sinai, NY USA; [Chang, Grace] Univ Chicago, Div Surg Crit Care, Chicago, IL 60637 USA		Matsushima, K (corresponding author), Univ Southern Calif, LAC USC Med Ctr, Surg, 2051 Marengo St,Inpatient Tower C,C5L100, Los Angeles, CA 90033 USA.	kazuhide.matsushima@med.usc.edu	Wong, Monica D/D-9016-2017	Wong, Monica D/0000-0001-7041-9518; Glass, Nina/0000-0002-6821-4289; Young, Katelyn/0000-0001-9394-7559; Matsushima, Kazuhide/0000-0001-9625-5363; Rodriguez Mederos, Dalier/0000-0002-4198-6932	NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR001855] Funding Source: Medline		Barnes GD, 2015, AM J MED, V128, P1300, DOI 10.1016/j.amjmed.2015.05.044; Byrnes MC, 2012, WORLD J EMERG SURG, V7, DOI 10.1186/1749-7922-7-25; CANNEGIETER SC, 1994, CIRCULATION, V89, P635, DOI 10.1161/01.CIR.89.2.635; Deepika A, 2015, ACTA NEUROCHIR, V157, P2033, DOI 10.1007/s00701-015-2575-5; Douketis JD, 2015, NEW ENGL J MED, V373, P823, DOI 10.1056/NEJMoa1501035; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hornor MA, 2018, J AM COLL SURGEONS, V227, P521, DOI 10.1016/j.jamcollsurg.2018.08.183; Lip GYH, 2018, CHEST, V154, P1121, DOI 10.1016/j.chest.2018.07.040; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Matsushima K, 2016, J SURG RES, V205, P186, DOI 10.1016/j.jss.2016.06.042; Maung AA, 2016, J TRAUMA ACUTE CARE, V81, P652, DOI 10.1097/TA.0000000000001189; Nielsen PB, 2017, JAMA INTERN MED, V177, P563, DOI 10.1001/jamainternmed.2016.9369; Pandya U, 2018, AM SURGEON, V84, P416; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Prexl O, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0487-0; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; Shahan CP, 2016, J TRAUMA ACUTE CARE, V81, P173, DOI 10.1097/TA.0000000000001058; Shin SS, 2020, NEUROCRIT CARE, V32, P407, DOI 10.1007/s12028-019-00898-y; The American College of Surgeons Trauma Quality Improvement Program, NEST PRACT MAN TRAUM; Thorson CM, 2012, CRIT CARE MED, V40, P2967, DOI 10.1097/CCM.0b013e31825bcb60; Wells PS, 2014, JAMA-J AM MED ASSOC, V311, P717, DOI 10.1001/jama.2014.65; Whitlock RP, 2012, CHEST, V141, pE576S, DOI 10.1378/chest.11-2305	23	2	2	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	FEB	2021	169	2					470	476		10.1016/j.surg.2020.07.040			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	PT3DH	WOS:000608497000037	32928573	Green Accepted			2022-02-06	
J	Meade, MJ; Tumati, A; Chantachote, C; Huang, EC; Rutigliano, DN; Rubano, JA; Vosswinkel, JA; Jawa, RS				Meade, Michael J.; Tumati, Abhinay; Chantachote, Chanak; Huang, Emily C.; Rutigliano, Daniel N.; Rubano, Jerry A.; Vosswinkel, James A.; Jawa, Randeep S.			Antithrombotic Agent Use in Elderly Patients Sustaining Low-Level Falls	JOURNAL OF SURGICAL RESEARCH			English	Article						Antithrombotics; Anticoagulants; Antiplatelet agents; Trauma	TRAUMATIC BRAIN-INJURY; PREINJURY WARFARIN; INTRACRANIAL HEMORRHAGE; ORAL ANTICOAGULANTS; ATRIAL-FIBRILLATION; HEAD TRAUMA; OUTCOMES; ANTIPLATELET; RISK; IMPACT	Background: Elderly patients who are injured from a low-level fall comprise an increasing percentage of trauma admissions. We sought to evaluate the prevalence of antithrombotic (anticoagulant or antiplatelet) agent use, injury patterns, and outcomes in this population, focusing on intracranial hemorrhage (ICH). Methods: We retrospectively reviewed the trauma registry at an American College of Surgeons-verified Level I trauma center for all patients aged 65 y or older admitted between 2007 and 2016 following a low-level fall. Medical records of patients on antithrombotic agents were examined in detail. Patients were divided into four groups based on the presence/ absence of ICH and presence/absence of preadmission antithrombotic medication use. Results: There were 4074 elderly patients admitted after a low-level fall, of which 1153 (28.3%) had a traumatic ICH, and 1238 (30.4%) were on antithrombotic agents. Notably, 35.9% of patients on antithrombotics had an ICH, as compared to 25.0% of 2836 patients not on antithrombotics other than aspirin (P < 0.001). The overall distribution of antithrombotic agent use differed significantly between the ICH and non-ICH groups; the ICH group had more coumadin usage. The mortality rate was significantly different across groups, with the group having ICH and a history of antithrombotics having the highest mortality at 14.2% (P < 0.001). Excluding the 27.8% of patients who were transferred into our hospital demonstrated that significantly more admissions on antithrombotics had ICH (22.4%) versus ICH admissions not on antithrombotics (14.7%, P < 0.001). The mortality rate was significantly different across groups, with the group having ICH and a history of antithrombotics having the highest mortality at 12.0% (P < 0.001). On multivariable analysis, anticoagulants, antiplatelets, and aspirin were all significantly associated with ICH; but only anticoagulants were significantly associated with mortality. Conclusions: Antithrombotic agent use was common in admitted elderly patients sustaining a low-level fall and is associated with an elevated rate of ICH. Anticoagulants were also associated with increased mortality. (C) 2020 Elsevier Inc. All rights reserved.	[Meade, Michael J.; Tumati, Abhinay; Chantachote, Chanak; Huang, Emily C.; Rutigliano, Daniel N.; Rubano, Jerry A.; Vosswinkel, James A.; Jawa, Randeep S.] SUNY Stony Brook, Dept Surg, Sch Med, Div Trauma, Stony Brook, NY 11794 USA		Jawa, RS (corresponding author), SUNY Stony Brook, Hlth Sci Ctr T18 040, Stony Brook, NY 11794 USA.	randeep.jawa@stonybrookmedicine.edu					Ahmed N, 2009, SOUTH MED J, V102, P476, DOI 10.1097/SMJ.0b013e31819f97a3; American College of Surgeon National Trauma Data Bank, NAT TRAUM DAT STAND; American College of Surgeons, NAT TRAUM DAT BNAK 2; Angelozzi A, 2015, AM COLL CARDIOLOGY R; Association for the Advancement of Automotive Medicine, 2008, AIS 2005 ABBR INJ SC; Barnes GD, 2015, AM J MED, V128, P1300, DOI 10.1016/j.amjmed.2015.05.044; Batey M, 2018, SURGERY, V164, P814, DOI 10.1016/j.surg.2018.05.060; Centers for Disease Control and Prevention, HOM RECR SAF FALLS O; Collins CE, 2014, AM J SURG, V208, P544, DOI 10.1016/j.amjsurg.2014.05.019; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Falzon CM, 2013, EMERG MED J, V30, P809, DOI 10.1136/emermed-2012-201687; FitzGerald RJ, 2009, BRIT J CLIN PHARMACO, V67, P671, DOI 10.1111/j.1365-2125.2009.03424.x; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Gaist D, 2017, JAMA-J AM MED ASSOC, V317, P836, DOI 10.1001/jama.2017.0639; Ganetsky M, 2017, ACAD EMERG MED, V24, P1258, DOI 10.1111/acem.13217; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; HART RG, 1995, STROKE, V26, P1471, DOI 10.1161/01.STR.26.8.1471; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000142, 10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022]; Kobayashi L, 2017, J TRAUMA ACUTE CARE, V82, P827, DOI 10.1097/TA.0000000000001414; Narum S, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0094-1; Nishijima DK, 2013, ACAD EMERG MED, V20, P140, DOI 10.1111/acem.12074; Ohlmeier C, 2013, EUROPACE, V15, P1436, DOI 10.1093/europace/eut048; Pagani L, 2011, CRIT CARE, V15, DOI 10.1186/cc10425; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Sanchez-Pinto LN, 2018, INT J MED INFORM, V116, P10, DOI 10.1016/j.ijmedinf.2018.05.006; Simonds AK, 2004, NEUROMUSCULAR DISORD, V14, P351, DOI 10.1016/j.nmd.2004.04.001; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Tollefsen MH, 2018, WORLD NEUROSURG, V114, pE209, DOI 10.1016/j.wneu.2018.02.167; Xiong QM, 2015, EUR J HEART FAIL, V17, P1192, DOI 10.1002/ejhf.343	36	2	2	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	FEB	2021	258						216	223		10.1016/j.jss.2020.08.047			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	PH5YK	WOS:000600487500028	33032140				2022-02-06	
J	Memmini, AK; La Fountaine, MF; Broglio, SP; Moore, RD				Memmini, Allyssa K.; La Fountaine, Michael F.; Broglio, Steven P.; Moore, Robert D.			Long-Term Influence of Concussion on Cardio-Autonomic Function in Adolescent Hockey Players	JOURNAL OF ATHLETIC TRAINING			English	Article						dysautonomia; heart rate variability; mild traumatic brain injury	HEART-RATE-VARIABILITY; RATE RECOVERY; EXERCISE; INJURY	Context: Concussion may negatively influence cardiovascular function and the autonomic nervous system, defined by alteration in heart rate variability (HRV). Differences in HRV most commonly emerge during a physical challenge, such as the final steps of the return-to-sport progression. Objective: To assess the effect of concussion history on aspects of cardio-autonomic function during recovery from a bout of submaximal exercise in adolescent male hockey athletes. Design: Case-control study. Setting: Research laboratory. Patients or Other Participants: Thirty-three male athletes participating in Midget-AAA hockey were divided into those with (n = 15; age = 16 +/- 1 years, height = 1.78 +/- 0.06 m, mass = 73.9 6 7.4 kg, 10.5 +/- 1.6 years of sport experience, 25.2 +/- 18.3 months since last injury) or without (n = 18; age = 16 +/- 1 years, height = 1.78 +/- 0.05 m, mass = 74.8 6 7.6 kg, 10.6 +/- 1.9 years of sport experience) a concussion history. Those with a concussion history were binned on total count: 1 concussion or 2 or more concussions. Intervention(s): All athletes underwent 5 minutes of resting HRV assessment, followed by 20 minutes of aerobic exercise at 60% to 70% of their maximal target heart rate and a 9-minute, postexercise HRV assessment. Main Outcome Measure(s): Heart rate variability measures of mean NN interval, root mean square of successive differences, and standard deviation of NN interval (SDNN). Results: Group demographic characteristics were not different. When the control and concussed groups were compared, group and time main effects for heart rate recovery, root mean square of successive differences, and SDNN (P values,.01), and an interaction effect for SDNN (P,.05) were demonstrated. Recovery trends for each group indicated that a history of 2 or more concussions may negatively affect cardio-autonomic recovery postexercise. Conclusions: Our findings suggest that those with more than 1 previous concussion may be associated with a greater risk for long-term dysautonomia. Future use of HRV may provide clinicians with objective guidelines for concussion-management and safe return-to-participation protocols.	[Memmini, Allyssa K.; Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, 401 Washtenaw Ave, Ann Arbor, MI 48109 USA; [La Fountaine, Michael F.] Seton Hall Univ, Dept Phys Therapy, Sch Hlth & Med Sci, Nutley, NJ USA; [La Fountaine, Michael F.] Seton Hall Univ, Inst Adv Study Rehabil & Sports Sci, Nutley, NJ USA; [La Fountaine, Michael F.] Seton Hall Univ, Dept Med Sci & Neurol, Hackensack Meridian Sch Med, Nutley, NJ USA; [Moore, Robert D.] Univ South Carolina, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Moore, Robert D.] Univ South Carolina, Inst Mind & Brain, Columbia, SC 29208 USA		Memmini, AK (corresponding author), Univ Michigan, Michigan Concuss Ctr, 401 Washtenaw Ave, Ann Arbor, MI 48109 USA.	amemmini@umich.edu		Memmini, Allyssa K./0000-0002-5923-1335			Abaji JP, 2016, J NEUROTRAUM, V33, P811, DOI 10.1089/neu.2015.3989; Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Bishop S, 2017, BRAIN INJURY, V31, P247, DOI 10.1080/02699052.2016.1226385; Broglio SP, 2018, J NEUROTRAUM, V35, P2776, DOI 10.1089/neu.2018.5643; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Camm AJ, 1996, EUR HEART J, V17, P354; Fatisson J, 2016, HEART INT, V11, pE32, DOI 10.5301/heartint.5000232; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Giza CC, 2001, J ATHL TRAINING, V36, P228; Jancke L, 2015, HUM BRAIN MAPP, V36, P150, DOI 10.1002/hbm.22619; Javorka M, 2002, BRAZ J MED BIOL RES, V35, P991, DOI 10.1590/S0100-879X2002000800018; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kluess HA, 2000, AM J PHYSIOL-HEART C, V278, pH1648, DOI 10.1152/ajpheart.2000.278.5.H1648; La Fountaine MF, 2009, AUTON NEUROSCI-BASIC, V148, P101, DOI 10.1016/j.autneu.2009.03.001; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCorry LK, 2007, AM J PHARM EDUC, V71, DOI 10.5688/aj710478; McCraty Rollin, 2015, Glob Adv Health Med, V4, P46, DOI 10.7453/gahmj.2014.073; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moodithaya Shailaja, 2012, J Aging Res, V2012, P679345, DOI 10.1155/2012/679345; Munoz ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138921; Oida E, 1997, J APPL PHYSIOL, V82, P1794, DOI 10.1152/jappl.1997.82.6.1794; Sears CE, 1998, J APPL PHYSIOL, V84, P1596, DOI 10.1152/jappl.1998.84.5.1596; Shaffer F, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01040; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Takahashi Tatsuhisa, 2001, Frontiers of Medical and Biological Engineering, V11, P249, DOI 10.1163/156855701321138914; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Williamson John B, 2013, Front Neuroeng, V6, P13, DOI 10.3389/fneng.2013.00013	30	2	2	2	3	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	FEB	2021	56	2					141	147		10.4085/1062-6050-0578.19			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	QK3AH	WOS:000620252800003	33400783	gold			2022-02-06	
J	Paget, LM; Boutonnet, M; Moyer, JD; Delhaye, N; D'Aranda, E; Beltzer, N; Hamada, SR				Paget, Louis-Marie; Boutonnet, Mathieu; Moyer, Jean-Denis; Delhaye, Nathalie; D'Aranda, Erwan; Beltzer, Nathalie; Hamada, Sophie Rym			Trauma centre admissions for traumatic brain injury in France: One-year epidemiological analysis of prospectively collected data	ANAESTHESIA CRITICAL CARE & PAIN MEDICINE			English	Article						Traumatic brain injury; Injuries; Epidemiology		Introduction: In France, there is a lack of recent data on Traumatic brain injury (TBI), remaining a major global health challenge in terms of morbidity and mortality. The present study reports the epidemiology and the factors associated with mortality of patients with TBI admitted to 9 French trauma centres. Method: Patients >= 15 years old admitted, between the 1st of January and the 31st of December 2017, following TBI (Abbreviated Injury Scale head >= 2) were included. Descriptive analyses were carried out and a logistic regression was used in order to identify in-hospital mortality predictors. Results: 1,177 patients (889 males (76%), median age 42 [26-59]) were admitted following TBI. Road traffic accidents were the primary mechanism of TBI. Mechanisms leading to TBI were highly correlated with age. The in-hospital mortality was 23%. In-hospital mortality increased with age, from 15% in 15-24-year-olds to 71% among patients aged 85 years and older. Age, relevant past medical history, Glasgow coma scale motor score, subdural haematoma, systolic arterial blood pressure < 110 mmHg, pupillary abnormality and haemoglobin level were significantly associated with in-hospital mortality. Conclusions: TBI is still a major public health concern affecting mostly young patients, victims of road traffic accidents and elderly patients, victims of falls. These findings could help clinicians adjusting medical approaches, targeting prevention measures and planning new research projects according to these French TBI population characteristics. (C) 2021 Societe francaise d'anesthesie et de reanimation (Sfar). Published by Elsevier Masson SAS. All rights reserved.	[Paget, Louis-Marie; Beltzer, Nathalie] Sante Publ France, Direct Malad Nontransmissibles & Traumatismes, 12 Rue Val dOsne, F-94415 St Maurice, France; [Boutonnet, Mathieu] Percy Mil Teaching Hosp, Dept Anaesthesiol & Intens Care, 101 Ave Henri Barbusse,BP 406, F-92141 Clamart, France; [Moyer, Jean-Denis] Hop Univ Paris Nord Val de Seine, Hop Beaujon, AP HP, Dept Anaesthesia & Crit Care, Clichy, France; [Delhaye, Nathalie; Hamada, Sophie Rym] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Dept Anaesthesiol & Crit Care, 20 Rue Leblanc, F-75015 Paris, France; [D'Aranda, Erwan] Hop Instruct Armees St Anne, Dept Anaesthesiol & Intens Care, Mil Hosp, Toulon, France; [Hamada, Sophie Rym] Maison Solenn, CESP, INSERM U10 18, 97 Blvd Port Royal, F-75014 Paris, France		Paget, LM (corresponding author), Sante Publ France, Direct Malad Nontransmissibles & Traumatismes, 12 Rue Val dOsne, F-94415 St Maurice, France.	Louis-Marie.PAGET@santepubliquefrance.fr		Beltzer, Nathalie/0000-0002-9454-5006			Carroll EL, 2020, J HEAD TRAUMA REHAB; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Fuller G, 2014, INJURY, V45, P612, DOI 10.1016/j.injury.2013.09.008; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Hamada SR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223809; Kirkman MA, 2013, J NEUROTRAUM, V30, P1385, DOI 10.1089/neu.2013.2881; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Maas AI, 2017, LANCET NEUROL; Majdan M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002331; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Riou B, 2002, J SCI SAMU FR    OCT; Seo DE, 2019, AM J EMERG MED, V37, P1709, DOI 10.1016/j.ajem.2018.12.022; Soreide K, 2007, WORLD J SURG, V31, P2092, DOI 10.1007/s00268-007-9226-9; Spaite DW, 2017, ANN EMERG MED, V70, P522, DOI 10.1016/j.annemergmed.2017.03.027; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TEASDALE G, 1974, LANCET, V2, P81; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; Toulouse E, 2018, ANAESTH CRIT CARE PA, V37, P607, DOI 10.1016/j.accpm.2018.10.013; van den Brand CL, 2017, J NEUROTRAUM, V34, P1, DOI 10.1089/neu.2015.4393; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Zelinkova V, 2019, BRAIN INJURY, P1	29	2	2	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	2352-5568			ANAESTH CRIT CARE PA	Anaesth. Crit. Care Pain Med.	FEB	2021	40	1							100804	10.1016/j.accpm.2021.100804			8	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	RV1ET	WOS:000645581000001	33493628				2022-02-06	
J	Schwerin, SC; Chatterjee, M; Hutchinson, EB; Djankpa, FT; Armstrong, RC; McCabe, JT; Perl, DP; Juliano, SL				Schwerin, Susan C.; Chatterjee, Mitali; Hutchinson, Elizabeth B.; Djankpa, Francis T.; Armstrong, Regina C.; McCabe, Joseph T.; Perl, Daniel P.; Juliano, Sharon L.			Expression of GFAP and Tau Following Blast Exposure in the Cerebral Cortex of Ferrets	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Aquaporin; Astrocyte; Blood vessels; Phosphorylated tau; Pia; Tau isoforms		Blast exposures are a hallmark of contemporary military conflicts. We need improved preclinical models of blast traumatic brain injury for translation of pharmaceutical and therapeutic protocols. Compared with rodents, the ferret brain is larger, has substantial sulci, gyri, a higher white to gray matter ratio, and the hippocampus in a ventral position; these attributes facilitate comparison with the human brain. In this study, ferrets received compressed air shock waves and subsequent evaluation of glia and forms of tau following survival of up to 12 weeks. Immunohistochemistry and Western blot demonstrated altered distributions of astrogliosis and tau expression after blast exposure. Many aspects of the astrogliosis corresponded to human pathology: increased subpial reactivity, gliosis at gray-white matter interfaces, and extensive outlining of blood vessels. MRI analysis showed numerous hypointensities occurring in the 12-week survival animals, appearing to correspond to luminal expansions of blood vessels. Changes in forms of tau, including phosphorylated tau, and the isoforms 3R and 4R were noted using immunohistochemistry and Western blot in specific regions of the cerebral cortex. Of particular interest were the 3R and 4R isoforms, which modified their ratio after blast. Our data strongly support the ferret as an animal model with highly translational features to study blast injury.	[Schwerin, Susan C.; Djankpa, Francis T.; Armstrong, Regina C.; McCabe, Joseph T.; Juliano, Sharon L.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Hutchinson, Elizabeth B.] Natl Inst Biomed Imaging & Bioengn, Quantitat Med Imaging Sect, NIH, Bethesda, MD USA; [Djankpa, Francis T.; Armstrong, Regina C.; McCabe, Joseph T.; Perl, Daniel P.; Juliano, Sharon L.] Uniformed Serv Univ Hlth Sci, Program Neurosci, Bethesda, MD 20814 USA; [Djankpa, Francis T.] Univ Cape Coast, Sch Med Sci, Dept Physiol, Cape Coast, Ghana; [Perl, Daniel P.] Uniformed Serv Univ Hlth Sci, Dept Pathol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA		Juliano, SL (corresponding author), USUHS APG, B2082,4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	juliano@usuhs.edu	McCabe, Joseph T/J-6293-2014; Chatterjee, Mitali/AAV-2129-2021	McCabe, Joseph T/0000-0002-1159-7442; Schwerin, Susan/0000-0001-5435-2448; Djankpa, Francis/0000-0002-0924-0364	Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [CNRM-70-8956, USU-PAT-74-3439]; Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH-132-0018]	This study was supported by the Center for Neuroscience and Regenerative Medicine-CNRM-70-8956, USU-PAT-74-3439, and the Congressionally Directed Medical Research Program W81XWH-132-0018.	Arena JD, 2020, BRAIN, V143, P1572, DOI 10.1093/brain/awaa071; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Bryden DW, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519872213; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Cherry JD, 2020, BRAIN PATHOL, V30, P913, DOI 10.1111/bpa.12867; CONSTANT.J, 1974, EUR NEUROL, V11, P208, DOI 10.1159/000114320; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Dickstein DL, 2021, MOL PSYCHIATR, V26, P5940, DOI 10.1038/s41380-020-0674-z; Dong YY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034435, 10.1371/journal.pone.0051643, 10.1371/journal.pone.0039386]; Elder GA, 2019, NEUROSCI LETT, V707, DOI 10.1016/j.neulet.2019.134294; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Espinoza M, 2008, J ALZHEIMERS DIS, V14, P1; Fox JG, 2014, BIOLOGY AND DISEASES OF THE FERRET, 3RD EDITION, P1, DOI 10.1002/9781118782699; FRIEDLANDER FG, 1946, PROC R SOC LON SER-A, V186, P322, DOI 10.1098/rspa.1946.0046; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2017, ANNU REV NEUROSCI, V40, P189, DOI 10.1146/annurev-neuro-072116-031153; Goldstein LE, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0064-3; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Goodrich JA, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0395-3; Gotz J, 2019, ANNU REV PATHOL-MECH, V14, P239, DOI 10.1146/annurev-pathmechdis-012418-012936; Griffin AD, 2019, BRAIN, V142, P3550, DOI 10.1093/brain/awz290; Gupta RK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00059; Haj-Yasein NN, 2011, P NATL ACAD SCI USA, V108, P17815, DOI 10.1073/pnas.1110655108; HOF PR, 1990, J COMP NEUROL, V301, P44, DOI 10.1002/cne.903010105; Hutchinson EB, 2017, NEUROIMAGE, V152, P575, DOI 10.1016/j.neuroimage.2017.03.009; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Irwin DJ, 2016, ANN NEUROL, V79, P272, DOI 10.1002/ana.24559; Iverson GL, 2019, BRAIN, V142, P3672, DOI 10.1093/brain/awz286; Kallakuri S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169239; Kim JH, 2020, J NEUROPATH EXP NEUR, V79, P605, DOI 10.1093/jnen/nlaa026; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; Kulbe JR, 2017, PROG NEUROBIOL, V158, P15, DOI 10.1016/j.pneurobio.2017.08.003; LaValle CR, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00949; Li D, 2020, J NEUROCHEM, V152, P122, DOI 10.1111/jnc.14830; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Nolte C, 2001, GLIA, V33, P72; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Pekny M, 2016, BBA-MOL BASIS DIS, V1862, P483, DOI 10.1016/j.bbadis.2015.11.014; Perez-Garcia G, 2018, BEHAV BRAIN RES, V340, P117, DOI 10.1016/j.bbr.2016.09.061; Petry FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094251; Ritzel DV, 2011, RTO HUM FACT MED PAN; Robinson ME, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101651; Run XQ, 2009, J ALZHEIMERS DIS, V16, P619, DOI 10.3233/JAD-2009-1003; Santa-Maria I, 2012, ACTA NEUROPATHOL, V124, P693, DOI 10.1007/s00401-012-1017-1; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schwerin SC, 2018, J NEUROSCI RES, V96, P556, DOI 10.1002/jnr.24218; Schwerin SC, 2017, J NEUROSCI METH, V285, P82, DOI 10.1016/j.jneumeth.2017.05.010; Sealey MA, 2017, NEUROBIOL DIS, V105, P74, DOI 10.1016/j.nbd.2017.05.003; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Simic G, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010006; Sosa MAG, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-018-0647-5; Sosa MAG, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0483-z; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Tripathy A, 2019, J ALZHEIMERS DIS, V67, P1277, DOI 10.3233/JAD-181039; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Vu PA, 2018, BRAIN RES, V1700, P138, DOI 10.1016/j.brainres.2018.08.034; Wang ZY, 2020, J NEUROTRAUM, V37, P1221, DOI 10.1089/neu.2019.6742; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Whittington RA, 2013, PROG NEURO-PSYCHOPH, V47, P147, DOI 10.1016/j.pnpbp.2013.03.004; ZACK GW, 1977, J HISTOCHEM CYTOCHEM, V25, P741, DOI 10.1177/25.7.70454; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	76	2	2	1	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	FEB	2021	80	2					112	128		10.1093/jnen/nlaa157			17	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	RJ0RF	WOS:000637310000002	33421075	Green Published			2022-02-06	
J	Song, SJ; Kong, XY; Borlongan, C; Sava, V; Sanchez-Ramos, J				Song, Shijie; Kong, Xiaoyuan; Borlongan, Cesar; Sava, Vasyl; Sanchez-Ramos, Juan			Granulocyte Colony-Stimulating Factor Enhances Brain Repair Following Traumatic Brain Injury Without Requiring Activation of Cannabinoid Receptors	CANNABIS AND CANNABINOID RESEARCH			English	Article						brain repair; cannabinoid receptors; endocannabinoids; mouse; traumatic brain injury		Introduction: Treatment of traumatic brain injury (TBI) with granulocyte colony-stimulating factor (G-CSF) has been shown to enhance brain repair by direct neurotrophic actions on neural cells and by modulating the inflammatory response. Administration of cannabinoids after TBI has also been reported to enhance brain repair by similar mechanisms. Objectives: The primary objective of this study was to test the hypothesis that G-CSF mediates brain repair by interacting with the endocannabinoid system. Methods and Results: (i) Mice that underwent controlled cortical impact (CCI) were treated with G-CSF for 3 days either alone or in the presence of selective cannabinoid receptor 1 (CB1-R) or cannabinoid receptor 2 (CB2-R) agonists and antagonists. The trauma resulted in decreased expression of CB1-R and increased expression of CB2-R in the cortex, striatum, and hippocampus. Cortical and striatal levels of the major endocannabinoid ligand, 2-arachidonoyl-glycerol, were also increased by the CCI. Administration of the hematopoietic cytokine, G-CSF, following TBI, resulted in mitigation or reversal of trauma-induced CB1-R downregulation and CB2-R upregulation in the three brain regions. Treatment with CB1-R agonist (WIN55) or CB2-R agonist (HU308) mimicked the effects of G-CSF. (ii) Pharmacological blockade of CB1-R or CB2-R was not effective in preventing G-CSF's mitigation or reversal of trauma-induced alterations in these receptors. Conclusions: These results suggest that cellular and molecular mechanisms that mediate subacute effects of G-CSF do not depend on activation of CB1 or CB2 receptors. Failure of selective CB receptor antagonists to prevent the effects of G-CSF in this model has to be accepted with caution. CB receptor antagonists can interact with other CB and non-CB receptors. Investigation of the role of CB receptors in this TBI model will require studies with CB1-R and in CB2-R knockout mice to avoid nonspecific interaction of CB receptor agents with other receptors.	[Song, Shijie; Kong, Xiaoyuan; Borlongan, Cesar; Sava, Vasyl] James Haley VA Med Ctr, 3802 Spectrum Blvd, Tampa, FL 33612 USA; [Song, Shijie; Sava, Vasyl; Sanchez-Ramos, Juan] Univ S Florida, Dept Neurol, Tampa, FL 33620 USA; [Borlongan, Cesar] Univ S Florida, Dept Neurosurg, Tampa, FL 33620 USA		Song, SJ (corresponding author), James Haley VA Med Ctr, 3802 Spectrum Blvd, Tampa, FL 33612 USA.	ssong@usf.edu			BLRD VA [I01 BX004037] Funding Source: Medline		Acosta SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090953; Braun M, 2018, BRAIN BEHAV IMMUN, V68, P224, DOI 10.1016/j.bbi.2017.10.021; Costa B, 2010, PHARMACOL RES, V61, P537, DOI 10.1016/j.phrs.2010.02.001; Das A., 2019, CURR DEV NUTR, V3, P10, DOI [10 .1093/cdn/nzz031.FS15-01-19, DOI 10.1093/CDN/NZZ031.FS15-01-19]; Di Marzo V, 2015, NEUROTHERAPEUTICS, V12, P692, DOI 10.1007/s13311-015-0374-6; Golech SA, 2004, MOL BRAIN RES, V132, P87, DOI 10.1016/j.molbrainres.2004.08.025; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Hajos N, 2001, NEUROSCIENCE, V106, P1, DOI 10.1016/S0306-4522(01)00287-1; Hammels I, 2019, J LIPID RES, V60, P1396, DOI 10.1194/jlr.M094664; Hegde VL, 2010, EUR J IMMUNOL, V40, P3358, DOI 10.1002/eji.201040667; Katona I, 2001, J NEUROSCI, V21, P9506, DOI 10.1523/JNEUROSCI.21-23-09506.2001; Lopez-Rodriguez AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128782; Mackie K, 2006, ANNU REV PHARMACOL, V46, P101, DOI 10.1146/annurev.pharmtox.46.120604.141254; Maresz K, 2005, J NEUROCHEM, V95, P437, DOI 10.1111/j.1471-4159.2005.03380.x; Marino VJ, 2008, J CELL BIOCHEM, V103, P1512, DOI 10.1002/jcb.21542; Neary JT, 2005, IUBMB LIFE, V57, P711, DOI 10.1080/15216540500319143; Pertwee RG, 2008, ADDICT BIOL, V13, P147, DOI 10.1111/j.1369-1600.2008.00108.x; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Schabitz WR, 2003, STROKE, V34, P745, DOI 10.1161/01.STR.0000057814.70180.17; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Six I, 2003, EUR J PHARMACOL, V458, P327, DOI 10.1016/S0014-2999(02)02785-1; Solaroglu I, 2006, STROKE, V37, P1123, DOI 10.1161/01.STR.0000208205.26253.96; Song SJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071418; Song SJ, 2016, RESTOR NEUROL NEUROS, V34, P415, DOI 10.3233/RNN-150607; Song SJ, 2016, J NEUROSCI RES, V94, P409, DOI 10.1002/jnr.23714; Song SJ, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/205878; Turu G, 2010, J MOL ENDOCRINOL, V44, P75, DOI 10.1677/JME-08-0190; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zou SL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030833	29	2	2	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2578-5125	2378-8763		CANNABIS CANNABINOID	Cannabis Cannabinoid Res.	FEB 1	2021	6	1					48	57		10.1089/can.2019.0090			10	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	QL8EJ	WOS:000621313800007	33614952				2022-02-06	
J	Strotton, MC; Bodey, AJ; Wanelik, K; Hobbs, C; Rau, C; Bradbury, EJ				Strotton, Merrick C.; Bodey, Andrew J.; Wanelik, Kazimir; Hobbs, Carl; Rau, Christoph; Bradbury, Elizabeth J.			The spatiotemporal spread of cervical spinal cord contusion injury pathology revealed by 3D in-line phase contrast synchrotron X-ray microtomography	EXPERIMENTAL NEUROLOGY			English	Article						Synchrotron; Microtomography; Spinal cord injury; Neurotrauma; White matter; Gray matter	FUNCTIONAL RECOVERY; BLOOD-FLOW; RATS; MODEL; IMAGE; MICROVASCULATURE; VISUALIZATION; REGENERATION; TRAUMA; LESION	Extensive structural changes occur within the spinal cord following traumatic injury. Acute tissue debris and necrotic tissue are broken down, proliferating local glia and infiltrating leukocytes remodel tissue biochemical and biophysical properties, and a chronic cavity surrounded by a scar forms at the injury epicentre. Serial-section 2D histology has traditionally assessed these features in experimental models of spinal cord injury (SCI) to measure the extent of tissue pathology and evaluate efficacy of novel therapies. However, this 2D snapshot approach overlooks slice intervening features, with accurate representation of tissue compromised by mechanical processing artefacts. 3D imaging avoids these caveats and allows full exploration of the injured tissue volume to characterise whole tissue pathology. Amongst 3D imaging modalities, Synchrotron Radiation X-ray microtomography (SR mu CT) is advantageous for its speed, ability to cover large tissue volumes at high resolution, and need for minimal sample processing. Here we demonstrate how extended lengths of formalin-fixed, paraffin-embedded (FFPE) rat spinal cord can be completely imaged by SR mu CT with micron resolution. Label-free contrast derived from X-ray phase interactions with low-density soft tissues, reveals spinal cord white matter, gray matter, tissue damage and vasculature, with tissue still viable for targeted 2D-histology after 3D imaging. We used SR mu CT to quantify tissue pathology after a midline, cervical level (C6), 225 kDyne contusion injury over acute-to-chronic (24 h to 5 weeks) post injury time points. Quantification revealed acute tissue swelling prior to chronic atrophy across the whole imaged region (spanning 2 spinal segments above and below injury), along with rostro-caudal asymmetries in white and gray matter volume loss. 3D volumes revealed satellite damage in tissue far removed from the epicentre, and extensive rostro-caudal spread of damage through the base of the dorsal columns at 24 h post injury. This damage overlapped regions of vasogenic oedema, confirmed with subsequent histology. Tissue damage at later time points in border regions was most prominent in the dorsal columns, where it overlapped sites of damaged venous vasculature. Elaborating rostro-caudal and spatiotemporal asymmetries in reduced traumatic injury models centred on these regions may inform future treatments that seek to limit the spread of tissue pathology to these 'at-risk' regions.	[Strotton, Merrick C.; Hobbs, Carl; Bradbury, Elizabeth J.] Kings Coll London, Wolfson Ctr Age Related Dis, Inst Psychiat Psychol & Neurosci, Guys Campus,London Bridge, London SE1 1UL, England; [Bodey, Andrew J.; Wanelik, Kazimir; Rau, Christoph] Diamond Light Source, Didcot OX11 0DE, Oxon, England; [Strotton, Merrick C.] Univ Zurich, Dept Quantitat Biomed, CH-8057 Zurich, Switzerland		Strotton, MC; Bradbury, EJ (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, Inst Psychiat Psychol & Neurosci, Guys Campus,London Bridge, London SE1 1UL, England.	merrick.strotton@kcl.ac.uk; andrew.bodey@diamond.ac.uk; kaz.wanelik@diamond.ac.uk; carl.hobbs@kcl.ac.uk; christoph.rau@diamond.ac.uk; elizabeth.bradbury@kcl.ac.uk		Strotton, Merrick/0000-0002-1390-512X	King's Bioscience Institute PhD Programme in Biomedical and Translation Science from Guy's and St Thomas' charity; Medical Research Council UK (SNCF Award)UK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G1002055];  [MT14907];  [MT18417]	This work was supported by the King's Bioscience Institute PhD Programme in Biomedical and Translation Science from Guy's and St Thomas' charity to M.S. and the Medical Research Council UK (SNCF Award G1002055) to E.J.B. Tomography was performed at the Diamond-Manchester Imaging Branchline I13-2 of Diamond Light Source as part of projects MT14907 and MT18417.	Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Atwood RC, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0398; BALENTINE JD, 1978, LAB INVEST, V39, P236; Berg S, 2019, NAT METHODS, V16, P1226, DOI 10.1038/s41592-019-0582-9; Bilgen M, 2000, MAGN RESON MED, V43, P594; Bradbury EJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11707-7; Bunge R P, 1997, Adv Neurol, V72, P305; BUNGE RP, 1993, ADV NEUROL, V59, P75; Burnside ER, 2018, BRAIN, V141, P2362, DOI 10.1093/brain/awy158; Cai RY, 2019, NAT NEUROSCI, V22, P317, DOI 10.1038/s41593-018-0301-3; Cao Y, 2017, J NEUROTRAUM, V34, P1187, DOI 10.1089/neu.2016.4697; Cao Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep12643; Chen K, 2016, J NEUROTRAUM, V33, P1667, DOI 10.1089/neu.2015.4218; Fonseca MD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30501-x; Deng X, 2007, MAGN RESON MED, V57, P620, DOI 10.1002/mrm.21163; Didangelos A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21607; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Ek CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012021; Ellingson BM, 2008, J MAGN RESON IMAGING, V28, P1068, DOI 10.1002/jmri.21578; Errico C, 2015, NATURE, V527, P499, DOI 10.1038/nature16066; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Gensel JC, 2015, BRAIN RES, V1619, P1, DOI 10.1016/j.brainres.2014.12.045; Greenhalgh AD, 2020, NAT REV NEUROSCI, V21, P139, DOI 10.1038/s41583-020-0263-9; Griessenauer CJ, 2015, CLIN ANAT, V28, P75, DOI 10.1002/ca.22354; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hu J, 2015, SPINAL CORD, V53, P585, DOI 10.1038/sc.2015.49; Ito T, 1997, ACTA NEUROPATHOL, V93, P13; James ND, 2015, EXP NEUROL, V271, P131, DOI 10.1016/j.expneurol.2015.05.022; James ND, 2011, J NEUROSCI, V31, P18543, DOI 10.1523/JNEUROSCI.4306-11.2011; Jirjis MB, 2013, J NEUROTRAUM, V30, P1577, DOI 10.1089/neu.2013.2897; Kak A. C., 2001, PRINCIPLES COMPUTERI, DOI 10.1137/1.9780898719277; Kmiec Z., 2016, FOLIA HISTOCHEM CYTO, V54, P58; Komotar RJ, 2007, NAT PROTOC, V2, P2345, DOI 10.1038/nprot.2007.359; Koser DE, 2015, BIOPHYS J, V108, P2137, DOI 10.1016/j.bpj.2015.03.039; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kwon BK, 2011, J NEUROTRAUM, V28, P1545, DOI 10.1089/neu.2009.1149; Li YQ, 2017, NAT MED, V23, P733, DOI 10.1038/nm.4331; Marina E., 2019, P SOC PHOTO-OPT INS; MARTINEZARIZALA A, 1995, J NEUROTRAUM, V12, P199, DOI 10.1089/neu.1995.12.199; McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; Metz Gerlinde A, 2009, J Vis Exp, DOI 10.3791/1204; Meyer O A, 1979, Neurobehav Toxicol, V1, P233; Mizutani R, 2012, MICRON, V43, P104, DOI 10.1016/j.micron.2011.10.002; Moeendarbary E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14787; National Spinal Cord Injury Statistical Center at the University of Alabama, 2019, NSCISC ANN STAT REP; NOBLE LJ, 1985, EXP NEUROL, V88, P135, DOI 10.1016/0014-4886(85)90119-0; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Ouzounov DG, 2017, NAT METHODS, V14, P388, DOI 10.1038/nmeth.4183; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; Pan CC, 2016, NAT METHODS, V13, P859, DOI 10.1038/nmeth.3964; Patel SP, 2016, J NEUROTRAUM, V33, P917, DOI 10.1089/neu.2015.4185; Pesic ZD, 2013, J PHYS CONF SER, V425, DOI 10.1088/1742-6596/425/18/182003; Qian JC, 2010, J NEUROTRAUM, V27, P599, DOI 10.1089/neu.2009.1145; Rau C, 2011, PHYS STATUS SOLIDI A, V208, P2522, DOI 10.1002/pssa.201184272; Richardson DS, 2015, CELL, V162, P246, DOI 10.1016/j.cell.2015.06.067; RIVLIN AS, 1978, J NEUROSURG, V49, P844, DOI 10.3171/jns.1978.49.6.0844; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scholtes F, 2011, SPINAL CORD, V49, P345, DOI 10.1038/sc.2010.129; Shin M., 1972, J JPN ORTHOP ASSOC, V46, P155; Singh A, 2014, J NEUROSCI METH, V226, P124, DOI 10.1016/j.jneumeth.2014.01.001; Soubeyrand M, 2014, J NEUROTRAUM, V31, P1767, DOI 10.1089/neu.2013.3319; Soubeyrand M, 2013, EUR SPINE J, V22, P1810, DOI 10.1007/s00586-013-2744-2; Strotton MC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30520-8; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Thron AK, 1988, VASCULAR ANATOMY SPI; Titarenko V, 2010, SPIE OPTICAL ENG APP, V7804, P10; Titarenko V, 2016, J SYNCHROTRON RADIAT, V23, P1447, DOI 10.1107/S160057751601479X; Tomko P, 2017, SPINAL CORD, V55, P255, DOI 10.1038/sc.2016.133; Wadeson N., 2016, ARXIV161008015; Zhang Z, 2001, ACTA NEUROPATHOL, V102, P335; Zhang ZA, 1997, NEUROPATHOLOGY, V17, P32, DOI 10.1111/j.1440-1789.1997.tb00008.x	73	2	2	1	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	FEB	2021	336								113529	10.1016/j.expneurol.2020.113529			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PS7NL	WOS:000608112900007	33220238	hybrid, Green Published			2022-02-06	
J	Taylor, MA; Knochel, ML; Proctor, SJ; Brockmeyer, DL; Runyon, LA; Fenton, SJ; Russell, KW				Taylor, Mark A.; Knochel, Miguel L.; Proctor, Spencer J.; Brockmeyer, Douglas L.; Runyon, Lisa A.; Fenton, Stephen J.; Russell, Katie W.			Pediatric trauma telemedicine in a rural state: Lessons learned from a 1-year experience	JOURNAL OF PEDIATRIC SURGERY			English	Article						Interfacility transfer; Traumatic brain injury; Telehealth; Teletrauma		Background: Previous research from our center has shown that 27% of the pediatric trauma transfers from referring facilities are potentially preventable. Our hospital is the only level 1 pediatric trauma center (PTC) in our state, and we are developing a pediatric trauma telehealth network to help keep certain injured children closer to home. We instituted a pediatric trauma telehealth program with a partnering community-based hospital in our state and aim to report our experience over the first year. Methods: All pediatric trauma patients that presented to our partnering hospital from January 2019 to February 2020 were reviewed. Disposition was: a) telehealth consultation, b) admission to the children's unit without a telehealth consultation per our head trauma protocol, or c) transfer without telehealth consultation. Data on demographics, hospital course, and disposition were collected via chart review. Results: Eight patients underwent telehealth consults and another 8 patients were admitted to the partnering hospital's children's unit based on the head trauma protocol without a telehealth consult. Patient's ages ranged from 7 months to 15 years. Of the patients that underwent telehealth consult, 7 presented with a head injury and 1 presented with a rib fracture/small pneumothorax. The patient with a pneumothorax was observed for 6 h and discharged home after a repeat chest x-ray was stable. All 15 patients with head injuries were observed and discharged from either the emergency department or children's unit after passing concussion testing. No patients required transfer to our PTC after observation, and none were readmitted. Fifty-six patients were transferred without telehealth consultation, and 3 of these patients could potentially have avoided transfer with a telehealth consultation. Conclusions: Telehealth in pediatric trauma can be a safe mechanism for preventing the transfer of patients that can be safely observed at a partnering hospital. From a facility that transfers an average of 30 trauma patients per year to our hospital, this program prevented 16 such transfers. Development of a head trauma protocol in collaboration with a pediatric neurosurgeon leads to an unexpected number of patients being admitted to the partnering hospital for observation without utilization of a telehealth consultation. (C) 2020 Elsevier Inc. All rights reserved.	[Taylor, Mark A.; Fenton, Stephen J.; Russell, Katie W.] Univ Utah, Dept Surg, Salt Lake City, UT USA; [Knochel, Miguel L.] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Proctor, Spencer J.] Riverton Hosp, Dept Emergency Med, Riverton, UT USA; [Brockmeyer, Douglas L.] Univ Utah, Dept Neurosurg, Salt Lake City, UT USA; [Runyon, Lisa A.] Primary Childrens Med Ctr, Dept Pediat Surg, Salt Lake City, UT USA		Taylor, MA (corresponding author), 30 N 1900 E,RM 3B322, Salt Lake City, UT 84132 USA.	Mark.Taylor@hsc.utah.edu					Bureau of Emergency Medical Services & Preparedness Utah Department of Health, 2015, TRAUM INJ OUTC UT TR; Duchesne JC, 2008, J TRAUMA, V64, P92, DOI 10.1097/TA.0b013e31815dd4c4; Fenton SJ, 2016, J PEDIATR SURG, V51, P645, DOI 10.1016/j.jpedsurg.2015.09.020; Kim PT, 2017, SEMIN PEDIATR SURG, V26, P47, DOI 10.1053/j.sempedsurg.2017.01.008; Latifi Rifat, 2009, Am J Surg, V198, P905, DOI 10.1016/j.amjsurg.2009.08.011; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mollen CJ, 2019, PEDIATR EMERG CARE, V35, P180, DOI 10.1097/PEC.0000000000000957; Myers SR, 2019, PEDIATR EMERG CARE, V35, P1, DOI 10.1097/PEC.0000000000000902; Nance ML, 2009, ARCH PEDIAT ADOL MED, V163, P512, DOI 10.1001/archpediatrics.2009.65; Rogers E, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/13906; Wade V, 2012, J TELEMED TELECARE, V18, P490, DOI 10.1258/jtt.2012.GTH115; Webman RB, 2016, JAMA PEDIATR, V170, P780, DOI 10.1001/jamapediatrics.2016.0805	12	2	2	1	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	FEB	2021	56	2					385	389		10.1016/j.jpedsurg.2020.10.020			5	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	QF3TY	WOS:000616821600032	33228973				2022-02-06	
J	Wakam, GK; Biesterveld, BE; Pai, MJP; Kemp, MT; O'Connell, RL; Williams, AM; Srinivasan, A; Chtraklin, K; Siddiqui, AZ; Bhatti, UF; Vercruysse, CA; Alam, HB				Wakam, Glenn K.; Biesterveld, Ben E.; Pai, Manjunath P.; Kemp, Michael T.; O'Connell, Rachel L.; Williams, Aaron M.; Srinivasan, Ashok; Chtraklin, Kiril; Siddiqui, Ali Z.; Bhatti, Umar F.; Vercruysse, Claire A.; Alam, Hasan B.			Administration of valproic acid in clinically approved dose improves neurologic recovery and decreases brain lesion size in swine subjected to hemorrhagic shock and traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	79th Annual Meeting and Clinical Congress of the American-Association-for-the-Surgery-of-Trauma (AAST) / Clinical Congress of Acute Care Surgery	SEP 08-18, 2020	ELECTR NETWORK	Amer Assoc Surg Trauma		Traumatic brain injury; hemorrhagic shock; valproic acid; neuroprotection	HISTONE DEACETYLASE INHIBITION; FRESH-FROZEN PLASMA; RESUSCITATION; MODEL; ACETYLATION	BACKGROUND Traumatic brain injury (TBI) and hemorrhage remain the leading causes of death after trauma. We have previously shown that a dose of valproic acid (VPA) at (150 mg/kg) can decrease brain lesion size and hasten neurologic recovery. The current Food and Drug Administration-approved dose of VPA is 60 mg/kg. We evaluate neurologic outcomes and brain lesion size of a single dose of VPA at a level currently within Food and Drug Administration-approved dose in swine subjected to TBI and hemorrhagic shock. METHODS Swine (n = 5/group) were subjected to TBI and 40% blood volume hemorrhage. Animals remained in shock for 2 hours before randomization to normal saline (NS) resuscitation alone (control), NS-VPA 150 mg/kg (VPA 150), or NS-VPA 50 mg/kg (VPA 50). Neurologic severity scores (range, 0-32) were assessed daily for 14 days, and brain lesion size was measured via magnetic resonance imaging on postinjury day (PID) 3. RESULTS Shock severity and laboratory values were similar in all groups. Valproic acid-treated animals demonstrated significantly less neurologic impairment on PID 1 and returned to baseline faster (PID 1 mean neurologic severity score, control = 22 +/- 3 vs. VPA 150 mg/kg = 8 +/- 7 or VPA 50 mg/kg = 6 +/- 6; p = 0.02 and 0.003). Valproic acid-treated animals had significantly smaller brain lesion sizes (mean volume in mm(3), control = 1,268.0 +/- 241.2 vs. VPA 150 mg/kg = 620.4 +/- 328.0 or VPA 50 mg/kg = 438.6 +/- 234.8; p = 0.007 and 0.001). CONCLUSION In swine subjected to TBI and hemorrhagic shock, VPA treatment, in a dose that is approved for clinical use, decreases brain lesion size and reduces neurologic impairment compared with resuscitation alone.	[Wakam, Glenn K.; Biesterveld, Ben E.; Kemp, Michael T.; O'Connell, Rachel L.; Williams, Aaron M.; Chtraklin, Kiril; Siddiqui, Ali Z.; Bhatti, Umar F.; Vercruysse, Claire A.; Alam, Hasan B.] Univ Michigan, Dept Surg, Michigan Med, 1500 E Med Ctr Dr,2110 Taubman, Ann Arbor, MI 48109 USA; [Pai, Manjunath P.] Univ Michigan, Dept Clin Pharm, Michigan Med, Ann Arbor, MI 48109 USA; [Srinivasan, Ashok] Univ Michigan, Dept Radiol, Michigan Med, Neuroradiol Sect, Ann Arbor, MI 48109 USA		Alam, HB (corresponding author), Univ Michigan, Dept Surg, Michigan Med, 1500 E Med Ctr Dr,2110 Taubman, Ann Arbor, MI 48109 USA.	gwakam@med.umich.edu; bbiester@med.umich.edu; amitpai@med.umich.edu; mikemp@med.umich.edu; roconnel@umich.edu; willaaro@med.umich.edu; ashoks@med.umich.edu; kchtrak@med.umich.edu; asiddiqui@umc.edu; b.umar@wustl.edu; clairevercruysse@email.arizona.edu; alamh@med.umich.edu	Biesterveld, Ben/AAM-1087-2021		US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC)	The authors declare no conflicts of interest. This work was supported by the US Army Medical Research and Materiel Command under contract numberW81XWH-17-C-0246 to H.B.A. The views, opinions, and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy, or decision unless so designated by other documentation.	Alam HB, 2011, J TRAUMA, V70, P636, DOI 10.1097/TA.0b013e31820d0dcc; Alam HB, 2009, SURGERY, V146, P325, DOI 10.1016/j.surg.2009.04.007; Biesterveld B, 2019, J TRAUMA ACUTE CARE, V87, P1133, DOI 10.1097/TA.0000000000002460; Causey MW, 2013, J SURG RES, V184, P533, DOI 10.1016/j.jss.2013.03.087; Chang PP, 2019, J AM COLL SURGEONS, V228, P265, DOI 10.1016/j.jamcollsurg.2018.12.026; Das C, 2005, IUBMB LIFE, V57, P137, DOI 10.1080/15216540500090629; Drisaldi A, 2019, NEUROCRIT CARE, V30, P301, DOI 10.1007/s12028-018-0627-4; Georgoff PE, 2018, CLIN PHARMACOKINET, V57, P209, DOI 10.1007/s40262-017-0553-1; Georgoff PE, 2016, J AM COLL SURGEONS, V223, pS160, DOI 10.1016/j.jamcollsurg.2016.06.347; Georgoff PE, 2016, J TRAUMA ACUTE CARE, V81, P1020, DOI 10.1097/TA.0000000000001249; Gonzales E, 2006, SHOCK, V25, P395, DOI 10.1097/01.shk.0000209522.28120.c8; Halaweish I, 2015, J TRAUMA ACUTE CARE, V79, P911, DOI 10.1097/TA.0000000000000789; Halaweish I, 2015, SHOCK, V44, P6, DOI 10.1097/SHK.0000000000000319; Halaweish I, 2015, J AM COLL SURGEONS, V220, P809, DOI 10.1016/j.jamcollsurg.2015.01.057; Imam AM, 2013, SURGERY, V154, P388, DOI 10.1016/j.surg.2013.05.008; Kim K, 2012, RESUSCITATION, V83, P243, DOI 10.1016/j.resuscitation.2011.07.029; Lennartsson A, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0043-3; Li YQ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/523481; Li ZH, 2020, THER DRUG MONIT, V42, P610, DOI 10.1097/FTD.0000000000000749; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Nikolian VC, 2017, J TRAUMA ACUTE CARE, V83, P1066, DOI 10.1097/TA.0000000000001612; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Shults C, 2008, J TRAUMA, V64, P629, DOI 10.1097/TA.0b013e3181650ff3; VandenBerg A., 2018, MENT HLTH CLIN, V7, P13; Wanczyk M, 2011, FRONT BIOSCI-LANDMRK, V16, P340, DOI 10.2741/3691	25	2	2	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	FEB	2021	90	2					346	352		10.1097/TA.0000000000003036			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	QH5QD	WOS:000618329200024	33230090				2022-02-06	
J	Wang, HZ; Baker, EW; Mandal, A; Pidaparti, RM; West, FD; Kinder, HA				Wang, Hongzhi; Baker, Emily W.; Mandal, Abhyuday; Pidaparti, Ramana M.; West, Franklin D.; Kinder, Holly A.			Identification of predictive MRI and functional biomarkers in a pediatric piglet traumatic brain injury model	NEURAL REGENERATION RESEARCH			English	Article						controlled cortical impact; gait analysis; linear regression; magnetic resonance imaging; motor function; pediatric pig model; principal component analysis; traumatic brain injury	COMPUTED-TOMOGRAPHY; MIDLINE SHIFT; VOLUME LOSS; GAIT; SEVERITY; CHILDREN; RECOVERY; MOTOR; IMPACT; PATHOPHYSIOLOGY	Traumatic brain injury (TBI) at a young age can lead to the development of long-term functional impairments. Severity of injury is well demonstrated to have a strong influence on the extent of functional impairments; however, identification of specific magnetic resonance imaging (MRI) biomarkers that are most reflective of injury severity and functional prognosis remain elusive. Therefore, the objective of this study was to utilize advanced statistical approaches to identify clinically relevant MRI biomarkers and predict functional outcomes using MRI metrics in a translational large animal piglet TBI model. TBI was induced via controlled cortical impact and multiparametric MRI was performed at 24 hours and 12 weeks post-TBI using T1-weighted, T2-weighted, T2-weighted fluid attenuated inversion recovery, diffusion-weighted imaging, and diffusion tensor imaging. Changes in spatiotemporal gait parameters were also assessed using an automated gait mat at 24 hours and 12 weeks post-TBI. Principal component analysis was performed to determine the MRI metrics and spatiotemporal gait parameters that explain the largest sources of variation within the datasets. We found that linear combinations of lesion size and midline shift acquired using T2-weighted imaging explained most of the variability of the data at both 24 hours and 12 weeks post-TBI. In addition, linear combinations of velocity, cadence, and stride length were found to explain most of the gait data variability at 24 hours and 12 weeks post-TBI. Linear regression analysis was performed to determine if MRI metrics are predictive of changes in gait. We found that both lesion size and midline shift are significantly correlated with decreases in stride and step length. These results from this study provide an important first step at identifying relevant MRI and functional biomarkers that are predictive of functional outcomes in a clinically relevant piglet TBI model. This study was approved by the University of Georgia Institutional Animal Care and Use Committee (AUP: A2015 11-001) on December 22, 2015.	[Wang, Hongzhi; Mandal, Abhyuday] Univ Georgia, Dept Stat, Athens, GA 30602 USA; [Baker, Emily W.; West, Franklin D.; Kinder, Holly A.] Univ Georgia, Regenerat Biosci Ctr, Athens, GA 30602 USA; [Baker, Emily W.; West, Franklin D.; Kinder, Holly A.] Univ Georgia, Dept Anim & Dairy Sci, Athens, GA 30602 USA; [Pidaparti, Ramana M.] Univ Georgia, Coll Engn, Athens, GA 30602 USA		West, FD; Kinder, HA (corresponding author), Univ Georgia, Regenerat Biosci Ctr, Athens, GA 30602 USA.; West, FD; Kinder, HA (corresponding author), Univ Georgia, Dept Anim & Dairy Sci, Athens, GA 30602 USA.	westf@uga.edu; HollyK17@uga.edu		Kinder, Holly/0000-0001-8310-7265; Reis, AlessanRSS/0000-0001-8486-7469	University of Georgia Office of the Vice President for Research	Financial support was provided by the University of Georgia Office of the Vice President for Research to FDW.	Allen KA, 2016, J NEUROSCI NURS, V48, P15, DOI 10.1097/JNN.0000000000000176; Baker EW, 2019, J NEUROTRAUM, V36, P61, DOI 10.1089/neu.2017.5551; Beaumont A, 1999, NEUROL RES, V21, P742, DOI 10.1080/01616412.1999.11741008; Beretta E, 2009, BRAIN INJURY, V23, P751, DOI 10.1080/02699050903133988; Caeyenberghs K, 2009, BRAIN, V132, P684, DOI 10.1093/brain/awn344; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Chiewvit Pipat, 2010, Journal of the Medical Association of Thailand, V93, P99; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Conrad MS, 2015, ANNU REV ANIM BIOSCI, V3, P245, DOI 10.1146/annurev-animal-022114-111049; Conrad MS, 2012, DEV NEUROSCI-BASEL, V34, P291, DOI 10.1159/000339311; Cooper JM, 2014, J NEUROTRAUM, V31, P713, DOI 10.1089/neu.2013.3101; Costine BA, 2015, DEV NEUROSCI-BASEL, V37, P115, DOI 10.1159/000369091; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Drijkoningen D, 2017, J NEUROTRAUM, V34, P1022, DOI 10.1089/neu.2016.4500; Duhaime AC, 2003, J NEUROSURG, V99, P542, DOI 10.3171/jns.2003.99.3.0542; Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094; Faul M, 2010, TRAUMATIC BRAIN INJU; FLYNN TJ, 1984, NEUROCHEM RES, V9, P935, DOI 10.1007/BF00964525; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; Gieling ET, 2011, CURR TOP BEHAV NEURO, V7, P359, DOI 10.1007/7854_2010_112; Grate LL, 2003, J NEUROSCI METH, V123, P201, DOI 10.1016/S0165-0270(02)00361-8; Guild EB, 2015, J INT NEUROPSYCH SOC, V21, P650, DOI 10.1017/S1355617715000600; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; Jacobs B, 2011, J NEUROTRAUM, V28, P203, DOI 10.1089/neu.2010.1558; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Karlsson M, 2019, J NEUROTRAUM, V36, P14, DOI 10.1089/neu.2018.5706; Katz-Leurer M, 2009, DEV NEUROREHABIL, V12, P100, DOI 10.1080/17518420902800928; Katz-Leurer M, 2009, GAIT POSTURE, V29, P154, DOI 10.1016/j.gaitpost.2008.06.013; Kinder HA, 2019, J NEUROTRAUM, V36, P2930, DOI 10.1089/neu.2018.6303; Kinder HA, 2019, NEURAL REGEN RES, V14, P413, DOI 10.4103/1673-5374.245334; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Lee SY, 2012, J CLIN NEUROL, V8, P224, DOI 10.3988/jcn.2012.8.3.224; Marklund N, 2016, METHODS MOL BIOL, V1462, P29, DOI 10.1007/978-1-4939-3816-2_3; Martinez BI, 2019, J BIOL ENG, V13, DOI 10.1186/s13036-019-0145-8; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Mateos-Perez JM, 2018, NEUROIMAGE-CLIN, V20, P506, DOI 10.1016/j.nicl.2018.08.019; Paredes MF, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7073; Puffer RC, 2019, J NEUROSURG, V131, P596, DOI 10.3171/2018.2.JNS173138; R Development Core Team, 2012, R LANG ENV STAT COMP; Rosenthal G, 2008, J NEUROSURG, V108, P575, DOI 10.3171/JNS/2008/108/3/0575; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sauvigny T, 2016, WORLD NEUROSURG, V88, P519, DOI 10.1016/j.wneu.2015.10.072; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; Smitherman E, 2016, J NEUROTRAUM, V33, P35, DOI 10.1089/neu.2014.3801; Swanson JO, 2012, PEDIATR RADIOL, V42, P974, DOI 10.1007/s00247-012-2372-8; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Williams G, 2010, J HEAD TRAUMA REHAB, V25, P366, DOI 10.1097/HTR.0b013e3181cd3600; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	56	2	2	0	59	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	FEB	2021	16	2					338	344		10.4103/1673-5374.290915			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	NU5DI	WOS:000573661500029	32859794	gold, Green Published			2022-02-06	
J	Beauchamp, F; Boucher, V; Neveu, X; Ouellet, V; Archambault, P; Berthelot, S; Chauny, JM; de Guise, E; Emond, M; Frenette, JM; Lang, E; Lee, J; Mercier, E; Moore, L; Ouellet, MC; Perry, J; Le Sage, N				Beauchamp, Frederique; Boucher, Valerie; Neveu, Xavier; Ouellet, Vincent; Archambault, Patrick; Berthelot, Simon; Chauny, Jean-Marc; de Guise, Elaine; emond, Marcel; Frenette, Jerome; Lang, Eddy; Lee, Jacques; Mercier, Eric; Moore, Lynne; Ouellet, Marie-Christine; Perry, Jeffrey; Le Sage, Natalie			Post-concussion symptoms in sports-related mild traumatic brain injury compared to non-sports-related mild traumatic brain injury	CANADIAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Brain injury; Post-concussion symptoms; Sports; Mild traumatic brain injury; Sports-related mild traumatic brain injury		Objectives To compare post-concussion symptoms in patients who sustained a sports-related mild traumatic brain injury (TBI) to those with non-sports-related mild TBI at 7 and 90 days post-injury. Methods This prospective multicentre cohort study took place in seven Canadian Emergency Departments (ED). Non-hospitalized patients aged >= 14 years with a documented mild TBI that occurred <= 24 h of ED visit and a Glasgow Coma Scale score >= 13 were included. Main outcome measure was the presence of >= 3 symptoms on the Rivermead Post-concussion Questionnaire at 90 days post-injury. Secondary outcomes were the prevalence of (1) individual Rivermead Post-concussion Questionnaire symptom, (2) total Rivermead Post-concussion Questionnaire score >= 21 and (3) return to normal daily activities. Adjusted risk ratios (RR) were calculated. Results 1727 patients were included, 363 (21.0%) sustained a sports-related mild TBI. Similar proportions of patients with >= 3 symptoms, a Rivermead Post-concussion Questionnaire score >= 21 and those who returned to their normal daily activities were observed at 7 and 90 days post-injury. Sports-related mild TBI patients were at higher risk of poor concentration [RR: 1.3 (95% CI 1.05-1.54)] and non-return to sports activities [RR: 2.2 (95% CI 1.69-2.94)] at 7 days post-injury. At 90 days, sports-relate -mild TBI patients reported less fatigue [RR: 0.7 (95% CI 0.51-0.98)] and feeling of dizziness [RR: 0.6 (95% CI 0.35-0.99)]. Conclusion Patients who sustained sports-related mild TBI could be at lower risk of experiencing symptoms such as fatigue and dizziness 90 days post-injury. Clinicians should be mindful that non-sports-related mild TBI patients may experience more post-concussion symptoms and that the level of physical activity may influence the patient's rehabilitation.	[Beauchamp, Frederique; Boucher, Valerie; Neveu, Xavier; Ouellet, Vincent; Berthelot, Simon; emond, Marcel; Mercier, Eric; Le Sage, Natalie] Univ Laval, Populat Hlth & Optimal Hlth Practices Res Unit, Trauma Emergency Crit Care Med, CHU Quebec,Laval Res Ctr,Hop Enfant Jesus, 1401,18e Rue,H-610, Quebec City, PQ G1J 1Z4, Canada; [Beauchamp, Frederique; Boucher, Valerie; Neveu, Xavier; Ouellet, Vincent; Berthelot, Simon; emond, Marcel; Frenette, Jerome; Mercier, Eric; Moore, Lynne; Le Sage, Natalie] Univ Laval, CERSSPL, Ctr Rech Soins & Serv Premiere Ligne, Quebec City, PQ, Canada; [Beauchamp, Frederique; Ouellet, Vincent; Archambault, Patrick; Berthelot, Simon; emond, Marcel; Mercier, Eric; Moore, Lynne; Ouellet, Marie-Christine; Le Sage, Natalie] Univ Laval, Fac Med, Quebec City, PQ, Canada; [Archambault, Patrick] Ctr Hosp Affilie Univ Hotel Dieu Levis, Ctr Integre Sante & Serv Sociaux Chaudiere Appala, Levis, PQ, Canada; [Chauny, Jean-Marc; de Guise, Elaine] Univ Montreal, Montreal, PQ, Canada; [de Guise, Elaine] McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ, Canada; [de Guise, Elaine] Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; [Lang, Eddy] Univ Calgary, Calgary, AB, Canada; [Lee, Jacques] Schwartz Reisman Emergency Med Inst, Toronto, ON, Canada; [Moore, Lynne] Univ Laval, Dept Social & Preventat Med, Quebec City, PQ, Canada; [Ouellet, Marie-Christine] Ctr Interdisciplinaire Rech Readaptat & Integrat, Quebec City, PQ, Canada; [Perry, Jeffrey] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Perry, Jeffrey] Univ Ottawa, Dept Emergency Med, Ottawa, ON, Canada		Le Sage, N (corresponding author), Univ Laval, Populat Hlth & Optimal Hlth Practices Res Unit, Trauma Emergency Crit Care Med, CHU Quebec,Laval Res Ctr,Hop Enfant Jesus, 1401,18e Rue,H-610, Quebec City, PQ G1J 1Z4, Canada.; Le Sage, N (corresponding author), Univ Laval, CERSSPL, Ctr Rech Soins & Serv Premiere Ligne, Quebec City, PQ, Canada.; Le Sage, N (corresponding author), Univ Laval, Fac Med, Quebec City, PQ, Canada.	natalie.lesage@fmed.ulaval.ca	Le Sage, Natalie/G-7063-2016	Le Sage, Natalie/0000-0003-4762-8156; Boucher, Valerie/0000-0002-3117-2177	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Faculte de Medecine de l'Universite Laval	This study was funded by the Canadian Institutes of Health Research. FB was recipient of a scholarship from the Faculte de Medecine de l'Universite Laval.	Banks RE, 2019, SEMIN SPEECH LANG, V40, P333, DOI 10.1055/s-0039-1679887; Beauchamp MH, 2019, J INT NEUROPSYCH SOC, V25, P375, DOI 10.1017/S1355617719000286; Carroll Linda J., 2004, Journal of Rehabilitation Medicine Supplement, P113; Cassidy J. David, 2004, Journal of Rehabilitation Medicine Supplement, P28; Cookinham B, 2020, ARCH CLIN NEUROPSYCH, V35, P257, DOI 10.1093/arclin/acz012; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Fehr SD, 2019, CLIN J SPORT MED, V29, P11, DOI 10.1097/JSM.0000000000000494; Gordon KE, 2006, PEDIATR NEUROL, V34, P376, DOI 10.1016/j.pediatrneurol.2005.09.007; Hattrup N, 2020, J SPORT REHABIL, V29, P360, DOI 10.1123/jsr.2019-0187; Henke RD, 2020, J SPORT REHABIL, V29, P248, DOI 10.1123/jsr.2019-0070; Howe CJ, 2016, EPIDEMIOLOGY, V27, P91, DOI 10.1097/EDE.0000000000000409; Howell DR, 2019, MED SCI SPORT EXER, V51, P647, DOI 10.1249/MSS.0000000000001829; Hsieh TH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178186; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kerr ZY, 2018, J SCI MED SPORT, V21, P447, DOI 10.1016/j.jsams.2017.08.025; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kerr ZY, 2014, PEDIATRICS, V134, P489, DOI 10.1542/peds.2014-0770; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2018, CURR OPIN NEUROL, V31, P681, DOI 10.1097/WCO.0000000000000611; Mahooti N, 2018, CHILD ADOL PSYCH CL, V27, P93, DOI 10.1016/j.chc.2017.08.005; Mannix R, 2019, SEMIN PEDIATR NEUROL, V30, P35, DOI 10.1016/j.spen.2019.03.006; Marshall S., 2018, GUIDELINE CONCUSSION, V3rd; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Nelson LD, 2018, J NEUROTRAUM, V35, P249, DOI 10.1089/neu.2017.4988; Paluska SA, 2000, SPORTS MED, V29, P167, DOI 10.2165/00007256-200029030-00003; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2019, J REHABIL MED, V51, P32, DOI 10.2340/16501977-2492; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Seiger A, 2015, J HEAD TRAUMA REHAB, V30, pE52, DOI 10.1097/HTR.0000000000000051; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02	40	2	2	1	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1481-8035	1481-8043		CAN J EMERG MED	Can. J. Emerg. Med.	MAR	2021	23	2					223	231		10.1007/s43678-020-00060-0		JAN 2021	9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	QV2KR	WOS:000615694300002	33512694	Bronze			2022-02-06	
J	Muller, CR; Courelli, V; Lucas, A; Williams, AT; Li, JB; Dos Santos, F; Cuddington, CT; Moses, SR; Palmer, AF; Kistler, EB; Cabrales, P				Muller, Cynthia R.; Courelli, Vasiliki; Lucas, Alfredo; Williams, Alexander T.; Li, Joyce B.; Dos Santos, Fernando; Cuddington, Clayton T.; Moses, Savannah R.; Palmer, Andre F.; Kistler, Erik B.; Cabrales, Pedro			Resuscitation from hemorrhagic shock after traumatic brain injury with polymerized hemoglobin	SCIENTIFIC REPORTS			English	Article								Traumatic brain injury (TBI) is often accompanied by hemorrhage, and treatment of hemorrhagic shock (HS) after TBI is particularly challenging because the two therapeutic treatment strategies for TBI and HS often conflict. Ischemia/reperfusion injury from HS resuscitation can be exaggerated by TBI-induced loss of autoregulation. In HS resuscitation, the goal is to restore lost blood volume, while in the treatment of TBI the priority is focused on maintenance of adequate cerebral perfusion pressure and avoidance of secondary bleeding. In this study, we investigate the responses to resuscitation from severe HS after TBI in rats, using fresh blood, polymerized human hemoglobin (PolyhHb), and lactated Ringer's (LR). Rats were subjected to TBI by pneumatic controlled cortical impact. Shortly after TBI, HS was induced by blood withdrawal to reduce mean arterial pressure (MAP) to 35-40 mmHg for 90 min before resuscitation. Resuscitation fluids were delivered to restore MAP to similar to 65 mmHg and animals were monitored for 120 min. Increased systolic blood pressure variability (SBPV) confirmed TBI-induced loss of autoregulation. MAP after resuscitation was significantly higher in the blood and PolyhHb groups compared to the LR group. Furthermore, blood and PolyhHb restored diastolic pressure, while this remained depressed for the LR group, indicating a loss of vascular tone. Lactate increased in all groups during HS, and only returned to baseline level in the blood reperfused group. The PolyhHb group possessed lower SBPV compared to LR and blood groups. Finally, sympathetic nervous system (SNS) modulation was higher for the LR group and lower for the PolyhHb group compared to the blood group after reperfusion. In conclusion, our results suggest that PolyhHb could be an alternative to blood for resuscitation from HS after TBI when blood is not available, assuming additional testing demonstrate similar favorable results. PolyhHb restored hemodynamics and oxygen delivery, without the logistical constraints of refrigerated blood.	[Muller, Cynthia R.; Courelli, Vasiliki; Lucas, Alfredo; Williams, Alexander T.; Li, Joyce B.; Cabrales, Pedro] Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr La Jolla, San Diego, CA 92093 USA; [Cuddington, Clayton T.; Moses, Savannah R.; Palmer, Andre F.] Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA; [Dos Santos, Fernando; Kistler, Erik B.] Univ Calif San Diego, Dept Anesthesiol & Crit Care, San Diego, CA 92093 USA		Cabrales, P (corresponding author), Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr La Jolla, San Diego, CA 92093 USA.	pcabrales@ucsd.edu	Wolfe, Savannah R/AAV-1635-2021	Kistler, Erik/0000-0002-6512-4798	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HL126945, R01EB021926, T32-HL105373, R01HL138116]; Department of DefenseUnited States Department of Defense [W81XWH-18-1-0059, W81XWH-17-2-0047]	This work was supported by National Institutes of Health Grants R01HL126945, R01EB021926, T32-HL105373, and R01HL138116, and the Department of Defense under Grants W81XWH-18-1-0059, W81XWH-17-2-0047.	Belcher DA, 2020, BIOCONJUGATE CHEM, V31, P605, DOI 10.1021/acs.bioconjchem.9b00766; Bougle A, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-1; Brett SE, 2000, CIRCULATION, V101, P611, DOI 10.1161/01.CIR.101.6.611; Brotfain E, 2012, SHOCK, V38, P630, DOI 10.1097/SHK.0b013e318272d59f; Cabrales P, 2009, J APPL PHYSIOL, V107, P1548, DOI 10.1152/japplphysiol.00622.2009; Cabrales P, 2009, SHOCK, V31, P300, DOI 10.1097/SHK.0b013e318180ff63; Cuddington C, 2020, BIOTECHNOL PROGR, V36, DOI 10.1002/btpr.2958; Dakak N, 1998, HYPERTENSION, V32, P9, DOI 10.1161/01.HYP.32.1.9; FALK JL, 1995, CRIT CARE MED, V23, P4, DOI 10.1097/00003246-199501000-00003; Feldmann H, 1979, Acta Neurochir Suppl (Wien), V28, P74; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; IADECOLA C, 1992, P NATL ACAD SCI USA, V89, P3913, DOI 10.1073/pnas.89.9.3913; Joaquim MP, 2010, NEUROSURG, DOI [10.1055/s-0038-1625588, DOI 10.1055/S-0038-1625588]; Langfitt T W, 1981, Prog Neurol Surg, V10, P14, DOI 10.1159/000384767; Law MM, 1996, SHOCK, V6, P213, DOI 10.1097/00024382-199609000-00010; Li CX, 2014, MAGN RESON IMAGING, V32, P956, DOI 10.1016/j.mri.2014.04.019; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Madigan MC, 2008, J TRAUMA, V64, P280, DOI 10.1097/TA.0b013e3181622bb6; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; McKinley TO, 2018, J TRAUMA ACUTE CARE, V85, P1063, DOI 10.1097/TA.0000000000002069; McMahon CG, 2008, CRIT CARE MED, V36, P216, DOI 10.1097/01.CCM.0000295425.41831.85; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Moore EE, 2009, J AM COLL SURGEONS, V208, P1, DOI 10.1016/j.jamcollsurg.2008.09.023; Namas R, 2009, LIBYAN J MED, V4, P97, DOI 10.4176/090325; Patet C, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0638-5; Prough DS, 1997, J TRAUMA, V42, pS10, DOI 10.1097/00005373-199705001-00003; RAMMING S, 1994, J TRAUMA, V37, P705, DOI 10.1097/00005373-199411000-00003; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Seno S, 2020, BMC NEUROSCI, V21, DOI 10.1186/s12868-020-00571-7; Stern SA, 2000, J NEUROSURG, V93, P305, DOI 10.3171/jns.2000.93.2.0305; Tsai AG, 2006, BLOOD, V108, P3603, DOI 10.1182/blood-2006-02-005272; Williams AT, 2020, ACS APPL BIO MATER, V3, P2976, DOI 10.1021/acsabm.0c00039; Williams AT, 2020, J APPL PHYSIOL, V129, P97, DOI 10.1152/japplphysiol.00016.2020; Williams AT, 2020, SHOCK, V54, P464, DOI 10.1097/SHK.0000000000001530; YUAN XQ, 1992, SURG GYNECOL OBSTET, V174, P305; YUAN XQ, 1991, J NEUROSURG, V75, P408, DOI 10.3171/jns.1991.75.3.0408; Zhang R, 2002, CIRCULATION, V106, P1814, DOI 10.1161/01.CIR.0000031798.07790.FE	39	2	2	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	JAN 28	2021	11	1							2509	10.1038/s41598-021-81717-3			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF3TV	WOS:000616821300019	33510204	Green Published, gold			2022-02-06	
J	Xu, X; Wang, CY; Wu, YG; Houck, K; Hilton, T; Zhou, A; Wu, XP; Han, C; Yang, MC; Yang, W; Shi, FD; Stolla, M; Cruz, MA; Li, M; Zhang, JN; Dong, JF				Xu, Xin; Wang, Chenyu; Wu, Yingang; Houck, Katie; Hilton, Tristan; Zhou, Ashley; Wu, Xiaoping; Han, Cha; Yang, Mengchen; Yang, Wei; Shi, Fu-Dong; Stolla, Moritz; Cruz, Miguel A.; Li, Min; Zhang, Jianning; Dong, Jing-fei			Conformation-dependent blockage of activated VWF improves outcomes of traumatic brain injury in mice	BLOOD			English	Article							VON-WILLEBRAND-FACTOR; FACTOR-VIII BINDING; VONWILLEBRAND-FACTOR; ADAMTS-13 ACTIVITY; ENDOTHELIAL-CELLS; STRING FORMATION; FACTOR MULTIMERS; A2 DOMAIN; COAGULOPATHY; COAGULATION	Traumatic brain injury-induced coagulopathy (TBI-IC) causes life-threatening secondary intracranial bleeding. Its pathogenesis differs mechanistically from that of coagulopathy arising from extracranial injuries and hemorrhagic shock, but it remains poorly understood. We report results of a study designed to test the hypothesis that von Willebrand factor (VWF) released during acute TBI is intrinsically hyperadhesive because its platelet-binding A1-domain is exposed and contributes to TBI-induced vascular leakage and consumptive coagulopathy. This hyperadhesive VWF can be selectively blocked by a VWF A2-domain protein to prevent TBI-IC and to improve neurological function with a minimal risk of bleeding. We demonstrated that A2 given through intraperitoneal injection or IV infusion reduced TBI-induced death by >50% and significantly improved the neurological function of C57BL/6J male mice subjected to severe lateral fluid percussion injury. A2 protected the endothelium from extracellular vesicle-induced injury, reducing TBI-induced platelet activation and microvesiculation, and preventing a TBI-induced hypercoagulable state. A2 achieved this therapeutic efficacy by specifically blocking the A1 domain exposed on the hyperadhesive VWF released during acute TBI. These results suggest that VWF plays a causal role in the development of TBI-IC and is a therapeutic target for this life-threatening complication of TBI.	[Xu, Xin; Houck, Katie; Hilton, Tristan; Zhou, Ashley; Wu, Xiaoping; Yang, Wei; Stolla, Moritz; Dong, Jing-fei] Bloodworks Res Inst, 1551 Eastlake Ave East, Seattle, WA 98102 USA; [Xu, Xin; Han, Cha; Yang, Mengchen; Shi, Fu-Dong; Zhang, Jianning] Tianjin Med Univ Gen Hosp, Dept Neurosurg, 154 Anshan Rd, Tianjin 300052, Peoples R China; [Xu, Xin; Han, Cha; Yang, Mengchen; Shi, Fu-Dong; Zhang, Jianning] Tianjin Med Univ Gen Hosp, Dept Neurol, Tianjin, Peoples R China; [Xu, Xin; Han, Cha; Yang, Mengchen; Shi, Fu-Dong; Zhang, Jianning] Tianjin Med Univ Gen Hosp, Dept Obstet & Gynecol, Tianjin, Peoples R China; [Xu, Xin] Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing, Peoples R China; [Wang, Chenyu; Li, Min] Lanzhou Univ, Sch Med Sci, Inst Pathol, Lanzhou, Peoples R China; [Wang, Chenyu; Li, Min] Lanzhou Univ, Gansu Prov Key Lab Preclin Study New Drug Dev, Lanzhou, Peoples R China; [Wu, Yingang] Univ Sci & Technol, Affiliated Hosp 1, Dept Neurosurg, Hefei, Peoples R China; [Yang, Wei] NanoString Technol, Seattle, WA USA; [Cruz, Miguel A.] Baylor Coll Med, Dept Med, Cardiovasc Res Sect, Houston, TX 77030 USA; [Cruz, Miguel A.] Michael E DeBakey Vet Affairs VA Med Ctr, Ctr Translat Res Inflammatory Dis, Houston, TX USA; [Dong, Jing-fei] Univ Washington, Sch Med, Dept Med, Div Hematol, Seattle, WA 98195 USA		Dong, JF (corresponding author), Bloodworks Res Inst, 1551 Eastlake Ave East, Seattle, WA 98102 USA.; Zhang, JN (corresponding author), Tianjin Med Univ Gen Hosp, Dept Neurosurg, 154 Anshan Rd, Tianjin 300052, Peoples R China.; Li, M (corresponding author), Lanzhou Univ, Inst Pathol, Sch Basic Med Sci, 199 Donggang West Rd, Lanzhou 730000, Peoples R China.; Cruz, MA (corresponding author), Baylor Coll Med, Cardiovasc Res Sect, 1 Baylor Plaza, Houston, TX 77030 USA.	miguelc@bcm.edu; limin@lzu.edu.cn; jianningzhang@hotmail.com; jfdong@bloodworksnw.org		Xu, Xin/0000-0003-3395-9923	National Institutes of Health, National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS087296, NS094280]; National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL152200, HL125957]; National Institutes of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM112806]; Natural Science Foundation of China State Key Program [81330029, 81930031, 81271361, 81672399]	This study was supported by National Institutes of Health, National Institute of Neurological Disorders and Stroke Grants NS087296 (J.-f.D.) and NS094280 (M.A.C.), National Heart, Lung, and Blood Institute Grants HL152200 and HL125957 (J.-f.D.), and National Institutes of General Medical Sciences Grant GM112806 (M.A.C.); Natural Science Foundation of China State Key Program Grants 81330029 and 81930031 (J.N.Z.); and Research Grants 81271361 (J.N.Z.) and 81672399 (M.L.).	BAHOU WF, 1989, J CLIN INVEST, V84, P56, DOI 10.1172/JCI114169; Bhatti J, 2018, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00744; Brouland JP, 1999, ARTERIOSCL THROM VAS, V19, P3055, DOI 10.1161/01.ATV.19.12.3055; Butera D, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aaq1477; Chen JM, 2011, BLOOD, V117, P3680, DOI 10.1182/blood-2010-08-302539; Chen JM, 2010, BLOOD, V115, P706, DOI 10.1182/blood-2009-03-213967; Choi H, 2007, J BIOL CHEM, V282, P35604, DOI 10.1074/jbc.M704047200; Claus RA, 2010, CURR MOL MED, V10, P236, DOI 10.2174/156652410790963367; Claus RA, 2005, THROMB HAEMOSTASIS, V94, P41; Cohen MJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8152; COUNTS RB, 1978, J CLIN INVEST, V62, P702, DOI 10.1172/JCI109178; Cruz MA, 2003, THROMB HAEMOSTASIS, V90, P1204, DOI 10.1160/TH03-06-0398; Davenport RA, 2009, CURR OPIN ANESTHESIO, V22, P261, DOI 10.1097/ACO.0b013e328325a6d9; De Oliveira CO, 2007, J NEUROTRAUM, V24, P1331, DOI 10.1089/neu.2006.0159; Dong JF, 2005, J THROMB HAEMOST, V3, P1710, DOI 10.1111/j.1538-7836.2005.01360.x; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Dong JF, 2001, BLOOD, V97, P162, DOI 10.1182/blood.V97.1.162; Fasipe TA, 2018, STROKE, V49, P2536, DOI 10.1161/STROKEAHA.118.022888; FOSTER PA, 1987, J BIOL CHEM, V262, P8443; FOWLER WE, 1985, J CLIN INVEST, V76, P1491, DOI 10.1172/JCI112129; Frith D, 2010, SURG-J R COLL SURG E, V8, P159, DOI 10.1016/j.surge.2009.10.022; Furlan M, 1996, ANN HEMATOL, V72, P341, DOI 10.1007/s002770050184; Gerritsen HE, 1999, THROMB HAEMOSTASIS, V82, P1386; Han C, 2020, HAEMATOLOGICA, V105, P1686, DOI 10.3324/haematol.2019.226209; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hoots WK, 1997, SEMIN THROMB HEMOST, V23, P3; Huang J, 2009, BLOOD, V113, P1589, DOI 10.1182/blood-2008-05-158584; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Hulstein JJJ, 2005, BLOOD, V106, P3035, DOI 10.1182/blood-2005-03-1153; Johansson PI, 2011, CRIT CARE, V15, DOI 10.1186/cc10553; Kumar MA, 2019, J NEUROTRAUM, V36, P222, DOI 10.1089/neu.2018.5696; Lee K, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/207247; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Li Y, 2008, J THROMB HAEMOST, V6, P1135, DOI 10.1111/j.1538-7836.2008.02991.x; Ma MW, 2018, REDOX BIOL, V16, P285, DOI 10.1016/j.redox.2018.03.005; Maani CV, 2009, CURR OPIN ANESTHESIO, V22, P255, DOI 10.1097/ACO.0b013e32832922be; Martin C, 2007, J THROMB HAEMOST, V5, P1363, DOI 10.1111/j.1538-7836.2007.02536.x; MAYADAS TN, 1989, J BIOL CHEM, V264, P13497; Mitra B, 2012, INJURY, V43, P22, DOI 10.1016/j.injury.2010.10.015; Moake JL, 1998, J CLIN APHERESIS, V13, P126, DOI 10.1002/(SICI)1098-1101(1998)13:3<126::AID-JCA6>3.0.CO;2-U; Nguyen TC, 2015, THROMB RES, V135, P1025, DOI 10.1016/j.thromres.2015.02.033; Niles SE, 2008, J TRAUMA, V64, P1459, DOI 10.1097/TA.0b013e318174e8bc; Padilla A, 2004, BLOOD, V103, P2150, DOI 10.1182/blood-2003-08-2956; Pepin M, 2016, J THROMB HAEMOST, V14, P306, DOI 10.1111/jth.13205; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Shaz BH, 2011, J TRAUMA, V70, P1401, DOI 10.1097/TA.0b013e31821266e0; Shiltagh N, 2014, BLOOD, V123, P4143, DOI [10.1182/blood-2013-07-517086, 10.13018/BMR19646]; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; Siemiatkowski A, 2000, HAEMOSTASIS, V30, P189; Singh I, 2006, J BIOL CHEM, V281, P38266, DOI 10.1074/jbc.M607123200; SPORN LA, 1987, BLOOD, V69, P1531; SPORN LA, 1986, CELL, V46, P185, DOI 10.1016/0092-8674(86)90735-X; TAKAHASHI Y, 1987, BLOOD, V70, P1679; Tang N, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-70; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; VISCHER UM, 1994, BLOOD, V83, P3536; Wafaisade A, 2010, EMERG MED J, V27, P934, DOI 10.1136/emj.2009.088484; Wang Y, 2015, J BIOL CHEM, V290, P1422, DOI 10.1074/jbc.M114.599084; Whitelock JL, 2004, J THROMB HAEMOST, V2, P485, DOI 10.1111/j.1538-7836.2004.00601.x; Wu YG, 2018, BLOOD, V132, P1075, DOI 10.1182/blood-2018-03-841932; Yokota H, 2002, J NEUROTRAUM, V19, P1007, DOI 10.1089/089771502760341929; Zhang JN, 2018, BLOOD, V131, P2001, DOI 10.1182/blood-2017-11-784108; Zhang JN, 2003, THROMB HAEMOSTASIS, V90, P672, DOI 10.1160/TH03-03-0145; Zhang JN, 2002, THROMB HAEMOSTASIS, V88, P817, DOI 10.1055/s-0037-1613308; Zhao ZL, 2016, BLOOD, V127, P2763, DOI [10.1182/blood-2015-12688838, 10.1182/blood-2015-12-688838]; Zhou Y, 2018, BLOOD, V131, P563, DOI 10.1182/blood-2017-08-801738	66	2	2	4	5	AMER SOC HEMATOLOGY	WASHINGTON	2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA	0006-4971	1528-0020		BLOOD	Blood	JAN 28	2021	137	4					544	555		10.1182/blood.2020007364			12	Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Hematology	QB4VC	WOS:000614138100017	33507292	Green Published			2022-02-06	
J	Wilde, EA; Dennis, EL; Tate, DF				Wilde, Elisabeth A.; Dennis, Emily L.; Tate, David F.			The ENIGMA Brain Injury working group: approach, challenges, and potential benefits	BRAIN IMAGING AND BEHAVIOR			English	Article						Traumatic brain injury; Special issue; ENIGMA; Meta-analysis		The Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) consortium brings together researchers from around the world to try to identify the genetic underpinnings of brain structure and function, along with robust, generalizable effects of neurological and psychiatric disorders. The recently-formed ENIGMA Brain Injury working group includes 10 subgroups, based largely on injury mechanism and patient population. This introduction to the special issue summarizes the history, organization, and objectives of ENIGMA Brain Injury, and includes a discussion of strategies, challenges, opportunities and goals common across 6 of the subgroups under the umbrella of ENIGMA Brain Injury. The following articles in this special issue, including 6 articles from different subgroups, will detail the challenges and opportunities specific to each subgroup.	[Wilde, Elisabeth A.; Dennis, Emily L.; Tate, David F.] Univ Utah, Sch Med, Dept Neurol, TBICC, Salt Lake City, UT 84112 USA; [Wilde, Elisabeth A.; Dennis, Emily L.; Tate, David F.] George E Wahlen VA Med Ctr, Salt Lake City, UT 84148 USA; [Wilde, Elisabeth A.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Dennis, Emily L.] Harvard Med Sch, Brigham & Womens Hosp, Psychiat Neuroimaging Lab, Boston, MA 02115 USA; [Dennis, Emily L.] Keck Sch Med USC, Stevens Neuroimaging & Informat Inst, Imaging Genet Ctr, Marina Del Rey, CA 90292 USA; [Tate, David F.] Univ Missouri, Missouri Inst Mental Hlth, St Louis, MO 63121 USA		Dennis, EL (corresponding author), Univ Utah, Sch Med, Dept Neurol, TBICC, Salt Lake City, UT 84112 USA.; Dennis, EL (corresponding author), George E Wahlen VA Med Ctr, Salt Lake City, UT 84148 USA.; Dennis, EL (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Psychiat Neuroimaging Lab, Boston, MA 02115 USA.; Dennis, EL (corresponding author), Keck Sch Med USC, Stevens Neuroimaging & Informat Inst, Imaging Genet Ctr, Marina Del Rey, CA 90292 USA.	emily.dennis@hsc.utah.edu		Dennis, Emily/0000-0001-7112-4009	CENC [K99 NS096116, PT12051, I01 RX002174]	We acknowledge funding sources including K99 NS096116 to Dr. Dennis and PT12051 and I01 RX002174 (CENC) to Drs. Wilde, Tate, and Dennis. The authors wish to acknowledge the leadership of Dr. Paul Thompson (ENIGMA PI) as well as the leadership of Drs. Frank Hillary, Alexander Olsen, Inga Koerte, David Baron, Alexander Lin, Brenda Bartnik-Olson, Karen Caeyenberghs, Carrie Esopenko, and Neda Jahanshad, as well as ENIGMA support personnel and all working group members and contributors. We wish to acknowledge the contribution of Eamonn Kennedy in the conceptualization and creation of the figures. We also wish to thank all participants who have contributed to this research. Finally, we extend our gratitude to Drs. Erin D. Bigler and Martha E. Shenton for their thoughtful review of this manuscript and their enduring mentorship and support.	Adhikari BM, 2019, BRAIN IMAGING BEHAV, V13, P1453, DOI 10.1007/s11682-018-9941-x; Adhikari BM, 2018, BIOCOMPUT-PAC SYM, P307; Bartnik-Olson BL, 2021, BRAIN IMAGING BEHAV, V15, P504, DOI 10.1007/s11682-020-00330-6; Berger RP, 2012, J NEUROTRAUM, V29, P672, DOI 10.1089/neu.2011.1861; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Budin-Ljosne I, 2014, EUR J HUM GENET, V22, P317, DOI 10.1038/ejhg.2013.131; Carr, 2017, J CLIN RES BEST PRAC; Cetin-Karayumak S, 2020, MOL PSYCHIATR, V25, P3208, DOI 10.1038/s41380-019-0509-y; Choe, BRAIN IMAGING BEHAV; Dennis, 2019, POSTTRAUMATIC STRESS, DOI [10.1101/677153, DOI 10.1101/677153]; Dennis EL, 2021, BRAIN IMAGING BEHAV, V15, P555, DOI 10.1007/s11682-020-00363-x; Duncan D, 2018, FRONT NEUROINFORM, V12, DOI 10.3389/fninf.2018.00086; Esopenko C., 2020, BRAIN IMAGING BEHAV; Frodl T, 2017, J PSYCHIATR RES, V86, P58, DOI 10.1016/j.jpsychires.2016.11.010; Gorgolewski KJ, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.44; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Karayumak SC, 2019, NEUROIMAGE, V184, P180, DOI 10.1016/j.neuroimage.2018.08.073; Kelly S, 2017, BIOL PSYCHIAT, V81, pS381, DOI 10.1016/j.biopsych.2017.02.667; Kremen WS, 2013, TWIN RES HUM GENET, V16, P399, DOI 10.1017/thg.2012.86; Lepage C, 2018, BRAIN IMAGING BEHAV, V12, P870, DOI 10.1007/s11682-017-9744-5; Logue MW, 2018, BIOL PSYCHIAT, V83, P244, DOI 10.1016/j.biopsych.2017.09.006; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Mackey S, 2019, AM J PSYCHIAT, V176, P119, DOI 10.1176/appi.ajp.2018.17040415; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; Milchenko M, 2013, NEUROINFORMATICS, V11, P65, DOI 10.1007/s12021-012-9160-3; Olsen A., 2020, BRAIN IMAGING BEHAV; Paltoo DN, 2014, NAT GENET, V46, P934, DOI 10.1038/ng.3062; Plis SM, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00365; Putukian M, 2019, AM J SPORT MED, V47, P1236, DOI 10.1177/0363546519830100; Renteria ME, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.84; Sariyar M, 2015, BIOPRESERV BIOBANK, V13, P263, DOI 10.1089/bio.2015.0014; Schmaal L, 2017, MOL PSYCHIATR, V22, P900, DOI 10.1038/mp.2016.60; Schmaal L, 2016, MOL PSYCHIATR, V21, P806, DOI 10.1038/mp.2015.69; Silverberg ND, 2017, J NEUROTRAUM, V34, P363, DOI 10.1089/neu.2016.4443; Stein, 2019, NEUROIMAGE; Thompson PM, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0705-1; Tozzi L, 2020, PSYCHOL MED, V50, P1020, DOI 10.1017/S003329171900093X; Veer I., 2019, 25 ORG HUM BRAIN MAP; Voigt, 2017, EU GEN DATA PROTECTI, DOI [10.1007/978-3-319-57959-7.pdf, DOI 10.1007/978-3-319-57959-7.PDF]; Walker WC, 2016, BRAIN INJURY, V30, P1469, DOI 10.1080/02699052.2016.1219061; Weiner MW, 2014, ALZHEIMERS DEMENT, V10, pS226, DOI 10.1016/j.jalz.2014.04.005; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	42	2	2	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	APR	2021	15	2					465	474		10.1007/s11682-021-00450-7		JAN 2021	10	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RK3RJ	WOS:000612302600002	33506440				2022-02-06	
J	Rogan, A; Patel, V; Birdling, J; Lockett, J; Simmonds, H; McQuade, D; Quigley, P; Larsen, P				Rogan, Alice; Patel, Vimal; Birdling, Jane; Lockett, Jessica; Simmonds, Harnah; McQuade, David; Quigley, Paul; Larsen, Peter			Alcohol and acute traumatic brain injury in the emergency department	EMERGENCY MEDICINE AUSTRALASIA			English	Article						alcohol-related harm; computed tomography head scan; emergency department; traumatic brain injury	NEW-ZEALAND; IMPACT; CT	Objective: There is limited research from Australasian EDs describing the demographic make-up, injury severity and impact of alcohol in patients requiring computed tomography (CT) for suspected traumatic brain injury (TBI). The present study aims to review the frequency and presenting patterns of patients who consume alcohol prior to presenting with suspected TBI. Methods: Retrospective observational study of patients referred for head CT to exclude TBI from a major referral centre and regional ED in New Zealand, between 1 September 2018 and 31 August 2019. Comparison groups were defined as 'alcohol involved' or 'no alcohol involved'. Results: 97/425 (22.8% [95% CI 18.3-27.4]) of included TBI presentations involved alcohol. 73/97 (75.3% [95% CI 58.6-93.5]) were male and 41/97 (42.3% [95% CI 29.3-55.2]) were aged 18-30 years. The alcohol group were more likely to report assault as the injury mechanism (19.6% [95% CI 10.8-28.4] vs 5.2% [95% CI 2.7-7.7], P < 0.05) and have Glasgow Coma Scale scores reflecting more moderate (13.5% [95% CI 5.9-21.1] vs 3.5% [95% CI 1.5-5.6]) and severe (5.6% [95% CI 0.7-10.5] vs 3.2% [95% CI 1.2-5.2] TBI. Presentation times post-injury were delayed compared to the no alcohol group (3.4 h [interquartile range 1.9-14.8] vs 2.8 h [interquartile range 1.8-6.6], P < 0.05). Conclusion: One quarter of patients with suspected TBI had consumed alcohol prior to their injury. Predominantly, those affected were young males who reported higher rates of assault; however, alcohol use was recorded in all age groups and sex. Alcohol-affected patients presented later, potentially delaying time to diagnosis. The present study supports the call for public health interventions that aim to reduce alcohol misuse.	[Rogan, Alice; Larsen, Peter] Univ Otago, Dept Surg & Anaesthesia, Wellington, New Zealand; [Patel, Vimal] Hutt Valley Hosp, Emergency Dept, Lower Hutt, New Zealand; [Birdling, Jane; Lockett, Jessica; Simmonds, Harnah; McQuade, David; Quigley, Paul] Wellington Reg Hosp, Emergency Dept, Wellington, New Zealand		Rogan, A (corresponding author), Univ Otago, Dept Surg & Anaesthesia, POB 7343, Wellington 6242, New Zealand.	alice.rogan@otago.ac.nz		Rogan, Alice/0000-0003-1305-0325; Lockett, Jessica/0000-0003-3242-1486	research office at CCDHB; research office at HVDHB; University of Otago (Wellington) Department of Surgery and Anaesthesia	The authors would like to thank Hutt and Wellington EDs for their data contributions; the research offices at CCDHB and HVDHB for their local approval and support; the RAG-M and University of Otago Health Committees for their approval and the University of Otago (Wellington) Department of Surgery and Anaesthesia for their expertise and support.	Australasian College for Emergency Medicine, 2020, POS STAT ALC HARM; Australasian College for Emergency Medicine, 2019, AOT NZ MAN MAN STRA; Australasian College for Emergency Medicine, 2018, ALC BURD EM DEP; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Capital and Coast District Health Board, 2019, TAUR OR MAOR HLTH ST; DeAngelis J, 2017, WEST J EMERG MED, V18, P821, DOI 10.5811/westjem.2017.6.33685; DiGiorgio AM, 2020, WORLD NEUROSURG, V135, DOI 10.1016/j.wneu.2019.12.095; Egerton-Warburton D, 2018, ADDICTION, V113, P623, DOI 10.1111/add.14109; Egerton-Warburton D, 2016, MED J AUSTRALIA, V204, DOI 10.5694/mja15.00858; Esterman Adrian, 2018, Inj Epidemiol, V5, P40, DOI 10.1186/s40621-018-0172-9; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Health Information Standards Organisation, 2017, 100012017 HISO; Hoban Ciara, 2017, Emerg Nurse, V25, P30, DOI 10.7748/en.2017.e1670; Jones P, 2018, INJURY, V49, P1680, DOI 10.1016/j.injury.2018.05.011; Kaji AH, 2014, ANN EMERG MED, V64, P292, DOI 10.1016/j.annemergmed.2014.03.025; King D, 2019, J NEUROL SCI, V399, P61, DOI 10.1016/j.jns.2019.01.049; Kool B, 2018, INJURY, V49, P798, DOI 10.1016/j.injury.2018.02.028; Lagolago W, 2015, NEW ZEAL MED J, V128, P29; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Ministry of Health New Zealand, 2009, HLTH TARG SHORT STAY; Molina PE, 2018, ALCOHOL RES-CURR REV, V39, P99; National Institute for Health and Care Excellence, 2014, HEAD INJ NICE CLIN G; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Pozzato I, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034494; Skandsen T, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0495-0; Stewart R, 2014, NEW ZEAL MED J, V127, P23; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; van Wijck SF, 2021, EUR J EMERG MED, V28, P97, DOI 10.1097/MEJ.0000000000000754; WHO, 2009, ALCOHOL AND INJURIES: EMERGENCY DEPARTMENT STUDIES IN AN INTERNATIONAL PERSPECTIVE, P1; Woods C, 2019, AUSTRALAS EMERG CARE, V22, P22, DOI 10.1016/j.auec.2018.11.001; World Health Organization, 2007, ALC INJ EM DEP SUM R; World Health Organization, 2014, GLOB STAT REP ALC H	34	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-6731	1742-6723		EMERG MED AUSTRALAS	Emerg. Med. Australas.	AUG	2021	33	4					718	727		10.1111/1742-6723.13726		JAN 2021	10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	TK3KI	WOS:000611670900001	33496079				2022-02-06	
J	Karlsson, M; Yang, ZH; Chawla, S; Delso, N; Pukenas, B; Elmer, E; Hugerth, M; Margulies, SS; Ehinger, J; Hansson, MJ; Wang, KKW; Kilbaugh, TJ				Karlsson, Michael; Yang, Zhihui; Chawla, Sanjeev; Delso, Nile; Pukenas, Bryan; Elmer, Eskil; Hugerth, Matilda; Margulies, Susan S.; Ehinger, Johannes; Hansson, Magnus J.; Wang, Kevin K. W.; Kilbaugh, Todd J.			Evaluation of Diffusion Tensor Imaging and Fluid Based Biomarkers in a Large Animal Trial of Cyclosporine in Focal Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; cyclosporine; diffusion tensor imaging; traumatic brain injury	ACUTE MITOCHONDRIAL DYSFUNCTION; AXONAL INJURY; CLINICAL-TRIALS; DAMAGE; TAU; PROGESTERONE; ATTENUATION; INTEGRITY; NIM811	All phase III trials evaluating medical treatments for traumatic brain injury (TBI), performed to date, have failed. To facilitate future success there is a need for novel outcome metrics that can bridge pre-clinical studies to clinical proof of concept trials. Our objective was to assess diffusion tensor imaging (DTI) and biofluid-based biomarkers as efficacy outcome metrics in a large animal study evaluating the efficacy of cyclosporine in TBI. This work builds on our previously published study that demonstrated a reduced volume of injury by 35% with cyclosporine treatment based on magnetic resonance imaging (MRI) results. A focal contusion injury was induced in piglets using a controlled cortical impact (CCI) device. Cyclosporine in a novel Cremophor/Kolliphor EL-free lipid emulsion, NeuroSTAT, was administered by continuous intravenous infusion for 5 days. The animals underwent DTI on day 5. Glial fibrillary acidic protein (GFAP), as a measure of astroglia injury, and neurofilament light (NF-L), as a measure of axonal injury, were measured in blood on days 1, 2, and 5, and in cerebrospinal fluid (CSF) on day 5 post-injury. Normalized fractional anisotropy (FA) was significantly (p = 0.027) higher in in the treatment group, indicating preserved tissue integrity with treatment. For the biomarkers, we observed a statistical trend of a decreased level of NF-L in CSF (p = 0.051), in the treatment group relative to placebo, indicating less axonal injury. Our findings suggest that DTI, and possibly CSF NF-L, may be feasible as translational end-points assessing neuroprotective drugs in TBI.	[Karlsson, Michael] Rigshosp, Dept Neurosurg, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; [Karlsson, Michael; Elmer, Eskil; Ehinger, Johannes; Hansson, Magnus J.] Lund Univ, Mitochondrial Med, Dept Clin Sci, Lund, Sweden; [Karlsson, Michael; Delso, Nile; Kilbaugh, Todd J.] Univ Penn, Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Chawla, Sanjeev; Pukenas, Bryan] Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Yang, Zhihui; Wang, Kevin K. W.] Univ Florida, Dept Emergency Med, Program Neurotrauma Neuroprote & Biomarkers Res, Gainesville, FL USA; [Elmer, Eskil; Hugerth, Matilda; Hansson, Magnus J.] Abliva AB, Lund, Sweden; [Margulies, Susan S.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Margulies, Susan S.] Emory Univ, Atlanta, GA 30322 USA		Karlsson, M (corresponding author), Rigshosp, Dept Neurosurg, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	michael.karl.karlsson@regionh.dk	Ehinger, Johannes/D-7120-2013	Ehinger, Johannes/0000-0002-2417-5767	Department of Anesthesiology and Critical Care Medicine at The Children's Hospital of Philadelphia; Department of Anesthesiology and Critical Care Medicine Endowed Chair Funds at The Children's Hospital of Philadelphia; Children's Hospital of Philadelphia Research Institute Resuscitation Science Center of Emphasis; Mary Jane Raymond Foundation; Abliva AB	The study was in part funded by Abliva AB, previously known as NeuroVive Pharmaceutical AB, which owns the intellectual property for NeuroSTAT. Funding was also provided by the Department of Anesthesiology and Critical Care Medicine at The Children's Hospital of Philadelphia. Funding was also provided by the Department of Anesthesiology and Critical Care Medicine Endowed Chair Funds at The Children's Hospital of Philadelphia (Kilbaugh), The Children's Hospital of Philadelphia Research Institute Resuscitation Science Center of Emphasis (Kilbaugh), Mary Jane Raymond Foundation (Kilbaugh).	Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Brophy GM, 2013, J NEUROTRAUM, V30, P1484, DOI 10.1089/neu.2012.2524; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Colley BS, 2010, EXP NEUROL, V224, P241, DOI 10.1016/j.expneurol.2010.03.026; Czeiter E, 2020, EBIOMEDICINE, V56, DOI 10.1016/j.ebiom.2020.102785; Dhiman K, 2020, ALZH DEMENT-DADM, V12, DOI 10.1002/dad2.12005; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; FDA-NIH Biomarker Working Group, 2016, BEST BIOMARKERS ENDP; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; Hansson MJ, 2011, J NEUROTRAUM, V28, P143, DOI 10.1089/neu.2010.1613; Hatton J, 2008, J NEUROSURG, V109, P699, DOI 10.3171/JNS/2008/109/10/0699; Karlsson M., 2018, J NEUROTRAUM, V36, P14; Kelsen J, 2019, J NEUROTRAUM, V36, P3253, DOI 10.1089/neu.2018.6369; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Kirschen MP, 2020, PEDIATR CRIT CARE ME, V21, P656, DOI 10.1097/PCC.0000000000002294; Kochanek PM, 2013, LANCET NEUROL, V12, P1132, DOI 10.1016/S1474-4422(13)70245-X; Komakhidze M E, 1977, Vestn Khir Im I I Grek, V119, P26; Korley FK, 2018, J NEUROTRAUM, V35, P1185, DOI 10.1089/neu.2017.5581; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Lu J, 2012, BRAIN INJURY, V26, P1523, DOI 10.3109/02699052.2012.722257; Margulies SS, 2015, BRAIN PATHOL, V25, P289, DOI 10.1111/bpa.12247; Mazzeo AT, 2008, ACTA NEUROCHIR, V150, P1019, DOI 10.1007/s00701-008-0021-7; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; Menon DK, 2009, CRIT CARE MED, V37, pS129, DOI 10.1097/CCM.0b013e3181921225; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Riess P, 2001, RESTOR NEUROL NEUROS, V18, P1; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Signoretti S, 2004, J NEUROTRAUM, V21, P1154, DOI 10.1089/neu.2004.21.1154; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Soares JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00031; Staal JA, 2007, DEV NEUROBIOL, V67, P1831, DOI 10.1002/dneu.20552; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Suehiro E, 2001, J NEUROSURG, V94, P493, DOI 10.3171/jns.2001.94.3.0493; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Turkoglu OF, 2010, BRIT J NEUROSURG, V24, P578, DOI 10.3109/02688697.2010.487126; Uchino H, 1995, ACTA PHYSIOL SCAND, V155, P469, DOI 10.1111/j.1748-1716.1995.tb09999.x; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Van den Heuvel C, 2004, J NEUROTRAUM, V21, P1562, DOI 10.1089/0897715042441783; Vink R, 2004, EXPERT OPIN INV DRUG, V13, P1263, DOI 10.1517/13543784.13.10.1263; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Winston GP, 2012, QUANT IMAGING MED SU, V2, P254, DOI 10.3978/j.issn.2223-4292.2012.12.05; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0	62	2	2	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2021	38	13					1870	1878		10.1089/neu.2020.7317		JAN 2021	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SU3SJ	WOS:000613464900002	33191835				2022-02-06	
J	Georgina, G; Perez, GM; De Gasperi, R; Sosa, MAG; Otero-Pagan, A; Pryor, D; Abutarboush, R; Kawoos, U; Hof, PR; Cook, DG; Gandy, S; Ahlers, ST; Elder, GA				Perez Garcia, Georgina; Perez, Gissel M.; De Gasperi, Rita; Gama Sosa, Miguel A.; Otero-Pagan, Alena; Pryor, Dylan; Abutarboush, Rania; Kawoos, Usmah; Hof, Patrick R.; Cook, David G.; Gandy, Sam; Ahlers, Stephen T.; Elder, Gregory A.			Progressive Cognitive and Post-Traumatic Stress Disorder-Related Behavioral Traits in Rats Exposed to Repetitive Low-Level Blast	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; behavioral assessments; neurodegenerative disorders; traumatic brain injury	TRAUMATIC BRAIN-INJURY; PERSISTENT POSTCONCUSSIVE SYMPTOMS; MILITARY SERVICE MEMBERS; US ARMY; MODEL; TAU; VETERANS; DEFICITS; TBI; REHABILITATION	Many military veterans who experienced blast-related traumatic brain injuries (TBI) in the conflicts in Iraq and Afghanistan currently have chronic cognitive and mental health problems including post-traumatic stress disorder (PTSD). Besides static symptoms, new symptoms may emerge or existing symptoms may worsen. TBI is also a risk factor for later development of neurodegenerative diseases. In rats exposed to repetitive low-level blast overpressure (BOP), robust and enduring cognitive and PTSD-related behavioral traits develop that are present for at least one year after blast exposure. Here we determined the time-course of the appearance of these traits by testing rats in the immediate post-blast period. Three cohorts of rats examined within the first eight weeks exhibited no behavioral phenotype or, in one cohort, features of anxiety. None showed the altered cued fear responses or impaired novel object recognition characteristic of the fully developed phenotype. Two cohorts retested 36 to 42 weeks after blast exposure exhibited the expanded behavioral phenotype including anxiety as well as altered cued fear learning and impaired novel object recognition. Combined with previous work, the chronic behavioral phenotype has been observed in six cohorts of blast-exposed rats studied at 3-4 months or longer after blast injury, and the three cohorts studied here document the progressive nature of the cognitive/behavioral phenotype. These studies suggest the existence of a latent, delayed emerging and progressive blast-induced cognitive and behavioral phenotype. The delayed onset has implications for the evolution of post-blast neurobehavioral syndromes in military veterans and its modeling in experimental animals.	[Perez Garcia, Georgina; Perez, Gissel M.; De Gasperi, Rita; Otero-Pagan, Alena; Pryor, Dylan; Gandy, Sam] James J Peters Dept Vet Affairs Med Ctr, Res & Dev Serv, Bronx, NY USA; [Gama Sosa, Miguel A.] James J Peters Dept Vet Affairs Med Ctr, Gen Med Res Serv, Bronx, NY USA; [Elder, Gregory A.] James J Peters Dept Vet Affairs Med Ctr, Neurol Serv, Bronx, NY USA; [Perez Garcia, Georgina; Gandy, Sam; Elder, Gregory A.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [De Gasperi, Rita; Gama Sosa, Miguel A.; Gandy, Sam; Elder, Gregory A.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Hof, Patrick R.] Icahn Sch Med Mt Sinai, Dept Geriatr & Palliat Care, New York, NY 10029 USA; [Hof, Patrick R.] Icahn Sch Med Mt Sinai, Dept Nash Family Dept Neurosci, New York, NY 10029 USA; [Hof, Patrick R.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Hof, Patrick R.; Elder, Gregory A.] Icahn Sch Med Mt Sinai, Mt Sinai Alzheimers Dis Res Ctr, New York, NY 10029 USA; [Hof, Patrick R.; Elder, Gregory A.] Icahn Sch Med Mt Sinai, Ronald M Loeb Ctr Alzheimers Dis, New York, NY 10029 USA; [Abutarboush, Rania; Kawoos, Usmah; Ahlers, Stephen T.] Naval Med Res Ctr, Dept Neurotrauma, Silver Spring, MD USA; [Abutarboush, Rania; Kawoos, Usmah] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA; [Cook, David G.] VA Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA USA; [Cook, David G.] Univ Washington, Dept Med, Seattle, WA USA; [Gandy, Sam] Icahn Sch Med Mt Sinai, Barbara & Maurice A Deane Ctr Wellness & Cognit H, New York, NY 10029 USA; [Gandy, Sam] Icahn Sch Med Mt Sinai, Mt Sinai NFL Neurol Care Ctr, New York, NY 10029 USA		Georgina, G (corresponding author), James J Peters VA Med Ctr, Res & Dev 3F 26, 130 West Kingsbridge Rd, Bronx, NY 10468 USA.	georgina.perez-garcia@va.gov		Cox, Owen/0000-0002-1860-1491	Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service AwardsUS Department of Veterans Affairs [1I01RX000996, 1I01RX002660, 1I21RX003019, 1I01RX000684, 1I01RX002333]; Department of Veterans Affairs Office of Research and Development Medical Research ServiceUS Department of Veterans Affairs [1I01BX004067, 1I01BX002311]; Department of DefenseUnited States Department of Defense [0000B999.0000.000.A1503]; Alzheimer's Drug Discovery Foundation; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50 AG005138, P30 AG066514]	This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service Awards 1I01RX000996 (GE), 1I01RX002660 (GE), 1I21RX003019 (GE), 1I01RX000684 (SG), and 1I01RX002333 (SG), the Department of Veterans Affairs Office of Research and Development Medical Research Service 1I01BX004067 (GE) and 1I01BX002311 (DC), Department of Defense work unit number 0000B999.0000.000.A1503 (STA), the Alzheimer's Drug Discovery Foundation (SG) and by NIA P50 AG005138 and P30 AG066514 both to Mary Sano (SG, PRH).	Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Arun P, 2015, NEUROSCI LETT, V609, P152, DOI 10.1016/j.neulet.2015.10.036; Arun P, 2013, NEUROSCI LETT, V552, P87, DOI 10.1016/j.neulet.2013.07.047; Brenner LA, 2013, J HEAD TRAUMA REHAB, V28, P21, DOI 10.1097/HTR.0b013e31827df0b5; Bugay V, 2020, J NEUROTRAUM, V37, P248, DOI 10.1089/neu.2018.6333; Cao JM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09047-x; Cernak I, 2017, BRAIN INJURY, V31, P1168, DOI 10.1080/02699052.2016.1274779; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chen M, 2018, J ALZHEIMERS DIS, V66, P751, DOI 10.3233/JAD-180726; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; DePalma R.G., 2015, BRAIN NEUROTRAUMA MO, P5; Dickstein DL, 2021, MOL PSYCHIATR, V26, P5940, DOI 10.1038/s41380-020-0674-z; Dreer LE, 2018, CURR OPIN PSYCHOL, V22, P73, DOI 10.1016/j.copsyc.2017.08.030; Du XP, 2017, FREE RADICAL BIO MED, V108, P627, DOI 10.1016/j.freeradbiomed.2017.04.343; Du XP, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4159357; Edwards KA, 2020, BRAIN INJURY, V34, P1213, DOI 10.1080/02699052.2020.1797171; Elder GA, 2019, NEUROSCI LETT, V707, DOI 10.1016/j.neulet.2019.134294; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Elder GA, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0591-8; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Engel C., 2019, P FIND EXP REC 7 DEP; Fan Y, 2020, NEUROTOX RES, V38, P793, DOI 10.1007/s12640-020-00250-9; Gerson J, 2016, J NEUROTRAUM, V33, P2034, DOI 10.1089/neu.2015.4262; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Goncalves RA, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00124; Gubata ME, 2014, J HEAD TRAUMA REHAB, V29, P65, DOI 10.1097/HTR.0b013e318295f590; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoshino S, 1998, NEUROREPORT, V9, P1879, DOI 10.1097/00001756-199806010-00039; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; Kiryk A, 2020, BEHAV BRAIN RES, V388, DOI 10.1016/j.bbr.2020.112620; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Li YT, 2020, NEUROCHEM RES, V45, P2723, DOI 10.1007/s11064-020-03123-x; Liu MD, 2014, CHIN J TRAUMATOL, V17, P317, DOI 10.3760/cma.j.issn.1008-1275.2014.06.003; Logsdon AF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66113-7; Logsdon AF, 2017, ARCH NEUROSCI, V4, DOI 10.5812/archneurosci.44254; Lucke-Wold BP, 2017, J NEUROTRAUM, V34, pS62, DOI 10.1089/neu.2016.4680; Lucke-Wold BP, 2015, TRANSL RES, V166, P509, DOI 10.1016/j.trsl.2015.08.005; Lucke-Wold BP, 2016, J NEUROSURG, V124, P687, DOI 10.3171/2015.3.JNS141802; Mac Donald CL, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.6676; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Mammadova N, 2017, AM J PATHOL, V187, P1459, DOI 10.1016/j.ajpath.2017.03.005; Masuda A., 2018, JOVE-J VIS EXP, V138, P58009; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Pagulayan KF, 2018, J INT NEUROPSYCH SOC, V24, P324, DOI 10.1017/S1355617717001217; Perez-Garcia G, 2019, NEUROPHARMACOLOGY, V145, P220, DOI 10.1016/j.neuropharm.2018.09.023; Perez-Garcia G, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0357-17.2018; Perez-Garcia G, 2018, BEHAV BRAIN RES, V340, P117, DOI 10.1016/j.bbr.2016.09.061; Perez-Garcia G, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00176; Perez-Polo JR, 2015, J NEUROSCI RES, V93, P549, DOI 10.1002/jnr.23513; Sajja VSSS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15075; Sare RM, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00601; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shi QX, 2020, BRAIN RES BULL, V157, P149, DOI 10.1016/j.brainresbull.2020.02.002; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Song HL, 2018, BEHAV BRAIN RES, V340, P147, DOI 10.1016/j.bbr.2016.08.037; Sosa MAG, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-018-0647-5; Sosa MAG, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0483-z; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tschiffely AE, 2020, J NEUROTRAUM, V37, P1091, DOI 10.1089/neu.2019.6512; Wang ZY, 2020, J NEUROTRAUM, V37, P1221, DOI 10.1089/neu.2019.6742; Xu LY, 2016, EXP NEUROL, V277, P268, DOI 10.1016/j.expneurol.2016.01.010; Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134	74	2	2	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2021	38	14					2030	2045		10.1089/neu.2020.7398		JAN 2021	16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TD0YA	WOS:000613464900003	33115338				2022-02-06	
J	Sebastiao, YV; Metzger, GA; Chisolm, DJ; Xiang, H; Cooper, JN				Sebastiao, Yuri V.; Metzger, Gregory A.; Chisolm, Deena J.; Xiang, Henry; Cooper, Jennifer N.			Impact of ICD-9-CM to ICD-10-CM coding transition on trauma hospitalization trends among young adults in 12 states	INJURY EPIDEMIOLOGY			English	Article						ICD-10-CM; External cause of injury; Traumatic brain injury; Injury severity score	TIME-SERIES ANALYSIS	BackgroundWe aimed to estimate the impact of the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) coding transition on traumatic injury-related hospitalization trends among young adults across a geographically and demographically diverse group of U.S. states.MethodsInterrupted time series analyses were conducted using statewide inpatient databases from 12 states and including traumatic injury-related hospitalizations in adults aged 19-44years in 2011-2017. Segmented regression models were used to estimate the impact of the October 2015 coding transition on external cause of injury (ECOI) completeness (percentage of hospitalizations with a documented ECOI code) and on population-level rates of injury-related hospitalizations by nature, intent, mechanism, and severity of injury.ResultsThe transition to ICD-10-CM was associated with a drop in ECOI completion in the transition month (-3.7%; P<.0001), but there was no significant change in the positive trend in ECOI completion from the pre- to post-transition periods. There were significant increases post-transition in the measured rates of hospitalization for traumatic brain injury (TBI), unintentional injury, mild injury (injury severity score (ISS) <9), and injuries caused by drowning, firearms, machinery, other pedestrian, suffocation, and unspecified mechanism. Conversely, there were significant decreases in October 2015 in the rates of hospitalization for assault, injuries of undetermined intent, injuries of moderate severity (ISS 9-15), and injuries caused by fire/burn, other pedal cyclist, other transportation, natural/environmental, and other specified mechanism. A significant increase in the percentage of hospitalizations classified as resulting from severe injury (ISS>15) was observed when the general equivalence mapping maximum severity method for converting ICD-10-CM codes to ICD-9-CM codes was used. State-specific results for the outcomes of ECOI completion and TBI-related hospitalization rates are provided in an online supplement.ConclusionsThe U.S. transition from ICD-9-CM to ICD-10-CM coding led to a significant decrease in ECOI completion and several significant changes in measured rates of injury-related hospitalizations by injury intent, mechanism, nature, and severity. The results of this study can inform the design and analysis of future traumatic injury-related health services research studies that use both ICD-9-CM and ICD-10-CM coded data.Level of evidenceII (Interrupted Time Series)	[Sebastiao, Yuri V.; Metzger, Gregory A.; Chisolm, Deena J.; Cooper, Jennifer N.] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Surg Outcomes Res, Columbus, OH 43205 USA; [Sebastiao, Yuri V.; Metzger, Gregory A.; Chisolm, Deena J.; Cooper, Jennifer N.] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Innovat Pediat Practice, Columbus, OH 43205 USA; [Sebastiao, Yuri V.] Univ N Carolina, Sch Med, Div Global Womens Hlth, Chapel Hill, NC 27515 USA; [Metzger, Gregory A.] Ohio State Univ, Coll Med, Dept Surg, Columbus, OH 43210 USA; [Chisolm, Deena J.] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Populat Hlth & Equ Res, Columbus, OH USA; [Chisolm, Deena J.; Xiang, Henry; Cooper, Jennifer N.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Chisolm, Deena J.] Ohio State Univ, Coll Publ Hlth, Div Hlth Serv Management & Policy, Columbus, OH 43210 USA; [Xiang, Henry] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Pediat Trauma Res, Columbus, OH USA; [Xiang, Henry] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Injury Res & Policy, Columbus, OH USA; [Xiang, Henry; Cooper, Jennifer N.] Ohio State Univ, Div Epidemiol, Coll Publ Hlth, Columbus, OH 43210 USA		Cooper, JN (corresponding author), Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Surg Outcomes Res, Columbus, OH 43205 USA.; Cooper, JN (corresponding author), Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Innovat Pediat Practice, Columbus, OH 43205 USA.; Cooper, JN (corresponding author), Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA.	jennifer.cooper@nationwidechildrens.org		Sebastiao, Yuri Vanda/0000-0002-4268-3095; Cooper, Jennifer/0000-0001-7590-7166	National Institute on Minority Health and Health Disparities of the National Institutes of Health [R01MD013881]	Research reported in this manuscript was supported by the National Institute on Minority Health and Health Disparities of the National Institutes of Health under Award Number R01MD013881. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abajas-Bustillo R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216206; Annest J., 2014, PROPOSED FRAMEWORK P; Annest Joseph L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Centers for Disease Control and Prevention, 2018, TABL 1 REC FRAM ECOD TABL 1 REC FRAM ECOD; Chvosta J., 2009, 24320092009 SAS GLOB 24320092009 SAS GLOB; Clark David E, 2018, Inj Epidemiol, V5, P11, DOI 10.1186/s40621-018-0149-8; Fenton SH, 2014, PERSPECT HLTH INF MA, V11, p1G; Gagne M, 2017, J TRAUMA ACUTE CARE, V82, P374, DOI 10.1097/TA.0000000000001319; HCUP Central Distributor Availability of Databases, 2020, HEALTHC COST UTIL PR HEALTHC COST UTIL PR; Hedegaard H., 2016, NATL HLTH STAT REPOR, V89; Injury Surveillance Workgroup, 2003, CONS REC USING HOSP CONS REC USING HOSP; Injury Surveillance Workgroup 9, 2016, TRANS ICD 9CM ICD 10 TRANS ICD 9CM ICD 10; Johnson RL., 2019, NATL HLTH STAT REPOR, V125; Karnell L, 2016, HCUP METHODS SERIES; Linden A, 2015, STATA J, V15, P480, DOI 10.1177/1536867X1501500208; Najem D, 2018, BIOCHEM CELL BIOL, V96, P391, DOI 10.1139/bcb-2016-0160; National Center for Health Statistics, 2015, CTR DIS CONTROL PREV; National Center for Injury Prevention and Control Centers for Disease Control and Prevention, 2009, 10 LEAD CAUS DEATH 10 LEAD CAUS DEATH; Paixao ES, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007721; Palmer CS, 2016, INJURY, V47, P109, DOI 10.1016/j.injury.2015.07.003; Penfold RB, 2013, ACAD PEDIATR, V13, pS38, DOI 10.1016/j.acap.2013.08.002; Salemi JL, 2019, BIRTH DEFECTS RES, V111, P1365, DOI 10.1002/bdr2.1578; Slavova Svetla, 2018, Inj Epidemiol, V5, P36, DOI 10.1186/s40621-018-0165-8; The American College of Surgeons, 2020, NATL TRAUMA DATA BAN; The AUTOREG Procedure, 2014, SAS ETS 132 USERS GU SAS ETS 132 USERS GU; Thomas KE, 2019, INT CLASSIFICATION D; Tohira H, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-63; Topaz Maxim, 2013, Perspect Health Inf Manag, V10, p1d; Weems Shelley, 2015, Perspect Health Inf Manag, V12, p1b	30	2	2	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		2197-1714		INJURY EPIDEMIOL	Inj. Epidemiol.	JAN 25	2021	8	1							4	10.1186/s40621-021-00298-x			13	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	TP5IV	WOS:000677633800001	33487175	Green Published, gold			2022-02-06	
J	Trofimova, A; Smith, JL; Ahluwalia, V; Hurtado, J; Gore, RK; Allen, JW				Trofimova, Anna; Smith, Jeremy L.; Ahluwalia, Vishwadeep; Hurtado, Julia; Gore, Russell K.; Allen, Jason W.			Alterations in Resting-State Functional Brain Connectivity and Correlations with Vestibular/Ocular-Motor Screening Measures in Postconcussion Vestibular Dysfunction	JOURNAL OF NEUROIMAGING			English	Article						Concussion; vestibular; resting-state fMRI; Vestibular/Ocular-Motor Screening; traumatic brain injury		BACKGROUND AND PURPOSE: Vestibular symptoms after concussion are common and associated with protracted recovery. The purpose of this study is to define resting-state functional MRI (rs-fMRI) brain connectivity alterations in patients with postconcussion vestibular dysfunction (PCVD) and correlations between rs-fMRI connectivity and symptoms provoked during Vestibular/Ocular-Motor Screening (VOMS) assessment. METHODS: Prospective IRB approved study. Study group: 12 subjects with subacute PCVD (2-10 weeks); control group: 10 age-matched subjects without history of concussion or vestibular impairment. Both groups underwent clinical vestibular assessment. rs-fMRI was acquired on 3.0T Siemens Trio with a 12-channel head coil. rs-fMRI data analysis included independent component analysis-based functional connectivity group differences, graph theory analysis, and ROI-to-ROI connectivity correlation analysis with VOMS clinical derivatives. Group difference maps between resting-state networks were calculated using dual regression method and corrected for multiple comparisons. Correlation analysis between ROI-to-ROI rs-fMRI brain activation and VOMS assessment ratings was performed using Pearson correlation coefficient, with a significance threshold of P <= .05. RESULTS: Compared to controls, PCVD group demonstrated significantly increased rs-fMRI connectivity between the default-mode network and right middle frontal gyrus and right postcentral gyrus; and between a vestibular-sensorimotor network and right prefrontal cortex. Significant positive correlations were found between clinical derivative VOMS scores and components of the vestibular, visual networks, and multisensory processing cortical representations. CONCLUSION: Altered rs-fMRI brain connectivity with increased connectivity of visual input, multisensory processing, and spatial memory in PCVD is correlative with clinical derivative VOMS scores, suggesting maladaptive brain plasticity underlying vestibular symptomatology.	[Trofimova, Anna; Smith, Jeremy L.; Allen, Jason W.] Emory Univ, Dept Radiol & Imaging Sci, 1364 Clifton Rd NE,Suite BG20, Atlanta, GA 30322 USA; [Ahluwalia, Vishwadeep] Georgia Statue Univ, Georgia Tech Ctr Adv Brain Imaging, Atlanta, GA USA; [Hurtado, Julia; Gore, Russell K.] Shepherd Ctr, Atlanta, GA USA; [Gore, Russell K.; Allen, Jason W.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Gore, Russell K.; Allen, Jason W.] Emory Univ, Atlanta, GA 30322 USA; [Allen, Jason W.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA		Allen, JW (corresponding author), Emory Univ, Dept Radiol & Imaging Sci, 1364 Clifton Rd NE,Suite BG20, Atlanta, GA 30322 USA.	jwallen@emory.edu		Allen, Jason/0000-0002-5274-1105; Smith, Jeremy/0000-0003-0841-5297; Trofimova, Anna/0000-0002-3110-7914	Georgia State/Georgia Tech Center for Advanced Brain Imaging (CABI); Neural Engineering Center Seed Grant	The study was funded by a Georgia State/Georgia Tech Center for Advanced Brain Imaging (CABI) and the Neural Engineering Center Seed Grant. The authors declare no conflict of interest.	Ahluwalia V., AJNR AM J NEURORADIO; Alkathiry AA, 2019, SPORTS HEALTH, V11, P479, DOI 10.1177/1941738119865262; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Ashburner J, 2011, NEUROIMAGE, V55, P954, DOI 10.1016/j.neuroimage.2010.12.049; Babcock L, 2016, JAMA-J AM MED ASSOC, V315, P987, DOI 10.1001/jama.2016.1276; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2009, OHBM; Blum S, 2014, COGN NEUROSCI-UK, V5, P150, DOI 10.1080/17588928.2014.975680; Bronstein AM, 2013, SEMIN NEUROL, V33, P219, DOI 10.1055/s-0033-1354602; BRONSTEIN AM, 1995, J NEUROL NEUROSUR PS, V59, P472, DOI 10.1136/jnnp.59.5.472; Brown CA, 2018, CORTEX, V104, P58, DOI 10.1016/j.cortex.2018.04.006; Carroll Linda J., 2004, Journal of Rehabilitation Medicine Supplement, P113; Christy JB, 2019, J NEUROL PHYS THER, V43, P153, DOI 10.1097/NPT.0000000000000280; Dannenbaum E, 2011, J VESTIBUL RES-EQUIL, V21, P153, DOI 10.3233/VES-2011-0412; Della-Justina HM, 2015, EXP BRAIN RES, V233, P237, DOI 10.1007/s00221-014-4107-6; Dieterich M, 2015, ANN NY ACAD SCI, V1343, P10, DOI 10.1111/nyas.12585; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Eckner JT, 2009, PERCEPT MOTOR SKILL, V108, P717, DOI 10.2466/PMS.108.3.717-720; Eickhoff SB, 2006, HUM BRAIN MAPP, V27, P611, DOI 10.1002/hbm.20205; Elbin RJ, 2018, J NEUROL PHYS THER, V42, P142, DOI 10.1097/NPT.0000000000000230; Eulenburg PZ, 2012, NEUROIMAGE, V60, P162, DOI 10.1016/j.neuroimage.2011.12.032; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Franke LM, 2012, J REHABIL RES DEV, V49, P985, DOI 10.1682/JRRD.2011.12.0250; Geary, 2016, 34 NAT S NEUR SOC LE; Griffanti L, 2014, NEUROIMAGE, V95, P232, DOI 10.1016/j.neuroimage.2014.03.034; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hurtado JE, 2020, PHYSIOTHER THEOR PR, DOI 10.1080/09593985.2020.1815259; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Jamadar SD, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00749; Kirsch V, 2018, NEUROIMAGE, V178, P224, DOI 10.1016/j.neuroimage.2018.05.018; Kolster H, 2010, J NEUROSCI, V30, P9801, DOI 10.1523/JNEUROSCI.2069-10.2010; Kontos AP, 2017, MIL MED, V182, P99, DOI 10.7205/MILMED-D-16-00177; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; Mazaika P., 2007, HUM BRAIN MAPP; Medaglia JD, 2017, NEUROIMAG CLIN N AM, V27, P593, DOI 10.1016/j.nic.2017.06.008; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Nickerson LD, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00115; Park K, 2018, J SPORT REHABIL, V27, P485, DOI 10.1123/jsr.2016-0222; Patel AX, 2016, NEUROIMAGE, V142, P14, DOI 10.1016/j.neuroimage.2015.04.052; Poppenk J, 2010, J NEUROSCI, V30, P4707, DOI 10.1523/JNEUROSCI.5466-09.2010; Rajagopalan Archana, 2017, J Nat Sci Biol Med, V8, P11, DOI 10.4103/0976-9668.198350; Schall JD, 2004, VISION RES, V44, P1453, DOI 10.1016/j.visres.2003.10.025; Smith SM, 2013, NEUROIMAGE, V80, P144, DOI 10.1016/j.neuroimage.2013.05.039; Uddin LQ, 2017, J CLIN NEUROPHYSIOL, V34, P300, DOI 10.1097/WNP.0000000000000377; Vernet M, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00066; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Whitney SL, 2020, BRAIN INJURY, V34, P842, DOI 10.1080/02699052.2020.1755055; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060	50	2	2	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	MAR-APR	2021	31	2					277	286		10.1111/jon.12834		JAN 2021	10	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	TV2EP	WOS:000609303800001	33476477				2022-02-06	
J	Wallensten, J; Nager, A; Asberg, M; Borg, K; Beser, A; Wilczek, A; Mobarrez, F				Wallensten, Johanna; Nager, Anna; Asberg, Marie; Borg, Kristian; Beser, Aniella; Wilczek, Alexander; Mobarrez, Fariborz			Leakage of astrocyte-derived extracellular vesicles in stress-induced exhaustion disorder: a cross-sectional study	SCIENTIFIC REPORTS			English	Article							ACIDIC PROTEIN GFAP; IMPAIRMENTS	Patients with stress-induced exhaustion disorder (SED) demonstrate cognitive dysfunction similar to patients with minor traumatic brain injury (TBI). We have previously detected elevated concentrations of astrocyte-derived extracellular vesicles (EVs) in patients with TBI. As such, we hypothesized that astrocyte-derived EVs could be higher in patients with SED than in patients with major depressive disorder (MDD) and healthy controls. Patients with SED (n=31), MDD (n=31), and healthy matched controls (n=61) were included. Astrocyte-derived EVs (previously known as microparticles) were measured in plasma with flow cytometry and labeled against glial fibrillary acidic protein (GFAP) and aquaporin 4 (AQP4). In addition, platelet EVs and their CD40 ligand expression were measured. Patients with SED had significantly higher concentrations of AQP4 and GFAP-positive EVs and EVs co-expressing AQP4/GFAP than patients with MDD and healthy controls. Patients with MDD had significantly higher concentrations of GFAP-positive EVs and EVs co-expressing AQP4/GFAP than healthy controls. Platelet EVs did not differ between groups. CD40 ligand expression was significantly higher in patients with SED and MDD than in controls. In conclusion, the present study suggests that patients with SED, and to some extent, patients with MDD, have increased leakage of astrocyte-derived EVs through the blood-brain barrier.	[Wallensten, Johanna] Reg Stockholm, Acad Primary Hlth Care Ctr, Solnavagen 1E,Box 45436, S-10431 Stockholm, Sweden; [Wallensten, Johanna; Asberg, Marie; Borg, Kristian; Beser, Aniella; Wilczek, Alexander] Danderyd Hosp, Karolinska Inst, Dept Clin Sci, S-18288 Stockholm, Sweden; [Nager, Anna] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Family Med & Primary Hlth Care, S-14152 Stockholm, Sweden; [Mobarrez, Fariborz] Uppsala Univ, Dept Med Sci, S-75185 Uppsala, Sweden		Wallensten, J (corresponding author), Reg Stockholm, Acad Primary Hlth Care Ctr, Solnavagen 1E,Box 45436, S-10431 Stockholm, Sweden.; Wallensten, J (corresponding author), Danderyd Hosp, Karolinska Inst, Dept Clin Sci, S-18288 Stockholm, Sweden.	johanna.wallensten@ki.se			Skandia; Soderstrom Konigska Foundation; Foundation for Rehabilitation and Medical Research; Karolinska Institutet Kristian Borg grants; NVS project, Region Stockholm; Department of Rehabilitation Medicine, Danderyd University Hospital, Region Stockholm	This study was supported by grants provided by Skandia; Soderstrom Konigska Foundation; The Foundation for Rehabilitation and Medical Research; Karolinska Institutet Kristian Borg grants; the NVS project, Region Stockholm; and the Department of Rehabilitation Medicine, Danderyd University Hospital, Region Stockholm. Medical editor and writer Kimberly Kane, Region Stockholm, provided suggestions for editing the language in the final draft of the manuscript. The authors thank all the participants who took part in this study.	Aloui C, 2014, INT J MOL SCI, V15, P22342, DOI 10.3390/ijms151222342; Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Bejerot S, 2019, J MED CASE REP, V13, DOI 10.1186/s13256-018-1929-z; Blix E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064065; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Bryngelson A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001704; Eskildsen A, 2016, STRESS, V19, P559, DOI 10.1080/10253890.2016.1222370; Glise K, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-18; Gomez-Molina C, 2019, INT J NEUROPSYCHOPH, V22, P232, DOI 10.1093/ijnp/pyy098; Grossi G, 2015, SCAND J PSYCHOL, V56, P626, DOI 10.1111/sjop.12251; Hainfellner JA, 2001, J NEUROPATH EXP NEUR, V60, P449, DOI 10.1093/jnen/60.5.449; Hubbard JA, 2018, BRAIN RES BULL, V136, P118, DOI 10.1016/j.brainresbull.2017.02.011; Khalyfa A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246233; Khan AR, 2016, NEUROIMAGE, V142, P411, DOI 10.1016/j.neuroimage.2016.07.001; Knight MJ, 2018, CURR OPIN PSYCHIATR, V31, P26, DOI 10.1097/YCO.0000000000000378; Lidwall U., 2017, PSYKIATRISKA DIAGNOS; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Mobarrez F, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.13010; Murphy-Royal C, 2019, GLIA, V67, P1806, DOI 10.1002/glia.23610; Nekludov M, 2017, BRAIN INJURY, V31, P1856, DOI 10.1080/02699052.2017.1358395; Pavlisa G, 2006, COLLEGIUM ANTROPOL, V30, P565; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Riol H, 1997, J NEUROSCI RES, V48, P53; Savic I, 2018, CEREB CORTEX, V28, P894, DOI 10.1093/cercor/bhw413; sberg M, 2003, UTMATTNINGSSYNDROM K; Schaufeli W., 1998, BURNOUT COMPANION ST; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; SVANBORG P, 1994, ACTA PSYCHIAT SCAND, V89, P21, DOI 10.1111/j.1600-0447.1994.tb01480.x; Vajen T, 2015, THROMB HAEMOSTASIS, V114, P228, DOI 10.1160/TH14-11-0962; van Harmelen AL, 2010, BIOL PSYCHIAT, V68, P832, DOI 10.1016/j.biopsych.2010.06.011; Wallensten J, 2019, J REHABIL MED, V51, P331, DOI 10.2340/16501977-2545; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0	32	2	2	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	JAN 21	2021	11	1							2009	10.1038/s41598-021-81453-8			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PZ8HG	WOS:000612982200152	33479350	Green Published, gold			2022-02-06	
J	Oyesanya, TO; Loflin, C; Harris, G; Bettger, JP				Oyesanya, Tolu O.; Loflin, Callan; Harris, Gabrielle; Bettger, Janet Prvu			"Just tell me in a simple way": A qualitative study on opportunities to improve the transition from acute hospital care to home from the perspectives of patients with traumatic brain injury, families, and providers	CLINICAL REHABILITATION			English	Article						Brain injuries; traumatic; transitional care; attitude to health; attitude of health personnel		Objective: The purpose of this study was to identify areas to improve the transition from acute hospital care to home for patients with traumatic brain injury and their families. Design: Qualitative, descriptive. Setting: Level I trauma centered located in the Southeastern United States. Subjects: A total of 36 participants (12 patients with traumatic brain injury, 8 family caregivers, 16 providers). Main Measures: We conducted 55 semi-structured interviews with participants and used conventional content analysis to analyze the data. Results: Findings showed patients, families, and providers recommend three areas for improvement in the transition home from acute hospital care, described in three themes. Theme 1 was "improving patient and family education," with the following sub-themes: (a) TBI-related information and (b) discharge preparation. Theme 2 was "additional provider guidance," with the following sub-themes: (a) communication about patient's recovery timeline and (b) recovery roadmap development. Theme 3 was "increasing systems-level support," with the following sub-themes: (a) scheduling follow-up appointments, (b) using a patient navigator, (c) creating a provider follow-up structure, (d) linking pre-discharge care with post-discharge resources, and (e) addressing social issues. Conclusions: These findings delineate multiple areas where patients and families need additional support and education during the transition from acute hospital care to home in ways that are currently not being addressed. Findings may be used to improve education and support from providers and health systems given to patients with traumatic brain injury and families and to inform development and testing of transitional care interventions from acute hospital care to home.	[Oyesanya, Tolu O.; Loflin, Callan; Harris, Gabrielle; Bettger, Janet Prvu] Duke Univ, Sch Nursing, 307 Trent Dr,Room 2029,DUMC 3322, Durham, NC 27710 USA; [Loflin, Callan; Bettger, Janet Prvu] Duke Univ, Sch Med, Durham, NC USA		Oyesanya, TO (corresponding author), Duke Univ, Sch Nursing, 307 Trent Dr,Room 2029,DUMC 3322, Durham, NC 27710 USA.	tolu.oyesanya@duke.edu		Oyesanya, Tolu/0000-0001-8821-4510; Walker, Gabrielle/0000-0002-8977-3696	Duke University School of Nursing Center for Nursing Research Pilot Award; Duke Center for REACH Equity Career Development Award [5U54MD 012530-03]; NIH/NICHD R03 [1R03HD101055-01]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by (1) Duke University School of Nursing Center for Nursing Research Pilot Award (PI, Oyesanya), (2) Duke Center for REACH Equity Career Development Award (Grant #5U54MD 012530-03; PI, Johnson), and (3) NIH/NICHD R03 (Grant #1R03HD101055-01; PI, Oyesanya).	Bettger JP, 2012, ANN INTERN MED, V157, P407, DOI 10.7326/0003-4819-157-6-201209180-00004; Bindman AB, 2018, JAMA INTERN MED, V178, P1165, DOI 10.1001/jamainternmed.2018.2572; Bode RK, 2000, J HEAD TRAUMA REHAB, V15, P637, DOI 10.1097/00001199-200002000-00004; Bond A Elaine, 2003, Crit Care Nurse, V23, P63; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; de Koning ME, 2015, BRAIN INJURY, V29, P423, DOI 10.3109/02699052.2014.982188; DeSavigny D, 2009, SYSTEMS THINKING FOR HEALTH SYSTEMS STRENGTHENING, P1; Fleming J, 2012, SCAND J OCCUP THER, V19, P184, DOI 10.3109/11038128.2011.611531; Greene J, 2012, J GEN INTERN MED, V27, P520, DOI 10.1007/s11606-011-1931-2; Hart T, 2018, BRAIN INJURY, V32, P1295, DOI 10.1080/02699052.2018.1493226; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kertesz A., 2006, W APHASIA BATTERY RE; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Miles M. B., 2019, QUALITATIVE DATA ANA; Nalder E, 2012, BRAIN IMPAIR, V13, P108, DOI 10.1017/BrImp.2012.4; Naylor M., 2008, J SOC WORK ED S, V44, P65, DOI DOI 10.5175/JSWE.2008.773247714; Naylor MD, 2011, HEALTH AFFAIR, V30, P746, DOI 10.1377/hlthaff.2011.0041; Naylor Mary D, 2010, Issue Brief (Commonw Fund), V103, P1; Olson DM., 2011, EVID REP TECHNOL ASS, V202, P1; Oyesanya T, 2017, BRAIN INJURY, V31, P151, DOI 10.1080/02699052.2016.1225987; Oyesanya TO, 2021, DISABIL REHABIL, V43, P685, DOI 10.1080/09638288.2019.1638456; Oyesanya TO, 2017, QUAL HEALTH RES, V27, P1804, DOI 10.1177/1049732317697098; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Ryan DL., 2009, AM NURSE TODAY, V4, P18; SANDELOWSKI M, 1993, ADV NURS SCI, V16, P1; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Sander AM, 2018, J HEAD TRAUMA REHAB, V33, P219, DOI 10.1097/HTR.0000000000000395; Schumacher R, 2016, BRAIN INJURY, V30, P1186, DOI 10.1080/02699052.2016.1183821; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tracy SJ, 2010, QUAL INQ, V16, P837, DOI 10.1177/1077800410383121; Turner B, 2011, NEUROPSYCHOL REHABIL, V21, P64, DOI 10.1080/09602011.2010.527747; Turner BJ, 2008, DISABIL REHABIL, V30, P1153, DOI 10.1080/09638280701532854; Turner BJ, 2011, DISABIL REHABIL, V33, P818, DOI 10.3109/09638288.2010.513422	37	2	2	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	JUL	2021	35	7					1056	1072	0269215520988679	10.1177/0269215520988679		JAN 2021	17	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	SQ0HR	WOS:000631237600001	33472414				2022-02-06	
J	Ritter, K; Jung, K; Dolderer, C; Appel, D; Oswald, CC; Ritz, U; Schafer, MKE				Ritter, Katharina; Jung, Kirsten; Dolderer, Christopher; Appel, Dominik; Oswald, Christine C.; Ritz, Ulrike; Schaefer, Michael K. E.			Early Reciprocal Effects in a Murine Model of Traumatic Brain Injury and Femoral Fracture	MEDIATORS OF INFLAMMATION			English	Article								Traumatic brain injury (TBI) represents a major cause of death and disability in early adulthood. Concomitant extracranial injury such as long bone fracture was reported to exacerbate TBI pathology. However, early reciprocal effects and mechanisms have been barely investigated. To address this issue, C57BL/6N mice were subjected to either the controlled cortical impact (CCI) model of TBI, fracture of the left femur (FF), combined injury (CCI+FF), or sham procedure. Behavioral alterations were monitored until 5 days post injury (dpi), followed by (immuno-)histology, gene and protein expression analyses using quantitative PCR, western blot, and ELISA. We found that CCI+FF mice exhibited increased neurological impairments, reduced recovery, and altered anxiety-related behavior compared to single injury groups. At 5 dpi, cerebral lesion size was not affected by combined injury but exaggerated hippocampal substance loss and increased perilesional astrogliosis were observed in CCI+FF mice compared to isolated CCI. Bone gene expression of the osteogenic markers Runx2, osteocalcin, alkaline phosphatase, and bone sialoprotein was induced by fracture injury but attenuated by concomitant TBI. Plasma concentrations of the biomarkers osteopontin and progranulin were elevated in CCI+FF mice compared to other experimental groups. Taken together, using a murine model of TBI and femoral fracture, we report early reciprocal impairments of brain tissue maintenance, behavioral recovery, and bone repair gene expression. Increased circulating levels of the biomarkers osteopontin and progranulin indicate ongoing tissue inflammation and repair. Our results may have implications for future therapeutic approaches to interfere with the pathological crosstalk between TBI and concomitant bone fracture.	[Ritter, Katharina; Jung, Kirsten; Appel, Dominik; Oswald, Christine C.; Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Mainz, Germany; [Dolderer, Christopher; Ritz, Ulrike] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Orthoped & Traumatol, Mainz, Germany; [Schaefer, Michael K. E.] Res Ctr Immunotherapy FZI, Mainz, Germany; [Schaefer, Michael K. E.] Focus Program Translat Neurosci FTN, Mainz, Germany		Schafer, MKE (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Mainz, Germany.; Schafer, MKE (corresponding author), Res Ctr Immunotherapy FZI, Mainz, Germany.; Schafer, MKE (corresponding author), Focus Program Translat Neurosci FTN, Mainz, Germany.	katharina.ritter@unimedizin-mainz.de; kirsten.jung@mail.de; cdoldere@students.uni-mainz.de; dominik.appel@unimedizin-mainz.de; oswald@uni-mainz.de; ritz@uni-mainz.de; michael.schaefer@unimedizin-mainz.de	Ritz, Ulrike/N-6871-2016	Ritz, Ulrike/0000-0001-8936-3227; Schafer, Michael K.E./0000-0001-6055-6244	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [SCHA1261/4-3]	We are grateful for excellent technical assistance in tissue extractions by Angelika Ackermann (Department of Orthopedics and Traumatology), animal surgery by Tobias Hirnet (Department of Anesthesiology), and gene expression analyses by Dana Pieter (Department of Anesthesiology). The project was supported by the Deutsche Forschungsgemeinschaft SCHA1261/4-3 to MKES.	Abella V, 2017, DRUG DISCOV TODAY, V22, P1557, DOI 10.1016/j.drudis.2017.06.006; Alberdi F, 2014, MED INTENSIVA, V38, P580, DOI 10.1016/j.medin.2014.06.012; Bailey KR, 2009, FRONT NEUROSCI, P77; Brady RD, 2020, BONE, V133, DOI 10.1016/j.bone.2020.115263; Brady RD, 2018, BONE, V109, P35, DOI 10.1016/j.bone.2017.05.015; Brady RD, 2016, J NEUROTRAUM, V33, P2154, DOI 10.1089/neu.2014.3836; Brady RD, 2016, SCI REP-UK, V6, DOI 10.1038/srep34491; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Brown A, 2012, TRANSL NEUROSCI, V3, P288, DOI 10.2478/s13380-012-0028-7; Carobrez AP, 2005, NEUROSCI BIOBEHAV R, V29, P1193, DOI 10.1016/j.neubiorev.2005.04.017; Ching-Yun Y.-P., 2015, J CLIN EXPT ORTHOPAE, V1, DOI [10.4172/2471-8416.100006, DOI 10.4172/2471-8416.100006]; du Sert NP, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000410; Eriksen JL, 2008, J NEUROCHEM, V104, P287, DOI 10.1111/j.1471-4159.2007.04968.x; Gao N, 2020, J CEREBR BLOOD F MET, V40, P35, DOI 10.1177/0271678X19836412; Golz C, 2019, J NEUROCHEM, V150, P173, DOI 10.1111/jnc.14678; GRANT E. C., 1963, BEHAVIOUR, V21, P260, DOI 10.1163/156853963X00194; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Hall J, 2016, EUR J PAIN, V20, P1402, DOI 10.1002/ejp.863; Hofman M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/204842; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jullienne A, 2020, J NEUROSCI RES, V98, P141, DOI 10.1002/jnr.24405; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kramer T, 2017, J NEUROCHEM, V143, P523, DOI 10.1111/jnc.14220; Ladwig A, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/7189421; Lezak KR, 2017, DIALOGUES CLIN NEURO, V19, P181; Li M, 2016, GEN MED OPEN ACCESS, V4, P1, DOI [10.4172/2327-5146.1000275, DOI 10.4172/2327-5146.1000275]; Liu Q, 2018, TISSUE ENG PT A, V24, P1283, DOI [10.1089/ten.tea.2017.0462, 10.1089/ten.TEA.2017.0462]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locher RJ, 2015, J MUSCULOSKEL NEURON, V15, P309; Loi F, 2016, BONE, V86, P119, DOI 10.1016/j.bone.2016.02.020; Lou Y, 2009, HUM MOL GENET, V18, P556, DOI 10.1093/hmg/ddn383; Maegele M, 2019, DTSCH ARZTEBL INT, V116, P167, DOI 10.3238/arztebl.2019.0167; McDonald SJ, 2020, J NEUROTRAUM, V37, P770, DOI 10.1089/neu.2019.6885; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; Menzel L, 2017, GLIA, V65, P278, DOI 10.1002/glia.23091; Morioka K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48126-z; Parliament E Council E, 2010, EU OFFICIAL J, VL276; Pfeifer R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148844; Pottker B, 2017, BRAIN STRUCT FUNCT, V222, P4005, DOI 10.1007/s00429-017-1452-9; Popovitz J, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00006; Schafer M, 2014, CELL TISSUE RES, V357, P395, DOI 10.1007/s00441-014-1807-y; Schaible EV, 2014, J NEUROCHEM, V129, P940, DOI 10.1111/jnc.12708; Shi XY, 2018, ANESTHESIOLOGY, V129, P557, DOI 10.1097/ALN.0000000000002332; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Simonsen LL, 2007, INJURY, V38, P1146, DOI 10.1016/j.injury.2007.03.019; Singleton Q, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010063; Sturman O, 2018, STRESS, V21, P443, DOI 10.1080/10253890.2018.1438405; Sun MJ, 2017, BRAIN BEHAV IMMUN, V66, P359, DOI 10.1016/j.bbi.2017.08.005; Suto Y, 2019, J NEUROTRAUM, V36, P609, DOI 10.1089/neu.2018.5812; Suto Y, 2018, J TRAUMA ACUTE CARE, V85, P275, DOI 10.1097/TA.0000000000001957; Topkoru BC, 2013, STROKE, V44, P3189, DOI 10.1161/STROKEAHA.113.001574; Tsitsilonis S, 2015, INJURY, V46, P661, DOI 10.1016/j.injury.2015.01.044; Tu QS, 2007, WOUND REPAIR REGEN, V15, P404, DOI 10.1111/j.1524-475X.2007.00243.x; Wang N, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15038126; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yang L, 2016, SCAND J IMMUNOL, V83, P26, DOI 10.1111/sji.12393; Zhao YP, 2013, BIOMATERIALS, V34, P6412, DOI 10.1016/j.biomaterials.2013.05.030; Zhu YJ, 2016, BRAIN RES, V1644, P1, DOI 10.1016/j.brainres.2016.04.074	58	2	2	1	4	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0962-9351	1466-1861		MEDIAT INFLAMM	Mediat. Inflamm.	JAN 18	2021	2021								8835730	10.1155/2021/8835730			14	Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Immunology	QE6QJ	WOS:000616330500001	33531878	gold, Green Published			2022-02-06	
J	Ji, XB; Song, ZW; He, JS; Guo, SW; Chen, YW; Wang, HH; Zhang, JL; Xu, X; Liu, JB				Ji, Xubiao; Song, Zhiwen; He, Junsheng; Guo, Shiwu; Chen, Yuwei; Wang, Honghai; Zhang, Jinlong; Xu, Xu; Liu, Jinbo			NIMA-related kinase 7 amplifies NLRP3 inflammasome pro-inflammatory signaling in microglia/macrophages and mice models of spinal cord injury	EXPERIMENTAL CELL RESEARCH			English	Article						Spinal cord injury; Microglia/Macrophage; NEK7; NLRP3; Inflammasome	TRAUMATIC BRAIN-INJURY; NF-KAPPA-B; ACTIVATION; NEK7; NEUROINFLAMMATION; EXPRESSION; INHIBITOR; MICROGLIA; MECHANISM; RESPONSES	Background: NIMA-related kinase-7 (NEK7) is a serine/threonine kinase that drives cell-cycle dynamics by modulating mitotic spindle formation and cytokinesis. It is also a crucial modulator of the pro-inflammatory effects of NOD-like receptor 3 (NLRP3) inflammasome. However, the role of NEK7 in microglia/macrophages post-spinal cord injury (SCI) is not well defined. Methods: In this study, we performed both in vivo and in vitro experiments. Using an in vivo mouse SCI model, NEK7 siRNAs were administered intraspinally. For in vitro analysis, BV-2 microglia cells with NEK7-siRNA were stimulated with 1 mu g/ml lipopolysaccharide (LPS) and 2 mM Adenosine triphosphate (ATP). Results: Here, we found that the mRNA and protein levels of NEK7 and NLRP3 inflammasomes were upregulated in spinal cord tissues of injured mice and BV-2 microglia cells exposed to Lipopolysaccharide (LPS) and Adenosine triphosphate (ATP). Further experiments established that NEK7 and NLRP3 interacted in BV-2 microglia cells, an effect that was eliminated following NEK7 ablation. Moreover, NEK7 ablation suppressed the activation of NLRP3 inflammasomes. Although NEK7 inhibition did not significantly improve motor function post-SCI in mice, it was found to attenuate local inflammatory response and inhibit the activation of NLRP3 inflammasome in microglia/macrophages of the injured spinal cord. Conclusion: NEK7 amplifies NLRP3 inflammasome pro-inflammatory signaling in BV-2 microglia cells and mice models of SCI. Therefore, agents targeting the NEK7/NLRP3 signaling offers great promise in the treatment of inflammatory response post-SCI.	[Ji, Xubiao; Song, Zhiwen; He, Junsheng; Guo, Shiwu; Chen, Yuwei; Wang, Honghai; Zhang, Jinlong; Xu, Xu; Liu, Jinbo] Soochow Univ, Dept Spinal Surg, Affiliated Hosp 1, Changzhou 213003, Peoples R China; [Ji, Xubiao] Jiangsu Univ, Dept Orthoped, Affiliated Wujin Hosp, Changzhou 213003, Peoples R China		Liu, JB (corresponding author), Soochow Univ, Sch Med, Dept Spinal Surg, Affiliated Hosp 3, Changzhou 213003, Peoples R China.	czljbljb@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81972048, 81901247]; Foundation of the Youth Science and Technology Project of Changzhou Health Commission [QN202057]	This study was supported by grants from the National Natural Science Foundation of China (81972048, 81901247), Foundation of the Youth Science and Technology Project of Changzhou Health Commission (QN202057).	Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Ahuja CS, 2017, NEUROSURGERY, V80, pS9, DOI 10.1093/neuros/nyw080; Bartus K, 2014, J NEUROSCI, V34, P4822, DOI 10.1523/JNEUROSCI.4369-13.2014; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Blandino P, 2006, J NEUROIMMUNOL, V173, P87, DOI 10.1016/j.jneuroim.2005.11.021; Chen YH, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00202; Emmetsberger J, 2012, NEUROBIOL DIS, V47, P295, DOI 10.1016/j.nbd.2012.05.001; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Gustin A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130624; Harder J, 2009, J IMMUNOL, V183, P5823, DOI 10.4049/jimmunol.0900444; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; Ismael S, 2018, J NEUROTRAUM, V35, P1294, DOI 10.1089/neu.2017.5344; Jiang W, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0980-9; Jiang W, 2016, LIFE SCI, V157, P45, DOI 10.1016/j.lfs.2016.05.004; Jiang W, 2016, SPINE, V41, pE330, DOI 10.1097/BRS.0000000000001287; Kim S, 2011, J CELL SCI, V124, P3760, DOI 10.1242/jcs.078089; Kumamaru H, 2012, J CELL PHYSIOL, V227, P1335, DOI 10.1002/jcp.22845; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Louder RK, 2016, NATURE, V536, DOI 10.1038/nature17984; Madalena KM, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/8640970; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mortazavi MM, 2015, CLIN ANAT, V28, P27, DOI 10.1002/ca.22432; Mortezaee K, 2018, J CELL PHYSIOL, V233, P5160, DOI 10.1002/jcp.26287; Noorimotlagh Z, 2017, IRAN J BASIC MED SCI, V20, P1287, DOI 10.22038/IJBMS.2017.9620; O'Regan L, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-25; Saiwai H, 2010, AM J PATHOL, V176, P2352, DOI 10.2353/ajpath.2010.090839; Sanz JM, 2000, J IMMUNOL, V164, P4893, DOI 10.4049/jimmunol.164.9.4893; Schmid-Burgk JL, 2016, J BIOL CHEM, V291, P103, DOI 10.1074/jbc.C115.700492; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharif H, 2019, NATURE, V570, P338, DOI 10.1038/s41586-019-1295-z; Shi HX, 2016, NAT IMMUNOL, V17, P250, DOI 10.1038/ni.3333; Skaper SD, 2014, CNS NEUROL DISORD-DR, V13, P1654; Song ZW, 2018, CELL MOL LIFE SCI, V75, P4445, DOI 10.1007/s00018-018-2890-0; Sroga JM, 2003, J COMP NEUROL, V462, P223, DOI 10.1002/cne.10736; Wallisch JS, 2017, NEUROCRIT CARE, V27, P44, DOI 10.1007/s12028-017-0378-7; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Wilson JR, 2013, CAN MED ASSOC J, V185, P485, DOI 10.1503/cmaj.121206; Xu X, 2018, NEUROBIOL DIS, V117, P15, DOI 10.1016/j.nbd.2018.05.016; Yang XD, 2020, EMBO J, V39, DOI 10.15252/embj.2019102201; Zendedel A, 2018, MOL NEUROBIOL, V55, P1364, DOI 10.1007/s12035-017-0400-2; Zendedel A, 2016, MOL NEUROBIOL, V53, P3063, DOI 10.1007/s12035-015-9203-5	44	2	2	0	3	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4827	1090-2422		EXP CELL RES	Exp. Cell Res.	JAN 15	2021	398	2							112418	10.1016/j.yexcr.2020.112418			9	Oncology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Cell Biology	PO1AP	WOS:000604903500003	33309808				2022-02-06	
J	Muradashvili, N; Charkviani, M; Sulimai, N; Tyagi, N; Crosby, J; Lominadze, D				Muradashvili, Nino; Charkviani, Mariam; Sulimai, Nurul; Tyagi, Neetu; Crosby, Jeff; Lominadze, David			Effects of fibrinogen synthesis inhibition on vascular cognitive impairment during traumatic brain injury in mice	BRAIN RESEARCH			English	Article						Cortical contusion injury; Fg-ASO; Fg-PrPC complex; Short-term memory	CELLULAR PRION PROTEIN; SHORT-TERM-MEMORY; LONG-TERM; ALZHEIMERS-DISEASE; COMPLEX-FORMATION; BETA; PERMEABILITY; MECHANISMS; DEMENTIA; HYPERFIBRINOGENEMIA	Traumatic brain injury (TBI) is associated with increased blood content of fibrinogen (Fg), called hyperfibrinogenemia (HFg), which results in enhanced cerebrovascular permeability and leads to short-term memory (STM) reduction. Previously, we showed that extravasated Fg was deposited in the vasculo-astrocyte interface and was co-localized with cellular prion protein (PrPC) during mild-to-moderate TBI in mice. These effects were accompanied by neurodegeneration and STM reduction. However, there was no evidence presented that the described effects were the direct result of the HFg during TBI. We now present data indicating that inhibition of Fg synthesis can ameliorate TBI-induced cerebrovascular permeability and STM reduction. Cortical contusion injury (CCI) was induced in C57BL/6J mice. Then mice were treated with either Fg antisense oligonucleotide (Fg-ASO) or with control-ASO for two weeks. Cerebrovascular permeability to fluorescently labeled bovine serum albumin was assessed in cortical venules following evaluation of STM with memory assessement tests. Separately, brain samples were collected in order to define the expression of PrPC via Western blotting while deposition and co-localization of Fg and PrPC, as well as gene expression of inflammatory marker activating transcription factor 3 (ATF3), were characterized with real-time PCR. Results showed that inhibition of Fg synthesis with Fg-ASO reduced overexpression of AFT3, ameliorated enhanced cerebrovascular permeability, decreased expression of PrPC and Fg deposition, decreased formation of Fg-PrPC complexes in brain, and improved STM. These data provide direct evidence that a CCI-induced inflammation-mediated HFg could be a triggering mechanism involved in vascular cognitive impairment seen previously in our studies during mild-to-moderate TBI.	[Muradashvili, Nino; Charkviani, Mariam; Tyagi, Neetu; Lominadze, David] Univ Louisville, Dept Physiol, Sch Med, Louisville, KY USA; [Muradashvili, Nino] Caucasus Int Univ, Dept Basic Med, Tbilisi, Georgia; [Sulimai, Nurul; Lominadze, David] Univ S Florida, Dept Surg, USF Hlth Morsani Coll Med, Tampa, FL USA; [Crosby, Jeff] Ionis Pharmaceut, 2855 Gazelle Court, Carlsbad, CA 92010 USA; [Lominadze, David] Univ Louisville, Kentucky Spinal Cord Res Ctr, Sch Med, Louisville, KY USA		Lominadze, D (corresponding author), USF Hlth Morsani Coll Med, Dept Surg, MDC 4024,12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	dlominadze@usf.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-084823, HL-146832]; American Heart AssociationAmerican Heart Association [17SDG33670372]	This work was supported in part by funding from the National Institutes of Health (NS-084823 and HL-146832) and the American Heart Association (17SDG33670372).	Ahn HJ, 2010, P NATL ACAD SCI USA, V107, P21812, DOI 10.1073/pnas.1010373107; Cernich AN, 2010, CURR TREAT OPTION NE, V12, P412, DOI 10.1007/s11940-010-0085-6; Charkviani M, 2020, J NEUROPHYSIOL, V124, P536, DOI 10.1152/jn.00224.2020; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Coltinho AS, 2007, NEUROBIOL DIS, V26, P282, DOI 10.1016/j.nbd.2007.01.005; Corriveau RA, 2016, CELL MOL NEUROBIOL, V36, P281, DOI 10.1007/s10571-016-0334-7; del Zoppo GJ, 2009, STROKE, V40, P1687, DOI 10.1161/STROKEAHA.108.527804; Fischer MB, 2000, NATURE, V408, P479, DOI 10.1038/35044100; Forstner P, 2018, J NEUROTRAUM, V35, P2317, DOI 10.1089/neu.2017.5593; Fuller GM, 2001, ANN NY ACAD SCI, V936, P469; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Genest J, 2000, J CARDIOVASC PHARM, V35, P164, DOI 10.1097/00005344-200001000-00022; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; GORMAN LK, 1993, BRAIN RES, V614, P29, DOI 10.1016/0006-8993(93)91014-J; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Hai T, 1999, GENE EXPRESSION, V7, P321; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Hetz C, 2003, TRENDS MOL MED, V9, P237, DOI 10.1016/S1471-4914(03)00069-8; Jadavji NM, 2015, NEUROSCIENCE, V300, P1, DOI 10.1016/j.neuroscience.2015.04.067; Jenkins DR, 2018, J NEUROTRAUM, V35, P2259, DOI 10.1089/neu.2017.5291; Kanaani J, 2005, J NEUROCHEM, V95, P1373, DOI 10.1111/j.1471-4159.2005.03469.x; Kerlin B, 2004, BLOOD, V103, P1728, DOI 10.1182/blood-2003-08-2886; Kockx M, 1999, BLOOD, V93, P2991; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; MARTINEZ J, 1974, J CLIN INVEST, V53, P600, DOI 10.1172/JCI107595; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Muradashvili N., 2018, TRAUMATIC BRAIN INJU, P105; Muradashvili N, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070077; Muradashvili N, 2016, J PHYSIOL-LONDON, V594, P5941, DOI 10.1113/JP272558; Muradashvili N, 2015, METAB BRAIN DIS, V30, P411, DOI 10.1007/s11011-014-9550-3; Muradashvili N, 2014, J CEREBR BLOOD F MET, V34, P1472, DOI 10.1038/jcbfm.2014.102; Muradashvili N, 2014, AM J PHYSIOL-CELL PH, V307, pC169, DOI 10.1152/ajpcell.00305.2013; Muradashvili N, 2014, CELL BIOCHEM BIOPHYS, V69, P283, DOI 10.1007/s12013-013-9797-z; Muradashvili N, 2013, BRAIN INJURY, V27, P1508, DOI 10.3109/02699052.2013.823562; Muradashvili N, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00166; Muradashvili N, 2012, J CEREBR BLOOD F MET, V32, P150, DOI 10.1038/jcbfm.2011.144; Muradashvili N, 2011, BIOCHEM BIOPH RES CO, V413, P509, DOI 10.1016/j.bbrc.2011.07.133; Murphy MP, 2016, BBA-MOL BASIS DIS, V1862, P857, DOI 10.1016/j.bbadis.2016.02.010; Ni HY, 2000, J CLIN INVEST, V106, P385, DOI 10.1172/JCI9896; Onodera T, 2017, P JPN ACAD B-PHYS, V93, P155, DOI 10.2183/pjab.93.010; Pahatouridis D, 2010, BRAIN INJURY, V24, P1189, DOI 10.3109/02699052.2010.490510; Patibandla PK, 2009, J CELL PHYSIOL, V221, P195, DOI 10.1002/jcp.21845; Paul J, 2007, J EXP MED, V204, P1999, DOI 10.1084/jem.20070304; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Rhinn H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-62; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rubenstein R, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0435-7; Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010; Schneider B, 2003, P NATL ACAD SCI USA, V100, P13326, DOI 10.1073/pnas.2235648100; Starke R, 2002, BRIT J HAEMATOL, V119, P863, DOI 10.1046/j.1365-2141.2002.03847.x; Sun YR, 2011, BRIT J NEUROSURG, V25, P363, DOI 10.3109/02688697.2011.552650; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Tyagi N, 2008, MOL CELL BIOCHEM, V307, P13, DOI 10.1007/s11010-007-9579-2; Vasse M, 1996, HAEMOSTASIS, V26, P331; Vos CMP, 2005, NEUROBIOL DIS, V20, P953, DOI 10.1016/j.nbd.2005.06.012; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Wilberding JA, 2001, ANN NY ACAD SCI, V936, P542; Yuasa M, 2015, J CLIN INVEST, V125, P3117, DOI 10.1172/JCI80313; Zamani A, 2020, BRAIN RES BULL, V156, P43, DOI 10.1016/j.brainresbull.2019.12.015; Zhou JY, 2013, INTRACTABLE RARE DIS, V2, P35, DOI 10.5582/irdr.2013.v2.2.35	62	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 15	2021	1751								147208	10.1016/j.brainres.2020.147208			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PH7OW	WOS:000600598100027	33248061	Green Accepted			2022-02-06	
J	Zilli, J; Kressin, M; Schanzer, A; Kampschulte, M; Schmidt, MJ				Zilli, Jessica; Kressin, Monika; Schanzer, Anne; Kampschulte, Marian; Schmidt, Martin J.			Partial cortico-hippocampectomy in cats, as therapy for refractory temporal epilepsy: A descriptive cadaveric study	PLOS ONE			English	Article							SPATIAL DELAYED-RESPONSES; LOBE EPILEPSY; SELECTIVE AMYGDALOHIPPOCAMPECTOMY; LOBECTOMY; SCLEROSIS; LESIONS; FEATURES; DOG; AMYGDALA; SEIZURE	Cats, similar to humans, are known to be affected by hippocampal sclerosis (HS), potentially causing antiepileptic drug (AED) resistance. HS can occur as a consequence of chronic seizure activity, trauma, inflammation, or even as a primary disease. In humans, temporal lobe resection is the standardized therapy in patients with refractory temporal lobe epilepsy (TLE). The majority of TLE patients are seizure free after surgery. Therefore, the purpose of this prospective cadaveric study is to establish a surgical technique for hippocampal resection in cats as a treatment for AED resistant seizures. Ten cats of different head morphology were examined. Pre-surgical magnetic resonance imaging (MRI) and computed tomography (CT) studies of the animals' head were carried out to complete 3D reconstruction of the head, brain, and hippocampus. The resected hippocampal specimens and the brains were histologically examined for tissue injury adjacent to the hippocampus. The feasibility of the procedure, as well as the usability of the removed specimen for histopathological examination, was assessed. Moreover, a micro-CT (mCT) examination of the brain of two additional cats was performed in order to assess temporal vasculature as a reason for possible intraoperative complications. In all cats but one, the resection of the temporal cortex and the hippocampus were successful without any evidence of traumatic or vascular lesions in the surrounding neurovascular structures. In one cat, the presence of mechanical damage (a fissure) of the thalamic surface was evident in the histopathologic examination of the brain post-resection. All hippocampal fields and the dentate gyrus were identified in the majority of the cats via histological examination. The study describes a new surgical approach (partial temporal cortico-hippocampectomy) offering a potential treatment for cats with clinical and diagnostic evidence of temporal epilepsy which do not respond adequately to the medical therapy.	[Zilli, Jessica; Schmidt, Martin J.] Justus Liebig Univ, Small Anim Clin, Dept Vet Clin Sci, Giessen, Germany; [Kressin, Monika] Justus Liebig Univ, Inst Vet Anat Histol & Embryol, Giessen, Germany; [Schanzer, Anne] Justus Liebig Univ, Inst Neuropathol, Giessen, Germany; [Kampschulte, Marian] Justus Liebig Univ, Dept Radiol, Giessen, Germany		Zilli, J (corresponding author), Justus Liebig Univ, Small Anim Clin, Dept Vet Clin Sci, Giessen, Germany.	Jessica.Zilli@vetmed.uni-giessen.de		Zilli, Jessica/0000-0003-4112-6518			ADAMEC RE, 1983, PROG NEURO-PSYCHOPH, V7, P505, DOI 10.1016/0278-5846(83)90017-9; ANDY OJ, 1967, J COMP PHYSIOL PSYCH, V64, P516, DOI 10.1037/h0025193; [Anonymous], 2018, DIABETES CARE S1, V4, pS4, DOI 10.2337/dc18-Srev01; [Anonymous], 2015, TRANSPLANTATION DIRE, V1, pe2, DOI 10.1097/TXD.0000000000000509; Bate H, 2007, EUR J NEUROL, V14, P90, DOI 10.1111/j.1468-1331.2006.01565.x; Blumcke I, 2013, EPILEPSIA, V54, P1315, DOI 10.1111/epi.12220; Brini E, 2004, J FELINE MED SURG, V6, P377, DOI 10.1016/j.jfms.2003.12.007; BROWN TS, 1969, BRAIN RES, V12, P86, DOI 10.1016/0006-8993(69)90057-2; Bujarski KA, 2013, J NEUROSURG, V119, P16, DOI 10.3171/2013.3.JNS12714; Cheung LK, 1996, J ORAL MAXIL SURG, V54, P1439, DOI 10.1016/S0278-2391(96)90261-X; Classen AC, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0788-3; DELGADO JM, 1961, ELECTROEN CLIN NEURO, V13, P722, DOI 10.1016/0013-4694(61)90104-3; Ekenstedt KJ, 2012, MAMM GENOME, V23, P28, DOI 10.1007/s00335-011-9362-2; Ellenberger W, 1977, HDB VERGLEICHENDEN A; Fors S, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0127-x; Forterre F, 2009, J FELINE MED SURG, V11, P510, DOI 10.1016/j.jfms.2008.11.002; GAMBARYAN LS, 1979, ZH VYSSH NERV DEYAT+, V29, P56; GASTAUT H, 1959, J NEUROPATH EXP NEUR, V18, P270, DOI 10.1097/00005072-195904000-00004; GILLILAN LA, 1976, AM J ANAT, V146, P237, DOI 10.1002/aja.1001460303; Goetzen Bogdan, 1992, Neuropatologia Polska, V30, P173; Hamamoto Y, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00172; Hasegawa D, 2016, VET J, V215, P64, DOI 10.1016/j.tvjl.2016.03.005; Heller HB, 2018, VET CLIN N AM-SMALL, V48, P31, DOI 10.1016/j.cvsm.2017.08.011; Helmstaedter C, 2004, J NEUROL NEUROSUR PS, V75, P323; Hu WH, 2013, J NEUROSURG, V119, P1089, DOI 10.3171/2013.8.JNS121854; JARRARD LE, 1973, PSYCHOL BULL, V79, P1, DOI 10.1037/h0033792; Kitz S, 2017, J VET INTERN MED, V31, P633, DOI 10.1111/jvim.14699; KOWALSKA DM, 1992, ACTA NEUROBIOL EXP, V52, P119; Kowalska DM, 1999, ACTA NEUROBIOL EXP, V59, P303; Kowalska DM, 2000, PROG NEURO-PSYCHOPH, V24, P855, DOI 10.1016/S0278-5846(00)00110-X; KOWALSKA DM, 1995, HIPPOCAMPUS, V5, P363, DOI 10.1002/hipo.450050409; Loiselle M, 2012, NEUROPSYCHOLOGIA, V50, P630, DOI 10.1016/j.neuropsychologia.2011.12.023; Long S, 2014, J VET INTERN MED, V28, P189, DOI 10.1111/jvim.12235; Martle V, 2014, VET J, V199, P332, DOI 10.1016/j.tvjl.2013.09.055; MILLER LA, 1994, J NEUROL NEUROSUR PS, V57, P1099, DOI 10.1136/jnnp.57.9.1099; Mizoguchi S, 2014, EPILEPSY RES, V108, P1940, DOI 10.1016/j.eplepsyres.2014.09.009; Muzumdar D, 2016, INT J SURG, V36, P411, DOI 10.1016/j.ijsu.2016.10.027; Nascimento FA, 2016, ARQ NEURO-PSIQUIAT, V74, P35, DOI 10.1590/0004-282X20150188; Nicholson C, 1998, CENTRAL NERVOUS SYST, V3; Nilges RG, 1944, J COMP NEUROL, V80, P177, DOI 10.1002/cne.900800203; Olivier A, 2012, TECHNIQUES IN EPILEPSY SURGERY: THE MNI APPROACH, P1, DOI 10.1017/CBO9781139021951; Paglioli E, 2006, J NEUROSURG, V104, P70, DOI 10.3171/jns.2006.104.1.70; Pakozdy A, 2015, ANAT HISTOL EMBRYOL, V44, P422, DOI 10.1111/ahe.12153; Pakozdy A, 2014, J VET INTERN MED, V28, P255, DOI 10.1111/jvim.12297; Pakozdy A, 2017, MODELS OF SEIZURES AND EPILEPSY, 2ND EDITION, P399, DOI 10.1016/B978-0-12-804066-9.00029-8; Pakozdy A, 2014, EPILEPTIC DISORD, V16, P116, DOI 10.1684/epd.2014.0635; Polley Martin, 2000, CONTEMP BR HIST, V14, P100; REALE RA, 1980, J COMP NEUROL, V192, P265, DOI 10.1002/cne.901920207; Rusbridge C, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0466-x; Salanova V, 2002, EPILEPSIA, V43, P170, DOI 10.1046/j.1528-1157.2002.33800.x; Schmidt MJ, 2017, J VET INTERN MED, V31, P1487, DOI 10.1111/jvim.14805; Schmied O, 2008, VET RADIOL ULTRASOUN, V49, P343, DOI 10.1111/j.1740-8261.2008.00377.x; Schober W., 1974, Handbuch der Zoologie, V8, P1; Shihab N, 2014, VET SURG, V43, P877, DOI 10.1111/j.1532-950X.2014.12246.x; Shores A, 2017, CURRENT TECHNIQUES C; Shouse MN, 2004, BRAIN RES, V1027, P126, DOI 10.1016/j.brainres.2004.08.047; Sloviter RS, 2008, EPILEPSIA, V49, P85, DOI 10.1111/j.1528-1167.2008.01931.x; Snider RS, 1961, STEREOTAXIC ATLAS CA, DOI [10.1001/archinte.1961.03620120081011, DOI 10.1001/ARCHINTE.1961.03620120081011]; Tanaka T, 1989, No To Shinkei, V41, P1239; Tartygin NA, 1996, SOV PSYCHOL, V5, P38; TEITELBAUM H, 1964, EXP NEUROL, V9, P452, DOI 10.1016/0014-4886(64)90053-6; Vanhaesebrouck AE, 2012, J FELINE MED SURG, V14, P932, DOI 10.1177/1098612X12454419; WADA JA, 1975, EPILEPSIA, V16, P503, DOI 10.1111/j.1528-1157.1975.tb06080.x; Wagner E, 2014, BRAIN PATHOL, V24, P607, DOI 10.1111/bpa.12147; Wendling AS, 2013, EPILEPSY RES, V104, P94, DOI 10.1016/j.eplepsyres.2012.09.007; Wininger F, 2014, VET CLIN N AM-SMALL, V44, P1235, DOI 10.1016/j.cvsm.2014.07.015; Wouters EGH, 2011, VET COMP ORTHOPAED, V24, P72, DOI 10.3415/VCOT-10-02-0018; Yu Y, 2018, AM J VET RES, V79, P324, DOI 10.2460/ajvr.79.3.324	68	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0244892	10.1371/journal.pone.0244892			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	WOS:000609991600038	33449929	Green Published, gold			2022-02-06	
J	Lafrenaye, A; Mondello, S; Povlishock, J; Gorse, K; Walker, S; Hayes, R; Wang, K; Kochanek, PM				Lafrenaye, Audrey; Mondello, Stefania; Povlishock, John; Gorse, Karen; Walker, Susan; Hayes, Ronald; Wang, Kevin; Kochanek, Patrick M.			Operation Brain Trauma Therapy: An Exploratory Study of Levetiracetam Treatment Following Mild Traumatic Brain Injury in the Micro Pig	FRONTIERS IN NEUROLOGY			English	Article						mild traumatic brain injury; levetiracetam; diffuse axonal injury; GFAP; micro pig; axonal regrowth; operation brain trauma therapy	DIFFUSE AXONAL INJURY; LARGE ANIMAL-MODELS; SYNAPTIC PLASTICITY; GAP43; EXPRESSION; PROTEIN; DAMAGE; RECEPTORS; EFFICACY; SEIZURES	Operation brain trauma therapy (OBTT) is a drug- and biomarker-screening consortium intended to improve the quality of preclinical studies and provide a rigorous framework to increase the translational potential of experimental traumatic brain injury (TBI) treatments. Levetiracetam (LEV) is an antiepileptic agent that was the fifth drug tested by OBTT in three independent rodent models of moderate to severe TBI. To date, LEV has been the most promising drug tested by OBTT and was therefore advanced to testing in the pig. Adult male micro pigs were subjected to a mild central fluid percussion brain injury followed by a post-injury intravenous infusion of either 170 mg/kg LEV or vehicle. Systemic physiology was assessed throughout the post-injury period. Serial serum samples were obtained pre-injury as well as at 1 min, 30 min, 1 h, 3 h, and 6 h post-injury for a detailed analysis of the astroglial biomarker glial fibrillary acidic protein (GFAP) and ubiquitin carboxy-terminal hydrolase L1. Tissue was collected 6 h following injury for histological assessment of diffuse axonal injury using antibodies against the amyloid precursor protein (APP). The animals showed significant increases in circulating GFAP levels from baseline to 6 h post-injury; however, LEV treatment was associated with greater GFAP increases compared to the vehicle. There were no differences in the numbers of APP+ axonal swellings within the pig thalamus with LEV treatment; however, significant alterations in the morphological properties of the APP+ axonal swellings, including reduced swelling area and increased swelling roundness, were observed. Additionally, expression of the neurite outgrowth marker, growth-associated protein 43, was reduced in axonal swellings following LEV treatment, suggesting potential effects on axonal outgrowth that warrant further investigation.	[Lafrenaye, Audrey; Povlishock, John; Gorse, Karen; Walker, Susan] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23284 USA; Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy; [Mondello, Stefania] Oasi Res Inst IRCCS, Troina, Italy; [Hayes, Ronald] Banyan Biomarkers Inc, Alachua, FL USA; [Wang, Kevin] Univ Florida, Dept Psychiat & Neurosci, Ctr Neuroprote & Biomarkers Res, Gainesville, FL USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA		Lafrenaye, A (corresponding author), Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23284 USA.	audrey.lafrenaye@vcuhealth.org	Mondello, Stefania/A-1813-2012	Mondello, Stefania/0000-0002-8587-3614	US ArmyUnited States Department of Defense [W81XWH-10-1-0623, WH81XWH-14-2-0018]	This work was performed as a component of the Operation Brain Trauma Therapy consortium, which is supported by US Army grants W81XWH-10-1-0623 and WH81XWH-14-2-0018.	Aarli JA, 2006, NEUROLOGICAL DISORDE; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Aungst S, 2013, J NEUROPHYSIOL, V109, P813, DOI 10.1152/jn.00869.2012; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Begley CG, 2015, CIRC RES, V116, P116, DOI 10.1161/CIRCRESAHA.114.303819; BISBY MA, 1988, BRAIN RES, V458, P157, DOI 10.1016/0006-8993(88)90509-4; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Brau RH, 2018, P R HEALTH SCI J, V37, P67; Browning M, 2016, J NEUROTRAUM, V33, P581, DOI 10.1089/neu.2015.4131; Christman CW, 1997, ACTA NEUROPATHOL, V94, P329, DOI 10.1007/s004010050715; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; Dai JX, 2018, INT J NEUROSCI, V128, P243, DOI 10.1080/00207454.2017.1380008; DeGrauw X, 2018, EPILEPSY RES, V146, P41, DOI 10.1016/j.eplepsyres.2018.07.012; DeWitt DS, 2018, J NEUROTRAUM, V35, P2737, DOI 10.1089/neu.2018.5778; FFRENCHMULLEN JMH, 1987, J PHARMACOL EXP THER, V243, P915; Gorse KM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00778; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Grossman EJ, 2016, J NEUROTRAUM, V33, P163, DOI 10.1089/neu.2015.3965; Harris NG, 2010, J NEUROPATH EXP NEUR, V69, P139, DOI 10.1097/NEN.0b013e3181cb5bee; Huang TQ, 2017, MOL MED REP, V15, P3001, DOI 10.3892/mmr.2017.6350; Hulsebosch CE, 1998, NEUROSCI LETT, V255, P83, DOI 10.1016/S0304-3940(98)00712-5; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jia Tian-Ming, 2011, Zhongguo Dang Dai Er Ke Za Zhi, V13, P428; Kimbro JR, 2000, ANESTHESIOLOGY, V92, P806, DOI 10.1097/00000542-200003000-00024; Klitgaard H, 1998, EUR J PHARMACOL, V353, P191, DOI 10.1016/S0014-2999(98)00410-5; KLOCKGETHER T, 1988, BRAIN RES, V461, P343, DOI 10.1016/0006-8993(88)90265-X; Kochanek PM, 2020, J NEUROTRAUM, V37, P2353, DOI 10.1089/neu.2018.6203; Kochanek PM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00640; Kochanek PM, 2018, MIL MED, V183, P303, DOI 10.1093/milmed/usx184; Kochanek PM, 2016, J NEUROTRAUM, V33, P606, DOI 10.1089/neu.2015.4133; Kochanek PM, 2016, J NEUROTRAUM, V33, P513, DOI 10.1089/neu.2015.4113; Kononenko O, 2019, RESTOR NEUROL NEUROS, V37, P87, DOI 10.3233/RNN-180882; Koyama R, 2004, J NEUROSCI, V24, P7215, DOI 10.1523/JNEUROSCI.2045-04.2004; Lafrenaye AD, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70266-w; Lafrenaye AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0405-6; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mitchell J, 1996, NEUROPATH APPL NEURO, V22, P129; Mondello S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040977; Mondello S, 2018, EXPERT REV PROTEOMIC, V15, P451, DOI 10.1080/14789450.2018.1464914; Mondello S, 2016, J NEUROTRAUM, V33, P595, DOI 10.1089/neu.2015.4132; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Ortiz-Prado E, 2020, NEUROEPIDEMIOLOGY, V54, P33, DOI 10.1159/000502580; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Poloyac SM, 2020, J NEUROTRAUM, V37, P2435, DOI 10.1089/neu.2018.6295; Pourzitaki C, 2016, BRIT J CLIN PHARMACO, V82, P315, DOI 10.1111/bcp.12926; Shear DA, 2016, J NEUROTRAUM, V33, P523, DOI 10.1089/neu.2015.4115; Siddiqui AH, 2005, BRAIN RES, V1066, P129, DOI 10.1016/j.brainres.2005.10.066; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Stockburger C, 2016, J ALZHEIMERS DIS, V50, P201, DOI 10.3233/JAD-150687; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; VANDERZEE CEEM, 1989, J NEUROSCI, V9, P3505; VERGE VMK, 1990, J NEUROSCI, V10, P926; Vink R, 2018, J NEUROSCI RES, V96, P527, DOI 10.1002/jnr.24079; Wang HC, 2006, NEUROCRIT CARE, V5, P71, DOI 10.1385/NCC:5:1:71; Welch RD, 2017, J NEUROTRAUM, V34, P1957, DOI 10.1089/neu.2016.4772; WHO, PROJ MORT BURD DIS 2; World Health Organization, NEUROTRAUMA; Wu T, 2018, SEIZURE-EUR J EPILEP, V62, P84, DOI 10.1016/j.seizure.2018.09.008; Zou HC, 2013, NEUROREHAB NEURAL RE, V27, P878, DOI 10.1177/1545968313491007	67	2	2	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 13	2021	11								586958	10.3389/fneur.2020.586958			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PY4CO	WOS:000611993700001	33584493	Green Published, gold			2022-02-06	
J	Jha, KA; Gentry, J; Del Mar, NA; Reiner, A; Sohl, N; Gangaraju, R				Jha, Kumar Abhiram; Gentry, Jordy; Del Mar, Nobel A.; Reiner, Anton; Sohl, Nicolas; Gangaraju, Rajashekhar			Adipose Tissue-Derived Mesenchymal Stem Cell Concentrated Conditioned Medium Alters the Expression Pattern of Glutamate Regulatory Proteins and Aquaporin-4 in the Retina after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						confocal; glutamate; inflammation; mesenchymal; Muller; neurodegeneration	MULLER CELL; NEURAL RETINA; TRANSPORTER; SYNTHETASE; MICE; LIGHT; BLAST; MODEL; LOCALIZATION; METABOLISM	Concentrated conditioned media from adipose tissue-derived mesenchymal stem cells (ASC-CCM) show promise for retinal degenerative diseases. In this study, we hypothesized that ASC-CCM could rescue retinal damage and thereby improve visual function by acting through Muller glia in mild traumatic brain injury (mTBI). Adult C57Bl/6 mice were subjected to a 50-psi air pulse on the left side of the head, resulting in an mTBI. After blast injury, 1 mu L (similar to 100 ng total protein) of human ASC-CCM was delivered intravitreally and followed up after 4 weeks for visual function assessed by electroretinogram and histopathological markers for Muller cell-related markers. Blast mice that received ASC-CCM, compared with blast mice that received saline, demonstrated a significant improvement in a- and b-wave response correlated with a 1.3-fold decrease in extracellular glutamate levels and a concomitant increase in glutamine synthetase (GS), as well as the glutamate transporter (GLAST) in Muller cells. Additionally, an increase in aquaporin-4 (AQP4) in Muller cells in blast mice received saline restored to normal levels in blast mice that received ASC-CCM. In vitro studies on rMC-1 Muller glia exposed to 100 ng/mL glutamate or RNA interference knockdown of GLAST expression mimicked the increased Muller cell glial fibrillary acidic protein (a marker of gliosis) seen with mTBI, and suggested that an increase in glutamate and/or a decrease in GLAST might contribute to the Muller cell activation in vivo. Taken together, our data suggest a novel neuroprotective role for ASC-CCM in the rescue of the visual deficits and pathologies of mTBI via restoration of Muller cell health.	[Jha, Kumar Abhiram; Gentry, Jordy] Univ Tennessee, Ctr Hlth Sci, Dept Ophthalmol, Memphis, TN 38163 USA; [Del Mar, Nobel A.; Reiner, Anton; Gangaraju, Rajashekhar] Univ Tennessee, Ctr Hlth Sci, Dept Ophthalmol Anat & Neurobiol, Memphis, TN 38163 USA; [Sohl, Nicolas] Cell Care Therapeut Inc, Monrovia, CA USA		Gangaraju, R (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Ophthalmol Anat & Neurobiol, Neurosci Inst, 930 Madison Ave Suite 768, Memphis, TN 38163 USA.	sgangara@uthsc.edu			Department of DefenseUnited States Department of Defense [W81XWH-16-1-0076, W81XWH-16-1-0761]; National Eye InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [EY023427]; Research to Prevent BlindnessResearch to Prevent Blindness (RPB); Neuroscience Institute, UTHSC	This study was funded by grants from the Department of Defense (W81XWH-16-1-0761), National Eye Institute (EY023427), and unrestricted funds from Research to Prevent Blindness to R.G and Department of Defense (W81XWH-16-1-0076) to AR. KAJ is a recipient of a post-doctoral fellowship award from the Neuroscience Institute, UTHSC. The funders played no role in the conduct of the study, collection of data, management of the study, analysis of data, interpretation of data, or preparation of the manuscript.	Ambati J, 1997, ARCH OPHTHALMOL-CHIC, V115, P1161, DOI 10.1001/archopht.1997.01100160331011; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bringmann A, 2012, OPHTHALMOLOGICA, V227, P1, DOI 10.1159/000328979; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; BUCHI ER, 1992, EXP EYE RES, V55, P605, DOI 10.1016/S0014-4835(05)80173-3; Da T, 2004, INVEST OPHTH VIS SCI, V45, P4477, DOI 10.1167/iovs.04-0940; Delyfer MN, 2005, MOL VIS, V11, P688; Derouiche A, 1996, VISION RES, V36, P3875, DOI 10.1016/S0042-6989(96)00140-X; DEVITRY F, 1981, DEV NEUROSCI-BASEL, V4, P457; Dharmarajan S, 2014, MOL VIS, V20, P1085; Fukuda M, 2010, EXP EYE RES, V90, P17, DOI 10.1016/j.exer.2009.09.003; GINSBERG SD, 1995, J NEUROCHEM, V65, P2800; Gorovits R, 1996, MOL BRAIN RES, V43, P321, DOI 10.1016/S0169-328X(96)00213-6; Guley NH, 2016, J NEUROTRAUM, V33, P403, DOI 10.1089/neu.2015.3886; Holcombe DJ, 2008, ACTA OPHTHALMOL, V86, P408, DOI 10.1111/j.1600-0420.2007.01052.x; Honig MG, 2019, EXP NEUROL, V322, DOI 10.1016/j.expneurol.2019.113063; Iandiev I, 2008, INVEST OPHTH VIS SCI, V49, P3559, DOI 10.1167/iovs.08-1723; Iandiev I, 2007, NEUROSCI LETT, V421, P132, DOI 10.1016/j.neulet.2007.04.076; Jha KA, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1436-1; Jha KA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072016; Jha KA, 2015, NEUROCHEM RES, V40, P2153, DOI 10.1007/s11064-015-1698-7; Koh S, 2018, J NEUROSCI, V38, P2923, DOI 10.1523/JNEUROSCI.1532-17.2018; Koh S, 2015, J NEUROSCI, V35, P15649, DOI 10.1523/JNEUROSCI.1364-15.2015; Kuroiwa S, 1998, INVEST OPHTH VIS SCI, V39, P610; Li J, 2002, INVEST OPHTH VIS SCI, V43, P573; Li J, 2001, J BIOL CHEM, V276, P31233, DOI 10.1074/jbc.M104368200; Li XM, 2014, NEUROL SCI, V35, P847, DOI 10.1007/s10072-013-1610-7; LINSER P, 1979, P NATL ACAD SCI USA, V76, P6476, DOI 10.1073/pnas.76.12.6476; LOUZADAJUNIOR P, 1992, J NEUROCHEM, V59, P358, DOI 10.1111/j.1471-4159.1992.tb08912.x; Mammadova N, 2017, AM J PATHOL, V187, P1459, DOI 10.1016/j.ajpath.2017.03.005; Manogaran P, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0768-5; Martin KRG, 2002, INVEST OPHTH VIS SCI, V43, P2236; Mead B, 2020, PROG RETIN EYE RES, V79, DOI 10.1016/j.preteyeres.2020.100849; Nielsen S, 1997, J NEUROSCI, V17, P171; Oosuka S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072324; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; PETITO CK, 1992, BRAIN RES, V569, P275, DOI 10.1016/0006-8993(92)90639-Q; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Shaked I, 2002, J NEUROCHEM, V83, P574, DOI 10.1046/j.1471-4159.2002.01168.x; Sullivan SM, 2007, J BIOL CHEM, V282, P29414, DOI 10.1074/jbc.M704152200; ULSHAFER RJ, 1990, BRAIN RES, V531, P350, DOI 10.1016/0006-8993(90)90800-Q; Verkman AS, 2008, PROG RETIN EYE RES, V27, P420, DOI 10.1016/j.preteyeres.2008.04.001; Wang HJ, 2018, INT J IMMUNOPATH PH, V31, DOI 10.1177/2058738418801406; Wang L, 2013, CNS NEUROSCI THER, V19, P945, DOI 10.1111/cns.12150; Zou YY, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-79	45	2	2	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 15	2021	38	12					1702	1716		10.1089/neu.2020.7309		JAN 2021	15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SN7AR	WOS:000607612000001	33183134				2022-02-06	
J	Caccese, JB; Iverson, GL; Hunzinger, KJ; Asken, BM; Clugston, JR; Cameron, KL; Houston, MN; Svoboda, SJ; Jackson, JC; McGinty, GT; Estevez, CA; Susmarski, AJ; Enrique, A; Bryk, KN; Broglio, SP; McAllister, TW; McCrea, M; Pasquina, PF; Buckley, TA				Caccese, Jaclyn B.; Iverson, Grant L.; Hunzinger, Katherine J.; Asken, Breton M.; Clugston, James R.; Cameron, Kenneth L.; Houston, Megan N.; Svoboda, Steven J.; Jackson, Jonathan C.; McGinty, Gerald T.; Estevez, Carlos A.; Susmarski, Adam J.; Enrique, Alexander; Bryk, Kelsey N.; Broglio, Steven P.; McAllister, Thomas W.; McCrea, Michael; Pasquina, Paul F.; Buckley, Thomas A.		CARE Consortium	Factors Associated with Symptom Reporting in US Service Academy Cadets and NCAA Student Athletes without Concussion: Findings from the CARE Consortium	SPORTS MEDICINE			English	Article							SPORTS-RELATED CONCUSSION; BASE-LINE; HIGH-SCHOOL	Background Symptom resolution is a key marker in determining fitness for return to activity following concussion, but in some cases, distinguishing persistent symptoms due to concussion versus symptoms related to other factors can be challenging. Objective To determine base rates of postconcussional syndrome (PCS) diagnostic categorization in healthy cadets and student athletes with no recent concussion. Methods 13,009 cadets and 21,006 student athletes completed baseline preseason testing. After inclusion/exclusion criteria were applied, the final sample included 12,039 cadets [9123 men (75.8%); 2916 women (24.2%)] and 18,548 student athletes [10,192 men (54.9%); 8356 women (45.1%)]. Participants completed the Sport Concussion Assessment Tool-3rd Edition (SCAT3) symptom evaluation as part of baseline preseason testing. The PCS diagnostic categorization was classified by the International Classification of Diseases, 10th Revision (ICD-10) symptom criteria for PCS. Results In the absence of recent concussion, subgroups of cadets (17.8% of men; 27.6% of women) and student athletes (11.4% of men; 20.0% of women) reported a cluster of symptoms that would meet the ICD-10 symptom criteria for PCS. Participants with insufficient sleep and/or preexisting conditions (e.g., mental health problems), freshmen cadets, and cadets at the U.S. Coast Guard Academy and at the U.S. Air Force Academy (freshmen were tested during basic cadet training) were more likely to report a cluster of symptoms that would meet the ICD-10 symptom criteria for PCS. Conclusion The ICD-10 symptom criteria for PCS can be mimicked by preexisting conditions, insufficient sleep, and/or stress. Findings support person-specific assessment and management of symptoms following concussion.	[Caccese, Jaclyn B.] Ohio State Univ, 228H Atwell Hall,453 W 10th Ave, Columbus, OH 43210 USA; [Iverson, Grant L.] Harvard Med Sch, Spaulding Rehabil Hosp, Spaulding Res Inst,Red Sox Fdn, Mass Gen Hosp Children Sports Concuss Program,Hom, Charlestown, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp Program, Charlestown, MA USA; [Hunzinger, Katherine J.; Enrique, Alexander; Bryk, Kelsey N.; Buckley, Thomas A.] Univ Delaware, Newark, DE USA; [Asken, Breton M.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Clugston, James R.] Univ Florida, Gainesville, FL USA; [Cameron, Kenneth L.; Houston, Megan N.; Svoboda, Steven J.] US Mil Acad, West Point, NY 10996 USA; [Jackson, Jonathan C.; McGinty, Gerald T.] US Air Force Acad, Colorado Springs, CO 80840 USA; [Estevez, Carlos A.] US Coast Guard Acad, New London, CT USA; [Susmarski, Adam J.] US Naval Acad, Annapolis, MD 21402 USA; [Broglio, Steven P.] Univ Michigan, Ann Arbor, MI 48109 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [McCrea, Michael] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Pasquina, Paul F.] Uniformed Serv Univ Hlth Sci, Walter Reed Natl Mil Med Ctr, Bethesda, MD 20814 USA		Caccese, JB (corresponding author), Ohio State Univ, 228H Atwell Hall,453 W 10th Ave, Columbus, OH 43210 USA.	jaclyn.caccese@osumc.edu; giverson@mgh.harvard.edu; khunzing@udel.edu; breton.asken@ucsf.edu; jayclug@ufl.edu; kenneth.l.cameron.civ@mail.mil; megan.n.houston.ctr@mail.mil; stevensvoboda@me.com; jonathan.c.jackson10.mil@mail.mil; gerald.mcginty.ctr@usafa.edu; Carlos.A.Estevez@uscg.mil; adam.j.susmarski.mil@mail.mil; enriquea@udel.edu; kbryk@udel.edu; broglio@umich.edu; twmcalli@iupui.edu; mmccrea@mcw.edu; paul.f.pasquina.civ@mail.mil; tbuckley@udel.edu	Buckley, Thomas A/B-7525-2016; Hunzinger, Katherine J./AAJ-6332-2020	Buckley, Thomas A/0000-0002-0515-0150; Caccese, Jaclyn/0000-0003-2329-3603	Grand Alliance CARE Consortium - NCAA; DoDUnited States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]; DoD (DHP funds)	This publication was made possible, in part, with support from the Grand Alliance CARE Consortium, funded by the NCAA and the DoD. The USAMRAA, Fort Detrick, MD, USA, is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award No. W81XWH-14-2-0151. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the DoD (DHP funds).	[Anonymous], 2013, Br J Sports Med, V47, P259; Asken BM, ARCH CLIN NEUROPSYCH; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; Asken BM, 2017, CLIN NEUROPSYCHOL, V31, P138, DOI 10.1080/13854046.2016.1246672; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Chen HN, 2010, COMMUN STAT-SIMUL C, V39, P860, DOI 10.1080/03610911003650383; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Iverson GL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00489; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P745, DOI 10.1007/978-0-387-76978-3_24; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Silverberg ND, 2016, CLIN J SPORT MED, V26, P226, DOI 10.1097/JSM.0000000000000241; Sturdivant RX, 2013, APPL LOGISTIC REGRES, V3rd; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	26	2	2	0	9	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0112-1642	1179-2035		SPORTS MED	Sports Med.	MAY	2021	51	5					1087	1105		10.1007/s40279-020-01415-4		JAN 2021	19	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	RO2FU	WOS:000607014100001	33428120				2022-02-06	
J	Piatt, J				Piatt, Joseph			Racial disparities in mortality after severe traumatic brain injury in childhood: mediators identified by Oaxaca-Blinder decomposition of trauma registry data	INJURY EPIDEMIOLOGY			English	Article						Adolescents; Children; Decomposition; Infants; Racial disparities; Traumatic brain injury	INSURANCE STATUS; TRENDS; RACE	BackgroundIn the United States social disparities in health outcomes are found wherever they are sought, and they have been documented extensively in trauma care. Because social factors cannot cause a trauma outcome directly, there must exist mediating causal factors related to the nature and severity of the injury, the robustness of the victim, access to care, or processes of care. An understanding these mediators is the point of departure for addressing inequities in outcomes.FindingsData were extracted from the registry of the Trauma Quality Improvement Program of the American College of Surgeons for 2007 through 2010. Inclusion criteria were age less than 19years and head Abbreviated Injury Scale score of 4, 5, or 6. An Oaxaca-Blinder decomposition was undertaken to analyze the relative contributions of a large set of covariates to the difference in mortality rates between Black and White children. Covariates were aggregated into the following categories: "Severity," "Structure and Process," "Mechanism," "Demographics," and "Insurance." Eligible for analysis were 7273 White children and 2320 Black children. There were 1661 deaths (17.3%) The raw mortality rates were 15.6 and 22.8% for White and Black children, respectively. Factors categorized as "Severity" accounted for 95% of the mortality difference, "Mechanism" accounted for 13%, "Insurance" accounted for 5%, and "Demographics" accounted for 2%. The contribution of "Structure and Process" did not attain statistical significance.ConclusionsSeverity of injury accounts for most of the disparity between Black and White children in traumatic brain injury mortality rates. Mechanism, insurance status, and gender make a small contributions. Because insurance status like other social factors cannot directly affect trauma survival, what mediates its contribution requires further study.	[Piatt, Joseph] Nemours A duPont Hosp Children, Div Neurosurg, 1600 Rockland Rd, Wilmington, DE 19803 USA; [Piatt, Joseph] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Neurol Surg, Philadelphia, PA 19107 USA; [Piatt, Joseph] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Pediat, Philadelphia, PA 19107 USA		Piatt, J (corresponding author), Nemours A duPont Hosp Children, Div Neurosurg, 1600 Rockland Rd, Wilmington, DE 19803 USA.; Piatt, J (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Neurol Surg, Philadelphia, PA 19107 USA.; Piatt, J (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Pediat, Philadelphia, PA 19107 USA.	jpiatt@nemours.org		Piatt, Joseph/0000-0002-9332-8376			BLINDER AS, 1973, J HUM RESOUR, V8, P436, DOI 10.2307/144855; Fairlie RW, 2020, ADDRESSING PATH DEPE; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Gerry JM, 2016, INJURY, V47, P197, DOI 10.1016/j.injury.2015.09.003; Glance LG, 2013, HEALTH SERV RES, V48, P1684, DOI 10.1111/1475-6773.12064; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Haider AH, 2013, ANN SURG, V258, P572, DOI 10.1097/SLA.0b013e3182a50148; Hicks CW, 2015, ANN SURG, V262, P179, DOI 10.1097/SLA.0000000000000809; Marcin JP, 2003, AM J PUBLIC HEALTH, V93, P461, DOI 10.2105/AJPH.93.3.461; Oaxaca R., 1973, INT EC REV, V14, P693, DOI DOI 10.2307/2525981; Piatt J, 2020, J NEUROSURG-PEDIATR, V26, P476, DOI 10.3171/2020.5.PEDS20336; Rangel SJ, 2008, J PEDIATR SURG, V43, P200, DOI 10.1016/j.jpedsurg.2007.09.045; Rosen H, 2009, J PEDIATR SURG, V44, P1952, DOI 10.1016/j.jpedsurg.2008.12.026; Salim A, 2010, J TRAUMA, V68, P211, DOI 10.1097/TA.0b013e3181a0e659; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4; Wood JN, 2010, PEDIATRICS, V126, P408, DOI 10.1542/peds.2010-0031	16	2	2	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		2197-1714		INJURY EPIDEMIOL	Inj. Epidemiol.	JAN 11	2021	8	1							1	10.1186/s40621-020-00295-6			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	TP5IB	WOS:000677631800001	33423690	gold, Green Published			2022-02-06	
J	Paladini, MS; Feng, X; Krukowski, K; Rosi, S				Paladini, Maria Serena; Feng, Xi; Krukowski, Karen; Rosi, Susanna			Microglia depletion and cognitive functions after brain injury: From trauma to galactic cosmic ray	NEUROSCIENCE LETTERS			English	Article						Microglia; Traumatic brain injury; Whole-brain radiotherapy; Galactic cosmic ray; Microglia depletion; Microglia repopulation	CENTRAL-NERVOUS-SYSTEM; HIPPOCAMPAL NEUROGENESIS; PROGENITOR-CELL; RADIATION; RECEPTOR; IRRADIATION; DEFICIENCY; MECHANISMS; EXPRESSION; HEALTH	Microglia are the resident immune cells of the central nervous system (CNS). In physiological conditions, microglia contribute to maintaining brain homeostasis by scanning the surrounding parenchyma and acting as scavenger cells. Following different insults to the CNS, microglia turn into a "reactive" state characterized by the production of inflammatory mediators that promote tissue repair to restore homeostasis. Brain insults such as traumatic brain injury, therapeutic brain irradiation and galactic cosmic ray exposure are associated with chronic microglia activation. Chronic microglia activation contributes to injury-related impairments in cognitive functions. Microglia depletion achieved either by pharmacological or genetic techniques represents not only a useful tool for more extensive investigations of microglia roles, but also a potential therapeutic approach to ameliorate or prevent cognitive dysfunctions following brain injury.	[Paladini, Maria Serena; Feng, Xi; Krukowski, Karen; Rosi, Susanna] Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, San Francisco, CA 94143 USA; [Paladini, Maria Serena; Feng, Xi; Krukowski, Karen] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Rosi, Susanna] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Rosi, Susanna] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94143 USA; [Rosi, Susanna] Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94143 USA		Rosi, S (corresponding author), Lewis & Ruth Cozen Chair 2, 1001 Potrero Ave, San Francisco, CA 94110 USA.	susanna.rosi@ucsf.edu			National Institutes of Health: NIH/National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG056770]; NIH/National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01 CA213441, R01 CA246722]; National Aeronautic Space Agency NASA [NNX14AC94G, 80NSSC19K1581]	This work was supported by the National Institutes of Health: NIH/National Institute on Aging Grant R01AG056770 (to S.R.); NIH/National Cancer Institute Grants R01 CA213441 and R01 CA246722 (to S. R.), National Aeronautic Space Agency NASA grants NNX14AC94G and 80NSSC19K1581 (to S.R.).	Acharya MM, 2016, SCI REP-UK, V6, DOI 10.1038/srep31545; Akamatsu Y, 2020, NEUROTHERAPEUTICS, V17, P446, DOI 10.1007/s13311-020-00840-7; Allen BD, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01790-9; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Cekanaviciute E, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113669; Chen HX, 2016, BRAIN RES, V1646, P193, DOI 10.1016/j.brainres.2016.06.002; CHIANG CS, 1993, RADIOTHER ONCOL, V29, P60, DOI 10.1016/0167-8140(93)90174-7; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Crain JM, 2013, J NEUROSCI RES, V91, P1143, DOI 10.1002/jnr.23242; Cronk JC, 2018, J EXP MED, V215, P1627, DOI 10.1084/jem.20180247; Dagher NN, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0366-9; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Elmore MRP, 2018, AGING CELL, V17, DOI 10.1111/acel.12832; Elmore MRP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122912; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Erblich B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026317; Feng X, 2018, ELIFE, V7, DOI 10.7554/eLife.38865; Feng X, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0671-y; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Greene-Schloesser D, 2012, NEURO-ONCOLOGY, V14, P37, DOI 10.1093/neuonc/nos196; Greene-Schloesser D, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00073; Han JM, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0307-x; Henry RJ, 2020, J NEUROSCI, V40, P2960, DOI 10.1523/JNEUROSCI.2402-19.2020; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hua K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052728; Huang YB, 2018, NAT NEUROSCI, V21, P530, DOI 10.1038/s41593-018-0090-8; Izzy S, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00307; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Kitic M, 2019, METHODS MOL BIOL, V2034, P217, DOI 10.1007/978-1-4939-9658-2_16; Krukowski K, 2018, BRAIN BEHAV IMMUN, V74, P106, DOI 10.1016/j.bbi.2018.08.008; Krukowski K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26039-7; Labzin LI, 2018, ANNU REV MED, V69, P437, DOI 10.1146/annurev-med-050715-104343; Lehrman EK, 2018, NEURON, V100, P120, DOI 10.1016/j.neuron.2018.09.017; Li J, 2006, GENESIS, V44, P328, DOI 10.1002/dvg.20219; Li QY, 2018, NAT REV IMMUNOL, V18, P225, DOI 10.1038/nri.2017.125; Liu B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48615-1; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Menzel F, 2018, GLIA, V66, P15, DOI 10.1002/glia.23239; Mizumatsu S, 2003, CANCER RES, V63, P4021; Monje ML, 2007, ANN NEUROL, V62, P515, DOI 10.1002/ana.21214; Morganti JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093650; Mouton PR, 2002, BRAIN RES, V956, P30, DOI 10.1016/S0006-8993(02)03475-3; Parihar VK, 2018, EXP NEUROL, V305, P44, DOI 10.1016/j.expneurol.2018.03.009; Parihar VK, 2016, SCI REP-UK, V6, DOI 10.1038/srep34774; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Raber J, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00179; Raber J, 2016, RADIAT RES, V185, P20, DOI 10.1667/RR14222.1; Rice RA, 2017, GLIA, V65, P931, DOI 10.1002/glia.23135; Rola R, 2008, RADIAT RES, V169, P626, DOI 10.1667/RR1263.1; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Sasaki A, 2000, NEUROPATHOLOGY, V20, P134, DOI 10.1046/j.1440-1789.2000.00286.x; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Semple BD, 2019, NEUROBIOL DIS, V123, P27, DOI 10.1016/j.nbd.2018.07.018; Spangenberg EE, 2016, BRAIN, V139, P1265, DOI 10.1093/brain/aww016; Stanley ER, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a021857; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Vainchtein ID, 2018, SCIENCE, V359, P1269, DOI 10.1126/science.aal3589; Villa A, 2018, CELL REP, V23, P3501, DOI 10.1016/j.celrep.2018.05.048; Waisman A, 2015, TRENDS IMMUNOL, V36, P625, DOI 10.1016/j.it.2015.08.005; Wang CF, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6460; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Warrington JP, 2013, J VASC RES, V50, P445, DOI 10.1159/000354227; Willis EF, 2020, CELL, V180, P833, DOI 10.1016/j.cell.2020.02.013; Witcher KG, 2018, GLIA, V66, P2719, DOI 10.1002/glia.23523	71	2	2	2	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JAN 10	2021	741								135462	10.1016/j.neulet.2020.135462			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PH6VE	WOS:000600546900012	33259927				2022-02-06	
J	Ferguson, L; Giza, CC; Serpa, RO; Greco, T; Folkerts, M; Prins, ML				Ferguson, Lindsay; Giza, Christopher C.; Serpa, Rebecka O.; Greco, Tiffany; Folkerts, Michael; Prins, Mayumi L.			Recovery From Repeat Mild Traumatic Brain Injury in Adolescent Rats Is Dependent on Pre-injury Activity State	FRONTIERS IN NEUROLOGY			English	Article						secondary insult; pediatric brain injury; rat; cognitive function; behavioral assessment	EMERGENCY-DEPARTMENT VISITS; PLASTICITY-RELATED PROTEINS; PHYSICAL-ACTIVITY; PERITENDINOUS TISSUE; RECOGNITION MEMORY; AEROBIC FITNESS; UNITED-STATES; UP-REGULATION; TERM-MEMORY; EXERCISE	Adolescents and young adults have the highest incidence of mild traumatic brain injury (mTBI); sport-related activities are a major contributor. Roughly a third of these patients diagnosed with mTBI are estimated to have received a subsequent repeat mTBI (rTBI). Previously, animal studies have only modeled mTBI in sedentary animals. This study utilizes physical activity as a dependent variable prior to rTBI in adolescent rats by allowing voluntary exercise in males, establishing the rat athlete (rathlete). Rats were given access to locked or functional running wheels for 10 d prior to sham or rTBI injury. Following rTBI, rathletes were allowed voluntary access to running wheels beginning on different days post-injury: no run (rTBI+no run), immediate run (rTBI+Immed), or 3 day delay (rTBI+3dd). Rats were tested for motor and cognitive-behavioral (anxiety, social, memory) and mechanosensory (allodynia) dysfunction using a novel rat standardized concussion assessment tool on post-injury days 1,3,5,7, and 10. Protein expression of brain derived neurotrophic factor (BDNF) and proliferator-activated gamma coactivator 1-alpha (PGC1 alpha) was measured in the parietal cortex, hippocampus, and gastrocnemius muscle. Sedentary shams displayed lower anxiety-like behaviors compared to rathlete shams on all testing days. BDNF and PGC1 alpha levels increased in the parietal cortex and hippocampus with voluntary exercise. In rTBI rathletes, the rTBI+Immed group showed impaired social behavior, memory impairment in novel object recognition, and increased immobility compared to rathlete shams. All rats showed greater neuropathic mechanosensory sensitivity than previously published uninjured adults, with rTBI+3dd showing greatest sensitivity. These results demonstrate that voluntary exercise changes baseline functioning of the brain, and that among rTBI rathletes, delayed return to activity improved cognitive recovery.	[Ferguson, Lindsay; Giza, Christopher C.; Serpa, Rebecka O.; Greco, Tiffany; Prins, Mayumi L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Ferguson, Lindsay; Giza, Christopher C.; Serpa, Rebecka O.; Greco, Tiffany; Prins, Mayumi L.] Univ Calif Los Angeles, Steve Tisch BrainSPORT Program, Los Angeles, CA 90024 USA; [Folkerts, Michael] Pepperdine Univ, Seaver Coll, Dept Psychol, Malibu, CA 90265 USA		Ferguson, L (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Brain Injury Res Ctr, Los Angeles, CA 90095 USA.; Ferguson, L (corresponding author), Univ Calif Los Angeles, Steve Tisch BrainSPORT Program, Los Angeles, CA 90024 USA.	lmferguson@mednet.ucla.edu	Greco, Tiffany/ABA-3519-2021		National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS110757]; Easton Labs for Brain Injury; Brain injury Research Center; Steve Tisch BrainSPORT program at the University of California Los Angeles	The work of the current project was supported in part by the National Institute of Health (NS110757, Mayumi Prins), Easton Labs for Brain Injury, and the Brain injury Research Center and Steve Tisch BrainSPORT program at the University of California Los Angeles.	ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Archer T, 2012, NEUROTOX RES, V21, P418, DOI 10.1007/s12640-011-9297-0; Baldwin GT, 2018, HAND CLINIC, V158, P63, DOI 10.1016/B978-0-444-63954-7.00007-0; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; Bekinschtein P, 2014, NEUROPHARMACOLOGY, V76, P677, DOI 10.1016/j.neuropharm.2013.04.024; Campbell JE, 2009, J APPL PHYSIOL, V106, P66, DOI 10.1152/japplphysiol.91128.2008; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2003, J GERONTOL A-BIOL, V58, P176; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Crews F, 2007, PHARMACOL BIOCHEM BE, V86, P189, DOI 10.1016/j.pbb.2006.12.001; Curry AE, 2019, J PEDIATR-US, V210, P13, DOI 10.1016/j.jpeds.2019.04.001; Ding QX, 2006, EUR J NEUROSCI, V24, P1265, DOI 10.1111/j.1460-9568.2006.05026.x; Eiland L, 2013, NEUROSCIENCE, V249, P162, DOI 10.1016/j.neuroscience.2012.10.048; El Hayek L, 2019, J NEUROSCI, V39, P2369, DOI 10.1523/JNEUROSCI.1661-18.2019; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FORDYCE DE, 1991, BEHAV BRAIN RES, V46, P123, DOI 10.1016/S0166-4328(05)80105-6; Fox CK, 2010, J SCHOOL HEALTH, V80, P31, DOI 10.1111/j.1746-1561.2009.00454.x; Greco T, 2013, J NEUROTRAUM, V30, P1983, DOI 10.1089/neu.2013.2990; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Herbst EAF, 2016, APPL PHYSIOL NUTR ME, V41, P799, DOI 10.1139/apnm-2016-0033; Herting MM, 2017, BIRTH DEFECTS RES, V109, P1672, DOI 10.1002/bdr2.1178; Herting MM, 2014, DEV COGN NEUROS-NETH, V7, P65, DOI 10.1016/j.dcn.2013.11.003; Hopkins ME, 2011, NEUROSCIENCE, V194, P84, DOI 10.1016/j.neuroscience.2011.07.071; Kim Y, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.160245; Langberg H, 2002, J PHYSIOL-LONDON, V542, P985, DOI 10.1113/jphysiol.2002.019141; Langberg H, 2002, J PHYSIOL-LONDON, V542, P977, DOI 10.1113/jphysiol.2002.018077; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Macolino CM, 2014, J NEUROSCI METH, V226, P139, DOI 10.1016/j.jneumeth.2014.01.008; McCrea M, 2020, BRIT J SPORT MED, V54, P102, DOI 10.1136/bjsports-2019-100579; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; Mota BC, 2012, NEUROTOX RES, V21, P175, DOI 10.1007/s12640-011-9257-8; Munakata Y, 2004, TRENDS COGN SCI, V8, P122, DOI 10.1016/j.tics.2004.01.005; Murase S, 2010, J NEUROSCI, V30, P3752, DOI 10.1523/JNEUROSCI.3803-09.2010; Mustafa G, 2016, NEUROPHARMACOLOGY, V107, P27, DOI 10.1016/j.neuropharm.2016.03.016; Mychasiuk R, 2014, BEHAV BRAIN RES, V259, P284, DOI 10.1016/j.bbr.2013.10.048; Mychasiuk R, 2016, EUR J NEUROSCI, V44, P2407, DOI 10.1111/ejn.13360; Oshinsky ML, 2007, HEADACHE, V47, P1026, DOI 10.1111/j.1526-4610.2007.00871.x; Oshinsky ML, 2014, PAIN, V155, P1181, DOI 10.1016/j.pain.2014.04.001; Oshinsky ML, 2014, PAIN, V155, P1037, DOI 10.1016/j.pain.2014.02.009; OVERMAN WH, 1993, DEV PSYCHOBIOL, V26, P345, DOI 10.1002/dev.420260605; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Reger ML, 2009, DEV PSYCHOBIOL, V51, P672, DOI 10.1002/dev.20402; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Romeo RD, 2006, ANN NY ACAD SCI, V1094, P202, DOI 10.1196/annals.1376.022; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Schaeffer DJ, 2014, PSYCHOPHYSIOLOGY, V51, P728, DOI 10.1111/psyp.12227; Semple BD, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00069; Spear LP, 2004, ANN NY ACAD SCI, V1021, P23, DOI 10.1196/annals.1308.002; SPIRDUSO WW, 1978, J GERONTOL, V33, P26, DOI 10.1093/geronj/33.1.26; Stephan JS, 2019, CURR OPIN NEUROL, V32, P808, DOI 10.1097/WCO.0000000000000754; SUTTON RL, 1992, RESTOR NEUROL NEUROS, V4, P1, DOI 10.3233/RNN-1992-4101; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor JM, 2015, BRAIN RES, V1622, P414, DOI 10.1016/j.brainres.2015.07.009; Trabold R, 2010, J CEREBR BLOOD F MET, V30, P130, DOI 10.1038/jcbfm.2009.196; VOS BP, 1994, J NEUROSCI, V14, P2708; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Yang JL, 2014, NEUROMOL MED, V16, P161, DOI 10.1007/s12017-013-8270-x; Zhao ZR, 2015, J NEUROTRAUM, V32, P1347, DOI 10.1089/neu.2014.3739; Zhou J, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0113-2	71	2	2	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 8	2021	11								616661	10.3389/fneur.2020.616661			18	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PU6QH	WOS:000609425800001	33488505	Green Published, gold			2022-02-06	
J	Lemme, J; Holmes, S; Sibai, D; Mari, J; Simons, LE; Burstein, R; Zurakowski, D; Lebel, A; O'Brien, M; Upadhyay, J; Borsook, D				Lemme, Jordan; Holmes, Scott; Sibai, Diana; Mari, Joud; Simons, Laura E.; Burstein, Rami; Zurakowski, David; Lebel, Alyssa; O'Brien, Michael; Upadhyay, Jaymin; Borsook, David			Altered Brain Network Connectivity Underlies Persistent Post-Traumatic Headache following Mild Traumatic Brain Injury in Youth	JOURNAL OF NEUROTRAUMA			English	Article						fear of pain; pain catastrophizing; post-traumatic headaches; resting-state functional connectivity	PAIN-RELATED FEAR; FUNCTIONAL CONNECTIVITY; CEREBRAL-CORTEX; CHILDREN; RELIABILITY; ANXIETY; QUESTIONNAIRE; SEGMENTATION; CEREBELLUM; THICKNESS	Post-traumatic headaches (PTHs) are associated with mild traumatic brain injuries (mTBI) and may predict the persistence of concussion symptoms. Altered brain networks implicated in brain injury and the affective components of headache-related pain may underlie the resolution of PTH. This is a hypothesis-generating investigation to evaluate the extent to which pain symptom reporting and functional brain changes are different in a cohort of young mTBI patients with resolved (PTH-R) and persistent (PTH-P) post-traumatic headache symptoms relative to healthy controls. This was a cross-sectional investigation involving 59 participants between the ages of 12-24 (PTH-P, n = 21; PTH-R, n = 18; healthy control, n = 20). Participants had no significant history of pre-existing headaches, chronic pain, or psychiatric neurological conditions. The primary outcome was resting-state functional connectivity (RS-Fc) alterations between cohorts. Secondary outcomes were self-reported pain-related symptoms. Elevated scores were reported for fear of pain in both PTH cohorts. Using a false discovery rate of p = 0.05, the PTH-P cohort showed altered connectivity relative to healthy controls in brain regions such as the frontal, temporal, and cerebellar regions, as well as sub-cortical regions including the amygdala and accumbens. The PTH-R cohort showed altered RS-Fc between cerebellar and temporal lobe sub-regions. Our results indicate that a core network of brain regions implicated in the affective pain response are functionally altered in PTH cohorts. Results should be interpreted given limitations on sample size and multiple comparisons. Despite the resolution of symptoms, persons who experience PTH may experience ongoing functional brain abnormalities, which may underlie symptom chronification.	[Lemme, Jordan; Holmes, Scott; Sibai, Diana; Mari, Joud; Zurakowski, David; Lebel, Alyssa; Upadhyay, Jaymin; Borsook, David] Harvard Med Sch, Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA 02115 USA; [O'Brien, Michael] Harvard Med Sch, Boston Childrens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Simons, Laura E.] Stanford Univ, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Palo Alto, CA 94304 USA; [Burstein, Rami] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02115 USA		Lemme, J (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA 02115 USA.	jordan.lemme@childrens.harvard.edu		Lemme, Jordan D./0000-0002-1367-5555	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS095655]	The work was supported by a grant from NINDS (R01 NS095655) to David Borsook.	Ashina H, 2019, NAT REV NEUROL, V15, P607, DOI 10.1038/s41582-019-0243-8; Birn RM, 2013, NEUROIMAGE, V83, P550, DOI 10.1016/j.neuroimage.2013.05.099; Black AK, 2015, HEADACHE, V55, P669, DOI 10.1111/head.12561; Brascher AK, 2016, J NEUROSCI, V36, P5013, DOI 10.1523/JNEUROSCI.1954-15.2016; Chong CD, 2018, HEADACHE, V58, P53, DOI 10.1111/head.13223; Cole WR, 2017, J CLIN EXP NEUROPSYC, V39, P35, DOI 10.1080/13803395.2016.1198470; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Desikan R, 2006, ULTRAMICROSCOPY, V106, P795, DOI 10.1016/j.ultramic.2005.11.012; Dwyer B, 2018, SEMIN NEUROL, V38, P619, DOI 10.1055/s-0038-1673692; Fallon N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159198; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Holmes SA, 2019, BRAIN INJURY, V33, P383, DOI 10.1080/02699052.2018.1552023; Howard L, 2018, HEADACHE, V58, P1397, DOI 10.1111/head.13396; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Jakubowski M, 2005, NEUROLOGY, V65, P1419, DOI 10.1212/01.wnl.0000183358.53939.38; Jeneson A, 2012, J NEUROSCI, V32, P3584, DOI 10.1523/JNEUROSCI.6444-11.2012; Kirk C, 2008, DEV MED CHILD NEUROL, V50, P422, DOI 10.1111/j.1469-8749.2008.02063.x; Kros L, 2018, CEPHALALGIA, V38, P1782, DOI 10.1177/0333102417752120; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Lebel A, 2008, BRAIN, V131, P1854, DOI 10.1093/brain/awn123; Legrain V, 2011, PAIN, V152, P467, DOI 10.1016/j.pain.2010.11.011; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Moulton EA, 2011, J NEUROSCI, V31, P3795, DOI 10.1523/JNEUROSCI.6709-10.2011; Moulton EA, 2010, BRAIN RES REV, V65, P14, DOI 10.1016/j.brainresrev.2010.05.005; Neugebauer V, 2015, HANDB EXP PHARMACOL, V227, P261, DOI 10.1007/978-3-662-46450-2_13; Niu X, 2019, J NEUROL NEUROSUR PS, V90, P326, DOI 10.1136/jnnp-2018-318886; Obermann M, 2009, NEUROLOGY, V73, P978, DOI 10.1212/WNL.0b013e3181b8791a; Osman A, 1997, J BEHAV MED, V20, P589, DOI 10.1023/A:1025570508954; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; REYNOLDS CR, 1985, PSYCHOL REP, V56, P402, DOI 10.2466/pr0.1985.56.2.402; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Schwedt TJ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00615; Schwedt TJ, 2014, CEPHALALGIA, V34, P947, DOI 10.1177/0333102414526069; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Seminowicz DA, 2017, J PAIN, V18, P1027, DOI 10.1016/j.jpain.2017.03.008; Silverman WK, 1999, BEHAV RES THER, V37, P903, DOI 10.1016/S0005-7967(98)00189-2; Simons LE, 2016, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00703; Simons LE, 2015, PAIN, V156, P1511, DOI 10.1097/j.pain.0000000000000199; Simons LE, 2011, J PAIN, V12, P677, DOI 10.1016/j.jpain.2010.12.008; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Vincent M, 2007, HEADACHE, V47, P820, DOI 10.1111/j.1526-4610.2006.00715.x; Wei CB, 2016, CHINESE MED J-PEKING, V129, P1394, DOI 10.4103/0366-6999.183410; Xiong KL, 2016, NEURORADIOLOGY, V58, P733, DOI 10.1007/s00234-016-1675-0; Yu P, 2007, IEEE T MED IMAGING, V26, P582, DOI 10.1109/TMI.2007.892499; Zale EL, 2013, J PAIN, V14, P1019, DOI 10.1016/j.jpain.2013.05.005; Zhou HC, 2019, MOL PAIN, V15, DOI 10.1177/1744806919845739	53	2	2	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 15	2021	38	12					1632	1641		10.1089/neu.2020.7189		JAN 2021	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SN7AR	WOS:000606619300001	33183144				2022-02-06	
J	Lenstra, JJ; Hesselink, LKK; la Bastide-van Gemert, S; Jacobs, B; Nijsten, MWN; van der Horst, ICC; van der Naalt, J				Lenstra, Jelmer-Joost; Kuznecova-Keppel Hesselink, Lidija; la Bastide-van Gemert, Sacha; Jacobs, Bram; Nijsten, Maarten Willem Nicolaas; van der Horst, Iwan Cornelis Clemens; van der Naalt, Joukje			The Association of Early Electrocardiographic Abnormalities With Brain Injury Severity and Outcome in Severe Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						severe traumatic brain injury; cardiac dysfunction; electrocardiography (ECG); computerized tomography (CT); therapy intensity level (TIL); mortality outcome	CARDIAC DYSFUNCTION; ECG ABNORMALITIES; ARRHYTHMIAS; MANAGEMENT; CONTUSION; MODERATE; THERAPY; RISK	The aim of this study was to evaluate the frequency of electrocardiographic (ECG) abnormalities in the acute phase of severe traumatic brain injury (TBI) and the association with brain injury severity and outcome. In contrast to neurovascular diseases, sparse information is available on this issue. Data of adult patients with severe TBI admitted to the Intensive Care Unit (ICU) for intracranial pressure monitoring of a level-1 trauma center from 2002 till 2018 were analyzed. Patients with a cardiac history were excluded. An ECG recording was obtained within 24 h after ICU admission. Admission brain computerized tomography (CT)-scans were categorized by Marshall-criteria (diffuse vs. mass lesions) and for location of traumatic lesions. CT-characteristics and maximum Therapy Intensity Level (TILmax) were used as indicators for brain injury severity. We analyzed data of 198 patients, mean (SD) age of 40 +/- 19 years, median GCS score 3 [interquartile range (IQR) 3-6], and 105 patients (53%) had thoracic injury. In-hospital mortality was 30%, with sudden death by cardiac arrest in four patients. The incidence of ECG abnormalities was 88% comprising ventricular repolarization disorders (57%) mostly with ST-segment abnormalities, conduction disorders (45%) mostly with QTc-prolongation, and arrhythmias (38%) mostly of supraventricular origin. More cardiac arrhythmias were observed with increased grading of diffuse brain injury (p = 0.042) or in patients treated with hyperosmolar therapy (TILmax) (65%, p = 0.022). No association was found between ECG abnormalities and location of brain lesions nor with thoracic injury. Multivariate analysis with baseline outcome predictors showed that cardiac arrhythmias were not independently associated with in-hospital mortality (p = 0.097). Only hypotension (p = 0.029) and diffuse brain injury (p = 0.017) were associated with in-hospital mortality. In conclusion, a high incidence of ECG abnormalities was observed in patients with severe TBI in the acute phase after injury. No association between ECG abnormalities and location of brain lesions or presence of thoracic injury was present. Cardiac arrhythmias were indicative for brain injury severity but not independently associated with in-hospital mortality. Therefore, our findings likely suggest that ECG abnormalities should be considered as cardiac mimicry representing the secondary effect of traumatic brain injury allowing for a more rationale use of neuroprotective measures.	[Lenstra, Jelmer-Joost; Jacobs, Bram; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Kuznecova-Keppel Hesselink, Lidija; Nijsten, Maarten Willem Nicolaas; van der Horst, Iwan Cornelis Clemens] Univ Groningen, Univ Med Ctr Groningen, Dept Crit Care, Groningen, Netherlands; [la Bastide-van Gemert, Sacha] Univ Groningen, Univ Med Ctr Groningen, Dept Epidmiol, Groningen, Netherlands		van der Naalt, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.	j.van.der.naalt@umcg.nl	la Bastide-van Gemert, Sacha/C-5151-2013	la Bastide-van Gemert, Sacha/0000-0003-0666-6690; van der Naalt, Joukje/0000-0001-9873-2418			Abboud H, 2006, ANN NEUROL, V59, P691, DOI 10.1002/ana.20806; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Blackburn HW., 1982, MINNESOTA CODE MANUA; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen ZL, 2017, CIRC RES, V121, P451, DOI 10.1161/CIRCRESAHA.117.311170; Cheshire WP, 2006, NEUROLOGY, V66, P1296, DOI 10.1212/01.wnl.0000219563.87204.7d; Christensen H, 2005, J NEUROL NEUROSUR PS, V76, P269, DOI 10.1136/jnnp.2004.037531; Christensen H, 2005, J NEUROL SCI, V234, P99, DOI 10.1016/j.jns.2005.03.039; Colivicchi F, 2005, STROKE, V36, P1710, DOI 10.1161/01.STR.0000173400.19346.bd; Cuisinier A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0323-3; Diercks DB, 2004, J EMERG MED, V27, P153, DOI 10.1016/j.jemermed.2004.04.006; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Gibbons PW, 2019, J CRIT CARE, V54, P130, DOI 10.1016/j.jcrc.2019.08.017; Goodman S, 2008, CURR OPIN CRIT CARE, V14, P549, DOI 10.1097/MCC.0b013e32830a4c5d; Grunsfeld Alexander, 2005, Curr Neurol Neurosci Rep, V5, P488, DOI 10.1007/s11910-005-0039-7; Hadjizacharia P, 2011, AM SURGEON, V77, P634; Hasanin A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0246-z; Holanda MS, 2006, EUR J EMERG MED, V13, P373, DOI 10.1097/MEJ.0b013e32801112f6; JACHUCK SJ, 1975, BRIT MED J, V1, P242, DOI 10.1136/bmj.1.5952.242; Kaye P, 2002, EMERG MED J, V19, P8, DOI 10.1136/emj.19.1.8; KONO T, 1994, J AM COLL CARDIOL, V24, P636, DOI 10.1016/0735-1097(94)90008-6; Krishnamoorthy V, 2014, INDIAN J CRIT CARE M, V18, P570, DOI 10.4103/0972-5229.140144; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McDonald SJ, 2020, J NEUROTRAUM, V37, P770, DOI 10.1089/neu.2019.6885; Oppenheimer S, 2006, CLIN AUTON RES, V16, P6, DOI 10.1007/s10286-006-0276-0; Rincon F, 2008, STROKE, V39, P2425, DOI 10.1161/STROKEAHA.107.506055; Rizoli SB, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1620-6; Roche F, 2003, AM J CARDIOL, V91, P916, DOI 10.1016/S0002-9149(03)00040-7; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Smith M, 1972, Chest, V61, P125, DOI 10.1378/chest.61.2.125; Sommargren CE, 2002, J ELECTROCARDIOL, V35, P257, DOI 10.1054/jelc.2002.37187; Sommargren CE, 2002, AM J CRIT CARE, V11, P48, DOI 10.4037/ajcc2002.11.1.48; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Torre-Healy A, 2012, NEUROCRIT CARE, V17, P117, DOI 10.1007/s12028-011-9649-x; van Bree MDR, 2010, NEUROCRIT CARE, V12, P50, DOI 10.1007/s12028-009-9283-z; van der Ende MY, 2017, CLIN CARDIOL, V40, P865, DOI 10.1002/clc.22737; Venkata C, 2018, CLIN MED RES, V16, P57, DOI 10.3121/cmr.2018.1437; Zuercher P, 2016, J NEUROTRAUM, V33, P1768, DOI 10.1089/neu.2015.4266	40	2	2	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 8	2021	11								597737	10.3389/fneur.2020.597737			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PU6JY	WOS:000609409300001	33488498	Green Published, gold			2022-02-06	
J	Maigler, KC; Buhr, TJ; Park, CS; Miller, SA; Kozlowski, DA; Marr, RA				Maigler, Kathleen C.; Buhr, Trevor J.; Park, Christopher S.; Miller, Steven A.; Kozlowski, Dorothy A.; Marr, Robert A.			Assessment of the Effects of Altered Amyloid-Beta Clearance on Behavior following Repeat Closed-Head Brain Injury in Amyloid-Beta Precursor Protein Humanized Mice	JOURNAL OF NEUROTRAUMA			English	Article						amyloid-beta; neprilysin (NEP); neprilysin-2 (NEP2); repeat concussion; traumatic brain injury	CONTROLLED CORTICAL IMPACT; CHRONIC TRAUMATIC ENCEPHALOPATHY; MOUSE MODEL; A-BETA; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; TRANSGENIC MODEL; NEPRILYSIN; PATHOLOGY	Traumatic brain injury (TBI) increases the risk for dementias including Alzheimer's disease (AD) and chronic traumatic encephalopathy. Further, both human and animal model data indicate that amyloid-beta (A beta) peptide accumulation and its production machinery are upregulated by TBI. Considering the clear link between chronic A beta elevation and AD as well as tau pathology, the role(s) of A beta in TBI is of high importance. Endopeptidases, including the neprilysin (NEP)-like enzymes, are key mediators of A beta clearance and may affect susceptibility to pathology post-TBI. Here, we use a "humanized" mouse model of A beta production, which expresses normal human amyloid-beta precursor protein (APP) under its natural transcriptional regulation and exposed them to a more clinically relevant repeated closed-head TBI paradigm. These transgenic mice also were crossed with mice deficient for the A beta degrading enzymes NEP or NEP2 to assess models of reduced cerebral A beta clearance in our TBI model. Our results show that the presence of the human form of A beta did not exacerbate motor (Rotarod) and spatial learning/memory deficits (Morris water maze) post-injuries, while potentially reduced anxiety (Open Field) was observed. NEP and NEP2 deficiency also did not exacerbate these deficits post-injuries and was associated with protection from motor (NEP and NEP2) and spatial learning/memory deficits (NEP only). These data suggest that normally regulated expression of wild-type human APP/A beta does not contribute to deficits acutely after TBI and may be protective at this stage of injury.	[Maigler, Kathleen C.; Buhr, Trevor J.; Park, Christopher S.; Marr, Robert A.] Rosalind Franklin Univ Med & Sci, Ctr Neurodegenerat Dis & Therapeut, N Chicago, IL USA; [Miller, Steven A.] Rosalind Franklin Univ Med & Sci, Dept Psychol, N Chicago, IL USA; [Kozlowski, Dorothy A.] Depaul Univ, Dept Biol Sci, Chicago, IL 60604 USA; [Kozlowski, Dorothy A.] Depaul Univ, Neurosci Program, Chicago, IL 60604 USA		Marr, RA (corresponding author), Chicago Med Sch, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	robert.marr@rosalindfranklin.edu		Buhr, Trevor/0000-0001-5752-5674	National Institutes of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21 NS093570]	We would like to acknowledge funding from National Institutes of Health/National Institute of Neurological Disorders and Stroke R21 NS093570 (RAM, DAK).	al-Dahhak R, 2018, CLIN GERIATR MED, V34, P617, DOI 10.1016/j.cger.2018.06.008; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bennett DA, 2005, J NEUROL NEUROSUR PS, V76, P1194, DOI 10.1136/jnnp.2004.054445; Bennett DA, 2004, ARCH NEUROL-CHICAGO, V61, P378, DOI 10.1001/archneur.61.3.378; Bennett DA, 2003, NEUROLOGY, V60, P246, DOI 10.1212/01.WNL.0000042478.08543.F7; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Boche D, 2010, ACTA NEUROPATHOL, V120, P13, DOI 10.1007/s00401-010-0705-y; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Carpentier M, 2004, MOL CELL BIOL, V24, P4428, DOI 10.1128/MCB.24.10.4428-4437.2004; Centers for Disease Control and Prevention, 2014, SURV REP TRAUM BRAIN; Chabrier MA, 2012, J NEUROSCI, V32, P17345, DOI 10.1523/JNEUROSCI.0172-12.2012; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800; Corrigan F, 2012, J NEUROCHEM, V122, P208, DOI 10.1111/j.1471-4159.2012.07761.x; Corrigan F, 2012, BRAIN RES, V1451, P87, DOI 10.1016/j.brainres.2012.02.045; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Eckman EA, 2006, J BIOL CHEM, V281, P30471, DOI 10.1074/jbc.M605827200; Edwards G, 2017, BIOCHEM BIOPH RES CO, V483, P1137, DOI 10.1016/j.bbrc.2016.07.123; Farris W, 2007, AM J PATHOL, V171, P241, DOI 10.2353/ajpath.2007.070105; Gatson JW, 2013, J NEUROSURG, V118, P1336, DOI 10.3171/2013.2.JNS121771; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Hafez DM, 2012, NEUROSCIENCE, V223, P465, DOI 10.1016/j.neuroscience.2012.07.038; Hafez D, 2011, AM J PATHOL, V178, P306, DOI 10.1016/j.ajpath.2010.11.012; Hanson LR, 2011, J MOL NEUROSCI, V43, P424, DOI 10.1007/s12031-010-9460-8; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Huang JY, 2008, NEUROSCIENCE, V155, P258, DOI 10.1016/j.neuroscience.2008.05.006; Huang JY, 2012, J ALZHEIMERS DIS, V28, P433, DOI 10.3233/JAD-2011-111307; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Jamnia N, 2017, J NEUROTRAUM, V34, P1351, DOI 10.1089/neu.2016.4517; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2009, J NEUROTRAUM, V26, P1197, DOI [10.1089/neu.2008.0843, 10.1089/neu.2008-0843]; Kokubo Hideko, 2009, Int J Alzheimers Dis, V2009, DOI 10.4061/2009/689285; LAMB BT, 1993, NAT GENET, V5, P22, DOI 10.1038/ng0993-22; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; LoBue C, 2019, J ALZHEIMERS DIS, V70, P629, DOI 10.3233/JAD-190028; LU B, 1995, J EXP MED, V181, P2271, DOI 10.1084/jem.181.6.2271; Madani R, 2006, J NEUROSCI RES, V84, P1871, DOI 10.1002/jnr.21074; Mannix RC, 2013, BRAIN INJURY, V27, P743, DOI 10.3109/02699052.2013.771797; Mannix RC, 2011, J NEUROTRAUM, V28, P1855, DOI 10.1089/neu.2011.1759; Marklund N, 2014, J NEUROTRAUM, V31, P42, DOI 10.1089/neu.2013.2964; Marr R, 2016, GENES ENV ALZHEIMERS, P97; Marr R., 2013, HDB PROTEOLYTIC ENZY; Marr RA, 2010, CURR ALZHEIMER RES, V7, P223, DOI 10.2174/156720510791050849; Marr RA, 2004, J MOL NEUROSCI, V22, P5, DOI 10.1385/JMN:22:1-2:5; Marr RA, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00187; Mohamed AZ, 2018, NEUROIMAGE-CLIN, V19, P716, DOI 10.1016/j.nicl.2018.05.016; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Nogueira ML, 2018, ALZHEIMERS DEMENT, V14, P444, DOI 10.1016/j.jalz.2017.11.003; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Pajoohesh-Ganji A, 2014, BRAIN RES, V1560, P73, DOI 10.1016/j.brainres.2014.02.049; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Rose C, 2002, BIOCHEM J, V363, P697, DOI 10.1042/0264-6021:3630697; Rose JB, 2009, J NEUROSCI, V29, P1115, DOI 10.1523/JNEUROSCI.4220-08.2009; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Shen RQ, 2000, MOL CELL ENDOCRINOL, V170, P131, DOI 10.1016/S0303-7207(00)00326-9; Shishido H, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/3248519; Smith DH, 1998, AM J PATHOL, V153, P1005, DOI 10.1016/S0002-9440(10)65643-X; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Sturiale S, 1999, P NATL ACAD SCI USA, V96, P11653, DOI 10.1073/pnas.96.20.11653; Tajiri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078851; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Trivedi A, 2019, CELL MOL LIFE SCI, V76, P3141, DOI 10.1007/s00018-019-03176-4; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Turner RC, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00186; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Washington PM, 2014, J NEUROTRAUM, V31, P125, DOI 10.1089/neu.2013.3017; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015; Webster SJ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00088; Yang ST, 2015, J NEUROL SCI, V349, P99, DOI 10.1016/j.jns.2014.12.032; Zheng R, 2006, MOL CELL ENDOCRINOL, V259, P10, DOI 10.1016/j.mce.2006.07.004	76	2	2	1	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2021	38	5					665	676		10.1089/neu.2020.6989		JAN 2021	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	QP9GR	WOS:000606618700001	33176547				2022-02-06	
J	Miller, MR; Robinson, M; Bartha, R; Stewart, TC; Fischer, L; Dekaban, GA; Menon, RS; Shoemaker, JK; Fraser, DD				Miller, Michael R.; Robinson, Michael; Bartha, Robert; Stewart, Tanya Charyk; Fischer, Lisa; Dekaban, Gregory A.; Menon, Ravi S.; Shoemaker, J. Kevin; Fraser, Douglas D.			Concussion Acutely Decreases Plasma Glycerophospholipids in Adolescent Male Athletes	JOURNAL OF NEUROTRAUMA			English	Article						athlete; biomarker; concussion; diagnosis; glycerphospholipid	BRAIN; SYMPTOMS	Concussions are frequent in sports and can contribute to significant and long-lasting neurological disability. Adolescents are particularly susceptible to concussions, with accurate determination of the injury challenging. Our previous study demonstrated that concussion diagnoses could be aided by metabolomics profiling and machine learning, with particular weighting on changes in plasma glycerophospholipids (PCs). Here, our aim was to report directional change of PCs after concussion and develop a diagnostic concussion panel utilizing a minimum number of plasma PCs. To this end, we enrolled 12 concussed male athletes at our academic Sport Medicine Concussion Clinic, as well as 17 sex-, age-, and activity-matched healthy controls. Blood was drawn and 71 plasma PCs were measured for statistically significant changes within 72 h of injury, and individual PCs were further analyzed with receiver operating characteristic (ROC) curves. Our data demonstrated that 26 of 71 PCs measured were significantly decreased after sports-related concussion (p < 0.01). None of the PCs increased in plasma after concussion. ROC curve analyses identified the top four PCs with areas under the curve (AUCs) >= 0.86 for concussion diagnosis: PCaeC36:0 (0.92; p < 0.001); PCaaC42:6 (0.90; p < 0.001); PCaeC36:2 (0.86; p = 0.001), and PCaaC32:0 (0.86; p = 0.001). Cut-off values in mu M were <= 0.31, 0.22, 5.07, and 4.63, respectively. Importantly, combining these four PCs produced an AUC of 0.96 for concussion diagnoses (p < 0.001; 95% confidence interval, 0.89, 1.00). Our data suggest that as few as four circulating PCs may provide excellent diagnostic potential for adolescent concussion. External validation is required in larger cohorts.	[Miller, Michael R.; Stewart, Tanya Charyk; Fraser, Douglas D.] Western Univ, Pediat, London, ON, Canada; [Robinson, Michael] Western Univ, Hlth Sci, London, ON, Canada; [Bartha, Robert; Menon, Ravi S.] Western Univ, Med Biophys, London, ON, Canada; [Fischer, Lisa] Western Univ, Family Med, London, ON, Canada; [Dekaban, Gregory A.] Western Univ, Microbiol & Immunol, London, ON, Canada; [Shoemaker, J. Kevin] Western Univ, Kinesiol, London, ON, Canada; [Fraser, Douglas D.] Western Univ, Physiol & Pharmacol, London, ON, Canada; [Fraser, Douglas D.] Western Univ, Clin Neurol Sci, London, ON, Canada; [Miller, Michael R.; Fraser, Douglas D.] Childrens Hlth Res Inst, London, ON, Canada; [Bartha, Robert; Dekaban, Gregory A.; Menon, Ravi S.] Robarts Res Inst, London, ON, Canada; [Fraser, Douglas D.] Neurolytixs Inc, Toronto, ON, Canada		Fraser, DD (corresponding author), London Hlth Sci Ctr, Childrens Hosp, 800 Commissioners Rd East,Room C2-C82, London, ON N6A 5W9, Canada.	douglas.fraser@lhsc.on.ca	Dekaban, Gregory/L-1987-2013; Bartha, Robert/K-3611-2013; Menon, Ravi S/K-5500-2013	Dekaban, Gregory/0000-0002-3087-4660; Bartha, Robert/0000-0002-7118-9096; Menon, Ravi S/0000-0002-7916-0263	Children's Health Foundation	Dr. D.D. Fraser received research funding from the Children's Health Foundation (http://childhealth.ca/).	Asken BM, 2017, CLIN NEUROPSYCHOL, V31, P138, DOI 10.1080/13854046.2016.1246672; Babl FE, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-3258; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Centers for Disease Control and Prevention. (2020). Traumatic brain injury & concussion. U.S. Department of Health & Human Services, 2020, TRAUM BRAIN INJ CONC; Cusimano MD, 2017, CLIN J SPORT MED, V27, P375, DOI 10.1097/JSM.0000000000000372; Daley M, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1131-5; Farooqui AA, 2000, CHEM PHYS LIPIDS, V106, P1, DOI 10.1016/S0009-3084(00)00128-6; Glaviano NR, 2015, CLIN J SPORT MED, V25, P373, DOI 10.1097/JSM.0000000000000154; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Harriss AB, 2020, CLIN J SPORT MED, V30, pE147, DOI 10.1097/JSM.0000000000000714; Hasan KM, 2018, NEUROIMAG CLIN N AM, V28, P31, DOI 10.1016/j.nic.2017.09.001; Howell DR, 2021, CLIN J SPORT MED, V31, P133, DOI 10.1097/JSM.0000000000000722; Jacquin A, 2018, COMPUT BIOL MED, V102, P95, DOI 10.1016/j.compbiomed.2018.09.011; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Keightley M, 2011, JOVE-J VIS EXP, DOI 10.3791/2226; Kim HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97105; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Manning KY, 2017, NEUROLOGY, V89, P2157, DOI 10.1212/WNL.0000000000004669; Mannix R, 2020, J NEUROTRAUM, V37, P2029, DOI 10.1089/neu.2019.6956; McCrea M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.19771; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; OBRIEN JS, 1965, J LIPID RES, V6, P537; Patel DR, 2010, PEDIATR CLIN N AM, V57, P649, DOI 10.1016/j.pcl.2010.03.006; Ransom DM, 2016, J INT NEUROPSYCH SOC, V22, P1038, DOI 10.1017/S1355617716000916; Reddan JM, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00049; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stewart TC, 2014, J TRAUMA ACUTE CARE, V76, P736, DOI 10.1097/TA.0b013e3182aafdf5; Zhu W, 2010, P SOC PHOTO-OPT INS, V7695, DOI 10.1117/12.850573	32	2	2	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 15	2021	38	12					1608	1614		10.1089/neu.2020.7125		JAN 2021	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SN7AR	WOS:000606619200001	33176582				2022-02-06	
J	Clark, LR; Yun, S; Acquah, NK; Kumar, PL; Metheny, HE; Paixao, RCC; Cohen, AS; Eisch, AJ				Clark, Lyles R.; Yun, Sanghee; Acquah, Nana K.; Kumar, Priya L.; Metheny, Hannah E.; Paixao, Rikley C. C.; Cohen, Akivas S.; Eisch, Amelia J.			Mild Traumatic Brain Injury Induces Transient, Sequential Increases in Proliferation, Neuroblasts/Immature Neurons, and Cell Survival: A Time Course Study in the Male Mouse Dentate Gyrus	FRONTIERS IN NEUROSCIENCE			English	Article						neurogenesis; TBI; dentate gyrus; proliferation; LFPI	ADULT HIPPOCAMPAL NEUROGENESIS; SEPTO-TEMPORAL AXIS; GRANULE CELLS; DOUBLECORTIN EXPRESSION; COGNITIVE RECOVERY; DORSOVENTRAL AXIS; ANIMAL-MODELS; TERM; INHIBITION; DEATH	Mild traumatic brain injuries (mTBIs) are prevalent worldwide. mTBIs can impair hippocampal-based functions such as memory and cause network hyperexcitability of the dentate gyrus (DG), a key entry point to hippocampal circuitry. One candidate for mediating mTBI-induced hippocampal cognitive and physiological dysfunction is injury-induced changes in the process of DG neurogenesis. There are conflicting results on how TBI impacts the process of DG neurogenesis; this is not surprising given that both the neurogenesis process and the post-injury period are dynamic, and that the quantification of neurogenesis varies widely in the literature. Even within the minority of TBI studies focusing specifically on mild injuries, there is disagreement about if and how mTBI changes the process of DG neurogenesis. Here we utilized a clinically relevant rodent model of mTBI (lateral fluid percussion injury, LFPI), gold-standard markers and quantification of the neurogenesis process, and three time points post-injury to generate a comprehensive picture of how mTBI affects adult hippocampal DG neurogenesis. Male C57BL/6J mice (6-8 weeks old) received either sham surgery or mTBI via LFPI. Proliferating cells, neuroblasts/immature neurons, and surviving cells were quantified via stereology in DG subregions (subgranular zone [SGZ], outer granule cell layer [oGCL], molecular layer, and hilus) at short-term (3 days post-injury, dpi), intermediate (7 dpi), and long-term (31 dpi) time points. The data show this model of mTBI induces transient, sequential increases in ipsilateral SGZ/GCL proliferating cells, neuroblasts/immature neurons, and surviving cells which is suggestive of mTBI-induced neurogenesis. In contrast to these ipsilateral hemisphere findings, measures in the contralateral hemisphere were not increased in key neurogenic DG subregions after LFPI. Our work in this mTBI model is in line with most literature on other and more severe models of TBI in showing TBI stimulates the process of DG neurogenesis. However, as our DG data in mTBI provide temporal, subregional, and neurogenesis-stage resolution, these data are important to consider in regard to the functional importance of TBI-induction of the neurogenesis process and future work assessing the potential of replacing and/or repairing DG neurons in the brain after TBI.	[Clark, Lyles R.; Yun, Sanghee; Acquah, Nana K.; Kumar, Priya L.; Metheny, Hannah E.; Paixao, Rikley C. C.; Cohen, Akivas S.; Eisch, Amelia J.] Childrens Hosp Philadelphia CHOP Res Inst, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA; [Clark, Lyles R.; Yun, Sanghee; Cohen, Akivas S.; Eisch, Amelia J.] Perelman Sch Med, Mahoney Inst Neurosci, Philadelphia, PA 19104 USA; [Acquah, Nana K.] Univ Penn, Biol Basis Behav Program, Philadelphia, PA USA; [Kumar, Priya L.] Univ Penn, Biomech Engn, Philadelphia, PA USA		Clark, LR; Eisch, AJ (corresponding author), Childrens Hosp Philadelphia CHOP Res Inst, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA.; Clark, LR; Eisch, AJ (corresponding author), Perelman Sch Med, Mahoney Inst Neurosci, Philadelphia, PA 19104 USA.	k.lyles.clark@gmail.com; eisch@upenn.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32-GM07517]; Penn's McCabe Pilot Award; Penn Undergraduate Research Foundation Award; NARSAD Young Investigator Award from the Brain and Behavior Research FoundationNARSAD; Penn's Center for Undergraduate Research and Fellowships (CURF) program; Penn's Undergraduate Research Mentoring Program (PURM); CHOP Research Institute Summer Scholars Program (CRISSP);  [R37HD059288];  [DA023555];  [NNX15AE09G];  [80NSSC17K0060];  [MH117628];  [NS007413]	Funding for this work was provided by grants to AC (R37HD059288) and AE (DA023555, NNX15AE09G, 80NSSC17K0060, MH117628, and NS007413, PI: MB Robinson). LC was supported by NIH T32-GM07517 (PI: JI Gold). SY was supported by Penn'sMcCabe Pilot Award, a Penn Undergraduate Research Foundation Award, and a NARSAD Young Investigator Award from the Brain and Behavior Research Foundation. NA was supported by Penn's Center for Undergraduate Research and Fellowships (CURF) program. PK was supported by Penn's Undergraduate Research Mentoring Program (PURM). RP was supported by CHOP Research Institute Summer Scholars Program (CRISSP).	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Aertker BM, 2016, EXP NEUROL, V275, P411, DOI 10.1016/j.expneurol.2015.01.008; Aimone JB, 2014, PHYSIOL REV, V94, P991, DOI 10.1152/physrev.00004.2014; Aleem M, 2020, EXP NEUROL, V329, DOI 10.1016/j.expneurol.2020.113290; Arguello AA, 2008, NEUROSCIENCE, V157, P70, DOI 10.1016/j.neuroscience.2008.08.064; AVENDANO C, 1979, ANAT EMBRYOL, V157, P347, DOI 10.1007/BF00304998; Basler L, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00123; Bedi SS, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1122-8; Bielefeld P, 2019, BEHAV BRAIN RES, V372, DOI 10.1016/j.bbr.2019.112032; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Blumcke I, 2001, HIPPOCAMPUS, V11, P311, DOI 10.1002/hipo.1045; Bond AM, 2015, CELL STEM CELL, V17, P385, DOI 10.1016/j.stem.2015.09.003; Brady RD, 2019, NEUROBIOL DIS, V123, P8, DOI 10.1016/j.nbd.2018.08.007; Brown DC, 2002, HISTOPATHOLOGY, V40, P2, DOI 10.1046/j.1365-2559.2002.01343.x; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Brummelte S, 2010, NEUROSCIENCE, V168, P680, DOI 10.1016/j.neuroscience.2010.04.023; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Caplan HW, 2020, ASN NEURO, V12, DOI 10.1177/1759091420911770; Carlson SW, 2018, J NEUROTRAUM, V35, P1467, DOI 10.1089/neu.2017.5374; Catavero C, 2018, CELL TISSUE RES, V371, P33, DOI 10.1007/s00441-017-2668-y; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Cho KO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7606; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Cole JD, 2020, J NEUROSCI, V40, P5740, DOI 10.1523/JNEUROSCI.1665-19.2020; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Dashtipour K, 2003, EPILEPSY RES, V54, P141, DOI 10.1016/S0920-1211(03)00082-2; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; DeCarolis NA, 2014, LIFE SCI SPACE RES, V2, P70, DOI 10.1016/j.lssr.2014.06.004; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DRAGUNOW M, 1990, BRAIN RES, V527, P41, DOI 10.1016/0006-8993(90)91058-O; Du X, 2017, ANN NEUROL, V81, P790, DOI 10.1002/ana.24946; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Emery DL, 2005, J NEUROTRAUM, V22, P978, DOI 10.1089/neu.2005.22.978; Farioli-Vecchioli S, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00124; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; Folweiler KA, 2018, J NEUROTRAUM, V35, P1304, DOI 10.1089/neu.2017.5350; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Garcia-Martinez Y, 2020, J MOL HISTOL, V51, P437, DOI 10.1007/s10735-020-09895-4; Gilley JA, 2011, EUR J NEUROSCI, V34, P1712, DOI 10.1111/j.1460-9568.2011.07888.x; Gu Y, 2012, NAT NEUROSCI, V15, P1700, DOI 10.1038/nn.3260; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hailer NP, 1999, EUR J NEUROSCI, V11, P3359, DOI 10.1046/j.1460-9568.1999.00808.x; Harburg GC, 2007, NEUROSCIENCE, V144, P77, DOI 10.1016/j.neuroscience.2006.09.018; Hood KN, 2018, J NEUROSCI, V38, P2372, DOI 10.1523/JNEUROSCI.1756-17.2018; Hsu D, 2007, PROG BRAIN RES, V163, P601, DOI 10.1016/S0079-6123(07)63032-5; Ibrahim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21793; Ikrar T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00204; Karadottir RT, 2018, ANNU REV NEUROSCI, V41, P139, DOI 10.1146/annurev-neuro-072116-031054; Kathner-Schaffert C, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121654; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018929; Kempermann G, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018812; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Krukowski K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123753; La Rosa C, 2019, J CLIN MED, V8, DOI 10.3390/jcm8050685; Lacefield CO, 2012, HIPPOCAMPUS, V22, P106, DOI 10.1002/hipo.20860; Lagace DC, 2010, P NATL ACAD SCI USA, V107, P4436, DOI 10.1073/pnas.0910072107; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Levone BR, 2021, MOL PSYCHIATR, V26, P3240, DOI 10.1038/s41380-020-0848-8; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; Littlejohn EL, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-00925-6; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Ma DKK, 2009, ANN NY ACAD SCI, V1170, P664, DOI 10.1111/j.1749-6632.2009.04373.x; Mandyam CD, 2007, NEUROSCIENCE, V146, P108, DOI 10.1016/j.neuroscience.2006.12.064; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; McDonald HY, 2005, NEUROSCI LETT, V385, P70, DOI 10.1016/j.neulet.2005.05.022; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Murphy BL, 2012, EPILEPSIA, V53, P908, DOI 10.1111/j.1528-1167.2012.03463.x; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Neuberger EJ, 2017, STEM CELL REP, V9, P972, DOI 10.1016/j.stemcr.2017.07.015; Newell EA, 2020, J NEUROTRAUM, V37, P635, DOI 10.1089/neu.2019.6675; Ngwenya LB, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01014; Obernier K, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.156059; Park EH, 2015, J NEUROSCI, V35, P11656, DOI 10.1523/JNEUROSCI.0885-15.2015; Paterno R, 2018, J NEUROTRAUM, V35, P2117, DOI 10.1089/neu.2017.5170; Paxinos G, 2019, PAXINOS FRANKLINS MO; Peters AJ, 2018, ANESTHESIOLOGY, V129, P278, DOI 10.1097/ALN.0000000000002197; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Ratliff WA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59252-4; Report to Congress on Mild Traumatic Brain Injury in the United States, 2003, REP C MILD TRAUM BRA; Riquelme PA, 2008, PHILOS T R SOC B, V363, P123, DOI 10.1098/rstb.2006.2016; Rivera PD, 2013, RADIAT RES, V180, P658, DOI 10.1667/RR13480.1; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Scharfman H. E., 2011, DENTATE GYRUS COMPRE; Schurman LD, 2017, NEUROSCI LETT, V653, P31, DOI 10.1016/j.neulet.2017.05.032; Shapiro LA, 2008, EPILEPSIA, V49, P13, DOI 10.1111/j.1528-1167.2008.01633.x; Shapiro LA, 2017, CELL TRANSPLANT, V26, P1314, DOI 10.1177/0963689717714099; Shapiro LA, 2011, AGING DIS, V2, P286; Smith CJ, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur.2015.00240, 10.3389/fneur.2015.00073]; Smith CJ, 2012, JOVE-J VIS EXP, DOI 10.3791/4411; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Sun D, 2016, EXP NEUROL, V275, P405, DOI 10.1016/j.expneurol.2015.04.017; Sun D, 2015, J NEUROTRAUM, V32, P495, DOI 10.1089/neu.2014.3545; Tanti A, 2013, NEUROSCIENCE, V252, P234, DOI 10.1016/j.neuroscience.2013.08.017; Tanti A, 2012, NEUROPHARMACOLOGY, V63, P374, DOI 10.1016/j.neuropharm.2012.04.022; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Temprana SG, 2015, NEURON, V85, P116, DOI 10.1016/j.neuron.2014.11.023; Tensaouti Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229240; Tomura S, 2020, NEUROSCI LETT, V721, DOI 10.1016/j.neulet.2020.134827; Tran LD, 2006, J NEUROTRAUM, V23, P1330, DOI 10.1089/neu.2006.23.1330; Tronel S, 2010, P NATL ACAD SCI USA, V107, P7963, DOI 10.1073/pnas.0914613107; Turkovi K, 2017, MEDICINA, V53, P136, DOI DOI 10.21860/medflum2017_179749; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Villasana LE, 2019, J NEUROTRAUM, V36, P2454, DOI 10.1089/neu.2018.6162; Villasana LE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0056-15.2015; Wang CF, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6460; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wood JC, 2011, EXP NEUROL, V229, P484, DOI 10.1016/j.expneurol.2011.03.019; Wu HJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00592; Wu MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018978; Wu MV, 2014, HIPPOCAMPUS, V24, P751, DOI 10.1002/hipo.22265; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang BL, 2018, NEURAL REGEN RES, V13, P1753, DOI 10.4103/1673-5374.238618; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012506; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078; Zhou QG, 2016, SCI REP-UK, V6, DOI 10.1038/srep35572	134	2	2	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	JAN 7	2021	14								612749	10.3389/fnins.2020.612749			23	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PU2RV	WOS:000609154100001	33488351	Green Published, gold, Green Submitted			2022-02-06	
J	Kinoshita, T; Moriwaki, K; Hanaki, N; Kitamura, T; Yamakawa, K; Fukuda, T; Hunink, MGM; Fujimi, S				Kinoshita, Takahiro; Moriwaki, Kensuke; Hanaki, Nao; Kitamura, Tetsuhisa; Yamakawa, Kazuma; Fukuda, Takashi; Hunink, Myriam G. M.; Fujimi, Satoshi			Cost-effectiveness of a hybrid emergency room system for severe trauma: a health technology assessment from the perspective of the third-party payer in Japan	WORLD JOURNAL OF EMERGENCY SURGERY			English	Article						HERS; ICER; Markov model; QALY; Utility	QUALITY-OF-LIFE; COMPUTED-TOMOGRAPHY; RADIOLOGY	Background: Hybrid emergency room (ER) systems, consisting of an angiography-computed tomography (CT) machine in a trauma resuscitation room, are reported to be effective for reducing death from exsanguination in trauma patients. We aimed to investigate the cost-effectiveness of a hybrid ER system in severe trauma patients without severe traumatic brain injury (TBI). Methods: We conducted a cost-utility analysis comparing the hybrid ER system to the conventional ER system from the perspective of the third-party healthcare payer in Japan. A short-term decision tree and a long-term Markov model using a lifetime time horizon were constructed to estimate quality-adjusted life years (QALYs) and associated lifetime healthcare costs. Short-term mortality and healthcare costs were derived from medical records and claims data in a tertiary care hospital with a hybrid ER. Long-term mortality and utilities were extrapolated from the literature. The willingness-to-pay threshold was set at $47,619 per QALY gained and the discount rate was 2%. Deterministic and probabilistic sensitivity analyses were conducted. Results: The hybrid ER system was associated with a gain of 1.03 QALYs and an increment of $33,591 lifetime costs compared to the conventional ER system, resulting in an ICER of $32,522 per QALY gained. The ICER was lower than the willingness-to-pay threshold if the odds ratio of 28-day mortality was < 0.66. Probabilistic sensitivity analysis indicated that the hybrid ER system was cost-effective with a 79.3% probability. Conclusion: The present study suggested that the hybrid ER system is a likely cost-effective strategy for treating severe trauma patients without severe TBI.	[Kinoshita, Takahiro; Yamakawa, Kazuma; Fujimi, Satoshi] Osaka Gen Med Ctr, Div Trauma & Surg Crit Care, Sumiyoshi Ku, 3-1-56 Bandai Higashi, Osaka 5588558, Japan; [Kinoshita, Takahiro] Harvard TH Chan Sch Publ Hlth, Publ Hlth Program, Boston, MA 02115 USA; [Moriwaki, Kensuke] Ristumeikan Univ, Res Org Sci & Technol, Comprehens Unit Hlth Econ Evidence Review & Decis, Simogyo Ku, 209,Res Pk Bid 2,134 Minami Machi, Kyoto 6008813, Japan; [Hanaki, Nao] Osaka Univ, Grad Sch Med, Dept Publ Hlth, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan; [Kitamura, Tetsuhisa] Osaka Univ, Grad Sch Med, Div Environm Med & Populat Sci, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan; [Fukuda, Takashi] Natl Inst Publ Hlth, Ctr Outcomes Res & Econ Evaluat Hlth, 2-3-6 Minami, Wako, Saitama 3510197, Japan; [Hunink, Myriam G. M.] Erasmus MC Univ Med Ctr Rotterdam, Dept Radiol, Rotterdam, Netherlands; [Hunink, Myriam G. M.] Erasmus MC Univ Med Ctr Rotterdam, Dept Epidemiol, Rotterdam, Netherlands; [Hunink, Myriam G. M.] Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA USA		Kinoshita, T (corresponding author), Osaka Gen Med Ctr, Div Trauma & Surg Crit Care, Sumiyoshi Ku, 3-1-56 Bandai Higashi, Osaka 5588558, Japan.; Kinoshita, T (corresponding author), Harvard TH Chan Sch Publ Hlth, Publ Hlth Program, Boston, MA 02115 USA.	takahiro_kinoshita@hsph.harvard.edu	Kitamura, Tetsuhisa/AAA-2555-2020	Kitamura, Tetsuhisa/0000-0003-0107-0580	Fulbright Japan Graduate Study Program; American Diabetes AssociationAmerican Diabetes Association; Netherlands Organization for Health Research and DevelopmentNetherlands Organization for Health Research and Development; German Innovation Fund	Takahiro Kinoshita received lecture fees and travel expenses from Canon Medical Systems and supported by a Fulbright Japan Graduate Study Program during the conduct of this research. Myriam GM Hunink receives Royalties from Cambridge University Press for a textbook on Medical Decision Making, reimbursement of expenses from the European Society of Radiology (ESR) for work on the ESR guidelines for imaging referrals, reimbursement of expenses from the European Institute for Biomedical Imaging Research (EIBIR) for membership of the Scientific Advisory Board, and unrelated research funding from the American Diabetes Association, the Netherlands Organization for Health Research and Development, and the German Innovation Fund. For the remaining authors, no conflicts were declared. The authors received no funding for this project. We thank our colleagues from Osaka University Center of Medical Data Science, Advanced Clinical Epidemiology Investigator's Research Project, and Health Care Economics and Industrial Policy Research Project for their providing insight and expertise for our research.	Brenner M, 2018, J AM COLL SURGEONS, V226, P730, DOI 10.1016/j.jamcollsurg.2018.01.044; Coccolini F, 2020, WORLD J EMERG SURG, V15, DOI 10.1186/s13017-020-00302-7; de Vries R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190587; Fukuda T., 2019, J NATL I PUBLIC HLTH, V68, P27; Hayashida K, 2020, BMC CARDIOVASC DISOR, V20, DOI 10.1186/s12872-020-01332-4; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Hunink MGM, 2014, DECISION MAKING IN HEALTH AND MEDICINE: INTEGRATING EVIDENCE AND VALUES, 2ND EDITION, P1, DOI 10.1017/CBO9781139506779; Kinoshita T, 2018, WORLD J EMERG SURG, V13, DOI 10.1186/s13017-018-0218-x; Kinoshita T, 2019, ANN SURG, V269, P370, DOI 10.1097/SLA.0000000000002527; Kinoshita T, 2018, WORLD NEUROSURG, V118, pE792, DOI 10.1016/j.wneu.2018.07.053; Mahlich J, 2018, COST EFFECT RESOUR A, V16, DOI 10.1186/s12962-018-0103-1; Matsumura Y, 2019, J ENDOVASC RESUSC TR, V3, P27, DOI 10.26676/jevtm.v3i1.80; Matsushima K, 2018, J TRAUMA ACUTE CARE, V84, P685, DOI 10.1097/TA.0000000000001803; McGuire A, 2001, EC EVALUATION HLTH C; Ministry of Health Labour and Welfare, 2017, LIF TABL 2017; National Institute for Health and Care Excellence, 2013, GUID METH TECHN APPR; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Rinburg AN, 2009, BRIT J SURG, V96, P1365, DOI 10.1002/bjs.6720; Robert SA, 2009, J GERONTOL B-PSYCHOL, V64, P378, DOI 10.1093/geronb/gbp012; Saltzherr TP, 2012, BRIT J SURG, V99, P105, DOI 10.1002/bjs.7705; Sellers S, 2013, QUAL LIFE RES, V22, P1307, DOI [10.1007/s11136-012-0278-4, 10.1007/s11136-012-0258-8]; Shiroiwa T, 2017, VALUE HEALTH, V20, P372, DOI 10.1016/j.jval.2016.08.726; Siebert U, 2012, MED DECIS MAKING, V32, P690, DOI 10.1177/0272989X12455463; Skinner EH, 2013, CRIT CARE RESUSC, V15, P205; Takura T, 2015, THER APHER DIAL, V19, P441, DOI 10.1111/1744-9987.12314; Wong TH, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0497-y; Wurmb TE, 2009, J TRAUMA, V66, P658, DOI 10.1097/TA.0b013e31817de3f4; Yamakawa K, 2019, ACUTE MED SURG, V6, P247, DOI 10.1002/ams2.412	28	2	2	1	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-7922			WORLD J EMERG SURG	World J. Emerg. Surg.	JAN 7	2021	16	1							2	10.1186/s13017-020-00344-x			8	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	PS8KI	WOS:000608172400002	33413503	Green Published, gold, Green Submitted			2022-02-06	
J	Tate, DF; Dennis, EL; Adams, JT; Adamson, MM; Belanger, HG; Bigler, ED; Bouchard, HC; Clark, AL; Delano-Wood, LM; Disner, SG; Eapen, BC; Franz, CE; Geuze, E; Goodrich-Hunsaker, NJ; Han, K; Hayes, JP; Hinds, SR; Hodges, CB; Hovenden, ES; Irimia, A; Kenney, K; Koerte, IK; Kremen, WS; Levin, HS; Lindsey, HM; Morey, RA; Newsome, MR; Ollinger, J; Pugh, MJ; Scheibel, RS; Shenton, ME; Sullivan, DR; Taylor, BA; Troyanskaya, M; Velez, C; Wade, BSC; Wang, X; Ware, AL; Zafonte, R; Thompson, PM; Wilde, EA				Tate, David F.; Dennis, Emily L.; Adams, John T.; Adamson, Maheen M.; Belanger, Heather G.; Bigler, Erin D.; Bouchard, Heather C.; Clark, Alexandra L.; Delano-Wood, Lisa M.; Disner, Seth G.; Eapen, Blessen C.; Franz, Carol E.; Geuze, Elbert; Goodrich-Hunsaker, Naomi J.; Han, Kihwan; Hayes, Jasmeet P.; Hinds, Sidney R., II; Hodges, Cooper B.; Hovenden, Elizabeth S.; Irimia, Andrei; Kenney, Kimbra; Koerte, Inga K.; Kremen, William S.; Levin, Harvey S.; Lindsey, Hannah M.; Morey, Rajendra A.; Newsome, Mary R.; Ollinger, John; Pugh, Mary Jo; Scheibel, Randall S.; Shenton, Martha E.; Sullivan, Danielle R.; Taylor, Brian A.; Troyanskaya, Maya; Velez, Carmen; Wade, Benjamin S. C.; Wang, Xin; Ware, Ashley L.; Zafonte, Ross; Thompson, Paul M.; Wilde, Elisabeth A.			Coordinating Global Multi-Site Studies of Military-Relevant Traumatic Brain Injury: Opportunities, Challenges, and Harmonization Guidelines	BRAIN IMAGING AND BEHAVIOR			English	Article						TBI; traumatic brain injury; military; veteran; blast injury; ENIGMA	POSTTRAUMATIC-STRESS-DISORDER; COMMON DATA ELEMENTS; FIBRILLARY ACIDIC PROTEIN; OPERATION IRAQI FREEDOM; LOW-LEVEL BLAST; FUNCTIONAL CONNECTIVITY; SERVICE MEMBERS; AMYLOID-BETA; POSTCONCUSSIVE SYMPTOMS; AEROMEDICAL EVACUATION	Traumatic brain injury (TBI) is common among military personnel and the civilian population and is often followed by a heterogeneous array of clinical, cognitive, behavioral, mood, and neuroimaging changes. Unlike many neurological disorders that have a characteristic abnormal central neurologic area(s) of abnormality pathognomonic to the disorder, a sufficient head impact may cause focal, multifocal, diffuse or combination of injury to the brain. This inconsistent presentation makes it difficult to establish or validate biological and imaging markers that could help improve diagnostic and prognostic accuracy in this patient population. The purpose of this manuscript is to describe both the challenges and opportunities when conducting military-relevant TBI research and introduce the Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) Military Brain Injury working group. ENIGMA is a worldwide consortium focused on improving replicability and analytical power through data sharing and collaboration. In this paper, we discuss challenges affecting efforts to aggregate data in this patient group. In addition, we highlight how "big data" approaches might be used to understand better the role that each of these variables might play in the imaging and functional phenotypes of TBI in Service member and Veteran populations, and how data may be used to examine important military specific issues such as return to duty, the late effects of combat-related injury, and alteration of the natural aging processes.	[Tate, David F.; Dennis, Emily L.; Bigler, Erin D.; Goodrich-Hunsaker, Naomi J.; Hodges, Cooper B.; Hovenden, Elizabeth S.; Lindsey, Hannah M.; Velez, Carmen; Wade, Benjamin S. C.; Wilde, Elisabeth A.] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT 84112 USA; [Tate, David F.; Dennis, Emily L.; Goodrich-Hunsaker, Naomi J.; Hodges, Cooper B.; Lindsey, Hannah M.; Velez, Carmen; Wilde, Elisabeth A.] George E Wahlen Vet Affairs Med Ctr, Salt Lake City, UT 84148 USA; [Dennis, Emily L.; Thompson, Paul M.] Keck Sch Med USC, Stevens Neuroimaging & Informat Inst, Imaging Genet Ctr, Los Angeles, CA USA; [Adams, John T.] Western Univ Hlth Sci, Pomona, CA USA; [Adamson, Maheen M.] VA Palo Alto, Def & Vet Brain Injury Ctr, Palo Alto, CA USA; [Adamson, Maheen M.] Stanford Sch Med, Neurosurg, Stanford, CA 94305 USA; [Belanger, Heather G.] United States Special Operat Command USSOCOM, Tampa, FL USA; [Belanger, Heather G.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Belanger, Heather G.] Univ S Florida, Dept Psychiat & Behav Neurosci, Tampa, FL 33620 USA; [Belanger, Heather G.] St Michaels Inc, Tampa, FL USA; [Bigler, Erin D.; Goodrich-Hunsaker, Naomi J.; Hodges, Cooper B.; Lindsey, Hannah M.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Bouchard, Heather C.; Morey, Rajendra A.] Duke Univ, Duke UNC Brain Imaging & Anal Ctr, Durham, NC USA; [Clark, Alexandra L.; Delano-Wood, Lisa M.] VA San Diego Healthcare Syst, San Diego, CA USA; [Clark, Alexandra L.; Delano-Wood, Lisa M.; Franz, Carol E.; Kremen, William S.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Delano-Wood, Lisa M.; Kremen, William S.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, La Jolla, CA USA; [Disner, Seth G.] Univ Minnesota, Sch Med, Dept Psychiat, Minneapolis, MN 55455 USA; [Disner, Seth G.] Minneapolis VA Hlth Care Syst, Minneapolis, MN USA; [Eapen, Blessen C.] VA Greater Los Angeles Hlth Care Syst, Dept Phys Med & Rehabil, Los Angeles, CA USA; [Eapen, Blessen C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Franz, Carol E.; Kremen, William S.] Univ Calif San Diego, Ctr Behav Genet Aging, San Diego, CA 92103 USA; [Geuze, Elbert] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Geuze, Elbert] Minist Def, Brain Res & Innovat Ctr, Utrecht, Netherlands; [Han, Kihwan] Univ Texas Dallas, Sch Behav & Brain Sci, Dallas, TX USA; [Hayes, Jasmeet P.] Ohio State Univ, Dept Psychol, Columbus, OH USA; [Hayes, Jasmeet P.] Ohio State Univ, Chron Brain Injury Program, Columbus, OH 43210 USA; [Hinds, Sidney R., II] US Army, US Dept Def, Med Res & Mat Command, Frederick, MD USA; [Hinds, Sidney R., II; Kenney, Kimbra] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Irimia, Andrei] Univ Southern Calif, Leonard Davis Sch Gerontol, Los Angeles, CA 90007 USA; [Irimia, Andrei] Univ Southern Calif, Dept Biomed Engn, Viterbi Sch Engn, Los Angeles, CA 90007 USA; [Kenney, Kimbra; Ollinger, John] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Koerte, Inga K.; Shenton, Martha E.] Brigham & Womens Hosp, Psychiat Neuroimaging Lab, 75 Francis St, Boston, MA 02115 USA; [Koerte, Inga K.] Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat, Psychosomat & Psychotherapy, Munich, Germany; [Levin, Harvey S.; Newsome, Mary R.; Scheibel, Randall S.; Troyanskaya, Maya; Wilde, Elisabeth A.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Levin, Harvey S.; Newsome, Mary R.; Scheibel, Randall S.; Troyanskaya, Maya] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Morey, Rajendra A.] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC USA; [Pugh, Mary Jo] VA Salt Lake City, Informat Decis Enhancement & Analyt Sci Ctr, Salt Lake City, UT USA; [Pugh, Mary Jo] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT USA; [Shenton, Martha E.] VA Boston Healthcare Syst, Brockton Div, Brockton, MA USA; [Sullivan, Danielle R.] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA USA; [Sullivan, Danielle R.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA USA; [Taylor, Brian A.] Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA USA; [Taylor, Brian A.] Virginia Commonwealth Univ, C Kenneth & Dianne Wright Ctr Clin & Translat Res, Richmond, VA USA; [Wade, Benjamin S. C.] Univ Calif Los Angeles, Dept Neurol, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90024 USA; [Wang, Xin] Univ Toledo, Dept Psychiat, 2801 W Bancroft St, Toledo, OH 43606 USA; [Ware, Ashley L.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Zafonte, Ross] Brigham & Womens Hosp, Massachusetts Gen Hosp, Dept Phys Med & Rehabil, 75 Francis St, Boston, MA 02115 USA; [Zafonte, Ross] Harvard Med Sch, Spaulding Rehabil Hosp, Boston, MA 02115 USA; [Thompson, Paul M.] USC, Dept Neurol, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Pediat, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Psychiat, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Radiol, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Engn, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Ophthalmol, Los Angeles, CA USA		Tate, DF (corresponding author), Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT 84112 USA.; Tate, DF (corresponding author), George E Wahlen Vet Affairs Med Ctr, Salt Lake City, UT 84148 USA.	david.tate@hsc.utah.edu	Irimia, Andrei/B-8275-2008; Dennis, Emily/AAD-5223-2021; Thompson, Paul M/C-4194-2018; Koerte, Inga Katharina/AAW-3031-2021; Tate, David/G-5166-2011	Irimia, Andrei/0000-0002-9254-9388; Dennis, Emily/0000-0001-7112-4009; Thompson, Paul M/0000-0002-4720-8867; Wade, Benjamin/0000-0003-2461-6101; Tate, David/0000-0003-0213-1920	VA RD SPIRE AWARD; VA RRD [IK2RX002922-01A1]; DoDUnited States Department of Defense [W81XWH-18-1-0413]; VA Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [I01RX003443, I01RX003442]; VA Health Services Research and Development Service Research Career Scientist Award [IK6HX002608]; United States (U.S.) Department of Veterans Affairs Clinical Sciences R&D (CSRD) Service [I01 CX001820]; VA CSRD [1IK2CX001772-01]; Defense and Veterans Brain Injury Centers, the U.S. Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-13-2-0025]; Chronic Effects of Neurotrauma Consortium (CENC) [PT108802-SC104835]; Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC)United States Department of Defense [W81XWH-13-2-0095, 5 I01 RX002174];  [K99NS096116];  [R01AG058822];  [R01NS100973];  [UL1TR002649];  [U54EB020403]	VA R&D SPIRE AWARD to MA. K99NS096116 to ELD. VA RR&D IK2RX002922-01A1 to SGD. Dutch Ministry of Defence. R01AG058822 to JPH. R01NS100973 and DoD contract W81XWH-18-1-0413 to AI. VA Rehabilitation Research and Development Service I01RX003443, I01RX003442; VA Health Services Research and Development Service Research Career Scientist Award IK6HX002608 to MJP. This work was supported (or supported in part) by Merit Review Award Number I01 CX001820 from the United States (U.S.) Department of Veterans Affairs Clinical Sciences R&D (CSRD) Service. VA CSR&D 1IK2CX001772-01 to DRS. Defense and Veterans Brain Injury Centers, the U.S. Army Medical Research and Materiel Command (USAMRMC; W81XWH-13-2-0025) and the Chronic Effects of Neurotrauma Consortium (CENC; PT108802-SC104835) to DFT. UL1TR002649 to BAT. U54EB020403 to PMT. Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) Award W81XWH-13-2-0095, 5 I01 RX002174 to EAW.	Anda RF, 2002, PSYCHIAT SERV, V53, P1001, DOI 10.1176/appi.ps.53.8.1001; [Anonymous], 2013, IND COND IN THEAT PO; [Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; [Anonymous], 2016, VA DOD CLIN PRACTICE; [Anonymous], 2018, TRAUMATIC BRAIN INJU; Attilio PJ, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8398072; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; Barrett DH, 2001, NEUROTOXICOLOGY, V22, P491, DOI 10.1016/S0161-813X(01)00051-1; Bartnik-Olson BL, 2021, BRAIN IMAGING BEHAV, V15, P504, DOI 10.1007/s11682-020-00330-6; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Ben Barnes J, 2019, MIL MED, V184, pE218, DOI 10.1093/milmed/usy226; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Blennow K, 2011, ACTA NEUROL SCAND, V123, P245, DOI 10.1111/j.1600-0404.2010.01408.x; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Bowman GL, 2012, CURR GERONTOL GERIAT, V2012; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Butler O, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.288; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Chao LDL, 2017, MIL MED, V182, pE1625, DOI 10.7205/MILMED-D-16-00309; Chen H., 2015, BRAIN NEUROTRAUMA, DOI [10.1201/b18126-21, DOI 10.1201/B18126-21]; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Clark AL, 2016, J HEAD TRAUMA REHAB, V31, P346, DOI 10.1097/HTR.0000000000000183; Cooper DB, 2018, J HEAD TRAUMA REHAB, V33, P81, DOI 10.1097/HTR.0000000000000375; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Coull N, 2016, MED SCI SPORT EXER, V48, P277, DOI 10.1249/MSS.0000000000000757; Covey Dana C, 2006, J Am Acad Orthop Surg, V14, pS10; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Czeiter E, 2020, EBIOMEDICINE, V56, DOI 10.1016/j.ebiom.2020.102785; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Davenport ND, 2015, HUM BRAIN MAPP, V36, P1053, DOI 10.1002/hbm.22685; Dennis, 2019, POSTTRAUMATIC STRESS, DOI [10.1101/677153, DOI 10.1101/677153]; Dennis EL, 2021, BRAIN IMAGING BEHAV, V15, P555, DOI 10.1007/s11682-020-00363-x; Disner SG, 2017, CLIN PSYCHOL SCI, V5, P650, DOI 10.1177/2167702617703436; Dong MX, 2004, CIRCULATION, V110, P1761, DOI 10.1161/01.CIR.0000143074.54995.7F; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Dretsch MN, 2014, MIL MED, V179, P396, DOI 10.7205/MILMED-D-13-00395; Edwards VJ, 2003, AM J PSYCHIAT, V160, P1453, DOI 10.1176/appi.ajp.160.8.1453; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fear NT, 2010, LANCET, V375, P1783, DOI 10.1016/S0140-6736(10)60672-1; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Fox CJ, 2005, J VASC SURG, V41, P638, DOI 10.1016/j.jvs.2005.01.010; French L., 2008, J SPECIAL OPERATIONS, V8, P68; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gardner RC, 2014, ANN NEUROL, V75, P339, DOI 10.1002/ana.24121; Gatson JW, 2014, J NEUROSURG, V121, P1232, DOI 10.3171/2014.7.JNS132474; Gill J, 2018, BRAIN INJURY, V32, P1359, DOI 10.1080/02699052.2018.1471738; Gill J, 2018, NEUROLOGY, V91, pE1385, DOI 10.1212/WNL.0000000000006321; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Gopinath KS, 2019, NEUROSCI LETT, V701, P136, DOI 10.1016/j.neulet.2019.02.041; Grainger SA, 2020, INT PSYCHOGERIATR, V32, P1325, DOI 10.1017/S1041610219001583; Grande LJ, 2018, J INT NEUROPSYCH SOC, V24, P466, DOI 10.1017/S1355617717001242; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Groenewold N, 2018, BIOL PSYCHIAT, V83, pS247, DOI 10.1016/j.biopsych.2018.02.640; Guedes VA, 2020, NEUROLOGY, V94, pE2412, DOI 10.1212/WNL.0000000000009577; Haan MN, 2008, NEUROBIOL AGING, V29, P1774, DOI 10.1016/j.neurobiolaging.2007.04.020; Hafstad GS, 2017, PSYCHOL MED, V47, P1283, DOI 10.1017/S0033291716002968; Hall E.E., 2014, J ALZHEIMERS DIS PAR, V4, P1, DOI [10.4172/2161-0460.1000137, DOI 10.4172/2161-0460.1000137]; Han KW, 2018, HUM BRAIN MAPP, V39, P2955, DOI 10.1002/hbm.24052; Han K, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00231; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Hayes JP, 2017, BRAIN, V140, P813, DOI 10.1093/brain/aww344; Heany SJ, 2018, DEV PSYCHOPATHOL, V30, P1475, DOI 10.1017/S0954579417001717; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hoffman JR, 2015, AMINO ACIDS, V47, P2463, DOI 10.1007/s00726-015-2051-9; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, LANCET, V368, P837, DOI 10.1016/S0140-6736(06)69315-X; Hudak AM, 2012, J HEAD TRAUMA REHAB, V27, P87, DOI 10.1097/HTR.0b013e3182114efd; Ingalls N, 2014, JAMA SURG, V149, P807, DOI 10.1001/jamasurg.2014.621; Isaac L, 2015, BIOL PSYCHOL, V105, P20, DOI 10.1016/j.biopsycho.2014.12.011; Isoniemi H, 2006, J NEUROTRAUM, V23, P1600, DOI 10.1089/neu.2006.23.1600; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kabat MH, 2001, CLIN NEUROPSYCHOL, V15, P498, DOI 10.1076/clin.15.4.498.1882; Kaloupek DG, 2010, ARCH PHYS MED REHAB, V91, P1684, DOI 10.1016/j.apmr.2010.06.032; Kaup AR, 2019, J NEUROTRAUM, V36, P338, DOI 10.1089/neu.2018.5695; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Kazis Lewis E, 2004, J Ambul Care Manage, V27, P263; Kenney Kimbra, 2018, Brain Inj, V32, P1276, DOI 10.1080/02699052.2018.1483530; Kessels RPC, 2019, CLIN NEUROPSYCHOL, V33, P357, DOI 10.1080/13854046.2018.1518489; Khosravani V, 2019, CHILD ABUSE NEGLECT, V98, DOI 10.1016/j.chiabu.2019.104197; Kim HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97105; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Ko H, 2018, J ROY ARMY MED CORPS, V164, P197, DOI 10.1136/jramc-2016-000752; Kolakowsky-Hayner SA, 2013, BRAIN INJURY, V27, P578, DOI 10.3109/02699052.2013.765595; Kotwal RS, 2018, J TRAUMA ACUTE CARE, V85, P603, DOI 10.1097/TA.0000000000001997; Kroupa J, 1990, Acta Chir Orthop Traumatol Cech, V57, P347; Lange RT, 2020, NEUROPSYCHOL REHABIL, V30, P1762, DOI 10.1080/09602011.2019.1604385; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Larrabee GJ, 2015, AM PSYCHOL, V70, P779, DOI 10.1037/a0039835; Laurent JGC, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002605; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Logue MW, 2018, BIOL PSYCHIAT, V83, P244, DOI 10.1016/j.biopsych.2017.09.006; Lopez-Larson Melissa, 2013, Front Psychiatry, V4, P83, DOI 10.3389/fpsyt.2013.00083; Lui CW, 2019, APPL PHYSIOL NUTR ME, V44, P674, DOI 10.1139/apnm-2018-0576; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Mac Donald CL, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.6676; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Mackey S, 2019, AM J PSYCHIAT, V176, P119, DOI 10.1176/appi.ajp.2018.17040415; Maddry JK, 2018, MILITARY MED RES, V5, DOI 10.1186/s40779-018-0169-2; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Manchester J, 2017, MIL MED, V182, pE1726, DOI 10.7205/MILMED-D-16-00339; Manners JL, 2016, J NEUROTRAUM, V33, P1796, DOI 10.1089/neu.2015.4245; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Martin K, 2019, HUM FACTORS, V61, P1205, DOI 10.1177/0018720819839817; Marx BP, 2009, ARCH GEN PSYCHIAT, V66, P996, DOI 10.1001/archgenpsychiatry.2009.109; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDonald SD, 2009, J ANXIETY DISORD, V23, P247, DOI 10.1016/j.janxdis.2008.07.007; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Meinert S, 2019, NEUROPSYCHOPHARMACOL, V44, P2065, DOI 10.1038/s41386-019-0472-y; Merrick MT, 2018, JAMA PEDIATR, V172, P1038, DOI 10.1001/jamapediatrics.2018.2537; Michael AP, 2015, J NEUROTRAUM, V32, P1751, DOI 10.1089/neu.2015.3918; Miller JB, 2017, ARCH CLIN NEUROPSYCH, V32, P541, DOI 10.1093/arclin/acx050; Mooney SR, 2018, MIL MED, V183, pE546, DOI 10.1093/milmed/usy038; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Mu WY, 2017, J HEAD TRAUMA REHAB, V32, P55, DOI 10.1097/HTR.0000000000000213; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Munivenkatappa Ashok, 2016, Int J Crit Illn Inj Sci, V6, P70, DOI 10.4103/2229-5151.183024; Pham N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117286; Nelson NW, 2020, NEUROPSYCHOLOGY, V34, P116, DOI 10.1037/neu0000594; Nelson NW, 2011, BRAIN INJURY, V25, P511, DOI 10.3109/02699052.2011.558040; Nemeroff CB, 2016, NEURON, V89, P892, DOI 10.1016/j.neuron.2016.01.019; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Newsome MR, 2015, NEUROIMAGE-CLIN, V8, P543, DOI 10.1016/j.nicl.2015.04.024; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Olson EA, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1485; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Parnell N, 2018, J ROY ARMY MED CORPS, V164, P302, DOI 10.1136/jramc-2017-000765; Peltz CB, 2020, NEUROLOGY, V95, pE1126, DOI 10.1212/WNL.0000000000010087; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Piccenna Loretta, 2017, Epilepsia Open, V2, P123, DOI 10.1002/epi4.12049; Pisani V, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-188; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Posti JP, 2016, NEUROSURGERY, V79, P456, DOI 10.1227/NEU.0000000000001226; Rabin LA, 2016, ARCH CLIN NEUROPSYCH, V31, P206, DOI 10.1093/arclin/acw007; Raji CA, 2018, NEUROIMAG CLIN N AM, V28, P67, DOI 10.1016/j.nic.2017.09.003; Ramasamy A, 2009, J R Army Med Corps, V155, P265; Ringer FB, 2018, PSYCHOL ASSESSMENT, V30, P767, DOI 10.1037/pas0000519; Robinson ME, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101651; Robinson ME, 2017, J NEUROTRAUM, V34, pS53, DOI 10.1089/neu.2016.4709; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Rodriguez FS, 2019, DEMENT GERIATR COGN, V47, P335, DOI 10.1159/000501150; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Salat DH, 2017, BRAIN INJURY, V31, P1204, DOI 10.1080/02699052.2017.1327672; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Schmaal L, 2016, MOL PSYCHIATR, V21, P806, DOI 10.1038/mp.2015.69; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Scultetus AH, 2019, J TRAUMA ACUTE CARE, V86, P116, DOI 10.1097/TA.0000000000002014; Scultetus AH, 2016, J TRAUMA ACUTE CARE, V81, P101, DOI 10.1097/TA.0000000000001048; Shahim P, 2020, NEUROLOGY, V95, pE610, DOI 10.1212/WNL.0000000000009983; Shahim P, 2020, NEUROLOGY, V95, pE623, DOI 10.1212/WNL.0000000000009985; Silver JM, 2015, NEUROREHABILITATION, V36, P463, DOI 10.3233/NRE-151234; Skovira JW, 2016, J NEUROTRAUM, V33, P1292, DOI 10.1089/neu.2015.4189; Smith D. H., 2019, NAT REV NEUROL, V1; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Spencer RJ, 2017, BRAIN INJURY, V31, P32, DOI 10.1080/02699052.2016.1218546; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Stewart-Willis JJ, 2018, ARCH CLIN NEUROPSYCH, V33, P206, DOI 10.1093/arclin/acx053; Sullivan DR, 2019, J NEUROTRAUM, V36, P3264, DOI 10.1089/neu.2019.6489; Sun D, 2019, DEPRESS ANXIETY, V36, P442, DOI 10.1002/da.22883; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Thurmond VA, 2010, ARCH PHYS MED REHAB, V91, P1633, DOI 10.1016/j.apmr.2010.06.034; TIBBLING G, 1977, SCAND J CLIN LAB INV, V37, P385, DOI 10.3109/00365517709091496; Tozzi L, 2020, PSYCHOL MED, V50, P1020, DOI 10.1017/S003329171900093X; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Troyanskaya M, 2016, J CLIN EXP NEUROPSYC, V38, P811, DOI 10.1080/13803395.2016.1167172; Troyanskaya M, 2015, MIL MED, V180, P285, DOI 10.7205/MILMED-D-14-00256; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; van der Pols JC, 2017, PUBLIC HEALTH NUTR, V20, P3156, DOI [10.1017/S1368980017001975, 10.1017/s1368980017001975]; Vassallo JL, 2007, BRAIN INJURY, V21, P567, DOI 10.1080/02699050701426832; Veitch DP, 2013, CURR ALZHEIMER RES, V10, P907, DOI 10.2174/15672050113109990142; Verellen Rebecca M, 2010, Therapy, V7, P527, DOI 10.2217/thy.10.57; Villapol S, 2018, AMYLOIDOSIS, DOI [10.5772/intechopen.81945, DOI 10.5772/INTECHOPEN.81945]; Walcott BP, 2011, NEW ENGL J MED, V365, P860, DOI 10.1056/NEJMc1107891; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Walter KH, 2012, J TRAUMA STRESS, V25, P426, DOI 10.1002/jts.21722; Wang T, 2013, RESTOR NEUROL NEUROS, V31, P647, DOI 10.3233/RNN-130316; Ware AL, 2020, BRAIN IMAGING BEHAV, V14, P772, DOI 10.1007/s11682-018-0018-7; Weiner MW, 2015, ALZHEIMERS DEMENT, V11, P865, DOI 10.1016/j.jalz.2015.04.005; Whyte J, 2010, ARCH PHYS MED REHAB, V91, P1692, DOI 10.1016/j.apmr.2010.06.031; Wilde E A., 2019, BRAIN IMAGING BEHAV; Wilde EA, 2015, BRAIN IMAGING BEHAV, V9, P367, DOI 10.1007/s11682-015-9444-y; WILLIAMS DB, 1991, NEUROLOGY, V41, P1554, DOI 10.1212/WNL.41.10.1554; Wittchen HU, 2012, DTSCH ARZTEBL INT, V109, P559, DOI 10.3238/arztebl.2012.0559; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00288; Yarnell AM, 2016, J SPEC OPER MED, V16, P64; Yue JK, 2020, MEDICINA-LITHUANIA, V56, DOI 10.3390/medicina56020087; Ziemnik RE, 2019, PSYCHOL ASSESSMENT, V31, P1307, DOI 10.1037/pas0000751	215	2	2	2	6	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	APR	2021	15	2					585	613		10.1007/s11682-020-00423-2		JAN 2021	29	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	RK3RJ	WOS:000605508100001	33409819				2022-02-06	
J	Uzunalli, G; Herr, S; Dieterly, AM; Shi, RY; Lyle, LT				Uzunalli, Gozde; Herr, Seth; Dieterly, Alexandra M.; Shi, Riyi; Lyle, L. Tiffany			Structural disruption of the blood-brain barrier in repetitive primary blast injury	FLUIDS AND BARRIERS OF THE CNS			English	Article						Blast-induced traumatic brain injury; Repetitive injury; Blood-brain barrier; Pericytes; CD13; Desmin; Neurotrauma	RAT MODEL; PERICYTES; PROTEIN; MICROGLIA; PERMEABILITY; MICROVESSELS; INFLAMMATION; INTEGRITY; EXPOSURE; MATRIX	Background: Blast-induced traumatic brain injury (bTBI) is a growing health concern due to the increased use of low-cost improvised explosive devices in modern warfare. Mild blast exposures are common amongst military personnel; however, these women and men typically do not have adequate recovery time from their injuries due to the transient nature of behavioral symptoms. bTBI has been linked to heterogeneous neuropathology, including brain edema, neuronal degeneration and cognitive abnormalities depending on the intensity of blast overpressure and frequency. Recent studies have reported heterogeneity in blood-brain barrier (BBB) permeability following blast injury. There still remains a limited understanding of the pathologic changes in the BBB following primary blast injuries. In this study, our goal was to elucidate the pathologic pattern of BBB damage through structural analysis following single and repetitive blast injury using a clinically relevant rat model of bTBI. Methods: A validated, open-ended shock tube model was used to deliver single or repetitive primary blast waves. The pathology of the BBB was assessed using immunofluorescence and immunohistochemistry assays. All data were analyzed using the one-way ANOVA test. Results: We have demonstrated that exposure to repetitive blast injury affects the desmin-positive and CD13-positive subpopulations of pericytes in the BBB. Changes in astrocytes and microglia were also detected. Conclusion: This study provides analysis of the BBB components after repetitive blast injury. These results will be critical as preventative and therapeutic strategies are established for veterans recovering from blast-induced traumatic brain injury.	[Uzunalli, Gozde; Dieterly, Alexandra M.; Lyle, L. Tiffany] Purdue Univ, Dept Comparat Pathobiol, Coll Vet Med, W Lafayette, IN 47907 USA; [Herr, Seth; Shi, Riyi] Purdue Univ, Dept Basic Med Sci, Coll Vet Med, W Lafayette, IN 47907 USA; [Shi, Riyi] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Lyle, L. Tiffany] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Lyle, L. Tiffany] Purdue Univ, Ctr Comparat Translat Res, W Lafayette, IN 47907 USA		Lyle, LT (corresponding author), Purdue Univ, Dept Comparat Pathobiol, Coll Vet Med, W Lafayette, IN 47907 USA.; Lyle, LT (corresponding author), Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA.; Lyle, LT (corresponding author), Purdue Univ, Ctr Comparat Translat Res, W Lafayette, IN 47907 USA.	tiffanylyle@purdue.edu			Indiana Clinical and Translational Sciences Institute - National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award [UL1TR001108]; Purdue Research Foundation; Purdue University	This publication was supported in part by the Indiana Clinical and Translational Sciences Institute, funded in part by Award Number UL1TR001108 from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Alexandra M. Dieterly is supported by the Purdue Research Foundation. Publication of this article was funded in part by Purdue University Libraries Open Access Publishing Fund.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Acosta G, 2019, MOL CELL NEUROSCI, V98, P140, DOI 10.1016/j.mcn.2019.06.004; Ahmed FA, 2013, ELECTROPHORESIS, V34, P2229, DOI 10.1002/elps.201300077; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Attwell D, 2016, J CEREBR BLOOD F MET, V36, P451, DOI 10.1177/0271678X15610340; Baeten KM, 2011, DEV NEUROBIOL, V71, P1018, DOI 10.1002/dneu.20954; Bandopadhyay R, 2001, J NEUROCYTOL, V30, P35, DOI 10.1023/A:1011965307612; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Beynon SB, 2012, NEUROSCIENCE, V225, P162, DOI 10.1016/j.neuroscience.2012.07.029; Bondjers C, 2006, FASEB J, V20, P1703, DOI 10.1096/fj.05-4944fje; Brown LS, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00282; DePalma RG, 2018, BEHAV BRAIN RES, V340, P102, DOI 10.1016/j.bbr.2016.08.036; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Engelhardt B, 2009, SEMIN IMMUNOPATHOL, V31, P497, DOI 10.1007/s00281-009-0177-0; Fernandez-Arjona MD, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00235; Forrester JV, 2018, NAT REV NEUROSCI, V19, P655, DOI 10.1038/s41583-018-0070-8; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Kubotera H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37419-4; KUNZ J, 1994, J NEUROCHEM, V62, P2375; Kuriakose M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26813-7; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Lucke-Wold BP, 2015, MOL NEUROBIOL, V52, P1119, DOI 10.1007/s12035-014-8902-7; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Masel BE, 2012, J NEUROTRAUM, V29, P2143, DOI 10.1089/neu.2011.2258; Mathiisen TM, 2010, GLIA, V58, P1094, DOI 10.1002/glia.20990; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Newcombe EA, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1313-3; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Ohsawa K, 2004, J NEUROCHEM, V88, P844, DOI 10.1046/j.1471-4159.2003.02213.x; Paulin D, 2004, EXP CELL RES, V301, P1, DOI 10.1016/j.yexcr.2004.08.004; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Robinson C, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/1347987; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Scrimgeour AG, 2018, J NEUROTRAUM, V35, P2495, DOI 10.1089/neu.2017.5614; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Sweeney MD, 2018, NAT REV NEUROL, V14, P133, DOI 10.1038/nrneurol.2017.188; Sweeney MD, 2016, NAT NEUROSCI, V19, P771, DOI 10.1038/nn.4288; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Uzunalli Gozde, 2019, Oncotarget, V10, P6334, DOI 10.18632/oncotarget.27274; Walls MK, 2016, J NEUROSURG, V124, P675, DOI 10.3171/2015.1.JNS141571; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Wolburg-Buchholz K, 2009, ACTA NEUROPATHOL, V118, P219, DOI 10.1007/s00401-009-0558-4; Wyatt-Johnson SK, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00700; Xu LL, 2019, STROKE VASC NEUROL, V4, P78, DOI 10.1136/svn-2018-000198; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; Zehendner CM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13497; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067	57	2	2	5	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-8118			FLUIDS BARRIERS CNS	Fluids Barriers CNS	JAN 7	2021	18	1							2	10.1186/s12987-020-00231-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PS8FL	WOS:000608159700001	33413513	gold, Green Published			2022-02-06	
J	Zamani, A; O'Brien, TJ; Kershaw, J; Johnston, LA; Semple, BD; Wright, DK				Zamani, Akram; O'Brien, Terence J.; Kershaw, Jeff; Johnston, Leigh A.; Semple, Bridgette D.; Wright, David K.			White matter changes following experimental pediatric traumatic brain injury: an advanced diffusion-weighted imaging investigation	BRAIN IMAGING AND BEHAVIOR			English	Article						pediatric TBI; white matter; fiber density	FIBER DENSITY; AXONAL INJURY; HEAD-INJURY; RECOVERY; ANISOTROPY; PREDICTORS; DETECTS; METRICS	Pediatric traumatic brain injury (pTBI) is a major community health concern. Due to ongoing maturation, injury to the brain at a young age can have devastating consequences in later life. However, how pTBI affects brain development, including white matter maturation, is still poorly understood. Here, we used advanced diffusion weighted imaging (DWI) to assess chronic white matter changes after experimental pTBI. Mice at post-natal day 21 sustained a TBI using the controlled cortical impact model and magnetic resonance imaging (MRI) was performed at 6 months post-injury using a 4.7 T Bruker scanner. Four diffusion shells with 81 directions and b-values of 1000, 3000, 5000, and 7000s/mm(2) were acquired and analyzed using MRtrix3 software. Advanced DWI metrics, including fiber density, fiber cross-section and a combined fiber density and cross-section measure, were investigated together with three track-weighted images (TWI): the average pathlength map, mean curvature and the track density image. These advanced metrics were compared to traditional diffusion tensor imaging (DTI) metrics which indicated that TBI injured mice had reduced fractional anisotropy and increased radial diffusivity in the white matter when compared to age-matched sham controls. Consistent with previous findings, fiber density and TWI metrics appeared to be more sensitive to white matter changes than DTI metrics, revealing widespread reductions in fiber density and TWI metrics in pTBI mice compared to sham controls. These results provide additional support for the use of advanced DWI metrics in assessing white matter degeneration following injury and highlight the chronic outcomes that can follow pTBI.	[Zamani, Akram; O'Brien, Terence J.; Semple, Bridgette D.; Wright, David K.] Monash Univ, Cent Clin Sch, Dept Neurosci, Alfred Ctr, 99 Commercial Rd, Melbourne, Vic 3004, Australia; [O'Brien, Terence J.; Semple, Bridgette D.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia; [Kershaw, Jeff] Natl Inst Radiol Sci, QST, Appl MRI Res, Chiba, Japan; [Johnston, Leigh A.] Univ Melbourne, Dept Biomed Engn, Melbourne Brain Ctr, Imaging Unit, Parkville, Vic 3010, Australia		Wright, DK (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, Alfred Ctr, 99 Commercial Rd, Melbourne, Vic 3004, Australia.	david.wright@monash.edu	O'Brien, Terence/L-8102-2013; O'Brien, Terence/AAU-5525-2021	Wright, David/0000-0002-7535-8651; O'Brien, Terence/0000-0002-7198-8621	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1141347, 1122456, 1174040]	This work was supported by the National Health and Medical Research Council to BS [R. D. Wright Biomedical Career Development Fellowship, number: 1141347; Project grant, number: 1122456] and to DKW [Investigator grant, number: 1174040].	Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Assaf Y, 2008, MAGN RESON MED, V59, P1347, DOI 10.1002/mrm.21577; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Calamante F, 2012, NEUROIMAGE, V59, P2494, DOI 10.1016/j.neuroimage.2011.08.099; Calamante F, 2012, NEUROIMAGE, V59, P286, DOI 10.1016/j.neuroimage.2011.07.014; Calamante F, 2010, NEUROIMAGE, V53, P1233, DOI 10.1016/j.neuroimage.2010.07.024; Dhollander T., 2018, P 26 ANN M INT SOC M; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Frank LR, 2002, MAGN RESON MED, V47, P1083, DOI 10.1002/mrm.10156; Genc S, 2017, J NEUROTRAUM, V34, P798, DOI 10.1089/neu.2016.4584; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Harris NG, 2016, NEUROIMAGE, V133, P129, DOI 10.1016/j.neuroimage.2016.03.012; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Jensen JH, 2014, NMR BIOMED, V27, P202, DOI 10.1002/nbm.3053; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lazar M, 2008, MAGN RESON MED, V60, P774, DOI 10.1002/mrm.21725; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; Lu HZ, 2006, NMR BIOMED, V19, P236, DOI 10.1002/nbm.1020; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Malhotra A, 2019, NEUROIMAGE-CLIN, V24, DOI 10.1016/j.nicl.2019.101991; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Nigro S, 2019, HUM BRAIN MAPP, V40, P1729, DOI 10.1002/hbm.24484; Norenberg M. D., 2004, PATHOLOGY HUMAN SPIN; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Pannek K, 2011, NEUROIMAGE, V55, P133, DOI 10.1016/j.neuroimage.2010.12.010; Potts Mathew B, 2006, NeuroRx, V3, P143; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Raffelt DA, 2017, NEUROIMAGE, V144, P58, DOI 10.1016/j.neuroimage.2016.09.029; Raffelt DA, 2015, NEUROIMAGE, V117, P40, DOI 10.1016/j.neuroimage.2015.05.039; Robinson S, 2016, J NEUROSURG-PEDIATR, V17, P739, DOI 10.3171/2015.10.PEDS15554; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Semple BD, 2017, J NEUROSCI, V37, P7864, DOI 10.1523/JNEUROSCI.0982-17.2017; Semple BD, 2015, NEUROBIOL DIS, V74, P263, DOI 10.1016/j.nbd.2014.12.003; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P404, DOI 10.1007/s11682-012-9150-y; Wortman RC, 2018, ANN CLIN TRANSL NEUR, V5, P1588, DOI 10.1002/acn3.667; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254; Wright DK, 2017, J NEUROTRAUM, V34, P2109, DOI 10.1089/neu.2016.4730; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Wright DW, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41758-1; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	56	2	2	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	DEC	2021	15	6			SI		2766	2774		10.1007/s11682-020-00433-0		JAN 2021	9	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YH2SZ	WOS:000605903500001	33411159	Green Submitted			2022-02-06	
J	Blank, LJ; Acton, EK; Willis, AW				Blank, Leah J.; Acton, Emily K.; Willis, Allison W.			Predictors of Mortality in Older Adults With Epilepsy Implications for Learning Health Systems	NEUROLOGY			English	Article							PREVALENCE; STIMULATION; BURDEN; RACE	Objective To determine the incidence of epilepsy and subsequent 5-year mortality among older adults, as well as characteristics associated with mortality. Methods This was a retrospective cohort study of Medicare beneficiaries age 65 or above with at least 2 years enrollment before January 2009. Incident epilepsy cases were identified in 2009 using ICD-9-CM code-based algorithms; death was assessed through 2014. Cox regression models examined the association between 5-year mortality and incident epilepsy, and whether mortality differed by sociodemographic characteristics or comorbid disorders. Results Among the 99,990 of 33,615,037 beneficiaries who developed epilepsy, most were White (79.7%), female (57.3%), urban (80.5%), and without Medicaid (71.3%). The 5-year mortality rate for incident epilepsy was 62.8% (62,838 deaths). In multivariable models, lower mortality was associated with female sex (adjusted hazards ratio [AHR] 0.85, 95% confidence interval [CI] 0.84-0.87), Asian race (AHR 0.82, 95% CI 0.76-0.88), and Hispanic ethnicity (AHR 0.81, 95% CI 0.76-0.84). Hazard of death increased with comorbid disease burden (per 1-point increase: AHR 1.27, 95% CI 1.26-1.27) and Medicaid coinsurance (AHR 1.17, 95% CI 1.14-1.19). Incident epilepsy was particularly associated with higher mortality when diagnosed after another neurologic condition: Parkinson disease (AHR 1.29, 95% CI 1.21-1.38), multiple sclerosis (AHR 2.13, 95% CI 1.79-2.59), dementia (AHR 1.33, 95% CI 1.31-1.36), traumatic brain injury (AHR 1.55, 95% CI 1.45-1.66), and stroke/TIA (AHR 1.20, 95% CI 1.18-1.21). Conclusions Newly diagnosed epilepsy is associated with high 5-year mortality among Medicare beneficiaries. Future studies that parse the interplay of effects from underlying disease, race, sex, and poverty on mortality will be critical in the design of learning health care systems to reduce premature deaths.	[Blank, Leah J.] Icahn Sch Med Mt Sinai, Dept Neurol, Div Hlth Outcomes & Knowledge Translat Res, New York, NY 10029 USA; [Blank, Leah J.] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA; [Acton, Emily K.; Willis, Allison W.] Univ Penn, Ctr Clin Epidemiol & Biostat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Acton, Emily K.; Willis, Allison W.] Univ Penn, Perelman Sch Med, Translat Ctr Excellence Neuroepidemiol & Neurol O, Dept Neurol, Philadelphia, PA 19104 USA; [Willis, Allison W.] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Willis, Allison W.] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA; [Willis, Allison W.] Univ Penn, Leonard Davis Inst Hlth Econ, Perelman Sch Med, Philadelphia, PA 19104 USA		Blank, LJ (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, Div Hlth Outcomes & Knowledge Translat Res, New York, NY 10029 USA.; Blank, LJ (corresponding author), Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA.	Leah.Blank@mssm.edu		Blank, Leah J/0000-0001-8719-6752; Acton, Emily/0000-0002-5150-5995	Mirowski Family Fund [T32NS-061779]; Department of Neurology at the University of Pennsylvania	The first author was supported by the Mirowski Family Fund as well as the Pharmacoepidemiology Training Grant (T32NS-061779) and the Department of Neurology at the University of Pennsylvania.	[Anonymous], 2012, BEST CARE LOWER COST; Bell SP, 2016, CLIN GERIATR MED, V32, P215, DOI 10.1016/j.cger.2016.01.013; Benjamins MR, 2017, J RACIAL ETHN HEALTH, V4, P967, DOI 10.1007/s40615-016-0300-6; Blakeslee L., 2018, POPULATION 65 YEARS; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Choi H, 2017, NEUROLOGY, V88, P870, DOI 10.1212/WNL.0000000000003662; Cloyd J, 2006, EPILEPSY RES, V68, pS39, DOI 10.1016/j.eplepsyres.2005.07.016; Cossman J, 2017, SSM-POPUL HLTH, V3, P618, DOI 10.1016/j.ssmph.2017.07.013; Erdem E, 2014, J PUBLIC HEALTH MAN, V20, P445, DOI 10.1097/PHH.0b013e3182a3e958; Faught E, 2012, NEUROLOGY, V78, P448, DOI 10.1212/WNL.0b013e3182477edc; Frierson GM, 2013, ETHNIC DIS, V23, P35; Granbichler CA, 2017, EUR J NEUROL, V24, P667, DOI 10.1111/ene.13267; Greenlund SF, 2017, EPILEPSY BEHAV, V69, P28, DOI 10.1016/j.yebeh.2017.01.016; Hannerz H, 2001, STROKE, V32, P1739, DOI 10.1161/01.STR.32.8.1739; Ip Q, 2018, EPILEPSY RES, V139, P107, DOI 10.1016/j.eplepsyres.2017.11.022; Jallon P, 2001, EPILEPSIA, V42, P464, DOI 10.1046/j.1528-1157.2001.31400.x; Jette N, 2010, EPILEPSIA, V51, P62, DOI 10.1111/j.1528-1167.2009.02201.x; Lichtman JH, 2011, STROKE, V42, P3387, DOI 10.1161/STROKEAHA.111.622613; Martinez-Juarez Iris E, 2017, Epilepsia Open, V2, P453, DOI 10.1002/epi4.12082; Morrell MJ, 2011, NEUROLOGY, V77, P1295, DOI 10.1212/WNL.0b013e3182302056; O'Keefe EB, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00051; Ortman JMVV, 2014, AGING NATION OLDER P; Pandya A, 2013, HEALTH AFFAIR, V32, P1706, DOI 10.1377/hlthaff.2013.0449; ResDAC, RES DAT ASS CTR RES DAT ASS CTR; Salanova V, 2015, NEUROLOGY, V84, P1017, DOI 10.1212/WNL.0000000000001334; Sillanpaa M, 2011, EPILEPSIA, V52, P1857, DOI 10.1111/j.1528-1167.2011.03186.x; Singh GK, 2017, J ENVIRON PUBLIC HEA, V2017, P1, DOI 10.1155/2017/2819372; Sperling MR, 2016, NEUROLOGY, V86, P1938, DOI 10.1212/WNL.0000000000002700; Tang DH, 2015, J CLIN NEUROL, V11, P252, DOI 10.3988/jcn.2015.11.3.252; Thijs RD, 2019, LANCET, V393, P689, DOI 10.1016/S0140-6736(18)32596-0; Thurman DJ, 2017, EPILEPSIA, V58, P17, DOI 10.1111/epi.13604; Tu K, 2014, EPILEPSIA, V55, P335, DOI 10.1111/epi.12506; Van Dyke M, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6705a1; Vossler DG, 2018, EPILEPSY CURR, V18, DOI 10.5698/1535-7597.18.4s1.1; Weisgrau S, 1995, Health Care Financ Rev, V17, P1; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Wilson DA, 2016, EPILEPSY RES, V122, P7, DOI 10.1016/j.eplepsyres.2016.01.008	37	2	2	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JAN 5	2021	96	1					E93	E101		10.1212/WNL.0000000000011079			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TR0ZO	WOS:000678701900021	33087496	Green Published			2022-02-06	
J	Humaloja, J; Skrifvars, MB; Raj, R; Wilkman, E; Pekkarinen, PT; Bendel, S; Reinikainen, M; Litonius, E				Humaloja, Jaana; Skrifvars, Markus B.; Raj, Rahul; Wilkman, Erika; Pekkarinen, Pirkka T.; Bendel, Stepani; Reinikainen, Matti; Litonius, Erik			The Association Between Arterial Oxygen Level and Outcome in Neurocritically Ill Patients is not Affected by Blood Pressure	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Cardiac arrest; Subarachnoid hemorrhage; Intracranial hemorrhage; Acute ischemic stroke; Hypotension; Partial pressure of arterial oxygen; Hyperoxemia	TRAUMATIC BRAIN-INJURY; CEREBRAL-ISCHEMIA; CARDIAC-ARREST; HEAD-INJURY; HYPEROXIA; MORTALITY; CARE; GUIDELINES; STROKE; METABOLISM	Background In neurocritically ill patients, one early mechanism behind secondary brain injury is low systemic blood pressure resulting in inadequate cerebral perfusion and consequent hypoxia. Intuitively, higher partial pressures of arterial oxygen (PaO2) could be protective in case of inadequate cerebral circulation related to hemodynamic instability. Study purpose We examined whether the association between PaO2 and mortality is different in patients with low compared to normal and high mean arterial pressure (MAP) in patients after various types of brain injury. Methods We screened the Finnish Intensive Care Consortium database for mechanically ventilated adult (>= 18) brain injury patients treated in several tertiary intensive care units (ICUs) between 2003 and 2013. Admission diagnoses included traumatic brain injury, cardiac arrest, subarachnoid and intracranial hemorrhage, and acute ischemic stroke. The primary exposures of interest were PaO2 (recorded in connection with the lowest measured PaO2/fraction of inspired oxygen ratio) and the lowest MAP, recorded during the first 24 h in the ICU. PaO2 was grouped as follows: hypoxemia (< 8.2 kPa, the lowest 10th percentile), normoxemia (8.2-18.3 kPa), and hyperoxemia (> 18.3 kPa, the highest 10th percentile), and MAP was divided into equally sized tertiles (< 60, 60-68, and > 68 mmHg). The primary outcome was 1-year mortality. We tested the association between hyperoxemia, MAP, and mortality with a multivariable logistic regression model, including the PaO2, MAP, and interaction of PaO2*MAP, adjusting for age, admission diagnosis, premorbid physical performance, vasoactive use, intracranial pressure monitoring use, and disease severity. The relationship between predicted 1-year mortality and PaO2 was visualized with locally weighted scatterplot smoothing curves (Loess) for different MAP levels. Results From a total of 8290 patients, 3912 (47%) were dead at 1 year. PaO2 was not an independent predictor of mortality: the odds ratio (OR) for hyperoxemia was 1.16 (95% CI 0.85-1.59) and for hypoxemia 1.24 (95% CI 0.96-1.61) compared to normoxemia. Higher MAP predicted lower mortality: OR for MAP 60-68 mmHg was 0.73 (95% CI 0.64-0.84) and for MAP > 68 mmHg 0.80 (95% CI 0.69-0.92) compared to MAP < 60 mmHg. The interaction term PaO2*MAP was nonsignificant. In Loess visualization, the relationship between PaO2 and predicted mortality appeared similar in all MAP tertiles. Conclusions During the first 24 h of ICU treatment in mechanically ventilated brain injured patients, the association between PaO2 and mortality was not different in patients with low compared to normal MAP.	[Humaloja, Jaana; Skrifvars, Markus B.] Univ Helsinki, Dept Emergency Care & Serv, Helsinki, Finland; [Humaloja, Jaana; Skrifvars, Markus B.; Raj, Rahul; Wilkman, Erika; Pekkarinen, Pirkka T.; Litonius, Erik] Helsinki Univ Hosp, Helsinki, Finland; [Raj, Rahul] Univ Helsinki, Dept Neurosurg, Helsinki, Finland; [Wilkman, Erika; Pekkarinen, Pirkka T.] Univ Helsinki, Dept Anesthesiol Intens Care & Pain Med, Div Intens Care Med, Helsinki, Finland; [Bendel, Stepani; Reinikainen, Matti] Kuopio Univ Hosp, Dept Anesthesiol & Intens Care, Kuopio, Finland; [Bendel, Stepani; Reinikainen, Matti] Univ Eastern Finland, Kuopio, Finland; [Litonius, Erik] Univ Helsinki, Dept Anesthesiol Intens Care & Pain Med, Div Anesthesiol, Helsinki, Finland		Skrifvars, MB (corresponding author), Univ Helsinki, Dept Emergency Care & Serv, Helsinki, Finland.; Skrifvars, MB (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.	markus.skrifvars@hus.fi	; Raj, Rahul/K-7693-2012	Humaloja, Jaana/0000-0003-1092-6803; Raj, Rahul/0000-0003-4243-9591	Helsinki University [H3702 73702705]; Helsinki University Hospital [VTR-TYH2014221]; Finska Lakareskallskapet	This study was supported by grants from Helsinki University (three-year Project Grant: H3702 73702705) and Helsinki University Hospital (state funding: VTR-TYH2014221). The corresponding author was supported by a personal research grant from Finska Lakareskallskapet. The study supporters had no role in designing the study, collecting the data, the statistical analysis planning, the manuscript writing, or selection of the publication forum.	[Anonymous], 2016, ICD 10 VERSION; Bellomo R, 2011, CRIT CARE, V15, DOI 10.1186/cc10090; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Brenner M, 2012, ARCH SURG-CHICAGO, V147, P1042, DOI 10.1001/archsurg.2012.1560; Carney N., 2016, GUIDELINES MANAGEMEN, V4th; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chu DK, 2018, LANCET, V391, P1693, DOI 10.1016/S0140-6736(18)30479-3; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Esposito E, 2013, EXP NEUROL, V249, P33, DOI 10.1016/j.expneurol.2013.08.005; Floyd TF, 2003, J APPL PHYSIOL, V95, P2453, DOI 10.1152/japplphysiol.00303.2003; Frontera JA, 2009, STROKE, V40, P1963, DOI 10.1161/STROKEAHA.108.544700; Fukuda S, 2021, J NEUROSURG, V134, P25, DOI 10.3171/2019.9.JNS19781; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Helmerhorst HJF, 2015, CRIT CARE MED, V43, P1508, DOI 10.1097/CCM.0000000000000998; Jeon SB, 2014, J NEUROL NEUROSUR PS, V85, P1301, DOI 10.1136/jnnp-2013-307314; Johnston AJ, 2003, BRIT J ANAESTH, V90, P774, DOI 10.1093/bja/aeg104; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Lang M, 2016, NEUROSURGERY, V78, P540, DOI 10.1227/NEU.0000000000001111; Laurikkala J, 2016, RESUSCITATION, V105, P116, DOI 10.1016/j.resuscitation.2016.05.026; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Li KC, 2019, CRIT CARE RES PRACT, V2019, DOI 10.1155/2019/7584573; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; Ni YN, 2019, BMC PULM MED, V19, DOI 10.1186/s12890-019-0810-1; Nolan JP, 2015, RESUSCITATION, V95, P202, DOI 10.1016/j.resuscitation.2015.07.018; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Powers WJ, 2019, STROKE, V50, pE344, DOI 10.1161/STR.0000000000000211; Qi ZF, 2013, MED GAS RES, V3, DOI 10.1186/2045-9912-3-2; Raj R, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2151-5; Raj R, 2018, CRIT CARE MED, V46, pE302, DOI 10.1097/CCM.0000000000002959; Raj R, 2013, CRIT CARE, V17, DOI 10.1186/cc12856; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Reinikainen M, 2012, ACTA ANAESTH SCAND, V56, P1114, DOI 10.1111/j.1399-6576.2012.02669.x; Rincon F, 2014, J NEUROL NEUROSUR PS, V85, P799, DOI 10.1136/jnnp-2013-305505; Rincon F, 2014, CRIT CARE MED, V42, P387, DOI 10.1097/CCM.0b013e3182a27732; Roberts BW, 2018, CIRCULATION, V137, P2114, DOI 10.1161/CIRCULATIONAHA.117.032054; Roffe C, 2017, JAMA-J AM MED ASSOC, V318, P1125, DOI 10.1001/jama.2017.11463; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Singhal AB, 2007, STROKE, V38, P2851, DOI 10.1161/STROKEAHA.107.487280; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; Stamler JS, 1997, SCIENCE, V276, P2034, DOI 10.1126/science.276.5321.2034; Storm C, 2014, RESUSCITATION, V85, P1037, DOI 10.1016/j.resuscitation.2014.04.021; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wilkman E, 2013, ACTA ANAESTH SCAND, V57, P431, DOI 10.1111/aas.12056; Wilkman E, 2013, PANCREAS, V42, P272, DOI 10.1097/MPA.0b013e318264c9f7; Xu F, 2012, J CEREBR BLOOD F MET, V32, P1909, DOI 10.1038/jcbfm.2012.93; Young P, 2012, CRIT CARE RESUSC, V14, P14	50	2	2	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2021	34	2					413	422		10.1007/s12028-020-01178-w		JAN 2021	10	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SD6RK	WOS:000605135000007	33403587	hybrid, Green Published			2022-02-06	
J	Afzal, S; Maqsood, M; Mehmood, I; Niaz, MT; Seo, S				Afzal, Sitara; Maqsood, Muazzam; Mehmood, Irfan; Niaz, Muhammad Tabish; Seo, Sanghyun			An Efficient False-Positive Reduction System for Cerebral Microbleeds Detection	CMC-COMPUTERS MATERIALS & CONTINUA			English	Article						Microbleeds detection; false-positive; deep learning; CNN	COMPUTER-AIDED DETECTION; RISK-FACTOR	Cerebral Microbleeds (CMBs) are microhemorrhages caused by certain abnormalities of brain vessels. CMBs can be found in people with Traumatic Brain Injury (TBI), Alzheimer's disease, and in old individuals having a brain injury. Current research reveals that CMBs can be highly dangerous for individuals having dementia and stroke. The CMBs seriously impact individuals' life which makes it crucial to recognize the CMBs in its initial phase to stop deterioration and to assist individuals to have a normal life. The existing work report good results but often ignores false-positive's perspective for this research area. In this paper, an efficient approach is presented to detect CMBs from the Susceptibility Weighted Images (SWI). The proposed framework consists of four main phases (i) making clusters of brain Magnetic Resonance Imaging (MRI) using k-mean classifier (ii) reduce false positives for better classification results (iii) discriminative feature extraction specific to CMBs (iv) classification using a five layers convolutional neural network (CNN). The proposed method is evaluated on a public dataset available for 20 subjects. The proposed system shows an accuracy of 98.9% and a 1.1% false-positive rate value. The results show the superiority of the proposed work as compared to existing states of the art methods.	[Afzal, Sitara; Maqsood, Muazzam] COMSATS Univ Islamabad, Dept Comp Sci, Attock Campus, Attock, Pakistan; [Mehmood, Irfan] Univ Bradford, Fac Engn & Informat, Dept Media Design & Technol, Bradford BD7 1AZ, W Yorkshire, England; [Niaz, Muhammad Tabish] Sejong Univ, Sch Intelligent Mechatron Engn, Dept Smart Device Engn, Seoul, South Korea; [Seo, Sanghyun] Chung Ang Univ, Coll Art & Technol, Sch Comp Art, Anseong 17546, South Korea		Maqsood, M (corresponding author), COMSATS Univ Islamabad, Dept Comp Sci, Attock Campus, Attock, Pakistan.	muazzam.maqsood@cuiatk.edu.pk	Maqsood, Muazzam/AAW-1539-2021; Afzal, Sitara/AAM-4140-2021; Maqsood, Muazzam/ABE-1733-2021; Niaz, Muhammad Tabish/J-1845-2014	Maqsood, Muazzam/0000-0002-2709-0849; Niaz, Muhammad Tabish/0000-0002-5410-9410	National Research Foundation of Korea (NRF) - Korea government (MSIT) [NRF-2019R1F1A1058715]	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (NRF-2019R1F1A1058715).	Ateeq T, 2018, COMPUT ELECTR ENG, V69, P768, DOI 10.1016/j.compeleceng.2018.02.021; Barnes SRS, 2011, MAGN RESON IMAGING, V29, P844, DOI 10.1016/j.mri.2011.02.028; Bian W, 2013, NEUROIMAGE-CLIN, V2, P282, DOI 10.1016/j.nicl.2013.01.012; Chen H, 2015, I S BIOMED IMAGING, P764, DOI 10.1109/ISBI.2015.7163984; Cloutie R. S., 2018, ADV COMPUT SCI RES; Dou Q, 2016, IEEE T MED IMAGING, V35, P1182, DOI 10.1109/TMI.2016.2528129; Dou Q, 2015, IEEE ENG MED BIO, P7933, DOI 10.1109/EMBC.2015.7320232; Fan YH, 2003, STROKE, V34, P2459, DOI 10.1161/01.STR.0000090841.90286.81; Faziollahi A, 2014, I S BIOMED IMAGING, P113, DOI 10.1109/ISBI.2014.6867822; Feltrin FS, 2018, BRAIN INJURY, V32, P1413, DOI 10.1080/02699052.2018.1494852; Ghafaryasl B, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P138, DOI 10.1109/ISBI.2012.6235503; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Gregoire SM, 2010, J NEUROL NEUROSUR PS, V81, P679, DOI 10.1136/jnnp.2009.198994; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; He KM, 2016, LECT NOTES COMPUT SC, V9908, P630, DOI 10.1007/978-3-319-46493-0_38; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Kim PPC, 2017, J CLIN IMAG SCI, V7, DOI 10.4103/jcis.JCIS_29_17; Kuijf HJ, 2011, I S BIOMED IMAGING, P758, DOI 10.1109/ISBI.2011.5872516; LIU SF, 2017, NMR BIOMED, V30, DOI DOI 10.1002/NBM.3552; Lu SY, 2020, J AMB INTEL HUM COMP, DOI 10.1007/s12652-020-01789-3; Lu Z., 2019, ADV SOC SCI ED HUMAN; Padmanabhan, 2004, ARXIV200400218, V20, P1; Poels MMF, 2012, NEUROLOGY, V78, P326, DOI 10.1212/WNL.0b013e3182452928; Qi YJ, 2017, EURASIP J WIREL COMM, DOI 10.1186/s13638-016-0791-1; ROY S, 2015, P ASM INT MECH ENG; Seghier ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017547; van den Heuvel TLA, 2016, NEUROIMAGE-CLIN, V12, P241, DOI 10.1016/j.nicl.2016.07.002; Wang SH, 2020, CONCURR COMP-PRACT E, V32, DOI 10.1002/cpe.5130; Zhang YD, 2018, MULTIMED TOOLS APPL, V77, P10521, DOI 10.1007/s11042-017-4554-8; Zou XW, 2017, NEURORADIOLOGY, V59, P685, DOI 10.1007/s00234-017-1845-8	30	2	2	1	2	TECH SCIENCE PRESS	HENDERSON	871 CORONADO CENTER DR, SUTE 200, HENDERSON, NV 89052 USA	1546-2218	1546-2226		CMC-COMPUT MATER CON	CMC-Comput. Mat. Contin.		2021	66	3					2301	2315		10.32604/cmc.2021.013966			15	Computer Science, Information Systems; Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Materials Science	PN6ZR	WOS:000604625800006					2022-02-06	
J	Bannon, SM; Kumar, RG; Bogner, J; O'Neil-Pirozzi, TM; Spielman, L; Watson, EM; Dams-O'Connor, K				Bannon, Sarah M.; Kumar, Raj G.; Bogner, Jennifer; O'Neil-Pirozzi, Therese M.; Spielman, Lisa; Watson, Eric M.; Dams-O'Connor, Kristen			Reinjury After Moderate to Severe TBI: Rates and Risk Factors in the NIDILRR Traumatic Brain Injury Model Systems	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						injury prevention; rehabilitation; survival analysis; traumatic brain injury	LONG-TERM SURVIVAL; YOUNG-ADULTS; MORTALITY; RELIABILITY; CONCUSSION; DISABILITY; HISTORY; AGE; REPRESENTATIVENESS; INDIVIDUALS	Objectives: To compare characteristics of those who do and do not sustain subsequent traumatic brain injuries (TBIs) following index TBI and to identify reinjury risk factors. Design: Secondary data analysis of an ongoing longitudinal cohort study. Setting: TBI Model Systems Centers. Participants: In total, 11 353 individuals aged 16+ years. Main Outcome Measures: Ohio State University TBI Identification Method. Results: In total, 7.9% of individuals reported sustaining a TBI post-index TBI. Twenty percent of reinjuries occurred within a year of the index TBI. Reinjury risk followed an approximate U-shaped distribution such that risk was higher in the first year, declined 2 to 10 years postinjury, and then increased after 10 years. A multivariable Weibull model identified predictors of reinjury: younger (<29 years) and middle-aged and older (50+ years) age at index TBI relative to middle age, pre-index TBI, pre-index alcohol and illicit drug use, incarceration history, and less severe index TBI. Conclusions: A subset of individuals who receive inpatient rehabilitation for TBI are at an increased risk for reinjury, and an injury-prone phenotype may be characterized by engagement in risk behaviors. Factors associated with reinjury risk may differ for younger versus middle-aged and older adults. Findings underscore the need for empirically informed risk stratification models to identify TBI survivors at risk for reinjury.	[Bannon, Sarah M.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02115 USA; [O'Neil-Pirozzi, Therese M.] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Kumar, Raj G.; Spielman, Lisa; Watson, Eric M.; Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil & Human Performance, One Gustave L Levy Pl,Box 1163, New York, NY 10029 USA; [Bogner, Jennifer] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Dept Commun Sci & Disorders, Boston, MA 02115 USA		Dams-O'Connor, K (corresponding author), Icahn Sch Med Mt Sinai, Dept Rehabil & Human Performance, One Gustave L Levy Pl,Box 1163, New York, NY 10029 USA.	smbannon@mgh.harvard.edu; raj.kumar@mountsinai.org; jennifer.bogner@osumc.edu; t.oneil-pirozzi@northeastern.edu; spielman.lisa@gmail.com; watson.ericm@gmail.com; kristen.dams-o'connor@mountsinai.org		Watson, Eric/0000-0003-2072-9213			Allison PD, 2010, SURVIVAL ANAL USING, V2nd; Baguley IJ, 2008, BRAIN INJURY, V22, P919, DOI 10.1080/02699050802448578; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Botwinick I, 2016, ARCH GERONTOL GERIAT, V63, P43, DOI 10.1016/j.archger.2015.12.002; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Brown AW, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318280d3e6; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Centers for Disease Control and Prevention, 2018, MOD SEV TRAUM BRAIN; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Cuthbert J, 2012, BRAIN INJURY, V26, P363; Cuthbert JP, 2012, J HEAD TRAUMA REHAB, V27, pE15, DOI 10.1097/HTR.0b013e31826da983; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; Faul M, 2010, TRAUMATIC BRAIN INJU; Finlayson J, 2010, J INTELL DISABIL RES, V54, P966, DOI 10.1111/j.1365-2788.2010.01319.x; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Himanen L, 2011, BRAIN INJURY, V25, P443, DOI 10.3109/02699052.2011.556580; IBM Corp, 2017, IBM SPSS STAT WIND C; King JB, 2016, NEUROIMAGE-CLIN, V11, P81, DOI 10.1016/j.nicl.2016.01.003; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nabi H, 2005, AM J EPIDEMIOL, V161, P864, DOI 10.1093/aje/kwi110; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; Nott MT, 2015, AUSTRALAS J AGEING, V34, pE1, DOI 10.1111/ajag.12151; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sahler CS, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/659652; SAS Institute Inc, 2015, SAS 9 4 WIND COMP PR; Saunders LL, 2009, ARCH PHYS MED REHAB, V90, P1853, DOI 10.1016/j.apmr.2009.05.020; Saunders LL, 2009, BRAIN INJURY, V23, P866, DOI 10.1080/02699050903283213; Shi XQ, 2015, DISABIL HEALTH J, V8, P153, DOI 10.1016/j.dhjo.2014.09.012; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Spitz G, 2015, J NEUROTRAUM, V32, P1272, DOI 10.1089/neu.2014.3814; STODUTO G, 1993, ACCIDENT ANAL PREV, V25, P411, DOI 10.1016/0001-4575(93)90070-D; Talbot LA, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-86; Taylor O, 2015, BRAIN INJURY, V29, P709, DOI 10.3109/02699052.2015.1004739; Theadom A, 2015, J NEUROTRAUM, V32, P674, DOI 10.1089/neu.2014.3579; Traumatic Brain Injury Model Systems National Data and Statistical Center, SYLLABUS; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Vladutiu CJ, 2008, INJURY PREV, V14, P302, DOI 10.1136/ip.2008.018838; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Winqvist S, 2006, J ADOLESC HLTH, V39, p275e1, DOI DOI 10.1016/J.JADOHEALTH.2005.12.019; Winqvist S, 2007, BRAIN INJURY, V21, P1079, DOI 10.1080/02699050701553221; Xiang H, 2005, INJURY PREV, V11, P157, DOI 10.1136/ip.2004.006429; Zins M, 2009, ADV LIFE COURSE RES, V14, P135, DOI 10.1016/j.alcr.2010.02.003	59	2	2	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2021	36	1			SI		E50	E60		10.1097/HTR.0000000000000586			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	PM7ZE	WOS:000604011300010	32769829				2022-02-06	
J	Beard, K; Yang, ZJ; Haber, M; Flamholz, M; Diaz-Arrastia, R; Sandsmark, D; Meaney, DF; Issadore, D				Beard, Kryshawna; Yang, Zijian; Haber, Margalit; Flamholz, Miranda; Diaz-Arrastia, Ramon; Sandsmark, Danielle; Meaney, David F.; Issadore, David			Extracellular vesicles as distinct biomarker reservoirs for mild traumatic brain injury diagnosis	BRAIN COMMUNICATIONS			English	Article						traumatic brain injury; biomarkers; extracellular vesicles; machine learning	CEREBRAL VASCULAR INJURY; PROTEIN; PATHOPHYSIOLOGY; SENSITIVITY; EXPRESSION; PROGNOSIS; EXOSOMES; DISEASE; PANEL; TBI	Mild traumatic brain injury does not currently have a clear molecular diagnostic panel to either confirm the injury or to guide its treatment. Current biomarkers for traumatic brain injury rely mainly on detecting circulating proteins in blood that are associated with degenerating neurons, which are less common in mild traumatic brain injury, or with broad inflammatory cascades which are produced in multiple tissues and are thus not brain specific. To address this issue, we conducted an observational cohort study designed to measure a protein panel in two compartments-plasma and brain-derived extracellular vesicles-with the following hypotheses: (i) each compartment provides independent diagnostic information and (ii) algorithmically combining these compartments accurately classifies clinical mild traumatic brain injury. We evaluated this hypothesis using plasma samples from mild (Glasgow coma scale scores 13-15) traumatic brain injury patients (n = 47) and healthy and orthopaedic control subjects (n = 46) to evaluate biomarkers in brain-derived extracellular vesicles and plasma. We used our Track Etched Magnetic Nanopore technology to isolate brain-derived extracellular vesicles from plasma based on their expression of GluR2, combined with the ultrasensitive digital enzyme-linked immunosorbent assay technique, Single-Molecule Array. We quantified extracellular veside-packaged and plasma levels of biomarkers associated with two categories of traumatic brain injury pathology: neurodegeneration and neuronal/glial damage (ubiquitin C-terminal hydrolase L1, glial fibrillary acid protein, neuro-filament light and Tau) and inflammation (interleukin-6, interleukin-10 and tumour necrosis factor alpha). We found that GluR2+ extracellular vesicles have distinct biomarker distributions than those present in the plasma. As a proof of concept, we showed that using a panel of biomarkers comprised of both plasma and GluR2+ extracellular vesicles, injured patients could be accurately classified versus non-injured patients.	[Beard, Kryshawna] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Yang, Zijian] Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA; [Haber, Margalit; Flamholz, Miranda; Diaz-Arrastia, Ramon; Sandsmark, Danielle] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Meaney, David F.; Issadore, David] Univ Penn, Dept Bioengn, 210 33rd St, Philadelphia, PA 19104 USA; [Meaney, David F.] Univ Penn, Dept Neurosurg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Issadore, David] Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA		Meaney, DF; Issadore, D (corresponding author), Univ Penn, Dept Bioengn, 210 33rd St, Philadelphia, PA 19104 USA.	dmeaney@seas.upenn.edu; issadore@seas.upenn.edu			Paul G Allen Frontiers group [12347]; New Jersey Commission for Brain Injury Research; Department of DefenseUnited States Department of Defense [W81XWH-14-2-0176, W81XWH1920002]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 NS086090, K23 NS104239]; Pennsylvania Department of Health	This work was supported by a grant from the Paul G Allen Frontiers group (grant #12347), the New Jersey Commission for Brain Injury Research, and grant W81XWH1920002 from the Department of Defense. Work in the authors' laboratory was also supported by the Pennsylvania Department of Health. This work was also funded by National Institute of Neurological Disorders and Stroke U01 NS086090, K23 NS104239, and Department of Defense W81XWH-14-2-0176.	Acarin L, 2000, EUR J NEUROSCI, V12, P3505, DOI 10.1046/j.1460-9568.2000.00226.x; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Beard K, 2020, J NEUROTRAUM, V37, P2045, DOI 10.1089/neu.2020.6990; Binkowska AM, 2018, CENT EUR J IMMUNOL, V43, P33, DOI 10.5114/ceji.2018.74871; Buniatian GH, 2002, ANAT RECORD, V267, P296, DOI 10.1002/ar.10115; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Castellani RJ, 2019, J ALZHEIMERS DIS, V67, P447, DOI 10.3233/JAD-180721; Cheng Y, 2019, J CELL PHYSIOL, V234, P14377, DOI 10.1002/jcp.28139; Cohen JD, 2017, P NATL ACAD SCI USA, V114, P10202, DOI 10.1073/pnas.1704961114; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Dadas A, 2018, NEUROPSYCH DIS TREAT, V14, P2989, DOI 10.2147/NDT.S125620; Davies KD, 2008, J BIOL CHEM, V283, P33138, DOI 10.1074/jbc.M803431200; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dursun E, 2015, J NEUROIMMUNOL, V283, P50, DOI 10.1016/j.jneuroim.2015.04.014; Edwards G, 2019, J NEUROTRAUM, DOI 10.1089/neu.2018.6348; Gan ZS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00446; Gill J, 2018, BRAIN INJURY, V32, P1277, DOI 10.1080/02699052.2018.1471738; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Harrison EB, 2016, FEBS OPEN BIO, V6, P835, DOI 10.1002/2211-5463.12092; Hemphill M, 2020, J NEUROTRAUM, V37, P2424, DOI 10.1089/neu.2018.6220; Hirad AA, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3460; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Ko J, 2018, LAB CHIP, V18, P3617, DOI 10.1039/c8lc00672e; Ko J, 2017, ACS NANO, V11, P11182, DOI 10.1021/acsnano.7b05503; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; LANTZ MS, 1994, METHOD ENZYMOL, V235, P563; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Liu H, 2019, P NATL ACAD SCI USA, V116, P4643, DOI 10.1073/pnas.1821282116; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Madhavan B, 2015, INT J CANCER, V136, P2616, DOI 10.1002/ijc.29324; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Mondello S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040977; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Osteikoetxea X, 2015, ORG BIOMOL CHEM, V13, P9775, DOI 10.1039/c5ob01451d; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Ritzel RM, 2018, J NEUROTRAUM, V35, P1419, DOI 10.1089/neu.2017.5399; Shahim P, 2020, NEUROLOGY, V95, pE610, DOI 10.1212/WNL.0000000000009983; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Spurlock ME, 1997, J ANIM SCI, V75, P1773; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Vidal M, 2019, TRAFFIC, V20, P815, DOI 10.1111/tra.12687; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003; Yang ZJ, 2020, CLIN CANCER RES, V26, P3248, DOI 10.1158/1078-0432.CCR-19-3313; Yelleswarapu V, 2019, P NATL ACAD SCI USA, V116, P4489, DOI 10.1073/pnas.1814110116; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127	66	2	2	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2632-1297		BRAIN COMMUN	Brain Commun.		2021	3	3							fcab151	10.1093/braincomms/fcab151			14	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	XU5TR	WOS:000734327400024	34622206	gold, Green Published			2022-02-06	
J	Beidler, E; Wallace, J; Alghwiri, AA; O'Connor, S				Beidler, Erica; Wallace, Jessica; Alghwiri, Alia A.; O'Connor, Siobhan			Collegiate Athletes' Concussion Awareness, Understanding, and -Reporting Behaviors in Different Countries With Varying Concussion Publicity	JOURNAL OF ATHLETIC TRAINING			English	Article						head injuries; traumatic brain injuries; global health	SPORT SPECIALIZATION; KNOWLEDGE; ATTITUDES; SYMPTOMS; PLAYERS; INJURY; YOUTH; RATES	Context: Concussions are a global public health concern, and education on the importance of self-reporting may not reach all athletes to the same degree around the world. Objective: To determine if differences were present in the concussion awareness, understanding, and -reporting behaviors of collegiate athletes' in 3 countries with varied degrees of concussion publicity. Design: Cross-sectional survey. Setting: Collegiate sports medicine clinics. Patients or Other Participants: Collegiate athletes in the United States (n = 964; high publicity), Ireland (n = 302; moderate publicity), and Jordan (n = 129; low publicity). The degree of concussion publicity was categorized based on the extent of national public health awareness initiatives, care guidelines, research publications, and mass media coverage. Main Outcome Measure(s): Participants completed a 10-to 15-minute survey on concussion awareness, understanding, and -reporting behaviors. The main outcome measures were concussion education (awareness; 21 options; select all sources of concussion information), concussion knowledge (understanding; maximum score of 49), and diagnosed/nondisclosed concussion history (reporting behaviors; self-report yes/no items). Results: A higher proportion of Jordanian athletes reported never having received concussion information previously (73.6%) than Irish (24.2%) or US athletes (9.4%). Knowledge differed among countries (P < .0001, eta(2)= .28), with US athletes displaying higher total knowledge scores (40.9 +/- 4.5) than Jordanian (35.1 +/- 5.6) and Irish (32.1 +/- 3.5) athletes. Greater percentages of Irish and US athletes reported a history of a diagnosed concussion (31.8% and 29.6%, respectively) and history of concussion nondisclosure (25.2% and 15.5%, respectively) than Jordanian athletes (2.3% and 0.0% for history of a diagnosed concussion and history of concussion nondisclosure, respectively). Conclusions: In the United States, where concussion publicity is high, formal legislation exists, and sports medicine resources and concussion awareness and understanding were increased. More culturally appropriate concussion initiatives are needed globally to ensure that athletes around the world can identify concussive injuries and understand the dangers of continued sport participation while concussed.	[Beidler, Erica] Duquesne Univ, Dept Athlet Training, 118 Heath Sci Bldg,600 Forbes Ave, Pittsburgh, PA 15282 USA; [Wallace, Jessica] Univ Alabama, Dept Hlth Sci, Tuscaloosa, AL USA; [Alghwiri, Alia A.] Univ Jordan, Dept Physiotherapy, Amman, Jordan; [O'Connor, Siobhan] Dublin City Univ, Ctr Injury Prevent & Performance, Sch Hlth & Human Performance, Dublin, Ireland		Beidler, E (corresponding author), Duquesne Univ, Dept Athlet Training, 118 Heath Sci Bldg,600 Forbes Ave, Pittsburgh, PA 15282 USA.	johnsone1@duq.edu	O Connor, Siobhan/Q-8568-2018	O Connor, Siobhan/0000-0002-2001-0746			AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Baker JF, 2013, IRISH J MED SCI, V182, P121, DOI 10.1007/s11845-012-0846-1; Beidler E, 2018, J ATHL TRAINING, V53, P866, DOI 10.4085/1062-6050-266-17; Bell DR, 2016, AM J SPORT MED, V44, P1469, DOI 10.1177/0363546516629943; Bernstein JPK, 2019, CAN J NEUROL SCI, V46, P575, DOI 10.1017/cjn.2019.76; Cohen J., 1988, STAT POWER ANAL BEHA; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Eirale C, 2015, CLIN J SPORT MED, V25, P73, DOI 10.1097/JSM.0000000000000066; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Jayanthi NA, 2015, AM J SPORT MED, V43, P794, DOI 10.1177/0363546514567298; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Leahy R, 2020, PHYS THER SPORT, V43, P236, DOI 10.1016/j.ptsp.2019.06.004; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; MCCRORY P, 2017, BRIT J SPORT MED, V51, P838, DOI DOI 10.1136/BJSPORTS-2017-097699; Murphy M.H., 2015, STUDENT ACTIVITY SPO; Myer GD, 2015, SPORTS HEALTH, V7, P437, DOI 10.1177/1941738115598747; National Collegiate Athletic Association, 2019, EST PROB COMP COLL A; O'Connell E, 2016, IRISH J MED SCI, V185, P521, DOI 10.1007/s11845-015-1313-6; O'Connor S, 2020, CLIN J SPORT MED, V30, P578, DOI 10.1097/JSM.0000000000000658; Parsons JT, 2014, NCAA SPORTS MED HDB; Post EG, 2017, AM J SPORT MED, V45, P1405, DOI 10.1177/0363546517690848; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Sarmiento K, 2017, J SCHOOL HEALTH, V87, P790, DOI 10.1111/josh.12552; STOKOLS D, 1992, AM PSYCHOL, V47, P6, DOI 10.1037/0003-066X.47.1.6; Sullivan L, 2016, INT J ADOLESC MED HL, V29, DOI [10.1515/ijamh-2015-0084., DOI 10.1515/IJAMH-2015-0084]; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; World Health Organization (WHO), PROC TRANSL AD INSTR; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	34	2	2	1	1	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JAN	2021	56	1					77	84		10.4085/1062-6050-0575.19			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	QD1OV	WOS:000615297700009	33259602	Green Published, gold			2022-02-06	
J	Calzolari, E; Chepisheva, M; Smith, RM; Mahmud, M; Hellyer, PJ; Tahtis, V; Arshad, Q; Jolly, A; Wilson, M; Rust, H; Sharp, DJ; Seemungal, BM				Calzolari, Elena; Chepisheva, Mariya; Smith, Rebecca M.; Mahmud, Mohammad; Hellyer, Peter J.; Tahtis, Vassilios; Arshad, Qadeer; Jolly, Amy; Wilson, Mark; Rust, Heiko; Sharp, David J.; Seemungal, Barry M.			Vestibular agnosia in traumatic brain injury and its link to imbalance	BRAIN			English	Article						vestibular agnosia; traumatic brain injury; self-motion perception; vestibular cognition; vertigo	PAROXYSMAL POSITIONAL VERTIGO; WHITE-MATTER DAMAGE; DIZZINESS; EPIDEMIOLOGY; DEFICITS; BALANCE	Vestibular dysfunction, causing dizziness and imbalance, is a common yet poorly understood feature in patients with TBI. Damage to the inner ear, nerve, brainstem, cerebellum and cerebral hemispheres may all affect vestibular functioning, hence, a multi-level assessment-from reflex to perception-is required. In a previous report, postural instability was the commonest neurological feature in ambulating acute patients with TBI. During ward assessment, we also frequently observe a loss of vertigo sensation in patients with acute TBI, common inner ear conditions and a related vigorous vestibular-ocular reflex nystagmus, suggesting a 'vestibular agnosia'. Patients with vestibular agnosia were also more unbalanced; however, the link between vestibular agnosia and imbalance was confounded by the presence of inner ear conditions. We investigated the brain mechanisms of imbalance in acute TBI, its link with vestibular agnosia, and potential clinical impact, by prospective laboratory assessment of vestibular function, from reflex to perception, in patients with preserved peripheral vestibular function. Assessment included: vestibular reflex function, vestibular perception by participants' report of their passive yaw rotations in the dark, objective balance via posturography, subjective symptoms via questionnaires, and structural neuroimaging. We prospectively screened 918 acute admissions, assessed 146 and recruited 37. Compared to 37 matched controls, patients showed elevated vestibular-perceptual thresholds (patients 12.92 degrees/s versus 3.87 degrees/s) but normal vestibular-ocular reflex thresholds (patients 2.52 degrees/s versus 1.78 degrees/s). Patients with elevated vestibular-perceptual thresholds [3 standard deviations (SD) above controls' average], were designated as having vestibular agnosia, and displayed worse posturography than non-vestibular-agnosia patients, despite no difference in vestibular symptom scores. Only in patients with impaired postural control (3 SD above controls' mean), whole brain diffusion tensor voxel-wise analysis showed elevated mean diffusivity (and trend lower fractional anisotropy) in the inferior longitudinal fasciculus in the right temporal lobe that correlated with vestibular agnosia severity. Thus, impaired balance and vestibular agnosia are co-localized to the inferior longitudinal fasciculus in the right temporal lobe. Finally, a clinical audit showed a sevenfold reduction in clinician recognition of a common peripheral vestibular condition (benign paroxysmal positional vertigo) in acute patients with clinically apparent vestibular agnosia. That vestibular agnosia patients show worse balance, but without increased dizziness symptoms, explains why clinicians may miss treatable vestibular diagnoses in these patients. In conclusion, vestibular agnosia mediates imbalance in traumatic brain injury both directly via white matter tract damage in the right temporal lobe, and indirectly via reduced clinical recognition of common, treatable vestibular diagnoses.	[Calzolari, Elena; Chepisheva, Mariya; Smith, Rebecca M.; Mahmud, Mohammad; Tahtis, Vassilios; Rust, Heiko; Seemungal, Barry M.] Imperial Coll London, Charing Cross Hosp, Dept Brain Sci, Brain & Vestibular Grp,Neurootol Unit, London W6 8RF, England; [Hellyer, Peter J.] Kings Coll London, Ctr Neuroimaging Sci, London WC2R 2LS, England; [Tahtis, Vassilios] Kings Coll Hosp NHS Fdn Trust, London SE5 9RS, England; [Arshad, Qadeer] Univ Leicester, Dept Neurosci Psychol & Behav, InAmind Lab, Leicester LE1 7RH, Leics, England; [Jolly, Amy; Sharp, David J.] Imperial Coll London, Hammersmith Hosp, Dept Brain Sci, C3NL, London W12 0NN, England; [Wilson, Mark; Seemungal, Barry M.] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Major Trauma Ctr, London W2 1NY, England		Seemungal, BM (corresponding author), Imperial Coll London, Dept Brain Sci, Neurootol Unit, Brain & Vestibular Grp, Room 10L17,Charing Cross Campus, London W6 8RF, England.	bmseem@ic.ac.uk	; Hellyer, Peter/F-7112-2013	Wilson, Mark/0000-0002-2346-4911; Jolly, Amy/0000-0002-7413-9772; Hellyer, Peter/0000-0002-5139-3401; Smith, Rebecca/0000-0003-2628-9861; Seemungal, Barry/0000-0002-6578-0904	Medical Research Council (MRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); Imperial Health Charity; NIHR Imperial Biomedical Research Centre; NIHR Clinical Doctoral Research Fellowship; US Department of Defense -Congressionally Directed Medical Research Program (CDMRP); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [UKDRI-7006, MR/P006493/1, MR/J004685/1, MR/T023880/1] Funding Source: UKRI	The Medical Research Council (MRC). The Imperial Health Charity, The NIHR Imperial Biomedical Research Centre, NIHR Clinical Doctoral Research Fellowship, The US Department of Defense -Congressionally Directed Medical Research Program (CDMRP).	Agosta F, 2014, J NEUROL, V261, P913, DOI 10.1007/s00415-014-7301-3; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Brandt T, 1999, LANCET, V354, P746, DOI 10.1016/S0140-6736(99)03179-7; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Chiarovano E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00004; Cronin T, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00538; Dieterich M, 2003, CEREB CORTEX, V13, P994, DOI 10.1093/cercor/13.9.994; Gananca FF, 2010, BRAZ J OTORHINOLAR, V76, P113, DOI 10.1590/S1808-86942010000100019; Gordon CR, 2004, ARCH NEUROL-CHICAGO, V61, P1590, DOI 10.1001/archneur.61.10.1590; Ham TE, 2012, CURR OPIN NEUROL, V25, P662, DOI 10.1097/WCO.0b013e328359488f; Hoffer Michael E, 2007, Int Tinnitus J, V13, P69; Imbaud Genieys S, 2007, Ann Otolaryngol Chir Cervicofac, V124, P189; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kahane P, 2003, ANN NEUROL, V54, P615, DOI 10.1002/ana.10726; Kaski D, 2016, BRAIN, V139, P392, DOI 10.1093/brain/awv370; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kirsch V, 2016, BRAIN STRUCT FUNCT, V221, P1291, DOI 10.1007/s00429-014-0971-x; Klima D, 2019, PERCEPT MOTOR SKILL, V126, P50, DOI 10.1177/0031512518809203; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Marcus HJ, 2019, J NEUROL, V266, P2430, DOI 10.1007/s00415-019-09403-z; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; Maskell F, 2007, BRAIN INJURY, V21, P741, DOI 10.1080/02699050701472109; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nigmatullina Y, 2015, CEREB CORTEX, V25, P554, DOI 10.1093/cercor/bht266; Oghalai JS, 2000, OTOLARYNG HEAD NECK, V122, P630, DOI 10.1016/S0194-5998(00)70187-2; Ondo W, 2000, ARCH NEUROL-CHICAGO, V57, P1464, DOI 10.1001/archneur.57.10.1464; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Sargeant M, 2018, J CONCUSSION, DOI [10.1177/2059700218808121., DOI 10.1177/2059700218808121]; Seemungal BM, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3004; Seemungal BM, 2014, CURR OPIN NEUROL, V27, P125, DOI 10.1097/WCO.0000000000000060; Seemungal BM, 2004, J VESTIBUL RES-EQUIL, V14, P461; Seemungal BM, THESIS U LONDON; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; SHIPP S, 1994, BRAIN, V117, P1023, DOI 10.1093/brain/117.5.1023; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; TYRRELL RA, 1988, BEHAV RES METH INSTR, V20, P137, DOI 10.3758/BF03203817; Ventre-Dominey J, 2003, NEUROPSYCHOLOGIA, V41, P1884, DOI 10.1016/S0028-3932(03)00126-X; Ventre-Dominey J, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00053; Voineskos AN, 2012, NEUROBIOL AGING, V33, P21, DOI 10.1016/j.neurobiolaging.2010.02.009; von Brevern M, 2007, J NEUROL NEUROSUR PS, V78, P710, DOI 10.1136/jnnp.2006.100420; Whitwell JL, 2011, ARCH NEUROL-CHICAGO, V68, P753, DOI 10.1001/archneurol.2011.107; Wirth AM, 2018, BRAIN CONNECT, V8, P235, DOI 10.1089/brain.2017.0544; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055	48	2	2	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	JAN	2021	144		1				128	143		10.1093/brain/awaa386			16	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SA6XJ	WOS:000649444700027	33367536	hybrid, Green Published			2022-02-06	
J	Chan, AS; Lee, TL; Hamblin, MR; Cheung, MC				Chan, Agnes S.; Lee, Tsz-Lok; Hamblin, Michael R.; Cheung, Mei-Chun			Photobiomodulation Enhances Memory Processing in Older Adults with Mild Cognitive Impairment: A Functional Near-Infrared Spectroscopy Study	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Functional near-infrared spectroscopy; mild cognitive impairment; photoneuromodulation; visual memory	LASER STIMULATION; ALZHEIMERS; THERAPY; PERFORMANCE; SAFETY	Background: Recent studies of photobiomodulation (PBM) in patients with cognitive or psychological disorders (including traumatic brain injury, stroke, and dementia) have yielded some encouraging results. Objective: In this study, we aimed to investigate the effect of a single stimulation on memory in older adults with mild cognitive impairment (MCI). Methods: After PBM, hemodynamic changes, as a measure of functional brain activity, were evaluated using functional near-infrared spectroscopy (fNIRS). Eighteen subjects who met the criteria of MCI were randomly assigned to control and experimental groups. A single real or sham PBM session was administered to the forehead of each patient in the experimental and control groups, respectively. All subjects performed a visual memory span test before and after the stimulation, and their hemodynamic responses during the tasks were measured using fNIRS. Results: The results showed that among the MCI subjects, only those who received PBM, but not those who received the sham stimulation, demonstrated significant improvement in the visual memory performance and a reduction in the hemodynamic response during the tasks. Conclusion: These findings suggest that PBM may reduce the cognitive efforts needed to complete tasks that require high memory loads, and thus improve the cognitive performance of individuals with MCI.	[Chan, Agnes S.; Lee, Tsz-Lok] Chinese Univ Hong Kong, Dept Psychol, Hong Kong, Peoples R China; [Chan, Agnes S.] Chinese Univ Hong Kong, Res Ctr Neuropsychol Well Being, Hong Kong, Peoples R China; [Hamblin, Michael R.] Univ Johannesburg, Fac Hlth Sci, Laser Res Ctr, Doornfontein, South Africa; [Hamblin, Michael R.] Iran Univ Med Sci, Radiat Biol Res Ctr, Tehran, Iran; [Cheung, Mei-Chun] Chinese Univ Hong Kong, Dept Social Work, Hong Kong, Peoples R China		Chan, AS (corresponding author), Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China.	aschan@cuhk.edu.hk	Hamblin, Michael R/H-2758-2019; Cheung, Mei Chun/A-1261-2014	Hamblin, Michael R/0000-0001-6431-4605; Cheung, Mei Chun/0000-0002-0210-0772; Chan, Agnes/0000-0002-3321-182X	General Research Fund of the Research Grants Council in HongKong [14606519]; US NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AI050875, R21AI121700]	The authors would like to thank Samantha Mui, Sophia Sze, Quin Chan, Christy Cheung, and Weltor Hui for their assistance in collecting data for this study. Further, we extend our appreciation to all of the study participants for their assistance in the experiments. This study was supported by funding from the General Research Fund of the Research Grants Council in HongKong, granted to the Chinese University of Hong Kong (ASC, 14606519). MRH was supported by US NIH Grants R01AI050875 and R21AI121700.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Au A, 2003, J INT NEUROPSYCH SOC, V9, P363, DOI 10.1017/S1355617703930025; Barrett DW, 2013, NEUROSCIENCE, V230, P13, DOI 10.1016/j.neuroscience.2012.11.016; Berman Marvin H, 2017, J Neurol Neurosci, V8, DOI 10.21767/2171-6625.1000176; Blanco NJ, 2017, J NEUROPSYCHOL, V11, P14, DOI 10.1111/jnp.12074; CARLESIMO GA, 1994, ACTA NEUROL SCAND, V89, P132; Causse M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05378-x; Chan A.S., 2006, HONG KONG LIST LEARN; Chan AS, 2019, INT J GERIATR PSYCH, V34, P369, DOI 10.1002/gps.5039; Chan AS, 1999, J INT NEUROPSYCH SOC, V5, P525, DOI 10.1017/S135561779956606X; Cheung MC, 2000, ARCH NEUROL-CHICAGO, V57, P1347, DOI 10.1001/archneur.57.9.1347; Claessen MHG, 2015, APPL NEUROPSYCH-ADUL, V22, P180, DOI 10.1080/23279095.2014.892488; Corsi P. M., 1972, THESIS MCGILL U MONT; Cui X, 2010, NEUROIMAGE, V49, P3039, DOI 10.1016/j.neuroimage.2009.11.050; de Freitas LF, 2016, IEEE J SEL TOP QUANT, V22, DOI 10.1109/JSTQE.2016.2561201; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Farina N, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002854.pub5; Kessels R P, 2000, Appl Neuropsychol, V7, P252, DOI 10.1207/S15324826AN0704_8; Lam LCW, 2005, INT J GERIATR PSYCH, V20, P876, DOI 10.1002/gps.1370; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Naeser M, 2012, PROCD SOC BEHV, V61, P138, DOI 10.1016/j.sbspro.2012.10.116; Naeser MA, 2020, PHOTOBIOMOD PHOTOMED, V38, P115, DOI 10.1089/photob.2019.4630; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; Petersen Ronald C, 2016, Continuum (Minneap Minn), V22, P404, DOI 10.1212/CON.0000000000000313; Posten W, 2005, DERMATOL SURG, V31, P334, DOI 10.1097/00042728-200503000-00016; REGARD M, 1982, PERCEPT MOTOR SKILL, V55, P839, DOI 10.2466/pms.1982.55.3.839; Russ TC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009132.pub2; Salehpour F, 2019, PHOTOBIOMODULATION P, V37, P159, DOI 10.1089/photob.2018.4569; Saltmarche AE, 2017, PHOTOMED LASER SURG, V35, P432, DOI 10.1089/pho.2016.4227; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Tian FH, 2016, LASER SURG MED, V48, P343, DOI 10.1002/lsm.22471; Urquhart EL, 2020, BIOMED OPT EXPRESS, V11, P5783, DOI 10.1364/BOE.402047; Vargas E, 2017, LASER MED SCI, V32, P1153, DOI 10.1007/s10103-017-2221-y; Wang XL, 2019, NEUROPHOTONICS, V6, DOI 10.1117/1.NPh.6.2.025013; Wang XL, 2017, J CEREBR BLOOD F MET, V37, P3789, DOI 10.1177/0271678X17691783; Wang XL, 2018, NEUROPHOTONICS, V5, DOI 10.1117/1.NPh.5.1.011004; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Zhao QH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057333, 10.1371/journal.pone.0061140]; Zivin JA, 2009, STROKE, V40, P1359, DOI 10.1161/STROKEAHA.109.547547	41	2	2	3	6	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2021	83	4					1471	1480		10.3233/JAD-201600			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WJ3SG	WOS:000708967100006	33998541				2022-02-06	
J	Cheng, H; Di, GF; Gao, CC; He, GY; Wang, X; Han, YL; Sun, LA; Zhou, ML; Jiang, XC				Cheng, Hao; Di, Guangfu; Gao, Chao-Chao; He, Guoyuan; Wang, Xue; Han, Yan-Ling; Sun, Le-an; Zhou, Meng-Liang; Jiang, Xiaochun			FTY720 Reduces Endothelial Cell Apoptosis and Remodels Neurovascular Unit after Experimental Traumatic Brain Injury	INTERNATIONAL JOURNAL OF MEDICAL SCIENCES			English	Article						FTY720; sphingosine-1-phosphate receptor 1; traumatic brain injury; blood-brain barrier; endothelial cell	HEAD-INJURY; INFLAMMATION; MECHANISMS; HEALTH; MOUSE	Traumatic brain injury (TBI) is a major cause of death and disability worldwide. A sequence of pathological processes occurred when there is TBI. Previous studies showed that sphingosine-1 -phosphate receptor 1 (S1PR1) played a critical role in inflammatory response in the brain after TBI. Thus, the present study was designed to evaluate the effects of the S1PR1 modulator FTY720 on neurovascular unit (NVU) after experimental TBI in mice. The weight-drop TBI method was used to induce TBI. Western blot (WB) was performed to determine the levels of S1PR1, claudin-5 and occludin at different time points. FTY720 was intraperitoneally administered to mice after TBI was induced. The terminal deoxynucleotidyl transferase-dUTP nick end labeling (TUNEL) assay was used to assess endothelial cell apoptosis. Immunofluorescence and WB were performed to measure the expression of tight junction proteins: claudin-5 and occludin. Evans blue (EB) permeability assay and brain water content were applied to evaluate the blood-brain barrier (BBB) permeability and brain edema. Immunohistochemistry was performed to assess the activation of astrocytes and microglia. The results showed that FTY720 administration reduced endothelial cell apoptosis and improved BBB permeability. FTY720 also attenuated astrocytes and microglia activation. Furthermore, treatment with FTY720 not only improved neurological function, but also increased the survival rate of mice significantly. These findings suggest that FTY720 administration restored the structure of the NVU after experimental TBI by decreasing endothelial cell apoptosis and attenuating the activation of astrocytes. Moreover, FTY720 might reduce inflammation in the brain by reducing the activation of microglia in TBI mice.	[Cheng, Hao; Di, Guangfu; He, Guoyuan; Sun, Le-an; Jiang, Xiaochun] Yijishan Hosp, Warman Med Coll, Dept Neurosurg, 2 West Zheshan Rd, Wuhu 241002, Anhui, Peoples R China; [Gao, Chao-Chao] Nanjing Med Univ, Jinling Hosp, Jinling Sch Clin Med, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Wang, Xue; Han, Yan-Ling; Zhou, Meng-Liang] Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, 305 East Zhoangshan Rd, Nanjing 210002, Jiangsu, Peoples R China		Jiang, XC (corresponding author), Yijishan Hosp, Warman Med Coll, Dept Neurosurg, 2 West Zheshan Rd, Wuhu 241002, Anhui, Peoples R China.; Zhou, ML (corresponding author), Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, 305 East Zhoangshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	mengliangzhou@yahoo.com; jiangxiaochun@yjsyy.com			Nature Science Research Project of Anhui province [1908085QH356]	The present research was supported by grants from Nature Science Research Project of Anhui province (Grant #: 1908085QH356).	Allen NJ, 2018, SCIENCE, V362, P181, DOI 10.1126/science.aat0473; Campbell M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1852; Cohen JA, 2011, ANN NEUROL, V69, P759, DOI 10.1002/ana.22426; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Cuzzocrea S, 2018, J NEUROTRAUM, V35, P1452, DOI 10.1089/neu.2017.5391; Di Pardo A, 2018, TRENDS PHARMACOL SCI, V39, P468, DOI 10.1016/j.tips.2018.02.009; Fei M, 2019, BIOCHEM BIOPH RES CO; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gao C, 2017, MOL NEUROBIOL, V54, P8348, DOI 10.1007/s12035-016-0318-0; Hait NC, 2014, NAT NEUROSCI, V17, P971, DOI 10.1038/nn.3728; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hla T, 2011, NEUROLOGY, V76, pS3, DOI 10.1212/WNL.0b013e31820d5ec1; Keep RF, 2018, J CEREBR BLOOD F MET, V38, P1255, DOI 10.1177/0271678X18774666; Li QY, 2018, NAT REV IMMUNOL, V18, P225, DOI 10.1038/nri.2017.125; Lin CS, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0125554, 10.1371/journal.pone.0123687]; Long XB, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01761-0; Mohammad MG, 2014, J CLIN INVEST, V124, P1228, DOI 10.1172/JCI71544; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Morozov V I, 2013, Ukr Biokhim Zh (1999), V85, P5; Needham EJ, 2019, J NEUROIMMUNOL, V332, P112, DOI 10.1016/j.jneuroim.2019.04.005; Pi JJ, 2017, CIRC RES, V120, P85, DOI 10.1161/CIRCRESAHA.116.309757; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Rosen H, 2014, CURR TOP MICROBIOL, V378, P1, DOI 10.1007/978-3-319-05879-5_1; Sandsmark DK, 2019, NEURON, V103, P367, DOI 10.1016/j.neuron.2019.06.002; Shi KB, 2019, LANCET NEUROL, V18, P1058, DOI 10.1016/S1474-4422(19)30078-X; Su Y, 2014, NEUROSCIENCE, V266, P56, DOI 10.1016/j.neuroscience.2014.02.006; Sweeney MD, 2018, NAT NEUROSCI, V21, P1318, DOI 10.1038/s41593-018-0234-x; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Voskuhl RR, 2009, J NEUROSCI, V29, P11511, DOI 10.1523/JNEUROSCI.1514-09.2009; Wei Y, 2011, ANN NEUROL, V69, P119, DOI 10.1002/ana.22186; Yanagida K, 2017, P NATL ACAD SCI USA, V114, P4531, DOI 10.1073/pnas.1618659114; Ye SY, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1633-y; Zhang Lijuan, 2016, Zhongguo Zhen Jiu, V36, P131	34	2	2	0	0	IVYSPRING INT PUBL	LAKE HAVEN	PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA	1449-1907			INT J MED SCI	Int. J. Med. Sci.		2021	18	2					304	313		10.7150/ijms.49066			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PH7MZ	WOS:000600593200002	33390799	gold, Green Published			2022-02-06	
J	Cipriano, A; Park, N; Pecori, A; Bionda, A; Bardini, M; Frassi, F; Lami, V; Leoli, F; Manca, ML; Del Prato, S; Santini, M; Ghiadoni, L				Cipriano, Alessandro; Park, Naria; Pecori, Alessio; Bionda, Alessandra; Bardini, Michele; Frassi, Francesca; Lami, Valentina; Leoli, Francesco; Manca, Maria Laura; Del Prato, Stefano; Santini, Massimo; Ghiadoni, Lorenzo			Predictors of post-traumatic complication of mild brain injury in anticoagulated patients: DOACs are safer than VKAs	INTERNAL AND EMERGENCY MEDICINE			English	Article						Mild traumatic brain injury; Anticoagulation; Direct oral anticoagulants; Intracranial hemorrhage	MINOR HEAD-INJURY; TRAUMATIC INTRACRANIAL HEMORRHAGE; PREINJURY WARFARIN USE; ORAL ANTICOAGULANTS; ATRIAL-FIBRILLATION; METAANALYSIS; MORTALITY; OUTCOMES; MANAGEMENT; GUIDELINE	Although mild traumatic brain injury (MTBI) in people on oral anticoagulant treatment (OAT) is a frequent challenge for Emergency Department (ED), strong guidelines recommendations are lacking. In the attempt to assess the safety profile of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs), we have recruited 473 patients with a MTBI on OAT (43.6% males; age 81.8 +/- 8.7 years), admitted to the Pisa's University Hospital ED (Jan 2016-Oct 2018). All patients underwent a head CT scan with those with no sign of acute bleedings remaining under clinical observation for the ensuing 24 h. Fifty patients (10.6%, 95% CI: 8.1-13.7%) had immediate intracranial hemorrhage (ICH), with a prevalence of patient-important outcomes due to immediate ICH of 1.1% (95% CI 0.4-2.4%); 3 patients died (0.6%, 95% CI 0.2-1.8) and 2 required neurosurgical intervention. Immediate ICHs were more frequent in VKA-treated than in DOAC-treated patients (15.9 vs. 6.4%. RR 2.5. 95%CI 1.4-4.4. p < 0.05). Multivariate analysis identified that post-traumatic amnesia, evidence of trauma above clavicles, high blood glucose, high blood pressure (BP) at arrival, and low prothrombin activity were predictors of immediate ICH. The prevalence of delayed ICH was 1.0% (95%CI 0.4-2.5%) without differences between DOACs and VKAs. Despite ICH being a frequent complication of MTBI in patients on OAT, immediate and delayed patient-important outcomes are rare. DOACs have a better safety profile than VKAs. Simple clinical parameters such as blood pressure at arrival or blood glucose might provide useful predictors of immediate ICH. Trial registration number: 11924_CIPRIANO. Local ethics committee approval number 33096.	[Cipriano, Alessandro; Park, Naria; Pecori, Alessio; Bionda, Alessandra; Bardini, Michele; Frassi, Francesca; Lami, Valentina; Leoli, Francesco; Santini, Massimo] Nuovo Santa Chiara Hosp, Azienda Osped Univ Pisa, Emergency Dept, UO Med DUrgenza E Pronto Soccorso, Pisa, Italy; [Manca, Maria Laura; Del Prato, Stefano; Ghiadoni, Lorenzo] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy		Cipriano, A (corresponding author), Nuovo Santa Chiara Hosp, Azienda Osped Univ Pisa, Emergency Dept, UO Med DUrgenza E Pronto Soccorso, Pisa, Italy.	a.cipriano@ao-pisa.toscana.it; nariapark01@gmail.com; a.pecori91@hotmail.it; a.e.bionda@gmail.com; cronosis74@gmail.com; frassifrancesca@gmail.com; valentina.lami@gmail.com; burgundioleoli@gmail.com; l.manca@med.unipi.it; stefano.delprato@med.unipi.it; ma.santini@ao-pisa.toscana.it; lorenzo.ghiadoni@med.unipi.it	Cipriano, Alessandro/ABG-8127-2020; Del+Prato, Stefano/AAC-9197-2021; MANCA, MARIA LAURA/AAK-5995-2020; Ghiadoni, Lorenzo/AAC-5176-2022	Cipriano, Alessandro/0000-0001-7085-3621; MANCA, MARIA LAURA/0000-0002-9274-2313; Ghiadoni, Lorenzo/0000-0002-7399-2720			Abdi Herve, 2013, Methods Mol Biol, V930, P549, DOI 10.1007/978-1-62703-059-5_23; Akhter M, 2018, INTERN EMERG MED, V13, P557, DOI 10.1007/s11739-017-1680-2; Alrajhi KN, 2015, J EMERG MED, V48, P137, DOI 10.1016/j.jemermed.2014.08.016; American College of Surgeons' Committee on Trauma, 2018, HEAD TRAUM ADV TRAUM, P109; Batey M, 2018, SURGERY, V164, P814, DOI 10.1016/j.surg.2018.05.060; Bjork M, 2020, EUR J INTERN MED, V75, P71, DOI 10.1016/j.ejim.2020.01.010; Bobeff EJ, 2019, WORLD NEUROSURG, V128, pE129, DOI 10.1016/j.wneu.2019.04.060; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Chai-Adisaksopha C, 2015, J THROMB HAEMOST, V13, P2012, DOI 10.1111/jth.13139; Cipriano A, 2018, INTERN EMERG MED, V13, P1077, DOI 10.1007/s11739-018-1806-1; de Andrade JBC, 2020, ARQ NEURO-PSIQUIAT, V78, P390, DOI [10.1590/0004-282X20200008, 10.1590/0004-282x20200008]; Cohn B, 2014, J EMERG MED, V46, P410, DOI 10.1016/j.jemermed.2013.08.107; Collins CE, 2014, AM J SURG, V208, P544, DOI 10.1016/j.amjsurg.2014.05.019; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Conti Alberto, 2018, Crit Pathw Cardiol, V17, P139, DOI 10.1097/HPC.0000000000000139; Davis T, 2015, ARCH DIS CHILDHOOD-E, V100, P97, DOI 10.1136/archdischild-2014-306797; Dentali F, 2012, CIRCULATION, V126, P2381, DOI 10.1161/CIRCULATIONAHA.112.115410; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Dossett LA, 2011, ARCH SURG-CHICAGO, V146, P565, DOI 10.1001/archsurg.2010.313; Flibotte JJ, 2004, NEUROLOGY, V63, P1059, DOI 10.1212/01.WNL.0000138428.40673.83; Fuller GW, 2019, ANN EMERG MED, V73, P66, DOI 10.1016/j.annemergmed.2018.07.020; Garza N, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00112; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Kaen A, 2010, J TRAUMA, V68, P895, DOI 10.1097/TA.0b013e3181b28a76; Kato Y, 2019, J STROKE CEREBROVASC, V28, DOI 10.1016/j.jstrokecerebrovasdis.2019.07.008; Lim BL, 2016, AM J EMERG MED, V34, P75, DOI 10.1016/j.ajem.2015.09.009; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Mason S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014324; Menditto VG, 2012, ANN EMERG MED, V59, P451, DOI 10.1016/j.annemergmed.2011.12.003; Nishijima DK, 2013, AM J EMERG MED, V31, P1244, DOI 10.1016/j.ajem.2013.04.035; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Peck KA, 2011, J TRAUMA, V71, P1600, DOI 10.1097/TA.0b013e31823b9ce1; Pieracci FM, 2007, J TRAUMA, V63, P519, DOI 10.1097/TA.0b013e31812e519b; Prexl O, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0487-0; Prisco D, 2017, INTERN EMERG MED, V12, P387, DOI 10.1007/s11739-017-1628-6; Reynolds FD, 2003, J TRAUMA, V54, P492, DOI 10.1097/01.TA.0000051601.60556.FC; Ritsinger V, 2019, DIABETES VASC DIS RE, V16, P582, DOI 10.1177/1479164119871540; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Schulman S, 2010, J THROMB HAEMOST, V8, P202, DOI 10.1111/j.1538-7836.2009.03678.x; Seiffge DJ, 2019, J NEUROL, V266, P3126, DOI 10.1007/s00415-019-09536-1; Spinola MB, 2019, AM J EMERG MED, V37, P1677, DOI 10.1016/j.ajem.2018.12.003; Stiell IG, 2001, ANN EMERG MED, V38, P160, DOI 10.1067/mem.2001.116796; Turcato G, 2019, J EMERG MED, V57, P817, DOI 10.1016/j.jemermed.2019.09.007; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Wang F, 2018, ACTA DIABETOL, V55, P703, DOI 10.1007/s00592-018-1139-6; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wilson D, 2017, NEUROLOGY, V88, P1693, DOI 10.1212/WNL.0000000000003886; Zeeshan M, 2018, J TRAUMA ACUTE CARE, V85, P915, DOI 10.1097/TA.0000000000001995	49	2	2	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1828-0447	1970-9366		INTERN EMERG MED	Intern. Emerg. Med.	JUN	2021	16	4					1061	1070		10.1007/s11739-020-02576-w		JAN 2021	10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SQ7UB	WOS:000604088900001	33386604				2022-02-06	
J	Fakhri, S; Kiani, A; Jalili, C; Abbaszadeh, F; Piri, S; Farzaei, MH; Rastegari-Pouyani, M; Mohammadi-Noori, E; Khan, H				Fakhri, Sajad; Kiani, Amir; Jalili, Cyrus; Abbaszadeh, Fatemeh; Piri, Sana; Farzaei, Mohammad Hosein; Rastegari-Pouyani, Mohsen; Mohammadi-Noori, Ehsan; Khan, Haroon			Intrathecal Administration of Melatonin Ameliorates the Neuroinflamma-tion-Mediated Sensory and Motor Dysfunction in A Rat Model of Com-pression Spinal Cord Injury	CURRENT MOLECULAR PHARMACOLOGY			English	Article						Spinal cord injury; melatonin; neuropathic pain; motor dysfunction; inflammation; rat	TRAUMATIC BRAIN-INJURY; FUNCTIONAL RECOVERY; MATRIX METALLOPROTEINASES; MECHANICAL ALLODYNIA; TACTILE ALLODYNIA; SIGNALING PATHWAY; EXPRESSION; ACTIVATION; IMPROVES; INFLAMMATION	Background: Spinal cord injury (SCI), often characterized by sensory-motor dysfunction, is a major debilitating disorder of the central nervous system. As no useful treatment for post SCI complications has been approved thus far, finding novel treatments is of great importance. Objective: Considering the promising effects of melatonin (MEL) against destructive mechanisms in other models of brain damage, in the current study, we evaluated its ameliorative effects on sensory-motor outcomes, inflammatory mediators, histological changes and other post-SCI complications. Methods: Rats in SCI and MEL groups underwent laminectomy followed by a severe compression injury by an aneurysm clip. Then, intrathecal treatment with vehicle (5% dimethyl sulfoxide) or MEL was carried out post-injury. Acetone drop, von Frey, inclined plane, and BBB tests as well as weight changes and auricle temperature, were used to evaluate the neuropathic pain, motor function, and other post-SCI complications. The effects of MEL on the activity of MMP-2 and MMP-9 were assessed using the gelatin zymography method every week till day 28 post-SCI. Histopathological assessments were performed on days 14, 21, and 28. Results: MEL treatment resulted in decreased motor dysfunction, mechanical and cold allodynia, auricle temperature, and also ameliorated weight loss. Moreover, MEL suppressed MMP-9 activity while increasing that of MMP-2 post-SCI, indicating its anti-neuroinflammatory effects. Also, MEL significantly preserved white matter myelinated areas and the number of sensory neurons post-SCI. Conclusion: The results suggest MEL as a promising candidate for medical therapies with advantageous effects on improving functional recovery through suppressing inflammatory mediators, and attenuating spinal tissue damages.	[Fakhri, Sajad; Kiani, Amir; Piri, Sana; Farzaei, Mohammad Hosein; Mohammadi-Noori, Ehsan] Kermanshah Univ Med Sci, Pharmaceut Sci Res Ctr, Hlth Inst, Kermanshah 6734667149, Iran; [Kiani, Amir; Mohammadi-Noori, Ehsan] Kermanshah Univ Med Sci, Regenerat Med Res Ctr, Kermanshah 6734667149, Iran; [Jalili, Cyrus] Kermanshah Univ Med Sci, Hlth Technol Inst, Med Biol Res Ctr, Kermanshah, Iran; [Abbaszadeh, Fatemeh] Iran Univ Med Sci, Fac Adv Technol Med Sci, Dept Neurosci, Tehran, Iran; [Abbaszadeh, Fatemeh] Shahid Beheshti Univ Med Sci, Neurobiol Res Ctr, Tehran, Iran; [Rastegari-Pouyani, Mohsen] Shahid Beheshti Univ Med Sci, Sch Med, Dept Immunol, Student Res Comm, Tehran, Iran; [Khan, Haroon] Abdul Wali Khan Univ Mardan, Dept Pharm, Mardan 23200, Pakistan		Fakhri, S (corresponding author), Kermanshah Univ Med Sci, Pharmaceut Sci Res Ctr, Hlth Inst, Kermanshah 6734667149, Iran.; Khan, H (corresponding author), Abdul Wali Khan Univ Mardan, Dept Pharm, Mardan 23200, Pakistan.	sajad.fakhri@kums.ac.ir; haroonkhan@awkum.edu.pk		Khan, Prof. Dr. Haroon/0000-0002-1736-4404	Pharmaceutical Sciences Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran [980725]	The present article is financially supported by the Pharmaceutical Sciences Research Center, Kermanshah University of Medical Sciences [Grant No: 980725] , Kermanshah, Iran.	Alghamdi BS, 2018, J NEUROSCI RES, V96, P1136, DOI 10.1002/jnr.24220; Alluri H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154427; Ambriz-Tututi M, 2007, PAIN, V132, P273, DOI 10.1016/j.pain.2007.01.025; Barrenetxe J, 2004, J PHYSIOL BIOCHEM, V60, P61, DOI 10.1007/BF03168221; Beuche W, 2000, NEUROREPORT, V11, P3419, DOI 10.1097/00001756-200011090-00003; Buss A, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-17; Cheriyan T, 2014, SPINAL CORD, V52, P588, DOI 10.1038/sc.2014.91; Chung K., 2007, ENCY PAIN, P55, DOI [10.1007/978-3-540-29805-2_156, DOI 10.1007/978-3-540-29805-2_156]; Deuis JR, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00284; Dowdall T, 2005, PHARMACOL BIOCHEM BE, V80, P93, DOI 10.1016/j.pbb.2004.10.016; Esposito E, 2008, J PINEAL RES, V45, P149, DOI 10.1111/j.1600-079X.2008.00569.x; Fakhri S, 2019, EUR J PAIN, V23, P750, DOI 10.1002/ejp.1342; Fakhri S, 2018, BRAIN RES BULL, V143, P217, DOI 10.1016/j.brainresbull.2018.09.011; Ferland CE, 2011, PHARMACOL BIOCHEM BE, V97, P603, DOI 10.1016/j.pbb.2010.11.003; Gao K, 2019, EUR NEUROL, V81, P197, DOI 10.1159/000502004; Genovese T, 2008, SHOCK, V29, P32, DOI 10.1097/shk.0b013e318059053a; Gul S, 2005, SURG NEUROL, V64, P355, DOI 10.1016/j.surneu.2005.03.036; Hall ED, 2016, J NEUROTRAUM, V33, P972, DOI 10.1089/neu.2016.4473; Hama AT, 2010, PHARMACOL BIOCHEM BE, V97, P249, DOI 10.1016/j.pbb.2010.08.006; Han YP, 2001, J CELL SCI, V114, P131; Hardeland R, 2012, AGING DIS, V3, P194; Hsu JYC, 2006, J NEUROSCI, V26, P9841, DOI 10.1523/JNEUROSCI.1993-06.2006; Hulten VDT, 2020, J SPINAL CORD MED, V43, P775, DOI 10.1080/10790268.2018.1543925; Inoue M, 2012, BIOCHEM PHARMACOL, V84, P692, DOI 10.1016/j.bcp.2012.05.021; Jang JW, 2011, J KOREAN NEUROSURG S, V50, P288, DOI 10.3340/jkns.2011.50.4.288; Jones H, 2014, CHRONOBIOL INT, V31, P157, DOI 10.3109/07420528.2013.833516; Jongen PJ, 2016, J NEUROL, V263, P1641, DOI 10.1007/s00415-016-8183-3; Kanno H, 2012, CELL CYCLE, V11, P3175, DOI 10.4161/cc.21262; Kauppila T, 2000, EXP NEUROL, V161, P740, DOI 10.1006/exnr.1999.7287; Kong J, 2017, ONCOTARGET, V8, P14283, DOI 10.18632/oncotarget.15093; Kong YL, 2019, MOL THER-NUCL ACIDS, V17, P578, DOI 10.1016/j.omtn.2019.05.014; Laird AS, 2006, J PHYSIOL-LONDON, V577, P539, DOI 10.1113/jphysiol.2006.116301; Laurido C, 2002, NEUROREPORT, V13, P89, DOI 10.1097/00001756-200201210-00021; Li YL, 2019, NEUROCHEM RES, V44, P2007, DOI 10.1007/s11064-019-02838-w; Liang KC, 2007, J CELL PHYSIOL, V211, P759, DOI 10.1002/jcp.20992; Lin C, 2016, J PINEAL RES, V61, P177, DOI 10.1111/jpi.12337; Lin TB, 2016, J PINEAL RES, V60, P263, DOI 10.1111/jpi.12307; Lorenzl S, 2002, EXP NEUROL, V178, P13, DOI 10.1006/exnr.2002.8019; Mao L, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/238321; Masoudi A, 2017, BEHAV BRAIN RES, V329, P104, DOI 10.1016/j.bbr.2017.04.026; Mesenge C, 1998, J PINEAL RES, V25, P41, DOI 10.1111/j.1600-079X.1998.tb00384.x; MESTRE C, 1994, J PHARMACOL TOX MET, V32, P197, DOI 10.1016/1056-8719(94)90087-6; Moon YJ, 2012, J NEUROSCI RES, V90, P243, DOI 10.1002/jnr.22734; Naseem Mehar, 2014, ScientificWorldJournal, V2014, P586270, DOI 10.1155/2014/586270; Noble LJ, 2002, J NEUROSCI, V22, P7526; Noseda R, 2004, NEUROSCI LETT, V360, P41, DOI 10.1016/j.neulet.2004.01.080; Oguz E, 2015, RENAL FAILURE, V37, P318, DOI 10.3109/0886022X.2014.991263; Osier N, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051539; Park K, 2010, J PINEAL RES, V48, P270, DOI 10.1111/j.1600-079X.2010.00751.x; Piao MS, 2014, ACTA NEUROCHIR, V156, P2173, DOI 10.1007/s00701-014-2119-4; Pugazhenthi K, 2008, J PINEAL RES, V44, P387, DOI 10.1111/j.1600-079X.2007.00541.x; Qin WW, 2012, J ENDOCRINOL, V214, P145, DOI 10.1530/JOE-12-0147; Raghavendra V, 2000, EUR J PHARMACOL, V409, P279, DOI 10.1016/S0014-2999(00)00849-9; Rudra DS, 2013, J PINEAL RES, V54, P398, DOI 10.1111/jpi.12034; Sabapathy V, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/132172; Samini F, 2013, PHARMACOL BIOCHEM BE, V110, P238, DOI 10.1016/j.pbb.2013.07.019; Schiaveto-de-Souza A, 2013, BRAZ J MED BIOL RES, V46, P348, DOI 10.1590/1414-431X20132322; Shen ZL, 2017, NEUROCHEM RES, V42, P2336, DOI 10.1007/s11064-017-2251-7; Shibata N, 2005, NEUROBIOL AGING, V26, P1011, DOI 10.1016/j.neurobiolaging.2004.09.004; Shields SD, 2003, J PAIN, V4, P465, DOI 10.1067/S1526-5900(03)00781-8; Small CD, 2016, NEURAL REGEN RES, V11, P357, DOI 10.4103/1673-5374.179030; Srinivasan V., 2014, CLIN PRACTICE, DOI [10.1007/978-81-322-0825-9, DOI 10.1007/978-81-322-0825-9]; StetlerStevenson WG, 1996, AM J PATHOL, V148, P1345; Swarnakar S, 2011, J PINEAL RES, V50, P8, DOI 10.1111/j.1600-079X.2010.00812.x; Trivedi A, 2006, CLIN NEUROSCI RES, V6, P283, DOI 10.1016/j.cnr.2006.09.007; Tu YJ, 2004, PAIN, V109, P340, DOI 10.1016/j.pain.2004.01.027; Wells JEA, 2003, J NEUROSCI, V23, P10107, DOI 10.1523/jneurosci.23-31-10107.2003; Wu HJ, 2016, J PINEAL RES, V61, P241, DOI 10.1111/jpi.12344; Xu GH, 2019, J CELL BIOCHEM, V120, P5183, DOI 10.1002/jcb.27794; Xu LY, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00690; Yang R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084733; Yu CX, 2000, EUR J PHARMACOL, V403, P49, DOI 10.1016/S0014-2999(00)00421-0; Zahn PK, 2003, J PINEAL RES, V35, P24, DOI 10.1034/j.1600-079X.2003.00047.x; Zhang HQ, 2011, NEUROTHERAPEUTICS, V8, P206, DOI 10.1007/s13311-011-0038-0; Zhang PX, 2015, AM J TRANSL RES, V7, P2223; Zhang Y, 2018, J PINEAL RES, V64, DOI 10.1111/jpi.12449; Zhou X, 2014, NEURAL REGEN RES, V9, P1787, DOI 10.4103/1673-5374.143423; Zu JN, 2014, ACTA HISTOCHEM, V116, P1331, DOI 10.1016/j.acthis.2014.08.004; Zurowski D, 2012, J PHYSIOL PHARMACOL, V63, P641	79	2	2	0	0	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1874-4672	1874-4702		CURR MOL PHARMACOL	Curr. Molec. Pharmacol.		2021	14	4					646	657		10.2174/1874467213666201230101811			12	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	UY8VX	WOS:000701796100015	33380311				2022-02-06	
J	Fok, C; Bogosanovic, M; Pandya, M; Telang, R; Thorne, PR; Vlajkovic, SM				Fok, Christine; Bogosanovic, Milan; Pandya, Madhavi; Telang, Ravindra; Thorne, Peter R.; Vlajkovic, Srdjan M.			Regulator of G Protein Signalling 4 (RGS4) as a Novel Target for the Treatment of Sensorineural Hearing Loss	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						sensorineural hearing loss; noise-induced cochlear injury; cochlear rescue; otoprotection; adenosine A(1) receptor; regulator of G protein signalling 4; CCG-4986; intratympanic drug delivery	ADENOSINE RECEPTORS; HAIR CELL; EXPRESSION; SUSCEPTIBILITY; DEGENERATION; SELECTIVITY; INHIBITION; MECHANISMS; COCHLEA; INJURY	We and others have previously identified signalling pathways associated with the adenosine A(1) receptor (A(1)R) as important regulators of cellular responses to injury in the cochlea. We have shown that the "post-exposure" treatment with adenosine A(1)R agonists confers partial protection against acoustic trauma and other forms of sensorineural hearing loss (SNHL). The aim of this study was to determine if increasing A(1)R responsiveness to endogenous adenosine would have the same otoprotective effect. This was achieved by pharmacological targeting of the Regulator of G protein Signalling 4 (RGS4). RGS proteins inhibit signal transduction pathways initiated by G protein-coupled receptors (GPCR) by enhancing GPCR deactivation and receptor desensitisation. A molecular complex between RGS4 and neurabin, an intracellular scaffolding protein expressed in neural and cochlear tissues, is the key negative regulator of A(1)R activity in the brain. In this study, Wistar rats (6-8 weeks) were exposed to traumatic noise (110 dBSPL, 8-16 kHz) for 2 h and a small molecule RGS4 inhibitor CCG-4986 was delivered intratympanically in a Poloxamer-407 gel formulation for sustained drug release 24 or 48 h after noise exposure. Intratympanic administration of CCG-4986 48 h after noise exposure attenuated noise-induced permanent auditory threshold shifts by up to 19 dB, whilst the earlier drug administration (24 h) led to even better preservation of auditory thresholds (up to 32 dB). Significant improvement of auditory thresholds and suprathreshold responses was linked to improved survival of sensorineural tissues and afferent synapses in the cochlea. Our studies thus demonstrate that intratympanic administration of CCG-4986 can rescue cochlear injury and hearing loss induced by acoustic overexposure. This research represents a novel paradigm for the treatment of various forms of SNHL based on regulation of GPCR.	[Fok, Christine; Bogosanovic, Milan; Pandya, Madhavi; Telang, Ravindra; Thorne, Peter R.; Vlajkovic, Srdjan M.] Univ Auckland, Dept Physiol, Fac Med & Hlth Sci, Private Bag 92019, Auckland 1142, New Zealand; [Fok, Christine; Bogosanovic, Milan; Pandya, Madhavi; Telang, Ravindra; Thorne, Peter R.; Vlajkovic, Srdjan M.] Univ Auckland, Eisdell Moore Ctr, Fac Med & Hlth Sci, Private Bag 92019, Auckland 1142, New Zealand		Vlajkovic, SM (corresponding author), Univ Auckland, Dept Physiol, Fac Med & Hlth Sci, Private Bag 92019, Auckland 1142, New Zealand.	c.fok@auckland.ac.nz; milan.bogosanovic@uq.net.au; m.pandya@auckland.ac.nz; r.telang@auckland.ac.nz; pr.thorne@auckland.ac.nz; s.vlajkovic@auckland.ac.nz		Vlajkovic, Srdjan/0000-0001-8548-6844	Auckland Medical Research Foundation (New Zealand)	This study was supported by a research grant from the Auckland Medical Research Foundation (New Zealand).	Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; Blazer LL, 2015, ACS CHEM NEUROSCI, V6, P911, DOI 10.1021/acschemneuro.5b00063; Chen GD, 2003, HEARING RES, V177, P81, DOI 10.1016/S0378-5955(02)00802-X; Chen YJ, 2012, J NEUROSCI, V32, P2683, DOI 10.1523/JNEUROSCI.4125-11.2011; Cunha Rodrigo A, 2005, Purinergic Signal, V1, P111, DOI 10.1007/s11302-005-0649-1; Dror AA, 2010, NEURON, V68, P293, DOI 10.1016/j.neuron.2010.10.011; Ford MS, 1997, HEARING RES, V105, P130, DOI 10.1016/S0378-5955(96)00204-3; Furman AC, 2013, J NEUROPHYSIOL, V110, P577, DOI 10.1152/jn.00164.2013; Gunewardene N., 2013, WORLD J OTORHINOLARY, V3, P100, DOI [10.5319/wjo.v3.i3.100, DOI 10.5319/WJO.V3.I3.100]; Hayes MP, 2018, MOL PHARMACOL, V93, P25, DOI 10.1124/mol.117.109843; Hurst JH, 2009, BIOCHEM PHARMACOL, V78, P1289, DOI 10.1016/j.bcp.2009.06.028; Kaur T, 2016, J NEUROSCI, V36, P3962, DOI 10.1523/JNEUROSCI.3111-15.2016; Kimple AJ, 2007, BBA-PROTEINS PROTEOM, V1774, P1213, DOI 10.1016/j.bbapap.2007.06.002; Kujawa SG, 2015, HEARING RES, V330, P191, DOI 10.1016/j.heares.2015.02.009; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Kurabi A, 2017, HEARING RES, V349, P129, DOI 10.1016/j.heares.2016.11.013; Liberman LD, 2015, JARO-J ASSOC RES OTO, V16, P205, DOI 10.1007/s10162-015-0510-3; Liberman MC, 2016, ADV EXP MED BIOL, V875, P1, DOI 10.1007/978-1-4939-2981-8_1; Lin HW, 2011, JARO-J ASSOC RES OTO, V12, P605, DOI 10.1007/s10162-011-0277-0; Lin SCY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00207; Mittmann C, 2002, CARDIOVASC RES, V55, P778, DOI 10.1016/S0008-6363(02)00459-5; Neubig RR, 2015, PROG MOL BIOL TRANSL, V133, P13, DOI 10.1016/bs.pmbts.2015.04.010; Oishi N, 2011, EXPERT OPIN EMERG DR, V16, P235, DOI 10.1517/14728214.2011.552427; Ramkumar V, 2004, HEARING RES, V188, P47, DOI 10.1016/S0378-5955(03)00344-7; Riddle EL, 2005, CIRC RES, V96, P401, DOI 10.1161/01.RES.0000158287.49872.4e; Roman DL, 2010, MOL PHARMACOL, V78, P360, DOI 10.1124/mol.109.063388; SCHUKNECHT H F, 1955, J Laryngol Otol, V69, P75, DOI 10.1017/S0022215100050465; Sha SH, 2001, HEARING RES, V155, P1, DOI 10.1016/S0378-5955(01)00224-6; Sheth S, 2014, INT J MOL SCI, V15, P2024, DOI 10.3390/ijms15022024; Sjogren B, 2010, PROG MOL BIOL TRANSL, V91, P81, DOI 10.1016/S1877-1173(10)91004-1; Sjogren B, 2017, BRIT J PHARMACOL, V174, P427, DOI 10.1111/bph.13716; SOHMER H, 1981, ARCH OTO-RHINO-LARYN, V230, P189, DOI 10.1007/BF00456149; Suzuki J, 2016, SCI REP-UK, V6, DOI 10.1038/srep24907; Viberg A, 2004, HEARING RES, V197, P1, DOI 10.1016/j.heares.2004.04.016; Vlajkovic SM, 2007, CELL TISSUE RES, V328, P461, DOI 10.1007/s00441-006-0374-2; Vlajkovic SM, 2017, HEARING RES, V345, P43, DOI 10.1016/j.heares.2016.12.015; Vlajkovic SM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/841489; Vlajkovic SM, 2011, EXP GERONTOL, V46, P905, DOI 10.1016/j.exger.2011.08.001; Vlajkovic SM, 2010, PURINERG SIGNAL, V6, P273, DOI 10.1007/s11302-010-9188-5; Vlajkovic SM, 2009, CURR NEUROPHARMACOL, V7, P246, DOI 10.2174/157015909789152155; Wan GQ, 2015, HEARING RES, V329, P1, DOI 10.1016/j.heares.2015.04.008; Wang XB, 2009, AUDIOL NEURO-OTOL, V14, P393, DOI 10.1159/000241896; Wong ACY, 2010, HEARING RES, V260, P81, DOI 10.1016/j.heares.2009.12.004; World Health Organization, 2020, DEAFN HEAR LOSS	44	2	2	1	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	JAN	2021	22	1							3	10.3390/ijms22010003			19	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	PP8MH	WOS:000606109600001	33374915	Green Published, gold			2022-02-06	
J	Gregory, A; Poddar, S				Gregory, Andrew; Poddar, Sourav			Diagnosis and Sideline Management of Sport-Related Concussion	CLINICS IN SPORTS MEDICINE			English	Article						Concussion; Sports; Diagnosis; Sideline; Evaluation			[Gregory, Andrew] Vanderbilt Univ, Med Ctr, Vanderbilt Sports Med, Med Ctr East, Suite 3200, Nashville, TN 37232 USA; [Poddar, Sourav] Univ Colorado, Family Med & Orthoped, Sch Med, CU Sports Med Ctr, 2000 South Colorado Blvd,Colorado Ctr Tower One, Denver, CO 80222 USA		Gregory, A (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Sports Med, Med Ctr East, Suite 3200, Nashville, TN 37232 USA.	andrew.gregory@vumc.org					Breedlove KM, 2019, J ATHL TRAINING, V54, P1241, DOI 10.4085/1062-6050-219-18; Doperak J, 2019, CLIN SPORT MED, V38, P497, DOI 10.1016/j.csm.2019.06.003; Echemendia RJ, 2017, BRIT J SPORT MED, V51, DOI DOI 10.1136/BJSPORTS-2017-097506; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Legarreta AD, 2019, OPEN ACCESS J SPORTS, V10, P115, DOI 10.2147/OAJSM.S171815; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Mack C, 2019, J ATHL TRAINING, V54, P852, DOI 10.4085/1062-6050-181-19; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Norheim N, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000412; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Putukian M, 2017, J ATHL TRAINING, V52, P236, DOI 10.4085/1062-6050-52.1.08; Whitney SL, 2020, BRAIN INJURY, V34, P842, DOI 10.1080/02699052.2020.1755055	16	2	2	1	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	JAN	2021	40	1					53	63		10.1016/j.csm.2020.08.011			11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	PE8NO	WOS:000598618400006	33187613				2022-02-06	
J	Haider, MN; Herget, L; Zafonte, RD; Lamm, AG; Wong, BM; Leddy, JJ				Haider, Mohammad Nadir; Herget, Lenore; Zafonte, Ross D.; Lamm, Adam G.; Wong, Bonnie M.; Leddy, John J.			Rehabilitation of Sport-Related Concussion	CLINICS IN SPORTS MEDICINE			English	Article						Sport-related concussion; Rehabilitation; Exercise tolerance; Sub-symptom threshold exercise prescription	PHYSICAL-EXAMINATION TESTS; CERVICOGENIC HEADACHE; DIAGNOSTIC VALIDITY; SPURLING TEST; EYE-MOVEMENT; BLOOD-FLOW; EXERCISE; BRAIN; RECOVERY; PAIN		[Haider, Mohammad Nadir; Leddy, John J.] SUNY Buffalo, UBMD Orthopaed & Sports Med, Concuss Management Clin & Res Ctr, 160 Farber Hall, Buffalo, NY 14214 USA; [Herget, Lenore] Massachusetts Gen Hosp, MGH Sports Med, New England Patriots, Boston Bruins Boston Celt New England Revolut & B, 55 Fruit St, Boston, MA 02114 USA; [Zafonte, Ross D.; Lamm, Adam G.; Wong, Bonnie M.] Harvard Med Sch, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Massachusetts Gen Hosp,Brigham & Womens Hosp, 25 Shattuck St, Boston, MA 02115 USA		Leddy, JJ (corresponding author), SUNY Buffalo, UBMD Orthopaed & Sports Med, Concuss Management Clin & Res Ctr, 160 Farber Hall, Buffalo, NY 14214 USA.	leddy@buffalo.edu					Abraham Neethu G, 2015, Oman J Ophthalmol, V8, P14, DOI 10.4103/0974-620X.149856; Ahlskog JE, 2011, MAYO CLIN PROC, V86, P876, DOI 10.4065/mcp.2011.0252; Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Arciniegas, 2019, TXB TRAUMATIC BRAIN, P677; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; BARNSLEY L, 1995, SPINE, V20, P20, DOI 10.1097/00007632-199501000-00004; Bhattacharyya N, 2017, OTOLARYNG HEAD NECK, V156, pS1, DOI 10.1177/0194599816689667; Bin Zahid A, 2018, CLIN J SPORT MED; BOGDUK N, 1992, J MANIP PHYSIOL THER, V15, P67; Bogduk N, 2009, LANCET NEUROL, V8, P959, DOI 10.1016/S1474-4422(09)70209-1; Brinjikji W, 2015, AM J NEURORADIOL, V36, P811, DOI 10.3174/ajnr.A4173; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Campbell DG, 1944, J NERV MENT DIS, V99, P544, DOI 10.1097/00005053-194405000-00009; Carrick FR, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00414; Chang CW, 2011, EUR SPINE J, V20, P923, DOI 10.1007/s00586-010-1681-6; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Cole A, 1998, FUNCTIONAL REHABILIT, P127; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Coupe M, 2009, RESP PHYSIOL NEUROBI, V169, pS10, DOI 10.1016/j.resp.2009.04.009; CROCK HV, 1970, MED J AUSTRALIA, V1, P983, DOI 10.5694/j.1326-5377.1970.tb116676.x; Davidoff RA, 1998, CEPHALALGIA, V18, P436, DOI 10.1046/j.1468-2982.1998.1807436.x; Dematteo C, 2015, MED SCI SPORT EXER, V47, P2283, DOI 10.1249/MSS.0000000000000682; Du W., 2018, CLIN J SPORT MED, DOI 10.1097/JSM.0000000000000687; Ellenbogen RG, 2018, BRIT J SPORT MED, V52, P894, DOI 10.1136/bjsports-2018-099203; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Fife TD, 2013, POSTTRAUMATIC VERTIG; Garcia JD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00040; Gauvin-Lepage J, 2018, CLIN J SPORT MED; Gibbons RJ, 2002, J AM COLL CARDIOL, V40, P1531, DOI 10.1016/S0735-1097(02)02164-2; Glaser J A, 2001, Iowa Orthop J, V21, P49; Grabowski P, 2017, PHYS THER SPORT, V23, P22, DOI 10.1016/j.ptsp.2016.06.001; Griesbach GS, 2012, J NEUROTRAUM, V29, P1426, DOI 10.1089/neu.2011.2229; Haider MN, 2019, SPORTS HEALTH, V11, P492, DOI 10.1177/1941738119870189; Haider MN, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00395; Hall TM, 2008, J MANIP PHYSIOL THER, V31, P293, DOI 10.1016/j.jmpt.2008.03.012; Hammond FM, 2012, BRAIN INJURY MED PRI, P635; Hecht JS, 2004, J HEAD TRAUMA REHAB, V19, P58, DOI 10.1097/00001199-200401000-00006; Heick JD, 2017, INT J SPORTS PHYS TH, V12, P581; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Howel DR, 2017, J APPL BIOMECH, V33, P24, DOI 10.1123/jab.2015-0323; Howell DR, 2019, J ATHL TRAINING, V54, P1254, DOI 10.4085/1062-6050-525-18; Howell DR, 2018, CLIN J SPORT MED; Hutting N, 2013, PHYS THER, V93, P1686, DOI 10.2522/ptj.20130186; Iwanaga J, 2017, WORLD NEUROSURG, V100, P590, DOI 10.1016/j.wneu.2017.01.038; JACKSON R, 1982, GERIATRICS, V37, P123; Johnston W, 2017, QJM-INT J MED, V110, P779, DOI 10.1093/qjmed/hcw228; Jull G, 2002, SPINE, V27, P1835, DOI 10.1097/00007632-200209010-00004; Kaneoka K, 1999, SPINE, V24, P763, DOI 10.1097/00007632-199904150-00006; Karthikeyan Siddharth Karuppasamy, 2019, Oman J Ophthalmol, V12, P73, DOI 10.4103/ojo.OJO_226_2018; Kolev OI, 2016, FUNCT NEUROL, V31, P75; Kontos AP, 2020, JAMA NEUROL, V77, P435, DOI 10.1001/jamaneurol.2019.4552; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Kristjansson E, 2009, J ORTHOP SPORT PHYS, V39, P364, DOI 10.2519/jospt.2009.2834; Lawrence DW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196062; Lawrence JB, 2019, J NEUROL SCI, V398, P91, DOI 10.1016/j.jns.2018.12.020; Leddy J, 2017, J ATHL TRAINING, V52, P299, DOI 10.4085/1062-6050-51.11.08; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2018, CURR OPIN NEUROL, V31, P681, DOI 10.1097/WCO.0000000000000611; Leddy JJ, 2019, CLIN J SPORT MED, V29, P353, DOI 10.1097/JSM.0000000000000663; Leddy JJ, 2018, CURR SPORT MED REP, V17, P262, DOI 10.1249/JSR.0000000000000505; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Luedtke K, 2016, MANUAL THER, V23, P17, DOI 10.1016/j.math.2016.02.010; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P273, DOI 10.1080/87565641.2015.1067706; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Maruta J, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00611; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; MENSE S, 1993, PAIN, V54, P241, DOI 10.1016/0304-3959(93)90027-M; Micay R, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000404; Mitchell JA, 2003, J MANIP PHYSIOL THER, V26, P347, DOI 10.1016/S0161-4754(03)00074-5; Morganroth J, 2014, NEUROLOGY, V82, P267; Morin Michael, 2016, J Sports Med (Hindawi Publ Corp), V2016, P1590161, DOI 10.1155/2016/1590161; Ogince M, 2007, MANUAL THER, V12, P256, DOI 10.1016/j.math.2006.06.016; Oliva M, 1998, Acta Otorrinolaringol Esp, V49, P275; Orr R, 2018, CLIN J SPORT MED; Osmotherly PG, 2012, PHYS THER, V92, P718, DOI 10.2522/ptj.20110261; Pearson AM, 2004, SPINE, V29, P390, DOI 10.1097/01.BRS.0000090836.50508.F7; PERES G, 1987, J SPORT MED PHYS FIT, V27, P205; Rubio-Ochoa J, 2016, MANUAL THER, V21, P35, DOI 10.1016/j.math.2015.09.008; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Shabat S, 2012, J NEUROIMAGING, V22, P375, DOI 10.1111/j.1552-6569.2011.00644.x; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Tong HC, 2002, SPINE, V27, P156; Travell JG., 1983, MYOFASCIAL PAIN DYSF; Treleaven J, 2003, J REHABIL MED, V35, P36, DOI 10.1080/16501970306109; Treleaven J, 2008, MANUAL THER, V13, P2, DOI 10.1016/j.math.2007.06.003; UITVLUGT G, 1988, ARTHRITIS RHEUM, V31, P918, DOI 10.1002/art.1780310715; Von Noorden G., 2002, BINOCULAR VISION OCU, V6th ed, P52; Yin W, 2008, PAIN MED, V9, P1022, DOI 10.1111/j.1526-4637.2008.00493.x; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411; Zasler N. D., 2012, BRAIN INJURY MED PRI; Zasler N, 2019, J HEAD TRAUMA REHAB, V34, P409, DOI 10.1097/HTR.0000000000000524; Zasler ND, 2013, MANAGEMENT ADULTS TR, P395; Zhao Y, 2018, IRF2018: PROCEEDINGS OF THE 6TH INTERNATIONAL CONFERENCE ON INTEGRITY-RELIABILITY-FAILURE, P507	102	2	2	6	15	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	JAN	2021	40	1					93	109		10.1016/j.csm.2020.08.003			17	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	PE8NO	WOS:000598618400009	33187616				2022-02-06	
J	Houston, MN; Van Pelt, KL; D'Lauro, C; Brodeur, RM; Campbell, DE; McGinty, GT; Jackson, JC; Kelly, TF; Peck, KY; Svoboda, SJ; McAllister, TW; McCrea, MA; Broglio, SP; Cameron, KL				Houston, Megan N.; Van Pelt, Kathryn L.; D'Lauro, Christopher; Brodeur, Rachel M.; Campbell, Darren E.; McGinty, Gerald T.; Jackson, Jonathan C.; Kelly, Tim F.; Peck, Karen Y.; Svoboda, Steven J.; McAllister, Thomas W.; McCrea, Michael A.; Broglio, Steven P.; Cameron, Kenneth L.			Test-Retest Reliability of Concussion Baseline Assessments in United States Service Academy Cadets: A Report from the National Collegiate Athletic Association (NCAA)-Department of Defense (DoD) CARE Consortium	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Mild traumatic brain injury; Neuropsychological tests; Balance; Symptoms; Neurocognitive; Change score	NEUROCOGNITIVE ASSESSMENT TOOLS; TRAUMATIC BRAIN-INJURY; RELIABLE CHANGE; SPORT; VALIDITY; IMPACT	Objective: In response to advancing clinical practice guidelines regarding concussion management, service members, like athletes, complete a baseline assessment prior to participating in high-risk activities. While several studies have established test stability in athletes, no investigation to date has examined the stability of baseline assessment scores in military cadets. The objective of this study was to assess the test-retest reliability of a baseline concussion test battery in cadets at U.S. Service Academies. Methods: All cadets participating in the Concussion Assessment, Research, and Education (CARE) Consortium investigation completed a standard baseline battery that included memory, balance, symptom, and neurocognitive assessments. Annual baseline testing was completed during the first 3 years of the study. A two-way mixed-model analysis of variance (intraclass correlation coefficent (ICC)(3,1)) and Kappa statistics were used to assess the stability of the metrics at 1-year and 2-year time intervals. Results: ICC values for the 1-year test interval ranged from 0.28 to 0.67 and from 0.15 to 0.57 for the 2-year interval. Kappa values ranged from 0.16 to 0.21 for the 1-year interval and from 0.29 to 0.31 for the 2-year test interval. Across all measures, the observed effects were small, ranging from 0.01 to 0.44. Conclusions: This investigation noted less than optimal reliability for the most common concussion baseline assessments. While none of the assessments met or exceeded the accepted clinical threshold, the effect sizes were relatively small suggesting an overlap in performance from year-to-year. As such, baseline assessments beyond the initial evaluation in cadets are not essential but could aid concussion diagnosis.	[Houston, Megan N.; Cameron, Kenneth L.] Keller Army Hosp, John A Feagin Jr Sports Med Fellowship, 900 Washington Rd, West Point, NY 10996 USA; [Van Pelt, Kathryn L.] Univ Kentucky, Lexington, KY 40526 USA; [D'Lauro, Christopher; McGinty, Gerald T.; Jackson, Jonathan C.] US Air Force Acad, Colorado Springs, CO 80840 USA; [Brodeur, Rachel M.] US Coast Guard Acad, New London, CT 06320 USA; [Campbell, Darren E.] Logan Reg Orthoped, Logan, UT 84341 USA; [Kelly, Tim F.; Peck, Karen Y.] US Mil Acad, West Point, NY 10996 USA; [Svoboda, Steven J.] MedStar Orthopaed Inst, Washington, DC 20036 USA; [McAllister, Thomas W.] Indiana Univ, Dept Psychiat, Indianapolis, IN 46202 USA; [McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA		Houston, MN (corresponding author), Keller Army Hosp, John A Feagin Jr Sports Med Fellowship, 900 Washington Rd, West Point, NY 10996 USA.	megan.n.houston.ctr@mail.mil		Van Pelt, Kathryn/0000-0002-5494-2357; D'Lauro, Christopher/0000-0003-0894-6602	Grand Alliance Concussion Assessment, Research, and Education Consortium - National Collegiate Athletic Association; Department of DefenseUnited States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]; U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, USA	The authors would like to thank Bonnie Campbell, Lisa Campbell, Megan Jackson, Jennifer Miley, Joel Robb, and Kim Robb (United States Air Force Academy), Robin Miller and Jarrett Headley (United States Coast Guard Academy), Stephanie Carminati, Steven Malvasi, Story Miraldi, Jamie Reilly, Sean Roach, and Jesse Trump (United States Military Academy) for data acquisition, as well as, the research and medical staff that assisted with baseline data collection at each of the service academy sites. The authors would also like to thank Jaroslaw Harezlak, Jody Harland, Janetta Matesan, Larry Riggen (Indiana University), Ashley Rettmann, Nicole L'Heureux (University of Michigan), Melissa Koschnitzke (Medical College of Wisconsin), Michael Jarrett, Vibeke Brinck, and Bianca Byrne (Quesgen), Thomas Dompier, Erin B. Wasserman, Melissa Niceley Baker, and Sara Quetant (Datalys Center for Sports Injury Research and Prevention). This publication was made possible, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education Consortium, funded by the National Collegiate Athletic Association and the Department of Defense. The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014, USA is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award no. W81XWH-14-2-0151. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense (Defense Health Program funds).	[Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; [Anonymous], 2016, J CHIROPR MED, V15, P155, DOI DOI 10.1016/J.JCM.2016.02.012; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Barth JT, 1989, MILD HEAD INJURY, P257; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2008, CLIN J SPORT MED, V18, P148, DOI 10.1097/JSM.0b013e318164f42a; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2019, SPORTS MED, V49, P1977, DOI 10.1007/s40279-019-01155-0; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Cameron KL, 2012, J NEUROTRAUM, V29, P1313, DOI 10.1089/neu.2011.2168; Centers for Disease Control and Prevention, 2016, BAS INF TRAUM BRAIN; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Cohen J., 1988, STAT POWER ANAL BEHA; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Defense and Veterans Brain Injury Center, 2018, DEP DEF WORLDW NUMB; Department of Defense, 2015, DEP DEF INSTR 6490 1; Farnsworth JL, 2017, J ATHL TRAINING, V52, P826, DOI 10.4085/1062-6050-52.6.03; Grilo L. M., 2012, BIOMETRICAL LETT, V49, P45; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; Hoffman J.I., 2015, BIOSTATISTICS MED BI, P451, DOI DOI 10.1016/B978-0-12-802387-7.00027-5; Iverson G.L., 2011, ENCY CLIN NEUROPSYCH, P2150; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Lancaster MA, 2016, CLIN NEUROPSYCHOL, V30, P321, DOI 10.1080/13854046.2016.1138504; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leahy S., 2011, US TODAY; Lichtenstein JD, 2014, AM J SPORT MED, V42, P479, DOI 10.1177/0363546513509225; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Mehta S, 2018, STAT MED, V37, P2734, DOI 10.1002/sim.7679; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Ratcliff R, 2016, TRENDS COGN SCI, V20, P260, DOI 10.1016/j.tics.2016.01.007; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100107-01, 10.3928/02793695-20100108-02]; Vokaty S, 2013, BRIT J SPORT MED, V47, pe1, DOI [10.1136/bjsports-2012-092101.18, DOI 10.1136/BJSPORTS-2012-092101.18]	45	2	2	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2021	27	1					23	34	PII S1355617720000594	10.1017/S1355617720000594			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	PY4ML	WOS:000612019900003	32539884				2022-02-06	
J	Huang, GR; Hao, FG				Huang, Gui-Rong; Hao, Feng-Guan			Dexmedetomidine Inhibits Inflammation to Alleviate Early Neuronal Injury via TLR4/NF-kappa B Pathway in Rats with Traumatic Brain Injury	CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION			English	Article						dexinedetomidine; traumatic brain injury; TLR4/NF-kappa B pathway; cortical neuron autophagy	CEREBRAL-CORTEX; OXYMATRINE; HEART	Purpose - This study aims to explore the potential mechanism of dexmedetomidine in terms of inhibiting inflammation to alleviate early neuronal injury via TLR4/NF-kappa B pathway in rats with traumatic brain injury. Methods - The model of brain injury was established in rats. After the model was established, the rats were randomly divided into five groups: Sham, Sham + DEX, TBI, TBI + vehicle, and TBI + DEX. Each group included 10 rats. The water content in the brain tissue was measured. Thrminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assays were performed on histopathological tissue sections to evaluate neuronal apoptosis. Enzyme-linked immunosorbent assay and PCR were applied to detect the levels of the inflammatory factors, TNF-alpha, IL-1 beta, IL-6, and NF-kappa B. Results - TBI-challenged rats exhibited significant neuronal apoptosis, which was characterized via the wet-to-dry weight ratio, neurobehavioral functions, TUNEL assay results, and the levels of cleaved caspase-3, Bax upregulation, and Bcl-2, which were attenuated by DEX. Western blot, immunohistochemistry, and PCR results revealed that DEX promoted TLR4 expression and upregulated expression of the TLR4 downstream factors, HO-1 and NQO-1. Furthermore, DEX treatment markedly prevented the downregulation of inflammatory response factors, TNF-alpha, IL-1 beta and NF-kappa B, and IL-6. Conclusion - Dexmedetomidine is able to inhibit inflammation and attenuate early neuronal injury in rats with acute brain injury, which may act on TLR4/NF-kappa B pathway.	[Huang, Gui-Rong] Linyi Cent Hosp, Dept Anesthesiol, 17 Jiankang Rd, Linyi 276400, Shandong, Peoples R China; [Hao, Feng-Guan] Yishui Longjiaxuan St Community Hlth Serv Ctr, Linyi, Shandong, Peoples R China		Huang, GR (corresponding author), Linyi Cent Hosp, Dept Anesthesiol, 17 Jiankang Rd, Linyi 276400, Shandong, Peoples R China.	ktfzng@163.com					Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Cui LL, 2011, NEUROL RES, V33, P319, DOI 10.1179/016164110X12759951866876; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Fan HG, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/704706; Florian B, 2008, NEUROSCI LETT, V438, P180, DOI 10.1016/j.neulet.2008.04.020; Gan RT, 2011, PLANTA MED, V77, P226, DOI 10.1055/s-0030-1250256; Hu ST, 2011, J PHYSIOL SCI, V61, P363, DOI 10.1007/s12576-011-0154-y; Kunz A, 2010, BEST PRACT RES-CLIN, V24, P495, DOI 10.1016/j.bpa.2010.10.001; Li GZ, 2011, BRAIN RES, V1396, P96, DOI 10.1016/j.brainres.2011.04.014; Liu Y, 2009, BRAIN RES, V1268, P174, DOI 10.1016/j.brainres.2009.02.069; Ng G, 2005, MOL CARCINOGEN, V43, P183, DOI 10.1002/mc.20097; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Shen XC, 2011, J ASIAN NAT PROD RES, V13, P215, DOI 10.1080/10286020.2010.550883; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Wang YP, 2011, ANTIVIR RES, V89, P227, DOI 10.1016/j.antiviral.2011.01.005; Wang Z, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/848309; Xu GL, 2005, J ETHNOPHARMACOL, V98, P177, DOI 10.1016/j.jep.2005.01.026; Xu WS, 2010, WORLD J GASTROENTERO, V16, P2028, DOI 10.3748/wjg.v16.i16.2028; Yong-Gang C, 2010, PHYTOTHER RES, V24, P1844, DOI 10.1002/ptr.3206; Zhao JP, 2008, SURG TODAY, V38, P931, DOI 10.1007/s00595-008-3785-8	20	2	2	1	1	BEGELL HOUSE INC	DANBURY	50 NORTH ST, DANBURY, CT 06810 USA	1045-4403	2162-6502		CRIT REV EUKAR GENE	Crit. Rev. Eukaryot. Gene Expr.		2021	31	1											8	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	QS5TV	WOS:000625963400005	33639054				2022-02-06	
J	Khandelwal, A; Jangra, K; Katikar, MD; Durga, P; Rao, GSUM				Khandelwal, Ankur; Jangra, Kiran; Katikar, Manisha D.; Durga, Padmaja; Rao, G. S. Uma Maheswara			Choosing Neuroanaesthesia as a career: Marching towards new horizons	INDIAN JOURNAL OF ANAESTHESIA			English	Article						Anaesthesiology; curriculum; neurosciences; neurosurgery	TOTAL INTRAVENOUS ANESTHESIA; TRAUMATIC BRAIN-INJURY; GENERAL-ANESTHESIA; NEUROSURGERY; MANAGEMENT; OUTCOMES; SEVOFLURANE; MULTICENTER; HYPOTHERMIA; CRANIOTOMY	Anaesthesiology is an ever-changing science and amongst its sub-specialities, the field of neuroanaesthesia is making rapid strides. The fragility of the brain and spinal cord and the multitude of complexities involved in neurosurgery and interventional neuroradiological procedures demand dedicated training in neuroanaesthesia. With rapid advancement in other neuroscience specialties, neuroanaesthesia too has made outstanding progress, owing to establishment of structured training, publication of high-quality scientific research, and invention of novel medications and monitoring modalities. The opportunities for training in India and abroad and resources to broaden knowledge in neuroanaesthesia have increased over the last two decades. A career in neuroanaesthesia offers a great future for budding anaesthesiologists.	[Khandelwal, Ankur] Sharda Univ, Sch Med Sci & Res, Dept Anaesthesia & Crit Care, Greater Noida, Uttar Pradesh, India; [Khandelwal, Ankur] Sharda Univ, Sharda Hosp, Greater Noida, Uttar Pradesh, India; [Jangra, Kiran] PGIMER, Dept Anaesthesia & Intens Care, Chandigarh, India; [Katikar, Manisha D.] Balwant Inst Neurosurg & Intens Trauma Care, Solapur, Maharashtra, India; [Durga, Padmaja] Nizams Inst Med Sci, Dept Anaesthesiol & Intens Care, Hyderabad 500089, Telangana, India; [Rao, G. S. Uma Maheswara] Natl Inst Mental Hlth & Neurosci, Dept Neuronaesthesia, Bengaluru, Karnataka, India		Durga, P (corresponding author), Nizams Inst Med Sci, Dept Anaesthesiol & Intens Care, Hyderabad 500089, Telangana, India.	padmajanims@yahoo.com	Khandelwal, Ankur/AAW-1717-2020	Khandelwal, Ankur/0000-0002-7915-9158			Ali ZS, 2019, J NEUROSURG-SPINE, V30, P532, DOI 10.3171/2018.9.SPINE18681; Balakrishnan S, 2022, J NEUROSURG ANESTH, V34, pE52, DOI 10.1097/ANA.0000000000000706; Balkarli H, 2017, REV BRAS ANESTESIOL, V67, P205, DOI [10.1016/j.bjane.2014.07.007, 10.1016/j.bjan.2016.08.004]; BINGHAM WF, 1973, J NEUROSURG, V39, P568, DOI 10.3171/jns.1973.39.5.0568; Biscevic M, 2020, EFORT OPEN REV, V5, P9, DOI 10.1302/2058-5241.5.180032; Brinjikji W, 2015, AM J NEURORADIOL, V36, P525, DOI 10.3174/ajnr.A4159; Builes-Aguilar A, 2018, CURR OPIN ANESTHESIO, V31, P520, DOI 10.1097/ACO.0000000000000628; Calland V, 2005, EMERG MED J, V22, P817, DOI 10.1136/emj.2004.022616; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cole CD, 2007, NEUROSURGERY, V61, P369, DOI 10.1227/01.neu.0000303996.74526.30; Cottrell JE, 2020, J NEUROSURG ANESTH, V32, P9, DOI 10.1097/ANA.0000000000000640; Endo T, 2001, J NEUROSURG ANESTH, V13, P310, DOI 10.1097/00008506-200110000-00005; Guan J, 2016, SPINE, V41, pE416, DOI 10.1097/BRS.0000000000001259; Gupta P, 2018, NEUROL INDIA, V66, P217, DOI 10.4103/0028-3886.222852; Hrishi Ajay Prasad, 2017, Anesth Essays Res, V11, P630, DOI 10.4103/aer.AER_252_16; Hurmath FK, 2016, NEUROCHEM INT, V94, P32, DOI 10.1016/j.neuint.2016.02.003; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Khanna RBP, 2018, J NEUROANAESTHESIOL, V5, P4; Labib MA, 2018, J NEUROSURG SCI, V62, P615, DOI 10.23736/S0390-5616.18.04600-3; Lauta E, 2010, J NEUROSURG ANESTH, V22, P110, DOI 10.1097/ANA.0b013e3181c959da; Lee SH, 2020, J CRIT CARE, V56, P182, DOI 10.1016/j.jcrc.2020.01.006; Li J, 2016, BRIT J ANAESTH, V116, P759, DOI 10.1093/bja/aew096; Mahajan Charu, 2013, Anesth Essays Res, V7, P312, DOI 10.4103/0259-1162.123216; Markandaya M, 2012, NEUROCRIT CARE, V16, P72, DOI 10.1007/s12028-011-9628-2; Martorano PP, 2008, MINERVA ANESTESIOL, V74, P233; McCann ME, 2019, LANCET, V393, P664, DOI 10.1016/S0140-6736(18)32485-1; Meng LZ, 2015, J NEUROSURG ANESTH, V27, P310, DOI 10.1097/ANA.0000000000000179; Miller CM, 2015, NEUROCRIT CARE, V23, pS1, DOI 10.1007/s12028-015-0170-5; Mishra RK KI, 2017, J NEUROANAESTHESIOL, V4, P5; Nagel Simon, 2008, Expert Rev Neurother, V8, P1255, DOI 10.1586/14737175.8.8.1255; Prabhakar H, 2017, CURR OPIN ANESTHESIO, V30, P546, DOI 10.1097/ACO.0000000000000499; Rajan S, 2021, J NEUROSURG ANESTH, V33, P167, DOI 10.1097/ANA.0000000000000655; Schenone AL, 2016, RESUSCITATION, V108, P102, DOI 10.1016/j.resuscitation.2016.07.238; Schulenburg E, 2011, CURR OPIN ANESTHESIO, V24, P426, DOI 10.1097/ACO.0b013e328347ca12; Sef D, 2018, J STROKE CEREBROVASC, V27, P1395, DOI 10.1016/j.jstrokecerebrovasdis.2017.12.030; Sheshadri V, 2018, J NEUROSURG ANESTH, V30, P299, DOI 10.1097/ANA.0000000000000483; Spina A, 2017, WORLD NEUROSURG, V101, P773, DOI 10.1016/j.wneu.2017.02.005; Stevanovic A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156448; Sun LS, 2016, JAMA-J AM MED ASSOC, V315, P2312, DOI 10.1001/jama.2016.6967; Sundararaman LV, 2018, ANESTH ANALG, V126, P322, DOI 10.1213/ANE.0000000000002576; Todd MM, 2005, NEW ENGL J MED, V352, P135, DOI 10.1056/NEJMoa040975; Venkatraghavan L, 2010, ANESTH ANALG, V110, P1138, DOI 10.1213/ANE.0b013e3181d2a782; Voorhees Jennifer R, 2005, Neurosurg Focus, V18, pe2; Vutskits L, 2019, ANESTHESIOLOGY, V131, P762, DOI 10.1097/ALN.0000000000002863; Warner DO, 2018, ANESTHESIOLOGY, V129, P89, DOI 10.1097/ALN.0000000000002232; Xie ZC, 2013, ANESTHESIOLOGY, V119, P501, DOI 10.1097/ALN.0b013e31829e4819; Zhang Q, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1281-y; Zhang Y, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011754	48	2	2	2	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0019-5049	0976-2817		INDIAN J ANAESTH	Indian J. Anaesth.	JAN	2021	65	1					35	42		10.4103/ija.IJA_1531_20			8	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	PX2JA	WOS:000611186100007	33767501	Green Published			2022-02-06	
J	Kim, S; Connaughton, DP				Kim, Sungwon; Connaughton, Daniel P.			Youth Soccer Parents' Attitudes and Perceptions About Concussions	JOURNAL OF ADOLESCENT HEALTH			English	Article						Traumatic brain injury; Adolescent; Youth sport; Injury prevention	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; KNOWLEDGE; HEALTH; COACHES	Purpose: Parents are important figures in properly managing youth sport concussions. Although media attention has predominantly centered on concussions in contact/collision sports, evidence suggests that the concussion rate in soccer is comparable to those found in contact/collision sports. Given the high rate of concussions in youth soccer, this study aimed to examine parents of youth soccer athletes' attitudes and perceptions about concussions and associated factors. Methods: A cross-sectional study was conducted by surveying parents of youth soccer athletes from the five largest organized youth soccer programs across the U.S. The researchers developed a questionnaire after an extensive literature review and by modifying previously used instruments. Results: Overall, 419 parents completed the survey. The vast majority (85%) agreed that a concussion is a serious injury, but only 27.9% believed that their child could suffer a concussion during the next season. Parents were most concerned about permanent brain damage when their child suffers a concussion. The vast majority (4.37 +/- .89) perceived concussion reporting as an important injury prevention strategy. Greater appreciation and perceived risk about concussions was found particularly among parents who received concussion education and those who had witnessed or heard about a concussive incidence(s). Conclusions: Findings suggest that youth soccer parents have high appreciation and perceived risk about concussions. However, the need for more targeted education was noted, as improvements to better manage and reduce concussions can be made. Future research should continue examining youth sport parents' belief and understanding about concussions as well as factors affecting them. (C) 2020 Society for Adolescent Health and Medicine. Published by Elsevier Inc.	[Kim, Sungwon] St Johns Univ, Div Sport Management, Queens, NY USA; [Connaughton, Daniel P.] Univ Florida, Dept Sport Management, Gainesville, FL USA		Kim, S (corresponding author), St Johns Univ, 8000 Utopia Pkwy, Queens, NY 11439 USA.	kims1@stjohns.edu		Connaughton, Daniel/0000-0001-7421-3138			Aust CF, 1996, JOURNALISM MASS COMM, V73, P787, DOI 10.1177/107769909607300403; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Brooks BL, 2018, AM J SPORT MED, V46, P961, DOI 10.1177/0363546517749588; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Concannon LG, 2016, PHYS MED REH CLIN N, V27, P513, DOI 10.1016/j.pmr.2015.12.006; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Craig BM, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2903; D'Amico N, 2017, INT J EXERC SCI, V11, pe35; ESPN, MOST PARENTS HAV STA; ESPN, YOUTH FOOTB PART DRO; Finch C, 2002, INJ PREV, V8, P151, DOI 10.1136/ip.8.2.151; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hunt C, 2018, CAN J NEUROL SCI, V45, P283, DOI 10.1017/cjn.2017.299; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kay MC, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117742370; Kroshus E, 2019, SOC SCI MED, V222, P359, DOI 10.1016/j.socscimed.2018.12.037; Kroshus E, 2018, HEALTH EDUC BEHAV, V45, P254, DOI 10.1177/1090198117715669; Lawrence DW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196062; Levy ML, 2012, WORLD NEUROSURG, V78, P535, DOI 10.1016/j.wneu.2011.10.032; Lin AC, 2015, SPORTS HEALTH, V7, P124, DOI 10.1177/1941738115571570; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Macdonald I, 2016, J NEUROSCI NURS, V48, P297, DOI 10.1097/JNN.0000000000000212; Matthews KA, 2010, ANN NY ACAD SCI, V1186, P146, DOI 10.1111/j.1749-6632.2009.05332.x; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; Mrazik M, 2015, J HEAD TRAUMA REHAB, V30, P219, DOI 10.1097/HTR.0000000000000018; Murphy AM, 2017, SPORT EXERC PERFORM, V6, P230, DOI 10.1037/spy0000102; Nanos KN, 2017, MAYO CLIN PROC, V92, P1782, DOI 10.1016/j.mayocp.2017.10.003; Perloff RM, 2006, AM BEHAV SCI, V49, P835, DOI 10.1177/0002764205283804; Popovich M, 2019, CLIN J SPORT MED, V91, pS15; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rieger B, 2018, CUREUS, V10, DOI 10.7759/cureus.2268; Romaine A, 2016, J CLIN SPORT PSYCHOL, V10, P253, DOI 10.1123/jcsp.2016-0018; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Wahlin T, 2012, AUST NZ J PSYCHIAT, V46, P553, DOI 10.1177/0004867412441929; Weerdenburg K, 2016, PAED CHILD HEALT-CAN, V21, pE22, DOI 10.1093/pch/21.3.e22	40	2	2	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1054-139X	1879-1972		J ADOLESCENT HEALTH	J. Adolesc. Health	JAN	2021	68	1					184	190		10.1016/j.jadohealth.2020.04.029			7	Psychology, Developmental; Public, Environmental & Occupational Health; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Public, Environmental & Occupational Health; Pediatrics	PZ2DI	WOS:000612549900029	32636138	hybrid			2022-02-06	
J	Lai, CQ; Ibrahim, H; Abdullah, JM; Azman, A; Abdullah, MZ				Lai, Chi Qin; Ibrahim, Haidi; Abdullah, Jafri Malin; Azman, Azlinda; Abdullah, Mohd Zaid			Convolutional Neural Network Utilizing Error-Correcting Output Codes Support Vector Machine for Classification of Non-Severe Traumatic Brain Injury From Electroencephalogram Signal	IEEE ACCESS			English	Article						Electroencephalography; Feature extraction; Insurance; Task analysis; Support vector machines; Brain injuries; Biomedical imaging; Accuracy; batch normalization; convolutional neural networks; electroencephalography; data preparation	EEG; IDENTIFICATION; BIOMARKER	A sudden blow or jolt to the human brain called traumatic brain injury (TBI) is one of the most common injuries recorded in the health insurance claim. Generally, computed tomography (CT) or magnetic resonance imaging (MRI) is required to identify the trauma's severity. Unfortunately, CT and MRI equipment are bulky, expensive, and not always available, limiting their use in TBI detection. Therefore, as an alternative, this study presents a novel classification architecture that can classify non-severe TBI patients from healthy subjects by using resting-state electroencephalogram (EEG) as the input. The proposed architecture employs a convolutional neural network (CNN), and error-correcting output codes support vector machine (ECOC-SVM) to perform automated feature extraction and multi-class classification. In this architecture, complex feature selection and extraction steps are avoided. The proposed architecture attained a high-performance classification accuracy of 99.76%, potentially being used as a classification approach to preventing healthcare insurance fraud. The proposed method is compared to existing studies in the literature. The outcome from the comparisons indicates that the proposed method has outperformed the benchmarked methods by presenting the highest classification accuracy and precision.	[Lai, Chi Qin; Ibrahim, Haidi; Abdullah, Mohd Zaid] Univ Sains Malaysia, Sch Elect & Elect Engn, Engn Campus, Nibong Tebal 14300, Malaysia; [Abdullah, Jafri Malin] Univ Sains Malaysia, Sch Med Sci, Brain & Behav Cluster, Hlth Campus, Kota Baharu 16150, Kelantan, Malaysia; [Abdullah, Jafri Malin] Univ Sains Malaysia, Sch Med Sci, Dept Neurosci, Hlth Campus, Kota Baharu 16150, Kelantan, Malaysia; [Azman, Azlinda] Univ Sains Malaysia, Sch Social Sci, George Town 11800, Malaysia		Ibrahim, H (corresponding author), Univ Sains Malaysia, Sch Elect & Elect Engn, Engn Campus, Nibong Tebal 14300, Malaysia.	haidi_ibrahim@ieee.org	Ibrahim, Haidi/B-3131-2011; Abdullah, Jafri Malin/C-2828-2011	Ibrahim, Haidi/0000-0002-6401-1791; lai, chi qin/0000-0002-2513-6620; Abdullah, Jafri Malin/0000-0002-0258-7410	Ministry of Higher Education (MoHE), Malaysia, through the Trans-Disciplinary Research Grant Scheme (TRGS) [203/PELECT/6768002]	This work was supported by the Ministry of Higher Education (MoHE), Malaysia, through the Trans-Disciplinary Research Grant Scheme (TRGS), under Grant 203/PELECT/6768002.	Albert B, 2016, PROCEDIA COMPUT SCI, V96, P703, DOI 10.1016/j.procs.2016.08.253; Amin SU, 2019, IEEE ACCESS, V7, P18940, DOI 10.1109/ACCESS.2019.2895688; [Anonymous], TRAUMATIC BRAIN INJU; Arciniegas DB, 2011, INT J PSYCHOPHYSIOL, V82, P41, DOI 10.1016/j.ijpsycho.2011.03.004; BASAR E, 1976, BIOL CYBERN, V25, P27; Bengio Yoshua, 2012, Neural Networks: Tricks of the Trade. Second Edition: LNCS 7700, P437, DOI 10.1007/978-3-642-35289-8_26; Bottou L, 2010, COMPSTAT'2010: 19TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL STATISTICS, P177, DOI 10.1007/978-3-7908-2604-3_16; Chi Qin Lai, 2019, 10th International Conference on Robotics, Vision, Signal Processing and Power Applications. Enabling Research and Innovation Towards Sustainability. Lecture Notes in Electrical Engineering (LNEE 547), P521, DOI 10.1007/978-981-13-6447-1_66; EFRON B, 1981, BIOMETRIKA, V68, P589, DOI 10.2307/2335441; Fisher JAN, 2016, IEEE T NEUR SYS REH, V24, P1003, DOI 10.1109/TNSRE.2016.2529663; Golik P, 2013, INTERSPEECH, P1755; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Hanley D, 2018, J NEUROTRAUM, V35, P41, DOI 10.1089/neu.2017.5004; Hine G. E., 2017, P 2017 INT C BIOM SP, P1, DOI DOI 10.23919/BIOSIG.2017.8053519; Ianof Jéssica Natuline, 2017, Dement. neuropsychol., V11, P3, DOI 10.1590/1980-57642016dn11-010002; Ibrahim R., 2012, BMC HLTH SERVICES RE, V12; Islam MK, 2016, NEUROPHYSIOL CLIN, V46, P287, DOI 10.1016/j.neucli.2016.07.002; Jacquin A, 2018, COMPUT BIOL MED, V102, P95, DOI 10.1016/j.compbiomed.2018.09.011; Keskar N. S., 2016, ARXIV160904836 CORR; Khan SU, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27515-w; Kuhn M., 2013, APPL PREDICTIVE MODE, V26; Lai CQ, 2019, PROCEEDINGS OF 2019 2ND INTERNATIONAL CONFERENCE ON ELECTRONICS AND ELECTRICAL ENGINEERING TECHNOLOGY (EEET 2019), P99, DOI 10.1145/3362752.3362758; Lai CQ, 2020, COMPUT INTEL NEUROSC, V2020, DOI 10.1155/2020/8923906; Lai CQ, 2019, COMPUT INTEL NEUROSC, V2019, DOI 10.1155/2019/7895924; Lai CPY, 2019, 2019 7TH INTERNATIONAL CONFERENCE ON SMART COMPUTING & COMMUNICATIONS (ICSCC), P260; Lassey M. L., 1996, HLTH CARE SYSTEMS WO; LeCun Y, 1989, NEURAL COMPUT, V1, P541, DOI 10.1162/neco.1989.1.4.541; Lee Bruce, 2005, NeuroRx, V2, P372; Luschi C., 2018, ARXIV180407612; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McBride J, 2013, IEEE T BIO-MED ENG, V60, P90, DOI 10.1109/TBME.2012.2223698; McNerney MW, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0187-y; Muhammad K, 2018, IEEE ACCESS, V6, P18174, DOI 10.1109/ACCESS.2018.2812835; Murphy KP, 2012, MACHINE LEARNING: A PROBABILISTIC PERSPECTIVE, P1; Ngoya PS, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.2016.25.99.9736; Noor NSEM, 2020, IEEE ACCESS, V8, P102075, DOI 10.1109/ACCESS.2020.2998934; Nunez PL, 2000, BEHAV BRAIN SCI, V23, P371, DOI 10.1017/S0140525X00003253; Ortega P., 2006, P 2006 INT C DAT MIN, P224; Prichep LS, 2014, COMPUT BIOL MED, V53, P125, DOI 10.1016/j.compbiomed.2014.07.011; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Reeves T. M., 2012, ELECTROPHYSIOLOGICAL, P313; Rosenbaum A. M., 2017, TRAUMATIC BRAIN INJU; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schmitt Sarah, 2015, Handb Clin Neurol, V127, P319, DOI 10.1016/B978-0-444-52892-6.00021-0; Sehgal A, 2018, IEEE ACCESS, V6, P9017, DOI 10.1109/ACCESS.2018.2800728; Tan L., 2013, DIGIT SIGNAL PROCESS, P15; Tolonen A, 2018, CLIN EEG NEUROSCI, V49, P248, DOI 10.1177/1550059417742232; van den Brink RL, 2018, NEUROIMAGE-CLIN, V17, P43, DOI 10.1016/j.nicl.2017.10.003; Walsh T., 2011, FLEXIBLE HIGH PERFOR, P1237; Wen ZY, 2017, 2017 INTERNATIONAL CONFERENCE ON SECURITY, PATTERN ANALYSIS, AND CYBERNETICS (SPAC), P672, DOI 10.1109/SPAC.2017.8304360; Yadav NK, 2015, BRAIN INJURY, V29, P352, DOI 10.3109/02699052.2014.979229; Yang S, 2018, PATTERN ANAL APPL, V21, P105, DOI 10.1007/s10044-016-0569-4	53	2	2	0	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2169-3536			IEEE ACCESS	IEEE Access		2021	9						24946	24964		10.1109/ACCESS.2021.3056724			19	Computer Science, Information Systems; Engineering, Electrical & Electronic; Telecommunications	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Telecommunications	QG7EN	WOS:000617746400001		gold			2022-02-06	
J	Li, LP; Liang, JW; Fu, HJ				Li, Liangping; Liang, Jiawen; Fu, Hongjun			An update on the association between traumatic brain injury and Alzheimer's disease: Focus on Tau pathology and synaptic dysfunction	NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS			English	Article						Traumatic brain injury; Alzheimer's disease; Animal models; Tau pathology; Synaptic dysfunction	CASPASE-CLEAVED TAU; FLUID PERCUSSION INJURY; PROTEIN PHOSPHATASE 2A; MOUSE MODEL; RAT MODEL; HYPERPHOSPHORYLATED TAU; SODIUM SELENATE; COGNITIVE DEFICITS; OXIDATIVE STRESS; ALKALINE-PHOSPHATASE	L.P. Li, J.W. Liang and H.J. Fu. An update on the association between traumatic brain injury and Alzheimer's disease: Focus on Tau pathology and synaptic dysfunction. NEUROSCI BIOBEHAV REVXXX-XXX,2020.Traumatic brain injury (TBI) and Alzheimer's disease (AD) are devastating conditions that have long-term consequences on individual's cognitive functions. Although TBI has been considered a risk factor for the development of AD, the link between TBI and AD is still in debate. Aggregation of hyperphosphorylated tau and intercorrelated synaptic dysfunction, two key pathological elements in both TBI and AD, play a pivotal role in mediating neurodegeneration and cognitive deficits, providing a mechanistic link between these two diseases. In the first part of this review, we analyze the experimental literatures on tau pathology in various TBI models and review the distribution, biological features and mechanisms of tau pathology following TBI with implications in AD pathogenesis. In the second part, we review evidences of TBI-mediated structural and functional impairments in synapses, with a focus on the overlapped mechanisms underlying synaptic abnormalities in both TBI and AD. Finally, future perspectives are proposed for uncovering the complex relationship between TBI and neuro degeneration, and developing potential therapeutic avenues for alleviating cognitive deficits after TBI.	[Li, Liangping; Liang, Jiawen; Fu, Hongjun] Ohio State Univ, Dept Neurosci, Chron Brain Injury Discovery Themes, Columbus, OH 43210 USA		Fu, HJ (corresponding author), Ohio State Univ, 616 Biomed Res Tower,460 W 12th Ave, Columbus, OH 43210 USA.	Hongjun.Fu@osumc.edu	Fu, Hongjun/ABB-3558-2021	Fu, Hongjun/0000-0001-5346-7075; Li, Liangping/0000-0002-9406-4034	Department of DefenseUnited States Department of Defense [W81XWH1910309]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG056673]; Alzheimer's AssociationAlzheimer's Association [AARF-17-505009]; Neuroscience Research Institute Pilot Award from The Ohio State University; Chronic Brain Injury Pilot Award from The Ohio State University	This work was supported by the Department of Defense [grant number, W81XWH1910309]; the National Institutes of Health [grant number, AG056673]; the Alzheimer's Association [grant number, AARF-17-505009]; and the Neuroscience Research Institute Pilot Award and the Chronic Brain Injury Pilot Award from The Ohio State University.	Abdul HM, 2009, J NEUROSCI, V29, P12957, DOI 10.1523/JNEUROSCI.1064-09.2009; Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Acosta SA, 2017, J CELL PHYSIOL, V232, P665, DOI 10.1002/jcp.25629; Adams C, 2018, THERANOSTICS, V8, P4824, DOI 10.7150/thno.24747; Albayram O, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01068-4; Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Alonso AD, 2010, J BIOL CHEM, V285, P30851, DOI 10.1074/jbc.M110.110957; Amadoro G, 2010, J ALZHEIMERS DIS, V21, P445, DOI 10.3233/JAD-2010-100120; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Arneson D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06222-0; Arun P, 2015, NEUROSCI LETT, V609, P152, DOI 10.1016/j.neulet.2015.10.036; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Bashir S, 2012, RESTOR NEUROL NEUROS, V30, P277, DOI 10.3233/RNN-2012-110207; Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; Bibow S, 2011, J AM CHEM SOC, V133, P15842, DOI 10.1021/ja205836j; Bittar A, 2019, BRAIN COMMUN, V1, DOI 10.1093/braincomms/fcz004; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Brizuela M, 2017, J NEUROTRAUM, V34, P2504, DOI 10.1089/neu.2017.4977; Busche MA, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0429; Campbell JN, 2012, J NEUROTRAUM, V29, P218, DOI 10.1089/neu.2011.1762; Campbell JN, 2012, J NEUROTRAUM, V29, P201, DOI 10.1089/neu.2011.1761; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Cao JQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11654-7; Cardoso BR, 2019, NEUROTHERAPEUTICS, V16, P192, DOI 10.1007/s13311-018-0662-z; Cartagena CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158576; Chandrasekar A, 2019, CEREB CORTEX, V29, P2701, DOI 10.1093/cercor/bhy139; Chen HW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28842-8; Chen LJ, 2010, J NEUROTRAUM, V27, P1657, DOI 10.1089/neu.2010.1308; Chen M, 2018, J ALZHEIMERS DIS, V66, P751, DOI 10.3233/JAD-180726; Chen Yuan-Hao, 2018, Oncotarget, V9, P11515, DOI 10.18632/oncotarget.23923; Chou A, 2017, P NATL ACAD SCI USA, V114, pE6420, DOI 10.1073/pnas.1707661114; Chung CW, 2001, NEUROBIOL DIS, V8, P162, DOI 10.1006/nbdi.2000.0335; Clavaguera F, 2013, BRAIN PATHOL, V23, P342, DOI 10.1111/bpa.12044; Collins-Praino L., 2018, J NEUROINFLAMM, V2, P1; Congdon EE, 2018, NAT REV NEUROL, V14, P399, DOI 10.1038/s41582-018-0013-z; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Dejanovic B, 2018, NEURON, V100, P1322, DOI 10.1016/j.neuron.2018.10.014; Delaney SL, 2020, STEM CELLS DEV, V29, P187, DOI 10.1089/scd.2019.0187; Diaz-Hernandez M, 2010, J BIOL CHEM, V285, P32539, DOI 10.1074/jbc.M110.145003; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Dong YY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034435, 10.1371/journal.pone.0051643, 10.1371/journal.pone.0039386]; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Du H, 2014, BBA-MOL BASIS DIS, V1842, P2517, DOI 10.1016/j.bbadis.2013.03.004; Du XP, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4159357; Edwards G, 2019, J NEUROTRAUM, DOI 10.1089/neu.2018.6348; Fa M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19393; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Fonseca MI, 2004, J NEUROSCI, V24, P6457, DOI 10.1523/JNEUROSCI.0901-04.2004; Forner S, 2017, TRENDS NEUROSCI, V40, P347, DOI 10.1016/j.tins.2017.04.002; Franklin W, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44635-z; Frankowski JC, 2019, NEUROBIOL DIS, V129, P208, DOI 10.1016/j.nbd.2018.07.022; Furman JL, 2016, J NEUROSCI, V36, P1502, DOI 10.1523/JNEUROSCI.1930-15.2016; Furman JL, 2012, J NEUROSCI, V32, P16129, DOI 10.1523/JNEUROSCI.2323-12.2012; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Gerson J, 2016, J NEUROTRAUM, V33, P2034, DOI 10.1089/neu.2015.4262; Glushakova OY, 2018, J NEUROTRAUM, V35, P157, DOI 10.1089/neu.2017.4999; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gomez-Palacio-Schjetnan Andrea, 2013, Curr Top Behav Neurosci, V15, P117, DOI 10.1007/7854_2012_231; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Haar CV, 2019, EXP NEUROL, V317, P87, DOI 10.1016/j.expneurol.2019.02.012; Haase C, 2004, J NEUROCHEM, V88, P1509, DOI 10.1046/j.1471-4159.2003.02287.x; Hanell A, 2015, J NEUROTRAUM, V32, P1590, DOI 10.1089/neu.2014.3592; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Hensch TK, 2005, PROG BRAIN RES, V147, P115, DOI 10.1016/S0079-6123(04)47009-5; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hoshino S, 1998, NEUROREPORT, V9, P1879, DOI 10.1097/00001756-199806010-00039; Hu W, 2018, J ALZHEIMERS DIS, V64, P709, DOI 10.3233/JAD-180177; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Hudry E, 2012, J NEUROSCI, V32, P3176, DOI 10.1523/JNEUROSCI.6439-11.2012; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iverson GL, 2019, BRAIN, V142, P3672, DOI 10.1093/brain/awz286; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; Jarrahi A, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8100389; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Perez MJ, 2018, MOL NEUROBIOL, V55, P1004, DOI 10.1007/s12035-017-0385-x; Jucker M, 2018, NAT NEUROSCI, V21, P1341, DOI 10.1038/s41593-018-0238-6; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Katsumoto A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00980; Kim Y, 2016, NEUROBIOL DIS, V87, P19, DOI 10.1016/j.nbd.2015.12.006; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kokiko-Cochran ON, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00672; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Krukowski K., 2018, INT J MOL SCI, V19; Krukowski K, 2020, J NEUROTRAUM, V37, P1370, DOI 10.1089/neu.2019.6827; Kurz JE, 2005, J NEUROTRAUM, V22, P476, DOI 10.1089/neu.2005.22.476; Lasagna-Reeves CA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00700; Lasagna-Reeves CA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-39; Laskowitz DT, 2010, J NEUROTRAUM, V27, P1983, DOI 10.1089/neu.2010.1396; Lin WL, 2011, J NEUROPATH EXP NEUR, V70, P779, DOI 10.1097/NEN.0b013e31822ac9c9; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Liu MC, 2011, ASN NEURO, V3, P25, DOI 10.1042/AN20100012; Liu SJ, 2016, BRAIN, V139, P1919, DOI 10.1093/brain/aww116; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Lv QS, 2014, J NEUROL SCI, V345, P48, DOI 10.1016/j.jns.2014.06.037; Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Malpas CB, 2016, J ALZHEIMERS DIS, V54, P223, DOI 10.3233/JAD-160544; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Marschner L, 2016, ARCH NEUROSCI, V3, DOI 10.5812/archneurosci.38039; Marshall IJ, 2017, PROCEEDINGS OF THE 55TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2017): SYSTEM DEMONSTRATIONS, P7, DOI 10.18653/v1/P17-4002; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meconi A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197187; Mei ZR, 2018, BEHAV BRAIN RES, V340, P195, DOI 10.1016/j.bbr.2017.04.017; Mouzon B, 2018, BRAIN INJURY, V32, P1285, DOI 10.1080/02699052.2018.1486457; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Nakamura K, 2012, CELL, V149, P232, DOI 10.1016/j.cell.2012.02.016; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Nichols J, 2018, J PHYSIOL-LONDON, V596, P1277, DOI 10.1113/JP275393; Nogueira ML, 2018, ALZHEIMERS DEMENT, V14, P444, DOI 10.1016/j.jalz.2017.11.003; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; Norris CM, 2005, J NEUROSCI, V25, P4649, DOI 10.1523/JNEUROSCI.0365-05.2005; Ohno M, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00022; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Perez EJ, 2016, NEUROBIOL DIS, V94, P73, DOI 10.1016/j.nbd.2016.06.007; Perez-Polo JR, 2015, J NEUROSCI RES, V93, P549, DOI 10.1002/jnr.23513; Peterson AB, 2019, SURVEILLANCE REPORT; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Pham L, 2019, J NEUROTRAUM, V36, P2260, DOI 10.1089/neu.2018.6169; Pijet B, 2019, NEURAL PLAST, V2019, DOI 10.1155/2019/3259295; Plassman Brenda L, 2015, Handb Clin Neurol, V128, P711, DOI 10.1016/B978-0-444-63521-1.00044-3; Przybyla M., 2020, BRAIN; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rachmany L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03792-9; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Rankin CA, 2008, NEUROBIOL DIS, V31, P368, DOI 10.1016/j.nbd.2008.05.011; Rehman SU, 2018, CEREB CORTEX, V28, P2854, DOI 10.1093/cercor/bhx164; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Rodriques SG, 2019, SCIENCE, V363, P1463, DOI 10.1126/science.aaw1219; Rozkalne A, 2011, NEUROBIOL DIS, V41, P650, DOI 10.1016/j.nbd.2010.11.014; Rubenstein R, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00124; Rubenstein R, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0435-7; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Sauerbeck A.D., 2020, NEURON; Sawmiller D, 2014, INT J MOL SCI, V15, P895, DOI 10.3390/ijms15010895; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Sen T, 2017, J NEUROSCI, V37, P5900, DOI 10.1523/JNEUROSCI.2343-16.2017; Shaw GJ, 2002, ANN EMERG MED, V39, P254, DOI 10.1067/mem.2002.121214; Shi QQ, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf6295; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Siahaan Andre Marolop Pangihutan, 2018, Open Access Maced J Med Sci, V6, P1953, DOI 10.3889/oamjms.2018.440; Smith CJ, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur.2015.00240, 10.3389/fneur.2015.00073]; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Steinhilb ML, 2007, MOL BIOL CELL, V18, P5060, DOI 10.1091/mbc.E07-04-0327; Su ZX, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43026; Sugarman MA, 2019, ALZHEIMERS DEMENT, V15, P686, DOI 10.1016/j.jalz.2018.12.015; Sun JL, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00063, 10.3389/hsys.2015.00063]; Sun YY, 2020, EXP NEUROL, V328, DOI 10.1016/j.expneurol.2020.113253; Tan XL, 2016, NEUROPHARMACOLOGY, V108, P382, DOI 10.1016/j.neuropharm.2016.05.001; Titus DJ, 2016, J NEUROSCI, V36, P7095, DOI 10.1523/JNEUROSCI.3212-15.2016; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; Tran HT, 2012, J NEUROPATH EXP NEUR, V71, P116, DOI 10.1097/NEN.0b013e3182456aed; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Vossel KA, 2017, LANCET NEUROL, V16, P311, DOI 10.1016/S1474-4422(17)30044-3; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang B, 2018, CEREBELLUM, V17, P477, DOI 10.1007/s12311-018-0934-5; Wang B, 2018, MOL CELL NEUROSCI, V88, P158, DOI 10.1016/j.mcn.2018.02.002; Wang YB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12236-3; Wang ZF, 2017, BIOCHEM BIOPH RES CO, V482, P948, DOI 10.1016/j.bbrc.2016.11.138; Weiner MW, 2017, NEUROLOGY, V89, P1923, DOI 10.1212/WNL.0000000000004608; White ER, 2017, J NEUROTRAUM, V34, P1111, DOI 10.1089/neu.2016.4638; Wilson NM, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00005; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010; Wu JW, 2016, NAT NEUROSCI, V19, P1085, DOI 10.1038/nn.4328; Wu ZR, 2020, PROG NEUROBIOL, V185, DOI 10.1016/j.pneurobio.2019.101730; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu H, 2014, CURR GENE THER, V14, P343, DOI 10.2174/156652321405140926160602; Xu LY, 2015, EXP NEUROL, V273, P168, DOI 10.1016/j.expneurol.2015.08.014; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Yaka R, 2007, FASEB J, V21, P2033, DOI 10.1096/fj.06-7856com; Yamashita Shin, 2011, Kurume Medical Journal, V58, P47; Yin YL, 2016, P NATL ACAD SCI USA, V113, pE3773, DOI 10.1073/pnas.1604519113; Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134; Zanier ER, 2018, BRAIN, V141, P2685, DOI 10.1093/brain/awy193; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zhang DN, 2019, NEUROTOX RES, V35, P360, DOI 10.1007/s12640-018-9961-8; Zhang YC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40678-4; Zhang YL, 2019, J NEUROTRAUM, V36, P589, DOI 10.1089/neu.2018.5790; Zhang ZT, 2014, NAT MED, V20, P1254, DOI 10.1038/nm.3700; Zhao ML, 2018, J ALZHEIMERS DIS, V63, P303, DOI 10.3233/JAD-180002; Zhao S, 2016, MOL NEUROBIOL, V53, P1884, DOI 10.1007/s12035-015-9128-z; Zhao Z J, 2017, CROPS, V2, P7; Zhao ZA, 2017, BEHAV BRAIN RES, V323, P146, DOI 10.1016/j.bbr.2017.02.002; Zheng P, 2014, MOL NEUROBIOL, V49, P1532, DOI 10.1007/s12035-013-8601-9; Zilka N., 2012, SELF PERPETUATING TA	208	2	2	0	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0149-7634	1873-7528		NEUROSCI BIOBEHAV R	Neurosci. Biobehav. Rev.	JAN	2021	120						372	386		10.1016/j.neubiorev.2020.10.020			15	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	QB6VH	WOS:000614277800004	33171143	Bronze			2022-02-06	
J	Li, T; Zhang, W; Hu, E; Sun, ZJ; Li, PF; Yu, Z; Zhu, XF; Zheng, F; Xing, ZH; Xia, Z; He, F; Luo, JK; Tang, T; Wang, Y				Li, Teng; Zhang, Wei; Hu, En; Sun, Zhengji; Li, Pengfei; Yu, Zhe; Zhu, Xiaofei; Zheng, Fei; Xing, Zhihua; Xia, Zian; He, Feng; Luo, Jiekun; Tang, Tao; Wang, Yang			Integrated metabolomics and network pharmacology to reveal the mechanisms of hydroxysafflor yellow A against acute traumatic brain injury	COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL			English	Article						Traumatic brain injury; Hydroxysafflor yellow A; Metabolomics; Network pharmacology; Mechanisms	PATHWAY; METABOLISM; MEDICINE; ARGININE; DAMAGE	Traumatic brain injury (TBI) has become a leading cause of mortality, morbidity and disability worldwide. Hydroxysafflor yellow A (HSYA) is effective in treating TBI, but the potential mechanisms require further exploration. We aimed to reveal the mechanisms of HSYA against acute TBI by an integrated strategy combining metabolomics with network pharmacology. A controlled cortical impact (CCI) rat model was established, and neurological functions were evaluated. Metabolomics of brain tissues was used to identify differential metabolites, and the metabolic pathways were enriched by MetaboAnalyst. Then, network pharmacology was applied to dig out the potential targets against TBI induced by HSYA. The integrated network of metabolomics and network pharmacology was constructed based on Cytoscape. Finally, the obtained key targets were verified by molecular docking. HSYA alleviated the neurological deficits of TBI. Fifteen potentially significant metabolites were found to be involved in the therapeutic effects of HSYA against acute TBI. Most of these metabolites were regulated to recover after HSYA treatment. We found 10 hub genes according to network pharmacology, which was partly consistent with the metabolomics findings. Further integrated analysis focused on 4 key targets, including NOS1, ACHE, PTGS2 and XDH, as well as their related core metabolites and pathways. Molecular docking showed high affinities between key targets and HSYA. Region-specific metabolic alterations in the cortex and hippocampus were illuminated. This study reveals the complicated mechanisms of HSYA against acute TBI. Our work provides a novel paradigm to identify the potential mechanisms of pharmacological effects derived from a natural compound. (C) 2021 The Author(s). Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.	[Li, Teng; Hu, En; Yu, Zhe; Zhu, Xiaofei; Xing, Zhihua; Xia, Zian; Luo, Jiekun; Tang, Tao; Wang, Yang] Cent South Univ, Xiangya Hosp, Dept Integrated Tradit Chinese & Western Med, Inst Integrat Med, Changsha 410008, Peoples R China; [Zhang, Wei; Sun, Zhengji; Zheng, Fei] Hunan Univ Chinese Med, Coll Integrated Tradit Chinese & Western Med, Changsha 410208, Peoples R China; [Li, Pengfei] Zhengzhou Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Zhengzhou 450052, Peoples R China; [He, Feng] Cent South Univ, Xiangya Hosp, Dept Hepatobiliary Surg, Changsha 410008, Peoples R China		Wang, Y (corresponding author), Cent South Univ, Xiangya Hosp, Dept Integrated Tradit Chinese & Western Med, Inst Integrat Med, Changsha 410008, Peoples R China.	wangyang_xy87@csu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81973665, 81673719, 81874409, 81803948]; Hunan Provincial Natural Science Foun-dation of ChinaNatural Science Foundation of Hunan Province [2019JJ30042]; Outstanding Youth Fund ofHunan Natural Science [2020JJ2024]; Innovation-Driven Project of Central South University [2020CX047]	This study was funded by grants from the National Natural Science Foundation of China (No. 81973665, 81673719, 81874409 and 81803948) , Hunan Provincial Natural Science Foun-dation of China (No. 2019JJ30042) , The Outstanding Youth Fund ofHunan Natural Science (No. 2020JJ2024) , and Innovation-Driven Project of Central South University (No. 2020CX047) .	Aid S, 2011, BIOCHIMIE, V93, P46, DOI 10.1016/j.biochi.2010.09.009; Amorini AM, 2017, J CELL MOL MED, V21, P530, DOI 10.1111/jcmm.12998; Blusztajn JK, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080815; Bonsack B, 2020, NEURAL REGEN RES, V15, P1179, DOI 10.4103/1673-5374.270294; Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001; Caldwell RW, 2018, PHYSIOL REV, V98, P641, DOI 10.1152/physrev.00037.2016; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Chen HS, 2017, CURR NEUROPHARMACOL, V15, P134, DOI 10.2174/1570159X14666160620102055; Chen L, 2013, NEUROCHEM RES, V38, P2268, DOI 10.1007/s11064-013-1135-8; Dasuri K, 2013, FREE RADICAL BIO MED, V62, P170, DOI 10.1016/j.freeradbiomed.2012.09.016; Di Pietro V, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9030260; Donat CK, 2007, BRAIN INJURY, V21, P1031, DOI 10.1080/02699050701630359; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Durham WJ, 2017, J NEUROTRAUM, V34, P385, DOI 10.1089/neu.2015.4350; Eicher T, 2020, METABOLITES, V10, DOI 10.3390/metabo10050202; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Fouda AY, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00277; Fu CY, 2019, J ETHNOPHARMACOL, V245, DOI 10.1016/j.jep.2019.112149; Garry PS, 2015, EXP NEUROL, V263, P235, DOI 10.1016/j.expneurol.2014.10.017; Gertsch J, 2011, PLANTA MED, V77, P1086, DOI 10.1055/s-0030-1270904; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hoglund E, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00158; Hopkins AL, 2007, NAT BIOTECHNOL, V25, P1110, DOI 10.1038/nbt1007-1110; Kibble M, 2015, NAT PROD REP, V32, P1249, DOI 10.1039/c5np00005j; Li CC, 2020, NEUROCHEM INT, V138, DOI 10.1016/j.neuint.2020.104771; Li PF, 2019, INT J BIOL SCI, V15, P895, DOI 10.7150/ijbs.29744; Louin G, 2007, NITRIC OXIDE-BIOL CH, V17, P91, DOI 10.1016/j.niox.2007.05.006; Lv YN, 2016, CELL MOL NEUROBIOL, V36, P1241, DOI 10.1007/s10571-015-0322-3; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; Ozturk Erdogan, 2005, Prog Neuropsychopharmacol Biol Psychiatry, V29, P922, DOI 10.1016/j.pnpbp.2005.04.028; Scheff SW, 2017, J NEUROTRAUM, V34, P1491, DOI 10.1089/neu.2016.4718; Sheng CX, 2020, XENOBIOTICA, V50, P545, DOI 10.1080/00498254.2019.1668983; Sheng SJ, 2014, J ETHNOPHARMACOL, V154, P735, DOI 10.1016/j.jep.2014.04.048; Simon-Manso Y, 2013, ANAL CHEM, V85, P11725, DOI 10.1021/ac402503m; Singh K, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3764; Sun Li, 2018, OXID MED CELL LONGEV, V2018, P1; Tian JW, 2008, PHARMACOLOGY, V82, P121, DOI 10.1159/000141653; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep37098; Wang Y, 2016, MOL MED REP, V14, P3690, DOI 10.3892/mmr.2016.5720; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; WURTMAN RJ, 1992, TRENDS NEUROSCI, V15, P117, DOI 10.1016/0166-2236(92)90351-8; Xu XL, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/8172706; Yang SG, 2012, J NEUROTRAUM, V29, P2696, DOI 10.1089/neu.2012.2442; Yu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037608; Yu L, 2020, CELL MOL NEUROBIOL, V40, P1271, DOI 10.1007/s10571-020-00812-7; Zhong Y, EVIDENCE BASED COMPL, V2018, P1	49	2	2	41	47	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2001-0370			COMPUT STRUCT BIOTEC	Comp. Struct. Biotechnol. J..		2021	19						1002	1013		10.1016/j.csbj.2021.01.033			12	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	UA0PL	WOS:000684867500018	33613866	Green Published, gold			2022-02-06	
J	Liang, XY; Yeh, CH; Dominguez, DJF; Poudel, G; Swinnen, SP; Caeyenberghs, K				Liang, Xiaoyun; Yeh, Chun-Hung; Dominguez, Juan F. D.; Poudel, Govinda; Swinnen, Stephan P.; Caeyenberghs, Karen			Longitudinal fixel-based analysis reveals restoration of white matter alterations following balance training in young brain-injured patients	NEUROIMAGE-CLINICAL			English	Article						Brain injury; Diffusion MRI; Training; Neuroplasticity; Rehabilitation	POSTURAL-CONTROL; SPHERICAL-DECONVOLUTION; FIBER DENSITY; PLASTICITY; CONNECTIVITY; PERFORMANCE; CHILDREN; SYSTEM; GAIT; DEGENERATION	Background and objectives: Traumatic brain injury (TBI) is one of the leading causes of death and disability in children and adolescents. Young TBI patients suffer from gross motor deficits, such as postural control deficits, which can severely compromise their daily life activities. However, little attention has been devoted to uncovering the underlying white matter changes in response to training in TBI. In this study, we used longitudinal fixelbased analysis (FBA), an advanced diffusion imaging analysis technique, to investigate the effect of a balance training program on white matter fibre density and morphology in a group of young TBI patients. Methods: Young patients with moderate-to-severe TBI (N = 17, 10 females, mean age = 13 +/- 3 years) and agematched controls (N = 17) underwent a home-based balance training program. Diffusion MRI scans together with gross motor assessments, including the gross motor items of the Bruininks-Oseretsky Test of Motor Proficiency, the Activities-Specific Balance Confidence (ABC) Scale, and the Sensory Organization Test (SOT) were administered before and at completion of 8-weeks of training. We used FBA to compare microstructural differences in fibre density (FD), macrostructural (morphological) changes in fibre cross-section (FC), and the combined FD and FC (FDC) metric across the whole brain. We then performed a longitudinal analysis to test whether training restores the white matter in the regions found to be damaged before treatment. Results: Whole-brain fixel-based analysis revealed lower FD and FC in TBI patients compared to the control group across several commissural tracts, association fibres and projection fibres, with FD reductions of up to 50%. Following training, TBI patients showed a significant interaction effect between Group and Time for the SOT test, as well as significant increases in macrostructural white matter (i.e., FC & FDC) in left sensorimotor tracts. The amount of change in FC and FDC over time was, however, not associated with behavioural changes. Discussion: Our fixel-based findings identified both microstructural and macrostructural abnormalities in young TBI patients. The longitudinal results provide a deeper understanding of the neurobiological mechanisms underlying balance training, which will allow clinicians to make more effective treatment decisions in everyday clinical practice with brain-injured patients.	[Liang, Xiaoyun; Poudel, Govinda] Australian Catholic Univ, Mary Mackillop Inst Hlth Res, Melbourne, Vic, Australia; [Liang, Xiaoyun] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Yeh, Chun-Hung] Chang Gung Univ, Inst Radiol Res, Taoyuan, Taiwan; [Yeh, Chun-Hung] Chang Gung Mem Hosp, Taoyuan, Taiwan; [Yeh, Chun-Hung] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Child & Adolescent Psychiat, Taoyuan, Taiwan; [Dominguez, Juan F. D.; Caeyenberghs, Karen] Deakin Univ, Sch Psychol, Cognit Neurosci Unit, Geelong, Vic, Australia; [Swinnen, Stephan P.] Katholieke Univ Leuven, Motor Control Lab, Movement Control & Neuroplastic Res Grp, Leuven, Belgium		Caeyenberghs, K (corresponding author), Deakin Univ, Neuroplastic & Multimodal Imaging NMI Lab, NHMRC Career Dev Fellowship, Cognit Neurosci Unit,Sch Psychol, Melbourne Burwood Campus,221 Burwood Highway, Burwood, Vic 3125, Australia.	k.caeyenberghs@deakin.edu.au	Liang, Xiaoyun/K-1106-2015	Liang, Xiaoyun/0000-0002-1851-3408	Research Program of the Research Foundation Flanders (FWO)FWO [G.0482.10]; National Health and Medical Research Council Career Development FellowshipNational Health and Medical Research Council of Australia [APP1143816]; Australian Catholic University Research Funding (ACURF) Program Grant; Ministry of Science and Technology of TaiwanMinistry of Science and Technology, Taiwan [MOST 109-2222-E-182-001-MY3]	This work was supported by a grant from the Research Program of the Research Foundation Flanders (FWO) (Levenslijn G.0482.10). KC is supported by a National Health and Medical Research Council Career Development Fellowship (APP1143816). XL and GP are funded by an Australian Catholic University Research Funding (ACURF) Program Grant. CHY is grateful to the Ministry of Science and Technology of Taiwan (MOST 109-2222-E-182-001-MY3) for the support.	Alsalaheen BA, 2016, CLIN J SPORT MED, V26, P46, DOI 10.1097/JSM.0000000000000185; Alsalaheen BA, 2014, PEDIATR PHYS THER, V26, P191, DOI 10.1097/PEP.0000000000000037; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bruininks RH, 2005, BRUININKS OSERETSKY; Burciu RG, 2013, J NEUROSCI, V33, P4594, DOI 10.1523/JNEUROSCI.3381-12.2013; Button KS, 2013, NAT REV NEUROSCI, V14, DOI 10.1038/nrn3475-c4; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Caeyenberghs K, 2018, NEUROREHAB NEURAL RE, V32, P99, DOI 10.1177/1545968317753076; Caeyenberghs K, 2011, NEUROREHAB NEURAL RE, V25, P492, DOI 10.1177/1545968310394870; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; CHAPLIN D, 1993, ARCH PHYS MED REHAB, V74, P161; Dennis EL, 2021, BRAIN IMAGING BEHAV, V15, P555, DOI 10.1007/s11682-020-00363-x; Dennis EL, 2022, HUM BRAIN MAPP, V43, P149, DOI 10.1002/hbm.25046; Dhollander T., 2016, UNSUPERVISED 3 TISSU; Dhollander T.R.D., 2018, 26 INT SOC MAGN RES; Drijkoningen D, 2017, J NEUROTRAUM, V34, P1022, DOI 10.1089/neu.2016.4500; Drijkoningen D, 2015, J NEUROTRAUM, V32, P1324, DOI 10.1089/neu.2014.3787; Drijkoningen D, 2015, NEUROIMAGE-CLIN, V7, P240, DOI 10.1016/j.nicl.2014.12.006; Duque G, 2013, CLIN INTERV AGING, V8, P257, DOI 10.2147/CIA.S41453; Egorova N, 2020, STROKE, V51, P1507, DOI 10.1161/STROKEAHA.119.028143; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Hafstrom Anna, 2016, Gerontol Geriatr Med, V2, p2333721416644149, DOI 10.1177/2333721416644149; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jeurissen B, 2014, NEUROIMAGE, V103, P411, DOI 10.1016/j.neuroimage.2014.07.061; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Kellner E, 2016, MAGN RESON MED, V76, P1574, DOI 10.1002/mrm.26054; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Lindsey H.M., 2019, BRAIN IMAGING BEHAV; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mito R, 2018, BRAIN, V141, P888, DOI 10.1093/brain/awx355; Mizuguchi N, 2019, NEUROIMAGE, V197, P191, DOI 10.1016/j.neuroimage.2019.04.062; Mohajerani MH, 2011, P NATL ACAD SCI USA, V108, pE183, DOI 10.1073/pnas.1101914108; Mori S, 2005, MRI ATLAS HUMAN WHIT; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Noack H, 2009, RESTOR NEUROL NEUROS, V27, P435, DOI 10.3233/RNN-2009-0496; Oberman L, 2013, PROG BRAIN RES, V207, P91, DOI 10.1016/B978-0-444-63327-9.00016-3; Peterson M. G., 2011, BALANCE PROBLEMS TRA; Poudel GR, 2020, ANN CLIN TRANSL NEUR, V7, P270, DOI 10.1002/acn3.50984; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Prosperini L, 2014, RADIOLOGY, V273, P529, DOI 10.1148/radiol.14140168; Raffelt D, 2012, NEUROIMAGE, V59, P3976, DOI 10.1016/j.neuroimage.2011.10.045; Raffelt D, 2011, NEUROIMAGE, V56, P1171, DOI 10.1016/j.neuroimage.2011.02.014; Raffelt DA, 2017, NEUROIMAGE, V144, P58, DOI 10.1016/j.neuroimage.2016.09.029; Raffelt DA, 2015, NEUROIMAGE, V117, P40, DOI 10.1016/j.neuroimage.2015.05.039; Rau YA, 2019, NEUROIMAGE-CLIN, V24, DOI 10.1016/j.nicl.2019.102098; Roberts RM, 2014, DEV NEUROPSYCHOL, V39, P600, DOI 10.1080/87565641.2014.973958; Roiser JP, 2016, NEUROIMAGE-CLIN, V12, P1045, DOI 10.1016/j.nicl.2016.08.002; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Schwarz KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130492; Sehm B, 2014, NEUROBIOL AGING, V35, P232, DOI 10.1016/j.neurobiolaging.2013.06.021; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Smith RE, 2013, NEUROIMAGE, V67, P298, DOI 10.1016/j.neuroimage.2012.11.049; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Spear LP, 2013, J ADOLESCENT HEALTH, V52, pS7, DOI 10.1016/j.jadohealth.2012.05.006; Thomas C, 2013, NEUROIMAGE, V73, P225, DOI 10.1016/j.neuroimage.2012.03.069; Tournier J.D., 2010, P INT SOC MAG RES ME, P18; Tournier JD, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116137; Tournier JD, 2013, NMR BIOMED, V26, P1775, DOI 10.1002/nbm.3017; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Veraart J, 2016, NEUROIMAGE, V142, P384, DOI 10.1016/j.neuroimage.2016.08.016; Verhelst H, 2019, NEUROREHAB NEURAL RE, V33, P813, DOI 10.1177/1545968319868720; Wallace EJ, 2018, NEUROSCI BIOBEHAV R, V92, P93, DOI 10.1016/j.neubiorev.2018.05.023; Wallace EJ, 2020, HUM BRAIN MAPP, V41, P2187, DOI 10.1002/hbm.24939; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Wang SJ, 2017, FRONT NEUROINFORM, V11, DOI 10.3389/fninf.2017.00017; Zamani A, 2020, J NEUROTRAUM, V37, P724, DOI 10.1089/neu.2019.6895	72	2	2	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2021	30								102621	10.1016/j.nicl.2021.102621			12	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	TE9JI	WOS:000670322100009	33780865	Green Published, gold			2022-02-06	
J	Logan, MW; McNeeley, S; Morgan, MA				Logan, Matthew William; McNeeley, Susan; Morgan, Mark Alden			Not-so-special forces? Revisiting the "veteran effect" in the context of prison research	JOURNAL OF CRIMINAL JUSTICE			English	Article								Purpose: Prior studies of incarcerated military veterans center on the notion that they are fundamentally different from non-veterans in terms of criminogenic risk. Some scholars have argued that prior military service is a liability in terms of institutional adjustment and may increase the likelihood of experiencing negative outcomes; others have posited that it might serve as an asset and subsequently work to buffer the pains of imprisonment. Methods: Our study contributes to this burgeoning body of research by employing a series of survival analyses to explore the possibility of a "veteran effect" among a sample of veteran and non-veteran offenders in the state of Minnesota. Results: Despite statistically significant (albeit modest) differences between veterans and non-veterans in the prevalence of theoretically relevant variables, such as traumatic brain injury and post-traumatic stress disorder, we observed no differences between the two groups regarding the likelihood of experiencing various metrics of institutional adjustment and recidivism. Conclusions: Our findings stand in contrast to those of previous studies on incarcerated veterans and call into question the theoretical assumptions (and the subsequent criminal justice policy on which those assumptions are based) regarding the effects of prior military experience on prison (mal)adjustment.	[Logan, Matthew William] Texas State Univ, Sch Criminal Justice & Criminol, San Marcos, TX 78666 USA; [McNeeley, Susan] Minnesota Dept Correct, St Paul, MN USA		Logan, MW (corresponding author), Texas State Univ, Sch Criminal Justice & Criminol, San Marcos, TX 78666 USA.	mwl39@txstate.edu					Albertson K., 2017, PRISON SERV J, V234, P23; Athens L. H., 2003, VIOLENT ACTS VIOLENT, V4; Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Bronson J, 2015, VETERANS PRISON JAIL, P1; Brooke E.J., 2020, CORRECTIONS, V5, P292, DOI [10.1080/23774657.2018.1542284, DOI 10.1080/23774657.2018.1542284]; Brooke EJ, 2019, CRIME DELINQUENCY, V65, P1925, DOI 10.1177/0011128718779570; Burke C, 2019, VETERANS MOVING FORW; Campbell TA, 2009, PSYCHIAT ANN, V39, P796, DOI 10.3928/00485713-20090728-01; Carson EA, 2020, PRISONERS 2018; Connor Tray, 2017, NBC NEWS; Cullen FT, 2009, VICTIMS OFFENDERS, V4, P197, DOI 10.1080/15564880802612631; DeLisi M, 2006, J CRIM JUST, V34, P17, DOI 10.1016/j.jcrimjus.2005.11.002; DELISI M, 2005, CAREER CRIMINALS SOC; DeLisi M., 2004, CRIMINAL JUSTICE STU, V17, P369; DeLisi M, 2010, YOUTH VIOLENCE JUV J, V8, P107, DOI 10.1177/1541204009349399; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Drapela LA, 2019, JUSTICE Q, V36, P1023, DOI 10.1080/07418825.2018.1481221; Edelman B., 2016, 13CS20A001; Elbogen EB, 2014, AM J PSYCHIAT, V171, P749, DOI 10.1176/appi.ajp.2014.13101316; Elbogen EB, 2010, CLIN PSYCHOL REV, V30, P595, DOI 10.1016/j.cpr.2010.03.009; Fahmy C, 2020, J CRIM JUST, V67, DOI 10.1016/j.jcrimjus.2020.101658; Finlay Andrea K, 2016, Crim Justice Policy Rev, V27, DOI 10.1177/0887403414562601; Finlay AK, 2017, ADM POLICY MENT HLTH, V44, P177, DOI 10.1007/s10488-015-0708-z; Hajjar RM, 2014, ARMED FORCES SOC, V40, P118, DOI 10.1177/0095327X12465261; Highfill-McRoy RM, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-88; Hill M., 2018, VETERANS BARS US JAI; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Houser K, 2015, PSYCHIATR REHABIL J, V38, P24, DOI 10.1037/prj0000110; Houser KA, 2012, JUSTICE Q, V29, P799, DOI 10.1080/07418825.2011.641026; IRWIN J, 1962, SOC PROBL, V10, P142, DOI 10.1525/sp.1962.10.2.03a00040; Jaffee CMS, 2009, CLIN NEUROPSYCHOL, V23, P1291, DOI 10.1080/13854040903307250; Logan M.W., 2017, CRIMINAL JUSTICE POL, V28, P814, DOI [10.1177/0887403415623033, DOI 10.1177/0887403415623033]; Logan MW, 2019, VICTIMS OFFENDERS, V14, P283, DOI 10.1080/15564886.2019.1595249; Lunasco TK, 2010, MIL MED, V175, P509, DOI 10.7205/MILMED-D-09-00182; Matheson FI, 2020, BRAIN INJURY, V34, P757, DOI 10.1080/02699052.2020.1753114; May D.C., 2017, CRIMINAL JUSTICE POL, V28, P770; McCallum K, 2018, J FORENSIC PRACT, V20, P229, DOI 10.1108/JFP-12-2017-0055; McNeeley S, 2015, EUR J CRIMINOL, V12, P581, DOI 10.1177/1477370815578197; Minnesota Department of Corrections, 2017, ADULT PRISON POPULAT; Najavits L., 2002, SEEKING SAFETY TREAT; National Institute of Corrections, 2018, PRISONS JAILS DORMS; Pietrzak RH, 2009, PSYCHIAT SERV, V60, P1118, DOI 10.1176/ps.2009.60.8.1118; Prescan, 2013, CORRECTIONS FORUM, V22, P37; Sayers SL, 2009, J CLIN PSYCHIAT, V70, P163, DOI 10.4088/JCP.07m03863; Shackelford JL, 2019, J PSYCHOSOC NURS MEN, V57, P35, DOI 10.3928/02793695-20180924-02; Sykes G., 1958, SOC CAPTIVES STUDY M; Vogt D, 2011, PSYCHIAT SERV, V62, P135, DOI 10.1176/ps.62.2.pss6202_0135; Willbach H, 1948, J CRIM LAW CRIM, V38, P501, DOI 10.2307/1138926; Wright JP, 2005, J RES CRIME DELINQ, V42, P55, DOI 10.1177/0022427804270436; Wright JP, 2014, CRIMINALS MAKING CRI	51	2	2	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0047-2352	1873-6203		J CRIM JUST	J. Crim. Justice	JAN-FEB	2021	72								101762	10.1016/j.jcrimjus.2020.101762			8	Criminology & Penology	Social Science Citation Index (SSCI)	Criminology & Penology	QP6BT	WOS:000623920900003					2022-02-06	
J	Lokhandwala, AM; Asmar, S; Khurrum, M; Chehab, M; Bible, L; Castanon, L; Ditillo, M; Joseph, B				Lokhandwala, Adil M.; Asmar, Samer; Khurrum, Muhammad; Chehab, Mohamad; Bible, Letitia; Castanon, Lourdes; Ditillo, Michael; Joseph, Bellal			Platelet Transfusion After Traumatic Intracranial Hemorrhage in Patients on Antiplatelet Agents	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury; Antiplatelet agents; Platelet transfusion; Intracranial bleeding	BRAIN-INJURY PATIENTS; PREINJURY CLOPIDOGREL; ELDERLY-PATIENTS; HEAD-INJURY; MANAGEMENT; REVERSAL; OUTCOMES; ASPIRIN; GUIDELINES; MORTALITY	Background: With an aging population, the number of patients on antiplatelet medications and traumatic brain injury (TBI) is increasing. Our study aimed to evaluate the role of platelet transfusion on outcomes after traumatic intracranial bleeding (IB) in these patients. Methods: We analyzed our prospectively maintained TBI database from 2014 to 2016. We included all isolated TBI patients with an IB, who were on preinjury antiplatelet agents and excluded patients taking anticoagulants. Outcome measures included the progression of IB, neurosurgical intervention, and mortality. Regression analysis was performed. Results: A total of 343 patients met the inclusion criteria. Mean age was 58 11 y, 58% were men, and median injury severity score was 15 (10-24). Distribution of antiplatelet agents was as follows: aspirin (60%) and clopidogrel (35%). Overall, 74% patients received platelet transfusion after admission with a median number of two platelet units. After controlling for confounders, patients who received one unit of pooled platelets had no difference in progression of IB (odds ratio [OR]: 0.98, [0.6-1.9], P = 0.41), need for neurosurgical intervention (OR: 1.09, [0.7-2.5], P = 0.53), and mortality (OR: 0.84, [0.6-1.8], P = 0.51). However, patients who received two units of pooled platelets had lower rate of progression of IB (OR: 0.69, [0.4-0.8], P = 0.02), the need for neurosurgical intervention (OR: 0.81, [0.3-0.9], P = 0.03), and mortality (OR: 0.84, [0.5-0.9], P = 0.04). Both groups were compared with those who did not receive platelet transfusion. Conclusions: The use of two units of platelet may decrease the risk of IB progression, neurosurgical intervention, and mortality in patients on preinjury antiplatelet agents and TBI. Further studies should focus on developing protocols for platelet transfusion to improve outcomes in these patients. (c) 2020 Elsevier Inc. All rights reserved.	[Lokhandwala, Adil M.; Asmar, Samer; Khurrum, Muhammad; Chehab, Mohamad; Bible, Letitia; Castanon, Lourdes; Ditillo, Michael; Joseph, Bellal] Univ Arizona, Coll Med, Dept Surg, Div Trauma Crit Care Emergency Surg & Burns, Tucson, AZ USA		Joseph, B (corresponding author), Univ Arizona, Dept Surg, Div Trauma Crit Care & Emergency Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85724 USA.	bjoseph@surgery.arizona.edu		Chehab, Mohamad/0000-0002-3890-0691			Ajani UA, 2006, AM J PREV MED, V30, P74, DOI 10.1016/j.amepre.2005.08.042; Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622; [Anonymous], 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3795; Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; Beynon C, 2012, CRIT CARE, V16, DOI 10.1186/cc11292; Briggs A, 2015, J SURG RES, V193, P802, DOI 10.1016/j.jss.2014.08.016; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chapman SA, 2011, ANN PHARMACOTHER, V45, P869, DOI 10.1345/aph.1P605; Downey DM, 2009, AM SURGEON, V75, P1100; Hindy-Francois C, 2010, THROMB HAEMOSTASIS, V104, P823, DOI 10.1160/TH10-01-0039; Holzmacher JL, 2018, BRAIN INJURY, V32, P325, DOI 10.1080/02699052.2018.1425804; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Jehan F, 2019, J SURG RES, V236, P224, DOI 10.1016/j.jss.2018.11.050; Jones K, 2006, AM J SURG, V192, P743, DOI 10.1016/j.amjsurg.2006.08.037; Joseph B, 2015, CURR OPIN CRIT CARE, V21, P506, DOI 10.1097/MCC.0000000000000247; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P817, DOI 10.1097/TA.0b013e3182aafcf0; Joseph B, 2014, AM SURGEON, V80, P43; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P990, DOI 10.1097/TA.0b013e3182a96591; Karni A, 2001, AM SURGEON, V67, P1098; Kaufman RM, 2015, ANN INTERN MED, V162, P205, DOI 10.7326/M14-1589; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; PATRONO C, 1985, CIRCULATION, V72, P1177, DOI 10.1161/01.CIR.72.6.1177; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Rossaint R, 2010, CRIT CARE, V14, DOI 10.1186/cc8943; Vang ML, 2011, ACTA ANAESTH SCAND, V55, P507, DOI 10.1111/j.1399-6576.2011.02414.x; Vilahur G, 2007, J THROMB HAEMOST, V5, P82, DOI 10.1111/j.1538-7836.2006.02245.x; Washington CW, 2011, J TRAUMA, V71, P358, DOI 10.1097/TA.0b013e318220ad7e; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234	33	2	2	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JAN	2021	257						239	245		10.1016/j.jss.2020.07.076			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	PF5MA	WOS:000599097100026	32862051				2022-02-06	
J	Minta, K; Brinkmalm, G; Thelin, EP; Al Nimer, F; Piehl, F; Tullberg, M; Jeppsson, A; Portelius, E; Zetterberg, H; Blennow, K; Andreasson, U				Minta, Karolina; Brinkmalm, Gunnar; Thelin, Eric P.; Al Nimer, Faiez; Piehl, Fredrik; Tullberg, Mats; Jeppsson, Anna; Portelius, Erik; Zetterberg, Henrik; Blennow, Kaj; Andreasson, Ulf			Cerebrospinal fluid brevican and neurocan fragment patterns in human traumatic brain injury	CLINICA CHIMICA ACTA			English	Article						Brevican; Cerebrospinal fluid; Idiopathic normal pressure hydrocephalus; Neurocan; Parallel reaction monitoring mass spectrometry, traumatic brain injury	NORMAL-PRESSURE HYDROCEPHALUS; FIBRILLARY ACIDIC PROTEIN; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; TAU; ASSOCIATION; BIOMARKER; BLOOD; RAT	Background: Altered levels of two extracellular matrix (ECM) pmteoglycans, brevican and neurocan, have been found in brain injury models; however, their proteolytic processing in traumatic brain injury (TBI) remains unexplored. A disintegrin and metalloproteinase with thmmbospondin motifs (ADAMTS) is a possible contributor to ECM remodelling following TBI. The aims of this study were to evaluate proteolytic brevican/neurocan patterns and ADAMTS-like activity in cerebrospinal fluid (CSF) in the context of TBI. Materials and methods: Forty-two acute TBI patients and 37 idiopathic normal pressure hydrocephalus (iNPH) patients were included in the analysis of tryptic brevican and neurocan peptides in CSF using parallel reaction monitoring mass spectrometry. Twenty-nine TBI and 36 iNPH patients were analysed for ADAMTS-like activity in CSF using a quenched fluorescent substrate. Results: The majority of CSF concentrations of brevican peptides significantly decreased in TBI patients compared with the iNPH group (p <= 0.002), while ADAMTS-like activity increased (p < 0.0001). Two C-terminal brevican peptides strongly correlated with unfavourable outcome of TBI patients (rho = 0.85-0.93, p <= 0.001). Conclusions: The decreased CSF concentrations of brevican peptides in TBI are associated with their increased degradation by ADAMTS enzymes. Furthermore, the N- and C-terminal parts of brevican are differentially regulated following TBI and may serve as outcome markers.	[Minta, Karolina; Brinkmalm, Gunnar; Portelius, Erik; Zetterberg, Henrik; Blennow, Kaj; Andreasson, Ulf] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden; [Brinkmalm, Gunnar; Portelius, Erik; Zetterberg, Henrik; Blennow, Kaj; Andreasson, Ulf] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Thelin, Eric P.; Al Nimer, Faiez; Piehl, Fredrik] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Thelin, Eric P.] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden; [Tullberg, Mats; Jeppsson, Anna] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci, Gothenburg, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Dept Neurodegenerat Dis, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England		Minta, K (corresponding author), Sahlgrenska Univ Hosp Molndal, Dept Psychiat & Neurochem, S-43180 Molndal, Sweden.	karolina.minta@neuro.gu.se	Thelin, Eric Peter/K-2144-2012; Brinkmalm, Gunnar/AAH-3914-2021	Thelin, Eric Peter/0000-0002-2338-4364; Zetterberg, Henrik/0000-0003-3930-4354; Al Nimer, Faiez/0000-0003-0937-5995; Piehl, Fredrik/0000-0001-8329-5219; Jeppsson, Anna/0000-0002-5908-1904; Tullberg, Mats/0000-0003-4997-5266; Minta, Karolina/0000-0002-3346-5088	Stiftelsen for Gamla Tjanarinnor; Herbert och Karin Jacobssons Stiftelse; Gun och Bertil Stohnes Stiftelse; Swedish Research CouncilSwedish Research CouncilEuropean Commission [2018-02532, 2017-00915]; European Research CouncilEuropean Research Council (ERC)European Commission [681712]; Swedish State Support for Clinical Research [ALFGBG-720931]; Alzheimer Drug Discovery Foundation (ADDF), USA [201809-2016862, RDAPB-201809-2016615]; UK Dementia Research Institute at UCL; Swedish Alzheimer Foundation [AF-742881]; Hjarnfonden, Sweden [FO2017-0243]; Swedish government [ALFGBG-715986]; Swedish County Councils, the ALF [ALFGBG-715986]; European Union Joint Program for Neurodegenerative Disorders [JPND2019-466-236]; Hjarnfonden [FO2019-0006]; Svenska Sallskapet for Medicinsk Forskning (SSMF); ALF [ALFGBG 720121]	KM acknowledges fundings from Stiftelsen for Gamla Tjanarinnor, Herbert och Karin Jacobssons Stiftelse and Gun och Bertil Stohnes Stiftelse. HZ is a Wallenberg Scholar supported by grants from the Swedish Research Council (#2018-02532), the European Research Council (#681712), Swedish State Support for Clinical Research (#ALFGBG-720931), the Alzheimer Drug Discovery Foundation (ADDF), USA (#201809-2016862), and the UK Dementia Research Institute at UCL. KB is supported by the Swedish Research Council (#2017-00915), the Alzheimer Drug Discovery Foundation (ADDF), USA (#RDAPB-201809-2016615), the Swedish Alzheimer Foundation (#AF-742881), Hjarnfonden, Sweden (#FO2017-0243), the Swedish state under the agreement between the Swedish government and the County Councils, the ALF-agreement (#ALFGBG-715986), and European Union Joint Program for Neurodegenerative Disorders (JPND2019-466-236). EPT acknowledges funding from Hjarnfonden (#FO2019-0006) and postdoctoral scholarships from Svenska Sallskapet for Medicinsk Forskning (SSMF). MT acknowledges support from the ALF agreement (#ALFGBG 720121).	Abu-Rumeileh S, 2019, J ALZHEIMERS DIS, V68, P723, DOI 10.3233/JAD-181012; Al Nimer F., 2015, PLOS ONE, V10; ALBRECHTSEN M, 1985, J NEUROL SCI, V70, P269, DOI 10.1016/0022-510X(85)90168-6; Asher RA, 2000, J NEUROSCI, V20, P2427; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Brinkmalm G, 2018, PROTEOM CLIN APPL, V12, DOI 10.1002/prca.201700131; Chen W., 2015, CELL BIOCH BIOPHYS, V73; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Cox T.R., 2011, DIS MODELS MECH, V4; Cross AK, 2006, BRAIN RES, V1088, P19, DOI 10.1016/j.brainres.2006.02.136; Danielson M, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1318-y; Dewan MC, 2019, J NEUROSURG, V130, P1065, DOI 10.3171/2017.10.JNS17439; Dinet V, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01178; Fontanil T., 2019, CELL PHYSL BIOCH, V52; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; George N, 2018, J NEUROSCI RES, V96, P573, DOI 10.1002/jnr.24151; Gottschall P.E., 2015, MATRIX BIOL, P44; Goyal A., 2013, J NEUROTRAUMA, V30; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Jennett B., 1975, LANCET, V1; Jeppsson A, 2013, NEUROLOGY, V80, P1385, DOI 10.1212/WNL.0b013e31828c2fda; Li X, 2014, J INTERN MED, V275, P418, DOI 10.1111/joim.12164; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marshall L.F., 1992, J NEUROTRAUMA S1, V9; MATSUI F, 1994, NEUROCHEM INT, V25, P425, DOI 10.1016/0197-0186(94)90018-3; Matthews RT, 2000, J BIOL CHEM, V275, P22695, DOI 10.1074/jbc.M909764199; Mayer J, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-52; MINTA K, 2020, SCI REP, V12, DOI DOI 10.1186/S13195-020-00585-7; Minta K, 2021, J Alzheimers Dis; Minta K., 2019, CLIN CHEM, V57; Nakamura H, 2000, J BIOL CHEM, V275, P38885, DOI 10.1074/jbc.M003875200; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Rosenberg GA, 1998, STROKE, V29, P2189, DOI 10.1161/01.STR.29.10.2189; Schirinzi T., 2018, J NEURAL TRANSM, V125; Siebert JR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/845323; TEASDALE G, 1974, LANCET, V2, P81; Tullberg M, 1998, NEUROLOGY, V50, P1122, DOI 10.1212/WNL.50.4.1122; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Vilalta A., 2008, ACTA NEUROCHIR S, V102; Yamada H., 1994, J BIOL CHEM, V269; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zetterberg H., 2006, ARCH NEUROL, V63; Zimmermann DR, 2008, HISTOCHEM CELL BIOL, V130, P635, DOI 10.1007/s00418-008-0485-9	48	2	2	3	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	JAN	2021	512						74	83		10.1016/j.cca.2020.11.017			10	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	PI1BF	WOS:000600833300014	33275942	Green Submitted			2022-02-06	
J	Richard, M; Lagares, A; Bondanese, V; de la Cruz, J; Mejan, O; Pavlov, V; Payen, JF; Maignan, M				Richard, Marion; Lagares, Alfonso; Bondanese, Victor; de la Cruz, Javier; Mejan, Odile; Pavlov, Vladislav; Payen, Jean-Francois; Maignan, Maxime		BRAINI investigators	Study protocol for investigating the performance of an automated blood test measuring GFAP and UCH-L1 in a prospective observational cohort of patients with mild traumatic brain injury: European BRAINI study	BMJ OPEN			English	Article							HEAD-INJURY; SCALE; COMA; MANAGEMENT; PROGNOSIS; SCORE	Introduction Mild traumatic brain injury (mTBI) is a common cause of clinical consultation in the emergency department. Patients with mTBI may undergo brain CT scans based on clinical criteria. However, the proportion of patients with brain lesions on CT is very low. Two serum biomarkers, glial fibrillar acidic protein (GFAP) and ubiquitin carboxy-terminal hydrolase L1 (UCH-L1), have been shown to discriminate patients regarding the presence or absence of brain lesions on initial CT scan when assessed within the first 12 hours after TBI. However, the current technique for measuring serum concentrations of GFAP and UCH-L1 is manual and time consuming, which may hinder its use in routine clinical practice. This study assesses the diagnostic accuracy of an automated assay for the measurement of serum GFAP and UCH-L1 in a cohort of patients with mTBI who received a CT scan as the standard of care. Methods and analysis This is a prospective muiticentre observational study of 1760 patients with mTBI recruited in France and Spain across 16 participating sites. Adult patients with an initial Glasgow Coma Scale score of 13-15 and a brain CT scan underwent blood sampling within 12 hours after TBI. The primary outcome measure is the diagnostic performance of an automated assay measuring serum concentrations of GFAP and UCH-L1 for discriminating between patients with positive and negative findings on brain CT-scans. Secondary outcome measures include the performance of these two biomarkers in predicting the neurological status and quality of life at 1 week and 3 months after the trauma. Ethics and dissemination Ethics approval was obtained by the Institutional Review Board of Sud-Ouest Outre Mer III in France (Re#2019-A01525-52) and Hospital 12 de Octubre in Spain (Re#19/322). The results will be presented at scientific meetings and published in peer-reviewed publications.	[Richard, Marion; Maignan, Maxime] Univ Grenoble Alpes, Grenoble Inst Neurosci, Dept Anaesthesia & Intens Care, Ctr Hosp Univ Grenoble Alpes,INSERM,U1216, Grenoble, France; [Lagares, Alfonso] Univ Complutense Madrid, Inst Invest Imas12, Hosp Univ Octubre 12, Serv Neurocirugia, Madrid, Spain; [Bondanese, Victor; Mejan, Odile] bioMerieux, Clin Unit, Chemin Orme, Marcy Letoile, Spain; [de la Cruz, Javier] Hosp Univ 12 Octubre, Inst Invest Imas12, SAMID, Madrid, France; [Pavlov, Vladislav] bioMerieux, Med Affairs, Chemin Orme, Marcy Letoile, France		Lagares, A (corresponding author), Univ Complutense Madrid, Inst Invest Imas12, Hosp Univ Octubre 12, Serv Neurocirugia, Madrid, Spain.	alfonlag@ucm.es	Lagares, Alfonso/B-2969-2011; JACQUIN, Laurent/AAE-9752-2020	Lagares, Alfonso/0000-0003-3996-0554; JACQUIN, Laurent/0000-0002-1653-0722; Douplat, Marion/0000-0003-1592-4065	European Institute of Innovation and Technology (EIT) Health; EIT, a body of the European Union	This study is supported by a grant from the European Institute of Innovation and Technology (EIT) Health (BP 2019-2020). EIT Health is supported by EIT, a body of the European Union. bioMerieux is responsible for the development and manufacturing of the VIDAS GFAP and VIDAS UCHL-1 assays. bioMerieux will provide in-kind support to the study by supplying the assays for the measurement of UCH-L1 and GFAP necessary for this study.	Banyan BTI, 2020, BAN BTI PACK INS; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Castano-Leon AM, 2018, EVAL HEALTH PROF, V41, P456, DOI 10.1177/0163278717702696; Czeiter E, 2020, EBIOMEDICINE, V56, DOI 10.1016/j.ebiom.2020.102785; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Gill J, 2018, NEUROLOGY, V91, pE1385, DOI 10.1212/WNL.0000000000006321; Gomez PA, 2000, NEUROCIRUGIA, V11, P351; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Jehle E, 2012, ANN FR MED URGENCE, V2, P199, DOI 10.1007/s13341-012-0202-4; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Maas AIR, 2018, LANCET NEUROL, V17, P737, DOI 10.1016/S1474-4422(18)30275-8; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Shahjouei S, 2018, BRAIN INJURY, V32, P1, DOI 10.1080/02699052.2017.1382717; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0	25	2	2	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2021	11	2							e043635	10.1136/bmjopen-2020-043635			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QO6WQ	WOS:000623282300010	33632753	gold, Green Published			2022-02-06	
J	Silva, MA; Jantz, ABV; Klocksieben, F; Monden, KR; Rabinowitz, AR; Cotner, BA; Dillahunt-Aspillaga, C; Nakase-Richardson, R				Silva, Marc A.; Jantz, Alicia B. VandenBussche; Klocksieben, Farina; Monden, Kimberley R.; Rabinowitz, Amanda R.; Cotner, Bridget A.; Dillahunt-Aspillaga, Christina; Nakase-Richardson, Risa			Unmet Rehabilitation Needs Indirectly Influence Life Satisfaction 5 Years After Traumatic Brain Injury: A Veterans Affairs TBI Model Systems Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Traumatic; Personal satisfaction; Personnel; Rehabilitation; Social participation; Veterans		Objective: To describe the association between unmet rehabilitation needs and life satisfaction 5 years after traumatic brain injury (TBI). Design: Prospective observational cohort. Setting: Five Veterans Affairs (VA) Polytrauma Rehabilitation Centers. Participants: VA TBI Model Systems participants (NZ301); 95% male; 77% white; average age, 39 +/- 14y). Interventions: Not applicable. Main Outcome Measures: Satisfaction With Life Scale (SWLS). Results: Average SWLS score was 22 +/- 8. Univariable analyses demonstrated several statistically significant predictors of life satisfaction, including employment status, participation, psychiatric symptom severity, past year mental health treatment, and total number of unmet rehabilitation needs (all P<.05). Multivariable analyses revealed that depression and participation were each associated with life satisfaction. An ad hoc mediation model suggested that unmet rehabilitation needs total was indirectly related to life satisfaction. Total unmet rehabilitation needs ranged from 0-21 (mean, 2.0 +/- 3.4). Correlational analyses showed that 14 of the 21 unmet rehabilitation needs were associated with life satisfaction. Conclusions: Findings support the need for rehabilitation engagement in later stages of TBI recovery. Ongoing assessment of and intervention for unmet rehabilitation needs in the chronic phase of recovery have the potential to mitigate decline in life satisfaction. Archives of Physical Medicine and Rehabilitation 2021;102:58-67 (c) 2020 by the American Congress of Rehabilitation Medicine	[Silva, Marc A.; Jantz, Alicia B. VandenBussche; Nakase-Richardson, Risa] James A Haley Vet Hosp, Mental Hlth & Behav Sci Sect MHBSS, Tampa, FL 33612 USA; [Silva, Marc A.] Univ S Florida, Dept Psychiat & Behav Neurosci, Tampa, FL 33620 USA; [Silva, Marc A.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Silva, Marc A.; Nakase-Richardson, Risa] James A Haley Vet Hosp, Def & Vet Brain Injury Ctr DVBIC, Tampa, FL 33612 USA; [Klocksieben, Farina; Nakase-Richardson, Risa] Univ S Florida, Dept Internal Med, Tampa, FL 33620 USA; [Monden, Kimberley R.] Craig Hosp, Res Dept, Englewood, CO USA; [Monden, Kimberley R.] Univ Minnesota, Dept Rehabil Med, Minneapolis, MN USA; [Rabinowitz, Amanda R.] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Cotner, Bridget A.] James A Haley Vet Hosp, Res Serv, Tampa, FL 33612 USA; [Cotner, Bridget A.] Univ S Florida, Dept Anthropol, Tampa, FL 33620 USA; [Dillahunt-Aspillaga, Christina] Univ S Florida, Rehabil & Mental Hlth Counseling, Tampa, FL 33620 USA		Silva, MA (corresponding author), James A Haley Vet Hosp, Mental Hlth & Behav Sci Serv, 13000 Bruce B Downs Blvd 116-B, Tampa, FL 33612 USA.	marc.silva1@va.gov	Monden, Kimberley/AAE-9831-2020	Monden, Kimberley/0000-0002-5207-0452	VHA Central Office VATBI Model System Program of Research; General Dynamics Information Technology (GDIT) from the Defense and Veterans Brain Injury Center [W91YTZ-13-C-0015, HT0014-19-C-0004]; Rocky Mountain Regional Brain Injury System [90DPTB00070]; Department of Veterans AffairsUS Department of Veterans Affairs; Department of Health and Human Services: National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)	Supported by VHA Central Office VATBI Model System Program of Research (Drs Richardson and Silva), Subcontract from General Dynamics Information Technology (GDIT) (W91YTZ-13-C-0015; HT0014-19-C-0004) (Dr Richardson) from the Defense and Veterans Brain Injury Center as official government work (contactdha.DVBICinfo@mail.mil with questions), and Rocky Mountain Regional Brain Injury System (90DPTB00070) (Dr Monden). The VATBI Model Systems is a funded collaboration between the Department of Veterans Affairs and the Department of Health and Human Services: National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR). This research was conducted with resources and the use of facilities at the Hunter Holmes McGuire Veterans Affairs Medical Center, James A. Haley Veterans' Hospital, Minneapolis VA Health Care System, Palo Alto VA Health Care System, and South Texas Veterans Health Care System. The views, opinion, and/or findings contained in this article are those of the authors and should not be construed as an official US Department of Defense, Defense Health Agency, Department of Army/Navy/Air Force, Veterans Affairs, or any other federal agency position, policy, or decision unless so designated by other official documentation. No official endorsement should be inferred.	Al-Jarrah MD, 2009, NEUROSCIENCES, V14, P41; Amtmann D, 2019, ASSESSMENT, V26, P695, DOI 10.1177/1073191117693921; Anke A, 2015, J HEAD TRAUMA REHAB, V30, pE38, DOI 10.1097/HTR.0000000000000080; Arango-Lasprilla JC, 2009, NEUROREHABILITATION, V24, P5, DOI 10.3233/NRE-2009-0449; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Centers for Disease Control and Prevention, 1998, BEH RISK FACT SURV S; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Davis LC, 2012, ARCH PHYS MED REHAB, V93, P1324, DOI 10.1016/j.apmr.2012.02.036; Department of Veterans Affairs, POL TBI SYST CAR; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dillahunt-Aspillaga C, J REHABIL; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Gause LR, 2017, J HEAD TRAUMA REHAB, V32, P255, DOI 10.1097/HTR.0000000000000309; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Hammond FM, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000465; Harrison-Felix C., 2018, ONE 5 YEAR OUTCOMES; Hayes, 2018, INTRO MEDIATION MODE; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS178, DOI 10.1016/j.apmr.2014.09.042; Huebner RA, 2003, AM J OCCUP THER, V57, P177, DOI 10.5014/ajot.57.2.177; Juengst SB, 2015, REHABIL PSYCHOL, V60, P353, DOI 10.1037/rep0000056; Kalpinski RJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/102570; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Kumar RG, 2020, J HEAD TRAUMA REHAB, V35, pE372, DOI 10.1097/HTR.0000000000000572; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Masel BE, UNDERSTANDING TRAUMA; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Richardson R, 2016, ARCH PHYS MED REHAB, V97, pE127; Nakase-Richardson R, 2017, J HEAD TRAUMA REHAB, V32, P221, DOI 10.1097/HTR.0000000000000334; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Preacher KJ, 2011, PSYCHOL METHODS, V16, P93, DOI 10.1037/a0022658; Resnik L, 2012, J REHABIL RES DEV, V49, P87, DOI 10.1682/JRRD.2010.06.0107; Royer AC, 2018, ARCH PHYS MED REHAB, V99, pE174; Rutherford GW, 2009, J HEAD TRAUMA REHAB, V24, P421, DOI 10.1097/HTR.0b013e3181c13439; Saban KL, 2011, J WOMENS HEALTH, V20, P179, DOI 10.1089/jwh.2010.2334; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Sveen U, 2016, EUR J PHYS REHAB MED, V52, P650; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Weathers FW, 1991, PCL C DSM 4; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Williamson MLC, 2013, BRAIN INJURY, V27, P992, DOI 10.3109/02699052.2013.801512; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	56	2	2	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2021	102	1					58	67		10.1016/j.apmr.2020.08.012			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	QA5ST	WOS:000613505800008	32949552				2022-02-06	
J	Tchantchou, F; Miller, C; Goodfellow, M; Puche, A; Fiskum, G				Tchantchou, Flaubert; Miller, Catriona; Goodfellow, Molly; Puche, Adam; Fiskum, Gary			Hypobaria-Induced Oxidative Stress Facilitates Homocysteine Transsulfuration and Promotes Glutathione Oxidation in Rats with Mild Traumatic Brain Injury	JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE			English	Article						Hypobaria; homocysteine; oxidative stress; glutathione; traumatic brain injury		Background: United States service members injured in combat theatre are often aeromedically evacuated within a few days to regional military hospitals. Animal and epidemiological research indicates that early exposure to flight hypobaria may worsen brain and other injuries. The mechanisms by which secondary exposure to hypobaria worsen trauma outcomes are not well elucidated. This study tested the hypothesis that hypobaria-induced oxidative stress and associated changes in homocysteine levels play a role in traumatic brain injury (TBI) pathological progression caused by hypobaria. Methods: Male Sprague Dawley rats were exposed to a 6 h hypobaria 24 h after mild TBI by the controlled cortical impact. Plasma and brain tissues were assessed for homocysteine levels, oxidative stress markers or glutathione metabolism, and behavioral deficits post-injury in the absence and presence of hypobaria exposure. Results: We found that hypobaria after TBI increased oxidative stress markers, altered homocysteine metabolism, and promoted glutathione oxidation. Increased glutathione metabolism was driven by differential upregulation of glutathione metabolizing genes. These changes correlated with increased anxiety-like behavior. Conclusion: These data provide evidence that hypobaria exposure after TBI increases oxidative stress and alters homocysteine elimination likely through enhanced glutathione metabolism. This pathway may represent a compensatory mechanism to attenuate free radical formation. Thus, hypobaria-induced enhancement of glutathione metabolism represents a potential therapeutic target for TBI management.	[Tchantchou, Flaubert; Goodfellow, Molly; Fiskum, Gary] Univ Maryland, Sch Med, Dept Anesthesiol, 685 W Baltimore St, Baltimore, MD 21201 USA; [Tchantchou, Flaubert; Goodfellow, Molly; Fiskum, Gary] Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA; [Miller, Catriona] US Air Force, Aeromed Res, Sch Aerosp Med, Wright Patterson AFB, OH USA; [Puche, Adam] Univ Maryland, Dept Anat & Neurobiol, Sch Med, Baltimore, MD 21201 USA		Tchantchou, F (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, 685 W Baltimore St, Baltimore, MD 21201 USA.	ftchantchou@som.umaryland.edu	Goodfellow, Molly/V-9947-2019		Department of Defense, U.S Air Force [FA8650-17-2-6H10]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Department of Defense, U.S Air Force, Grant #FA8650-17-2-6H10	Aksenov MY, 1998, J MOL NEUROSCI, V11, P151, DOI 10.1385/JMN:11:2:151; Balan IS, 2013, J NEUROTRAUM, V30, P367, DOI 10.1089/neu.2012.2339; Bellinger FP, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-8; Clark RSB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180280; Cobb CA, 2015, NEUROBIOL DIS, V84, P4, DOI 10.1016/j.nbd.2015.04.020; D'Urso G, 2018, J ECT, V34, P172, DOI 10.1097/YCT.0000000000000538; Dadas A, 2018, NEUROPSYCH DIS TREAT, V14, P2989, DOI 10.2147/NDT.S125620; Dayani Y, 2019, J TRAUMA ACUTE CARE, V87, P205, DOI 10.1097/TA.0000000000002337; de Pablos RM, 2006, J NEUROSCI, V26, P5709, DOI 10.1523/JNEUROSCI.0802-06.2006; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; GEREMIA E, 1990, NEUROCHEM RES, V15, P719, DOI 10.1007/BF00973653; Goodman MD, 2011, J SURG RES, V165, P30, DOI 10.1016/j.jss.2010.05.055; Haber M, 2018, J CEREBR BLOOD F MET, V38, P1312, DOI 10.1177/0271678X17718106; Hashimoto M, 2000, AM J PATHOL, V156, P734, DOI 10.1016/S0002-9440(10)64777-3; Ho PI, 2002, J NEUROSCI RES, V70, P694, DOI 10.1002/jnr.10416; Joshi M C, 2010, Med J Armed Forces India, V66, P63, DOI 10.1016/S0377-1237(10)80097-8; Julio-Amilpas A, 2015, J CEREBR BLOOD F MET, V35, P851, DOI 10.1038/jcbfm.2015.1; Kamat PK, 2016, ALCOHOL CLIN EXP RES, V40, P2474, DOI 10.1111/acer.13234; Kamath AF, 2006, BLOOD, V107, P591, DOI 10.1182/blood-2005-06-2506; Karalija A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041086; Kim CY, 2005, J MED PRIMATOL, V34, P188, DOI 10.1111/j.1600-0684.2005.00116.x; KISH SJ, 1986, NEUROCHEM PATHOL, V4, P23, DOI 10.1007/BF02834296; Kumar S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5537; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Luo Y, 2007, NEUROREPORT, V18, P2005, DOI 10.1097/WNR.0b013e3282f29100; MAKAR TK, 1994, J NEUROCHEM, V62, P45; MARCHENA OD, 1974, J NEUROCHEM, V22, P773, DOI 10.1111/j.1471-4159.1974.tb04293.x; McEwen BS, 2016, NEUROPSYCHOPHARMACOL, V41, P3, DOI 10.1038/npp.2015.171; McEwen BS, 2013, NEURON, V79, P16, DOI 10.1016/j.neuron.2013.06.028; McIntosh IB, 1998, J TRAVEL MED, V5, P198, DOI 10.1111/j.1708-8305.1998.tb00507.x; Miller AL, 2008, ALTERN MED REV, V13, P216; Moshal KS, 2006, AM J PHYSIOL-HEART C, V291, pH2825, DOI 10.1152/ajpheart.00377.2006; Perna AF, 2003, AMINO ACIDS, V25, P409, DOI 10.1007/s00726-003-0026-8; Peterson AL, 2018, MIL MED, V183, pE649, DOI 10.1093/milmed/usy188; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Power JHT, 2009, ACTA NEUROPATHOL, V117, P63, DOI 10.1007/s00401-008-0438-3; Proctor JL, 2017, J TRAUMA ACUTE CARE, V83, pS35, DOI 10.1097/TA.0000000000001478; Rahmani A, 2016, WORLD NEUROSURG, V87, P507, DOI 10.1016/j.wneu.2015.09.016; Ramos-Cabrer P, 2011, STROKE, V42, pS7, DOI 10.1161/STROKEAHA.110.596684; Ravi GP., 2016, J MED RES, V2, P20; Rossi R, 2006, CLIN CHEM, V52, P1406, DOI 10.1373/clinchem.2006.067793; Sandhir R, 2012, NEURODEGENER DIS, V9, P145, DOI 10.1159/000334273; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; Sharma VK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101448; Skandsen T, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00638; Skovira JW, 2016, J NEUROTRAUM, V33, P1292, DOI 10.1089/neu.2015.4189; Solleiro-Villavicencio H, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00114; Tchantchou F, 2005, J ALZHEIMERS DIS, V7, P135; Tchantchou F, 2006, J ALZHEIMERS DIS, V9, P421; Tchantchou F, 2021, CELL MOL NEUROBIOL, V41, P487, DOI 10.1007/s10571-020-00866-7; Tchantchou F, 2018, J NEUROTRAUM, V35, P1192, DOI 10.1089/neu.2017.5401; Tchantchou F, 2017, EXP NEUROL, V289, P9, DOI 10.1016/j.expneurol.2016.12.001; Tchantchou F, 2013, J NEUROTRAUM, V30, P565, DOI 10.1089/neu.2012.2647; Vera M, 2018, CELL PHYSIOL BIOCHEM, V51, P1287, DOI 10.1159/000495540; Wright DJ, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2014.131; Yang Y, 2019, REDOX BIOL, V20, P157, DOI 10.1016/j.redox.2018.09.019; Zhang CE, 2008, NEUROBIOL AGING, V29, P1654, DOI 10.1016/j.neurobiolaging.2007.04.015; Zhou XW, 2008, NEUROBIOL DIS, V31, P386, DOI 10.1016/j.nbd.2008.05.013	61	2	2	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1179-5735			J CENT NERV SYST DIS	J. Cent. Nerv. Syst. Dis.	JAN	2021	13								1179573520988193	10.1177/1179573520988193			11	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	QG5GO	WOS:000617613800001	33597815	gold, Green Published			2022-02-06	
J	Waltzman, D; Daugherty, J; Sarmiento, K; Proescholdbell, S				Waltzman, Dana; Daugherty, Jill; Sarmiento, Kelly; Proescholdbell, Scott			Lifetime History of Traumatic Brain Injury With Loss of Consciousness and the Likelihood for Lifetime Depression and Risk Behaviors: 2017 BRFSS North Carolina	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						age; health risk behaviors; LOC; TBI	SUBSTANCE USE; OUTCOMES; POPULATION; PREVALENCE; ABUSE; ASSOCIATION; GUIDELINE; YOUTH; TBI	Objective: Because of the growing concern about the potential effects of traumatic brain injuries (TBIs) on a child's developing brain and the potential impact of lifetime depression and risk behaviors associated with TBI, further exploration is warranted. Setting and Participants: Data (N = 4917) from the 2017 North Carolina Behavioral Risk Factors Surveillance System (BRFSS). Design: Cross-sectional. Main Measures: Examine whether a lifetime history of TBI with loss of consciousness (LOC) or having a history of TBI with LOC prior to 18 years of age was associated with a greater likelihood of lifetime depression, current binge drinking, and current cigarette and e-cigarette smoking. Results: Respondents with a history of TBI with LOC had 2.1 (95% CI, 1.6-2.8) times higher odds of lifetime depression and 1.7 to 1.8 (95% CI, 1.02-2.97) times higher odds of all risk behaviors than those without a lifetime history of TBI with LOC. There were no statistical differences between age of first TBI with LOC and lifetime depression, binge drinking, cigarette smoking, and e-cigarette use after controlling for key demographics. Conclusion: These findings underscore the importance of increasing awareness among healthcare providers of the prevalence of lifetime depression and risk behaviors among individuals with a history of TBI and the need for improved screening and referrals to evidence-based services.	[Waltzman, Dana; Daugherty, Jill; Sarmiento, Kelly] Ctr Dis Control & Prevent, Div Injury Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Hwy NE, Atlanta, GA 30341 USA; [Proescholdbell, Scott] North Carolina Dept Hlth & Human Serv, Div Publ Hlth, Raleigh, NC USA		Waltzman, D (corresponding author), Ctr Dis Control & Prevent, Div Injury Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Hwy NE, Atlanta, GA 30341 USA.	nmc3@cdc.gov; xdu1@cdc.gov; egz8@cdc.gov; scott.proescholdbell@dhhs.nc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline		Allen S, 2016, SUBST USE MISUSE, V51, P1577, DOI 10.1080/10826084.2016.1188955; [Anonymous], 2018, BEH RISK FACT SURV S; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bin Abdullah MFIL, 2018, ASIAN J PSYCHIATR, V37, P67, DOI 10.1016/j.ajp.2018.08.017; Bogner J, 2020, J HEAD TRAUMA REHAB, V35, pE43, DOI 10.1097/HTR.0000000000000488; Centers for Disease Control and Prevention, 2017, TBI GET THE FACTS; Centers for Disease Control and Prevention, 2018, C MAN TRAUM BRAIN IN; Centers for Disease Control and Prevention, 2017, TRAUM BRAIN INJ CONC; Centers for Disease Control and Prevention, 2018, MAN DEPR; Centers for Disease Control and Prevention, 2018, CDCS ALC SCREEN BRIE; Centers for Disease Control and Prevention Office on Smoking and Health, 2018, STAT COMM RES; Centers for Disease Control and Prevention US Department of Health and Human Services Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Gupta D, 2016, WORLD NEUROSURG, V89, P169, DOI 10.1016/j.wneu.2015.12.097; Ilie G, 2015, J HEAD TRAUMA REHAB, V30, P293, DOI 10.1097/HTR.0000000000000101; Kann L, 2014, MMWR SURVEILL SUMM, V63, P1; Kennedy E, 2017, EUR CHILD ADOLES PSY, V26, P1197, DOI 10.1007/s00787-017-0975-1; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Marr A., 2004, CENTRAL NERVOUS SYST; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Narad ME, 2019, J DEV BEHAV PEDIATR, V40, P451, DOI 10.1097/DBP.0000000000000681; National Institute of Neurological Disorders and Stroke, 2002, TRAUM BRAIN INJ HOP; North Carolina State Center for Health Statistics Department of Public Health, 2017, N CAR BEH RISK FACT; Nybo T, 2004, J INT NEUROPSYCH SOC, V10, P719, DOI 10.1017/S1355617704105109; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Singh R, 2018, BRAIN INJURY, V32, P84, DOI 10.1080/02699052.2017.1376756; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Weil ZM, 2016, NEUROSCI BIOBEHAV R, V62, P89, DOI 10.1016/j.neubiorev.2016.01.005; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE43, DOI 10.1097/HTR.0000000000000141; Winqvist S, 2007, BRAIN INJURY, V21, P1079, DOI 10.1080/02699050701553221	44	2	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2021	36	1			SI		E40	E49		10.1097/HTR.0000000000000603			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	PM7ZE	WOS:000604011300008	32769836	Green Accepted			2022-02-06	
J	Wrede, AH; Luo, J; Montazami, R; Kanthasamy, A; Hashemi, NN				Wrede, Alex H.; Luo, Jie; Montazami, Reza; Kanthasamy, Anumantha; Hashemi, Nicole N.			How do neuroglial cells respond to ultrasound induced cavitation?	AIP ADVANCES			English	Article							MICROBUBBLES; INJURY; DAMAGE	Reactive astrocytes are known to play a vital role in the overall response of the brain during a traumatic brain injury (TBI). Modern studies have speculated the existence of cavitation in the skull during a TBI, which has alarming potential to cause detrimental damage. Previous studies have confirmed the upregulation of various harmful genes in neurodegenerative diseases. Studying the longitudinal presence of these harmful genes in response to cavitation allows for optimized understanding of and treatment methods for cavitation exposure. We seek to characterize the longitudinal genetic expression levels that astrocytes exhibit after exposure to cavitation and further elucidate the startling presence of cranial cavitation. We have designed a system to induce cavitation on targeted microbubbles. Astrocytic expression levels of various common genes, like TNF alpha, IL-1 beta, and NOS1, that have been documented in TBI studies are our target of interest. Results summarize specific gene trends from 1 h to 48 h after cavitation. Our data conclude that maximum expression is not consistently exhibited immediately after cavitation exposure and most genes have individualized genetic trends. IL-1 beta shows a decreasing expression over 48 h, and TNF alpha shows upregulation until the 6 h time point but then begins to decrease in expression. The upregulation of NOS1 has been documented in neurodegenerative diseases, like Alzheimer's and Parkinson's disease. This study has shown a consistent upregulation in NOS1 expression from 0 h to 48 h. These results postulate a possible linkage between cavitation damage and neurodegenerative diseases. This analysis also provides novelty in optimizing treatments for the astrocytic function after TBI and legitimizing the concern of cranial cavitation existence.	[Wrede, Alex H.; Montazami, Reza; Hashemi, Nicole N.] Iowa State Univ, Dept Mech Engn, Ames, IA 50011 USA; [Luo, Jie; Kanthasamy, Anumantha; Hashemi, Nicole N.] Iowa State Univ, Dept Biomed Sci, Ames, IA 50011 USA		Hashemi, NN (corresponding author), Iowa State Univ, Dept Mech Engn, Ames, IA 50011 USA.; Hashemi, NN (corresponding author), Iowa State Univ, Dept Biomed Sci, Ames, IA 50011 USA.	nastaran@iastate.edu	Hashemi, Nicole/AAW-1384-2021	Hashemi, Nicole/0000-0001-8921-7588; Wrede, Alex/0000-0001-9509-924X	Office of Naval Research (ONR)Office of Naval Research [N000141612246, N000141712620]	This work was supported by the Office of Naval Research (ONR), Grant Nos. N000141612246 and N000141712620. The authors thank Timothy Bigelow for his help with ultrasound logistics and lending a power amplifier. There are no conflicts to declare.	[Anonymous], 2017, LANCET HIV, V2, pe115, DOI DOI 10.2217/cnc-2017-0011; Bai ZH, 2014, J MATER CHEM A, V2, P4878, DOI 10.1039/c3ta14573e; Bhattacharya A, 2016, PSYCHOPHARMACOLOGY, V233, P1623, DOI 10.1007/s00213-016-4214-0; Buckey JC, 2005, ACTA ASTRONAUT, V56, P1041, DOI 10.1016/j.actaastro.2005.01.032; Canchi S, 2017, J MECH BEHAV BIOMED, V74, P261, DOI 10.1016/j.jmbbm.2017.06.018; Caplin JD, 2015, ADV HEALTHC MATER, V4, P1426, DOI 10.1002/adhm.201500040; Chen YH, 2019, BRAIN RES, V1710, P163, DOI 10.1016/j.brainres.2019.01.005; Chernin L, 2017, RENEW ENERG, V113, P688, DOI 10.1016/j.renene.2017.06.037; Hashemi N, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3608136; Hashemi N, 2010, LAB CHIP, V10, P1952, DOI 10.1039/c004696e; Jang H, 2014, J NEUROSCI RES, V92, P1520, DOI 10.1002/jnr.23427; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McNamara MC, 2020, FRONT MATER, V7, DOI 10.3389/fmats.2020.00061; McNamara MC, 2019, ACS APPL BIO MATER, V2, P1603, DOI 10.1021/acsabm.9b00022; Meis C, 2015, ANAL METHODS-UK, V7, P10217, DOI 10.1039/c5ay01061f; Meis C, 2014, J APPL PHYS, V115, DOI 10.1063/1.4870181; Ransohoff RM, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020560; Salzar RS, 2017, J NEUROTRAUM, V34, P1589, DOI 10.1089/neu.2016.4600; Sharifi F, 2019, ACS APPL MATER INTER, V11, P18797, DOI 10.1021/acsami.9b05555; Sharifi F, 2016, BIOMACROMOLECULES, V17, P3287, DOI 10.1021/acs.biomac.6b01028; Sun S, 2015, J NEUROTRAUM, V32, P1441, DOI 10.1089/neu.2014.3699; The Lancet, 2020, LANCET PLANET HEALTH, V4, pe168, DOI DOI 10.1002/gch2.201900014; Wrede A. H., 2020, DO NEUROGLIAL CELLS, DOI [10.1101/2020.10.14.339002, DOI 10.1101/2020.10.14.339002]; Wrede AH, 2019, ANAL METHODS-UK, V11, P5038, DOI 10.1039/c9ay01576k; Wrede AH, 2018, ULTRASON SONOCHEM, V43, P114, DOI 10.1016/j.ultsonch.2018.01.006; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhu ZF, 2012, J HYDRODYN, V24, P347, DOI 10.1016/S1001-6058(11)60254-0	28	2	2	0	1	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA		2158-3226		AIP ADV	AIP Adv.	JAN 1	2021	11	1							015314	10.1063/5.0034936			6	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Materials Science; Physics	PS6ZD	WOS:000608075600006		Green Submitted, gold			2022-02-06	
J	Xiong, A; Xiong, RP; Yu, J; Liu, YJ; Liu, K; Jin, G; Xu, JZ; Yan, J				Xiong, Ao; Xiong, Renping; Yu, Jing; Liu, Yijia; Liu, Ke; Jin, Ge; Xu, Jianzhong; Yan, Jun			Aquaporin-4 is a potential drug target for traumatic brain injury via aggravating the severity of brain edema	BURNS & TRAUMA			English	Article						Aquaporin-4; Brain edema; Traumatic brain injury; Hypoxia inducible factor-1 alpha; Microtubule-associated protein 2		Background: Traumatic brain edema (TBE) is caused by a specific water channel mediated by membrane aquaporins. Aquaporin-4 (AQP4) plays an especially important role in this process, but the relationship between AQP4 and TBE remains unclear. The purpose of this study was to explore expression of AQP4 in the hippocampus after traumatic brain injury (TBI), as well as the effect of brain edema on skeletal protein and its function in hippocampal neurons. Methods: The adult male Wistar rats we divided into a sham group and a TBI group, the latter of which was further divided into 1, 3, 6, 12, 24 and 72 hours (h) and 15 days (d) post injury subgroups. A proper TBI model was established, and brain edema was assessed in each group by water content. We measured the abundance of various proteins, including hypoxia inducible factor-1 alpha (HIF-1 alpha), AQP4, microtubule-associated protein 2 (MAP2), tau-5 protein, phosphorylated level of TAU, synaptophysin, cyclic adenosine monophosphate response element binding protein (CREB), phosphorylated CREB and general control nonrepressed 2, in each group. Hippocampal neurons and spatial memory test were analyzed in different time points. Results: Compared with that in the sham group, the level of AQP4 in hippocampal neurons began to significantly increase at 1 h post TBI and then decreased at 15 d post TBI. During this time frame, AQP4 level peaked at 12 and 72 h, and these peaks were closely correlated with high brain water content. HIF-1 alpha displayed a similar trend. Conversely, levels of MAP2 began to decrease at 1 h post TBI and then increase at 15 d post TBI. In addition, the most severe brain edema in rats was found at 24 h post TBI, with neuronal loss and hippocampal dendritic spine injury. Compared to those in the sham group, rats in the TBI groups had significantly prolonged latency and significantly shortened exploration time. Conclusions: AQP4 level was closely correlated with severity of brain edema, and abnormal levels thereof aggravated such severity after TBI.	[Xiong, Ao; Xu, Jianzhong] Zhengzhou Univ, Dept Orthopaed, Affiliated Hosp 1, Zhengzhou 450042, Henan, Peoples R China; [Xiong, Ao; Xiong, Renping; Yu, Jing; Liu, Yijia; Liu, Ke; Yan, Jun] Third Mil Med Univ, State Key Lab Trauma Burns & Combined Injury, Res Inst Surg, Daping Hosp,Army Med Univ, Chongqing 400042, Peoples R China; [Liu, Yijia; Liu, Ke] Southwest Jiaotong Univ, Sch Life Sci & Engn, Chengdu 610031, Sichuan, Peoples R China; [Jin, Ge] Zhengzhou Univ, Dept Biochem & Mol Biol, Basic Med Coll, Zhengzhou 450001, Henan, Peoples R China		Xu, JZ (corresponding author), Zhengzhou Univ, Dept Orthopaed, Affiliated Hosp 1, Zhengzhou 450042, Henan, Peoples R China.; Yan, J (corresponding author), Third Mil Med Univ, State Key Lab Trauma Burns & Combined Injury, Res Inst Surg, Daping Hosp,Army Med Univ, Chongqing 400042, Peoples R China.	13937133786@163.com; 13883092250@163.com					Ablikim M, 2017, PHYS REV D, V95, DOI 10.1103/PhysRevD.95.072004; Banerjee S, 2009, NEURON, V64, P871, DOI 10.1016/j.neuron.2009.11.023; Brittain JM, 2011, J BIOL CHEM, V286, P37778, DOI 10.1074/jbc.M111.255455; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cash A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093344; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Griesdale DEG, 2004, SURG NEUROL, V61, P418, DOI 10.1016/j.surneu.2003.10.047; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Ho JD, 2009, P NATL ACAD SCI USA, V106, P7437, DOI 10.1073/pnas.0902725106; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Neri M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113544; Papadopoulos MC, 2002, MT SINAI J MED, V69, P242; Peters J, 2009, HIPPOCAMPUS, V19, P141, DOI 10.1002/hipo.20490; Phan A, 2012, NEUROPSYCHOPHARMACOL, V37, P2299, DOI 10.1038/npp.2012.82; Phan A, 2011, ENDOCRINOLOGY, V152, P1492, DOI 10.1210/en.2010-1273; Scharfman HE, 2013, NEUROCHEM INT, V63, P702, DOI 10.1016/j.neuint.2013.05.003; Shenaq M, 2012, J NEUROL SCI, V323, P134, DOI 10.1016/j.jns.2012.08.036; Stubbs JL, 2020, LANCET PUBLIC HEALTH, V5, pE19, DOI 10.1016/S2468-2667(19)30188-4; Szczygielski J, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00799; Szu JI, 2016, FRONT INTEGR NEUROSC, V10, DOI 10.3389/fnint.2016.00008; Verkman AS, 2011, J CELL SCI, V124, P2107, DOI 10.1242/jcs.079467; Xu L, 2015, BBA-MOL BASIS DIS, V1852, P1298, DOI 10.1016/j.bbadis.2015.03.009; Yao XM, 2015, J NEUROTRAUM, V32, P1458, DOI 10.1089/neu.2014.3675; Yu LS, 2016, EXP THER MED, V11, P709, DOI 10.3892/etm.2016.3022; Zelinkova V, 2019, BRAIN INJURY, V33, P830, DOI 10.1080/02699052.2019.1605622; Zhao ZA, 2017, BEHAV BRAIN RES, V323, P146, DOI 10.1016/j.bbr.2017.02.002	31	2	2	4	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2321-3868	2321-3876		BURNS TRAUMA	Burns Trauma		2021	9								tkaa050	10.1093/burnst/tkaa050			10	Emergency Medicine; Dermatology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Dermatology; Surgery	RG5WV	WOS:000635609200001	33748293	gold, Green Published			2022-02-06	
J	Zhao, ZB; Ren, Y; Jiang, H; Huang, Y				Zhao, Zhongbai; Ren, Yu; Jiang, Hong; Huang, Yan			Dexmedetomidine inhibits the PSD95-NMDA receptor interaction to promote functional recovery following traumatic brain injury	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						dexmedetomidine; post-synaptic density 95; N-methyl-D-aspartic acid; traumatic brain injury	POSTSYNAPTIC DENSITY; SIGNALING PATHWAY; ACTIVATION; EXPRESSION; NEUROPROTECTION; IMPAIRMENT; PROTEINS; MODERATE; MEMORY; RATS	The present study examined the effects of dexmedetomidine (Dex) on cognitive and motor recovery in mice following traumatic brain injury (TBI). TBI induces synaptic damage, which leads to motor dysfunction and cognitive decline. Although Dex is known to induce neuroprotection, its role following TBI remains unknown. In the present study, male C57BL/6 mice (8 weeks old; n=72) were subjected to cortical impact injury to generate a TBI mice model. Mice were divided into four groups: TBI, sham, TBI + vehicle, and TBI + Dex. Mice in the TBI + vehicle and TBI + Dex groups received intraperitoneal injections of saline (n=18) and 100 mu g/kg Dex (n=18), respectively, at 1 and 12 h following surgery. At 24 h post-injury, 10 animals from each group were sacrificed, and brain tissue was isolated for Fluoro-Jade B staining and RNA and protein extraction. At 72 h post-TBI, motor function was evaluated. Furthermore, cognitive impairment was assessed between day 14 and 19 using the Morris water maze. The results demonstrated that the mRNA and protein expression of post-synaptic density 95 (PSD95) was reduced post-TBI. In addition, neuronal degeneration was evaluated using FJB staining, where PSD95 formed a complex with the N-methyl-D-aspartic acid (NMDA) receptor subunit (NR2B) and neuronal nitric oxide synthase (nNOS) inducing neuronal death post-TBI. Treatment with Dex efficiently decreased the PSD95-NR2B-nNOS interaction, which reduced the TBI-induced neuronal death. Furthermore, Dex treatment contributed to the enhanced cognitive and motor recovery following TBI. The results from the present study reported a potential mechanistic action of Dex treatment post-TBI, which may be associated with the inhibition of PSD95-NMDA interaction.	[Zhao, Zhongbai; Jiang, Hong; Huang, Yan] Shanghai Jiao Tong Univ, Shanghai Ninth Peoples Hosp, Dept Anesthesiol, Sch Med, 639 Zhizhaoju Rd, Shanghai 200011, Peoples R China; [Ren, Yu] Fudan Univ, Dept Anesthesiol, Shanghai Canc Ctr, Shanghai 200032, Peoples R China		Huang, Y (corresponding author), Shanghai Jiao Tong Univ, Shanghai Ninth Peoples Hosp, Dept Anesthesiol, Sch Med, 639 Zhizhaoju Rd, Shanghai 200011, Peoples R China.	hanelineaencer@yahoo.com					American Veterinary Medical Association, 2013, AVMA GUIDELINES EUTH; Bejian S, 2009, CARDIOL YOUNG, V19, P98, DOI 10.1017/S1047951109003515; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Cheung ZDH, 2011, INT J NEUROPSYCHOPH, V14, P1247, DOI 10.1017/S1461145710001537; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dahmani S, 2010, ANESTHESIOLOGY, V112, P373, DOI 10.1097/ALN.0b013e3181ca6982; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; FLOWER O, 2012, EMERG MED INT, V2012, DOI DOI 10.1155/2012/637171; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Guidi M, 2012, METHODS MOL BIOL, V829, P145, DOI 10.1007/978-1-61779-458-2_8; Hausser N, 2018, JOVE-J VIS EXP, DOI 10.3791/56044; Joseph B, 2015, CURR OPIN CRIT CARE, V21, P506, DOI 10.1097/MCC.0000000000000247; Keith D, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.004.2008; Kilkenny C, 2011, J CEREBR BLOOD F MET, V31, P991, DOI 10.1038/jcbfm.2010.220; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; Luong TN, 2011, JOVE-J VIS EXP, DOI 10.3791/2376; Lv J, 2016, NEUROPSYCH DIS TREAT, V12, P3153, DOI 10.2147/NDT.S120078; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Merlo L, 2014, J NEUROTRAUM, V31, P1375, DOI 10.1089/neu.2014.3385; Mo SF, 2016, BRAIN RES, V1648, P250, DOI 10.1016/j.brainres.2016.07.012; MORIOKAMOTO J, 1991, BRAIN RES, V539, P67, DOI 10.1016/0006-8993(91)90687-Q; Nakayama K, 2005, J NEUROSCI, V25, P4040, DOI 10.1523/JNEUROSCI.4115-04.2005; Oddo M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1294-5; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Schoeler M, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-20; Sen T, 2017, J NEUROSCI, V37, P5900, DOI 10.1523/JNEUROSCI.2343-16.2017; Shao CY, 2011, ACTA NEUROPATHOL, V122, P285, DOI 10.1007/s00401-011-0843-x; Shen M, 2017, BIOMED PHARMACOTHER, V95, P885, DOI 10.1016/j.biopha.2017.08.125; Sheriff FG, 2015, SEMIN NEUROL, V35, P42, DOI 10.1055/s-0035-1544238; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Sultana R, 2010, J NEUROSCI RES, V88, P469, DOI 10.1002/jnr.22227; Travaglia A, 2016, NEUROBIOL LEARN MEM, V135, P125, DOI 10.1016/j.nlm.2016.08.005; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Wang CF, 2016, SCI REP-UK, V6, DOI 10.1038/srep37063; Wang Y, 2016, BRIT J ANAESTH, V116, P384, DOI 10.1093/bja/aev549; Wu J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23003-3; Zhang MH, 2018, MOL MED REP, V17, P8079, DOI 10.3892/mmr.2018.8898; Zhang Yonghua, 2005, Current Neuropharmacology, V3, P317, DOI 10.2174/157015905774322534	41	2	2	1	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	JAN	2021	21	1							4	10.3892/etm.2020.9436			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	PI6IB	WOS:000601191200001	33235613	gold, Green Published			2022-02-06	
J	Caplan, HW; Prabhakara, KS; Furman, NET; Zorofchian, S; Kumar, A; Martin, C; Xue, HS; Olson, SD; Cox, CS				Caplan, Henry W.; Prabhakara, Karthik S.; Furman, Naama E. Toledano; Zorofchian, Soheil; Kumar, Akshita; Martin, Cecilia; Xue, Hasen; Olson, Scott D.; Cox, Charles S., Jr.			Combination therapy with Treg and mesenchymal stromal cells enhances potency and attenuation of inflammation after traumatic brain injury compared to monotherapy	STEM CELLS			English	Article						cell therapy; mesenchymal stem cell; mesenchymal stromal cell; microglia; neuroinflammation; regulatory T&#8201; cell; traumatic brain injury	STEM-CELLS; MICROGLIA; NEUROINFLAMMATION	The inflammatory response after traumatic brain injury (TBI) can lead to significant secondary brain injury and chronic inflammation within the central nervous system. Cell therapies, including mesenchymal stromal cells (MSC), have led to improvements in animal models of TBI and are under investigation in human trials. One potential mechanism for the therapeutic potential of MSC is their ability to augment the endogenous response of immune suppressive regulatory T cells (Treg). We have recently shown that infusion of human cord blood Treg decreased chronic microgliosis after TBI and altered the systemic immune response in a rodent model. These cells likely use both overlapping and distinct mechanisms to modulate the immune system; therefore, combining Treg and MSC as a combination therapy may confer therapeutic benefit over either monotherapy. However, investigation of Treg + MSC combination therapy in TBI is lacking. In this study, we compared the ability MSC + Treg combination therapy, as well as MSC and Treg monotherapies, to inhibit the neuroinflammatory response to TBI in vivo and in vitro. Treg + MSC combination therapy demonstrated increased potency to reduce the neuro- and peripheral inflammatory response compared to monotherapy; furthermore, the timing of infusion proved to be a significant variable in the efficacy of both MSC monotherapy and Treg + MSC combination therapy in vivo and in vitro.	[Caplan, Henry W.; Prabhakara, Karthik S.; Furman, Naama E. Toledano; Zorofchian, Soheil; Kumar, Akshita; Martin, Cecilia; Xue, Hasen; Olson, Scott D.; Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Pediat Surg, Houston, TX 77030 USA		Olson, SD (corresponding author), 6431 Fannin St,MSE R162, Houston, TX 77030 USA.; Cox, CS (corresponding author), 431 Fannin St,MSB 5-230, Houston, TX 77030 USA.	scott.d.olson@uth.tmc.edu; charles.s.cox@uth.tmc.edu			Clare A Glassell Family Pediatric Surgery Research Fund; Senator Lloyd and B.A. Bentsen Center for Stroke Research; Grace Reynolds Wall Research Endowment; NIH 2T32United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM0879201-11A1]	Clare A Glassell Family Pediatric Surgery Research Fund; Senator Lloyd and B.A. Bentsen Center for Stroke Research; Grace Reynolds Wall Research Endowment; NIH 2T32, Grant/Award Number: GM0879201-11A1	[Anonymous], 2015, C TRAUM BRAIN INJ US; Bai RJ, 2017, NEUROCHEM RES, V42, P2892, DOI 10.1007/s11064-017-2310-0; Bai RJ, 2017, MED SCI MONITOR, V23, P1707, DOI 10.12659/MSM.901124; Bedi SS, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1122-8; Bolli R, 2017, CIRC RES, V120, P1072, DOI [10.1161/CIRCRESAHA.117.310710, 10.1161/CIRCRESAHA.117.310936]; Caplan H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01645; Caplan HW, 2020, STEM CELL TRANSL MED, V9, P903, DOI 10.1002/sctm.19-0444; Caplan HW, 2017, J NEUROSCI RES, V95, P509, DOI 10.1002/jnr.23854; Castro LL, 2020, STEM CELL TRANSL MED, V9, P250, DOI 10.1002/sctm.19-0120; Cox CS, 2019, TRANSFUSION, V59, P858, DOI 10.1111/trf.14834; Di Lanni M, 2008, EXP HEMATOL, V36, P309, DOI 10.1016/j.exphem.2007.11.007; Diaz MF, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2513; Engela AU, 2013, CELL TRANSPLANT, V22, P41, DOI 10.3727/096368912X636984; Engela AU, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00126; Faul M, 2010, TRAUMATIC BRAIN INJU; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Furman NET, 2018, NEUROMETHODS, V139, P191, DOI 10.1007/978-1-4939-8564-7_12; George MJ, 2018, STEM CELL TRANSL MED, V7, P731, DOI 10.1002/sctm.18-0015; Hopperton K, 2018, MOL PSYCHIATR, V23, P177, DOI 10.1038/mp.2017.246; Izzy S, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00307; Jackson ML, 2017, J SURG RES, V214, P38, DOI 10.1016/j.jss.2017.02.078; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Kochanek PM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00640; Kota DJ, 2017, STEM CELLS, V35, P1416, DOI 10.1002/stem.2603; Kota DJ, 2016, STEM CELL TRANSL MED, V5, P33, DOI 10.5966/sctm.2015-0065; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee ES, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138846; Li QY, 2018, NAT REV IMMUNOL, V18, P225, DOI 10.1038/nri.2017.125; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Melief J, 2012, GLIA, V60, P1506, DOI 10.1002/glia.22370; Negi N, 2020, STEM CELLS, V38, P596, DOI 10.1002/stem.3151; Prabhakara KS, 2018, MOL THER, V26, P2152, DOI 10.1016/j.ymthe.2018.06.022; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Sakaguchi S, 2020, ANNU REV IMMUNOL, V38, P541, DOI 10.1146/annurev-immunol-042718-041717; Sanchez-Fueyo A, 2020, AM J TRANSPLANT, V20, P1125, DOI 10.1111/ajt.15700; Schittenhelm L, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01866; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Srivastava AK, 2019, REGEN MED, V14, P295, DOI 10.2217/rme-2018-0106; Takahashi T, 2014, STEM CELL TRANSL MED, V3, P1484, DOI 10.5966/sctm.2014-0012; Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005; Zhou YF, 2014, J THORAC CARDIOV SUR, V148, P1131, DOI 10.1016/j.jtcvs.2014.06.029	42	2	2	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	MAR	2021	39	3					358	370		10.1002/stem.3320		DEC 2020	13	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	QK9RI	WOS:000603606500001	33368792	Green Accepted			2022-02-06	
J	Liu, XB; Li, M; Zhu, JB; Huang, WD; Song, JN				Liu, Xiaobin; Li, Min; Zhu, Jiabao; Huang, Weidong; Song, Jinning			Sestrin2 protects against traumatic brain injury by reinforcing the activation of Nrf2 signaling	HUMAN & EXPERIMENTAL TOXICOLOGY			English	Article						Apoptosis; Nrf2; oxidative stress; SESN2; traumatic brain injury		Sestrin2 (SESN2) is stress-inducible protein that confers cytoprotective effects against various noxious stimuli. Accumulating evidence has documented that SESN2 has potent anti-apoptosis and anti-oxidative stress functions. However, whether it provides neuroprotection in traumatic brain injury (TBI) models remains unexplored. The purpose of this study was to explore the regulatory effect of SESN2 on TBI using in vivo and in vitro models. We found that TBI resulted in a marked induction of SESN2 in the cerebral cortex tissues of mice. SESN2 overexpression in the brain by in vivo gene transfer significantly decreased neurological deficit, brain edema, and neuronal apoptosis of mice with TBI. Moreover, the overexpression of SESN2 significantly decreased the oxidative stress induced by TBI in mice. In vitro studies of TBI demonstrated that SESN2 overexpression decreased apoptosis and oxidative stress in scratch-injured cortical neurons. Notably, SESN2 overexpression increased the nuclear levels of nuclear factor-erythroid 2-related factor 2 (Nrf2) and enhanced the activation of Nrf2 antioxidant signaling in in vivo and in vitro models of TBI. In addition, the inhibition of Nrf2 significantly abolished SESN2-mediated neuroprotective effects in vivo and in vitro. In conclusion, these results of our work demonstrate that SESN2 protects against TBI by enhancing the activation of Nrf2 antioxidant signaling.	[Liu, Xiaobin; Song, Jinning] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Neurosurg, 277 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China; [Liu, Xiaobin; Li, Min; Huang, Weidong] Shaanxi Prov Peoples Hosp, Dept Neurosurg, Xian, Shaanxi, Peoples R China; [Zhu, Jiabao] Shanxi Med Univ, Dept Neurosurg, Yuncheng Cent Hosp, Yucheng, Shanxi, Peoples R China		Song, JN (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Neurosurg, 277 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China.	jinning_song@163.com		Song, Jinning/0000-0002-6959-5693			Bae SH, 2013, CELL METAB, V17, P73, DOI 10.1016/j.cmet.2012.12.002; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Chen MJ, 2021, J CELL PHYSIOL, V236, P392, DOI 10.1002/jcp.29867; Chen PQ, 2019, J INTEGR NEUROSCI, V18, P153, DOI 10.31083/j.jin.2019.02.120; Chen YS, 2014, EXP NEUROL, V253, P63, DOI 10.1016/j.expneurol.2013.12.009; Chuang YC, 2015, INT J MOL SCI, V16, P26406, DOI 10.3390/ijms161125963; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Dai W, 2018, BRAIN RES BULL, V140, P65, DOI 10.1016/j.brainresbull.2018.03.020; Di Pietro V, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9030260; Du Y, 2020, CLIN EXP PHARMACOL P, V47, P561, DOI 10.1111/1440-1681.13231; Fan YZ, 2020, CHEM-BIOL INTERACT, V324, DOI 10.1016/j.cbi.2020.109086; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Han X, 2020, BIOCHEM BIOPH RES CO, V525, P895, DOI 10.1016/j.bbrc.2020.03.032; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Hou YS, 2015, MOL CELL BIOL, V35, P2740, DOI 10.1128/MCB.00285-15; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee SJ, 2020, AM J REPROD IMMUNOL, V83, DOI 10.1111/aji.13222; Li FY, 2019, J CELL BIOCHEM, V120, P14899, DOI 10.1002/jcb.28751; Li LY, 2016, SCI REP-UK, V6, DOI 10.1038/srep30272; Li YX, 2020, BRAIN RES, V1745, DOI 10.1016/j.brainres.2020.146948; Lin QX, 2020, INT J MOL MED, V45, P1361, DOI 10.3892/ijmm.2020.4508; Pasha M, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/3296294; Sabella SA, 2018, BRAIN INJURY, V32, P926, DOI 10.1080/02699052.2018.1469168; Sandberg M, 2014, NEUROPHARMACOLOGY, V79, P298, DOI 10.1016/j.neuropharm.2013.11.004; Seo K, 2015, CELL SIGNAL, V27, P1533, DOI 10.1016/j.cellsig.2015.03.003; Shaw P, 2020, J CELL PHYSIOL, V235, P3119, DOI 10.1002/jcp.29219; Shi XD, 2017, J CEREBR BLOOD F MET, V37, P1447, DOI 10.1177/0271678X16656201; Soontornniyomkij V, 2012, J NEUROIMMUNE PHARM, V7, P579, DOI 10.1007/s11481-012-9357-0; Sun WQ, 2020, AGING DIS, V11, P154, DOI 10.14336/AD.2019.0320; Wang H, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01863-9; Wang LX, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2324-4; Wang P, 2019, NEUROSCIENCE, V410, P140, DOI 10.1016/j.neuroscience.2019.05.005; Xia DY, 2019, J CELL MOL MED, V23, P4088, DOI 10.1111/jcmm.14296; Xiao T, 2019, LIFE SCI, V218, P132, DOI 10.1016/j.lfs.2018.12.043; Zhang LL, 2018, EUR REV MED PHARMACO, V22, P3493, DOI 10.26355/eurrev_201806_15176; Zhang L, 2020, BRAIN RES BULL, V157, P26, DOI 10.1016/j.brainresbull.2020.01.019; Zhang L, 2018, MOL NEUROBIOL, V55, P1773, DOI 10.1007/s12035-017-0456-z; Zhao BZ, 2017, PHOTOCHEM PHOTOBIOL, V93, P375, DOI 10.1111/php.12624; Zhou DX, 2013, J MOL NEUROSCI, V51, P967, DOI 10.1007/s12031-013-0081-x	41	2	2	1	5	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0960-3271	1477-0903		HUM EXP TOXICOL	Hum. Exp. Toxicol.	JUL	2021	40	7					1095	1111	0960327120984224	10.1177/0960327120984224		DEC 2020	17	Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Toxicology	SN0FH	WOS:000636021600001	33375867				2022-02-06	
J	Sheng, JT; Li, T; Zhuang, DZ; Cai, SR; Yang, JH; Ding, FX; Chen, XX; Tian, F; Huang, MD; Li, LJ; Li, KS; Chen, WQ				Sheng, Jiangtao; Li, Tian; Zhuang, Dongzhou; Cai, Shirong; Yang, Jinhua; Ding, Faxiu; Chen, Xiaoxuan; Tian, Fei; Huang, Mindong; Li, Lianjie; Li, Kangsheng; Chen, Weiqiang			The Monocyte-to-Lymphocyte Ratio at Hospital Admission Is a Novel Predictor for Acute Traumatic Intraparenchymal Hemorrhage Expansion after Cerebral Contusion	MEDIATORS OF INFLAMMATION			English	Article							BRAIN-INJURY; HEMATOMA EXPANSION; PROGNOSTIC VALUE; RISK SCORE; METALLOPROTEINASES; INFILTRATION; COAGULOPATHY; PROGRESSION; PATHOLOGY	Purpose. To explore the potential of monocyte-to-lymphocyte ratio (MLR) at hospital admission for predicting acute traumatic intraparenchymal hematoma (tICH) expansion in patients with cerebral contusion. Patients and Methods. This multicenter, observational study included patients with available at-hospital admission (baseline) and follow-up computed tomography for volumetric analysis (retrospective development cohort: 1146 patients; prospective validation cohort: 207 patients). Semiautomated software assessed tICH expansion (defined as >= 33% or 5 mL absolute growth). MLR was acquired from routine blood tests upon admission. We constructed two predictive models: basic combined model of clinical and imaging variables and MLR combined model of both MLR and other variables in the basic model. Receiver operating characteristic (ROC) analysis and decision curve analysis (DCA) were used to estimate the performance of MLR for predicting acute tICH expansion. Results. MLR was significantly larger in patients with acute tICH expansion compared to those without acute tICH expansion (mean [SD], 1.08 [1.05] vs. 0.59 [0.37], P<0.001). A nonlinear positive relationship between MLR and the incidence of acute tICH expansion was observed. Multivariate logistic regression indicated MLR as an independent risk factor for acute tICH expansion (odds ratio (OR), 5.88; 95% confidence interval (CI), 4.02-8.61). The power of the multivariate model for predicting acute tICH expansion was substantially improved with the inclusion of MLR (AUC 0.86 vs. AUC 0.74, P<0.001), as was also observed in an external validation cohort (AUC 0.83 vs. AUC 0.71, P<0.001). The net benefit of MLR model was higher between threshold probabilities of 20-100% in DCA. For clinical application, a nomogram derived from the multivariate model with MLR was introduced. In addition, MLR was positively associated with 6-month unfavorable outcome. Conclusion. MLR is a novel predictor for traumatic parenchymatous hematoma expansion. A nomogram derived from the MLR model may provide an easy-to-use tool for predicting acute tICH expansion and promoting the individualized treatment of patients with hemorrhagic cerebral contusion. MLR is associated with long-term outcome after cerebral contusion.	[Sheng, Jiangtao; Li, Tian; Chen, Xiaoxuan; Li, Kangsheng] Shantou Univ, Dept Microbiol & Immunol, Med Coll, Shantou, Guangdong, Peoples R China; [Sheng, Jiangtao; Li, Tian; Chen, Xiaoxuan; Li, Kangsheng] Shantou Univ, Key Immunopathol Lab Guangdong Prov, Med Coll, Shantou, Guangdong, Peoples R China; [Zhuang, Dongzhou; Cai, Shirong; Yang, Jinhua; Ding, Faxiu; Chen, Weiqiang] Shantou Univ, Dept Neurosurg, Affiliated Hosp 1, Med Coll, Shantou, Guangdong, Peoples R China; [Tian, Fei] Shantou Univ, Dept Neurosurg, Affiliated Hosp 2, Med Coll, Shantou, Guangdong, Peoples R China; [Huang, Mindong] Sun Yat Sen Univ, Dept Neurosurg, Affiliated Jieyang Hosp, Jieyang, Guangdong, Peoples R China; [Li, Lianjie] Xiamen Univ, Dept Neurosurg, Fuzhou Gen Hosp, Med Coll, Fuzhou, Fujian, Peoples R China		Li, KS (corresponding author), Shantou Univ, Dept Microbiol & Immunol, Med Coll, Shantou, Guangdong, Peoples R China.; Li, KS (corresponding author), Shantou Univ, Key Immunopathol Lab Guangdong Prov, Med Coll, Shantou, Guangdong, Peoples R China.; Chen, WQ (corresponding author), Shantou Univ, Dept Neurosurg, Affiliated Hosp 1, Med Coll, Shantou, Guangdong, Peoples R China.	ksli2013@yeah.net; wqchen@stu.edu.cn		Li, Kangsheng/0000-0002-6981-9263; Sheng, Jiangtao/0000-0003-2438-7345	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471622, 81773976]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2018M633091]; Natural Science Foundation of Guangdong ProvinceNational Natural Science Foundation of Guangdong Province [2019A1515010649]; Medical Scientific Research Foundation of Guangdong Province, China [A2017168]; Clinical Improvement Program of Shantou University Medical College [201405]; Top-tier University Development Scheme for Research and Control of Infectious Diseases [2015026]	This study was supported by the National Natural Science Foundation of China (grant numbers 81471622 and 81773976), China Postdoctoral Science Foundation (grant number 2018M633091), Natural Science Foundation of Guangdong Province (grant number 2019A1515010649), Medical Scientific Research Foundation of Guangdong Province, China (grant number A2017168), Clinical Improvement Program of Shantou University Medical College (grant number 201405), and Top-tier University Development Scheme for Research and Control of Infectious Diseases (grant number 2015026).	Abdul-Muneer PM, 2016, MOL NEUROBIOL, V53, P6106, DOI 10.1007/s12035-015-9520-8; Almandoz JED, 2009, STROKE, V40, P2994, DOI 10.1161/STROKEAHA.109.554667; Carnevale JA, 2018, J NEUROSURG, V129, P1305, DOI 10.3171/2017.7.JNS17988; Chou A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061616; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Eisenberg HM, 2020, J NEUROTRAUM, V37, P185, DOI 10.1089/neu.2019.6538; Fan ZY, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023459; Greenberg JK, 2017, JAMA PEDIATR, V171, P342, DOI 10.1001/jamapediatrics.2016.4520; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hemond CC, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1245-2; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jha RM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020409; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Kwon BS, 2018, J CANCER, V9, P1127, DOI 10.7150/jca.24057; Lamain-de Ruiter M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4338; Lattanzi S, 2020, NEUROTHERAPEUTICS, V17, P484, DOI 10.1007/s13311-020-00839-0; Lattanzi S, 2019, TRANSL STROKE RES, V10, P137, DOI 10.1007/s12975-018-0649-4; Li ZM, 2016, CLIN NEUROL NEUROSUR, V150, P80, DOI 10.1016/j.clineuro.2016.09.001; Liesz A, 2015, STROKE, V46, P1422, DOI 10.1161/STROKEAHA.114.008608; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Lin YJ, 2019, BIOMARK MED, V13, P1263, DOI 10.2217/bmm-2018-0423; Lustenberger T, 2016, IMMUNOBIOLOGY, V221, P427, DOI 10.1016/j.imbio.2015.11.011; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Makinde HM, 2017, J IMMUNOL, V199, P3583, DOI 10.4049/jimmunol.1700896; Mano Y, 2018, LIVER TRANSPLANT, V24, P1603, DOI 10.1002/lt.25204; Mazzeo AT, 2006, J NEUROTRAUM, V23, P962, DOI 10.1089/neu.2006.23.962; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Nishijima TF, 2015, CANCER TREAT REV, V41, P971, DOI 10.1016/j.ctrv.2015.10.003; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Ren H, 2017, MED SCI MONITOR, V23, P5826, DOI 10.12659/MSM.907919; Ren H, 2017, J STROKE CEREBROVASC, V26, P2595, DOI 10.1016/j.jstrokecerebrovasdis.2017.06.019; Rosa M, 2016, J NEUROTRAUM, V33, P1015, DOI 10.1089/neu.2015.4062; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Smrcka M, 2005, Bratisl Lek Listy, V106, P144; Song QH, 2021, NEUROL SCI, V42, P765, DOI 10.1007/s10072-020-04871-y; Stein DM, 2009, J TRAUMA, V66, P63, DOI 10.1097/TA.0b013e318191bc8a; Sulhan S, 2020, J NEUROSCI RES, V98, P19, DOI 10.1002/jnr.24331; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Sun YX, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01120; Team RC, 2016, R LANGUAGE ENV STAT; van Buuren S, 2011, J STAT SOFTW, V45, P1; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Yao XY, 2015, NEUROCRIT CARE, V23, P179, DOI 10.1007/s12028-015-0147-4; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Yu XD, 2013, ENVIRON RES, V121, P79, DOI 10.1016/j.envres.2012.11.002; Zhang GS, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/3578702; Zhang ZY, 2019, CLIN CHIM ACTA, V497, P6, DOI 10.1016/j.cca.2019.07.008; Zhu HM, 2019, PROG NEUROBIOL, V178, P6, DOI 10.1016/j.pneurobio.2019.03.003	51	2	2	3	4	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0962-9351	1466-1861		MEDIAT INFLAMM	Mediat. Inflamm.	DEC 29	2020	2020								5483981	10.1155/2020/5483981			12	Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Immunology	PU7DN	WOS:000609460500001	33456370	gold, Green Published			2022-02-06	
J	Skiba, M; Rekas-Dudziak, A; Bekala, A; Plotek, W				Skiba, Malgorzata; Rekas-Dudziak, Anna; Bekala, Artur; Plotek, Wlodzimierz			Late application of hyperbaric oxygen therapy during the rehabilitation of a patient with severe cognitive impairment after a traumatic brain injury	CLINICAL CASE REPORTS			English	Article						cognitive functioning; hyperbaric oxygen therapy; traumatic brain injury	NEUROPROTECTION; MODEL	The hyperbaric therapy resulted in the patient's quick recovery and significantly accelerated the recovery after the brain injury.	[Skiba, Malgorzata] Stefan Cardinal Wyszynski Dist Specialist Hosp, Lublin, Poland; [Rekas-Dudziak, Anna; Bekala, Artur; Plotek, Wlodzimierz] Poznan Univ Med Sci, Gynaecol Obstetr Clin Hosp, Poznan, Poland		Rekas-Dudziak, A (corresponding author), Poznan Univ Med Sci, Gynaecol Obstetr Clin Hosp, Clin Anaesthesiol Obstet & Gynaecol, Ul Polna 33, PL-60535 Poznan, Poland.	aniarks@gmail.com		Bekala, Artur/0000-0001-7053-425X; Rekas-Dudziak, Anna/0000-0003-4438-6083			Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Baratz-Goldstein R, 2017, MOL CELL NEUROSCI, V83, P74, DOI 10.1016/j.mcn.2017.06.004; Boerema I, 1960, J CARDIOVASC SURG, V1, P133; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Chen X, 2014, NEUROSCIENCE, V266, P235, DOI 10.1016/j.neuroscience.2013.11.036; Cihan YB, 2009, J SURG ONCOL, V100, P732, DOI 10.1002/jso.21387; Daugherty WP, 2004, J NEUROSURG, V101, P499, DOI 10.3171/jns.2004.101.3.0499; Demchenko IT, 2000, J APPL PHYSIOL, V88, P1381, DOI 10.1152/jappl.2000.88.4.1381; Deng Z, 2018, NIGER J CLIN PRACT, V21, P401, DOI 10.4103/njcp.njcp_315_16; Efrati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053716; Feldmeier JJ, 2004, UNDERSEA HYPERBAR M, V31, P133; Golden ZL, 2009, J NEUROSCI, V112, P119; Hadanny A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023387; Harch PG, 2007, BRAIN RES, V1174, P120, DOI 10.1016/j.brainres.2007.06.105; Harch PG, 2017, MED GAS RES, V7, P156, DOI 10.4103/2045-9912.215745; Hukkelhoven CWPM, 2006, J CLIN EPIDEMIOL, V59, P132, DOI 10.1016/j.jclinepi.2005.06.009; JAIN KK, 2004, TXB HYPERBARIC MED; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Knefel G, 2006, LECZENIE RAN, V3, P83; Mathieu D., 2006, HDB HYPERB MED, DOI [10.1007/1-4020-4448-8_7, DOI 10.1007/1-4020-4448-8_7]; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; MINK RB, 1995, CRIT CARE MED, V23, P1398, DOI 10.1097/00003246-199508000-00014; Narony W, 2007, FORUM MED RODZ, V1, P368; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Stewart RJ, 1989, UNDERSEA BIOMED RES, V16, P53; Szymanska Bozena, 2006, Wiad Lek, V59, P105; Tibbles PM, 1996, NEW ENGL J MED, V334, P1642, DOI 10.1056/NEJM199606203342506; TISHCHENKO A T, 1976, Zhurnal Nevropatologii i Psikhiatrii Imeni S. S. Korsakova, V76, P262; Wang GH, 2010, J NEUROTRAUM, V27, P1733, DOI 10.1089/neu.2009.1175; Wood RL, 1990, NEUROBEHAVIORAL SEQU, P98; Zhang YM, 2014, NEUROCHEM RES, V39, P950, DOI 10.1007/s11064-014-1292-4	31	2	2	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2050-0904			CLIN CASE REP	Clin. Case Rep.	FEB	2021	9	2					960	965		10.1002/ccr3.3658		DEC 2020	6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	QE0QV	WOS:000603122500001	33598279	Green Published, Green Submitted, gold			2022-02-06	
J	Campos-Pires, R; Onggradito, H; Ujvari, E; Karimi, S; Valeo, F; Aldhoun, J; Edge, CJ; Franks, NP; Dickinson, R				Campos-Pires, Rita; Onggradito, Haldis; Ujvari, Eszter; Karimi, Shughoofa; Valeo, Flavia; Aldhoun, Jitka; Edge, Christopher J.; Franks, Nicholas P.; Dickinson, Robert			Xenon treatment after severe traumatic brain injury improves locomotor outcome, reduces acute neuronal loss and enhances early beneficial neuroinflammation: a randomized, blinded, controlled animal study	CRITICAL CARE			English	Article						Xenon; Noble gases; Neuroprotection; Neurotrauma; Acquired brain injury; Neuroinflammation; Neuroglia; Locomotor deficit	D-ASPARTATE RECEPTOR; WHITE-MATTER DAMAGE; COMPETITIVE-INHIBITION; TERM NEUROPROTECTION; CARDIAC-ARREST; INHALED XENON; NITROUS-OXIDE; HYPOTHERMIA; MICROGLIA; BUPRENORPHINE	BackgroundTraumatic brain injury (TBI) is a major cause of morbidity and mortality, but there are no clinically proven treatments that specifically target neuronal loss and secondary injury development following TBI. In this study, we evaluate the effect of xenon treatment on functional outcome, lesion volume, neuronal loss and neuroinflammation after severe TBI in rats.MethodsYoung adult male Sprague Dawley rats were subjected to controlled cortical impact (CCI) brain trauma or sham surgery followed by treatment with either 50% xenon:25% oxygen balance nitrogen, or control gas 75% nitrogen:25% oxygen. Locomotor function was assessed using Catwalk-XT automated gait analysis at baseline and 24 h after injury. Histological outcomes were assessed following perfusion fixation at 15 min or 24 h after injury or sham procedure. ResultsXenon treatment reduced lesion volume, reduced early locomotor deficits, and attenuated neuronal loss in clinically relevant cortical and subcortical areas. Xenon treatment resulted in significant increases in Iba1-positive microglia and GFAP-positive reactive astrocytes that was associated with neuronal preservation.ConclusionsOur findings demonstrate that xenon improves functional outcome and reduces neuronal loss after brain trauma in rats. Neuronal preservation was associated with a xenon-induced enhancement of microglial cell numbers and astrocyte activation, consistent with a role for early beneficial neuroinflammation in xenon's neuroprotective effect. These findings suggest that xenon may be a first-line clinical treatment for brain trauma.	[Campos-Pires, Rita; Onggradito, Haldis; Ujvari, Eszter; Karimi, Shughoofa; Valeo, Flavia; Aldhoun, Jitka; Dickinson, Robert] Imperial Coll London, Anaesthet Pain Med & Intens Care Sect, Dept Surg & Canc, Sir Ernst Chain Bldg, London SW7 2AZ, England; [Campos-Pires, Rita; Dickinson, Robert] Imperial Coll London, Dept Bioengn, Royal British Legion Ctr Blast Injury Studies, Bessemer Bldg, London SW7 2AZ, England; [Campos-Pires, Rita] Imperial Coll Healthcare NHS Trust, Charing Cross Hosp Intens Care Unit, Crit Care Directorate, London, England; [Edge, Christopher J.; Franks, Nicholas P.] Imperial Coll London, Dept Life Sci, Sir Ernst Chain Bldg, London SW7 2AZ, England; [Edge, Christopher J.] Royal Berkshire Hosp NHS Fdn Trust, Dept Anaesthet, London Rd, Reading RG1 5AN, Berks, England		Dickinson, R (corresponding author), Imperial Coll London, Anaesthet Pain Med & Intens Care Sect, Dept Surg & Canc, Sir Ernst Chain Bldg, London SW7 2AZ, England.	r.dickinson@imperial.ac.uk		Dickinson, Robert/0000-0003-2423-2108; Ujvari, Eszter/0000-0002-9650-1912	Medical Research Council, London, United KingdomUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/N027736/1]; Association of Paediatric Anaesthetists of Great Britain Ireland; Royal Centre for Defence Medicine, Birmingham, United Kingdom; Royal British Legion Centre for Blast Injury Studies, Imperial College London, United Kingdom; Gas Safety Trust, London United Kingdom; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/N027736/1] Funding Source: UKRI	Supported by: Medical Research Council, London, United Kingdom (MR/N027736/1). Association of Paediatric Anaesthetists of Great Britain & Ireland. Royal Centre for Defence Medicine, Birmingham, United Kingdom. Royal British Legion Centre for Blast Injury Studies, Imperial College London, United Kingdom. The Gas Safety Trust, London United Kingdom.	Abraini JH, 2005, ANN NY ACAD SCI, V1053, P289, DOI 10.1196/annals.1344.025; Armstrong SP, 2012, ANESTHESIOLOGY, V117, P38, DOI 10.1097/ALN.0b013e31825ada2e; Azzopardi D, 2016, LANCET NEUROL, V15, P145, DOI 10.1016/S1474-4422(15)00347-6; Azzopardi D, 2013, ARCH DIS CHILD-FETAL, V98, pF437, DOI 10.1136/archdischild-2013-303786; Bantel C, 2010, ANESTHESIOLOGY, V112, P623, DOI 10.1097/ALN.0b013e3181cf894a; Boghdadi AG, 2020, J NEUROTRAUM, V37, P681, DOI 10.1089/neu.2019.6938; Borich MR, 2015, NEUROPSYCHOLOGIA, V79, P246, DOI 10.1016/j.neuropsychologia.2015.07.007; Campos-Pires R, 2018, J VIS EXP, P142; Campos-Pires R, 2019, BRIT J ANAESTH, V123, P60, DOI 10.1016/j.bja.2019.02.032; Campos-Pires R, 2018, J NEUROTRAUM, V35, P1037, DOI 10.1089/neu.2017.5360; Campos-Pires R, 2015, CRIT CARE MED, V43, P149, DOI 10.1097/CCM.0000000000000624; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; Dahan A, 2005, BRIT J ANAESTH, V94, P825, DOI 10.1093/bja/aei145; Davis BM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01747-8; Dickinson R, 2007, ANESTHESIOLOGY, V107, P756, DOI 10.1097/01.anes.0000287061.77674.71; Dickinson R, 2010, CRIT CARE, V14, DOI 10.1186/cc9051; Dingley J, 2006, STROKE, V37, P501, DOI 10.1161/01.STR.0000198867.31134.ac; Dingley J, 2014, PEDIATRICS, V133, P809, DOI 10.1542/peds.2013-0787; Faul M, 2010, TRAUMATIC BRAIN INJU; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Frankowski JC, 2019, NEUROBIOL DIS, V129, P208, DOI 10.1016/j.nbd.2018.07.022; Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525; Fries M, 2008, CRIT CARE MED, V36, P2420, DOI 10.1097/CCM.0b013e3181802874; Gruss M, 2004, MOL PHARMACOL, V65, P443, DOI 10.1124/mol.65.2.443; Guarnieri M, 2012, LAB ANIMAL, V41, P337, DOI 10.1038/laban.152; Harris K, 2013, ANESTHESIOLOGY, V119, P1137, DOI 10.1097/ALN.0b013e3182a2a265; Homi HM, 2003, ANESTHESIOLOGY, V99, P876, DOI 10.1097/00000542-200310000-00020; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Klose M, 2018, NAT REV ENDOCRINOL, V14, P57, DOI 10.1038/nrendo.2017.103; Laitio R, 2016, JAMA-J AM MED ASSOC, V315, P1120, DOI 10.1001/jama.2016.1933; Ling GSF, 2008, NEUROL CLIN, V26, P409, DOI 10.1016/j.ncl.2008.02.001; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Luh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019948; Ma DQ, 2009, J AM SOC NEPHROL, V20, P713, DOI 10.1681/ASN.2008070712; Ma DQ, 2005, ANN NEUROL, V58, P182, DOI 10.1002/ana.20547; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mammarappallil JG, 2019, J THORAC IMAG, V34, P136, DOI 10.1097/RTI.0000000000000392; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sheng SP, 2012, ANESTHESIOLOGY, V117, P1262, DOI 10.1097/ALN.0b013e3182746b81; Shinozaki Y, 2017, CELL REP, V19, P1151, DOI 10.1016/j.celrep.2017.04.047; Simon DW, 2017, NAT REV NEUROL, V13, P572, DOI 10.1038/nrneurol.2017.116; Soltys Z, 2001, J NEUROSCI RES, V63, P90, DOI 10.1002/1097-4547(20010101)63:1<90::AID-JNR11>3.0.CO;2-9; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; Stoppe C, 2016, SPORTS MED, V46, P1753, DOI 10.1007/s40279-016-0505-1; Thoresen M, 2009, J CEREBR BLOOD F MET, V29, P707, DOI 10.1038/jcbfm.2008.163; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Weiss P, 1995, MATH J, V9, P803; Williams G, 2010, J HEAD TRAUMA REHAB, V25, P366, DOI 10.1097/HTR.0b013e3181cd3600; Zoerle T, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00354	56	2	2	2	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1364-8535	1466-609X		CRIT CARE	Crit. Care	DEC 27	2020	24	1							667	10.1186/s13054-020-03373-9			18	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PA8YW	WOS:000595915800001	33246487	gold, Green Published			2022-02-06	
J	Mao, LL; Sun, LM; Sun, JY; Sun, BL; Gao, YQ; Shi, H				Mao, Leilei; Sun, Limin; Sun, Jingyi; Sun, Baoliang; Gao, Yanqin; Shi, Hong			Ethyl pyruvate improves white matter remodeling in rats after traumatic brain injury	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						ethyl pyruvate; microglia; traumatic brain injury; white matter injury	MODULATING MICROGLIA/MACROPHAGE POLARIZATION; MODEL; INHIBITION; PROTECTS; DAMAGE	Background Severe traumatic brain injury (TBI) results in long-term neurological deficits associated with white matter injury (WMI). Ethyl pyruvate (EP) is a simple derivative of the endogenous energy substrate pyruvate with neuroprotective properties, but its role in recovery from WMI has not been explored. Aims This study examines the effect of EP treatment on rats following TBI using behavioral tests and white matter histological analysis up to 28 days post-injury. Materials and Methods Anaesthetised adult rats were subjected to TBI by controlled cortical impact. After surgery, EP or Ringers solution (RS) was administrated intraperitoneally at 15 min after TBI and again at 12, 24, 36, 48, and 60 h after TBI. Sensorimotor deficits were evaluated up to day 21 after TBI by four independent tests. Immunofluorescence and transmission electron microscopy (TEM) were performed to assess white matter injury. Microglia activation and related inflammatory molecules were examined up to day 14 after TBI by immunohistochemistry or real-time PCR. Results Here, we demonstrate that EP improves sensorimotor function following TBI as well as improves white matter outcomes up to 28 d after TBI, as shown by reduced myelin loss. Furthermore, EP administration during the acute phase of TBI recovery shifted microglia polarization toward the anti-inflammatoryM2 phenotype, modulating the release of inflammatory-related factors. Conclusion EP treatment may protect TBI-induced WMI via modulating microglia polarization toward M2.	[Mao, Leilei; Sun, Limin; Sun, Jingyi; Sun, Baoliang] Shandong First Med Univ, Key Lab Cerebral Microcirculat Univ Shandong, Affiliated Hosp 2, Dept Neurol, Tai An, Shandong, Peoples R China; [Gao, Yanqin] Fudan Univ, MOE Frontiers Ctr Brain Sci, State Key Lab Med Neurobiol, Shanghai, Peoples R China; [Gao, Yanqin] Fudan Univ, Inst Brain Sci, Shanghai, Peoples R China; [Shi, Hong] Tongji Univ, Dept Anesthesiol, Shanghai Pulm Hosp, Shanghai 200433, Peoples R China		Shi, H (corresponding author), Tongji Univ, Dept Anesthesiol, Shanghai Pulm Hosp, Shanghai 200433, Peoples R China.; Sun, BL (corresponding author), First Med Univ, Key Lab Cerebral Microcirculat Shandong, Tai An 271000, Shandong, Peoples R China.; Sun, BL (corresponding author), Shandong Acad Med Sci, Tai An 271000, Shandong, Peoples R China.	blsun88@163.com; ada-shi@139.com		mao, leilei/0000-0001-8586-7532	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81701220, 81701179]; Academic elite program of Shanghai Pulmonary Hospital [fkgg1809]	This research was funded by the National Natural Science Foundation of China 81701220 (to Hong Shi), 81701179 (to Leilei Mao), and Academic elite program of Shanghai Pulmonary Hospital (fkgg1809, to Hong Shi).	Bai LJ, 2020, HUM BRAIN MAPP, V41, P4431, DOI 10.1002/hbm.25135; Chung HJ, 2019, NEUROCHEM RES, V44, P1964, DOI 10.1007/s11064-019-02830-4; Dai XJ, 2020, J CEREBR BLOOD F MET, V40, P639, DOI 10.1177/0271678X19830791; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; di Penta A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054722; He Y, 2019, INT IMMUNOPHARMACOL, V77, DOI 10.1016/j.intimp.2019.105929; Hu XM, 2020, J CEREBR BLOOD F MET, V40, pS134, DOI 10.1177/0271678X20963405; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Jolly AE, 2020, BRAIN, V143, P1158, DOI 10.1093/brain/awaa067; Kansagara D., 2013, COMPLICATIONS MILD T; Kluge MG, 2019, J CEREBR BLOOD F MET, V39, P2456, DOI 10.1177/0271678X18797346; Kurisu K, 2019, J CEREBR BLOOD F MET, V39, P1906, DOI 10.1177/0271678X18817282; Lee HK, 2019, NEUROTHERAPEUTICS, V16, P523, DOI 10.1007/s13311-019-00711-w; Lee HK, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep42891; Lee J, 2019, CNS NEUROSCI THER, V25, P1290, DOI 10.1111/cns.13266; Liu ZJ, 2019, CNS NEUROSCI THER, V25, P1353, DOI 10.1111/cns.13261; Lv T, 2017, NEUROCHEM RES, V42, P1044, DOI 10.1007/s11064-016-2138-z; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Massey N, 2019, TOXICOL SCI, V169, P579, DOI 10.1093/toxsci/kfz071; da Silva NM, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00369; Moro N, 2016, BRAIN RES, V1642, P270, DOI 10.1016/j.brainres.2016.04.005; Mouihate A, 2020, CNS NEUROSCI THER, V26, P240, DOI 10.1111/cns.13195; Nygaard KH, 2020, METABOLITES, V10, DOI 10.3390/metabo10070287; Park BS, 2015, ANIM CELLS SYST, V19, P262, DOI 10.1080/19768354.2015.1053520; Peng J, 2019, CNS NEUROSCI THER, V25, P1363, DOI 10.1111/cns.13265; Shi H, 2015, EXP NEUROL, V272, P17, DOI 10.1016/j.expneurol.2015.03.017; Shi H, 2015, CNS NEUROSCI THER, V21, P374, DOI 10.1111/cns.12366; Shijo K, 2017, NEUROCHEM INT, V102, P66, DOI 10.1016/j.neuint.2016.11.014; Turkmen S, 2016, AM J EMERG MED, V34, P1804, DOI 10.1016/j.ajem.2016.06.003; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang M, 2019, CNS NEUROSCI THER, V25, P1126, DOI 10.1111/cns.13208; Yang H, 2019, CNS NEUROSCI THER, V25, P1195, DOI 10.1111/cns.13220; Zhang WT, 2019, CNS NEUROSCI THER, V25, P1329, DOI 10.1111/cns.13256	33	2	2	4	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	JAN	2021	27	1			SI		113	122		10.1111/cns.13534		DEC 2020	10	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	PR4BD	WOS:000602555000001	33369165	Green Published, gold			2022-02-06	
J	Bertolini, G; Romano, F; Straumann, D; Keller, K; Palla, A; Feddermann-Demont, N				Bertolini, Giovanni; Romano, Fausto; Straumann, Dominik; Keller, Katharine; Palla, Antonella; Feddermann-Demont, Nina			Measuring optokinetic after-nystagmus: potential for detecting patients with signs of visual dependence following concussion	JOURNAL OF NEUROLOGY			English	Article						Velocity storage; Self-motion perception; Human; Vestibulo-ocular reflex; Psychophysics	AFTERNYSTAGMUS; QUESTIONNAIRE; POSITION; VERTIGO; VISION	Concussed patients with chronic symptoms commonly report dizziness during exposure to environments with complex visual stimuli (e.g. supermarket aisles, busy crossroads). Such visual induced dizziness is well-known in patients with vestibular deficits, in whom it indicates an overreliance on visual cues in sensory integration. Considering that optokinetic after-nystagmus (OKAN) reflects the response of the central network integrating visual and vestibular self-motion signals (velocity storage network), we investigated OKAN in 71 patients [17 (23.9%) females, 30.36 +/- 9.05 years old] who suffered from persistent symptoms after a concussion and presented clinical signs suggesting visual dependence. Data were retrospectively compared with 21 healthy individuals [13 (61.9%) females, 26.29 +/- 10.00 years old]. The median values of the slow cumulative eye position and of the time constant of OKAN were significantly higher in patients than in healthy individuals (slow cumulative eye position: 124.15 +/- 55.61 degrees in patients and 77.87 +/- 45.63 degrees in healthy individuals-p = 0.012; time constant: 25.17 +/- 10.27 s in patients and 13.95 +/- 4.92 s in healthy individuals-p = 0.003). The receiving operating curve (ROC) estimated on the time constant had an overall area under the curve of 0.73. Analysis of the ROC suggests that a test measuring the OKAN time constant could obtain a sensitivity of 0.73 and specificity of 0.72 in determining the origin of the visual-related disturbances in those patients (threshold 16.6 s). In a subset of 43 patients who also performed the Sensory Organization Test (SOT), the proposed OKAN test was twice as sensitive as the SOT. This study suggests that concussed patients with persisting visual symptoms may have an underlying impairment of the velocity storage mechanism and that measuring the OKAN time constant can objectify such impairment.	[Bertolini, Giovanni; Romano, Fausto; Palla, Antonella; Feddermann-Demont, Nina] Swiss Concuss Ctr, Schulthess Clin, Zurich, Switzerland; [Bertolini, Giovanni; Romano, Fausto; Straumann, Dominik; Keller, Katharine; Feddermann-Demont, Nina] Univ Hosp, Dept Neurol, Frauenklinikstr 26, CH-8091 Zurich, Switzerland; [Bertolini, Giovanni; Romano, Fausto; Straumann, Dominik; Keller, Katharine; Feddermann-Demont, Nina] Univ Zurich, Frauenklinikstr 26, CH-8091 Zurich, Switzerland; [Bertolini, Giovanni; Romano, Fausto; Straumann, Dominik; Feddermann-Demont, Nina] Clin Neurosci Ctr, Zurich, Switzerland		Bertolini, G (corresponding author), Swiss Concuss Ctr, Schulthess Clin, Zurich, Switzerland.; Bertolini, G (corresponding author), Univ Hosp, Dept Neurol, Frauenklinikstr 26, CH-8091 Zurich, Switzerland.; Bertolini, G (corresponding author), Univ Zurich, Frauenklinikstr 26, CH-8091 Zurich, Switzerland.; Bertolini, G (corresponding author), Clin Neurosci Ctr, Zurich, Switzerland.	giovanni.bertolini@usz.ch			University of Zurich; Schulthess Foundation; Betty and David Koetser Foundation for Brain Research	Open access funding provided by University of Zurich. Schulthess Foundation; Betty and David Koetser Foundation for Brain Research.	Akhand O, 2019, CURR OPIN NEUROL; Bisdorff A, 2009, J VESTIBUL RES-EQUIL, V19, P1, DOI 10.3233/VES-2009-0343; BRONSTEIN AM, 1995, J NEUROL NEUROSUR PS, V59, P472, DOI 10.1136/jnnp.59.5.472; Cousins S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105426; Dannenbaum E, 2011, J VESTIBUL RES-EQUIL, V21, P153, DOI 10.3233/VES-2011-0412; de Dhaem OB, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0767-5; DICHGANS J, 1972, SCIENCE, V178, P1217, DOI 10.1126/science.178.4066.1217; Feddermann-Demont N, 2017, BR J SPORTS MED; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Guerraz M, 2001, VISUAL VERTIGO SYMPT; Guo CCT, 2017, APPL ERGON, V63, P1, DOI 10.1016/j.apergo.2017.03.011; HAIN TC, 1994, ANN OTO RHINOL LARYN, V103, P806, DOI 10.1177/000348949410301011; HAIN TC, 1992, ANN OTO RHINOL LARYN, V101, P255, DOI 10.1177/000348949210100309; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hunfalvay Melissa, 2019, Concussion, V4, pCNC60, DOI 10.2217/cnc-2019-0001; Karmali F, 2019, PROG BRAIN RES, V248, P269, DOI 10.1016/bs.pbr.2019.04.038; Kelly KM, 2019, J HEAD TRAUMA REHAB, V34, P176, DOI 10.1097/HTR.0000000000000437; Kramer PD, 1998, J VESTIBUL RES-EQUIL, DOI [10.3233/ves-1998-8503, DOI 10.3233/VES-1998-8503]; LAFORTUNE S, 1986, ACTA OTO-LARYNGOL, V101, P353, DOI 10.3109/00016488609108619; LAFORTUNE S, 1986, ACTA OTO-LARYNGOL, V101, P183, DOI 10.3109/00016488609132826; Laurens J, 2011, EXPT BRAIN RES; Leigh RJ, 2015, NEUROLOGY EYE MOVEME; Maire R, 2017, J INT ADV OTOL; McCrory P, 2017, BR J SPORTS MED; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Mucci V, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01200; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Nashner LM, 1990, NEUROL CLIN; NeuroCom International, 2010, BAL MAN SYST CLIN OP; Nooij SAE, 2018, EXP BRAIN RES, V236, P3031, DOI 10.1007/s00221-018-5340-1; Nooij SAE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175305; Pavlou M, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00656; Pavlou M, 2016, J PEDIATR-US, V168, P171, DOI 10.1016/j.jpeds.2015.09.075; Raphan T, 1979, VELOCITY STORAGE VES, DOI [10.1007/BF00236613, DOI 10.1007/BF00236613]; Robinson D. A., 1977, CONTROL GAZE BRAIN S, P49; Schneider E, 2009, ANN NEW YORK ACAD SC; Snegireva N, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aaef44; TIJSSEN MAJ, 1989, ANN OTO RHINOL LARYN, V98, P741, DOI 10.1177/000348948909800916; Ventura RE, 2015, SEMIN NEUROL, V35, P599, DOI 10.1055/s-0035-1563567; Wearne S, 1998, J NEUROPHYSIOL, V79, P2690, DOI 10.1152/jn.1998.79.5.2690; Whitney SL, 2019, J NEUROL PHYS THER, V43, pS31, DOI 10.1097/NPT.0000000000000272	41	2	2	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	MAY	2021	268	5					1747	1761		10.1007/s00415-020-10359-8		DEC 2020	15	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RR7EJ	WOS:000602290900001	33367947	hybrid, Green Published			2022-02-06	
J	Wirtz, MR; Moekotte, J; Balvers, K; Admiraal, MM; Pittet, JF; Colombo, J; Wagener, BM; Goslings, JC; Juffermans, N				Wirtz, Mathijs R.; Moekotte, Jiri; Balvers, Kirsten; Admiraal, Marjolein M.; Pittet, Jean-Francois; Colombo, Joe; Wagener, Brant M.; Goslings, J. Carel; Juffermans, Nicole			Autonomic nervous system activity and the risk of nosocomial infection in critically ill patients with brain injury	INTENSIVE CARE MEDICINE EXPERIMENTAL			English	Article						Autonomic nervous system; Brain injury; Immunosuppression; Nosocomial infection	HEART-RATE-VARIABILITY; ISCHEMIC-STROKE; IMMUNE-RESPONSE; BETA-BLOCKER; ACTIVATION; PNEUMONIA; MORTALITY	Purpose: Nosocomial infection contributes to adverse outcome after brain injury. This study investigates whether autonomic nervous system activity is associated with a decreased host immune response in patients following stroke or traumatic brain injury (TBI). Methods: A prospective study was performed in adult patients with TBI or stroke who were admitted to the Intensive Care Unit of our tertiary university hospital between 2013 and 2016. Heart rate variability (HRV) was recorded daily and assessed for autonomic nervous system activity. Outcomes were nosocomial infections and immunosuppression, which was assessed ex vivo using whole blood stimulations with plasma of patients with infections, matched non-infected patients and healthy controls. Results: Out of 64 brain injured patients, 23 (36%) developed an infection during their hospital stay. The ability of brain injured patients to generate a host response to the bacterial endotoxin lipopolysaccharides (LPS) was diminished compared to healthy controls (p < 0.001). Patients who developed an infection yielded significantly lower TNF-alpha values (86 vs 192 pg/mL, p = 0.030) and a trend towards higher IL-10 values (122 vs 84 pg/mL, p = 0.071) following ex vivo whole blood stimulations when compared to patients not developing an infection. This decreased host immune response was associated with altered admission HRV values. Brain injured patients who developed an infection showed increased normalized high-frequency power compared to patients not developing an infection (0.54 vs 0.36, p = 0.033), whereas normalized low-frequency power was lower in infected patients (0.46 vs 0.64, p = 0.033). Conclusion: Brain injured patients developing a nosocomial infection show parasympathetic predominance in the acute phase following brain injury, reflected by alterations in HRV, which parallels a decreased ability to generate an immune response to stimulation with LPS.	[Wirtz, Mathijs R.; Moekotte, Jiri; Balvers, Kirsten; Admiraal, Marjolein M.; Juffermans, Nicole] Onze Lieve Vrouw Hosp, Dept Intens Care Med, Amsterdam, Netherlands; [Wirtz, Mathijs R.; Moekotte, Jiri; Balvers, Kirsten; Admiraal, Marjolein M.; Juffermans, Nicole] Amsterdam Univ Med Ctr, Amsterdam, Netherlands; [Wirtz, Mathijs R.; Moekotte, Jiri; Balvers, Kirsten; Admiraal, Marjolein M.; Juffermans, Nicole] Amsterdam Univ Med Ctr, Lab Expt Intens Care & Anesthesiol, Amsterdam, Netherlands; [Wirtz, Mathijs R.] Amsterdam Univ Med Ctr, Trauma Unit, Dept Surg, Amsterdam, Netherlands; [Goslings, J. Carel] Onze Lieve Vrouw Hosp, Trauma Unit, Dept Surg, Amsterdam, Netherlands; [Pittet, Jean-Francois; Wagener, Brant M.] Univ Alabama Birmingham, Dept Anesthesiol & Perioperat Med, Birmingham, AL USA; [Colombo, Joe] Drexel Univ, Dept Cardiol, Coll Med, Philadelphia, PA 19104 USA; [Colombo, Joe] ANSAR Med Technol Inc, Philadelphia, PA USA		Wirtz, MR (corresponding author), Onze Lieve Vrouw Hosp, Dept Intens Care Med, Amsterdam, Netherlands.; Wirtz, MR (corresponding author), Amsterdam Univ Med Ctr, Amsterdam, Netherlands.	m.r.wirtz@amsterdamumc.nl					Aboab J, 2018, INTENS CARE MED EXP, V6, DOI 10.1186/s40635-018-0178-1; Aysin B, 2006, 2006 28TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-15, P1726; Balvers K, 2015, SHOCK, V43, P317, DOI 10.1097/SHK.0000000000000321; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Buchman Timothy G, 2002, Curr Opin Crit Care, V8, P311, DOI 10.1097/00075198-200208000-00007; Busl KM, 2018, NEUROSURG CLIN N AM, V29, P299, DOI 10.1016/j.nec.2017.11.008; Camm AJ, 1996, CIRCULATION, V93, P1043; Chen ZF, 2017, J CRIT CARE, V41, P240, DOI 10.1016/j.jcrc.2017.05.035; Colombo J, 2008, J TRAUMA, V65, P1364, DOI 10.1097/TA.0b013e31818cc307; Demetriades, 2017, J CLIN ANESTH PAIN M, V2017, P1; Doran SJ, 2020, CRIT CARE MED, V48, pE418, DOI 10.1097/CCM.0000000000004273; Emsley HC, 2008, LANCET NEUROL, V7, P341, DOI 10.1016/S1474-4422(08)70061-9; Engel O, 2015, STROKE, V46, P3232, DOI 10.1161/STROKEAHA.115.008989; Gunther A, 2012, ACTA NEUROL SCAND, V126, P189, DOI 10.1111/j.1600-0404.2011.01626.x; Hoffmann S, 2017, J CEREBR BLOOD F MET, V37, P3671, DOI 10.1177/0271678X16671964; Kox M, 2012, J NEUROTRAUM, V29, P747, DOI 10.1089/neu.2011.2035; Lafargue M, 2012, FASEB J, V26, P2919, DOI 10.1096/fj.11-197384; Lees T, 2018, BIOMARK INSIGHTS, V13, DOI 10.1177/1177271918786931; Maier IL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196174; Poole D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113676; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Shim R, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010064; Shin SS, 2015, J NEUROTRAUM, V32, P1429, DOI 10.1089/neu.2014.3445; Starr JB, 2017, NEUROL SCI, V38, P967, DOI 10.1007/s10072-017-2877-x; Sykora M, 2015, STROKE, V46, P1269, DOI 10.1161/STROKEAHA.114.008260; van Vught LA, 2016, JAMA-J AM MED ASSOC, V315, P1469, DOI 10.1001/jama.2016.2691; Vermeij JD, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008530.pub3; Wastfelt M, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1046-z; 2016, CRITICAL CARE LONDON, V20, P391, DOI DOI 10.1186/S13054-016-1573-1	29	2	2	2	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2197-425X			INTENS CARE MED EXP	Int. Care Med. Exp.	DEC 25	2020	8	1							69	10.1186/s40635-020-00359-3			14	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	PA9HI	WOS:000595937900001	33237337	gold, Green Published, Green Submitted			2022-02-06	
J	Xiao, SN; Wang, CG; Yang, QM; Xu, HB; Lu, JW; Xu, K				Xiao, Shining; Wang, Chenggui; Yang, Quanming; Xu, Haibin; Lu, Jinwei; Xu, Kan			Rea regulates microglial polarization and attenuates neuronal apoptosis via inhibition of the NF-kappa B and MAPK signalings for spinal cord injury repair	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						microglia polarization; neuronal apoptosis; Rehmannioside A; spinal cord injury	ENDOPLASMIC-RETICULUM STRESS; PATHWAY; DIFFERENTIATION; REGENERATION; INFLAMMATION; NEUROTRAUMA; ACTIVATION; THERAPY; KLF2	Inflammation and neuronal apoptosis aggravate the secondary damage after spinal cord injury (SCI). Rehmannioside A (Rea) is a bioactive herbal extract isolated from Rehmanniae radix with low toxicity and neuroprotection effects. Rea treatment inhibited the release of pro-inflammatory mediators from microglial cells, and promoted M2 polarization in vitro, which in turn protected the co-cultured neurons from apoptosis via suppression of the NF-kappa B and MAPK signalling pathways. Furthermore, daily intraperitoneal injections of 80 mg/kg Rea into a rat model of SCI significantly improved the behavioural and histological indices, promoted M2 microglial polarization, alleviated neuronal apoptosis, and increased motor function recovery. Therefore, Rea is a promising therapeutic option for SCI and should be clinically explored.	[Xiao, Shining; Wang, Chenggui; Yang, Quanming; Xu, Haibin; Lu, Jinwei; Xu, Kan] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Orthoped Surg, Hangzhou, Peoples R China		Xu, K (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Orthoped Surg, Hangzhou, Peoples R China.	xukan@zju.edu.cn			Zhejiang medical and health science and technology project [2017ZD017]	Zhejiang medical and health science and technology project, Grant/Award Number: 2017ZD017	Tran AP, 2018, PHYSIOL REV, V98, P881, DOI 10.1152/physrev.00017.2017; [Anonymous], 2020, OCCUP ENVIRON MED, V77, P142, DOI [DOI 10.1136/oemed-2019-106012, 10.1136/oemed-2019-106012]; Cho JJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08605-3; Clausen BH, 2016, ACTA NEUROPATHOL, V131, P775, DOI 10.1007/s00401-016-1541-5; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Das M, 2012, CURR MOL MED, V12, P113, DOI 10.2174/156652412798889090; DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5; Duncan GJ, 2020, GLIA, V68, P227, DOI 10.1002/glia.23706; Gong G, 2020, BIOMED PHARMACOTHER, V128, DOI 10.1016/j.biopha.2020.110301; Gong Z, 2020, CYTOTHERAPY, V22, P193, DOI 10.1016/j.jcyt.2020.01.016; Greenhalgh AD, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005264; Hammouda MB, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040857; Han Q, 2020, CELL METAB, V31, P623, DOI 10.1016/j.cmet.2020.02.002; He LZ, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay9751; Hong JY, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051310; Hou YH, 2018, BEHAV BRAIN RES, V336, P32, DOI 10.1016/j.bbr.2017.06.027; Hu WJ, 2020, EXP NEUROL, V331, DOI 10.1016/j.expneurol.2020.113374; Jha P, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112383; Ji MH, 2020, BRAIN BEHAV IMMUN, V89, P133, DOI 10.1016/j.bbi.2020.06.001; Jin X, 2019, PHARMACOL RES, V145, DOI 10.1016/j.phrs.2019.104253; Kjell J, 2016, DIS MODEL MECH, V9, P1125, DOI 10.1242/dmm.025833; Li HT, 2019, INT J BIOL SCI, V15, P277, DOI 10.7150/ijbs.30348; Li LM, 2020, NANO LETT, V20, P4298, DOI 10.1021/acs.nanolett.0c00929; Lin JL, 2020, J CELL MOL MED, V24, P671, DOI 10.1111/jcmm.14776; Liu C, 2019, INFLAMMATION, V42, P2192, DOI 10.1007/s10753-019-01083-1; Liu SY, 2018, BIOCHEM PHARMACOL, V149, P153, DOI 10.1016/j.bcp.2017.10.010; Liu WY, 2020, BIOMATERIALS, V243, DOI 10.1016/j.biomaterials.2020.119941; Lynch MA, 2020, PROG NEUROBIOL, V184, DOI 10.1016/j.pneurobio.2019.101719; Ma DZ, 2020, BIOMATERIALS, V237, DOI 10.1016/j.biomaterials.2020.119830; Mai LJ, 2020, LIFE SCI, V256, DOI 10.1016/j.lfs.2020.117885; Meng JH, 2020, BIOCHEM PHARMACOL, V171, DOI 10.1016/j.bcp.2019.113715; Milich LM, 2019, ACTA NEUROPATHOL, V137, P785, DOI 10.1007/s00401-019-01992-3; Peferoen L, 2014, IMMUNOLOGY, V141, P302, DOI 10.1111/imm.12163; Penas C, 2007, J NEUROCHEM, V102, P1242, DOI 10.1111/j.1471-4159.2007.04671.x; Rahimifard M, 2017, AGEING RES REV, V36, P11, DOI 10.1016/j.arr.2017.02.004; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; Rodriguez-Ortiz ME, 2020, CLIN SCI, V134, P15, DOI 10.1042/CS20190779; Rong YL, 2019, BRAIN RES BULL, V148, P91, DOI 10.1016/j.brainresbull.2019.03.014; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Saadoun S, 2020, NEUROTHERAPEUTICS, V17, P511, DOI 10.1007/s13311-019-00820-6; Sarfraz A, 2020, SCI TOTAL ENVIRON, V722, DOI 10.1016/j.scitotenv.2020.137907; Shi CX, 2018, EUR REV MED PHARMACO, V22, P1770, DOI 10.26355/eurrev_201803_14595; Sun M, 2019, BIOMED PHARMACOTHER, V120, DOI 10.1016/j.biopha.2019.109492; Sun Y, 2015, J RECEPT SIG TRANSD, V35, P600, DOI 10.3109/10799893.2015.1030412; Tan LW, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070739; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Thalhamer T, 2008, RHEUMATOLOGY, V47, P409, DOI 10.1093/rheumatology/kem297; Uddin R, 2013, EXCLI J, V12, P541; Voet S, 2019, TRENDS MOL MED, V25, P112, DOI 10.1016/j.molmed.2018.11.005; Wang CG, 2019, THERANOSTICS, V9, P7016, DOI 10.7150/thno.37601; Wang CG, 2018, J CELL MOL MED, V22, P1148, DOI 10.1111/jcmm.13368; Wang DM, 2020, AGING-US, V12, P8953, DOI 10.18632/aging.103125; Wang JK, 2020, SMALL, V16, DOI 10.1002/smll.201906415; White S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061348	55	2	2	7	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1582-1838	1582-4934		J CELL MOL MED	J. Cell. Mol. Med.	FEB	2021	25	3					1371	1382		10.1111/jcmm.16220		DEC 2020	12	Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	QF2IF	WOS:000601785200001	33369103	Green Published, gold			2022-02-06	
J	Castellanos, J; Phoo, CP; Eckner, JT; Franco, L; Broglio, SP; McCrea, M; McAllister, T; Wiens, J				Castellanos, Joel; Phoo, Cheng Perng; Eckner, James T.; Franco, Lea; Broglio, Steven P.; McCrea, Mike; McAllister, Thomas; Wiens, Jenna		CARE Consortium Investigators	Predicting Risk of Sport-Related Concussion in Collegiate Athletes and Military Cadets: A Machine Learning Approach Using Baseline Data from the CARE Consortium Study	SPORTS MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; LIFE COGNITIVE IMPAIRMENT; 1ST EXPOSURE; HIGH-SCHOOL; RECURRENT CONCUSSION; AMERICAN FOOTBALL; CONTACT SPORTS; AGE; EPIDEMIOLOGY; MIGRAINE	Objective To develop a predictive model for sport-related concussion in collegiate athletes and military service academy cadets using baseline data collecting during the pre-participation examination. Methods Baseline assessments were performed in 15,682 participants from 21 US academic institutions and military service academies participating in the CARE Consortium Study during the 2015-2016 academic year. Participants were monitored for sport-related concussion during the subsequent season. 176 baseline covariates mapped to 957 binary features were used as input into a support vector machine model with the goal of learning to stratify participants according to their risk for sport-related concussion. Performance was evaluated in terms of area under the receiver operating characteristic curve (AUROC) on a held-out test set. Model inputs significantly associated with either increased or decreased risk were identified. Results 595 participants (3.79%) sustained a concussion during the study period. The predictive model achieved an AUROC of 0.73 (95% confidence interval 0.70-0.76), with variable performance across sports. Features with significant positive and negative associations with subsequent sport-related concussion were identified. Conclusion(s) This predictive model using only baseline data identified athletes and cadets who would go on to sustain sport-related concussion with comparable accuracy to many existing concussion assessment tools for identifying concussion. Furthermore, this study provides insight into potential concussion risk and protective factors.	[Castellanos, Joel; Eckner, James T.; Franco, Lea] Univ Michigan, Dept Phys Med & Rehabil, Michigan Med, 325 E Eisenhower Pkwy, Ann Arbor, MI 48108 USA; [Castellanos, Joel] Univ Calif San Diego, Sch Med, Anestheshiol, San Diego, CA 92103 USA; [Phoo, Cheng Perng; Wiens, Jenna] Univ Michigan, Comp Sci & Engn, Ann Arbor, MI 48109 USA; [Phoo, Cheng Perng] Cornell Univ, Comp Sci, New York, NY 10021 USA; [Broglio, Steven P.] Univ Michigan, Kinesiol, Ann Arbor, MI 48109 USA; [McCrea, Mike] Med Coll Wisconsin, Neurosurg, Milwaukee, WI 53226 USA; [McAllister, Thomas] Indiana Univ, Psychiat, Indianapolis, IN 46204 USA		Eckner, JT (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, Michigan Med, 325 E Eisenhower Pkwy, Ann Arbor, MI 48108 USA.	jeckner@med.umich.edu			Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium; National Collegiate Athletic Association (NCAA); Department of Defense (DOD)United States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Combat Casualty Care Program [W81XWH-BA170608]	This project was supported, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, in part by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DOD). The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Combat Casualty Care Program, endorsed by the Department of Defense under Award No. W81XWH-BA170608. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Office of the Assistant Secretary of Defense for Health Affairs.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; [Anonymous], 2018, MAN SERV MEMB HAV SU; Barlow M, 2011, INT J SPORTS PHYS TH, V6, P150; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Blumenfeld RS, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00098; Brett BL, 2019, SPORTS HEALTH, V11, P332, DOI 10.1177/1941738119849076; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Caccese JB, 2020, J NEUROTRAUM, V37, P334, DOI 10.1089/neu.2019.6571; Caccese JB, 2020, RES SPORTS MED, V28, P594, DOI 10.1080/15438627.2019.1641500; Caccese JB, 2019, SPORTS MED, V49, P477, DOI 10.1007/s40279-019-01069-x; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1007/BF00994018; Curran-Sills G, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000348; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dretsch MN, 2017, APPL NEUROPSYCH-ADUL, V24, P376, DOI 10.1080/23279095.2016.1220947; Eckner JT, 2017, CLIN J SPORT MED, V27, P266, DOI 10.1097/JSM.0000000000000346; Finnoff JT, 2011, PM&R, V3, pS452, DOI 10.1016/j.pmrj.2011.07.014; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gordon KE, 2006, BRIT J SPORT MED, V40, P184, DOI 10.1136/bjsm.2005.022251; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hollis SJ, 2011, BRIT J SPORT MED, V45, P997, DOI 10.1136/bjsm.2010.079707; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kerr HA, 2014, PEDIATR ANN, V43, pE309, DOI 10.3928/00904481-20141124-10; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lipton RB, 2003, NEUROLOGY, V61, P375, DOI 10.1212/01.WNL.0000078940.53438.83; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; National Collegiate Athletic Association, 2018, NUMB NCAA COLL ATHL; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Schmidt JD, 2018, PEDIATR NEUROL, V81, P19, DOI 10.1016/j.pediatrneurol.2017.12.017; Schneider KJ, 2013, CLIN J SPORT MED, V23, P267, DOI 10.1097/JSM.0b013e318281f09f; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Teramoto M, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115620365; US Department of Defense, 2015, SPEC REP TRAUM BRAIN; Ustun B, 2014, ARXIV13066677; Van Pelt KL, 2019, INJURY EPIDEMIOL, V6, DOI 10.1186/s40621-018-0178-3; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Yeung A, 2017, BRAIN INJURY, V31, P542, DOI 10.1080/02699052.2016.1271456	58	2	2	0	5	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0112-1642	1179-2035		SPORTS MED	Sports Med.	MAR	2021	51	3					567	579		10.1007/s40279-020-01390-w		DEC 2020	13	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	QK7ZT	WOS:000601626100003	33368027				2022-02-06	
J	Kaimal, G; Jones, JP; Dieterich-Hartwell, R; Wang, X				Kaimal, Girija; Jones, Jacqueline P.; Dieterich-Hartwell, Rebekka; Wang, Xi			Long-term art therapy clinical interventions with military service members with traumatic brain injury and post-traumatic stress: Findings from a mixed methods program evaluation study	MILITARY PSYCHOLOGY			English	Article						Art therapy; post-traumatic stress; traumatic brain injury; active duty military; program evaluation	DISORDER; PTSD; IRAQ; AFGHANISTAN; VETERANS; ARTWORK; HEALTH	Art therapy has been found to help Veterans with symptoms of post-traumatic stress. There is however limited scholarship on the differences in outcomes based on dosage (short-term vs. long-term treatment) especially for active duty military service members (SMs). This mixed methods program evaluation study examined feedback from SMs on their experiences of art therapy in an integrative medical care center after 3 weeks of group therapy and at the end of treatment (average time of 2 years). Data included participant demographics, feedback surveys, and narrative responses from SMs experiences of art therapy. The results indicate that longer-term art therapy resulted in improved perceived outcomes compared with the short term 3-week intervention. SMs with longer time in service reported the most improved self-reported outcomes. Women SMs expressed more positive emotions during their art making. Specific themes that were effectively addressed through art therapy included frustration tolerance, grief and loss, emotion regulation, personal insight, resiliency, and trauma processing. SMs also highlighted the unique and transformative role of the relationship with the therapist with alleviation of symptoms. The findings suggest benefits to long-term art therapy including improved ability in SMs to be aware of their symptoms and communicate effectively with others.	[Kaimal, Girija; Wang, Xi] Drexel Univ, Creat Arts Therapies Dept, 1601 Cherry St 3 Q7 Parkway, Philadelphia, PA 19102 USA; [Jones, Jacqueline P.] Ft Belvoir Community Hosp, Intrepid Spirit One, Ft Belvoir, VA USA; [Jones, Jacqueline P.] US Air Force, Reg Hosp, Med Grp 96th, Invisible Wounds Ctr, Eglin AFB, FL USA; [Dieterich-Hartwell, Rebekka] Childrens Hosp Philadelphia, Policy Lab, Philadelphia, PA 19104 USA		Dieterich-Hartwell, R (corresponding author), Drexel Univ, Creat Arts Therapies Dept, 1601 Cherry St 3 Q7 Parkway, Philadelphia, PA 19102 USA.	rebekka.hartwell@gmail.com		Kaimal, Girija/0000-0002-7316-0473; Jones, Jacqueline/0000-0002-8484-2891; Wang, Xi/0000-0003-2470-4187	National Endowment for the Arts [1855995-38-C-19]	National Endowment for the Arts [1855995-38-C-19].	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Bahraini NH, 2014, PSYCHIAT CLIN N AM, V37, P55, DOI 10.1016/j.psc.2013.11.002; Baker DG, 2009, MIL MED, V174, P773; Berberian M, 2019, MED HUMANIT, V45, P353, DOI 10.1136/medhum-2018-011493; Braun V., 2012, AM PSYCHOL ASS HDB R, V2, DOI 10.1037/1362-004; Coleman JA, 2016, J AGGRESS MALTREAT T, V25, P561, DOI 10.1080/10926771.2016.1157842; Collie K, 2006, ART THER, V23, P157, DOI 10.1080/07421656.2006.10129335; Decker KP, 2018, ART THER, V35, P184, DOI 10.1080/07421656.2018.1540822; Defense & Veterans Brain Injury Center, 2017, DOD WORLDW NUMB TBI; Department of Veterans Affairs & Department of Defense, 2016, CLIN PRACT GUID MAN; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Eren N, 2014, ART PSYCHOTHER, V41, P375, DOI 10.1016/j.aip.2014.06.004; Gantt L., 2017, ART THERAPY MILITARY; Goodman D, 2016, BMJ QUAL SAF, V25, DOI [10.1136/bmjqs-2015-004480, 10.1136/bmjqs-2015-004411]; Greenwood H., 2011, INT J ART THERAPY, V16, DOI [10.1080/17454832.2011.570274, DOI 10.1080/17454832.2011.570274]; Greenwood H, 2007, PSYCHOTHER RES, V17, P588, DOI 10.1080/10503300701227550; Harris DA, 2009, ART PSYCHOTHER, V36, P94, DOI 10.1016/j.aip.2009.01.006; JAHNKE JP, 2016, INT J ART THERAPY, V21, DOI DOI 10.1080/17454832.2016.1170055; Kaimal, 2018, INT J ART THERAPY, V23, P70, DOI [10.1080/17454832.2017.1388263, DOI 10.1080/17454832.2017.1388263]; Kaimal G, 2019, ART PSYCHOTHER, V62, P28, DOI 10.1016/j.aip.2018.10.003; Kaimal G, 2015, ART THER, V32, P89, DOI 10.1080/07421656.2015.1028310; Kline A, 2010, AM J PUBLIC HEALTH, V100, P276, DOI 10.2105/AJPH.2009.162925; Kroch R., 2009, THESIS; Lande RG, 2010, ART PSYCHOTHER, V37, P42, DOI 10.1016/j.aip.2009.09.007; Landless BM, 2019, ART PSYCHOTHER, V62, P77, DOI 10.1016/j.aip.2018.10.002; Lobban J, 2016, INT J ART THER, V21, P15, DOI DOI 10.1080/17454832.2015.1124899; Lobban J., 2014, INT J ART THER, V19, P3, DOI [https://doi.org/10.1080/17454832.2012.725547, DOI 10.1080/17454832.2012.725547]; Lobban J., 2017, ART THERAPY MILITARY; McCarthy N., 2018, 2 77 MILLION SERVICE; Nanda U, 2010, ENVIRON BEHAV, V42, P376, DOI 10.1177/0013916510361874; National Endowment for the Arts, 2015, CREAT ARTS THER US T; Pachalska M., 2013, ACTA NEUROPSYCHOLOGI, V11; Palmer E., 2017, INT J ART THER INSCA, V22, P132, DOI [10.1080/17454832.2016.1277250, DOI 10.1080/17454832.2016.1277250]; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Reger MA, 2009, J CLIN PSYCHIAT, V70, P1266, DOI 10.4088/JCP.08m04361; Steenkamp MM, 2020, JAMA-J AM MED ASSOC, V323, P656, DOI 10.1001/jama.2019.20825; Summerall E. L., 2017, TRAUMATIC BRAIN INJU; Tanielian T., 2008, INVISIBLE WOUNDS MEN; U.S. Government Accountability Office, 2011, GAO1212; van der Kolk B.A., 2014, BODY KEEPS SCORE BRA; Walker MS, 2017, INT J QUAL STUD HEAL, V12, DOI 10.1080/17482631.2016.1267317; Walker MS, 2016, ART PSYCHOTHER, V49, P10, DOI 10.1016/j.aip.2016.05.015; Wall PLH, 2012, J AM PSYCHIAT NURSES, V18, P278, DOI 10.1177/1078390312460578; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	44	2	2	3	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0899-5605	1532-7876		MIL PSYCHOL	Milit. Psychol.	JAN 2	2021	33	1					29	40		10.1080/08995605.2020.1842639		DEC 2020	12	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	QB0AD	WOS:000601040100001		hybrid			2022-02-06	
J	Shin, YH; Cho, HN; Choi, BY; Kim, J; Ha, J; Suh, SW; Park, SB				Shin, Young-Hee; Cho, Hana; Choi, Bo Young; Kim, Jonghoon; Ha, Jaeyoung; Suh, Sang Won; Park, Seung Bum			Phenotypic Discovery of Neuroprotective Agents by Regulation of Tau Proteostasis via Stress-Responsive Activation of PERK Signaling	ANGEWANDTE CHEMIE-INTERNATIONAL EDITION			English	Article						ER stress response; PERK signaling; proteostasis; target Identification; tauopathies	ENDOPLASMIC-RETICULUM STRESS; PROTEIN-DISULFIDE-ISOMERASE; PHOTOAFFINITY LINKERS; ER STRESS; ERP57; PATHWAY; PATHOLOGY	Tau protein aggregates are a recognized neuropathological feature in Alzheimer's disease as well as many other neurodegenerative disorders, known as tauopathies. The development of tau-targeting therapies is therefore extremely important but efficient strategies or protein targets are still unclear. Here, we performed a cell-based phenotypic screening under endoplasmic reticulum (ER) stress conditions and identified a small molecule, SB1617, capable of suppressing abnormal tau protein aggregation. By applying label-free target identification technology, we revealed that the transient enhancement of protein kinase-like endoplasmic reticulum kinase (PERK) signaling pathway through the inhibition of stress-responsive SB1617 targets, PDIA3 and DNAJC3, is an effective strategy for regulating proteostasis in tauopathies. The molecular mechanism and the promising efficacy of SB1617 were demonstrated in neuronal cells and a mouse model with traumatic brain injury, a tauopathy known to involve ER stress.	[Shin, Young-Hee; Kim, Jonghoon; Park, Seung Bum] Seoul Natl Univ, CRI Ctr Chem Prote, Dept Chem, Seoul 08826, South Korea; [Choi, Bo Young; Suh, Sang Won] Hallym Univ, Coll Med, Dept Physiol, Chunchon 24252, South Korea; [Cho, Hana; Ha, Jaeyoung; Park, Seung Bum] Seoul Natl Univ, Dept Biophys & Chem Biol, Seoul 08826, South Korea; [Kim, Jonghoon] Soongsil Univ, Dept Chem, Seoul 06978, South Korea		Park, SB (corresponding author), Seoul Natl Univ, CRI Ctr Chem Prote, Dept Chem, Seoul 08826, South Korea.	sbpark@snu.ac.kr	; Park, Seung Bum/N-1901-2014	Shin, Young-Hee/0000-0003-0235-7081; Ha, Jaeyoung/0000-0003-4479-4466; Kim, Jonghoon/0000-0003-4951-5497; Park, Seung Bum/0000-0003-1753-1433	National Creative Research Initiative Grant through the National Research Foundation of Korea (NRF) - Korean Government (Ministry of Science ICT) [2014R1A3A2030423]; Bio & Medical Technology Development Program through the National Research Foundation of Korea (NRF) - Korean Government (Ministry of Science ICT) [2012M3A9C4048780]; BK21 Postdoctoral Fellowship Program; Fostering Core Leaders of the Future Basic Science Program/Global Ph.D. Fellowship Program [NRF-2016H1A2A1907084]	This work was supported by the National Creative Research Initiative Grant (2014R1A3A2030423) and the Bio & Medical Technology Development Program (2012M3A9C4048780) through the National Research Foundation of Korea (NRF) funded by the Korean Government (Ministry of Science & ICT). We thank Dr. Yun Kyung Kim, Korea Institute of Science and Technology (KIST) for kindly providing BiFC-tau stable HEK293 human embryonic kidney cell line. Y.-H.S. is grateful for the BK21 Postdoctoral Fellowship Program. J.H. is grateful for the Fostering Core Leaders of the Future Basic Science Program/Global Ph.D. Fellowship Program (NRF-2016H1A2A1907084).	B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Blackwood EA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08129-2; Bocai NI, 2019, J ALZHEIMERS DIS, V68, P439, DOI 10.3233/JAD-181021; Boriushkin Evgenii, 2014, J Ophthalmic Vis Res, V9, P134; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Cagnetta R, 2019, MOL CELL, V73, P474, DOI 10.1016/j.molcel.2018.11.013; Castillo V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136620; Colla E, 2012, J NEUROSCI, V32, P3306, DOI 10.1523/JNEUROSCI.5367-11.2012; Congdon EE, 2018, NAT REV NEUROL, V14, P399, DOI 10.1038/s41582-018-0013-z; Das I, 2015, SCIENCE, V348, P239, DOI 10.1126/science.aaa4484; Edwards G, 2017, BIOCHEM BIOPH RES CO, V483, P1137, DOI 10.1016/j.bbrc.2016.07.123; Foldi I, 2013, NEUROCHEM INT, V62, P58, DOI 10.1016/j.neuint.2012.11.003; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hettinghouse A, 2018, PHARMACOL THERAPEUT, V181, P34, DOI 10.1016/j.pharmthera.2017.07.011; Hetz C, 2017, NAT REV NEUROL, V13, P477, DOI 10.1038/nrneurol.2017.99; Hetz C, 2015, NAT CELL BIOL, V17, P829, DOI 10.1038/ncb3184; Hoffstrom BG, 2010, NAT CHEM BIOL, V6, P900, DOI 10.1038/NCHEMBIO.467; Iqbal K, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.225; Kaplan A, 2015, P NATL ACAD SCI USA, V112, pE2245, DOI 10.1073/pnas.1500439112; Kim J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13196; Kim J, 2014, J AM CHEM SOC, V136, P14629, DOI 10.1021/ja508343a; Kranz P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.369; Lasagna-Reeves CA, 2016, NEURON, V92, P407, DOI 10.1016/j.neuron.2016.09.022; Linz A, 2015, J BONE MINER RES, V30, P1481, DOI 10.1002/jbmr.2484; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Park H, 2017, CHEM SCI, V8, P1127, DOI 10.1039/c6sc03238a; Park H, 2016, CHEM COMMUN, V52, P5828, DOI 10.1039/c6cc01426g; Park J, 2016, ACS CHEM BIOL, V11, P44, DOI 10.1021/acschembio.5b00671; Pitale PM, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00410; Plate L, 2016, ELIFE, V5, DOI 10.7554/eLife.15550; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Rubovitch V, 2015, NEUROMOL MED, V17, P58, DOI 10.1007/s12017-015-8340-3; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Sepulveda M, 2016, PRION, V10, P50, DOI 10.1080/19336896.2015.1129485; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Starck SR, 2016, SCIENCE, V351, DOI 10.1126/science.aad3867; Tak H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081682; Torres M, 2015, J BIOL CHEM, V290, P23631, DOI 10.1074/jbc.M114.635565; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Yan W, 2002, P NATL ACAD SCI USA, V99, P15920, DOI 10.1073/pnas.252341799	42	2	2	4	8	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1433-7851	1521-3773		ANGEW CHEM INT EDIT	Angew. Chem.-Int. Edit.	JAN 25	2021	60	4					1831	1838		10.1002/anie.202013915		DEC 2020	8	Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	PT0GV	WOS:000601057400001	33210431	hybrid, Green Published			2022-02-06	
J	Levy-Lamdan, O; Zifman, N; Sasson, E; Efrati, S; Hack, DC; Tanne, D; Dolev, I; Fogel, H				Levy-Lamdan, Ofri; Zifman, Noa; Sasson, Efrat; Efrati, Shai; Hack, Dallas C.; Tanne, David; Dolev, Iftach; Fogel, Hilla			Evaluation of White Matter Integrity Utilizing the DELPHI (TMS-EEG) System	FRONTIERS IN NEUROSCIENCE			English	Article						brain; white matter; DELPHI; connectivity; imaging; network; stroke; TBI	TRANSCRANIAL MAGNETIC STIMULATION; TRAUMATIC BRAIN-INJURY; AXONAL INJURY; DIFFUSION; REPRODUCIBILITY; CLASSIFICATION; ORGANIZATION; RELIABILITY; EXPLORATION; INHIBITION	Objective The aim of this study was to evaluate brain white matter (WM) fibers connectivity damage in stroke and traumatic brain injury (TBI) subjects by direct electrophysiological imaging (DELPHI) that analyzes transcranial magnetic stimulation (TMS)-evoked potentials (TEPs). Methods The study included 123 participants, out of which 53 subjects with WM-related pathologies (39 stroke, 14 TBI) and 70 healthy age-related controls. All subjects underwent DELPHI brain network evaluations of TMS-electroencephalogram (EEG)-evoked potentials and diffusion tensor imaging (DTI) scans for quantification of WM microstructure fractional anisotropy (FA). Results DELPHI output measures show a significant difference between the healthy and stroke/TBI groups. A multidimensional approach was able to classify healthy from unhealthy with a balanced accuracy of 0.81 +/- 0.02 and area under the curve (AUC) of 0.88 +/- 0.01. Moreover, a multivariant regression model of DELPHI output measures achieved prediction of WM microstructure changes measured by FA with the highest correlations observed for fibers proximal to the stimulation area, such as frontal corpus callosum (r = 0.7 +/- 0.02), anterior internal capsule (r = 0.7 +/- 0.02), and fronto-occipital fasciculus (r = 0.65 +/- 0.03). Conclusion These results indicate that features of TMS-evoked response are correlated to WM microstructure changes observed in pathological conditions, such as stroke and TBI, and that a multidimensional approach combining these features in supervised learning methods serves as a strong indicator for abnormalities and changes in WM integrity.	[Levy-Lamdan, Ofri; Zifman, Noa; Dolev, Iftach; Fogel, Hilla] QuantalX Neurosci, Beer Yaagov, Israel; [Sasson, Efrat; Efrati, Shai] Shamir Med Ctr, Sagol Ctr Hyperbar Med & Res, Zerifin, Israel; [Efrati, Shai; Tanne, David] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Efrati, Shai; Tanne, David] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Hack, Dallas C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Tanne, David] Rambam Healthcare Campus, Stroke & Cognit Inst, Haifa, Israel		Dolev, I (corresponding author), QuantalX Neurosci, Beer Yaagov, Israel.	iftach@quantalx.com					Adalbert R, 2013, NEUROPATH APPL NEURO, V39, P90, DOI 10.1111/j.1365-2990.2012.01308.x; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bagattini C, 2019, NEUROBIOL AGING, V80, P38, DOI 10.1016/j.neurobiolaging.2019.04.008; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bordet R, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0869-6; Bortoletto M, 2015, NEUROSCI BIOBEHAV R, V49, P114, DOI 10.1016/j.neubiorev.2014.12.014; Casarotto S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010281; Chen YJ, 2017, J NEUROIMAGING, V27, P272, DOI 10.1111/jon.12404; Chung SW, 2015, BRAIN STIMUL, V8, P1010, DOI 10.1016/j.brs.2015.07.029; Di Paola M, 2010, NEUROLOGY, V74, P1136, DOI 10.1212/WNL.0b013e3181d7d8cb; Farzan F, 2010, J NEUROPHYSIOL, V104, P1339, DOI 10.1152/jn.00279.2010; Ferreri F, 2014, ARCH ITAL BIOL, V152, P216, DOI 10.12871/00039829201443; Ferreri F, 2017, NEUROSCI LETT, V647, P141, DOI 10.1016/j.neulet.2017.03.021; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; HEALY JD, 1980, J MULTIVARIATE ANAL, V10, P243, DOI 10.1016/0047-259X(80)90016-0; Hordacre B, 2019, J STROKE CEREBROVASC, V28, DOI 10.1016/j.jstrokecerebrovasdis.2019.104452; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Ilmoniemi RJ, 2010, BRAIN TOPOGR, V22, P233, DOI 10.1007/s10548-009-0123-4; Ilmoniemi RJ, 1999, CRIT REV BIOMED ENG, V27, P241; Ilmoniemi RJ, 1997, NEUROREPORT, V8, P3537, DOI 10.1097/00001756-199711100-00024; Kerwin LJ, 2018, BRAIN STIMUL, V11, P536, DOI 10.1016/j.brs.2017.12.010; Kirton A, 2010, CLIN NEUROPHYSIOL, V121, P1922, DOI 10.1016/j.clinph.2010.04.021; Kugiumtzis D, 2015, INT J NEURAL SYST, V25, DOI 10.1142/S0129065715500069; Lanza G, 2017, BEHAV NEUROL, V2017, DOI 10.1155/2017/1421326; Lanza G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/351680; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Li XO, 2014, SENSORS-BASEL, V14, P12784, DOI 10.3390/s140712784; Lioumis P, 2009, HUM BRAIN MAPP, V30, P1387, DOI 10.1002/hbm.20608; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Lotte F, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aab2f2; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Manganotti P, 2015, FUNCT NEUROL, V30, P125; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Moura LM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00445; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Opie GM, 2019, J NEUROTRAUM, V36, P2774, DOI 10.1089/neu.2018.6353; Pennisi G, 2015, CLIN NEUROPHYSIOL, V126, P851, DOI 10.1016/j.clinph.2014.09.001; Pennisi M, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8154969; Puig J, 2020, J NEUROTRAUM, V37, P1761, DOI 10.1089/neu.2019.6623; Puig J, 2013, STROKE, V44, P2016, DOI 10.1161/STROKEAHA.111.000382; Rogasch NC, 2013, HUM BRAIN MAPP, V34, P1652, DOI 10.1002/hbm.22016; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; Rossini PM, 2020, J PERS MED, V10, DOI 10.3390/jpm10020034; Salvadores N, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00451; Shafi MM, 2012, EUR J NEUROSCI, V35, P805, DOI 10.1111/j.1460-9568.2012.08035.x; Tremblay S, 2019, CLIN NEUROPHYSIOL, V130, P802, DOI 10.1016/j.clinph.2019.01.001; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang Y, 2016, PROG NEUROBIOL, V141, P45, DOI [10.1016/j.pneurobio.2016.04.00, 10.1016/j.pneurobio.2016.04.005]; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Zifman N, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00248	55	2	2	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	DEC 21	2020	14								589107	10.3389/fnins.2020.589107			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PN2EN	WOS:000604297900001	33408607	Green Published, gold			2022-02-06	
J	Palmer, D; Florida-James, G; Ball, C				Palmer, Debbie; Florida-James, Geraint; Ball, Chris			Enduro World Series (EWS) Mountain Biking Injuries: A 2-year Prospective Study of 2010 Riders	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						injury risk; racing; practice; shoulder injuries; concussion	SPORTS INJURIES; OVERUSE INJURIES; FOOTBALL PLAYERS; ILLNESSES; EPIDEMIOLOGY; CONCUSSION; GAMES; CUP	The sport of Enduro is the newest International Cycling Union sanctioned discipline in mountain biking. There are a number of studies reporting mountain biking injury to date however there are none detailing injuries in Enduro. The aim of the present study was to determine the rate, severity and nature of rider injury during the Enduro World Series. Rider injury, and race and practice exposure data were recorded prospectively during 10 events across the 2017 and 2018 seasons. Incorporating 2010 riders (males 90%; females 10%) from 46 countries. 8.9% of riders were injured with mean 12.3 days time-loss per injury. Racing injury incidence was 38.3/1000 hours and practice injury incidence 3.6/1000 hours (p=0.01). The shoulder/clavicle (12.8% of all injuries), hand (9.0%) and head (9.0%) were the most injured locations. Concussion injury was the most frequent diagnosis (7.4%), and shoulder/clavicle fractures caused the greatest burden (442 total days lost). Of those with concussion 28.6% continued racing, and 42.9% reported no time-loss (i.e. time off) post-race. In conclusion, the rate of injury during EWS race events was comparable to Downhill racing. Targeted injury prevention strategies around rider concussion education and rider qualification criteria may help to reduce the risk of injury in Enduro.	[Palmer, Debbie; Florida-James, Geraint] Edinburgh Napier Univ, Sch Appl Sci, Edinburgh, Midlothian, Scotland; [Palmer, Debbie] Univ Nottingham, Sch Med, Nottingham, England; [Palmer, Debbie] Univ Edinburgh, Moray House Sch Educ & Sport, Inst Sport PE & Hlth Sci, Edinburgh, Midlothian, Scotland; [Florida-James, Geraint] Edinburgh Napier Univ, Mt Bike Ctr Scotland, Edinburgh, Midlothian, Scotland; [Ball, Chris] Enduro World Series, Innerleithen, Scotland		Palmer, D (corresponding author), Univ Edinburgh, Moray House Sch Educ & Sport, Holyrood Rd, Edinburgh EH8 8AQ, Midlothian, Scotland.	dpalmer@ed.ac.uk			Enduro World Series	The Enduro World Series funded the two-season rider injury surveillance study.	Alonso JM, 2010, BRIT J SPORT MED, V44, P1100, DOI 10.1136/bjsm.2010.078030; [Anonymous], 2017, Br J Sports Med, V51, P872, DOI 10.1136/bjsports-2017-097508CRT5; Apsingi S, 2006, AM J SPORT MED, V34, P487, DOI 10.1177/0363546505279917; Arnold MP, 2005, ORTHOPADE, V34, P405, DOI 10.1007/s00132-005-0791-z; Ashwell Z, 2012, WILD ENVIRON MED, V23, P140, DOI 10.1016/j.wem.2012.02.002; Bahr R, 2020, BRIT J SPORT MED, V54, P372, DOI 10.1136/bjsports-2019-101969; Becker J, 2017, EXTREME SPORTS MED, P139; Becker J, 2013, BRIT J SPORT MED, V47, P458, DOI 10.1136/bjsports-2012-091755; Brooks JHM, 2006, SPORTS MED, V36, P459, DOI 10.2165/00007256-200636060-00001; Clarsen B, 2013, BRIT J SPORT MED, V47, P495, DOI 10.1136/bjsports-2012-091524; Clarsen B, 2010, AM J SPORT MED, V38, P2494, DOI 10.1177/0363546510376816; Cosgrave M, 2019, PHYS THER SPORT, V35, P99, DOI 10.1016/j.ptsp.2018.11.010; COUGHLIN SS, 1990, J CLIN EPIDEMIOL, V43, P87, DOI 10.1016/0895-4356(90)90060-3; Dvorak J, 2011, BRIT J SPORT MED, V45, P626, DOI 10.1136/bjsm.2010.079905; Emery CA, 2003, CLIN J SPORT MED, V13, P256, DOI 10.1097/00042752-200307000-00011; Enduro World Series, 2020, QUAL WORKS; Engebretsen L, 2013, BRIT J SPORT MED, V47, P407, DOI 10.1136/bjsports-2013-092380; Fuller CW, 2013, BRIT J SPORT MED, V47, P1184, DOI 10.1136/bjsports-2012-091155; Gaulrapp H, 2001, KNEE SURG SPORT TR A, V9, P48, DOI 10.1007/s001670000145; Greenland S, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1981; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harriss DJ, 2019, INT J SPORTS MED, V40, P813, DOI 10.1055/a-1015-3123; Himmelreich H, 2007, SPORTVERLETZ SPORTSC, V21, P180, DOI 10.1055/s-2007-963613; Jeys LM, 2001, BRIT J SPORT MED, V35, P197, DOI 10.1136/bjsm.35.3.197; Junge A, 2008, BRIT J SPORT MED, V42, P413, DOI 10.1136/bjsm.2008.046631; Junge A, 2015, BRIT J SPORT MED, V49, P599, DOI 10.1136/bjsports-2014-094469; Kemp S, 2017, ENGLAND PROFESSIONAL; Kirkwood L. A., 2017, J SCI CYCLING, V6, P13, DOI DOI 10.28985/171231.JSC.09; Kronisch RL, 1996, MED SCI SPORT EXER, V28, P1351, DOI 10.1097/00005768-199611000-00002; Kronisch RL, 1996, AM J SPORT MED, V24, P88, DOI 10.1177/036354659602400116; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mountjoy M, 2010, BRIT J SPORT MED, V44, P522, DOI 10.1136/bjsm.2010.071720; Palmer D, 2019, ENDURO WORLD SERIES; Palmer-Green D, 2014, BRIT J SPORT MED, V48, P650; Palmer-Green Debbie, 2013, J Sports Med (Hindawi Publ Corp), V2013, P523974, DOI 10.1155/2013/523974; Pinkbike, 2016, BRAIN INJ MOUNT BIK; Soligard T, 2017, BRIT J SPORT MED, V51, P1265, DOI 10.1136/bjsports-2017-097956; Sterne, 2003, ESSENTIAL MED STAT; Stoop R, 2019, J SPORT SCI MED, V18, P207; Willick SE, 2021, J SCI MED SPORT, V24, P1032, DOI 10.1016/j.jsams.2020.05.021	40	2	2	0	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	OCT	2021	42	11					1012	1018		10.1055/a-1320-1116		DEC 2020	7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	UZ9JF	WOS:000600591500001	33348388	hybrid, Green Published			2022-02-06	
